VAERS_ID,RECVDATE,STATE,AGE_YRS,CAGE_YR,CAGE_MO,SEX,RPT_DATE,SYMPTOM_TEXT,DIED,DATEDIED,L_THREAT,ER_VISIT,HOSPITAL,HOSPDAYS,X_STAY,DISABLE,RECOVD,VAX_DATE,ONSET_DATE,NUMDAYS,LAB_DATA,V_ADMINBY,V_FUNDBY,OTHER_MEDS,CUR_ILL,HISTORY,PRIOR_VAX,SPLTTYPE,FORM_VERS,TODAYS_DATE,BIRTH_DEFECT,OFC_VISIT,ER_ED_VISIT,ALLERGIES
0832582,09/09/2019,CA,,,,F,,no adverse effect; 53-old female received one dose of gardasil 9; This spontaneous report as received from a pharmacist refers to a 53 year old female patient.    On 2019 the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis.       On 2019 the patient experienced product administered to patient of inappropriate age.  On an unknown date the patient experienced no adverse event.    The outcome of product administered to patient of inappropriate age and no adverse event is unknown.,,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA002424,2,09/09/2019,,,,
0832583,09/09/2019,NY,,,,U,,"no adverse effects; patient received a dose of a vaccine following temperature excursion; This spontaneous report was received from a physician refers to a patient of unknown demographics.    The patient's concomitant medications, pertinent medical history, drug reactions or allergies were not reported. On 04-SEP-2019, the patient was vaccinated with improperly stored (also reported as ""following a temperature excursion"") varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dosage information, route of administration and anatomical locations were unknown) of lot # S005077 and expiry date of 19-FEB-2021 for prophylaxis (product storage error). No adverse effects reported. It was reported that the vaccine was exposed to a temperature of 15 degree Fahrenheit (F) to 46 degree Fahrenheit (-9 degree Celsius to 8 degree Celsius) (45F) for a time frame of 1 hour 30 minutes. There was no previous temperature excursion reported. Data logger was involved. No product quality complaint (PQC) was associated with this report.",,,,,,,,,U,09/04/2019,09/04/2019,0,,UNK,,,,,,US0095075131909USA002429,2,09/09/2019,,,,
0832584,09/09/2019,TX,61.0,61,,M,,"Flu Like Symptoms; This case was reported by a other health professional via call center representative and described the occurrence of influenza-like symptoms in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th July 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than a year after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional information received were as follows: The patient experienced flu like symptoms that lasted for 2 weeks. No further details were provided.  The pharmacy tech was reporting adverse event for two patients. Thsi case has been linked with US2019158355, reported by the same reporter.",,,,,,,,,Y,07/11/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832585,09/09/2019,CA,64.0,63,,M,,"Flu like symptoms; Injection Site Pain; Injection Site Swelling; Red Circle at the Injection Site; Area was hot as fire and swollen; Hurt muscles; shivering; headache; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles. Previously administered products included Zostavax.   On 27th August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 27th August 2019, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms, injection site pain, injection site swelling, injection site erythema, injection site warmth, muscle pain, shivering and headache. On an unknown date, the outcome of the influenza-like symptoms, injection site pain, injection site swelling, injection site erythema, injection site warmth, muscle pain, shivering and headache were not recovered/not resolved.   It was unknown if the reporter considered the influenza-like symptoms, injection site pain, injection site swelling, injection site erythema, injection site warmth, muscle pain, shivering and headache to be related to Shingrix.  Additional details were provided as follows: The patient had the Zostavax vaccine many years ago and he got shingles later. The patient received Shingrix in his left arm at physician's office. The patient immediately experienced pain, swelling and a red circle at the injection site. The area was hot as fire and swollen. He also reported about hurt muscles, flu like symptoms, shivering and headache. The patient stated, these side effects were worse than when he had shingles previously. The experience was so painful that he would not be getting the 2nd dose of Shingrix. All of his reactions continued and were unchanged. The patient consented to follow up and provided his physician's address. This case has been linked to US2019158373, reported by the same reporter.",,,,,,,,,N,08/27/2019,08/27/2019,0,,PVT,,,,Medical History/Concurrent Conditions: Shingles,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832586,09/09/2019,PA,66.0,66,,U,,"Body aches; Tired/ exhaustion; This case was reported by a consumer and described the occurrence of general body pain in a 66-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on unknown date, refer case US2019AMR157415).   On 27th August 2019, the patient received the 2nd dose of Shingrix. In August 2019, less than a week after receiving Shingrix, the patient experienced general body pain and tiredness. On an unknown date, the outcome of the general body pain and tiredness were not recovered/not resolved.   It was unknown if the reporter considered the general body pain and tiredness to be related to Shingrix.  Additional details were provided as follows: The patient experienced body aches and so tired. The patient asked how long it would last.",,,,,,,,,N,08/27/2019,08/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/06/2019,,,,
0832587,09/09/2019,NY,,,,F,,"Shingles; This case was reported by a physician via sales rep and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 30 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. Approximately, a month post first dose, the patient experienced shingles.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/06/2019,,,,
0832588,09/09/2019,FL,,,,F,,"Redness on her arm near the injection site; This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a 74-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced erythema of extremities. On an unknown date, the outcome of the erythema of extremities was recovered/resolved.   It was unknown if the reporter considered the erythema of extremities to be related to Influenza vaccine Quadrivalent unspecified season.  Additional information received were as follows: The age at vaccination was not reported. The patient experienced redness on her arm near the injection site. This case is linked to the case US2019158360, reported by the same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/06/2019,,,,
0832589,09/09/2019,NJ,73.0,73,,F,,"Sore Arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th June 2019, the patient received the 1st dose of Shingrix. On 28th June 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. On 1st July 2019, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left arm. The patient experienced sore arm which resolved within 3 days. For tolerance to 2nd dose, refer linked case US2019158370.",,,,,,,,,Y,06/28/2019,06/28/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/06/2019,,,,
0832590,09/09/2019,CT,,,,F,,"Full body paresthesia; This case was reported by a physician via sales rep and described the occurrence of paresthesia generalized in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced paresthesia generalized. Shingrix was discontinued. On an unknown date, the outcome of the paresthesia generalized was recovered/resolved.   It was unknown if the reporter considered the paresthesia generalized to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported but it could be 79 years or 80 years. Approximately 4 months before the date of reporting, in 2019, the patient received Shingrix. The patient experienced full body paresthesia which lasted about 2 days. The patient was fully recovered but refused to receive 2nd dose. The reporter denied for follow up contact.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/06/2019,,,,
0832591,09/09/2019,CT,17.0,,,F,,"Firm lump at the site of injection; This case was reported by a physician via sales rep and described the occurrence of injection site lump in a 17-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, 30 days after receiving Bexsero, the patient experienced injection site lump. On an unknown date, the outcome of the injection site lump was recovered/resolved.   It was unknown if the reporter considered the injection site lump to be related to Bexsero.  Additional details were reported as follows: The patient experienced a residual firm lump at the site of injection post 1 month. At 2 months, no lump. No pain associated with lump at the 1 month post injection. Patient received 2nd dose 2 months post 1st injection. No side effects after 2nd injection.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/06/2019,,,,
0832592,09/09/2019,,,,,M,,"synovitis in his first metatarsal of his left hand; inappropriate schedule of vaccine; This case was reported by a physician via sales rep and described the occurrence of synovitis in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of synovitis (received 1st dose on 19th April 2018, refer case US2018GSK169735).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced synovitis and drug dose administration interval too long. On an unknown date, the outcome of the synovitis and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the synovitis to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The health care professional has self report of synovitis in his first metatarsal of his left hand after receiving his 2nd dose of Shingrix. He had it evaluated by a rheumatologist and it did not appear to the rheumatoid arthritis. He had a similar adverse event after 1st dose however it happened on his right hand. That was previously reported. His 2nd dose occurred 1 year and 2 months after his 1st dose.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/06/2019,,,,
0832593,09/09/2019,WA,,,,F,,"Pain in the muscle in arm; This case was reported by a consumer and described the occurrence of muscle pain in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced muscle pain. The patient was treated with ibuprofen and non-drug therapy (Ice Pack (No Medication)). On an unknown date, the outcome of the muscle pain was not recovered/not resolved.   It was unknown if the reporter considered the muscle pain to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. About 3 months ago, the patient received Shingrix. At the time of reporting, the patient still had pain in the muscle in my arm. The patient asked what could she do and should she still receive the 2nd vaccination. The patient had already iced, ibuprofen, massages and moved it.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832594,09/09/2019,TX,,,,U,,"suspected vaccination failure; Shingles outbreak; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 65-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (since puberty).   On an unknown date, the patient received the 1st dose of Shingrix. In February 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and less than a year after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient suffers from shingles since puberty. The patient received 1st Shingrix vaccine in 2018. The patient received 2nd Shingrix vaccine in February 2019. After that the patient had shingles outbreak on leg. This case was considered as suspected vaccination failure since the details regarding completion of time to onset and laboratory confirmation were unknown at the time of reporting.",,,,,,,,,U,02/01/2019,,,,UNK,,,,Medical History/Concurrent Conditions: Shingles (since puberty),,USGLAXOSMITHKLINEUS2019AM,2,09/06/2019,,,,
0832595,09/09/2019,HI,,,,U,,"extremely irritated left eye (red); eye infection; left eye with possibly herpes zoster; irritation in left eye; This case was reported by a consumer via call center representative and described the occurrence of ophthalmic herpes zoster in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in May 2019, but had no problems).   On 26th August 2019, the patient received the 2nd dose of Shingrix. On 28th August 2019, 2 days after receiving Shingrix, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant), eye irritation and eye infection. On 29th August 2019, the patient experienced eye red. The patient was treated with artificial tears nos (Artificial Tears) and antivirals nos (Anti-Viral Medicine (Nos)). On an unknown date, the outcome of the ophthalmic herpes zoster, eye irritation, eye red and eye infection were unknown.   It was unknown if the reporter considered the ophthalmic herpes zoster, eye irritation, eye red and eye infection to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient started having irritation in left eye, which the patient believed was a foreign body. The patient was tried flushing with artificial tears to no avail. Three days after vaccination, the patient woke up with an extremely irritated left eye and the eye was red. On 30th August 2019, the patient went to the eye physician who diagnosed the patient's left eye with possibly herpes zoster and was treating for an eye infection to be followed by some anti-virals based on the patient's response. The patient read the Shingrix literature and understand it did not contain a virus only proteins to mimic an immune response. The patient asked that, was there any reported side effects of eye infections was bacterial or viral with the administration of Shingrix.",,,,,,,,,U,08/26/2019,08/28/2019,2,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/06/2019,,Y,,
0832596,09/09/2019,,,,,U,,"pneumonia; This case was reported by a consumer via interactive digital media and described the occurrence of pneumonia in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, unknown after receiving Flu vaccine, the patient experienced pneumonia (serious criteria GSK medically significant). Flu vaccine was discontinued. On an unknown date, the outcome of the pneumonia was unknown.   It was unknown if the reporter considered the pneumonia to be related to Flu vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The Flu shot give pneumonia to the patient 5 years in row. The patient never took it again and never had the flu. This case has been linked with case US2019AMR153058, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/06/2019,,,,
0832597,09/09/2019,,,,,F,,"acute viral syndrome; This subject was enrolled in a blinded study. The subject received daprodustat (gsk1278863) vs rhepo from 27th July 2018, for chronic renal failure anemia.   On 12th June 2019, 320 days after the first dose of daprodustat (gsk1278863) vs rhepo, the subject developed mild - grade 1 weakness generalized. Serious criteria included clinically significant/intervention required. Daprodustat (gsk1278863) vs rhepo was continued with no change. The outcome of weakness generalized was recovered/resolved on 16th June 2019.   The investigator considered that there was no reasonable possibility that the weakness generalized may have been caused by daprodustat (gsk1278863) vs rhepo.  Follow up information received on 03 Jul 2019: The subject's demographics age sex (Female) and weight (88.1 kg) were included. This 71 year old female subject was enrolled in a blinded study. Concurrent medical conditions End stage renal disease and Diabetic peripheral neuropathy were included. The Seriousness Criteria of the event Generalized weakness is updated to requires or prolongs hospitalization (Previously it was clinically significant) Other possible cause of the event Generalized weakness included medical condition (End stage renal disease and Diabetic peripheral neuropathy). Concomitant medications sevelamer carbonate, pantoprazole dr, gabapentin, docusate, diltiazem and apixaban were included. Treatment medications 0.9 percent sodium chloride, acetaminophen, albumin, ceftriaxone, hydrocodone-acetaminophen 5-325, insulin glargine, lidocaine 5% patch, senna, simethicone and vancomycin were included. Other Relevant Risk Factors were none.  Relevant lab: On 14 Jun 2019: labs baseline for patient glucose 175, 307. On 16 Jun 2019: labs baseline for patient except glucose 169. On 15 Jun 2019: normal x ray for pelvis, left. Elbow, right. Elbow, lumbar x ray no evidence of acute trauma. Right and left knee no evidence of fracture were included.  Narrative remark: 14 jun2019 subject went to  emergency room and complained of generalized weakness and myalgia's x2 days since receiving shingles vaccine. Upon admission, patient started vancomycin or ceftriaxone, discharged on 14 Jun 2019 low suspicion for bacterial process. Patient missed dialysis of 11 Jun2019, 13 Jun2019 and 15 Jun2019. patient reported fall at home, patient monitored closely at hospital due to high fall risk. Patient denied head strike. Knee, elbows, pelvis and lumber spine x ray completed. Patient discharged with pain controlled, per oral tolerated, worked with physical therapy or occupational therapy.  Query responses: The site confirmed that the primary discharged diagnosis was generalized weakness. Thought to be a result of Acute Viral Syndrome indicated as separate AE(Adverse event).  Follow up information received on 05 Jul 2019: Verbatim was updated to acute viral syndrome (previously reported generalized weakness). Relevant assessment: On 15 Jun 2019 total bilirubin was 0.1, Alanine aminotransferase was 13, Aspartate aminotransferase was 17. On an unknown date albumin was 3.1. Query response: Site confirmed that albumin for subject was baseline 3.1, but low comparatively to reference ranges. No loss of consciousness, arrhythmias or seizures noted by subject or discharge summary. Glucose reference range was 70-100 mg/dL.  Follow up information received on 22 Jul 2019 : Shingrix was updated as concomitant medication. Narrative remark: 14 Jun2019 subject went to emergency room and complained of generalized weakness and myalgia's x2 days since receiving shingles vaccine (Shingrix).  Follow up information received on 24 Jul 2019 and 26 Jul 2019 : The adverse event (Acute viral syndrome) form includes following information : Narrative remarks : Weakness and myalgias were deemed likely due to recent shingles vaccine (Shingrex), Per discharge summary. Patient presented with general weakness & myalgias x 2days, post-shingrix dose. Patient was admitted and monitored. Influenza panel was negative and workout unremarkable. Symptoms improved with care and deemed likely due to shingrix. Query response from site : The site confirmed that shingles vaccine (SHINGRIX) was likely the cause of the weakness and myalgias patient discharge summary shows that.  Follow up information received on 14 Aug 2019 : The intensity of the event (Acute viral infection) was updated to Moderate-Grade 2 (Previously reported as Mild Grade-1). Query response from site : The event term was verified and updated.  Follow up information received on 20 Aug 2019 : Shingrex updated as co suspect medication. The subject was vaccinated with shingrex on 12 Jun 2019 the dose was 50 ug single. The other possible cause for the event was updated as concomitant medication and medical condition. (Previously reported only medical condition). Narrative remarks : 14 Jun2019 subject went to  emergency room and complained of generalized weakness and myalgia's x2 days since receiving shingles vaccine (Shingrex). Query response from site : The site confirmed that fall was caused by generalized weakness -fall was reported as AE and generalized weakness reported as AE .; Reporter's Comments: The company considers that there was no reasonable possibility that the event viral infection may have been caused by the study drug. The patient's medical history/risk factors could be considered as confounding factors. The co-medication (shingrix) could be considered as alternative cause.",,,,,Y,,,,Y,07/27/2018,06/12/2019,320,"Test Date: 20190615; Test Name: Alanine aminotransferase; Result Unstructured Data: Test Result: 13, Test Result Unit: unknown; Test Date: 20190615; Test Name: Aspartate aminotransferase; Result Unstructured Data: Test Result: 17, Test Result Unit: unknown; Test Name: Albumin; Result Unstructured Data: Test Result: baseline 3.1, Test Result Unit: unknown; Test Date: 20190615; Test Name: Bilirubin total; Result Unstructured Data: Test Result: 0.1, Test Result Unit: unknown; Test Date: 20190614; Test Name: Glucose; Result Unstructured Data: Test Result: 175, 307 (Base line), Test Result Unit: mg/dL; Test Date: 20190616; Test Name: Glucose; Result Unstructured Data: Test Result: 169 (Baseline except glucose), Test Result Unit: mg/dL; Test Date: 20190615; Test Name: X-ray of lumbar spine; Result Unstructured Data: Test Result: No evidence of acute trauma., Test Result Unit: unknown; Test Date: 20190615; Test Name: Lower limb X-ray; Result Unstructured Data: Test Result: No evidence of fracture were included., Test Result Unit: unknown; Test Date: 20190615; Test Name: Upper limb X-ray; Result Unstructured Data: Test Result: No evidence of acute trauma, Test Result Unit: unknown; Test Date: 20190615; Test Name: X-ray of pelvis and hip; Result Unstructured Data: Test Result: No evidence of acute trauma., Test Result Unit: unknown",UNK,,SEVELAMER CARBONATE; POLYETHYLENE GLYCOL 3350; PANTOPRAZOLE DR; GABAPENTIN; DOCUSATE; APIXABAN; DILTIAZEM Daprodustat; Epoetin alfa; Darbepoetin alfa,Diabetic peripheral neuropathy; End stage renal disease; Myalgia; Weakness,,,USGLAXOSMITHKLINEUS2019GS,2,09/06/2019,,,Y,
0832598,09/09/2019,MO,,,,F,,"Bad reaction; This case was reported by a consumer via call center representative and described the occurrence of adverse reaction in a child female patient who received DTPa (DTPa vaccine) for an unknown indication.   On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to DTPa vaccine.  Additional details were provided as follows: The reporter was the patient's mother. The age at vaccination was not reported. The patient's mother reported that, the patient previously had bad reaction to the immunization, but did not stated to which vaccine, patient had a bad reaction. The reporter was trying to find out if the Whooping cough vaccine was available as an individual vaccine. The reporter needed to get updates on dtap and meningococcal vaccine. No additional information was provided.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832599,09/09/2019,IN,,,,F,,"Rash in a few different areas of body; This case was reported by a pharmacist via call center representative and described the occurrence of generalized rash in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced generalized rash. On an unknown date, the outcome of the generalized rash was recovered/resolved.   It was unknown if the reporter considered the generalized rash to be related to Shingrix.  Additional information received were as follows: The caller was a pharmacist and was calling on behalf of his friend that was the patient. The age at vaccination was not reported. The patient received Shingrix shot at pharmacy a little bit more than two months ago. The patient experienced rash in a few different areas of her body. The patient had recovered from the rash. It took a few days to clear up. This case has been linked with US2019157515, reported by the same reporter.",,,,,,,,,Y,,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832600,09/09/2019,TX,72.0,72,,F,,"Hematoma; Bluish Bruise hard and has a nodule; Bluish Bruise hard and has a nodule; Bluish Bruise hard and has a nodule; This case was reported by a pharmacist via call center representative and described the occurrence of injection site hematoma in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number 3LL4P, expiry date 19th October 2021) for prophylaxis.   On 26th August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In August 2019, less than a week after receiving Shingrix, the patient experienced injection site hematoma, injection site bruising, injection site induration and injection site nodule. On an unknown date, the outcome of the injection site hematoma, injection site bruising, injection site induration and injection site nodule were not recovered/not resolved.   It was unknown if the reporter considered the injection site hematoma, injection site bruising, injection site induration and injection site nodule to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left deltoid. The pharmacist reported that her patient who was a nurse presented to her pharmacy a day before the reporting date with a hematoma on the upper arm of injection.  The hematoma described as a bluish bruise, hard and had a nodule. The pharmacist would call back at a more convenient time to report other Shingrix adverse events.",,,,,,,,,N,08/26/2019,08/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832601,09/09/2019,TX,69.0,69,,F,,"Rash on her entire torso; This case was reported by a other health professional via call center representative and described the occurrence of rash in a 69-year-old female patient who received Herpes zoster (Shingrix) (batch number unknown, expiry date 26th August 2020) for prophylaxis.   On 26th August 2019, the patient received the 1st dose of Shingrix .5 ml. In August 2019, less than a week after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were reported as follows: Patient experienced rash on her entire torso. No further details were provided.  The case has been linked with case US2019158353, reported by same reporter.",,,,,,,,,U,08/26/2019,08/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832602,09/09/2019,SC,53.0,53,,F,,"Redness at injection site; Tenderness at injection site; Peeling skin; Painful / Hurt like crazy; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd June 2019, the patient received the 1st dose of Shingrix. In June 2019, 3 days after receiving Shingrix, the patient experienced injection site erythema, injection site tenderness, skin peeling and pain. On an unknown date, the outcome of the injection site erythema, injection site tenderness, skin peeling and pain were recovered/resolved.   It was unknown if the reporter considered the injection site erythema, injection site tenderness, skin peeling and pain to be related to Shingrix.  Additional details were provided as follows: The pharmacist stated that the patient received Shingrix about three days later she had redness and tenderness at the site, which pharmacist states looked normal. Then about 7 days after the injection the patient experienced skin peeling at the site, which was painful and hurt like crazy. The pharmacist stated that the symptoms were resolved. The reporter consented to follow up. The pharmacist grants permission to follow up.",,,,,,,,,Y,06/22/2019,06/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832603,09/09/2019,NJ,74.0,74,,F,,"Injection site soreness; Body aches; chills; nausea; Slight increase in blood pressure; increase in pulse rate; headache; Feeling of being unwell; Heart is pounding; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received on 28th June 2019, refer linked case US2019AMR158858).   On 28th August 2019, the patient received the 2nd dose of Shingrix. On 28th August 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, general body pain, chills, nausea, increased blood pressure, pulse rate increased, headache, feeling unwell and heart pounding. On an unknown date, the outcome of the injection site pain was recovered/resolved and the outcome of the general body pain, chills and nausea were not recovered/not resolved and the outcome of the increased blood pressure, pulse rate increased, headache, feeling unwell and heart pounding were unknown.   It was unknown if the reporter considered the injection site pain, general body pain, chills, nausea, increased blood pressure, pulse rate increased, headache, feeling unwell and heart pounding to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left arm. The patient experienced a feeling of being unwell which includes body aches, chills, nausea and headache. The patient stated that her heart was pounding with a slight increase in blood pressure and also reported increase in pulse rate.  The reporter consented to follow up.",,,,,,,,,N,08/28/2019,08/28/2019,0,"Test Date: 20190828; Test Name: Blood pressure; Result Unstructured Data: Test Result: increased, Test Result Unit: mm Hg; Test Date: 20190828; Test Name: Pulse rate; Result Unstructured Data: Test Result: increased, Test Result Unit: beats/min",PHM,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832604,09/09/2019,CA,63.0,63,,F,,"Injection Site Pain; Injection Site Swelling; Red circle at the injection site; Area was hot as fire; hurt muscles; flu like symptoms; shivering; headache; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 27th August 2019, immediately after receiving Shingrix, the patient experienced injection site pain, injection site swelling, injection site erythema, injection site warmth, muscle pain, influenza-like symptoms, shivering and headache. On an unknown date, the outcome of the injection site pain, injection site swelling, injection site erythema, injection site warmth, muscle pain, influenza-like symptoms, shivering and headache were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, injection site swelling, injection site erythema, injection site warmth, muscle pain, influenza-like symptoms, shivering and headache to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left arm in her physician's office. The patient experienced pain, swelling and a red circle at the injection site. Less than a day after receiving Shingrix, the area was hot as fire and swollen. Less than a day after receiving Shingrix, the patient experienced hurt muscles, flu like symptoms, shivering and a headache. The patient's reactions continue to be unchanged. The reporter consented to follow up. This case has been linked with US2019158372, reported by the same reporter.",,,,,,,,,N,08/27/2019,08/27/2019,0,,PVT,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832605,09/09/2019,AK,,,,F,,"Rash; Blisters (fluid filled); This case was reported by a other health professional via call center representative and described the occurrence of rash in a 87-year-old female patient who received Herpes zoster (Shingrix) (batch number JC55P, expiry date 20th April 2021) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced rash and blistery rash. On an unknown date, the outcome of the rash and blistery rash were unknown.   It was unknown if the reporter considered the rash and blistery rash to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The pharmacy intern called to report that the patient experienced rash within a few hours after receiving first dose of Shingrix. Within 7 days after receiving Shingrix, the patient experienced developed blisters (fluid filled). The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832606,09/09/2019,VA,67.0,67,,M,,"pain at injection site / feels like a bee sting; indentation in skin at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 67-year-old male patient who received Herpes zoster (Shingrix) (batch number 4LH35, expiry date 11th September 2021) for prophylaxis.   On 16th July 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In August 2019, 35 days after receiving Shingrix, the patient experienced injection site pain and injection site indentation. On an unknown date, the outcome of the injection site pain and injection site indentation were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain and injection site indentation to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on the right deltoid. Approximately 1 week before the date of reporting, the patient developed pain at the injection site that he stated felt like a bee sting.  The patient also experienced an indentation at the injection site. The caller did not provide any additional information.",,,,,,,,,N,07/16/2019,08/01/2019,16,,PHM,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832607,09/09/2019,OK,,,,F,,"non therapy-responder; This case was reported by a pharmacist via call center representative and described the occurrence of therapy non-responder in a 57-year-old female patient who received Hepatitis B vaccine for prophylaxis.   Co-suspect products included Hepatitis B vaccine for prophylaxis and Hepatitis B vaccine for prophylaxis.   On an unknown date, the patient received the 1st dose of Hepatitis B vaccine, the 2nd dose of Hepatitis B vaccine and the 3rd dose of Hepatitis B vaccine. On an unknown date, less than a year after receiving Hepatitis B vaccine, Hepatitis B vaccine and Hepatitis B vaccine, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown.   It was unknown if the reporter considered the therapy non-responder to be related to Hepatitis B vaccine, Hepatitis B vaccine and Hepatitis B vaccine.  Additional information received were as follows: The age at vaccination was not reported. The healthcare professional reported that the patient received the 3 dose series of Hepatitis B vaccine this past year. The doctor said that the patient had no antibodies against Hepatitis B vaccine, which led the patient to be therapy non-responder. The reporter consented to follow up.      Lab Comments: Lab test done on an unknown date",,,,,,,,,U,,,,"Test Name: Hepatitis B antibody; Result Unstructured Data: Test Result: no antibodies, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832608,09/09/2019,NJ,79.0,79,,F,,"Soreness when arm is raised/Pain at site and area when arm is raised; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 79-year-old female patient who received Herpes zoster (Shingrix) (batch number GZ29L, expiry date 23rd May 2021) for prophylaxis.   On 31st July 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were reported as follows: The pharmacist asked if any information available as the patient experienced soreness and pain at the site and area when patient raises arm. The patient has to support arm.  The reporter had consented to follow up.",,,,,,,,,U,07/31/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832609,09/09/2019,VA,,,,F,,"Heptatis Ainfection; Incomplete course of vaccination; This case was reported by a consumer via call center representative and described the occurrence of hepatitis a in a adult female patient who received HAV (Havrix adult) for prophylaxis.   Co-suspect products included HAV (Havrix adult) for prophylaxis.   On an unknown date, the patient received the 1st dose of Havrix adult and the 2nd dose of Havrix adult. On an unknown date, several years after receiving Havrix adult and not applicable after receiving Havrix adult, the patient experienced hepatitis a and incomplete course of vaccination. On an unknown date, the outcome of the hepatitis a and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the hepatitis a to be related to Havrix adult.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the vaccine years ago and experienced hepatitis a. Till the time of reporting the patient not receive the booster dose which led to incomplete course of vaccination. The patient stated that the health department told her to just get the booster vaccination, but the CDC told her to get the Havrix series again.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832610,09/09/2019,PA,66.0,66,,M,,"flu like symptoms; This case was reported by a physician via sales rep and described the occurrence of influenza-like symptoms in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th August 2019, the patient received the 1st dose of Shingrix. On 28th August 2019, 1 days after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The report was notifed by friend of family via text, stated that he received Shingrix he had flu like symptoms.  No other details were shared by the friend. The reporter stated that she received a text last evening from the friend.",,,,,,,,,U,08/27/2019,08/28/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832611,09/09/2019,NJ,,,,U,,"Flu-like symptoms; Swelling; Malaise; This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.  On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms, swelling and malaise. On an unknown date, the outcome of the influenza-like symptoms, swelling and malaise were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, swelling and malaise to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not applicable for this report. The number of patient's have reported having general flu-like symptoms, malaise, swelling, after receiving a dose of Shingrix. The symptoms had resolved. The reporter did not consent to followup. No specific patient or vaccine details available.",,,,,,,,,Y,,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832613,09/09/2019,ID,,59,,M,,"itchy rash; This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In December 2018, the patient received the 2nd dose of Shingrix (intramuscular). In January 2019, between 1 and 2 months after receiving Shingrix, the patient experienced itchy rash. The patient was treated with dermatologicals nos (Calamine Lotion). On an unknown date, the outcome of the itchy rash was recovered/resolved.   It was unknown if the reporter considered the itchy rash to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. In mid December 2018, the patient received Shingrix. In late January 2019, the patient experienced experienced itchy rash around the inside and back of his knees that resolved after a few days and using Calamine lotion. The patient reported that the rash would occur every 2 to 3 weeks between January 2019 and May 2019, but had not recurred since May 2019. The reporter consented to follow up.",,,,,,,,,Y,12/01/2018,01/01/2019,31,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/06/2019,,,,
0832614,09/09/2019,NJ,74.0,74,,F,,"felt like a vegetable/wet washcloth; slept most of the day; fatigue; arm is red; This case was reported by a consumer via call center representative and described the occurrence of feeling abnormal in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax (received 2 years ago).   On 28th August 2019, the patient received Shingrix. On 28th August 2019, less than a day after receiving Shingrix, the patient experienced feeling abnormal, sleepiness, fatigue and erythema of extremities. On 30th August 2019, the outcome of the feeling abnormal was recovered/resolved. On an unknown date, the outcome of the sleepiness was recovered/resolved and the outcome of the fatigue was unknown and the outcome of the erythema of extremities was not recovered/not resolved.   It was unknown if the reporter considered the feeling abnormal, sleepiness, fatigue and erythema of extremities to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left deltoid and felt like a vegetable, wet washcloth, she slept most of the day. The 2nd day she was still fatigued, but able to walk outside for 25 minutes. At the time of reporting she was feeling better. Her arm was red. The reporter did not consent to follow up.",,,,,,,,,N,08/28/2019,08/28/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832615,09/09/2019,KY,74.0,74,,M,,"Iritis; blood shot eyes; This case was reported by a pharmacist via call center representative and described the occurrence of iritis in a 74-year-old male patient who received Herpes zoster (Shingrix) (batch number YA724, expiry date unknown) for prophylaxis.   Concomitant products included triamcinolone (Triamcinolone Cream).   On 31st July 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 9th August 2019, 9 days after receiving Shingrix, the patient experienced iritis and bloodshot eye. The patient was treated with steroids nos (Oral Steroid (Brand Unknown)) and difluprednate (Durezol Eye Drops). On an unknown date, the outcome of the iritis was not recovered/not resolved and the outcome of the bloodshot eye was unknown.   The reporter considered the iritis and bloodshot eye to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left arm. The patient experienced blood shot eyes (may had been a little before this date, but this was the date it was diagnosed) and progressed into iritis, which was pretty severe. The patient's eye doctor believes it was related to the Shingrix. The patient was prescribed an oral steroid and Durezol 0.05 percent eye drops, 1 drop each eye four times a day until resolved. The patient was also using topical triamcinolone cream all over body (for a previous diagnosis, which they held for the vaccine but had been using this month a lot). The oral medication was unknown. The reporter consented to follow up. The expiry date was unknown.",,,,,,,,,N,07/31/2019,08/09/2019,9,,UNK,,TRIAMCINOLONE CREAM; TRIAMCINOLONE CREAM,,,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832616,09/09/2019,OK,,,,U,,"administered a Flublok to a 14 year old; Initial information received on 28-Aug-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 14 years old patient who received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot QFAA1906 via unknown route.  It was a case of potential medication error due to Inappropriate age at vaccine administration.  It was unknown whether adverse event was experienced or not.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA244102,2,09/04/2019,,,,
0832617,09/09/2019,OH,18.0,18,,F,,"gave expired Menactra to a patient and was expired 3 days; Initial information received on 28-Aug-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves an 18 years old female patient who received an expired dose of vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA]   The patient's medical history, medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.   On 27-Aug-2019, the patient received a single 0.5 ml booster dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U5986AA (expiry date: 24-Aug-2019) via intramuscular route in the left deltoid.  It was a case of actual medication error due to expired vaccine used.  It was unknown whether adverse event was experienced by the patient or not. .  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,08/27/2019,,,,UNK,,,,,,USSA2019SA244485,2,09/04/2019,,,,
0832618,09/09/2019,PA,,7,,M,,"Quadracel was administered to a 7 years old/no AE; Initial information received on 28-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 7 years old male patient who received vaccine DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3), VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (PROQUAD) for Immunisation; and HEPATITIS A VACCINE (HEPATITIS A VACCINE) for Immunisation.  On 23-Aug-2019, the patient received a 0.5 ml dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE lot C5635AA via intramuscular route in the right deltoid.  It was a case of actual medication error due to Inappropriate age at vaccine administration.   Patient experienced no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/23/2019,,,,UNK,,PROQUAD; HEPATITIS A VACCINE,,,,USSA2019SA244512,2,09/04/2019,,,,
0832619,09/09/2019,IL,,82,,F,,"Fluzone Highdose was administered on august 27th 2019 to patient, however doctor realize the dose was expired/No AE; Initial information received on 28-Aug-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an 82 years old female patient who received an expired dose of vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (pre-filled syringe).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Patient was not on any concomitant medication.  On 27-Aug-2019, the patient received a single 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ036AB (expiry date: 09-May-2019) via intramuscular route in the left deltoid.  It was a case of actual medication error due to expired vaccine used.  It was reported that no adverse event was experienced.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,08/27/2019,,,,UNK,,,,,,USSA2019SA244551,2,09/04/2019,,,,
0832620,09/09/2019,NY,,,,F,,"patient received Menactra twice within a week apart/ NO AE; Initial information received on 28-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 15 years old female patient who received 0.5 mL dose of vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] twice within a week apart lot U6365AA, expiry date: 23-FEB-2021 via intramuscular route in the left deltoid on 20-Aug-2019 and 28-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No other vaccines received.   It was a case of actual medication error due to extra dose administered.  It was unknown whether the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,08/20/2019,,,,UNK,,,,,,USSA2019SA244566,2,09/05/2019,,,,
0832621,09/09/2019,ME,56.0,56,,M,,"Ultimate diagnosis:  acute disseminated encephalitis  Event Details July 1, 2019, 9:20 PM ? Headache behind left eye came on over the course of about 10 minutes, followed by intense nausea, beginning about an hour later.  About mid-way through the nausea, left facial numbness began, starting at left tip of tongue, and progressing over the course of less than an hour to the left upper palate, upper and lower left teeth, nose, check, forehead, scalp, and jaw, to the front of the left ear.  Sense of taste on the left side of the tongue disappeared, as well.  Headache abated at or before start of numbness.  No loss of coordination, loss of strength, confusion, slurring, drooping of muscles or other symptoms beyond those described above.  Went to urgent care after finding that the numbness persisted into the following morning.  Urgent care staff directed me to the emergency room.  Will begin a course of 4 days of IV steroid.  Currently pending insurance coordination and facility scheduling.",,,,,,,,,N,05/22/2019,07/01/2019,40,"CT scan (with and without contrast) showed ?normal sulcal pattern and gyro configuration.  Gray and white matter differentiation is normal.  No parenchymal mass or hemorrhage is seen.  Sinuses show opacification of the ethmoid air cells and left sphenoid sinus.  Aorta is normal in caliber.  Brachiocephalic artery, left subclavian artery and left carotid artery are widely patent.  Both common carotid arteries are widely patent in the neck with widely patent carotid bifurcations.  Internal carotid arteries are widely patent to the skull base.  The petrous portion of the carotid arteries widely patent.  ACAs, MCAs, and PCAs are widely patent.  Both vertebral arteries are widely patent.  The basilar artery is a small vessel, but is widely patent.  Dural venous sinuses appear to enhance appropriately.  No parenchymal mass is seen.  Salivary tissue appears normal.  No cervical adenopathy is seen.  Thyroid appears normal.  Impression:  Sphenoid and ethic sinus disease, but negative CT angiography of the head and neck.?  Tick-borne Ab Panel, Serum:  Negative for ehrlichia, anaplasmosis, babesiosis, and Lyme.  ESR ( sed rate ) Value 16  ANA panel (EIA) negative  Antineurotrophilic cytoplasmic AB ( anca neutrophilic pANCA cANCA ) Negative for cANCA and pANCA patterns by immunofluorescence  Lyme disease antibody, Western Blot IGG immunoblot:  negative IGG detected against:  none  IGM immunoblot:  negative IGM detected against:  none  Brain MRI with and without contrast showed ?There is normal sulcal  pattern and gyro configuration.  No cortical encephalomalacia seen.  There is a single 10 mm white matter lesion in the centrum semiovale on the right radiating outward from the corpus callous suggestive of demyelinating plaque.  There is a large lesion in the left middle cerebral peduncle.  Tiny 1-2 mm lesions are seen in the frontal white matter and occipital white matter.  There appears to be subcortical U-fiber involvement in the frontal lobes bilaterally.  The appearance is consistent with demyelination and multiple sclerosis, particularly at the left middle cerebellar peduncle lesion.  No other abnormal enhancement is seen.  Trigeminal nerves appear normal.  Meckel?s cave appears normal.  Cavernous sinus appears normal.  Incidental developmental venous anomaly seen in the right cerebellar hemisphere.?    Vitamin B12 value 359  Vitamin D 25 - OH value 25  T event - holter monitor report:  ?1.  The basic rhythm is sinus.  There is no atrial fibrillation.  2.  Sinus node function is normal with average rate of 67 beats per minute.  No sinus pauses.  Sinus bradycardia is present 32% of beats.  3.  AV conduction normal.  4a  Supraventricular arrhythmia:  There was 1 episode of paroxysmal supra ventricular tachycardia of 7 beats duration at 127 beats per minute.  4b. Ventricular Arrhythmia:  There were no ventricular tachyarrhythmias detected.?  T Ultrasound (Carotid Duplex Scan). ?Findings.  Left Carotid Artery:  Duplex imaging of the left carotid artery system notes that it is tortuous.  There is a very small shelf of smooth mixed plaque at the bifurcation and extending into the origin of the external carotid artery.  The left internal carotid artery is without plaque.  Velocity measurements in the internal carotid artery of 120/47 cm per second and the 2-D image support no significant disease or stenosis in the internal carotid artery.  The left vertebral has normal integrate flow, the left subclavian has normal traphasic flow.  Blood pressure in the left arm is 120/70.  Impression:  Normal left carotid study. Right Carotid Artery:  Duplex imaging of the right carotid artery system reveals normal vessels that are tortuous without plaque.  Velocity measurements in the internal carotid artery of 93/34 cm per second are negative for any hemodynamically significant lesion.  The right subclavian/innominate have normal traphasic flow.  Blood pressure in the right arm is 122/70.  Impression:  Normal right carotid study.  I do not have available to me at this time a copy of the results of the lumbar puncture test.  What I can remember of the results that I reviewed with my neurologist, is that the results were inconsistent with either a viral infection or MS.  Overall, and combined with the results of all other information and diagnostic testing to date, the results were consistent with a diagnosis of acute disseminated encephalitis; likely triggered by an adverse reaction to the Shingrix vaccine.",PHM,,"Budesonide (as a daily nasal wash), Nasonex (occasionally, as a nasal spray), sildenafil (occasionally, as needed)",None,Recurring nasal polyps,,,2,09/09/2019,,Y,Y,None
0832622,09/09/2019,MA,65.0,65,,F,,Reports redness to palms f both hands that went up each arm to chest. Also reports  headache and sensation of feeling very hot.,,,,,,,,,Y,08/13/2019,08/13/2019,0,,PVT,,,,,,,2,09/09/2019,,,Y,"Dextromethoraphen, Pseudoephedrine, Benadryl, Sulfonamides, Doxycycline, Topamax,"
0832623,09/09/2019,MA,17.0,17,,M,,"Pain at injection site starting about 3 hours after injection. By 7 hours after injection, redness and swelling was present at the injection site. Large localized reaction appreciated on exam 2 days after vaccine was administered. Headache, subjective fever, fatigue and nausea began several hours after the injection was given and resolved by the next day.",,,,,,,,,Y,09/05/2019,09/05/2019,0,none,PVT,,None,,Papular rash on thighs: referred to dermatology History of elevated ANA per mother,,,2,09/09/2019,,,,None
0832627,09/09/2019,CA,,,,U,,"No adverse effects were reported; patient received improperly stored dose of VARN AX; This spontaneous report was received from an office manager referring to an unspecified patient of unknown age and unknown gender. Information of concurrent condition, medical history, and drug reactions/allergies were not provided. Concomitant therapy included sterile diluent.  On 03-JAN-2019, the patient received improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # N014368 with expiration date 09-MAY-2019, dose detail and route were not reported), for prophylaxis. No adverse effects were reported. The vaccine was stored at 15 to 46 Fahrenheit degrees (-9 Celsius degree to 8 Celsius degree) (1.93 Celsius degree) for 34.5 hours. There was no previous temperature excursion and data logger was involved.",,,,,,,,,U,01/03/2019,01/03/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA000083,2,09/09/2019,,,,
0832629,09/09/2019,WA,,,,F,,"shingles; Information has been received from a lawyer regarding a case in litigation concerning a unknown age female patient. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.  On an unspecified date in 2016 , the patient was vaccinated with zoster vaccine live(ZOSTAVAX)(strength, dose, frequency, route, lot # and expiration date were not reported) for the long-term prevention of shingles and zoster-related condition.  On an unknown date, the patient was treated for shingles. The event caused the patient hospitalization. As a direct and proximate result of Plaintiff's use of the zoster vaccine live(ZOSTAVAX) vaccine, Plaintiff has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of event was unknown. The reporter considered herpes zoster to be related to zoster vaccine live(ZOSTAVAX).",,,,,Y,,,,U,,,,,PHM,,,,,,US0095075131909USA001436,2,09/09/2019,,Y,,
0832630,09/09/2019,TX,,,,F,,"shingles; Information has been received from a lawyer regarding a case in litigation concerning a unknown age female patient. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.  On or about 08-MAR-2011, the patient was vaccinated with zoster vaccine live(ZOSTAVAX)(strength, dose, frequency, route, lot # and expiration date were not reported) for the long-term prevention of shingles and zoster-related condition.  On an unknown date, the patient was treated for shingles. The event caused the patient hospitalization. As a direct and proximate result of Plaintiff's use of the zoster vaccine live(ZOSTAVAX) vaccine, Plaintiff has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of event was unknown. The reporter considered herpes zoster to be related to zoster vaccine live(ZOSTAVAX).",,,,,Y,,,,U,03/08/2011,,,,UNK,,,,,,US0095075131909USA001442,2,09/09/2019,,Y,,
0832631,09/09/2019,MI,57.0,57,,F,,"facial swelling/cheek swelling; This case was reported by a pharmacist via call center representative and described the occurrence of facial swelling in a 57-year-old female patient who received Herpes zoster (Shingrix) (batch number K9M5N, expiry date 7th November 2021) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of swelling face (1st dose received on 7th May 2019, refer linked case US2019159156).   On 28th August 2019, the patient received the 2nd dose of Shingrix .5 ml. On 29th August 2019, 1 days after receiving Shingrix, the patient experienced facial swelling. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the facial swelling was not recovered/not resolved.   It was unknown if the reporter considered the facial swelling to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left arm. The day after receiving Shingrix, the patient experienced facial swelling on her left cheek. This exact same event and onset time happened after the 1st and 2nd dose. Both injections were administered in the left arm. The reporter consented to follow up.",,,,,,,,,N,08/28/2019,08/29/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832632,09/09/2019,MA,,,,U,,"Rash on face; This case was reported by a other health professional via call center representative and described the occurrence of rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per vaccine indication. The pharmacy intern stated that the physician's office contacted the pharmacy and stated that the patient received Shingrix and then had a rash on their face. The reporter consented to follow up. The pharmacy intern stated no further details were provided by the physician's office, so she was unable to provide additional details at the time of this call.  The pharmacy intern consented to follow up from safety.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832633,09/09/2019,LA,64.0,64,,F,,"Muscle Aches; Rash; This case was reported by a physician via sales rep and described the occurrence of muscle pain in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th July 2019, the patient received Shingrix. In July 2019, less than a week after receiving Shingrix, the patient experienced muscle pain and rash. On an unknown date, the outcome of the muscle pain and rash were unknown.   It was unknown if the reporter considered the muscle pain and rash to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in unknown arm. The patient called the next day of vaccination to report muscle aches and a rash. It was unknown how long adverse reactions lasted. The reporter was a field representative and was at physician's office on day of reporting and notified of adverse event. The field representative had very limited information (i.e. vaccinated arm).  The physician office okay with receiving follow-up for additional details. The reporter consented to follow up.",,,,,,,,,U,07/19/2019,07/01/2019,,,PVT,,,,,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832634,09/09/2019,OH,,,,F,,"fatigue; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th June 2019, the patient received the 1st dose of Shingrix (intramuscular). On 27th June 2019, 1 days after receiving Shingrix, the patient experienced fatigue. On 28th June 2019, the outcome of the fatigue was recovered/resolved.   It was unknown if the reporter considered the fatigue to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The day after vaccination, the patient felt very fatigued. The symptoms resolved after 1 day. The reporter did not consent to follow-up. This case has been linked with US2019AMR159652, reported by the same reporter.",,,,,,,,,Y,06/26/2019,06/27/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832635,09/09/2019,,,,,M,,"Fever; Weakness/Lack of energy; Fatigue; Muscle ache; Limited daily life activities; This case was reported by a consumer via call center representative and described the occurrence of fever in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever, weakness, fatigue, muscle pain and activities of daily living impaired. On an unknown date, the outcome of the fever, weakness, fatigue, muscle pain and activities of daily living impaired were unknown.   It was unknown if the reporter considered the fever, weakness, fatigue, muscle pain and activities of daily living impaired to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and experienced fever, weakness, fatigue, lack of energy and muscle aches. His daily life activities were limited for 3 to 4 days. Call  The caller did not want to provide any additional details in regards to the adverse event, therefore limited data was available.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832638,09/09/2019,WI,19.0,19,,F,,"About 12 hours after the two shots, I got very cold and shivering. Once I warmed up, my face got very hot. My entire body felt terrible; my back ached, I felt dizzy upon standing, and my head would throb and ache whenever I moved my neck. Some of the time, I felt like throwing up. I slept restlessly for 11.5 hours, feeling immense pain every time I moved. The next morning, I felt pain behind my ears when I turned my head and my head throbbed when bending down. I was also sensitive to loud noises and bright lights.",,,,,,,,,Y,09/06/2019,09/06/2019,0,NA,PVT,,NA,Slight cough at time of vaccination,NA,,,2,09/09/2019,,,,NA
0832639,09/09/2019,MN,5.0,5,,F,,MOTHER CALLED 08/14/2019 STATING PATIENT HAD A RAISED RED INJECTION SITE (HALF DOLLAR SIZE) WITH NO OTHER SYMPTOMS.  WAS ADVISED TO DRAW A LINE AROUND INJECTION SITE AND CALL BACK IF IT HAD SPREAD OUTSIDE OF THE LINE THE NEXT DAY.  CALLED BACK 08/15 THE REDNESS HAD GOTTEN WORSE REDNESS HAD SPREAD OUTSIDE OF THE MARKINGS ON HER INJECTION SITE AND WAS RX'D CEPHALEXIN.,,,,,,,,,Y,08/13/2019,08/14/2019,1,none,PVT,,NONE,NONE,NONE,,,2,08/22/2019,,Y,,NONE KNOWN
0832640,09/09/2019,PA,64.0,64,,F,,"Last Thursday she received her second vaccine for Shingrix. She tells me within 1 hour she developed a fever, aches, pains and chills. She says that her temperature was 102. She says during the day she has low grade temp 99 and at bedtime it went to 102.1. She went to the hospital on September 3rd. She had an IV and labs and was sent home.",,,,,,,,,Y,08/28/2019,08/28/2019,0,"All from 9/3/19 ER Highest temp ER 99.4F CBC and Chest X-ray WNL AST/ALT elevated 103/118 Urinalysis: trace ketones, protein 30, leuk est trace, RBCs 9",PVT,,Taking Paroxetine HCl 20 MG Tablet    Taking Paroxetine HCl 40 MG Tablet    Taking Synthroid 75 MCG Tablet    Taking Lorazepam 0.5 MG Tablet    Taking Caltrate 600+D 600-400 MG-UNIT Tablet    Taking Vitamin D 2000 UNIT Tablet    Taking Mult,None,"F41.9 Anxiety and depression         E03.9 Hypothyroid         M19.90 Arthritis of hand, left         M19.041 Arthritis of hand, right",,,2,09/09/2019,,,Y,NKDA
0832641,09/09/2019,MD,67.0,67,,M,,Very sore and painful at site of injection; 2-3 days duration Elevated temperature (99.4) for 24 hours Lethargy 24 hours,,,,,,,,,Y,08/31/2019,09/01/2019,1,None,PHM,,Atenolol Oxtellar Losartin,None,HBP Simple partial seizures,"First Shingrix vaccine; 04/2019; age 66. Reaction was more severe than this one, approx 2 degree fever. Reported to VAERS",,2,09/09/2019,,,,None
0832642,09/09/2019,UT,65.0,65,,F,,"I had the higher dose because I just turned 65.  I have never had a reaction to a flu shot before.  About 5 - 6 hours after getting it I had aches, fever, and chills for several hours.  It was better in the morning, but I felt ill occasionally for the next 2 days. I do not have a primary physician right now because I recently moved here.",,,,,,,,,,09/06/2019,09/06/2019,0,,PUB,,"Pantoprazole, Zyrtec, Advair, Flonase.",none,"Allergic rhinitis, mild asthma, arthritis",,,2,09/09/2019,,,,"Sulfa, sensitivity to shrimp (causes increased heart rate)"
0832643,09/09/2019,NJ,,,,U,,"No adverse effects; one patient received one dose of improperly stored ROTATEQ; This spontaneous report has been received from an office manager referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug allergy or reactions were not reported.         On 27-JUN-2019, the patient was vaccinated with one dose of improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # R025713, expiration date 20-JUN-2020; dose and route were not reported) for prophylaxis (improper storage of product in use). No additional doses were administrated. No adverse effects were reported.   The administrated vaccine experienced the following temperature excursion: total time and lowest temperature below 36 degree Fahrenheit (33.9 Fahrenheit) for 40 minutes. The digital data logger was involved. Previous temperature excursions included total time and lowest temperature below 36 degree Fahrenheit (30.3 Fahrenheit) for 90 hours and 7 minutes, total time and lowest temperature below 36 degree Fahrenheit (30.5 Fahrenheit) for 1 hour and 45 minutes and total time and lowest temperature below 36 degree Fahrenheit (35.2 Fahrenheit) for 2 hours and 5 minutes.",,,,,,,,,U,06/27/2019,06/27/2019,0,,UNK,,,,,,US0095075131908USA009361,2,09/09/2019,,,,
0832644,09/09/2019,ND,68.0,,,F,,"Pain in arm not in the same spot but around where the shot was given'; This case was reported by a consumer and described the occurrence of injection site pain in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included non-alcoholic steatohepatitis (stage 4 NASH a hereditary liver disease), renal disease (stage 3), diabetes, fibromyalgia and sleep apnea.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient was 68 years old at the time of reporting. The age at vaccination was not reported. The patient had so many physician appointments, etc. due to having ""Stage 4 Nash""(a hereditary liver disease), a ""Stage 3"" kidney disease, diabetis, fibromyalgia, sleep apnea, among other things, she needed medicine for, so it was hard to remember when she had the shot or when she got the letter. The patient was wondering if there was any solution for the pain in her arm. The patient requsted response. The patient thought that she received Shingrix 3 years ago from the physician and then at one of follow up visits, the patient told the physician that since vaccination, the patient's arm hurt every day, not in the same spot but around where the shot was given. The patient thought that the physician contacted GSK and GSK response (she believed) was a letter from GSK to the patient. When the patient received the letter she could not think what it was about and did not finish even reading it and what it concerned, due to the fact of receiving so much junk mail.",,,,,,,,,U,,,,,UNK,,,Diabetes; Fibromyalgia; Non-alcoholic steatohepatitis (stage 4 NASH a hereditary liver disease); Renal disease (stage 3); Sleep apnea,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832645,09/09/2019,NC,58.0,58,,F,,"Injection site redness; Injection site with a rash-like appearance; Burning; Itchy; Blotches of red; Swelling; Sore arm; Difficult to raise her arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In August 2019, 2 days after receiving Shingrix, the patient experienced injection site erythema, injection site rash, injection site burning, injection site itching, red blotches and swelling. On 24th August 2019, the patient experienced pain in arm and movements reduced. On an unknown date, the outcome of the pain in arm, movements reduced, red blotches and swelling were recovered/resolved and the outcome of the injection site erythema, injection site rash, injection site burning and injection site itching were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, movements reduced, injection site erythema, injection site rash, injection site burning, injection site itching, red blotches and swelling to be related to Shingrix.  Additional details were reported as follows: The patient received the first dose of the Shingrix vaccine and within 1 hour, her arm became sore and she noted it was difficult to raise her arm. These symptoms resolved within 2 to 3 days. Approximately 2 to 3 days after receiving the vaccination, the injection site became red with a rash-like appearance.  The patient estimated the area was approximately 5 inches long and 3 to 4 inches wide, but in blotches of red. The patient noted that the redness had gotten darker and more prominent over time. It was reported that, the red area had became itchy and it burns. The reporter consented to follow up.",,,,,,,,,N,08/24/2019,08/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832646,09/09/2019,AZ,60.0,60,,F,,"soreness at injection site; rash at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included breast cancer (left side).   On 28th August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 29th August 2019, 1 days after receiving Shingrix, the patient experienced injection site pain and injection site rash. On an unknown date, the outcome of the injection site pain and injection site rash were recovering/resolving.   It was unknown if the reporter considered the injection site pain and injection site rash to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the right arm. The patient planned to follow up with the physician on an unknown date. The patient consented to follow up. There was discrepancy in the event outcome reported in source document(Recovering) and in system (Not recovered).",,,,,,,,,N,08/28/2019,08/29/2019,1,,UNK,,,Breast cancer (left side),,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832647,09/09/2019,MI,57.0,57,,F,,"facial swelling; This case was reported by a pharmacist via call center representative and described the occurrence of facial swelling in a 57-year-old female patient who received Herpes zoster (Shingrix) (batch number C5E43, expiry date 10th August 2021) for prophylaxis.   On 7th May 2019, the patient received the 1st dose of Shingrix .5 ml. On 8th May 2019, 1 days after receiving Shingrix, the patient experienced facial swelling. On an unknown date, the outcome of the facial swelling was recovered/resolved.   It was unknown if the reporter considered the facial swelling to be related to Shingrix.  Additional details were reported as follows: The patient experienced Shingrix in the left arm. The patient experienced facial swelling on her left cheek the day after she received the vaccine.  The patient consented to follow up. This case has been linked to the case US2019AMR159589, reported by same reporter for same patient.",,,,,,,,,Y,05/07/2019,05/08/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832648,09/09/2019,WA,57.0,57,,F,,"Trouble breathing; Dizziness; Heaviness in head; This case was reported by a pharmacist via call center representative and described the occurrence of difficulty breathing in a 57-year-old female patient who received Herpes zoster (Shingrix) (batch number MP42R, expiry date 19th September 2021) for prophylaxis.   On 8th June 2019, the patient received the 1st dose of Shingrix. On an unknown date, between 2 and 3 months after receiving Shingrix, the patient experienced difficulty breathing, dizziness and heaviness of head. On an unknown date, the outcome of the difficulty breathing, dizziness and heaviness of head were unknown.   It was unknown if the reporter considered the difficulty breathing, dizziness and heaviness of head to be related to Shingrix.  Additional case details were reported as follows: The patient came in to get her 2nd dose of Shingrix on day of reporting but reported having trouble breathing, dizziness, and her head felt heavy after receiving the first dose. The reporter enquired if there were any recommendations/safety precautions on a patient receiving the 2nd dose after having adverse reactions to the first dose. The reporter consented to follow up.",,,,,,,,,U,06/08/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832651,09/09/2019,MI,2.0,2,.8,M,,"left upper thigh erythema, edema ( lump and bruise )  and pain, extending to the midthigh about 10 cm .",,,,,,,,,Y,08/29/2019,08/29/2019,0,none,PVT,,none,none,dental caries,,,2,09/09/2019,,Y,,none known
0832652,09/09/2019,NY,69.0,69,,M,,Injection site reactoin and medrol dose pack needed from MD 9 days later,,,,,,,,,Y,08/28/2019,09/05/2019,8,,PHM,,Patient got medrol dose pack on 9/6/19 because of injection site reaction,,,,,2,09/09/2019,,Y,,
0832653,09/09/2019,NY,68.0,68,,F,,"significant arm swelling, redness, and tenderness upper half of left arm initially, lasting for 4 days, then generalized joint aches, chills, fatigue, and myalgias for the next 11 days as of today",,,,,,,,,N,08/26/2019,08/26/2019,0,none,PVT,,"atorvastatin, omega 6 oils, vitamin D, calcium",none,"hypercholesterolemia, inactive Grave's disease",,,2,09/09/2019,,,,clindamycin
0832654,09/09/2019,MI,11.0,11,,F,,Patient given the wrong vaccine: Trumenba. She should have been given Menactra due to age. No adverse reaction.,,,,,,,,,U,07/19/2019,07/19/2019,0,,PVT,,"Fluoxetine 10mg daily, Omega 3 daily, Multi-vitamin daily.",none,irritability and anger,,,2,09/09/2019,,,,NKDA
0832655,09/09/2019,IL,53.0,53,,F,,Went for an afternoon walk and experienced previously ankle injury agitation. Started on right ankle then progressed upwards with joint pain. Also had some nausea and headache. Experienced frequent urination throughout the night.,,,,,,,,,Y,09/06/2019,09/06/2019,0,,PUB,,"antidepressant, occasional turmeric (new brand used)",,,,,2,09/09/2019,,,,Penicillin
0832656,09/09/2019,TX,66.0,66,,M,,Peripheral nerve pain Taking Gabapentin,,,,,,,,,N,07/26/2019,08/22/2019,27,,PVT,,"Vitamin B12 injection, Rosuvastatin calcium (Crestor) and Vitamin D",None,None,,,2,09/09/2019,,Y,,None
0832657,09/09/2019,NM,63.0,63,,F,,Fever of 101 degrees Achy muscles Large red hot area of 3inch diameter around the injection site,,,,,,,,,Y,07/05/2019,07/06/2019,1,,PHM,,Paroxetine hcl 5mg/day Losartan 50mg/day,,,,,2,09/09/2019,,,,
0832658,09/09/2019,MI,48.0,48,,M,,"Pt was given two doses of Pediatric Hep B, same manufacture and lot number, at the same appt in place of giving one adult dose of Hep B. No adverse events or reactions reported.",,,,,,,,,Y,09/09/2019,09/09/2019,0,na,PUB,,na,na,na,,,2,09/09/2019,,,,na
0832660,09/09/2019,VA,,,,U,,"No adverse effects; patient inadvertently received an expired dose of GARDASIL 9 on 8/20/2019; This spontaneous report was received from a medical assistant referring to a patient of unknown gender and age. The patient's concurrent condition, pertinent medical history, concomitant therapy and drug reactions/allergies were not reported.  On 20-AUG-2019, the patient was inadvertently vaccinated with an expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, frequency and route of administration not reported) (lot #: M042853, expiration date: 17-JUL-2019) (expired product administered) for prophylaxis. No adverse effects were reported.",,,,,,,,,U,08/20/2019,08/20/2019,0,,UNK,,,,,,US0095075131908USA008589,2,09/09/2019,,,,
0832661,09/09/2019,,,,,M,,"feeling tired; fever; pain left arm; weakness; This case was reported by a consumer via call center representative and described the occurrence of fever in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th August 2019, the patient received the 1st dose of Shingrix. In August 2019, less than a week after receiving Shingrix, the patient experienced fever, pain in arm and weakness. On an unknown date, the patient experienced tiredness. On an unknown date, the outcome of the fever, pain in arm, weakness and tiredness were recovering/resolving.   It was unknown if the reporter considered the fever, pain in arm, weakness and tiredness to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient himself. The age at vaccination was not reported. The patient received dose of Shingrix in the left arm. The patient reported that, currently had fever, pain in the left arm, weakness and also felt tired. The patient did not provide any additional information and disconnected the call before date of birth and address could be obtained. The patient did not consent to follow up. There was discrepancy in the event outcome reported in source document (recovering and resolving) and in system (not recovered and not resolved).",,,,,,,,,N,08/29/2019,08/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832662,09/09/2019,CA,16.0,16,,F,,"3 days after received vaccines, student noticed left deltoid area became red, swollen, hard, and tender to touch. Student proceeded with warm compress for three days. Yet, the swollen, warm, and hardness did not decrease.  9/9/2019, when student came to the clinic, provider noticed left deltoid are is still slightly swollen but no redness no warm and no longer hard to touch. Student indicated: area is not tender to touch at this time. Left arm would get really sore after the game that had never happened.",,,,,,,,,U,08/29/2019,09/01/2019,3,none,SCH,,none,none,none,,,2,09/09/2019,,Y,,none
0832663,09/09/2019,NY,16.0,16,,F,,Patient's mother states that patient was crying and nauseous and had loss of appetite. She was not able to sleep and was shaking and feeling nervous and her eyes were rolling back. There was no loss on consciousness. No reaction at the site of injection. Symptoms presented on and off for 3 days. Patient was examined on 09/09/2019 and is feeling better.,,,,,,,,,Y,09/05/2019,09/05/2019,0,none,PVT,,None taken orally at the time of vaccination. Getain Violet applied topically on toe for 5 weeks. Prednisone 20mg taken for 3 days one week prior. Biaxin taken for 5 days starting on 08/09/2019,Headache and sinusitis on 08/09/2019.,none,,,2,09/09/2019,,Y,,"Penicillin, azithromycin, walnuts, cefdinir, cefzol"
0832664,09/09/2019,TX,11.0,11,,F,,"The shot was given to the patient around 8:30 A.M. After she was finished she waited in the room about 5 minutes and than walked to the waiting room.  She was standing up in the front about to leave but she passed out and her head hit the floor. She lost concussion and was shaking according to witnesses in the front. Doctor gave the patient .half cc of benadryl and her temperature  dropped to 94.5 ,911 was called and the ambulance arrived around 8:50 A.M.",,,,,,,,,Y,09/09/2019,09/09/2019,0,,PVT,,BENADRYL,N/A,N/A,,,2,09/09/2019,,,,NKDA
0832665,09/09/2019,MN,90.0,90,,F,,Arm was bruised and sore,,,,,,,,,Y,08/28/2019,08/30/2019,2,not known,PHM,,"Simvastatin, Proair",no,"diabetes, glaucome",,,2,09/09/2019,,,,none known
0832666,09/09/2019,KY,65.0,65,,F,,"I felt fatigue, then overall muscle weakness.   About 2 hours later I felt very warm and then chills.  Later my abdomen became very warm and a slight reddening started at my abdomen and covered my body.  I did not feel I needed to call my doctor.  The following 3 days the fatigue and overall muscle weakness stayed with me.  I am fine now *;}",,,,,,,,,Y,08/30/2019,08/30/2019,0,None,PHM,,"Synthyroid,  Buspar,  Straterra,  Loratidine, Mega Red",None,"Hypothyroidism,  ADHD,  GAD,  seasonal allergies",,,2,09/09/2019,,,,None. I am hypersensitive though.
0832667,09/09/2019,OK,72.0,72,,F,,PATIENT RECEIVED DOSE AT 11:11AM ON 8/31/19 BY EVENING TIME AROUND 9PM SHE STATES THAT SHE WAS VERY COLD AND GOT A BLANKET TO WARM UP. SHE HAD INVOLENTARY MOVENTS OF HER ARMS AND JERKING OF HER NECK/HEAD. SHE PROCEEDED TO GO TO SLEEP AND WOKE UP THE NEXT MORNING WITH FLU-LIKE SYMPTOMS FOR THE NEXT DAY AND IMPROVED ON DAY 2. **PATIENT ALSO REPORTED ON 1ST DOSE SHE HAD  NERVE PAIN DOWN HER ARM WITH FLU LIKE SYMPTOMS FOR 3 DAYS.,,,,,,,,,Y,08/30/2019,08/30/2019,0,NONE,PHM,,,,,,,2,09/09/2019,,,,
0832668,09/09/2019,FL,32.0,32,,F,,"High fever of 102.3, severe headache and muscle pain. Dizziness and sweats. For 48 hours",,,,,,,,,N,09/07/2019,09/07/2019,0,Went to dr. On 9-9-19 and gave a four test Incase it was unrelated. Dr. Decided it was a reaction to shot and gave steroids,PHM,,None,Seasonal allergies,None,,,2,09/09/2019,,Y,,Pineapple
0832669,09/09/2019,CA,5.0,5,,F,,episode of syncope,,,,,,,,,Y,09/09/2019,09/09/2019,0,monitored,PUB,,n/a,n/a,n/a,,,2,09/09/2019,,,,nka
0832670,09/09/2019,MD,73.0,73,,F,,"Rashes on arms and knees. Headache, tired",,,,,,,,,Y,09/05/2019,09/07/2019,2,,PHM,,Atenolol 50mg Synthroid 50 mcg Ezetimibe 10 mg  Vitamin tablet,,WPW KNEE replacements Cataract surgery,,,2,09/09/2019,,,,"Caffeine, digitalis, Vaso constrictors, chocolate, alcohol, certain Novocain"
0832676,09/09/2019,TN,18.0,18,,F,,"No adverse effects; pregnant patient received VARIVAX; a pregnant patient received VARlVAX; This spontaneous prospective pregnancy report was received from a nurse practitioner and refers to an 18-year-old female patient. Her pertinent medical history included asthma and obesity. The patient did not have any concomitant medications, drug reactions or allergies. On 15-AUG-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) injection (lot # R034392 has been verified to be a valid lot number, expiration date 27-NOV-2020) for prophylaxis (exact dose and route of administration were not reported). The vaccine was reconstituted with sterile diluent diluent (STERLIE DILUENT) injection (lot # has been verified to be a valid lot number, expiration date 04-AUG-2020 (formulation, strength, dose, frequency and route of administration were not reported).  On an unknown date, the patient had unspecified pregnancy test performed (result not provided). On an unspecified date in 2019, the patient became pregnant with last menstruation period (LMP) of 21-JUL-2019 and estimated due date (EDD) of 26-APR-2020. The patient was vaccinated at 3 weeks of gestation. The patient sought medical attention and visited an unspecified office. She did not receive any treatment.  At the time of the report, the pregnancy outcome was pending and the fetal outcome was unknown. No adverse effects were reported.",,,,,,,,,U,08/15/2019,08/15/2019,0,,UNK,,Sterile diluent,Asthma; Obesity; Prophylaxis,,,US0095075131908USA006952,2,09/09/2019,,,,
0832677,09/09/2019,CA,,,,F,,"bilateral sensorineural sloping hearing loss; vertigo; post herpetic neuralgia; herpes zoster; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On or about 05-DEC-2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot number and expiry date were not provided) for routine health maintenance and the prevention of shingles (herpes zoster). On an unknown date (reported as shortly after vaccination), the patient suffered a sharp pain in her head and was diagnosed with herpes zoster. As further result of herpes zoster, the patient suffered and was diagnosed with bilateral sensorineural sloping hearing loss, vertigo, and postherpetic neuralgia. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms resulted in physical limitations not present prior to using vaccine. The patient also experience mental and emotional distress due to resulting physical limitations and seriousness of patient's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt suffered severe and permanent personal injuries. Further, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) use, she had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.  The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the event of bilateral sensorineural sloping hearing loss was determined to be medically significant. The events were considered to be disabling.",,,,,,,,Y,N,12/05/2016,,,,UNK,,,Routine health maintenance,,,US0095075131909USA002347,2,09/09/2019,,,,
0832678,09/09/2019,,61.0,61,,M,,"Muscle aches; Felt warm; nausea; Sore Injection Site; Shivers / Chills / Severe Shivering; This case was reported by a physician via sales rep and described the occurrence of injection site pain in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of chills (1st dose received on 11th March 2019, refer linked case US2019GSK045802).   On 27th August 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 27th August 2019, less than a day after receiving Shingrix, the patient experienced injection site pain and shivers. On 28th August 2019, the patient experienced muscle pain, feeling of warmth and nausea. The patient was treated with paracetamol (Tylenol). On 29th August 2019, the outcome of the injection site pain, shivers, muscle pain, feeling of warmth and nausea were recovered/resolved.   It was unknown if the reporter considered the injection site pain, shivers, muscle pain, feeling of warmth and nausea to be related to Shingrix.  Additional information received were as follows: The patient was a physician who received both doses of the Shingrix vaccine. The lot number was unknown. The patient received Shingrix on left deltoid in the evening. The patient experienced sore injection site that resolved the next morning of vaccination date. The patient experienced shivers and was treated with Tylenol every 6 hours and was fine until 11:00 am. At that time, the patient began to experience chills, muscle aches, and severe shivering which lasted approximately 45 minutes.  At 7:00 pm that evening, the patient again had chills and felt warm, but he did not take his temperature.  On 28th August 2019, the patient went to bed at 9:30 pm and woke up on 29th August 2019 with all symptoms resolved.  The reporter was unable to provide any additional details and unable to locate case number for first case. The caller stated that all symptoms had resolved, however, he still had a little soreness in his left arm. The patient also mentioned that he had experienced soreness at the injection site following previous flu shots (unknown manufacturer).  The caller did not provide any additional details. This was 1 of the 3 cases reported by same reporter.",,,,,,,,,Y,08/27/2019,08/27/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832679,09/09/2019,,,,,U,,"Developed 3 smaller bumps resembling hives; This case was reported by a other health professional via interactive digital media and described the occurrence of papular rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received Shingrix. In August 2019, less than 3 weeks after receiving Shingrix, the patient experienced papular rash. On an unknown date, the outcome of the papular rash was unknown.   It was unknown if the reporter considered the papular rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced 3 smaller bumps resembling hives. The patient asked could this be a side effect and is it safe to be around my pregnant daughter-in-law.",,,,,,,,,U,08/01/2019,08/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832681,09/09/2019,PA,,,,F,,"Pain, redness, swelling at injection site; Pain, redness, swelling at injection site; Pain, redness, swelling at injection site; This is a spontaneous report from a contactable other healthcare professional (HCP) via company representative. A female patient of an unspecified age (65+, Unit: unknown) started to receive pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced pain, redness, swelling at injection site on an unspecified date after vaccination. Pain lasted 2 weeks. The outcome of events was unknown.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZERINC2019385760,2,09/09/2019,,,,
0832682,09/09/2019,FL,50.0,50,,M,,"Fever-like symptoms started in the afternoon/evening, including uneasy stomach, headache, aches and chills. Sweat profusely during the night and difficulty sleeping. Felt much better in morning and all symptoms were gone by end of day.",,,,,,,,,Y,09/04/2019,09/04/2019,0,,PVT,,None,Some recent vertigo in mornings which I attribute to congestion,None,,,2,09/09/2019,,,,None
0832683,09/09/2019,CA,13.0,13,,F,,"Patient was given bexero on 9/4/19 and on 9/6/19 mother called in patient broke out in rash on 9/5/19 small bumps on face, arms and legs , sore at injection site.",,,,,,,,,,09/04/2019,09/06/2019,2,,UNK,,,NO,,,,2,09/09/2019,,Y,,NKA
0832684,09/09/2019,IL,4.0,4,,M,,Mom noted hive like rash from waist to feet that started on Tuesday after school that persisted through Sunday 9/8/19.  Administered Children's Benadryl as directed.,,,,,,,,,Y,08/28/2019,09/03/2019,6,N?A,PVT,,"Children's Zyrtec Daily Flovent 44mcg/HFA inhaler, 2 puffs BID Albuterol 90 mcg/HFA inhaler, 2 puffs q 4 hours, PRN",N/A,Asthma,,,2,09/09/2019,,,,NKDA
0832685,09/09/2019,,13.0,13,,F,,"PT developed rash thigh, right axilla and face.",,,,,,,,,,08/27/2019,08/31/2019,4,,UNK,,,,,,,2,09/09/2019,,Y,,NKA
0832686,09/09/2019,NY,90.0,90,,M,,3rd Dose of Shingrix given when unneeded,,,,,,,,,Y,08/31/2019,09/07/2019,7,,PHM,,,,,,,2,09/09/2019,,,,
0832687,09/09/2019,MD,60.0,60,,M,,Fatigue (2+ days) Slight headache Slight nausea Soreness at site of injection (more than expected),,,,,,,,,Y,09/06/2019,09/07/2019,1,N/A,PHM,,Levothyroxine 75 Lipitor hydrochlorothiazide losartan,None,hypothyroidism (well controlled) blood pressure cholesterol (well controlled),,,2,09/09/2019,,,,None
0832688,09/09/2019,,12.0,12,,F,,"PT HAD 3 VACCINES AND HAD RASH ON ARMS, FACE , BACK AND NECK.",,,,,,,,,,08/05/2019,,,,UNK,,,,,,,2,09/09/2019,,Y,,
0832689,09/09/2019,AZ,63.0,63,,M,,"fever, chills, neck soreness, fatigue, dizziness",,,,,,,,,U,09/05/2019,09/06/2019,1,none,SCH,,"Alprazolam, Cialis, Cymbalta, Flomax, Testosterone, Trazodone, Trimex, Zovirax",none,"Idiopathic small fiber neuropathy, low testosterone levels, voiding dysfunction",,,2,09/09/2019,,,,NKDA
0832690,09/09/2019,FL,67.0,67,,M,,"1 week after vaccination still has ""knot"" at vaccination site and arm is still sore",,,,,,,,,N,09/03/2019,09/04/2019,1,,PHM,,,,,,,2,09/09/2019,,,,
0832691,09/09/2019,MD,58.0,58,,M,,"Experienced illness and symptoms of the following:  temporary loss of appetite and redness/tenderness where the shot was given.  Experienced a high fever over 103.  Additionally, experienced fatigue, ear burning sensation, severe headache and chills.   Note:  I didn't notify my primary physician.  Too ill during that time.",,,,,,,,,,09/03/2019,09/04/2019,1,,UNK,,,,,,,2,09/09/2019,,Y,,
0832692,09/09/2019,WI,77.0,77,,M,,"Immunized on 8/9/2019 (Friday).  Very fatigued over the weekend and spent most of the day in bed.  8/12/2019 c/o legs feeling shaky, unsteady gait, fear of falling, ""jitteriness in the legs.""  .  Symptoms progressed through the week.  Fear of falling increased especially with going down steps or walking down incline.  The 3rd week after immunization, symptoms became worse and contacted family doctor.  Physician exam on 9/3/2019 - c/o sweaty several times/day, heart beating funny but relieved with Valsalva, gait more unsteady.  Today (9/9/2019) unsteady gait continues, reflexes - ok, no foot drop, no falls, denies muscle weakness, most unsteady when going from sitting to standing position, fear of falling continues - especially with downward incline.",,,,,,,,,N,08/09/2019,08/12/2019,3,"12 lead EKG - Normal sinus rhythm, Normal ECG, rate 62, normal wave forms throughout,  a bit of delayed R-wave progression (clinically insignificant).",PVT,,"Amlodipine (Norvasc), aspirin EC - 1 daily, cholecalciferol Vit D 5000U daily, coenzyme Q10, metoprolol XL (Toprol XL) 25 mg daily, Multivitamin daily",0,"Right hip pain  Dyslipidemia (*): on statin Rx  Thrombocytopenia (*)  Grade I hemorrhoids  History of adenomatous polyp of colon (2012)  Hypogonadism male: on testosterone replacement (Urology)  Nuclear sclerosis - Both Eyes  Refractive disorder - Both Eyes  IHD: h/o TAXUS Liberte stent to the RLV branch, LAD & PTCA to D2 lesion, July 2009  Hx of Nonalcoholic steatohepatitis  Hypovitaminosis D",,,2,09/09/2019,,Y,,0
0832693,09/09/2019,PA,61.0,61,,M,,April 10th I received the first dose of Shingrix vaccine. By April 21st I had a full on outbreak of shingles including severe derm pain on head and forehead. Nowhere in labeling is this reported as a side effect of this vaccine,,,,,,,,,Y,04/10/2019,04/20/2019,10,Rx for valtrex,PVT,,Avapro Nexium Mavic Zocor,None,BP controlled Gerd controlled Cholesterol controlled Arthritis,,,2,09/09/2019,,Y,,None
0832694,09/09/2019,NC,4.0,4,,M,,Difficulty breathing and wheezing developing within 5-10 minutes of receiving vaccines,,,,,,,,,Y,09/06/2019,09/06/2019,0,,PVT,,None reported,Mild congestion and cough. No fever.,None,,,2,09/09/2019,,,Y,"Egg, fish, lactase, dairy, mango, tree nut, peanut, black bean, chickpea, green pea, sesame"
0832695,09/09/2019,MO,68.0,68,,F,,Patient states she started forming blisters on face and extremities and had itching 1 day after receiving vaccines. States she also did not feel well.  I instructed patient to seek medical attention to have blisters looked at.,,,,,,,,,U,09/07/2019,09/08/2019,1,,PHM,,unknown,unknown,unknown,,,2,09/09/2019,,Y,,no known allergies
0832696,09/09/2019,VA,3.0,3,,M,,Severe swelling spreading from deltoid to elbow.  no fever.  normal range of motion.  Reaction site resolved after 24 hours.  Parents and I have pictures,,,,,,,,,Y,09/06/2019,09/06/2019,0,,PVT,,Amoxicillin 400mg/5ml 10 ml bid started 9/3/2019,left otitis media,Reactive Airway Disease;,,,2,09/09/2019,,,,none
0832706,09/09/2019,NY,,,,U,,"No adverse effects reported; patient received second dose in Varivax series that was improperly stored.; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's medical history, drug allergies or reactions, and concurrent conditions were not disclosed.  On 23-JUL-2019, the patient was vaccinated with the second dose of varicella virus vaccine live (oka/merck)(VARIVAX) (strength, frequency, anatomical injection site and route of administration were not disclosed), lot # R020650 and expiration date 18-JUL-2020, for prophylaxis. This vaccine was diluted with a properly stored sterile diluent.  It was reported that this vaccine had been on a temperature excursion that started in April 2019, and was stored at 7.7 F during 30 minutes. It was also noted that there had been a previous temperature excursion, and the vaccine had been stored between 6 F and 14 F, for 188 minutes.  At the time of this report, there were no adverse events reported. Digital data logger was involved.",,,,,,,,,U,07/23/2019,07/23/2019,0,,UNK,,MERCK STERILE DILUENT,,,,US0095075131909USA001302,2,09/09/2019,,,,
0832707,09/09/2019,ND,,,,U,,"No Adverse Effect; administered PROQUAD & VARIVAX concomitantly; This spontaneous report was received from a nurse and refers to a 12-month-old patient of unknown gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported.  On 03-SEP-2019, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and varicella virus vaccine live (oka/merck) (VARIVAX) (exact dose, frequency, site and route of administration, lot# and expiration date were not reported for both), concomitantly for prophylaxis. No adverse effects were reported.",,,,,,,,,U,09/03/2019,09/03/2019,0,,UNK,,,,,,US0095075131909USA002710,2,09/09/2019,,,,
0832708,09/09/2019,,,,,U,,"fatigued; little pinkness / red; swelling of arm; arm pain; This case was reported by a consumer and described the occurrence of fatigue in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 28th August 2019, the patient received the 2nd dose of Shingrix. On 29th August 2019, 1 days after receiving Shingrix, the patient experienced fatigue, erythema of extremities, swelling arm and pain in arm. On an unknown date, the outcome of the fatigue, erythema of extremities, swelling arm and pain in arm were unknown.   It was unknown if the reporter considered the fatigue, erythema of extremities, swelling arm and pain in arm to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication. The patient was told that he/she might be contagious to people who never had measles. The patient was very fatigued a day before reporting, but seem almost normal on day of reporting, with the exception of a little pinkness and swelling of arm (It was red a day before reporting, but did not hurt patient to the point that he/she couldn't sleep on it. The reporter did not give permission to follow up.",,,,,,,,,U,08/28/2019,08/29/2019,1,,UNK,,Shingrix,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832709,09/09/2019,,67.0,,,M,,"Inappropriate schedule of vaccine; Pain at injection site/painful; This case was reported by a consumer and described the occurrence of injection site pain in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (1st dose received in January 2018, refer case US2019AMR159031).   On 29th August 2019, the patient received the 2nd dose of Shingrix. In August 2019, less than a day after receiving Shingrix, the patient experienced injection site pain. On 29th August 2019, the patient experienced drug dose administration interval too long. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional case details were provided as follows: The patient had an opportunity to move to and forgot to go back for my 2nd followup vaccination, which patient finally did the day before reporting, which led to which led to lengthening of the vaccination schedule. The reaction to my second dose was much more painful than initial one, in terms of second-day pain at injection site.",,,,,,,,,U,08/29/2019,08/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832710,09/09/2019,,,,,M,,"Pain at injection site/painful; This case was reported by a consumer and described the occurrence of injection site pain in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In January 2018, the patient received the 1st dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional case details were provided as follows: The age at vaccination was not reported but could be 66 or 67 years. The patient experienced injection site pain. For tolerance after 2nd dose refer case US2019AMR159021.",,,,,,,,,U,01/01/2018,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832711,09/09/2019,,53.0,53,,U,,"Nauseous; Very tired; Felt like I had a bit of a fever; Feel little nervous; Very large red circle around the injection site; Injection site hot to the touch; Itchy; Arm is Painful; This case was reported by a consumer and described the occurrence of injection site erythema in a 53-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th August 2019, the patient received Shingrix. In August 2019, less than a week after receiving Shingrix, the patient experienced injection site erythema, injection site warmth, injection site itching, pain in arm, fever and nervous. On 28th August 2019, the patient experienced nausea and tiredness. On an unknown date, the outcome of the injection site erythema, injection site warmth, injection site itching, pain in arm, nausea, tiredness and nervous were not recovered/not resolved and the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the injection site erythema, injection site warmth, injection site itching, pain in arm, nausea, tiredness, fever and nervous to be related to Shingrix.  Additional details were provided as follows: The patient reported that, after vaccination with the dose of Shingrix, had very large red area around the inejction site which was still hot to touch and it was itchy. The patient's arm was painful and was very tired. The first day after vaccination, the patient was nauseous. After vaccination, the patient felt like had fever, but at the time of reporting, did not feel like have fever anymore. The patient felt little nervous. There was discrepancy in the name of suspect given in the source document and that reported in system.",,,,,,,,,N,08/27/2019,08/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832712,09/09/2019,OH,,,,F,,"Arm is red; Arm is sore; Inappropriate preparation of medication; Inappropriate dose of vaccine administered; This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of fatigue (1st dose received on 26th June 2019 refer case, US2019159135). Concomitant products included Herpes zoster (Shingrix).   On 28th August 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 28th August 2019, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On 29th August 2019, the patient experienced erythema of extremities and pain in arm. On an unknown date, the outcome of the erythema of extremities and pain in arm were recovering/resolving and the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   It was unknown if the reporter considered the erythema of extremities and pain in arm to be related to Shingrix.  Additional case details were provided as follows: The age at vaccination was not reported. The patient received only the adjuvant of Shingrix, as the pharmacist forgotten to reconstitute the vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. After being administered, the patient's arm  was red and sore after receiving only the adjuvant. The patient did not consent to follow-up.",,,,,,,,,N,08/28/2019,08/28/2019,0,,PHM,,Shingrix,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832713,09/09/2019,NJ,,,,U,,"Feeling very tired; Feeling achy / Pain; Headache; Fever; Numbness of my arm; Weakness throughout my body; Stomachache; nightmare; This case was reported by a consumer and described the occurrence of tiredness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included TETANUS VACCINE for prophylaxis.   On 26th August 2019 12:00, the patient received the 1st dose of Shingrix. On an unknown date, the patient received TETANUS VACCINE at an unknown dose. In August 2019, 15 hrs 33 min after receiving Shingrix and unknown after receiving TETANUS VACCINE, the patient experienced headache, fever, numbness of upper extremities, weakness generalized, stomach pain and nightmare. On 26th August 2019, the patient experienced tiredness and pain. The patient was treated with ibuprofen (Motrin). On an unknown date, the outcome of the tiredness, pain, headache, fever, numbness of upper extremities, weakness generalized, stomach pain and nightmare were unknown.   It was unknown if the reporter considered the tiredness, pain, headache, fever, numbness of upper extremities, weakness generalized, stomach pain and nightmare to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The reporter just wanted to report the horrible experience had with vaccination.  The patient's physician told to the patient that the patient would experience some swelling at the site, might be some chills.  The patient received Shingrix at about noon time and started feeling very tired and achy that evening. The patient went to sleep. On 27th August 2019 at 3:33 am, the patient woke up living the worst nightmare of life. The pain, the headache, fever, numbness of my arm, weakness throughout body and stomachache.  The patient spent two days out of work, in bed recovering with Motrin. The patient reported that its first shingles vaccination and my last. The reporter was not informed of returning for a second part of the shot and was also given a tetanus vaccination and asked could that have compounded the reactions. The reporter was just curious why the side effects were so severe. It was unknown if the reporter considered the tiredness, pain, headache, fever, numbness of upper extremities, weakness generalized, stomach pain and nightmare to be related to tetanus vaccine.",,,,,,,,,U,08/26/2019,08/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832714,09/09/2019,TX,16.0,,,F,,"Severe Pain; Redness (large wheel); Swelling in her right arm; This case was reported by a physician via sales rep and described the occurrence of pain in arm in a 16-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included MENACTRA for prophylaxis.   On 28th August 2019, the patient received the 1st dose of Bexsero .5 ml and MENACTRA. In August 2019, less than a week after receiving Bexsero, the patient experienced pain in arm, erythema of extremities and swelling arm. On an unknown date, the outcome of the pain in arm, erythema of extremities and swelling arm were unknown.   It was unknown if the reporter considered the pain in arm, erythema of extremities and swelling arm to be related to Bexsero.  Additional details were provided as follows: The patient received Bexsero in right deltoid muscle and also received Menactra in her left arm at the same visit. The reporter stated that, the patient experienced severe pain, redness (large wheel), and swelling in her right arm.",,,,,,,,,U,08/28/2019,08/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832715,09/09/2019,NC,57.0,57,,M,,"Sore; Difficulty moving arm/difficulty lifting his arm up and down; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 24th August 2019, less than a day after receiving Shingrix, the patient experienced pain in arm and mobility decreased. On an unknown date, the outcome of the pain in arm and mobility decreased were recovered/resolved.   It was unknown if the reporter considered the pain in arm and mobility decreased to be related to Shingrix.  Additional details were provided as follows: The case was reportered by patient's wife. The patient received Shingrix in his left arm. Within 1.5 hours of receiving the Shingrix, the patient's arm became sore and he had difficulty lifting his arm up and down. These symptoms resolved 3 days later. The reporter would not provide any additional details.",,,,,,,,,Y,08/24/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/09/2019,,,,
0832717,09/09/2019,OH,,,,U,,"Have an hypersensitivity reaction to a pneumococcal vaccine; This is a spontaneous report from a contactable pharmacist.  A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (manufacture unknown), via an unspecified route of administration on an unspecified date at single dose for immunization.  Medical history included post splenectomy.  The patient's concomitant medications were not reported. The patient had a hypersensitivity reaction to a pneumococcal vaccine on an unspecified date with outcome of unknown.    Pfizer is a marketing authorization holder of [Pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein)] in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of [Pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein)] has submitted the same report to the regulatory authorities.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Splenectomy,,USPFIZER INC2019382244,2,09/09/2019,,,,
0832718,09/09/2019,TX,,,,F,,"Have a knot on arm at the injection site; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at a single dose for pneumonia (immunization).  The patient's medical history and concomitant medications were not reported. The patient had a knot on arm at the injection site on an unspecified date. The outcome of event was unknown.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2019384395,2,09/09/2019,,,,
0832719,09/09/2019,IN,74.0,74,,M,,arm is red and hot from shoulder to elbow,,,,,,,,,N,09/05/2019,09/06/2019,1,,PHM,,"levothyroxine 25mcg, atorvastatin 20mg, ranitidine 300 mg, omeprazole 40mg, dutasteride 0.5mg , gamma gard",no,,,,2,09/09/2019,,Y,,no
0832720,09/09/2019,SC,0.75,0,.8,M,,"Seizures (non-febrile) beginning within hours of the injection. He had dozens of seizures each day for weeks. 4 years later he is still having subclinical and absence seizures daily. He lost all previously gained speech and didn't speak for 3 years. He lost gross and fine motor skills and began losing weight, losing his hair and became severely anemic.",,,,,,,,Y,N,06/15/2015,06/15/2015,0,,PVT,,None,None,Constipation,,,2,09/09/2019,,,,None
0832721,09/09/2019,TX,70.0,70,,F,,Patient reported a fever of 101 F and redness on arm around injection sites that took up a large space on her upper arm. These symptoms began on the day after her vaccinations.,,,,,,,,,U,09/07/2019,09/08/2019,1,,PHM,,Unknown,None reported,Unknown,,,2,09/09/2019,,,,NKDA
0832722,09/09/2019,GA,60.0,60,,F,,"Sore arm, red, swollen, itchy, red blotch on skin from injection towards elbow - 3"" by 6"" - began 4 hours after injection and lasted 5 days Low grade fever (99.4), full body aches, chills, lethargic -began 8 hours after injection and lasted 48 hours",,,,,,,,,Y,08/29/2019,08/29/2019,0,none,PHM,,Synthroid Zocor Calcium AREDS2 Fishoid CoQ10 Biotin Magnesium Imitrex Nasonex Restasis,none,high cholesterol Thyroid removed Hysterectomy,Fever  and chills at annual flu shot,,2,09/09/2019,,,,Neosporin(Topical) Hydrocortizone (topical)
0832723,09/09/2019,IL,67.0,67,,F,,"wide-spread rash, hives, and itching.  Swelling and feeling of warmth around injection site.  Taking diphenhydramine otc to help resolve symptoms",,,,,,,,,U,09/06/2019,09/07/2019,1,none yet,PHM,,,,,,,2,09/09/2019,,,,sulfa
0832724,09/09/2019,AL,1.0,1,.6,M,,"Fever, red bumpy rash all over body, swollen lymph nodes, dizziness, loss of balance, conjunctivitis, and possible loss of hearing.",,,,,,,,,U,03/07/2019,03/18/2019,11,,PVT,,None,Virus,None,,,2,09/09/2019,,,,Penicillin
0832725,09/09/2019,AR,13.0,13,,M,,Adult dose of 50 units was given to 13 year old patient instead of the ped/adolescent dose of 25 units.,,,,,,,,,,09/05/2019,09/09/2019,4,n/a,PVT,,,,,,,2,09/09/2019,,,,
0832726,09/09/2019,CA,60.0,60,,M,,Severe flu like symptoms with fever,,,,,,,,,Y,06/18/2018,06/18/2018,0,,PVT,,Hypertension      Triamterene/HCTZ cap 37.5/25 1 AM AMLODIPINE/OLMESARTAN tabs 10/40 MG 1 AM Metoprolol Succ(Toprol) Er Tab 50 mg 1 AM Potassium CL ER 20 MEQ TAB 1 AM    Cholesterol       Vascepa 1 gram 2 AM Vascepa 1 gram 2 PM Rosuvastatin,none,Type II Diabetes,,,2,09/09/2019,,,,none
0832727,09/09/2019,NY,65.0,65,,F,,"Patient reports redened area, warm to the touch surrounding area of vaccination to left upper arm. Patient reports pain and discomfort at injection site. Denies fever started 9/6/19, the day after vaccination.",,,,,,,,,Y,09/05/2019,09/06/2019,1,,OTH,,"Meclizine 25mg, MVI, Voltaren 1% gel, Ditropan XL 10mg, Aspirin 81mg, Losartan Potassium 50mg, Carvedilol 25mg, Gabapentin 300mg, Melatonin 10mg, Amitriptyline HCL 10mg","Light Headache, dizziness, swelling right foot with pain","Hypertension, Combined Hyperlipidemia, Fatty Liver, Vitamin D Deficiency, Nephrolithiasis, Osteoarthritis",,,2,09/09/2019,,Y,,No known drug or food allergies
0832728,09/09/2019,TX,10.0,10,,F,,Rash on the face and torso.,,,,,,,,,Y,08/12/2019,08/23/2019,11,None.,PVT,,None.,None known.,None.,,,2,09/09/2019,,,,None known.
0832729,09/09/2019,SC,55.0,55,,F,,patient states her arm & shoulder are still painful & is unable to lift her arm,,,,,,,,,N,08/26/2019,08/26/2019,0,,PHM,,,,,,,2,09/09/2019,,,,
0832730,09/09/2019,MI,52.0,52,,F,,Heated Red Patch that continued to expand. Arm Soreness that lasted more than a week. Extreme Fatigue that continued past a week.,,,,,,,,,U,08/29/2019,08/29/2019,0,,PHM,,Sertraline 100 mg tablet propranolol 20 mg tablet alprazolam 1 mg tablet buspirone 10 mg tablet quetiapine 100 mg tablet quetiapine 50 mg tablet,None known,,,,2,09/09/2019,,Y,,None Known
0832733,09/09/2019,VA,11.0,11,,M,08/26/2019,"Patient received Tdap/Boostrix and MCV4/Menveo at our office on 08-20-2019 in his left deltoid. Presented to office today 08-26-19 with redness and heat to left deltoid. Area is flat, no hardness noted. Will treat with ice pack to area. Started 08-25-19. Per Dad: put ice on it 08-30-19 and it went right away.",,,,,,,,,Y,08/20/2019,08/25/2019,5,,PUB,PVT,None,None,,,,1,,,,,
0832734,09/09/2019,VA,1.25,1,.3,F,09/07/2019,"Pt seen on 9/7 with multiple chicken like spots (papules) on torso, arms, leg",,,,Y,,,,,Y,08/28/2019,09/06/2019,9,,PVT,PVT,,0,0,,,1,,,,,
0832749,09/09/2019,IL,0.5,,,U,,"six months old patient received a dose of pneumovax23; no adverse effect; This spontaneous report was received from a registered nurse referring to a 6-month-old patient of unknown gender. The patient's concurrent condition, medical history and concomitant therapy details were not reported.     On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, frequency, route of administration, lot# and expiry date were not reported) for prophylaxis (product administered to patient of inappropriate age). No adverse event was reported. No product quality(PQC) complaint was filed.; Sender's Comments:  US-009507513-1909USA002286:",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA002944,2,09/09/2019,,,,
0832750,09/09/2019,FL,,,,U,,"suspected vaccination failure; flu; This case was reported by a other health professional via sales rep and described the occurrence of suspected vaccination failure in an unknown number of patients who received Flu Seasonal QIV Dresden (Fluarix Tetra) for prophylaxis.   On an unknown date, the patient received Fluarix Tetra at an unknown dose. On an unknown date, unknown after receiving Fluarix Tetra, the patient experienced vaccination failure (serious criteria GSK medically significant) and influenza. On an unknown date, the outcome of the vaccination failure and influenza were unknown.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Fluarix Tetra.  Additional details were provided as follows: The age at vaccination was not reported. The health care professional reported that in his experience patients had come down with the flu after being vaccinated with Fluarix. This case was considered as suspected vaccination failure, since the details regarding the time to onset for event and dose number were not provided. The reporter did not give permission for follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832751,09/09/2019,MI,,,,U,,"The pain shoots down the arm all the way to the fingers; Disables the arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In March 2019, the patient received the 2nd dose of Shingles vaccine. In April 2019, 30 days after receiving Shingles vaccine, the patient experienced pain in arm and injected limb mobility decreased. On an unknown date, the outcome of the pain in arm and injected limb mobility decreased were unknown.   It was unknown if the reporter considered the pain in arm and injected limb mobility decreased to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient stated that about a month after receiving the vaccine began experiencing extreme pain at the injection site if raised arm above the shoulder. The patient stated that, the pain shoots down the arm all the way to the fingers and disables the arm for a period of 1 minute. The patient did some research on side effects of the shot and have found that approximately 1 in 6 people who get the shot experience a similar reaction.",,,,,,,,,U,03/01/2019,04/01/2019,31,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/09/2019,,,,
0832752,09/09/2019,NJ,68.0,68,,F,,"Night injections in both arms had heat at injection site, fever, aches and pains.  Has lasted for two weeks with arms itching and overall weakness, dizzyness and night sweats.",,,,,,,,,N,08/26/2019,08/26/2019,0,Trying to get appointment with primary Dr.,PHM,,"Super B, D and Omega vitamins",severe Spinal Stenosis and neuropathy lower extremities diagnosed April 2019,none,,,2,09/09/2019,,,,Contrast dye for testing
0832753,09/09/2019,,4.0,4,,F,,woke up after the vaccines with a fever and large and hot bump on her upper right arm. Resolved the next day,,,,,,,,,Y,09/03/2019,09/04/2019,1,,PVT,,,,,,,2,09/09/2019,,,,
0832754,09/09/2019,,18.0,18,,F,,"patient had cold sweats, chills, low grade fever of approx 99. Her arm is sore, symptoms occurred the following day",,,,,,,,,U,09/04/2019,09/05/2019,1,,PVT,,,,,,,2,09/09/2019,,,,
0832755,09/09/2019,FL,58.0,58,,F,,Received vaccine after rubella titer came back not immune.  Vaccine given on 8/23/19.  Developed rash and stiffness to joints on 9/6/19.  Report incident to our office 9/9/19.  Her rash and stiffness to joints have diminished from initial encounter but wanted to report incident to our employee health office .,,,,,,,,,Y,08/23/2019,09/06/2019,14,,OTH,,none,No,None,,,2,09/09/2019,,Y,,None
0832756,09/09/2019,CA,11.0,11,,M,,"Parent reported 2 days after vaccination :   On the afternoon after vaccination, patient exhibited shortness of breath, dizziness and nausea.  No action was taken at the time of the symptoms.  Nausea, fever and fatigue continued for the following 2 days.  Appointment  was recommended but declined by parent (father).",,,,,,,,,Y,09/04/2019,09/04/2019,0,None,PVT,,None,None,None,,,2,09/09/2019,,,,NKA's
0832757,09/09/2019,VA,,0,.1,M,,Stopped Breathing - turned Blue - started having Seizures. Transferred to a Hospital - had uncontrollable seizures and apnea for 20 days.  Was put on two anti seizure meds.,,,,,,,,,U,11/23/2018,11/24/2018,1,Spinal Tap - Negative  Ultrasound - Negative  MRI - Normal  4 EEG?s - Seizure Activity,PVT,,N/A,N/A,,,,2,09/09/2019,,,,N/A
0832758,09/09/2019,IL,6.0,6,,F,,Syncopal episode approximately 10-15 minutes after the vaccine. Patient starting to fall. Mom grabbed her and together we had her lie down on the exam table. I elevated her legs and began taking her vitals.,,,,,,,,,Y,09/08/2019,09/08/2019,0,N/A,OTH,,None,None,None,,,2,09/09/2019,,,,None
0832759,09/09/2019,KS,85.0,85,,F,,"Patient presented with a rash on her chest, neck, and face that occurred 5 days after the Shingrix shot. She went to the Dr and it was 75% resolved. She had not SOB, wheezing, etc.  She declined treatment for the rash at that time. She was given prednisone to take with the 2nd shot.",,,,,,,,,Y,08/12/2019,08/17/2019,5,none,PHM,,,,,,,2,09/09/2019,,Y,,"Sulfa, ace inhibitors"
0832760,09/09/2019,IN,66.0,66,,F,,L ear hearing loss,,,,,,,,,N,10/08/2018,10/09/2018,1,"hearing test, physical evaluation",OTH,,None,None,None,,,2,09/09/2019,,Y,,None
0832761,09/09/2019,IL,68.0,68,,F,,"pt had low fever on 09/07 and gone on 09/08 AM, but left arm was red and pain. on 09/09 AM pt feel nausea and fever again, arm still pain and red.",,,,,,,,,N,09/07/2019,09/08/2019,1,N/A,UNK,,,no,no,,,2,09/09/2019,,Y,,"morphine, sulfa, trimethoprim, hydrocodone."
0832762,09/09/2019,,65.0,65,,F,,"9/6/20197 AM body aches, including neck, hips, low back. Fatigue. 1,000 mg Tylenol taken at 8 AM . Within 45 mins, symptoms abated. 6 hours later, symptoms reappeared. Another dose of Tylenol 1,000 mg taken at 2:30 PM. 6:00 PM fever 100.5 (normal temp 97.4).  Slept through the night  6/7/19 Awoke 7 AM, fatigued, less achyness, but some,  sore arm, large hot red area at injection site. Tylenol every 6 hours through the day.   9/8/19 symptoms gone, except for redness and heat at injection site. Still sore to the touch 1000 mg tylenol taken at 1 PM  9/9/19 all symptoms except redness and heat at injection site gone",,,,,,,,,Y,09/05/2019,09/06/2019,1,,UNK,,none,none,none,,,2,09/09/2019,,,,none
0832763,09/09/2019,TX,72.0,72,,F,,swelling and tenderness to the muscle,,,,,,,,,N,08/29/2019,09/06/2019,8,none,PHM,,"vitamin D ,  Fish oil  and aspirin",not sick prior to vaccination,"high blood pressure , diabetes",,,2,09/09/2019,,,,none
0832764,09/09/2019,AK,55.0,55,,F,,"Extreme drainage from nose, then developed into severe cough and flu-like symptoms. Ended up flat in bed without being able to drink or eat for 3 days, missed a week of work. Tested and did not have flu, but determined had flu-like virus..With help from my holistic doctor treating adverse reaction to the shingrix vaccine, I began drinking and eating and am recovering.",,,,,,,,,Y,08/30/2019,09/01/2019,2,"Wednesday, September 3, 2019 - tested for flu virus. negative. Determined had another flu-like virus",PHM,,"Flovent, Rhinocort, Singulair, XYZAL, NAC, Adrenal Complex, Vitamin D., Vitamin B, Probiotic, Similase Sensitive Stomach, Omega 3, Mometasone Furoate Ointment 1%, Clotrimazole Topical Solution 1%, Nystatin Ointment 30 GM, Ketoconazole Shamp",,"endometriosis, morphia, gastritis",,,2,09/09/2019,,Y,,"Formaldehyde, gold, shellfish, eggs, tomatoes, strawberries, dairy, sulpha drugs, robitussin, aspirin,"
0832765,09/09/2019,PA,45.0,45,,F,,"I have no idea which Tdap vaccine was used, ask hospital. Next day I had sharp stomach aches in the lever area all day. Also, I had pain in my arm at the shot area. Then, I had slight fever couple of times over the night and sharp stomach aches continued. During night severe diarrhea began.  All next day my stomach aches got heavier and longer, diarrhea continued until next morning. I had no appetite, felt very tired, had mild fever few times during the day. All problems began to subside in the morning on 09/08/2019, three days after shot was given. I did not seek any medical help, as it was during weekend.",,,,,,,,,Y,09/04/2019,09/05/2019,1,,PVT,,"Iron, Fluconazol",None,,,,2,09/09/2019,,,,none
0832766,09/09/2019,FL,14.0,13,,F,,"Redness and swelling the size of a tennis ball, and it was itchy.  Resolved with cool and warm compresses.",,,,,,,,,Y,08/29/2019,08/29/2019,0,,PVT,,,,,,,2,09/09/2019,,,,
0832767,09/09/2019,AZ,,,,U,,"three patients received a dose of high dose fluzone which shipment was delayed for 48 hours, Three patients received the dose/No AE; Initial information received on 30-Aug-2019 regarding an unsolicited valid non-serious case received from a non-health care professional (pharmacy other).  This case involves three patients of unknown demographics who received a dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] which shipment was delayed for 48 hours lot number and expiry date not reported (route and site of administration not reported).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to incorrect product storage.  Adverse event was not reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA245138,2,09/08/2019,,,,
0832768,09/09/2019,PA,,,,M,,"He has had a bloody nose for three days; Initial information received on 30-Aug-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 6 years old male patient who experienced bloody nose for three days (epistaxis), while he received vaccine IPV (VERO) [IPOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing cerebral cyst.   On an unknown date, the patient received a dose of suspect IPV (VERO) lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient had a bloody nose for three days (epistaxis) (Unknown latency) following the administration of IPV (VERO).  Final diagnosis was epistaxis.   It was not reported if the patient received a corrective treatment.  The patient outcome was reported as unknown for epistaxis.  List of document held by sender: none.",,,,,,,,,U,,,,,UNK,,,Cerebral cyst,,,USSA2019SA245870,2,09/09/2019,,,,
0832769,09/09/2019,WA,31.0,31,,F,,"Patient reported to the clinic because her PCP is here. states she got a second dose of the varicella  Vaccine at pharmacy last night between 4 & 5. This morning she noticed the approximately 3"" chickpox like rash at the injections site. the rash itches, red , mild discomfort, no fevers.",,,,,,,,,N,09/08/2019,09/09/2019,1,None,PHM,,Sertraline HCL 50 mg Oral Tab,None,Hormone Imlabance IBS Diverticulitis migraine headache,,,2,09/09/2019,,Y,,None
0832770,09/09/2019,NM,,0,.0,M,,PER PATIENT MOTHER HAD REACTIONS TO HEP B WHICH INCLUDED SWELLING/RASH TO BILATER LOWER EXTREMITIES AND LOWER ABDOMEN GIVEN AT ANOTHER FACILITY.  ROTATEQ GIVEN PO  ON 01/17/2014 1ST DOSE SERIES PER PATIENT MOTHER STATES CAUSED BOWEL ISSUES AND PATIENT HAD TO BE SEEN IN THE ER,,,,,,,,,Y,09/12/2013,09/01/2013,,UNKNOWN,PVT,,UNKNOWN,UNKNOWN,UNKNOWN,,,2,09/09/2019,,,,UNKNOWN
0832771,09/09/2019,LA,64.0,64,,F,,"PATIENT HAD RED, ITCHY SITE REACTION",,,,,,,,,Y,09/04/2019,09/08/2019,4,N/A,PHM,,SIMVISTATIN 40 CITALOPRAM 20 CHLORTHALIDONE 25  METOPROLOL TARTRATE 25 TOPIRAMATE 25 RELPAX 15  ZIGDUO XR TAB  OTC ESOMEPRAZOLE 20 FISH OIL 1200  OSTEO BI-FLEX CETIRIZINE 10,,HBP DIABETES,,,2,09/09/2019,,,,NKDA
0832772,09/09/2019,FL,18.0,18,,F,,"Patient reported numbness in hand, headache, nausea, and swelling in throat",,,,,,,,,U,09/09/2019,09/09/2019,0,At ~3:00pm BP was 113/87 with HR of 90,PHM,,,Stomach ulcers,,,,2,09/09/2019,,,Y,Blueberries and grapes
0832773,09/09/2019,OR,58.0,58,,F,,"Fever of 101.3. For 4 days of fever, chills, vomiting, fatigue.",,,,,,,,,Y,08/06/2019,08/07/2019,1,,PHM,,,,,,,2,09/09/2019,,Y,,
0832774,09/09/2019,AZ,61.0,61,,F,,VERY BIG RED AND BLACK SPOTS WITH SWELLING AND LITTLE ITCHING FOR LAST 3 DAYS AND STILL NOT GOING AWAY,,,,,,,,,N,09/06/2019,09/07/2019,1,UNKNOWN,PHM,,UNKNOWN,NONE,NONE,,,2,09/09/2019,,,,NO KNOWN ALLERGY
0832775,09/09/2019,WI,63.0,63,,M,,Patient called me on 9/8/19 at 10 am and let me know that around 10 pm on 9/7/19 he started to experience fits of hiccuping followed by vomiting. This continued throughout the night until around 8 am the next morning. When he and I spoke at 10 am he was still feeling nauseous but was no longer hiccuping or throwing up.,,,,,,,,,Y,09/07/2019,09/07/2019,0,n/a,PHM,,Lisinopril,None reported,High blood pressure,,,2,09/09/2019,,,,none reported
0832776,09/09/2019,IL,17.0,17,,M,,Patient 17yo  presented to the office that had never had any vaccinations. Wrong vaccinations given per patient age per doctors order.,,,,,,,,,Y,09/09/2019,09/09/2019,0,none,PVT,,none,no known illnesses,none,,,2,09/09/2019,,,,no known allergies
0832777,09/09/2019,FL,16.0,16,,M,,"ON 09/05/2019 LEFT UPPER ARM RED AND HOT WHICH STARTED AT INJECTION SITEAND WENT HALF WAY DOWN THE ARM AND THE TISSUE HAD WRINKLY WAVY LINES THROUGH IT AND ON 09/06/2019 HE HAD A FEVER ALL DAY AND THE ARM WASNT AS HARD, ON 09/07/2019 REDDNESS AND SWELLING WAS RECEEDING AND FEVER DOWN 09/09/2019 ARM IS MUCH BETTER. TREATMENT CEFDINIR 600MG FOR 10 DAYS AND DIPHENHYDRAMINE 50MG EVERY 6 HOURS FOR 72 HOURS.",,,,,,,,,Y,09/03/2019,09/05/2019,2,,PVT,,NONE,NONE,NONE,,,2,09/09/2019,,Y,,NONE
0832778,09/09/2019,ID,50.0,50,,F,,"At about 0330 on 09/07/19  patient began having nausea, vomiting, body aches, chills, extreme sweating, pain and redness around injection site, and fatigue. Patient took Tylenol for pain, but could not hold anything down due to nausea. Signs and symptoms resolved by the evening of 09/08/19.",,,,,,,,,Y,09/06/2019,09/07/2019,1,None,PUB,,None,None,Asthma,Shingrix on 07/01/19. Patient was 50 years old at time of vaccine and experienced similar symptoms to the reactions reported ear,,2,09/09/2019,,Y,,None
0832779,09/09/2019,TN,12.0,12,,F,,"Golf ball size knot within 2 hours as well as slight fever in arm. After acetaminophen and an ice pack overnight, fever increased in arm and large red mark. ***TYPE OF INFLUENZA VACCINE NOT KNOWN.",,,,,,,,,N,09/08/2019,09/08/2019,0,"9/9/19 visit to doctor confirming injection site reaction. Seeing a NP. She also prescribed an antibiotic in case is was a case of cellulitis as my son, meds of Quillivant and singular had the same reaction.",PHM,,Acetaminophen,NA,ADHD,,,2,09/09/2019,,Y,,NA
0832780,09/09/2019,TN,1.25,1,.3,M,,"Fever developed 6 hours after immunization--Received ibuprofen/tylenol, rash developed about 15-18 hours after immunization and he was a bit more tired and clingy than normal.  rash looked similar to the post viral exanthum type of rash.",,,,,,,,,U,09/03/2019,09/03/2019,0,patient seen in office and reassurances offered.,PVT,,none,no known,none,,,2,09/09/2019,,Y,,none
0832781,09/09/2019,CA,65.0,65,,F,,"After gettting the shots, at nighttime, patient complaint of hot/ burning, swollen, very sore, painful and red (but not itchy) left upper arm. In the afternoon of the next day when she came to the pharmacy to share with us, we took some photos to document it and to make sure the redness did not spread some more.",,,,,,,,,U,09/07/2019,09/07/2019,0,none,PHM,,"valcyclovir, atorvastatin, hydrochloroquine and estradiol",none,,,,2,09/09/2019,,,,none
0832782,09/09/2019,VA,70.0,70,,F,,"Itchy hives on anterior & posterior trunk & face. Swelling, redness, pain, and warmth at injection site.",,,,,,,,,N,09/07/2019,09/07/2019,0,None done,PHM,,"losartan, atenolol, pravastatin, vitamins, fish oil, ranitidine",mastitis,"HTN, GERD, hyperlipidemia",,,2,09/09/2019,,Y,,diclofenac
0832783,09/09/2019,CO,57.0,57,,F,,"Patient came into our clinic on 09/09/19 with significant swelling at sight of injection, site was hot to the touch, and felt knotted at the site. According to patient this was the 3rd day she said that the 24 hours after the injection she felt fine but that she started to  notice that the sight was swelling hot to the touch and felt a bump, she also explained that due to pain she was unable to rest on her right side and that she felt fatigued the past 2 days.",,,,,,,,,U,09/04/2019,09/06/2019,2,"Our physician assessed the injection site, stated no noticeable sign of infection and suggested that the patient come back on Friday 09-13-19 to follow-up he also suggested that should she feel that her condition has worsened she come in before Friday, September 13th.",WRK,,"Zoloft, Hydrochlorothiazide, Fexofenadine, Losartan, Potassium",None,None,,,2,09/09/2019,,Y,,"Erythromycin, Tetracycline"
0832784,09/09/2019,NY,15.0,15,,F,,PATIENT FELT FAINT AND EXPERIENCED SYNCOPE,,,,,,,,,Y,09/08/2019,09/08/2019,0,NONE,PHM,,NONE,NONE,GOOD,,,2,09/09/2019,,,,NONE
0832785,09/09/2019,SC,68.0,68,,M,,"Patient had a rash, soreness, warmth, and swelling on her arm which she received the flu shot",,,,,,,,,N,09/05/2019,09/08/2019,3,,PHM,,,,,,,2,09/09/2019,,Y,,
0832786,09/09/2019,CO,67.0,67,,F,,she got pneumovax 23 and developed redness on the arm,,,,,,,,,U,09/07/2019,09/08/2019,1,The patient went to the doctor today and got Keflex for 10 days,PHM,,unknown,none,none,,,2,09/09/2019,,Y,,nkda
0832787,09/09/2019,AZ,76.0,76,,M,,"Pt began experiencing pain within 24 hours after receiving the vaccine. Pt also had an extremely large bruise around the vaccination site, he said when he received the vaccine he did not experience any pain",,,,,,,,,N,09/04/2019,09/05/2019,1,n/a,PHM,,n/a,n/a,hypertension Hyperlipidemia,,,2,09/09/2019,,,,n/a
0832788,09/09/2019,NY,1.75,1,.8,M,,Fever 101.6 by 5pm as well as large raised deep red hives or spots. Hot to the touch.  He won't stand or let anyone touch his legs Especially tge right one. Hip to ankle in red spots,,,,,,,,,,09/09/2019,09/09/2019,0,,PVT,,,,,Dtap,,2,09/09/2019,,,,
0832790,09/09/2019,CA,0.5,0,.5,F,,She woke me up at 5 am going through a seizure and she had two more at the hospital!,,,,,Y,,,,U,09/04/2019,09/05/2019,1,They did a CAT scan and MRI and an EEG the CAT scan and MRI showed her brain abnormalities but she passed the EEG now we did a genetics test waiting on the results,PVT,,Nystatin for oral thrush,None,After my daughter was hospitalized because of the seizureI did an MRI and found That she has dysgenesis of the corpus callosum them but they said this did not cause her seizures,,,2,09/09/2019,,,Y,None
0832791,09/09/2019,PA,59.0,59,,M,,"PT CAME TO THE PHARMACY COMPLAINING ABOUT RASH , REDNESS AND TIREDNESS. PT WAS DIAGNOSED WITH SHINGLE ON 09/09/2019 AS WELL",,,,,,,,,Y,08/30/2019,08/31/2019,1,NA,PHM,,NA,NOTHING,NOTHING,,,2,09/09/2019,,Y,,NOTHING
0832792,09/09/2019,IN,26.0,26,,M,,DONOR REPORTED SEVERAL WELTS APPEARED ONLY ON HIS L ARM WHERE SHOT WAS GIVEN THE DAY AFTER RECEIVING THE IMMUNIZATION. DONOR STATES THE WELTS LASTED FOR 2 DAYS AND  RESOLVED  ON THEIR OWN. DONOR DID NOT SEEK MEDICAL TX .,,,,,,,,,Y,09/03/2019,09/04/2019,1,NONE,OTH,,NONE,NONE,NONE,,,2,09/09/2019,,,,DONOR STATES ALLERGY TO IODINE/BETADINE
0832793,09/09/2019,PA,31.0,31,,M,,Pt experienced increasing pain and redness at the injection site.,,,,,,,,,N,09/07/2019,09/07/2019,0,none,PHM,,"sucralfate, docusate sod, dicyclomine, metformin, gabapentin",unknown,diabetes,,,2,09/09/2019,,Y,,nka
0832794,09/09/2019,KY,58.0,58,,F,,rash on injection site and under breasts/across front torso. started night of vaccine or next day and continued a week. rash would go away and come back on torso/under breasts faintly. notices that rash begins after playing sports in the heat. rash has resolved now and patient doesn't have any ongoing issues. patient is consulting with md to see if can get dose 2.,,,,,,,,,Y,06/08/2019,06/09/2019,1,,PHM,,,,,,,2,09/09/2019,,,,
0832795,09/09/2019,NM,0.25,0,.3,F,,Patient was administered HIB vaccine by mouth instead of intramuscularly at 9/9/19 @ ~1200.  Pt was observed for 30 minutes post-ingestion and no adverse reactions were observed.  Poison Control was contacted 9/9/2019 @ 1215 and they recommended to vaccinate the child correctly today and that no adverse reactions were anticipated.,,,,,,,,,Y,09/09/2019,09/09/2019,0,None,PVT,,None,None,None,,,2,09/09/2019,,,,None
0832796,09/09/2019,NY,1.0,1,.0,M,,Inconsolable screaming that evening. Spreading rash that evening increasing the following days.,,,,,,,,,Y,08/08/2019,08/08/2019,0,Doctor is visit (approximately) 3 days after the vaccine. Doctor stated it was likely a reaction to the vaccine.,PVT,,None,None,No,,,2,09/09/2019,,Y,,Cows milk allergy
0832797,09/09/2019,AZ,61.0,61,,F,,"Within the first week of having the vaccination, I noticed handfuls of hair loss.  Within the 4 weeks after the injection so much hair loss, hair breakage and thinning resulted in me having to purchase a full wig.  For 6-8 weeks after the injection I also experienced excessive coughing,  and difficulty breathing that my rescue inhale could not handle so I was using a nebulizer to get relief.",,,,,,,,,U,07/03/2019,07/09/2019,6,"Chem panel, thyroid, hormones estrogen and testosterone,  all tests were negative",PVT,,"Breo, ProAir, mulivitiamin",none,Asthma,,,2,09/09/2019,,Y,,none
0832798,09/09/2019,HI,72.0,72,,M,,pt developed rash from elbows down to fingers within 48 hours of recieving flu vaccine,,,,,,,,,U,09/03/2019,09/05/2019,2,Pt visited his primary MD and got rx for prednisone for rash,PHM,,"lisinopril, hydrochlorothiazide, amlodipine",none known,hypertension,,,2,09/09/2019,,Y,,no known
0832833,09/09/2019,IN,16.0,16,,F,,"Gave patient wrong vaccine instead of Menactra I gave her Bexsero (which are almost similar) per RN. Bexsero is recommended at age 16 like a booster vaccine and she shouldn't have any reactions to the vaccine, N.P and I",,,,,,,,,,08/28/2019,,,NO test done,SCH,,NONE,NONE,NONE,,,2,08/28/2019,,,,NKDA
0832834,09/09/2019,FL,64.0,,,F,,"on 9/3/19, I had the first dose of the SHINGRIX 50 MCG vaccine. Within hours, the injection site was beginning to swell. Within 24, I had a headache, nausea, fever, and chills. These symptoms lasted about 36 hours. 5 days later, the injection site is still swollen, red, and warm.",,,,,,,,,,,09/03/2019,,,UNK,,simvastatin 20 levothyroxine 0.075mcg multivitamin D3 Fish oil probiotic,,"diabetes, high cholesterol, hypothyroid",,,2,09/07/2019,,,,"ambien,levoquin"
0832835,09/09/2019,WA,,57,,M,,Got second shingles vaccine injection about 6PM. Just as I was about to fall asleep in bed (11:30PM) I began to shiver. It lasted about 2 hours.,,,,,,,,,,07/05/2019,09/03/2019,60,,UNK,,"cpap machine, propranolol B-complex, D3, magnesium, krill oil",,"high blood pressure, depression, sleep apnea",,,2,09/05/2019,,,,cat dander
0832836,09/09/2019,,,,,F,,Got shingrix # 2 on left deltoid. Claims huge lipoma left shoulder chest wall after that,,,,,,,,,,,11/21/2018,,US/ MRI chest (13 x 8 cm Lipoma),UNK,,,,,,,2,08/27/2019,,,,
0832837,09/09/2019,OH,62.0,62,,F,,"C/O shivers for 2 days after receiving vaccine on 9/1/19, noticed bumps on wrist of right arm. Bumps have continued to increase & are covering 3/4 of her arm. They itch & states had 10-12 bumps currently. Encouraged client to call her PCP to be seen. 9/9/19 Talk to client Left message to return call re condition of bumps on arm & if saw PCP. Client returned call & left message. States she seen her PCP on Friday 9/6/19 & is being treated for shingles. States is taken an antiviral medication & antibiotic medication.",,,,,,,,,N,08/27/2019,09/01/2019,5,,PUB,,,,none,,,2,09/05/2019,,Y,,"Penicillin, codeine"
0832838,09/09/2019,FL,62.0,62,,M,,"pt came to pharmacy on 9/9/19 around noon time reported that his arm is still sore, had constant vomiting post vaccination and had to call 911- he had his shot on 9/5/2019 and he had to take 3 advils po for pain. as per pt, his side effects were more moderate such as arm soreness ( still painful). he said, he went to hospital and did all reports, check up, MRI- but everything was normal, and they did not find anything wrong as per pt. he has ENT visit coming up next to find out more.  educated pt on common side effects such as soreness, HA, redness, injection site pain. but pt was saying his side effects were not mild and he had to call 911 because constant vomit & not feeling well post vaccine",,,,,,,,,,09/05/2019,09/06/2019,1,,UNK,,,,,,,2,09/09/2019,,,Y,
0832839,09/09/2019,CA,0.5,0,.5,F,,"Pt has had fever every day since vaccine - @ 101.3 & watery diarrhea, spitting up after breast feedings, more lethargic. No rednes or swelling at sites.",,,,,,,,,N,09/05/2019,09/05/2019,0,,PVT,,Motrin,,,,,2,09/09/2019,,Y,,None
0832840,09/09/2019,WA,9.0,9,,F,,Swelling and bruising of arm where vaccine was administered. Also caused entire body aches. Treating with Acetaminophen and Benadryl.,,,,,,,,,Y,09/06/2019,09/06/2019,0,N/A,PVT,,N/A,N/A,N/A,,,2,09/09/2019,,Y,,Amoxicillin
0832841,09/09/2019,IL,,84,,U,,"Pt. had pain in left arm, which was intense in 1st week, which diminished. Pt used Tylenol w/pain, with some relief. Patient still has some residual pain 2 months after",,,,,,,,,U,07/11/2019,07/12/2019,1,None,PHM,,Tylenol after vaccination,None,Hypothyroidism,,,2,09/09/2019,,,,NKDA
0832842,09/09/2019,CA,11.0,11,,F,09/09/2019,"Lt deltoid a size of an egg. Swelling warm on the area. Some pain. Mom gave pt Benadryl, Motrin and hydrocortisone cream was applied. By the day after reaction was mostly cleared.",,,,,,,,,Y,08/30/2019,08/30/2019,0,,PVT,PVT,,None,,,,1,,,,,
0832843,09/09/2019,CA,31.0,31,,F,,"9/6/2019 12:35 pm c/o quarter size bump at (L) deltoid; hot & itchy, sl. redness. (- SOB, - fever) 9/6/2019 4:21 PM - swelling @ (L) lymph node 9/9/2019 9:33 AM - (L) clavicle pain/swelling resolving",,,,,,,,,Y,09/05/2019,09/06/2019,1,N/A,PVT,,,,,,,2,09/09/2019,,,,"latex, Diflucan, PCN"
0832844,09/09/2019,NY,11.0,11,,M,09/06/2019,"Local swelling, warmth & mild erythema at right upper arm & extending into right axilla",,,,,,,,,U,09/04/2019,09/06/2019,2,0,PVT,PVT,,0,"Allergic Rhinitis, Chiari Malfunction",,,1,,,,,
0832845,09/09/2019,PA,79.0,79,,F,,"patient reported to pharmacy with red blotching near injection site. Also complained of nausea, chills, fatigue and increased heart-rate",,,,,,,,,N,09/06/2019,09/09/2019,3,,PHM,,"amlodipine, celecoxib, hctz, and pantoprazole",none,unknown,,,2,09/09/2019,,,,penicillin
0832847,09/09/2019,VT,5.0,5,,F,,"Fever, arm redness & swelling 8/29/19",,,,,,,,,Y,08/28/2019,08/29/2019,1,0,PVT,PUB,,0,,,,1,,,,,
0832861,09/09/2019,AZ,66.0,66,,M,,Patient had severe bruising on 9/6 since vaccine administration.,,,,,,,,,N,08/27/2019,08/27/2019,0,,PHM,,,,,,,2,09/06/2019,,,,None
0832862,09/09/2019,NY,40.0,40,,F,,"Called Public Health (where treatment was authorized) 8/21 and c/o numbness, tingling, feeling ""on fire"" since ""earlier"" in the day. Advised PCP, who advised ED. Presented c/o light-headedness, SOB, Nausea, tingling and syncope. Responded to IVF and Zofran, discharged later in day. Denied similar Sx w/subsequent doses, and has since complete Rabies PEP series.",,,,,,,,,Y,08/20/2019,08/21/2019,1,"CBC, BMP, UA, free T4, TSH, urine preg, ECG, CXR, IVFluids, IV Zofran, orthostatic BPs.",PVT,,"Zoloft, Klonopin, Topamax, Gabapentin, Trazodone",UTI treated with Macrobid w/ little improvement of Sx,"Anxiety, Panic disorder, Anorexia, Depression, Asthma, GERD, migraines w/aura",,,2,09/06/2019,,,Y,"Cipro, Gentamicin, PCN, Sulfa, Azithromycin"
0832886,09/09/2019,AZ,60.0,60,,F,,Patient had broken out in a red stinging/burning rash on the inside of her (R) arm all the way down starting on 9/5/19. Patient came into the clinic on 9/6/19 was evaluated and given a kenalog shot and told to go to ER if she got woRse.,,,,,,,,,U,09/04/2019,09/05/2019,1,,PHM,,,,,,,2,09/06/2019,,Y,,
0832909,09/09/2019,,70.0,70,,M,03/25/2018,Fever,,,,,,,,,U,03/20/2018,03/20/2018,0,,OTH,OTH,,,,,,1,,,,,
0832911,09/09/2019,OH,66.0,66,,M,04/29/2019,Patient presented to clinic to be evaluated. SkinRash & Chills,,,,,,,,,U,04/25/2019,04/26/2019,1,,OTH,OTH,,,,,,1,,,,,
0832912,09/09/2019,,68.0,68,,M,07/02/2018,Dizziness & Rash,,,,,,,,,Y,06/26/2018,06/26/2018,0,,OTH,OTH,,,,,,1,,,,,
0832967,09/09/2019,,69.0,69,,M,05/08/2019,Myalgia & flu like symptoms,,,,,,,,,U,05/03/2019,05/04/2019,1,,OTH,OTH,,,,,,1,,,,,
0833248,09/09/2019,AZ,,,,F,,"24 hrs after immunization, had rotator cuff type pain, especially when reaching. Arm goes limp and painful upon most but not all movements. Debilitating. Struggling to changes clothes by onseself. Pain/unable to reach to wash hands without good arm assisting. Seems like SIRVA possibly due to bad injection location. Headed to urgent care today. Problem is with medical service injecting too high on the arm (1-2 fingers width down instead of 3 fingers width down). Also provider stood while patient sal.",,,,,,,,,,09/05/2019,09/06/2019,1,,UNK,,None; None,None,None,,,2,09/07/2019,,,,Amoxicillin penicillin
0832799,09/10/2019,LA,12.0,11,,F,,"Joint pain, chronic fatigue, depression, headaches, muscular aching, fibromyalgia symptoms",,,,,,,,,N,06/01/2011,07/01/2012,396,Rheumatologist visits and bloodwork 2015 and 2019,PVT,,None,None,None,,,2,09/10/2019,,Y,Y,None
0832800,09/10/2019,MI,29.0,29,,F,,"patient had redness, swelling, and warm to the touch of injection site and pain that went up into her neck. Patient was prescribed Pepcid, Prednisone, and Clindamycin. Patient should be taking steroids for the next 7 days. Patient was also given Methylprednisolone at time of visit before she left.",,,,,,,,,,09/05/2019,09/06/2019,1,,PVT,,None,None,"Ovarian Cyst Bilateral, Rheumatoid arthritis, Bipolar, Alcohol Related Seizures, GERD",,,2,09/10/2019,,Y,,"Antihistamines, Tramadol"
0832801,09/10/2019,OH,61.0,61,,M,,"Site edema, redness, and pain; Left shoulder swelling and Pain; Left anterior aspect of neck swelling, pain; General malaise, nausea, chills, and headache",,,,,,,,,Y,08/13/2019,08/13/2019,0,,PVT,,Prenatal/Folic Acid; Aspirin; Men's Multivitamin,None,Peritoneal Adhesions; Actinic Keratosis; Lipoma; Bladder Hypertrophy; Cataracts bilateral; Colonic Diverticulosis; Diabetes Mellitus Type II; HTN; GERD; HLP; Inguinal Hernia Bilateral; Insomnia; Obesity; Osteoarthritis; Presbyopia; Refractive Error - Hypermetropia; Rheumatoid Arthritis; Ventral Hernia,,,2,09/10/2019,,Y,,Atorvastatin; Bandaging Tape
0832802,09/10/2019,NY,65.0,65,,F,,"Extreme pain in arm,  unable to move arm in any direction.  Lasted 12 hours.  Could not drive. Could not use arm at all.",,,,,,,,,Y,09/09/2019,09/09/2019,0,,PVT,,Gabapentin 600 mg Ropinarole  Crestor,None,None,,,2,09/10/2019,,,,Bees
0832809,09/10/2019,CA,,,,U,,"No adverse effects reported; a 32 year old patient, received one dose of PROQUAD/Adult patient received PROQUAD; This spontaneous report was received from a medical assistant referring to a 32 years old patient of unknown gender. Information of concomitant medication, concurrent condition, pertinent medical history and drug reaction/allergy was not provided.  On 22-AUG-2019, the patient was vaccinated with one dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (lot # S006830 with expiration date 02-SEP-2020; strength and dose detail were not reported) subcutaneously for prophylaxis(adult use of a child product). Other suspect therapy included sterile diluent (lot # S013899 with expiration date 07-MAR-2022; strength, dose, route and indication were not reported). No adverse effects were reported. The outcome of the event was unknown.",,,,,,,,,U,08/22/2019,08/22/2019,0,,UNK,,STERILE DILUENT,,,,US0095075131908USA012285,2,09/09/2019,,,,
0832810,09/10/2019,KY,,,,U,,"The patient was vaccinated with an improperly stored dose of VAQTA; This spontaneous report was received from a medical assistance, referring to a patient of unknown age and gender. The patient's medical history, drug allergies, concurrent conditions and concomitant therapies were not reported.  On 23-APR-2019, the patient was vaccinated with an improperly stored dose of Hepatitis A Vaccine, Inactivated (VAQTA) for prophylaxis, lot # S002459 and expiration date on 15-MAY-2020 (dose and frequency was not reported).   The temperature was of 52.5 for 4 hours and 40 minutes and there were no previous temperature excursion. The call was placed because of a digital data logger report.",,,,,,,,,U,04/23/2019,04/23/2019,0,,UNK,,,,,,US0095075131908USA013115,2,09/09/2019,,,,
0832811,09/10/2019,PA,13.0,,,U,,"No adverse effects were reported; the patient, who is 13 years old, was inadvertently administered one dose of the adult VAQTA; This spontaneous report was received from a medical assistant referring to a 13 years old patient of unknown gender. Information of concomitant medication, concurrent condition, pertinent medical history and drug reaction/allergy was not provided.  On 29-AUG-2019, the patient was vaccinated with one dose of the adult hepatitis a vaccine, inactivated(VAQTA) (lot # R025518 with expiration date 15-NOV-2019; strength and dose detail were not reported) intramuscularly for prophylaxis (inappropriate age at vaccine administration). No adverse effects were reported. The outcome of the event was unknown.",,,,,,,,,U,08/29/2019,08/29/2019,0,,UNK,,,,,,US0095075131909USA000070,2,09/09/2019,,,,
0832812,09/10/2019,KY,,,,F,,"double pneumonia; Also suffered an outbreak of herpes zoster and cellulitis of her face resulting in facial swelling, severe pain, ear problems and medical treatment; Also suffered an outbreak of herpes zoster and cellulitis of her face resulting in facial swelling, severe pain, ear problems and medical treatment; ear problems; swelling of her lower extremities; edema; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 03-JUN-2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (the dosage regimen information was not reported). In December 2016 (also reported as ""shortly thereafter""), the patient was diagnosed with double pneumonia, which was caused by the zoster vaccine live (ZOSTAVAX) vaccine, resulting in her hospitalization (unknown dates). As a result of zoster vaccine live (ZOSTAVAX), the patient also suffered an outbreak of herpes zoster and cellulitis of her face resulting in facial swelling, severe pain, ear problems and medical treatment. Since zoster vaccine live (ZOSTAVAX) vaccination, the patient suffered swelling of her lower extremities and edema that continued at the time of the report. As a direct and proximate result of the zoster Vaccine Live (ZOSTAVAX) vaccination, the patient's symptoms have resulted in physical limitations not present prior to using the zoster vaccine live (ZOSTAVAX). The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition and has suffered economic losses due to her inability to work. The outcome of the events was considered as not recovered. The events were considered to be related to zoster vaccine live (ZOSTAVAX). The adverse events were considered to be disabling as the patient suffered serious, progressive, permanent and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and inability to work.  Upon internal review, pneumonia and cellulitis were considered to be medically significant.",,,,,Y,,,Y,N,06/03/2016,12/01/2016,181,,UNK,,,Routine health maintenance,,,US0095075131909USA001931,2,09/09/2019,,,,
0832813,09/10/2019,NM,1.25,,,U,,"No adverse effects reported; one unspecified ""15 month old patient"" received both MMR II and VARIVAX via intramuscular route on the same day.; This spontaneous report was received from a pharmacist referring to a 15 months old patient of unknown gender.  Information of concomitant medication, concurrent condition, pertinent medical history and drug reaction/allergy was not provided.  On 03-SEP-2019, the patient was vaccinated with both measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (strength, dose, lot # and expiration date were not reported) and varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose, lot # and expiration date were not reported) via intramuscular route for prophylaxis(subcutaneous injection formulation administered by other route). Other suspect therapy included sterile diluent (strength, dose, lot # and expiration date were not reported) via intramuscular route for prophylaxis. No adverse effects were reported. The outcome of the event was unknown.",,,,,,,,,U,09/03/2019,09/03/2019,0,,UNK,,Sterile diluent,,,,US0095075131909USA002122,2,09/10/2019,,,,
0832814,09/10/2019,IL,0.17,,,U,,"two months old patient received a dose of pneumovax23; no adverse effect; This spontaneous report was received from a registered nurse referring to a 2-month-old patient of unknown gender. The patient's concurrent condition, medical history and concomitant therapy details were not reported.     On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, frequency, route of administration, lot# and expiry date were not reported) for prophylaxis (product administered to patient of inappropriate age). No adverse event was reported. No product quality(PQC) complaint was filed.; Sender's Comments:  US-009507513-1909USA002944:",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA002286,2,09/09/2019,,,,
0832815,09/10/2019,PA,,,,U,,"Patient was administered Gardasil 9 after administered first dose of HPV series (unknown if it was Gardasil Quadrivalent or Gardasil 9); 25 year old patient was administered Gardasil 9 on unspecifieddate after was administered first dose of HPV series as 11 year old; No adverse effects reported; This spontaneous report was received from a physician, referring to a 25 year old patient of unknown gender. The patient's pertinent medical history, concomitant therapies, drug allergies or reactions, and concurrent conditions were not reported.      On an unknown date, reported as ""the patient was 11 years-old"", the patient was vaccinated with the first dose of Human Papilloma Virus (HPV) series; however it was unknown if the vaccine administered was quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) or hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (strength, frequency, route of administration, anatomical site of vaccination, lot # and expiration date were not provided).  Afterwards, on an unknown date, when the patient was 25 years-old, a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was administered (strength, frequency, route of administration, anatomical site of vaccination, lot # and expiration date were not provided) (interchange of vaccine products and inappropriate schedule of product administration). No adverse effects were reported.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA002370,2,09/09/2019,,,,
0832816,09/10/2019,,16.0,,,F,,"first dose of GARDASIL 9 was on 12-DEC-2016 and the second was on 07-AUG-2019; ""absence of menstruation"" for the past 4 months; This spontaneous report was received from a the mother of the patient who reported to the physician regarding a 16-year-old female patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications.  On 16-DEC-2016, the patient was vaccinated with a first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dosage schedule, route, anatomical location, lot number and expiration date were not reported) for prophylaxis.         On an unknown date in May 2019 (reported as: ""for the past 4 months""), the patient has experienced absence of menstruation (amenorrhoea). On 07-AUG-2019, the patient was administered a second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (inappropriate schedule of product administration). The patient was sent to take a pregnancy test but results were still not available. The patient has still not have her period and the physician considered that either the amenorrhoea was caused by the HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) or that the patient was pregnant.",,,,,,,,,N,12/12/2016,05/01/2019,870,,UNK,,,,,,US0095075131909USA002404,2,09/09/2019,,,,
0832817,09/10/2019,NY,2.0,,,M,,"patient had custard icecream and afterwards had an extreme reaction/ patient had strawberry yogurt and had another reaction/ teacher gave the patient a donut hole and patient had allergic reaction; Chest was sunken in and he could hardly breath; Chest was sunken in and he could hardly breath; This spontaneous report was received from the patient's mother referred to a 2 year old (currently 15 year old) male patient. The patient did not have any medical history, and concomitant medications. The patient had numerous food allergies including pears, peaches, legumes, soy, mustard, hot dogs, pepperoni, peanuts, eggs, chicken, pumpkin, squash, and strawberries. On an unknown date, approximately in 2006 (reported as about 13 years ago), when the patient was 2-year-old, he was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) dose 1, for prophylaxis (normal shots from pediatrician) injected in the arm (dose, route, lot # and expiry date were not reported). On an unknown date, approximately in 2006 (reported as about 13 years ago), one week after receiving the vaccine, patient had custard ice cream and afterwards had an extreme reaction. It was reported that, the patient's chest was sunken in and he could hardly breath (chest discomfort, dyspnoea). The next week the patient had strawberry yogurt and had another reaction. The reporter took the patient to pediatrician on an unknown date after the first reaction and the patient had skin and blood tests for allergies. The reporter stated that, the patient was allergy tested every 6 months and on an unspecified date switched allergy testing every year. At the time of reporting, the patient was being tested yearly. The patient had gradually outgrown all the allergies but eggs, tree nuts, peanuts and chicken (reporter was not sure about chicken). On an unknown date, a teacher in school gave the patient a doughnut hole and patient had an allergic reaction (food allergy). At the time of reporting, the patient was extremely allergic to eggs. The patient was treated with diphenhydramine (BENADRYL) for the reactions. The outcome of the events was not resolved. The reporter did not provide any causality assessment. Product quality complaint was not involved.",,,,,,,,,N,,,,,UNK,,,"Food allergy (numerous food allergies including pears, peaches, legumes, soy, mustard, hot dogs, pepperoni, peanuts, eggs, chicken, pumpkin, squash, and strawberries.)",,,US0095075131909USA002466,2,09/10/2019,,Y,,
0832818,09/10/2019,CA,,,,U,,"NO adverse effect reported; patient was administered a dose of PROQUAD that was less than the full recommended; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 03-SEP-2019, the patient was vaccinated with  a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (dose, frequency, route and vaccination site were not reported) lot # S006828, expiration date 02-SEP-2020, for prophylaxis that was less than the full recommended dose. Medical assistant reports that after administration a ""few drops"" of the vaccine ""dripped from the insertion site"". No adverse effect reported.",,,,,,,,,U,09/03/2019,09/03/2019,0,,UNK,,,,,,US0095075131909USA002927,2,09/09/2019,,,,
0832819,09/10/2019,IL,,,,U,,"No adverse effect reported; one patient received an improperly stored PROQUAD; This spontaneous report was received from a registered nurse referring to a 4 year old patient of unknown gender. The patient's pertinent medical history, concomitant medications, drug reactions and allergies were not reported.    On 21-AUG-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # R023499 with an expiration date on 13-FEB-2020 and lot# R026722 with expiration date on 17-MAR-2020 (dose, route and site of administration were not reported) indicated for prophylaxis, which were reconstituted with properly stored sterile diluent(MERCK STERILE DILUENT) (lot# and expiration date was not reported).  The nurse did not have the specific lot and expiration date of administered vaccine to the patient, but it was one of the listed above.  No adverse effect reported.       The administered doses of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) experienced two temperature excursions, one on 12-AUG-2019 and the other one was on 13-AUG-2019 for a time frame of  -14C Celsius degrees to -10 C (-11.91 C) for 8 hours, as recorded by a data logger.   There were no previous excursions reported.",,,,,,,,,U,,08/21/2019,,,UNK,,MERCK STERILE DILUENT,,,,US0095075131909USA002946,2,09/09/2019,,,,
0832820,09/10/2019,OR,34.0,,,F,,"""redness near the injection site has spread in diameter to to 16 cm in length and 10 cm in width which was initially bard and has now softened"".; the patient starting ""feeling fatigue and experiencing pain at the injection site"".; the patient starting ""feeling fatigue and experiencing pain at the injection site"".; ""fever, extreme fatigue, and redness near the injection site has spread in diameter to to 16 cm in length and 10 cm in width which was initially bard and has now softened"".; ""redness near the injection site was initially hard and has now softened"".; ""fever, extreme fatigue, and redness near the injection site has spread in diameter to to 16 cm in length and 10 cm in width which was initially bard and has now softened"".; This spontaneous report as received from a consumer refers to a 34 year old female patient..   The patient's pertinent medical history included Crohn's disease. The patient did not have any drug reaction or allergy. Concomitant therapies included adalimumab (HUMIRA) and azathioprine (IMURAN (AZATHIOPRINE).  On 03-SEP-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), route of administration reported as injection, for prophylaxis (dose, lot# and expiration date were not provided).   Later that same day, the patient starting feeling fatigue and experiencing pain at the injection site. The patient also reported that every day since being vaccinated her adverse symptoms range from fever, extreme fatigue, and redness near the injection site (injection site erythema) had spread in diameter to to 16 cm in length and 10 cm in width which was initially hard (vaccination site induration) and had now softened. She contacted her physician by telephone. The patient was given treatment with diphenhydramine (BENADRYL) on an unknown date. No further symptoms were provided. At the time of reporting, the patient had not recovered from the events of fever, vaccination site pain, fatigue, injection site erythema. The outcome of vaccination site induration was recovering. The causality assessment between the events and pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) was not provided.",,,,,,,,,N,09/03/2019,09/01/2019,,,UNK,,HUMIRA; IMURAN (azathioprine),Crohn's disease,,,US0095075131909USA002979,2,09/09/2019,,,,
0832821,09/10/2019,,,,,U,,"Acute Gastroenteritis; received (delayed penta concordant dose); missed last dose of rotarix vaccine; This case was reported in a literature article and described the occurrence of acute gastroenteritis in a infant patient who received Rota (Rotarix liquid formulation) for prophylaxis.  Co-suspect products included DTPw-HBV+Hib (DTPw-HBV/Hib) for prophylaxis and Rota (Rotarix) for prophylaxis.   Previously administered products included DTPw-HBV/Hib (1st dose received on an unknown date).   On an unknown date, the patient received the 1st dose of Rotarix liquid formulation, the 1st dose of DTPw-HBV/Hib and the 2nd dose of Rotarix. On an unknown date, unknown after receiving Rotarix liquid formulation and DTPw-HBV/Hib and not applicable after receiving Rotarix, the patient experienced acute gastroenteritis (serious criteria hospitalization), drug dose administration interval too long and incomplete course of vaccination. On an unknown date, the outcome of the acute gastroenteritis, drug dose administration interval too long and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the acute gastroenteritis to be related to Rotarix liquid formulation and DTPw-HBV/Hib.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of acute gastroenteritis in an infant aged between 14 weeks and 36 months who was vaccinated with diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type B (DTPw-HepB-Hib) vaccine (manufacturer unknown) and rotarix vaccine (GlaxoSmithKline) for prophylaxis. The patient was part of the active rotavirus surveillance platform from 2013 to 2017. That aimed to examined the timeliness of rotavirus vaccine versus DTPw-HepB-Hib (pentavalent) vaccine first dose and last dose were compared at 15 and 32 weeks of age, respectively, which was concurrently administered without age restrictions, in two RV1 (rotarix) introducing countries and two RV5 (Rotateq) introducing countries that implemented vaccination between 2012 and 2014. As these countries made the decision to implement rotavirus vaccination prior to or soon after WHO0s 2013 decision to remove age restrictions. They hypothesized that the previous age restrictions might have had some impact on the timeliness of rotavirus vaccination. [In this study, surveillance and enrollment periods varied by country. A stool specimen that tested rotavirus-negative were included in the analysis. A total 3568 Rotavirus-negtive children were enrolled in the surveillance programs, 464 children, median age ranged from 45 to 49 weeks old, 169 were female. No information on patient's medical or family history or concurrent condition were provided. [In this study, on unspecified date, the 438 patient's received  1st dose of rotarix on-time (penta concordant dose) 1st dose of diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type B (DTPw-HepB-Hib) vaccine and 9 patient's received 1st dose of rotarix as delayed (penta concordant dose)]. (administration route and site unspecified, batch number not provided for both vaccines). The age of vaccination was not provided]. On unspecified date, the patient had received (delayed penta concordant dose) 2nd dose of diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type B (DTPw-HepB-Hib) vaccine and missed last dose of rotarix vaccine (administration route and site unspecified, batch number not provided for both vaccines). The age of vaccination was not provided. [In this study, two oral live attenuated rotavirus vaccines are currently licensed for global use Rotarix (RV1), a 2-dose vaccine administered at 6 and 10 weeks of age. The countries introduced rotavirus vaccine at (April 2012). In 2009, the World Health Organization (WHO) recommended routine vaccination against rotavirus worldwide, with unique age recommendations to administer the first dose before 15?weeks of age and last dose by 32?weeks of age. This analysis includes infant, who were born at least 2 months after rotavirus vaccine was introduced into the national vaccination program. For the last dose of RV1, the concordant pentavalent dose was the second dose in the series]. On an unspecified date, unknown period after vaccination, the patient fecal specimen was obtained to test for the rotavirus and the patient experienced acute gastroenteritis. The patient hospitalized between February 2013 and April 2015. Due to the delayed penta concordant 2nd dose, the patient missed last dose of rotarix, which led to missed dose (i.e incomplete course of vaccination). [In this study, a missed opportunity for rotavirus vaccine was defined as a pentavalent vaccine dose administration without concordant rotavirus vaccine dose administration. Delayed vaccine administration was defined as vaccine administration at least 1 week after the recommended rotavirus vaccination schedule. Active surveillance for acute gastroenteritis hospitalizations was conducted using the WHO generic protocol and a fecal specimen was obtained to test for rotavirus. The median number of months between the date of rotavirus vaccine introduction and the date of admission was lowest for children (22 months]. Treatment was unknown. The outcome of the event was not provided.  The author commented, ""Delayed pentavalent vaccine administration was clearly associated with missed rotavirus vaccination opportunity for the first dose alone. Children who received a delayed concordant dose of pentavalent vaccine were also more likely to miss a last dose of rotavirus vaccine as compared to children who had received concordant pentavalent dose on time, and findings were not confounded by age on admission, months between vaccine introduction and admission date, and sex. However, when restricting the cohort to children who had received first dose of rotavirus vaccine and pentavalent vaccine, there was no association between missed last dose of rotavirus vaccine and timeliness of concordant pentavalent dose in any country. This indicates that rotavirus vaccine last dose findings were driven primarily by missed rotavirus vaccine first doses."" The author concluded ""Rotavirus vaccine administration was timely among children enrolled at sentinel sites in these four early rotavirus vaccine introducing countries, and age restrictions had minimal impact on rotavirus vaccine use due to timely vaccine administration. In countries with less timely vaccine administration, disparities in coverage between rotavirus vaccine and pentavalent vaccine may be more prominent if age restrictions continue to be followed to some extent and this should be examined in future evaluations."". This is 1 of the 2 valid cases reported in this literature article.      Lab Comments: Lab test don on an unknown date before enrollment in the study. In this study, surveillance and enrollment periods varied by country. A stool specimen that tested rotavirus-negative were included in the analysis. A total 3568 Rotavirus-negtive children were enrolled in the surveillance programs.",,,,,Y,,,,U,,,,"Test Name: Stool analysis; Result Unstructured Data: Test Result: See text, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEGH2019GS,2,09/10/2019,,,,
0832822,09/10/2019,NC,,,,F,,"Severe reaction; This case was reported by a consumer and described the occurrence of adverse event in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th August 2019, the patient received the 1st dose of Shingrix. In August 2019, less than a week after receiving Shingrix, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. On Monday, the patient received her my first shingrix shot and experienced severe reaction. Because of this the patient assumeed that she should not get the second shot. The patient question was would the first shot provided any protection if she are unable to take the second shot.",,,,,,,,,U,08/26/2019,08/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/10/2019,,,,
0832823,09/10/2019,,,,,U,,"Acute Gastroenteritis; delayed penta concordant 2nd dose; missed last dose of rotarix vaccine; This case was reported in a literature article and described the occurrence of acute gastroenteritis in a infant patient who received Rota (Rotarix liquid formulation) for prophylaxis. Co-suspect products included DTPw-HBV+Hib (DTPw-HBV/Hib) for prophylaxis and Rota (Rotarix) for prophylaxis.   Previously administered products included DTPw-HBV/Hib (1st dose on an unknown date).   On an unknown date, the patient received the 1st dose of Rotarix liquid formulation, the 2nd dose of DTPw-HBV/Hib and the 2nd dose of Rotarix. On an unknown date, unknown after receiving Rotarix liquid formulation and DTPw-HBV/Hib and not applicable after receiving Rotarix, the patient experienced acute gastroenteritis (serious criteria hospitalization), drug dose administration interval too long and incomplete course of vaccination. On an unknown date, the outcome of the acute gastroenteritis, drug dose administration interval too long and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the acute gastroenteritis to be related to Rotarix liquid formulation and DTPw-HBV/Hib.  Additional details were provided as follows: This case was reported in a literature article and described the missed dose (incomplete course of vaccination) in an infant aged between 14 weeks and 36 months who was vaccinated with diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type B (DTPw-HepB-Hib) vaccine (manufacturer unknown) and rotarix vaccine (GlaxoSmithKline) for prophylaxis. This case corresponds to supplementary table number 4 reported in this literature article. The patient was part of the active rotavirus surveillance platform from 2013 to 2017. That aimed to examined the timeliness of rotavirus vaccine versus DTPw-HepB-Hib (pentavalent) vaccine first dose and last dose were compared at 15 and 32 weeks of age, respectively, which was concurrently administered without age restrictions, in two RV1 (rotarix) introducing countries (April 2012) and (May 2014) and two RV5 (Rotateq) introducing countries that implemented vaccination between 2012 and 2014. As these countries made the decision to implement rotavirus vaccination prior to or soon after WHO0s 2013 decision to remove age restrictions. They hypothesized that the previous age restrictions might have had some impact on the timeliness of rotavirus vaccination. [In this study, Surveillance and enrollment periods varied by country. A stool specimen that tested rotavirus-negative were included in the analysis. A total 3568 Rotavirus-genagtive children were enrolled in the surveillance programs, 1592 children from one country, median age ranged from 45 to 49 weeks old, 669 were female]. No information on patient's medical or family history or concurrent condition were provided. [In this study, on unspecified date, the 1469 patient's received 1st dose of rotarix on-time (penta concordant dose) 1st dose of diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type B (DTPw-HepB-Hib) vaccine and 22 patient's received 1st dose of rotarix as delayed (penta concordant dose) (administration route and site unspecified, batch number not provided for both vaccines). The age of vaccination was not provided]. On unspecified date, the patient had received delayed (penta concordant dose) 2nd dose of diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type B (DTPw-HepB-Hib) vaccine (manufacturer unknown) and missed last dose of rotarix vaccine (administration route and site unspecified, batch number not provided for both vaccines). The age of vaccination was not provided. [In this study, two oral live attenuated rotavirus vaccines are currently licensed for global use Rotarix (RV1), a 2-dose vaccine administered at 6 and 10 weeks of age. The countries introduced rotavirus vaccine at (May 2014). In 2009, the World Health Organization (WHO) recommended routine vaccination against rotavirus worldwide, with unique age recommendations to administer the first dose before 15?weeks of age and last dose by 32?weeks of age. This analysis includes infant, who were born at least 2 months after rotavirus vaccine was introduced into the national vaccination program. For the last dose of RV1, the concordant pentavalent dose was the second dose in the series]. On an unspecified date, unknown period after vaccination, the patient fecal specimen was obtained to test for the rotavirus and the patient experienced acute gastroenteritis. The patient hospitalized from October 2014 to December 2016. Due to the delayed penta concordant 2nd dose, the patient missed last dose of rotarix, which led to missed dose (i.e incomplete course of vaccination). [In this study, a missed opportunity for rotavirus vaccine was defined as a pentavalent vaccine dose administration without concordant rotavirus vaccine dose administration. Delayed vaccine administration was defined as vaccine administration at least 1 week after the recommended rotavirus vaccination schedule. Active surveillance for acute gastroenteritis hospitalizations was conducted using the WHO generic protocol and a fecal specimen was obtained to test for rotavirus. The median number of months between the date of rotavirus vaccine introduction and the date of admission was lowest for children in  (24 months)]. Treatment was unknown. The outcome of the event was not provided. The author commented, ""Delayed pentavalent vaccine administration was clearly associated with missed rotavirus vaccination opportunity for the first dose alone. Children who received a delayed concordant dose of pentavalent vaccine were also more likely to miss a last dose of rotavirus vaccine as compared to children who had received concordant pentavalent dose on time, and findings were not confounded by age on admission, months between vaccine introduction and admission date, and sex. However, when restricting the cohort to children who had received first dose of rotavirus vaccine and pentavalent vaccine, there was no association between missed last dose of rotavirus vaccine and timeliness of concordant pentavalent dose in any country. This indicates that rotavirus vaccine lastdose findings were driven primarily by missed rotavirus vaccine first doses."" The author concluded ""Rotavirus vaccine administration was timely among children enrolled at sentinel sites in these four early rotavirus vaccine introducing countries, and age restrictions had minimal impact on rotavirus vaccine use due to timely vaccine administration. In countries with less timely vaccine administration, disparities in coverage between rotavirus vaccine and pentavalent vaccine may be more prominent if age restrictions continue to be followed to some extent and this should be examined in future evaluations."". This is 1 of the 2 valid cases reported in this literature article.      Lab Comments: Lab test done on an unknown date between October 2014 to December 2016. In this study, a stool specimen that tested rotavirus-negative were included in the analysis. A total 3568 Rotavirus-genagtive children were enrolled in the surveillance programs.",,,,,Y,,,,U,,,,Test Name: Stool analysis,UNK,,,,,,USGLAXOSMITHKLINEZW2019GS,2,09/10/2019,,,,
0832824,09/10/2019,GA,,,,M,,"classic neurophathy; warm on the bottom of feet; face tingling; This case was reported by a consumer via call center representative and described the occurrence of neuropathy in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 17th February 2019, refer case US2019AMR161883 ). Concurrent medical conditions included bone spur.   In May 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced neuropathy (serious criteria GSK medically significant), localized feeling of warmth and tingling. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the neuropathy and tingling were unknown and the outcome of the localized feeling of warmth was not recovered/not resolved.   It was unknown if the reporter considered the neuropathy, localized feeling of warmth and tingling to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received dose 2 of Shingrix and that months later he started to feel warm on the bottoms of his feet and it feels like, classic neuropathy to him. He states he sought medical care and his physician told him it was bone spurs and not related to Shingrix, but patient felt it was incorrect.  The patient stated that 3 weeks ago he experienced like his face was started tingling as well. The reporter consented to follow up.",,,,,,,,,N,05/01/2019,,,,UNK,,,Bone spur,,,USGLAXOSMITHKLINEUS201915,2,09/10/2019,,Y,,
0832825,09/10/2019,OR,,17,,F,,"patient received expired Menactra/ No AE; Initial information received on 28-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to case 2019SA244699 same reporter.  This case involves a 17 years old female patient who received 0.5 mL dose of expired vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] lot U5835AA, expired date: 17-FEB-2019 (Frequency- once) via intramuscular route in the left deltoid on 02-Apr-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  It was unknown whether the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,04/02/2019,,,,UNK,,,,,,USSA2019SA244698,2,09/05/2019,,,,
0832826,09/10/2019,OR,15.0,15,,M,,"patient received expired Menactra, no AE; Initial information received on 28-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to case 2019SA244698 (same reporter).  This case involves a 15 years old male patient who received an expired 0.5 ml dose of vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot U5835AA, Exp. Date 27-Feb-2019) via intramuscular route in the right arm, on 25-Mar-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  It was reported that there were three different patients total who received expired doses of vaccines. Two patients received expired Menactra and one patient received expired ActHIB.  At the time of reporting no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.   Documents held by the sender: none.",,,,,,,,,U,03/25/2019,,,,UNK,,,,,,USSA2019SA244699,2,09/04/2019,,,,
0832827,09/10/2019,PA,,,,M,,"are there any adverse reactions expected due to third dose being given too early, No AE; Initial information received on 30-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves an unknown age (reported as 6) patient who received 0.5 ml third dose of vaccine IPV (VERO) [IPOL] (lot: N1J45, expiry date: 05-Oct-2019) too early on 22-Aug-2019, via intramuscular route in the left thigh.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  no concurrent vaccines given  It was an actual medication error due to inappropriate schedule of vaccine administration.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/22/2019,,,,UNK,,,,,,USSA2019SA245897,2,09/08/2019,,,,
0832828,09/10/2019,IL,3.0,,,F,,"administered .5ml of Flublock Quad to a 3 year old,/ NO AE; Initial information received on 29-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse  This case involves a 3 years old female patient who was vaccinated with 0.5 ml dose of Flublock quad vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (Product administered to patient of inappropriate age).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No other concomitant therapy was given.   On 28-Aug-2019, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot QFAA1905, exp date: May 21, 2020, via unknown route in the right thigh.  It was a case of actual medication error due to Inappropriate age at vaccine administration.  At the time of the report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by the sender: none.",,,,,,,,,U,08/28/2019,,,,UNK,,,,,,USSA2019SA246042,2,09/08/2019,,,,
0832829,09/10/2019,TX,,7,,M,,"same leg of the injection site of the thigh to swell to double its size that night; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 7 years old male patient who experienced same leg of the injection site of the thigh to swell to double its size that night (swelling), while he received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past vaccination(s) included Fluzone Quadrivalent with no reaction.  The patient's past medical history, medical treatment(s) and family history were not provided.    On 10-Nov-2018, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UT6262LA via intramuscular route in the thigh nos.  On 10-Nov-2018, the patient developed a non-serious same leg of the injection site of the thigh to swell to double its size that night (swelling) on same day at night following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was same leg of the injection site of the thigh to swell to double its size that night.  the consumer was taken to the emergency room on the same day of the injection; that the exact treatments were not known by the caller but possible Benadryl, that the consumer was advised not to get the Fluzone Quadrivalent again.  The father of the consumer, a physician as well, is contemplating the nasal mist influenza immunization.  The patient outcome is reported as Unknown for same leg of the injection site of the thigh to swell to double its size that night.",,,,,,,,,U,11/10/2018,11/10/2018,0,,UNK,,,,,,USSA2019SA247882,2,09/09/2019,,,Y,
0832830,09/10/2019,WI,67.0,67,,F,,"Developed jaw pain on left side, similar to TMJ only much worse than usual.  Sore gums on left lower jaw.  Pre-existing but aggravated after the shot.",,,,,,,,,U,09/09/2019,09/09/2019,0,none,PHM,,none,some GI issues.,None,,,2,09/10/2019,,,,"erythromycin, codeine"
0832831,09/10/2019,IL,12.0,12,,F,,After vaccination patient felt dizzy and shaky. Stomach upset. Syncope with no injuries. Afterwards slightly shaky but resolved after sitting for 10 minutes and drinking water. No seizure symptoms.,,,,,,,,,Y,09/09/2019,09/09/2019,0,,PVT,,none,,,,,2,09/10/2019,,,,none
0832832,09/10/2019,MI,4.0,4,,M,,No adverse event gave combo vaccination out of series,,,,,,,,,Y,09/03/2019,09/03/2019,0,none,PUB,,,,,,,2,09/10/2019,,,,
0832848,09/10/2019,PR,2.0,2,.0,F,,"Almost 3 days after vaccination patient presents signs of seizure with temperature of 37.6 Celsius, mother indicates child was with father when he called ambulance and that the child was cyanotic, drowsy and unresponsive.",,,,,,,,,Y,06/28/2019,07/01/2019,3,"CBC, Influenza test-NEG, RSV test-NEG, Basic Metabolic Panel",PVT,,"Flovent, Albuterol, Trispec, Levocarnitine","Asma, metabolic disorder",Asma,,,2,09/10/2019,,,,None
0832849,09/10/2019,MI,1.42,1,.5,F,,"3 DAYS AFTER VACCINES ADMINISTERED, DEVELOPED HIVES  ON ABDOMEN  AND  HANDS.  PERIODIC IN NATURE.  TAKEN TO EMERGENCY ROOM ON 09/03/19 AND WAS PRESCRIBED PREDNISOLONE  AND BENADRYL.      NO LABS OR OTHER TESTING WERE DONE.   NO RESPIRATORY PROBLEMS.   NO LIP OR TONGUE SWELLING.       FOLLOWED UP IN CLINIC ON 09/05/19.  HIVES IMPROVED, NOT COMPLETELY RESOLVED.    SL. RUNNY NOSE.   EATING AND DRINKING WELL.   ALERT.",,,,,,,,,U,08/29/2019,09/01/2019,3,NONE,PVT,,none,none,None,,,2,09/10/2019,,Y,Y,none
0832850,09/10/2019,NY,67.0,67,,F,,patient received fluad in pharmacy on 09/02/19 was feeling fine when she left the store. the next day she went to her cardiologist and told him she received her flu shot. the md then administered a pneumonia shot to her. patient developed tiredness and fever after the pneumonia shot the next day. a few days later patient called to say she had weakness and fell when she tried to get out of bed and hurt her ankle. she visited  md to examine her ankle.,,,,,,,,,Y,09/02/2019,09/04/2019,2,,PHM,,unknown,unknown,hypertension diabetes,,,2,09/10/2019,,Y,,penicillin
0832855,09/10/2019,PA,73.0,,,F,,"Soreness or achhiness; This case was reported by a consumer via call center representative and described the occurrence of pain in a 73-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Influenza vaccine Quadrivalent unspecified season.  Additional information received were as follows: The age at vaccination was not reported. The patient experienced soreness or achhiness. This case has been linked with US2019148654, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/10/2019,,,,
0832856,09/10/2019,,,,,M,,"Neisseria meningitidis; Urethral gonorrhea infection; This case was reported in a literature article and described the occurrence of neisseria meningitidis infection nos in a male patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.  On an unknown date, the patient received Meningococcal B vaccine at an unknown dose. On an unknown date, unknown after receiving Meningococcal B vaccine, the patient experienced neisseria meningitidis infection nos (serious criteria GSK medically significant) and urethritis gonococcal. On an unknown date, the outcome of the neisseria meningitidis infection nos and urethritis gonococcal were unknown.   It was unknown if the reporter considered the neisseria meningitidis infection nos and urethritis gonococcal to be related to Meningococcal B vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of urethral gonorrhea infection in a male patient of unspecified age who was vaccinated with unspecified meningococcal B vaccine (Unknown manufacturer) for prophylaxis. The patient was part of dataset constructed by combining surveillance and medical record data from men diagnosed with uropathogenic, non-groupable Neisseria meningitidis (NmNG) clade urethritis in a local sexually transmitted disease (STD) clinic. Time-to-event analyses of clinic visits between January 2015 and April 2018 was used to examine prospective urethral gonorrhea risk. In this study, subsequent gonorrhea acquisition for men with NmNG clade urethritis at baseline was compared to men with Neisseria gonorrhea (Ng) urethritis (n=255), chlamydial urethritis (n=253), or no infection (n=257) at baseline. [In this study, participants were primarily Black and heterosexual with a median age of 28 years. At baseline, 13% had prior gonorrhea history]. No information on patient's medical or family history or concurrent condition or concomitant medication was provided. On an unspecified date, the patient received unspecified meningococcal B vaccine (administration route and site unspecified, dosage unknown; batch number not provided). The age of vaccination was not provided.  On an unspecified date, an unknown period after vaccination, the patient was diagnosed with uropathogenic, non-groupable Neisseria meningitidis (NmNG) clade urethritis in a local STD clinic. Subsequently, on an unspecified date between January 2015 and April 2018, the patient developed urethral gonorrhea infection.  Treatment was unknown. The outcome of the event was not provided. [In this study, half of men returned for STD screening at least once during the follow-up period.] The author did not comment on the relationship between the event of urethral gonorrhea infection and unspecified meningococcal B vaccine. The authors stated, ""Men with NmNG clade urethritis at baseline had similar gonorrhea risk as men with Ng at baseline. Results were not meaningfully different when assessing extragenital gonococcal infections, or after adjustment for time since baseline, age, race, sexual orientation, prior gonorrhea infection, and sexual behavior (number of partners, condom use, and oral sex). In contrast, those with NmNG clade urethritis had increased gonorrhea incidence compared to men with chlamydial urethritis and men with no infection at baseline."" The authors concluded ""Natural infection with NmNG urethritis clade does not appear to protect men against subsequent acquisition of gonorrhea"".      Lab Comments: On an unspecified date between January 2015 and April 2018, the patient was diagnosed with NmNG clade urethritis in a local STD clinic.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019GS,2,09/10/2019,,,,
0832857,09/10/2019,NY,86.0,86,,M,,"Shingles; Holes with blood spurting out; Pain; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 86-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (outbreak in December 2005), blister, nerve damage and pain in arm. Concomitant products included Herpes zoster (Shingrix).   On 10th July 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 17th July 2019, 7 days after receiving Shingrix, the patient experienced shingles, skin bleeding and pain. On an unknown date, the outcome of the shingles, skin bleeding and pain were unknown.   It was unknown if the reporter considered the shingles, skin bleeding and pain to be related to Shingrix.  Additional information received were as follows: The patient had shingles in December 2005 which occurred on the right upper arm (including under the arm), right shoulder, and back of right should (around scapula). The patient received Shingrix on left arm. The patient experienced shingles again on the right upper arm (and under the right upper arm), right shoulder, and right scapula area of the back. The patient reportsed that this outbreak was milder, and he had less pain than when he had the first outbreak. He also reported that with the first outbreak he had blisters. This time the patient had holes with blood spurting out. The patient reported that he had nerve damage and pain in his right arm since having the shingles in December 2005. The reporter gave permission for his physician to be contacted.",,,,,,,,,U,07/10/2019,07/17/2019,7,,UNK,,Shingrix,,Medical History/Concurrent Conditions: Blister; Nerve damage; Pain in arm; Shingles (outbreak in December 2005),,USGLAXOSMITHKLINEUS201913,2,09/10/2019,,,,
0832858,09/10/2019,NJ,,,,U,,"Severe pain; The initial case was missing the following minimum criteria: unspecified patient and event. Upon receipt of follow-up information on (03Sep2019), this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, lot number: X70865) intramuscularly (IM) on 09May2019 at a single dose for routine shot (immunization). The patient's medical history was not reported. There was no concomitant medication. The patient experienced severe pain on an unspecified date. The outcome of event was unknown.",,,,,,,,,U,05/09/2019,,,,UNK,,,,,,USPFIZER INC2019347972,2,09/10/2019,,,,
0832860,09/10/2019,CA,,,,M,,"The patient received an expired dose of Menactra on 30Aug2019, No AE; 21-year-old male received a delayed dose of Menactra  intramuscularly on 30Aug2019 as dose number 2 out of 2. the patient received dose number 1 as a child, No AE; Initial information received on 30-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse in the United States.  This case involves a 21 years old male patient who received MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE (HPV VACCINE) in right deltoid via intramuscular route for immunisation, on 30-Aug-2019.  On 30-Aug-2019, the patient received a delayed (second dose) and expired dose 0.5 ml dose once of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot: U5984AB, expiry date: 14-Aug-2019) via intramuscular route in the left deltoid.  It was also reported that the patient received dose number 1 as a child.  It was an actual medication error due to inappropriate schedule of vaccine administration and expired vaccine used.  At the time of reporting no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/30/2019,,,,UNK,,HPV VACCINE,,,,USSA2019SA245904,2,09/09/2019,,,,
0832863,09/10/2019,NC,4.0,4,,F,,FEVER OF 103.5 AND LEFT LEG SORENESS.  Motrin given for the fever and pain with the fever coming down.  Left leg remained sore.,,,,,,,,,N,09/09/2019,09/09/2019,0,NONE,PVT,,MOTRIN,NONE,NONE,,,2,09/10/2019,,Y,,NKA
0832864,09/10/2019,TN,66.0,66,,F,,"Pt reported redness, swelling and pain at site of injection",,,,,,,,,Y,09/04/2019,09/04/2019,0,,PVT,,"Alendronate, Atorvastatin, Lisinopril",None,"Hypertension, hyperlipidemia, Osteoporosis",,,2,09/10/2019,,Y,,NKA
0832865,09/10/2019,MI,34.0,34,,F,,"Patient is 32.6 weeks pregnant, she received adacel on 09/06/2019 and previous dose  of Adacel was on 08/19/2019. Estimated due date 10/30/19.",,,,,,,,,U,09/06/2019,09/09/2019,3,,PVT,,N/A,N/A,N/A,,,2,09/10/2019,,,,N/A
0832866,09/10/2019,VA,65.0,65,,F,,Redness and swelling of most of the left arm- She just started prednisone- pt put on Prednisone 9/9/19,,,,,,,,,N,09/04/2019,09/09/2019,5,none,PVT,,"Amlodopine 5mg, Levothyroxine 50mcg, Lipitor 10mg, Sertraline 50mg , Zolmitriptan 5ng PRN",none,"HTN, HLP, Hypothyroidism, Migraines",,,2,09/10/2019,,Y,,none
0832867,09/10/2019,MI,69.0,69,,F,,"The night of 9/2, patient fainted and hit her head. Her husband helped her up and she did not go to hospital or call her Dr.  She was clammy and had chills.  Also she had a swollen, red and warm LEFT arm only (pneumovax arm).  The only professional visit was to stop in here (pharmacy) and tell me about it.",,,,,,,,,Y,09/02/2019,09/02/2019,0,none,PHM,,"metoprolol, clopidogrel, losartan",,,,,2,09/10/2019,,,,nka
0832868,09/10/2019,FL,73.0,73,,M,,"Left arm EXTREMELY sore, almost totally unusable for 24-36 hours, Uvula swollen to approx twice normal size-3 days to fully return to normal",,,,,,,,,Y,08/28/2019,08/28/2019,0,,PHM,,"clonidine, perindipril, metoprolol, lipitor, flomax, L-Arginine, Xanax ER,",,controlled high blood pressure,,,2,09/10/2019,,Y,,"antibiotics, NSAIDs, iodine dye,"
0832869,09/10/2019,MI,35.0,35,,M,,"Fainted with in 10 seconds, was out about 10 seconds.  Felt warm for about 15 minutes, laid down for roughly 20-25 minutes.  felt fine afterwards and was able to leave on his own.  Patient stated that he has a history of fainting during shots or lab tests but did not faint during his flu shot last year",,,,,,,,,Y,09/10/2019,09/10/2019,0,,PHM,,none,none,,fainting,,2,09/10/2019,,,,none
0832870,09/10/2019,IA,12.0,12,,F,,"PATIENT WAS IN FOR IMMUNIZATIONS AND IS NEEDING TO USE A CATCH UP SCHEDULE.  THE DOCTOR ORDER ""IPOL"" AS SHE NEEDED A POLIO AND IS ABOVE THE AGE OF 6 WHEN THE COMBINATION  Dtap IMMUNIZATIONS RECOMMEND NOT USING. THE IPOL WAS GIVEN AND WHEN WENT TO ENTER INTO REPORTING SYSTEM THE EXPIRATION DATE CAME UP EXPIRED. THE PATIENT SHOWED NO SYMPTOMS.",,,,,,,,,Y,09/10/2019,09/10/2019,0,,PVT,,NONE,NONE,NONE,,,2,09/10/2019,,,,NKDA
0832871,09/10/2019,MI,17.0,17,,M,,"Given dose of Trumenba on 9/3/2019, client had already received dose of Bexsero on 07/15/2019. inadvertently gave wrong Men B product which are not interchangeable",,,,,,,,,Y,09/03/2019,09/10/2019,7,,PUB,,none,,,"at 4months reacted to DTap, IPV, HiB, PCV7 given that data 8/16/2002.  Specifics of reaction unable to recall, but reports no re",,2,09/10/2019,,,,none
0832877,09/10/2019,IN,,,,F,,"patient did at home pregnancy test, on 8/24/2019, that was positive; no adverse effects; This spontaneous prospective pregnancy report was received from a nurse practitioner and refers to a female patient of unknown age. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 23-AUG-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection (dose, route of administration, lot # and expiration date were not reported) for prophylaxis. Other suspect therapies included sterile diluent. The patient did an at home pregnancy test on 24-AUG-2019, that was positive. The patient became pregnant with last menstrual period LMP of 10-AUG-2019, approximate date of conception was 24-AUG-2019 and estimated date of delivery (EDD) was 16-MAY-2020 (all dates calculated based on LMP). Initial exposure to varicella virus vaccine live (oka/merck) (VARIVAX) was at 1 week. The pregnancy outcome was pending. No adverse effects were reported.",,,,,,,,,U,08/23/2019,,,,UNK,,Sterile diluent,,,,US0095075131908USA011136,2,09/10/2019,,,,
0832878,09/10/2019,NJ,,,,U,,"a bit of soreness; This case was reported by a consumer and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix 2 months before the time of reporting and experienced only a bit of soreness. For tolerances of 2nd dose refer case US2019AMR160237, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/10/2019,,,,
0832879,09/10/2019,FL,,,,F,,"On one side of her chest and neck there is a very red rash with blisters; Blisters; Very painful; This case was reported by a consumer via call center representative and described the occurrence of vesicular rash in a 84-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced vesicular rash, blister and pain. On an unknown date, the outcome of the vesicular rash, blister and pain were unknown.   It was unknown if the reporter considered the vesicular rash, blister and pain to be related to Shingrix.  Additional details were reported as follows: The reporter reported adverse events experienced by their mother in law. The age at vaccination was not reported but it could be 83 years or 84 years. The patient was vaccinated about a year before the reporting date. The reporter believed that, the patient had shingles and described symptoms of it. On one side of the patient's chest and neck there was a very red rash with blisters. It started small and spread over a couple of days. It was very painful and looked just like images of shingles that the reporter seen during research. The reporter also asked, could a person who was vaccinated with Shingrix develop shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for herpes zoster were not provided.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/10/2019,,,,
0832880,09/10/2019,,,,,F,,"Fever; Blisters; This case was reported by a consumer via call center representative and described the occurrence of fever in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine at an unknown dose. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced fever and blister. On an unknown date, the outcome of the fever and blister were unknown.   It was unknown if the reporter considered the fever and blister to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingles vaccine and developed a fever and blister. The reporter was unable to provide any additional details. This case linked with US2019160421, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/10/2019,,,,
0832881,09/10/2019,KS,,,,U,,"expired Ipol was inadvertently administered, the vaccine was 4 days beyond expiration when it was given/ no AE; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 4 years old patient who received vaccine IPV (VERO) [IPOL] and reported that expired Ipol was inadvertently administered to a patient in the right thigh, the vaccine was 4 days beyond expiration when it was given (product storage error).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR VACCIN); and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DAPTACEL).  On 06-Aug-2019, the patient received 4th dose of suspect IPV (VERO) lot N1G511M via unknown route in the right thigh.  It was a case of actual medication error due to expired vaccine used.  At the time of the report, adverse event was not reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender- none.",,,,,,,,,U,08/06/2019,,,,UNK,,MMR VACCIN; DAPTACEL,,,,USSA2019SA247251,2,09/10/2019,,,,
0832882,09/10/2019,FL,1.25,1,.3,M,,"ActHIB portion only of a Pentacel vaccine was given, diluted with 04 % sodium chloride. The DTaP/ IPV portion was not given, no AE; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a other healthcare professional.  This case involves a 15 months old male patient who received a fourth 0.5 ml dose of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] lot UJ097AA and Exp. Date 19-Sep-2020 via intramuscular route in the left vastus lateralis, on 03-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for Immunisation.  It was a case of actual medication error due to inappropriate reconstitution technique.  It was reported that the ActHIB portion only of a Pentacel vaccine was given, diluted with 0.4 % sodium chloride. The DTaP/ IPV portion was not given.  At the time of reporting no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/03/2019,,,,UNK,,PREVNAR,,,,USSA2019SA247527,2,09/10/2019,,,,
0832883,09/10/2019,NY,,,,F,,"patient received an expired dose of Menactra from her provider on 03-Sep-2019, no AE; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves female patient (age reported as possibly 20-30) who received an expired dose of vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (expired in June or July 2019) lot number not reported via unknown route in unknown administration site, on 03-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history and concomitant therapies were not provided.  It was a case of actual medication error due to expired vaccine used.  It was reported that a female of unknown age (possibly 20-30) said she received an expired dose of Menactra from her provider on 03-Sep-2019. Consumer reported the Menactra expired in June or July 2019.  At the time of reporting no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,09/03/2019,,,,UNK,,,,,,USSA2019SA247528,2,09/10/2019,,,,
0832884,09/10/2019,MN,,10,,M,,"Flublock was given inadvertently to a 10 year old child, no AE; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 10 years old male patient who was vaccinated with a 0.5 mL dose of vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot QFAA1901, expiry date: 17-May-2020 via unknown route in unknown administration site on 21-Aug-2019.  It is an actual medication error case due to Inappropriate age at vaccine administration.  It was not known whether the patient had any adverse event or not.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/21/2019,,,,UNK,,,,,,USSA2019SA247580,2,09/10/2019,,,,
0832885,09/10/2019,,,,,U,,"Allergy with Tetanus toxoid; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves unknown demographic patient who experienced allergy with tetanus toxoid, while received vaccine TETANUS TOXOID.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect TETANUS TOXOID produced by unknown manufacturer (lot number and Expiry date unknown) via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious allergy with tetanus toxoid (allergy to vaccine) (Unknown latency) following the administration of TETANUS TOXOID.  (Other relevant tests included no lab data).  Final diagnosis was allergy with tetanus toxoid.  It was not reported if the patient received a corrective treatment.  The event outcome is reported as Unknown for allergy with tetanus toxoid.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA249197,2,09/10/2019,,,,
0832887,09/10/2019,MN,1.25,1,.3,M,,Patient woke - up at 7:00 am on 9/10/19 with hives. Also has a temp of 100.9. Patient got tylenol and Benadryl in office.,,,,,,,,,U,09/09/2019,09/10/2019,1,Strep test on 9/10/19,PVT,,N/A,N/A,N/A,Rotateq,,2,09/10/2019,,Y,,Rotateq
0832888,09/10/2019,NY,12.0,12,,M,09/10/2019,Immediately after vaccine administration patient had a syncopal episode. Patient was placed in supine position for 15 min until he felt better. He drank gatorade and left office in good condition after 30 mins.,,,,,,,,,Y,09/10/2019,09/10/2019,0,,PVT,PVT,,N/A,NKDA,,,1,,,,,
0832889,09/10/2019,CT,56.0,56,,M,,None stated.,,,,,,,,Y,Y,07/11/2019,07/11/2019,0,"LAB WORK, (1-PG. INCLUDED)",PHM,,"LITHIUM, GABAPENTIN, MULTI VITAMIN",NONE,"DDD, DJD.",,,2,09/04/2019,,Y,Y,NONE
0832890,09/10/2019,GA,78.0,78,,F,,"Patient stood up and walked around corner and started complaining about trouble breathing, had patient sit down and continued to complain of trouble breathing, face started getting red.  Called 911 gave patient epipen and started feeling better. EMS came and took patient to hospital.",,,,,,,,,N,09/10/2019,09/10/2019,0,Check blood pressure after Epipen dose was 143/95 and pulse 71. Then EMS checked was 134/75 with 99% o2.,PHM,,N/A,Cancer,Cancer,,,2,09/10/2019,,,Y,Soma
0832891,09/10/2019,UT,19.0,19,,F,,"Documentation of appropriately spaced primary childhood series followed by negative titer upon hire.  Challenge dose of Heplisav-B.  No immediate reaction.  Reported that approximately 30-45 minutes later she felt flushed, developed headache, nausea and vomiting.  No rash or any respiratory symptoms.",,,,,,,,,Y,08/26/2019,08/26/2019,0,none,PVT,,,,,,,2,09/10/2019,,,,Sulfa
0832892,09/10/2019,GA,56.0,56,,F,,"Sore arm started about 2 hours after injected. In next 2 hours body/ joint aches began.  Two hours later headache and tummy pain began- took NSAID and went to bed. Woke up in morning with 101.1 f fever- chills, tremor, tummy ache, and extreme headache.",,,,,,,,,N,09/09/2019,09/10/2019,1,N/a,PHM,,"Toprol, imuran, Prevacid, levothyroxine, sero vitals, baby asa, Crestor, zetia, metforman, fish oil, probiotics, iron, calcium, magnesium, ubiquinol,",None,"Lupus, left coronary dominant circulation, borderline type 2 diabetes, hypertension history- not at present, hx  migranes",,,2,09/10/2019,,,,"Latex, cucumber peel, sulfa"
0832893,09/10/2019,NY,78.0,78,,F,,pt also recieved a flu shot from the doctor but failed to communicate that when asked if she wants her flu shot with prevnar 13 at the pharmacy,,,,,,,,,U,09/10/2019,09/10/2019,0,,PHM,,,,,,,2,09/10/2019,,,,
0832894,09/10/2019,FL,53.0,53,,M,,"I developed allodynia  on the right side of my trunk from the axillae to the umbilicus front and back.  Symptoms did not cross the midline.  I self medicated with NSAIDs, no better.  I saw my internist on 8/29/19 and had labs, started prednisone 60 mg tapering by 10 mg over 6 days.  Symptoms much improved on steroids but not resolved.  As of today I am 5 days off steroids and my symptoms continue to improve gradually.",,,,,,,,,N,07/31/2019,08/05/2019,5,"Normal ESR, CRP, CBC, and blood chemistries.",PHM,,"omeprazole 20 mg daily, allopurinol 300 mg daily",None,None,,,2,09/10/2019,,Y,,None
0832895,09/10/2019,OR,66.0,66,,F,,"SHE SAID SHE PHONED ANOTHER PHARMACY THAT WAS OPENED AT 5:00 AM (09/08/19);  SHE COMPLAINED OF CHILLS, BODY ACHE, HEADACHE, NAUSEA, SWELLING, REDNESS",,,,,,,,,N,09/06/2019,09/07/2019,1,N/A,PHM,,NOT KNOWN,N/A,N/A,,,2,09/10/2019,,,,N/A
0832896,09/10/2019,MO,63.0,63,,F,,"1.) Arm began to hurt. Mild, about a 2-3. 2.) Then, extreme pain- of level 10 in lower left area of back- (below ribs, above hip ). Pain felt like a kick by boot, or a deep bruise caused by a car accident. Pain was localized.  No fever.  No vomiting. Lack of appitite. Unable to move without pain. I slept for 32 hours  ( First 24:hrs only drank water, used restroom). 3.) After 32 hours, pain remained at about a 5 level  for next 24 hours.  Able to eat small amount of food . No fever, no vomiting- just pain. 4.) Dull pain (2 level) in lower back at site on left side continues after 6 days.",,,,,,,,,U,09/05/2019,09/05/2019,0,None. Did not seek treatment. Reported event to Clinic on 09/09/2019,MIL,,Vitamin D gummies,None,None,,,2,09/10/2019,,,,Aspertaime ( sweetner used in diet foods)
0832897,09/10/2019,MO,70.0,70,,M,,Pt states neck/arm/ back have been itching since getting injection.,,,,,,,,,U,08/02/2019,08/22/2019,20,,PHM,,,,,,,2,09/10/2019,,,,
0832898,09/10/2019,AL,13.0,13,,F,,Started within  the first 36 hours  Body twitches Fatigue Headache Arm thumbless Chest pain and tightness  Shortness of breath  Balance problems Eyelid inflammation and eye pain,,,,,,,,,N,07/30/2019,07/31/2019,1,Blood test  normal  08/2019 EEG normal 08/2019  EKG normal 08/2019 No other tests yet to date,PVT,,None,None,Constipation as a toddler,,,2,09/10/2019,,Y,Y,None
0832899,09/10/2019,NY,6.0,6,,F,,"A few minutes after vaccination the child fell, hit her head on the floor and had a seizure lasting less than 1 minute.  The child then sat up and climbed into her father's lap, BP 120/70 left arm, child alert and oriented, father was offered emergency treatment/assessment of child through 911 but father declined.  Encouraged father to bring the child to facility for assessment, father stated he would do that.  Child ambulated out of the office independently, accompanied by her father.",,,,,,,,,Y,09/10/2019,09/10/2019,0,"none at the Health Department, unknown if child was assessed or treated after leaving clinic",PUB,,unknown,none,none,,none,2,09/10/2019,,,,none
0832900,09/10/2019,MO,70.0,70,,F,,Pt states itchy arm/neck/back since receiving the shingrix vaccination.,,,,,,,,,U,08/02/2019,08/22/2019,20,,PHM,,,,,,,2,09/10/2019,,,,
0832901,09/10/2019,,0.58,0,.6,F,,Diarrhea with 2 episodes of small amount of blood with mucus in stool started the evening after vaccine was given. Continues with diarrhea about 5 episodes of loose watery stool today(the day after vaccine is given).,,,,,,,,,,09/09/2019,09/09/2019,0,US abdomen done in ER: no signs of intussusception,PVT,,None,None,None,,,2,09/10/2019,,Y,Y,None
0832902,09/10/2019,MI,66.0,66,,M,,"patient started noticing swelling on his arm that spread down to about his elbow, starting yesterday. he woke up and it was more red, but he hadn't noticed it getting any worse since he woke up. patient states he had no other symptoms except the swelling but found it unusual since he has had shots before and no problems. he has had a flu shot last year with no problem and the prevnar13. this year he received the flu shot and pneumovax 23 when it occurred. he  just wanted to let us know and said he would keep an eye on it and let us know if it got worse or if he wanted to go get it looked at or etc.",,,,,,,,,U,09/09/2019,09/09/2019,0,none,PHM,,,,,,,2,09/10/2019,,,,no
0832903,09/10/2019,MT,5.0,5,,M,09/05/2019,Fever x3days - Tmax 105.3-started evening of vaccination. emesis x2 day of vaccine. poor appetite x2 days very low energy x3days,,,,,,,,,Y,08/28/2019,08/28/2019,0,none,PVT,PVT,Cetirizine 5mg PO q HS,none,none,,,1,,,,,
0832904,09/10/2019,NY,11.0,11,,M,09/04/2019,"Pt received Menveo on 9/3/19. That evening he complained of not feeling well, @ nausea, fatigue. Slept ~ 14 hrs. Today without symptoms however site of injection is red & indurated 8x9 cm in size.",,,,,,,,,U,09/03/2019,09/03/2019,0,None,PVT,PVT,"Zyrtec, Flonase, Singulair ProAir HFA, Advair HFA, Epi-pen",N/A,"Allergy to foods, mild intermittent asthma, allergic rhinitis",,,1,,,,,
0832905,09/10/2019,AZ,38.0,38,,F,,"The nurse did the shot to heard and went up to high on my right arm She hit the bone my shoulder still ant the same my hand keeps going numb I got sick from the shot I had lightheadness, dizzens, heart racing,",,,,,,,,,,07/22/2019,07/23/2019,1,,UNK,,,,,,,2,09/03/2019,,Y,,
0832906,09/10/2019,OH,82.0,83,,F,,"VERY SORE ARM - COULD HARDLY MOVE IT VERY PAINFUL iF I HAD TO USE iT WAS LiKE THAT FOR A COUPE DAYS THEN PAiN LESSENED, BUT WAS SORE FOR ABOUT A WEEK",,,,,,,,,Y,07/24/2019,07/24/2019,0,DID NOT GO TO THE DOCTOR,PHM,,"Lovastatin Preserv2-Latanoprost Eliquis, Advair, Flecanide, Metoporol",COPD - Congestive Heart Failure,"Atrial Fibrillation, High Blood Press",,,2,09/06/2019,,,,"Amoxicillin, Tetanus - Bactrim"
0832907,09/10/2019,OH,5.0,5,,M,,"(Reported to nurse by parent via phone) Pt was emotional and cried at school 9/9/19 afternoon. Woke suddenly at 10:30 pm screaming, crying, shaking. Body went stiff the patient urinated on self. Episode lased approximately 2 minutes, but patient Remained disoriented an additional 8 mins. Pt then went to sleep, no further incidents Remainder of the night. Pt awoke 9/10/19 a.m. at normal time, acting normally, no recollection of event.",,,,,,,,,Y,09/09/2019,09/09/2019,0,None,PVT,,Qvar 40 mcg/actuation one puff bid,None,Asthma,,,2,09/10/2019,,,,None
0832910,09/10/2019,AZ,76.0,76,,M,,"Chills, shaking, Fever 101.1 Lethargic, drowsy",,,,,,,,,Y,08/17/2019,08/19/2019,2,,PHM,,,NONe,,,,2,09/05/2019,,Y,,
0832913,09/10/2019,FL,17.0,17,,F,,"1) Patient Received vaccine MMR on 8/21/19 seen @ office 8/23/19 with itchy rash urticaria on trunk. Initially 50mg Benadryl taken 2) Patient referred to allergy specialist & seen within 4 hours. Dx skin rash drug eruption vs allergic contact dermatitis vs idiopathic urticaria. Per allergist dx skin rash - drug eruption vs allergic contact dermatitis vs idiopathic urticaria. To start Zyrtec or Xyzal one pill BID until Rash & itching controlled - then once a day. Also Prednisone taper 30mg day one, 20 mg BID & taper down over 8 days. May need skin Bx if no improved. To follow up @1 week - Patient has not returned for follow up.",,,,,,,,,U,08/21/2019,08/23/2019,2,No labs done - patient to allergist late in the day,SCH,,None,No Known,None,,,2,09/10/2019,,Y,,None
0832918,09/10/2019,IL,,,,F,,"hearing loss; vertigo; Information has been received from a lawyer and the patient regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided.  On or about 26-SEP-2017, the patient (pt) was vaccinated with zoster vaccine live (ZOSTAVAX), (lot# and route unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after  zoster vaccine live (ZOSTAVAX) vaccination, the pt suffered hearing loss and vertigo (dates unspecified).   As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms have resulted in physical limitations not present prior to using the product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events were considered not resolved. The events were considered related to zoster vaccine live (ZOSTAVAX).  Hearing loss and vertigo were considered to be disabling events. Upon internal review, the event hearing loss was determined to be medically significant.",,,,,,,,Y,N,09/26/2017,,,,UNK,,,,,,US0095075131908USA010683,2,09/04/2019,,,,
0832920,09/10/2019,NY,,,,F,,"patient ""fainted"" after receiving the first dose in the GARDASIL 9 series; Information has been received from a nurse via an employee referring to a 12 years old female patient. The patient was not pregnant. The patient's concomitant medications, pertinent medical history and drug reactions/allergies were unknown by the reporter.  On an unspecified date, the patient was vaccinated with the first dose HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (frequency, anatomical location, route of administration, lot number and expiration date were unknown) for prophylaxis (reported as cervical cancer prevention) and the patient fainted after receiving vaccination.   No product quality complaint (PQC) was involved. Information about treatment given for adverse event, lab diagnostics/studies performed and medical attention was unknown by the reporter. The outcome of the event was reported as recovered. The causality between the event and HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) therapy was not provided.  Upon internal review, the event of faint was determined to be medically significant.",,,,,,,,,Y,,,,,UNK,,,,,,US0095075131909USA002481,2,09/10/2019,,,,
0832921,09/10/2019,IL,4.0,4,,U,,"no adverse effect; improperly stored VARIVAX; This spontaneous report was received from a registered nurse referring to a 4-year-old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications.  On 12-AUG-2019 and 13-AUG-2019, vaccines had a temperature excursion.  On 30-AUG-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) lot # R006221 with expiration date on 29-FEB-2020 or R029517 with expiration date on 10-OCT-2020 (dosage schedule, route and anatomical location were not reported), for prophylaxis (incorrect product storage).  Administered doses of vaccine experienced temperature excursion of -14 degrees Celsius (C) to -10 C (-11.91 C) for 8 hours. There was no previous temperature excursion. Digital data logger was involved. Vaccines were reconstituted with a properly stored sterile diluent. No adverse effects were reported.",,,,,,,,,U,08/30/2019,08/30/2019,0,,UNK,,,,,,US0095075131909USA002971,2,09/10/2019,,,,
0832922,09/10/2019,IL,5.0,5,,U,,"no adverse effect reported; improperly stored VARIVAX; This spontaneous report was received from a registered nurse referring to a 5-year-old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications.  On 12-AUG-2019 and 13-AUG-2019, vaccines had a temperature excursion.  On 30-AUG-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) lot # R006221 with expiration date on 29-FEB-2020 or R029517 with expiration date on 14-OCT-2020 (dosage schedule, route and anatomical location were not reported), for prophylaxis (incorrect product storage).  Administered doses of vaccine experienced temperature excursion of -14 degrees Celsius (C) to -10 C (-11.91 C) for 8 hours. There was no previous temperature excursion. Digital data logger was involved. Vaccines were reconstituted with a properly stored sterile diluent. No adverse effects were reported.",,,,,,,,,U,08/30/2019,08/30/2019,0,,UNK,,,,,,US0095075131909USA003010,2,09/10/2019,,,,
0832923,09/10/2019,NY,,,,U,,"No adverse effects; One expired dose of VAQTA was inadvertently administered to a patient on 9/9/2019; This spontaneous report was received from a nurse concerning to a patient of unknown age and gender. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported.       On 09-SEP-2019, one expired dose of hepatitis a vaccine, inactivated (VAQTA) was inadvertently vaccinated to a patient (expired product administered) 0.5 milliliter, for prophylaxis (lot # R021233 has been verified to be a valid lot number for hepatitis a vaccine, inactivated; expiration date reported and establish as 05-SEP-2019) (strength and route of administration were not reported).       No adverse effects reported.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,US0095075131909USA003368,2,09/10/2019,,,,
0832924,09/10/2019,,,,,F,,"Intrauterine growth restriciton; Foetal exposure during pregnancy; Preterm birth; Low birth weight; Laryngomalacia; This is an observational study case, initially received from other health professional on 06-Aug-2019, concerning an infant subject. The mother was a 24-year-old, female pregnant subject of body weight: 221 lbs, height: 60 inches and body mass index (BMI): 43.2, enrolled in a prospective observational safety study.  The mother's concomitant medications included prenatal vitamins (unspecified vitamins and minerals, 1 tablet orally every day, from 18-Oct-2018 to 08-Feb-2019, for pregnancy and promethazine for nausea. The mother's medical history included nausea.  The mother's obstetrical history included three previous pregnancies: two live births and one spontaneous abortion. The mother had no history of offspring with major congenital malformation nor maternal or paternal history with major congenital malformations. The mother did not use tobacco, alcohol or illicit drugs during pregnancy. The pregnancy status of the mother was collected and there were no complications noted.  The mother's last menstrual period (LMP) was 15-Jun-2018. The type of pregnancy was singleton. The estimated delivery date (EDD) was 22-Mar-2019 and corrected estimated date of delivery (CEDD) was 05-Mar-2019.   On 18-Oct-2018, haemoglobin electrophoresis, spinal muscular atrophy screen and fibrosis mutation analysis were done and no major congenital malformation (MCM) were noted.  On 01-Nov-2018, at gestation age of 19 weeks, the mother was administered with Flu Vaccine Cell Subunit QIV NVD [influenza vaccine, subunit influenza virus vaccine polyvalent, batch number: 252664, route of administration, expiration date and anatomical location were not reported] (explicitly coded as foetal exposure during pregnancy) for influenza immunisation. On the same day, ultrasound was performed and no MCM were noted.  On an unspecified date, the mother developed oligohydramnios.  On 08-Feb-2019, three months and seven days after vaccination, at 36,4 weeks gestation, the mother gave a live birth to normal female neonate by caesarean delivery. The neonate's birth weight was 1928 grams (head circumference and body length were not reported). The appearance, pulse, grimace, activity, and respiration (APGAR) scores were 8 at one minute and 8 at five minutes. APGAR score was not reported for 10 minutes. On the same day, the congenital malformation laryngomalacia was noted by neonatal intensive care unit, possibly due to preterm birth and intrauterine growth restriction, as reported.   At the time of follow up, the outcome of the events low birth weight, preterm birth, intrauterine growth restriction and laryngomalacia was not reported.   This case is linked to 201904355, the corresponding mother report.  Follow up received from other health professional on 03-Sep-2019 and process together on 04-Sep-2019 included: The events of laryngomalacia and intrauterine growth restriction added. Indications for concomitant medications populated with null flavors. Narrative was amended accordingly.   Company comment: Reportedly, the female neonate subject was delivered as premature baby, low birth weight baby, with laryngomalacia and foetal growth restriction after foetal exposure during pregnancy, at gestation age of 19 weeks with the suspect product Flu Vaccine Cell Subunit QIV NVD. Chronology is plausible. The mother's historical conditions of class 3 obesity (BMI 43.2) may have contributed to development of the events. Causality was confounded by therapy with concomitant medication promethazine. Foetal exposure during pregnancy is assessed as unrelated based on company's conventions. For all other events, causal role of the suspect product cannot be totally excluded and is assessed as related.; Reporter's Comments: Reportedly, the female neonate subject was delivered as premature baby, low birth weight baby, with laryngomalacia and foetal growth restriction after foetal exposure during pregnancy, at gestation age of 19 weeks with the suspect product Flu Vaccine Cell Subunit QIV NVD. Chronology is plausible. The mother's historical conditions of class 3 obesity (BMI 43.2) may have contributed to development of the events. Causality was confounded by therapy with concomitant medication promethazine. Foetal exposure during pregnancy is assessed as unrelated based on company's conventions. For all other events, causal role of the suspect product cannot be totally excluded and is assessed as related.",,,,,,,,,U,11/01/2018,02/08/2019,99,,OTH,,PROMETHAZINE; PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS],,Comments: None,,USSEQIRUS201904356,2,09/10/2019,Y,,,
0832925,09/10/2019,,33.0,33,,F,,"SIRS; Administered flu vaccine intravenously; This is a spontaneous case, initially received from pharmacist via Agency (reference number: SEQ19-02270) on 04-Sep-2019, concerning a 33-year-old female patient.  The patient's medical history included chest pain, symptomatic anaemia and viral gastroenteritis.  The patient's concomitant medications included ferrous sulphate, amitriptyline, Duoneb (ipratropium bromide, albuterol sulfate), Zofran (ondansetron), Percocet (oxycodone, acetaminophen), oxycodone, Miralax (polyethylene glycol 3350) and senna; all for unknown indication.  On 11-Jan-2019, while was in hospital due to chest pain related to anemia, the patient was administered intravenously Afluria Quadrivalent [influenza vaccine, dose: 0.5 ml, batch number: YG40008, expiration date and anatomical location not reported] (explicitly coded as Inappropriate route of vaccination') for influenza prophylaxis. On the same day, the patient was discharged home.  On 12-Jan-2019, one day after vaccination, the patient developed nausea and vomiting with elevated white blood cell count. The patient was readmitted to hospital and diagnosed with Systemic inflammatory response syndrome (SIRS).  On 15-Jan-2019, the event of SIRS was resolved.  It was unknown if the event of SIRS was caused by IV administration of influenza vaccine or from viral gastroenteritis.  The reporter assessed the case as serious.  Company Comment: The patient experienced systemic inflammatory response syndrome after incorrect route of the suspect product Afluria Quadrivalent administration (reported as flu vaccine intravenously administered). Chronology is plausible. Medical history of anaemia and viral gastroenteritis may have contributed to development of the event systemic inflammatory response syndrome. Causality was also confounded by therapy with multiple concomitant medications. Considering all the above mentioned, causal relationship between the suspect product and the event systemic inflammatory response syndrome is assessed as related and as not related for incorrect route of product administration.; Reporter's Comments: The patient experienced systemic inflammatory response syndrome after incorrect route of the suspect product Afluria Quadrivalent administration (reported as flu vaccine intravenously administered). Chronology is plausible. Medical history of anaemia and viral gastroenteritis may have contributed to development of the event systemic inflammatory response syndrome. Causality was also confounded by therapy with multiple concomitant medications. Considering all the above mentioned, causal relationship between the suspect product and the event systemic inflammatory response syndrome is assessed as related and as not related for incorrect route of product administration.",,,,,Y,3,,,Y,01/11/2019,01/11/2019,0,Test Date: 20190112; Test Name: White blood cell count; Result Unstructured Data: Elevated,UNK,,FERROUS SULFATE; AMITRIPTYLINE; DUONEB; ZOFRAN [ONDANSETRON HYDROCHLORIDE]; PERCOCET [OXYCODONE HYDROCHLORIDE;PARACETAMOL]; OXYCODONE; MIRALAX; SENNA ACUTIFOLIA,Anaemia; Chest pain,Medical History/Concurrent Conditions: Viral gastroenteritis,,USSEQIRUS201904555,2,09/10/2019,,,,
0832926,09/10/2019,,35.0,,,F,,"Pre-eclampsia; Vaccine exposure during pregnancy; This is an observational study case, initially received from other health professional on 05-Sep-2019, concerning a 35-year-old, pregnant, female subject of body weight: 213.8 lbs, height: 59 inches and body mass index (BMI): 43.2, enrolled in a prospective observational safety study. The subject's obstetrical history noted that she had no previous pregnancies and that she was in advanced maternal age. Also, the subject had no relevant maternal and paternal medical history. The subject did not use tobacco, alcohol or illicit drugs during pregnancy. The subject's medical history included depressive disorder, left lower quadrant pain, anxiety, seasonal allergies, dyspareunia and heartburn. The concomitant medications of the subject included Prenatal gummy as health supplement, ranitidine for heartburn and fluticasone propionate for seasonal allergies.   The subject's last menstrual period date was 01-Dec-2018, the estimated delivery date and corrected delivery date were reported as 07-Sep-2019. The type of pregnancy was singleton.   On 21-Jan-2019, the subject underwent prenatal tests toxoplasma IgG and IgM and no major congenital malformations were noted.   On 04-Feb-2019, at gestational age of approximately nine weeks, the subject was administered Flu Vaccine Egg Split QIV CSL [influenza vaccine, batch number: YF41608, dose, route of administration, anatomical location and expiration date: not reported] (explicitly coded as 'vaccine exposure during pregnancy') for influenza immunisation.   On 27-Feb-2019, the subject underwent Maternal serum alfa-fetoprotein (MSAFP)/ serum markers test, Essential panel and Non-invasive prenatal test and no major congenital malformations were noted.   On 22-Apr-2019, the subject underwent ultrasound and no major congenital malformations were noted.   On 20-Aug-2019, approximately six months after vaccination, the subject experienced pre-eclampsia and was treated with labetalol at a dose of 200 mg, administered two times per day via oral route.   At 37.9 gestational week, the subject vaginally delivered live birth male neonate. The neonate's birth weight was 2841 g, length 48.9 cm and his head circumference 34.5 cm. The appearance, pulse, grimace, activity, and respiration (APGAR) scores were 8 (one minute) and 9 (five minutes). APGAR score was not reported for 10 minutes. There was no major congenital malformation identified at birth.   At the time of initial reporting, the subject had not recovered from the event of 'pre-eclampsia'.  Company Comment: The subject experienced pre-eclampsia 6 months and 16 days after vaccination with the suspect product Flu Vaccine Egg Split QIV CSL. Reportedly, vaccination occurred during pregnancy.  Chronology is unsuggestive due to long latency onset. Medical history of depressive disorder, seasonal allergies and pregnant state may have contributed to development of the event. Causality was confounded by therapy with concomitant medications ranitidine and fluticasone propionate. Considering all the above mentioned, causal relationship between the suspect product and exposure during pregnancy is assessed as not related and as related for the event pre-eclampsia.; Reporter's Comments: The subject experienced pre-eclampsia 6 months and 16 days after vaccination with the suspect product Flu Vaccine Egg Split QIV CSL. Reportedly, vaccination occurred during pregnancy.  Chronology is unsuggestive due to long latency onset. Medical history of depressive disorder, seasonal allergies and pregnant state may have contributed to development of the event. Causality was confounded by therapy with concomitant medications ranitidine and fluticasone propionate. Considering all the above mentioned, causal relationship between the suspect product and exposure during pregnancy is assessed as not related and as related for the event pre-eclampsia.",,,,,,,,,N,02/04/2019,02/04/2019,0,Test Date: 20190227; Test Name: MSAFP/ serum markers; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20190227; Test Name: Essential Panel; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20190227; Test Name: Non-invasive Prenatal test; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20190121; Test Name: Toxoplasma IgG; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20190121; Test Name: Toxoplasma IgM; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20190422; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.,UNK,,RANITIDINE; FLUTICASONE PROPIONATE,Anxiety (Start date reported as 0 weeks (prior to conception).); Depressive disorder (Start date reported as 0 weeks (prior to conception).); Dyspareunia (Start date reported as 0 weeks (prior to conception).); Heartburn; Left lower quadrant pain (Start date reported as 0 weeks (prior to conception).); Seasonal allergy (Start date reported as 0 weeks (prior to conception).),Medical History/Concurrent Conditions: Pregnancy with advanced maternal age,,USSEQIRUS201904558,2,09/10/2019,,,,
0832927,09/10/2019,CO,0.08,0,.2,F,09/10/2019,"9/10/19 - 65 day old female with blood in stools for 2 days. Parents report 3-4 diapers with small amount blood, some mucus. Pt is awake, alert & happy. No other symptoms noted. Plan is to start alimentun for 2 month, probiotics & monitor",,,,Y,,,,,U,09/06/2019,09/09/2019,3,hemoccult of stool - positive for blood 9/10/19,PVT,PVT,NA,NA,"Laryngotracheitis, Thrush, Torticollis, Positional plagiocephaly",,,1,,,,,
0832928,09/10/2019,NJ,69.0,69,,F,,"Patient returned to pharmacy on 9/10 stating that she was diagnosed with cellulitis in the injection arm (this was per physician). Upon examination, arm appeared red and swollen.  Patient states that she was experiencing pain in the arm and that she was feverish.  Patient received prescriptions for methylprednisolone dose pack and amoxicillin-clav antibiotic.",,,,,,,,,U,09/08/2019,09/09/2019,1,,PHM,,,,,,,2,09/10/2019,,Y,,
0832929,09/10/2019,PA,62.0,62,,F,,"Patient reported intitially on 09-08-19 that she had a lot of pain/swelling on the ""inside"" of the arm where she had the vaccinations. She also reported the area was hot to the touch. When questioned if it was on the outside of the arm where the needle went in she said,""no, on the inside of the arm""  She called back later stating that she sees the issue on the outside of the arm, as well.",,,,,,,,,U,09/06/2019,09/06/2019,0,none known,PHM,,"Hydrocodone/ apap 5/325, Simvastatin 20 mg, Hctz 12.5 mg",unknown,"hyperlippidemia, smoker",,,2,09/10/2019,,,Y,nka
0832930,09/10/2019,NY,53.0,53,,F,,FEVER 102.9F (PT WAS ACCIDENTALLY GIVEN THE VACCINE INTRAVENOUSLY),,,,,,,Y,,Y,08/14/2019,08/15/2019,1,,PVT,,,,"COPD/asthma,OA, lymphoma (s/p chemo in 2015), ankylosing spondylitis, bipolar disorder, and chronic pain syndrome",,,2,09/10/2019,,,,PENICILLIN
0832931,09/10/2019,AL,0.75,0,.8,M,,"8/10/17 - 10 months - Vaccine reaction to prevnar 13 3rd dose- fever of 102, high pitched crying for over a week, especially at night, lost all sounds, became non verbal, lost eye contact, would not respond appropriately to stimuli.  1/24/18 - 15 months - Complained to Dr. about his ?regression? with sounds and speech. Said it happened after his last immunization and he never regained his sounds.  4/23/18 - 18 months - Complained to Dr. about his limited eating. He ate everything up until recently and was self limiting to about 5 foods at this time. Asked about getting speech therapy. Was told he still had time to catch up. But I pressed her because he was making NO SOUNDS anymore. She referred him for an Speech evaluation.  5/14/18 - 19 months- Evaluated for speech, scored at a 10month old level.  5/16/18 - 19 months - TDAP vaccine 3rd dose, stopped eating all foods but quinoa and almond milk post vaccination. Became chronically constipated. 6/1/18 - 20 months - Began speech therapy.  6/4/2018 - Appoint with MD, ENT- Concerns about speech, hearing and swallowing. Had Audiometric test. Tympanograms normal, Type A bilaterally. Diagnosed with Dysphagia.  7/10/18 - 21 months - Meeting with Early Intervention System. Had a 25% deficit an was approved for Early intervention services. In home speech and OT once a month. 10/1/2018- MD, ENT- Follow up for issues with related to Dysphagia, performed Laryngoscopy. Enlarged inflamed adenoidal tissue. Referred to Pediatric Gastroenterologist.  10/30/2018 24 months - Upper and Lower Frenectomy Laser Revision 11/21/2018-  MD, ENT Six week follow up.  11/28/18 - 25 months - MD - Upper GI Endoscopy - Diagnosed with Reflux Esophagitis, prescibled 40mg of Nexium 12/6/2018 - MD - Sleep Study Consult  12/17/18 - 26 months - Evaluated for Occupational Therapy. Scored 15months on grasping and 21months on visual motor integration. Started weekly OT.  1/9/2019 - Failed Sleep Study. 1/30/2019 -  MD, ENT - Follow up. Discuss and schedule adenoidectomy and tympanostomy tubes. 2/8/19 - 28 months - MD, ENT-  adenoidectomy and tympanostomy tubes. 2/23/19 - 28 months -  Implemented Cod Liver Oil- Significant improve in eye contact and speech and overall behavior 2/27/2019 - MD- GI Post op follow up. Instructed to do milk and molasses enemas for constipation. Prescribed Generlac.  3/21/2019 -MD, ENT- Post op follow up. Audiometric test. 5/16/19 - 30 months -  Extensive Labs done, high thyroid, low iron, high urea  9/4/2019 -  Evaluated at School for integration into school systems Special Needs program out of early intervention.",,,,,,,,Y,N,08/10/2017,08/10/2017,0,"8/10/17 - 10 months - Vaccine reaction to prevnar 13 3rd dose- fever of 102, high pitched crying for over a week, especially at night, lost all sounds, became non verbal, lost eye contact, would not respond appropriately to stimuli.  1/24/18 - 15 months - Complained to Dr. about his ?regression? with sounds and speech. Said it happened after his last immunization and he never regained his sounds.  4/23/18 - 18 months - Complained to Dr. about his limited eating. He ate everything up until recently and was self limiting to about 5 foods at this time. Asked about getting speech therapy. Was told he still had time to catch up. But I pressed her because he was making NO SOUNDS anymore. She referred him for an Speech evaluation.  5/14/18 - 19 months- Evaluated for speech, scored at a 10month old level.  5/16/18 - 19 months - TDAP vaccine 3rd dose, stopped eating all foods but quinoa and almond milk post vaccination. Became chronically constipated. 6/1/18 - 20 months - Began speech therapy.  6/4/2018 - Appoint with MD, ENT- Concerns about speech, hearing and swallowing. Had Audiometric test. Tympanograms normal, Type A bilaterally. Diagnosed with Dysphagia.  7/10/18 - 21 months - Meeting with Early Intervention System. Had a 25% deficit an was approved for Early intervention services. In home speech and OT once a month. 10/1/2018- MD, ENT- Follow up for issues with related to Dysphagia, performed Laryngoscopy. Enlarged inflamed adenoidal tissue. Referred to Pediatric Gastroenterologist.  10/30/2018 24 months - Upper and Lower Frenectomy Laser Revision 11/21/2018-  MD, ENT Six week follow up.  11/28/18 - 25 months - MD - Upper GI Endoscopy - Diagnosed with Reflux Esophagitis, prescibled 40mg of Nexium 12/6/2018 - MD - Sleep Study Consult  12/17/18 - 26 months - Evaluated for Occupational Therapy. Scored 15months on grasping and 21months on visual motor integration. Started weekly OT.  1/9/2019 - Failed Sleep Study. 1/30/2019 -  MD, ENT - Follow up. Discuss and schedule adenoidectomy and tympanostomy tubes. 2/8/19 - 28 months - MD, ENT-  adenoidectomy and tympanostomy tubes. 2/23/19 - 28 months -  Implemented Cod Liver Oil- Significant improve in eye contact and speech and overall behavior 2/27/2019 - MD- GI Post op follow up. Instructed to do milk and molasses enemas for constipation. Prescribed Generlac.  3/21/2019 -MD, ENT- Post op follow up. Audiometric test. 5/16/19 - 30 months -  Extensive Labs done, high thyroid, low iron, high urea  9/4/2019 -  Evaluated at School for integration into school systems Special Needs program out of early intervention.",PVT,,None,None,Developmental Delay. Speech Delay. Motor deficits. Sensory Processing Disorder. Eating Disorder. Dysphagia. Chronic Serous Otitis Media. Hypertrophy Adenoid.  Bilateral Eustachian tube dysfunction. Chronic Rhinitis. Sleep disordered breathing.  Reflux Esaphogiatis. Anemia. High BUN.,,,2,09/10/2019,,Y,,None
0832932,09/10/2019,MI,5.0,5,,F,,An MMRV was given along with a Varicella.,,,,,,,,,U,09/07/2019,09/07/2019,0,,OTH,,,,,,,2,09/10/2019,,,,
0832933,09/10/2019,MI,4.0,4,,M,,Varicella vaccine was given with an MMRV vaccine.,,,,,,,,,U,09/07/2019,09/07/2019,0,,OTH,,,,,,,2,09/10/2019,,,,
0832934,09/10/2019,IN,73.0,73,,F,,"Pain, bruising and swelling at injection site. General muscle pain, tiredness, weakness, headache, shivering, fever, nausea, joint pain.",,,,,,,,,Y,09/09/2019,09/09/2019,0,None,PHM,,Venlafaxine; multivitamins,None,Mild depression,,,2,09/10/2019,,,,None
0832935,09/10/2019,MI,5.0,5,,F,,A Varicella vaccine was given at the same time as an MMRV vaccine.,,,,,,,,,U,09/07/2019,09/07/2019,0,,OTH,,,,,,,2,09/10/2019,,,,
0832936,09/10/2019,,67.0,67,,F,,"patient developed a red, swollen and warm arm from the mid deltoid down to the elbow in the left arm starting the day after receiving the vaccine.  She eventually saw a doctor and they recommended she take benadryl which she has started yesterday 9/9 and it has been improving since.",,,,,,,,,,09/06/2019,09/07/2019,1,,PHM,,,,,,,2,09/10/2019,,Y,,
0832937,09/10/2019,MN,17.0,17,,F,,"Patient received her second Meningococcal B (Bexero) vaccine today, 9/10/19, at 8:20 am.   The first dose was given on 7/30/19. The vaccine was given properly in the left deltoid after the patient passed the nursing protocol for administration.  When patient left, she was feeling well and had no complaints.  Her mother called our nurse triage line at 11:05 am stating that she was having left arm pain, numbness and weakness and that she was unable to make a fist or raise her arm above her head.  She arrived to our clinic at 12:45 to be seen by a provider.  She was having chills, left arm pain 6/10 and generalized body aches/pain 8/10 and felt shaky. Her vitals were as follows: temperature 39 degrees Celsius, blood pressures were 72/38 initially and then 90/38, pulse 89, and 99% oxygen saturation.  The patient was given something to eat as she had only a small breakfast and no lunch.  After further discussion with the provider, the mother stated that the symptoms started an hour and a half after she received the vaccine.  There was no swelling, redness or warmth at the injection site.  Patient?s repeat blood pressure thirty minutes later was 98/61 and pulse was 89, she was not flush-appearing and was starting to feel better.  The arm weakness had improved prior to being seen in clinic, and was completely resolved prior to her leaving the clinic.  She was observed for over an hour in clinic and was sent home with instructions to return should symptoms reappear.",,,,,,,,,Y,09/10/2019,09/10/2019,0,None,PVT,,Flonase Albuterol,None,Asthma Vocal Cord Dysfunction,,,2,09/10/2019,,Y,,Nickel Pollen
0832938,09/10/2019,,1.75,1,.8,F,,Pediarix given when patient was due for only Dtap. No adverse reaction. Provider notified.,,,,,,,,,,09/10/2019,09/10/2019,0,,PVT,,,,,,,2,09/10/2019,,,,
0832939,09/10/2019,WA,31.0,31,,F,,"Shortly after recieving the vaccination i expierenced the usual symptoms (fatigue, sore arm, etc). After a few days i noticed i had a lump inferior to the mid clavicle area. I assumed it to by a lymph node, and waited 4 weeks to see if it went away. When it did not go away I made an appt w/ my Dr. He ordered an ultrasound. It took almost three weeks to get an appt for ultrasound. They confirmed it was a 1.4cm lymph node, possible reactive. The report stated they could not rule out malignancy and suggested further test. My provider ordered a chest X-ray which came back negative for lung effusion or masses. However, once again the report said it could not rule out soft tissue tumors or malignancy. Im not awaiting a surgical consult for biopsy. Ive had this lymph node for nearly 3 months.",,,,,,,,,N,06/24/2019,06/28/2019,4,"After the lymph node persisted >4 weeks, Dr ordered ultrasound, it revealed a 1.4 cm reactive inferior clavicle lymph node. Suggested further evaluation given the area and highly likelihood of malignancy associated with those lymph nodes.  Provider then ordered a chest X-ray. Report came back clear, no effusions or tumors. However it suggested further work up because it could not rule out soft tissue tumors in chest/breast. Currently awaiting general surgery consult for biopsy. Consult is scheduled for 9/16/19.",PHM,,Multivitamin Levothyroixine 0.25mcg Adderall 20mg Ceterizine 10mg Flonase,I was being treated for allergies when my allergy doctor suspected an immune deficiency (recurrent sinusitis). She ordered labs to test antibodies and they came back low. She prescribed Prevnar 13 to be followed by Prevnar 23 and HIB at later dates. I have only received the prevnar 13. Due to this adverse reaction I have not continued my vaccination schedule. My doctor suggested waiting for additional vaccine until this issue is resolved.,Chronic sinusitis Hypothyroidism ADHD,,,2,09/10/2019,,Y,,n/a
0832940,09/10/2019,CO,29.0,29,,F,,"Patient presented the day after receiving the flu shot with a ""spidery-looking"" bruising at the injection site. Patient said her arm hurt that night after receiving the flu shot and applied topical Biofreeze which said provided relief. Patient states the bruising was continuing to worsen and wanted to report the adverse event. Patient presented not in acute pain and was advised to apply a cold compress, if needed, and to continue to monitor if the bruise worsens. Advised patient to seek medical attention if bruise worsens or acute pain occurs and report the information to the pharmacy.",,,,,,,,,,09/07/2019,09/07/2019,0,,PHM,,Nuvaring,,,,,2,09/10/2019,,,,
0832941,09/10/2019,PA,67.0,67,,F,,patient stated she got hives starting 1 day after administration.  she took benadryl to help with the hives,,,,,,,,,Y,09/04/2019,09/05/2019,1,unknown,PHM,,levothyroxine,unknown,hypothyroid,,,2,09/10/2019,,,,"biaxin, pencillin, sulfa"
0832942,09/10/2019,FL,57.0,57,,F,,"pt following day developed red raised rash over entire chest/neck area, and psread over next few days",,,,,,,,,Y,05/05/2019,05/06/2019,1,unknown,PHM,,unknown,unknown,unknown,,,2,09/10/2019,,,,"nsaid, sulfa"
0832943,09/10/2019,FL,58.0,58,,F,,"Started with a light headache , Left are sore and tired and swallon glands in jaw line. As the day progressed, symptoms worsen. By evening, started to run low fever with chills, aching all over and extremely tired. I could hardly stay awake.  I felt so bad with the chills and aching I went to bed early after taking 2 extra strenght Tylenol. I woke up crying around 2:00 am hurting so bad, I felt like someone beat me with a 2x4 board, so I took a Percocet 325 and went back to bed. When I woke up I had chills, severe pain all over, very weak and could hardly move my left arm which was red and swallon.  Then my skin was burning and itching in different places. I laid in my recliner and couldn't stay awake. Slept most of the day.  Fever stayed under 101 and finally stopped by Sunday morning, weakness stayed till Monday morning. Swallon glands in jaw line got better each day afterwards.",,,,,,,,,Y,08/30/2019,08/30/2019,0,"I didn't go to doctor, my husband wanted to take me to ER, but I was hurting too bad. But my chest did hurt Saturday night and has since went away.",OTH,,"theophylline 300 mg, estradiol 1 mg, potassium chloride, Lasik & Phentermine",None,Asthma,,,2,09/10/2019,,,,"Clinoril, Some anti inflammatory drugs, Sulfate drug. Dust, mold, pollen, cat & dogs"
0832944,09/10/2019,AK,66.0,66,,F,,"Patient called 2 weeks after the vaccine was administered stating that 48 hours after receiving the Hep B vaccine, she was dropping and having a hard time holding makeup brushes, as well as having a disturbance in her gait as she walked. No more vaccines administered after this due to reaction.",,,,,,,,,Y,02/13/2019,02/15/2019,2,none that i'm aware of.,WRK,,"Unknown, you will need to contact the patient. I'm part of Employee health and do not have this information.",none that i was made aware of. Ask patient.,None that i am aware of. This vaccine was part of a health screen. I can not ask this information.,,,2,09/10/2019,,,,none that i am aware of. Should ask patient.
0832945,09/10/2019,GA,50.0,50,,F,,I started having  a reaction to the vaccine about 1pm in the afternoon. I found a big RED mark where the injection was put in along  with my arm being sore and swollen I was not able  to raise my hand about my head. Getting dressed is very difficult because putting my right arm in the sleeves is very painful. I cant  sleep on my side because of the pain and I have a pain in my neck that is also very bothersome.,,,,,,,,,N,09/06/2019,09/06/2019,0,,PVT,,"Cephalexin 500 mg  for a UTI Lexapro 50 mg 1x a day Meloxicam 7.5 mg for pain management as needed Stress B-Complex, Flaxseed oil, B-50 Complex, Sentry Senior Multi Vitamin, Active Mind & Calcium, Magnesium and Zinc W/ vitamin D3",Have had lots of seizures prior to the vaccination.,"Yes, Seizures and depression",,,2,09/10/2019,,,,Only Erythomycin I get hives.
0832946,09/10/2019,TN,20.0,20,,F,,Developed 2x2 palpable knot at injection site. Tender to touch,,,,,,,,,N,08/15/2019,09/08/2019,24,,PVT,,Zyrtec,,,,,2,09/10/2019,,Y,,N/a
0832947,09/10/2019,MI,,,,U,,"improperly stored dose of GARDASIL 9 was administered; No adverse effect reported; This spontaneous report was received from a nurse, referring to patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications and previous drugs reactions or allergies were not provided.  On 28-AUG-2019, the patient was vaccinated with an improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) from a two doses series, as prophylaxis (concentration, number of administered dose, vaccination scheme frequency, route and anatomical location of vaccination were not reported; reported lot number 1614897, expiration date 20-SEP-2021, have been confirmed as valid) . No adverse effects were reported for the patient.  According to the reporter, the temperature excursion was 48.5 degrees Fahrenheit(F) for a time frame of four hours and 15 minutes on an unspecified date (product storage error), without any previous temperature excursion; which was detected by a digital data logger, as the ""no alarm went off"".  This is one of three reports received from the same reporter.; Sender's Comments:  US-009507513-1908USA012909: US-009507513-1908USA012939:",,,,,,,,,U,08/28/2019,,,,UNK,,,,,,US0095075131908USA013035,2,09/10/2019,,,,
0832948,09/10/2019,MA,67.0,67,,F,,"Drug dose administration interval too long; Injection site reaction; redness from her shoulder to her elbow; Deep cough in chest; Flu-like symptoms; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number 99D9F, expiry date unknown) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site reaction (received 1st dose on 8th October 2018, refer case US2019107209).   On 4th June 2019, the patient received the 2nd dose of Shingrix. On 4th June 2019, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. In June 2019, the patient experienced injection site pain, erythema, cough and influenza-like symptoms. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain, erythema, cough, influenza-like symptoms and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the injection site pain, erythema, cough and influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix in left arm. The pharmacist stated that the patient experienced injection site reactions. The reaction was worse with redness from her shoulder to her elbow; the redness was still ongoing at the site and developed a deep cough in her chest and flu-like symptoms.  The pharmacist notes the injection was given by a rotating pharmacist.  She states the patient gives permission for GlaxoSmithKline to reach out to her.  The patient provided the pharmacist with a phone number if safety needs to follow up directly. The pharmacist also consents to follow up.",,,,,,,,,U,06/04/2019,06/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/10/2019,,,,
0832949,09/10/2019,NY,6.0,6,,M,,"The Shingrix vaccine was given in error in place of Flucelvax. His grandmother was supposed to get the shingrix. He was crying, kicking and giving a really hard time prior to vaccine being giving. To calm him down the correct vaccine I place back in the bin and it took 3 adults to hold him down to get the vaccine bc his mom was inisting to give it and during that time is when I grabbed the wrong vaccine and gave it to him in error. I noticed the mistake right after vaccine was injected. Pt has experienced no adverse effects known to date, have followed up with his mom 2-3 times since event.",,,,,,,,,U,08/30/2019,08/30/2019,0,,PHM,,,,,,,2,09/10/2019,,,,
0832950,09/10/2019,KY,52.0,52,,F,,"On 7/8/19 while preparing for vacation, patient began acting a bit unlike her usual self the night before leaving.  The morning (4:30am) of the trip she said she was not feeling great but we all seemed to think this was due to lack of sleep.  When we drove to the airport about 2 hours later she began showing signs of confusion and had obvious trouble with word finding. She also had some occasional ""tick like"" jerking of her arms/legs.  She could not tell what year it was.   We were taken to hospital.  Stroke was ruled out from MRI.  An abnormal EEG indicated a weakness toward seizure activity. A lumber puncture the next day indicated inflammation in the spinal fluid with an slightly abnormal high viral count.  After 24 hours her symptoms had cleared completely.  She was released from the hospital after 2 nights.",,,,,Y,3,,,Y,07/01/2019,07/08/2019,7,7/9/2019 MRI (without contrast) Negative for CVA 7/9/2019 EEG   Abnormal with weakness toward seizure activity 7/10/2019  Echocardiogram   Negative 7/10/2019 Lumbar puncture   Inflammation found with elevated viral component of unknown/undetermined origin.  7/24/2019 EEG  Abnormal with weakness toward seizure activity 8/20/2019 MRI with contrast     Normal,PHM,,"Lisinopril, Tamoxifen, Venlafaxine",None,"Sleep apnea, overweight, breast cancer detected and removed 2015",,,2,09/10/2019,,,,None
0832951,09/10/2019,,26.0,26,,F,,"1 hive on cheek developed shortly after receiving both vaccines, also reported itching face resolved on own without intervention",,,,,,,,,,09/10/2019,09/10/2019,0,,UNK,,,,,,,2,09/10/2019,,Y,,
0832952,09/10/2019,CA,41.0,41,,M,,"pt called to state he had developed a fever that night after the vaccine.  He called the next morning and stated his fever was 102 that day and that he had taken 650mg of APAP. Pt has kidney failure so he could not take any NSAIDs. He was told to have a cool bath and continue APAP every 6 hours.  Called pt the next day, his fever had reduced to 100 that day.  He said he had been resting and sleeping a lot to try to combat the fever.  Spoke the the patient 3 days later and he said his temperature returned to normal the 3rd day.",,,,,,,,,Y,09/04/2019,09/04/2019,0,pt was at home monitoring fever,PHM,,"trazodone, lisinopril,lasix,reglan, hydralazine, labetolol, humulin r, humulin n",hospitalized for kidney failure,"diabetic, hypertension",,,2,09/10/2019,,,,nka
0832953,09/10/2019,MI,64.0,64,,M,,"Patient was given a pediatric dose of Hepatitis A for his second dose in the series.  He did not have any adverse reaction to this vaccine.  The incident was caught immediately and discussed with patient.  The office was out of adult Hepatitis A, so patient was instructed that he would be given the adult Hep A, 2nd dose, at his next office visit.",,,,,,,,,Y,09/10/2019,09/10/2019,0,None,PVT,,None,No,"Chronic pain, HTN, hyperlipidemia, anemia, hypothyroidism",,,2,09/10/2019,,,,Crestor
0832954,09/10/2019,MI,64.0,64,,M,,"PATIENT CALLED THE DAY AFTER VACCINE ADMINISTRATION COMPLAINING OF A SWOLLEN ARM WITH A RASH AS WELL.HE WAS ADVISED TO TAKE BENADRYL AND TYLENOL AND GO TO THE HOSPITAL,URGENT CARE OR HIS DOCTOR.A COUPLE OF HOURS LATER PATIENT REPORTED HE WAS FEELING NO BETTER AND WAS ALSO FEELING LIGHT HEADED. HE HAD TO GO TO THE MERGENCY ROOM AND LAST I SPOKE WITH THE PATIENT'S WIFE HE WAS ON IV STEROIDS AND WAS BEING MONITORED",,,,,,,,,N,09/09/2019,09/09/2019,0,PATIENT CURRENTLY IN TH ER,PHM,,BENADRYL AND TYLENOL,NONE,ENDOCRINE DISORDERS,,,2,09/10/2019,,,Y,NO KNOWN ALLERGIES
0832955,09/10/2019,CA,3.0,3,,M,,"Three days after his vaccine, my son woke up not very hungry and before he ate breakfast, he started to vomit everything that was in his stomach. That began at 8:00. We gave him some oat milk after that and within five minutes he'd thrown it up. We then tried water and within five minutes he'd thrown that up too. He was tired and dry heaving every fifteen minutes until about 900. Then he only vomited if he drank water. By 10:00 he was asleep again. he woke up at 1:00 he drank  some water, threw it up, but he seemed more awake. We waited a half hour, so 130 we tried water again and he didn't throw it up. By 2:00 I gave him a banana and he didn't throw up again. By 3:00 he was eating regularly again.",,,,,,,,,Y,09/03/2019,09/06/2019,3,None,PVT,,"No prescriptions, he was taking herbal remedies.",none,none,,,2,09/10/2019,,,,none
0832956,09/10/2019,AK,73.0,73,,F,,"A few hrs. after administration of vaccine patient reported local pain and irritation.  Next day she came in and had local pain, swelling and redness.",,,,,,,,,U,09/09/2019,09/09/2019,0,none,PHM,,None Known,Slightly sick feeling but well enough to run around and do her errands and regular activity.,none known,,,2,09/10/2019,,,,No Know Drug or Food Allergies
0832957,09/10/2019,CA,18.0,18,,F,,EXPIRED VACCINE  8/31/2019  WAS GIVEN BY ACCIDENT AT AROUND 2:45PM. PATIENT DID NOT REPORT ANY ADVERSE EVENT AT THIS MOMENT,,,,,,,,,,09/09/2019,09/09/2019,0,NONE,PVT,,NONE,NONE,NONE,,,2,09/10/2019,,,,NONE
0832958,09/10/2019,TX,1.0,1,.0,F,,"About 6 days after my daughter received  her routine 12 month shots, she developed hives all over her body. Spots included: belly button, inner thighs, arm pits, eye lids, back of her neck, and torso. I figured it was just a normal reaction to the measles shot so I took her to the pediatrician just to be sure. They informed me it was not a normal reaction to MMR shot, but that it was hives. The told me it was something she came in contact with, food or household items that she was allergic to. However, all the food or other products she has had since then or before that date and never had hives. She had the hives for a fee weeks. We visited the pediatrician twice during that time and the urgent care once due to the hives and a strong fever. Nothing they prescribed worked. They prescribed benadryl and hydrocortisone ointment. Every time we visited for this matter, they said it was nuts, eggs, shellfish, milk. Since she was 12 months, we have given her these food items on a regular basis, weekly, and no hives. Hives have not come back since this time period.",,,,,,,,,Y,07/18/2018,07/24/2018,6,"None, just visual",PVT,,None,None,None,,,2,09/10/2019,,Y,Y,None aware of
0832959,09/10/2019,CA,65.0,65,,M,,"Patient was down from the shot for 4-5days in bed. He didn't take any OTC supplements and complained of nausea,extreme fatigue, joint pain, severe headaches and diarhea",,,,,,,,,Y,09/01/2018,09/25/2018,24,,UNK,,lisinopril-HCTZ,None,high blood pressure,,,2,09/10/2019,,,,No known allergies
0832960,09/10/2019,SC,0.33,0,.4,M,,"The baby reportedly was well prior to his vaccines. Cried briefly after vaccinations (20 seconds). Feel asleep in his mother's arms, but approx. 5-10min after she noted he was pale and lethargic with poor tone. He improved with stimulation and at time of clinic visit approx. 20min after his vaccines had recovered back to baseline.",,,,,,,,,Y,09/10/2019,09/10/2019,0,Vitals were normal upon examination in clinic after.,MIL,,Vitamin D drops,No illness at time of vaccination. Seen 15AUG2019 for rash and vomiting.,None,,,2,09/10/2019,,Y,,none
0832961,09/10/2019,VA,78.0,78,,F,,"Patient was in her usual state of health at home on 02 Sep 2019, when she developed fairly sudden onset of severe R shoulder and arm pain.  Evaluated in ED and found to have low-grade fever, swelling and redness extending from right chest area thru right shoulder and arm, and severe R arm pain, limiting any movement.  Admitted to Internal Medicine on 03 Sep 2019.    Initial concern for infxn prompted empiric abx.  Tx resulted in resolution of swelling and redness, and reduction in pain - although 8/10 R shoulder and R wrist pain persist.  Care team questioned whether Shingrix vaccine (RZV, dose #1, administered IM in R deltoid on 09 Aug 2019) could be related to persistent R arm pain.  Immunization Healthcare team consulted.",,,,,Y,8,,,N,08/09/2019,09/02/2019,24,Fusobacteria on Gram stain led ID consults to suggests clot related to bacteremia as source of acute event.   Blood cxs and US-evals for thrombus were unrevealing.,MIL,,Cinryz infusions twice weekly for HAE; Allegra; Zantac; Amlodipine; Synthroid; Firazyr prn HAE event; EpiPen prn HAE event;  fentanyl lozenges and morphine pump prn chronic post-chemotherapy pain,"Long-standing HAE (hereditary angio edema); ovarian CA survivor; breast CA survivor; thyroid CA survivor, hypothyroidism; HTN; chronic pain syndromes","Long-standing HAE (hereditary angio edema); ovarian CA survivor; breast CA survivor; thyroid CA survivor, hypothyroidism; HTN; chronic pain syndromes",,,2,09/10/2019,,,,ACE-inhibitors; Alendronate; ARB-Angiotensin-antagonists; Aspirin; Sulfa-drugs
0832962,09/10/2019,IN,50.0,50,,M,,Phototoxicity -Severe burning to sun exposed areas esp areas not previously having tanned.  Fever and chills for 24 hrs and severe pain lasting over 1 week and multiple day long dermal reaction consisting of numerous evenescent  vesiculo  bullous lesion that responded well to antihistamines and steroid,,,,,,,,,N,08/01/2019,08/11/2019,10,None- may need to see dermatology vs follow-up with pcp or rheumatology in near future if Persistence/ reoccurrence of puritic rash with further sun exposure continues,PHM,,Methotrexate  20 mg weekly Celebrex 200mg daily Nexium 40mg daily Cymbalta 30mg daily Leucovorin 10mg weekly Crestor 20 daily Losartan 100mg daily,None,Ankylosing spondylitis htn Hld  Gerd  Migraine ha Obesity,Shingrix #1 ?age 50- myalgias and low grade temp for 2-3 days after first shot.  Pneumoxax 23- age 26- severe erythema and swell,,2,09/10/2019,,,,Phenergan? confusion
0832964,09/10/2019,KY,79.0,79,,F,,redness/swelling/pain at the injection site after the injection. The patients husband said she was having trouble lifting her arm and was only able to lift her arm using her other arm. The patients husband said he has given her tylenol.,,,,,,,,,U,09/10/2019,09/10/2019,0,none.,PHM,,"allopurinol 100mg, singulair 10mg,  sertraline 50mg, isororbide  mono er 60mg, clopidogrel 75mg, atenolol 50 mg, simvastatin 20mg",unknown,"no confirmed health conditions listed on profile, prescriptions suggest hypertension, hyperlipidemia, depression, gout, allergies",,,2,09/10/2019,,,,morphine
0832965,09/10/2019,FL,69.0,69,,M,,"Hives all over my body, took some Benadryl, and a few hours later it subsided",,,,,,,,,Y,09/06/2019,09/07/2019,1,None,PHM,,"Lisinopril, Carvedilol, Eliquis,",None,"Asthma, seasonal allergies, MI in 2000 ( 2 RCA stents), stroke in 1994  on left side and later 9 coils in same area, pacemaker/defibrilator.",,,2,09/10/2019,,,,Iodine
0832966,09/10/2019,KS,78.0,78,,M,,"The patient came to the pharmacy requesting to receive a pneumococcal vaccine.  We administered Prevnar 13, in accordance with ACIP guidelines, because the patient is over age 65 and confirmed he had never received a pneumococcal vaccine before.  After sending the vaccine administration record to the patient's primary care provider, I received a call from nurse.  She also administered Prevnar 13 earlier that day.  The patient was supposed to ask for Shingrix, but he thought that was the one administered at his doctor's office.  I followed up with the patient and encouraged him to monitor and report adverse effects.  The patient will come in at a later date to receive the intended Shingrix vaccination.",,,,,,,,,U,09/10/2019,09/10/2019,0,,PHM,,"Amlodipine, Calcitriol",N/A,,,,2,09/10/2019,,,,N/A
0832968,09/10/2019,NC,67.0,67,,F,,"Pt came in about 2 months later and said that after the shot they got chills that night and then the next morning  ended up passing out on the bathroom floor for an entire day, woke up and was fine",,,,,,,,,Y,06/26/2019,06/26/2019,0,none,PHM,,none stated at time,none,none,,,2,09/10/2019,,,,"opiods,quinolones"
0832969,09/10/2019,GA,57.0,57,,F,,"Fever, chills, body aches,, soreness in right arm",,,,,,,,,Y,09/07/2019,09/08/2019,1,None,PHM,,"Synthroid, biotin, Iron, Flonase, vitamin D, allegra",None,Hashimoto disease.,,,2,09/10/2019,,,,None
0832970,09/10/2019,OR,71.0,71,,M,,"Woke up at 6 am  (9/10/2019) and felt fine, not even any pain at the injection site. BY 10 am I was feeling totally exhausted/tired, and the injection site started to get painful. The level of exhaustion was extreme and kept getting worse so I came home and tried to take nap..unsuccessfully.  It is now 4 pm and I am still exhausted and my injection site is painful.",,,,,,,,,N,09/09/2019,09/10/2019,1,none,PHM,,zarelto 20 mg tamsulosin,none,arthritis,When I was 10 years old I was given Copper head snake bite anti-venom and had a bear fatal hive reaction. I have no idea what th,,2,09/10/2019,,,,none
0832971,09/10/2019,CA,65.0,65,,F,,"Intense chills and nausea. Dizziness. Dry-mouth and thirst. 101 temperature began around 9 PM, about 12 hours after the vaccine was administered, spiked at 101.6 around 3AM and stayed over 101 until about 8AM the next day. Continued slight nausea and low-grade fever (99) for another 6 hours.",,,,,,,,,Y,09/09/2019,09/09/2019,0,"Labs from 9/3/2019 were generally normal, although ANC (1.3) and WBC (3.1) are still below normal, and have been post-chemo (12/2017-5/2018). Slightly elevated MCV and MCH, characteristic since CLL diagnosis in 2015.",PVT,,"Vemlidy 25 mg qd, Calcium Patient has been on a prophylactic dose of 800 mg qd Valacyclovir since last shingles occurrence, about 3 months prior.",,Compromised immune system due to CLL (chemo completed 5/2018). Perhaps a half-dozen outbreaks of shingles in the past 24 months. Received Zostavax vaccine in 2014 at age 60.,,,2,09/10/2019,,,,Codeine
0832972,09/10/2019,CA,11.0,11,,M,,"right upper arm swelling and itching noted 12 hours after injection. 4.5inx5in of erythema, warmth. No fluctuance or drainage from injection site. OTC treatment cold packs, hydrocortisone cream for itch, oral OTC benadryl if worsening itch. Monitor for signs of systemic allergic reaction or infection and follow up as needed.",,,,,,,,,N,09/09/2019,09/10/2019,1,,PVT,,Vyvanse 30mg,NONE,ADD,,,2,09/10/2019,,Y,,NKDA
0832973,09/10/2019,IA,73.0,73,,F,,patient states the day after the vaccination she experienced rash and spots at site of injection and states they are painful and red but not itchy.    I followed up with her today 3 days post vaccination and she states the arm is blotchy with a red color but that it is fading and getting better.  She claims no issue with movement or pain today.,,,,,,,,,Y,09/07/2019,09/08/2019,1,none done,PHM,,unknown,feeling well no illness reported,diabetes,,,2,09/10/2019,,,,NKA  to meds and unknown about foods.
0832974,09/10/2019,NM,4.0,4,,M,,"Redness , warmth and some slight swelling at the injections site, rash on face, itchy skin. No fever and child was active at school and had an appetite. Dr. contacted regarding this matter and per Dr. ok for client  to take some ibuprofen or  Benadryl and ice the area of swelling.  Parents to monitor child and if symptoms persist or get worse then they are to follow up with PCP.  Parents verbalized understanding and agreement.   Nurse to call parents tomorrow morning and follow up.",,,,,,,,,U,09/09/2019,09/10/2019,1,n/a,PUB,,none,none,none,,,2,09/10/2019,,,,none
0832975,09/10/2019,KY,23.0,23,,M,,"Swollen hand, heavy breathing, sweaty (also thought he might be having a panic attack)",,,,,,,,,U,09/10/2019,09/10/2019,0,Went to ER,PHM,,"trazodone, lisinopril",None,Blood pressure,,,2,09/10/2019,,,Y,None
0832976,09/10/2019,MD,72.0,72,,M,,Chills - Fever (101.4) - Upset Stomach - Body Ache - Head Ache - Tinnitus Symptoms subsided after 12 hours.,,,,,,,,,Y,09/05/2019,09/06/2019,1,"None.  However, if my fever had gone over 102, I was resolved to go to an emergency room.",PHM,,Tamsulosin 0.4MG CAP three times daily Finasteride 5MG TAB once daily Amphetamine Salts 20 MG TAB twice daily Multiple Vitamins,None,Enlarged Prostate (benign prostatic hyperplasia) Attention Deficit Disorder,,,2,09/10/2019,,,,"tomatoes, peppers, potatoes, egg plant"
0832977,09/10/2019,WI,11.0,11,,F,,Woke up with a headache. Went to school and the headache got worse throughout the day. Was feeling so bad by the end of school she was unable to ride the bus because she was so nauseated. Displaying flu like symptoms.  Slept 3 hrs after school and still has headache. Dispensed Tylenol for headache and Mild fever.,,,,,,,,,,09/09/2019,09/10/2019,1,None,PHM,,None,None,None,Flu shot,,2,09/10/2019,,,,None
0832978,09/10/2019,CT,58.0,58,,F,,"I had very high fever the first night, and high fever for the next five days, with headache and fatigue. I am approaching a month since the vaccine and I still have almost constant headache, fatigue, and fever between 99.3 and 99.5 (axillary).",,,,,,,,,N,08/15/2019,08/15/2019,0,Blood work on 09/03/2019 at my doctor's office. All results normal.,PHM,,"Nexium, Vitamins C,D, calcium, magnesium",none,none,"Shingrix, first doze, fever for five-six days (March, 2019)",,2,09/10/2019,,Y,,"erythromycin, codein"
0832979,09/10/2019,TX,32.0,32,,F,,Patient stated that she had a slight fever and was itching all over.  I did not see a full rash on her body.,,,,,,,,,U,09/09/2019,09/10/2019,1,,PHM,,N/A,NO,NO,,,2,09/10/2019,,,,NO
0832980,09/10/2019,CA,73.0,73,,F,,"small, non painful rash that lasted about 2 days",,,,,,,,,Y,07/22/2019,07/23/2019,1,,PHM,,,,,,,2,09/10/2019,,,,
0832981,09/10/2019,OH,23.0,23,,F,,"After receiving vaccination, patient reported feeling light headed.  She was visibly pale, sweating and shaking.  We gave her ice water, candy, put an ice pack on her neck and within 15 minutes the patient was fine.  We rechecked her in 45 minutes and the patient was not having any recurring symptoms.",,,,,,,,,Y,09/10/2019,09/10/2019,0,,WRK,,,,,,,2,09/10/2019,,,,
0832982,09/10/2019,OR,61.0,61,,M,,"about 13 hours after getting vaccine, pt woke up shivering/shaking violently--reported as ""almost felt like convulsions"" lasting more than 1 hour.  he almost called 911 ----pt was extremely nauseous and took pepto-bismol.  never vomited.  also had a massive headache.  felt like he had a fever, but took no temp.  went back to bed.  did not sleep well.  reported every muscle in his body being very sore, from head to toe for the next few days.",,,,,,,,,Y,08/27/2019,08/28/2019,1,none,PHM,,"hctz, duloxetine, losartan, levothyroxine, tramadol  mvi, fiber",none,"degen disc dz, chronic low back pain",,,2,09/10/2019,,Y,,"hydromorphone (mild), shellfish, peanuts oyster-shell calcium"
0832983,09/10/2019,NV,67.0,67,,M,,"I've never had a reaction to a flu shot, other than minor soreness lasting a few hours. In this case, I had significant soreness for 48 hours, and swelling that has yet to cease (78 hours after injection). The swelling was originally in the upper arm.  It is now also in the lower arm (forearm).  The arm is warm to the touch and the skin is red.  As for treatment, I've been putting an ice-pack on it. That seems to help. The side effects warning mentioned soreness and swelling for 1 - 2 days. It's been 3.25 days so far, so I thought I'd report it.",,,,,,,,,N,09/07/2019,09/07/2019,0,none,PHM,,"Crestor (the generic version), Zolpidem 10mg, Clonazepam (0.5mg)",non,sarcoidosis in remission,,,2,09/10/2019,,,,Augmentin
0832984,09/10/2019,CA,57.0,57,,M,,"PAIN THROUGHOUT MY BODY/ESPECIALLY IN MY SHOULDERS, BACK, GROIN, HIPS, LEGS AND UPPER ARMS. LETHARGIC, LOWER BODY/HIP WEAKNESS. PAIN IN ELBOWS/SHOULDERS WHEN TRYING TO GET OUT OF CHAIRS, TO NAME BUT A FEW.POSSIBLE SHINGLES ISSUES ARE MENTIONED PER NOTES IN , JAN 2019, JULY 2019, JUNE 2019  AND I COMPLAINED ABOUT THE SIDE EFFECTS I WAS HAVING FROM APRIL 2019 TO THE PRESENT DAY.",,,,,,,,Y,N,04/01/2019,04/01/2019,0,THERE WERE NO TESTS TO THE BEST OF MY RECOLLECTION PRIOR TO THE APRIL/JUNE 2019 INJECTIONS FOR SHINGLES. I HAD TESTED POSITIVE FOR FIBROMYALGIA IN 2019 WHICH IN CONJUNCTION WITH MY OTHER INJURIES AND SURGERIES POSSIBLY COMPROMISED MY IMMUNE SYSTEM.,OTH,,"ADDERALL , VYVANSE, ASPIRIN (81MG), VITAMIN C 1000MG",POSSIBLE SHINGLES RASH REPORTED IN 1-2019 AND WAS ACTIVE/VISABLE ON THE L SIDE OF MY FACE UNDER THE EYE DURING BOTH DOSES OF SHINGRIX.,"MULTIPLE ORTHOPEDIC SURGERIES TO INCLUDE L SPINE FUSION/ C SPINE FUSION WITH BILATERAL NERVE DAMAGE VIA THE S 1 NERVE ROOT/ C SPINE FUSION C 3 ,C 4 WITH SIGNIFICANT DAMAGE TO C 5 AS WELL. CAUDA EQUINA SYNDROME RELATED TO THE L SPINE FUSION, DDD THROUGHOUT THE ENTIRE SPINE MOST SIGNIFICANT AT THE C AND L SPINE. 5X ACL RECONSTRUCTION, RIB CAGE RESECTION L SIDE ETC",,,2,09/10/2019,,Y,Y,VICODIN AND VICOPROFEN
0832985,09/10/2019,AZ,72.0,72,,M,,"On Sept 3, 2019.  3 days after the vaccination rashes in front and back part of  the body was developed. When he came to the Pharmacy to show it to me I told him to take Benadryl over the counter. He made an appointment to his Doctor on Thursday and showed it to his MD and was told to continue taking the Beandryl. Today, 9-10-2019 all the rashes was all cleared.",,,,,,,,,Y,09/01/2019,09/03/2019,2,N.A.,PHM,,N.A.,N.A.,N.A.,,,2,09/10/2019,,,,No known allergies
0832986,09/10/2019,CA,79.0,79,,M,,Extreme abdominal pain for approximately 90 minutes.,,,,,,,,,Y,09/10/2019,09/10/2019,0,None because of immediate occurrence.,OTH,,"Prescribed medications for rheumatoid arthritis. Prednisone Plaquenil., basic, atenolol.",Motor operation on intestine.,Rheumatoid arthritis,,,2,09/10/2019,,,,Two antibiotics
0832987,09/10/2019,GA,95.0,95,,F,,Swelling and bruising in a semi-circle 3 inches in diameter.  Pt claims there is a little warmth from the site but no pain or discomfort.,,,,,,,,,U,09/08/2019,09/09/2019,1,n/a,PHM,,"Verapamil Er 180mg qd, Glipizide 10mg qd, LEvothyroxine 50mcg qd, Losartan 100mg qd, OTC Aleve Tablets (strength unknown) 4 times per day,",N/A,Type 2 Diabetes and Hypertension,,,2,09/10/2019,,,,Azithromycin and Penicillin
0832988,09/10/2019,WA,77.0,77,,M,,"PATIENT NOTICED 2 BULGED MUSCLES NEAR THE SITE OF VACCINATION A FEW DAYS AFTER. IT IS NOT OBVIOUS FROM FRONTAL VIEW BUT ON SIDE VIEW ONE BULGE IS ON TOP LEFT SHOULDER AND ANOTHER ONE A THE BACK OF THE ARM. HE EXPERIENCES NO PAIN, NO SWELLING NOR REDNESS AT SITE. PATIENT TO TO SEE HIS PCP ON 8/9/2019 TO ASSESS  WHAT MAY BE THE CAUSE OF BULGES MUSCLES. DR ORDERED ULTRASOUND SCAN.",,,,,,,,,U,07/25/2019,08/01/2019,7,ULTRASOUND PERFORMED ON 8/13/19 AND RESULTS SHOWED SWOLLEN MUSCLE PATIENT IS FOLLOWING UP WITH PCP 9/12/19,PHM,,"AMLODIPINE 5MG, HYDROCO/APAP7.5/325MG, METOPROLOL 100MG, GLIMEPIRIDE 4MG, LISIN/HCT 20/25, METFORMIN 1000MG  OTC UNKNOWN",NOT REPORTED,"DIABETES, HYPERTENSION",,,2,09/10/2019,,Y,,NONE
0832989,09/10/2019,,21.0,21,,M,,"Pt received Smallpox vaccination on 16AUG19 on the left upper arm and had first check up on 29AUG19 at Immunization. Pt had normal reaction on the vaccination site without any remarkable symptoms or adverse reactions at the check up. Pt started to have rash spreading out all aver left arm with itching from 7SEP19. Pt currently has a scab in normal process on the vaccination site and has 2 additional pruritic lesions sized less than 1cm on left upper arm distal to the vaccination site. Pt also has pruritic rash spreading out on both arms and both thighs. V/S with in normal range, no fever. Pt denied any other symptoms, chest congestion or pain and difficulty breathing. Pt denied any medical history related to skin condition or weaken immunity but there is Agency encounters documented in AUG and SEP2016 that  state he was prescribed oral antibiotics and doxycycline for acne vulgaris but had possible allergic reaction(or dermatitis) after using those medications. Denied CP/SOB/abd pain/fever/chills/N/V.  Completed Smallpox Screening sheet by Pt on 19AUG is not in the website. .",,,,,,,,,,08/16/2019,09/07/2019,22,"-MED: Diphenhydramine 50mg oral  -LAB: CBC, BMP, HSV, VZV DAN",MIL,,NONE,NONE,NONE,,,2,09/11/2019,,Y,,No Known Allergies
0833022,09/10/2019,CA,65.0,65,,F,,-Rash similar to poison oak or chicken pox. -Swelling + redness -both legs + some arm areas.   After patient saw MD on 9/5/19 it was determined the pt had poison oak + was prescribed Medrol + Lidex cream. Pharmacy still wanted to report the adverse reaction in case there was a link.,,,,,,,,,U,08/30/2019,09/01/2019,2,,PHM,,"lisinopril, Atorvastatin",,high blood pressure; high cholesterol,,,2,09/04/2019,,Y,,
0833023,09/10/2019,CA,48.0,47,,F,09/10/2019,"-Patient experienced pain in the shoulder that did not go away for 2 months.  -Ibuprofen 600 mg, Cyclobenazeprine 5mg, Tizanidine 2mg",,,,Y,,,,,N,05/01/2019,07/01/2019,61,Dr ordered x-ray & physical therapy,OTH,OTH,,No,N/A,,,1,,,,,
0833030,09/10/2019,OH,65.0,65,,F,,Patient came to clinic 9/10/19 with complaint of redness & warmth that started on left arm 35mm below where vaccine had been given. Area 70mm x 50mm irregular shaped & warm. Pt also reported this started 3 days after shot given but pain in arm started 1 day after shot.,,,,,,,,,N,09/04/2019,09/07/2019,3,,PVT,,none,0,,,,2,09/10/2019,,Y,,"PCN, Tetracycline, Naprosyn"
0833037,09/10/2019,CA,55.0,55,,F,,"Patient received Shingrix vaccine on 9/06/19. And three days later, on 9/09/19, she noticed of small and painful lump forming on her left lower side of the neck. Patient was advised to contact the PCP and monitor for any worsening of symptoms",,,,,,,,,,09/05/2019,09/09/2019,4,,PHM,,,,,,,2,09/10/2019,,,,
0832990,09/11/2019,WA,67.0,67,,F,,"Pt called approximately 7 hours after receiving vaccine. Said she was experiencing swelling, itching, and redness at the immunization site. Pt has had influenza shots in the past with no history of reactions, however this was the first time she had received the high dose influenza vaccine.",,,,,,,,,U,09/10/2019,09/10/2019,0,,PHM,,,,,,,2,09/11/2019,,,,
0832991,09/11/2019,NY,28.0,28,,F,,"At 3 am that night I woke up and my legs were suddenly numb. I was shaking uncontrollably , with chill like symptoms. My teeth were chattering. I was cold in a normal temperature room. This went on for 3 hours. Since then I am having different pains and symptoms in my body. ANA tests are coming back positive which I never had before. I now have a possible auto immune disease.",,,,,,,,Y,N,12/01/2015,12/01/2015,0,,WRK,,no,no,no,,,2,09/11/2019,,,,none
0832992,09/11/2019,CT,72.0,72,,F,,"nausea, fever, dry heaves fatigue",,,,,,,,,Y,09/08/2019,09/08/2019,0,n/a,PHM,,"contulose, lisinopril, tylenol with codeine, carvedilol, HCTZ, sertraline",no,Chronic pain and Heart/BP issues,,,2,09/11/2019,,,,Pcn
0833001,09/11/2019,NY,,,,F,,"No adverse effect; The patient had her first dose of GARDASIL 9 on 10-JUL-2019 and is in the office on 13-AUG-2019 to get her second dose of GARDASIL 9; This spontaneous report was received from a nurse referring to a female patient of unknown age. The patient had no concomitant therapies, pertinent medical history or drug reactions or allergies.  On 10-JUL-2019, the patient was vaccinated with her first dose of hpv rL1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # 1602283, expiration date 18-AUG-2021, strength, dose and route were not reported) for prophylaxis. On 13-AUG-2019, she got her second dose of hpv rL1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot #, expiration date, strength, dose and route were not reported) (inappropriate schedule of vaccine administered). No adverse effects were reported.",,,,,,,,,U,07/10/2019,08/13/2019,34,,UNK,,,,,,US0095075131908USA005889,2,09/10/2019,,,,
0833002,09/11/2019,CO,,,,U,,"No adverse effects reported by the Nurse.; pediatric dose of RECOMBIVAX HB vaccine instead of an Adult Dose of RECOMBIV AX HB; This spontaneous report was received from a nurse referring to a patient of unknown age.  Information about concurrent condition, concomitant medication and medical history was not reported.   On unknown dates, the patient was vaccinated with the first and second dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (strength, dose, route, lot # and expiration date were not reported) for prophylaxis. In 2003, the patient was vaccinated with the third dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (lot# 641071/1069L, reported batch number was 1069L, expiration date 01-JUN-2004, strength and dose, route were not provided). The nurse reported that there was a possibility that the patient was administered a pediatric dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) instead of an adult dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) for the third dose of the hepatitis b vaccine (recombinant) (RECOMBIVAX HB) vaccination series (inappropriate dose of vaccine administered). No adverse effects reported by the Nurse.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131908USA006059,2,09/11/2019,,,,
0833003,09/11/2019,WI,,,,F,,"No adverse effects; a patient was administered her first dose of the three dose series of GARDASIL 9 (lot and expiration unknown) on 8/19/2013 and was administered her second dose of GARDASIL 9 (1602283  8/16/2021) late on 6/18/2019; This spontaneous report was received from a registered nurse referring to a currently 26-year-old female patient. The patient's concurrent conditions, pertinent medical history, concomitant therapies and drug reactions/allergies were not reported.   On 19-AUG-2013, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, frequency and route of administration not reported; lot # and expiration date unknown) as prophylaxis. Late on 18-JUN-2019, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # 1602283, expiration date reported as 16-AUG-2021, but upon internal validation established as 18-AUG-2021) (dose, frequency and route of administration not reported) as prophylaxis (inappropriate schedule of product administration). No adverse effects were reported.",,,,,,,,,U,08/19/2013,06/18/2019,2129,,UNK,,,,,,US0095075131908USA007258,2,09/10/2019,,,,
0833004,09/11/2019,FL,,,,U,,"no adverse effect; the patient received first dose, second dose and third dose of GARDASIL 9 in August 2018, February 2019 and August 2019 respectively; Information has been received from a pharmacist referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.  On unknown date in August 2018, the patient was administered the first dose of hpv rL1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # N003703, expiration date: 29-OCT-2019, strength, dose and route were unknown) for prophylaxis. In February 2019, the patient received the second dose of hpv rL1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # N003703, expiration date: 29-OCT-2019, strength, dose and route were unknown). On an unspecified date in August 2019, the patient received the third dose of hpv rL1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # N003703, expiration date: 29-OCT-2019, strength, dose and route were unknown) (inappropriate schedule of vaccine administered). No adverse effects were reported.",,,,,,,,,U,08/01/2018,08/01/2019,365,,UNK,,,,,,US0095075131908USA007690,2,09/10/2019,,,,
0833005,09/11/2019,,,,,U,,"No adverse effects; patient received one dose of improperly stored ROTATEQ; This spontaneous report was received from a healthcare business professional regarding a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, drug reactions, allergies and concomitant therapies were not reported.  On 08-AUG-2019, the patient was vaccinated with one dose of improperly stored (product storage error) rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # R025713, expiration date: 20-JUN-2020 (dose, unit were not reported) orally for prophylaxis. The vaccine was exposed to 33.9 Fahrenheit degrees (F) for 40 minutes. The previous temperature excursion included: total time and lowest temperature below 36 F (30.3F) for 90 hours and 7 minutes, total time and lowest temperature below 36 F (30.5F) for 1 hours and 45 minutes and total time and lowest temperature below 36 F (35.2F) for 2 hours and 5 minutes. Data logger was involved. No adverse effects were reported",,,,,,,,,U,08/08/2019,08/08/2019,0,,UNK,,,,,,US0095075131908USA009258,2,09/10/2019,,,,
0833006,09/11/2019,PA,29.0,,,F,,"a noticeable indentation was seen at the site of the first injection; This spontaneous report has been received from a physician via field representative referring to a 29-year-old female patient. The patient's concurrent conditions, medical history, concomitant therapies and drug allergy or reactions were not reported.      On 19-JUN-2019, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # 1602283, expiration date reported as 16-AUG-2021, but upon internal validation established as 18-AUG-2021; dose not reported) intramuscularly for prevent human papillomavirus (HPV).         The patient was seen in the office on 22-AUG-2019 (reported as today) for the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # 1602283, expiration date reported as 16-AUG-2021, but upon internal validation established as 18-AUG-2021; dose not reported) intramuscularly for prevent human papillomavirus (HPV). On that date, a noticeable indentation was seen at the site of the first injection. The patient was in no pain and there was just a depression (indentation) at the site. There was no treatment given to the patient. There was no lab diagnostics or studies performed. The patient sought medical attention. No product quality complaint (PQC) involved.   The outcome of the event was recovering. The causality between the event and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not reported.",,,,,,,,,N,06/19/2019,08/22/2019,64,,UNK,,,,,,US0095075131908USA009352,2,09/11/2019,,,,
0833007,09/11/2019,HI,19.0,,,U,,"No adverse event; Product administered to patient of inappropriate age; This spontaneous report as received from a nurse refering to a 19 year old patient (gender unknown). No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications.  On 23-AUG-2019, the patient was vaccinated with the second dose of hepatitis a vaccine, inactivated(VAQTA),pediatric dose, 0.5 milliliter for prophylaxis (route of administration, lot number and expiration date were not reported) (incorrect dose administered). There was no adverse symtoms reported.",,,,,,,,,U,08/23/2019,08/23/2019,0,,UNK,,,,,,US0095075131908USA009836,2,09/10/2019,,,,
0833008,09/11/2019,IL,24.0,24,,F,,"patient was inadvertently administered the first dose of GARDASIL 9 on 8/27/2019, 2 minutes after her pregnancy test was resulted as positive; This spontaneous report was received from a nurse prescriber referring to a currently 24-year-old female patient, who had no pertinent medical history, drug reactions or allergies or concomitant therapies. Her pregnancy test was performed on 27-AUG-2019 and was resulted as positive.  On 27-AUG-2019, 2 minutes after her pregnancy test was resulted as positive, the patient was inadvertently vaccinated the first dose with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot# 1614897, expiration date 29-SEP-2021, upon internal validation established as 20-SEP-2021, dose not reported) intramuscularly for prophylaxis (vaccine exposure during pregnancy). The last menstrual period (LMP) and estimated date of delivery (EDD) was unknown. The pregnancy outcome was pending. At the reporting time, the outcome of the event was unknown.",,,,,,,,,U,08/27/2019,,,Test Date: 20190827; Test Name: pregnancy test; Test Result: Positive,UNK,,,,,,US0095075131908USA010914,2,09/11/2019,,,,
0833009,09/11/2019,MI,23.0,,,F,,"shakes and quivers in her arms and legs; numbness and tingling in her left arm that eventually traveled to her entire left side of her body; numbness and tingling in her left arm that eventually traveled to her entire left side of her body; buzzing in her head; This spontaneous report was received from a nurse (patient's aunt) and refers to a 23-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 12-JUN-2019, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (exact dose, route of administration, lot # and expiration date were not reported) for HPV prevention. On 20-JUN-2019, the patient experienced numbness and tingling in her left arm that eventually traveled to her entire left side of her body and buzzing in her head. On unknown date in July 2019 (reported as one month ago), she starting having shakes and quivers in her arms and legs. On an unspecified date, the patient sought medical attention and was sent to an unspecified neurologist, who ordered unspecified blood tests (reported as ""blood work"", thyroid and creatine phosphokinase (CPK)) (results not provided) and unspecified magnesium supplements, that did not help. The neurologist sent the patient to outpatient physical therapy 3 times a week for the last 2 weeks, without any improvement. The outcome of numbness and tingling in left arm that eventually traveled to entire left side of the body and buzzing in head was reported as eventually improved on an unknown date in 2019. The outcome of tremor was reported as not recovered/not resolved. There was no causality assessment provided by the reporter.",,,,,,,,,N,06/12/2019,06/20/2019,8,,UNK,,,,,,US0095075131908USA011165,2,09/11/2019,,,,
0833010,09/11/2019,KY,,,,U,,"improperly stored vaccines were inadvertently administered to unspecified patients; This spontaneous report was received from a medical assistant referring to unspecified patients of unknown age and gender. Information about the patients' concurrent conditions, pertinent medical history, previous drug reactions or allergies and concomitant medications was not provided.  On unspecified dates in 2019 (reported as between May 2019 and August 2019), the patients were inadvertently vaccinated with improperly stored vaccines as haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) one dose, for prophylaxis, lot number R021078 and expiration date 12-JUN-2021 (strength, route of administration and anatomical location were not provided); rotavirus vaccine, live, oral, pentavalent (ROTATEQ) for prophylaxis, lot number R028189 and expiration date 06-JUN-2020 (strength, route of administration and anatomical location were not provided); hepatitis a vaccine, inactivated (VAQTA) for prophylaxis, lot number S002459 and expiration date 15-MAY-2020 (strength, route of administration and anatomical location were not provided); measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) for prophylaxis, lot number R030799 and expiration date 22-APR-2020 (strength, route of administration and anatomical location were not provided) and varicella virus vaccine live (Oka/Merck) (VARIVAX) for prophylaxis, lot number S002736 and expiration date 28-JAN-2021 (strength, route of administration and anatomical location were not provided) (product storage error).  It was reported that on an unknown date, the vaccines haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), rotavirus vaccine, live, oral, pentavalent (ROTATEQ) and hepatitis a vaccine, inactivated (VAQTA) were exposed to a temperature excursion of 52.5 degrees Fahrenheit (F) for 4 hours and 40 minutes. There was no previous temperature excursion reported. The call was placed because of a digital data logger.  It was reported that on an unknown date, the vaccines measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) and varicella virus vaccine live (Oka/Merck) (VARIVAX) were exposed to a temperature excursion of 9.9 F for 57 minutes. There was a previous temperature excursion of 28.9 F for 5 hours and 30 minutes. The call was placed because of a digital data logger.  This is a non-valid case because there were no patients identifiers.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131908USA012920,2,09/10/2019,,,,
0833011,09/11/2019,IA,,,,U,,"No adverse effects; one dose of GARDASIL 9 that had expired was inadvertently administered to the patient on 8/21/2019; This spontaneous report was received from a nurse prescriber via company representative, referring to a patient of unknown gender and age. The patient's concurrent condition, pertinent medical history, concomitant therapy and drug reactions/allergies were not reported.  On 21-AUG-2019, the patient was inadvertently vaccinated with one dose of expired hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, frequency and route of administration not reported) (lot #: M037770, expiration date: 01-JUN-2019) (expired product administered) for prophylaxis. No adverse effects were reported.",,,,,,,,,U,08/21/2019,08/21/2019,0,,UNK,,,,,,US0095075131909USA000727,2,09/10/2019,,,,
0833012,09/11/2019,IL,5.0,5,,U,,"No adverse effect reported; one patient received an improperly stored VARIVAX; This spontaneous report was received from a nurse, concerning to a 5-years-old patient of unknown gender. The patient's medical history, concurrent conditions and past drug allergies or reactions were not reported.  On 12-AUG-2019 and on 13-AUG-2019, varicella virus vaccine live (Oka/Merck) (VARIVAX) vaccine experienced two temperature excursions. On 04-SEP-2019, the patient received an improperly stored dose (product storage error) of varicella virus vaccine live (Oka/Merck) (VARIVAX) (strength, dose, schedule, anatomical site of injection, route of administration were not reported). Lot numbers R006221 and R029517 have been verified to be a valid lot of numbers for varicella virus vaccine live (Oka/Merck) with expiration dates on 29-FEB-2020 and on 14-OCT-2020 (reported as "" 14/2020) respectively. It was reported that the vaccine was reconstituted with properly stored sterile diluent.  The reporter did not have the specific lot and expiration date administered to the patient, but it was one of two listed above.    The administered dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) experienced a temperature of -14 degrees Celsius to -10 degrees Celsius (-11.91 degrees Celsius) for 8 hours as recorded by a data logger. There was no adverse effect reported.  No product quality complaint was involved.",,,,,,,,,U,09/04/2019,09/04/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA002893,2,09/10/2019,,,,
0833013,09/11/2019,,,,,F,,"No adverse effects were reported; she received tbe first dose of GARDASIL 9 in October of 2018 and tbe second dose in June of 2019; This spontaneous report was received from a female patient of unknown age referring to herself. No information regarding her pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On an unknown date in October 2018, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, exact dose, route of administration, lot # and expiration date were not reported) for prophylaxis. On an unknown date in June 2019, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, exact dose, route of administration, lot # and expiration date were not reported) for the same indication. No adverse effects were reported.",,,,,,,,,U,10/01/2018,06/01/2019,243,,UNK,,,,,,US0095075131909USA003216,2,09/11/2019,,,,
0833014,09/11/2019,CA,,,,U,,"no adverse effect; inadverently administered a dose of varivax by intramuscular injection instead of subcutaneous; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender.   No information was provided regarding the patient's medical history, concurrent conditions, previous drug reactions or concomitant medications.  On 06-SEP-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (lot # S015459, expiry date: 20-MAY-2021) strength, dosage information and anatomical locations were unknown inadvertently administered by intramuscular injection instead of subcutaneous injection for prophylaxis (incorrect route of product administration). The outcome of incorrect route of product administration and no adverse event was unknown. No adverse effects were reported. No additional information provided.",,,,,,,,,U,09/06/2019,09/06/2019,0,,UNK,,,,,,US0095075131909USA003481,2,09/11/2019,,,,
0833015,09/11/2019,NJ,47.0,47,,M,,Hives & rash,,,,,,,,,N,09/10/2019,09/10/2019,0,,WRK,,none,coxsackievirus  (2 weeks prior),none,,,2,09/11/2019,,Y,,silver
0833016,09/11/2019,OH,59.0,59,,F,,"Body aches, awakened with shivering. Tiredess persisting into the day.",,,,,,,,,N,09/10/2019,09/11/2019,1,N/A,PHM,,,,,,,2,09/11/2019,,,,Sulfas
0833017,09/11/2019,MI,37.0,37,,F,,"Redness, swelling, and pain in the area of her right upper arm around the lateral deltoid where she was given a Tdap on 9/5/19. Meloxicam and doxycycline given for oral treatment. Tdap vaccine added to patients allergies.",,,,,,,,,U,09/05/2019,09/10/2019,5,,PVT,,"Linzess, Celexa, Retin-A cream, spironolactone, Mirena IUD, hyoscyamine",,Irritable bowel syndrome,,,2,09/11/2019,,Y,,"Penicillin, vicodin"
0833018,09/11/2019,VA,70.0,70,,F,,"Both arms were slightly sore at the site of the injections.  At 9:00 PM I began to be chilly, that turned to chills and shaking.  Took my temperature 99.8, it kept going up to 100.6 when I took one 650mg tablet of Acetaminophen.  I also had a slight headache and was very tired.   Fever broke around 12:30 AM.  When I got up on 9/11/19, my temperature was 99.4 and my headache was a little worse.  Took a second 650mg tablet of Acetaminophen.",,,,,,,,,N,09/10/2019,09/10/2019,0,None,PHM,,"Valsartan 80 mg, Atorvastatin 20 mg, Carvedilol 6.25 mg twice a day, Synthroid 0.075 mg, Centrum Silver, Caltrate 600+D3, Aspirin 81mg, magnesium 250mg. Also had FLUAD vaccine at the same time I received Shingles vaccine.",None,"Hypertension, Hypothyroidism, Arthritis",,,2,09/11/2019,,,,no known allergies
0833019,09/11/2019,MA,45.0,45,,F,,"The initial shot hurt more than I can remember and my arm was very sore for the rest of day and night.  The soreness never really went away and instead became increasingly debilitating.  Without significant pain, I cannot dress myself, put on seat belt, pick up my children, sleep, exercise etc.  I have no strong reflex and am concerned if I fall, I will not be able to save myself.  I have been to the Dr., and tried advil but nothing is helping to ease the pain.  It is AWFUL.",,,,,,,,,N,08/22/2019,08/29/2019,7,none,PHM,,none,none,none,,,2,09/11/2019,,Y,,none
0833020,09/11/2019,TX,23.0,23,,F,,"complaint of pain and weakness in legs, Admitted to inpatient facility, still undergoing treatment.",,,,,Y,,,,U,09/01/2019,09/01/2019,0,Unknown,WRK,,Unknown,None,Unknown,,,2,09/11/2019,,,,Unknown
0833021,09/11/2019,OH,29.0,29,,F,,"Last menstrual period approx. 4-26-19, + home pregnancy test ""early June.""  She was given Varivax, MMR, Tdap on 6-6-19 as required for entry into nursing school.",,,,,,,,,U,06/06/2019,06/07/2019,1,none,PVT,,smoking marijuana,none,none,,,2,09/11/2019,,Y,,none
0833029,09/11/2019,MA,,,,U,,"No adverse affects; an expired dose of GARDASIL 9 was administered; This spontaneous report was received from a health care worker, referring to a patient of unknown age and gender. The patient's concurrent condition, pertinent medical history, concomitant therapy and drug reactions/allergies were not reported.  On 08-AUG-2019, the patient was vaccinated with an expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, frequency and route of administration not reported) (lot #: M041990, expiration date: 28-JUN-2019) (expired product administered) for prophylaxis. No adverse effects were reported. No product quality issue was involved.",,,,,,,,,U,08/08/2019,08/08/2019,0,,UNK,,,,,,US0095075131908USA007633,2,09/11/2019,,,,
0833031,09/11/2019,NJ,72.0,72,,F,,"The patient is a 72-year-old female who received a Shingrix vaccine on August 29, 2019. This was administered in her left upper extremity at the pharmacy. Following day patient complained of nausea headaches and arthralgias. She also had pain at the injection site without erythema or edema. Later that evening patient developed diffuse hives, cyst and swelling involving ""my lips my tongue in the top of my throat."" Patient presented to the Emergency room where she was treated with IV Benadryl and corticosteroids. Patient was discharged on oral prednisone and Benadryl. The hives increased later that day and the patient returned to the Emergency Room. However she did not wait to be seen due to long wait time. I spoke with the patient on the morning of September 1st. I increased her prednisone dose 60 mg that day and we tapered by 10 mg daily. Patient took 20 mg of prednisone this morning. Since that time patient denies recurrent hives. Patient states ""overall I fell okay now.""",,,,,,,,,Y,08/29/2019,08/30/2019,1,,PHM,,"Zetia, Metoprolol, Advair, MVI",,,,,2,09/11/2019,,Y,Y,Atorvastatin - elevated LFTs
0833032,09/11/2019,MA,1.33,1,.4,M,,9/10/19: Seen and diagnosed with local reaction 9/11/19: (+) extension of area with fever dx'd with cellulitis,,,,,,,,,N,09/09/2019,09/10/2019,1,N/A,PVT,,Motrin,"pulling on ears, ears were clear",0,,,2,09/11/2019,,Y,,0
0833033,09/11/2019,NC,46.0,46,,F,,"injection site swelling, soreness, tenderness, injection site erythema",,,,,,,,,N,09/10/2019,09/10/2019,0,none,PVT,,Had not taken any of the above,none,"diabetes, high cholesterol",,,2,09/11/2019,,Y,,Sulfa drugs
0833034,09/11/2019,NC,60.0,60,,F,,"Fever 101.7, flu like symptoms (extreme body aches and weakness) for 6 hours, fever broke after taking Tylenol",,,,,,,,,Y,09/09/2019,09/10/2019,1,none,PHM,,"Biotin, Omega 3","a cold (runny nose, congestion)",none,,,2,09/11/2019,,,,none
0833035,09/11/2019,MO,50.0,50,,F,,"MUSCLE ACHES, CHILLS, NAUSEA, PAIN IN ARM - RADIATING TO NECK AND SHOULDER AREAS. RESULTED IN SICK LEAVE FROM WORK AND A PHONE CONSULT WITH PHYSICIAN'S OFFICE. PATIENT TO REPORT TO CLINIC OR HOSPITAL IF SYMPTOMS WORSEN OR RASH DEVELOPS.",,,,,,,,,N,09/10/2019,09/11/2019,1,NONE,PHM,,LEVOTHYROXINE,NONE,NONE,,,2,09/11/2019,,,,NONE
0833036,09/11/2019,AK,5.0,5,,F,08/31/2019,Localized fluid filled blisters (several) at injection site that appeared after administration of varicella iz. given on 8/29/19,,,,,,,,,N,08/29/2019,08/29/2019,0,,PVT,PUB,O,None,,large raised redness warm to touch~Measles + Mumps + Rubella (no brand name)~2~5.00~Patient,,1,,,,,
0833040,09/11/2019,NY,19.0,,,U,,"no adverse effects; 19-year-old patient who received GARDASIL 9 this week after patient was administered complete HPV series ofGARDASIL (quadrivalent) in the past (on unspecififed dates); This spontaneous report was received from a nurse via company representative referring to a 19-year-old patient of unknown gender. The patient's concurrent conditions, pertinent medical history, concomitant therapies and drug reactions/allergies were not reported.  On an unspecified date in August 2019 (reported as this week), the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9)  (strength, dose, frequency and route of administration were not reported; lot# and expiration date were unknown by the reporter) for prophylaxis, after the patient completed the series of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) in the past (on unspecified dates) (inappropriate schedule of product administration). No adverse effects were reported.",,,,,,,,,U,08/01/2019,08/01/2019,0,,UNK,,,,,,US0095075131908USA008927,2,09/11/2019,,,,
0833041,09/11/2019,TX,,,,F,,"a lot of weight gain; anxiety; nause; This spontaneous report has been received from an office manager via company representative referring to a current 21-year-old female patient of unknown age. The patient's concurrent condition, medical history and concomitant therapy information was not provided.      On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), intramuscularly for prophylaxis (also reported as vaccination) (strength, dose, frequency, lot # and expiration date were not reported) as a teenager. It was unknown if the patient received treatment for the event. It was unknown whether laboratory diagnostics were performed.         On an unknown date, the patient experienced a lot of weight gain, anxiety, nausea, and she now only had 4 periods per year. The outcome of all events was not reported. The causality between all events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131908USA010862,2,09/11/2019,,,,
0833042,09/11/2019,IN,,,,U,,"No adverse affects; patient received their third dose of GARDASIL 9 sooner that what is recommended; This spontaneous report was received from a nurse practitioner referring to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date, the patient was vaccinated with the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot# R017624, expiration date 17-MAR-2021, dose and route not reported) for prophylaxis. The patient received the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) sooner than what was recommended (Inappropriate schedule of product administration) (onset date was reported as 27-AUG-2019). No adverse effects were reported.",,,,,,,,,U,,08/27/2019,,,UNK,,,,,,US0095075131908USA010970,2,09/11/2019,,,,
0833043,09/11/2019,VA,13.0,13,,F,,"it was noticed that the first syringe was empty.; it was noticed that the first syringe was empty.; This spontaneous report was received from the patient's mother referring to her daughter of a 13 years old female patient. Information about pertinent medical history, concurrent condition, concomitant medication and drug reaction/allergy was not provided.  On 29-AUG-2019, the patient came to receive her second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (strength, dose detail, route, lot # and expiration date were not reported) for prophylaxis. On the same day, after the nurse stuck the patient, it was noticed that the first syringe was empty (product quality issue and circumstance or information capable of leading to medication error). The nurse got another syringe and administered second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9). The outcome of the event was unknown. The causality was not provided.",,,,,,,,,U,08/29/2019,08/29/2019,0,,UNK,,,,,,US0095075131909USA000053,2,09/11/2019,,,,
0833044,09/11/2019,NV,,,,U,,"No adverse effects reported.; patient received unspecified dose of ROTATEQ that was improperly stored; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No information on patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided.     On 22-AUG-2019, the patient was vaccinated with a dose of improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # S009940, expiration date 04-OCT-2020) (dose was not reported) orally for prophylaxis. Excursions occurred on 13-AUG-2019 and 14-AUG-2019. The vaccine underwent excursion of 34.7 Fahrenheit degrees for 3 hours and 2 minutes and 34.1 Fahrenheit degrees for 4 hours and 33 minutes. No adverse effects were reported. Data logger was involved.",,,,,,,,,U,08/22/2019,08/22/2019,0,,UNK,,,,,,US0095075131909USA001703,2,09/11/2019,,,,
0833045,09/11/2019,MO,,,,M,,"post herpetic neuralgia; Herpes Zoster; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On an unknown date, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot number and expiry date were not provided) for routine health maintenance and the prevention of shingles. On an unknown date, the patient suffered a painful rash. As a result of these symptoms, he presented to a medical provider and was diagnosed with herpes zoster and postherpetic neuralgia. Thereafter, the patient continued to suffer the effects of herpes zoster and post herpetic neuralgia. As a result, he suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, the patient's symptoms and diagnoses resulted in physical limitations not present prior to using the vaccine. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt suffered severe and permanent personal injuries. Further, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.   The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX). The events were considered to be disabling.",,,,,,,,Y,N,,,,,UNK,,,Routine health maintenance,,,US0095075131909USA003357,2,09/11/2019,,Y,,
0833046,09/11/2019,NV,11.0,,,F,,"Redness; Swelling; Itchy; This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 11-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 43E4T, expiry date 1st October 2021) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, less than 6 months after receiving Boostrix, the patient experienced injection site erythema, injection site swelling and injection site itching. On an unknown date, the outcome of the injection site erythema, injection site swelling and injection site itching were unknown.   It was unknown if the reporter considered the injection site erythema, injection site swelling and injection site itching to be related to Boostrix.  Additional details were provided as follows: The health care professional reported that the patient had redness, swelling and itching at the site of Injection with Boostrix.  The reporter consented to follow up. The batch number was updated from 43E47 to 43E4T as per sales data sheet. This was one of the 6 cases, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/11/2019,,,,
0833047,09/11/2019,CA,54.0,,,M,,"feeling pain; chills; fatigue; This case was reported by a physician via sales rep and described the occurrence of pain in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced pain, chills and fatigue. On an unknown date, the outcome of the pain and chills were recovered/resolved and the outcome of the fatigue was recovering/resolving.   It was unknown if the reporter considered the pain, chills and fatigue to be related to Shingrix.  Additional details were provided as follows: The patient described feeling pain from the Shingrix shot, chills and fatigue. The doctor called GlaxoSmithKline to inquire about the adverse event experienced by the patient and was told it would pass in 2-3 days. On the fourth day after the patient received the shot the doctor called the patient to inquire if the adverse event still persisted.  The patient said he felt better on the second day itself and he did not experience adverse event any more.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/11/2019,,,,
0833048,09/11/2019,TX,,,,U,,"Compression fracture; Shingles; This case was reported by a consumer via call center representative and described the occurrence of compression fracture in a elderly patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced compression fracture (serious criteria hospitalization) and shingles. On an unknown date, the outcome of the compression fracture and shingles were unknown.   It was unknown if the reporter considered the compression fracture and shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 1st dose of Shingrix one and half year ago. Meantime, the patient was hospitalized for compression fracture and had attack of shingles. The reporter consented for follow up.",,,,,Y,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/11/2019,,,,
0833049,09/11/2019,PA,73.0,73,,F,,"Cold; Sore throat; left arm soreness; This case was reported by a consumer via call center representative and described the occurrence of cold in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Flu vaccine with an associated reaction of pain.   On 18th June 2019, the patient received the 1st dose of Shingrix (intramuscular). On 18th June 2019, 2 hrs after receiving Shingrix, the patient experienced pain in arm. On 21st June 2019, the patient experienced sore throat. On 22nd June 2019, the patient experienced cold. On an unknown date, the outcome of the cold, sore throat and pain in arm were recovered/resolved.   It was unknown if the reporter considered the cold, sore throat and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left deltoid. The patient had some left arm soreness or achiness, which started about 2 hours after the injection and lasted about 2 to 3 days. The patient stated the soreness or achiness was like when you had a flu vaccine but she did not mention any name of the Flu vaccine she was referring.  3 days after receiving vaccination, the caller also stated that she developed a sore throat and then that weekend ( 4 days after) developed a cold which lasted about 10 days. The caller stated she did not know if the sore throat or cold was related to the vaccine but that her husband was also sick around the same time and when he was sick previously she got his cold as well. The reporter gave consent to follow up.",,,,,,,,,Y,06/18/2019,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201914,2,09/11/2019,,,,
0833050,09/11/2019,NV,,,,M,,"Swelling at injection site; Redness at injection site; Pain at injection site; This case was reported by a other health professional via call center representative and described the occurrence of injection site swelling in a 10-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 43E4T, expiry date 1st October 2021) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, less than 6 months after receiving Boostrix, the patient experienced injection site swelling, injection site erythema and injection site pain. On an unknown date, the outcome of the injection site swelling, injection site erythema and injection site pain were unknown.   It was unknown if the reporter considered the injection site swelling, injection site erythema and injection site pain to be related to Boostrix.  Additional information received were as follows: The age at vaccination was not reported. The healthcare professional reported that the patient had redness, swelling and pain at the site of Injection with Boostrix. The reporter consented to follow up. The batch number was updated from 43E47 to 43E4T as per sales data sheet. This was one of the 6 cases, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/11/2019,,,,
0833051,09/11/2019,NJ,60.0,60,,F,,"chest tightness; generalized weakness; palpitations; body aches; This case was reported by a physician via call center representative and described the occurrence of chest tightness in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number XJ57B, expiry date 18th October 2021) for prophylaxis.   The patient's past medical history included neck pain, shoulder pain and pain in arm.   On 21st August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 22nd August 2019, 1 days after receiving Shingrix, the patient experienced general body pain. On 23rd August 2019, the patient experienced palpitation. On 27th August 2019, the patient experienced weakness generalized. On 3rd September 2019, the patient experienced chest tightness. On an unknown date, the outcome of the chest tightness, palpitation, weakness generalized and general body pain were not recovered/not resolved.   It was unknown if the reporter considered the chest tightness, palpitation, weakness generalized and general body pain to be related to Shingrix.  Additional details were provided as follows: The health care professional stated that patient received Shingrix and experienced had body aches. On 23rd August 2019, 2 days after vaccination the patient experienced palpitations. On 27th August 2019, 6 days after vaccination, the patient experienced generalized weakness and on 3rd September 2019, 13 days after vaccination the patient experienced chest tightness. None of these symptoms have resolved at the time of reporting. The reporter had consented to follow up.",,,,,,,,,N,08/21/2019,08/22/2019,1,,UNK,,,,Medical History/Concurrent Conditions: Neck pain; Pain in arm; Shoulder pain,,USGLAXOSMITHKLINEUS201916,2,09/11/2019,,,,
0833052,09/11/2019,,33.0,,,F,,"Oligohydramnios; Insomnia; Vaccine exposure during pregnancy; This is an observational study case, initially received from other health professional on 06-Sep-2019, concerning a 33-year-old, pregnant, female subject of body weight 155 lbs, height: 63.5 inches and body mass index (BMI) 27.1, enrolled in a prospective observational safety study during pregnancy.  The subject's obstetrical history noted that the subject had 5 previous pregnancies which included three full term live births, one preterm live birth and one spontaneous abortion. No birth defects were reported. Also, the subject had no maternal or paternal history with major congenital malformations. The subject did not have a prior history of use of tobacco, alcohol or illicit drugs during pregnancy. The subject's medical history included hypothyroidism. The subject's concomitant medications included Prenatal Vitamins (mineral NOS, vitamin NOS) as a supplement.  The subject's last menstrual period (LMP) date was 30-Nov-2018, estimated delivery date (EDD) and corrected estimated date of delivery (CEDD) were reported as 06-Sep-2019. The type of pregnancy was singleton.   On 24-Jan-2019, the subject underwent ultrasound scan, and no major congenital malformation was noted.  On 31-Jan-2019, at gestation age of 8.9 weeks, the subject received Flu Vaccine Egg Split QIV CSL [influenza vaccine, batch number: YF41608; dose, expiration date, route of administration and anatomical location: not reported] (explicitly coded as 'vaccine exposure during pregnancy') for influenza immunisation.  On 05-Apr-2019, the subject underwent ultrasound scan, and no major congenital malformation was noted.  On 19-Aug-2019, approximately six months after vaccination, the subject developed insomnia. The subject received Ambien (zolpidem tartrate) at a dose of 5 mg, administered via oral route, every day as required, as a corrective treatment.  On 27-Aug-2019, approximately six months after vaccination, the subject developed oligohydramnios.   At gestational age of 39 weeks, the subject vaginally delivered live birth, female neonate. The neonate's birth weight was 3439 g, head circumference 35.5 cm and length 53.3 cm. The appearance, pulse, grimace, activity and respiration (APGAR) scores were 8 (one minute) and 9 (five minutes). No major congenital malformation was identified at birth. Oligohydramnios was noted as pregnancy complication.  On the same day, the subject recovered from the event 'oligohydramnios'.   At the time of initial reporting, the patient had not recovered from the event of 'insomnia'.  Company comment: A pregnant subject was administered Flu Vaccine Egg Split QIV CSL at 8.9 weeks of gestation. The subject developed insomnia and oligohydramnios, approximately six months after vaccination. Considering the implausible temporal relationship between vaccination and reported events, medical history of one preterm live birth and one spontaneous abortion, causality was confounded. However, causal role of the suspect vaccine cannot be totally excluded and it is assessed as related. The event of vaccine exposure during pregnancy is assessed as unrelated per company's conventions.; Reporter's Comments: A pregnant subject was administered Flu Vaccine Egg Split QIV CSL at 8.9 weeks of gestation. The subject developed insomnia and oligohydramnios, approximately six months after vaccination. Considering the implausible temporal relationship between vaccination and reported events, medical history of one preterm live birth and one spontaneous abortion, causality was confounded. However, causal role of the suspect vaccine cannot be totally excluded and it is assessed as related. The event of vaccine exposure during pregnancy is assessed as unrelated per company's conventions.",,,,,,,,,N,01/31/2019,01/31/2019,0,Test Date: 20190121; Test Name: Ultrasound; Comments: No major congenital malformation noted; Test Date: 20190405; Test Name: Ultrasound; Comments: No major congenital malformation noted,UNK,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS],Hypothyroidism,Medical History/Concurrent Conditions: Live birth (Three full term live births); Multigravida (Five previous pregnancies); Premature delivery (One premature birth); Spontaneous abortion (One spontaneous abortion),,USSEQIRUS201904563,2,09/10/2019,,,,
0833053,09/11/2019,,30.0,30,,F,,"injection site arm was red and hives. patient went to urgent care on Saturday night and was told the arm was infected and started doxycycline treatment. When it did not help, patient went to ER and was told it was anaphylactic reaction. patient was given Benadryl.",,,,,,,,,Y,09/06/2019,,,,SCH,,,,,,,2,09/11/2019,,,Y,
0833054,09/11/2019,NY,17.0,17,,F,,"Patient states that within 24 hours of receiving the vaccine, she became tired and lethargic, fell asleep during the afternoon and when she awoke, the side of her face that she had been sleeping on was swollen and numb.  Patient states that the swelling has since reduced, but some swelling remains 72 hours after the vaccine.",,,,,,,,,Y,09/09/2019,09/10/2019,1,,PVT,,"Albuterol Sulfate 108 Mcg/Act 2 puffs q6h PRN for wheeze, cough, shortness of breath",None,Asthma,,,2,09/11/2019,,Y,,NKA
0833055,09/11/2019,ME,61.0,61,,F,,swollen red localized reaction,,,,,,,,,Y,09/05/2019,09/07/2019,2,,PHM,,"furosemide, levothyroxine, lisinopril, bupropion",,,,,2,09/11/2019,,,,spiriva
0833056,09/11/2019,TN,84.0,84,,F,,"PT CALLED IN AND ADVISED SHE FELT SHE REACTED TO ONE OF THE INJECTIONS, CLAIMING LEGS ACHING, GENERAL WEAKNESS, AND HEADACHE",,,,,,,,,U,09/10/2019,09/11/2019,1,NONE YET,PHM,,UNKNOWN,UNKNIOWN,UNKNOWN,,,2,09/11/2019,,,,PENICILLIN
0833057,09/11/2019,WI,59.0,59,,M,,"The night of the vaccine I had extreme restlessness and malaise and couldn't sleep whole night. The next day I had extreme chills, so bad I could barely stop shaking to use my computer for work. Also had a high fever of 103.5 and other symptoms similar to the worse case of the flu I used to get before I started getting annual flu shots years ago. Stiff neck, leg pains, sore skin, very tired, hard to think. Very debilitating and the worse reaction I've ever had to a vaccine. Also, the sorest my arm has ever been after a shot. On 3rd day I luckily feel  a little better. I do wonder this. I'm sure there was no one like me included in the clinical trials. About 1 1/2 months ago after being bitten by a bat, I had to undergo a three week series of rabies shots. With having such a severe reaction to the Shingles shot I wonder if that could have anything to do with it?",,,,,,,,,U,09/09/2019,09/09/2019,0,None,PHM,,"Atenanol, Simvastatin",None,None,,,2,09/11/2019,,Y,,None
0833059,09/11/2019,CA,42.0,42,,F,,"Headache, nausea, pain at IM injection site only",,,,,,,,,Y,09/08/2019,09/09/2019,1,None,PVT,,None,None,None,,,2,09/11/2019,,,,None
0833060,09/11/2019,IL,0.33,0,.3,M,,Pt was given shots on 9/5/19 and later that evening mom called and stated pt started to run a fever. Pt was taken to the ER and had a fever of 101-1'F. Pt was seen and Dr discussed with mom outcome of testing and what to watch for and when to bring back to Er.,,,,,,,,,U,09/05/2019,09/05/2019,0,Patient was tested for RSV-neg and chest x-ray taken and also tested for UTI while in the ER,PVT,,None,None,None,,,2,09/10/2019,,,Y,None
0833061,09/11/2019,OH,0.42,0,.4,F,,"Immediate:Highfever(100.4),Encephalitis:inconsolablehighpitchedscreaming,lethargy,whimpering,refusaltonurse;Shebeganhavingneurologicalsymptoms.Shestartedhavinginvolontaryspasms,shestartedwalkingonhertoes,stoppedrespondingtohername,startedhavingsensoryprocessingissuesandmotorplanningdelays;regressedspeechandsocialskills.Shebeganoccuptionalandspeechtherapiesandtreatmentishelping.",,,,,,,,,Y,10/06/2016,10/06/2016,0,,PVT,,n/a,nasalcongestion,n/a,,,2,09/11/2019,,Y,,n/a
0833062,09/11/2019,PA,72.0,72,,F,,"I woke up with shivers, and a headache.  Earlier I had cramps in my legs and feet.  I took 1 500mg. Acetaminophen and put a blanket on.  I fell asleep what seemed like a few minutes, but I am not sure.  I woke up this morning feeling better.",,,,,,,,,Y,09/10/2019,09/11/2019,1,,PHM,,"Pantoprazole Sod EC TB 40MG, Rosuvastatin TAB 5MG.  CoQ10, 200mg. 1 a day, Dry Eye Omega Benefits with vitamin D3,  Probiotics, dietary supplement. Green Tea 500 Mg twice a day,, velvet antler 250mg. 1 a day, Magnesium 400 MG twice a day.",None,None,,,2,09/11/2019,,,,"Tetanus toxin, Penicillin, some statin drugs."
0833063,09/11/2019,AR,56.0,56,,F,,"3AM woke up with fever (~12 hours), severe body aches (lasted ~12 hours) and severe shaking. Patient states she was unable to move her arms, hands, legs and mouth  or speak for 5-8 minutes after waking up.",,,,,,,,,Y,09/05/2019,09/06/2019,1,none--patient did not seek care from PCP or ED,PHM,,Paroxetine 20 mg 1 tablet daily,"""under a lot of stress""",Depression In-remission for ovarian cancer,,,2,09/11/2019,,,,none
0833064,09/11/2019,FL,68.0,68,,F,,Patient experienced swelling and redness,,,,,,,,,U,09/10/2019,09/10/2019,0,,PHM,,,,,,,2,09/11/2019,,,,
0833065,09/11/2019,CA,3.0,3,,M,,"5/1 - Patient will not wake up from nap time at school. He is often the first kid to wake up from naps at school. Teacher notified me of this strange symptom. 5/2 - Same as above. Patient begins slight stuttering in the evening. 5/3 - Patient begins to stutter more. Cannot form sentences. Very irritable, lots of outbursts and tantrums. Can't seem to follow through on simple tasks and follow sequences. 5/4 - Stuttering gets worse. Big big emotions, screaming, crying.  Loss of appetite. This is unusual.  Same as above with follow through on tasks and sequences 5/5  - Stuttering is terrible. Same symptoms as above. 5/6 - Stuttering begins to get marginally better.  Trouble focusing and following through with simple tasks and sequences at school. 5/7 - Stuttering gets a little better.  5/8 - Stuttering is now much less than after initial shot. 5/9 - Mild stuttering  Complaints of stomach aches often after MMR shot. Diet has not changed. In general, the neurological symptoms lasted a week and a half. The focus and attention issues that came up after MMR has now subsided a little, but was severe post MMR shot and lasted nearly 4 months.  5/5 - Stuttering gets even worse. Volatile emotions. Appetite is unstable.",,,,,,,,,U,04/30/2019,05/01/2019,1,,PVT,,NONE,NONE,NONE,Fevers,,2,09/11/2019,,Y,,Gluten
0833066,09/11/2019,NY,12.0,12,,M,,Patient broke out in rashes across the right side of his body. The injection site was a baseball size bright red  hard lump and  hot to touch. His entire right inside  forearm was a raised red thickened bumpy skin with 5-6 puss leasions that was draining a clear fluid. Patient's torso was a bright red rash-and every time he exerts himself his rash carries up to the chest and acrosss entire back. This has been very hard on Patient he has become sad and withdrawn since getting this rash.,,,,,,,,,N,08/20/2019,08/21/2019,1,Dr recommended allergist urgent care Saturday 24th steroid offered      Patient seen Dr august 27th 2019,PVT,,NONE,NONE,NONE,"Fever, and redness around injection site, grumpy, cried a lot,",,2,09/11/2019,,Y,Y,NONE
0833067,09/11/2019,MD,14.0,14,,F,,"Child presented to our clinic September 11 (12 days after vaccine) with symptoms consistent with a mild case of Chicken Pox.  She states symptoms appeared 3 days ago.  Child is afebrile, reports no pain.  Presents with disperse pruritic erythemic rash at approximately half dozen sites, as well as an indurated angry looking patch 4x6 cm at injection site.  Child appeared to be 'weary'.",,,,,,,,,N,08/30/2019,09/08/2019,9,None,PUB,,none,none known,none known,,,2,09/11/2019,,,,shrimp
0833068,09/11/2019,PA,73.0,73,,M,,"Pt presented with bright red raised distorted area (approximately 4 -5 in) directly below the band-aid injection site. Pt reported no pain, fever, or itching. The application area of the circular ""Inject-Safe"" covering was also reactive, though not at all red.  I directed the patient to take a picture of the area and report the reaction to Family Physician, watch for changes or no improvement. Patient may be directed to take antihistamine prior to the 2nd Shingrix if no further complications. Pharmacist will also notify the FP  of this report",,,,,,,,,Y,09/09/2019,09/10/2019,1,None,PHM,,"Glipizide 5mg BID / Ramipril 2.5mg daily/ Atorvastatin 20mg daily/Allopurinol 300 mg daily / Metoprolol Tart 25mg daily / Metformin ER 500mg 3 daily, bupropion SR 150mg BID/ Ventolin Inhaler prn",None,"Diabetes, Hypertension, Gout, elevated cholesterol,",,,2,09/11/2019,,,,"Penicillin, Cephalosporins"
0833069,09/11/2019,AZ,12.0,12,,F,,"My daughter began to complain of a burning/warming sensation primarily in her head but radiated throughout her chest and stomach areas.  Also stinging sensation in chest area, headaches, extreme weakness in entire body.  Her hands and fingers could not hold a fork for breakfast the following day after the vaccine.  We took her to Hospital ER (9-10).  They performed the whole works: blood, urine ( came back normal). Also performed an MRI on brain, which also came back normal.  she was discharged and told to take ibuprofen for pain as needed and to follow up with pediatrician.  Its been a week since her vaccine and her symptoms have not diminished but have remained in tact.  We are worried for her health and would like to know what went wrong.  We strongly believe this vaccine caused her body to react in this manner.",,,,,,,,,N,09/04/2019,09/05/2019,1,"9-10-19:  Blood work, Urine, Brain MRI all came back normal.  (Hospital)",PVT,,none,none,none,,,2,09/11/2019,,,Y,none
0833070,09/11/2019,CA,49.0,49,,F,,"Redness, swelling, warmth at injection site where VZV vaccine administered OTC  NSAIDs by patient and cold compress",,,,,,,,,U,09/05/2019,09/06/2019,1,none,OTH,,"Atorvastatin, Certirizine HCl, Evening Primrose oil, Ibuprofen, Montelukast, Terbinafine HCl, Ventolin HFA","onychomycosis , benign neoplasm of the paratid lymph node, prediabetes, hypertriglycerides, hyperlipidemia","post surgical state absence of part of digestive tract, benign neoplasm of the paratid lymph node, prediabetes, hypertriglycerides, hyperlipidemia",,,2,09/11/2019,,Y,,NKA
0833071,09/11/2019,KS,71.0,71,,F,,"- large rash covering entire area between elbow and shoulder (appeared 1 hour after immunization), continuing thru 2 days later (and currently at time of this report) - body aches starting next day - soar throat starting next day  prednisone to treat rash, body aches/soar throat has subsided.",,,,,,,,,N,09/09/2019,09/09/2019,0,,PVT,,"lisinopril, tizanidine, synthroid",n/a,"hypertension, hypothyroid",,,2,09/11/2019,,Y,,n/a
0833072,09/11/2019,,65.0,65,,F,,"redness,  swelling, itchiness, and rash spreading to the chest,  back, and face. Also complained of an itchy throat.",,,,,,,,,U,09/09/2019,09/01/2019,,,PVT,,,,,,,2,09/11/2019,,Y,Y,NKA
0833073,09/11/2019,IL,,,,U,,"No adverse effects reported; the patient received a dose of VARIVAX via the intramuscular route; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Concomitant therapy included sterile diluent (STERILE DILUENT). No information regarding the patient's pertinent medical history and drug reactions or allergies was provided. On 29-AUG-2019, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) intramuscularly (lot # R035223, expiry date 04-DEC-2020) (exact dose was not reported) for prophylaxis.  No adverse effects were reported. The outcome of inappropriate route of vaccination and no adverse effects was unknown.",,,,,,,,,U,08/29/2019,08/29/2019,0,,UNK,,STERILE DILUENT,,,,US0095075131909USA000256,2,09/11/2019,,,,
0833074,09/11/2019,CA,,,,U,,"the patient received their first dose of Gardasil on 12/7/2009 and the second dose of Gardasil on 1/4/2010; No adverse effect; This spontaneous report was received from a pharmacy technician refers to a 27 year old patient. Information about patient's concurrent condition, medical history, drug allergy/reaction, concomitant medication was not reported.   On 07-DEC-2009, the patient was vaccinated with first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) and on 04-JAN-2010, the patient was vaccinated with second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) (strength, dose, route, anatomical location, lot/batch #, expiration date was not reported) for prophylaxis (inappropriate schedule of product administration). No adverse events were reported. No product quality complaint was involved.",,,,,,,,,U,12/07/2009,,,,UNK,,,,,,US0095075131909USA003702,2,09/11/2019,,,,
0833075,09/11/2019,IL,68.0,68,,F,,"Injection site is red; Injection site swollen; Injection site painful; This case was reported by a consumer and described the occurrence of injection site erythema in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 31st August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced injection site erythema, injection site swelling and injection site pain. On an unknown date, the outcome of the injection site erythema, injection site swelling and injection site pain were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site swelling and injection site pain to be related to Shingrix.  Additional case details were reported as follows: It was reported that the patient received Shingrix and her injection site was still red, Swollen and painful.",,,,,,,,,N,08/31/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/11/2019,,,,
0833076,09/11/2019,TX,2.0,2,.9,M,,"-Swelling, Redness, Pain to vaccine site a day after vaccine given. -Patient was seen here on 9/5/19 for evaluation of Redness and swelling. -Patient started on Bactrim Suspension twice a day - Symptoms Resolved on 9/9/19 on F/U visit.",,,,,,,,,Y,09/03/2019,09/04/2019,1,,PVT,,No,None,None,,,2,09/11/2019,,Y,,No
0833077,09/11/2019,NV,27.0,27,,F,,Patient c/o arm pain in right shoulder. Patient unable to complete range of motion with right arm without severe pain/,,,,,,,,,N,09/10/2019,09/10/2019,0,,PVT,,birth control,none,none,,,2,09/11/2019,,Y,,macrobid
0833078,09/11/2019,TX,23.0,23,,F,,"Received the Hepatitis B #2  vaccine at 3:30 pm. Went out to dinner with family around 6:30. When we arrived at the restaurant, we sat outside and I described that I ""felt weird."" My heart was racing, I was covered in goosebumps even though I was sitting in direct sunlight, and I felt dizzy. It felt that I had to try harder to swallow and it took longer to start breathing again after swallowing. I went into the bathroom at the restaurant and had really bad diarrhea. Another adult at the table asked if I had any medication allergies and I told her I couldn't have Cephalosporins or Penicillins. She asked if I needed an Epi Pen, but I got confused and told her that I couldn't have it because I was allergic to Penicillin (even though my normal self was aware they are completely different things). I felt like something awful was going to happen. I continued to be confused and she gave me Benadryl from her purse. A friend stayed with me for the next couple hours. I was exhausted and felt awful, but no more symptoms occurred.",,,,,,,,,Y,08/03/2016,08/03/2016,0,"I called the Student Health Center the following day to report what happened. MSN, RN told me that what I experienced were adverse effects and that Benadryl has no effect in an allergic reaction.  I did not know at the time that I could self-report a reaction.",SCH,,Oral birth control,N/A,N/A,MMR and Hep B received together in the month or two previous. Age 23. Adverse event was heart racing for full day following vacc,,2,09/11/2019,,,,N/A
0833079,09/11/2019,MI,32.0,32,,M,,"The patient was given the VIS form and stayed  in the room with me for 15 minutes since it was his first flu shot. Approximately 30 minutes later he returned to the area with another employee who stated he complained of feeling ""fuzzy"". I had him sit down and I asked him how he was feeling,He said he felt fine but he came back to see me because his fellow employee insisted. His blood pressure was 118/82. I asked him if he had eaten this morning and he said he only had been drinking coffee  and hadn't had enough sleep the night before. I gave him my protein bar and asked someone to get him some juice. I had him finish the protein bar and juice and retook his blood pressure ten minutes later and it was 118/-80. He said he felt much better and I told him to please come back if he was feeling poorly again. He didn't return.",,,,,,,,,Y,09/11/2019,09/11/2019,0,,WRK,,,,,,,2,09/11/2019,,,,
0833080,09/11/2019,GA,64.0,64,,M,,"Patient experienced nausea, vomiting, fever,  loss of strength and energy.  Patient took ibuprofen for the fever on 09/10/19 and called pharmacy 09/11/19. Patient stated that he had gotten better and so far did not need to take any ibuprofen today.",,,,,,,,,U,09/10/2019,09/10/2019,0,,PHM,,,,,,,2,09/11/2019,,,,
0833081,09/11/2019,MA,65.0,65,,F,,"Pt claims that as soon as she left the pharmacy, she experienced severe pain all over her body that kept her up all night, as well as GI upset. Says pain has remained constant. She called the pharmacy the morning of 9/11/19 to report it. RPh instructed her to contact her PCA and to seek medical attention if her pain gets worse or doesn't resolve in the next day.",,,,,,,,,U,09/10/2019,09/10/2019,0,,PHM,,"tramadol, valacyclovir, lidocaine ointment, losartan, omeprazole, levothyroxine, cetirizine, triamterene/hctz",unknown,unknown,,,2,09/11/2019,,,,"biaxin, codeine"
0833082,09/11/2019,OR,77.0,77,,F,,Patient is fine. Patient was suppose to be given PCV13 and was given Pneumo23,,,,,,,,,Y,09/04/2019,09/11/2019,7,none,PVT,,"Albuterol Sulfate, amlodipine, atorvastatin, Flonase, gabapentin, miralax, novolog, Soliqua",none,"Diabetic, Neuropathy, HTN, CKD",,,2,09/11/2019,,,,none
0833083,09/11/2019,WI,10.0,10,,M,,"he stated he could feel numbness in his R arm and hand an electrical shock. numbness and tingling in right bicep, down into the forearm, to the top of the hand, into thumb, index finger, middle finger which continued into the next day. NSAIDs, ice, elevation and rest for the symptoms",,,,,,,,,N,05/02/2019,05/02/2019,0,"None, patient in the office today due to symptoms continue with some intermittent tingling, patient has been referred to Pediatric Neurology and labs ordered.",PVT,,None,None,HLA  B27+,,,2,09/11/2019,,Y,Y,None
0833084,09/11/2019,MD,64.0,64,,F,,"The injection site was swollen, red, hot, had small blisters and very painful. On 9/7/19 I saw  Dr. at Urgent Care. I was diagnosed with Shingles in that area only and prescribed Acyclovir, Amoxicillin, Doxycycline Monohydrate. As of 9/10/19 the blisters had dried up and the other symptoms had dissipated. The area is healed but the skin is darker.",,,,,,,,,Y,09/04/2019,09/04/2019,0,"CBC NO Differential,  Chem 7, Non-Fasting (NA, K, CL, CO2, Bun, Gluc, Cr and an HIV test. All test were within normal range and HIV was negative.",PHM,,"Metoprolol, HCTZ, Diphenhydramine (OTC Allergy Pill)",,"Osteoarthritis of knees, hands, feet, Hep C (undetectable since 10/15), Heart Palpitations at times",,,2,09/11/2019,,,,"Lactose Intolerant,  Oxycodone Acetaminophen"
0833087,09/11/2019,NM,,,,U,,"No adverse effects; the patient was administered improperly stored VARIVAX; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 05-SEP-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) injection, lot # R002506, expiration date: 25-JAN-2020 (exact dose, injection site and route of administration were not provided) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (MERCK) injection (exact dose, injection site, route of administration, indication, lot # and expiration date were not provided). Administered dose experienced the temperature excursions of (7.7 degrees Fahrenheit) 6 degrees Fahrenheit to 14 degrees Fahrenheit for 3 hours 55 minutes. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. No adverse effects were reported.",,,,,,,,,U,09/05/2019,09/05/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA003294,2,09/11/2019,,,,
0833088,09/11/2019,NC,16.0,16,,M,,"1/16/19 Extreme fatigue, light headed, sore throat. Strep test, mono test, CBC & sick appointment with Dr., Pediatrician Platelet count 7,000 & very low WBC 1/17/19 CBC PLT 8,000 & very low WBC from 8:00 am appt. Dr Admitted to hospital under Dr., Hematologist at 4:00 pm At 6:00 pm CBC drawn results were PLT 10,000 & low WBC Diagnosed ITP resulting from MMR II vaccination 1/18/19 CBC drawn 6:00 am PLT 18,000 & WBC 3.9 discharged from hospital. No physical activities 1/21/19 CBC PLT 140,000 & WBC 4.61 Patient's symptoms from Jan. through May range from extreme tiredness, low energy & having a hard time focusing in school. He has not been able to participate in physical activities if his PLT are below 50,000 due to concern of internal bleeding. He plays Club Soccer at a high level year round along with High School soccer with the goal of being recruited & scholarship to play in college. He has to go weekly for bloodwork to see if his PLT counts are high enough each week to play. He has had to take Prednisone to increase PLT counts so he can participate in Club championship/state/regional games multiple times to ensure high enough counts & be able to play! His numbers have continued fluctuating & dropping down to 13,000 requiring Promacta prescription medicine to force his bone marrow to increase PLT production. Zofran also needed to deal with nausea from Promacta. He has been told his ITP could last 6 months to 5 plus years until his body re-sets itself & stops attacking his own PLT. We have his liver/organs checked each month to ensure the Promacta does not damage his liver & cause future health issues. This MMR vaccination has changed our son's life dramatically now & well into his future!",,,,,Y,1,,,N,01/04/2019,01/16/2019,12,"2/4/19 CBC PLT 86,000 3/6/19 CBC PLT 64,000 3/19/19 CBC PLT 39,000 4/2/19 PLT 49,000 4/10/19 PLT 90,000 4/22/19 PLT 30,000 4/30/19 PLT 65,000 5/6/19 PLT 62,000 5/14/19 PLT 41,000 5/17/19 PLT 59,000 5/29/19 PLT 46,000 6/4/19 44,000 6/5-15/19 prednisone 6/7/19 47,000 6/10/19 60,000 6/24/19 27,000 7/2/19 31,000 7/11/19 26,000 7/17/19 13,000 7/17-26/19 prednisone 7/19/19 60,000 7/26/19 109,000 7/29/19 started Promacta 8/2/19 65,000 8/6/19 81,000 8/14/19 103,000 8/22/19 132,000 8/29/19 66,000 9/5/19 114,000",PUB,,"Viamin C, Black Elderberry",no,seasonal allergies,3 months old (10 days after immunizations) labored breathing/fever admitted hospital,,2,09/10/2019,,Y,,"peanuts, tree nuts, eggs, coffee"
0833089,09/11/2019,NC,76.0,76,,F,,Patient called me this morning 9/11 to let me now that she started having reaction to the vaccine last night after receiving it from our store yesterday. Her arm started having swelling and a knot under the area where she received the shot. I told her to go to the dr and let us know what he said.,,,,,,,,,U,09/10/2019,09/10/2019,0,went to physician 9/11 and given prednisone,PHM,,,,,,,2,09/11/2019,,Y,,
0833090,09/11/2019,CA,70.0,70,,F,09/09/2019,Redness and swelling at site of injection and keeps swelling. Causing discomfort. Advised to take Benadryl and ice the area for swelling.,,,,,,,,,U,09/08/2019,09/08/2019,0,,OTH,OTH,,,,,,1,,,,,
0833091,09/11/2019,,33.0,33,,F,,"Patient has no record of adverse reactions to vaccinations or medications in the past. About 1 hour after the immunization, patient experienced severe itching, and redness at injection site in a 3"" x 3"". Patient experiences no pain during injection, nor pain afterwards. Only redness, heat, and itching.",,,,,,,,,U,09/11/2019,09/11/2019,0,Patient was advised to take Benadryl and seek MD care if symptoms worsen.,UNK,,,,,,,2,09/11/2019,,,,no allergies
0833092,09/11/2019,MA,4.0,4,,M,,"localized redness around injection site, appeared two days after injection",,,,,,,,,Y,09/06/2019,09/08/2019,2,,PVT,,no,no,no,,,2,09/11/2019,,Y,,no
0833093,09/11/2019,MA,4.0,4,,M,,"localized redness around injection site, appeared two days after injection",,,,,,,,,Y,09/06/2019,09/08/2019,2,,PVT,,no,no,no,,,2,09/11/2019,,Y,,no
0833094,09/11/2019,TX,64.0,64,,F,,"Temperature between 99 to 100, constant vomiting and diarrhea for ~10 hours (diarrhea still on-going), muscle aches, joint aches, headache",,,,,,,,,N,09/10/2019,09/10/2019,0,,PHM,,"lansoprazole 30mg, metoprolol tartrate 50mg, Montelukast 10mg, estradiol 0.0375mg patch, Trulicity 1.5mg inj, Janumet XR 50mg/1000mg, atorvastatin 40mg, valacyclovir 1gm",,"diabetes, high blood pressure, high cholesterol","sore, swollen arm to a flu shot at some point in the past",,2,09/11/2019,,Y,,"opioids, sulfa"
0833095,09/11/2019,NY,24.0,24,,F,,"HPV vaccine administered without incident.  Immediately after Hepatitis B vaccine administration, pt requested to lay back.  Reclined and attempted to elevated legs, at which point patient stiffened.  Called for help, NP and MA responded immediately.  Pt began having  seizure like activity for approximately 30 seconds.  Sat up suddenly, confused and pale.  Ice packs applied to forehead and neck.  Pt reported feeling disoriented and nauseous. Remained in reclined position for approximately 20 minutes, reported feeling better.  Observed for additional 15 minutes.  Recommend she go home and rest, follow up with neurologist.  Left clinic in NAD.",,,,,,,,,Y,09/11/2019,09/11/2019,0,,WRK,,Yaz,subacute vaginitis,,"Reports ""fainting"" in high school after vaccination.  Unsure which vaccine was administered",,2,09/11/2019,,,,Azithromycin
0833096,09/11/2019,TX,66.0,66,,F,,Patient said she got sick next day after receiving the vaccination with following symptoms: High fever and  rash on her right arm,,,,,,,,,Y,09/06/2019,09/07/2019,1,,PHM,,patient doesn't want to disclose prescription information,nothing that patient was aware of,patient doesn't want to disclose health condition,,,2,09/11/2019,,,,"Pnicillin, Sulfa drugs"
0833097,09/11/2019,NC,68.0,67,,F,,"HEADACHE, INJECTION SITE REDNESS & SWELLING, FEVER, SORE SHOULDER, SORE NECK",,,,,,,,,U,09/07/2018,09/08/2018,1,NO,PHM,,NO,NO,DIABETES,,,2,09/11/2019,,,,"CODEINE, GLIMIPERIDE, METFORMIN, PHENERGAN"
0833099,09/11/2019,MI,1.0,1,.0,F,,Delayed type hypersensitivity reaction to aluminum component in Hepatitis A or B vaccine caused a subcutaneous nodule. patient had bump on left leg.,,,,,,,,,U,09/05/2019,09/09/2019,4,,PVT,,,,,,,2,09/11/2019,,Y,,
0833100,09/11/2019,AK,36.0,36,,F,,"BODY ACHES; HA; DIARRHEA; INJECTION SITE RED, SWOLLEN, HOT, TENDER",,,,,,,,,N,09/09/2019,09/09/2019,0,NO,WRK,,"IRON SUPPLEMENTS, LIQUID, 220MG/5 ML, 2.5 ML BID; GABAPENTEIN 100 MG, 2 TABLETS Q PM",ANEMIA,ANEMIA; DDD,,,2,09/11/2019,,,,SULFA DRUGS
0833101,09/11/2019,CA,62.0,62,,M,,"Vesicular rash on patient: It is mainly on his back spreading to his left and right axilla and  Upper and lower extremities.  It looks like chickenpox.  He is not complaining about itch or pain.  We did not give him anything for it since he did not complain.  The staff noticed when they were bathing him and felt the bumps on his back. It was hard to see initially bc of his skin color, so it was noticed 9/9/19 during his shower. It could have been there this past weekend, but possibly not noticeable yet.",,,,,,,,,Y,09/06/2019,09/01/2019,,none,OTH,,"acetaminophen (TYLENOL) 325 mg tablet   baclofen (LIORESAL) 10 mg tablet   bisacodyl (BISAC-EVAC RECTAL)   carbamide peroxide (DEBROX) 6.5 % otic solution   cyanocobalamin 1,000 mcg tablet   doxazosin (CARDURA) 1 mg tablet   feeding tubes -",none,Spastic Quadriplegia B12 def Gastrostomy GERD,,,2,09/11/2019,,Y,,NKDA
0833102,09/11/2019,OH,0.42,0,.4,M,,Febrile seizure on 06/04/2019 - went to Medical Center,,,,,,,,,Y,06/03/2019,06/04/2019,1,,PVT,,NONE,NONE,NONE,,,2,09/11/2019,,,Y,NKA
0833103,09/11/2019,IL,79.0,79,,F,,"Patient reported feeling a tingling in her left side of head 13 minutes after receiving immunization. I explained that should not be an effect of the shot, especially that quickly. I did offer to call Dr. She refused and wanted to call herself. I offered our phone. She left AMA. No mark on arm at time and no swelling. Called doctors office at 11:20am. Heard from employee at the office that the patient had talked to, RN. RN reassured her the tingling is not an affect from the Shringix shot. Patient wished to be seen. Patient in office with NP at 12:05pm. Per other employee, NP could not verify that the symptoms were caused by the shringrix vaccine. NP told patient that if she wanted additional attention that she would need to go to the ER. She refused and left the office AMA.",,,,,,,,,U,09/11/2019,09/11/2019,0,None,UNK,,,,,,,2,09/11/2019,,Y,,
0833104,09/11/2019,FL,72.0,72,,M,,"patient stated arm is still sore as of today Sept 11, 2019",,,,,,,,,,05/20/2019,05/20/2019,0,,UNK,,,,,,,2,,,,,
0833113,09/11/2019,,,,,U,,"Side effects; This case was reported by a consumer and described the occurrence of adverse drug reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  The patient wondering how long the side effects last after the vaccine. The reporter denied permission to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/11/2019,,,,
0833114,09/11/2019,,,,,F,,"Bad arm pain; Abdominal pain that would not go away; This case was reported by a physician via sales rep and described the occurrence of pain in arm in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm (serious criteria hospitalization) and abdominal pain (serious criteria hospitalization). On an unknown date, the outcome of the pain in arm and abdominal pain were recovered/resolved.   It was unknown if the reporter considered the pain in arm and abdominal pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but the patient was 74 years old at the time of reporting. The patient experienced bad arm pain and abdominal pain that would not go away. The patient was hospitalized for a week.",,,,,Y,7,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/11/2019,,,,
0833115,09/11/2019,CA,74.0,74,,F,,"Muscle weakness; weakness; Became red / Eventually the redness and blisters spread to her chest, shoulders, back and face.; Developed elevated CPK enzymes levels; Rash containing macular patches; Injection site redness; Injection site blister; Developed some blisters / Eventually the redness and blisters spread to her chest, shoulders, back and face.; Area was itchy; Area was hot; Painful; This case was reported by a pharmacist via call center representative and described the occurrence of macular rash in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included methylprednisolone sodium succinate (Solumedrol) for an unknown indication.   The patient's past medical history included asthma and hypothyroidism.   In July 2019, the patient received the 1st dose of Shingrix .5 ml and Solumedrol (intravenous) 60 mg twice daily (120 mg daily). In July 2019, 7 days after receiving Shingrix, the patient experienced macular rash (serious criteria hospitalization), injection site erythema (serious criteria hospitalization), injection site blisters (serious criteria hospitalization), blister (serious criteria hospitalization), pruritus (serious criteria hospitalization), skin warm (serious criteria hospitalization) and injection site pain. On 26th August 2019, the patient experienced creatine phosphokinase increased (serious criteria hospitalization). On an unknown date, the patient experienced localized erythema (serious criteria hospitalization), muscle weakness (serious criteria hospitalization) and weakness (serious criteria hospitalization). The patient was treated with valaciclovir hydrochloride (Valtrex), cefalexin (Keflex), topical steroid nos (Topical Steroids) and topical steroid nos (Steroid Cream). On an unknown date, the outcome of the macular rash, injection site erythema, injection site blisters, localized erythema, blister, pruritus, skin warm, creatine phosphokinase increased, muscle weakness, weakness and injection site pain were unknown.   It was unknown if the reporter considered the macular rash, injection site erythema, injection site blisters, localized erythema, blister, pruritus, skin warm, creatine phosphokinase increased, muscle weakness, weakness and injection site pain to be related to Shingrix.  Additional details were received as follows:  On 10th July 2019 or 12th July 2019, the patient received a dose of Shingrix at the pharmacy. The reporter did not sure of date of vaccination. The injection was very painful.  One week after vaccination, where the patient had the vaccine, it became red and developed some blisters. Eventually the redness and blisters spread to the patient's chest, shoulders, back and face. Less than three weeks, after vaccination, the area was itchy and hot. The patient went to the primary care physician (PCP) who prescribed steroid cream. But, it did not help so she went to dermatologist who prescribed Keflex and Valtrex. The dermatologist did not think it was shingles but prescribed these since there had been no improvement. There was no improvement. On 26th August 2019, the patient presented to the emergency room where the patient was administered intravenous steroids on then tapered off on 1st September 2019.  The patient developed elevated creatine phosphokinase (CPK) enzymes levels.  They were not sure, if it was due to the reaction or to the steroids. On 26th August 2019, the patient was admitted to the hospital due to muscle weakness and skin lesions which were at injections site, arms, chest, shoulders, back and face. The CPK level on admission to hospital was 8594. At the time of reporting, the patient was off topical steroids, IV steroids, Keflex and Valtrex. The reporter was unsure if patient was experiencing muscle weakness or weakness.",,,,,Y,,,,U,07/01/2019,07/01/2019,0,"Test Date: 20190904; Test Name: Alanine aminotransferase; Result Unstructured Data: Test Result: 493, Test Result Unit: unknown; Test Date: 20190904; Test Name: Aspartate aminotransferase; Result Unstructured Data: Test Result: 321, Test Result Unit: unknown; Test Date: 20190826; Test Name: Creatine phosphokinase; Result Unstructured Data: Test Result: 8594, Test Result Unit: unknown; Test Date: 20190904; Test Name: Creatine phosphokinase; Result Unstructured Data: Test Result: 4764, Test Result Unit: unknown; Test Date: 201909; Test Name: Creatine phosphokinase; Result Unstructured Data: Test Result: elevated, Test Result Unit: unknown",PHM,,SOLUMEDROL,,Medical History/Concurrent Conditions: Asthma; Hypothyroidism,,USGLAXOSMITHKLINEUS201916,2,09/11/2019,,,Y,
0833116,09/11/2019,MI,18.0,18,,F,,Adult dose given to 18 year old,,,,,,,,,U,08/22/2019,08/22/2019,0,None,PUB,,Unknown,None,Unknown,,,2,09/11/2019,,,,None
0833117,09/11/2019,NM,21.0,21,,F,,"1st Hep B vaccine was given 8/5/19 but GSK 3JD32 was used WITHOUT INCIDENT.   Hospital changed to Dynavax for remaining vaccine doses, and 2nd dose was given on 9/4/19 and this incident occurred. Employee contact EH RN (Reporter) on 9/6/19 am and stated she had started having a fever at home on 9/5/19 as high as 102.1 and her right arm, where injection was given, was very sore and hot, and also mild dizziness/fatigue. She came to EH dept as instructed, Rt Deltoid area with approx. 3 inches of erythema in diameter and very warm to touch. No drainage or area of fluid under skin visually noted.  Employee sent to Medical Group for provider exam and recommendations.  Employee was afebrile at the time of exam.  Provider's diagnosis  was Atopic Dermatitis, a minor common local skin reaction to the immunization.  She was prescribed Zyrtex daily x 1 month, Meclizine 25 mg TID x 5 days, and Hydrocortisone cream applied topically for itching prn.",,,,,,,,,Y,09/04/2019,09/05/2019,1,None,PVT,,Estarylla 0.25mg-35 mcg ; metformin 500 mg;  motrin 600 mh;,None,HISTORY OF;  GYN issues; shoulder joint pain/bursitis,,,2,09/11/2019,,,,Iodine and Shellfish (Severe)
0833118,09/11/2019,NC,60.0,60,,F,,"PATIENT STATED THAT IN THE EVENING OF THE DAY SHE GOT THE SHOT, SHE STARTED FEELING EXTREME FLU LIKE SYMPTOMS THAT MADE HER NAUSEOUS  AND HAVE A HEADACHE. PATIENT STATED SHE THREW UP TWICE. PATIENT ALSO HAD A RED MARK AROUND THE INJECTION SITE. TOTAL SYMPTOMS LASTED UNTIL THE NEXT EVENING.",,,,,,,,,Y,08/09/2019,08/09/2019,0,,PHM,,"FROVA 2.5 MG, OMEPRAZOLE",,,,,2,09/11/2019,,,,NKDA
0833119,09/11/2019,MN,30.0,30,,F,,"Pt reported back to pharmacy about adverse event. Has since gone to clinic to have monitored and checked. Per patient had ""big red hot bump"".  Clinic will be monitoring in case of infection.  Per patient, clinic reason for possible reaction is that immunization was given too low and missed the muscle arm.",,,,,,,,,Y,09/09/2019,09/09/2019,0,,PHM,,"Montelukast, Spironolacton, doxycycline, apri",,Allergies,,,2,09/11/2019,,Y,,
0833120,09/11/2019,TX,68.0,68,,M,,Patient's wife called stating that starting on 9/10/2019 the patient started to have flu like symptoms and his arm was red and hot where the vaccines were given and that he had a low grade fever. She called today 9/11/2019 stating his arm was swollen and it was red and hot all the way down to his elbow. I told her that the flu like symptoms and redness were normal but because it is spreading down his arm and it is swollen to contact his primary care physician.,,,,,,,,,U,09/09/2019,09/10/2019,1,,PHM,,Unknown,Unknown,Unknown,,,2,09/11/2019,,Y,,No known drug allergies
0833121,09/11/2019,NY,62.0,62,,F,,"On 9/7/2019  pain began in left  shoulder and moved towards left side of face and increased in severity , patient visited pcp on 9/11/2019 and was diagnosed as trigeminal neuralgia.",,,,,,,,,U,09/06/2019,09/07/2019,1,"none reported , physical exam",PHM,,none reported,none reported,none reported,,,2,09/11/2019,,Y,,nka
0833122,09/11/2019,IN,65.0,65,,F,,"dehydrated, couldnt get out of bed, chills, passed out, fever, red and hot at injection site",,,,,,,,,Y,09/07/2019,09/07/2019,0,went to er twice,PHM,,,,,,,2,09/11/2019,,,Y,
0833123,09/11/2019,NC,65.0,65,,F,,"Severe neck, shoulder, and arm pain, both arms. Weakness in both arms. Tylenol and ibuprofen did not work. Used tramadol and heat, which helped with pain and mobility. Still as painful but better able to move 4 days later.",,,,,,,,,N,09/07/2019,09/08/2019,1,None,PHM,,"Mobic, zyrtec, prilosec, migrarelief",None,Arthritis,,,2,09/11/2019,,,,shellfish
0833124,09/11/2019,PA,75.0,75,,M,,APHASIA THAT LASTED ABOUT AN HOUR. COULD NOT FORM WORDS. ADMITTED TO HOSPITAL FOR OVER NIGHT OBSERVATION AND TESTS. VALSARTAN DOSE INCREASED FROM 40 TO 80 MG  1/DAY.   CORRECTED DEHYDRATION CONDITION.,,,,,Y,1,,,Y,08/21/2019,08/21/2019,0,TESTS INCLUDED  MRA-NORMAL                  BLOOD WORK WITHIN NORMAL RANGES MRI-NORMAL EKG-NORMAL EEG-NORMAL,PHM,,"Olmesartan Medoxomil, Amlodipine Besylate, Metoprolol Tartrate, Proair HFA, Valsartan, Lisinopril, Vitamin C, Vitamin E, CoQ10, glucosamine",None,"high blood pressure, high cholesterol, asthma",,,2,09/11/2019,,,,None
0833125,09/11/2019,CA,37.0,37,,M,,Pt fainted after receiving the immunization.,,,,,,,,,Y,09/09/2019,09/09/2019,0,"Blood pressure, heart rate and glucose level all normal. Could be only a reaction to needles and sharp objects since same reaction happened when patient finger was poked for blood sugar test.",PHM,,N/A,Mild eye infection. Mild redness in the right eye and patient picked up an eye drop at the same time.,No known chronic or long standing health conditions. Patient stated that he is not taking any medications or supplements.,,,2,09/11/2019,,,,NKA
0833126,09/11/2019,UT,40.0,40,,F,,Employee reported feeling anxious and heart racing. Lasted approximately 4 hours. No other symptoms.,,,,,,,,,Y,09/09/2019,09/09/2019,0,None needed,PVT,,Sumatriptan,None,None,,,2,09/11/2019,,,,None
0833127,09/11/2019,AL,72.0,72,,F,,Patient described injection site as red and sore with a knot.  She said it is feverish and approximately 4 inches in diameter.,,,,,,,,,U,09/04/2019,09/05/2019,1,none,PHM,,"losartan 100mg daily,  alternating levothyroxine 88mcg and 100mcg",none,hypothyroidism and hypertension,,,2,09/11/2019,,,,codeine and penicillin
0833128,09/11/2019,IL,4.0,4,,F,,Vesicular rash on both thighs was reported by the child's mother by telephone call.  Parent advised to bring child to Emergency room for any worsening of symptoms or change in level of consciousness.,,,,,,,,,N,09/10/2019,09/11/2019,1,none,MIL,,None,None,None,,,2,09/11/2019,,,,"Probiotic,MVI"
0833129,09/11/2019,MA,7.0,7,,M,,n/a,,,,,,,,,,09/11/2019,09/11/2019,0,n/a,PVT,,none,none,none,,,2,09/11/2019,,,,none
0833130,09/11/2019,FL,74.0,74,,M,,Red and swollen in first 24-48 hr after injection.  This resolved.  On the evening  of 8/21 patient started to experience severe pain directly in the  left shoulder joint.  Patient also concurrently received Fluad in the right deltoid at the same time.  He has had no unusual reaction in his right arm. On 8/22 the patient experienced fever and chills.  He had difficulty toweling off after his shower and difficulty putting on his shirt.  He had to sleep with his arm over his head.  His pain level was reported at 10.  The patient used Ibuprofen 400 mg to manage pain.  The patient continues to have occasional flares of joint pain.  Patient massages the area to alleviate discomfort.   The patient currently describes his condition as having deep joint  pain in his left shoulder.,,,,,,,,,N,08/15/2019,08/21/2019,6,,PHM,,,,,Red and swollen at injection site from 2018/19 Fluad administered  9/9/18. He had the same reaction to this years Fluad administ,,2,09/11/2019,,Y,,
0833131,09/11/2019,ID,73.0,73,,F,,Patient stated that her arm began to swell about 2 hours after the injection.  She rubbed and took antihistamine,,,,,,,,,U,09/10/2019,09/10/2019,0,,PHM,,,,,,,2,09/11/2019,,,,
0833132,09/11/2019,PA,1.0,1,.0,U,,Patient developed a scabbed area then ulceration on the skin at the site of the vaccination. No other symptoms.,,,,,,,,,,09/03/2019,09/07/2019,4,none,UNK,,none,none,none,,,2,09/11/2019,,,,none
0833136,09/11/2019,TX,,,,M,,"acute encephalopaty; stroke/weakness on his left side/Altered mental status; Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or around 16-JUN--2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot number, dosage and route of administration not provided), for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after, the patient was admitted after suffering weakness on his left side, acute encephalopathy, altered mental status and he was ultimately diagnosed with a stroke. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the product.  The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of zoster vaccine live (ZOSTAVAX), the patient sustained serious, progressive, severe and permanent personal injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment, suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events were considered not recovered. The events were considered related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the events stroke and encephalopathy were considered to be medically significant.",,,,,Y,,,Y,N,06/16/2017,,,,UNK,,,,,,US0095075131909USA001455,2,09/11/2019,,,,
0833137,09/11/2019,,,,,U,,"Gastroschisis; My daughter is now pregnant and we recently learned that her baby has gastroschisis; This spontaneous report was received from a consumer concerning a child patient of unknown gender. The patient's concurrent condition, medical history and concomitant medications were not reported.   On 16-JAN-2014, the the patient's mother started on etonogestrel (+) ethinyl estradiol (NUVARING), in place for three weeks, remove for one week, then replace. On that day, 03-APR-2014 and 11-AUG-2014, the patient's mother received 3 doses (respectively) of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) intramuscularly (IM) for prophylaxis (vaccine exposure before pregnancy, # 1801USA004493). On 12-JUL-2016, 20-SEP-2016 and 12-SEP-2017, three additional doses (respectively) of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) for prophylaxis were administered to the patient's mother (fetal exposure during pregnancy). On an unknown date, the patient experienced gastroschisis as result of the six doses of the vaccine, but no causality assessment was provided to etonogestrel (+) ethinyl estradiol (NUVARING). The outcome of the event of gastroschisis considered as not recovered.   Upon internal review, the event of gastroschisis was determined to be serious due to medically significant and congenital anomaly.; Sender's Comments:  US-009507513-1801USA004493:1801USA004493",,,,,,,,,N,01/16/2014,,,,OTH,,NUVARING,Contraception,,,US0095075131909USA002039,2,09/11/2019,Y,,,
0833138,09/11/2019,SC,,,,U,,"arm pain after receiving Prevnar13; This is a spontaneous report from a contactable physician via a Pfizer sales representative. A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient complained of arm pain after receiving pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) on an unspecified date and then needed 6 months of physical therapy. Outcome of the event was unknown.  No follow-up attempts are possible; information about the batch number cannot be obtained.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2019389272,2,09/11/2019,,,,
0833139,09/11/2019,KY,5.0,5,,M,,"pt developed mild erythema surrounding injection site on bilateral thighs on lateral side of each thigh. no SOB, reaction happened 5 minutes post injection, recommended Benadryl and observation to parents and go to ER or ICC if any concerns or rash worsens.",,,,,,,,,,09/11/2019,09/11/2019,0,,PVT,,,,,,,2,09/11/2019,,Y,,
0833140,09/11/2019,FL,4.0,4,,F,,Hives started 24 hours after vaccines given and have continued 4 days later,,,,,,,,,N,09/06/2019,09/07/2019,1,,MIL,,Over the counter multivitamin,"Cough, congestion & runny nose started 2 days prior to vaccination",None,,,2,09/11/2019,,Y,Y,None
0833141,09/11/2019,TX,50.0,50,,F,,"PATIENT DEVELOPED A FEVER ON THE DAY FOLLOWING VACCINATION, THEN A RASH ON DAY 5 AFTER VACCINATION",,,,,,,,,Y,09/03/2019,09/08/2019,5,NA,PVT,,"ADVAIR DISKUS 250-50 PRN, VENTOLIN 90MCG PRN, XYZAL 5MG QDAY, MICROGESTIN 1/20 ONCE A DAY",NONE,MILD INTERMITTENT ASTHMA AND SEASONAL ALLERGIES,,,2,09/11/2019,,Y,,BACTRIM CODEINE
0833142,09/11/2019,WA,52.0,52,,F,,"Rash - Was given Shingrix vaccination 9/5/19. Rash began next day at injection site in L deltoid. Red, itching, burning, warm. Triage nursing advised Tylenol and Benadryl, appt scheduled to be seen in clinic today - When injection was going in felt pain, stinging different than a shot. Could feel the medicine going into her system. Sat for 10 minutes after injection, felt tightness in chest and in head like pressure. Vaccine placed around 5:15, Tired, left pharmacy around 6pm. Pressure in chest and head resolved within a few hours and has not returned since - On 9/6 first noticed rash, started feeling warm in the arm around injection site, red and itchy. Burning, unpleasant. - Since noticing it the burning and itching comes and goes. Rash seemes to be receeding. - Has not taken any medicine or used any cream",,,,,,,,,N,09/05/2019,09/06/2019,1,None,PHM,,None,None,"Hypertension, asthma, allergic rhinitis, sciatica, fibroids",,,2,09/11/2019,,Y,,"Allergies to shellfish, sulfa and amoxicillin"
0833143,09/11/2019,MS,40.0,40,,F,,"PT REPORTS WARMTH, REDNESS, SWELLING, AND TENDERNESS AT THE SITE OF INJECTION.  PT HAS A KNOT AT THE SITE OF INJECTION.  SHE SAID THAT SHE HAD FEVER AND FELT FATIGUED THE DAY AFTER GETTING THE TDAP INJECTION. PT STATED THAT SHE ""USUALLY FEELS THIS WAY AFTER RECEIVING THE FLU SHOT"".",,,,,,,,,N,09/05/2019,09/06/2019,1,"WARM COMPRESSES TO SITE, IBUPROFEN AND TYLENOL FOR PAIN, RTC FOR WORSENING SYMPTOMS",PVT,,"LABETALOL, ZOLOFT, VISTARIL, PRAVASTATIN, PROCARDIA XL",NONE.,"HYPERLIPIDEMIA, HYPERTENSION, ANXIETY,",INFLUENZA VACCINE,,2,09/11/2019,,Y,,PENICILLINS
0833145,09/11/2019,CO,83.0,83,,F,,"arm is extremely red and is swollen in a large area around the injection site.   It is warm to touch.  Patient noticed right after injection was given,",,,,,,,,,N,09/08/2019,09/08/2019,0,patient has an appointment with her dermatologist 09-12-2019.  She is currently taking benadryl,PHM,,vitamins,none,chronic fibro myalgia,,,2,09/11/2019,,Y,,sulfa and diazepam
0833146,09/11/2019,ME,71.0,71,,F,,Painful joints in limbs & digits (upper & lower); skin hurt; chills and shaking; frequent urination (six times over night); temperature of 100.6 degrees upon waking at 6 AM,,,,,,,,,Y,09/10/2019,09/10/2019,0,No tests - took three doses of 2 Tylenol  tablets over 14 hours,PHM,,Estradiol cream,None,None,"Shingles, but not as severe as this event.",,2,09/11/2019,,,,Sulfa
0833147,09/11/2019,LA,56.0,56,,F,,"About 6 hours after the vaccine was given, the patient started feeling bad. She was shivering and started running a fever of 102 degrees.  She grew weak as hours passed. She also developed a headache. The fever lasted all throughout the night with shivering.  Her body began to hurt. The next day the fever was down in the morning, but her body hurt and had a headache.  Her arm was sore as well at injection site.  That evening, she started running fever again, 101 degrees.  The next day, her body hurt worse, like flu like body aches. This was mostly in the shoulder blades, back of the neck and down her back. The pain is getting worse today in her back.  The site of injection is turning red and feels hard to the touch",,,,,,,,,N,09/09/2019,09/09/2019,0,none. have not gone to the md yet,PHM,,Combipatch,none,none,,,2,09/11/2019,,,,nka
0833148,09/11/2019,TX,37.0,37,,F,,"I began to have a sore throat around 6pm.  Later in the evening my lips had some swelling, then I noticed my eyes were red.  About 10pm I checked my blood pressure which was 200/100.",,,,,,,,,Y,09/10/2019,09/10/2019,0,None,PHM,,None,None,None,,,2,09/11/2019,,,,None
0833149,09/11/2019,MI,66.0,66,,M,,"PATIENT REPORTS BEGINNING AT ABOUT 11PM THE FOLLOWING SYMPTOMS: FELT AS IF GETTING A COLD, SEVERE HEADACHE, BP 141/91 AND PULSE 102BPM, TREMORS/SHAKING THAT LASTED 2 HOURS, EXCESSIVE URINATION, WEIGHT LOSS (5LB FROM ONSET TO ""RECOVERY""), LACK OF APPETITE, FEELING OF SEVERE DEPRESSION, PINK SPLOTCHES IN VISION (PATIENT IS BLIND). SYMPTOMS SLOWLY STARTED TO WANE OVER TIME. HEADACHE RESOLVED ON 9/7 AND EXTREME MUSCLE SORENESS RESOLVED 9/10/19",,,,,,,,,Y,09/05/2019,09/05/2019,0,N/A,PHM,,UNKNOWN,UNKNOWN,DIABETES,,,2,09/11/2019,,,,LATEX
0833150,09/11/2019,NY,69.0,69,,F,,frozen shoulder. extremely painful at onset. improvement in pain day 2 with Motrin. Started physical therapy for frozen shoulder,,,,,,,,,N,09/09/2019,09/09/2019,0,none,PHM,,High Blood Pressure meds,none,none,,,2,09/11/2019,,,,none
0833151,09/11/2019,PA,66.0,66,,F,,SWELLING OF LEFT ARM STARTED AT NIGHT,,,,,,,,,N,09/09/2019,09/09/2019,0,PT WENT TO ED AND DOCTOR DIAGNOSED HER WITH CELLULITIS MOST LIKELY DUE T SCRATCHING THE INJECTION SITE WHILE SLEEPING.,PHM,,NA,NA,HEART DISEASE,,,2,09/11/2019,,,Y,NA
0833152,09/11/2019,CA,69.0,69,,F,,"Within 3-4 hours severe shoulder pain, severe headache, blurred vision, left arm above crook of arm but below shoulder swelled up - this lasted until today (Thursday 9/11/2019) when bruise appeared where had been swollen. I felt so ill - never had reaction after flu shot before. Don't know that I will ever rush to get one again.",,,,,,,,,Y,09/06/2019,09/06/2019,0,,PHM,,"Ursodiol, prednisone, xopenex",None,"Primary Biliary Cirrhosis, Lupus, Undifferentiated Mixed Connective Disease, migraines, bronchiestasis",,,2,09/11/2019,,,,".penicillin, Velosef,  ciprofloxacin, contrast dye, erythromycin,  levaquin, tetracycline, sulfa drugs, bee stings, ECG leads, meloxicam"
0833153,09/11/2019,CA,24.0,24,,M,,"Patient c/o feeling bad. I ask for him to explain ""feeling bad"" he could not. I explained it is possible to feel tired. He stated that he did not feel tired. I asked and he denied the following: Pain at site, H/A, shoulder pain, feverish, redness at site of injection, confused, S.O.B., tongue swelling, rash on body. I also asked if was taking any medication or consumption of alcohol, which he denied. He asked if there was anything that he could do. I stated rest and Tylenol for pain. Symptoms should resolve in a day or so, if not seek medical treatment either with his PCP or ED if conditions worsen.",,,,,,,,,U,09/09/2019,09/10/2019,1,None,PUB,,None indicated,None indicated,None indicated,,,2,09/11/2019,,,,"Broccoli, Oats Patients states in causes insomnia"
0833154,09/11/2019,WA,48.0,48,,F,,"The next day, pt woke up in upper R arm pain, which worsened for a few days. The day after, she noticed some swelling and tenderness in the R supraclavicular fossa. No erythema. Starting a few days later, all symptoms started to improve. Continues to have a 3cmx2cm indurated area subcutaneously at the R upper arm on 9/11.",,,,,,,,,N,09/05/2019,09/06/2019,1,N/A,PVT,,Lisinopril,,Hypertension,,,2,09/11/2019,,Y,,Penicillins - rash
0833155,09/11/2019,CA,18.0,18,,F,,"Felt dizzy, laid back on exam chair and had upper body convulsions for about 10 seconds",,,,,,,,,Y,09/11/2019,09/11/2019,0,,PVT,,Blisovi Fe 1/20 oral contraceptives,,,,,2,09/11/2019,,,,
0833156,09/11/2019,WA,11.0,11,,M,,"Parent of child who received vaccine noted that the morning after getting the vaccine the child had a headache, weakness in their legs, and two visual hallucinations. the child's symptoms resolved the same day. Child was evaluated at a local hospital through the emergency room but all symptoms had resolved by that time.",,,,,,,,,Y,09/09/2019,09/10/2019,1,,PVT,,,possible upper respiratory infection,,,,2,09/11/2019,,Y,Y,
0833157,09/11/2019,OH,62.0,62,,F,,"patient stated that she experienced extreme headache, nerve pain, and pan from the back of spine to her head.  She  experienced pain in her back and was unable to move from Saturday 9/7/19 to Monday 9/9/19",,,,,,,,,Y,09/07/2019,09/07/2019,0,,PHM,,"pantoprazole, gabapentin, rosuvastatin, armour thyroid,",none,,,,2,09/11/2019,,,,"cephalosporin, ciprofloxacin, hydrocodone, lactose, dermabond"
0833158,09/11/2019,VA,44.0,44,,F,,Redness and swelling around the area the vaccine was given. Arm also feels warm to the touch.,,,,,,,,,,09/09/2019,09/10/2019,1,,PHM,,"Buproprion, Myrbetriq",,,,,2,09/11/2019,,,,None
0833159,09/11/2019,PA,53.0,53,,F,,Headache Body and muscle aches  Joint pain Fatigue Chills Nausea,,,,,,,,,N,09/10/2019,09/10/2019,0,,PVT,,Copaxone Linzess Synthroid,,Multiple Sclerosis,,,2,09/11/2019,,,,
0833160,09/11/2019,IL,69.0,69,,M,,Patient complaining  body ache and joint aches  whole body,,,,,,,,,U,09/10/2019,09/11/2019,1,,PHM,,,none,"blood pressure, thyroid and cholesterol med",,,2,09/11/2019,,,,nkda
0833161,09/11/2019,IL,81.0,81,,F,,PATIENT'S DAUGHTER WHO IS AN RN CALLED AND INFORMED US THAT SHE NOTICED THAT HER MOM HAD A RED LEFT SHOULDER (IT WAS WARM TO THE TOUCH) AND THERE WAS SWELLING/WHAT LOOKED TO APPEAR LIKE FLUID BUILD UP TILL THE EPICONDYL (ELBOW).  SHE GAVE HER MOM IBUPROFEN.  PT WAS GIVEN PNEUMOVAX 23 IN THE LEFT ARM.  I ADVISED HER TO CALL PT'S MD  AND TOLD HER TO CONTINUE APPLYING ICE AND GIVING IBUPROFEN.  IF THE CONDITION WORSENS BETWEEN NOW AND TOMORROW TO CALL MD. PT'S DAUGHTER STATED THAT SHE WOULD TAKE HER MOM IN TO SEE THE DOCTOR AND WOULD KEEP AN EYE ON THE ARM.  I TOLD HER THAT A PHARMACIST WILL CONTACT HER IN THE MORNING TO SEE HOW SHE'S DOING AND THAT WE WILL REPORT THIS AS AN ADVERSE EVENT TO THE PNEUMOVAX. PT'S DAUGHTER SAID THAT HER MOM RECEIVED PNEUMONIA VACCINATIONS TWO TIMES BEFORE BUT WAS UNSURE IF IT WAS PREVNAR OR PNEUMOVAX,,,,,,,,,N,09/10/2019,09/11/2019,1,N/A PT STILL NEEDS TO SEE MD,PHM,,LOSARTAN METOPROLOL TARTRATE PROAIR SPIRIVA  OTC ARE UNKNOWN. TAKING IBUPROFEN AT THE MOMENT FOR INFLAMMATION AT INJECTION SITE,HTN,HTN,,,2,09/11/2019,,Y,,NONE ACCORDING TO OUR RECORDS
0833162,09/11/2019,KS,62.0,62,,F,,"Patient reported having sore, red and warm sensation at injection site, also Saturday night 9/6/19 had chills and headache. Sunday felt tired and had a fever. Monday felt back to normal no issues, same for Tuesday and Wednesday no complaints. Patient just called the pharmacy after the following occurred and she was feeling better to inform them of",,,,,,,,,Y,09/06/2019,09/06/2019,0,,PHM,,,,,,,2,09/11/2019,,,,Sulfa drugs
0833163,09/11/2019,MT,67.0,67,,F,,"Patient's vaccine arm started with redness about the size of a silver dollar the day after given, then the redness spread down and around the arm to about the elbow and not quite all the circumference of the arm. It was also warm to the touch, but not painful.",,,,,,,,,Y,09/05/2019,09/06/2019,1,,PHM,,,,,,,2,09/11/2019,,,,
0833164,09/11/2019,OH,58.0,58,,F,,"Fever, headache, total body ache, nausea. Missed 8 hours of work the next day. Symptoms lasted 21 hrs",,,,,,,,,U,09/10/2019,09/10/2019,0,,PVT,,"Zoloft, synthroid",None,"Fibromyalgia, asthma, hypothyroid",,,2,09/11/2019,,,,None
0833165,09/11/2019,CA,17.0,17,,M,,"Patient received multiple vaccines on 7/30/19 in March 2019. Patient was admitted to Hospital 8/2-8/25/19 for new diagnosis of mixed phenotype acute leukemia (B-myeloid, Philadelphia chromosome positive, CNS 2A). He received chemotherapy with IT cytarabine on 8/23 and vincristine and daunorubicin on 8/24. He was given IT methotrexate on 8/30 and noted to have rash on neck that was initially thought to be steroid induced acne. PCR testing of the lesion was positive for VZV. He was admitted again on 9/4 for fever and neutropenia and was started on empiric therapy with acyclovir on 9/5/19. Patient has recovered from infection and all lesions are scabbed over. He has also resumed chemotherapy",,,,,Y,7,,,Y,07/30/2019,08/30/2019,31,VZV DNA PCR (skin lesion)- positive,UNK,,None known,"None reported. However, on 8/2/19 when patient was diagnosed with leukemia, he reported history of fatigue, bilateral leg swelling, and intermittent nausea with emesis",None reported until diagnosis of leukemia on 8/2/19,,,2,09/11/2019,,,,None
0833166,09/11/2019,ID,86.0,86,,M,,Patient reports to clinic with redness and swelling with pruritis on medial side of left arm.,,,,,,,,,N,09/10/2019,09/10/2019,0,,PHM,,Tamsulosin,None known,None known,,,2,09/11/2019,,,,Penicillin
0833167,09/11/2019,AL,69.0,69,,F,,"Headache, Fever, Rash, Swollen Face",,,,,,,,,Y,09/06/2019,09/07/2019,1,,PHM,,"Jardiance 10mg, Lovastatin 20mg, Lisinopril  40mg",,"Diabetes, High Blood Pressure",,,2,09/11/2019,,,,"Iron, Iodine, Penicillin"
0833169,09/11/2019,FL,91.0,91,,M,,Patient complained of pruritis starting in his left hand around the knuckles around 2 PM it then spread throughout his entire body by about 5:30 or 6pm. I instructed him to take Benadryl for the itching and to follow up with his primary care physician in the morning. There were no signs of a rash around the site of the shot. No signs of hives on the areas of the body where the itching was occurring.,,,,,,,,,U,09/11/2019,09/11/2019,0,N/A,PHM,,Unknown,Unknown,Unknown,,,2,09/11/2019,,,,None
0833170,09/11/2019,AZ,75.0,75,,F,,Patient developed significant swelling/pain along with a rash that spread down arm and across the chest.,,,,,,,,,N,09/10/2019,09/10/2019,0,,PHM,,unknown,,,,,2,09/11/2019,,Y,,"Benzodiazepines, sulfa antibiotics, phenothiazines"
0833171,09/11/2019,NC,51.0,51,,F,,"Severe chills, temp of 103",,,,,,,,,Y,09/09/2019,09/09/2019,0,None,PVT,,,None,Hereditary angioedema,,,2,09/11/2019,,,,Codeine
0833172,09/11/2019,TX,24.0,24,,F,,"Pt. came to clinic requesting Tdap and influenza vaccines. Denied any hx of adverse reactions to any vaccinations in the past. States her last flu vaccine was 5 years ago which she had tolerated well, pt. also had 1 Tdap dose when she was 12 years of age with no known reaction. Pt. was counseled by clinician and both vaccines were administered by staff. Pt. showed no S/s for the first 10 minutes. However, while walking out of the room, pt. reported she has difficulty breathing. Pt. was brought back in the room for further assessment during which pt. reported she cannot breathe. 911 was called. Benadryl 50 mg IM was administered by clinician. Pt. stated she felt a little better with Benadryl. EMS arrived, assessed pateint. VS - 139/94 BP, 114 HR, 18 RR, O2 Sat 100%. Pt. has hx of anxiety and panic attacks and states she got little anxious when she received the vaccine. Pt. is currently taking no medication for anxiety. Pt. refused to go to ER stating ""I feel better now"". VS before leaving clinic - BP 130/85 sitting L arm, Pulse 112 regular, RR 18, O2 Sat 100% Room air. Pt. left clinic with Family member. Pt. was advised to follow up with PCP.",,,,,,,,,Y,09/11/2019,09/11/2019,0,Advised to follow up with PCP for further evaluation. pt. verbalized understanding and states she will follow up with her PCP.,PVT,,None taken currently by patient. Has prescription of Proair inhaler to use as needed for allergy induced asthma,"No illness at the time of vaccination or in the month prior per pt. However, pt. has hx of seasonal allergy, allergy-induced asthma, eczema and anxiety",None per pt,,,2,09/11/2019,,Y,,Medication - Codeine. No know food or other products allergy per pt.
0833173,09/11/2019,HI,65.0,65,,F,,"RIGHT ARM CANNOT PICK UP ANYTHING, CAN ONLY LIFT ARM UP TO ABDOMINAL LEVEL.  STATIONARY MOVEMENT IS OK. RIGHT ARM TENDER TO TOUCH. EXPERIENCING FATIGUE, NASEA WITHOUT VOMITING, LOW GRADE FEVER AND CHILLS.",,,,,,,,,N,09/09/2019,09/10/2019,1,,PHM,,METOPROLOL AND ELIQUIS. NO OTC MEDS.,NONE,"HEART PROBLEMS, ARTHRITIS",,,2,09/11/2019,,Y,,STATINS
0833174,09/11/2019,PA,14.0,14,,F,,patient reported headache and dizziness that started the day after vaccination and persisted for 4-5 days after the vaccination with some episodes of pre-syncope,,,,,,,,,N,09/06/2019,09/07/2019,1,none,PVT,,escitalopram,none,depression  anxiety,,,2,09/11/2019,,Y,Y,none
0833175,09/11/2019,TX,63.0,63,,F,,"Patient called day after flu vaccine administration saying her eyes were swollen, almost shut in the morning. Also said they were very red and inflamed. Patient was advised to followup with doctor and take Benadryl in meantime. She came back couple days later and symptoms were much improved.",,,,,,,,,Y,09/04/2019,09/05/2019,1,,PHM,,,,,,,2,09/11/2019,,Y,,
0833176,09/11/2019,ID,69.0,69,,F,,"Patient awoke with facial droop on same side as the vaccine was given.  Of interest, she had the forehead sparing and so a stroke was strongly considered.  A stroke was ruled out and she was diagnosed with Bell's like palsy",,,,,,,,,N,08/30/2019,08/31/2019,1,She was seen an evaluated by the Stroke Team with an MRI and the Neurologist who is a stroke specialist ordered special fine cuts through the areas of concern and found nothing to indicate a stroke.  31 Aug --- She was treated with steroids and antivirals.  The lower facial weakness has improved but is still present to this day (12 days after onset),PHM,,,None,"Osteopenia, hypothryoidism, allergic rhinitis, allergic asthma, DJD",,,2,09/11/2019,,Y,Y,Levaquin
0833177,09/11/2019,TX,53.0,53,,F,,"Chills, aches, fever started at 3 am the next day and lasted until the afternoon.  I started taking Ibuprofen as soon as I got home from the vaccine and continued taking every 4 hours until all symptoms were gone about 24 hours later.",,,,,,,,,Y,07/10/2019,07/11/2019,1,,PVT,,"Centrum Silver for Women, Fish Oil 1400 mg",none,Ulcerative Colitis,,,2,09/11/2019,,,,none
0833178,09/11/2019,TX,64.0,64,,F,,developed breast pain in july 2019.   reports other individuals traveling who had received similar vaccines had also developed breast pain or neck pain after vaccines.,,,,,,,,,Y,05/01/2019,07/01/2019,61,none,OTH,,n/a,none,"rosacea, hyperlipidemia",,,2,09/11/2019,,Y,,none
0833179,09/11/2019,OR,67.0,67,,F,,"Severe pain in L deltoid, nausea, H/A, fatigue, weakness, generalized achiness",,,,,,,,,N,09/09/2019,09/10/2019,1,N/A,PVT,,ASA 80 mg QD DHA 450 mg QD DHEA 25 Mg QD L-glutamine 500mg QD Lutein 20 mg QD MVI QD MSM/Chondroitin SO4 12oomg QD Nobiliten (Tangerine oil) 270 mg QD Nicotinamide riboside 250 mg QD Pterostilbene/NAD+ (Basis) 2 cap QD St. John's Wort 150,None,"ARTHRITIS, CERVICAL SPINAL STENOSIS","Red & swelling at injection, years ago",,2,09/11/2019,,,,NKA
0833180,09/11/2019,GA,61.0,61,,M,,"Sore, swelling, itching No treatment",,,,,,,,,N,09/10/2019,09/11/2019,1,None,PVT,,"Triumeq, valtrex, elavil, men's multivitamin, Omega-3, low dose aspirin, vitamin D, peppermint, cinnamon capsules, metformin, Vit B12, Ativan 1mg PRN for sleep.",None,HIV+(33 yrs),,,2,09/11/2019,,,,"Dapsone, mycobutin"
0833181,09/11/2019,WA,61.0,61,,M,,"Muscle Aches, Joint pain, mild headache, mild fever, fatigued.  Feels just like the flu, without the nausea.",,,,,,,,,,09/10/2019,09/11/2019,1,,PHM,,,,,,,2,09/11/2019,,,,
0833222,09/11/2019,FL,60.0,60,,F,09/11/2019,"Pt. experienced arm soreness for about 2 days post vaccination. No pain to report for 2 weeks, then pain in vaccinated area started along with 3, pea sized lumps. Lumps are tender & arm is tender",,,,,,,,,U,08/08/2019,08/22/2019,14,unknown,UNK,PVT,,NONE,NONE,,,1,,,,,
0833223,09/11/2019,CA,18.0,18,,F,,"Patient Had a severe redness, pain, extending to underarm on the site of Bexero. Fevers, chills x4 days Exam - negative for any other. Redness improved with Zyrtec 10mg QD for 5 days.",,,,,,,,,Y,08/21/2019,,,"CBC, US-arm-CBC-NL, CPP-abnormal LUE - soft tissue swelling over deltoid",PVT,,0,0,0,,,2,09/10/2019,,Y,,0
0833224,09/11/2019,AZ,,,,F,,"(9-9) swelling & redness tender, warm @ injection site next day (9-11) called pt & she said it had resolved",,,,,,,,,Y,09/08/2019,09/08/2019,0,DR visit 9-9,PHM,,"HCTZ 12.5mg, losartan 100, metoprolol succ ER 50, levothyroxine 25MG, amlodipine 10MG, atorvastatin",N/A,N/A,,,2,,,Y,,NKA
0833247,09/11/2019,CA,3.0,3,,F,,Pt developed mild local vaccine reaction at the site of injection (R deltoid area): swelling & redness approximately 2 inches. Seen back by us on 9/5/2019. No other systemic condition. Given 1 dose of Benadryl & Ibuprofen,,,,,,,,,Y,09/04/2019,09/04/2019,0,No test,PVT,,None,None,None,,,2,09/10/2019,,Y,,NKDA
0833249,09/11/2019,IL,71.0,71,,F,,Patient's lips started to get numb and she said she felt really heavy. She took a Benadryl and felt better and was able to go home about 20 minutes later.,,,,,,,,,Y,09/07/2019,09/07/2019,0,,PHM,,,,High blood pressure,,,2,09/11/2019,,,,anchovies
0833252,09/11/2019,IN,48.0,48,,F,,"PATIENT RECEIVED VACCINATION AT 6PM 9/10/19. AT 6:30PM PATIENT REPORTED TINGLING IN THE FACE AND BODY-WIDE ITCHING. SHE TOOK 2 BENADRYL AT THIS TIME. AT 8PM SHE REPORTED STILL ITCHING BUT ALSO HAD ""THROAT ISSUES"" - SHORTLY AFTER THIS SHE LEFT WORK TO GO TO ER. THE NEXT DAY SHE HAD A FOLLOW UP VISIT TO URGENT CARE.",,,,,,,,,N,09/10/2019,09/10/2019,0,UNKNOWN,PHM,,"VITAMIN-D, HUMULIN RU-500, VENTOLIN HFA MONTELUKAST 10MG, LOSARTAN 25MG ATORVASTATIN 10MG, OZEMPIC, SYMBICORT 160/4.5","DIABETES, ASTHMA, HBP","DIABETES, ASTHMA, HBP",,,2,09/11/2019,,Y,Y,NKA
0833297,09/11/2019,AL,68.0,68,,M,,"Difficulty sleeping, legs locking up while trying to sleep, chills and congestion.",,,,,,,,,N,09/10/2019,09/10/2019,0,n/a,PHM,,"Iron 325mg, clindamycin, ciprofloxacin, spiriva",Just getting over pneumonia,n/a,,,2,09/11/2019,,,,n/a
0833298,09/11/2019,MT,11.0,11,,F,09/11/2019,Local reaction (6-7 cm) redness swelling,,,,Y,,,,,Y,09/10/2019,09/11/2019,1,,PVT,PUB,"Levothyroxine, proair, flovert",no,"Asthma, Hashimoto's thyroiditis",,,1,,,,,
0833182,09/12/2019,WA,,,,U,,"9/3/19y- arm was sore, felt tired,  hot, by the time I got home from work had fever (~101,7) 9/4/19- arm still sore, tired, nauseous,   9/5/19- arm sore, pain in my armpit, some digestive issues  9/6/19- nauseous,  arm sore,  armpit sore,  tired 9/7/19- tired soreness",,,,,,,,,Y,,,,N/a,PHM,,,,,,,2,09/12/2019,,,,
0833183,09/12/2019,MI,65.0,65,,F,,"Started with cough and runny nose, then tightness in chest (used inhaler) then shivered for 3 hrs. Followed by fever and heart rate that went from 80 to 110 in two hrs at which point I went to the er",,,,,,,,,N,09/09/2019,09/09/2019,0,"Blood work,  chest xray, urine",PHM,,"Xarelto, omeprazole, metoprolol,  hct, multivitamins,  vitamins d & e, flaxseed",None,Afib,,,2,09/12/2019,,,Y,Penicillin
0833184,09/12/2019,WA,49.0,49,,F,,"Severe Headache, nausea, stomach upset, diarrhea and overall unease. Took Advil for headache but it didn?t subside until after I fell asleep. Symptoms continued into the early AM hours when I could finally sleep.",,,,,,,,,Y,09/05/2019,09/05/2019,0,Never went back to the doctor.,PVT,,None,None,None,,,2,09/12/2019,,,,None
0833185,09/12/2019,TX,16.0,16,,M,,"severe pain in neck, back and legs. loss of feeling in both legs. hospitalized due to pain, neurological issues and elevated CRP, CK levels.  Advised suffered from neuralgia and acute kidney injury",,,,,Y,2,,,Y,09/03/2019,09/03/2019,0,"CRP, Creatnine Kinease, MRI, Blood Cultures, CMP, BMP",PVT,,none,none,"Asthma, Wolfe Parkinson White",,,2,09/12/2019,,,Y,none
0833186,09/12/2019,FL,10.0,10,,M,,"right arms swelling, erythema, warmth, and tenderness since 9/11/2019 at 8 am and increasingly worsening. Patient re-evaluated on 9/11/19 at 5pm and treatment prescribed.  9/12/19 @ 0816a mother verbalized son feels much better, right arm swelling has decreased to half the size, and son reported been able to move the arm without pain.",,,,,,,,,,09/10/2019,09/11/2019,1,N/A,OTH,,None,None,None,,,2,09/12/2019,,Y,,None
0833187,09/12/2019,TN,70.0,70,,F,,At 4 weeks I still have some redness and occasional itching at injection site,,,,,,,,,,08/14/2019,08/14/2019,0,,PVT,,Sertraline,,,,,2,09/12/2019,,,,
0833188,09/12/2019,MA,4.0,4,,M,,"varicella to left arm. area (redness) measuring Length15mm x width 20mm, round warm to touch, tender. patient advised to apply  ice to the area,  Benadryl Q 8 hours for redness, pruritus, inflammation of area. Return to the clinic with worsening symptoms.",,,,,,,,,Y,09/04/2019,09/05/2019,1,none,PVT,,Multivitamin,none,none,,,2,09/12/2019,,Y,,NKA
0833189,09/12/2019,FL,23.0,23,,F,,Patient came in for second dose today. Not given as she states after the first one she had a large area of redness and swelling to right arm and had a day of fever and flu like symptoms. Resolved after 24-48 hours.,,,,,,,,,Y,07/03/2019,07/03/2019,0,,PVT,,,,,,,2,09/12/2019,,,,Sulfa Drugs
0833196,09/12/2019,VA,4.0,,,F,,"No adverse effect; the patient received the first dose of PROQUAD on 25-APR-2018, and was inadvently administered a second dose of PROQUAD on 07-AUG-2019; the patient was inadvently administered a second dose of PROQUAD on 07-AUG-2019/mother did not disclose patient had been to another office, we gave PROQUAD then found out after patient left she had been seen elsewhere last year; Information has been received from an office manager referring to a 69 months old female patient. No information on patient's pertinent medical history, concomitant medications, drug reaction or allergies was provided.  On 25-APR-2018, approximately at the patient's age of 53 months old, the patient was vaccinated with the first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # S002926, expiration date 28-JUL-2020 (possibly incorrect information provided from reporter, as the patient received the second dose with the same lot#), anatomical location was right vastus lateralis, dose and route of administration were not provided) for prophylaxis. On 07-AUG-2019, the patient was inadvertently administered a second dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # S002926, expiration date 28-JUL-2020, anatomical location, dose and route of administration were not provided) for prophylaxis. After the patient left, it was found out that she had been seen elsewhere last year (inappropriate schedule of product administration, product prescribing issue). The patient's mother did not disclose that the patient had been to another office previously. No adverse effects were reported. The patient had no illness at time of vaccination. No temperature excursion occurred as a result of a reading from a digital data logger. There was no prescription drug treatment for the experience required.",,,,,,,,,U,04/25/2018,08/07/2019,469,,OTH,,,,,,US0095075131908USA005884,2,09/12/2019,,,,
0833197,09/12/2019,VA,13.0,,,U,,"No adverse effects; a dose of PROQUAD was inadvertently administered to a 13 year old patient.; This spontaneous report has been received from a nurse referring to a 13-year-old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant therapies and drug allergy or reactions were not reported.     On 13-AUG-2019, the patient was inadvertently vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (lot # S006832, expiration date reported as 02-SEP-2020; dose and route were not reported) for prophylaxis (inappropriate age at vaccine administration). No adverse effects was reported.",,,,,,,,,U,08/13/2019,08/13/2019,0,,UNK,,,,,,US0095075131908USA006317,2,09/12/2019,,,,
0833198,09/12/2019,SC,,,,U,,"No adverse effects; a patient received a dose of VARIVAX following a temperature excursion; This spontaneous report was received from an office manager regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies and drug reactions/allergies were not provided.  On 16-JUN-2019, the patient received a dose of varicella virus vaccine live (oka/merck) (VARIVAX)  batch/lot # N034553, expiration date: 05-DEC-2019 (dose, unit and route of administration were not reported) following a temperature excursion (product storage error) for prophylaxis. There were no previous temperatures excursion. The vaccine was exposed at the temperature from 15 Fahrenheit degrees to 46 Fahrenheit degrees for 30 days. Data digital logger was involved. No adverse effects were reported.",,,,,,,,,U,06/16/2019,06/16/2019,0,,UNK,,,,,,US0095075131908USA007184,2,09/12/2019,,,,
0833199,09/12/2019,SC,,,,U,,"No adverse effects; patient received a dose of VARIVAX following a temperature excursion; This spontaneous report was received from an office manager referring to a patient(age and gender unknown). The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not provided. On 16-AUG-2019, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # N034553, expiration date 05-DEC-2019) for prophylaxis, following a temperature excursion (product storage error). Current temperature excursion was 15 Fahrenheit degrees to 46 Fahrenheit degrees for 30 hours. There was no previous temperature excursion. No adverse effects were reported. Data logger was involved.",,,,,,,,,U,08/16/2019,08/16/2019,0,,UNK,,,,,,US0095075131908USA007608,2,09/12/2019,,,,
0833200,09/12/2019,VA,,,,U,,"Improperly stored dose of PEDVAXHIB was administered to the patient; No adverse effect; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug allergies/ reactions and concomitant medications were unknown. On 21-AUG-2019, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB), 1 dosage form (strength, formulation, frequency, route were unknown) ( lot# S000352 and expiry date 17-OCT-2021) for prophylaxis. On an unknown date, the patient was administered with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) (product storage error) and no adverse event was reported. The outcome of product storage error and no adverse event was unknown.",,,,,,,,,U,08/21/2019,,,,UNK,,,,,,US0095075131908USA011224,2,09/12/2019,,,,
0833201,09/12/2019,CA,,,,U,,"no adverse effect reported; 26 year old patient received one dose of PROQUAD; This spontaneous report has been received from a medical assistant referring to a 26-year-old patient of unknown gender. No information was provided regarding the patient's pertinent medical history, concomitant medication and drug reactions/allergies.   On 27-AUG-2019, the 26-year-old patient was vaccinated with one dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), via subcutaneous route for prophylaxis (Therapy type: rHA, Lot # S006830, expiry date: 02-SEP-2020). Other suspect therapies included sterile diluent (Lot # S013899, expiry date: 07-MAR-2022) (Inappropriate age at vaccine administration). No adverse effect reported. It was unknown if the patient received treatment for the event. It was unknown whether laboratory diagnostics were performed.  This is one of the two report received from the same reporter.; Sender's Comments:  US-009507513-1908USA012364:",,,,,,,,,U,08/27/2019,08/27/2019,0,,UNK,,sterile diluent,Prophylaxis,,,US0095075131909USA000005,2,09/12/2019,,,,
0833202,09/12/2019,NY,,,,U,,"no adverse event; improperly stored dose administered; This spontaneous report was received from a nurse concerning a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concurrent conditions or drug reactions/allergies.     On 29-AUG-2019, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), (lot # S00352, expiration date 17-OCT-2020) intramuscularly, for prophylaxis (strength, dose and frequency were not reported) (improper storage of product in use). No adverse effects reported. It was unknown if the patient received treatment for the event. It was unknown whether laboratory diagnostics were performed.  The temperature excursion was below 36 Fahrenheit (F)/2 degree Celsius (35.4F) for 27 minutes and the data logger was involved. There was no previous temperature excursion.  Lot number S00352 is an invalid lot number for haemophilus b conjugate vaccine (meningococcal protein conjugate).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1908USA013017:",,,,,,,,,U,08/29/2019,08/29/2019,0,,UNK,,,,,,US0095075131909USA000102,2,09/12/2019,,,,
0833203,09/12/2019,PA,,,,U,,"No adverse effects reported; expired dose of MMR II was administered; This spontaneous report was received from a health professional and refers to a patient of unknown age and gender. Concomitant therapies included sterile diluent (STERILE DILUENT). No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 29-AUG-2019, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) lot # N020923, expiry date 01-AUG-2019 (exact dose and route of administration were not reported) for prophylaxis. No adverse effects were reported.  The outcome of expired product administered and no adverse event was unknown.",,,,,,,,,U,08/29/2019,08/29/2019,0,,UNK,,STERILE DILUENT,,,,US0095075131909USA000285,2,09/12/2019,,,,
0833204,09/12/2019,IA,,,,U,,"No adverse effects reported; Pharmacist reports that the vaccines were not administered within at least 4 weeks apart, as specified by the Prescribing Information.; Information has been received from a pharmacist referring to a unknown gender patient of unknown age. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.  On 20-AUG-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (dose, frequency, route, lot # and expiration date were not reported) for prophylaxis. On 03-SEP-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX)(lot # R020652, expiration date: 18-JUL-2020, dose, frequency and route were not reported) for prophylaxis (inappropriate schedule of product administration). Other suspect product included sterile diluent (manufacturer unknown)(dose, frequency, route, lot # and expiration date were not reported) used for reconstitute with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) and varicella virus vaccine live (oka/merck)(VARIVAX). No adverse effects reported. The sterile diluent (manufacturer unknown) used to reconstitute varicella virus vaccine live (oka/merck)(VARIVAX) was stored in the correct temperature storage range. And the varicella virus vaccine live (oka/merck)(VARIVAX) was stored in the correct temperature storage range as well. It was unknown the temperature storage conditions of the sterile diluent(manufacturer unknown) used to reconstitute the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) vaccine and the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) vaccine.",,,,,,,,,U,08/20/2019,09/03/2019,14,,UNK,,Sterile diluent,,,,US0095075131909USA002017,2,09/11/2019,,,,
0833205,09/12/2019,MT,,21,,F,,"plunger rod on prefilled syringe was bent and difficult to depress on 9/4/2019; The patient flinched and complained of pain at the injection site; Information has been received from a pharmacy intern referring to a 21 year old female patient. The patient was allergied to eggs, amoxicillin, acetaminophen(+)hydrocodone bitartrate(LORTAB). The patient's historical condition and concomitant medications were not reported.  On 04-SEP-2019, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) intramuscularly (lot # reported as 1602284, expiration date reported as 03-SEP-2020 and auto generated as 26-SEP-2021, dose, frequency were not reported) for vaccination. The plunger rod on hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) prefilled syringe was bent and difficult to depress (Syringe issue) and was not injected into the patient. A few minutes later, the patient received another dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9)(dose, frequency,lot # and expiration date were not reported) without any difficulty.The patient flinched and complained of pain at the injection site. The outcome of product quality issue was unknown. The outcome of injection site pain was reported as recovered on the same day (reported as recovery date: today). No treatment given for the event. No lab diagnostics/studies was provided. The patient wasn't sought medical attention. The causality assessment was not provided.",,,,,,,,,Y,09/04/2019,09/04/2019,0,,UNK,,,Drug hypersensitivity; Egg allergy,,,US0095075131909USA002503,2,09/12/2019,,,,
0833206,09/12/2019,IL,,4,,U,,"No adverse effect reported; one patient received an improperly stored VARIVAX; This spontaneous report as received from a registered nurse and refers to a 4 year old patient (gender not reported). The patient's concurrent and historical conditions, as well as drug reactions or allergies,  were not reported.  On 05-SEP-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot # R006221 with expiration date 29-FEB-2020 R029517 with expiration date reported as 14-2020, but upon internal validation established as 14-OCT-2020). The route and dose was not reported, and the patient was vaccinated for prophylaxis. The varicella virus vaccine live (oka/merck) (VARIVAX) was reconstituted with properly stored Sterile diluent (unspecified).  It was reported that the temperature time frame was -14C to -10C (-11.91 C, multiple), for 8 hours. There were no previous temperature excursions and the call was because of a data logger.",,,,,,,,,U,09/05/2019,09/05/2019,0,,UNK,,,,,,US0095075131909USA002876,2,09/11/2019,,,,
0833207,09/12/2019,CO,,,,U,,"No known adverse effects; A patient received a dose of M-M-RII on 29-SEP-2015, on 12-JUL-2018 and on 03-SEP-2019.; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug and allergy history or concomitant medications.  On 29-SEP-2015, the patient was vaccinated with one dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (strength, frequency, route of administration, lot# and expiration date were not provided) for prophylaxis. The reporter stated that the patient received another dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) on 12-JUL-2018 and another one on 03-SEP-2019 (inappropriate schedule of product administration). No adverse effects were reported.",,,,,,,,,U,09/29/2015,07/12/2018,1017,,UNK,,,,,,US0095075131909USA002882,2,09/11/2019,,,,
0833208,09/12/2019,CA,,,,F,,"hearing loss; benign paroxymal positinal vertigo; bilateral tinnitus; herpes zoster; Information has been received regarding a case in litigation, referring to a female pt of unknown age. Information regarding the pt's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. On or about 04-AUG-2017, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (route of administration, strength, dose, lot # and expiration date were not provided) for routine health maintenance and for it. s intended purpose: the prevention of shingles. On an unknown date, shortly after receiving, the pt suffered herpes zoster along the left side of abdomen, benign paroxysmal positional vertigo, bilateral tinnitus and hearing loss  (deafness). As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, symptoms have resulted in physical limitations not present prior to vaccination. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. The pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. At the time of the report, the outcome of deafness, herpes zoster, tinnitus and vertigo positional was considered as not recovered. The lawyer considered herpes zoster, deafness, tinnitus and vertigo positional to be related to Zoster Vaccine Live (ZOSTAVAX). Upon internal review, deafness was determined to be medically significant and all the pt experiences were considered as disabling due to the severe and permanent incurable injuries.",,,,,,,,Y,N,08/04/2017,,,,UNK,,,,,,US0095075131909USA002920,2,09/11/2019,,,,
0833209,09/12/2019,IN,,,,U,,"No adverse effects; patient received one dose of Gardasil on 22-SEP-2010 and then received one dose of Gardasil 9 on 03-SEP-2019; This spontaneous report was received from a pharmacist referring to a patient of unknown gender and age. The patient's concurrent conditions and medical history were not reported. There was no concomitant medication reported.   On 22-SEP-2010, the patient was vaccinated with a dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, route, lot number and expiration date were not reported) for prophylaxis. Later, on 03-SEP-2019, the patient received a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (lot number: 1621934, expiration date: 29-JAN-2022, dose and route were not reported) also for prophylaxis. No adverse effects were reported.",,,,,,,,,U,09/22/2010,09/03/2019,3268,,UNK,,,,,,US0095075131909USA003375,2,09/11/2019,,,,
0833210,09/12/2019,IN,,,,U,,"No adverse events; Expired dose of VAQTA; This spontaneous report was received from a medical assistant refers to a 66 year old patient. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 09-SEP-2019, the patient was vaccinated with expired hepatitis a vaccine, inactivated (VAQTA) (strength, dosage information, route of administration and anatomical location were unknown) of lot # R022983 has been verified to be a valid lot number with an expiry date of 09-AUG-2019 for prophylaxis. No adverse events reported. The outcome of expired product administered was unknown. No product quality complaint reported.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,US0095075131909USA003588,2,09/11/2019,,,,
0833211,09/12/2019,NY,,,,U,,"patient was administered 1 dose of improperly stored M-M-R II; No adverse effects reported.; This spontaneous report was received from a physician regarding a patient of unknown age and gender. There was no information reported about the patient's concomitant medications, pertinent medical history and drug reactions or allergies.   On 26-JUL-2019, the patient received an improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (Lot No. R015165 and expiration date 29-MAY-2020 have been verified to be a valid) for prophylaxis (product storage error) (dose, route of administration and anatomical site were not provided). The vaccine was reconstituted with a properly stored Merck STERILE DILUENT. The temperature excursion was of 50 Fahrenheit degrees within a time frame of 4 hours. There was no previous temperature excursion and it was reported that the call was because of data logger. No adverse effects or product quality complaint were reported.",,,,,,,,,U,07/26/2019,,,,UNK,,STERILE DILUENT,,,,US0095075131909USA003818,2,09/11/2019,,,,
0833212,09/12/2019,NY,,,,U,,"No adverse effects reported; improperly stored M-M-R II was administered to a patient; This spontaneous report was received from a physician and refers to a patient of unknown age and gender.  The patient's concurrent conditions, pertinent medical history, concomitant therapies, drug reactions and allergies were not reported.  On 02-AUG-2019, the patient was vaccinated with an improperly stored dose of recombinant human albumin (rha) measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, (M-M-R II) with lot # R015165, expiration date 29-MAY-2020, for prophylaxis (dose, dose number, route and anatomical location were not provided). The vaccine was reconstituted with properly stored sterile diluent. The vaccine was exposed to a temperature of 50 degree Fahrenheit (F) for a time frame of 4 hours. No previous temperature excursions were reported and a digital data logger was involved. No adverse effects and no product quality complaints were reported.",,,,,,,,,U,08/02/2019,08/02/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA003877,2,09/11/2019,,,,
0833213,09/12/2019,OH,,,,F,,"The patient was diagnosed with Hepatitis A within the last year after traveling overseas; This spontaneous report was received from a company representative regarding a female patient of unknown age. The patient's concurrent conditions, pertinent medical history, drug reactions, allergies and concomitant therapies were unknown by the reported.   On unspecified date in 2012 (reported as 7 years ago), the patient was vaccinated with the first dose of Hepatitis A Vaccine, Inactivated (VAQTA) and in 2013 (reported as 6 years ago) the second dose for prevent hepatitis A (strength, dose, frequency, lot number and expiration date were not reported).   On unspecified date in 2018 (reported as within last year), the patient was diagnosed with hepatitis A after traveling overseas. The patient did not received any treatment, and the patient went to the doctors office for sought medical attention.  At the reporting time, the outcome of the event was reported as recovering (doing well).   The causal relationship between the event and therapy with Hepatitis A Vaccine, Inactivated (VAQTA) was not reported.",,,,,,,,,N,,,,,UNK,,,,,,US0095075131909USA003882,2,09/11/2019,,,,
0833214,09/12/2019,VA,0.33,,,U,,"No known adverse effects; on 10/05/2011, a 4 month old patient received a dose of VAQTA; This spontaneous report was received from a medical assisstant referring to a 4 month old patient of unknown gender. The patient's concurrent conditions, past medical history and concomitant medications were not reported.    On 05-OCT-2011, the patient was vaccinated with hepatitis a vaccine, inactivated(VAQTA) (dose, frequency, route, lot/batch # and expiration date were not provided) for prophylaxis (product administered to patient of inappropriate age). There was no known adverse effects.",,,,,,,,,U,10/05/2011,10/05/2011,0,,UNK,,,,,,US0095075131909USA003891,2,09/11/2019,,,,
0833215,09/12/2019,PA,12.0,,,M,,"no adverse effect; improperly stored dose inadvertantly administered; This spontaneous report as received from a Healthcare business professional refers to a 12-year-old male patient.    The patient's pertinent medical history, concurrent condition and drug reactions/allergies were not reported.  On 12-JUL-2019, the patient was inadvertently vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (lot # 1602283, expiry date: 18-AUG-2021) (Strength, dose, frequency, anatomical location and route were not reported) for prophylaxis (product storage error).  It was reported that the vaccine was exposed to a temperature below2 degree Celsius (-0.6 degree Celsius) for a time frame of 50 minutes. There was no previous temperature excursion reported. Data logger was involved. No adverse effect was reported. No additional information provided. No product quality complaint (PQC) was reported. The outcome of product storage error and no adverse event was unknown.",,,,,,,,,U,07/12/2019,07/12/2019,0,,UNK,,,,,,US0095075131909USA003998,2,09/12/2019,,,,
0833216,09/12/2019,NY,,,,U,,"No dverse effects; patient was administered with 1 dose of Imroperly stored M-M-R II; This spontaneous report was received from a physician refers to a patient of unknown age. The patient's pertinent medical history and drug reactions or allergies were not reported. Concomitant therapies included sterile diluent(STERILE DILUENT). On 16-AUG-2019, the patient was vaccinated with 1 dose of improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (lot # R015165, expiry date:29-MAY-2020, anatomical location and route was not reported) for prophylaxis (product storage error) which was reconstituted with properly stored sterile diluent(STERILE DILUENT). The vaccine was exposed to a temperature of 50 F for a time frame of 4 hours which was recorded in digital data logger. There was no previous temperature excursion. No adverse effects reported. No PQC was filed.",,,,,,,,,U,08/16/2019,08/16/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA004004,2,09/12/2019,,,,
0833217,09/12/2019,CA,,,,F,,"cellulitis; diastolic heart failure; Asthma aggravated; reflux; anxiety; peripheral edema; condition aggravated; Oropharyngeal dysphagia; Airways obstruction; Allergic rhinitis; white sputum production / cough; mucus production; This case was reported by a physician via patient support programs and described the occurrence of cellulitis in a elderly female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   The patient had a Family History of heart disorder (patient's brother), cancer (patient's father), diabetes mellitus (patient's mother) and chronic obstructive pulmonary disease (patient's sister). Previously administered products included Pneumococcal vaccine (received on 7th June 2017) and Fluvirin 2016-2017 (received on 19th October 2017). Concurrent medical conditions included asthma chronic, chronic obstructive pulmonary disease, productive cough and pollen allergy.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, less than a year after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced cellulitis (serious criteria GSK medically significant), diastolic heart failure (serious criteria GSK medically significant), asthma aggravated, reflux gastritis, anxiety, peripheral edema, condition aggravated, oropharyngeal dysphagia, airways obstruction, allergic rhinitis, sputum and mucus discharge. The patient was treated with fluticasone furoate (Arnuity Ellipta), fluticasone furoate (Arnuity Ellipta), salbutamol sulphate (Albuterol Sulfate), fluticasone furoate, vilanterol trifenatate (Breo Ellipta), thyroxine sodium (Levothyroxine), omeprazole, simethicone, omalizumab (Xolair), furosemide (Lasix), formoterol fumarate + glycopyrronium bromide (Bevespi), acetylsalicylic acid (Aspir 81), atorvastatin, cyanocobalamin, colestyramine (Cholestyramine), hydrocortisone, lidocaine, loperamide, losartan, melatonin, minerals nos + vitamins nos (Multiple Vitamins-Minerals), potassium chloride, sertraline, montelukast sodium (Singulair), tiotropium bromide (Spiriva), theophylline (Theo-24), trazodone hydrochloride (Trazodone Tablet), dextromethorphan + guaifenesin (Tussin Dm) and alprazolam (Xanax). On an unknown date, the outcome of the cellulitis, diastolic heart failure, asthma aggravated, reflux gastritis, anxiety, peripheral edema, condition aggravated, oropharyngeal dysphagia, airways obstruction, allergic rhinitis, sputum and mucus discharge were unknown.   It was unknown if the reporter considered the cellulitis, diastolic heart failure, asthma aggravated, reflux gastritis, anxiety, peripheral edema, condition aggravated, oropharyngeal dysphagia, airways obstruction, allergic rhinitis, sputum and mucus discharge to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient was never smoked tobacco and consumed alcohol, but the patient was passive smoke exposure. The patient used caffeine as one cup a day. In 2018, the patient had a severe local reaction after the influenza vaccine, cellulitis, reflux, coughing at night, anxiety, peripheral edema and diastolic heart failure. The chronic therapy for the patient's asthma had included dual long-acting bronchodilator therapy with Bevespi and inhaled steroid therapy with Arnuity.  She uses nebulized albuterol as needed. She will occasionally use an albuterol metered-dose inhaler as well. Patient does have a chronic cough with white sputum production The patient performed video swallow study for the oropharyngeal dysphagia. The patient with mild to moderate asthma with a component of COPD and the etiology appears to be allergic asthma. The previous pulmonary function tests had shown moderate airways obstruction.  The patient's recent FEVl was mildly reduced at 74%. The patient is mostly bothered with an increased cough and sputum production and continued the Bevespi, Arnuity and albuterol as needed. The patient's cough was associated with daily mucus production. The respiratory system was positive for the asthma, cough and sputum. The patient's physical exam, which was constitutional head/face eyes, ears, nose or mouth or throat, nasopharynx  neck exam, lymph detail cardiovascular, vascular respiratory, abdomen, skin back or spine musculoskeletal extremity neurological and psychiatric were normal. The reporter also mentioned on 22nd August 2018, the symptoms worsened. The patient did not have chills, fatigue, fever, malaise, night sweats, weight gain and weight loss. This case has been linked with case US2019AMR158895 (pharma case), reported by the same reporter.      Lab Comments: The patient had respiratory test was found to be positive for Asthma, Cough, Sputum.  The patient had other physical examination was found to be negative. On an unknown date, blood pressure, pulse, swallowing test  and oxygen saturation were performed",,,,,,,,,U,,,,"Test Name: Blood immunoglobulin E; Result Unstructured Data: Test Result: 108, Test Result Unit: unknown; Test Name: Blood pressure; Result Unstructured Data: Test Result: 123/66, Test Result Unit: mm Hg; Test Date: 20190430; Test Name: Body mass index; Result Unstructured Data: Test Result: 36.6, Test Result Unit: unknown; Test Name: Body mass index; Result Unstructured Data: Test Result: 68.36, Test Result Unit: unknown; Test Name: Body temperature; Result Unstructured Data: Test Result: 98.60, Test Result Unit: degree F; Test Date: 20190430; Test Name: FEV1/FVC ratio; Test Result:  76 %; Test Date: 20190430; Test Name: Forced expiratory volume; Test Result:  74 %; Test Date: 20190430; Test Name: Forced vital capacity; Test Result:  73 %; Test Name: Pulse rate; Result Unstructured Data: Test Result: 65, Test Result Unit: /min; Test Date: 20190430; Test Name: Oxygen saturation; Test Result:  95 %; Test Date: 20190430; Test Name: Spirometry; Result Unstructured Data: Test Result: unknown, Test Result Unit: unknown",UNK,,,Asthma chronic; Chronic obstructive pulmonary disease; Pollen allergy; Productive cough,Medical History/Concurrent Conditions: Cancer (patient's father); Chronic obstructive pulmonary disease (patient's sister); Diabetes mellitus (patient's mother); Heart disorder (patient's brother),,USGLAXOSMITHKLINEUS2019AM,2,09/12/2019,,,,
0833218,09/12/2019,NY,40.0,,,M,,"adult patient received 0.25 ml doses of Fluzone Quadrivalent/no AE; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a office staff.  This case involves a 40 years old male patient who vaccinated with a 0.25 mL dose of vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] lot number: UT6647JA, expiry date: 30-Jun-2020) via unknown route in the left arm on an unspecified date on 28-AUG-2019 .  It is an actual medication error case due to vaccine underdose. It was reported that a 0.25 mL dose of vaccine FLUZONE was administered to a adult patient.  It was reported that Symptoms were none reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/28/2019,,,,UNK,,,,,,USSA2019SA247570,2,09/10/2019,,,,
0833219,09/12/2019,MI,,,,M,,"2 week old male infant received a dose of Pentacel, no AE; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a two weeks old male patient who was vaccinated with a 0.5 mL dose of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] lot UJ071AAB, expiry date: 13-Jun-2020 via intramuscular route in the left thigh on 03-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR); and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ).  It is an actual medication error case due to Inappropriate age at vaccine administration.  Symptoms none reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/03/2019,,,,UNK,,PREVNAR; ROTATEQ,,,,USSA2019SA247654,2,09/10/2019,,,,
0833220,09/12/2019,IL,,,,F,,"by mistake gave a female patient 17yr old Ipol 0.1ml instead of the Tubersol test, Patient has had 4 doses of polio vaccine as a child/ NO AE; by mistake gave a female patient 17yr old Ipol 0.1ml instead of the Tubersol test / NO AE; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 17 years old female patient who received 0.1 mL dose of vaccine IPV (VERO) [IPOL] lot N1K92, Expiry date- 14-11-2019 via unknown route in unknown administration site instead of TUBERCULIN TEST [TUBERSOL].  Patient has had 4 doses of polio vaccine as a child. No other vaccines administered. The patient's past medical history, medical treatment(s) and family history were not provided.  It was a case of actual medication error due to Wrong product administered and extra dose administered. Nurse by mistake gave a female patient 17years old Ipol 0.1ml instead of the Tubersol test today.  No specific symptoms are being reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA248277,2,09/10/2019,,,,
0833221,09/12/2019,PA,,17,,M,,"patient receiving a 3rd dose of Menactra / no AE; Initial information received on 04-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 17 years old male patient who receive 0.5 ml third dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] lot U6541AA (Expiry date 31-Mar-2021) via unknown route in unknown administration site on 03-Sep-2019.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL) (it was reported as Gaurdacel).   It was an actual medication error case due extra dose administered.  At a time of vaccination No adverse events were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/03/2019,,,,UNK,,GARDASIL,,,,USSA2019SA249653,2,09/11/2019,,,,
0833225,09/12/2019,FL,68.0,68,,F,,patient reported severe flu-like symptoms with nausea,,,,,,,,,Y,09/01/2019,09/01/2019,0,unknown,PHM,,"azelastine 137mcg nasal spray,valacyclovir 500mg,nitrofurantoin mcr 50mg,",unknown,unknown,68- shingrix  05/14/2018,,2,09/12/2019,,,,unknown
0833226,09/12/2019,NE,47.0,47,,M,,Dizziness Fainting,,,,,,,,,N,09/10/2019,09/10/2019,0,None,PHM,,Ibuprofen Nugenix Lipitor,None,None,,,2,09/12/2019,,,,Betadine
0833227,09/12/2019,MI,50.0,50,,F,,"Patient developed Severe redness at injection site (warm to touch & painful), High Fevers x 3 days, Nausea w/vomiting & diarrhea that lasted from Saturday to Monday 9/9/2019.",,,,,,,,,Y,09/06/2019,09/06/2019,0,None,OTH,,Unknown,No,No,,,2,09/12/2019,,,,"Dairy, ? Flu vaccine"
0833228,09/12/2019,OR,50.0,50,,F,,"I received my first Shingrix shot on 9/3/19, on 9/5/19 I felt like I was going to be sick and went to the bathroom and blacked out. I was unconscious for 5 minutes. My husband called 911, My breathing was labored and I was pale in color. and was extreemly weak. with my neck and right arm in so much pain. I went to the emergency room and was given IV therapy, labs and a CT scan. was told that this was a reaction of the Shingrix vaccine. Today my right arm and shoulder and neck are still achy. I still have a faint headache and arm still fatigued.",,,,,,,,,U,09/03/2019,09/05/2019,2,"ECG x 2, CT of the chest, blood work=all normal on 9/5/2019 done at the emergency room",PVT,,"Tirosint 88mcg, Escitalopram 20mg, cytomel 10mcg, phentermine",NONE,Illiostomy since 6 years old.//no issues,,,2,09/11/2019,,,Y,"sulfa, morphine, phenothiazines"
0833229,09/12/2019,KS,62.0,62,,M,,"Patient presented to our hospital with fever of 102 F, elevated white blood count at 30.7, tachycardic at 123 beats/min and respiratory rate of 33 breaths/min. Patient presented with right-sided weakness in both the right arm and right leg. Infectious Disease consult determine patient has received pneumovax 23 within the past 5 years and this reaction could likely be due to an acute allergic reaction. Patient was given cool compresses, as needed acetaminophen for pain and started on piperacillin/tazobactam for empiric antibiotic treatment while cultures were finalizing. Piperacillin/Tazobactam was discontinued on 7/22/2019 due to rule out of infectious processes, symptoms resolved by 7/23/2019 with no further treatment and patient was discharged on 7/24/2019 in stable condition to home.",,,,,Y,6,,,Y,07/17/2019,07/19/2019,2,,PVT,,,Possible transient ischemic attack or cardiovascular accident,"Dyslipidemia, Diverticulosis",,,2,09/12/2019,,,Y,Sulfa with unknown reaction
0833230,09/12/2019,MA,69.0,69,,F,,"Pt noted right arm became sore 2-3 hours after administration. Felt warm and swollen. Over night felt chilled and heart racing. Pt came into office at 8am 09/11/2019 for eval.  Redness noted to inner arm, upper arm ""well below"" the injection site. Swelling with warmth and firmness of proximal upper arm. Pain with movement, is able to move her shoulder joint. Pain extends to axillae and upper back.",,,,,,,,,U,09/10/2019,09/10/2019,0,None,PVT,,Unknown,None,"HTN, DM",,,2,09/12/2019,,Y,,"Steroids, Sulfa, Lisinopril, ASA"
0833231,09/12/2019,VT,64.0,64,,F,,itchy arm and leg and turned red. Then bumps with blister centers. Upper legs and arms and abdomen. Then shingles occurred at the site of the biopsy. The bumps occurred for a few weeks and are now all gone. All that remains is shingles at site of biopsy.,,,,,,,,,N,08/02/2019,08/05/2019,3,,PHM,,n/a,no sickness. Had skin cancer biopsy on right rib cage towards the front done the morning of vaccination,Hypothyroidism,,,2,09/12/2019,,Y,,latex
0833232,09/12/2019,GA,50.0,50,,F,,"The next day after the shot I started to get the aches almost like the flu.  Once I got home and into bed it went down hill from there.  I had aches, chills really bad, fever and stomach ache, nothing would get rid of the aches and chills  I tried everything.  It lasted about 24 hours.  I started to feel better the next day and but was still weak for about two day afterwards.  I am so nervous about the second dose which I am scheduled for next Friday.  I want the weekend to recover if I need to.",,,,,,,,,Y,08/20/2019,08/21/2019,1,,PVT,,lisinopril 20 mg-hydrochlorothiazide 12.5 mg tablet Take 1 tablet every day by oral route. amlodipine 10 mg tablet Take 1 tablet every day by oral route.,None,High Blood Pressure,,,2,09/12/2019,,,,Penn
0833233,09/12/2019,NH,63.0,63,,F,,"Patient reported severe diarrhea, vomiting, and dizziness. Patient went to emergency room where she reported receiving IV fluids.",,,,,,,,,Y,09/08/2019,09/09/2019,1,Blood tests,PHM,,Metoprolol tartrate 25mg BID,,essential HTN,,,2,09/12/2019,,Y,Y,"aspirin, erythromycin base, Norvasc, penicillins, wound dressing adhesive"
0833239,09/12/2019,IA,,,,U,,"patient was administered an expired dose of Vaqta; Improperly stored and administered vaccine; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 12-AUG-2019, the patient was vaccinated with an improperly stored and expired dose of hepatitis a vaccine, inactivated (VAQTA) lot # R018775, expiration date 09-AUG-2019 (exact dose, injection site and route of administration were not reported) for prophylaxis. There were no details about improper storage provided.",,,,,,,,,U,08/12/2019,08/12/2019,0,,UNK,,,,,,US0095075131908USA005998,2,09/12/2019,,,,
0833240,09/12/2019,AZ,,,,U,,"no adverse affects; improperly stored MMR II was administered; Information has been received from a pharmacy technician referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.  On 15-AUG-2019, the patient received Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (lot # R027063, expiration date: 20-SEP-2020, strength, dose, frequency and route were unknown) that was improperly stored (incorrect product storage). Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was exposed to temperature at 70 Fahrenheit degrees for 4 days. The data logger was involved. No previous excursions were reported. No adverse effects were reported.",,,,,,,,,U,,08/15/2019,,,UNK,,,,,,US0095075131908USA007146,2,09/12/2019,,,,
0833241,09/12/2019,ID,,5,,M,,"No adverse effect reported; one male patient received improperly stored PROQUAD/ Vaccine administered after a temperature excursion; This spontaneous report was received from a medical assistant and refers to a 5-year-old male patient. There was no information about the patient's concurrent condition, concomitant medication and medically history provided.   On 03-SEP-2019, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, lot number: R015741, expiration date: 02-DEC-2019 (dose, indication and route of administration were not reported) reconstituted with properly stored sterile diluent. No adverse effect reported.  The administrated dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was exposed to the highest temperature of 6 degree Fahrenheit to 14 degree Fahrenheit for 1 hour and 8 minutes. The previous temperature excursion was 15 degree Fahrenheit to 46 degree Fahrenheit (42.8) for 37 hours and 7 minutes. The digital data logger was involved.",,,,,,,,,U,09/03/2019,09/03/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA004272,2,09/12/2019,,,,
0833242,09/12/2019,CA,0.17,0,.2,F,,"Vomiting; Intussusception; Rotavirus infection/diarrhea; This case was reported by a physician via sales rep and described the occurrence of intussusception in a 2-month-old female patient who received Rota (Rotarix lyophilized formulation) (batch number 4TB5G, expiry date unknown) for prophylaxis.   On 22nd August 2019, the patient received the 1st dose of Rotarix lyophilized formulation (oral). In August 2019, less than a week after receiving Rotarix lyophilized formulation, the patient experienced vomiting (serious criteria hospitalization). On 30th August 2019, the patient experienced intussusception (serious criteria hospitalization and GSK medically significant) and diarrhea rotavirus (serious criteria hospitalization and GSK medically significant). The patient was treated with enema preparations (nos) (Enema (Nos)). In August 2019, the outcome of the vomiting was recovered/resolved. On an unknown date, the outcome of the intussusception and diarrhea rotavirus were recovered/resolved.   The reporter considered the intussusception, diarrhea rotavirus and vomiting to be possibly related to Rotarix lyophilized formulation.  Additional details were provided as follows: On 27th August 2019, the patient came back and complaining of vomiting and diarrhea. On 29th August 2019, the patient's mother took the patient to hospital and performed the laboratory tests, but the all tests were negative. On 30th August 2019, the patient's mother went to another hospital and tested positive for rotavirus. The patient was given an enema for the diagnosis of intussusception. No surgery needed because the enema resolved the problem. The patient followed up with on 4th September 2019 and the patient was much improved. The patient had no symptoms after leaving the overnight stay in the hospital. The reporter consented to follow up.",,,,,Y,,,,Y,08/22/2019,08/30/2019,8,"Test Date: 201908; Test Name: Laboratory test; Result Unstructured Data: Test Result: all tests were negative, Test Result Unit: unknown; Test Date: 20190830; Test Name: Rotavirus test; Result Unstructured Data: Test Result: Positive, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/12/2019,,,,
0833243,09/12/2019,IN,,,,U,,"Inappropriate schedule of vaccine; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were received as follows: The age at vaccination was not applicable for this report. The patient was unable to obtain a second dose until at the time of reporting. How effective would a second dose be now since it is over a year since my first dose, which led to incomplete course of vaccination.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/12/2019,,,,
0833244,09/12/2019,MA,55.0,55,,U,,"product supply issue; Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 6th January 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. In June 2019, less than 5 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles. On an unknown date, the patient experienced product supply issue. On an unknown date, the outcome of the shingles and product supply issue were unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were received as follows: The pharmacist inquiring about the recommendations for a patient who went over the time frame for the 2nd dose.  The late dose was due to product shortage.  The reporter consented to follow up.",,,,,,,,,U,01/06/2019,06/01/2019,146,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/12/2019,,,,
0833245,09/12/2019,NY,65.0,66,,F,,"Inappropriate schedule of vaccine; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix  (1st dose was received in 24th March 2019).   In September 2019, the patient received the 2nd dose of Shingrix. In September 2019, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were received as follows: The pharmacist reports a patient was supposed to come in tomorrow to get their second dose of Shingrix vaccine, which was late, which led to lengthening of vaccination schedule. The reporter consented to follow up.",,,,,,,,,U,09/01/2019,09/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/12/2019,,,,
0833246,09/12/2019,MD,0.42,,,M,,"Allergic reaction to vaccine; Hives; This is a spontaneous report from a contactable consumer. An 8-month-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), second dose (lot number: X90022, expiry date: 01Nov20120) at 5-month-old via an unspecified route of administration in right thigh on 26Feb2019 14:37 at a single dose, then third dose (lot number: AF5647, expiry date: 31May20121) intramuscular in left thigh on 18Jul2019 10:32 at 0.5 ml single at 10-month-old for immunization. Medical history included diagnosed allergies. The patient's concomitant medication were not reported. The patient previously received first dose of pneumococcal 13-val conj vac (dipht crm197 protein), diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTAP), and hib vaccine (HIB); all on 12Nov2018 at 2-month-old for immunization. On May2019, the patient had an allergic reaction after receiving pneumococcal 13-val conj vac (dipht crm197 protein). The patient added that the patient had 2 instances of hives and was sent to an allergist. In Aug2019, the allergist said he felt the reaction was caused by the pneumococcal 13-val conj vac (dipht crm197 protein). The 1st hives reaction was in May2019 and the 2nd instance was in Jul2019. She said he got the vaccine on 18Jul2019 and broke out in hives on the 19Jul2019. She said the office was beginning to look into the ingredients in the vaccines. He was treated with over-the-counter Benadryl and the parents were given an epinephrine auto-injector, as a precaution, that was not used. He was seen on 05Aug2019. She said he had blood work for allergy testing including the ImmunoCap, IgE with component reflex. On 06Jul2019, IgE peanut, IgE Ara H2, IgE Ara h6, allergy testing to Egg white and allergy testing to Dog dander was positive. The outcome of the event allergic reaction to vaccine was recovered while the outcome of was unknown.",,,,,,,,,Y,02/26/2019,05/01/2019,64,Test Name: IgE; Comments: (IgE peanut): (06Jul2019): (positive) (IgE Ara H2): (06Jul2019): (positive) (IgE Ara h6): (06Jul2019): (positive) (Egg white): (06Jul2019): (positive) (Dog dander): (06Jul2019): (positive) (ImmunoCap): (Unknown); Test Name: Blood test; Comments: (IgE peanut): (06Jul2019): (positive) (IgE Ara H2): (06Jul2019): (positive) (IgE Ara h6): (06Jul2019): (positive) (Egg white): (06Jul2019): (positive) (Dog dander): (06Jul2019): (positive) (ImmunoCap): (Unknown),UNK,,,,Medical History/Concurrent Conditions: Allergy,,USPFIZER INC2019393052,2,09/12/2019,,,,
0833250,09/12/2019,FL,64.0,64,,M,,"Slight nausea/flu like symptoms  evening day 1, intermittent for 6 + days. Chills evening of day 2-3. soreness at injection site right arm day 1pm-day 3 redness at injection site (2-3"" diameter) day 2-4",,,,,,,,,U,09/06/2019,09/06/2019,0,,PHM,,none,none,none,"1972 received combination inoculation, flu like symptoms commenced within 12 hours, doctor-ordered bedrest 2 days.  Of 55 cowork",,2,09/12/2019,,,,"Amoxicillin, sensitivity to dairy"
0833251,09/12/2019,NJ,56.0,56,,F,,"Patient called office today stating that she feels nausea, vomiting, fever and abdominal pain since Tuesday, September 10th.",,,,,,,,,U,09/09/2019,09/10/2019,1,,PVT,,Fludrocortisone 0.1 mg Hydrocortisone 5 mg 4 times daily,N/A,Addison disease Anxiety,,,2,09/12/2019,,,,Avocado Raw Mushrooms
0833253,09/12/2019,VA,1.4,1,.3,F,09/12/2019,16  mo with rash which started 9/10/19  no fever,,,,Y,,,,,Y,08/30/2019,09/10/2019,11,o,PVT,UNK,,None,o,,,1,,,,,
0833254,09/12/2019,MA,70.0,70,,F,,Patient claimed to her Health Insurance that she felt ill and had sepsis reaction after vaccination.,,,,,,,,,U,06/19/2019,07/02/2019,13,,UNK,,,,,,,2,09/12/2019,,,,
0833255,09/12/2019,PA,1.92,1,.9,F,,"Pt had 2 restless nights, Mon & tuesday, developed a hard lump & redness at site. Improved today, slept well last night & redness gone. Hard lump remains",,,,,,,,,Y,09/09/2019,09/09/2019,0,none,PVT,,no,no,none,,,2,09/12/2019,,,,NKDA
0833256,09/12/2019,PA,74.0,74,,F,,"Patient describes redness, swelling and warmth. Also said the redness is moving across arm.",,,,,,,,,U,09/10/2019,09/11/2019,1,,PHM,,,,,,,2,09/12/2019,,,,codiene
0833257,09/12/2019,IL,0.17,0,.2,M,,"baby received vaccines on 5-6-19. 2 days later at around 3:00 pm. Mother had sudden onset of chest pain, nausea and severe vomiting. they called 911. the symptoms lasted around 20 minutes and were gone. she did not go to the hospital   then baby received same vaccines on 7-5-19 at 4 month well visit. the next day mother had same symptoms at around 11 at night. again lasted around 20 minutes. they did not go to the ER. mother just notified the pediatrician at the 6 month well visit.",,,,,,,,,Y,05/06/2019,05/08/2019,2,none,PVT,,the reaction was in mother. she only takes prenatal vitamins,none,none,,,2,09/12/2019,,,,no allergies in baby. mother has allergy to sulfa drugs
0833258,09/12/2019,AL,74.0,74,,F,,"Redness, heat, swelling present at the injection site.",,,,,,,,,U,09/09/2019,09/09/2019,0,No tests performed,PHM,,"Flexeril prn, melatonin prn, brimonidine opth drops, drozolamide opth drops, Imuran, HSN vitamin, calcium tablet",Shingles,Glaucoma,,,2,09/12/2019,,,,NKDA
0833259,09/12/2019,CO,61.0,61,,F,,"The shot hurt pretty significantly, then the arm truly hurts at shot site muscle. Extreme uncontrollable shivering and teeth chattering in the night, that I could not control. Today, 9/13/2019 such extreme pain in all muscles.",,,,,,,,,U,09/11/2019,09/12/2019,1,,PHM,,"levothyroxin, cytalopram, generic zyrtec, gabapentin, clonazopram",none,hypothyroid,,,2,09/12/2019,,,,amoxicillin family
0833260,09/12/2019,MD,49.0,49,,F,,"Patient had a Tdap injection in her left deltoid on August 13, 2019 in the office.  She complains of sharp pain at the injection site and it radiates down to her forearm.  Her left arm is slightly swollen.  She has pain when she moves or lifts her arm.  She has pain when turning steering wheel, and grabbing items.  She has a permanent bandage mark where the band-aid was applied.   Patient was seen in the office on August 30, 2019 for pain and was advised to take OTC ibuprofen at night and during the day as needed. She was advised to  apply alternating heat and ice to the area to relieve pain.  For the hyperpigmentation from the band aid mark she was prescribed triamcinolone (ARISTOCORT) 0.1 % topical cream; Apply topically 2 (two) times daily.",,,,,,,,,N,08/13/2019,08/13/2019,0,None,PVT,,"ergocalciferol (Vitamin D2) 50,000 unit capsule, one capsule by mouth weekly","Bunion of great toe, pelvic pain","GERD, vitamin D deficiency",,,2,09/12/2019,,Y,,No know drug allergies
0833261,09/12/2019,MN,50.0,50,,F,,"She developed several markedly tender, swollen, red areas both at and adjacent to the area the pneumovax was given in the upper arm.  First noted the next morning.  Denies itching, other rash, oral/mucosal lesions, resp symptoms, fever, joint pain. On exam, there are 5 distinct oval to round areas of redness, warmth, tenderness, induration on left upper arm.  (see physical exam notes below) Treated with naproxen and cold compresses, Benadryl at bedtime. Plan to recheck next clinic in 4 days. The patient did not recall prior pneumovax but review of the state vaccine registry, shows she had a  pneumovax on 1/7/11. Physical exam notes: The spot where the injection was given is present over the left deltoid. There is an 8x5cm area of mild redness, warmth, mild induration and moderate tenderness around that. There is no fluctuance or streaking. Medial to that she has two similar areas (but more red and tender) approx 1.5x2cm; inferomedial to that a similar 3x2cm area and inferomedial to that a 7x4cm area. The areas are adjacent rather than confluent. There is no central clearing.  There are no vesicles, papules or pustules.  Has FROM.  CMS intact distally.  Mild, tender left axillary lymphadenopathy without erythema.  The right deltoid where the Shingrix was given is mildly tender but there is no erythema, rash or induration.",,,,,,,,,N,09/09/2019,09/10/2019,1,none,WRK,,"Venlafaxine, melatonin,  cyclobenzaprine, fluticasone nasal spray, clindamycin lotion (not applied to any area near vaccine)","upper respiratory/sinus infection, folliculitis groin","tobacco use, sp hyst for abnormal paps, menopausal",,,2,09/12/2019,,Y,,percocet- hallucinations (denies food or latex allergy)
0833262,09/12/2019,FM,88.0,88,,M,,Syncope after roughly 3 minutes after vaccination.,,,,,,,,,Y,09/12/2019,09/12/2019,0,,PHM,,"megace, combigan, ipratropium nasal spray, tramadol, Lexapro, tamsulosin, Mobic, latanaprost, furosemide, and fluocinonide cream",none,many including syncope,,,2,09/12/2019,,,,nka
0833263,09/12/2019,MI,2.0,2,.1,F,,I gave the Dtap Guadracel  when I should have given Dtap Daptacel,,,,,,,,,Y,09/11/2019,09/11/2019,0,none,PVT,,no,no,no,,,2,09/12/2019,,,,no
0833264,09/12/2019,TN,1.83,1,.9,M,,"Mom called today, 9/12/19, stating that the day after vaccination on 9/5/19 the child's right leg was very swollen the following day.  She states that it finally went down and now is left with a scaly almost bruised looking circular area to the right thigh.  I advised mom to take the child to see his PCP for evaluation.",,,,,,,,,,09/05/2019,09/06/2019,1,,PUB,,none that I am aware of,none that I am aware of,none,,,2,09/12/2019,,Y,,none
0833265,09/12/2019,MD,76.0,76,,F,,patient has diarrhea,,,,,,,,,N,09/11/2019,09/12/2019,1,,PHM,,n/a,n/a,hypertension high cholesterol,,,2,09/12/2019,,,,nkda
0833272,09/12/2019,KY,,,,U,,"a patient received improperly stored vaccine; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided.  On 15-APR-2019, the patient was administrated with improperly stored one dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  (strength, frequency and route were not reported) (lot # R028189, Expiration Date: 06-JUN-2020) for prophylaxis and with haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) (strength, dose, frequency and route were not reported) (lot # R021078, Expiration Date: 12-JUN-2021) for prophylaxis. The stored temperature was 52.5 Fahrenheit (F) for 4 hours 40 minutes and the data logger was involved. There was no previous temperature excursion.; Sender's Comments:  US-009507513-1908USA013062:",,,,,,,,,U,04/15/2019,04/15/2019,0,,UNK,,,,,,US0095075131909USA000110,2,09/12/2019,,,,
0833275,09/12/2019,IL,4.0,4,,U,,"No adverse effect reported; On 9/5/2019, one patient received an improperly stored VARlVAX; This spontaneous report was received from a registered nurse and refers to a 4-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 05-SEP-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) injection, lot # R006221 with expiration date on 29-FEB-2020 or lot # R029517, expiration date reported as ""14/2020"", upon an internal verification expiration date was established on 14-OCT-2020 (exact dose, injection site and route of administration were not provided) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (MERCK) injection (exact dose, injection site, route of administration, indication, lot # and expiration date were not provided). On 12-AUG-2019 and 13-AUG-2019, administered dose experienced the temperature excursions of -14 degrees Celsius to -10 degrees Celsius (-11.91 degrees Celsius, multiple) for 8 hours. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. No adverse effects were reported.",,,,,,,,,U,09/05/2019,09/05/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA003250,2,09/12/2019,,,,
0833276,09/12/2019,IN,,,,U,,"No adverse effects; inadvertently administered an expired dose of ROTATEQ; This spontaneous report was received from a medical assistant and refers to a patient of unspecified age and gender.   The patient's concurrent conditions, medical history, drug reaction/allergies or concomitant medications were not reported.  On 07-JUN-2019, the patient was inadvertently administered an expired dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally as prophylaxis (dose and frequency were not reported) (lot number R003148 with expiration date 05-JUN-2019). No adverse effects were reported nor temperature excursion.",,,,,,,,,U,06/07/2019,06/07/2019,0,,UNK,,,,,,US0095075131909USA003848,2,09/12/2019,,,,
0833277,09/12/2019,NM,,,,U,,"No adverse effects reported.; Patient received unspecified dose of ROTATEQ on 9/3/2019 after temperature excursion on 8/30/2019; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 03-SEP-2019, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally, lot # R026541, expiration date: 11-JUL-2020 (exact dose was not provided) for prophylaxis. Administered dose experienced the temperature excursions of 34.1 degrees Fahrenheit for 20 minutes and 47.6 degrees Fahrenheit for 40 minutes on 30-AUG-2019. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. No adverse effects were reported.",,,,,,,,,U,09/03/2019,09/03/2019,0,,UNK,,,,,,US0095075131909USA004244,2,09/12/2019,,,,
0833278,09/12/2019,NV,11.0,,,F,,"Swelling the size of a goose egg at the site of Injection; This case was reported by a other health professional via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 11-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 43E4T, expiry date 1st October 2021) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced extensive swelling of vaccinated limb. On an unknown date, the outcome of the extensive swelling of vaccinated limb was unknown.   It was unknown if the reporter considered the extensive swelling of vaccinated limb to be related to Boostrix.  Additional details were provided as follows: The batch number was updated from 43E47 to 43E4T as per sales data sheet. The health care professional reported that the patient had swelling the size of a goose egg at the site of Injection with Boostrix. Th reporter consented to follow up. This case linked with US2019160466, US2019160503, US2019160497 and US2019160491, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/12/2019,,,,
0833279,09/12/2019,MA,,,,F,,"Redness on all four of her extremities; Pruritis on all four of her extremities; Areas has a vesicular appearance; Mild chills; This case was reported by a physician and described the occurrence of erythema of extremities in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced erythema of extremities, pruritus, vesicular rash and chills. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the erythema of extremities, pruritus, vesicular rash and chills were not recovered/not resolved.   It was unknown if the reporter considered the erythema of extremities, pruritus, vesicular rash and chills to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received dose of Shingrix, 3 weeks ago from the date of reporting. Past few days after vaccination, the patient experinced few areas of redness and pruritis on all four of her extremities and few of the areas has a vesicular appearance and mild chills. The reporter at first thought it was related to some kind of bites, but inquiring if this could be related to the vaccine. The patient had no fever and no sweats and had no improvement on benadryl.",,,,,,,,,N,08/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/12/2019,,,,
0833280,09/12/2019,VA,,,,U,,"Felt numbness; Achiness in left bicep down to elbow; This case was reported by a pharmacist and described the occurrence of numbness in a patient who received Herpes zoster (Shingrix) (batch number 2AH5M, expiry date unknown) for prophylaxis.   On 3rd January 2019, the patient received Shingrix. On an unknown date, less than 9 months after receiving Shingrix, the patient experienced numbness and pain in arm. On an unknown date, the outcome of the numbness and pain in arm were recovering/resolving.   It was unknown if the reporter considered the numbness and pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and felt numbness and achiness in left bicep down to elbow. At the time of this report, the felt numbness and achiness in left bicep down to elbow was persisting.",,,,,,,,,N,01/03/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/12/2019,,,,
0833281,09/12/2019,,70.0,,,F,,"The injection site started hurting / felt sore/painful; Redness at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In April 2019, the patient received Shingrix. In April 2019, 4 hrs after receiving Shingrix, the patient experienced injection site pain and injection site erythema. On an unknown date, the outcome of the injection site pain and injection site erythema were recovered/resolved.   It was unknown if the reporter considered the injection site pain and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The reporter stated that four hours after receiving the Shingrix vaccine, the injection site started hurting, and felt sore. She said it was painful for two days and then resolved. Redness at the injection site started sometime on the first day, and the injection site stayed the same shade of red for the first three days. Subsequently, the redness began to fade a little every day until it was fully resolved within a week.  The reporter did not consent to follow up. The reporter would not provide any additional details.",,,,,,,,,Y,04/01/2019,04/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/12/2019,,,,
0833282,09/12/2019,MA,66.0,65,,F,,"worst flu I have ever had; weakness; sweats; headache; body ache; dizziness; This case was reported by a nurse via call center representative and described the occurrence of influenza like illness in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th August 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a week after receiving Shingrix, the patient experienced influenza like illness, weakness, sweating, headache, general body pain and dizziness. On an unknown date, the outcome of the influenza like illness, weakness, sweating, headache, general body pain and dizziness were recovering/resolving.   It was unknown if the reporter considered the influenza like illness, weakness, sweating, headache, general body pain and dizziness to be related to Shingrix.  Additional details were provided as follow: The patient received Shingrix and experienced weakness, sweats, headache, body ache, dizziness. The caller describes it as the worst flu the have ever had.  The caller reports that symptoms have improved but not totally resolved yet.  The reporter consented to follow up. The caller requests that any follow up be directed to herself.",,,,,,,,,N,08/29/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/12/2019,,,,
0833283,09/12/2019,CA,,,,F,,"COPD; Chest problems; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on 15Jun2016 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had chronic obstructive pulmonary disease (COPD), and chest problems. Possible adverse event. Her physician was suggesting her to update her vaccine with PSSV 23 but she did not feel she needed it, PSSV 23 was not a Pfizer Product. The outcome of events was unknown.",,,,,,,,,U,06/15/2016,,,,UNK,,,,,,USPFIZER INC2019389056,2,09/12/2019,,,,
0833284,09/12/2019,,,,,M,,"Arm is not quite twice the size of his other arm but it is very inflamed; very red; Arm is not quite twice the size of his other arm but it is very inflamed; very red; Back of upper arm is red; This is a spontaneous report from a contactable Nurse who reported for a male patient (Brother-in-Law). A male patient of an unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) , intramuscular on an unspecified date at single dose for immunisation. The patient medical history and concomitant medications were not reported.On an unspecified date the patient reported ""his arm was not quite twice the size of his other arm but it was very inflamed"" and it was very red and back of upper arm was red. Events were non serious with outcome of unknown.  The nurse was wondering will he have to repeat that injection intra-muscularly for it to be effective. Information on the batch number has been requested.",,,,,,,,,U,,,,,PVT,,,,,,USPFIZER INC2019391247,2,09/12/2019,,,,
0833285,09/12/2019,MD,78.0,78,,M,,PATIENT REPORTS DIARRHEA (WATERY STOOLS),,,,,,,,,N,09/11/2019,09/12/2019,1,NA,PHM,,N/A,N/A,N/A,,,2,09/12/2019,,,,NKDA
0833286,09/12/2019,FL,19.0,19,,M,,"@0825am, patient sitting in chair,, HEP A VACCINE was administered. Right after receiving HEP A VACCINE, noted patient went unresponsive. CODE BLUE was paged overhead. Put patient on a lying position with both legs elevated. Multiple staff rushed and came to help and assessed the patient. VS 134/61, 59 HR, 20 rr, 99% 02 sat at RA.   @0827AM, patient alert and verbally responsive. Patient stated ""i'm fine "". No c/o pain or discomfort. No sob. Patient still remains in lying position with both legs elevated.   @0832am, patient alert and verbally responsive. No c/o pain or discomfort. No s/sx of resp distress. VS 129/7, 76 HR, 20 RR, 99% 02 SAT at RA. Advised patient to stay in the room for 15 more minutes to be monitored.   @0847am, patient stated he feels fine. No c/o pain or discomfort. No s/sx of resp distress. Advised patient to f/u with his PCC/COMMAND regarding the incident that happened today.",,,,,,,,,Y,09/12/2019,09/12/2019,0,unknown,WRK,,unknown,unknown,unknown,,,2,09/12/2019,,Y,,unknown
0833287,09/12/2019,NC,1.25,1,.3,M,,Parent describes that approximately 24 hours following vaccination the bottom of the feet were both red and hot  Also had some white bumps on feet that were fine  On exam in ED the treating physician described blanching erythema of both soles of feet with papular lesions up leg Also noted blanching erythema of both arms,,,,,,,,,Y,09/03/2019,09/04/2019,1,None,PVT,,Hydrocortisone 1% Cream  Daily PRN,Eczema,Eczema,,,2,09/12/2019,,,Y,None
0833289,09/12/2019,CT,57.0,57,,F,,"Intense soreness of the arm, felt feverish, and nauseous",,,,,,,,,Y,09/02/2019,09/03/2019,1,,PHM,,"valsartan, evista",sty in left eye - began 4 drop/day regimen of Tobramycin ophthalmic solution on 9/2/2019,"high blood pressure, LCIS",,,2,09/12/2019,,,,"sulfa, latex"
0833290,09/12/2019,MI,53.0,53,,M,,"Patient received second herpes zoster vaccine, reported signs of herpes simplex on right shoulder. No issues. Patient gets this reaction outbreaks occasionally since 18 years of age.",,,,,,,,,N,09/09/2019,09/10/2019,1,,PHM,,,,,,,2,09/12/2019,,,,
0833291,09/12/2019,NM,0.58,0,.6,M,,"Pt developed fiver of 101.6  on  8/24/19, swelling of  hands, feet, eyelids, generalized rash",,,,,Y,1,,,Y,08/23/2019,08/24/2019,1,"Pt  taken to ER 8/24/19. Labs done:  CBC,  BMP,  urine culture, negative.   8/25/19   C-Reactive protein 3.6.",PVT,,None,"04/13/2019  Viral URI, seen in ER 07/30/2019 Wheezing, skin rash, seen in office",,,,2,09/12/2019,,Y,Y,None
0833292,09/12/2019,PA,67.0,67,,F,,"injection site rxn, localized to location of shringix shot given red hot painful",,,,,,,,,N,09/10/2019,09/10/2019,0,na,PHM,,amitriptyline proair pravastatin bupropion omeprazole,n/a,,,,2,09/12/2019,,,,n/a
0833293,09/12/2019,OR,23.0,23,,F,,"Pain at site radiating to left thumb, redness, and warm to touch. Symptoms developed day of vaccination. Redness and site warmth have resolved after oral diphenhydramine 3 days post-vaccination. Continues to have pain 4 days post-vaccination.",,,,,,,,,N,09/09/2019,09/09/2019,0,None,WRK,,unknown,No,None known,,,2,09/12/2019,,,,pollen
0833294,09/12/2019,OH,35.0,35,,F,,"Patient is 28 weeks pregnant EDD 12/1/2019, presented to hospital on 9/11/2019.  Received the vaccine on 9/5/2019 and since then the injection site got worse. She started with redness on 9/8/2019 that spread and has a hard area at the center. It is very tender to touch. No fever or chills.",,,,,Y,1,,,N,09/05/2019,09/08/2019,3,"CBC 9/11/2019, NST 9/11/2019, and consult with wound care",PVT,,Prenatal Tabs,none,,,,2,09/12/2019,,Y,,Penicillin
0833295,09/12/2019,NE,85.0,85,,F,,"White wheel , approximately 2.5 cm, formed around the injection site of the mid-deltoid muscle of the patient's left arm.  It was red and indurated and painful to the touch.  Patient's son is a medical physician, of which she consulted.  He instructed her to use ice to the area and to take acetaminophen as needed.",,,,,,,,,Y,08/26/2019,08/27/2019,1,,PHM,,,,,,,2,09/12/2019,,,,NSAIDs
0833296,09/12/2019,NY,15.0,15,,F,,I don?t know the exact manufacturer or vax but it was for meningitis and the lot number is U6543AA Symptoms include fever pain chills hot and cold cough headache,,,,,,,,,U,09/01/2019,09/06/2019,5,None yet ????,PVT,,Synthroid,Nothing,"Allergies, asthma, thyroid",,,2,09/12/2019,,Y,,Food
0833299,09/12/2019,TN,75.0,75,,M,,"While showering 7AM Monday 9/2/19 morning, ankles were itching on left leg. Monday evening rash moved up. Tuesday spread to knee. Wednesday, spread to groin. Bumps blisters, very itchy. He has been using cortisone cream. Patient has dermatology appointment Monday.",,,,,,,,,N,08/30/2019,09/02/2019,3,,PHM,,"Atorvastatin 20.5mg, Toproixl 12.5mg Centrum Silver B complex, Aspirin, Co-Q-10, Omega 3, 6.9",None,None,,,2,09/12/2019,,,,NKA
0833300,09/12/2019,NY,,4,,M,09/12/2019,"Within 10min pt returned to office w/cough, wheezing and SOB. Pt also had facial swelling. Benadryl and Duo Neb given in office.",,,,,,,,,Y,09/11/2019,09/11/2019,0,,PVT,PVT,,none,"Peanut Asthma, Dairy, Egg, sesame seed, Tree nut, amoxicillin",,,1,,,,,
0833301,09/12/2019,GA,61.0,61,,F,,Chicken pox type rash and general malaise - still have this one week after receiving shot,,,,,,,,,N,09/05/2019,09/06/2019,1,None,PHM,,"Citalopram, Levothyroxine",none,low thyroid,,,2,09/12/2019,,,,cat dander
0833302,09/12/2019,MA,9.0,9,,M,,Severe abdominal pain following final dose. Vomiting and unable to keep food in stomach throughout the second day (9/11/2019).,,,,,,,,,Y,09/10/2019,09/10/2019,0,None. Visited urgent care but no tests done and sent home.,PVT,,none,none,none,,,2,09/12/2019,,,Y,amoxicillin
0833303,09/12/2019,CA,4.0,4,,F,,"Mom called stating Babysitter called her at 10:14am today reporting the following:  front arm near shoulder (HBV)vaccine has a light red circular mark, warm and sore to touch, no swelling nor rash noted.  The injection on the back side of the arm (MMRV), is redder in color, also warm and sore to touch, redness is 1/2 inch in diameter with it moving down the arm toward the elbow by 1 inch, no rash or swelling noted.  baby sitter applied a cold pack to area and will repeat process for 30m every hour as child tolerates.  no fever no headache, no nausea/vomiting, no irritability of patient.   Tylenol given per weight/age (mom said got over the counter and followed label directions.)  advised Urgent care should the areas of irritation/redness get larger, get more painful or a fever of over 102.5'F develops.  will follow up with mom tomorrow. she is aware this report is being done.",,,,,,,,,N,09/11/2019,09/12/2019,1,none at this time,PUB,,none per mother's verbal statement,none per mother's verbal statement,none per mother's verbal statement,,,2,09/12/2019,,,,none per mother's verbal statement
0833304,09/12/2019,CO,59.0,59,,F,,"Starting 8/31 - Rash and Swelling of the legs (red circle with striations) on both legs the size of of an orange for a week, then it went away, and there's only a single spot the size of a quarter on each leg now. Self resolving. Patient also has had nerve pain that's shooting up from her knee up to her hip, but given gabapentin at the ER but it has not been helping. Patient's usual oxycodone that she gets for her arthritis isn't helping either.  9/5 - left hand was swollen like a blown up latex glove, patient was unable to move fingers of hand. Patient was seen on day 1 of hand symptoms by urgent care and referred to ER and was given cephalexin , and the swelling went down after 4 days. ER Dr stated it can possibly be cellulitis. Patient's blood pressure was measured at urgent care and it was 187/97. Patient has never been diagnosed with high blood pressure before, previously patient had always been 120/80.  9/11 - patient's blood pressure has been high since measuring at her doctor's office as 168/88. circular rash (swollen and hard) has occurred on her right forearm the size 6 inches in length, 3-4 inches in width. Patient's PCP (who doesn't believe that the patient should have been given shingrix in the first place) believes it's also cellulitis.   9/12 - measured patient's blood pressure as well and it measured at 148/88. patient's forearm rash has doubled in size since the markings made yesterday.",,,,,,,,,N,08/24/2019,08/31/2019,7,"No medical tests were done by either the Urgent Care, ER or PCP.",PHM,,"Ambien, Levothyroxine, Oxycodone",None,"Chronic Pain, Arthritis, Hypothyroidism",,,2,09/12/2019,,Y,Y,None
0833305,09/12/2019,,72.0,72,,F,,Patient reported not being able to move her arm right arm with lots of pain this morning. It started with pain around the injection site then radiating down her neck and back starting the night she received the vaccine. Pt was unable to sleep lying down due to the pain in her arm. Took Tylenol for pain but seems to not have helped with pain. Pt says the pain is getting better from when it initially happened.,,,,,,,,,,09/11/2019,09/11/2019,0,,UNK,,,,,,,2,09/12/2019,,,,
0833310,09/12/2019,OK,,,,F,,"Suffered an itchy, burning rash all over the left side of her body and was diagnosed with herpes zoster; fever; headache; fatigue; Information has been received from a lawyer, regarding a case in litigation, referring to a female pt of unknown age. Information regarding the pt's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. On or about 25-SEP-2014, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (route of administration, strength, dose, lot # and expiration date were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles. On an unknown date, shortly after receiving, the pt suffered an itchy, burning rash all over the left side of her body and was diagnosed with herpes zoster. The pt also suffered from fever, headaches, and fatigue during her painful herpes zoster outbreaks. As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, symptoms have resulted in physical limitations not present prior to vaccination. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result, the pt sustained severe, serious, progressive, incurable and permanent personal injuries. At the time of the report, the outcome of herpes zoster, fatigue, headache and pyrexia was considered as not recovered. The lawyer considered herpes zoster, fatigue, headache and pyrexia to be related to Zoster Vaccine Live (ZOSTAVAX). The pt's experiences were considered to be disabling, due to permanent and incurable personal injuries.",,,,,,,,Y,N,09/25/2014,,,,UNK,,,,,,US0095075131909USA002933,2,09/12/2019,,,,
0833311,09/12/2019,,72.0,72,,F,,Patient came in yesterday reporting her reaction to the vaccine that has last greater than one month. Her arm swelled around the injection site and wrapped around her arm. She ended up going to see the doctor and received prednisone to relieve the swelling and pain. The prednisone helped some but her arm is still red with slight swelling over a month later.,,,,,,,,,,08/16/2019,08/16/2019,0,,UNK,,,,,,,2,,,Y,,
0833312,09/12/2019,NY,54.0,54,,F,,"Patient called pharmacy 9/12/19 to report feeling sick since 12:30 AM. Patient reports chills, fever, nausea and vomiting. Patient made appointment with physician for today (9/12/19) at 3 PM for follow up.",,,,,,,,,U,09/11/2019,09/12/2019,1,,PHM,,,,,,,2,09/12/2019,,Y,,Penicillins
0833313,09/12/2019,NY,5.0,5,,F,,"Patient  had extensive swelling and redness of injection site within 24 hours of receiving Pediarix on 08/06/2019, no fever or other symptoms.  Ice applied to site.  Mother wanted reported",,,,,,,,,,08/06/2019,08/08/2019,2,none,OTH,,none,,none,,,2,09/12/2019,,,,none
0833314,09/12/2019,CA,62.0,62,,F,,"Headache, chills, nausea, sore muscles and joints, dizzy",,,,,,,,,Y,09/09/2019,09/10/2019,1,NONE,PHM,,"Insulin - Novolog and Lantus, Gabapentin, Lisinopril, Atorvastatin, 81 mg aspirin",NONE,"Type 1 Diabetic, High Blood Pressure",,,2,09/12/2019,,,,Sulfa drugs
0833315,09/12/2019,IA,17.0,17,,F,,6cm X 5.75cm area on anterior left with erythema and induration and tender to palpation.  Cellulitis of left thigh . Limping Prescribed Amoxicillin-Pot Clavulanate 875-125 MG,,,,,,,,,N,09/10/2019,09/11/2019,1,,PVT,,norgestimate-ethinyl estradiol (SPRINTEC 28) 0.25-35 mg-mcg  per tablet  clindamycin (CLEOCIN T) 1 % SWAB,None,Acne Vulgaris Anxiety State Vasovagal Syncope,,,2,09/12/2019,,,,NKA/NKDA
0833316,09/12/2019,MA,17.0,17,,F,,"Before administering the vaccine the nurse with interpreter assistance asked  patient ""is there any chance you may be pregnant"". Patient replied no and the vaccine was administered. While walking the patient out to the lobby the patient turned to the nurse and stated "" I think I'm pregnant"". At that time nurse obtained urine to test for pregnancy and test was positive. Patient was immediately seen by an MD who referred her to an OBGYN.",,,,,,,,,U,09/12/2019,09/12/2019,0,Urine HCG,PVT,,,,,,,2,09/12/2019,,Y,,
0833317,09/12/2019,VA,77.0,77,,F,,"Malaise, loss of appetite, chills, aches,  just did not feel like doing anything except trying to get warm under a blanket on the sofa. i was freezing. I am due for the 2nd vaccine this month and I am not looking forward to it. i did not have any problems with the original Shingles vaccine.",,,,,,,,,Y,07/16/2019,07/17/2019,1,none,PHM,,Claritin,none,"HPB, Hypothyroidism, Hyperlipidemia, Seasonal allergies",,,2,09/12/2019,,,,none
0833318,09/12/2019,,56.0,56,,F,,"Patient initially developed a local reaction on the Friday she received the vaccine. On Sunday, she presented to the emergency department with a rash that was treated with Benadryl. After the Benadryl, she had improvement in her symptoms and was discharged home. On Monday, she presented to our emergency department with return of her symptoms, diffuse urticarial, and fevers to 101. Biopsy of the rash returned as superficial and deep perivascular dermatitis with eosinophils consistent with dermal hypersensitivity reaction. Her infectious disease workup remained negative. During her hospitalization, her highest temperature recorded was 102.5F. She is presently being treated with famotidine, hydroxyzine, loratadine, diphenhydramine, and IV methylprednisolone. Her skin rash is visibly improving, although she remains febrile and still has the rash. She at present still hospitalized.",,,,,Y,4,,,,09/06/2019,09/06/2019,0,,WRK,,,,,,,2,09/12/2019,,,Y,
0833319,09/12/2019,CA,17.0,17,,F,,"PATIENT'S  MOM REPORTED PATIENT HAVING SWOLLEN LIPS WITH BUMPS AND  SWOLLEN LEFT EYE WITH BUMPS ON THE SKIN SAC BELOW THE LEFT EYE ON TUESDAY NIGHT (09/10/2019) DAY AFTER THE SHOT (09/09/2019).  PT ALSO COMPLAINED ABOUT ""NOT FEELING WELL "" ON WEDNESDAY (09/11/2019).",,,,,,,,,U,09/09/2019,09/10/2019,1,NONE,PHM,,NONE-REPORTED,NONE-REPORTED,NONE-REPORTED,,,2,09/12/2019,,,,NONE-REPORTED
0833320,09/12/2019,OH,4.0,4,,M,,"Left arm extremely swollen from shoulder to just past the elbow,  Bicep diameter in left arm 2 inches larger than the unaffected arm.  pain, redness, and hot to the touch. First noticed the morning of 9/11, has persisted and is still present at this current time 9/12 3:12 PM.",,,,,,,,,N,09/10/2019,09/11/2019,1,,PVT,,None,None,None,,,2,09/12/2019,,Y,,None
0833321,09/12/2019,CA,4.0,4,,M,,"Excessive bleeding & bruising due to thrombocytopenia (plt count of 6K), confirmed by hematology, who also feels that it is most likely due to Proquad",,,,,,,,,N,07/31/2019,08/12/2019,12,"CBC with diff on 8/26/19 showed plt of 6K, H/H 11.4/34;  rpt CBC on 9/11/19 showed plt 35K, H/H 12.9/37",PVT,,none,none,none,,,2,09/12/2019,,Y,,cow's milk allergy
0833322,09/12/2019,IN,71.0,71,,M,,Patient had pain at previous site where he had shingles in the past. Also had a temperature the evening after the vaccine. He also had swelling and pain at site of injection along with rash that Dr. thought looked similar to shingles.,,,,,,,,,N,09/10/2019,09/10/2019,0,,PHM,,,,,,,2,09/12/2019,,Y,,
0833323,09/12/2019,MI,72.0,72,,F,,Guillian Barre Syndrome,,,,,Y,,,,Y,06/01/2019,06/01/2019,0,"multiple blood tests, imaging and referral to Neurology.",PVT,,"vitamin d3, Losartan potassium 50mg, Vitamin E",none known,hypertension,,,2,09/12/2019,,,Y,"Aleve,bactim,fosamax, lisinopril"
0833324,09/12/2019,SC,74.0,74,,F,,"The patient called at 3:05pm on 09-12-2019 saying that since her flu shot on 09-10-2019 she has had some arm soreness and swelling that has occured. I also double checked with the patient to make sure she had no shoulder pain or tingling and she does not. She said she did not feel any pain while giving her flu shot or in the immediate time after but her arm began to swell later. I also discussed with her the location of the shot and how she and I both remember that it was not given high up in the arm, but in the muscle. I reassured the patient that this is something that can happen occasionally when you get a flu shot. We will notify her MD.",,,,,,,,,Y,09/10/2019,09/11/2019,1,,PHM,,,,,,,2,09/12/2019,,,,"Penicillin, Sulfa drugs, ""mycin"" drugs"
0833325,09/12/2019,FL,0.17,0,.1,M,,"Red, swollen, seizures started shortly after",,,,,,,,,N,01/01/2019,04/01/2019,90,"Hemoglobin draws  7/2019, 8/2019, 9/2019",PVT,,None,None,None,,,2,09/12/2019,,Y,,None
0833326,09/12/2019,MI,12.0,12,,M,,"Redness, swelling at injection site. Treated with Benadryl oral and applied ice.",,,,,,,,,Y,09/11/2019,09/11/2019,0,n/a,PVT,,,none,,,,2,09/12/2019,,Y,,morphine
0833327,09/12/2019,MT,57.0,,,U,,"Patient stated she had a rash (redness), swelling, and warmth around injection site. I explained this was a histamine reaction and to take benadryl for a few days to resolve and if it does not resolve to contact the pharmacy again.",,,,,,,,,N,09/10/2019,09/11/2019,1,,PHM,,,,,,,2,09/12/2019,,,,
0833328,09/12/2019,NC,18.0,18,,F,,"3/13/19 - Seen in office with complaint of  arm pain, weakness, difficulty with lifting, difficulty with pulling and pushing, redness and swelling.  Per MD, small patches of redness approximately the size of a quarter, warm, red and mildly tender. Doctor recommended - Ice, Benadryl and Motrin. 3/15/19 - Seen in office for complaint of redness, burning sensation in left arm and neck. Per MD, there were red round patches approximately quarter sized on right shoulder, chest and back. Suspect allergic reaction to vaccine, prescription given for Prednisone 5mg oral tablets, taper for 6 days.",,,,,,,,,Y,03/11/2019,03/11/2019,0,None,PVT,,"Melatonin, Sertraline, Claritin and Depo-Provera.",2/20/2019 - Fever and Otitis Media 2/28/2019 - Fever and Sinusitis,"Hearing Loss, Scoliosis and Anxiety Disorder.",,,2,09/12/2019,,Y,,"Augmentin, Cefzil and Latex."
0833329,09/12/2019,MI,4.0,4,,M,,redness swelling at injection site immediately following injection,,,,,,,,,Y,09/11/2019,09/11/2019,0,n/a,PVT,,,n/a,,,,2,09/12/2019,,Y,,none
0833330,09/12/2019,MI,5.0,5,,M,,reddened macular area on the vaccine injection site.  It was demarcated,,,,,,,,,Y,08/13/2019,08/13/2019,0,none,PVT,,,,,,,2,09/12/2019,,Y,,none
0833331,09/12/2019,PA,29.0,29,,F,,"Patient reported feeling nauseous, anxious, dizzy, shaky about 15 minutes after receiving her flu vaccination. Patient was nervous at time of vaccination.",,,,,,,,,U,09/12/2019,09/01/2019,,,OTH,,,"Migraines, anxiety","migraines, anxiety",,,2,09/12/2019,,,Y,
0833332,09/12/2019,MI,4.0,4,,F,," Patient had an MMR vaccine and had slight erythema around it, was demarcated.  Patient was given Benadryl and ice, and over an hour's time there was no progression and actually shrinkage of the redness.",,,,,,,,,Y,08/14/2019,08/14/2019,0,,PVT,,n/a,,,,,2,09/12/2019,,Y,,none
0833333,09/12/2019,IL,51.0,51,,M,,"Rash across the abdomen, then the following day redness down the left arm, both of which continued to get worse.  Fever around 101, muscle soreness. Treated with oral ibuprofen and oral diphenhydramine. Fever and muscle cleared in 3 days.  Redness still there today.",,,,,,,,,N,09/07/2019,09/08/2019,1,none,PHM,,Pravastatin 40mg,None,None,,,2,09/12/2019,,,,None
0833334,09/12/2019,IL,50.0,50,,F,,"Patient had weakness, SOB, throat pain and dryness approx 15-30 mins after vaccine was given. Went to ED and symptoms subsided.",,,,,,,,,Y,09/08/2019,09/08/2019,0,,PHM,,"Alprazolam, Escitalopram, Fluticasone, Amytriptyline, Relpax, Emgality, Multivitamin",,"GAD, migraines",,,2,09/12/2019,,Y,Y,NKA
0833335,09/12/2019,FL,19.0,19,,M,,The morning after patient took the first does he started vomiting.  After vomiting all day we took him to Hospital,,,,,Y,5,,,U,09/06/2019,09/07/2019,1,He had to have IV fluids and they found that his creatinine levels were at 2.9 resulting in an acute kidney injury.  They kept him in the hospital from Saturday until Wednesday when his levels have finally dropped to 1.5,PHM,,none,none,none,,,2,09/12/2019,,,,none
0833336,09/12/2019,MI,1.0,1,.0,F,,red erythema around injection site,,,,,,,,,Y,08/15/2019,08/15/2019,0,,PVT,,,,,,,2,09/12/2019,,Y,,none
0833337,09/12/2019,HI,23.0,23,,M,,"vesicular lesions over body, primarily palmar; tingling in hands; discomfort when making a fist. Patient was seen at the ACC. Cultures taken. Rx: Naproxen, Acetaminophen , and Diphenhydramine",,,,,,,,,U,08/15/2019,09/06/2019,22,Coxsackie virus A AB panel Viral Culture; comments HFM/generalized vaccinia,MIL,,Unknown,unknown,unknown,,,2,09/12/2019,,Y,,NKA
0833339,09/12/2019,FL,11.0,11,,F,,"Swelling and induration about 20 cm X 23 cm, pain, itching, warmth,  developed around 24 hours, pain worsening over next 24 hours, swelling improved slighty over second 24 hours.",,,,,,,,,N,09/10/2019,09/11/2019,1,None,PVT,,"Albuterol, Claritin,",,"Asthma, obesity",,,2,09/12/2019,,Y,,Amoxicillin
0833340,09/12/2019,MA,0.33,0,.3,F,,"Tremors/seizures/tonic clonic  - lasted for 5 months, seem to have stopped at the time of this reporting",,,,,,,,,U,02/27/2019,02/27/2019,0,"ER visit 3/28 to Hospital, ran bloodwork, had EEG performed at Hospital a few weeks later.",PVT,,None,Had a cold,None,,,2,09/12/2019,,Y,Y,None
0833341,09/12/2019,MN,7.0,7,,F,,"Patient was given immunization at a school flu clinic. She received the FLUAD for 65 and older, rather than the Flucelvax or other age appropriate flu vaccine.. No side effects or adverse events were reported to the Pharmacy. Patient's parents have been left message on house phone to call us back so we can give the information to them.",,,,,,,,,,08/29/2019,09/05/2019,7,,SCH,,,,,,,2,09/12/2019,,,,
0833342,09/12/2019,MI,72.0,72,,F,,IG bottle expired on 8/26/19.  Informed patient. Called manufacturer  and they also did a report. Patient informed she should repeat. She decided not to at this time and stated she will call if she changes her mind.,,,,,,,,,U,08/30/2019,08/30/2019,0,None,PUB,,Unknown; IG,None,None,,,2,09/12/2019,,,,NKDA
0833343,09/12/2019,IL,56.0,56,,F,,"Shot given 9-10...experienced flu like symptoms on 9-11.  Beginn 9-12 in the morning injection site became warm, red, and swollen (about 3 inch in diameter).  Patient is putting ice on it.  Patient was referred to contact MD",,,,,,,,,U,09/10/2019,09/12/2019,2,,PHM,,unknown,unknown,unknown,,,2,09/12/2019,,Y,,latex sensitivity
0833344,09/12/2019,MI,36.0,36,,M,,PATIENT RECIVED A PEDIATRIC DOSE OF HEPATITIS A VACCINE INSTEAD OF A ADULT DOSE. PROVIDER AND PATIENT NOTIFIED. PATIENT RECIVED CORRECT DOSE (ADULT DOSE) OF HEPATITIS A VACCINE. PATIENT HAS NO SIGNS OR SYMPTOMS CAUSED BY OCCURANCE. NO TREATMENT NEEDED.,,,,,,,,,Y,08/20/2019,08/20/2019,0,NONE,PVT,,NONE,HERPES ZOSTER,NONE,,,2,09/12/2019,,Y,,NO KNOWN ALLERGIES
0833345,09/12/2019,WA,34.0,34,,F,,"I had a positive HPV test on 6/18/19 and I decided to get the HPV vaccine based on the recent FDA recommendations. I received my first and only HPV vaccine on 7/23/19. Two days after the vaccination I had flu like symptoms including high temperatures, body aches, headaches, and fatigue. The body aches improved after a few days but high temperature and weakness continued to be a problem intermittently.  I had some labs done to rule out infection including CMP (normal). About one week following vaccination I went to urgent care and was given antibiotics for possible sinusitis. I finished the course of antibiotic with no improvements. The high temperatures were not intermittent anymore and I started having severe joint and bone pain around 8/14/2019. The pain was worst in my hands. My PCP ordered some inflammatory markers (ANA, ARP, RA factor, ESR) to rule out RA, the labs were all negative. It has been about 7 weeks since my vaccination now, bone and joint pain have improved but fatigue continues to be an issue. I sometimes experience the warm feeling (almost like hot flashes) and also miscellaneous body pains (abdominal pain, muscle and joint pain, headache).  I have to point out that prior to this event I was a perfectly healthy individual, I have no history of chronic diseases or reactions to vaccines. I am also a clinical pharmacist and completely pro-vaccine. I understand that current data and research does not support some of the current public concerns about this vaccine but I truly believe that a closer investigation needs to be done regarding these concerns.",,,,,,,,,N,07/23/2019,07/25/2019,2,"CMP, TSH, ANA, ARP, RA factor, ESR (all normal/negative)",PHM,,Birth control pill,None,None,,,2,09/12/2019,,Y,Y,None
0833346,09/12/2019,CA,66.0,66,,M,,weakness for 2 to 3 days no other flu-like symptons,,,,,,,,,Y,09/05/2019,09/05/2019,0,none,PHM,,"Fish oil,  AREDS-2,  multivitamin, choline",none,none,"Flue shot in high school, followed by flu-like symptons same day",,2,09/12/2019,,,,wheat
0833347,09/12/2019,KS,69.0,69,,F,,"Welting  and induration 4-6 cm, hives on forearm and chest,  pain in back and neck for approximately 24 hours",,,,,,,,,N,09/10/2019,09/11/2019,1,,PUB,,"Albuterol, B Complex, Cranberry Juice Extract, ASA81, Estrace, Fluocinomide  cream, lipitor, losartan, melatonin, metoprolol, Miralax, Multivitamin, Keflex, Omega fish oil, Pepcid AC, Prevacid, Slow-Mag,  Carafate, Ultra CoQ10, Vitamin D3,",None,"HTN, Chronic UTI, Chronic Constipation, Anxiety, GERD,",,,2,09/12/2019,,Y,,Nkda
0833348,09/12/2019,CT,11.0,11,,M,,hive like reaction to arm around the site of the 2 injections.  area is itchy -started several hours after receiving vaccines,,,,,,,,,N,09/11/2019,09/11/2019,0,none,PVT,,none noted,,asthma,mom reports a red raised warm area on his arm after his kindergarten vaccines - thinks he got antibiotics,,2,09/12/2019,,Y,,nkda
0833349,09/12/2019,TX,3.0,3,,M,,Localized Swelling/Redness around injection site & leg.,,,,,,,,,Y,09/10/2019,09/11/2019,1,None,PVT,,None,None,None,,,2,09/12/2019,,Y,,None
0833350,09/12/2019,OH,76.0,75,,F,09/12/2019,"Administration site had a large, raised area about 2-3 inch in diameter. It was bruised and painful to the touch and when pressure was applied for approximately one month.",,,,Y,,,,,Y,04/26/2019,04/26/2019,0,N/A,OTH,PVT,"Glimepiride, Lansoprazole, losartan/HCTZ, metformin, minocycline, crestor",N/A,N/A,,,1,,,,,
0833351,09/12/2019,,3.0,3,,F,,"LEFT UUPER ARM WITH MODERATE -LARGE DEGREE OF SWELLING . MULTIPLE URTICARIAL PATCHES ON UPPER ARM ; ARM WARM TO TOUCH . MILD PAIN WITH TOUCH   This reaction has happened with the 2018 and 2019 flu vaccine, but not previous to those years.",,,,,,,,,,09/11/2019,09/11/2019,0,,PVT,,,,,,,2,09/12/2019,,Y,,None
0833352,09/12/2019,CT,75.0,75,,F,,"fever, chills, upset stomach x 6 hrs followed by fatigue x 6 hrs (unable to carry out normal activities)",,,,,,,,,Y,09/10/2019,09/11/2019,1,none,PHM,,"anastrozole 1 mg, atorvastatin 40 mg, synthroid 88 mcg, Prolia 60 mg, melatonin 1 mg, Caltrate, multivitamins, probiotic",None,"hypothyroid , IBS, s/p breast ca, osteopenia, high cholesterol, spinal stenosis, mild sleep apnea,",,,2,09/12/2019,,,,None
0833353,09/12/2019,PA,44.0,44,,M,,"From start of left shoulder to elbow, arm became swollen and red after 1 day of receiving both vaccines. Patient taken Aleve and used ice to decrease swelling and pain. Left arm became stiff and unable to move properly. Patient described to the left arm to be in a paralyzed with the arm flexed. Patient received new prescriptions for a arm brace and prednisone after 4 days of receiving the vaccines.",,,,,,,,,Y,09/01/2019,09/03/2019,2,None.,PHM,,None.,None.,None.,,,2,09/12/2019,,Y,,None.
0833354,09/12/2019,FL,69.0,69,,F,,Redness in arm from shoulder to elbow. Was taking Benadryl but didn?t seem to help much. She then called pharmacy to seek advice. Was notified to seek medical assistance for possible steroid to reduce inflammation.,,,,,,,,,U,09/08/2019,09/09/2019,1,,PHM,,,,,,,2,09/12/2019,,Y,,
0833355,09/12/2019,CA,61.0,61,,F,,"the injection sites were painful for a few days then resulted into a blister.  The blister is about as big as a grain of rice, with clear fluid and some red clotted blood inside",,,,,,,,,U,09/05/2019,09/11/2019,6,,PHM,,"amlodipine, losartan, glipizide, metformin",no,"diabetes, hypertension",,,2,09/12/2019,,,,no food or med allergies
0833356,09/12/2019,WA,31.0,31,,M,,"Presented to clinic on 08/20 for difficulty breathing and shortness of breath. States he received anthrax vaccine three days prior. Went to Hospital on 08/23 for worsening shortness of breath, mild productive cough, intermittent fever and chills was treated with azithromycin, vantin, albuterol PRN. Admitted with multifocal pneumonia, non-severe sepsis, bilateral pleural effusion, superimposed pulmonary edema, SEPSIS, ARDS, Acute hypoxic respiratory failure, and suspicion of hypersensitivity pneumonia. Treated with antibiotics and empirical steroids. Started on BIPAP in ICU",,,Y,,Y,7,,,U,08/16/2019,08/20/2019,4,"Numerous chest xrays in hospital (6), R thoracentesis to remove 600mL, bronchoscopy, CT angio of lungs, serial labs,",MIL,,"Buspirone 15mg, Adderall XR 20mg, fluoxetine 20mg, zantac 150 , Zofran 8mg",none,"ADHD, tobacco use, abdominal pain, muscle ossification, psychosocial circumstances",,,2,09/12/2019,,Y,Y,meperidine
0833357,09/12/2019,MI,77.0,77,,F,,"The patient reported having significant pain, redness, and swelling at injection site within a day after administration. She stated that a large hard nodule about the size of her fist developed below the site of injection and traveled down her arm toward her elbow. She also developed severe mouth sores, similar to canker sores that are very painful. She states that her doctor told her it is related to the herpes zoster virus, and treated her with valacyclovir.",,,,,,,,,U,08/06/2019,08/06/2019,0,,PHM,,DIAZEPAM,NONE,DIABETES,"She also had a similar localized reaction to her first dose (May 2019), but she thought it was due to the administration. Howeve",,2,09/12/2019,,Y,,NONE
0833358,09/12/2019,CA,31.0,31,,F,,Patient was vaccinated in left deltoid muscle with prevnar vaccine and afluria.  Prevnar had to be done twice  since pt moved arm (flinched) with 1st prevnar and full dose wasnt injected. therefore another dose was given 1 inch apart.  patients arm hurt 2 days later and continued for more than a week. On 09-09-19 RPH told patient to go to urgent care. Dr referred patient to neurologist since there were no physical findings. we are now awaiting the patient contacting us after she sees neurologist,,,,,,,,,U,08/31/2019,09/02/2019,2,,PHM,,venlafaxine er 75mg daily trazodone 100mg daily ciclopirox cream  pt verbally told RPH she is on immunosuppressants,,rheumatoid arthritis,,,2,09/12/2019,,Y,Y,none
0833359,09/12/2019,NJ,79.0,79,,F,,Patient presented with redness around the injection site diameter of 3 inches to 4 inches. Patient noticed it around 7 am this morning. As per patient there was no pain just the redness. Advised patient to apply cold compress and to take an antihistamine (Benadryl) as patient has taken it prior. Advised patient if worsens or spreads to immediately call her Physician and seek medical attention.  Called Patient at 4:30pm. Patient has been applying cold compress and as per patient it has gotten better.,,,,,,,,,U,09/10/2019,09/12/2019,2,,PHM,,"Multaq, Latanoprost, Eliquis< Multivitamin and Calcium",None,,,,2,09/12/2019,,,,No
0833360,09/12/2019,NC,72.0,72,,M,,"patient complained of severe joint aches, whole body hurt, believed he had a fever, malaise for several days",,,,,,,,,Y,09/06/2019,09/07/2019,1,none,PHM,,unknown,unknown,unknown,,,2,09/12/2019,,,,nka
0833361,09/12/2019,VA,50.0,50,,M,,Swelling and very sore gland in armpit of vaccination site.,,,,,,,,,N,09/10/2019,09/12/2019,2,,PHM,,"Androgel 1.62, 2 arms worth, Valtrex, Omeprazole, Flexeril, Flonase, Allegra- D, Metamucil, advair, multivitamin, glucosamine chondroitin.",None,"Asthma, seasonal allergies, GERD, hypogonadism",,,2,09/12/2019,,,,"Sulfa antibiotic, erythromycin"
0833362,09/12/2019,PA,49.0,49,,F,,"Exactly twelve hours following injections acute, excruciating, debilitating abdominal pain progressing to loss of consciousness and transport to ER via 911.  Ten hours in ER with severe pain , nausea, and bloody diarrhea.  Loss of work two days.  Recovery lasting ten days.",,,,,,,,,Y,08/26/2019,08/26/2019,0,Labs UA CT scan IV Cipro PO Cipro PO Flagyl,WRK,,Lamictal,,Epilepsy,,,2,09/12/2019,,Y,Y,Sulfonamides
0833363,09/12/2019,NJ,57.0,57,,F,,pt claimed has bad muscle aches and had flu symptoms,,,,,,,,,U,09/09/2019,09/09/2019,0,,PHM,,ibuprofen xanax losartan hct buspirone duloxetine  acetaminophen gabapentin,dile buct blockage,bp  chronic pain,,,2,09/12/2019,,,,penicillans
0833364,09/12/2019,CO,12.0,12,,M,,"HIVES---FROM HEAD TO TOE, TREATMENT: BENADRYL 25MG Q4H , ZANTAC 150 Q12",,,,,,,,,N,09/06/2019,09/10/2019,4,NONE YET,PHM,,NONE,NONE,NONE,,,2,09/12/2019,,Y,,AMOXICILLIN
0833365,09/12/2019,HI,49.0,49,,F,,"-Slight HA occurring minuted after injection -Woke @ 0430 8/28 to extreme HA pain (9/10) to base of head/occipital area -Within half hour has emesis X 2 with slight nausea & diarrhea -Took Advil (no relief) Took APAP (no relief) -Unable to hold down food or water -Emesis after each dosing of OTC pain medications -HA pain lasted at 7-9/10 pain through the rest of the day, until approx 1600 -3 more episodes of emesis with continued diarrhea throughout the day -Upon waking 8/29 I experienced right arm pain to elbow, on the top side of my upper arm, below the deltoid with calor, no redness, with limited ROM (not just site pain)  -8/29 All day experienced generalized fatigue and body aches -8/30 All sx resolved -",,,,,,,,,Y,08/27/2019,08/28/2019,1,-None,PVT,,-CBD oil without THC -Omega Oil -Probiotics -Multivitamin -Iron -Pantothenic Acid -Glycine -Magnesium -Milk Thistle -Benadryl -Chromium (eye drops) -Oxycodone (2.5 - 5mg PRN pain),-None,"-RA, endometriosis, IC, IBS",,,2,09/12/2019,,,,"-MSG -Gluten sensitive (haven't been tested for celiac) -Latex, dermabond, adhesives -Chlorella -ABX (flagyl, keflex, minocycline, minocine, levaquin, tetracycline, erythromycin) -Fragrance -Environmental pesticides, herbicides, insecticides -Dish sanitizer (industrial kind)"
0833366,09/12/2019,NV,79.0,79,,M,,"patient's wife claimed that after he received the shot, he developed a bad fever (105 F) later night and ends up in ER. Doctors cannot figure out the reason why. There is no other unusual things he did on that day. So the wife is thinking the flu shot gave him the fever.",,,,,,,,,Y,09/10/2019,09/10/2019,0,Don't know as a pharmacy,PHM,,"Pravastatin, Losartan, metformin",not known,not known,,,2,09/12/2019,,,Y,No known allergy
0833367,09/12/2019,MO,26.0,26,,F,,"Developed pneumonia roughly three weeks after injection requiring heavy, broad spectrum antibiotics and  albuterol treatments.",,,,,,,,,U,10/16/2014,11/05/2014,20,,MIL,,None,None,None at time of vaccination,,,2,09/12/2019,,,Y,"Azithromycin, raw carrot"
0833368,09/12/2019,OH,72.0,72,,F,,"Fever for 24 hours, welts, hives in various places and red spots on abdomen for 2 weeks.",,,,,,,,,Y,08/14/2019,08/14/2019,0,,PHM,,,,,,,2,09/12/2019,,,,"Lipitor, sulfa"
0833369,09/12/2019,FL,64.0,64,,F,,"Patient reported to the pharmacy to receive a flu shot and reported swelling at the injection site, pain, and redness. She said the symptoms were really extreme and persisted for multiple days. She said she used NSAIDs to treat the symptoms.",,,,,,,,,,08/06/2019,08/06/2019,0,,PHM,,,,,,,2,09/12/2019,,,,
0833370,09/12/2019,NC,63.0,63,,F,,"By 11:30pm started with severe chills, maybe had fever, severe headache that lasted for several hours, severe nausea but did never threw up; did not sleep all night or next morning. The headache was so severe that even eyes hurtfelt like her head was going to explode.  Patient considered calling ambulance but knew that it was not an anaphylactic reaction. Did not want to scare mom that was in the other room so at 8am called her to bring some aspirin.  Symptoms improved 3-4 hours after taking medicine; slept from 12pm to 7pm.   After headache was gone could walk but weakness lasted for the next 2-3 days. Patient did not take any other medication. Spoke to pharmacist about the adverse event and was encouraged to call VAERS; pharmacist mentioned that had another patient reporting similar symptoms.  Mother and brother-in-law had no symptoms and sister had severe headache but nothing like patient's. Patient had severe chickenpox in childhood and shingles episode at 42 years",,,,,,,,,Y,08/29/2019,08/29/2019,0,,PHM,,"Simvastatin, Thumbs and baby aspirin as needed.",Not at the time however had just finished using Prednisone eye drops but was told that they would not affect vaccine.,Cholesterol,"Shingrix dose #1, football size rash around the vaccine area, was told that it was an overreaction and to take Benadryl",,2,09/12/2019,,,,No
0833371,09/12/2019,PA,66.0,66,,F,,"The patient's doctor called the pharmacy to report the adverse events the patient was experiencing. Per physician, patient showed up to the office with hives and rashes all over the body.  Physician reported that the hives were raised, red, and itchy.",,,,,,,,,U,09/09/2019,09/12/2019,3,,PHM,,unknown,unknown,unknown,,,2,09/12/2019,,Y,,no allergies
0833372,09/12/2019,MA,50.0,40,,F,,"Chills, fatigue, headache, nausea lasting 5-6 hours. Localized reaction circular, well demarcated erythematous, puritic hematoma 2.5 inches in diameter at injection site",,,,,,,,,N,09/10/2009,09/10/2009,0,None,UNK,,"Levothyroxine, Vit D3, probiotics",None,Hypothyroidism,,,2,09/12/2019,,,,None
0833373,09/12/2019,IA,57.0,57,,M,,"Patient reports sore arm and local reaction. A day or two after he noticed a knot, which may have been a blister that ruptured when he rubbed it. It now healed up and had a scab over it. He said it was getting better and healing. Patient also said he had nausea and stomach issues and had green colored stools.",,,,,,,,,Y,09/04/2019,09/05/2019,1,,PHM,,NA,NA,NA,,,2,09/12/2019,,,,None
0833374,09/12/2019,RI,67.0,67,,F,,day after receiving vaccine pt woke up with very large red rash covering her arm where she received the injection as well as her neck and her chest. she went to the md office and md stated it was a cellulitis and prescribed cephalexin to treat it. md told her it was due to the injection.,,,,,,,,,Y,08/25/2019,08/26/2019,1,,PHM,,NA,NA,NA,,,2,09/12/2019,,,,"SULFA, PENICILLIN"
0833375,09/12/2019,NM,67.0,67,,F,,Patient was administered first dose of shingrix on 9/9/19 and reported an adverse event on 9/12/19.  Patient sought medical treatment and was diagnosed as having cellulitis. Patient was treated with antibiotics.,,,,,,,,,U,09/09/2019,09/09/2019,0,,PHM,,,,,,,2,09/12/2019,,,Y,
0833376,09/12/2019,CA,52.0,52,,F,,pt had severe body pain 20 hr post injection,,,,,,,,,U,09/11/2019,09/12/2019,1,unknown,PHM,,no record,n/a,n/a,,,2,09/12/2019,,,,nka
0833377,09/12/2019,PA,64.0,64,,F,,"Patient experienced pain, swolleness, and rash, including itchiness on left arm.",,,,,,,,,U,09/05/2019,09/05/2019,0,,PHM,,,,COPD,,,2,09/12/2019,,,,NKDA
0833378,09/12/2019,TN,69.0,69,,F,,Patient says had sore arm and was really hard around the shot area it was swollen .Pt stated couldn't move arm and was unable to do routine work and exercise,,,,,,,,,Y,09/05/2019,09/06/2019,1,none,PHM,,UNKNOWN,NONE,NONE,,,2,09/12/2019,,,,MACROLIDES
0833379,09/12/2019,VA,66.0,66,,F,,Patient received Pneumovax in left arm and high dose fluzone in right arm on 9/11.  That evening the left arm became swollen and sensitive/painful to touch.  on the evening of 9/12 she presented to pharmacy with bruising at the injection site of the left arm (pneumovax) and redness/swelling going down the arm around the elbow.,,,,,,,,,U,09/11/2019,09/11/2019,0,Patient was referred to an urgent care facility for evaluation - results to be determined.,PHM,,"Alprazolam, lisinopril, unithroid,",none known,none known,,,2,09/12/2019,,Y,,PCN
0833380,09/12/2019,NY,61.0,61,,M,,"pt called pharmacy stating that he noticed redness approximately 3 inches below shot area, no swelling burning or pain, wouldnt have noticed really except when he went to remove bandaid",,,,,,,,,U,09/07/2019,09/10/2019,3,,PHM,,"glimepiride,finasteride, alfuzosin,januvia,allopurinol,atorvastatin,triamterene-hctz",,,,,2,09/12/2019,,,,
0833381,09/12/2019,FL,66.0,66,,F,,"Patient visited local ER after shoulder pain resulting from flu immunization did not resolve in 1-2 days. MRI was performed at ER, patient was prescribed tramadol for pain on 9/4. I followed up with the patient on 9/7 and she stated the shoulder pain had resolved.",,,,,,,,,Y,08/21/2019,09/04/2019,14,MRI at ER,PHM,,unknown,unknown,unknown,,,2,09/12/2019,,,Y,NSAIDs
0833382,09/12/2019,NY,9.0,9,,F,,"Major migraine headache, stomach aches, fatigue, chills, coordination is off",,,,,,,,,U,09/06/2019,09/12/2019,6,None,PVT,,"Multi vitamin, probiotic",None,"Seasonal allergies (sinusitis),  lactose intolerance, SPD, Dyspraxia, Convergence eye problem",,,2,09/12/2019,,,,"Amoxicillin, dairy"
0833424,09/12/2019,NE,70.0,70,,F,,Patient said her arm became red and puffy 2 hours after vaccine was given on 9/10/19. She waited until the morning of 9/12/19 to go to an Urgent Care. She said she took Benadryl on her own at home in the meantime and it did not help. It was determined that she had a reaction and they prescribed a steroid taper and an antibiotic (she said she had a tooth or gum problem x 1 week prior and was told to f/u with dentist). They sent her home and she came to the pharmacy and told me about the reaction and showed me. Red and puffy from her shoulder to her elbow on the left arm. Said it was not painful unless touched. Said she felt fine otherwise. The area has not changed since she first noticed it. She has appointment with PCP on 9/18 and I told her to mark the area on her arm so she can see if it gets better. Told her to call us with any concerns in the meantime and that I would follow up with her over the next few days.,,,,,,,,,U,09/10/2019,09/12/2019,2,Basic physical exam,PHM,,"Buspirone, Provigil, Vitamin D, Amlodipine, Metoprolol, Olmesartan/HCTZ, Sertraline, Tylenol, Rosuvastatin",None,"anxiety, hypertension, cerebral hemorrhage 2014, hyperlipidemia, narcolepsy, sleep apnea",,,2,09/12/2019,,Y,,None
0833425,09/12/2019,FL,1.33,1,.4,F,,"Redness, swellin in L lateral thigh area .",,,,,,,,,N,09/10/2019,09/11/2019,1,None,PVT,,Tylenol,None,None,"after 12 mo shots with MMR, Varivax, PCV13, Hib",,2,09/12/2019,,Y,,NKDA
0833426,09/12/2019,NJ,,49,,F,,Fever Body ache Dizziness  Cough,,,,,,,,,N,09/07/2019,09/08/2019,1,,UNK,,,,,,,2,09/12/2019,,Y,,
0833433,09/12/2019,AZ,11.0,11,,M,,(R) ARM Swelling and Red,,,,,,,,,N,09/10/2019,09/11/2019,1,none,PVT,,None,,,,,2,09/12/2019,,Y,,NKDA
0833442,09/12/2019,VA,55.0,55,,F,09/12/2019,"Rash, swollen, red area warm & Hot to touch, tenderness in Arm, chills, fever.",,,,,,,,,Y,09/04/2019,09/05/2019,1,N/A,PVT,PVT,ASA 81mg Valsartan 40mg,None,HTN; Hypercholesterolemia,,,1,,,,,
0833383,09/13/2019,WA,58.0,58,,F,,The patient told me that her arm was red and very swollen. She went to the doctor's office and they though it was due to the Shingrix shot. The patient notified me a week after she started having the symptoms and she said that her arm was not swollen anymore but she still had red spots on it.,,,,,,,,,Y,08/31/2019,09/03/2019,3,,PVT,,Levothyroxine,None known,Hypothyroidism,,,2,09/13/2019,,Y,,No known Allergies
0833384,09/13/2019,NY,13.0,13,,M,,He continues having fevers and rashes. i don't know where to take him . i don't trust doctors now,,,,,,,,,N,08/02/2019,08/13/2019,11,DR office is refusing to provide lab work but Hospital may have taken it. Patient's father took him to the hospital cause i wasn't home,PVT,,Patient went to get a physical with a new primary care Physican. I  explained he has not been vaccinated and there is no record of vaccines after a discussion she asked me to step outside so she can ask him about depression and smoking etc.,3 high fevers that last for days and a rash on his back,never had any chronic illness until now. He was always a healthy child but now I'm worried,,,2,09/13/2019,,,Y,He Was never allergic to anything and never had high fevers like this or rashes
0833385,09/13/2019,CA,4.0,4,,M,,"Right upper arm from injection site (below shoulder area) to elbow swelling, warmth, redness. Hives under left eye, followed by swelling in both eyes the morning after initial hive symptom appeared. Ongoing treatment with Claritin and Benadryl. Still with swelling to R upper arm, and reduced swelling to eyes.",,,,,,,,,,09/10/2019,09/11/2019,1,,PVT,,Gummy vitamins,None,None,,,2,09/13/2019,,Y,,None
0833386,09/13/2019,TX,1.0,1,.0,F,,At 4:30 PM patient had a generalized tonic -clonic seizure and fever of 103. Seizure lasted 3-4 minutes and was postictal for 45-50 mins. Was transferred by EMS to ER. In ER  temp was 100.2. her physical exam waas normal. Labs: WBC8.63k; Hgb 12.2; Plts 374.2k ; neut 60 %; Urinanalysis  was negative; procalcitonin .10,,,,,,,,,Y,09/09/2019,09/09/2019,0,Labs 09/09/2019 : WBC8.63k; Hgb 12.2; Plts 374.2k ; neut 60 %; Urinanalysis  was negative; procalcitonin .10,PVT,,none,,none,,,2,09/13/2019,,,Y,none
0833395,09/13/2019,TX,1.0,,,U,,"No adverse effects; 12 month old patient was administered a dose of GARDASIL 9; This spontaneous report has been received from a nurse referring to a 12 month old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not provided.  On 28-DEC-2012, the patient was vaccinated with a dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) for prophylaxis (strength, dose, frequency, route, lot# and expiration date were not provided) (inappropriate age at vaccine administration). No adverse effects. The outcome of the events was unknown. No product quality complaint (PQC) involved.",,,,,,,,,U,12/28/2012,12/28/2012,0,,UNK,,,,,,US0095075131908USA005843,2,09/12/2019,,,,
0833396,09/13/2019,OH,,,,U,,"administered via intramusclar route; no adverse  event; This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions were not reported. The patient's concomitant medication included sterile diluent. On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (lot # R029517, expiry date: 14-OCT-2020) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # R031636, expiry date: 01-NOV-2020) (dose details unknown) for prophylaxis. Both the vaccines were administered via intramuscular route instead of subcutaneous route (incorrect route of product administration). No adverse event reported. measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) therapy type of rHA involved.",,,,,,,,,U,,,,,UNK,,sterile diluent,,,,US0095075131909USA003494,2,09/13/2019,,,,
0833398,09/13/2019,IA,44.0,44,,F,,"the syringe broke and cut her; the syringe broke and cut her; This spontaneous report was received from a patient (nurse) via human resource registered nurse (Rn) regarding a 44-year-old female patient. The patient's medical history, concurrent conditions, concomitant medications and drug allergies/reactions were not provided. On 05-SEP-2019, while the patient was receiving vaccination of pneumococcal vaccine, polyvalent (23 valent) (PNEUMOVAX23) a dose (1 dosage form) (lot# R033080, expiry date: 06-JUN-2020) (strength, dose number anatomical location and route of administration were not provided) for prophylaxis, ""the syringe broke and cut her (injury, syringe issue)"". The syringe broken into two pieces and the location was on finger flange of the syringe. The patient sought medical attention and washed her hand and placed a band-aid. The syringe tip cap was attached properly prior to use and the syringe tray was intact and undamaged on receipt. The cellophane cover of the syringe tray was intact and completely sealed. The syringe carton was not damaged prior to use. The outcome of the events was unknown. The reporter's causality assessment was not reported.",,,,,,,,,U,09/05/2019,09/05/2019,0,,UNK,,,,,,US0095075131909USA004248,2,09/13/2019,,,,
0833399,09/13/2019,KS,16.0,16,,F,,"PREGNANCY; A nurse prospectively reported that a 16-year-old female subject was inadvertently vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) during the first trimester of pregnancy.  On 21 October 2005 the subject received a dose of Boostrix (lot AC52B001AB) during the 1st trimester of pregnancy.  The date of the last menstrual cycle was not reported.  The estimated due date is June 2006. Follow-up will not be available.  Upon internal review done on 13 Sep 2019, the pregnancy outcome was updated to lost to follow-up.",,,,,,,,,U,10/21/2005,,,,PUB,,,,"Medical History/Concurrent Conditions: No adverse event (The subject's medical history, concurrent conditions, and concurrent medications were not reported.)",,USGLAXOSMITHKLINEA0594830,2,09/13/2019,,,,
0833400,09/13/2019,NC,18.0,,,F,,"PREGNANCY; This case was reported by a healthcare professional and described the occurrence of drug exposure during pregnancy in a 18-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis.   On 30 May 2007 at 10:00 the subject received 1st dose of Boostrix at 0.5 ml in the left arm. The subject was 21 weeks pregnant at the time of vaccination.  No adverse events were reported.  At the time of reporting the outcome of the event was was unspecified.  Upon internal review done on 13th September 2019, the pregnancy outcome was updated to lost to follow-up.",,,,,,,,,U,05/30/2007,,,,PVT,,,,Medical History/Concurrent Conditions: No adverse event (The subject is 21 weeks pregnant.),,USGLAXOSMITHKLINEA0654118,2,09/13/2019,,,,
0833401,09/13/2019,CA,17.0,,,F,,"PREGNANCY; This case was reported by a consumer and described the occurrence of pregnancy in a 17-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis. A physician or other health care professional has not verified this report.  The subject's medical history, concurrent conditions, and concurrent medications were not provided.  In April 2007 the subject received an unspecified dose of Boostrix (unknown).   On an unspecified date, the subject, who was immunized two months earlier, told the reporter that she was pregnant.   The reporter, who works with providing immunizations to a school district, refused to provide any further details.  Upon internal review done on 13th September 2019, the pregnancy outcome was updated to lost to follow-up.",,,,,,,,,U,04/01/2007,,,,PUB,,,,"Medical History/Concurrent Conditions: No adverse event (The subject's medical history, concurrent conditions, and concurrent medications were not provided.)",,USGLAXOSMITHKLINEA0655158,2,09/13/2019,,,,
0833402,09/13/2019,NV,,,,F,,"Swelling; This case was reported by a other health professional via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 10-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 43E4T, expiry date 1st October 2021) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, less than 6 months after receiving Boostrix, the patient experienced extensive swelling of vaccinated limb. On an unknown date, the outcome of the extensive swelling of vaccinated limb was unknown.   It was unknown if the reporter considered the extensive swelling of vaccinated limb to be related to Boostrix.  Additional information received were as follows: The age at vaccination was not reported. The reported batch number 43E47 was updated to 43E4T as per sales data sheet. The healthcare professional reported that the patient had swelling the size of a goose egg at the site of Injection with Boostrix, which led to extensive swelling of vaccinated limb. The reporter consented to follow up. This case is 1 of the 4 linked cases, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833403,09/13/2019,NV,,,,U,,"Reactions at the site of Injection; This case was reported by a other health professional via call center representative and described the occurrence of injection site reaction in a patient who received DTPa (Reduced antigen) (Boostrix) (batch number 43E4T, expiry date 1st September 2021) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, less than 6 months after receiving Boostrix, the patient experienced injection site reaction. On an unknown date, the outcome of the injection site reaction was unknown.   It was unknown if the reporter considered the injection site reaction to be related to Boostrix.  Additional details were provided as follows: Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient had reactions at the site of injection with Boostrix. The batch number reported for Boostrix(43E47) did not exist and was updated to 43E4T, as per sales database. The reporter consented to follow up. This was one of the 6 cases, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833404,09/13/2019,MD,,,,U,,"Burning Mouth Syndrome; This case was reported by a consumer via call center representative and described the occurrence of burning mouth syndrome in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced burning mouth syndrome. The patient was treated with nortriptyline. On an unknown date, the outcome of the burning mouth syndrome was unknown.   It was unknown if the reporter considered the burning mouth syndrome to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced burning mouth syndrome after receiving Shingrix. The patient went to dentist and primary care doctor and they said that they fell it also could be the vaccination. The patient took Nortiptyline from primary care.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,Y,,
0833405,09/13/2019,,,,,U,,"Fever of 103; This case was reported by a other health professional via other manufacturer and described the occurrence of fever in a adult patient who received Hepatitis B vaccine for prophylaxis.   Concurrent medical conditions included rheumatoid arthritis. Concomitant products included tofacitinib citrate (Xeljanz).   On an unknown date, the patient received Hepatitis B vaccine at an unknown dose. On an unknown date, less than 9 months after receiving Hepatitis B vaccine, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Hepatitis B vaccine.  Additional details were provided as follows: The age at vaccination was not reported. In 2019, the patient experienced fever. The patient after receiving the last injection in February 2019 experienced fever of 103. The reporter stated that the patient was missing 2 months due to insurance mishap and another 1 month down the line due to switching pharmacies and noticing that he needed xeljanz again. The patient reported that xeljanz was working very well.      Lab Comments: On an unknown date body temperature was recorded",,,,,,,,,U,,,,"Test Name: Body temperature; Result Unstructured Data: Test Result: 103, Test Result Unit: unknown",UNK,,XELJANZ,Rheumatoid arthritis,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,,
0833406,09/13/2019,,,,,U,,"Injection site red; Injection site swollen; Injection site painful; This case was reported by a other health professional via interactive digital media and described the occurrence of injection site erythema in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced injection site erythema, injection site swelling and injection site pain. On an unknown date, the outcome of the injection site erythema, injection site swelling and injection site pain were unknown.   It was unknown if the reporter considered the injection site erythema, injection site swelling and injection site pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  On 5th September 2019, at 13:37 hrs. the injection site was still red, swollen and painful. The patient enquired should I be concerned. The follow up was not required. The clarification has been requested for the onset date of event.",,,,,,,,,U,08/30/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,,
0833407,09/13/2019,NJ,61.0,61,,F,,"Large patch of redness on her left arm; This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In April 2019, the patient received the 1st dose of Shingrix (intramuscular). In April 2019, 1 day after receiving Shingrix, the patient experienced erythema of extremities. On an unknown date, the outcome of the erythema of extremities was recovered/resolved.   It was unknown if the reporter considered the erythema of extremities to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient received Shingrix on left arm. The day after vaccination, the patient noticed a large patch of redness on her left arm that went up and down her arm. The red area was approximately 6 inches long. The reporter consented to follow up. The caller did not provide any additional details.",,,,,,,,,Y,04/01/2019,04/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833408,09/13/2019,MA,,,,F,,"Pain at injection site; Inadvertantly administered into bursae; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 51-year-old female patient who received Herpes zoster (Shingrix) (batch number K9M5N, expiry date 7th November 2021) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced injection site pain and vaccine administered at inappropriate site. On an unknown date, the outcome of the injection site pain was not recovered/not resolved and the outcome of the vaccine administered at inappropriate site was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The pharmacist called to report that the patient inadvertantly received Shingrix into bursae, which led to vaccine administered at inappropriate site. The patient had ongoing pain at injection site. The reporter consented to follow up.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833409,09/13/2019,MA,,,,F,,"Cellulitis at injeciton site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site cellulitis in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site cellulitis. The patient was treated with sulfamethoxazole (Bactrium (Sulfamethoxazole)). On an unknown date, the outcome of the injection site cellulitis was unknown.   It was unknown if the reporter considered the injection site cellulitis to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient developed cellulitis at injection site after receiving vaccine. The reporter consented to follow up. The reporter did not have lot or expiration date, as the vaccine was given somewhere else. The reporter did not provide vaccination facility information. This case has been linked with case US2019160454, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833410,09/13/2019,WA,,,,F,,"hives on left arm at injection site; injection site pain; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th June 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 28th June 2019, immediately after receiving Shingrix, the patient experienced injection site pain. On 5th July 2019, the patient experienced injection site hives. On 30th June 2019, the outcome of the injection site pain was recovered/resolved. On 8th July 2019, the outcome of the injection site hives was recovered/resolved.   It was unknown if the reporter considered the injection site pain and injection site hives to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient after receiving vaccine had immediate injection site pain that lasted for 1 to 2 days. The patient one week after receiving vaccine noticed hives on her left arm at the injection site that lasted for 2 to 3 days. The patient consented to follow up.",,,,,,,,,Y,06/28/2019,06/28/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833411,09/13/2019,,,,,F,,"shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   In April 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient had a history of previous episodes of shingles before receiving Shingrix. The patient had multiple episodes of shingles after the first dose of shingles. The patient would like to remain anonymous. The patient did not consent to follow up.",,,,,,,,,U,04/01/2019,,,,UNK,,,,Medical History/Concurrent Conditions: Shingles,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833412,09/13/2019,CA,30.0,30,,M,,"diarrhea; dry heaving; nausea; vomiting; This case was reported by a consumer via call center representative and described the occurrence of diarrhea in a 30-year-old male patient who received Flu unspecified (Flu vaccine) for prophylaxis.   In August 2019, the patient received Flu vaccine. On an unknown date, less than a week after receiving Flu vaccine, the patient experienced diarrhea, dry heaves, nausea and vomiting. On an unknown date, the outcome of the diarrhea, dry heaves, nausea and vomiting were recovering/resolving.   It was unknown if the reporter considered the diarrhea, dry heaves, nausea and vomiting to be related to Flu vaccine.  Additional details were provided as follows: The patient experienced frequent diarrhea, dry heaving, nausea, and vomiting. The patient consented to follow up. Emergency room visit was required. The patient did not provide any additional information. The patient did not have healthcare professional contact information at the time of reporting.",,,,,,,,,N,08/01/2019,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,Y,
0833413,09/13/2019,ME,,,,M,,"cold sore; This case was reported by a pharmacist via call center representative and described the occurrence of cold sores in a male patient who received Herpes zoster (Shingrix) (batch number 494PR, expiry date 13th September 2021) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced cold sores. On an unknown date, the outcome of the cold sores was unknown.   It was unknown if the reporter considered the cold sores to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient developed a cold sore immediately after getting first Shingrix vaccine. The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833414,09/13/2019,NJ,66.0,66,,F,,"barely move her arm; generalized arm pain at the injection site; This case was reported by a other health professional via sales rep and described the occurrence of injection site pain in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th August 2019, the patient received Shingrix. On 28th August 2019, immediately after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the patient experienced injected limb mobility decreased. On an unknown date, the outcome of the injection site pain was recovering/resolving and the outcome of the injected limb mobility decreased was unknown.   It was unknown if the reporter considered the injection site pain and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient had generalized arm pain at the injection site starting at the time of vaccination. The patient stated that she can barely move her arm. The patient is also a former practice manager who is acquainted with the field representative. The field representative did not have any additional contact information other than the patient's phone number to follow up with her.",,,,,,,,,N,08/28/2019,08/28/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833415,09/13/2019,,,,,F,,"rash on abdomen and a little onto back; This case was reported by a consumer via call center representative and described the occurrence of rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 3 days after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was recovered/resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The caller reported that 3 days after getting Shingrix, she developed a rash on her abdomen and a little onto her back.  The rash was not itchy or raised.  The event resolved in about 2 to 3 days.  The caller would provide only her initials.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833416,09/13/2019,AK,65.0,,,F,,"Shingles; This case was reported by a nurse via call center representative and described the occurrence of shingles in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 2G2T7, expiry date unknown) for prophylaxis.   On 3rd September 2019, the patient received Shingrix (intramuscular). In September 2019, less than a week after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional information received were as follows: The nurse reported that the patient received Shingrix on left deltoid and experienced shingles. The healthcare professional did not had the expiry date.",,,,,,,,,U,09/03/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833417,09/13/2019,VA,,18,,M,,"Patient was administered an extra dose of Menactra instead of the Meningococcal B; Patient was administered an extra dose of Menactra instead of the Meningococcal B; Initial information received on 26-Aug-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 18 years old male patient who experienced patient was administered an extra dose of menactra instead of the meningococcal b while he received vaccines MENINGOCOCCAL VACCINE B and MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 25-Aug-2019, the patient received a 0.5ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U6220AA via intramuscular route instead of MENINGOCOCCAL VACCINE B not produced by Sanofi Pasteur.  It was a case of actual medication error due to extra dose administered and wrong vaccine administered.  It was unknown if any adverse event occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,08/25/2019,,,,UNK,,,,,,USSA2019SA239582,2,09/10/2019,,,,
0833418,09/13/2019,CA,,18,,M,,"gave an expired dose of Menactra/no AE; Initial information received on 26-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves an 18 years old male patient who received an expired dose of vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Patient received VARICELLA ZOSTER VACCINE (VARICELLA VACCINE as concomitant therapy.   On 26-Aug-2019, the patient received a 0.5 ml single dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U5986AA via intramuscular route in the right deltoid.  It was a case of actual medication error due to expired vaccine used.  It was unknown whether adverse event was experienced or not.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,08/26/2019,,,,UNK,,VARICELLA VACCINE,,,,USSA2019SA239636,2,09/10/2019,,,,
0833419,09/13/2019,,,,,U,,"patient was given Menactra today that had an expiration date of 8/14/19/no AE; Initial information received on 26-Aug-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a patient of unknown demographics who received an expired dose of vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  The patient's past medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  It was unknown whether adverse event was observed or not.  Information on the batch number was requested.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA239644,2,09/10/2019,,,,
0833420,09/13/2019,PA,4.0,,,M,,"a 4 year old patient was accidentally given the Adacel vaccination instead of Daptacel/no AE; a 4 year old patient was accidentally given the Adacel vaccination instead of Daptacel/no AE; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 4 years old male patient who received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (Prefilled Syringe) instead of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) for Immunisation.  On 20-Aug-2019, the patient received a 0.5 ml single dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot number U5748AA via intramuscular route in the left thigh.  It was of actual medication error due to Product administered to patient of inappropriate age and wrong product administered..  It was reported that no adverse event was observed.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,08/20/2019,,,,UNK,,MMR,,,,USSA2019SA248669,2,09/12/2019,,,,
0833421,09/13/2019,,,,,U,,"allergies with Tetanus; Initial information received on 05-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves unknown demographic patient who experienced allergies with tetanus, while received vaccine TETANUS TOXOID.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect TETANUS TOXOID produced by unknown manufacturer (lot number and Expiry date unknown) via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious allergies with tetanus (allergy to vaccine) (Unknown latency) following the administration of TETANUS TOXOID.  (Other relevant tests included no lab data.) Final diagnosis was allergies with tetanus.  It was not reported if the patient received a corrective treatment.  The event outcome is reported as Unknown for allergies with tetanus.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA251071,2,09/12/2019,,,,
0833422,09/13/2019,TN,,18,,F,,"accidentally gave Fluzone High Dose to a 19 year old female patient/ no AE; accidentally gave Fluzone High Dose to a 19 year old female patient/ no AE; Initial information received on 05-Sep-2019 regarding an unsolicited valid non-serious case received from Non-HCP (Office Staff).  This case involves a 19 years old female patient who received 0.5 ml dose of vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ221AA (Expiry date 01-Apr-2020) via unknown route in the left arm, on 04-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error case due to inappropriate age at vaccine administration and overdose.  It was reported that accidentally gave Fluzone High Dose to a 19 year old female patient.  At the time of reporting no adverse reaction was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/04/2019,,,,UNK,,,,,,USSA2019SA251430,2,09/12/2019,,,,
0833423,09/13/2019,IA,63.0,,,M,,"Pentacel administered to a 63 year old stem transplant patient, no AE; Initial information received on 05-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 63 years old male patient received 0.5 ml  first dose of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot UJ067AAA, Exp. Date 13-Jun-2020) via intramuscular route in the left deltoid on 11-Jul-2019.  The patient's past medical history included Stem cell transplant. The patient's past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HEPATITIS B VACCINE and MENINGOCOCCAL VACCINE A/C/Y/W CONJ (DIP TOX) (MENACTRA) for Immunisation.  It was a case of actual medication error due to inappropriate age at vaccine administration.  At the time of reporting no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,07/11/2019,,,,UNK,,MENACTRA; HEPATITIS B [HEPATITIS B VACCINE],,Medical History/Concurrent Conditions: Stem cell transplant,,USSA2019SA251468,2,09/12/2019,,,,
0833427,09/13/2019,FL,11.0,11,,M,,"Patient scheduled an appointment on 09/12/2019 to report "" a knot in his muscle"". His mother states it formed shortly after receiving the HPV vaccine the previous month during his annual physical exam. Patient developed a 1.5in x1.5 in mass centrally located in his right deltoid. When pressed it causes him pain.",,,,,,,,,N,08/12/2019,08/13/2019,1,,PVT,,Adderall XR 10mg capsule and Adderall 5mg tablet daily,Allergic rhinitis,ADHD; sensory processing behavioral disorder,,,2,09/13/2019,,Y,,NKDA
0833428,09/13/2019,CO,67.0,,,F,,"Injection site swollen, red and itchy; area about 2"" diameter; treated with ice packs and dermal antihistamine cream. By 11 PM day of injection, joints in extremities achy. During night, experienced fever, chills, shakes, shivers and aching muscles. Treated with Tylenol. Next day awoke with severe headache and nausea. Didn't eat much due to nausea but did not vomit. Treated headache with Fioricet which I have for PRN use with migraines. It didn't help. Slept during afternoon but not as tired as from first dose of Shingrix. Headache gone after about 36 hours. Site reaction resolved by Thursday, August 8, 2019.",,,,,,,,,Y,08/03/2019,08/03/2019,0,,PHM,,"nifedipine XL 30 mg, nasacort, allegra, Vit B+C; Vit E, Red Ri Red Rice Yeast and a Hair, Skin and Nails product",none,"migraines, allergies",,,2,09/04/2019,,,,latex
0833429,09/13/2019,NC,71.0,71,,M,,"Extreme weakness and very tired, pain at injection site.  Felt like I got hit by a truck.  Today is 3rd day after injection and symptoms have lessened, but still sluggish.  Right elbow below injection site warm to touch with slight swelling today.",,,,,,,,,N,09/10/2019,09/11/2019,1,None,PHM,,Atorvastatin.  Received flu shot at same time as Zoster (RZV),None,None,,,2,09/13/2019,,,,None
0833430,09/13/2019,PA,70.0,70,,F,,"BASEBALL SIZED LUMP ON ARM, VERY WARM TO TOUCH, VERY SORE. OVERALL ACHY FEELING FOR DAYS",,,,,,,,,,09/10/2019,09/10/2019,0,,PHM,,,,,,,2,09/13/2019,,,,
0833431,09/13/2019,PA,75.0,75,,F,,Patient had headache starting the day after the vaccine and it lasted for about 5 days.,,,,,,,,,,09/01/2019,09/02/2019,1,,PHM,,,,,,,2,09/13/2019,,Y,,
0833432,09/13/2019,WI,59.0,59,,F,,"1. Very sore arm began about 9pm on day of immunization, radiating to the shoulder, mid-back and sternum. I do not notice any swelling or redness to the site.  2. 3am day after immunization- woke with chills, shakes, body aches, nausea and headache. Temp. was 99.8. I'm taking ibuprofen.",,,,,,,,,N,09/12/2019,09/12/2019,0,none,PVT,,"acetaminophen    Ascorbic Acid (VITAMIN C)   citalopram   docusate sodium   Ferrous Sulfate (IRON)   Magnesium Gluconate  Melatonin    multivitamin tablet   vitamin D3, cholecalciferol,",none,"GAD, insomnia, iron deficiency, depression, vitamin d deficiency",,,2,09/13/2019,,,,"ceftriaxone, vancomycin, sulfa, cephalosporins, moxifloxacin, zolpidem"
0833435,09/13/2019,NY,29.0,29,,M,,"Called medical center 9/5/19 to report ""since receiving Tdap vaccine  on 4/419 Has not been feeling well"" Reports  ""Fatigue, Brain Fog, Nausea & dizzyness"" Reports under care of private HD who suggested he  ""report Tdap possible reaction"".",,,,,,,,,N,04/04/2019,,,"Reports Had MRI and viral cultures - ""All NeG""",PVT,,None,None,None,,,2,09/13/2019,,Y,,None
0833436,09/13/2019,TN,65.0,65,,M,,"Nausea within two hours of injection, Soreness  at injection site within two hours, Enlarged redness around injection site within 24 hrs.- 48 hrs, Vomiting within 48 hrs and continued gastro intestinal  disturbance at 72 hrs.",,,,,,,,,N,09/10/2019,09/10/2019,0,None at time of report,PHM,,"Victoza, Tresiba, Metformin, Diovan",None,Diabetes,,,2,09/13/2019,,,,None Known
0833437,09/13/2019,TX,5.0,5,,M,,"Pt has redness, swelling, and several pimple size fluid blisters on the left deltoid.  The skin is tight along the entire left upper arm.  The redness and swelling when measured is 16cm x 14cm.  Mom states the child complained about it hurting.  Child has no fever.   Cold compresses have been applied for 20 minutes at a time as tolerated.  Tylenol and Motrin have been alternated for pain.  Child is moving arm around with no issues and does not display pain at the time of observation.   Area was marked and instructed mom to watch area and to let us know if the redness extends beyond the markings.  Instructed to continue the compresses.",,,,,,,,,U,09/10/2019,09/11/2019,1,,PUB,,,,,,,2,09/13/2019,,,,None
0833438,09/13/2019,FL,23.0,23,,F,,"Took vaccine 6:30am; around 11:00 am: Flu-like/fever symptoms, abdominal pain that came and went in waves, nausea. Over the counter medications (tums and pepto bismol) did nothing for the side effects. Received ondansetron from doctors office after same symptoms occurred on dose #2 and premedicated with that and ibuprofen for dose #3 which lessened all side effects to be manageable with mild stomach ache and gassiness. The 4th capsule/dose had a broken capsule that was leaking powder out of the capsule in the packaging.",,,,,,,,,Y,09/08/2019,09/08/2019,0,None,PHM,,Birth control,None,None,,,2,09/13/2019,,Y,,None
0833439,09/13/2019,MN,75.0,75,,F,,"Chills ,,,,, Aches and pain ?. Headache     Rapid Heart Beat Dizziness'",,,,,,,,,Y,09/12/2019,09/12/2019,0,,PVT,,none,none,none,,,2,09/13/2019,,,,penicllan
0833440,09/13/2019,NE,18.0,18,,F,,On 9/11/2019 patient reported to mother that since the day after vaccination she has had mild diarrhea and jaw pain.,,,,,,,,,U,09/05/2019,09/06/2019,1,None,PVT,,None,None,Mitral valve prolapse Heterozygous Leydon Factor V GERD,,,2,09/13/2019,,,,Sulfa
0833441,09/13/2019,ME,74.0,74,,M,,"STABBING PAIN SO BAD PATIENT COULD NOT STAND THE PAIN-LITTLE SWOLLEN AREA WENT TO WALKIN CLINIC AND THEY DID NOT KNOW WHAT TO DO SO SENT HIM TO ER AND THEY DID NOT KNOW WHAT TO DO EITHER. HOT PACKS WERE BETTER THAN COLD PACKS, GAVE HIM 3 MOTRIN AND 2 TYLENOL AND SENT HIM HOME IN ASCURSIATING PAIN  AND TOLD HIM TO REPEAT EVERY 6 HOURS-PAIN SUBSIDED ABOUT 2 AM BUT IS EXTREMELY SORE AND HURTS  STILL AND CANNOT MOVE THE ARM UP OR OUT.",,,,,,,,,N,09/12/2019,09/12/2019,0,NONE,PHM,,"advair , spiriva, tamsulosin,omeprazole 40mg, simvastatin, chlorthalid, D3, B12, calcium",none,COPD,,,2,09/13/2019,,,,vicodin
0833444,09/13/2019,TN,,,,F,,"was very lethargic for about a year; This spontaneous report as received from a receptionist at a provider's office via a company representative refers to an adolescent female patient of unknown age (reported as 13 or 14-year-old). No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, route of administration, lot # and expiration date were not reported) or hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route of administration, lot # and expiration date were not reported) for prophylaxis (the company representative was unable to determine which one it was).    On an unknown date, the patient was very lethargic for about a year.  The outcome of the event was unknown.  The relatedness between the event and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA002185,2,09/13/2019,,,,
0833445,09/13/2019,IA,63.0,63,,F,,"Muscle pain in back; Muscle pain in neck / arms; Dull headache; Intestinal upset; Low grade fever; This case was reported by a consumer and described the occurrence of muscular back pain in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd September 2019 16:00, the patient received the 1st dose of Shingrix. In September 2019, less than a day after receiving Shingrix, the patient experienced muscular back pain, muscle pain, headache dull, gastrointestinal upset and low grade fever. On an unknown date, the outcome of the muscular back pain, muscle pain, headache dull, gastrointestinal upset and low grade fever were not recovered/not resolved.   It was unknown if the reporter considered the muscular back pain, muscle pain, headache dull, gastrointestinal upset and low grade fever to be related to Shingrix.  Additional details were provided as follows: The patient received the Shingrix and experienced muscle pain in back, neck, arms, dull headache and some intestinal upset. The patient had a low grade fever.  The patient asked if she could take Tylenol or something else to relieve the symptoms.",,,,,,,,,N,09/03/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,,
0833448,09/13/2019,,,,,F,,"Chills; Soreness; Chest Pain; Difficulty breathing; Fever; This case was reported by a consumer via call center representative and described the occurrence of fever in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced fever, chills, pain, chest pain and difficulty breathing. On an unknown date, the outcome of the fever, chills, pain, chest pain and difficulty breathing were recovered/resolved.   It was unknown if the reporter considered the fever, chills, pain, chest pain and difficulty breathing to be related to Bexsero.  Additional details were provided as follows: This case was reported by patient's mother. The age at vaccination was not provided. The reporter stated that, after vaccination, the patient experienced fever of 103.4 degree C, which lasted for 5 days. The patient's physician recommended for emergency room visit. No further details were provided. The reporter did not want to provide any demographic or address information. For tolerance to the 2nd dose, refer case US2019AMR161774      Lab Comments: On an unknown date, lab test performed.",,,,,,,,,Y,,,,"Test Name: Body temperature; Result Unstructured Data: Test Result: 103.4, Test Result Unit: degree C",UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,Y,Y,
0833449,09/13/2019,IL,64.0,64,,M,,"arm swelling down the arm almost reaching the tip of the finger / arm swelling spread across arm /injection site swelling; bruised arm; This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 64-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) (batch number 7AR35, expiry date 30th June 2020) for prophylaxis.   On 29th August 2019, the patient received Fluarix Quadrivalent 2019-2020 season (intramuscular). On 31st August 2019, 2 days after receiving Fluarix Quadrivalent 2019-2020 season, the patient experienced extensive swelling of vaccinated limb and bruising of arm. On an unknown date, the outcome of the extensive swelling of vaccinated limb and bruising of arm were recovering/resolving.   It was unknown if the reporter considered the extensive swelling of vaccinated limb and bruising of arm to be related to Fluarix Quadrivalent 2019-2020 season.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. Approximately two days later, the patient experienced extensive swelling of vaccinated limb, injection site swelling, swelling arm and bruising of arm. The reporter reported that, the swelling spread across the arm horizontally, then proceeded downward on the arm, almost reaching the tip of the finger. The swelling did also appear bruised. At the time of reporting, the symptom's were improving. The reporter consented to follow up.",,,,,,,,,N,08/29/2019,08/31/2019,2,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833450,09/13/2019,MT,24.0,24,,M,,"Sporadic Muscle Spasms; This case was reported by a nurse via call center representative and described the occurrence of muscle spasm in a 24-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number MF9EA, expiry date 1st June 2021) for prophylaxis.   Concurrent medical conditions included muscular dystrophy.   On 14th August 2019, the patient received Boostrix. On an unknown date, less than a month after receiving Boostrix, the patient experienced muscle spasm. On an unknown date, the outcome of the muscle spasm was unknown.   It was unknown if the reporter considered the muscle spasm to be related to Boostrix.  Additional details were provided as follows: The patient received dose of Boostrix in the right deltoid. The healthe care professional stated that, the patient had muscular dystrophy, then received boostrix vaccine and experinced muscle spasms. The reporter consented to follow up.",,,,,,,,,U,08/14/2019,,,,UNK,,,Muscular dystrophy,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833451,09/13/2019,IA,,,,F,,"breast cancer; This case was reported by a pharmacist via call center representative and described the occurrence of breast cancer in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th June 2019, the patient received the 1st dose of Shingrix. In September 2019, less than 3 months after receiving Shingrix, the patient experienced breast cancer (serious criteria GSK medically significant). On an unknown date, the outcome of the breast cancer was unknown.   It was unknown if the reporter considered the breast cancer to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. In the week of date of reporting, the patient was diagnosed with breast cancer. The reporter consented to follow up.",,,,,,,,,U,06/24/2019,09/01/2019,69,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833452,09/13/2019,,,,,F,,"Bilateral optic neuritis; This is a literature case, initially received on 10-Sep-2019, concerning a 6-year-old, child, female patient.   The patient had no previous medical problems. There was no family history of autoimmune, ocular, or neurologic disorders.  On an unknown date, the patient was administered with unspecified Flu vaccine [quadrivalent inactivated flu vaccine, route of administration: intramuscular, dose, batch number and anatomical location: not provided] for an unknown indication.   On an unspecified date, one week after receiving a flu vaccine the patient developed bilateral vision loss and was diagnosed with bilateral optic neuritis.  The patient's identical twin received the same vaccination without subsequent changes in vision.  At presentation to the emergency department, her visual acuities were hand motion in the right eye and counting fingers in the left with no afferent pupillary defect (APD). Examination revealed severe optic disc swelling with vessel obscuration bilaterally and peripapillary hemorrhages on the left. There were no anterior chamber cells, vitreous cells, or macular exudates in either eye. Magnetic resonance imaging (MRI) of the brain, orbits, and spinal cord with and without intravenous (IV) contrast showed increased T2/FLAIR signal and abnormal enhancement in the retrobulbar optic nerves bilaterally, but no white matter lesions in the brain or spinal cord. Cerebrospinal fluid (CSF) analysis revealed 1,000 red blood cells/mL, 5 nucleated cells (WBC)/mL, protein level of 23 mg/dL, and glucose level of 58 mg/dL. There were no oligoclonal bands, positive cultures, Lyme antibodies, aquaporin-4 antibodies, or evidence of any of the following by polymerase chain reaction in the CSF: EpsteinBarr virus, herpes simplex virus, and varicella-zoster virus. Serologic testing was also negative for culture growth, Lyme antibodies, and aquaporin-4 antibodies; white blood cell count, erythrocyte sedimentation rate, C-reactive protein, and angiotensin-converting enzyme levels were normal.  The patient was treated with intravenous methylprednisolone.   After 5 days of IV methylprednisolone, visual acuities improved to 20/20, and she recognized 10/10 Ishihara color plates with each eye. The patient was discharged to home without a steroid taper.  Six days after her last dose of IV steroids, the patient experienced decreased vision in the left eye. Examination showed visual acuities of 20/25 in the right eye and no light perception in the left eye. There was a left APD.   Ophthalmoscopy showed mild atrophy of the right optic disc from her initial inflammation and swelling of the left optic disc. Optical coherence tomography (OCT) of the peripapillary retinal nerve fiber layer showed average thicknesses of 144 m in the right eye and 203 m in the left eye, consistent bilateral disc edema.   The patient was started oral prednisolone 2 mg/kg/day. Two weeks later, her visual acuities returned to 20/20 with normal color vision (14/14 Ishihara plates) in each eye. Optic disc swelling in the left eye had resolved, leaving mild pallor of both optic discs. The oral steroid dose was tapered over the subsequent 4 weeks without recurrence of vision loss. At her last follow-up evaluation (11 weeks after the influenza vaccination and 10 weeks after initial vision loss), neuro-ophthalmic examination was stable.  The patient has remained without recurrence off steroids over the past 2 years.  Per reporter, the divergent reactions to the influenza vaccine in their patient and patient's identical twin suggest that the interplay between environmental exposures and genetic predisposition in postinfluenza vaccination optic neuritis may be more complicated and warrants further research.  Company Comment: The patient experienced optic neuritis one week after vaccination with unspecified Flu vaccine. Chronology is plausible. It was reported that the patient had no previous medical problems. Examination revealed severe optic disc swelling with vessel obscuration bilaterally and peripapillary haemorrhages. No concomitant medications were reported. Considering all the above mentioned, causal relationship between the suspect product and the event is assessed as related.; Reporter's Comments: The patient experienced optic neuritis one week after vaccination with unspecified Flu vaccine. Chronology is plausible. It was reported that the patient had no previous medical problems. Examination revealed severe optic disc swelling with vessel obscuration bilaterally and peripapillary haemorrhages. No concomitant medications were reported. Considering all the above mentioned, causal relationship between the suspect product and the event is assessed as related.",,,,,Y,5,,,Y,,,,"Test Name: Cerebrospinal fluid analysis; Result Unstructured Data: Cerebrospinal fluid analysis revealed 1,000 red blood cells/mL, 5 nucleated cells (WBC)/mL, protein level of 23 mg/dL, and glucose level of 58 mg/dL. There were no oligoclonal bands, positive cultures, Lyme antibodies, aquaporin-4 antibodies, or evidence of any of the following by polymerase chain reaction in the CSF: EpsteinBarr virus, herpes simplex virus, and varicella-zoster virus.; Test Name: MRI of the brain, orbits, and spinal cord; Result Unstructured Data: MRI of the brain, orbits, and spinal cord with and without intravenous (IV) contrast showed increased T2/FLAIR signal and abnormal enhancement in the retrobulbar optic nerves bilaterally, but no white matter lesions in the brain or spinal cord.; Test Name: Neuro-ophthalmic examination; Result Unstructured Data: At the patient's last follow-up evaluation (11 weeks after the influenza vaccination and 10 weeks after initial vision loss), neuro-ophthalmic examination was stable.; Test Name: Ophthalmoscopy; Result Unstructured Data: Ophthalmoscopy showed mild atrophy of the right optic disc from the patient's initial inflammation and swelling of the left optic disc.; Test Name: Optical coherence tomography (OCT); Result Unstructured Data: OCT of the peripapillary retinal nerve fiber layer showed average thicknesses of 144 mm in the right eye and 203 mm in the left eye, consistent bilateral disc edema.; Test Name: Serologic testing; Result Unstructured Data: Negative for culture growth, Lyme antibodies, and aquaporin-4 antibodies; white blood cell count, erythrocyte sedimentation rate, C-reactive protein, and angiotensin-converting enzyme levels were normal.; Test Name: Visual acuities; Result Unstructured Data: The patient's visual acuities were hand motion in the right eye and counting fingers in the left with no afferent pupillary defect (APD). Examination revealed severe optic disc swelling with vessel obscuration bilaterally and peripapillary hemorrhages on the left. There were no anterior chamber cells, vitreous cells, or macular exudates in either eye.; Test Name: Visual acuities; Result Unstructured Data: After 5 days of IV methylprednisolone, visual acuities improved to 20/20, and she recognized 10/10 Ishihara color plates with each eye.; Test Name: Visual acuities; Result Unstructured Data: Examination showed visual acuities of 20/25 in the right eye and no light perception in the left eye. There was a left APD.; Test Name: Visual acuities; Result Unstructured Data: Visual acuities returned to 20/20 with normal color vision (14/14 Ishihara plates) in each eye. Optic disc swelling in the left eye had resolved, leaving mild pallor of both optic discs.",UNK,,,,Comments: None,,USSEQIRUS201904581,2,09/12/2019,,,,
0833453,09/13/2019,,25.0,,,F,,"Preterm labour; Vaccine exposure during pregnancy; This is an observational study case initially received from other health professional on 10-Sep-2019, concerning a 25-year-old pregnant, female subject of body weight 179 lbs, height 64 in and body mass index (BMI) 30,7, enrolled in a prospective observational safety study on pregnancy outcomes in women immunized with seasonal cell culture influenza trivalent (TIVc) or quadrivalent (QIVc) vaccine during pregnancy.  The subject's obstetrical history noted that the subject had two previous pregnancies with two spontaneous abortions. The subject had no history of offspring with major congenital malformation. Also, the subject had no maternal or paternal history with major congenital malformations. The subject did not have a prior history of use of tobacco, alcohol or illicit drugs during pregnancy. The subject's medical history included depression. Concomitant medication included Prenatal vitamin (vitamin NOS, mineral NOS), clonazepam and Effexor XR (venlafaxine hydrochloride).  The subject's last menstrual period was on 23-Apr-2018 and estimated delivery date (EDD) and corrected estimated delivery date was reported as 28-Jan-2019. The type of pregnancy was singleton.   On 07-Jun-2018, the subject underwent ultrasound scan and no major congenital malformation was noted.  On 16-Aug-2018, the subject underwent ultrasound scan and quad screen and no major congenital malformation was noted.  On 17-Sep-2018, the subject underwent ultrasound scan and no major congenital malformation was noted.  On 08-Oct-2018, at gestational age of 24 weeks, the subject was administered Flucelvax QIVc [influenza vaccine, subunit influenza virus vaccine polyvalent, batch number: 252664, dose: 0.5 ml, expiration date, route of administration and anatomical location: not reported] (explicitly coded as 'vaccine exposure during pregnancy') for influenza immunisation.  On 06-Dec-2018, the subject underwent ultrasound scan and no major congenital malformation was noted.  At gestational age of 36.9 weeks [explicitly coded as 'premature labour'), the subject vaginally delivered female neonate. The neonate's birth weight was 3459 grams, head circumference was 33 cm and length was 50.8 cm. The appearance, pulse, grimace, activity and respiration (APGAR) scores were 8 (one minute) and 9 (five minutes), and no data was reported for APGAR score at ten minutes. No major congenital malformation was identified at birth.  This case is linked to 201904583, the corresponding child case.  Company comment: The patient was administered Flu Vaccine Cell Subunit QIV NVD at 24 weeks of gestational age (coded as vaccine exposure during pregnancy). The patient experienced premature labour (at gestational age of 36.9 weeks) 3 months after vaccination. Chronology seems plausible. The patient's medical history of two spontaneous abortions and concomitant use of clonazepam and Effexor XR confound causality. However, causal role of the suspect vaccine cannot be totally excluded and it is assessed as related. The event of vaccine exposure during pregnancy is assessed as unrelated per company's conventions.; Reporter's Comments: The patient was administered Flu Vaccine Cell Subunit QIV NVD at 24 weeks of gestational age (coded as vaccine exposure during pregnancy). The patient experienced premature labour (at gestational age of 36.9 weeks) 3 months after vaccination. Chronology seems plausible. The patient's medical history of two spontaneous abortions and concomitant use of clonazepam and Effexor XR confound causality. However, causal role of the suspect vaccine cannot be totally excluded and it is assessed as related. The event of vaccine exposure during pregnancy is assessed as unrelated per company's conventions.",,,,,,,,,U,10/08/2018,10/08/2018,0,Test Date: 20180816; Test Name: Quad screen; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20180607; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20180816; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20180917; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20181206; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.,UNK,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; CLONAZEPAM; EFFEXOR,Depression,Medical History/Concurrent Conditions: Abortion spontaneous; Multigravida; Comments: None,,USSEQIRUS201904582,2,09/12/2019,,,,
0833454,09/13/2019,,,,,F,,"Fetal exposure during pregnancy; Pre-term birth; This is a serious retrospective pregnancy study case, initially received from other health professional on 10-Sep-2019, concerning a neonate, female subject, whose mother was a 25-year-old, pregnant, female subject of body weight 179 lbs, height 64 inches and body mass index (BMI) 30.7, enrolled in a prospective observational safety study on pregnancy outcomes in women immunized with seasonal cell culture influenza trivalent (TIVc) or quadrivalent (QIVc) vaccine during pregnancy.  The mother's medical history included depression. Concomitant medications included Prenatal vitamins (mineral NOS, vitamins NOS), clonazepam and Effexor XR (venlafaxine hydrochloride).  The mother's obstetrical history noted that mother had two previous pregnancies with two spontaneous abortions. The subject's mother had no history of offspring with major congenital malformation and no relevant maternal and paternal medical history. The mother did not use tobacco, alcohol or illicit drugs during pregnancy.  The mother's last menstrual period (LMP) date was 23-Apr-2018. Estimated delivery date (EDD) and corrected delivery date (CEDD) were 28-Jan-2019. The pregnancy was singleton.  On 07-Jun-2018, the mother underwent ultrasound and no major congenital malformations were noted.   On 16-Aug-2018, the mother underwent Quad screen and ultrasound and no major congenital malformations were noted.   On 17-Sep-2018, the mother underwent ultrasound and no major congenital malformations were noted.   On 08-Oct-2018, at gestational age at 24 weeks, the subject's mother was administered with Flu Vaccine Cell Subunit QIV NVD [influenza vaccine, subunit influenza virus vaccine polyvalent, batch number: 252664, dose: 0.5ml, anatomical location, route of administration and expiration date: not reported] (explicitly coded as fetal exposure during pregnancy) for immunization to Influenza virus.  On 06-Dec-2018, the mother underwent ultrasound and no major congenital malformations were noted.   at gestational age of 36.9 weeks, the mother vaginally delivered premature live birth, female neonate. The neonate's birth weight was 3459 g, head circumference 33 cm and length 50.8 cm. The appearance, pulse, grimace, activity, and respiration (APGAR) scores were 8 (one minute) and 9 (five minutes). No data was provided for Apgar score in 10 minutes. There was no major congenital malformation identified at birth.   The outcome of event premature birth' was not reported.   The case is linked to 201904582, corresponding mother case.  Company comment: A female neonate patient experienced preterm birth, 3 months after maternal receipt of Flu Vaccine Cell Subunit QIV NVD at 24 weeks of gestation (considered as foetal exposure during pregnancy). Chronology seems plausible. Maternal medical history of two spontaneous abortions and concomitant use of clonazepam and Effexor XR confound causality. However, causal role of the suspect vaccine cannot be totally excluded and it is assessed as related. The event foetal exposure during pregnancy is assessed as unrelated per company's conventions.; Reporter's Comments: A female neonate patient experienced preterm birth, 3 months after maternal receipt of Flu Vaccine Cell Subunit QIV NVD at 24 weeks of gestation (considered as foetal exposure during pregnancy). Chronology seems plausible. Maternal medical history of two spontaneous abortions and concomitant use of clonazepam and Effexor XR confound causality. However, causal role of the suspect vaccine cannot be totally excluded and it is assessed as related. The event foetal exposure during pregnancy is assessed as unrelated per company's conventions.",,,,,,,,,U,10/08/2018,01/06/2019,90,,UNK,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; CLONAZEPAM; EFFEXOR XR,,Comments: None,,USSEQIRUS201904583,2,09/12/2019,,,,
0833455,09/13/2019,MD,39.0,39,,F,,"Multipara, 31 weeks gestation AMA, Rh negative s/p Rhogam 8/2019, obesity  Developed significant swelling and pain after 24 hours - was given Claritin and Tylenol through an Urgent Care. 4 days post injection, went to ED and diagnosed with cellulitis. Prescribed Keflex with improvement so far. Based on site of swelling and cellulitis, injection not given intramuscularly, but appeared to be given subcutaneously inferior to the deltoid",,,,,,,,,Y,09/05/2019,09/06/2019,1,,PVT,,prenatal vitamin Slow release iron,none,obesity,,,2,09/13/2019,,Y,Y,none
0833456,09/13/2019,IL,1.0,1,.0,M,,Redness and swelling over anterior RT and LT thigh. 0.5 cm wheal appeared near injection sight on RT thigh along with a 2cm sized welt under skin. Doctor was notified and assessed the patient. Ice packs applied to both thighs and patient monitored. Swelling and redness decreased and wheal resolved. Welt still palpable but had decreased in size. Patient given Motrin for inflammation and instructed on follow-up care. Attempted to contact parent next morning to check on patient status. Left message to call office back for update,,,,,,,,,U,09/12/2019,09/12/2019,0,N/A,PVT,,"Vitamin D, generic stool softener, Nystatin",NA,"Plagiocephaly, acquired",,,2,09/13/2019,,,,"NKA, per mom patient has sensitive skin"
0833457,09/13/2019,IL,12.0,12,,F,,"Patient was given HPV on 8/12/19, Mom stated 5 minutes after bandaid was placed on arm the the area  around where injection was given was red and itchy. Dr aware and spoke with Mom ice pack applied to site. Mom called when she got home stating arm still itching, she will continue with ice and update the next day. Mom called on 8/13/19 and states that the itching resolved. Mom called back on 8/28/19 stating that patient is complaining that the are where injection was given is sore and there is a mosquito size ""lump"". Mom advised Dr said that it should resolve and patient should not ever receive another HPV.",,,,,,,,,Y,08/12/2019,08/12/2019,0,None,PVT,,"Dulera, Ranitidine, Loratadine, Multivitamin gummy",None,"Mild persistent asthma, chronic abdominal pain",,,2,09/13/2019,,,,None
0833458,09/13/2019,WY,53.0,53,,F,,"Client presented with hive like rash to left upper extremity, area was warm to the touch and slightly swollen.  Client reported that area itched and that she applied topical hydrocortisone cream to area.  Client also reports that she has had flew shots before but this is the first time she has had a reaction.  Client denied any difficulty breathing.",,,,,,,,,U,09/11/2019,09/12/2019,1,n/a,PUB,,n/a,n/a,n/a,,,2,09/13/2019,,,,Egg allergy
0833459,09/13/2019,ID,68.0,68,,F,,"LT deltoid redness, swelling, and painful",,,,,,,,,N,09/11/2019,09/12/2019,1,,PVT,,NONE,None,None,,,2,09/13/2019,,Y,,Lidocaine
0833460,09/13/2019,FL,3.0,3,,M,,MOM STATES THAT THE NEXT MORNING AFTER PATIENT RECEIVED HIS FIRST DOSE OF VARIVAX HE BROKE OUT IN A RASH AND WAS DIAGNOSED WITH CHICKEN POX AT HIS LOCAL PEDIATRICIAN'S OFFICE.,,,,,,,,,Y,02/27/2017,02/28/2017,1,,PVT,,,,,,,2,09/13/2019,,Y,,
0833461,09/13/2019,VA,79.0,79,,F,,"PATIENT STATED SHE HAD SOME SWELLING AROUND THE INJECTION SITE.  THE SWOLLEN AREA WAS RED AND IN AN OVAL SHAPE COVERING ABOUT 4IN X 2.5IN, WITH THE INJECTION ENTRY AT THE CENTER.  PATIENT WAS TREATING WITH ICE AND TAKING OTC MOTRIN WHICH SHE STATED HAS BEEN HELPING.  THE SWELLING STARTED A FEW HOURS AFTER RECEIVING VACCINE AND HAS ONLY GOTTEN BETTER SINCE AND THE REDNESS HAS NOT SPREAD BEYOND CURRENT MARGINS.  PATIENT HAS FULL ROTATION/MOVEMENT OF ARM AND ONLY SORE TO THE TOUCH.",,,,,,,,,U,09/12/2019,09/12/2019,0,,PHM,,,,,,,2,09/13/2019,,,,
0833462,09/13/2019,FL,52.0,52,,M,,"Swollen, hard, redness, stiffness, aching.  Warmth at injection site.  Has not improved since symptoms began, taking naproxen for pain relief.",,,,,,,,,N,09/10/2019,09/11/2019,1,None,PVT,,"lisinopril, aspirin, atorvastatin, carvedilol, gabapentin",,Torn rotator cuff (chronic); opposite arm,Shingrix (6/27/2019),,2,09/13/2019,,,,penicillin
0833463,09/13/2019,PA,65.0,65,,F,,"Patient developed temp of 100.7-102,  chills, loss of appetite, abdominal pain and nausea, bodyaches, and slight swelling at injection site but no redness or warmth",,,,,,,,,Y,08/01/2019,08/02/2019,1,,PVT,,calcium with Vitamin D  Pristiq 100mg daily Multiple vitamin Benicar HCT 20/ 12.5 one half tablet daily Premarin cream  weekly Synthroid 112 mcg daily,none,Hypothyroidism Depression Essential Hypertension,,,2,09/13/2019,,Y,,Amoxicillin Diovan Latex  Norvasc penicillin
0833464,09/13/2019,CA,63.0,63,,F,,"Chills, Fever, weakness, cough,  (fever range 99.5 - 102.7), sweat.     First night  symptoms were worst, woke up with . 100.7 fever, weak with sore arm",,,,,,,,,U,09/12/2019,09/12/2019,0,None,PVT,,"Metoprolol, Cozaar, Provigil, levothyroxine, Citamel, Restasis, Norvasac, Cymalta, virmin D, Curcumin, B complex, Omega 3, vitamin C, calcium, multivitamin","Respiratory, approximately 1 month earlier","Hypertension, hypothyroidism",,,2,09/13/2019,,,,"Guifenisen, latex"
0833465,09/13/2019,FL,81.0,81,,M,,"About 6-7 hours after injection began not feeling well.  Generalized aching, swelling at the injection site.  Muscle and joint pain increased over night.  9/12 had flushing, felt hot, acute soreness of muscles and joints.  Slept all day.  Wheezing present.  Did not seek medical help.  Treated with Tylenol q6 hours - two 500 mg each time.  No appetite, genderalized weakness.    Flushing/ fever broke during the night.   9/13 - Generalized weakness continues.  Symptoms lessened. Injection site swollen, sore and hot. Felt like he had had flu/ flu like symptoms.",,,,,,,,,U,09/11/2019,09/11/2019,0,None,PHM,,"Occuvite, Vitamin D, Pantoprazole in a.m.",None,"Asthma, cardiac stent, BPH,",,,2,09/13/2019,,,,"Theophylline, Sinvastatin"
0833466,09/13/2019,WI,56.0,56,,F,,"9/9/19 - pAiN iN lEft ARm, Achy joiNts 9/10/19 - HEADAchE @ 7pm, REDNEss At iNjEction site 9/11/19 sx iMpRovED some, hot not REsolvED 9/12/19 site RED swollen & wARm to thE touch",,,,,,,,,N,09/09/2019,09/09/2019,0,0,PVT,,,0,0,TD was some REDNEss at sitE,,2,09/12/2019,,Y,,PENicilliNs
0833467,09/13/2019,IL,38.0,38,,F,,"Vaccine was received Wednesday afternoon which resulted in mild arm discomfort which began to get better through Friday. On Saturday Morning, I woke up and there was a bright red mark at the sight of injection and then extended below it by about 3 inches, and was about 4 inches wide. It was painful and hot to the touch. I consulted a Nurse at my PCP by phone who advised me to go to medical Care since all the regular clinics were closed. I went to medical Care and the Dr diagnosed me with Cellulitis, likely staph infection from the Tetanus shot. I started Cephalexin antibiotic treatment on Saturday. So far, the infection has reacted well to the treatment and the mark has mostly disappeared. I still have two more days of antibiotics to take.",,,,,,,,,Y,09/04/2019,09/07/2019,3,"No medical tests/laboratory results, only doctor visit.",PHM,,"Allegra, Fluticasone, Prevacid, Multivitamin, Omega 3 Supplement;  Flu shot on same day: Fluarix QIV PHS 2019-2020 INJ 0.5ML NDC: 58160-0896-52",No other illnesses in that time frame,Environmental allergies,,,2,09/13/2019,,Y,,No known allergies
0833468,09/13/2019,FL,55.0,55,,M,,"JOINT PAIN.  Joint pain began in hands on Day 4 (Aug 12).  Pain spread to feet approximately one week later, and then quickly spread to other joints, including knees, hips, shoulders, elbows, and wrists.",,,,,,,,,N,08/08/2019,08/12/2019,4,None. Contacted doctor and was told that joint pain for vaccine was not uncommon.,PVT,,Ranitidine Finasteride,none,IgA deficiency,,,2,09/13/2019,,,,Penicillin
0833469,09/13/2019,TX,61.0,61,,F,,103 degree fever for 15 hours before diminishing to 100 degrees for another 12 hours.,,,,,,,,,Y,09/11/2019,09/11/2019,0,,PHM,,Lyrica,None,Fibromyalgia,,,2,09/13/2019,,,,None
0833470,09/13/2019,CO,47.0,47,,M,,"woke up at 2 am with severe right arm pain, on examination by provider large hematoma noted with swelling, tenderness, pain with range of motion",,,,,,,,,U,09/12/2019,09/13/2019,1,,PVT,,EPINEPHrine (ADRENACLICK/EPIPEN) 0.3 mg/0.3 mL Inj AutoInjector 1 3/3 8/14/2018  -- Sig - Route: Inject 1 shot intramuscularly to upper thigh as needed for severe allergic reaction - intraMUSCULAR Sent to pharmacy as: EPINEPHrine 0.3 mg/0.3,No,SHELLFISH ANAPHYLAXIS Edit Overview 2-HIGH -1 yr    UNHEALTHY DRINKING BEHAVIOR Create Overview 3-MEDIUM -1 yr   INTERMITTENT ASTHMA Edit Overview 3-MEDIUM -3 mo    ELEVATED TRANSAMINASE Create Overview 3-MEDIUM -1 yr     TOBACCO SMOKER Create Overview 4-LOW -1 yr     RIGHT CLAVICLE STERNAL END FX Create Overview 4-LOW -1 yr    ALLERGIC RHINITIS DUE TO ANIMAL HAIR OR DANDER Edit Overview 4-LOW -1 yr     ALLERGIC RHINITIS,,,2,09/13/2019,,Y,,Shellfish
0833471,09/13/2019,OK,63.0,63,,F,,"Night chills and low fever, aches and fatigue",,,,,,,,,Y,09/11/2019,09/11/2019,0,None,OTH,,"Metformin 500 mgm /clonazepam 1 mg,  Fluoxetine, Estradiol, Atorvastatin, calcium, vit D3,  1 a day multiple vitamin",None,"Obesity, type II diabetes, high Cholesteral, depression, anxiety",,,2,09/13/2019,,,,none
0833472,09/13/2019,MD,77.0,77,,F,,"patient has painful shoulder, cant raise left arm above shoulder level,  believes it is adhesive capsulitis",,,,,,,,,N,09/10/2019,09/10/2019,0,,PHM,,"levothyroxine, letrozole",,,,,2,09/13/2019,,Y,,
0833473,09/13/2019,PA,66.0,66,,F,,"PATIENT STATES RED, PAINFUL AND SLIGHTLY WARM RASH FOR 72 HOURS. RASH IS 6 INCH BY 3 INCH SIZE, ABOUT 3 INCHES LOWER THEN VACCINE AREA (RASH DOES NOT INCORPORATE EITHER OF THE VACCINE LOCATIONS). AREA IS NOT ITCHY BUT IT HAS BEEN HARD TO THE TOUCH FOR 24-48 HOURS.  COMPLAINS OF FEVERISH SYMPTOMS AND FULL BODY ACHES THAT CAME ON 12 HOURS AFTER THE VACCINE AND LASTED FOR LESS THEN 24 HOURS.",,,,,,,,,N,09/10/2019,09/10/2019,0,NONE,PHM,,NONE,NONE,NONE,,,2,09/13/2019,,,,NONE
0833474,09/13/2019,CA,65.0,65,,F,,"states chronic pain in right shoulder ""like bursitis"" and can't lift over heard or vacuum and such. some days hurt worse than others but pain is there all the time.",,,,,,,,,N,07/12/2019,07/12/2019,0,,PUB,,,,,,,2,09/13/2019,,,,
0833477,09/13/2019,,,,,F,,"Pain at injection site; Swelling at injection site; Joint pain; Body aches; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd September 2019, the patient received the 1st dose of Shingrix (intramuscular). In September 2019, less than a week after receiving Shingrix, the patient experienced injection site pain, injection site swelling, joint pain and general body pain. On an unknown date, the outcome of the injection site pain, injection site swelling, joint pain and general body pain were unknown.   It was unknown if the reporter considered the injection site pain, injection site swelling, joint pain and general body pain to be related to Shingrix.  Additional details were provided as follows: This case was reported by patient's husband. The age at vaccination was not reported but it could be 64 or 65 years. The patient experienced pain at injection site, swelling at injection site, joint pain, body aches. The reporter asked to remain anonymous and did not provide demographics. This case has been linked with US2019161263, reported by same reporter.",,,,,,,,,U,09/03/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833478,09/13/2019,NC,,,,U,,"Pain at injection site; Not feeling well; This case was reported by a pharmacist via sales rep and described the occurrence of injection site pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site pain and feeling unwell. On an unknown date, the outcome of the injection site pain and feeling unwell were unknown.   It was unknown if the reporter considered the injection site pain and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix from her general patient population and had pain at injection site and not feeling well. It was a general observation but provided a small point of clarity stating that she has seen a greater of reaction from healthier patients as opposed to those whose immune system has declined.  No further information was provided.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,,
0833479,09/13/2019,CA,,,,F,,"myalgia; This case was reported by a physician via call center representative and described the occurrence of myalgia in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced myalgia. The patient was treated with paracetamol (Acetaminophen). On an unknown date, the outcome of the myalgia was recovered/resolved.   It was unknown if the reporter considered the myalgia to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The shingrix batch number was unknown. The physician reported that, after vaccination with dose of Shingrix, the patient experienced myalgia, which was relieved by acetaminophen and resolved in approximately two days. The reporter consent to follow up. No further details were provided. For tolerance to 2nd dose, refer case US2019162043.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,,
0833480,09/13/2019,TN,64.0,64,,F,,"Heart problem; Stabbing chest pain that went through to her back; Stabbing chest pain that went through to her back; Rash on breast; Pain under arm; Shingles; Arm swelled up really bad; Arm was very sore; This case was reported by a pharmacist via call center representative and described the occurrence of swelling arm in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number XC972, expiry date 29th August 2021) and (batch number H2HM2, expiry date 29th August 2021) for prophylaxis.   On 23rd August 2019, the patient received the 1st dose of Shingrix. On an unknown date, the dose was an unknown dose. On 23rd August 2019, less than a day after receiving Shingrix, the patient experienced swelling arm. On 4th September 2019, the patient experienced pain in arm, chest pain, back pain, rash, axillary pain and shingles. On an unknown date, the patient experienced heart disorder. On an unknown date, the outcome of the swelling arm, chest pain, back pain, rash, axillary pain, shingles and heart disorder were unknown and the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the swelling arm, pain in arm, chest pain, back pain, rash, axillary pain, shingles and heart disorder to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in unknown arm. The patient said her arm was swelled up really bad and was very sore for 3 or 4 days.  On 1st September 2019, the patient went to the emergency room with stabbing chest pain that went through to her back. The patient was checked for heart problems and released.  On 3rd September 2019, patient went to her family doctor with the same pain and a rash on her breast.  The pain also under her arm. The patient was diagnosed with Shingles. The reporter consented to follow up.",,,,,,,,,Y,08/23/2019,08/23/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,Y,
0833481,09/13/2019,IA,73.0,73,,F,,"swelling at injection site; redness at injection site; hot to touch at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 73-year-old female patient who received Herpes zoster (Shingrix) (batch number G72ZD, expiry date 30th November 2020) for prophylaxis.   On 1st July 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 1st July 2019, less than a day after receiving Shingrix, the patient experienced extensive swelling of vaccinated limb, erythema of extremities and skin warm. On 4th July 2019, the outcome of the extensive swelling of vaccinated limb, erythema of extremities and skin warm were recovered/resolved.   It was unknown if the reporter considered the extensive swelling of vaccinated limb, erythema of extremities and skin warm to be related to Shingrix.  Additional details were provided as follows: The patient received Shingix in left arm. The pharmacist reported that the injection site reactions the patient experienced spread throughout her left arm.",,,,,,,,,Y,07/01/2019,07/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833482,09/13/2019,MS,43.0,43,,F,,15 minutes after the injection and application of bandaid at injection site patient complained of itching. On evaluation of the site noted  redness 5-6cm around the injection site. Bandaid was removed. Continued to monitor site. within 45 minutes she no longer complained of itching and redness was almost gone.,,,,,,,,,Y,09/13/2019,09/13/2019,0,none,PVT,,none,none,Diabetes,,,2,09/13/2019,,,,NKA
0833483,09/13/2019,NY,66.0,66,,F,,patient states she had a fever and chills and then an abdominal rash. she called md,,,,,,,,,Y,09/11/2019,09/12/2019,1,unknown,PVT,,she states none,unsure,none,,,2,09/13/2019,,,,she states none
0833484,09/13/2019,CA,39.0,39,,F,,None stated.,,,,,,,,,,11/20/2018,11/20/2018,0,,UNK,,Effexor Gabapentin Wellbutrin Trazadone,None,Multiple sclerosis,,,2,09/13/2019,,,,None
0833485,09/13/2019,VA,9.0,9,,F,,On same day mother reports patient had an elevated indurated large circular erythematous lesion that was painful and firm.  Slight tactile fever.  Pain slightly improved with Tylenol.,,,,,,,,,Y,09/10/2019,09/10/2019,0,none,PVT,,"Albuterol, Astelin, Zyrtec, Flonase, Dulera 200, montelukast, MiraLAX",viral URI,"chronic constipation, chronic pharyngitis, chronic rhinitis, megarectum, moderate persistent asthma, obesity",,,2,09/13/2019,,Y,,none
0833486,09/13/2019,OR,40.0,40,,F,,"Breathing problems started around 9pm-ish last night. I used a rescue inhaler various times throughout the middle of the night as well as this morning though it didn't help much; I'm still experiencing hoarseness and wheezing.  My heart was racing last night and I was agitated and dizzy. Within a couple hours, I felt a low-grade fever, body aches, a headache, and extreme sinus drainage/post nasal drip which hasn't let up yet and I'm still experiencing these symptoms.",,,,,,,,,N,09/12/2019,09/12/2019,0,,PHM,,"Levothyroxine, Liothyronine, magnesium, melatonin, Ashwaganda (adaptogen blend), milk thistle, turmeric, probiotic, collagen, vitamin d, hair/skin/nails gummy vitamin",none,low thyroid,,,2,09/13/2019,,,,Benzoin allergy
0833487,09/13/2019,MA,55.0,55,,F,,"""red marks like blotches on my chest area and shoulders""",,,,,,,,,U,09/10/2019,09/10/2019,0,None,PVT,,levothyroxine,None,None,,,2,09/13/2019,,,,none
0833488,09/13/2019,LA,1.67,1,.7,M,,"RED, MILD HOT/ INDURATED 4 X 5 CM AREA ON ANTERIOR LT. THIGH AT INJECTION SITE. TACTILE FEVER ON 09/13/2019 A.M RX- ORAL MOTRIN.;  SEEN TODAY AND RX 9/13/2019- TMP/SMX 7 ML P.O. BID X 7 DAYS ; DIPHENHYDRAMINE 2.5 ML Q6H PRN",,,,,,,,,U,09/11/2019,09/12/2019,1,,PVT,,,,,,,2,09/13/2019,,,,NKDA
0833489,09/13/2019,KS,98.0,98,,F,,Res had palpitations that started in the evening of 8/3/19.  Physician notified.,,,,,,,,,Y,08/02/2019,08/03/2019,1,Res had appointment with Dr. on 8/9/19.   He gave order to fill out Vaers form from CDC on PVC 13.  No other information provided from Physician.,SEN,,Propranolol Synthroid Vitamin D3 Florajen KCL Allegra Aspirin Multivitamin Magnesium Vitamin C Lasix Celexa Calcium Simvastatin Systane eye drops,No,Hypertension Chronic Atrial  Fib Hypothyroidism Heart Failure Depression Osteoporosis,,,2,09/13/2019,,Y,,NKDA
0833490,09/13/2019,TX,1.0,1,.0,M,,"Developed cellulitis in the area the vaccine was administered.  Started ~7 days after vaccine was administered.  Developed fever, redness, induration at that site.  Started on oral antibiotics to treat it.",,,,,,,,,U,08/27/2019,09/05/2019,9,n/a,PVT,,n/a,n/a,n/a,,,2,09/13/2019,,Y,,n/a
0833493,09/13/2019,WI,,,,U,,"no known adverse effects; patient received a dose of M-M-R II via the intramuscular route in error; patient received a dose of M-M-R II via the intramuscular route in error; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On 23-AUG-2019, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (exact dose, injection site, lot # and expiration date were not reported) for prophylaxis via intramuscular route in error. There was no known adverse effects reported.",,,,,,,,,U,08/23/2019,08/23/2019,0,,UNK,,,,,,US0095075131908USA009520,2,09/13/2019,,,,
0833494,09/13/2019,NJ,,,,U,,"no adverse effects; improperly stored vaccine administered; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On 23-AUG-2019, the patient was vaccinated with improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) lot # R035227, expiration date 01-JAN-2020 (exact dose, injection site and route of administration were not reported) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 50 degrees Fahrenheit for 49 minutes. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. There was no adverse effects reported.",,,,,,,,,U,08/23/2019,08/23/2019,0,,UNK,,,,,,US0095075131908USA009539,2,09/13/2019,,,,
0833495,09/13/2019,FL,27.0,27,,U,,"No adverse effects; the patient inadvertently received proquad due to medication error; This spontaneous report as received from a nurse refers to a 27-year-old patient of unknown gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 20-JUN-2019, the patient was inadvertently vaccinated with the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection (lot number, expiration date and route of administration were not reported) dose of 0.5 ml, diluted in sterile diluent. The patient received the vaccine due to medication error. It was unknown if the intended vaccine was measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) or varicella virus vaccine live (Oka/Merck) (VARIVAX). Confirmed that was not product confusion. No adverse effects were reported.",,,,,,,,,U,06/20/2019,06/20/2019,0,,UNK,,sterile diluent,,,,US0095075131908USA012667,2,09/13/2019,,,,
0833496,09/13/2019,,,,,M,,"sore arm; This case was reported by a other health professional via sales rep and described the occurrence of pain in arm in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 49 or 50 years. It was reported that the patient had 2 to 3 days of a sore arm and went away on its own. The reporter did not agree to follow up.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,,
0833497,09/13/2019,,,,,F,,"Fever; Chills; Soreness; Chest Pain; Difficulty breathing; This case was reported by a consumer via call center representative and described the occurrence of fever in a female patient who received Men B NVS (Bexsero) for prophylaxis.   Previously administered products included Bexsero with an associated reaction of pyrexia (received 1st dose on an unknown date and experienced chills, difficulty in breathing, refer case US2019161286).   On an unknown date, the patient received the 2nd dose of Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced fever, chills, pain, chest pain and difficulty breathing. Rechallenge with Bexsero was positive. On an unknown date, the outcome of the fever, chills, pain, chest pain and difficulty breathing were unknown.   It was unknown if the reporter considered the fever, chills, pain, chest pain and difficulty breathing to be related to Bexsero.  Additional details were provided as follows: This case was reported by patient's mother. The age at vaccination was not provided. The reporter stated that, after vaccination, the patient experienced fever of 103.4 degree C. The patient's physician recommended for emergency room visit. No further details were provided. The reporter did not want to provide any demographic or address information.      Lab Comments: on a unknown date, patient had fever",,,,,,,,,U,,,,"Test Name: Body temperature; Result Unstructured Data: Test Result: 103.4, Test Result Unit: degree C",UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,Y,
0833498,09/13/2019,NJ,71.0,71,,F,,"Have pain in my arm; This case was reported by a consumer and described the occurrence of pain in arm in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In July 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional information received were as follows: The patient experienced pain in arm. The patient waanted to know whether how long should this pain exist and should she get her second shot while her arm was still hurting at the time of reporting.",,,,,,,,,N,07/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,,
0833499,09/13/2019,TX,62.0,,,F,,"My arm stated hurting; I got a headache; Felt feverish; Feel like I have the flu; This case was reported by a consumer and described the occurrence of pain in arm in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu unspecified (Flu vaccine) for prophylaxis.   On 4th September 2019, the patient received the 1st dose of Shingrix and Flu vaccine. On 4th September 2019, 4 hrs after receiving Shingrix and Flu vaccine, the patient experienced pain in arm. In September 2019, the patient experienced headache, feeling hot and influenza like illness. On an unknown date, the outcome of the pain in arm, headache, feeling hot and influenza like illness were unknown.   It was unknown if the reporter considered the pain in arm, headache, feeling hot and influenza like illness to be related to Shingrix and Flu vaccine.  Additional case details were reported as follows: The patient got the first Shingrix vaccine the day before reporting. The patient received vaccine in unknown arm. The patient's husband did as well. They asked their local pharmacist about side effects, and he didnt seem to think there were any unusual ones. The patient arm stated hurting about 4 hours later, got a headache and felt feverish overnight and still do. The patient felt almost like that she had the flu. It has been about 30 hrs. since the injection. The patient reported that we did also get the flu shot at the same time, but we had got it many times with no side effects.  Our pharmacist said it should not cause a problem. The reporter requesting consent to follow up.",,,,,,,,,U,09/04/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,,
0833500,09/13/2019,GA,80.0,,,F,,"lymphoma side effects of itchy feet and odd feeling to her left ear had resolved; This case was reported by a consumer via call center representative and described the occurrence of unexpected therapeutic drug effect in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included lymphoma, pruritus (Itchy feet) and night sweat.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced unexpected therapeutic drug effect. On an unknown date, the outcome of the unexpected therapeutic drug effect was unknown.   It was unknown if the reporter considered the unexpected therapeutic drug effect to be related to Shingrix.  Additional details were provided as follows: The patient stated that shortly after vaccination she noticed that her lymphoma side effects of itchy feet and odd feeling to her left ear had resolved, and her night sweats, also a side effect of her lymphoma, was not as bad. The patient went to her oncologist. The patient was due for her second Shingrix vaccination at the end of September. The patient consented to follow up.",,,,,,,,,U,,,,,UNK,,,Lymphoma; Night sweat; Pruritus (Itchy feet),,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,Y,,
0833501,09/13/2019,CA,,,,F,,"severe arthralgia; pleuritic pain; confusion; making stupid mistakes; myalgia; upset stomach; fever of approximately 100 degrees; chills; shakes; feeling weak; unable to get out of bed; This case was reported by a physician via call center representative and described the occurrence of myalgia in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of myalgia (after receiving 1st dose, see case US2019AMR166034).   On 3rd September 2019, the patient received the 2nd dose of Shingrix. On 3rd September 2019, less than a day after receiving Shingrix, the patient experienced myalgia, upset stomach, fever, chills, tremor and feelings of weakness. On an unknown date, the patient experienced arthralgia, pleuritic pain, bedridden, confusion and behavior abnormal. On an unknown date, the outcome of the myalgia, upset stomach, fever, chills, tremor, arthralgia, pleuritic pain, bedridden, confusion and behavior abnormal were recovered/resolved and the outcome of the feelings of weakness was not recovered/not resolved.   It was unknown if the reporter considered the myalgia, upset stomach, fever, chills, tremor, feelings of weakness, arthralgia, pleuritic pain, bedridden, confusion and behavior abnormal to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number of Shingrix vaccine was not reported. The physician reported that, approximately 10 am on 3rd Septrember 2019, the patient received 2nd dose of Shingrix. After vaccination, the patient developed severe arthralgia, pleuritic pain, which described as pain on inhalation. The reporter reported that, the patient could not get out of bed for almost 2 days and also mentioned that, during those two days post vaccination experienced confusion, and making stupid mistakes on the computer. The confusion described as telling her son the same things more than once. The patient had fever of approximately 100 degrees. The patient stated that, at the time of reporting, the symptoms were recovered, but stii had feeling weak. The reporter consented to follow up. No further details were provided.",,,,,,,,,N,09/03/2019,09/03/2019,0,"Test Date: 20190903; Test Name: Body temperature; Result Unstructured Data: Test Result: Approximately 100, Test Result Unit: degree F",UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833502,09/13/2019,TX,74.0,74,,M,,"sack of fluid on elbow; numbness feeling on left arm; soreness at injection site; bruise at injection site; difficulty lifting arm; rash on chest; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th July 2019, the patient received the 1st dose of Shingrix (intramuscular). On 6th July 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, injection site bruising, injected limb mobility decreased and rash. On 9th July 2019, the patient experienced elbow bursitis and numbness of upper extremities. On 13th July 2019, the outcome of the injection site bruising, injected limb mobility decreased and rash were recovered/resolved. On 9th August 2019, the outcome of the elbow bursitis and numbness of upper extremities were recovered/resolved. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site bruising, injected limb mobility decreased, rash, elbow bursitis and numbness of upper extremities to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left deltoid. The patient experienced difficulty lifting arm, rash on chest, sack of fluid on elbow and numbness feeling on left arm. The patient planned to follow up with his pharmacist on an unknown date. The reporter consented to follow up.",,,,,,,,,Y,07/06/2019,07/06/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833503,09/13/2019,PA,,,,U,,"Hives; This case was reported by a pharmacist via call center representative and described the occurrence of hives in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   Concurrent medical conditions included allergic reaction.   On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, unknown after receiving Flu vaccine, the patient experienced hives. On an unknown date, the outcome of the hives was unknown.   It was unknown if the reporter considered the hives to be related to Flu vaccine.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced hives with the flu vaccine. The pharmacist inquired if a patient who was allergic to the flu shot (unknown if it was a GSK brand or non-GSK), would be okay to get the Shingrix vaccine. The healthcare professional declined to leave any patient demographics. The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,Allergic reaction,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833505,09/13/2019,WI,50.0,50,,F,,"Patient reports onset 1 day ago with redness at injection site, feverish, started the morning after injection. Today redness still at injection site, are is warm to touch, pain at site, area is ""hard"". Patient states she has been taking tylenol for the pain and fever. Ice to injection site",,,,,,,,,U,09/10/2019,09/12/2019,2,None done,PVT,,"Allegra, clindamycin, fluticasone propionate, levothyroxine, meclizine, metronidazole, montelukast, ProAir HFA, simvastatin, valacyclovir",unkn,"asthma, rosacea, HS1, hypothyroism, hyperlipidemia, othrostatic hypotension",,,2,09/12/2019,,Y,,"augmentin, levaquin"
0833506,09/13/2019,MA,52.0,52,,M,,-pt arrived on 9/7/19 at pharmacy presented with  a non raised Red Blotchy Rash on medial left arm -referred pt to pcp -follow up with pt. pt has not responded to calls  pt has not responded to follow up requests,,,,,,,,,U,09/05/2019,09/07/2019,2,not known,PHM,,,,K21.9 I10 E78.2,,,2,09/08/2019,,,,NKA
0833507,09/13/2019,NY,71.0,71,,M,,"Patient returned to pharmacy and stated he received 3 doses of Shingrix. Confirmed patient was vaccinated on 8/8/2018, 12/27/2018, 9/10/2019.",,,,,,,,,,09/10/2019,09/13/2019,3,,UNK,,,,,,,2,09/13/2019,,,,
0833508,09/13/2019,IN,27.0,27,,F,,None stated.,,,,,,,,,,09/12/2019,09/13/2019,1,,WRK,,N/A,N/A,N/A,,,2,09/13/2019,,,,"Sulfa base, codiene"
0833509,09/13/2019,CA,1.42,1,.4,F,,"Patient fell asleep on the way home from her vaccinations. She woke up within an hour or so. Around 3:00pm she spiked a fever of 104.4 so I gave her Tylenol. 4-6 hours later I gave her Motrin and a luke warm bath. Her fever remained high for 3 consecutive days and eventually breaking by day 4. I continued alternating the motrin/tylenol during this time as medical professionals in my family suggested. During that time, she began banging her head like she was in pain, screaming a very loud pitch sound I had never heard before and just wasn't ""herself"" The fever broke, but her behaviors continued. Within 4-6 weeks she lost all words, eye contact, and socialization. Her behaviors remained the same and I then took her into her Pediatrician. Her doctor referred us to a Ped Neurologist where they then began tests. She began to have chronic ear infection and tubes were placed in July 2018 by Dr at the Medical Clinic.",,,Y,,,,,Y,N,10/06/2017,10/06/2017,0,Full Labs- Chromosomal testing done- All negative 5-18-18 Chronic Ear Infections with tubes placed 7-2018 Autism Diagnosis 7-20-2018 Hearing Screening 7-27-2018- Passed MTHFR Genotype- Homogygous (2 copies) C677T - Positive Global Developmental Delay  Aug 2019 Mixed Receptive Expressive Language Disorder- Aug 2019 Sleep Disturbance Disorder Aug 2019,PVT,,none,none,none,High Fevers,,2,09/13/2019,,Y,,none
0833510,09/13/2019,,11.0,11,,M,,"Lightheadedness, fatigue, borderline low blood pressure",,,,,,,,,,09/13/2019,09/13/2019,0,,PVT,,"Ginkgo biloba, fish oil, iron",None,ADHD,,,2,09/13/2019,,Y,,None
0833511,09/13/2019,TN,4.0,4,,F,,Mild localized reaction with induration 48 hrs after vaccines were given in reaction to ProQuad and Kinrix vaccinations.,,,,,,,,,U,09/11/2019,09/13/2019,2,,PVT,,,,,,,2,09/13/2019,,Y,,
0833512,09/13/2019,OH,3.0,3,,M,,My son was given his dtap and polio vaccines 9 days before he turned 4. So now he might have to have them again.,,,,,,,,,U,11/21/2017,09/12/2019,660,,PVT,,None,None,None,,,2,09/13/2019,,,,None
0833513,09/13/2019,AZ,66.0,66,,M,,"I developed the typical symptoms beginning about 8 hours after the shot.  Soreness at injection sight, muscle aching throughout my body, nausea and feeling feverish.  However, beginning about 8 hours after the shot my nose began turning red and throbbing with pain.  It looked/looks like a severe sunburn, however I haven't been out in the sun for more than a few minutes.  I received the Vaccine on Monday, 9-9-19.  It is now Friday, 9-13-19 and my nose is finally getting a little better.  It is less red and less sore.  I returned to the Pharmacist who administered the Vaccine and she said she had never heard or seen this before.",,,,,,,,,N,09/09/2019,09/09/2019,0,,PHM,,"Pravastatin, Omeprazole, 81mg aspirin, Repaglinide, Linsinopril, Metformin, Levimir, Metoprolol, Preservision AREDS 2 + Multi Vitamin, OsteoBiflex",None,Diabetic,,,2,09/13/2019,,,,None
0833514,09/13/2019,AZ,41.0,41,,F,,"9 days after vaccine administration (5/15/19), developed fairly acute onset of headache, chills and malaise.  Over the subsequent 4 days she developed  worsening arthralgias, starting in distal medium joints that progressed to generalized arthralgias to the point that she had difficulty ambulating.  On 5/20/19 admitted to hospital for 24 hr observation and started on a 6 week course of steroids.  She had to cancel her planned overseas trip for which she received the vaccinations in the first place. She went on to a complete recovery of her symptoms over the subsequent weeks of treatment with steroids and has no permanent sequelae or persistent symptoms.",,,,,,,,,Y,05/06/2019,05/15/2019,9,"No medical records or results available to this reporter. Per the patient, extensive bloodwork obtained in the hospital (about 5/20/19 -including inflammatory markers in the normal range) showed no apparent   etiology for her symptoms.",PVT,,none,none,none,,,2,09/13/2019,,,,rash with cefalexin
0833515,09/13/2019,CA,67.0,67,,F,,Radiating pain from joints. Extreme fatigue Lightheadedness Not able to continue giving lecture,,,,,,,,,U,09/11/2019,09/12/2019,1,none,PVT,,Metopropanol 100 mg Losartan 100 mg,bitten by tick,None except HBP genetic,,,2,09/13/2019,,,,PCN Walnuts Pinenuts Wool
0833516,09/13/2019,NV,67.0,67,,F,,"On 9/12/19 around 4 pm the client developed redness, swelling, pain at injection site (right deltoid area) and  pain upon moving right arm.  Per the client the redness was about the size of her palm and the swelling went from her upper arm down to her elbow. She took an Ibuproten last night for pain. This morning the client states her arm isn't as red, swollen or as  painful.  She still has pain upon movement of her arm. The client was encourage to contact her doctor especially if her symptoms became worse.",,,,,,,,,U,09/12/2019,09/12/2019,0,None at this time,PUB,,"Metromidazole 500 mg, Cetphalxin 500mg,",Urinary tract infection,Fatty liver disease,,,2,09/13/2019,,,,No known allergies
0833517,09/13/2019,VT,76.0,76,,F,,"Very tired one day after injection. Next day (second day after vaccine) started having aches in joints mostly on left side of body?knee, ankle, wrist. Then muscles aches on left.. Tingling started in left foot and left hand, traveled up leg. Over the next few days knee and ankle on right side had aches, and tingling spread to both feet, shins, hands, face including eyelids, inside eyes, inside mouth, side of face. Swelling developed behind left knee which primary care doctor thought could be popliteal cyst from possible arthritis in left knee irritated by immune response to vaccine. Now can?t bend left knee easily. as too painful. Now three and a half weeks out, most joint aches are gone except for left knee but tingling has continued, moving to different parts of body including face, especially eyelids, feet, hands, legs.",,,,,,,,,N,08/20/2019,08/22/2019,2,None,PVT,,"Diltiazem, metoprolol, calcium, magnesium, lutein zeaxanthin, multi-vitamin",None,Osteoporosis  Small brain aneurysms Hypertension,,,2,09/13/2019,,,,none
0833518,09/13/2019,WV,66.0,66,,F,,"The patient called to let us know that he arm that she had gotten her shingrix shot in was red, and hot radiating down from the injection site to her elbow. She did not notice this reaction until Friday morning and got the vaccine on Wednesday evening.",,,,,,,,,,09/11/2019,09/13/2019,2,,PHM,,,,,,,2,09/13/2019,,,,
0833519,09/13/2019,NY,66.0,66,,M,,"The onset of pain occurred almost immediately, the pain worsened and continued in the following days. The pain was a burning, aching and throbbing sensation that took over my left shoulder. As the days progressed my range of motion and strength in my left arm was severely limited. It became difficult to put on clothes and sleep on my left side. I saw my PCP and was given Celebrex, I went to a chiropractor for soft tissue laser treatments to reduce the pain and inflammation. I was admitted to Hospital on March 9,2019 due to a total loss of function on my left arm and extreme pain from my shoulder down to my left hand and across the left side of my chest. I was prescribed steriods.",,,,,,,,,U,01/09/2019,01/10/2019,1,2/20/19 was given an X-Ray by an orthopedist. 3/9/19 had a MRI and Ultrasound test. 3/13/19 was given another X-Ray and MRI by an orthopedist. 4/10/2019 had a EMG test.,PVT,,"metoprolol succinate 50mg, lipitor 10mg,xanax .25mg",elevated blood pressure,none,,,2,09/13/2019,,Y,Y,none
0833520,09/13/2019,CA,29.0,29,,F,,"Client experienced malaise, achiness, and headache that lasted until the next day. Client also experienced a fever of 104 for approximately 5 hours; unrelieved by Tylenol.",,,,,,,,,Y,06/25/2019,06/25/2019,0,,PUB,,,,Epilepsy: last seizure at 29 yrs old Juvenile Schizophrenia,,,2,09/13/2019,,,,Neosporin: makes pus worse in wounds Cephalexin: hives
0833521,09/13/2019,MD,69.0,69,,M,,About 3.5 hours after the shot was administered patient experienced body aches congestion headache and slight fever lasted the entire next day and by thursday morning had resolved/gone away. Also patient complained of a very sore arm.,,,,,,,,,Y,09/03/2019,09/03/2019,0,,PHM,,Atorvastatin Lisinopril,,,,,2,09/13/2019,,,,
0833522,09/13/2019,VA,80.0,80,,F,09/12/2019,"Patient stated that 1 hr after immunization she developed a headache and vision problems (blurred vision and flashing) that lasted approx. 3 hours. Also reported a line under injection site that was red, hot, and itchy and had burning pain in the area. She stated rash was slowly diminishing.",,,,,,,,,Y,09/04/2019,09/05/2019,1,none,OTH,PVT,,unknown,unknown,,,1,,,,,
0833526,09/13/2019,PA,,,,U,,"patient received one improperly stored dose of PROQUAD; no adverse effects; This spontaneous report was received from a medical assistant concerning to an patient of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions or concomitant medications.  Since 12-JUL-2019, vaccines had a temperature excursion.  On 14-AUG-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) lot number S008570 with expiration date on 16-SEP-2020 (dosage schedule, route and anatomical location were not reported) for prophylaxis.  Administered doses of vaccine experienced temperature excursion of 5 degrees Celsius (C)  for more than 30 days. The excursion ended on 05-SEP-2019. There was no previous temperature excursion. Digital data logger was not involved. No adverse effects were reported.",,,,,,,,,U,08/14/2019,,,,UNK,,,,,,US0095075131909USA002380,2,09/13/2019,,,,
0833527,09/13/2019,PA,,,,U,,"no adverse effects; patient received one improperly stored dose of PROQUAD; This spontaneous report was received from a medical assistant concerning to an patient of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions or concomitant medications.  Since 12-JUL-2019, vaccines had a temperature excursion.  On 14-AUG-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) lot number S008570 with expiration date on 16-SEP-2020 (dosage schedule, route and anatomical location were not reported) for prophylaxis.  Administered doses of vaccine experienced temperature excursion of 5 degrees Celsius (C)  for more than 30 days. The excursion ended on 05-SEP-2019. There was no previous temperature excursion. Digital data logger was not involved. No adverse effects were reported.",,,,,,,,,U,08/27/2019,08/27/2019,0,,UNK,,,,,,US0095075131909USA002400,2,09/13/2019,,,,
0833528,09/13/2019,IL,,,,U,,"no adverse event; The patient received an improperly stored PROQUAD; This spontaneous report was received from a nurse concerning a 4 year old male patient of unknown gender. No information was provided regarding the patient's pertinent medical history, concurrent conditions or drug reactions/allergies.    On 12-AUG-2019 and on 13-AUG-2019, the vaccine Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) experienced two temperature excursions each date respectively. On 19-AUG-2019, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot # R026722, expiration date 17-MAR-2020) or (lot # R023499, expiration date 13-FEB-2020) for prophylaxis (strength, dose, frequency, route of administration, lot number and expiration date were not reported) (product storage error). The vaccine was reconstituted with properly stored sterile diluent (lot # and expiration date were not reported). The administered dose of the vaccine experienced a temperature excursion of -14C to -10C (-11.91 C, multiple) for 8 hours, as recorded by a data logger. There was no adverse effect reported.",,,,,,,,,U,,08/19/2019,,,UNK,,sterile diluent,,,,US0095075131909USA002867,2,09/11/2019,,,,
0833529,09/13/2019,IL,,,,U,,"No adverse effect reported; one patient received an improperly stored VARIVAX; This spontaneous report was received from a registered nurse referring to a 3-year-old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications.  On 28-AUG-2019, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) lot # R006221 with expiration date 29-FEB-2020 or R029517 with expiration date 14-OCT-2020 (reported as 14 of unknown month 2020) (dosage schedule, route and anatomical location were not reported), for prophylaxis (incorrect product storage). The vaccine was reconstituted with properly stored sterile diluent. No adverse effects were reported.  On 12-AUG-2019 and 13-AUG-2019, administered doses of vaccine experienced temperature excursion of -14 degrees Celsius (C) to -10 C (-11.91 C) for 8 hours. There was no previous temperature excursion. Digital data logger was involved.",,,,,,,,,U,,08/28/2019,,,UNK,,sterile diluent,,,,US0095075131909USA003259,2,09/13/2019,,,,
0833530,09/13/2019,NY,,,,F,,"Patient is 16 year old female who is hospitalized with VZV Meningitis; This spontaneous report was received from a physician referring to a 16-year-old female patient. The patient's past medical history, concurrent condition and concomitant medications were not reported. On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose, route, lot/batch, expiry date not reported) when she was a child for prophylaxis. The physician reported that the patient was in hospital with VZV meningitis (varicella zoster virus meningitis (herpes zoster meningitis)) documented on polymerase chain reaction (PCR) with a rash on her left arm for several weeks that was painful. The physician believed that VZV meningitis was not classic, but vaccine associated zoster. The patient was having an immune work-up. The physician was planning to test the cerebrospinal fluid (CSF) and see if this was a wild type or vaccine strain. The outcome of the event herpes zoster meningitis was not reported. The reporter considered the event herpes zoster meningitis to be related to varicella virus vaccine live (Oka/Merck)(VARIVAX).  Upon internal review, the event herpes zoster meningitis was determined to be medically significant.",,,,,Y,,,,U,,,,,UNK,,,,,,US0095075131909USA004129,2,09/13/2019,,,,
0833531,09/13/2019,TX,68.0,68,,F,,"redness on injection site; swelling on injection site / huge knot; Injection site knot; neck swelling; neck pain; neck stiffness; This case was reported by a nurse and described the occurrence of injection site erythema in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number 4G5HX, expiry date 9th July 2021) for prophylaxis.   Previously administered products included Keflex, Naproxen and Simvastatin.   On 8th March 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 8th March 2019, less than a day after receiving Shingrix, the patient experienced injection site erythema, injection site swelling, injection site lump, neck swelling, neck pain and stiff neck. On an unknown date, the outcome of the injection site erythema, injection site swelling, injection site lump, neck swelling, neck pain and stiff neck were unknown.   It was unknown if the reporter considered the injection site erythema, injection site swelling, injection site lump, neck swelling, neck pain and stiff neck to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in right deltoid. The patient experienced redness, swelling on injection site. After vaccine the patient reported a huge knot and redness neck stiffness. The patient complained of neck swelling and pain",,,,,,,,,U,03/08/2019,03/08/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,,
0833532,09/13/2019,VA,,,,M,,"Heptatis A infection; Incomplete course of vaccination; This case was reported by a consumer via call center representative and described the occurrence of hepatitis a in a male patient who received HAV (Havrix adult) for prophylaxis.   Co-suspect products included HAV (Havrix adult) for prophylaxis.   On an unknown date, the patient received the 1st dose of Havrix adult and Havrix adult at an unknown dose. On an unknown date, several years after receiving Havrix adult and not applicable after receiving Havrix adult, the patient experienced hepatitis a and incomplete course of vaccination. On an unknown date, the outcome of the hepatitis a and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the hepatitis a to be related to Havrix adult.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the vaccine years ago and experienced hepatitis A. Till the time of reporting the patient had not received the booster dose, which led to incomplete course of vaccination. The patient stated that the health department told her to just get the booster vaccination, but the centers for disease control (CDC) told to get the Havrix series again. This case has been considered as medication error associated with adverse event. This case has been linked with case US2019158421, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,,
0833533,09/13/2019,IL,56.0,56,,F,,"Raised bump at injection site / golf ball size; Swollen tongue; Cough; This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number BP57E, expiry date 7th December 2021) for prophylaxis.   On 28th August 2019, the patient received Shingrix (intramuscular). On an unknown date, less than a week after receiving Shingrix, the patient experienced injection site swelling, swollen tongue and cough. The patient was treated with benadryl (nos) (Benadryl) and prednisone. On an unknown date, the outcome of the injection site swelling, swollen tongue and cough were unknown.   It was unknown if the reporter considered the injection site swelling, swollen tongue and cough to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left deltoid. On the reporting date, the patient informed the pharmacist that after an unspecified time after the injection, she experienced a raised bump on the injection site that turned into golf ball size, which led to extensive swelling of vaccinated limb. The patient also experienced a swollen tongue and cough. The patient went to an emergency department and was given Benadryl and prednisone, monitored for 2 hours, and sent home. The reporter consented to follow up. The emergency room visit required.",,,,,,,,,U,08/28/2019,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,Y,
0833534,09/13/2019,LA,65.0,65,,F,,"My left arm hurt a great deal all the time for 2 weeks after getting the vaccine on Jan. 15, 2019, with stiffness beginning in my both my arms. I woke up around the date of  Jan. 25, 2019 and could not left myself up from my bed because my arms were too weak and I couldn't lift them up. I had to roll out of bed and crawl to a chest of drawers to pull myself up using the knobs.   Along with that, my hips and legs became stiff and painful. By Jan. 31 and shortly before that date, I had trouble walking and could only take small steps. After taking Prednisone 10mg  starting May 13, 2019 I felt as I could finally walk and move well.  On this date of 9-13-19 I still feel a lot of pain in my arms and legs and the pain comes and goes.  A rheumatologist confirmed  on July 29, 2019 that I have Polymyalgia. I've tapered off to 7 mg a day of Prednisone but still feel the symptoms, although I can get out of bed easier and walks outside a few times a week when the pain isn't severe.",,,,,,,,,N,01/15/2019,01/16/2019,1,"I had only 5 mins left. I will describe over the phone but I had a MRI, blood tests, nerve tests...",PVT,,"Eszopiclone -1.5 mg,  Olmesaartan Medoxomil 20 mg, Lithium Carbonate 300 mg  daily",None,High blood pressure which is controlled by bp medicine.  Depression which is controlled by seeing a social worker and taking 1 dose of 300 mg Lithium a day.,,,2,09/13/2019,,,,None
0833535,09/13/2019,CA,30.0,30,,F,,"Client complained of achiness, malaise, headache that started that night and went into the next day. Client complained of a fever of 101 that lasted approximately 5 hours; unrelieved by Tylenol. Client had a golf ball sized swollen lymph found on 9/12/19 by client; was resolving on 9/13/19 at 8:45 am when examined by M.D. and nurse (myself), no longer visible, just slightly swollen and tender to the touch.",,,,,,,,,Y,09/10/2019,09/10/2019,0,,PUB,,,"Client was possibly exposed to an illness; boyfriend sick from 9/11/19-9/13/19 Boyfriend complaining of achiness, fever and headache.",Epilepsy; last seizure at 29 yrs old Juvenile Schizophrenia,,,2,09/13/2019,,,,Neosporin: makes pus to wounds worse Cephalexin: hives
0833536,09/13/2019,,60.0,60,,F,,pt came in with rash at injection site reaction,,,,,,,,,,09/10/2019,09/13/2019,3,,PHM,,,,,,,2,09/13/2019,,Y,,
0833537,09/13/2019,KY,66.0,66,,F,,"Pt reported ""sore, red, warm, puffed out"" area 2.5in x 4in ""moving down on inside of arm.""",,,,,,,,,U,09/06/2019,09/07/2019,1,,PHM,,,,,"red, edema (likely from previous flu shot)",,2,09/13/2019,,,,"Penicillin, Biaxin, Lipitor, Betadine"
0833538,09/13/2019,NE,79.0,79,,F,,Patient received the vaccine on 9/7/19 and started getting chills that evening.  The next morning the patient noticed painful welts on arms and a lump around the injection site.  Patient has been lathargic the following the 5 days.  The pharmacy left a message with the patient physician to make them aware of the fact that patient and the physician followed up with the patient.,,,,,,,,,U,09/07/2019,09/07/2019,0,,PHM,,,,,,,2,09/13/2019,,,,"Several medication allergies, blood pressure medications, pain medications. diabetic medications"
0833539,09/13/2019,MO,70.0,70,,F,,"Beginning the evening of the vaccine, she developed a small erythematous wheal. This has progressed over the intervening 2 days to encompass a large area, ~10cm in length, 6cm in width around the area of injection. it is hot, and tender. Skin is mildly edematous.",,,,,,,,,N,09/11/2019,09/11/2019,0,,PHM,,"Omeprazole, Ranitidine",,"IBS. Subglottic Stenosis, Osteoporosis",,,2,09/13/2019,,Y,,Ibuprofen causes hives
0833540,09/13/2019,TX,63.0,63,,M,,"I had a sore arm and body aches and a mild fever and mild diarrhea from 8/7/19 to 8/8/19  On the evening of 8/13/19 I felt extremely tired, so went to bed around 9 pm. I woke up in the middle of the night to go to the bathroom but was unsteady. Went back to sleep and woke up late around 7:40 am, and was disoriented. My wife tells me I shaved with toothpaste, and when I spoke it was gibberish. She took me to a minor emergency place where they started doing tests. Was there from 10:30 am to around 4 pm. then was transferred to hospital for further evaluation and more tests.",,,,,Y,1,,,Y,08/06/2019,08/13/2019,7,"At the minor emergency place on 8/14/19 performed the following: EKG, Blood Culture, Metlac, Urine analysis, Bedside Glucose, CBC with Diff, CMP, Cardiac Profile, D-Dimer, Chest Views, CT Head/Brain WO Contrast. At the hospital on 8/15/19 they did Procedure Date Performed Status ROUTINE VENIPUNCTURE August 14th, 2019 completed ROUTINE VENIPUNCTURE August 14th, 2019 completed CT HEAD/BRAIN W/O DYE August 14th, 2019 completed MR ANGIOGRAPHY HEAD W/O DYE August 14th, 2019 completed MR ANGIOGRAPHY NECK W/DYE August 14th, 2019 completed MRI BRAIN STEM W/O DYE August 14th, 2019 completed METABOLIC PANEL TOTAL CA August 14th, 2019 completed COMPREHEN METABOLIC PANEL August 14th, 2019 completed LIPID PANEL August 14th, 2019 completed ASSAY OF CK (CPK) August 14th, 2019 completed CREATINE MB FRACTION August 14th, 2019 completed GLYCOSYLATED HEMOGLOBIN TEST August 14th, 2019 completed ASSAY OF MAGNESIUM August 14th, 2019 completed ASSAY OF PHOSPHORUS August 14th, 2019 completed ASSAY THYROID STIM HORMONE August 14th, 2019 completed ASSAY OF TROPONIN QUANT August 14th, 2019 completed COMPLETE CBC W/AUTO DIFF WBC August 14th, 2019 completed COMPLETE CBC AUTOMATED August 14th, 2019 completed PROTHROMBIN TIME August 14th, 2019 completed THROMBOPLASTIN TIME PARTIAL August 14th, 2019 completed EVALUATE SWALLOWING FUNCTION August 14th, 2019 completed ELECTROCARDIOGRAM TRACING August 14th, 2019 completed TTE W/DOPPLER COMPLETE Got evaluated by a cardiologist for rapid pulse on  8/21/19",PHM,,"LIPITOR 10MG, METFORMIN ER 500MG, TIMOPTIC 0.5% EYE DROPS, TRIPLE STRENGTH FISH OIL, CO-Q10 100MG",NONE,,,,2,09/13/2019,,Y,Y,ALLERGIC TO WALNUTS & PECANS
0833541,09/13/2019,NV,66.0,66,,M,,Pateint States extreme overall body malaise and fatigue as well as pain in upper right extremity. Injection site was right deltoid. There is also presence of an approximately six inches in diameter welt/rash in area just distal and medial to the injection site in the deltoid.,,,,,,,,,Y,09/10/2019,09/01/2019,,,PHM,,"amlodipine, losartan,",na,na,,,2,09/13/2019,,,,na
0833542,09/13/2019,TX,68.0,68,,F,,pt came in today with a 1 inch by 1/2inch yellowing-bruise on her arm - she said it was there the next day after her flu shot- arm doesn't hurt to move - muscle hurts a little,,,,,,,,,Y,09/01/2019,09/02/2019,1,no test- no medical person seen,PHM,,zolpidem and raloxifene and escitalopram,no known,no known,,,2,09/13/2019,,,,no known
0833543,09/13/2019,NV,63.0,63,,F,,Pateint presented with an approximately 4 to 6 inch in diameter rash/welt in upper left extremity. It was distal and medial to the injection site in the left deltoid. She also stated the area to be more painful than expected.,,,,,,,,,U,09/02/2019,09/01/2019,,,PHM,,,,,,,2,09/13/2019,,,,
0833544,09/13/2019,TX,60.0,60,,F,,"chills, fever (101.8), muscle cramps, shivering, headache, body aches",,,,,,,,,Y,09/10/2019,09/10/2019,0,NA,WRK,,"vitamins from GNC, tylenol",none,none,,,2,09/13/2019,,,,Iodine
0833547,09/13/2019,MI,71.0,71,,F,,"Intramuscular formulation administered by other route; Tenderness; Redness; Swelling; This case was reported by a consumer via call center representative and described the occurrence of tenderness in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 4th July 2019, the patient received the 1st dose of Shingrix (intramuscular). On 3rd September 2019, the patient received the 2nd dose of Shingrix. On 4th July 2019, 30 min after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced tenderness, erythema and swelling. On 3rd September 2019, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the tenderness, erythema and swelling were recovered/resolved and the outcome of the intramuscular formulation administered by other route was unknown.   It was unknown if the reporter considered the tenderness, erythema and swelling to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left arm. Approximately 30 minutes after the injection, the patient experienced tenderness, redness, and swelling. After 36 hours, the symptoms resolved. The patient received 2nd dose of Shingrix, was not administered intramuscularly because she didn't even feel the vaccine going into her muscle, which led to inappropriate route of vaccine administration. The patient experienced no local site reaction at all. The reporter consented to follow up. The reporter could follow-up with the patient directly.",,,,,,,,,Y,07/04/2019,09/03/2019,61,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833548,09/13/2019,,,,,M,,"Pain at injection site; Swelling at injection site; Joint pain; Body aches; Upset stomach; Fatigue; Headache; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd September 2019, the patient received the 1st dose of Shingrix. In September 2019, 10 hrs after receiving Shingrix, the patient experienced injection site pain, injection site swelling, joint pain, general body pain, upset stomach, fatigue and headache. On an unknown date, the outcome of the injection site pain, injection site swelling, joint pain, general body pain, upset stomach, fatigue and headache were unknown.   It was unknown if the reporter considered the injection site pain, injection site swelling, joint pain, general body pain, upset stomach, fatigue and headache to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 70 or 71 years. The patient experienced pain at injection site, swelling at injection site, joint pain, body aches, upset stomach, fatigue and headache about 10 hours after the dose. The reporter asked to remain anonymous and did not provide demographics. This case has been linked with US2019161261, reported by same reporter.",,,,,,,,,U,09/03/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833549,09/13/2019,GA,87.0,87,,F,,"Vesicular rash; This case was reported by a nurse via call center representative and described the occurrence of vesicular rash in a 87-year-old female patient who received Herpes zoster (Shingrix) (batch number 353S5, expiry date 31st May 2021) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received on 1st April 2019).   On 24th July 2019, the patient received the 2nd dose of Shingrix (intramuscular). In July 2019, 1 day after receiving Shingrix, the patient experienced vesicular rash. The patient was treated with antivirals nos, antivirals nos, antivirals nos, antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the vesicular rash was recovering/resolving.   It was unknown if the reporter considered the vesicular rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left deltoid. The patient had a generalized vesicular rash that started 24 to 48 hours after the Shingrix vaccination.  The patient was improving and was being treated with antiviral medications. The reporter consented to follow up and provided contact details.",,,,,,,,,N,07/24/2019,07/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833550,09/13/2019,NY,59.0,59,,F,,"Red Dots; Burning; Shingles; Pain / Soreness; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 13th August 2019, less than a day after receiving Shingrix, the patient experienced pain. On 1st September 2019, the patient experienced shingles. On an unknown date, the patient experienced erythromacular rash and burning sensation. The patient was treated with valaciclovir (Valacyclovir). On an unknown date, the outcome of the shingles, pain and erythromacular rash were recovering/resolving and the outcome of the burning sensation was not recovered/not resolved.   The reporter considered the shingles, pain, erythromacular rash and burning sensation to be related to Shingrix.  Additional case details were reported as follows: The patient received Shingrix in left deltoid. The patient developed an area about 2 inches in diameter on the back inside of her right leg. The patient asked her neighbor who was a nurse practitioner to look at the area and she thought it appeared to be shingles.  The patient then went to the doctor on 3rd September 2019 and her physician thought it appeared to be shingles and prescribed Valacyclovir. Emergency room visit required The reporter consented to follow up.",,,,,,,,,N,08/13/2019,08/13/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,Y,
0833551,09/13/2019,CA,57.0,57,,F,,"Arm hurt; not feeling well / Feeling awfull; Hot flashes; Felt Hot; trouble sleeping; pain; redness; swelling at injection site; myalgia; fatigue; headache; fever; Gastrointestinal symptoms; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included hot flashes.   On 4th September 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 4th September 2019, 1 hr after receiving Shingrix, the patient experienced pain in arm, feeling unwell, hot flashes, feeling hot, difficulty sleeping, injection site pain, injection site erythema, injection site swelling, myalgia, fatigue, headache, fever and gastrointestinal symptom nos. On an unknown date, the outcome of the pain in arm, feeling unwell, hot flashes, feeling hot, difficulty sleeping and injection site pain were recovering/resolving and the outcome of the injection site erythema, injection site swelling, myalgia, fatigue, headache, fever and gastrointestinal symptom nos were unknown.   It was unknown if the reporter considered the pain in arm, feeling unwell, hot flashes, feeling hot, difficulty sleeping, injection site pain, injection site erythema, injection site swelling, myalgia, fatigue, headache, fever and gastrointestinal symptom nos to be related to Shingrix.  Additional details were provided as follows: The patient reported that an hour after the injection, her arm hurt and she did not feel well which she described as ""feeling awful."" The patient felt hot and she was not certain if it was related to her ongoing hot flashes or from the vaccine. The patient attempted to lift a box with 4 items inside and her arm hurt worse and worse and she had trouble sleeping last night. The patient also experienced pain, redness, swelling at the injection site, myalgia, fatigue, headache, fever and gastrointestinal symptoms. The patient consented to follow up.",,,,,,,,,N,09/04/2019,09/04/2019,0,,UNK,,,Hot flashes,,,USGLAXOSMITHKLINEUS2019GS,2,09/13/2019,,,,
0833552,09/13/2019,VA,78.0,78,,F,,"Painful; Unable to raise arm that received the injection dose; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th April 2019, the patient received the 1st dose of Shingrix (intramuscular). On 17th April 2019, couple of hours after receiving Shingrix, the patient experienced pain in arm and injected limb mobility decreased. On an unknown date, the outcome of the pain in arm and injected limb mobility decreased were recovered/resolved.   It was unknown if the reporter considered the pain in arm and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient reporter for herself. The patient received Shingrix her left arm.    A few hours after injection, she experienced painful and unable to raise arm that received the injection dose. The event was improved over the next few days and had resolved. The patient consented to follow up and provided her doctor's details.",,,,,,,,,Y,04/17/2019,04/17/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833554,09/13/2019,AR,,,,U,,"Pentacel was given and not mixed with ActHib lyophilized component and they just gave the liquid portion, no AE; Initial information received on 26-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a patient of unknown demography for whom it was reported that DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] was given and not mixed with ACTHIB lyophilized component and they just gave the liquid portion, (lot number, expiry date, dose, route and site of administration not reported) on an unknown date.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to inappropriate reconstitution technique.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA239524,2,09/13/2019,,,,
0833555,09/13/2019,,,,,U,,"the Pentacel vaccine and didn't realize she had to mix with ActHIB portion/no AE; Initial information received on 26-Aug-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a patient who did not received Act-hib portion of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a only portion of a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot number not reported.  It was of actual medication error due to Inappropriate reconstitution technique..  It was unknown whether any adverse event was observed or not...  The information on the batch number was requested.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA239538,2,09/13/2019,,,,
0833556,09/13/2019,SD,22.0,22,,F,,"pregnant females that were given the invalid Adacel, no side effects observed; caused by Human Error, The Excursion was Negative 40 degrees C and 22.7 degrees C/ There were no side effects observed; Initial information received on 06-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to case ID: 2019SA250873 and 2019SA250874 (same reporter).  This case involves a 22 year old female pregnant patient who was exposed to a second dose vaccine of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (dosage form: Prefilled Syringe) lot U6273AA via intramuscular route in the left arm on 20-Aug-2019.  Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported administered invalid Adacel occurred at unknown gestation period. The date of last menstrual period was reported as 28-Jan-2019. The estimated due date is 28-Oct-2019. The patient previous pregnancy was not reported.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is a case of vaccine exposure during pregnancy. It was reported that excursion was caused by Human Error, The Excursion was Negative 40 degrees C and 22.7 degrees C/ There were no side effects observed. Incorrect product storage.  It was reported that the patient had no adverse event following the vaccination.  Additionally, at time of reporting, the outcome of the pregnancy is unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error  List of documents held by sender: none.",,,,,,,,,U,08/20/2019,,,,UNK,,,,,,USSA2019SA250866,2,09/13/2019,,,,
0833557,09/13/2019,SD,,49,,F,,"the excursion was Negative 40 degrees C and 22.7 degrees C. Caller stated that these invalid Adacels were given to 3 pregnant patients, no side effects; the excursion (caused by Human Error) was Negative 40 degrees C and 22.7 degrees C. Caller stated that these invalid Adacels were given to 3 pregnant patients, no side effects; Initial information received on 06-Sep-2019 regarding an unsolicited valid non-serious case received from an other health professional.  This case is linked to case ID: 2019SA250873 and 2019SA250866 (same reporter).  This case involves a 49 year old female pregnant patient who was exposed to a second dose vaccine of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (dosage form: Prefilled Syringe) lot U6273AA, expiry date: 24-Apr-2021 via intramuscular route in the right arm on 23-Aug-2019.  The patient was exposed to DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE at 32 weeks of pregnancy, during third pregnancy trimester.  The date of last menstrual period was reported as 09-Jan-2019.  The estimated due date is 16-Oct-2019.  The patient previous pregnancy was not reported.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No concomitant vaccines were given.  It was a case of actual medication error due to product storage error and patient received it. It was reported that The Excursion (caused by human error) was Negative 40 degrees C and 22.7 degrees C. Caller stated that these invalid Adacels were given to 3 pregnant patients.  It is a case of vaccine exposure during pregnancy.  There were no side effects during this prenatal visit.  Additionally, at time of reporting, the outcome of the pregnancy is unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,08/23/2019,,,,UNK,,,,,,USSA2019SA250874,2,09/13/2019,,,,
0833558,09/13/2019,MS,14.0,,,U,,"14 year old was administered Fluzone High Dose, no AE; 14 year old was administered Fluzone High Dose, no AE; Initial and follow up information received on 06-Sep-2019 and 10-Sep-2019 regarding an unsolicited valid non-serious case received from a other healthcare professional.  This case is linked to cases 2019SA251863 and 2019SA251864 (same reporter).  This case involves a 14 years old patient who was received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UJ232AA, Exp. Date 10-Apr-2020) via intramuscular route in the left deltoid on 05-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to inappropriate age at vaccine administration.  It was also a case of overdose.  At the time of reporting no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/05/2019,,,,UNK,,,,,,USSA2019SA251857,2,09/13/2019,,,,
0833559,09/13/2019,MS,,,,M,,"25 year old was administered Fluzone High Dose, no AE; 25 year old was administered Fluzone High Dose, no AE; Initial and follow up information received on 06-Sep-2019 and 10-Sep-2019 regarding an unsolicited valid non-serious case received from a other healthcare professional.  This case is linked to cases 2019SA251863 and 2019SA251857 (same reporter).  This case involves a 25 years old male patient who was received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UJ232AA, Exp. Date 10-Apr-2020) via intramuscular route in the left deltoid on 06-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to inappropriate age at vaccine administration.  It was also a case of overdose.  At the time of reporting no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/06/2019,,,,UNK,,,,,,USSA2019SA251864,2,09/13/2019,,,,
0833560,09/13/2019,CA,,,,M,,"Ipol reached an unknown temperature for an unknown cumulative time since 06Sep2019, no AE; Initial information received on 06-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 68 years old male patient who received vaccine IPV (VERO) [IPOL] (batch number and expiry date was not reported) 05-Sep-2019. The patient started a three dose series of Ipol every other month, due to facility regulations, the patient must keep the Ipol vial with him and transport back and forth to the administration facility. The Ipol is transported with ice packs but no specific temperature reading device. No additional information was available at the time of this report. It was also reported that vaccines reached an unknown temperature for an unknown cumulative time since 06-sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error due to incorrect product storage.   It was unknown if any adverse event occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,09/05/2019,,,,UNK,,,,,,USSA2019SA252876,2,09/13/2019,,,,
0833561,09/13/2019,IN,,,,M,,"expired Menactra being administered; Initial information received on 06-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 11 years old male patient who received a 0.5 ml once dose of expired MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (batch number: U5986AA, expiry date: 24-Aug-2019) via unknown route and unknown site of administration.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant vaccination included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DAPTACEL) for Immunisation  It was an actual medication error due to expired vaccine used.   It was unknown if any adverse event occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/03/2019,,,,UNK,,,,,,USSA2019SA252879,2,09/13/2019,,,,
0833562,09/13/2019,NC,75.0,75,,F,,patient reported profuse sweating and shaking 3 days after receiving the vaccine and general malaise in between.,,,,,,,,,Y,09/10/2019,09/13/2019,3,,PHM,,,,,,,2,09/13/2019,,,,NDKA
0833563,09/13/2019,CO,0.33,0,.4,F,,Got a calcified lump where she received the vaccine.  Also got cold like symptoms  10 days after vaccine.  Now has a severe anaphylactic reaction to peanuts. Also reacted to eggs as a baby and reacts with FPIES to dairy.,,,Y,,,,,Y,N,08/19/2014,10/10/2014,52,,PVT,,None. C-Section baby.,none.,"Food allergies at age 5. Peanut allergy remains and Dairy (FPIES). Also of note, we declined the Hepatits B vaccine but on our vaccine record it is shown that it was administered at her birth. Otherwise, this is the first vaccine she received.",,,2,09/13/2019,,,,"Peanut allergy, egg allergy, dairy intolerance (FPIES)."
0833564,09/13/2019,GA,4.0,4,,M,,"large, local reaction-redness, swelling, warmth, firmness reaction is 4.5 by 2.5 inches in size",,,,,,,,,,09/11/2019,09/11/2019,0,,PVT,,none,"seasonal allergies, eczema",,,,2,09/13/2019,,Y,,allergy to peanuts
0833565,09/13/2019,,0.5,0,.5,F,,"Severe peanut allergy, egg allergy, FPIES to dairy.",,,Y,,,,,Y,N,09/26/2014,10/10/2014,14,Available upon request.,PVT,,None,Cold symptoms 09/01/2014-09/15/2014,Food Allergies,"calcified lump, severe food allergy present later in life.  DTAP; age 4 month; Daptacel; LOt C4644AA",,2,09/13/2019,,Y,,"Now has a severe peanut, egg allergy and dairy (FPIES)."
0833566,09/13/2019,PA,48.0,48,,F,,"12 hours after vaccine, patient awoke with severe shortness of breath and cough.  Over the ensuing 12 hours it worsened considerably and she went to an ED.  There she had a high fever, hypoxia, hypotension, and tachycardia.  She was treated with BiPAP and admitted to the ICU.  CXR looked like fluid overload vs infiltrate.  She was treated with IV antibiotics.  She recovered over the course of 3 days and was sent home 9/10/19.",,,Y,,Y,3,,,Y,09/06/2019,09/07/2019,1,"9/7:  CXR:  Findings consistent with increased volume overload: 1.Increased hilar haze with increased generalized hazy opacity in predominantly lower lung distribution as well as increased thickening of interstitial markings, congruent with interval onset of pulmonary edema.  2.Interval addition of bilateral blunting of costophrenic angles as well as likely layering pleural effusion.  9/7:  Rapid respiratory panel negative  9/7:  VBG:  ABL Spec Venous Venous   Final pH Ven 7.37  7.31 - 7.41 Final p Co2 Venous 40  40 - 50 mmHg Final pO2 Ven 31  30 - 45 mmHg Final Hemoglobin 9.5Low   12.0 - 16.0 g/dL Final Hematocrit 29Low   33 - 45 % Final MEASURED O2 SAT VEN 51.5Low   70.0 - 80.0 % Final O2Hb Venous 50.5  40.0 - 85.0 % Final CarboxyHgb Ven 1.4  0.5 - 1.5 % Final Chronic heavy smokers may have levels up to 10%. MetHgb Venous <1.0  0.0 - 1.4 % Final Sodium 139  133 - 143 mmol/L Final Chloride 106  96 - 110 mmol/L Final CALCIUM LEVEL IONIZED 1.03  1.00 - 1.25 mmol/L Final Whole Blood Glucose 207High   70 - 99 mg/dL Final LACTIC ACID 2.8High   0.5 - 2.2 mmol/L Final Base Excess Venous -2.4  -3.0 - 3.0 mmol/L Final HCO3 Ven 21.8Low   22.0 - 29.0 mmol/L Final  9/8/19:    Component                                    Latest Ref Rng & Units                   9/8/2019             White Blood Cells                            4.0 - 11.0 THO/uL                        11.8 (H)             Red Blood Cells                              3.80 - 5.30 MIL/uL                       2.92 (L)             Hemoglobin                                   12.0 - 16.0 g/dL                         8.1 (L)              Hematocrit                                   36 - 46 %                                24 (L)               RDW                                          11.5 - 14.5 %                            15.8 (H)             MCH                                          27 - 33 pg                               28                   MCHC                                         31 - 36 g/dL                             33                   MCV                                          80 - 100 fL                              84                   Platelets                                    150 - 400 THO/uL                         169                  Glucose                                      70 - 99 mg/dL                            113 (H)              Urea Nitrogen                                8 - 20 mg/dL                             67 (H)               Creatinine                                   0.44 - 1.03 mg/dL                        5.16 (H)             Sodium                                       136 - 144 mmol/L                         141                  Potassium                                    3.6 - 5.1 mmol/L                         4.7                  Chloride                                     101 - 111 mmol/L                         108                  Carbon Dioxide                               22 - 32 mmol/L                           23                   ANION GAP                                    3 - 12                                   10                   Calcium                                      8.9 - 10.3 mg/dL                         7.8 (L)              Protein, Total                               6.1 - 7.9 g/dL                           5.6 (L)              Albumin                                      3.5 - 5.1 g/dL                           3.0 (L)              ALT                                          14 - 54 U/L                              8 (L)                AST                                          15 - 41 U/L                              17                   Alkaline Phosphatase                         38 - 126 U/L                             61                   Bilirubin, Total                             0.3 - 1.2 mg/dL                          0.7                  Bilirubin, Direct                            0.1 - 0.5 mg/dL                          0.1                  Bilirubin, Unconjugated                      0.2 - 0.7 mg/dL                          0.6",PVT,,"Current outpatient prescriptions: 1) Amlodipine 10 mg tablet, take 1 tablet by mouth daily.   2) Aspirin (aspir-81) 81 mg po tbec, 1 tablet daily   3) Cefpodoxime 200 mg tablet, take 1 tablet by mouth daily.   4) Cholecalciferol 1000 units",Lupus; lupus nephritis; rheumatoid arthritis; Stage IV CKD; multinodular goiter; chronic anemia; chronic prescription opioid use; recurrent UTI,Same as Item 11,,,2,09/13/2019,,,Y,"Adhesive tape, Contrast dye, gabapentin"
0833567,09/13/2019,FL,82.0,82,,F,,"The day after the vaccine, the patient states she suddenly became very dizziness, to the point she could not move then once that passed she felt a tingling from her elbow to her index finger on the left arm.  It did not last long, the next day she noticed in in the pinky, and is still having slight numbness in the hand on the pinky side.",,,,,,,,,,09/10/2019,09/11/2019,1,,PHM,,"Amlodipine, mupirocin ointment, hydrochlorothiazide",,,,,2,09/13/2019,,,,
0833568,09/13/2019,GA,29.0,29,,F,,"hives, urticaria on chest and bilateral arms ; patient broke out in hives 15-20 mins after the injection",,,,,,,,,U,09/13/2019,09/13/2019,0,n/a,PVT,,,ear infection (otitis media),n/a,,,2,09/13/2019,,Y,,codeine
0833570,09/13/2019,DE,53.0,53,,F,,"Debilitating  headache, rise in body temperature, trouble sleeping, sever fatigue, red rash at injection site.",,,,,,,,,,09/07/2019,09/07/2019,0,,PHM,,"atorvastatin 10mg, gabapentin 300mg",N/A,N/A,,,2,09/13/2019,,,,Penicillin
0833571,09/13/2019,WA,66.0,66,,F,,"Patient called reporting they had chills, fever, high pulse rate, heart palpitations, and headache.",,,,,,,,,U,09/11/2019,09/12/2019,1,,PHM,,,,,,,2,09/13/2019,,Y,,Penicillins
0833572,09/13/2019,IL,84.0,84,,M,,The patient experienced fever and malaise and other symptoms similar to when he had pneumonia. They ended up taking him to the emergency room and he was treated there and released.,,,,,,,,,Y,09/04/2019,09/01/2019,,,PHM,,,,,,,2,09/13/2019,,,Y,
0833573,09/13/2019,CA,77.0,77,,F,,"Excruciating pain that traveled to brain/skull, flu like symptoms, weak, painful neck, loss of appetite, she described like she was in a car-crash and she has whiplash.",,,,,,,,,Y,09/03/2019,09/04/2019,1,none,PVT,,lisinopril,none,hypertension,,,2,09/13/2019,,,,nkda
0833574,09/13/2019,CA,0.17,0,.2,M,,My baby lost eye contact for three days and capacity for varied expression.  Once smiling and interacting went to vacant and distant.  Reaction time slowed or was stunted,,,,,,,,,Y,02/11/2014,02/13/2014,2,n/a,PVT,,"zero, breast fed",zero,zero,,,2,09/13/2019,,Y,,zero
0833575,09/13/2019,TX,60.0,60,,F,,"Severe case of Shingles on upper inside of left thigh, groin area approximately a week after the vaccine. I saw my PCP on 8-13-19. I was prescribed  Gabapentin, Cephalexin and ValACYclovir. Had a follow-up on 8-19-19 with the PCP and the shingles seemed to be slightly improving. On 8-27-19 after finishing the Cephalexin the shingles flared up worst than before. There was quite a bit of discharge/fluid from the inflamed area.  Was sent to a dermatologist on 8-29-19 who upped my doses of Gabaapentin and ValACYclovir. On 9-6-19 I had a follow-up visit with Dr. at Dermatology - the rash had started spreading and the area was a mess! I was prescribed Fluconazole and a cream to apply twice a day. Follow-up visit with Dr on 9-13-19 fianlly saw improvement.",,,,,,,,,,07/24/2019,08/07/2019,14,,PHM,,,,Celiac Disease,,,2,09/13/2019,,Y,,Gluten (celiac disease) and Sulpa Drugs/Bactrum
0833576,09/13/2019,ME,71.0,71,,M,,"Soar arm, discomfort sleeping, head ache, no energy, swollen shoulder",,,,,,,,,U,09/12/2019,09/12/2019,0,None,PHM,,"Metformin, hydrochloride, elliquis, Bp med . Metropol , robistatin",None,Heart afib,,,2,09/13/2019,,,,None known
0833577,09/13/2019,TX,86.0,86,,F,,"Patient was injected in the right deltoid, and presented with swelling and redness below the injection site and continuing down to her hand.  Two days post injection when the patient returned to the pharmacy,  the redness, pain and swelling were resolving.  The pharmacy contacted her primary physician to advise of the condition, and the patient said she will call her doctor if the condition worsens or does not improve.",,,,,,,,,U,09/11/2019,09/11/2019,0,None,PHM,,"Atenolol 50mg qd, Zolpidem,",None,Macular degeneration,,,2,09/13/2019,,,,Codeine
0833578,09/13/2019,IL,33.0,33,,F,,Patient called the pharmacy on 9/13/19 at approximately 130 pm and stated that she has complaining of dizziness and skin crawling for the past day and started feeling this way shortly after receiving her flu shot around 1130 am on 9/12/19,,,,,,,,,U,09/12/2019,09/12/2019,0,,PHM,,N/A,None reported,None reported,,,2,09/13/2019,,,,NKDA
0833579,09/13/2019,OH,58.0,58,,F,,Flu-like symptoms with aches and a headache for 2 days. The nurse said these side effects  could happen and were fairly common. Lasted for 2 days.,,,,,,,,,N,09/12/2019,09/12/2019,0,N/A,PVT,,None,None,None,,,2,09/13/2019,,,,Penicillin
0833580,09/13/2019,CA,28.0,28,,M,,"Fatigue/ tiredness, dizzy/ light-headed, foggy-headed, chronic allergies, inflammation, dark eyes and swollen eyelids.",,,,,,,,,N,05/27/2019,06/30/2019,34,low platelet count.,PVT,,Claritin,Chemical injury on eyes.,no.,,,2,09/13/2019,,Y,,no.
0833581,09/13/2019,OR,28.0,28,,M,,"Nine days after receiving the rabies vaccine, donor developed soreness at the site of vaccination. He also developed a fever to 101.5, diarrhea, cough and congestion. These symptoms lasted for approximately four days.",,,,,,,,,Y,08/24/2019,09/02/2019,9,none,OTH,,none,none,none,,,2,09/13/2019,,,,none
0833582,09/13/2019,MD,39.0,39,,F,,"Nausea, vomiting, dry heaving, lump in throat feeling, general lethargy and malaise, stuffed ears feeling",,,,,,,,,Y,09/11/2019,09/12/2019,1,,WRK,,"Ocella, ritual, zyrtec (all evening doses) Synthroid (morning)",None,"Mild aortic stenosis, mild hypothyroidism",,,2,09/13/2019,,,,Suspected cipro
0833583,09/13/2019,FL,72.0,72,,F,,"PATIENT REPORTS LOW GRADE FEVER, SORENESS AT INJECTION SITE, AND LOSS OF FUNCTION BELOW THE WRIST",,,,,,,,,N,09/11/2019,09/12/2019,1,UNKNOWN,PHM,,UNKNOWN,BROKEN SHOULDER,,,,2,09/13/2019,,Y,,NKDA
0833584,09/13/2019,PA,7.0,7,,M,,"Patient immunized in a sitting position in arm and did well with vaccine, reported that vaccine did not hurt. Patient moved chairs at that time to allow for brother to take a seat in chair as well to start his vaccine,patient was in another chair in a room at that time. I was headed up to clean up vaccine and finish paperwork for child and patient slid down chair and fell forward and eyes up at that time, patient appeared to bump left side of head.   NP jumped to the floor at that time and held child to support neck and patient with gurgle sound in mouth and had decerbrate posturing and eyes rolled back with slight shake to arms in a rigid position. Clinical appearance with seizure vs vagovagal response. Patient with eyes rolling, rigidity and posturing and slight shake and oxygen level immediately obtained that time and dropped in the 70 range, episode lasted approximately 30 seconds. After episode developed facial pallor, severe fatigue and very tired. NP on floor with patient and NP student in room helping with obtaining vitals and assisting NP, Mom called EMS and older brother also in room.   Patient very tired and wanted to sleep. NP had patient flat on table at this point as awaking for EMS arrival, oxygen level back up in high 90s and breathing and speaking once again. Glucose obtained at this time and was 93 in clinic. (lot# MW3320S, exp 11/20/2020) Police arrived on site about 10 minutes prior to EMS. 2 groups then came via EMS. Neuro exam completed on patient and was able to follow EOMS and pupils equal and reactive to light after episode, speech is not slurred at this point but patient with sweating and facial pallor. Patient with no signs of angioedema, no hives, airway open as patient now speaking.   Mom does report patient is following with neurology at hospital for arachnoid cyst along with DVA in which he had MRI back in may, also follows with neurology as patient has had migraine history, mom reports starring spell and possible seizure at age 2 in which he started following at hospital.  EMS arrived obtained a brief history and then took the patient via ambulance, I updated EMS and I took older brother out of room and discussed baseball to avoid scaring him with the whole situation and mom stayed with patient. Patient taken from clinic at 3:50 PM, worker from EMS arrived back at 4:20 and reports father requesting type of vaccine given and wanted to ensure it did not have eggs. Immunization report provided to EMS worker and showed box and lot of vaccine and confirmed it did not have egg component. Dad did not come back to clinic and NP went into other room on B to provide EMS with the rest of information needed as I was actively seeing patients. Dad told older son so mom could be with patient in ambulance.   Mom signed paper for care everywhere to be pulled, documentation from MD monitoring headaches and also neurosurgery reviewed. Patient with increasing headaches recently from 2 a month to weekly frontal headaches. Patient taken to hospital in which doctors who already know his case are there, has been getting flu vaccines yearly but monitored in allergist office due to egg allergy. Mom reports patient started Xopenex this this week for asthma which was new for him.    Detailed medical history obtained after vaccine administered per mom during event and was not part of routine vaccine screening. Patient will be called to check in on patient and see of status after ER transport and is scheduled for a call back .  This may not have at all been related to vaccine or administration as safety precautions maintained and patient was sitting for administration and after, but will contact VAERS due to this being after vaccine.",,,,,,,,,U,09/13/2019,09/13/2019,0,Went in ambulance to hospital  for ongoing monitoring and evaluation.,OTH,,"xopnex, zyrtec",Seasonal allergies/asthma,"DVA, allergies, arachnoid cyst, possible seizure at age 2",,,2,09/13/2019,,,Y,"Egg, Milk, Dander (hives)"
0833585,09/13/2019,CA,54.0,54,,F,,"Rash, itching, swelling at injection site, general malaise, trouble breathing, fatigue",,,,,,,,,N,08/15/2019,08/16/2019,1,Patient to follow up with primary dr.,PHM,,none.,none,none stated,,,2,09/13/2019,,Y,,"penicillin, Sulfa"
0833586,09/13/2019,MA,75.0,75,,F,,"Received 2nd dose, 5 months after the first dose in same facility.  Started to feel very tired by supper.  At 10-11pm started to feel nauseous, tried to throw up but could not until 1 hour latervomited 3 times.  Patient took usual medications at night: Vitamins, Eliquis, Lisinopril, and Singulair. In the morning, woke up and felt very achy on back so put heating pad on couch.  Started to feel nauseous again so went to the bathroom and could not throw up.  On the way back to the couch, a strange feeling came over, and fainted.  Patient hit head on washer/dryer when fell down; not sure how long was out.   Woke up and went back to lay on down, put heating pack on back and icepack on head.   At about 9: 30am, patient's",,,,,,,,,U,09/05/2019,09/05/2019,0,,PHM,,"Albuterol, Montelukast, Omeprazole, Potassium, Mesethalo,","No, No.","Heart failure in June, cardiomyopathy, Asthma, Hyperthyroidism",,,2,09/12/2019,,Y,Y,"raw shrimp, Amoxicillin"
0833587,09/13/2019,,0.17,0,.2,F,,chronic immune mediated allergic autoimmune dermatitis,,,,,,,,,Y,04/02/2015,04/06/2015,4,,UNK,,,,,,,2,09/13/2019,,Y,,
0833588,09/13/2019,MI,22.0,22,,M,,"after given the shot ask him to stay for 2 minutes,after 2 minutes I ask him to leave,then he said Iam not feeling well,feeling dizzy.ringing ears and sweating,then I put him on the floor and called 911,then slowly he recovered in couple of minutes and he sat on chair,after 10 minutes paramedical came and talk to me and the patient,then he said he is ok.paramedical asked him to come to hospital and check,then patient denied and he said fine,next day I called to patient and asked about his health,he said he is fine",,,,,,,,,Y,09/03/2019,09/03/2019,0,no,PHM,,no,no,no,,,2,09/13/2019,,,,no
0833589,09/13/2019,AZ,18.0,18,,F,,Complaint of severe pain to injection site 5 days after received. Redness and swelling to site present.,,,,,,,,,N,09/09/2019,09/13/2019,4,Physical exam on 9/13/19,SCH,,Levonorgestrel-Ethinyl Estrad,No illness,No known medical conditions,,,2,09/13/2019,,Y,,No allergies
0833590,09/13/2019,MD,67.0,67,,F,,"Patient was ok the day vaccine was administered - 9/12/19. The morning of 9/13/19 patient experienced nausea, sweating, malaise, fever (101.4), and fainted. She stayed in bed all day and reported events to pharmacist at 7:30 pm 9/13/19.  Patient was advised to seek medical attention.",,,,,,,,,N,09/12/2019,09/13/2019,1,,PHM,,No,,Depression,,,2,09/13/2019,,,,No
0833591,09/13/2019,UT,50.0,50,,F,,"Error - administered high dose flu vaccine instead of regular flu vaccine. Stiff, sore, painful arm.",,,,,,,,,Y,09/10/2019,09/10/2019,0,None,PHM,,,,,,,2,09/13/2019,,,,
0833592,09/13/2019,CA,63.0,63,,U,,PATIENT COMPLAINED OF RASH ON CHEST AND FOREHEAD. SHE WAS GIVEN STEROIDS FOR 5 DAYS. AN ADDITIONAL RASH WAS SEEN UNDER THE ARM THAT DID NOT RECEIVE THE VACCINATION,,,,,,,,,Y,07/08/2019,07/08/2019,0,,PHM,,,,,,,2,09/13/2019,,Y,,
0833593,09/13/2019,FL,71.0,71,,M,,Hives on arm of injection site and trunk (chest/back),,,,,,,,,U,09/12/2019,09/12/2019,0,,PHM,,"Amlodipine, metformin, atorvastatin, metoprolol, latanoprost, tamsulosin",None,,,,2,09/13/2019,,,,Penicillins
0833594,09/13/2019,UT,14.0,14,,F,,"Error - administered high dose flu vaccine instead of regular flu vaccine. Stiff, sore, painful arm.",,,,,,,,,Y,09/10/2019,09/10/2019,0,,PHM,,,,,,,2,09/13/2019,,,,
0833595,09/13/2019,WA,71.0,71,,F,,"injection site reaction (painful, itchy, red, hard lump)",,,,,,,,,U,09/03/2019,09/04/2019,1,na,PHM,,"morphine, percocet, estradiol, medroxyprogesterone, cyclobenzaprine, benazepril, simvastatin, naproxen",none known,"hypercholesterolemia, chronic pain, hypertension",,,2,09/13/2019,,,,sulfa drugs
0833596,09/13/2019,NV,20.0,20,,F,,EMPLOYEE RETURNED TO WORK REPORTING RASH AND HIVES ON BILATERAL ARMS AND LEGS,,,,,,,,,U,09/12/2019,09/13/2019,1,,OTH,,NONE REPORTED,NONE,NONE REPORTED,,,2,09/13/2019,,,Y,NO KNOWN
0833597,09/13/2019,MA,76.0,76,,F,,"The patient called the pharmacist today, 9/13/19 and states that she had a small red spot below the site of injection and it was warm to the touch. The patient was adviced to keep an eye out and see if it got worse.",,,,,,,,,Y,09/12/2019,09/13/2019,1,n/a,PHM,,none,none,none,,,2,09/13/2019,,,,none
0833598,09/13/2019,MI,18.0,18,,M,,"Patient got his HAVRIX vaccine last week with his mom and his brother cause the mom was worried about the incident that happens, after, he got the shot by nearly 15-20 minutes and while they are moving to go home, my tech noticed that he was loosing his balance, I got the epipen from the drawer and ran to him immediately , my tech and his brother lay him on the floor, trying to talk to him to keep him awake, in less than two minutes , he got the epipen shot. during this time , my other tech contact 911. they came in 5-10 minutes and went to the hospital the patient's mom called me the next day, everything went ok",,,,,,,,,Y,09/05/2019,09/05/2019,0,not as I know,PHM,,no,no,no,,,2,09/13/2019,,,Y,no
0833599,09/13/2019,TX,71.0,71,,F,,Per patient the arm was very swollen for 3 days,,,,,,,,,Y,07/30/2019,07/31/2019,1,,PHM,,,,,,,2,09/13/2019,,,,
0833600,09/13/2019,AL,55.0,55,,F,,Rash pain fever vomiting dizziness,,,,,,,,,N,09/11/2019,09/12/2019,1,,PHM,,Ambien,None,Back fusion,,,2,09/13/2019,,,Y,None
0833601,09/13/2019,,75.0,75,,F,,"Patient states reaction of swelling, itching, redness, rash, discomfort and lasted about 2 weeks. Patient spoke with PCP/NP and has had similar incidents with previous vaccines and patient reports that she has sensitivity with low tolerance and wants to continue receiving vaccinations routinely because these reactions are localized.",,,,,,,,,,06/28/2019,06/28/2019,0,,PHM,,,,,,,2,09/13/2019,,,,
0833602,09/13/2019,CA,34.0,34,,F,,"Patient developed tingling sensation in throat while at home, 1 hour after receiving vaccination. She went to the emergency room and was treated for trouble breathing and swelling.",,,,,,,,,Y,08/25/2019,08/25/2019,0,I am not sure. She was seen in the ER.,PHM,,"ondansetron odt 8mg, linzess 290mcg, blisovi fe 1-20, metoclopramide, vitamin d2",unknown,unknown,,,2,09/13/2019,,,Y,amoxicillin
0833603,09/13/2019,NV,66.0,66,,F,,"patient reported symptoms of: local redness, excessive swelling/edema wrapping around almost entire upper arm, heat, headaches, dizziness, lethargy",,,,,,,,,U,09/12/2019,09/13/2019,1,,PHM,,"alendronate, Breo Ellipta, amitriptyline, mirtazapine, hydroxyzine",none known,"osteopenia, depression/anxiety.",,,2,09/13/2019,,,,NKA
0833782,09/13/2019,NY,11.0,11,,M,09/12/2019,"Pt developed redness, itching and mild swelling at injection site within a few minutes of administration. Directed to take benadryl, tylenol, ice by PCP No immediate direct care given.",,,,,,,,,Y,09/12/2019,09/12/2019,0,,PVT,PVT,,None,None,,,1,,,,,
0833821,09/13/2019,CO,0.25,0,.3,M,,"On 8-29-19, patient's mother called us to report an increased heart rate to 212/min and oxygen desaturation to 83% During a feeding, he desaturated to 79% for four minutes. Mother called patient's neurologist to see what their thoughts were. His neurologist increased the seizure medication (trileptal) He did not have any further issues after this.",,,,,,,,,Y,08/27/2019,,,N/A,PVT,,"ranitidine, Trileptal, vitamin D",,"Seizures, prematurity",,,2,09/09/2019,,,,nkda
0833823,09/13/2019,TX,8.0,8,,F,,"Small painful bruised, mild edematous nodule size of a dime to the left deltoid area.",,,,,,,,,N,10/23/2018,,,8-30-2019 sonogram of arm,PVT,,,,,,,2,09/12/2019,,Y,,
0833824,09/13/2019,MS,50.0,50,,M,09/13/2019,Pt received Havrix on 8/06/19. States he had some swelling but now has a small lump at injection site but no pain. He says it seems to be bigger than it was a few weeks ago. Showed MD when went for regular visit. MD not concerned,,,,,,,,,U,08/06/2019,08/07/2019,1,N/A,OTH,PVT,,N/A,None,,,1,,,,,
0833825,09/13/2019,MA,66.0,66,,F,,Pt complained of swelling in arm and redness and pain around injection site and in arm.,,,,,,,,,Y,09/11/2019,09/11/2019,0,,PHM,,,,,,,2,09/13/2019,,Y,,
0833838,09/13/2019,WA,71.0,71,,F,,"Pt developed a local reaction (L) Deltoid region with pain, swelling & redness. She also developed flu-like symptoms as fatigue, malaise and weakness. Started several hours later - was evaluated on 08/28 and 08/29 - has continued to improve.",,,,,,,,,U,08/26/2019,,,No,PVT,,Centrum Silver; Vit D; Yuvafem; Aciphex; Montelukast,,Hyperglycemia; Hyperlipidemia; Asthma; GERD; Osteopenia,,,2,08/28/2019,,Y,,Erythromycin; Cephalexin
0833604,09/14/2019,OR,54.0,54,,F,,PATIENT IMMEDIATELY FELT PAIN IN HER ARM AND BACK FOLLOWED BY NAUSEA AND VOMITING AND LIGHTHEADEDNESS.,,,,,,,,,Y,09/13/2019,09/13/2019,0,NA,PHM,,,,,,,2,09/14/2019,,,,NO ALLERGIES
0833605,09/14/2019,CA,97.0,97,,F,,Patient began to experience sore arm and notice a bruise forming above the injection site with band-aid still on the arm the day after. Bruise was larger than quarter size and bright red when presented at the pharmacy on 09/13/2019 at 1pm. Patient will see primary care provider if bruise or symptoms worsen.,,,,,,,,,N,09/10/2019,09/11/2019,1,,PHM,,"Furosemide 20 mg once daily, metoprolol succinate er 50 mg once daily, OTC aspirin 81 mg once daily",,,,,2,09/14/2019,,Y,,drug allergies to penicillins
0833606,09/14/2019,CA,65.0,65,,F,,Muscle pains throughout body Fever  Headache Severe drop in blood pressure Dehydration Itching,,,,,,,,,Y,09/11/2019,09/11/2019,0,9/12/2019  Saline drip.  Medication for pain  and fever through IV  Taken to emergency room by ambulance,PHM,,Peridex Metoprolol atorvastatin amitriptyline CoQ10 diazapam,Gum infection,Migraines Breast Cancer HBP,,,2,09/14/2019,,,Y,Augmentin
0833607,09/14/2019,IL,60.0,60,,F,,Patient has redness at site of administration. Also stated site of administration is slightly warm upon touching.,,,,,,,,,N,09/12/2019,09/13/2019,1,,PHM,,,,,,,2,09/14/2019,,,,
0833608,09/14/2019,IL,17.0,17,,F,,"Next day, during volleyball game heart started racing, arms felt funny--tingling in her fingertips--, felt somewhat faint.   Reporter is not sure for long how symptoms lasted; patient ate and went to sleep. Next day patient went to school, complained that she was weak, that her vision was not rightseeing little things-- and started crying.   On 8/28 at around 12:38pm, took patient to ER visit due to the palpitations. All symptoms experienced were discussed, including ringing in the ears, with the doctor and upon discharge ER doctor recommended follow-up with doctor to possibly get a holter cardiac monitor a psychiatric consultation. On 8/29 went to follow-up with doctor after ER visit, again mentioned all the symptoms to the doctor including palpitations and that arm was sore/hurting at vaccination site. Doctor did not link any of the symptoms to the vaccination and gave order for labs and a holter cardiac monitor. Doctor also revoked the sports clearance that had been granted to the patient.  On 8/29 went to get labs including blood and urine samples; all came back normal.  Not sure, which day it was after the vaccination but patient woke up with a swollen arm and swollen help; she thought her allergy medication helped to control it. On 8/31, patient started wearing monitor until 9/9.   Patient went back to the same ER on 9/4 complaining of bad shortness of breath; the doctor still considered that it was related to panic attacks.  At the ER, heart monitor company (Cardiomedic) faxed results they had so far for review and they showed heart a little heart rate increase but not out of normal.  Contacted doctor to let them know they were back at the ER but did not have a follow-up appointment available until 9/9.   On 9/7, patient had difficulty breathing again so taken to doctor to get possibly a breathing treatment.   Per doctor, she could not give patient a breathing treatment and specified that the symptoms mentioned were not related to the vaccine.  Patient's parents were given the vaccine handouts that daythey had not received them before.   Patient reviewed the vaccine adverse event sheet and highlighted the following adverse events that were listed:   soreness, redness and swelling at site, shoulder and face, headache, feeling dizzy, vision problems, ringing in the ears, and difficulty breathing.   Went to follow-up appointment with doctor on 9/9 and discussed all symptoms highlighted and they were still blaming it on anxiety; patient's parents filed a complaint with the facility about the doctor's care they had received so far and that they did not receive the proper paperwork.  Patient is following up with cardiologist to review holter heart monitor results.  The cardiologist in their facility did not have any open appointments soon so she is going to a different one.  As of now patient reports that vision have improved, she still has difficulty breathing, arm still hurts bad and still is feeling weak.  Patient will also use the Behavioral order to follow-up for anxiety just in case.     Patient started taking Omeprazole for acid reflux on 8/27 and continued taking it daily until 9/7 when doctor told her to stop The last vaccination patient received was in March for Meningitis.",,,,,,,,,U,08/26/2019,08/27/2019,1,,PVT,,"Multi-Vitamin, Fiber Chews, Loratadine",Prior week heart rate racing  but cleared for sports physical; Heart racing probably due to anxiety,No,,,2,09/10/2019,,Y,Y,"Seasonal Allergies, Penicillin, Decongestants"
0833609,09/14/2019,,77.0,77,,F,,"Pt had minor redness around injection site with soreness. Size of a quarter-half dollar. No other symptoms. Pt received ice pack to injection site which she said helped. She was consulted to call her md, or to seek emergency medical care if she notices any chest pain/tightness/ swelling in face/tongue/throat or any other alarming symptoms.   upon follow up phone call 09142019 921am pt reports that she is fine and that symptoms resolved yesterday.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,PHM,,,,,,,2,09/14/2019,,,,
0833610,09/14/2019,CA,67.0,67,,F,,"Very sore arm/shoulder, chills, fever, body aches",,,,,,,,,N,09/13/2019,09/13/2019,0,None,PHM,,Biktarvy once a day lansoprazole 30 mg once a day Singulair 10 mg once a day Dulera 2 puffs 2 times a day Flonase 2 squirts 2 times a day Allegra 180mg Vitamin D 5000 IU (125 mcg) Vitamin B12 1000 mcg Flu shot at the same time as Shingrx,None,HIV+,,,2,09/14/2019,,,,No
0833612,09/14/2019,AL,5.0,5,,M,,"Hsp/ purpura. Started on one thigh around injection and spread down leg, both buttocks, other leg over course of 1 month. Also had swelling of both feet, both hands, joint pain and fever.",,,,,,,,,Y,08/09/2019,08/10/2019,1,Dr. diagnosed patient with purpura about a week after injection.,PVT,,N/a,None,None,,,2,09/14/2019,,Y,,None
0833613,09/14/2019,FL,69.0,69,,M,,PT STATED THAT ARM WAS SEVERLY SWOLLEN AND INTENSE PAIN. pT TOOK TYLENOL AND THIS ABATED PAIN A SMALL AMOUNT. PATIENT CALLED PHARMACY 9/12 AND i TOLD PT TO ICE ON AND OFF FOR 15 MIN AND TO CALL ME LATER IN THE DAY. PT CALLED AGAIN LATER THAT DAY AND STATED THAT IT WAS STILL A BIT SWOLLEN BUT IT FELT BETTER. PT CALLED AGAIN ON 9/13 AND STATED THAT HE WAS GOING TO THE ER,,,,,,,,,U,09/11/2019,09/12/2019,1,,PHM,,,,,,,2,09/14/2019,,,Y,
0833614,09/14/2019,CA,24.0,24,,M,,"Diffuse hives on all extremities, abdomen, and back. Still ongoing at time of report. Will take an antihistamine for symptoms.",,,,,,,,,N,09/13/2019,09/13/2019,0,None,PHM,,None,None,None,,,2,09/14/2019,,,,None
0833615,09/14/2019,OH,55.0,55,,F,,"fever 102+ 4 inch diameter red, swollen circle around injection site with additional areas of red ""streaks"" body aches, headache, fatigue",,,,,,,,,Y,08/21/2019,08/22/2019,1,none,PHM,,,none,hypertension,,,2,09/14/2019,,Y,,none
0833616,09/14/2019,PA,94.0,94,,F,,"Patient called pharmacy 9/13/19 around 8:30am stating her arm was red around the site of injection of Shingrix 2nd dose. Described the size as ""bigger than a half dollar"" with some swelling.  Redness appeared the morning of 9/13/19. Patient had no other symptoms except redness and swelling around injection site. Informed patient this was a common reaction to the vaccine and was not a concern, should subside in the next couple days. If it got worse, she should seek medical attention or call her doctor. Patient then came in 9/13/19 at 9am to show me the reaction, which looked exactly as she described. Followed up with patient 9/14/19 at 1:00pm, patient stated there was no more swelling. Redness was lighter/fainter than previous day. No new symptoms were noted by the patient.",,,,,,,,,N,09/11/2019,09/13/2019,2,,PHM,,,,,,,2,09/14/2019,,,,
0833617,09/14/2019,VA,80.0,80,,F,,Patient reports SOB and throbbing pain in shoulder immediately after receiving the vaccine on 9/11/19.  Later that night she had chest tightness.  Thursday night 9/12/19 pain radiated to her neck.  Friday 9/13/19 patient took an aspirin because her neck was still hurting.  Patient said she has had SOB and throbbing pain after receiving the vaccine in the past but symptoms stopped by the next day.,,,,,,,,,U,09/11/2019,09/13/2019,2,,OTH,,,,,,,2,09/14/2019,,,,
0833618,09/14/2019,FL,32.0,32,,M,,"Large bruise or blood accumulation under skin on left lower thigh, 4 inches by 3 inches appeared about 3-4 hours after injection along with reddening of right ear. No other explanation of bruise/blood accumulation under skin that's still there 2 days later, not worsening, but still looks the same. Off and on chills and fatigue about 6 hours after vaccination continuing to the present.",,,,,,,,,N,09/11/2019,09/11/2019,0,,PVT,,"Methylprednisolone, triamcinolone ointment",Unknown dermatitis,,,,2,09/14/2019,,,,None
0833619,09/14/2019,IL,66.0,66,,F,,Patient had redness and swelling near injection site and down arm.  She also experienced a fever,,,,,,,,,,07/10/2019,07/11/2019,1,,PHM,,,,,,,2,09/14/2019,,,,
0833620,09/14/2019,VA,65.0,65,,F,,"Headache, muscle ache, joint pain, nausea, fatigue, chills (no fever), reddened and itching area below injection site Started morning after and continue but decreasing at day 3 post. Except for red and itching, other symptoms are intermittent and helped with Motrin",,,,,,,,,N,09/11/2019,09/12/2019,1,,PHM,,"Fiasp  insulin, lisinopril, simvastatin,  vitamin D, Zantac, Advil pm",None,"Type I diabetes, hypertension, hypercholesterolemia, GERD, vitamin D deficiency",,,2,09/14/2019,,,,None
0833621,09/14/2019,UT,29.0,29,,M,,"PAIN AT THE INJECTION SITE AND ABOUT 2 INCH ABOVE AND BELOW THE SITE OF THE FLUZONE INJECTION SITE.  THE PAIN WAS INTENSE ENOUGH THAT IS EFFECTING SLEEP.  PATIENT ALSO REPORTS FEVER REDNESS, AND WEAKNESS.",,,,,,,,,N,09/12/2019,09/13/2019,1,NONE.,PHM,,UNKNOWN,NONE,NONE,,,2,09/14/2019,,Y,,NKDA
0833622,09/14/2019,UT,38.0,38,,F,,"Extreme head pressure, headache, ringing in ears, clogged ears, chronic fatigue, hightened/more severe seasonal allergies, additional vision impairment. All symptoms lasted for months, resulting in need for hearing aids (additional hearing loss: currently at 85%, up from previous 40%--hearing aids prescribed on 02/14/2018). Also ultimately resulting in need for ear tubes to treat ear pressure (ENT tested ears, ear damage confirmed on 08/16/2018, tubes inserted on 08/21/2018). NOTE: This vaccine was given, then afterward was discovered to be a ""bad batch"". The shot was given again on 10/11/2017 (lot #195216), when symptoms started. Because it is unclear which vaccine caused reactions (or both), both are reported.",,,,,,,,Y,N,10/03/2017,10/11/2017,8,"Audiological Screening 2/14/2018, ENT ear pressure test 08/16/2018",PVT,,"Multi-vitamin, Calcium supplement",No,"Chronic Fatigue, 40%+ Hearing Damage, Asthma, Seasonal Allergies, Vision Impairment",,,2,09/12/2019,,,,No
0833623,09/14/2019,AL,74.0,74,,F,,"A few hours after getting the shot I began having pain in the shoulder which got a lot worse as the day went on.  By 10PM I was having multiple symptoms: severe pain and limited motion of my left arm where the shot was given.  I have also been throwing up, running low grade fever, no appetite, very unsteady gait.  Husband had to help me get to the BR, change clothes, etc.  Had to sleep in recliner as could not get up and down on the bed.  Considered ER visit due to extreme pain and other symptoms. Did not know what was happening.  I called the phone number for after hours for the doctor's office and was told to put heating pad on and take Tylenol.  9/12/19 ? Called to let doctor?s office that I?m having severe pain and limited motion of my left are where the shot was given.  I also have been throwing up, running low grade fever, no appetite, very unsteady gait.  Husband was having to help me get to the BR, change clothes, etc. They said if I?m not better by Monday (5 days from now) to call them back.   9/13/2019 ? I woke up with congested head and some coughing so went to urgent care. Still having symptoms as above. .  He said he thinks I caught some ?bug? at the doctor?s office.  Said nothing abnormal involving shot. Prescribed Prednisone for 7 days.  9/14/2019 ?.  Arm still painful to move but doing a little PT to try and get it back in shape.   Feeling better.  Tolerating food.",,,,,,,,,U,09/11/2019,09/11/2019,0,Went to urgent care on 9/13/2019 as I felt someone needed to examine me and get an opinion.  My temp was 99.3 (I usually run 96 to 97). Heart rate was over a 100.  BP normal at 126/76. X-ray show not pneumonia or joint involvement. He prescribed Prednisone for 7 days.,PVT,,"Nov. 28, 2016 Eliquis 5 mg. Tabs ? One twice daily ? (Zolpidem Tartrate)  Nov. 25, 2016 Propafenone HCL SR (Rythmol) 325 mg Cap ?One twice daily ?   Estrace 0.1 mg cream ? apply to vagina 2X  wk  June 6, 2019 Pantoprazone Sod DR 40 mg.",Non Tuberculin Mycobacterium Bronchiectasis,"A-Fib, acid reflux, diverticulitis, high cholesterol, Lichen Planus, Non Tuberculin Mycobacterium, Bronchiectasis",,,2,09/14/2019,,Y,,Macrodantin Bactrim Lactose sensitivity
0833624,09/14/2019,IL,81.0,81,,F,,"patient noticed that left arm started to itch and was becoming warm and light pink, woke up in morning on 9/14/19 and was darker and still warm to touch",,,,,,,,,U,09/13/2019,09/13/2019,0,none patient is aware of,PVT,,"clopidogrel, low dose aspirin, metoprolol succinate 25 mg, atorvastatin 40mg",stents placed October 2018,high blood pressure,,,2,09/14/2019,,,,no known drug allergies
0833625,09/14/2019,NC,52.0,52,,F,,"patient has some swollen, red knots that are thick and hard on her lower left arm (not at the sight of injection), itching on entire body, and patient has been breaking out in a cold sweat. patient was seen at dr office on saturday morning 9/14 and was given prednisone to treat the allergic reaction that she seemed to be having.",,,,,,,,,N,09/11/2019,09/14/2019,3,none,PHM,,"losartan, generic Zetia, and metformin er 500mg",none,"diabetes, high blood pressure, high cholesterol",,,2,09/14/2019,,Y,,none
0833626,09/14/2019,CA,65.0,65,,F,,"terrible muscle pain, bottom of feet pain, not comfortable walking.. Extreme tenderness on eyeballs.  Chills,  shivering, headache, , upset stomach , could not eat., weakness. Pain and redness on innoculation site,  I felt awful. All symtoms lasted about 30 hours.",,,,,,,,,Y,09/12/2019,09/13/2019,1,,PHM,,vitamin  D fish oil,,"arthritis, IBS.",,,2,09/14/2019,,,,Penicilin
0833627,09/14/2019,TN,76.0,76,,F,,"High fever(unchecked with thermometer), upset stomach, arm sore and hot, no reddness or rash on arm, severe headache, dizziness, pain in ears and teeth.",,,,,,,,,N,09/12/2019,09/12/2019,0,None,PHM,,atenolol cyclobenzeprine Simvastatin Amlodipine Loratidine Biotin Bilberry  Fish oil Psedofed Multivitamin Melatonin Aspirin,None,Myalgia Blood pressure Cholesterol  Irregular heart rate,,,2,09/14/2019,,,,Codeine Wheat Coconut Barley  Green tea Peanuts  Cashews Hazelnut  Uncooked egg whites Nickel Aluminum Mold Pollen
0833629,09/14/2019,,74.0,74,,F,,Injection site reaction. Red un-raised rash at injection site. Started day after vaccination and lasted for multiple days. Patient also complained of fatigue following vaccination.,,,,,,,,,,09/11/2019,09/12/2019,1,,PHM,,,,,,,2,09/14/2019,,,,
0833630,09/14/2019,,77.0,77,,F,,"Patient did not have any redness but terrible pain in her arm starting day of vaccine. Post 3 days today (9-14-19) and is just starting to be able to move it.  Could not move at all the first day, could not lay on it and took around the clock tylenol.",,,,,,,,,,09/11/2019,09/11/2019,0,,PHM,,,,,,,2,09/14/2019,,,,
0833631,09/14/2019,PA,57.0,57,,F,,"Headache, swelling/redness/pain at injection site, muscle/joint pain, shivering, malaise",,,,,,,,,N,09/13/2019,09/13/2019,0,None,PVT,,"Omeprozole 20 mg, welbutrin 300 mg, magnesium 500 mg, vit D 4000i.u.,",None,None,,,2,09/14/2019,,,,"Cipro, Levaquin"
0833632,09/14/2019,FL,72.0,72,,F,,"Patient stated she had cough, congestion, and  ""head pain under the scalp"" following the injection.  She also stated she had some soreness at the injection site following the injection.  She was advised to follow up with a physician.",,,,,,,,,N,09/05/2019,09/06/2019,1,,PHM,,,,,,,2,09/14/2019,,,,
0833633,09/14/2019,WI,70.0,70,,F,,"Muscle weakness, fever of 100 degrees, headache, neckache, nerve pain, dizziness.  These symptoms were worse the first four days, now they have mostly resolved but patient is left with weakness and dizziness.",,,,,,,,,N,09/01/2019,09/01/2019,0,"Blood pressue checks, bloodwork, EKG on 9/12/19",PHM,,"atorvastatin, fluticasone nasal spray, lisinopril, metformin, zyrtec, and pseudoephedrine",none,"high blood pressure, pre-diabetes, bronchitis in the winter",,,2,09/14/2019,,Y,,"topamax, bactrim, macrobid, levaquin, ceftin, mold, and ragweed"
0833634,09/14/2019,MI,51.0,51,,F,,"Extreme fatigue, muscle pain and weakness.  Felt like I had caught the flu.  Slept over 15 hours.  Felt better the following day.",,,,,,,,,Y,09/12/2019,09/13/2019,1,,PHM,,"metoprolol, celexa, spirinolactone, aspirin, colace, zyrtec",none,,,,2,09/14/2019,,,,"augmentin, silver, penicillin"
0833635,09/14/2019,AZ,62.0,62,,F,,"I had my first dose in March of 2019 and second dose in May 2019 as directed by information provided. Yesterday, September 14th, I broke out in Shingles. This vacination which I paid out of pocket, did not prevent the Shingles from reoccuring.",,,,,,,,,N,05/11/2019,09/13/2019,125,,PHM,,none,none,"none, other than shingles",,,2,09/14/2019,,,,none
0833636,09/14/2019,TX,65.0,65,,F,,"Shivering/chills, fever, tired, achy, headache",,,,,,,,,N,09/13/2019,09/13/2019,0,N/a,PHM,,Lisinopril. Simvastatin. Vit D. Magnesium. Fish oil. Also had flu vaccine at the same time as getting shingles vaccine,None,None,,,2,09/14/2019,,,,Penicillin. Erythromycin Cefalexin (keflex
0833637,09/14/2019,AZ,0.17,0,.2,F,,"Within a few weeks of getting her two month shots, my daughter basically went silent. She stopped cooing and talking, she seemed very withdrawn. She stopped rolling. She was doing very advanced things for her age and just stopped. She then developed a bright red, dry and scaly rash that started on her elbows and was spreading with each day over most of her body.",,,,,,,,,U,07/24/2019,08/01/2019,8,"I have been seeing Dr. myself since 2015 and believe in the power of natural vitamins to heal the body. I took my daughter to see him knowing that he would give her the best chance to heal from this naturally. I took patient to see Dr. on Monday September 2 after I saw the rash getting worse before my eyes and knew something wasn't right. He uses nutritional response testing and determine the rash was from hard metals. He also found that her kidneys were suffering from trying to push out the toxins in her body.  He gave us some all natural lotion to put on the rash and some whole food vitamins for her kidneys and parotid glands to push the toxins out.  I saw the rash get better within a day of her taking the supplements.   I saw Dr. again on September 11 because I was concerned about the rash still. He used his vaccine kit to test patient and determine the rash was from the vaccines. Since her body is working hard to push the toxins out, I expected to see the rash get worse before it got better. It is getting better everyday and I can tell she feels better.",PVT,,none,none,none,,,2,09/14/2019,,Y,,none that we know of
0833638,09/14/2019,FL,20.0,20,,F,,"Patient was very nervous and anxious about getting a vaccine and had not eaten since 6 am. About 30 seconds after vaccine was administered patient stated she felt a little dizzy and started to look pale. I had the patient remain seated in the chair and within a minute she passed out, going completely limp in the chair. Her boyfriend was standing right next to her and held her up in the chair while I checked her pulse, breathing and looked at her injection site for any symptoms of allergic reaction. She did not appear to be struggling to breathe or have any symptoms of an allergic reaction. We kept her safely supported in the chair, and called out her name trying to help her regain consciousness. Within 45 to 60 seconds patient began to regain consciousness and was able to respond to her name and then answer some questions. Her color came back and we gave her water and saltine crackers. Patient stated she didn't even remember losing consciousness. Patient never experienced any difficulty breathing and the injection site did not appear red or swollen. Patient remained seated for about 25 minutes and then felt well enough to walk out of the store. When I called to check on the patient 2 hours later she had eaten and was feeling better.",,,,,,,,,Y,09/14/2019,09/14/2019,0,,PHM,,None,Some Allergy Symptoms - Congestion/Post Nasal Drip/Sneezing,None,,,2,09/14/2019,,,,None
0833639,09/14/2019,FL,59.0,59,,M,,"injection-site - pain, redness. Also fatigue, headache, shivering, fever, and gastrointestinal issues.",,,,,,,,,,09/13/2019,09/13/2019,0,,PHM,,None,None,None,,,2,09/14/2019,,,,"Penicillin, shell fish"
0833640,09/14/2019,IL,68.0,68,,F,,"Evening of the next day after the shot her left bicept was erthymous, inflammed, and warm to the touch. She has had taken some tylenol the morning after the shot and had iced the shot the evening after the shot.",,,,,,,,,N,09/11/2019,09/12/2019,1,,PHM,,"Tylenol taken 9/12/19 AM also on; Vit C, rutin, Calcium + Vit D.",None,GERD,,,2,09/14/2019,,,,None
0833641,09/14/2019,PA,51.0,51,,F,,"Patient was given shingrix on her left arm. She felt the vaccine entering her arm. Said that she did not like that feeling or sensation but does not mind the needles at all. I told her what the side effect and what to expect of the shingrix vaccine. We exchanged seat and I gave her flu vaccine on the right arm. As soon as I was gave her the flu vaccine, she said she was not feeling right and she felt dizzy and seeing white spot, she felt like fainting. I help to her to support her. She also said she felt hot and I started fanning her. I was trying to hold to her and hug to support her. She rolled her head and she slightly tug her head on the wall and fainted for her seconds and became conscious when she hit her head slightly on the wall. I stabilized her a bit . I went to get her cold water while I asked her 15 year old daughter to watched her. She drunk the cold water and said she felt a little better. No fainting spell but she still felt rubbery. I asked her to stay for a while and observed her. She did not have any hives or allergic reaction. She said she also have stomach upset. Her older daughter came after 30-45 minutes and brought her home. Around 5pm I called patient at home and said she felt better but still is cold and wearing sweater and has blanket on. Slight headache  but not from bumping her head.  for follow up and observation and told her to inform her pcp on Monday as well.",,,,,,,,,N,09/14/2019,09/14/2019,0,none,PHM,,none,none,none,,,2,09/14/2019,,,,none
0833642,09/14/2019,MA,51.0,51,,F,,"fever, aches, arm pain, nausea, headache",,,,,,,,,N,09/13/2019,09/13/2019,0,,PHM,,,,,,,2,09/14/2019,,,,
0833643,09/14/2019,LA,76.0,76,,F,,"PATIENT REPORTED  REDNESS, ITCH, AND SWELLING IN THE GENERAL AREA OF THE INJECTION SITE.",,,,,,,,,N,09/07/2019,09/13/2019,6,,PHM,,,NONE REPORTED,NONE REPORTED,,,2,09/14/2019,,,,NONE REPORTED
0833644,09/14/2019,MO,79.0,79,,F,,Arm blue and purple at site of injection. Looks slightly high for area of injection.  Patient states painful and feels swollen,,,,,,,,,N,09/13/2019,09/13/2019,0,,PHM,,,,,,,2,09/14/2019,,,,
0833645,09/14/2019,,77.0,77,,M,,"SYMPTOMS: body aches, weakness, fatigue all day, left eye swollen shut with white discharge and pain in eyelid appearing day after vaccination and lasting one week; has improved  but not yet resolved.  Took course of zithromax (ZPAK) and children's claritin (2 doses upon symptom onset).",,,,,,,,,N,09/06/2019,09/07/2019,1,none,PHM,,,NONE,HTN; HYPERCHOLESTEROLEMIA,,,2,09/14/2019,,Y,,NKA
0833646,09/14/2019,MA,79.0,79,,F,,"Patient received 2nd Shingrix vaccines on 9/6/19 (1st 6/21/19-no reactions).  patient informed us that redness, swelling, very warm to touch  developed  few hours after the injection around the site of injection.  Irritation grew to about size of 2 inches wide and 4 inches long.  Today 9/14/19 patient informed us it all went away and no more redness, swelling, and all back to normal. She also mentioned she has been having physical therapy on the same shoulder and arm as well.",,,,,,,,,Y,09/06/2019,09/06/2019,0,,PHM,,"Patient received 2nd Shingrix vaccines on 9/6/19 (1st 6/21/19-no reactions).  patient informed us that redness, swelling, very warm to touch  developed  few hours after the injection around the site of injection.  Irritation grew to about s",none known,none known,,,2,09/14/2019,,,,none known
0833647,09/14/2019,ID,72.0,72,,M,,"I was notified by the Physicians Assistant that the patient reported to urgent care with trunk and arm pain. I later directly spoke to the patient who described an ""achy, sore"" pain throughout his trunk with occasional ""sharp-shooting"" pains in his whole trunk. He also reported a sore left arm and no pain in his right arm.",,,,,,,,,N,09/03/2019,09/12/2019,9,None administered by pharmacy,PHM,,No chronic medications on record at our pharmacy. Otherwise unknown.,None reported,None reported,,,2,09/14/2019,,Y,,No known drug allergies on record at our pharmacy
0833648,09/14/2019,CA,34.0,34,,M,,"After receiving the MMR vaccine. patient felt dizzy and fainted for about 15 to 30  seconds on the chair. I was keeping him from sliding down and kept him on the chair. He came back to his senses after about 15 to 30 seconds. After he came back to his senses, he felt nauseous. He vomited 20 minutes later. I continued to monitor him for another 20 to 25 minutes while he was sitting down. He felt ok afterwards and had someone gave him a ride home. I told him to go to ER if any signs of trouble breathing. This does not seem like he is allergic to the vaccination.",,,,,,,,,Y,09/14/2019,09/14/2019,0,N/A,PHM,,none that I am aware of,none reported by patient,none reported by patient,"He reported a one off fainting experience when he was young because he thinks he was scared of needles. However, he says he was ",,2,09/14/2019,,,,none reported by patient
0833649,09/14/2019,NJ,54.0,54,,F,,Patient has bruising below injection site. Bruising is still present 2 weeks after immunization.,,,,,,,,,,09/02/2019,09/01/2019,,,PHM,,,,,,,2,09/14/2019,,Y,,
0833650,09/14/2019,,0.33,0,.3,M,,Rash fever swollen leg,,,,,,,,,N,09/12/2019,09/14/2019,2,,PVT,,,,,,,2,09/14/2019,,,,
0833651,09/14/2019,OR,71.0,71,,F,,PATIENT PRESENTED WITH FIST SIZED RED WELT AROUND THE VACCINE ADMINISTRATION SITE. PATIENT STATES IT IS PAINFUL TO THE TOUCH,,,,,,,,,U,09/11/2019,09/12/2019,1,NONE,PHM,,ATORVASTATIN,NONE,HYPERLIPIDEMIA,,,2,09/14/2019,,,,NO ALLERGIES
0833817,09/14/2019,MA,61.0,61,,F,,"Patient states redness developed several inches below injection site, area was warm to the touch, sore and red. Patient stated she took some Benadryl and the area has become less red and sore with time.",,,,,,,,,Y,09/11/2019,09/12/2019,1,,WRK,,Unknown,Unknown,Unknown,,,2,09/14/2019,,,,NKA
0833819,09/14/2019,PA,60.0,60,,F,09/12/2019,Swelling & bruising at injection site,,,,,,,,,Y,09/12/2019,09/12/2019,0,,PUB,UNK,,,,,,1,,,,,
0833820,09/14/2019,,70.0,70,,F,,"Pt stated experienced discomfort and cramping from the first shingrix vaccine (right arm). Once the second vaccine (right arm) was given, pt experienced severe muscle cramping, diarrhea, flu-like symptoms, spine tingling. She believes the vaccine caused her fibromyalgia to flare. She was in severe pain, was considering going to the emergency room, but did not.   Vaccine info for 2nd vaccine: Lot N4C23 EXP: 11/15/21, Diluent Lot: ks549 EXP: 1/29/22 Vaccine info for fluzoneHD: Lot: UJ221AB EXP: 04/01/20",,,,,,,,,,09/08/2019,09/08/2019,0,,UNK,,,,,,,2,,,,,
0833822,09/14/2019,NC,4.0,4,,F,,"Right thigh Anterior warm to touch, red & tender",,,,,,,,,,09/11/2019,,,0,PVT,,0,Right Otitis/URI,0,,,2,09/13/2019,,Y,,NKA
0833652,09/15/2019,CA,3.0,3,,M,,"With in an hour patient was lethargic crying uncontrollably, unable to walk with extreme pain. In so much pain he could barley speak. Had to be carried to bathroom. Fever spikes to over 106-107z This lasted 5 days- with the leg pain and crying and moaning barley able to talk.",,,,,,,,,U,04/04/2012,04/04/2012,0,Was told this was a normal side effect.,PVT,,N/a,N/a,N/a,,,2,09/15/2019,,,,N/a
0833653,09/15/2019,HI,66.0,66,,F,,"Pt reported noticing redness/swelling by right deltoid at around 8-9pm on 9/13/19 (day of administration). Reported it being very itchy and slightly hot to the touch. Came in to report this at around 2:30pm on 9/14/19 . Right arm was still slightly swollen and per pt, swelling is moving slowly down arm from area of vaccine administration to bicep area.",,,,,,,,,U,09/13/2019,09/13/2019,0,N/A,PHM,,"Anoro Ellipta, lisinopril/HCTZ, Vascepa, promethazine, fluticasone nasal spray, oxycodone, hydrocodone/ibuprofen",Unknown,"asthma, COPD",,,2,09/15/2019,,,,"No known drug or food allergies. Pt did state reaction with steroids, but did not specify."
0833654,09/15/2019,PA,64.0,64,,F,,pain- soreness- right arm,,,,,,,,,U,09/11/2019,09/12/2019,1,none,PHM,,none,none,hypothyroid- high blood pressure- high cholesterol,,,2,09/15/2019,,,,none
0833655,09/15/2019,,16.0,16,,F,,Lip swelling with no other signs of allergic reaction,,,,,,,,,Y,09/09/2019,09/10/2019,1,,PVT,,,,,,,2,09/15/2019,,Y,,
0833656,09/15/2019,WI,65.0,65,,F,,Left arm pain (injection arm) from shoulder to wrist for 7 days; severe for 4 days. Right arm pain from shoulder to wrist for 4 days. Upper back pain for 4 days. Frontal headache for 5 days; severe for 2 days. Fatigue for 4 days; severe for 3 days. Weakness for 5 days; sever for 3 days. Nausea and vomiting for 1 1/2 days. Fasting blood sugar elevation to 240 mg/dl day after injection; 212 2nd day after injection.,,,,,,,,,Y,06/19/2019,06/19/2019,0,,PVT,,"Chlorthalidone, Valsartan, Amlodipine, Januvia, Metformin, Trulicity, Calcium supplement, Magnesium supplement, Multivitamin, Pravastatin",None,"Hypertension, Diabetes Type II, Obesity",,,2,09/15/2019,,,,None
0833657,09/15/2019,CO,60.0,60,,F,,"Fever, chills, sore muscles, fatigue",,,,,,,,,N,09/14/2019,09/15/2019,1,,PHM,,Metformin 500mg X 2 a day Gabapentin 300 MG X3 to 4 a day Hydrochlorothiazide 12.5 MG X 1 a day Amiodipine Besylate 10 MG X 1 a day Meloxicam 15MG X1 a day Amatriptaline 10 MG X 1 a day,No,diabetes Type 2 under control with medicine,,,2,09/15/2019,,,,Penicillin
0833658,09/15/2019,IN,66.0,66,,F,,"Pt had swelling, redness, and pain that radiated around arm and almost down to elbow. Pt used ice packs, antihistamines, and otc pain relievers. Symptoms were diminishing, but not gone completely on 9-14-19 when she visited the pharmacy.",,,,,,,,,Y,09/12/2019,09/13/2019,1,,PHM,,"citalopram, lisinopril",n/a,"depression, hypertension",,,2,09/15/2019,,,,n/a
0833659,09/15/2019,IL,0.25,0,.3,F,,Infantile Spasms/Seizure Disorder began soon after the vaccination and worsened with the next set of vaccines when baby was 6 months old.,,,,,Y,5,,Y,U,07/19/2018,09/30/2018,73,"EEG confirmed seizures on November 17, 2018",PVT,,None,,,,,2,09/15/2019,,,Y,
0833660,09/15/2019,NM,65.0,65,,F,,"Pain immediately, with swelling developing over the next several hours.  Next day malaise, fever 99.5 with warmth at vaccine site and limited range of motion.  Vaccine site visualized as and confirmed to be correct placement in right deltoid muscle.  Discussed with patient this is likely a vaccine reaction, however due to upcoming trip and concern for early cellulitis began antibiotic treatment along with supportive care for pain and swelling.",,,,,,,,,U,09/13/2019,09/13/2019,0,NA,PVT,,"gabapentin, omeprazole, lorazepam",aphthous ulcer,fibromyalgia,,,2,09/15/2019,,,,"morphine, NSAIDs"
0833661,09/15/2019,FL,68.0,68,,F,,"prevnar on 4/26/18,,,,,,,arm inflamed from injection site distally to elbow.",,,,,,,,,U,09/13/2019,09/14/2019,1,N/A,PHM,,No,No,No,,,2,09/15/2019,,,,No
0833662,09/15/2019,FL,53.0,53,,F,,swelling & stiffness in both knees & right elbow,,,,,,,,,U,08/30/2019,09/14/2019,15,none,UNK,,"fish oil, multivitamin,  vitamin C, ginko, zyrtec",none,none,,,2,09/15/2019,,Y,,none
0833663,09/15/2019,AL,73.0,73,,F,,Patient said she developed a rash and whelps in the area the shot was given and a sore arm the day after the shot.,,,,,,,,,U,09/13/2019,09/14/2019,1,,PHM,,,,,,,2,09/15/2019,,Y,,
0833664,09/15/2019,VA,71.0,71,,F,,bruise developed at the injection site. Also redness about 5 inches below injection site developed,,,,,,,,,N,09/12/2019,09/14/2019,2,none,PHM,,None at the time,Parkinson's,Parkinson's,,,2,09/15/2019,,,,NKDA
0833665,09/15/2019,,30.0,30,,F,,"Fainted moments after receiving the flu shot,  revived and had a meal. No further effects.",,,,,,,,,Y,09/14/2019,09/14/2019,0,,PHM,,flonase,,mild asthma,"fainted after flu shot in January, 2017 at age 27",,2,09/15/2019,,,,
0833666,09/15/2019,TX,74.0,74,,F,,"PATIENT WOKE UP DIZZY WITH A MILD FEVER AND NOT ABLE TO MAINTAIN BALANCE, FEELING GENERALLY AWFUL",,,,,,,,,U,09/14/2019,09/15/2019,1,,PHM,,"SERTRALINE, TRAZODONE, AUGMENTIN",CAT BITE,DEPRESSION,,,2,09/15/2019,,,,SULFA
0833667,09/15/2019,OK,,0,.3,F,,My daughter developed a rash on her thighs on injection site.,,,,,,,,,N,09/10/2019,09/15/2019,5,,MIL,,,"Cold, possible teething",,,,2,09/15/2019,,,,"Dairy, soy"
0833668,09/15/2019,IL,58.0,58,,F,,"Severe dizziness 2 hours after injection. I was driving and had to pull over to let my husband drive. It lasted about 3 minutes. I also had a 101.2 fever and headache 24 hours later that improved with Tylenol, diarrhea 48 hours later.",,,,,,,,,Y,09/13/2019,09/13/2019,0,None,PHM,,"Verapamil, lisinopril, plavix, tramadol, reglan, Prilosec",None,"High blood pressure, gastroparesis, fibromyalgia, migraines",,,2,09/15/2019,,,,"NSAIDs, sulfa, tetracycline, toradol, keflex"
0833669,09/15/2019,UT,60.0,60,,M,,severe daily headache,,,,,,,,,N,08/03/2019,08/04/2019,1,CBC,PHM,,"trazodone, suboxone, sildenafil, testosterone",none,BPH and restless leg syndrome,,,2,09/15/2019,,Y,,none
0833670,09/15/2019,GA,48.0,48,,M,,"Brachial nerve pain radiating into arms, with weakness, burning and tingling. Symptoms continue and are exacerbated with activity. Seen in ER on 9/11/19. Given Decadron, Toradol and valium; symptoms lessened, i.e. tingling reduced, pain reduced but was not relieved. Valium and Motrin ordered until can be seen by PCP.",,,,,,,,,N,09/10/2019,09/11/2019,1,Physical exam only.,PVT,,Motin 800mg at bedtime,none,Moderate nerve damage bilateral ulnar nerves and carpal tunnel,,,2,09/15/2019,,Y,Y,"Tramadol, Chantix, Iodine (IVP)"
0833671,09/15/2019,OR,52.0,52,,F,,"Began having chills, aches and nausea a few hours after receiving the vaccine. The side effects were strong enough to keep me in bed for two days.",,,,,,,,,Y,07/01/2019,07/01/2019,0,,PHM,,Multivitamin dietary supplement,None,None,,,2,09/15/2019,,,,None
0833672,09/15/2019,FL,73.0,73,,M,,"Pain and stiffness in the left side of the neck for several days. Later I developed pain and stiffness in the left shoulder, getting worse and lasting still today.  I reported this to my Primary Care Provider. He examined me on 8-30-2019, made a diagnosis of Tenosynovitis of left shoulder and prescribed me Ibuprofen 325 mg tablets and Tizanidine 4 mg tablets.",,,,,,,,,N,08/26/2019,08/26/2019,0,Normal temperature.,PVT,,Aspirin 81 mg one tablet daily,None,History of Myocardial infarction in  1999 and cerebral TIA in 2005.,,,2,09/15/2019,,Y,,None
0833673,09/15/2019,OR,52.0,52,,F,,"Side effects began the next day after receiving the vaccine: aches, nausea, vomiting, headache. Spent the day in bed, and felt better by the next day.",,,,,,,,,Y,09/13/2019,09/14/2019,1,,PHM,,"Ibuprofen, multivitamin dietary supplement",None,None,"Similar side effects after receiving the Shingrix vaccine in July 2019, at age 52.",,2,09/15/2019,,,,None
0833674,09/15/2019,NJ,63.0,63,,F,,"I had this vaccine at my local pharmacy and was told the worst case side effect would be arm pain. The injection itself was painless. Within 12 hours I def had the arm pain which indicated below the actual injection site to my elbow, then I had tingling (creepy crawly) on bottom of feet and palms of hands, which spread to extremeties, severe flushing of the face, redness on arms, and very slight raspy breathing. Having dealt with allergies to antibiotics before I decided to take two benedryl immediately, which helped keep reaction controlled, but later the next day I spiked a high fever, headache and severe fatigue.  I had the injection on Friday at 4:30pm, today is Sunday at 1:30pm - still have some  of the ""creepy crawly"" itching on feet/hands,  still have arm pain , am controlling reaction and  fever with both benedryl and tylenol.",,,,,,,,,N,09/13/2019,09/14/2019,1,None - I self treated with plans to go to  ER of it worsens.,PHM,,Standard Daily Medications taken 7am each morning - these were taken the day of the vaccine: Bisoprolol-HCTZ      5 - 6.25mg Losartan -  50mg Metformin - 500mg Simvastin - 20mg,High blood pressure - controlled by meds High cholesterol - controlled by meds Type 2 Diabetes - controlled by meds MDS - no treatment at this time,See  Item 11,,,2,09/15/2019,,,,Clindamycin Amoxicilin Azithromycin Penicillin Recephin Latex
0833675,09/15/2019,TN,67.0,67,,F,,"Patient has blister like bumps on her arms and she said it was on her chest. However,  those on her chest were not as bad and getting  better. The spots did itch and she did get some cortisone cream to put on them. She did claim that she had been working on pulling weeds around the same time she had received the shot so she was unsure if the shot had caused this or if she was exposed to something.",,,,,,,,,N,09/04/2019,09/06/2019,2,,PHM,,,,,,,2,09/15/2019,,,,
0833676,09/15/2019,FL,72.0,72,,F,,THE PATIENT REPORTS GETTING CELLULITIS.  HER ARM IS RED AND SWOLLEN AND SHE IS ON ANTIBIOTICS.,,,,,,,,,N,09/13/2019,09/15/2019,2,,PHM,,,,,,,2,09/15/2019,,,,
0833677,09/15/2019,OR,66.0,66,,F,,"Arm pain which became so extreme I could not sleep in any position. Edema that went under my arm, down my back and down my arm. I was unable to move my arm for 2 days Ibuprofen helped.  The pain lasted for 5 days I should have had the nurse inject the other arm since this side was my mastectomy side and I am missing some of my lymph nodes",,,,,,,,,Y,09/11/2019,09/11/2019,0,,OTH,,Letrozole Effexor,,Inflitrating lobular breast cancer,,,2,09/15/2019,,,,Bee sting
0833678,09/15/2019,VA,58.0,58,,M,,"Swelling and redness and pain at injection site, Body ache, fever, chills, rash, muscle and joint pain",,,,,,,,,Y,09/08/2019,09/08/2019,0,N/A,PHM,,"atorvastatin, prilosec, xyzal",none,"hypercholestremia, GERD",,,2,09/15/2019,,,,vespids
0833679,09/15/2019,CA,60.0,60,,F,,"9/10/2019 6:45 pm - Shingrix injectionon left arm 9/11/2019 8:00 am - left arm rash (3 inches below injection location, pink, finger nail size, painful); High Fever (101F-109F) 9/11/2019 8:00 pm - took Tylenol 1000mg, fever gone after 40 minutes 9/12/2019 rash developing (tender, bigger, more painful, ~1 inch diameter) 9/13/2019 rash developing (bigger, more painful, ~2 inches diameter) 9/14/2019 9:00 am went to Clinic, no treatment was given, asked us to go to Emergency Room. 9/14/2019 10:10 am went to ER, doctor was not sure if the rash is or isn't shingles, but provided prescription Acyclovir 800mg 9/15/2019 9:00 am rash getting smaller and pain decreased",,,,,,,,,U,09/10/2019,09/11/2019,1,,PHM,,"Prescription: Alendronate 70mg, 1 tablet was taken on Monday morning (9/9/2019) 6:30 am",,osteoporosis,,,2,09/15/2019,,,Y,
0833680,09/15/2019,SC,65.0,65,,F,,"Began with fever 100.4 on 9/11/19 which persisted for 2 days. Had aches in my back, knees, headaches unrelieved by Tylenol Extra Strength or Motrin. Left arm was sore but not painful. Small area of acute redness at injection site on 9/11/19 enlarged to an area measuring 3 x 4 inches with the center swollen by that evening. Slight fading of the redness and decreased swelling noted on 9/14/19 but as of today on 9/15/19 the area is still visible. Itching extreme to the area where the vaccine was injected and still persists. I used Benadryl tablets and hydrocortisone cream to combat the itching and swelling/redness but did not go to urgent care since the symptoms responded to these medications.",,,,,,,,,Y,09/10/2019,09/11/2019,1,None,MIL,,"Hychlorothiazide, Lialda, Metformin,Zantac, Toprol, Multiple vitamin, Pravachol, Simbrinza eye drops, Xalatan eyedrops",None,"Ulcerative colitis, Pre Diabetes, Glaucoma, Hypertension, Elevated cholesterol",,,2,09/15/2019,,,,"Latex, Demerol, Sulfa"
0833681,09/15/2019,MO,71.0,71,,M,,"Rash on arms,chest and back",,,,,,,,,N,09/14/2019,09/14/2019,0,,PHM,,"Blood pressure,water pill,meds for nueropthy,thyroid,ibuprofen,insulin.",None,"Diabetic,heart patient",,,2,09/15/2019,,,,None
0833682,09/15/2019,PA,65.0,65,,F,,Patient explained that she has been vomiting since she received the flu shot.  Vomited a black liquid (said she drank Coca Cola) but also vomited green.,,,,,,,,,U,09/14/2019,09/14/2019,0,,PHM,,"Percocet, Sodium Chloride, Linzess, Neurontin, Pepcid",,,,,2,09/15/2019,,,,Latex and Salonpas patch
0833683,09/15/2019,MD,71.0,71,,F,,"Extreme tiredness, muscle pain",,,,,,,,,N,08/15/2019,08/16/2019,1,NA,PHM,,"Losartan, levothyroxine",,Blind,,,2,09/15/2019,,Y,,None
0833684,09/15/2019,AZ,66.0,66,,F,,"Immediate severe flushing, mile shortness of breath, and mile dizziness (all within 2-3 seconds of vaccine).  Shortness of breath lasted less than 20 seconds.  Dizziness lasted a few minutes.  Flushing lasted over an hour.",,,,,,,,,Y,09/12/2019,09/12/2019,0,,PVT,,"Cymbalta, esterace, lorazepam",None,"Hyperlipidemia, depression.",,,2,09/15/2019,,,,None.
0833686,09/15/2019,GA,10.0,10,,M,,"INJECTION SITE HAS LARGE, RED, RAISED SPOT WHICH IS HOT TO TOUCH.",,,,,,,,,N,09/13/2019,09/13/2019,0,N/A,PHM,,ZYRTEC 10 MG AT BEDTIME,NONE,NONE,,,2,09/15/2019,,Y,,NONE
0833687,09/15/2019,WA,65.0,65,,F,,"Fever of 101.9 F for over 72 hours. Headache, body ache, painful skin over whole body, injection site swelling to 9 inches with redness and heat, fatigue (continues until today). Began to resolve on day four after immunization. /after four weeks still have a small, hard bump where vaccine was injected.  Alternated ibuprofen and acetaminophen around the clock to bring fever down and relieve aches.",,,,,,,,,Y,08/20/2019,08/21/2019,1,None,PVT,,"Cymbalta, Eliquis, Toprol, levoxyl, forteo, ambien,",None,"Atrial fibrillation, hypothyroidism, mild depression, osteoporosis",,,2,09/15/2019,,,,No
0833688,09/15/2019,CA,34.0,34,,M,,"Patient fainted momentarily after flu shot administered; stated he felt a little dizzy prior to fainting.  His blood pressure  reading was normal afterwards 126/80.  He recovered quickly, no injury reported.  He left the pharmacy and continued grocery shopping.  I checked on him as he was leaving the store about 5:20.  He was fine",,,,,,,,,Y,09/14/2019,09/14/2019,0,None,PHM,,None,None,None,,,2,09/15/2019,,,,Penicillin
0833689,09/15/2019,NY,58.0,58,,M,,PATIENT GOT THE SHOT ON WEDNESDAY AND FOUND OUT SATURDAY MORNIG THAT HIS ARM IS BUISING ABOUT PALM SIZE ON INJECTION SITE.,,,,,,,,,,09/11/2019,09/14/2019,3,,PHM,,,,CROHN'S  DISEASE,,,2,09/15/2019,,,,
0833690,09/15/2019,MI,60.0,60,,U,,pt had rash on her  arm.. not directly on the injection site. patient confirmed having alot of food and drug allergies,,,,,,,,,Y,09/12/2019,09/12/2019,0,,PHM,,patient called on 9/15/19 to report swelling and redness on her arm after she got the shingrix shot but not directly on the injection site,,,,,2,09/15/2019,,,,
0833691,09/15/2019,NY,58.0,58,,F,,"PATIENT HAD A 5 INCH RASH BELOW THE INJECTION AREA.  WHEN SHE CONTACTED THE PHARMACY ON 9/4/2019 THE DAY AFTER THE IMMUNIZATION, THE RASH WAS GETTING BETTER.",,,,,,,,,U,09/03/2019,09/03/2019,0,N/A,PHM,,FLOVENT  ATORVASTATIN,N/A,N/A,,,2,09/15/2019,,,,PENICILLIN
0833692,09/15/2019,NY,72.0,72,,M,,Patient reported pain at time of the injection and continued pain that has increased.,,,,,,,,,N,09/13/2019,09/13/2019,0,,PHM,,N/A,,,,,2,09/15/2019,,,,ketoconazole
0833693,09/15/2019,MD,65.0,65,,F,,Patient called stating she was having trouble breathing and both arms are sore and she does not feel well. I asked if she had an inhaler and she said yes so I advised her to use it and get to an emergency room.  I called back after a couple of minutes and she was breathing better but not normal. I advised her to get to an er to be seen. She said she would go.,,,,,,,,,N,09/15/2019,09/15/2019,0,,PHM,,"ventolin, augmentin, clonazepam, cyclobenzaprine,  verapamil",sinus,"asthma, copd",,,2,09/15/2019,,,,no known allergies
0833694,09/15/2019,GA,1.0,1,.0,M,,Broke out in a rash on back that began similar to chicken pox and within 10 hours swelled into huge welps that also had redness expanding beyond the bumps. High pitched cry for several days and excessive crankiness and fussiness.,,,,,,,,,U,09/12/2019,09/12/2019,0,None - went back to pediatrician and nothing was done,UNK,,None,None,None,,,2,09/15/2019,,Y,,None
0833695,09/15/2019,MN,64.0,64,,F,,"Chills when I went to bed. Woke up 12:30 am with nausea, chills, rapid heartbeat. Took Tums.",,,,,,,,,Y,09/13/2019,09/14/2019,1,None,PHM,,Metformin Fenofibrate Atorvastatin Losartan Levothyroxine Magnesium CoQ10 Low dose aspirin,None,Type 2 diabetes Low thyroid,,,2,09/15/2019,,,,Penicillin
0833696,09/15/2019,MI,74.0,74,,F,,Intense burning pain from left deltoid down to elbow,,,,,,,,,Y,08/29/2019,08/30/2019,1,,PHM,,"metoprolol, gabapentin, alendronate, hydrochlorothiazide",none,hypertension,,,2,09/15/2019,,,,fentanyl
0833697,09/15/2019,MA,56.0,56,,F,,Prolific itchy rash on administration arm. Recommended diphenhydramine. No outcome yet.,,,,,,,,,U,09/12/2019,09/13/2019,1,,PHM,,Restasis eye drops,none known,unknown,,,2,09/15/2019,,,,"ketoconazole, erythromycin, phenytoin, sulfamethoprim, Exelderm. No details available as to reactions."
0833698,09/15/2019,WA,58.0,58,,F,,"Began to ache from my jawline down to my feet.  Aching increasing became worse until I could barely turn over in bed or sleep properly - almost shooting pain primarily in the neck, back and hips. Also got the chills during the night and had to wrap up in a blanket for several hours until I could get warm.  The next morning (today), aching continues although I am able to function.  Also had diarrhea today.",,,,,,,,,N,09/14/2019,09/14/2019,0,"As it was the weekend, I have not gone to see a doctor.  Hoping tomorrow will be a better day.",PHM,,None,None,None,,,2,09/15/2019,,,,None
0833699,09/15/2019,NY,76.0,76,,F,,site is swollen and painful.had pain radiating to neck and other arm,,,,,,,,,Y,09/12/2019,09/13/2019,1,,PHM,,"alendronate,levothyroxine",no,,,,2,09/15/2019,,,,sulfa
0833700,09/15/2019,TN,58.0,58,,M,,"Patient reported to me on 9/14/19 that within 2-3 hours he devoloped an itching rash on body, in both axilla, and in mouth. The itching was unbearable. I recommended that he go to an urgent care clinic or the ER. He reported back to after the physician visit that he received a shot of steroid and the doctor told him to also take Zyrtec. I was unable to reach him on 9/15/19 to determine his status today.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,,,,,,2,09/15/2019,,Y,,no allergies
0833701,09/15/2019,NY,77.0,77,,F,,"Upper arm pink to deep pink, hot, pimply, itchy,  Ice packs, benadryl tablet, benadryl liquid spray to site, lasted about 5 days,   two weeks later, electric shocks from trigeminal  nerve radiating from lower left jaw upward to eyetooth are",,,,,,,,,N,08/28/2019,08/29/2019,1,"Dental visit, xrays, no cavities, no tumors, no appearance of infection.  9/12/2019",PVT,,"Protonix, klor-kon, triamterine/hctz, carvedilol, ecotrin, mucinex, D3, spironolactone,",none,"Factor XI deficiency, gastroparesis, interstitial cystitis, esophageal motility disorder, mild left ventricle hypertrophy, skin cancer(BC carcinoma stage 2), urethral polyps",,,2,09/15/2019,,,,"penicillin, Vancomycin, cefuroxime, clarythromycin, cantelope,"
0833702,09/15/2019,CA,65.0,65,,F,,"Patient received the vaccines around 11L30am on 9/13/2019. She had soreness, swelling, heat and delineated redness in area around injection site of left arm by that evening. States the symptoms were worse on day 2 including redness and swelling of the upper arm spreading to bicep area, hardness of the upper arm.  She came to pharmacy on day 3 to report her symptoms and said her left upper arm isn't as swollen but redness has spread. Still feels soreness/pain as well as heat on the upper arm. Patients is directed to follow-up with her PCP or go to urgent care/ED if new symptoms present. Otherwise, no tightness of the chest or difficulty with breathing per patient.",,,,,,,,,,09/13/2019,09/13/2019,0,,PHM,,,,,,,2,09/15/2019,,,,
0833703,09/15/2019,FL,74.0,74,,M,,cellulitis.  redness swelling.  hot.  pt went to urgent care,,,,,,,,,N,09/14/2019,09/15/2019,1,,PHM,,,,,,,2,09/15/2019,,Y,,
0833704,09/15/2019,,82.0,82,,F,,"swelling, redness on the upper half of the left arm",,,,,,,,,,09/12/2019,09/14/2019,2,,UNK,,None,None,,,,2,09/15/2019,,,,None
0833705,09/15/2019,LA,62.0,62,,F,,"PATIENT SAID SHE WOKE UP AT 3 AM ITCHING ALL OVER HER BODY, HAD SPOTS EVERY WHERE AND BURNING PAIN ON BOTH LEGS AND FEET. I TOLD HER TO TAKE A BENADRYL AND GO TO URGENT CARE OR SEE HER PCP AS SOON AS POSSIBLE. SHE SAID ONE LEG STARTED TO GET BETTER BUT THE OTHER LEG STILL HAS SPOTS. SHE WILL CALL HER DR ON MONDAY WHEN THE OFFICE IS OPEN.",,,,,,,,,U,09/13/2019,09/14/2019,1,,PHM,,"ALBUTEROL 0.083, PANTOPROZOLE 40, MONTELUKAST 10, LEVOTHYROXINE 200MCG, CLOPIDOGREL 75, CLONZEPAM 0.5",8/14/19 HAD ASTHMA EXACERBATION  TAKING ZPACK AND PREDNISONE,"ASTHMA/COPD, HYPO THYROID",,,2,09/15/2019,,,,"NSAIDS, ACE AND ARBS INHIBITORS, CORTICOSTEROIDS TETRACYCLINE"
0833706,09/15/2019,CO,68.0,68,,F,,"Pt described injection site reaction.  Says tolerated  first shot well with minimal reaction.  This was 2nd shot & pt reported redness & swelling at injection site (approx 1.5 inches diameter) & feeling like had ""flu"".  Pt called pharmacy the day after having 2nd shot to report adverse reaction.",,,,,,,,,U,09/14/2019,09/15/2019,1,,PHM,,NONE ON FILE,,,,,2,09/15/2019,,,,NAPROXEN
0833707,09/15/2019,KY,53.0,53,,F,,"Patient states about  1 hour to 1.5 hours after receiving vaccine she started feeling tingling around the mouth, face itching. Thought eyes felt puffy but checked in mirror and no facial swelling. Took one dose of benadryl then in one hour took another dose. No problems with tingling/itching after 2nd dose. She did feel sluggish, tired and had low grade fever the next three days.",,,,,,,,,Y,09/08/2019,09/08/2019,0,None,PHM,,"PHentermine, prevacid, allegra, lisinopril/HCTZ",none,"obesity, HTN, GERD",,,2,09/15/2019,,,,"metronidazole, zyrtec, bethanecol, sudafed, codeine, sulfa"
0833708,09/15/2019,NY,11.0,11,,F,,"Right arm sore, swollen and hot around shot area (tricep area where varicela shot was given) Fever, face itching, tiredness and arm pain.  Next day she woke up with no fever, no face itching  but around 6pm (sep 15th) she felt tired and cold. Arm still swollen but less pain.",,,,,,,,,N,09/04/2019,09/14/2019,10,,PUB,,None,None,None,,507496,2,09/15/2019,,,,None
0833709,09/15/2019,AK,65.0,65,,M,,"Providing report while still recuperating so final outcome TBD.  Some arm soreness at site of injection but normal activity and diet until 4 am with onset of chills, body aches, and other flu like symptoms. Temperature not measured but may have been feverish. In bed until about 1 pm, still on couch at 4 pm.",,,,,,,,,N,09/14/2019,09/15/2019,1,,PHM,,atorvastatin 10 mg,none,,,,2,09/15/2019,,,,nka
0833710,09/15/2019,OR,61.0,61,,M,,"Donor reported approx. three hours after vaccine that his face was numb on the left side from his eye to mid way down his cheek, He also reported numbness on the left side of his tongue and left neck. No swelling, pain, speech or swallowing difficulties. When donor called the symptoms had been present for approx. 45min not increasing or decreasing. Donor had eaten and drank well. Donor felt otherwise normal. Donor stated he has had this happen once or twice before when he has been active all day and not eaten.",,,,,,,,,N,09/15/2019,09/15/2019,0,Donor advised to go to ER or urgent care for assessment.,OTH,,"Vit D, Celebrex, fluoxetine, multivitamin",none known,"arthritis, anxiety",,,2,09/15/2019,,,Y,unknown
0833711,09/15/2019,SC,50.0,50,,F,,"Swelling, redness at and around injection site that has extended to a larger area over the last 24 hours. Entire arm sore, muscles soreness, fatigue, upset stomach and headache,",,,,,,,,,N,09/14/2019,09/14/2019,0,N:A,PHM,,N/A?- no meds,None,Sleep apnea,,,2,09/15/2019,,,,N/A
0833712,09/15/2019,FL,59.0,59,,F,,"Patient usually receives the flu shot every year with no problems - Pharmacist decides to administer the shingles vaccine first (shingrix) within a minute patient starts to have itchy throat, by the time the flu shot is administered it's become apparent to the patient that she is experiencing symptoms- she reports chest tightness, difficulty breathing and reaches for her inhaler, pharmacist reaches for the epipen as symptoms progress and shows obvious distress... pt adamantly refuses the injection, pharmacist insists she says NO, pharmacist then offers to administer diphenhydramine 50mg as an alternative and pt accepts... symptoms seem to stop getting worse after treatment with diphenhydramine... pharmacist recommends that patient goes to the hospital, pt refuses, she starts feeling better and wants to go home. pharmacist again recommends the hospital for follow up as symptoms may return patient says No, pharmacist then trains husband on how to use the Epipen and recommends a second dose of diphenhydramine in about 6 hours ...",,,,,,,,,Y,09/09/2019,09/09/2019,0,when the event started happening BP was measured as 148/100 around 7:40pm at 8:15 BP was 148/80,PHM,,"meloxicam, Spiriva, montelukast, omeprazole, estradiol, Advair, albuterol",recovered from a cold 2 weeks ago was treated with azithromycin,asthma,,,2,09/15/2019,,,,"cleaning products, alcohol"
0833713,09/15/2019,NE,71.0,71,,M,,"Received vaccination around 9:20AM. At 7:30PM started feeling fatigued, chilled, headache, generalized muscle and joint pain. By 8:30PM was having severe chills and fatigue.  Went to bed, fitful night with waking every hour. Awoke at 7:20AM still fatigued and sore. No injection site redness or swelling, but minor soreness.  Have received flu vaccine every year since 1973 without incident.",,,,,,,,,Y,09/14/2019,09/14/2019,0,None,PHM,,"Tamulosin 0.8 mg  QD, Finasteride 5mg QD, Pramipexole 1mg BID for RLS",NONE,NONE,,,2,09/15/2019,,,,NKDA
0833714,09/15/2019,MA,66.0,66,,M,,48 hours of rash. 36 hours of 102 fever and chills,,,,,,,,,Y,09/13/2019,09/14/2019,1,,PVT,,None,None,None,,,2,09/15/2019,,,,None
0833715,09/15/2019,TX,51.0,51,,M,,"Started  later in the evening  with achy muscles, fever, and cold or flu like symptoms.  Middle of the night stomach cramps and feeling of nausea.  Lasted about 3 days and then progressed to an earache in the left ear.  Ear became badly infected and had to go back to the doctor for tests and Rx antibiotic oral medication and ear drops.",,,,,,,,,Y,08/26/2019,08/26/2019,0,9/5 appointment with doctor to diagnose  ear infection,PVT,,"Novolog Insulin, lorazepam, duloxetine, atorvastatin, pantoprazole, lisinopril, amlodipine, busiprione,  Bayer 81 mg aspirin",N/A,Type 1 Diabetes,,,2,09/15/2019,,Y,,N/A
0833716,09/15/2019,TX,51.0,51,,F,,Extreme burning sensation during injection and significant pain in upper arm for 3 days and minor pain for additional 3 days.,,,,,,,,,Y,08/26/2019,08/26/2019,0,N/A,PVT,,"Acyclovir, doxycycline",N/A,N/A,,,2,09/15/2019,,,,N/AA
0833717,09/15/2019,MD,64.0,64,,F,,"Injection site became red, swollen, hard, and quite painful. Swelling Lasted  more than 2 days. Became itchy on second day. Took ibuprofen for pain.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,PHM,,"Meds: Amlodopine hctz, atorvastatin, baby aspirin, irbesartan , paxil, reloxafene.  Supplements:  Multivitamin w/iron, turmeric, fish oil, CoQ10, Vitamin B  Complex, Vitamin D,  Biotin",None,None,,,2,09/15/2019,,,,None
0833718,09/15/2019,OH,63.0,63,,F,,"Woke up last night with bad chills and fever (103.1 F); also stabbing pains in upper thighs, cramping around shins and worse headache. Once up in the morning, mild nausea and lack of appetite, very tired (slept at least 4-5 more hours during the day), impaired concentration and ability to function, e.g. too tired to watch a movie or even part of one. Vision may have been off - or just too tired for sustained focus of eyes (could read some but had convergence difficulties). Fever reduced by ibuprofen but returning if more not taken.",,,,,,,,,N,09/14/2019,09/15/2019,1,None - contacted advice nurse at local hospital.,PHM,,"Prescriptions: paroxetine 10 mg, clonazepam .75 mg, raloxifene 60 mg Received Afluria injection same day (flu shot) Take Senna-lax for constipation at night.",frequent migraines - had mild unilateral headache at time of vaccination.Migraine,"Migraine, myoclonus",,,2,09/15/2019,,,,mild skin sensitivity to bandage tape and some metal (probably nickel)
0833818,09/15/2019,MD,67.0,69,,F,,"Patient received influenza vaccine in (L) deltoid on 9/12/19. On 9/13/19 pt developed headache & redness in area of injection. Since then, developed hive like reaction at injection site. No other rash. No respiratory symptoms. Rash measures 8 cm x 8 cm on (L) deltoid.",,,,,,,,,N,07/12/2019,07/13/2019,1,None,PHM,,"METROPROLOL ER, PREMARIN, OMEPRAZOLE",No,No,FLU SHOT UNSURE OF WHEN,,2,09/15/2019,,,Y,NSAIDS (GI SYMPTOMS)
0833719,09/16/2019,CA,76.0,76,,F,,When I woke up the morning after the injection I experienced dizziness  on that one day.,,,,,,,,,Y,09/13/2019,09/14/2019,1,,PHM,,none,none,none,,,2,09/16/2019,,,,none
0833720,09/16/2019,CA,5.0,5,,F,,"First symptom of ALL Leukemia (thinning hair and paleness) was noted 9/13/2016. First low grade fever was noted 10/1/2016. Low grade fevers were noted throughout October 2016, always resolving themselves after a day. She continued to become more and more pale, loose more hair and get more tired. On 11/9/2016 she had sudden pain on her shin and went to the ER for multiple tests. Leukemia suspected on 11/10/2016 and diagnosed on 11/11/2016. Her oncologist stated that based on the number of blasts in her blood and marrow, they estimate her leukemia started about a week after her vaccination. It was the first vaccination she had had for varicella and she had had over a year in between her previous vaccinations.",,,Y,,Y,12,,Y,N,08/30/2016,09/13/2016,14,Bone marrow aspiration done bun Hospital on 11/11/2016.,PVT,,None,None,In remission for ALL Leukemia,,,2,09/16/2019,,Y,Y,None
0833721,09/16/2019,PA,66.0,66,,F,,"Pt had chills, body aches, severe nausea & tachycardia beginning 5:30pm on day of 2nd vaccine (9-13-19) that lasted until sunday 9-15-19 4pm EST",,,,,,,,,Y,09/13/2019,09/13/2019,0,none,OTH,,no,no,"stent, main led, 2 heart ablasions",,,2,09/16/2019,,,,IVP dye
0833738,09/16/2019,SD,,,,U,,"no adverse event; patients received improperly stored vaccines; This spontaneous report was received from a nurse and refers to a unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. Their concomitant therapies included properly stored sterile diluent.  On unknown dates in 2019 (reported as between 01-JUL-2019 and 02-AUG-2019), the patients were vaccinated with improperly stored doses of varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot # R030612, expiration date 23-OCT-2020 and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin) (PROQUAD) injection, lot # S002490, expiration 23-JUL-2020 (doses, routes, vaccination sites and concentration were not reported) for prophylaxis. The temperature was from -14C to -10C (-14.2 C) for 6 hours. Previous temperature excursion was from -14C to -10C (-14.2 C) for 30 minutes. Digital data logger was involved. No adverse events were reported.   This case was considered to be non-valid due to lack of patients' identifiers.  Upon receipt of follow-up information it was determined that this case is now valid because patient identifier was received.  Follow-up information was received from the nurse on 27-AUG-2019 and refers to three 1-year-old patients. On an unknown dates in 2019 (reported as between 01-JUL-2019 and 12-AUG-2019), the patients were vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin) (PROQUAD) lot # S002490, expiration 23-JUL-2020. There was no reactions or problems with the patients. The freezer was defrosted on 08-AUG-2019 (reported as last Thursday). On 12-AUG-2019, the temperature was -14.9C for 30 minutes. The clinic manager was checking into getting a lab grade/ vaccine grade freezer. Total hours of excursions was 6 hours and 30 minutes at -14C.  This is one of 4 cases received from the same reporter.; Sender's Comments:  US-009507513-1908USA010528: US-009507513-1908USA010527: US-009507513-1908USA010526:",,,,,,,,,U,,,,,UNK,,MERCK STERILE DILUENT,,,,US0095075131908USA004659,2,09/16/2019,,,,
0833739,09/16/2019,OH,,,,M,,"No adverse effects; the administration of one dose of an improperly stored vaccine, PROQUAD; PROQUAD was administered to a 58 year old male patient; This spontaneous report as received from a registered nurse refers to a 58 year old male patient. No pertinent medical history, concurrent conditions, drug reactions or allergies were provided.  On 20-AUG-2019,  the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA)(PROQUAD) (lot # S009756 expiration date 27-SEP-2020) 0.5 milligram/once time, first dose for prophylaxis (route and anatomical location were not reported). The sterile diluent used to reconstitute the measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) was stored in the correct temperature storage range. There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 46 degrees Fahrenheit for 336 hours. Data logger was involved. There were no previous excursions reported.",,,,,,,,,U,08/20/2019,08/20/2019,0,,UNK,,sterile diluent,Medication dilution,,,US0095075131908USA009819,2,09/13/2019,,,,
0833740,09/16/2019,SD,,,,U,,"no adverse event; patients received improperly stored vaccines; This spontaneous report was received from a nurse and refers to a unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. Their concomitant therapies included properly stored sterile diluent.  On unknown dates in 2019 (reported as between 01-JUL-2019 and 02-AUG-2019), the patients were vaccinated with improperly stored doses of varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot # R030612, expiration date 23-OCT-2020 and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, lot # S002490, expiration 23-JUL-2020 (doses, routes, vaccination sites and concentration were not reported) for prophylaxis. The temperature was from -14C to -10C (-14.2 C) for 6 hours. Previous temperature excursion was from -14C to -10C (-14.2 C) for 30 minutes. Digital data logger was involved. No adverse events were reported.   This case was considered to be non-valid due to lack of patients' identifiers.  Upon receipt of follow-up information it was determined that this case is now valid because patient identifier was received.  Follow-up information was received from the nurse on 27-AUG-2019 and refers to ten children patients at the age between 3 and 5 years old. On an unknown dates in 2019 (reported as between 01-JUL-2019 and 12-AUG-2019), the patients were vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin) (PROQUAD) lot # S002490, expiration 23-JUL-2020. There was no reactions or problems with the patients. The freezer was defrosted on 08-AUG-2019 (reported as last Thursday). On 12-AUG-2019, the temperature was -14.9C for 30 minutes. The clinic manager was checking into getting a lab grade/ vaccine grade freezer. Total hours of excursions was 6 hours and 30 minutes at -14C.  This is one of 4 cases received from the same reporter.; Sender's Comments:  US-009507513-1908USA004659: US-009507513-1908USA010527: US-009507513-1908USA010528:",,,,,,,,,U,,,,,UNK,,sterile diluent,,,,US0095075131908USA010526,2,09/16/2019,,,,
0833741,09/16/2019,CA,,,,U,,"No adverse effects; accidental administration of PROQUAD in place of MMR II concomitantly with VARIVAX in patient; accidental administration of PROQUAD in place of MMR II concomitantly with VARIVAX in patient resulting in an extra dose ofVARIVAX; This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies and drug reactions/allergies were not provided.  On 27-AUG-2019, the patient was accidental vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S003176, expiration date: 30-JUL-2020 (dose, unit, and route of administration were not reported) in place of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (Wrong product administered) concomitantly with varicella virus vaccine live (oka/merck) (VARIVAX) (dose, unit, lot#, expiration date and route of administration were not reported) for prophylaxis. This resulting in an extra dose of varicella virus vaccine live (oka/merck) (VARIVAX) (Extra dose administered). No adverse effects were reported.",,,,,,,,,U,08/27/2019,08/27/2019,0,,UNK,,,,,,US0095075131908USA010861,2,09/16/2019,,,,
0833742,09/16/2019,CA,,,,U,,"No adverse effects; the patient was administered improperly stored V ARlV AX (reconstituted with properly stored Merck STERILE DILUENT); This spontaneous report has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug allergy or reactions were not reported.       On 26-AUG-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # S006017, expiration date was reported as 27-FEB-2021; dose and route were not reported) for prophylaxis; reconstituted with properly stored Merck sterile diluent (lot # R034106, expiration date reported as 22-JUN-2021; dose and route were not reported). No adverse effects were reported. No additional information was provided.    The administrated vaccine experienced the following temperature excursion: temperature -4.5 Celsius (C) (-9 degree Celsius to 8 degree Celsius) for 3 hours 20 minutes. There were no previous temperature excursions. The digital data logger was involved.",,,,,,,,,U,08/26/2019,08/26/2019,0,,UNK,,sterile diluent,,,,US0095075131908USA010865,2,09/16/2019,,,,
0833743,09/16/2019,WA,,16,,U,,"No adverse effects reported; administered properly stored M-M-R II on 1/31/2019 two weeks after administration of properly stored V ARIV AX; This spontaneous report as received from a physician refers to a 16 year old patient of unknown gender. No information on patient's pertinent medical history, concomitant medications and drug reaction or allergies was provided.     On 15-JAN-2019, the patient was vaccinated with properly stored varicella virus vaccine live (oka/merck)(VARIVAX) (lot # reported as M023963 that is an invalid lot number for varicella virus vaccine live (oka/merck)(VARIVAX) , expiration date reported as 01-SEP-2019, dose and route of administration were not provided) for prophylaxis. On 31-JAN-2019 (also reported as two weeks after vaccination with  varicella virus vaccine live (oka/merck)(VARIVAX)) , the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # reported as M025898 that is an invalid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), expiration date reported as 19-SEP-2019, dose and route of administration were not provided) for prophylaxis. Both vaccines were reconstituted with properly stored sterile diluent. No adverse effects reported.",,,,,,,,,U,01/15/2019,01/31/2019,16,,UNK,,sterile diluent,,,,US0095075131909USA001720,2,09/16/2019,,,,
0833744,09/16/2019,IL,,0,.2,U,,"No adverse events; a patient who was administered the first dose of ROTATEQ on 6/18/2019 and the second dose of ROTATEQ on 9/4/2019; This spontaneous report was received from a registered nurse referring to a 4 month old patient of an unknown gender. No information was provided regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions and allergies.  On 18-JUN-2019, the patient was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally (dose, lot number and expiration date were not reported) for prophylaxis. On 04-SEP-2019, the second dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) was administered to the patient orally, with lot number S010046 and expiration date on 08-NOV-2020 (dose was not reported) for prophylaxis (inappropriate schedule of product administration). No adverse events.",,,,,,,,,U,06/18/2019,09/04/2019,78,,UNK,,,,,,US0095075131909USA001825,2,09/14/2019,,,,
0833745,09/16/2019,PA,,70,,M,,"The patient experienced ""excruciating pain and can't move his arm.""; The patient experienced ""excruciating pain and can't move his arm.""; This spontaneous report was received from a pharmacist concerning a 70 year old male patient. No information was provided regarding the patient's pertinent medical history, concomitant medications or drug reactions/allergies. On 03-SEP-2019, the patient received a dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), intramuscular, lot # S004548, expiration date 12-AUG-2020 for vaccination (strength, dose and frequency were not reported). On the same date, he experienced excruciating pain and couldn't move his arm (movement disorder).  The outcome of pain and movement disorder was reported as not recovered. The causal relationship between the events and therapy with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) was not reported.",,,,,,,,,N,09/03/2019,09/03/2019,0,,UNK,,,,,,US0095075131909USA002375,2,09/15/2019,,,,
0833746,09/16/2019,NM,,,,U,,"no adverse effects were reported; The patient was administered improperly stored Varivax; This spontaneous report has been received from a nurse regarding a patient of unknown age and gender. There was no information provided about the patient's concurrent conditions, concomitant therapies, historical drugs, drug reactions or allergies, or pertinent medical history.  On 30-JUL-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) lot # R002506, expiration date reported as 25-JAN-2020 for prophylaxis.  (strength, dosage schedule, route and anatomical location were not reported) which was reconstituted with sterile diluent (DILUENT MRK).  The varicella virus vaccine live (Oka/Merck) (VARIVAX) was stored at a temperature range of 6F to 14F (7.7 F) for the time frame of 3 hours and 55 minutes. There was no previous temperature excursion and the call was because of a data logger.  No adverse effects reported.",,,,,,,,,U,07/30/2019,07/30/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA002982,2,09/16/2019,,,,
0833747,09/16/2019,TN,,,,U,,"No adverse effects reported; The primary reporter states an expired dose of VAQTA was given on 9/9/2019; This spontaneous report was received from a registered nurse, concerning a patient of an unknown age and gender. The patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications were not reported.   On 09-SEP-2019, an expired dose of Hepatitis A Vaccine, inactivated (VAQTA) (expired product administered) lot number R027987, expiration date 09-AUG-2019, was administered per intramuscular route, to the patient (strength, dose and frequency were not reported) for prophylaxis. No adverse effects were reported. The outcome of the event was not reported.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,US0095075131909USA003392,2,09/12/2019,,,,
0833748,09/16/2019,,,,,F,,"When the needle went in, the patient said, ""ow""; patient had received MMR II several years ago but there was no record of her receiving it so she got another one on 07Sep2019; The pharmacist inadvertently gave it ( content of one vial) intramuscularly instead of subcutaneously; This spontaneous report was received from a pharmacist, concerning a 21 year female patient. The patient's pertinent medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported.   On an unspecified date, several years ago, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) for prophylaxis, (strength, dose, frequency, route of administration, lot number and expiration date were not reported), however there was no registry of this vaccination, then on 07-SEP-2019, the patient had a new vaccination with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II) (extra dose administered) which was inadvertently administrated intramuscularly instead of subcutaneously (incorrect route of product administration) for prophylaxis, expiration date reported as 09-DEC-2020 (strength, dose, frequency and lot number were not reported).   On the same date, upon administration of vaccination with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II), when the needle went in, the patient said ""ow"" (injection site pain).   At the time of reporting, the outcome of injection site pain was unknown.   The causal relationship between the vaccination with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II)  and injection site pain was not provided by the reporting pharmacist.",,,,,,,,,U,,09/07/2019,,,UNK,,,,,,US0095075131909USA003436,2,09/14/2019,,,,
0833749,09/16/2019,,,,,F,,"ZOSTAVAX is not effective beyond 3 to 5 years and only 50% effective originally; ZOSTAVAX is not effective beyond 3 to 5 years and only 50% effective originally; This spontaneous report was received from a female patient of unknown age regarding herself. Patient's medical history, concomitant medication and drug allergies/reactions were not reported. On an unknown date in 2009, (mentioned as 10 years ago), the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, frequency, route, strength, lot/batch and expiry: unknown) for prophylaxis. The patient called to verify the availability status of zoster rgE vaccine (mammalian) (SHINGRIX). The patient reported that her physician recommended zoster rgE vaccine (mammalian) (SHINGRIX), because the physician stated to her that the zoster vaccine live (ZOSTAVAX) was not effective (drug ineffective) beyond 3 to 5 years, and only 50% effective originally whereas zoster rgE vaccine (mammalian) (SHINGRIX) was 90% (therapeutic product effect decreased). Outcome and causality of the events were not reported.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA003577,2,09/14/2019,,,,
0833750,09/16/2019,TX,65.0,65,,M,,"stroke; shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation involving a 65 years old male patient (pt). There was no information about the pt's concurrent conditions, concomitant therapies or medical history provided. On an unknown day in February 2017, the pt was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dosage regimen, route of administration, lot number and expiration date were not reported) at military clinic as prescribed and/or administered by a healthcare provider, for prevention of shingles and herpes Zoster related conditions. On 09-SEP-2019, the pt experienced shingles and a stroke (cerebrovascular accident), including any and all of its sequalae. It was reported that the pt would continue to suffer ongoing personal injuries, pain, suffering and emotional distress, as well as to incur substantial economic damages. The outcome of the events of shingles and cerebrovascular accident was not reported.   The reporter considered shingles and cerebrovascular accident to be related to Zoster Vaccine Live (ZOSTAVAX).  Upon internal review, the event of cerebrovascular accident was determined to be medically significant.",,,,,,,,,U,02/01/2017,09/09/2019,950,,OTH,,,Prophylaxis,,,US0095075131909USA003960,2,09/13/2019,,,,
0833751,09/16/2019,SD,19.0,,,F,,"the patient confirmed that she was not pregnant when she received the one dose of GARDASIL; adenocarcinoma of the cervix; Information has been received from a 28 years old female physician assistant referring to herself. The patient had no concomitant therapy, pertinent medical history or drug reactions/allergies.  On an unknown date in 2007 (approximately at 19 years old), she received the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (batch/lot #, expiration date, strength, dose and route were unknown) for prophylaxis. She did not receive any additional doses of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).  On an unspecified date in 2016, she was diagnosed with adenocarcinoma of the cervix. Medical attention was sought with office visits. She had the following procedures colposcopy, loop electrical excision procedure (LEEP) and cold knife conization. On an unknown date, the adenocarcinoma was fully removed with surgery and she recovered from the event. She was monitored every 6 months with Pap smears. Eventually she would have a hysterectomy, however, she was still in her childbearing ears. It was reported at time of diagnosis, the event was not life threatening. However, if she had left the adenocarcinoma untreated, it eventually would have become life threatening. The patient mentioned that she recently had a baby. She confirmed that she was not pregnant when she received the one dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (maternal exposure before pregnancy).  The causality between quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) and adenocarcinoma of the cervix was not provided.  Upon internal review, adenocarcinoma of the cervix was determined to be medically significant.",,,,,,,,,Y,,,,,UNK,,,,,,US0095075131909USA004095,2,09/16/2019,,Y,,
0833752,09/16/2019,,4.0,4,,U,,"No adverse effects; patient received improperly stored VARlVAX; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not provided.   On 10-SEP-2019, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) (strength, dose, route, frequency, were not provided) for prophylaxis; the Lot No. S003864 has been verified to be a valid lot number for [Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live], expiration date reported as 08-AUG-2020, and upon internal validation established as the same.   The medical assistant reported that the vaccine dose was administered to the patient and the vaccine was improperly stored (incorrect product storage). The vaccine presented a temperature excursion with a temperature of 6F to 14F (7.7 degrees F) for 30 minutes. And no adverse events were reported.   Moreover, it was stated that the sterile diluent that was used to reconstitute the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was properly stored. The Lot was No. S016519 and the expiration date reported as 01-APR-2022.",,,,,,,,,U,09/10/2019,09/10/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA004402,2,09/13/2019,,,,
0833753,09/16/2019,NY,,,,F,,"nerve pain; joint pain; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 05-OCT-2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for the prevention of shingles (the dosage regimen information was not reported) in a pharmacy. Shortly thereafter, the vaccine caused the patient to suffer from severe and persistent joint and nerve pain. As a direct and proximate result of vaccination, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient had suffered and would continue suffered significant medical expenses, pain, and suffering and other damages. The outcome of the events was considered as not recovered. The events were considered to be related to zoster vaccine live (ZOSTAVAX). The adverse events were considered to be disabling as the patient suffered serious and persistent injuries.",,,,,,,,Y,N,10/05/2016,,,,PHM,,,,,,US0095075131909USA004536,2,09/13/2019,,,,
0833754,09/16/2019,OH,,,,U,,"no adverse effect reported; the patient was administered an expired dose of vaqta; This spontaneous report as received from a nurse refers to a patient of unknown age. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies, historical drugs, familial history and concomitant medications were not reported.   On 09-SEP-2019, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated(VAQTA) Expiration date: 05-SEP-2019 (strength, route of administration, lot/batch # were not reported) for prophylaxis (expired product administered). The patient experienced no adverse event. No product quality complaint was reported.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,US0095075131909USA004658,2,09/13/2019,,,,
0833755,09/16/2019,CO,0.33,,,U,,"No known adverse effects; A 4 month old patient received a dose of PNEUMOVAX; This spontaneous report was received from a medical assistant concerning to a 4 month old patient of unspecified gender. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported.      On 09-SEP-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (product administered to patient of inappropriate age) for prophylaxis (lot # S012247 has been verified to be a valid lot number for pneumococcal vaccine, polyvalent (23-valent), expiration date reported as10-FEB-2021) (strength, dose, frequency and route of administration were not reported).   No adverse effects were reported.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,US0095075131909USA004971,2,09/13/2019,,,,
0833756,09/16/2019,FL,,,,U,,"No adverse effects; The primary reporter reports a 56 year old patient was administered a dose of PROQUAD; This spontaneous report was received from a nurse, regarding a 56 year old patient of unknown gender. The patient's concurrent condition, pertinent medical history, drug reactions, allergies, and concomitant therapies were not reported.   On 22-AUG-2019, the patient of 56 year old was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (appropriate age at vaccine administration) for prophylaxis (strength, route of administration, dose, frequency, lot number and expiration date were not reported). No adverse effects were reported.",,,,,,,,,U,08/22/2019,08/22/2019,0,,UNK,,,,,,US0095075131909USA005036,2,09/15/2019,,,,
0833757,09/16/2019,CA,4.0,4,,U,,"no adverse effects reported; A patient received improperly stored PROQUAD; Information has been received from a medical assistant and refers to a 4 year old patient of unknown gender. There was no information about patient's concurrent conditions, medical history or concomitant medications.  On 04-SEP-2019, the patient was vaccinated with a dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rha)(PROQUAD) lot # S002494 with expiration date of 23-JUL-2020 (dose, frequency, route of administration and anatomical location were not reported), for prophylaxis which were stored in the range of 6 Fahrenheit degrees to 14 Fahrenheit degrees (10.2 Fahrenheit degrees) for 50 minutes. The vaccine was reconstituted with properly stored sterile diluent(MERCK STERILE DILUENT). No previous temperature excursion was reported.  No adverse effects were reported.   Digital data logger was involved.",,,,,,,,,U,09/04/2019,09/04/2019,0,,UNK,,MERCK STERILE DILUENT,,,,US0095075131909USA005078,2,09/13/2019,,,,
0833758,09/16/2019,CA,,1,.1,U,,"No adverse effect; improperly stored vaccine administration; This spontaneous report has been received from a medical assistant referring to a 12-month-old patient with unknown gender. The patient's concurrent condition, medical history and concomitant therapy information was not provided.      On 04-SEP-2019, the patient received improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose, frequency and route were not reported) (lot # S002874, Expiration Date: 29-JAN-2021) for prophylaxis. There was no adverse effect. The stored temperature was 6 Fahrenheit (F) to 14 F (10.2 F, multiple) for 50 minutes and the data logger was involved. There was no previous temperature excursion. It was used to reconstitute sterile diluent (strength, dose, frequency, route, lot # and expiration date were not reported) for prophylaxis. The storage of sterile diluent was properly.",,,,,,,,,U,09/04/2019,09/04/2019,0,,UNK,,sterile diluent,Prophylaxis,,,US0095075131909USA005220,2,09/16/2019,,,,
0833759,09/16/2019,CA,,1,.0,U,,"No adverse effect; improperly stored vaccine administration; This spontaneous report has been received from a medical assistant referring to a 12-month-old patient with unknown gender. The patient's concurrent condition, medical history and concomitant therapy information was not provided.      On 11-SEP-2019, the patient received improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose, frequency and route were not reported) (lot # S002874, Expiration Date: 29-JAN-2021) for prophylaxis. There was no adverse effect. The stored temperature was 6 Fahrenheit (F) to 14 F (10.2 F, multiple) for 50 minutes and the data logger was involved. There was no previous temperature excursion. It was used to reconstitute sterile diluent (strength, dose, frequency, route, lot # and expiration date were not reported) for prophylaxis. The storage of sterile diluent was properly.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA005220:",,,,,,,,,U,09/11/2019,09/11/2019,0,,UNK,,sterile diluent,Prophylaxis,,,US0095075131909USA005223,2,09/16/2019,,,,
0833760,09/16/2019,OH,18.0,18,,F,,"DRUG EXPOSURE DURING PREGNANCY; This case was reported by a healthcare professional and described the occurrence of drug exposure during pregnancy in a 18-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis while pregnant.  Concurrent vaccination included hepatitis B vaccine recombinant (Merck) given intramuscularly on 10 October 2007. Concurrent medications included Prenatal vitamins.   On 10 October 2007 at 16:25 the pregnant subject received a dose of Boostrix, intramuscularly, at 0.5 ml in the right arm.  This was considered a case of drug exposure during pregnancy.  No events were reported.  The subject is reportedly due to deliver in December 2007.  At the time of reporting the outcome of the event was unspecified.  Upon internal review done on 13th September 2019, the pregnancy outcome was updated to lost to follow-up.",,,,,,,,,U,10/10/2007,10/10/2007,0,,PUB,,Recombivax; Prenatal vitamins,,Medical History/Concurrent Conditions: No adverse event (No report of any adverse reactions following previous vaccinations.  No history of prenatal care.),,USGLAXOSMITHKLINEA0688989,2,09/16/2019,,,,
0833761,09/16/2019,NC,15.0,15,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 15-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis while pregnant.  Concurrent vaccination included hepatitis B vaccine (Recombivax, Merck), inactivated poliomyelitis virus vaccine (Sanofi) and seasonal influenza vaccine (Fluzone, Sanofi) given on 15 January 2009. Pervious vaccination included two TD vaccines given in 2005.  On 15 January 2009 at 10:45 the subject received a dose of Boostrix at 0.5 ml in the left arm. This was a case of vaccine exposure during pregnancy. No adverse events were reported.    On 27 January 2009, follow-up information was received from the reporting nurse. The nurse reported that the subject received only immunization series from her Health Department. She reported that she had no way of assessing the information requested on the Pregnancy Initial Notification Form. She tried to call unspecified phone numbers, but no one was available.  Upon internal review done on 13th September 2019, the pregnancy outcome was updated to lost to follow-up.",,,,,,,,,U,01/15/2009,01/15/2009,0,,PUB,,,,Medical History/Concurrent Conditions: No adverse event (The subject has no relevant medical history and no history of adverse events following previous vacc),,USGLAXOSMITHKLINEA0763823,2,09/16/2019,,,,
0833762,09/16/2019,CA,31.0,31,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of drug exposure during pregnancy in a 31-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis while pregnant.   There were no concurrent medications.   On 20 December 2010 at 11:20 the subject received 1st dose of Boostrix at 0.5 ml inthe left arm. The subject experienced drug exposure during pregnancy. Her date of last menstrual period was not reported and her estimated date of delivery was 28 March 2011. No adverse events were noted at the time of reporting.  Upon internal review done on 13th September 2019, the pregnancy outcome was updated to lost to follow-up.",,,,,,,,,U,12/20/2010,12/20/2010,0,,PUB,,No concurrent medication,,Medical History/Concurrent Conditions: No adverse event (There was no relevant medical history noted or history of adverse events following previous vaccinat),,USGLAXOSMITHKLINEA0902896,2,09/16/2019,,,,
0833763,09/16/2019,CA,38.0,38,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 38-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis while pregnant.   On 10 May 2011 at 16:45 the subject received a dose of Boostrix at 0.5 ml in the left arm. The subject experienced vaccine exposure during pregnancy. Her date of last menstrual period and estimated date of delivery were not provided. At the time of reporting the pregnancy was ongoing. No additional information is expected as subject's at this facility are only seen once and outcomes are not known.   Upon internal review done on 13th September 2019, the pregnancy outcome was updated to lost to follow-up.",,,,,,,,,U,05/10/2011,,,,PUB,,,,Medical History/Concurrent Conditions: No adverse event (No available medical history.),,USGLAXOSMITHKLINEA0926882,2,09/16/2019,,,,
0833765,09/16/2019,CA,19.0,19,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a consumer (the subject's mother) and described the occurrence of vaccine exposure during pregnancy in a 19-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy. A physician or other health care professional has not verified this report.  Concurrent medications included Prenatal vitamins.   On an unspecified date in April 2011 the subject received a dose of Boostrix (details unknown), and experienced vaccine exposure during pregnancy.  The subject was 27 weeks pregnant at the time of vaccination.  The consumer believed that the dtap vaccine administered was Boostrix, but was not sure.  The subject had had 3 ultrasounds since the vaccination and there were no abnormalities or issues identified.  The pregnancy had been without complications at the time of reporting.  Estimated delivery date was 13 September 2011.   Upon internal review done on 13th September 2019, the pregnancy outcome was updated to lost to follow-up.",,,,,,,,,U,04/01/2011,04/01/2011,0,,PUB,,Prenatal vitamins,,,,USGLAXOSMITHKLINEA0942873,2,09/16/2019,,,,
0833766,09/16/2019,WA,40.0,40,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 40-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's medical history included two previous normal full-term live births. Concurrent medical conditions included anemia and depression.   Concurrent medications included Sertraline hydrochloride (Zoloft).   On 1 September 2011 the subject received a dose of Boostrix (.5 unknown units, intramuscular, unknown site), and experienced vaccine exposure during pregnancy.  The subejct was approximately 25 weeks gestation at the time of vaccination.  Date of last menstrual period was 15 March 2011 and estimated delivery date was 09 December 2011.  The subject had not been using contraception prior to becoming pregnant and the conception was reported to be normal.  Prenatal testing, including ultrasound and amniocentesis on 21 July 2011 revealed no evidence of a defect.   Upon internal review done on 16th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound and amniocentesis on 21 July 2011 revealed no evidence of a defect.",,,,,,,,,U,09/01/2011,09/01/2011,0,,UNK,,Zoloft,Depression,Medical History/Concurrent Conditions: Anemia; Live birth,,USGLAXOSMITHKLINEA0944481,2,09/16/2019,,,,
0833767,09/16/2019,,,,,F,,"Muscle twitching in the area of the injection; This case was reported by a consumer and described the occurrence of injection site muscle reaction in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced injection site muscle reaction. On an unknown date, the outcome of the injection site muscle reaction was unknown.   It was unknown if the reporter considered the injection site muscle reaction to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The patient asked if the muscle twitching a normal side effect of the vaccine. The patient experienced muscle twitching in the area of the injection.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/16/2019,,,,
0833768,09/16/2019,,0.5,,,M,,"Grand mal seizure; This case was reported by a consumer via interactive digital media and described the occurrence of grand mal seizure in a 6-month-old patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, immediately after receiving DTPa vaccine, the patient experienced grand mal seizure (serious criteria GSK medically significant). On an unknown date, the outcome of the grand mal seizure was unknown.   The reporter considered the grand mal seizure to be related to DTPa vaccine.  Additional details were provided as follows: This case received from interactive digital media. The patient mother reported case on behalf of her son. The patient received DTPa vaccine and reacted to pertussis. Right after that the patient had Grand mal seizure. The physician advised to the patient's mother that they would remove pertussis from DTPa for next doses.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/13/2019,,,,
0833769,09/16/2019,KS,,,,F,,"Rash on the arm; This case was reported by a nurse via sales rep and described the occurrence of rash in a 16-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, 4 days after receiving Bexsero, the patient experienced rash. On an unknown date, the outcome of the rash was recovered/resolved.   It was unknown if the reporter considered the rash to be related to Bexsero.  Additional case details were reported as follows: The age at vaccination was not reported. The patient received a dose of Shingrix on an unknown arm. Four to five days after vaccination, the patient experienced a rash on the arm, not in the area of the injection, but same arm. The event was resolved without treatment. The reporter did not agree to follow up.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/16/2019,,,,
0833770,09/16/2019,MI,77.0,77,,M,,"Felt like he had the flu; Arm was sore below injection sit; Arm was swollen bellow injection site; Red spot below the injection site that was swollen and hard; Red spot below the injection site that was swollen and hard; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 77-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th August 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 7th August 2019, 1 days after receiving Shingrix, the patient experienced influenza-like symptoms. On 9th August 2019, the patient experienced pain in arm and swelling arm. In August 2019, the patient experienced localized erythema and induration. On 9th August 2019, the outcome of the influenza-like symptoms was recovered/resolved. On an unknown date, the outcome of the pain in arm, swelling arm, localized erythema and induration were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, pain in arm, swelling arm, localized erythema and induration to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's wife. The patient felt like he had the flu the next day after receiving the vaccination and resolved after two days. The third day after receiving the vaccination, the patient's arm was sore and swollen approximately 4 inches below the injection site.  The patient also experienced red spot again 4 inches below the injection site that was swollen, and hard. The patient gave permission for her physician to be contacted. This case has been linked with case US2019160424, reported by the same reporter.",,,,,,,,,Y,08/06/2019,08/07/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833771,09/16/2019,CA,57.0,57,,M,,"Indented line at the site of the injection; This case was reported by a pharmacist via call center representative and described the occurrence of injection site indentation in a 57-year-old male patient who received Herpes zoster (Shingrix) (batch number GX25K, expiry date 19th November 2021) for prophylaxis.   On 31st August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 3rd September 2019, 3 days after receiving Shingrix, the patient experienced injection site indentation. On an unknown date, the outcome of the injection site indentation was unknown.   It was unknown if the reporter considered the injection site indentation to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix vaccine in his left deltoid. The patient noticed an indented line at the site of the injection on left upper arm. The reporter consented to follow up.",,,,,,,,,U,08/31/2019,09/03/2019,3,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833772,09/16/2019,CO,,,,M,,"Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a elderly male patient who received Herpes zoster (Shingrix) (batch number E3Z7E, expiry date 18th May 2021) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that patient developed Shingles after receiving first dose of Shingrix. The reporter consented to follow up.",,,,,,,,,U,,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,,
0833773,09/16/2019,PA,,,,M,,"joint pain; This case was reported by a consumer via call center representative and described the occurrence of joint pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shoulder injury and shoulder pain.   On 3rd September 2019, the patient received the 1st dose of Shingrix. On 3rd September 2019, 30 min after receiving Shingrix, the patient experienced joint pain. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the joint pain was not recovered/not resolved.   It was unknown if the reporter considered the joint pain to be related to Shingrix.  Additional details were provided as follows: The patient reported the adverse event for himself. The age at vaccination was not reported. The day before the reporting date, the patient received Shingrix.  About half an hour later, he started experiencing joint pain. The pain was a 10 from a scale of 1 to 10.  The joint pain was specifically happening on the joint in his shoulder where he previously had an injury in that shoulder. The patient went down to pharmacy and then to emergency room and did a series of tests and he received Tylenol 1,000 mg.  The joint pain was decreased a little bit but he still had it. The patient consented to follow up and provided contact details of his doctor who treated patient's should pain previously.",,,,,,,,,N,09/03/2019,09/03/2019,0,"Test Date: 20190903; Test Name: Laboratory test; Result Unstructured Data: Test Result: Unknown, Test Result Unit: unknown",PHM,,,,Medical History/Concurrent Conditions: Shoulder injury; Shoulder pain,,USGLAXOSMITHKLINEUS201916,2,09/13/2019,,,Y,
0833774,09/16/2019,PA,66.0,66,,F,,"Pain at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 66-year-old female patient who received Herpes zoster (Shingrix) (batch number BP57E, expiry date unknown) for prophylaxis.   On 2nd September 2019, the patient received Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional information received were as follows: The pharmacist called to report that the patient received Shingrix. The patient experienced pain at injection site for 4 days. The reporter consented to follow up. The caller did not have expiration date of Shingrix.",,,,,,,,,Y,09/02/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833775,09/16/2019,AZ,62.0,62,,F,,"redness at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was unknown.   It was unknown if the reporter considered the injection site erythema to be related to Shingrix.  Additional details were provided as follows: The patient was hesitant to provide demographics. The patient received dose 1 of Shingrix and she experienced redness at the injection site measuring approximately 2 inches by two inches. The reporter did not consent to follow-up.",,,,,,,,,U,09/04/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833776,09/16/2019,SC,,,,F,,"Flu-like Symptoms; This case was reported by a other health professional via call center representative and described the occurrence of influenza-like symptoms in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. The patient experienced Flu-like symptoms after receiving a dose of Shingrix. The reporter did not consent to follow-up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833777,09/16/2019,,,,,F,,"In a wheelchair totally paralyzed; This case was reported by a consumer via interactive digital media and described the occurrence of paralysis in a female patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, unknown after receiving Flu vaccine, the patient experienced paralysis (serious criteria disability and GSK medically significant). On an unknown date, the outcome of the paralysis was unknown.   The reporter considered the paralysis to be related to Flu vaccine.  Additional details were provided as follows: This case reported by the reporter's friend sister. The age at vaccination was not reported. The patient was in a wheelchair and totally paralyzed from the Flu shot. The reporter stated that the reporter knew too many people getting lupus and auto-immune disease after an unspecified vaccine. The reporter stated that there was massive aluminum in vaccines (name not specified) and 1 in 3 get Alzheimers and they found the aluminum in their brains at autopsies.",,,,,,,,Y,U,,,,,UNK,,,,,,USID BIOMEDICAL CORPORATI,2,09/16/2019,,,,
0833778,09/16/2019,WA,,,,U,,"A patient received a dose Daptacel vaccine that reached at 1.7 degree Celsius for 30 minutes due to temperature excursion on July 30 in refrigerator due an unknown reason/No AE; Based on information received on 06-SEP-2019, the report previously considered as non-valid became valid: [patient identifier updated].  Initial information received on 09-Aug-2019 regarding an unsolicited non-valid non-serious case received from a nurse.  This case involves a patient of unknown demographics who received a dose of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (Lot: C55118A, Expiry date: 30-Aug-2020 and Lot: C53668A, Expiry date: 07-Feb-2020), which had a temperature excursion for reasons not known. Nurse stated on July 30 the refrigeratore reached a temperature of 1.7 degree Celsius for 30 minutes.  It was as actual medication error due to incorrect product storage.  The patient did not experience any averse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.  Follow up information received on 06-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  Case became valid and the patient experienced no adverse event.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA224299,2,09/13/2019,,,,
0833779,09/16/2019,GA,,,,F,,"rash at the injection site that spreads down to the elbow; abnormal pain; hotness to touch; Initial information received on 05-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves an unknown age female patient who experienced rash at the injection site that spreads down to the elbow (rash), abnormal pain (pain) and hotness to touch (skin warm), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On 05-Sep-2019, 28-Aug-2019, the patient received a first and second dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number and Expiry date unknown) via intramuscular route in unknown administration site.  On an unknown date, the patient developed a non-serious rash at the injection site that spreads down to the elbow (rash), abnormal pain (pain) and hotness to touch (skin warm) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  (Other relevant tests included no lab data.) Final diagnosis was Localized rash, pain and Skin warm.  It was not reported if the patient received a corrective treatment.  The event outcome is reported as Recovering for Localized rash, pain and Skin warm.  Information on the batch number was requested.  List of documents held by sender- none.",,,,,,,,,N,08/28/2019,,,,UNK,,,,,,USSA2019SA250783,2,09/13/2019,,,,
0833780,09/16/2019,SD,25.0,25,,F,,"pregnant females that were given the invalid Adacel, no side effects observed; It was reported that excursion was caused by Human Error, The Excursion was Negative 40 degrees C and 22.7 degrees C/ There were no side effects observed.; Initial information received on 06-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to case ID: 2019SA250866 and 2019SA250874 (same reporter).  This case involves a 25 year old female pregnant patient who was exposed to a second dose vaccine of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (dosage form: Prefilled Syringe) lot U6273AA, expiry date: 24-Apr-2021 via intramuscular route in the right arm on 21-Aug-2019.  The reported pregnant females that were given Adacel and no side effects observed occurred at unknown gestation period and the patient was exposed to DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE at 31 weeks of pregnancy, during third pregnancy trimester for DIPHTHERIA- 2/TETANUS/5 AC PERTUSSIS VACCINE. The date of last menstrual period was reported as 19-Jan-2019. The estimated due date is 25-Oct-2019. The patient previous pregnancy was not reported.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is a case of vaccine exposure during pregnancy. It was reported that excursion was caused by Human Error, The Excursion was Negative 40 degrees C and 22.7 degrees C/ There were no side effects observed. Incorrect product storage.  It was reported that the patient had no adverse event following the vaccination.  Additionally, at time of reporting, the outcome of the pregnancy is unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error List of documents held by sender: none.",,,,,,,,,U,08/21/2019,,,,UNK,,,,,,USSA2019SA250873,2,09/13/2019,,,,
0833781,09/16/2019,MS,,,,M,,"17 year old was administered Fluzone High Dose, no AE; 17 year old was administered Fluzone High Dose, no AE; Initial and follow up information received on 06-Sep-2019 and 10-Sep-2019 regarding an unsolicited valid non-serious case received from a other healthcare professional.  This case is linked to cases 2019SA251863 and 2019SA251864 (same reporter).  This case involves a 17 years old male patient who was received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UJ232AA, Exp. Date 10-Apr-2020) via intramuscular route in the left deltoid on 05-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to inappropriate age at vaccine administration.  It was also a case of overdose.  At the time of reporting no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/05/2019,,,,UNK,,,,,,USSA2019SA251863,2,09/13/2019,,,,
0833783,09/16/2019,OH,66.0,66,,F,,"Chills, nausea-vomiting, headache, body aches",,,,,,,,,Y,09/11/2019,09/11/2019,0,,PHM,,"Simvastaton, Estradiol, vitamins D E Folic Acid, calcium, Tumeric, fish oil, 81mg aspirin daily. Occasionally Lysine, K, B. Black Seed Oil",None,None,,,2,09/16/2019,,,,"In the past sulphate, high dose aspirin, Very allergic to dogs and cats"
0833784,09/16/2019,NY,43.0,43,,F,,"Sore throat, shooting pains in ears, swollen eyes/face",,,,,,,,,Y,09/13/2019,09/13/2019,0,,WRK,,None,None,None,,,2,09/16/2019,,Y,,None
0833785,09/16/2019,OH,51.0,51,,F,,"The next day after the vaccine she got a weird itch across her shoulders and base of neck. No sign of rash , no sign of shingle. Described the itch as under her skin. Continuous for a month, bad at beginning but has gotten better. Also had a headache the day after but went away the same day.",,,,,,,,,N,08/12/2019,08/13/2019,1,"None done, waiting for office visit.",PHM,,"methylphenidate er 27 mg once daily, ibuprofen 200 mg prn, omeprazole 20 mg tablet once daily",NA,GERD and ADHD,,,2,09/16/2019,,Y,,NKA
0833786,09/16/2019,GA,51.0,51,,M,,"Injection site soreness - lasting days, flu like symptoms beginning the next day and lasting 48 hours, 101 fever beginning 12 hours post injection and lasting 30 hours managed by Tylenol. Fever re-emerged 3 times",,,,,,,,,Y,09/13/2019,09/14/2019,1,,PHM,,"Diovan HCTZ, Synthroid, Crestor, Meloxicam",none,"hypertension, high cholesterol, thyroid",,,2,09/16/2019,,,,None
0833787,09/16/2019,VA,0.17,0,.2,F,,"Flu vaccine administered in error in 2 month old patient, no adverse outcomes noted at this time",,,,,,,,,Y,09/13/2019,09/13/2019,0,N/A,PVT,,Vitamin D,None,None,,,2,09/16/2019,,,,None
0833788,09/16/2019,FL,66.0,66,,F,,Patient described  arm as red and swollen. States the muscle is tight. It is now red from injection site and traveled to elbow. Stated starting to feel side effects within a few hours of vaccine.,,,,,,,,,N,09/13/2019,09/13/2019,0,,PHM,,Valtrex,Shingrix 8/30/19,N/A,,,2,09/16/2019,,Y,,Latex
0833789,09/16/2019,NC,2.0,2,.7,M,,Fever to Tmax of 104 persisting for 48 hours.  No other associated signs or symptoms.  Exam on 9/16/2019 normal,,,,,,,,,N,09/14/2019,09/14/2019,0,,PVT,,,,,,,2,09/16/2019,,,,
0833790,09/16/2019,,65.0,65,,F,,"3 hours post vaccination violent vomiting, rapid heart rate, high blood pressure, abnormal ekg",,,,,,,,,Y,09/01/2019,09/01/2019,0,Per md possible adverse effect of flu shot. Pt has received flu shot previously with no AE except muscle soreness,UNK,,,,,,,2,09/16/2019,,,Y,
0833791,09/16/2019,OR,11.0,11,,F,,"Patient fainted within a few minutes after injection, patient was sitting on exam table while medical assistant and patient's aunt were scheduling the patient's follow up visit, patient fell forward onto the floor, patient landed on her face and broke off part of her two front teeth.",,,,,,,,,U,08/09/2019,08/09/2019,0,"Clinic RN and Dr. immediately assessed patient, patient sent to xray for radiographs; arranged appointment with local dentist to address broken teeth; patient is receiving all follow up care needed, and is still seeing Physical Therapy; potential for long term injury is unknown at this time as it will depend on follow up medical and dental care.",PVT,,none,none,none,,,2,09/16/2019,,,,"amoxicillin, penicillins"
0833793,09/16/2019,AR,8.0,8,,M,,"No adverse effects; reconstituted in error with the diluent that is for ""Menveo""; This spontaneous report as received from a nurse refers to a 8-year-old male patient. The patient's pertinent medical history, concomitant medications, drug reactions and allergies were not reported.  On 19-AUG-2019, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot # R035221, expiration date reported as 04-DEC-2020, but upon internal validation established as 04-DEC-2019, dose and route of administration were not reported) and was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin) (M-M-R II) (lot # reported as: S006646, expiration date reported as 05-MAR-2021, dose and route of administration were not reported), that were reconstituted in error with the diluent for meningococcal ACYW conj vaccine (CRM197) (MENVEO) (NDC 58160-959-01 MenCYW-135 liquid conjugate component), both vaccines were administered for prophylaxis. No adverse effects were reported.",,,,,,,,,U,08/19/2019,08/19/2019,0,,UNK,,,,,,US0095075131908USA007736,2,09/16/2019,,,,
0833794,09/16/2019,IN,4.0,4,,F,,"No adverse effects; needle bent; child received a partial dose of PROQUAD; This spontaneous report was received from a registered nurse and refers to a 4-year-old female patient. The patient's pertinent medical history, concomitant therapies, drug reactions and allergies were not reported.  On 23-AUG-2019, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection in the right thigh (lot # S002497 and expiry date 23-JUL-2020; exact dose was not provided) which was reconstituted with sterile diluent (lot # S000978 and expiry date 22-JUL-2021) for prophylaxis. There was administered a partial dose, because the child was moving so much during the vaccination, that the needle bent and the syringe had to be removed from the thigh. The needle disengaged from the syringe and the remainder of the product was lost on the table. No adverse effects were reported. The outcome of the event was unknown.  The causality assessment was not provided.",,,,,,,,,U,08/23/2019,08/23/2019,0,,UNK,,Sterile diluent,,,,US0095075131908USA009607,2,09/16/2019,,,,
0833795,09/16/2019,MI,,,,U,,"No adverse effects; improperly stored doses of PROQUAD and VARIVAX were administered to patient; This spontaneous report as received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.     On 19-AUG-2019, the patient was vaccinated with an improperly stored doses of varicella virus vaccine live (oka/merck) (VARIVAX) lot # R034398, expiration date 27-NOV-2020 and with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S003178, expiration date 30-JUL-2020 (dose, frequency, route of administration and anatomical location were not provided) for prophylaxis. The temperature excursion was between 6 to 14 degree Fahrenheit for 2 hours and 30 minutes and between 15 to  46 degree Fahrenheit (36 F) for 2 hours and 30 minutes. There was no previous temperature excursion. The digital data logger was involved. Concomitant therapies included sterile diluent which was stored properly. The patient did not experience adverse event.",,,,,,,,,U,08/19/2019,08/19/2019,0,,UNK,,sterile diluent,,,,US0095075131908USA011039,2,09/16/2019,,,,
0833796,09/16/2019,IL,1.0,,,U,,"No adverse effects; on 3/7/2017 a 12 month old patient was administered 1 dose of PROQUAD and 1 dose of VARIVAX, On 7/31/2019 the patient who is now 3 years old was administered 1 dose of VARIVAX; This spontaneous report was received from a medical assistant referring to a 12-months old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies and drug reactions/allergies were not provided.  On 07-MAR-2017, the patient was vaccinated with one dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot# N028459 (is an invalid lot number for varicella virus vaccine live (oka/merck) (VARIVAX)), expiration date: 07-JUN-2018, dose and route were not reported) and one dose of  measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot# was reported as N035689, expiration date: 06-FEB-2018, dose and route were not reported) for prophylaxis (overdose).  On 31-JUL-2019, the patient was 3 years old and was vaccinated with one dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot# R018933, expiration date: 02-JUL-2020, dose and route were not reported). No adverse effects were reported.",,,,,,,,,U,03/07/2017,03/07/2017,0,,UNK,,,,,,US0095075131908USA012314,2,09/16/2019,,,,
0833797,09/16/2019,TX,,,,U,,"No adverse event; patient was administered a dose of improperly stored PROQUAD; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's drug reactions or allergies, medical history and concomitant medications were not reported.   On 28-AUG-2019, the patient was vaccinated with a dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # S003863, expiration date 08-AUG-2020) (dose, route of administration were not reported) for prophylaxis. No adverse effects was reported. The vaccine underwent temperature excursion of -14 degree Celsius to -10 degree Celsius (also reported as ""-14.4 C"") for 18 minutes. There was no previous temperature excursion. Data logger was involved. No product quality complains involved. No further information provided.",,,,,,,,,U,08/28/2019,08/28/2019,0,,UNK,,,,,,US0095075131909USA000879,2,09/16/2019,,,,
0833798,09/16/2019,GA,36.0,,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a female subject of unspecified age who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   On an unspecified date the subject received a dose of Boostrix (details unknown), and experienced vaccine exposure during pregnancy.  The subject was 4 weeks gestational age when she received the vaccine.  No further information was provided.  Follow-up received from a healthcare professional on 07 July 2011: The subject was 36 years-old.  Her last menstrual period was on 16 February 2011.  She received Boostrix intramuscularly at 4 weeks gestation, before she knew she was pregnant.  The estimated delivery date was reported as 21 November 2011.  The conception was reported as normal and not in-vitro fertilization.  The pregnancy was a single foetus.  At the time of reporting, the subject had no adverse events or complications.  03 April 2012:  Reporter indicated follow-up information was forthcoming.  Upon internal review done on 13th September 2019, the pregnancy outcome was updated to lost to follow-up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEA0920558,2,09/16/2019,,,,
0833799,09/16/2019,WA,37.0,37,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 37-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's medical history included ectopic pregnancy and three normal full-term live births.      On 1 September 2011 the subject received a dose of Boostrix (.5 unknown units, intramuscular, unknown route), and experienced vaccine exposure during pregnancy.  The subejct was vaccinated at approximately 37 weeks gestation.  Date of last menstrual period was 09 December 2010 and estimated delivery date was 22 September 2011.  The subject had not been using contraception prior to becoming pregnant.  The conception was normal.  Prenatal testing revealed no evidence of a defect, including 4 ultrasounds.  Maternal serum alfa-fetoprotein was positive on 07 April 2011.  Quad screen was positive, but scans revealed normal anatomy.  The subject declined an amniocentesis.  The subject had one abnormal value on 3 hour glucose tolerance test, but was negative for gestational diabetes mellitus.   Upon internal review done on 16th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasounds performed on 07 April, 22 April, 08 June and 17 August 2011, with no evidence of fetal defect. Amniocentesis was not performed. One abnormal value on 3 hour glucose tolerance test (not gestational diabetes mellitus). Quad screen positive; normal anatomy scan.",,,,,,,,,U,09/01/2011,09/01/2011,0,"Test Date: 20110407; Test Name: Alphafetoprotein; Result Unstructured Data: Test Result: positive, Test Result Unit: unknown",UNK,,,,Medical History/Concurrent Conditions: Ectopic pregnancy; Live birth,,USGLAXOSMITHKLINEA0944358,2,09/16/2019,,,,
0833800,09/16/2019,WA,21.0,21,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 20-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's past medical history included no previous pregnancies.  Prior to becoming pregnant the subject had not been using contraception.  On 29 August 2011 at 13:30 the subject received a booster dose of Boostrix (.5 unknown units, intramuscular, right deltoid), and experienced vaccine exposure during the second trimester of her pregnancy.  The conception was reported to be normal.  The subject was approximately 24 weeks gestation at the time of vaccination.  Date of last menstrual period was 24 February 2011 and estimated delivery date was 16 December 2011.  Prenatal testing including ultrasound on 31 August 2011 had revealed no evidence of a defect.  There were no adverse events at the time of reporting.   Upon internal review done on 16th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound performed on 31 August 2011 revealed no evidence of a defect.",,,,,,,,,U,08/29/2011,08/29/2011,0,,PUB,,,,Medical History/Concurrent Conditions: No adverse event (There was no relevant maternal or paternal medical history.),,USGLAXOSMITHKLINEA0944645,2,09/16/2019,,,,
0833801,09/16/2019,WA,29.0,29,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 29-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's past medical history included one previous pregnancy resulting in a normal birth of a full-term infant with no defects.  The subject had not been using contraception before becoming pregnant.  On 29 August 2011 at 14:55 the subject received a booster dose of Boostrix (.5 mL, intramuscular, right deltoid), and experienced vaccine exposure during her third trimester of pregnancy.  The conception was reported to be normal.  The subject was approximately 38 weeks pregnant at the time of vaccination.  Date of last menstrual period was 26 November 2010 and estimated delivery date was 10 September 2011.  Ultrasound on 22 April 2011 and maternal serum alpha-fetoprotein on 30 March 2011 had revealed no evidence of a defect.  There were no adverse events at the time of reporting.   Upon internal review done on 16th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound on 22 April 2011 and maternal serum alpha-fetoprotein on 30 March 2011 revealed no evidence of a defect.",,,,,,,,,U,08/29/2011,08/29/2011,0,,PUB,,,,Medical History/Concurrent Conditions: Live birth,,USGLAXOSMITHKLINEA0944647,2,09/16/2019,,,,
0833802,09/16/2019,WA,26.0,26,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 26-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.  Past medical history included no previous pregnancies.  The subject and the father of the baby were smokers.  Prior to becoming pregnant the subject did not use contraception.  On 29 August 2011 at 15:00 the subject received a booster dose of Boostrix (.5 unknown units, intramuscular, right deltoid), and experienced vaccine exposure during the third trimester of her pregnancy.  The subject was approximately 37 weeks gestation at the time of vaccination.  The conception was reported to be normal.  Date of last menstrual period was 07 December 2010 and estimated delivery date was 13 September 2011.  Prenatal testing including ultrasounds on 25 April 2011 and 11 July 2011, and maternal serum alpha-fetoprotein on 28 March 2011 had revealed no evidence of a defect.  There were no adverse events at the time of reporting.   Upon internal review done on 16th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound on 25 April 2011 and 11 July 2011, and maternal serum alpha-fetoprotein on 28 March 2011 revealed no evidence of a defect.",,,,,,,,,U,08/29/2011,,,,PUB,,,Smoker,Medical History/Concurrent Conditions: No adverse event (The baby's father was also a smoker.),,USGLAXOSMITHKLINEA0944648,2,09/16/2019,,,,
0833803,09/16/2019,WA,21.0,21,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 21-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's past medical history included no previous pregnancies.  Prior to becoming pregnant she had not been using contraception.  On 31 August 2011 at 08:40 the subject received a booster dose of Boostrix (.5 unknown units, intramuscular, right deltoid), and experienced vaccine exposure during the third trimester of her pregnancy.  The conception was reported to be normal.  The subject was approximately 32 weeks gestation at the time of vaccination.  Date of last menstrual period was 19 January 2011 and estimated delivery date was 26 October 2011.  Prenatal testing including ultrasounds performed on 11 March 2011 and 03 June 2011 had revealed no evidence of a defect.   Upon internal review done on 16th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasounds on 11 March 2011 and 03 June 2011 revealed no evidence of a defect.",,,,,,,,,U,08/31/2011,,,,UNK,,,,Medical History/Concurrent Conditions: No adverse event (There was no relevant maternal or paternal medical history.),,USGLAXOSMITHKLINEA0944649,2,09/16/2019,,,,
0833804,09/16/2019,WA,37.0,37,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 37-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.  The subject's past medical history included two previous pregnancies resulting in normal births of two full-term infants with no defects.  Concurrent medical conditions included gestational diabetes mellitus under diet control.  The subject had not been using contraception before becoming pregnant.  On 31 August 2011, the subject received a booster dose of Boostrix (.5 mL, intramuscular, right deltoid), and experienced vaccine exposure during her third trimester of pregnancy.  The conception was reported to be normal.  The subject was approximately 36 weeks gestation at the time of vaccination.  Date of last menstrual period was 22 December 2010 and estimated delivery date was 28 September 2011.  Ultrasound on 10 May 2011 and maternal serum alpha-fetoprotein on 20 April 2011 had revealed no defects.   Upon internal review done on 16th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound on 10 May 2011 and maternal serum alpha-fetoprotein on 20 April 2011 had revealed no defects.",,,,,,,,,U,08/31/2011,08/31/2011,0,,UNK,,,Gestational diabetes mellitus,Medical History/Concurrent Conditions: Live birth,,USGLAXOSMITHKLINEA0944650,2,09/16/2019,,,,
0833805,09/16/2019,WA,23.0,23,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 23-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's medical history included three previous pregnancies resulting in one elective abortion and two normal full-term live births.  The subject had not been using contraception prior to becoming pregnant.  On 8 September 2011 the subject received a dose of Boostrix (.5 ml, intramuscular, unknown site), and experienced vaccine exposure during the third trimester of her pregnancy.  The conception was reported to be normal and date of last menstrual period was 22 December 2010.  Estimated date of delivery was 29 September 2011.  Prenatal testing, including ultrasounds performed on 11 May and 31 August 2011, and maternal serum alpha-fetoprotein on 07 April 2011 revealed no evidence of a defect.   Upon internal review done on 16th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasounds performed on 11 May and 31 August 2011 revealed no evidence of a defect. Maternal serum alpha-fetoprotein on 07 April 2011 revealed no evidence of a defect.",,,,,,,,,U,09/08/2011,09/08/2011,0,,UNK,,,,Medical History/Concurrent Conditions: Induced abortion; Live birth,,USGLAXOSMITHKLINEA0944690,2,09/16/2019,,,,
0833806,09/16/2019,WA,27.0,27,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 27-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's past medical history included one previous pregnancy resulting in normal birth of a full-term live infant with no defect.  The subject had not been using contraception before becoming pregnant.  On 7 September 2011 at 13:48 the subject received a booster dose of Boostrix (.5 mL, intramuscular, right deltoid), and experienced vaccine exposure during the third trimester of her pregnancy.  The conception was reported to be normal.  The subject was approximately 34 weeks pregnant at the time of vaccination.  Date of last menstrual period was 12 January 2011 and estimated date of delivery was 19 October 2011.  Ultrasound on 18 May 2011 had revealed no evidence of a defect.  Upon internal review done on 16th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound on 18 May 2011 had revealed no evidence of a defect.",,,,,,,,,U,09/07/2011,09/07/2011,0,,UNK,,,,Medical History/Concurrent Conditions: Live birth,,USGLAXOSMITHKLINEA0944813,2,09/16/2019,,,,
0833807,09/16/2019,WA,24.0,24,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 24-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's past medical history included two previous pregnancies resulting in normal births of two full-term live infants with no defects.  The subject had not been using contraception before becoming pregnant.  On 08 September 2011 the subject received a booster dose of Boostrix (.5 mL, intramuscular, right deltoid), and experienced vaccine exposure during the second trimester of her pregnancy.  The conception was reported to be normal.  The subject was approximately 24 weeks gestation at the time of vaccination.  Date of last menstrual period was 15 March 2011 and estimated date of delivery was 20 December 2011.  Ultrasound on 02 September 2011 revealed no evidence of a defect.   Upon internal review done on 16th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound on 02 September 2011 revealed no evidence of a defect.",,,,,,,,,U,09/08/2011,09/08/2011,0,,UNK,,,,Medical History/Concurrent Conditions: Live birth,,USGLAXOSMITHKLINEA0944816,2,09/16/2019,,,,
0833808,09/16/2019,NY,,,,U,,"Some patients are in bed for days; This case was reported by a physician via call center representative and described the occurrence of bedridden in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced bedridden. On an unknown date, the outcome of the bedridden was unknown.   It was unknown if the reporter considered the bedridden to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not applicable for this report. The age group was not reported but it was selected as adult as per vaccine indication. The physician stated that after receiving Shingrix, the patients were in bed for days.  No further details were provided. The reporter consented to follow up. The physician was in a hurry as patients were waiting, and she did not provide any further details after making this general statement, but she did give permission to follow up at the following address. This case has been linked with US2019162773, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833809,09/16/2019,IL,45.0,45,,U,,"Blistery-painful rash; Blistery-painful rash; Extremely painful arm at injection site; Armpit is swollen on injection site arm; Armpit is tender on injection site arm; Inappropriate age at vaccination; This case was reported by a consumer and described the occurrence of blistery rash in a 45-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 5th September 2019, less than a day after receiving Shingrix, the patient experienced blistery rash, painful rash, injection site pain, local swelling, axillary pain and inappropriate age at vaccine administration. On an unknown date, the outcome of the blistery rash, painful rash, injection site pain, local swelling, axillary pain and inappropriate age at vaccine administration were unknown.   It was unknown if the reporter considered the blistery rash, painful rash, injection site pain, local swelling and axillary pain to be related to Shingrix.  Additional information received were as follows: A day before the reporting date, at 10:30 am, the patient received Shingrix. In the evening of the day before the reporting date, the patient experienced blistery-painful rash on side. The patient called the pharmacy who gave the vaccine to ask about side effects and they told the patient to call patient's MD. The patient was seeing MD in the afternoon but wonder if this was an expected reaction. The event was not listed in the common reactions. The patient also experienced extremely painful arm at injection site and my armpit was swollen and tender on injection site arm. The reporter thought that the longer needle was used thus she thought it was intramuscular. The NDC number was reported as 58160-0823-11.",,,,,,,,,U,09/05/2019,09/05/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/16/2019,,,,
0833810,09/16/2019,CA,13.0,13,,F,,"RASH ON FACE/RASH ON BODY; rash is pimply; This case was reported by a nurse via sales rep and described the occurrence of generalized rash in a 13-year-old female patient who received Men B NVS (Bexsero) (batch number ABXA12BA, expiry date 28th February 2021) for prophylaxis.   Co-suspect products included HPV 16-18 (HPV vaccine) (batch number RO24271 ?, expiry date 8th May 2021) for prophylaxis and MENACTRA (batch number U6521AA, expiry date 26th January 2021) for prophylaxis.   On 27th August 2019, the patient received the 1st dose of Bexsero, HPV vaccine and MENACTRA. In August 2019, less than a week after receiving Bexsero and HPV vaccine, the patient experienced generalized rash and papular rash. The patient was treated with doxycycline and prednisone. On an unknown date, the outcome of the generalized rash and papular rash were recovered/resolved.   It was unknown if the reporter considered the generalized rash and papular rash to be related to Bexsero and HPV vaccine.  Additional information received were as follows: The licensed vocational nurse stated that received Bexsero and Menactra a week before the reporting date and experienced a rash on their face and body that was not itchy. The reporter had had 3 patients that had experienced a rash after having Bexsero, not itchy, on the face and body. First they thought it was giving the menectra and bexsero together the other had them both. On the reporting date, the third person and she did not had any other vaccine called complaining of the same rash. The healthcare professional stated that they assumed the rash was due to Bexsero since one of the patients experienced the rash received no other vaccine.  All patients reported the rash appearing within 2 days of vaccination.  The rash was pimply in appearance on face, arms, and neck. The rash lasted for 3 weeks where she saw the doctor again on 4th September 2019 and was given doxycycline and prednisone. The patient was told to see the doctor again in 10 days. The MSL confirmed that patient had not yet been back to the office on the reporting date. For the other 2 patient's, it is unknown how long the rashes lasted and if they were treated because they only called in to report the adverse event. The reporter consented to follow up. No additional details regarding patients or product were available but licensed vocational nurse was agreeable to follow up recontact. This case is 1 of the 4 linked cases, reported by the same reporter.",,,,,,,,,Y,08/27/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,Y,,
0833811,09/16/2019,VA,33.0,33,,F,,"That evening (Wednesday) began experiencing fever and shaking chills, pain and swelling at the injection site. The next day (Thursday) the shaking chills had subsided, continued to have a fever and nerve/joint aches and sensitivity. Called Dr.'s office and was told ""this happens"" and to take Tylenol or Motrin.   By Friday afternoon, the fever and aches had subsided. Today, (Monday, 5 days after the shot) the injection area is painful, hot, and red, an area about the size of the palm of my hand. The rest of my arm and shoulder now also ache.",,,,,,,,,N,09/11/2019,09/11/2019,0,,PVT,,"Cimzia, 200mg; Buproprion HCL 150 mg",,Rheumatoid arthritis,,,2,09/16/2019,,,,None
0833812,09/16/2019,MI,4.0,4,,M,,Child received DTP/IPV for wrong series.  No adverse reaction noted.,,,,,,,,,U,09/09/2019,09/09/2019,0,none,PUB,,unknown,unknown,unknown,,,2,09/16/2019,,,,unknown
0833813,09/16/2019,NC,72.0,72,,F,,"Pt came back the day after vaccine administration and showed me a red, hot, swollen bruised place on her arm where the vaccine was administered",,,,,,,,,,09/13/2019,09/13/2019,0,,PHM,,,,,,,2,09/16/2019,,,,
0833814,09/16/2019,NY,59.0,59,,F,,"Patient described having a ""Hot Flash"" and then felt short of breath. Listened to patients breath sounds. They were clear to auscultation. Offered to call 911, she declined. Gave patient dose of benedryl and had her sit for approx 5-10 minutes. Patient then stated going back to her office. Checked back in with patient 30 minutes later, stated she felt better.",,,,,,,,,Y,09/10/2019,09/10/2019,0,,WRK,,,,,,,2,09/16/2019,,,,
0833815,09/16/2019,AL,65.0,65,,F,,"After vaccination, arm was a bit sore and a bit bruised which was expected.  On 9/13, after lunchtime noticed huge welt mark, very hot, 2 inches wide by 4 inches long, area had irregular borders, and was oval.   Patient went to doctor specified that it related to a reaction and outlined area with a marker to observe changes. By 9/14, affected area grew outside of the line so doctor prescribed Cephalexin (500mg, 2xday, 10 days).  Medication helped, today, area not as red, small area with pinkness, still feels a little bruise especially if you touch from underneath, and feels pressure/heat in the area when raise arm. In terms of recovery, patient is 98% back to normal.  In the past has experienced soreness and a little redness on vaccine site but nothing like what happened this time.",,,,,,,,,U,09/11/2019,09/13/2019,2,,PHM,,"Low dose aspirin, Omeprazole  for acid reflux, Simvastatin, Montelukast, over the counter allergy medication, Calcium, Glucosamine, Fish Oil, MacuHealth, Advair HFA 115/21 inhaler.","No, No",Asthma,,,2,09/16/2019,,Y,,"Codeine, Sulfa, Sulfur, Solu-Medrol, Latex"
0833816,09/16/2019,NC,56.0,56,,M,,Patient came to pharmacy on 9/11/19 claiming flu shot was given too high on his arm that caused pain to radiate down his arm & up to his neck. He said he had bursitis. Patient was seen at urgent care 9/13/19 and mentioned he is going to orthopedist on 9/16/19,,,,,,,,,N,08/31/2019,09/11/2019,11,none known,PVT,,None known by pharmacy,None known by pharmacy,None known by pharmacy,,,2,09/16/2019,,Y,,NKA
0833826,09/16/2019,NY,69.0,69,,F,,"Severe headache, muscle aches, chills. I'm bed-ridden.",,,,,,,,,N,09/15/2019,09/16/2019,1,None,PHM,,"Lamotrigen, Cymbalta, multi vitamin, amoxicillin, Tylenol",Osteonecrosis of the jaw,See above,,,2,09/16/2019,,,,Penicillin
0833827,09/16/2019,MI,4.0,4,,F,,"MMRV and MMR was given at the same time , Mom was notified and given instructions on what to watch for.  No reports of any side effects or issues.",,,,,,,,,,09/13/2019,09/13/2019,0,None,PUB,,None,None,None,,,2,09/16/2019,,,,None known
0833828,09/16/2019,FL,74.0,74,,F,,"Since the 1st shot ( the 2nd was August 14,  I can no longer sleep on my left side , it is too painful..  I get a very sharp  pain from my shoulder to my wrist when strain to take a shirt over my head.  If I strain my left are to try to reach something, the pain shoots down my arm.  there has be no inprovement or change in almost 4 months",,,,,,,,,N,05/26/2019,05/26/2019,0,,PHM,,"Diltiazem CD,  Spironolactone, Cadesartan,  Flonase W/S, Melatonin 2.5 QHS,  Alprazolam 1/2   .25 mg  PRN QHS,  Women's 50+ multivitamin,  Glucosimine Chondroitin ,  Vitamin D3,    Curcumin,  Tums 750",,,,,2,09/16/2019,,,,Cipro      sensitive to wheat and lactose
0833829,09/16/2019,MD,4.0,4,,F,,Patient was administered MMR instead of MMR-. Patient did not receive the Varicella portion as ordered/scheduled. Varicella was administered on 8/28/19 as a catch up dose. There was no Varicella outbreak.,,,,,,,,,Y,08/23/2018,08/23/2018,0,na,PVT,,,,,,,2,09/16/2019,,,,
0833830,09/16/2019,GA,61.0,61,,F,,"Patient reported feeling fatigue, chills, dry/puffy lips, bright red 3"" red spot below the injection site that began 1-2 days after injection. Denies any difficulty breathing or shortness of breath.",,,,,,,,,Y,09/05/2019,09/07/2019,2,,PUB,,none,None,None,,,2,09/16/2019,,,,None
0833831,09/16/2019,MD,1.25,1,.3,M,,Patient received MMR on 3/7/2019 instead of MMR-V as ordered. Patient not immunized with Varicella vaccine on this date. Varicella was given on 6/18/19 as the catch up dose. No Varicella outbreak reported during lack of coverage.,,,,,,,,,Y,03/07/2019,03/07/2019,0,NA,PVT,,,,,,,2,09/16/2019,,,,
0833832,09/16/2019,NC,67.0,67,,F,,"Approximately 14 hours after injection, experienced severe shivering with elevated temp 99.8, headache and muscle/joint aches. Took Ibuprofen 400 mg and shivering & fever subsided within 3 hours.  Muscle aches subsided in about 6 hours. Headache persisted for about 12 hours and required additional Ibuprofen. Experienced malaise, fatigue (which necessitated bed rest, sleep), loss of appetite until 8pm .....19 hours from onset. Also left arm, site of injection painful, seemed swollen, and was red/hot to touch a hands width below the injection site. The redness/hotness persists 48 hours later....slight cellulitis?",,,,,,,,,Y,09/13/2019,09/14/2019,1,None,PHM,,"Metoprolol,  Valacyclovir, Vit B12, Vit C, Vitamin D, Tumeric, Diclofenac",,,,,2,09/16/2019,,,,None
0833833,09/16/2019,TX,63.0,63,,F,,Patient was nervous before shot was given Immediately after administration patient had an episode of syncope She lost conciousness but breathing was normal Patient was laid down horizontally and came by just before EMT arrived EMT  thought it might have been a panick attack,,,,,,,,,Y,09/13/2019,09/13/2019,0,not sure as ambulance took patient to the hospital,PHM,,none,blood pressure controlled,none,,,2,09/16/2019,,,Y,none
0833834,09/16/2019,NM,67.0,67,,F,,"Immediately after the vaccine, I felt no symptoms, when I went to the check out desk approximately 3-4 minutes later, I felt a surge of tightness and flushing in my head, neck and arms.  I thought I had broken out in a rash on my arms, but it didn?t appear so. The feeling intensified and I felt I needed water or something for the throat constriction. After reporting to the desk clerks that something was wrong, I sat down before being escorted into a room. The constriction feeling continued along with a severe pulsating abdominal pain- feeling like deep bone pain. I couldn?t stand because of it and the weakness in my legs. I laid down. The nurse continued to monitor me and ask questions. I felt more numbness throughout my arms, hands and legs. The constriction subsided, but was followed by my upper lip feeling swollen and numb. I felt somewhat dizzy throughout.  After awhile I determined I could drive home. I did feel somewhat unsteady, but okay. The time when I left was about noon or a little after. I came home and took a benedryl and slept for a couple of hours. I still have what feels like soreness in the hip and back areas. I felt a little short of breath and had some chest discomfort off and on the remainder of the day and next. I wonder if it was an allergic reaction common to some Ehlers- Danlos patients.",,,,,,,,,U,09/12/2019,09/12/2019,0,None,PVT,,"Vitamin D3, probiotic, B12, levothyroxine",None,"Hypothyroidism, high cholesterol, Ehlers-Danlos Type3 Hypermobile",Fainting with penicillin at age 6 approximately 1958,,2,09/16/2019,,,,"Penicillin, morphine, tape adhesives"
0833835,09/16/2019,IN,27.0,27,,F,,Pt was admitted to hospital with sepsis,,,,,Y,2,,,Y,09/12/2019,09/14/2019,2,,PUB,,,none,None,,,2,09/16/2019,,,,NKA
0833836,09/16/2019,TX,6.0,6,,F,,development of crops of vesicles 10 days after vaccination,,,,,,,,,N,09/04/2019,09/14/2019,10,,PVT,,"fluticasone nasal spray, ipratropium, albuterol, spinraza,",none,"spinal muscular atrophy, ventilator dependence, gastrostomy tube dependence",,,2,09/16/2019,,Y,,NKDA
0833837,09/16/2019,WV,1.0,1,.0,F,,patient received MMR on 12/18/2018 instead of MMR-V as ordered. Patient not immunized with Varicella on this date. Varicella was given on 6/28/2019 as a catch up dose once error was discovered. No Varicella outbreak during lack of coverage.,,,,,,,,,Y,12/18/2018,12/18/2018,0,,PVT,,,,,,,2,09/16/2019,,,,
0833845,09/16/2019,SD,,,,U,,"no adverse event; patients received improperly stored vaccines; This spontaneous report was received from a nurse and refers to a unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. Their concomitant therapies included properly stored sterile diluent.  On unknown dates in 2019 (reported as between 01-JUL-2019 and 02-AUG-2019), the patients were vaccinated with improperly stored doses of varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot # R030612, expiration date 23-OCT-2020 and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, lot # S002490, expiration 23-JUL-2020 (doses, routes, vaccination sites and concentration were not reported) for prophylaxis. The temperature was from -14C to -10C (-14.2 C) for 6 hours. Previous temperature excursion was from -14C to -10C (-14.2 C) for 30 minutes. Digital data logger was involved. No adverse events were reported.   This case was considered to be non-valid due to lack of patients' identifiers.  Upon receipt of follow-up information it was determined that this case is now valid because patient identifier was received.  Follow-up information was received from the nurse on 27-AUG-2019 and refers to two adolescent patients at the age between 13 and 18 years old. On an unknown dates in 2019 (reported as between 01-JUL-2019 and 12-AUG-2019), the patients were vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) lot # R030612, expiration date 23-OCT-2020. There was no reactions or problems with the patients. The freezer was defrosted on 08-AUG-2019 (reported as last Thursday). On 12-AUG-2019, the temperature was -14.9C for 30 minutes. The clinic manager was checking into getting a lab grade/ vaccine grade freezer. Total hours of excursions was 6 hours and 30 minutes at -14C.  This is one of 4 cases received from the same reporter.; Sender's Comments:  US-009507513-1908USA010526: US-009507513-1908USA004659: US-009507513-1908USA010528:",,,,,,,,,U,,,,,UNK,,sterile diluent,,,,US0095075131908USA010527,2,09/16/2019,,,,
0833846,09/16/2019,SD,,,,U,,"no adverse event; patients received improperly stored vaccines; This spontaneous report was received from a nurse and refers to a unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. Their concomitant therapies included properly stored sterile diluent.  On unknown dates in 2019 (reported as between 01-JUL-2019 and 02-AUG-2019), the patients were vaccinated with improperly stored doses of varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot # R030612, expiration date 23-OCT-2020 and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, lot # S002490, expiration 23-JUL-2020 (doses, routes, vaccination sites and concentration were not reported) for prophylaxis. The temperature was from -14C to -10C (-14.2 C) for 6 hours. Previous temperature excursion was from -14C to -10C (-14.2 C) for 30 minutes. Digital data logger was involved. No adverse events were reported.   This case was considered to be non-valid due to lack of patients' identifiers.  Upon receipt of follow-up information it was determined that this case is now valid because patient identifier was received.  Follow-up information was received from the nurse on 27-AUG-2019 and refers to an adult patient at the age between 19 and 24 years old. On an unknown date in 2019 (reported as between 01-JUL-2019 and 12-AUG-2019), the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) lot # R030612, expiration date 23-OCT-2020. There was no reactions or problems with the patient. The freezer was defrosted on 08-AUG-2019 (reported as last Thursday). On 12-AUG-2019, the temperature was -14.9C for 30 minutes. The clinic manager was checking into getting a lab grade/ vaccine grade freezer. Total hours of excursions was 6 hours and 30 minutes at -14C.  This is one of 4 cases received from the same reporter.; Sender's Comments:  US-009507513-1908USA010526: US-009507513-1908USA010527: US-009507513-1908USA004659:",,,,,,,,,U,,,,,UNK,,sterile diluent,,,,US0095075131908USA010528,2,09/16/2019,,,,
0833847,09/16/2019,MI,,,,U,,"No adverse effects; improperly stored doses of PROQUAD and VARIVAX were administered to patient; This spontaneous report was received from a medical assistant and from vaccine coordinator and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 20-AUG-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (therapy type: RHA) injection (lot # S003178, expiry date 30-JUL-2020) (strength, dose, route and site of administration were not reported) and with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot # R030487, expiry date 22-OCT-2020; also reported as: lot number R034398, expiry date 27-NOV-2020) (strength, dose, route and site of administration were not reported); both for prophylaxis. The sterile diluent used to reconstitute the vaccines was stored properly.   The suspect vaccines were stored in a temperature of 36 degrees Fahrenheit for 15 hours. There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported.",,,,,,,,,U,08/20/2019,08/20/2019,0,,UNK,,sterile diluent,,,,US0095075131908USA011015,2,09/16/2019,,,,
0833848,09/16/2019,NV,,,,U,,"no adverse effects; patient received unspecified dose of Rotateq that was improperly stored; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On 20-AUG-2019, the patient was vaccinated with improperly stored unspecified dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # S009940, expiration date 04-OCT-2020 (exact dose, injection site and route of administration were not reported) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 34.1 degrees Fahrenheit for 4 hours and 30 minutes. The digital data logger was involved in recording the temperature excursion details. Administered dose of vaccine experienced previous temperature excursion of 34.7 degrees Fahrenheit for 3 hours and 2 minutes. There was no adverse effects reported.   This is one of several reports received from the same reporter.",,,,,,,,,U,08/20/2019,08/20/2019,0,,UNK,,,,,,US0095075131909USA001722,2,09/16/2019,,,,
0833849,09/16/2019,WA,,,,U,,"No known adverse effects; a patient received an expired dose ofV ARlV AX (lot: N022978; expiration: 08/23/2019).; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On 04-SEP-2019, the patient was vaccinated with expired dose of varicella virus vaccine live (oka/merck) (VARIVAX), lot # N022978, expiration date 23-AUG-2019 (strength, exact dose and route of administration were not reported) for prophylaxis. The vaccine was reconstituted with unexpired sterile diluent (lot # S003613, expiration date: 22-JUL-2021). No known adverse effects were reported.",,,,,,,,,U,09/04/2019,09/04/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA003257,2,09/16/2019,,,,
0833850,09/16/2019,CA,13.0,,,U,,"No adverse effects; patient was administered GARDASIL 9 two years ago/The second dose was administered today; This spontaneous report was received from a nurse prescriber, referring to a 15 year old patient of unknown gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported.  In September 2017 (reported as ""two years ago""), the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (strength, dose, route, frequency, lot# and expiration date were not reported).  On 10-SEP-2019 (reported as ""today""),  the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot# R029512, expiration date 08-JUL-2021, for prophylaxis (strength, dose, route and frequency were not reported). No adverse effects reported.",,,,,,,,,U,09/01/2017,09/10/2019,739,,UNK,,,,,,US0095075131909USA003927,2,09/16/2019,,,,
0833851,09/16/2019,,9.0,9,,U,,"A patient received improperly stored PROQUAD; No adverse effect; This spontaneous report was received from a medical assistant, referring to a 9 year old patient of unknown gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported.  On 05-SEP-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live rHA (recombinant Human albumin) (PROQUAD) lot# S002494, expiration date 23-JUL-2020, for prophylaxis (strength, dose, route and frequency were not reported). Measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD)was reconstituted with a properly sterile diluent (MERCK STERILE DILUENT).   The temperature excursion was of 6 fahrenheit degrees (F) to 14 F (102F), during 50 minutes. A previous temperature excursion was not reported. A digital data logger was involved. No adverse effects were reported.",,,,,,,,,U,09/05/2019,09/05/2019,0,,UNK,,MERCK STERILE DILUENT,,,,US0095075131909USA005134,2,09/16/2019,,,,
0833852,09/16/2019,TX,,,,F,,"inflammation; lightheaded/dizzy; there was a double temperature excursion on the vaccine/patient recieved; there was a double temperature excursion on the vaccine/patient recieved; numbness in her arms, that progress to all 4 limbs; choking; severe pressure in chest/ intense pressure on the chest; fainted/required her rescue inhaler atleast twice during these episodes and that is when she fainted; intense sharp pain, at level 10/ her pain level is now at a 7; This is a spontaneous report from a contactable Other-HCP. This Other-HCP reported on behalf of another Other-HCP . A 16-year-old female patient received meningococcal group b rlp2086 (TRUMENBA, Lot Number: X46476, Expiry date: 30Apr2020) intramuscular in right deltoid on 16Aug2019 at 0.5 ml single dose for immunization at a health fair for back to school. Medical history included asthma chronic prevention inhaler. Ongoing concomitant medications included mometasone furoate (ASMANEX) (started before 22Sep2016), fluticasone propionate (PROAIR) (noticed in 2016 already started). On 16Aug2019 a physical was did on her. The patient experienced severe pressure in chest, like she was choking, it was intense sharp pain, at level 10 on 16Aug2019. From what she read at the time, if the pressure was blood vessles constricting then this was angina. She required her rescue inhaler at least twice during these episodes and that was when she fainted on 16Aug2019. She had numbness in her arms on 17Aug2019, that progress to all 4 limbs on 03Sep2019. The biggest things with her complaint was the intense pressure on the chest, she has been in the office for the intense chest pressure for follow up. The patient did go to the Emergency Room but was not admitted into the hospital. If she kept having this then would refer her to cardiology for echocardiogram, they did do electrocardiogram (EKG) and it came out to normal and prescribed her prednisone to help with inflammation. It was also reported that there was a double temperature excursion on the vaccine, it went to highest point of 56.3 degrees Fahrenheit and above range for 7 hours, they were simultaneous, with another at 13 hours and 55mins at 32.7 degrees Fahrenheit. Her pain level was now at a 7. The patient still got lightheaded and dizzy as of 09Sep2019. All tests were done on 04Sep2019, EKG, C-reactive Protein, Creatinine Kinase, CBC/CMP, and red blood cell sedimentation rate all resulting in normal. The events ""sharp pain at level 10"", ""numbness in her arms/progress to all 4 limbs"" were considered serious as medically significant, the event ""fainted/required an rescue inhaler"" was considered serious as life threatening. The outcome of event ""fainted"" was recovered on 16Sep2019, outcome of ""pain"", ""severe pressure in chest/ intense pressure on the chest"" was recovering, outcome of ""numbness in her arms, that progress to all 4 limbs"" was not recovered, the outcome of rest events was unknown.; Sender's Comments: The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, as appropriate. The case will be reassessed if additional information becomes available.",,,Y,,,,,,N,08/16/2019,08/16/2019,0,Test Date: 20190904; Test Name: Creatine kinase; Result Unstructured Data: Test Result: normal; Test Date: 20190904; Test Name: C-reactive protein; Result Unstructured Data: Test Result: normal; Test Date: 20190904; Test Name: EKG; Result Unstructured Data: Test Result: normal; Test Date: 20190904; Test Name: CBC; Result Unstructured Data: Test Result: normal; Test Date: 20190904; Test Name: Comprehensive metabolic panel; Result Unstructured Data: Test Result: normal; Test Name: Pain scale; Result Unstructured Data: Test Result: 10; Test Name: Pain scale; Result Unstructured Data: Test Result: 7; Test Date: 20190904; Test Name: Erythrocyte sedimentation rate; Result Unstructured Data: Test Result: normal,UNK,,ASMANEX; PROAIR [FLUTICASONE PROPIONATE],,Medical History/Concurrent Conditions: Asthma chronic,,USPFIZERINC2019393865,2,09/16/2019,,,,
0833854,09/16/2019,MA,65.0,65,,M,,"Severe flu-like ague,vomiting starting 4-5 hours after innoculations. Temp went up to 101. symptoms lasted 6-8 hours.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,PVT,,"Lipitor, Diovan, Plavix",none,none,,,2,09/16/2019,,,,None
0833855,09/16/2019,NJ,68.0,68,,F,,"On 09/15/19 patient developed large red circle on upper shoulder area, next to the site of administration. Patient presented to the pharmacy 09/16/19 concerned about the area and complained that it hurt to touch as well. I told the patient to take Benadryl to help ease the reaction and to follow up with her PCP.",,,,,,,,,N,09/09/2019,09/15/2019,6,,PHM,,,,,,,2,09/16/2019,,Y,,
0833856,09/16/2019,AL,59.0,59,,F,,"headache, nausea followed by fever the rest of the 14th. Rash around neck that night, woke up Sunday 15th with rash down chest. Itching down torso. Went to medical office for steroid shot and medrol pack. Monday 16th now. Not as red still see rash up skin, itch is still there and down back.  Do I get second shot??",,,,,,,,,N,09/13/2019,09/13/2019,0,Sunday trip to medical office. If not better by Wednesday 18th I will go to GP,PHM,,"Topamax 100 mg twice daily, metoprolol 25 mg, zyrtec 10 mg, Dexilant dr 80mg, flonase spray, Zofron 8 mg, Zaleplom 10 mg",none,reflux and migraines,,,2,09/16/2019,,,,none
0833857,09/16/2019,CA,52.0,52,,F,,"SHINGLES LEFT ARM, AND CHIN APPEARED 9/14/19 3 DAYS AFTER SHOT. VERY MILD CASE LASTED 2 DAYS. NO PAIN. ITCHING, AND BLISTERS ONLY.",,,,,,,,,Y,09/11/2019,09/13/2019,2,NONE,PHM,,"LYRICA, LIVOLO, CYMBALTA, ATARAX, LOSARTIN, JANUMET, ATENELOL",N/A,"DIABETES, FIBROMEILGIA, ERTHROYMEILA",MMR 1996 FAINTED,,2,09/16/2019,,,,"CIRTUS, ANTOBIOTICS"
0833858,09/16/2019,MI,6.0,6,,F,,Child received DTP/IPV for wrong series.  No adverse reaction noted.,,,,,,,,,U,08/26/2019,08/26/2019,0,none,PUB,,unknown,unknown,unknown,,,2,09/16/2019,,,,unknown
0833859,09/16/2019,NV,11.0,11,,F,,"Patient blacked out, nausea, vomiting and headache",,,,,,,,,Y,09/16/2019,09/16/2019,0,,PVT,,None,None,None,,,2,09/16/2019,,Y,,none
0833860,09/16/2019,PA,4.0,4,,F,,She had her vaccine late evening on September 11th.  The next morning when she woke up she said her leg hurt and it hurt to walk. I just told her she would be fine.  Then I looked at her leg  when I got her dressed. It was a little swollen (which I expected) a little red and warm to the touch. She had a slight fever of 99.8.  She went to school and I picked her up at 11:30.  Her leg looked much worse. I called the dr office and they told me to put cold compress on the site and give her motrin.  I went back to work and an hour later I received a call that my daughter is really hurting. She is saying her head hurts and is not herself at all.  I called back the dr and got an apt to go in.  I saw a nurse for about 2 mins max. She looked at her leg and just said it was normal. No vitals were taken.  On the way home I stopped to pick up motrin from the store and gave it to her in the parking lot.  I picked up my son and we went home. When I got home I took her temp again (after I gave her motrin).  It was almost 103.  By that evening (5:00pm) Her whole upper thigh was huge.  Over the size of a baseball.  It was very red and very hot to the touch.  The next morning 9/13 there was no change in her leg.  Her fever was down to the upper 100's with no Motrin given.  She still said her leg hurt to walk.  On 9/14 the swelling went down slightly but was still very red and hot to the touch.  She no longer had a fever.  That evening she developed diarrhea.  9/15 she still had diarrhea that morning. Her leg was still red and  hot to the touch.  The swelling did go down a little more.  9/16 No diarrhea. The swelling continues to go down along with the redness.  It is no longer hot to the touch.,,,,,,,,,N,09/11/2019,09/12/2019,1,none,PVT,,none,She had a cold a week prior to vaccine,none,,,2,09/16/2019,,Y,,none
0833861,09/16/2019,PA,78.0,78,,F,,"Patient reported local pain which subsided over following days, but starting 09/13/2019 area began to be red, inflamed and warm to touch. Patient presented to pharmacy on 09/16/2019 with area red, inflamed and warm to touch. Patient denied any issues with breathing or swallowing. Patient advised to contact MD.",,,,,,,,,U,09/10/2019,09/13/2019,3,,PHM,,,,,,,2,09/16/2019,,Y,,
0833862,09/16/2019,FL,59.0,59,,F,,Patient experienced soreness after injection then the pain around her shoulder gotten worse over time.,,,,,,,,,N,05/23/2019,05/23/2019,0,None. Patient states that her pain specialist will order X-ray when she is due for appt,PHM,,"Amlodipine, Topamax, Ketamine, Tizanidine, Flonase, Advair, Prilosec, Norco",None,"Chronic bronchitis, Asthma",,,2,09/16/2019,,,,Codeine
0833863,09/16/2019,NY,38.0,38,,M,,"Patient had an annual visit with PCP and MD placed an order for a Influenza vaccine. I explained vaccine side effects, contraindications and CDC recommendations for vaccine. Patient given VIS. Patient reported never taken the influenza vaccine before. Patient reports allergies to Nuts only. Patient denies allergies to eggs, gelatin. Patient also denied history of Guiliam Barre Syndrome. I administered Afluria flu vaccine as per MD ordered on the left deltoid. Patient tolerated well no complains right after given vaccine. As Medical Assistant drew blood from patient approximately 10 minutes after patient reported red spots appeared on bilateral forearms. I immediately inform MD, and RN of reaction. Patient denied SOB, itchiness, neither swelling of face. MD assess patient lung sounds- negative wheezing. MD ordered PO Diphenhydramine. RN administered Diphenhydramine 25 mg as per MD ordered. Patient was observed for an hour after administration of medication. Patient denied any new symptoms, patient was informed to call office if new symptoms arise, also a prescription was sent to pharmacy. At time patient left no more concerns or questions. RN left voicemail to patient the following day. I called back patient as well to find out how he was feeling. Spoke with patient. Patient reported feeling well. Red spots are still there looked the same. Patient denies SOB, itchiness, or swelling. Patient informed no new spots appeared. Patient only felt a tight lower back later Wednesday. MD was made aware of this.",,,,,,,,,Y,09/04/2019,09/04/2019,0,,PVT,,,,,,,2,09/16/2019,,Y,,Allergies to nuts (peanuts)
0833864,09/16/2019,CA,22.0,22,,M,,RED RASH ON ARMS AND LEGS APPEARED THE DAY AFTER THE VACCINATION,,,,,,,,,Y,08/15/2019,08/16/2019,1,,UNK,,VITAMIN D3 2000IU AND SUMAPTRIPTAN,,,,,2,09/16/2019,,,,NKDA
0833865,09/16/2019,MI,42.0,42,,F,,"Client given pediatric dose of Hepatitis A vaccine. Follow pc made x2 on 9/16/19, Messages left. Client was informed Hep A dose given on 9/12/19 is invalid and needs to be repeated. Encouraged to call if has further questions or concerns. Given contact information to return pc. No return contact made.",,,,,,,,,U,09/12/2019,09/12/2019,0,None known,PUB,,Unknown,None reported,None reported,,,2,09/16/2019,,,,Bactrim
0833866,09/16/2019,WA,7.0,7,,M,,Patient received vaccine at age 7 when vaccine recommended for ages 6 and under. No adverse reaction reported.,,,,,,,,,Y,09/06/2019,09/06/2019,0,n/a,PVT,,Fluoride chewable tablet,None,None,,,2,09/16/2019,,,,NKDA
0833867,09/16/2019,MO,69.0,69,,F,,"Patient called in complaining of pain in the arm where shot was given, also redness and slight swelling around injection site.",,,,,,,,,U,09/12/2019,09/13/2019,1,,UNK,,,,,,,2,09/16/2019,,,,
0833868,09/16/2019,KS,63.0,63,,M,,Patient got shingles in which he had to go to doctor for treatment,,,,,,,,,,08/21/2019,09/10/2019,20,,PHM,,,,,,,2,09/16/2019,,Y,,
0833869,09/16/2019,VA,86.0,86,,M,,"FROM 8/31 UNTIL 9/4/2019 HE EXPERIENCED PAIN IN HIS LEFT ARM AND HE COULDNT PUT HIS ARM OVER HIS HEAD THE ENTIRE TIME. HE SAID "" IT HURT LIKE THE DICKENS"" BUT IT CLEARED UP ON THE DAY HE REPORTED ON 09/04/2019 AT 11:44AM",,,,,,,,,Y,08/30/2019,08/31/2019,1,NONE,PHM,,"ELIQUIS,RIVASTIGMINE,",NONE,UNKNOWN,,,2,09/16/2019,,,,NKA
0833870,09/16/2019,MD,1.0,1,.0,M,,patient received MMR 11/28/2018 instead of MMR-V as ordered. Patient not immunized with Varicella vaccine  on this date. Varicella was given 5/22/19 as a catch up dose. No Varicella outbreak during lack of coverage.,,,,,,,,,,11/28/2018,11/28/2018,0,,PVT,,,,,,,2,09/16/2019,,,,
0833871,09/16/2019,VA,63.0,63,,M,,"Soreness, pt stated that he was unable to bend and it just ached for over 2 weeks now",,,,,,,,,N,08/30/2019,08/31/2019,1,,PVT,,"labetalol, uloric, magnesium oxide, vitamin d, atorvastatin, spironolactone, amiodarone, tamsulosin, eliquis, nitroglycerin",N/A,"HTN, Hyperlipidemia, vitamin d def, hypomagnesemia,",,,2,09/16/2019,,,,Aspirin
0833872,09/16/2019,NY,67.0,67,,F,,"this was  the second shot - joints ached fever, chills, redness on left forearm which then developed into painful rash and blisters. As of today the 16th of September blisters have popped and pain  is less but still  present. On  Sept 13 doctor prescribed Valacyclovir 1 gram 3 x day for 10 days",,,,,,,,,Y,09/06/2019,09/07/2019,1,none,PHM,,"Levothyroxine 125mcg 1/day , Omperazole 20mg 2xday, Lisinopril/Hctz10-12.5 tab 1xdayMeloxicam 7.5mg 1xday, Cyclobenzaprine HCL 5mg 1 tablet 3xday as needed",none,"Hypo Thyroid,  arthritis and acid reflux",,,2,09/16/2019,,,,Sulfa Drugs
0833873,09/16/2019,PA,68.0,68,,F,,"PATIENT REPORTED A ""POX-LIKE"" RASH ON ARMS AND LEGS WHICH LASTED FOR 3 DAYS. PATIENT TOOK BENADRYL (ORAL) WHILE EXPERIENCING RASH)",,,,,,,,,Y,09/06/2019,09/08/2019,2,,PHM,,,,,,,2,09/16/2019,,,,NITROFURANTOIN
0833874,09/16/2019,FL,73.0,73,,F,,woke up morning after immunization with swollen and warm red upper arm. patient complained of sweats. patient went to doctor and was told she had an infection. she received a prescription for doxycycline.,,,,,,,,,N,09/11/2019,09/12/2019,1,,PHM,,,,,,,2,09/16/2019,,Y,,
0833875,09/16/2019,WV,2.0,2,.1,F,,patient received MMR on 10/4/2018 instead of MMR-V as ordered. Patient was not immunized with Varicella on this date. Varicella was given on 7/10/2019 as a catch up dose. No varicella outbreak during lack of coverage.,,,,,,,,,Y,10/04/2018,10/04/2018,0,,PVT,,,,,,,2,09/16/2019,,,,
0833876,09/16/2019,GA,62.0,62,,F,,"Rash started on left arm, then in back on buttocks and hands. Hard time breathing",,,,,,,,,N,09/14/2019,09/15/2019,1,no medical test at MD office. Patient has gone to hospital in ER,PHM,,none,None,None,,,2,09/16/2019,,,Y,"Egg allegy, Sulfa and patient has RH factor"
0833877,09/16/2019,CA,60.0,60,,F,,"Received a flu vaccine and Shingrix vaccine at the same time. By evening had joint/muscle pain and shivering. Got up feeling fatigued and weak, slight nausea. At approximately 8:00 a.m., felt dizzy and clammy, then passed out and hit forehead on marble floor. No further dizziness after that event. Fatigue and joint/muscle pain continued throughout that day but subsided by evening. On 09/16/2019 (four days after the shot), experienced nausea and diarrhea. Have never had an adverse reaction to a flu shot.",,,,,,,,,Y,09/12/2019,09/12/2019,0,None,PHM,,"Calcium with vitamin D, acetaminophen",None,None,,,2,09/16/2019,,,,None
0833878,09/16/2019,FL,5.0,5,,M,,"(L) arm inflammation  9.5 by 10.5 cm, red raised area on LA Deltoid",,,,,,,,,Y,09/11/2019,09/13/2019,2,None,PVT,,Multi-vitamins qd,None,None,,,2,09/16/2019,,Y,,NKDA
0833879,09/16/2019,CA,48.0,48,,M,,"Patient's wife called to stated pt. had ""bad reaction right arm is swollen red & hot w/a red ring on the whole arm.""",,,,,,,,,Y,09/13/2019,09/14/2019,1,0,PVT,,"Lipitor, Metformin",0 1st visit after an office,"DM II, morbid obesity, mixed hyperlipidemia, hypertension",,,2,09/16/2019,,,,Pineapple
0833889,09/16/2019,CA,4.0,4,,U,,"No adverse effect reported; patient received improperly stored PROQUAD; This spontaneous report was received from a medical assistant and refers to a 4-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 09-SEP-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) lot # S002494, expiration date: 23-JUL-2020 (exact dose, injection site and route of administration were not provided) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (MERCK) injection (exact dose, injection site, route of administration, indication, lot # and expiration date were not provided). Administered dose experienced the temperature excursions of 6 degrees Fahrenheit to 14 degrees Fahrenheit (10.2 degrees Fahrenheit, multiple) for 50 minutes. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. No adverse effects were reported.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005424,2,09/16/2019,,,,
0833890,09/16/2019,TX,,,,U,,"No adverse effects reported; one dose of an improperly stored vaccine, VARIVAX, was administered to one patient; VARIVAX / assistant confirmed route of administration was ""intramuscular""; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported.  On 11-SEP-2019, the patient was vaccinated with improperly stored vaccine of varicella virus vaccine live (oka/merck)(VARIVAX)0.5 ml, once, intramuscularly, lot # S002877, expiration date 29-JAN-2021, for prophylaxis (strength, lot#, expiration date were not reported). VARIVAX was reconstituted with a properly stored sterile diluent (MERCK STERILE DILUENT), possible lot # S000130 expiration date reported as 23-AUG-2021.  The temperature excursion was of 8.1 Fahrenheit degrees (F), for 20 minutes. However, a previous temperature excursion of 8.1 F for 17 minutes, and 9.5F for 21 minutes were also reported. A digital data logger was involved. No adverse effects were reported.",,,,,,,,,U,09/11/2019,09/11/2019,0,,UNK,,MERCK STERILE DILUENT,,,,US0095075131909USA005613,2,09/16/2019,,,,
0833891,09/16/2019,PA,,,,M,,"Painful; Wrong Injection Technique; This case was reported by a pharmacist via call center representative and described the occurrence of pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced pain and wrong injection technique. On an unknown date, the outcome of the pain and wrong injection technique were unknown.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The reporter administered the 1st dose of Shingrix injection in the deltoid muscle and the patient asked why the injection was given in the deltoid muscle. The reported stated she was researching this further and was not sure whether the Shingrix was given subcutaneously, which led to wrong injection technique. The pharmacist was not in the pharmacy at the time of this call, so limited details were available. The reporter consented to follow up. This case had been linked to the case US2019162812, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833893,09/16/2019,NJ,,,,F,,"Feeling of weakness; feeling of overall fever; Site of injection is very hot; Injection site red; Injection site a little tough to the touch; Side Effects; This case was reported by a consumer and described the occurrence of feeling hot in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd September 2019, the patient received the 1st dose of Shingrix. On 3rd September 2019, less than a day after receiving Shingrix, the patient experienced feeling hot and adverse drug reaction. On 4th September 2019, the patient experienced feelings of weakness. In September 2019, the patient experienced injection site warmth, injection site erythema and injection site induration. The patient was treated with paracetamol (Tylenol). On 4th September 2019, the outcome of the feeling hot was recovered/resolved. On an unknown date, the outcome of the feelings of weakness was unknown and the outcome of the injection site warmth, injection site erythema and injection site induration were not recovered/not resolved and the outcome of the adverse drug reaction was recovered/resolved.   It was unknown if the reporter considered the feeling hot, feelings of weakness, injection site warmth, injection site erythema, injection site induration and adverse drug reaction to be related to Shingrix.  Additional case details were provided as follows: The age at vaccination was not reported. On Tuesday evening, the patient had feeling of overall fever (but no high temperature was registered on thermometer) until midday on Wednesday. The next day morning, the patient had feeling of weakness.  The patient stated, till the time of reporting, the site of injection was very hot, red and a little tough to the touch (60 plus hours post injection). The other side effects were gone about 30 hours post injection. The patient had been taking extra strength Tylenol to help and was icing the injection site.  The patient asked if these were typical reaction occurs after vaccination and also asked if GlaxoSmithKline have any suggestions for it.",,,,,,,,,N,09/03/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/16/2019,,,,
0833894,09/16/2019,FL,66.0,65,,M,,"Arm ached; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In June 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional case details were reported as follows: The patient reported for himself. About 2 months and 1 week before the reporting date, the patient got his 1st dose of Shingrix in an unknown arm. Afterwards his arm ached quite a bit for about 1 week before resolving.  The patient consented to follow up. This case has been linked to US2019162791, reported by the same reporter.",,,,,,,,,Y,06/01/2019,,,,PHM,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/16/2019,,,,
0833895,09/16/2019,,,,,U,,"Feel very achy; Feel tired; Fell just not up to par; This case was reported by a consumer via call center representative and described the occurrence of pain in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 5th September 2019, the patient received the 1st dose of Shingles vaccine. In September 2019, less than a week after receiving Shingles vaccine, the patient experienced pain, tiredness and feeling abnormal. On an unknown date, the outcome of the pain, tiredness and feeling abnormal were unknown.   It was unknown if the reporter considered the pain, tiredness and feeling abnormal to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient felt very achy, tired, and just not up to par after receiving vaccine. The patient realized that these are common side-effects of the drug. The patient asked when they go away and when should I worry.",,,,,,,,,U,09/05/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/16/2019,,,,
0833896,09/16/2019,OH,17.0,,,F,,"lightheaded / dizzy; achy; queasy; This case was reported by a nurse via sales rep and described the occurrence of light headedness in a 17-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Bexsero. On an unknown date, 3 hrs after receiving Bexsero, the patient experienced light headedness, pain and queasy. On an unknown date, the outcome of the light headedness, pain and queasy were unknown.   It was unknown if the reporter considered the light headedness, pain and queasy to be related to Bexsero.  Additional case details were provided as follows: The patient's mother narrated the adverse events to the nurse and she reported to GlaxoSmithKline. About 3 hours after receiving the Bexsero vaccine, the patient started feeling lightheaded, dizzy, achy and queasy. The patient however did not faint. The reporter consented to follow up and provided her details.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833897,09/16/2019,CA,,,,F,,"Severe Muscle Pain; Injection Site Pain; Fever; Malaise; This case was reported by a pharmacist via call center representative and described the occurrence of muscle pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th September 2019, the patient received the 1st dose of Shingrix. On 6th September 2019, 2 days after receiving Shingrix, the patient experienced muscle pain, injection site pain, fever and malaise. On an unknown date, the outcome of the muscle pain, injection site pain, fever and malaise were unknown.   It was unknown if the reporter considered the muscle pain, injection site pain, fever and malaise to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that the patient vaccinated with Shingrix and was experiencing severe muscle pain, injection site pain, fever and malaise. The reporter did not consent to follow-up.",,,,,,,,,U,09/04/2019,09/06/2019,2,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833898,09/16/2019,OH,73.0,73,,F,,"Developed a hard knot at the site of injection and it is blackish-blue in color; Developed a hard knot at the site of injection and it is blackish-blue in color; This case was reported by a consumer via call center representative and described the occurrence of injection site induration in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced injection site induration and injection site discoloration. On an unknown date, the outcome of the injection site induration and injection site discoloration were unknown.   It was unknown if the reporter considered the injection site induration and injection site discoloration to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left arm. The patient got her first Shingrix shot two or three days ago.  She developed a hard knot at the site of injection and it was blackish-blue in color. The reporter did not consent to follow up.",,,,,,,,,U,09/01/2019,09/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833899,09/16/2019,VT,,,,F,,"Vertigo; This case was reported by a pharmacist via call center representative and described the occurrence of vertigo in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced vertigo. On an unknown date, the outcome of the vertigo was recovering/resolving.   It was unknown if the reporter considered the vertigo to be related to Shingrix.  Additional case details were provided as follows: The age at vaccination was not reported. The patient returned to the pharmacy to discuss vertigo which started after Shingrix administration. The reporter then spoke with the patient 1 week after her dose and the symptoms were subsiding. The reporter had no further details, they were not in the pharmacy at the time of reporting. The reporter consented to follow up.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833900,09/16/2019,TX,1.0,1,.6,M,,"Extensive swelling of vaccinated limb; Irregular shaped redness; Pain; This case was reported by a other health professional via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 1-year-old male patient who received DTPa (Infanrix) (batch number T753J, expiry date 1st February 2021) for prophylaxis.   On 23rd August 2019, the patient received Infanrix. On an unknown date, less than 2 weeks after receiving Infanrix, the patient experienced extensive swelling of vaccinated limb, injection site erythema and injection site pain. On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site erythema and injection site pain were unknown.   It was unknown if the reporter considered the extensive swelling of vaccinated limb, injection site erythema and injection site pain to be related to Infanrix.  Additional case details were reported as follows: The patient received vaccine in left thigh. The patient developed an injection site reaction, left lateral thigh swelling approximately 18cm, pain & irregular shaped redness. No additional details or resolution of symptoms were reported. The reporter consented to follow up.",,,,,,,,,U,08/23/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833901,09/16/2019,CO,,81,,F,,"cold sore; sore arm; felt bad; passed out; This case was reported by a consumer via call center representative and described the occurrence of cold sores in a 81-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (on an unknown date, received 1st dose).   In July 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, 1 day after receiving Shingrix, the patient experienced cold sores (serious criteria hospitalization), pain in arm (serious criteria hospitalization), feeling bad (serious criteria hospitalization) and passed out (serious criteria hospitalization and GSK medically significant). On an unknown date, the outcome of the cold sores was not recovered/not resolved and the outcome of the pain in arm, feeling bad and passed out were recovered/resolved.   It was unknown if the reporter considered the cold sores, pain in arm, feeling bad and passed out to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but it could be 80 or 81 years. The patient received Shingrix about 2 months before the date of reporting on right arm. The patient experienced sore arm. The day after receiving Shingrix, the patient felt bad, sat down and passed out. The patient was admitted to the hospital overnight for observation and was released the next day. The reporter consented to follow up. This case has been linked with cases US2019163766 and US2019163768 reported by the same reporter.",,,,,Y,1,,,N,07/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833902,09/16/2019,LA,68.0,68,,M,,"muscular pain; pain at injection site; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th August 2019, the patient received the 1st dose of Shingrix. On an unknown date, couple of days after receiving Shingrix, the patient experienced muscle pain and injection site pain. On an unknown date, the outcome of the muscle pain and injection site pain were not recovered/not resolved.   It was unknown if the reporter considered the muscle pain and injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient experienced muscular pain in and around the injection site.  The patient told that, the muscular pain in the whole arm that he noticed once he moves his arm. It was noticeable pain.",,,,,,,,,N,08/28/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833903,09/16/2019,GA,3.0,3,,F,,"CELLULITIS; INDURATION; WARM TO TOUCH; Vaccine administered at inappropriate site; This case was reported by a nurse via sales rep and described the occurrence of cellulitis in a 3-year-old female patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2018-2019 season) (batch number 2277M, expiry date 24th June 2020) for prophylaxis.   On 26th August 2019, the patient received the 1st dose of FluLaval Quadrivalent 2018-2019 season (intramuscular) .5 ml. On 26th August 2019, unknown after receiving FluLaval Quadrivalent 2018-2019 season, the patient experienced vaccine administered at inappropriate site. On 28th August 2019, the patient experienced cellulitis (serious criteria GSK medically significant), induration and skin warm. The patient was treated with cephalexin (Keflex) and mupirocin (Bactroban (Mupirocin)). On an unknown date, the outcome of the cellulitis, induration, skin warm and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the cellulitis, induration and skin warm to be related to FluLaval Quadrivalent 2018-2019 season.  Additional details were provided as follows: The patient received FluLaval Quadrivalent 2018-2019 season on right thigh, which led to vaccine administered at inappropriate site. The patient had not received any other vaccines while receiving FluLaval Quadrivalent 2018-2019 season. The patient experienced cellulitis, induration and was warm to touch. The patient was treated with Keflex and Bactroban. It was not necessary for the reporter to follow-up. This case has been linked with case US2019AMR164419 reported by the same reporter. Clarification has been raised to confirm the time to onset of event, as of now it was considered as 2 days.",,,,,,,,,U,08/26/2019,08/26/2019,0,,UNK,,,,,,USID BIOMEDICAL CORPORATI,2,09/16/2019,,,,
0833904,09/16/2019,MI,69.0,69,,F,,"Localized rx at time of injection on 9/9/19 and then on 9/14/19 noted inc in pain,swelling,redness,heat and firm tissue to Rt arm from shoulder to elbow. Presented to wlc on 9/16/19 with ongoing pain although decreased some,swelling, redness and heat with firm tissue from rt deltoid to elbow.",,,,,,,,,U,09/09/2019,09/14/2019,5,None.,PVT,,"atorvastatin,atenolol,lmlpramine,levothyroxie,gabapentin,asa",None,"gerd,osteoarthritis,sjogrens syndrome,htn,depressive disorder,hypothyroidism,stage 3 kidney disease.",,,2,09/16/2019,,Y,,zocor
0833905,09/16/2019,MI,24.0,24,,F,,"CLIENT GIVEN FIRST DOSE OF HEPATITIS A UNEVENTFULLY AROUND 10:20. CLIENT CALLED CLINIC AROUND 1520 COMPLAINING OF HAVING HIVES ALL OVER HER BODY WHEN SHE RETURNED HOME. INSTRUCTED TO TAKE BENADRYL, CALL PCP FOR FURTHER RECOMMENDATIONS, AND GO TO ER IF SYMPTOMS PROGRESS OF INVOLVE THE RESPIRTORY SYSTEM. F/U PC MADE 9/9/19 CLIENT REPORTS DID F/U WITH PCP VIA PC. NO FURTHER RECOMMENDATIONS WERE MADE. CLIENT WAS USING BENADRYL PO & TOPICALLY FOR 36 HOURS. REPORTS HIVES ARE STILL PRESENT BUT HAVE DECREASED IN SIZE AND SEVERITY. GIVEN CLINIC PH # TO CALL IF HAS FURTHER ?S OR CONCERNS.",,,,,,,,,U,09/06/2019,09/06/2019,0,NONE,PUB,,PRENATAL MVI,"CLIENT POSTPARTUM , DELIVERED TWINS ON 8/21/19. DENIES OTHER HEALTH ISSUES.",DENIES,,,2,09/16/2019,,,,NONE AT TIME OF VACCINATION
0833906,09/16/2019,NJ,54.0,54,,F,,Pt. reported feeling dizzy for 3-4 days after the immunization and having headache. Pt. stated she normally has vertigo but this dizziness was different from her usual symptoms and she also had headache. Pt. fully recovered as of today (6 days post immunization).,,,,,,,,,Y,09/11/2019,09/11/2019,0,None,WRK,,"Levoxyl 100 mcg, aspirin 81 mg, collagen, fiber, lansoprazole 30 mg, Montelukast 10 mg, nebivolol 2.5 mg","lump on the arm, hypothyroid, vertigo","hypothyroid, vertigo",,,2,09/16/2019,,,,"Morphine, many fruits and vegetables, animal dander, pollen"
0833907,09/16/2019,TX,68.0,68,,F,,"The patient's arm was bleeding upon removing the needle (more than a couple drops) and the patient's arm immediately began swelling after the injection.  The patient did not seem to be in any distress, and stated she was having no pain.",,,,,,,,,U,09/16/2019,09/16/2019,0,none to report,PHM,,"atorvastatin 20 mg, exemestane 25 mg, linzess 72 mcg, docusate 100 mg",unknown,none listed on VIS form,,,2,09/16/2019,,,,unknown
0833908,09/16/2019,MO,17.0,17,,M,,"fever, chills, weakness pain numbness in bilateral lower extremities, pain right axilla, left upper arm tingling",,,,,,,,,Y,09/12/2019,09/13/2019,1,none,PVT,,none,none,none,,,2,09/16/2019,,,,none
0833909,09/16/2019,MA,51.0,51,,M,,"4 weks after vaccination I was foud to have uveitis, initially in the right eye and then in both",,,,,,,,,N,07/11/2019,09/05/2019,56,,PHM,,none,none,history of retinal detachment,,,2,09/16/2019,,Y,,none
0833910,09/16/2019,ID,66.0,66,,F,,"nausea for 7 days, headache, backache and neck pain for 7 days -no treatment requested, advised if it continues past today to report to the doctor",,,,,,,,,N,09/08/2019,09/09/2019,1,,PHM,,,,,,,2,09/16/2019,,,,none
0833911,09/16/2019,KS,5.0,5,,M,,"LVL=8.25cm x 8.89 red, warm to touch, & itchy, irritated RVL= 1.9cm x 1.27 red, irritated",,,,,,,,,N,09/14/2019,09/14/2019,0,N/A,PUB,,chewable multivitamins,,"allergies, seasonal",,,2,09/16/2019,,,,PCN
0833912,09/16/2019,PA,69.0,69,,F,,"Patient bled initially, then immediately after removing the inject-safe bandage to replace with clean/dry bandage, the patient's arm puffed up right at injection site. Probably 1.5-2inches in diameter, obvious swelling and bruising under the skin. Reached out to patient 5 hours after administration, she said swelling has mostly gone down but there is a semi-hard bump where injection took place",,,,,,,,,U,09/16/2019,09/16/2019,0,none,PHM,,NONE,NONE,NONE,,,2,09/16/2019,,,,SULFA DRUGS
0833913,09/16/2019,ID,0.08,0,.2,F,,Child died.,Y,09/15/2019,,,,,,,N,09/14/2019,09/15/2019,1,Coroner case,PVT,,Neosure formula,None noted,None,,,2,09/16/2019,,,,None Known
0833914,09/16/2019,OH,43.0,43,,F,,"Injection was placed on the tip of my shoulder, in the joint space. With a couple hours, severe pain, joint stiffness. Still trouble rotating my shoulder without pain today.",,,,,,,,,N,09/12/2019,09/12/2019,0,None.,PHM,,Cosentyx Percocet  Atenolol  Celexa Wellbutrin Vitamin D3 Omeprazole Multivitamin,Psoriatic arthritis,Psoriatic arthritis,Tdap 2011. Fever 103.8 & general ?sick? feeling,,2,09/16/2019,,Y,,"Codeine, neurontin, fentanyl, phenergan Bees"
0833915,09/16/2019,AZ,63.0,63,,M,,TINGLING SENSATION AT INJECTION SITE,,,,,,,,,Y,09/10/2019,09/11/2019,1,,PHM,,,,,,,2,09/16/2019,,,,
0833916,09/16/2019,UT,67.0,67,,F,,"After 1 day, patient noticed redness / rash at the injection site. Patient contacted us at the pharmacy to report that the rash/redness had moved down her upper arm and is now above and on her elbow.",,,,,,,,,N,09/13/2019,09/14/2019,1,None,PVT,,"Premarin, Levothyroxine",None,Hypothryoidsim,,,2,09/16/2019,,,,"Bactrim DS, Penicillins, Codeine"
0833917,09/16/2019,FL,11.0,11,,M,,"Localized reaction to first Menveo vaccine on 8/5/19. Swelling, pain, redness to arm at site of injection. Size of baseball. Viewed picture of patient arm with reaction on MOC phone today. Reaction started same day, but by the next day was worse. Associated blotchy rash to face, neck, and arm. No anaphylaxis. Patient/family did seek care at urgent care and was treated with prednisone. Improvement within 24 hours and resolved within a few days of treatment.",,,,,,,,,Y,08/05/2019,08/05/2019,0,Referred to allergist.,PVT,,"Cetirizine, 10 mg, daily PRN Ventolin HFA, PRN",N/A,"Asthma Hyperinsulin Chilhood Obesity  Hypertrophy of nasal turbinate,Environmental and/or seasonal allergies","Parent states only other reaction to vaccine was second Hep A vaccine on 7/2/19, with noticable redness and swelling, but resolv",,2,09/16/2019,,,Y,"Egg  White - unknown reaction Nut - unknown reaction Metformin - syncope, low bloog sugar Tree pollen - runny nose, sneezing"
0833918,09/16/2019,MI,65.0,65,,F,,Patient reported 9/10 that Right Arm was warm at injection site. starting to swell by the 13th was still swollen and red warm to the touch redness and swelling gone by 9/15/2019,,,,,,,,,Y,09/09/2019,09/10/2019,1,NONE,PVT,,albuterol 90 mcg/actuation HFA inhaler    celecoxib (CeleBREX) 100 mg capsule   econazole nitrate 1 % cream   fexofenadine (ALLEGRA ALLERGY) 180 mg tablet   fluticasone (FLONASE) 50 mcg/actuation nasal spray   fluticasone-salmeterol (ADVAIR,No,Atrial premature contractions    Plantar fasciitis   Seasonal allergies   Hypertension   Obesity   Dry eyes   Asthma   Diabetes mellitus (CMS/HCC)   Sleep apnea   GERD (gastroesophageal reflux disease)   Complex atypical endometrial hyperplasia   Encounter for screening for diabetic retinopathy   Presbyopia   Nephrolithiasis   Plantar fasciitis of left foot   Type 2 diabetes mellitus without ophthalmic manifestations (CMS/HCC)   Colon polyps   Osteoarthritis of multiple joints   No cervical cancer screening: hysterectomy (benign conditions w/ cervix removed))   Primary osteoarthritis involving multiple joints,,,2,09/16/2019,,,,no known drug allergy
0833919,09/16/2019,MO,50.0,50,,F,,"Vaccination at 11:30 am on 9/11/19.  By 1 pm headache was noted then body aches.  Chills began at 7 pm leading to an early bedtime at 8 pm.  The next morning at 6:30 am (9/12/19) she had dizziness.  She continued to feel dizzy and passed out.  Her husband was present.  She had no memory of passing out.  She went to the ER and received fluids, toradol,  and Zofran.  She was released from the ER around 10:30 am and slept at home the rest of the day.  She also did not work the next day (9/13/19) and napped off and on all day.  She was tired the following day but felt better.",,,,,,,,,Y,09/11/2019,09/11/2019,0,,PHM,,,,,,,2,09/16/2019,,,Y,
0833920,09/16/2019,OR,76.0,76,,M,,RED RASH ON RIGHT INNER DELTOID (NOT AT INJECTION SITE). RASH IS WARM TO TOUCH. PATIENT FEELS TIRED AND RUN DOWN.,,,,,,,,,U,09/13/2019,09/14/2019,1,NONE,PHM,,"METOPROLOL SUCC, NIFEDIPINE, HYDROCHLOROTHIAZIDE, TRAZODONE, DUTASTERIDE",NONE,HIGH BLOOD PRESSURE,,,2,09/16/2019,,,,"AMOXICILLIN, IODINE"
0833921,09/16/2019,AR,63.0,63,,M,,"Patient started developing a large, red, sore arm at shot location the following day. Very painful to touch and very warm to touch. Counseled patient via phone to take tylenol if needed and to apply ice as needed. Started getting better by Monday 9/16/19.",,,,,,,,,Y,09/13/2019,09/14/2019,1,N/A,PHM,,"Restasis, Spiriva, Plavix, Lasix, Xarelto, Entresto, metoprolol, Prilosec, Crestor, Aldactone, Daliresp, Zofran, B 12 injection",unknown,unknow,,,2,09/16/2019,,,,NSAIDs
0833922,09/16/2019,,25.0,25,,F,,"The next morning, the patient noticed swelling, redness, and a welt at the site of injection. Reported itchiness and warmth at site.",,,,,,,,,,08/05/2019,08/06/2019,1,,UNK,,"Pepcid 20mg, Synthroid 75mcg",,,,,2,09/16/2019,,,,"Lactose sensitivity, cipro"
0833923,09/16/2019,MI,0.92,0,1,M,,Patient did not have a reaction - Immunizations given too soon against ACIP guidelines,,,,,,,,,U,08/22/2019,09/01/2019,10,NA - patient did not have a reaction,PVT,,Hydroxyzine Hcl 10 mg/5 mL,NA,NA,,,2,09/16/2019,,,,NA
0833924,09/16/2019,KS,44.0,44,,F,,"Employee Health office received word from the employee's manager that the employee was taken to the Emergency Room with facial drooping and inability to blink approximately 24 hrs after receiving flu vaccine. Manager verbalized the employee was diagnosed with having Bell's Palsy. Manager disclosed that employee has been complaining of ringing in the ears for past couple weeks and had an MRI already scheduled with her PCP prior to onset of Bell's Palsy symptoms. Manager reports the ED physician does not think the incident is vaccine related, rather coincidental.",,,,,,,,,U,09/11/2019,09/12/2019,1,unknown by this reporter,PVT,,,,,,,2,09/16/2019,,,Y,
0833927,09/16/2019,IA,62.0,62,,F,,"Headache, fatigue, hives No treatment, just rest Doing well, this lasted a few days",,,,,,,,,Y,06/21/2019,06/22/2019,1,NA,PUB,,not known,no,unknown,,,2,09/16/2019,,Y,,not known
0833928,09/16/2019,CO,23.0,23,,F,,"Patient received the flu shot in her right arm and is complaining of right shoulder pain, fever, sweating, chills, and a numbness in her fingers. She presented to urgent care and they said they were not concerned unless the fever lasted more than 48 hours. Patient presented to her pediatrician who stated the shot may have been injected into her bursa space (shoulder joint) and she needs to present back to the MD for an MRI if it continues after 7 days. Patient is still experiencing pain and will seek more medical attention this week.",,,,,,,,,N,09/10/2019,09/10/2019,0,MD visit on 9/10/19 and 9/11/19 will seek more medical attention for testing including MRI,PHM,,None,"Feeling ""under the weather""",none,Fainting -- unknown vaccination -- during teenage years,,2,09/16/2019,,Y,Y,Clindamycin
0833929,09/16/2019,,45.0,45,,F,,"Localized swelling, warmth, redness, pain at left anterolateral arm injection site.  Began day after vaccination and was reported to be persisting on day 5",,,,,,,,,,09/03/2019,09/04/2019,1,,WRK,,,,,,,2,09/16/2019,,,,
0833930,09/16/2019,FL,53.0,53,,F,,"Chills, fever, headache, body aches, fatigue, flu like symptoms",,,,,,,,,U,09/15/2019,09/16/2019,1,none,PHM,,estradiol D3 vitamin Calcium vitamin,none,none,,,2,09/16/2019,,,,none
0833931,09/16/2019,PA,77.0,77,,M,,After vaccination patient developed an active shingles infection,,,,,,,,,U,09/08/2019,09/16/2019,8,,PHM,,,,,,,2,09/16/2019,,Y,,No Known Drug Allergy
0833936,09/16/2019,KY,,,,U,,"No adverse effects were reported; A patient was inadvertently administered an expired dose of VARIVAX (N021314 8/7/2019) on 8/23/2019.; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No pertinent medical history, concurrent conditions, drug reactions or allergies were provided. Concomitant therapies included sterile diluent.  On 23-AUG-2019, the patient was inadvertently vaccinated with an expired dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # N021314 with an expiration date on 07-AUG-2019) for prophylaxis (dosage schedule, route and anatomical location). No adverse effects were reported. No temperature excursions were present.",,,,,,,,,U,08/23/2019,08/23/2019,0,,UNK,,sterile diluent,,,,US0095075131908USA009837,2,09/16/2019,,,,
0833937,09/16/2019,NJ,,,,U,,"No adverse affects reported; a improperly stored dose of ROTATEQ was administered; This spontaneous report as received from a license practical nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 23-AUG-2019, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) lot # R035369, expiration date 10-OCT-2020, orally, for prophylaxis (dosage schedule was not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 50 degrees Fahrenheit for 49 minutes. Data logger was involved. There were no previous excursions reported.",,,,,,,,,U,08/23/2019,08/23/2019,0,,UNK,,,,,,US0095075131908USA009838,2,09/16/2019,,,,
0833938,09/16/2019,TX,,,,U,,"No adverse effects reported; One dose of an improperly stored vaccine, VARIVAX, was administered to one patient of 9/12/2019; Assistant confirmed route of administration was ""intramuscular""; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported.  On 12-SEP-2019, the patient was vaccinated with an improperly stored vaccine of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 ml, once, intramuscularly, lot# S002877, expiration date 29-JAN-2021, for prophylaxis (strength was not reported). Varicella virus vaccine live (Oka/Merck) (VARIVAX) was reconstituted with a properly stored sterile diluent (MERCK STERILE DILUENT), possible lot # S000130, expiration date reported as 23-AUG-2021.  The temperature excursion was of 8.1 Fahrenheit degrees, during 20 minutes. However, a previous temperature excursion of 8.1F for 17 minutes and 9.5F for 21 minutes were also reported. A digital data logger was involved. No adverse effects were reported.",,,,,,,,,U,09/12/2019,09/12/2019,0,,UNK,,MERCK STERILE DILUENT,,,,US0095075131909USA005601,2,09/16/2019,,,,
0833939,09/16/2019,UT,65.0,65,,M,,"Inflammation; General aches and pains around my body; This case was reported by a consumer and described the occurrence of inflammation in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th September 2019, the patient received the 2nd dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced inflammation and general body pain. On an unknown date, the outcome of the inflammation and general body pain were unknown.   It was unknown if the reporter considered the inflammation and general body pain to be related to Shingrix.  Additional case details were reported as follows: The patient received second installment of vaccine the day before reporting. The patient had general aches and pains around body which he assumed that it was due to inflammation. The patient experienced some of the typical side effects and was wondering if an anti-inflmmatory would reduce the effectiveness of the vaccination. The patient would like to avoid damaging inflammation if possible. The reporter enquired whether the patient can take an anit-inflammatory such as diclofenac (75 mg) after vaccination. The reporter gave permission to follow up.",,,,,,,,,U,09/05/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/16/2019,,,,
0833940,09/16/2019,PA,,,,F,,"Painful; Wrong injection technique; This case was reported by a pharmacist via call center representative and described the occurrence of pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced pain and wrong injection technique. On an unknown date, the outcome of the pain and wrong injection technique were unknown.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  The patient received vaccine in unknown deltoid. The pharmacist stated she administered the first dose of Shingrix to patient who asked why the pharmacist was giving the injection in the deltoid muscle, which led to wrong injection technique. The reported stated she was researching this further, and was not sure whether the Shingrix was given subcutaneously. The pharmacist was not in the pharmacy at the time of this call, so limited details were available. The reporter consented to follow up. This case had been linked to the case US2019162813, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833941,09/16/2019,,56.0,,,M,,"Rash on arm; swelling on arm; Pain / pain on his left arm; This case was reported by a consumer via call center representative and described the occurrence of rash in a 56-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, between 3 and 4 months after receiving Shingrix, the patient experienced rash, swelling arm and pain in arm. On an unknown date, the outcome of the rash, swelling arm and pain in arm were recovered/resolved.   It was unknown if the reporter considered the rash, swelling arm and pain in arm to be related to Shingrix.  Additional case details were reported as follows: The niece did not have the patient exact age and estimated that he was 56 years old. The patient received vaccine in unknown arm. The reporter did not knew the lot number or expiry date of vaccine. The patient received the initial dose of Shingrix in either May or June of 2019 and developed a rash, a swollen area approximately 2.5 inches wide and 3.5 inches long, and pain on his left arm.   These events resolved after 10 days. The reporter declined to provide an address. The reporter did not give permission to follow up.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0833942,09/16/2019,PA,,,,U,,"that one of the nurses went to give a patient the Pentacel vaccine and didn't realize she had to mix with ActHIB portion of it, no adverse event; Initial information received on 26-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse. Follow-up was done on 27-Aug-2019.  This case involves a patient of unknown demography for whom it was reported that one of the nurses went to give a patient the DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] and did not realize she had to mix with acthib portion of it (lot number, exp date, route and site of administration were not reported) on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to product preparation issue.   At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA239630,2,09/16/2019,,,,
0833943,09/16/2019,LA,,0,.2,F,,"2 months baby received Pentacel without the Acthib portion, no AE; Initial information received on 27-Aug-2019 regarding an unsolicited valid non-serious case received from a  office staff/non-hcp.  This case involves a 2 months old female received DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot U6257AA expiry date: 27-Oct-2020 via intramuscular route in the right thigh) without the Act-Hib portion, on 26-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccinations included HEPATITIS B VACCINE (HEPATITIS B VACCINE); PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR); and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) for Immunisation.  It was an actual medication error due to inappropriate reconstitution technique.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/26/2019,,,,UNK,,HEPATITIS B VACCINE; PREVNAR; ROTATEQ,,,,USSA2019SA241921,2,09/16/2019,,,,
0833944,09/16/2019,OH,,18,,M,,"Menactra as a subcutaneous injection today in the right arm / no AE; Initial information received on 09-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 18 years old male patient who received 0.5 ml vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] lot U6179AA (Expiry date 29-Mar-2020) via subcutaneous route in the left arm, on 09- Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error case due to inappropriate route of vaccination.  It was reported that Menactra as a subcutaneous injection today in the right arm.  At a time of reporting no adverse effect reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/09/2019,,,,UNK,,,,,,USSA2019SA253191,2,09/16/2019,,,,
0833945,09/16/2019,OR,,63,,M,,"expired dose of Adacel given, no AE; Initial information received on 09-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 63 years old male patient  who was administered an expired 0.5 ml dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] lot U5726AA (Expiry date 11-Jul-2019) via intramuscular route in the right deltoid on 09-Sep-2019.  The patient's past medical history, vaccination(s) and family history were not provided.  Concomitant vaccination included Flu vaccine.    It was a case of actual medication error due to expired vaccine used.  At a time of reporting No adverse reactions reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/09/2019,,,,UNK,,FLU VACCINE VII,,,,USSA2019SA253322,2,09/16/2019,,,,
0833946,09/16/2019,IN,1.25,1,.3,F,,"15 month old patient that inadvertently received Quadracel / no AE; Initial information received on 09-Sep-2019 regarding an unsolicited valid non-serious case received from a non-hcp (Office Staff).  This case involves a 15 months old female patient who experienced 15 months old patient that inadvertently received 0.5 ml vaccine DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] lot C5532AB via intramuscular route in the left thigh on 09-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HIB VACCINE (HIB) and (Varicella vaccine).  It was an actual medication error case due to inappropriate age at vaccine administration.  It was reported that 15 month old patient that inadvertently received Quadracel.  At the time of reporting no adverse reaction was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/09/2019,,,,UNK,,HIB; VARICELLA VACCINE,,,,USSA2019SA253327,2,09/16/2019,,,,
0833947,09/16/2019,OH,,,,F,,"patient got Menactra SQ instead of IM, no AE; Initial information received on 09-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a female patient of unknown demography who received vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] and reported that patient got Menactra SQ instead of IM (incorrect route of product administration).  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medicatiuon(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot number not reported via subcutaneous route in unknown administration site.  It was a case of actual medication error due to inappropriate route of vaccination.  At the time of report, adverse event was not reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA253435,2,09/16/2019,,,,
0833948,09/16/2019,MN,,69,,M,,"swelling the size of a golf ball at the injection site; swelling the size of a golf ball at the injection site; Initial information received on 09-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 69 years old male patient who experienced swelling the size of a golf ball at the injection site (swelling and vaccination site reaction), while he received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 09-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ221AA expiration date: 30-Apr-2019 via unknown route in the left deltoid.  On an unknown date, the patient developed a non-serious swelling the size of a golf ball at the injection site (swelling and vaccination site reaction) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  Lab data was not reported.  The pharmacist stated that she administers this patient's Fluzone HD vaccine yearly for the past 5 or 6 years and he has no history of a reaction such as this.  Final diagnosis was swelling and vaccination site reaction.   It was not reported if the patient received a corrective treatment.  The patient outcome was reported as unknown for both the events.  List of document held by sender: none.",,,,,,,,,U,09/09/2019,,,,PHM,,,,,,USSA2019SA254196,2,09/16/2019,,,,
0833949,09/16/2019,,,,,F,,"very sick; flu; Initial information received on 09-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves an female patient of unknown age who experienced flu (influenza like illness) and very sick (malaise), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route.  On an unknown date The patient developed a non-serious flu (influenza like illness) and was very sick (malaise) same day following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  No lab test reported.  Final diagnosis was very sick and flu.   It was not reported if the patient received a corrective treatment.  The patient outcome was not reported..  Information on the batch number was requested.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA255728,2,09/16/2019,,,,
0833950,09/16/2019,,69.0,69,,M,,"arm swole up like a golf ball; arm swole up like a golf ball at the injection site (left deltoid); Initial information received on 09-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 69 years old male patient who experienced arm swole up like a golf ball at the injection site (left deltoid) (localised oedema, vaccination site swelling), while he received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.   On 09-Sep-2019, the patient received a 0.5 ml single dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ221AA via unknown route in the left deltoid.  On an unknown date, The patient developed a non-serious arm swole up like a golf ball at the injection site (left deltoid) (localised oedema, vaccination site swelling) Unknown latency following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  No lab test reported.  Final diagnosis was localised oedema, vaccination site swelling..   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Not Recovered / Not Resolved on an unknown date for the events.",,,,,,,,,N,09/09/2019,,,,UNK,,,,,,USSA2019SA255731,2,09/16/2019,,Y,,
0833951,09/16/2019,WI,,,,U,,"vaccine some came out of the syringe, outside the patient/no AE; cracking sound when applying the needle to the syringe/no AE; Initial information received on 09-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves Adult patient who received partial dose of vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (pre-filled syringes).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a partial dose of dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route.  It was of actual medication error due to Vaccine underdose and syringe issue..Reporting clinic staff complaint that Fluzone Quadrivalent pre-filled syringes crack and leak during preparation for injection.  It was unknown whether adverse event was experienced or not..  Information on the batch number was requested.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA257039,2,09/16/2019,,,,
0833952,09/16/2019,PA,50.0,50,,F,,"Swelling, redness and warmth at injection site",,,,,,,,,Y,09/09/2019,09/11/2019,2,None,PHM,,Flonase Xyzal OCPs,None,Allergic rhinitis,,,2,09/16/2019,,Y,,None
0833953,09/16/2019,MI,61.0,61,,F,,"muscle pain, tired, fever, chills, swelling, headache, nausea, shivering, redness, arm pain. Tylenol used.  Could not get out of bed on day 2. Total 4 days until all side effects over. Worse side effects ever from any vaccination. I would never repeat Shingrix unless it gets changed.",,,,,,,,,Y,09/09/2019,09/09/2019,0,None,PVT,,"Metformin, Jardiance, Tresiba, Lisinopril, Praulent, Toprol, Aspirin, Cranberry, Vit D3",None,"Diabetes, High blood pressure",,,2,09/16/2019,,,,"Glipizide, Farxiga, Lantus,Statins"
0833954,09/16/2019,PA,89.0,89,,M,,Patient is complaining of sore arm and received immunization on 9/05/2019,,,,,,,,,,09/05/2019,09/06/2019,1,,PHM,,,,,,,2,09/16/2019,,,,
0833955,09/16/2019,TX,1.0,1,.0,F,,Developed diffuse hives and itchiness few hours post immunizations that lasted for two days in addition to rash consistent with systemic mastocytosis,,,,,,,,,Y,09/05/2019,09/05/2019,0,None,PVT,,furosemide propranolol,Nasal congestion,Turner Syndrome History of coarctation of the aorta s/p repair Global developmental delay aortic valve stenosis,,,2,09/16/2019,,Y,,No known allergies
0833956,09/16/2019,MI,13.0,13,,F,,After given immunization while trying to chart Imm. I realized that I had given an adult dose of Hep a instead of a pediatric dose.,,,,,,,,,U,09/16/2019,09/16/2019,0,none,PVT,,None,None Known,None Known,,,2,09/16/2019,,,,None
0833957,09/16/2019,MI,1.08,1,.1,M,,"Pt's grandmother called to report symptoms starting soon after injection - she states he has had a fever, hives  and lymphadenopathy on and off since the injection. His temp has been as high as 102. Grandmother is an NP.  Symptoms are improving.  There was no office visit.",,,,,,,,,U,09/09/2019,09/09/2019,0,none,PVT,,Nystatin topical for diaper rash,AOM 8/15/2019,None,,,2,09/16/2019,,,,no known allergies
0833958,09/16/2019,ID,67.0,67,,F,,"extreme pain, could not lift or move arm, swelling and a hard lump that moved slowly  down my entire arm. Headache, dry mouth Painful to touch. Fatigue for 3 days.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,PVT,,Metformin Glimepiride amlodipine losartan hydrochloride,,"High blood pressure, diabetics",,,2,09/16/2019,,,,Vibramycin
0833959,09/16/2019,NC,19.0,19,,F,,Erythema in R arm at side of injection,,,,,,,,,N,09/13/2019,09/14/2019,1,,PVT,,Lexapro,none,"Autism, developmental disorder, chromosome abnormality, hypoplastic kidney",,,2,09/16/2019,,Y,,"Wasp venom, Keflex, clonidine, tenex, guanfacine, propofol."
0833960,09/16/2019,PA,37.0,37,,F,,"Patient stated that 1/2 hour after the vaccine, she developed severe shoulder joint pain that traveled to her elbow and wrist within an hour.",,,,,,,,,N,09/16/2019,09/16/2019,0,N/A,PHM,,None,N/A,N/A,,,2,09/16/2019,,Y,,"Acetaminophen, morphine and related, oxycodone"
0833961,09/16/2019,MD,71.0,71,,M,,"runny sinus and sore throat, slight headache, low fever, chills - all happened 4 hours after vaccine and have gotten worse but appear to be stable after 6 hours",,,,,,,,,N,09/16/2019,09/16/2019,0,had blood drawn for annual physical 30 minutes prior,PHM,,none,none,none,,,2,09/16/2019,,,,none
0833962,09/16/2019,FL,77.0,77,,F,,"Patient reported swelling, redness, and itching around the vaccination site, starting the day after administration and subsiding after 3 days.",,,,,,,,,Y,09/13/2019,09/14/2019,1,,PHM,,"Aspirin, Plavix, Lantus, Fluzone High-Dose, Nitrofurantion, Glimepiride, Atorvastatin, Carvedilol, Metformin, Levothyroxine, Omeprazole, Enalapril",,"Heart Disease, Diabetes",,,2,09/16/2019,,,,"Penicillin, Sulfa"
0833963,09/16/2019,WA,76.0,76,,F,,"Pt had whole body tremors, high fever, chills beginning that evening.  Had loss of mobility in left arm, swelling, pain, and rash.   Currently has somewhat reduced mobility in the arm, along with some swelling and the rash.",,,,,,,,,U,09/13/2019,09/13/2019,0,n/a,PHM,,"diovan 160 mg, simvastatin 10 mg,  voltaren gel",none,"hypercholesterolemia, hypertension",,,2,09/16/2019,,,,no allergies listed
0833964,09/16/2019,NY,12.0,12,,F,,Mother states patient got headache and felt fatigued.,,,,,,,,,U,09/11/2019,09/13/2019,2,none,PVT,,none,none,"Lyme, MTHFR mutation, Lichen Sclerosis",,,2,09/16/2019,,,,none
0833965,09/16/2019,CA,24.0,24,,F,,"Fainted at point of vaccine, which is normal for me. However, since the vaccine I have experienced constant headache, nausea, weakness, and fatigue.",,,,,,,,,N,09/13/2019,09/13/2019,0,n/a,PVT,,Birth control,n/a,n/a,,,2,09/16/2019,,,,n/a
0833966,09/16/2019,OR,0.5,0,.6,M,,"Mom reports that the next morning after the Rotavirus vaccine, he woke up screaming at 4 AM. He was seen in clinic after vomiting with loose stool. Sent home and asked to come back in a few hours, he was increasingly more fussy and had another episode of emesis. Family was asked to take him to the ER, he had an episode of bloody stool on the way to ER. In ER, diagnosed with intussusception which was reduced with air enema. Observed overnight at hospital and discharged home the next day .",,,,,Y,1,,,Y,08/26/2019,08/27/2019,1,Air enema reduction of intussusception on 8/27,PVT,,None.,None.,None.,,,2,09/16/2019,,Y,Y,None.
0833967,09/16/2019,TN,39.0,39,,F,,Patient presented with a blotchy rash 2 days after vaccination,,,,,,,,,Y,09/14/2019,09/16/2019,2,n/a,PHM,,None known of,none known,none known,,,2,09/16/2019,,,,KNDA
0833968,09/16/2019,CA,30.0,30,,F,,"pain with lifting shoulder at a 90degee.,cannot lift her left arm above my head. wake up from pain in arm/shoulder. took advil am & pm and got a doctor's note to get an MRI",,,,,,,,,N,08/20/2019,08/20/2019,0,,PHM,,,,,,,2,09/16/2019,,Y,,nka
0833969,09/16/2019,SC,76.0,76,,F,,"Swelling (worse at night), red patch, soreness, slight fever at night",,,,,,,,,N,09/02/2019,09/03/2019,1,,PHM,,Unknown,Unknown,Unknown,,,2,09/16/2019,,Y,,"Egg, tetracycline"
0833970,09/16/2019,CO,61.0,61,,F,,"Minor Swelling/itching,warm at injection site.  Low grade fever, body ache, nausea",,,,,,,,,Y,09/13/2019,09/13/2019,0,Na,PHM,,"Lexapro (5mg/day), Arimidex  (1mg/day), 7000 iu d3",None,None- full blood panel one week prior- all normal,Singrix,,2,09/16/2019,,,,None
0833971,09/16/2019,WA,85.0,85,,F,,Patient experienced muscle pain and stiffness in her whole body starting about 12 hours after her shot and lasting for about 24 hours.  Her muscle pain and stiffness gradually disappeared and was completely gone after 24 hours.,,,,,,,,,Y,09/13/2019,09/14/2019,1,none,PHM,,Hydrocodone/APAP Atorvastatin,none,chronic pain,,,2,09/16/2019,,,,nka
0833972,09/16/2019,OR,12.0,12,,M,,Patient was due to receive Meningococcal and got MMR instead and was not due for it at this time. patient was up to date on MMR,,,,,,,,,Y,08/30/2019,09/16/2019,17,none,PVT,,none,none,none,,,2,09/16/2019,,,,none
0833973,09/16/2019,AZ,63.0,63,,F,,"0912.2019 -patient reporting side effects :arm sore(cannot lift),nausea,vomiting (2 times). fatigue,heaache,shivering,fatigue . 0914.2019-patient is ablet to move her arm but still nauseated and has fatigue. 09.16.2019-patient is feeling better and all side effects are resolved.",,,,,,,,,Y,09/11/2019,09/12/2019,1,none,PHM,,n/a,none,allergic rhinitis,,,2,09/16/2019,,Y,,NKA
0833974,09/16/2019,PA,86.0,86,,M,,"Per nurse at Dr.'s office, and encounter notes form hospital:  the patient experienced severe pain in left deltoid 2 hours after administration of Shingrix on 9/10/19,  which revealed calcium pyrophosphate crystals on aspiration on 9/13/19",,,,,Y,3,,,Y,09/10/2019,09/10/2019,0,aspiration of left shoulder revealed calcium pyrophosphate crystals,PHM,,,,Diabetes,,,2,09/16/2019,,,,NKA
0833975,09/16/2019,CA,84.0,84,,F,,"At 8 pm on the same day of vaccination, patient experienced headache, upset stomach, terrible pain on the right arm and felt hot to touch/inflammation at injection site. Patient emphasized it's very severe for her. However, it was improved on Sunday (no more headache/upset stomach), but there is still sore (difficult with range of motion).",,,,,,,,,Y,09/14/2019,09/14/2019,0,None,PHM,,"SPIRONOLACTONE-HCTZ, LOVASTATIN, IRBESARTAN , METFORMIN, ALENDRONATE, TYLENOL",NONE,"HYPERTENSION, HYPERLIPIDEMIA, DIABETES TYPE 2,",,,2,09/16/2019,,,,NKDA/NKFA
0833976,09/16/2019,PA,76.0,76,,F,,PATIENT REPRESENTATIVE WAS IN THE STORE THE DAY AFTER THE VACCINATION (9/14/2019) AND SAID THE PATIENT WAS COMPLAINING OF PAIN/SORENESS AT INJECTION SITE OF SHINGRIX.  I EXPLAINED THE SITE WOULD BE SORE FOR A DAY OR TWO FOLLOWING ADMINISTRATION.  TOLD HIM TO KEEP ANY EYE ON THE SITE FOR ANY FURTHER SYMPTOMS.  PATIENT CAME INTO THE PHARMACY TODAY (9/16/19) AND SHOWED ME HER ARM.  THERE WAS REDNESS AND SWELLING BELOW THE INJECTION SITE AND IT WAS WARM TO THE TOUCH.  SHE SAID IT WAS STILL SORE AND SOME OF THE SORENESS MOVED UP INTO HER NECK.  SHE SAID SHE WAS AT THE PCP OFFICE TODAY AND THEY TOLD HER IT WAS AN ALLERGIC REACTION TO THE SHINGRIX VACCINE.,,,,,,,,,Y,09/13/2019,09/13/2019,0,NONE,PHM,,SYNTHROID,UTI,"THROAT CANCER, TRACH",,,2,09/16/2019,,Y,,METOCLOPRAMIDE
0833977,09/16/2019,CO,67.0,67,,F,,"PER PATIENT'S HUSBAND, SHE HAD A ""RED STAR PATTERN AND A LUMP ABOUT 1 INCH FROM INJECTION SITE, AND IT WAS WARM.""",,,,,,,,,U,09/12/2019,09/14/2019,2,NOT KNOWN. COULD NOT REACH PATIENT TO ASK. SHE WENT TO THE ER ON 9/14/2019.,PHM,,NOT KNOWN. NONE ON FILE. COULD NOT REACH PATIENT TO ASK.,NOT KNOWN. NONE ON FILE. COULD NOT REACH PATIENT TO ASK.,NOT KNOWN. NONE ON FILE. COULD NOT REACH PATIENT TO ASK.,,,2,09/16/2019,,,Y,NOT KNOWN. NONE ON FILE. COULD NOT REACH PATIENT TO ASK.
0833978,09/16/2019,AZ,47.0,47,,F,,"Patient reports feeling very sick with emesis X3, swelling arour right ankle",,,,,,,,,U,09/11/2019,09/12/2019,1,,PHM,,"Sumatriptan, venlafaxine",None,None,,,2,09/16/2019,,,,None
0833979,09/16/2019,OR,14.0,14,,M,,Patient did not report adverse event.  He was inadvertently given 9 doses of IPOL instead of 1.,,,,,,,,,U,09/13/2019,09/13/2019,0,No adverse reactions reported,PVT,,Nortriptyline,none,depression  anxiety PTSD,,,2,09/16/2019,,,,Escitalopram Oxalate
0833980,09/16/2019,MA,56.0,56,,F,,"swelling and hot at injection site and spread about six inches beyond, fever, rash, malaise, GI upset/nausea, dizziness, headache",,,,,,,,,N,09/14/2019,09/15/2019,1,none,PHM,,"citalopram 10mg/day, multi-vitamin",none,none,"first dose of Shingrix, pneumonia vaccine",,2,09/16/2019,,,,penicillin
0833981,09/16/2019,CA,0.25,0,.3,F,,for 9 days after above vaccines were given this baby appeared lethargic to mom; symptoms resolved thereafter,,,,,,,,,Y,07/28/2010,07/28/2010,0,none,PVT,,none,none,none,,,2,09/16/2019,,,,none
0833982,09/16/2019,FL,70.0,70,,M,,severe flu symptons...extreme sore throat...weakness...no appetite...sleeping 15 hours a day...head aches...running nose...steady cough...ringing in ears,,,,,,,,,Y,09/12/2019,09/14/2019,2,,PHM,,atorvistatin...doxsozin...finesteride,none,none,,,2,09/16/2019,,Y,Y,none
0833983,09/16/2019,NM,1.0,1,.1,F,,"Patient had local reaction. Redness, swelling, and warm to the touch at site after 15minutes, kept patient an additional 20 minutes in clinic for observation. No change to reaction did not decrease or increase.",,,,,,,,,U,09/16/2019,09/16/2019,0,,PVT,,none,none,none,,,2,09/16/2019,,Y,,none
0833984,09/16/2019,NY,1.58,1,.6,F,,"Rash all over arms, stomach, legs and back, itchiness, abdominal pain, diahrea, slight fever, sweating, lack of appetite, lethargic for about a week.",,,,,,,,,N,08/22/2017,08/23/2017,1,"none, called Doctor and was told it was ""normal""",PVT,,None,None,None,"All vaccines gave her abdominal distress and diahrea, wouldn't let us put her down, had to be held even during sleep, runny nose",,2,09/16/2019,,Y,Y,"Oatmeal, dairy, gluten, food colorings, grass, weeds, brown rice, blueberries, eggs"
0833985,09/16/2019,AK,51.0,51,,F,,2 inch diameter red spot around injection site. Spot is warm and firm to touch.  Patient reports that it is painful.,,,,,,,,,U,09/12/2019,09/12/2019,0,,PHM,,norco,none,,,,2,09/16/2019,,,,"quinolones, sulfites, penicillins"
0833986,09/16/2019,NM,1.08,1,.1,M,,"Raised, reddened area noted around site where MMR was given and where Varicella was given.  Dr. informed of reaction and Pt kept for additional observation (total observation time 35min) post vaccination. Improvement noted to sites prior to discharge. No dyspnea, hives, fever, or acute distress noted prior to discharge.",,,,,,,,,U,09/16/2019,09/16/2019,0,,PVT,,none,none,hydronephrosis,,,2,09/16/2019,,Y,,none
0833987,09/16/2019,CO,64.0,64,,F,,"patient was in today 2 days after receiving flu shot and said it gave her a reaction that felt like allergies, stuffy nose, itchy throat, itchy around her neck. she had some patchy looking redness on her arm and said she felt a lump at the injection site.",,,,,,,,,Y,09/14/2019,09/14/2019,0,,PHM,,,,,,,2,09/16/2019,,,,"sulfonamides, statins"
0833988,09/16/2019,MD,62.0,62,,F,,"Local reaction on arm where vaccine was given, swelling and painful. Patient felt generally under the weather as well.",,,,,,,,,Y,07/08/2019,07/09/2019,1,,PHM,,,,,,,2,09/16/2019,,Y,,
0833989,09/16/2019,NV,67.0,67,,F,,"Patient states that she experienced a bad headache the evening she received the vaccination. The next day the injection site was swollen and red and painful. She has had a half-dollar sized bruise for 2 weeks. It is no longer swollen or painful. She saw her doctor and they informed her ""the bruise may last for months and the vaccination administrator may have hit a nerve or blood vessel. Patient is a former nurse and states she ""has never seen anything like this before"".",,,,,,,,,N,09/05/2019,09/05/2019,0,,PHM,,Patient is on aspirin so bruises easier.,,,,,2,09/16/2019,,Y,,Penicillin
0833990,09/16/2019,FL,71.0,71,,F,,"the patient recieved the vaccine, she was doing well when she left the pharmacy. about 30min to an hour later, the daughter came reporting that her mother has been very nauseous and throwing up since she returned home. Counseld and advised patient, and made recommendations to control symtpoms, and followed up with the customer.",,,,,,,,,U,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/16/2019,,,,
0833991,09/16/2019,MO,60.0,60,,F,,Patient started having face numbness after about 3 minutes of administration of vaccines and chest tightness after 5 minutes. I administered an EpiPen 0.3mg in her left thigh which helped with her chest tightness after 3 minutes. My staff called 911 and the EMT's arrived and took her vitals. Her vitals were normal but they ended up taking her to the ER.,,,,,,,,,U,09/16/2019,09/16/2019,0,N/a,PHM,,,cough-she said it was due to choking on a cashew. She had been to the doctor and had x-rays so no lung damage just irritation.,Asthma,,,2,09/16/2019,,,Y,She stated that she had several drug allergies but none pertaining to the vaccines she was receiving.
0833992,09/16/2019,CA,67.0,67,,F,,Pale pinkness on bicep (away from the injection site - deltoid),,,,,,,,,U,09/14/2019,09/15/2019,1,,PHM,,,,,,,2,09/16/2019,,,,
0833993,09/16/2019,NC,67.0,67,,F,,"Starting 14  hours after the administration of the vaccine , patient reported the following: chills, fever, flu-like symptoms, headache and swelling, redness and heat sensation just below the administration site. None of the adverse events were deemed serious enough by the patient to seek treatment.",,,,,,,,,Y,09/11/2019,09/12/2019,1,,PHM,,"Clindamycin 1% solution , Apply as directed once to twice a day to affected area  Metonidazole 0.75% cream Apply as directed once to twice a day to affected area  Valacyclovir 500 mg tabs 1 qd Estradiol 0.075 mg/day biweekly patches Apply 1",,,,,2,09/16/2019,,,,None reported by patient
0833994,09/16/2019,VA,4.0,4,,M,,"He had a seizure 2 days later, had to call 911 and see ER",,,,,,,,,U,08/28/2019,08/30/2019,2,,PVT,,Vitamins,no,"Possible HFA, Language delay, not sure if also caused by vaccines",,,2,09/16/2019,,,Y,no
0833995,09/16/2019,MI,4.0,4,,M,,Woke up with a fever of 105 and very weak in the knees in the middle of the night. The fever went down with Motrin but remained in the 103-104 range for a few hours.,,,,,,,,,Y,07/10/2019,07/11/2019,1,,PVT,,N/A,N/A,N/A,He developed chicken pox (mild case) after getting the first dose of varicella vaccine  on 8/24/2016 (age 1).,,2,09/16/2019,,,,N/A
0833996,09/16/2019,AZ,65.0,65,,F,,"Very painful at site of injection, shortness of breath, Achy, Headache, Loss of Appetite, Dizziness, No Energy  Shortness of breath cleared up by late evening the day of injection; all other symptoms lasted through Wednesday, September 11.  Missed 3 days of work.",,,,,,,,,Y,09/08/2019,09/08/2019,0,,PHM,,"Amlodipine, Gabapentin, Fluoxetine, Red Yeast Rice w/Coq10; Biotin, Glucosamine; D3; Calcium, Multi-Vitamin; Cranberry",,Low Kidney Function; Mild Asthma,,,2,09/16/2019,,,,Sulfa products
0833997,09/16/2019,CA,78.0,78,,F,,"Patient experienced onset of symptoms redness, swelling, soreness, injection site warm to the touch starting about 6 hours after administration and lasting through today.  The injection site is surrounded by a demarcated red area of approximately 3"" diameter and extends down her arm appearing red and splotchy. Patient also c/o itching at injection site and site feeling painful with movement which was relieved with OTC acetaminophen.  Patient also experienced an immune response following vaccine including fatigue, and ""just not feeling well.""",,,,,,,,,Y,09/12/2019,09/12/2019,0,none,PHM,,"Prolia, Praluent, Vit D + Calcium",none,unknown,,,2,09/16/2019,,,,ciprofloxacin
0834038,09/16/2019,VA,61.0,61,,F,,"Patient received Afluria on 9/11/19. Then 4 hours after receiving vaccine, the patient reported that she felt ""achy"". She said she took 2 Alleve within 30 minutes. Then she had violent chills for 4 hours and her face was swollen. She called her primary care physician who instructed her to go to the emergency room. Patient went to the emergency room. The ER physician could not tell her exactly what was causing the reaction. Patient was discharged with Diphenhydramine and Prednisone. She called today, 9/15/19, to report the swelling and chills to us. She has had flu shots in the past without any severe reactions. Patient said she is doing better.",,,,,,,,,Y,09/11/2019,09/11/2019,0,,PHM,,Alleve,None,None,,,2,09/16/2019,,,Y,None
0834039,09/16/2019,WI,82.0,82,,F,,"Called patient on09/16/2019 to have her come in for second dose shingrix. Patient informed that doctor does not want he to get any vaccine until her arm heals. Two months later, patient states she still has a large red swollen  area at injection site. she rates pain 7 out 10yet. States pain shoots all the way down to thumb. Patient states doctor is treating patient with prednisone and is thinking about starting gabapentin to control pain. Patient states okay to contact if more info needed.",,,,,,,,,N,07/10/2019,07/10/2019,0,,PHM,,,,,,,2,09/16/2019,,Y,,
0834048,09/16/2019,PA,,,,M,,April 10th I received the first dose of Shingrix vaccine. By April 21st I had a full on outbreak of shingles including severe derm pain on head and forehead.Nowhere in labeling is this reported as a side effect of this vaccine,,,,,,,,,,04/10/2019,04/21/2019,11,,UNK,,Avapro Zocor Mavic Nexium,,High BP Cholesterol GERD Arthritis,,,2,09/09/2019,,,,none
0834049,09/16/2019,PA,1.25,,,U,,My child received the MMR shot and had both a high fever for three days (7 days after shot) and also got a rash all over the trunk of her body which lasted 2 days.,,,,,,,,,,,06/10/2019,,,UNK,,,,,,,2,09/13/2019,,,,
0834050,09/16/2019,TX,,,,F,,"Had shot at 1pm 9/7/19 at midnight I had a severe headache, fever, chills, body aches, nausea and then diarrhea two days later very weak and still have a slight headache and body ache",,,,,,,,,,09/07/2019,09/07/2019,0,,UNK,,"Ativan occasionally 1'2 times a week; multivitamin, melatonin by metagenics",,none,,,2,09/09/2019,,,,none
0834051,09/16/2019,CA,,,,F,,"I got a bad flu, starting evening after I got my 2nd Zoster Vaccine (Recombinant) and was in bed for 2 days; I also got swelling and bruising on left arm where I go the shot.",,,,,,,,,,09/06/2019,09/06/2019,0,,UNK,,,,,,,2,09/16/2019,,,,
0834052,09/16/2019,NE,71.0,,,M,,"Following our Dr's instructions I got my Shingrix shot on 9/4. The IM shot stung more then I would have expected. I have a pre existing condition with my left leg, I had a bulging disk at L4-5 approximately 19 years ago and again involving the right leg 3 years ago. With the left leg, every once in a blue moon I would have what feels like a wasp sting about mid shin on the outside of the leg which would cause me to jump when it hits. This would happen every couple of months or so or maybe when I exerted my lower back more then I should have. On the night of the 4th morning of the 5th after I went to bed, I had that stinging event occur. The bazaar thing was that I would lay quiet and it would hit, followed by two more times forcing me to move by sheer reaction. Then I would lay still and it would happen again, so I would move again and after a while it would start again, as long as I was in motion it wouldn't hit but when I laid still it would come back. Initial ""sting"" followed by two more if I stayed still. This went on all evening to the point my Fitbit didn't record any sleep at all; that was a first since I've it! When I got up in the morning for the day I no longer experienced the discomfort and it did not return the next night.",,,,,,,,,,09/04/2019,09/04/2019,0,,UNK,,"40 mg Atorvastatin daily, losartan 50 mg daily, ranitidine 150 bid prn, 2 grams calcium carbonate at bedtime, an occasional multivitamin","former smoker, alcohol use in the evening.","HTN, hyperlipidemia",,,2,09/09/2019,,,,"penicillin, naproxen, famotidine, amoxicillin"
0834054,09/16/2019,TX,62.0,,,M,,"Received second shingrex vaccine August 15, 2019. Had fever chills and shakes through the night. Tingles in left arm stayed with me. September 9, 2019 I was prescribed Amlodipine because my blood pressure was 199/124. Tingling in left arm continued. September 12, 2019 went to emergency room because tingling in other arm and left leg heading up to my neck and jaw. I had shooting pains in chest and right abdominal. I was kept overnight for a nuclear stress test. Test didn't show any severe blockage. I was prescribed Gabapentin for shingles symptoms and discharge.",,,Y,,,,,,,08/15/2019,09/12/2019,28,"Nuclear stress test, 13-Sep-2018, No severe blockage",UNK,,"Atenolol 25mg, Rouvostatin and fenofibrate 145, Entyvio 300mg infusions",,"Diabetes, heart disease, hypertension",,,2,09/15/2019,,,,
0834058,09/16/2019,OH,74.0,74,,F,,"Multiple adverse side effects 24 hours post injection: soreness, swelling, hardness at injection site; neck and shoulder muscle pain; extreme tiredness and weakness; headache; upset stomach; diarrhea; belly pain; gas (burping and flatulence; lasted three full days with several days of recovery",,,,,,,,,,08/12/2019,08/12/2019,0,,UNK,,"(Lexapro) Escitalopram 10 mg 1x day Ranitidine 200 mg 1x day  Digestive Advantage, Cal-600 (calcium), Vitamin D3",,GERD Colagenous Colitis,,,2,08/31/2019,,,,"Augmentin, Biaxin, Humibid DM"
0834059,09/16/2019,KY,18.0,18,,F,,"My daughter took Bexsero vaccine at the pediatrician's office on Aug 12, 2019 and went off to college. Next morning she woke up with a fever, chills and a big rash on her arm, looked like a burn and she was c/o of arm pain. Told her to take Benadryl and Tylenol. The next day she was able to move her arm and eventually swelling went down and then her skin started peeling. After the bubbling/redness of the skin there appeared like small tiny veins that were where the blister was and were blue/purplish in color. Those eventually darkened and her skin peeled. She has skin  discoloration over that area now. I need to know what to do about giving her the booster. I have pictures, if that helps, that I mail email somewhere.",,,,,,,,,,08/12/2019,08/13/2019,1,,UNK,,None Centrum multi vitamin/ Iron Vit C,N/A,None,,,2,09/09/2019,,,,Sulfas
0834098,09/16/2019,TX,52.0,52,,F,,"Delayed onset of redness, lump over site were vaccine was given. tender to palpation indurated.",,,,,,,,,N,08/08/2019,09/02/2019,25,none,WRK,,"Nexium, Librax, Lexapro, Lisinopril  Fluticasne",No different from chronic meds,"Anxiety, IBS, HTN, GERD, Allergic rhinitis",,,2,09/03/2019,,Y,,"Cephalosporins, Sudafed, Sulfa, steroids"
0834099,09/16/2019,TX,60.0,60,,F,,Flu like symptoms both times - I had two shots within the six months and got very sick both times.,,,,,,,,,Y,09/05/2019,09/06/2019,1,,PHM,,(thyroid medicine - levoxyl) (b-12 - nascobal) regular vitamin,none,Thyroid condition b-12 condition,The first shot for the shingles,,2,09/09/2019,,,,none
0834123,09/16/2019,MI,,4,,M,09/10/2019,"Pt received Proquad, Pentacel, Hep A, Hep B and PCV13 vaccines on Aug. 29, 2019 and pt broke out in a rash on Sept. 9, 2019. Pt did see Dr. and doctor wants a VAERS report filled out.",,,,,,,,,Y,08/29/2019,09/09/2019,11,,OTH,PUB,,None/ WCC visit,None (not previous vaccinated),,,1,,,,,
0834256,09/16/2019,MI,1.0,1,.0,M,09/09/2019,Pt received ProQuad and Varicella at the same office visit along with the other 1 yr immunizations. Pt is doing well,,,,,,,,,Y,08/29/2019,,,,OTH,PUB,N/A,WCC visit,none,,,1,,,,,
0834257,09/16/2019,MI,0.58,0,.6,M,09/16/2019,Pt received PedVax Hib (third dose) at his 6 mos. WCC visit. This dose should have not been given until his 1 year birthday or after.,,,,,,,,,Y,09/11/2019,,,N/A,OTH,PUB,N/A,6 mos. WCC visit,None,,,1,,,,,
0834258,09/16/2019,IL,25.0,25,,M,,"Patient received the flu vaccine walked out of the immunization room and had a seat. All of a sudden, he felt dizzy and lost consciousness for about a minute and then regained consciousness and started shaking Paramedics were called",,,,,,,,,Y,09/16/2019,09/16/2019,0,,PHM,,None listed,None,None,,,2,09/16/2019,,Y,,NKDA
0834259,09/16/2019,MI,18.0,,,F,,"Received Trumenba vaccine in R arm and complained of shooting pain radiating down the arm to her fingers, about 1 hr after she got the shot. Then she started complaining of nausea and dizziness which lasted until the next morning. Pt was unable to move her arm due to the pain, which resulted in the mom calling the office. All symptoms had subsided about 36 hours later.",,,,,,,,,,09/05/2019,09/05/2019,0,,UNK,,,,,,,2,09/11/2019,,,,
0834260,09/16/2019,VA,66.0,66,,F,09/16/2019,Redness & soreness around injection site. Pt. stated it was very painful & she couldn't move her arm.,,,,Y,,,,,Y,08/27/2019,08/29/2019,2,,OTH,UNK,,None,,,,1,,,,,
0833998,09/17/2019,CA,2.0,2,.6,M,,"My son was vaccinated and immediately started showing symptoms of stiffness in his lower extremities. Over the course of a month my son started experiencing paralysis until he was no longer able to walk. Multiple trips to his pediatrician over the course of the month. His pediatrician was perplexed as to patient's condition. My son went from active 2 1/2 year old to paralyzed with no use of his legs.  We were told by our pediatrician to go to the emergency room. We were checked into Hospital. After a spinal tap, multiple blood tests, MRI, X-rays a Neurologist diagnosed patient with Guillain-Barr syndrome.  We stayed in the hospital so my son could receive the IGIV treatment for a week and monitoring by doctors. He then endured months of physical therapy to regain his ability to stand/walk. This diagnosis of Guillain Barre was directly linked to the HepB vaccine.",,,,,Y,5,,Y,U,02/01/2018,03/01/2018,28,March 2018 X-RAYS  Blood Work MRI  Spinal Tap,PVT,,None,None,None,,,2,09/17/2019,,Y,Y,None
0833999,09/17/2019,RI,2.0,2,.1,M,,"Diarrhea,  mucus in stool, gastrointestinal discomfort, splotches on skin that come and go beginning the next day and continuing through current date (9/17)",,,,,,,,,N,09/13/2019,09/14/2019,1,None,PVT,,Gastrocrom oral,None,MCAS and FPIES,"Vomiting, acidic bloody diarrhea, skin rash, dermagraphism after Dtap (worsening symptoms with each vaccine), rotovirus vaccine ",,2,09/17/2019,,,,"FPIES to multiple foods including dairy, soy, wheat, oats, eggs, cashews, blueberries, turkey MCAS reactions to rice, dairy, soy, bell peppers, cauliflower Previous vaccine reactions to rotovirus, Dtap, and tDap via breastmilk"
0834000,09/17/2019,AK,45.0,45,,F,,"Very red, swollen, warm, size of palm of adult hand at injection site - still there, red and warm 4 days later. Entire body felt run down, achy and as if had a fever",,,,,,,,,N,09/13/2019,09/13/2019,0,,PVT,,"Synthroid, Nortriptyline, Hydroxychloroquine, Hydrochlorothiazide, alleve, vitamin D.",,"Asthma, chronic pain",Run down & achy with prior flu shots (but no redness or swelling) - had these multiple consecutive years.,,2,09/17/2019,,,,"Sulfa (all classes), penicillin"
0834001,09/17/2019,KY,62.0,62,,F,,The arm was red and swollen adn has a small bruise,,,,,,,,,Y,08/29/2019,09/01/2019,3,,PHM,,,,,,,2,09/17/2019,,,,
0834002,09/17/2019,TX,39.0,37,,M,,"New onset of rash, had bx 26 Oct 17 consistent with Lichen Planus. Per record review did have a rash prior to influenza vaccine with Lichen Planus listed in differential. Post vaccine had a increase in number of lesions.  Symptoms: RASH&OTH NONSPEC SKIN ERUPTION(R21), PRURITUS, UNSPECIFIED(L299).",,,,,,,,,N,09/27/2017,10/05/2017,8,biopsy: C/W Lichen planus,MIL,,unk,rash,unk,,,2,09/16/2019,,Y,,unk
0834003,09/17/2019,NY,67.0,67,,F,,patient claims she had hallucinations at night,,,,,,,,,Y,09/11/2019,09/11/2019,0,,PHM,,unknown,no,no,,,2,09/17/2019,,,Y,no
0834011,09/17/2019,NY,,,,F,,"negative varicella titers; received 2 doses of VARIVAX on unspecified dates ""approximately 20 years ago"" and one dose of VARIVAX on an unspecified date ""approximately 10 years ago""/after receiving 3 doses of VARIVAX; This spontaneous report was received from a physician assistant referring to an approximately 52 years old female patient. She had no pertinent medical history, or drug reactions/allergies. The patient received unspecified medications for diabetes.  In approximately 1999 (reported as approximately 20 years ago), the patient received 2 doses of varicella virus vaccine live (oka/merck) (VARIVAX) (dose, unit, route, lot number and expiration date were not reported) for prophylaxis. On an unspecified date in approximately 2009 (reported as approximately 10 years ago), she received one dose of varicella virus vaccine live (oka/merck) (VARIVAX) (dose, unit, route, lot number and expiration date were not reported) (extra dose administered).  After receiving 3 doses of varicella virus vaccine live (oka/merck) (VARIVAX), on 20-MAY-2019, the patient had blood work which showed negative varicella titers. No treatment was given. The patient had sought medical attention. The outcome of the event negative varicella titers was reported as not recovered. The causality between the event and varicella virus vaccine live (oka/merck) (VARIVAX) was not reported.",,,,,,,,,N,,05/20/2019,,Test Date: 20190520; Test Name: varicella titers; Test Result: Negative,UNK,,,Diabetes,,,US0095075131908USA008032,2,09/17/2019,,Y,,
0834012,09/17/2019,NJ,,,,U,,"No adverse effects; the patient received one dose of improperly stored ROTATEQ; Information has been received from an office manager referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.  On 08-AUG-2019, the patient received one dose of improperly stored Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) (lot # R025713, expiration date: 20-JUN-2020, strength and dose were unknown) orally for prophylaxis (product storage error). The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was exposed to lowest temperature below 36 Fahrenheit degrees (33.9F) for 40 minutes. There were previous temperature excursions of lowest temperature below 36 Fahrenheit degrees (30.3F) for 90 hours and 7 minutes, lowest temperature below 36 Fahrenheit degrees (30.5F) for 1 hour and 45 minutes and lowest temperature below 36 Fahrenheit degrees (35.2F) for 2 hour and 5 minutes. The data logger was involved. No adverse effects were reported.",,,,,,,,,U,08/08/2019,08/08/2019,0,,UNK,,,,,,US0095075131908USA009422,2,09/17/2019,,,,
0834013,09/17/2019,NJ,,,,U,,"No adverse affects reported; a improperly stored dose of MMRII was administered; This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 23-AUG-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) lot # S006647,  expiration date on 05-MAR-2021, for prophylaxis  (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 50 degrees Fahrenheit for 49 minutes. Data logger was involved. There were no previous excursions reported.",,,,,,,,,U,08/23/2019,08/23/2019,0,,UNK,,,,,,US0095075131908USA009831,2,09/16/2019,,,,
0834014,09/17/2019,IN,1.08,1,.1,M,,"the patient was inadvertently administered one dose of PROQUAD on 17-JUL-2019; The titers for varicella were less than 0.9, which the nurse reported as being negative titers to those diseases; The titers for rubeola were less than 0.6, which the nurse reported as being negative titers to those diseases; Information has been received from a registered nurse referring to a 19 years old male patient. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.  On 01-SEP-2000, the patient received one dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (batch/lot #, expiration date, strength, dose and route were unknown) for prophylaxis. On 10-NOV-2000, he received one dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (batch/lot #, expiration date, strength, dose and route were unknown) for prophylaxis. On 12-JUL-2004, he received another dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (batch/lot #, expiration date, strength, dose and route were unknown). On 24-MAY-2010, he received another of varicella virus vaccine live (Oka/Merck) (VARIVAX) (batch/lot #, expiration date, strength, dose and route were unknown).  On 12-JUN-2019, the patient had titers drawn because he was going to school to be a certified medical assistant, and titers were required. The titers for rubeola were less than 0.6 (unit not provided), and for varicella were less than 0.9 (unit not provided), which the nurse reported as being negative titers to those diseases (measles antibody negative, antibody test negative). Because of that, on 17-JUL-2019, the patient was inadvertently administered one dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (1 dose, batch/lot # S003173, expiration date: 30-JUL-2020, strength and route were unknown) for prophylaxis (inappropriate age at vaccine administration). Medical attention was sought to the physician. The outcome of the events was unknown.  The causality between the vaccines and the events was not provided.",,,,,,,,,U,09/01/2000,06/12/2019,6858,Test Date: 20190612; Test Name: The titers for rubeola; Test Result: Negative,UNK,,,,,,US0095075131908USA011112,2,09/16/2019,,Y,,
0834015,09/17/2019,OR,,,,U,,"No adverse effects; a patient was administered an improperly stored ROTATEQ.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.     On 23-AUG-2019 the patient was vaccinated with an improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # S010702, expiration date 16-JAN-2021; strength, dose, frequency and route were not reported) for prophylaxis (improper storage of product in use). No adverse effects were reported. The temperature and time frame were unknown. The previous excursion was not reported. The call was not because of a data logger.",,,,,,,,,U,08/23/2019,08/23/2019,0,,UNK,,,,,,US0095075131908USA012544,2,09/16/2019,,,,
0834017,09/17/2019,GA,,69,,F,,"Patient developed a sore throat, was unable to taste and smell normally and had a dry mouth; Patient developed a sore throat, was unable to taste and smell normally and had a dry mouth; Patient developed a sore throat, was unable to taste and smell normally and had a dry mouth; Patient developed a sore throat, was unable to taste and smell normally and had a dry mouth; Information has been received from a medical assistant, concerning a 69-years-old female patient. The patient's concurrent conditions included liver sclerosis, osteoporosis, thrombocytopenia, hypertension, osteoarthritis and electrocardiography abnormalities. The patient was allergic to depomedrol, penicillin, cortisone, levofloxacin (LEVAQUIN), red dye and sulfa. Patient's concomitant medications included calcium (+) vitamin D supplement, alprazolam (XANAX), desmopressin, escitalopram oxalate (LEXAPRO), lansoprazole (PREVACID), loperamide hydrochloride (IMODIUM), multivitamin, tramadol hydrochloride and ursodiol (ACTIGALL).  On 21-AUG-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) intramuscularly in her right arm to prevent pneumonia (lot number: R033342 with expiration date: 03-AUG-2020) (strength and dose was not provided).  On the same date later than night, the patient experienced a sore throat (oropharyngeal pain), was unable to taste (ageusia), and smell normally (parosmia) and had a dry mouth. The patient sought for medical attention and there was no lab diagnostics or studies performed. There was no treatment given for the adverse events.  It was unknown if the abovementioned adverse events were resolved at the time of this report.  The causal relationship between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and the abovementioned adverse events were not provided.",,,,,,,,,U,08/21/2019,08/21/2019,0,,UNK,,XANAX; calcium (unspecified) (+) vitamin D (unspecified); desmopressin; LEXAPRO; PREVACID; IMODIUM; vitamins (unspecified); tramadol hydrochloride; ACTIGALL,Allergic reaction to antibiotics; Drug hypersensitivity; Electrocardiogram abnormal; Hypersensitivity; Hypertension; Liver induration; Osteoarthritis; Osteoporosis; Penicillin allergy; Sulfonamide allergy; Thrombocytopenia,,,US0095075131909USA002367,2,09/16/2019,,,,
0834018,09/17/2019,IL,,,,U,,"no adverse event; patient received an improperly stored PROQUAD; This spontaneous report was received from a registered nurse referring to a 4 year old patient of unknown gender. No information regarding the patient's medical history or concurrent conditions was provided.  On 12-AUG-2019 and 13-AUG-2019, therapy of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) experienced two temperature excursions which were stored in the range of -14C to -10C (-11.91C, multiple) for 8 hours.   On 21-AUG-2019, the patient was vaccinated with the improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # R026722, expiration date on 17-MAR-2020 and R023499, expiration date on 13-FEB-2020 (strength, dose number, route and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent. No previous temperature excursion was reported. No adverse effects were reported.   Digital data logger was involved.",,,,,,,,,U,,08/21/2019,,,UNK,,sterile diluent,,,,US0095075131909USA002939,2,09/16/2019,,,,
0834019,09/17/2019,IL,4.0,4,,U,,"no adverse effect reported; Proquad experienced two temperature excursions; This spontaneous report was received from a registered nurse and refers to an 4-year-old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant therapies, drug reactions and allergies were not reported.   On 27-AUG-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) lot # R026722, expiration date 17-MAR-2020 (dose, route of administration and anatomical location were not reported) or measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) lot # R023499, expiration date 13-FEB-2020 (dose, route of administration and anatomical location were not reported) for prophylaxis. Concomitant therapies included sterile diluent. Administered dose of vaccine experienced the temperature excursion from -14 degrees Celsius to -10 degrees Celcius for 8 hours. Data logger was involved. There were no previous excursions reported. There was no adverse effect reported.",,,,,,,,,U,08/27/2019,08/27/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA003306,2,09/17/2019,,,,
0834020,09/17/2019,,77.0,,,F,,"Was diagnosed with Cellulitis/ ""cellulitis or staff infection""/fever; She has experienced diarrhea; Severe adverse reaction/Unable to do anything for more than a week; Nausea; Injection site hot to touch; Information has been received from a 77 year old female patient. No medical history, concurrent conditions nor concomitant medications were reported. On 08-SEP-2019 (also reported as ""unknown date""), the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (route, strength, lot number and expiration date not reported) for prophylaxis. In September 2019, the patient experienced a severe adverse reaction (adverse event), fever and the injection site was ""hot to touch"" (injection site warmth). On 09-SEP-2019 (also reported as ""24 hours after vaccination""), the patient was seen by a registered nurse who diagnosed her with cellulitis (also reported as ""cellulitis/staff infection""). The patient received treated with ondansentron hydrochloride (ZOFRAN) 8 mg and an unidentified ""strong antibiotic"". In September 2019, the patient experienced diarrhea and nausea but didn't know if it was due to pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) or the antibiotic. The patient reported she was ""unable to do anything for more than a week"" (adverse event) (conflicting information as report was received the same day of onset date). In September 2019, the patient saw a physician and was told to stop the antibiotic. The outcome of cellulitis, nausea, adverse event, injection site warmth and diarrhea was unknown.  The relationship between cellulitis, nausea, adverse event, diarrhea, injection site warmth and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.  Upon internal review, cellulitis was considered to be a medically significant event.",,,,,,,,,U,09/08/2019,09/01/2019,,,UNK,,,,,,US0095075131909USA003444,2,09/16/2019,,,,
0834021,09/17/2019,AZ,,,,F,,"cellulitis; This spontaneous report was received from a consumer who was referring to herself, a female patient of unknown age, via Pfizer (manufacturer control #2019391227). There was no information about the patient's concurrent conditions, concomitant therapies, drug reactions, allergies or medical history provided.      On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, frequency, route of administration, anatomical location, lot # and expiration date were not reported).        On an unknown date, the patient experienced side effects from pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) such as cellulitis and wanted unspecified medical information.  The outcome of cellulitis was unknown.    The reporter considered cellulitis to be related to pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23).     Upon internal review, cellulitis was determined to be medically significant.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA003661,2,09/17/2019,,,,
0834022,09/17/2019,CA,,,,U,,"No adverse effects were reported in the patient; the physician reports that a patient received a dose of PROQUAD following a temperature excursion; This spontaneous report was received from a physician referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions and allergies.  On 09-SEP-2019, the patient received a dose of with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) with lot number S012535 and expiration date on 20-OCT-2020 (dose, dose number, route of administration, anatomical injection site were not reported) for prophylaxis; following a temperature excursion (product storage error).  It was reported that on an unknown date, the vaccines were exposed to a temperature excursion between 15 Fahrenheit (F) degrees to 16 F degrees (-9 Celsius (C) degrees to 8 C degrees) (30 F degrees) for 60 minutes. There were no previous temperature excursions and the Digital Data logger report. was not involved. No adverse effects were reported in the patient.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,US0095075131909USA004476,2,09/16/2019,,,,
0834023,09/17/2019,PA,,,,F,,"syncope; This spontaneous report was received from a physician assistant, via company representative, concerning a female patient of currently 12 years old. The patient had no pertinent medical history or concomitant medications; concurrent conditions, previous drug reactions or allergies were not reported.  On an unknown date, the patient was vaccinated with first dosage of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, intramuscularly into the left deltoid (no concentration or dose reported; lot # N007931 expiration date reported as 17-NOV-2019 and upon internal validation stablished as the same) indicated for prophylaxis.  On an unknown date, 5 minutes after receiving the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), the patient experienced a syncope.  The outcome of the syncope was not reported. The relatedness between hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) and the syncope was not reported.  Upon internal review, the event of syncope was determined to be medically significant.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA004955,2,09/16/2019,,,,
0834024,09/17/2019,MN,,,,U,,"No adverse effects reported; One dose of VAQTA was accidentally administered to the patient in place of Recombivax; This spontaneous report was received from a nurse concerning to a patient of unknown age and gender. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported.      On 08-NOV-2018, the nurse reported that one dose of hepatitis a vaccine, inactivated (VAQTA) for prophylaxis (lot # R013859 has been verified to be a valid lot number for hepatitis a vaccine, inactivated, expiration date reported and establish as 14-JUN-2019) (strength, dose, frequency and route of administration were not reported); was accidentally administered to patient in place of hepatitis b virus vaccine rhbsag (yeast) (RECOMBIVAX) (wrong product administered).         No adverse effects reported.",,,,,,,,,U,11/08/2018,11/08/2018,0,,UNK,,,,,,US0095075131909USA005019,2,09/16/2019,,,,
0834025,09/17/2019,CA,1.92,1,.9,U,,"No adverse effect reported; a patient received improperly stored PROQUAD; This spontaneous report was received from a medical assistant regarding a 23 month old patient of unknown gender. Information on pertinent medical history and drug reactions/allergies was not reported. Concomitant medications included sterile diluent.  On 05-SEP-2019, the patient was vaccinated with an improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # S002494, expiration date: 23-JUL-2020, albumin status: rha) (dose, dose number, route, location of administration and frequency were not reported) administered for prophylaxis.  The vaccine was exposed to temperature of 6 to 14 degree Fahrenheit (F) (10.2 F, multiple) for 50 minutes as recorded by a digital data logger. There were no previous temperature excursions. No adverse effects were reported.",,,,,,,,,U,09/05/2019,09/05/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005119,2,09/16/2019,,,,
0834026,09/17/2019,CA,1.0,1,.0,U,,"No adverse effect; improperly stored vaccine administration; This spontaneous report has been received from a medical assistant referring to a 12-month-old patient with unknown gender. The patient's concurrent condition, medical history and concomitant therapy information was not provided.      On 10-SEP-2019, the patient received improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) (strength, dose, frequency and route were not reported) (lot # S002874, Expiration Date: 29-JAN-2021) for prophylaxis. There was no adverse effect. The stored temperature was 6 Fahrenheit (F) to 14 F (10.2 F, multiple) for 50 minutes and the data logger was involved. There was no previous temperature excursion. It was used to reconstitute sterile diluent (strength, dose, frequency, route, lot # and expiration date were not reported) for prophylaxis. The storage of sterile diluent was properly.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA005223: US-009507513-1909USA005220:",,,,,,,,,U,09/10/2019,09/10/2019,0,,UNK,,sterile diluent,Prophylaxis,,,US0095075131909USA005231,2,09/16/2019,,,,
0834027,09/17/2019,,,,,F,,"After all the girls were given the vaccine, many were becoming disabled and/or terminal; After all the girls were given the vaccine, many were becoming disabled and/or terminal; This spontaneous report was received from a consumer refers to unknown number of female patients of unknown age. The patients' medical history, concurrent conditions, historical dugs and concomitant medications were not reported. On an unknown date, the patients were vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (dose, frequency, route, lot # and expiration date not reported) for prophylaxis. It was reported that, after all the girls were given the vaccine, many were becoming disabled (adverse event) and/or terminal (terminal state). The outcome of the events was unknown. The causality assessment was not provided by the reporter.  The reporter considered the adverse event to be disabling.  Upon internal review, terminal state was determined to be medically significant.  This is one of several reports received from the same reporter (1909USA004907).; Sender's Comments:  US-009507513-1909USA004907:",,,,,,,,Y,U,,,,,UNK,,,,,,US0095075131909USA005356,2,09/17/2019,,,,
0834028,09/17/2019,TN,,,,U,,"reported ROTATEQ was given past 32 weeks of age to a patient. No adverse symptoms reported.; reported ROTATEQ was given past 32 weeks of age to a patient. No adverse symptoms reported.; This spontaneous report was received from an administrator and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 13-SEP-2019, the patient, who was past 32 weeks of age, was vaccinated with a dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally, for prophylaxis (lot/batch # and expiration date were not reported). No adverse symptoms reported. No further information provided.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,,,,,US0095075131909USA005617,2,09/16/2019,,,,
0834029,09/17/2019,TX,,,,U,,"no adverse event; improperly stored vaccine administered intramuscularly; confirmed route of administartation was intramuscular; This spontaneous report as received from a other health professional refers to a patient of unknown age.    On 10-SEP-2019 the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot # S002736 dose 1, .5 milliliter, intramuscular for prophylaxis.    Concomitant therapies included sterile diluent (STERILE DILUENT) (possible lot # S000130, expiry date: 23-AUG-2021).   On 10-SEP-2019, 1 day after onset of therapy the patient experienced product storage error and incorrect route of product administration.  On an unknown date the patient experienced no adverse event.",,,,,,,,,U,09/10/2019,09/10/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005758,2,09/17/2019,,,,
0834030,09/17/2019,TX,,,,U,,"no adverse effect; one dose of an improperly stored vaccine, VARIVAX, was administered; route of adminsitration was intramuscular; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, historical drugs and drug reactions/ allergies were not reported. Concomitant therapies included sterile diluent which was used to reconstitute the varicella virus vaccine live (oka/merck) (VARIVAX) was stored in the correct storage temperature range. On 10-SEP-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX), lot # S002877 and expiration date 29-JAN-2021, at a dose of 0.5 milliliter once via intramuscular route for prophylaxis (product storage error) and (incorrect route of product administration). The storage temperature was reported as 8.1 Fahrenheit (F) for time frame of 20 minutes. Previous temperature excursions included 8.1 F for 17 minutes and 9.5 F for 21 minutes. The call was because of a data logger. No adverse effects reported. No product quality complaint (PQC) present.",,,,,,,,,U,09/10/2019,09/10/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005803,2,09/17/2019,,,,
0834031,09/17/2019,MD,,,,M,,"Generalized Vaccinia; This case was obtained from a scientific literature on date 03SEP2019.  A 19-year-old-male patient developed generalized vaccinia (GV) (PT: Generalised vaccinia) and Epstein Barr Virus Infection/ mononucleosis (PT: Infectious mononucleosis), following the administration of ACAM2000 (smallpox (vaccinia) vaccine, live)   Case report: A 19-year-old presented to his aid station with concern for a spreading vesicular rash 9 days after a primary inoculation with the smallpox vaccine. The rash was limited to the inoculation site on his left shoulder. He had no medical history of eczema, atopic dermatitis, or other rashes and reported no systemic symptoms. His vitals also were within normal limits. A clinical diagnosis of inadvertent inoculation (also termed accidental infection) with satellite lesions was made, and he was discharged with counseling on wound care and close follow-up. Two days later, on post vaccination day 11, he presented with new symptoms of a headache, fever, chills, diffuse myalgia, sore throat, and spreading erythematous macules, papules, and vesicles on his arms, chest, abdomen, back, legs, and face. His vital signs were remarkable for tachycardia with heart rate of 100 bpm and a fever of 103 degree Fahrenheit (39.4 degree Celsius). He was sent to the emergency department with a presumed generalized GV diagnosis.   A complete blood count, liver function tests, and basic metabolic panel were unremarkable. Given his symptom of pharyngitis, a rapid strep test was performed. The test was negative, and a throat culture showed no growth. A mononucleosis screen also was performed and was positive. The patient was diagnosed with mononucleosis and GV. His condition improved, and his vital signs stabilized with conservative treatment without the need for vaccine immune globulin (VIG). He convalesced for 72 hours and was referred to dermatology on the following day. He was quarantined in a single occupancy barracks room until all lesions crusted over to address the concern for spread of the virus to non-immunized coworkers or family members.   On post vaccination day 12, the patient continued to be clinically well, and he remained afebrile. The dermatologist obtained a skin biopsy from a lesion on the patient's right shin. The biopsy demonstrated marked epidermal necrosis with peripheral keratinocytes showing ballooning degeneration and viral cytopathic changes consistent with GV. Antibody titers showing high levels of Epstein-Barr virus (EBV) capsid IgM and IgG present confirmed mononucleosis infection within the past 6 months. The patient remained clinically well and was released from quarantine on post vaccination day 22 when all lesions crusted over.  Author's comment: The smallpox vaccination is unique among vaccinations. It is the only vaccine that is administered via inoculation with a bifurcated needle, requires regular follow-up care, and can be spread to casual contacts. It is important for any practitioner administering the smallpox vaccine to be aware of associated AEs. A greater knowledge of the unique challenges with the smallpox vaccine allows for better patient selection that eliminates those with conditions that impair their immune system and improves patient education.  Company' comment:The Company considers that the generalized vaccinia (GV) was probably related to the ACAM vaccination. Such widespread skin reaction to vaccine occurs due to virus dissemination beyond the initial inoculation site of small pox vaccine throughout systemic transmission. Mononucleosis is considered concurrent condition and present symptoms were probably due to a relapse or worsened due to the GV. Because the tests showed an onset of about six months, mononucleosis a concurrent infection and not considered as an adverse event. Symptoms are not coded as per MedDRA point to consider. The case met the criterion of medically significant.; Sender's Comments: The Company considers that the generalized vaccinia (GV) was probably related to the ACAM vaccination. Such widespread skin reaction to vaccine occurs due to virus dissemination beyond the initial inoculation site of small pox vaccine throughout systemic transmission. Mononucleosis is considered concurrent condition and present symptoms were probably due to a relapse or worsened due to the GV. Because the tests showed an onset of about six months, mononucleosis a concurrent infection and not considered as an adverse event. Symptoms are not coded as per MedDRA point to consider. The case met the criterion of medically significant.",,,,,,,,,Y,,,,"Test Name: Biopsy skin; Comments: See Relevant Tests Section; Test Name: Blood count; Comments: Unremarkable; Test Name: Body temperature; Comments: 39.4 degree Celsius; Test Name: Epstein-Barr virus antibody; Comments: High levels of IgG & IgM present; Test Name: Heart rate; Comments: 100 bpm; Test Name: Liver function test; Comments: Unremarkable; Test Name: Metabolic function test; Comments: Unremarkable; Test Name: Mononucleosis heterophile test; Comments: Positive; Test Name: Streptococcus test; Comments: Negative, and a throat culture showed no growth.; Test Name: Vital signs measurement; Comments: Normal; Test Name: Vital signs measurement; Comments: Stabilized with conservative treatment",OTH,,,,Medical History/Concurrent Conditions: Mononucleosis; Comments: No medical history,,USEMERGENT BIOSOLUTIONS19,2,09/16/2019,,,Y,
0834033,09/17/2019,FL,72.0,72,,U,,"Feel achy all over; Chills; Low grade fever; Feels tired; This case was reported by a consumer and described the occurrence of pain in a 72-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of heart rate increased (1st dose received on 1st March 2019 and experienced fever and other events, refer case US2019052626).   On 9th September 2019, the patient received the 2nd dose of Shingrix. On 9th September 2019, less than a day after receiving Shingrix, the patient experienced pain, chills, low grade fever and tiredness. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the pain, chills, low grade fever and tiredness were unknown.   It was unknown if the reporter considered the pain, chills, low grade fever and tiredness to be related to Shingrix.  Additional details were received as follows:  In the morning, the patient received Shingrix at around 8 am. The patient noted it was a little under 6 months from his first dose. Later in the day he began to feel achy all over, chills, low grade fever of 98.8 to 99 (which he also had with the first dose) and he feels tired. He has treated the fever with Tylenol. He continued to have the symptoms today.",,,,,,,,,U,09/09/2019,09/09/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/17/2019,,,,
0834034,09/17/2019,AL,,,,U,,"flu like symptoms; This case was reported by a nurse via sales rep and described the occurrence of influenza-like symptoms in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.  Additional details were received as follows: The age at vaccination was not was reported. The age group selected as per vaccine specification.  The patient reported flu like symptoms after receiving a dose of shingrix. This case was linked with cases US2019AMR165395 and US2019AMR165390, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/17/2019,,,,
0834035,09/17/2019,CA,71.0,71,,M,,"ringworm infection; rash/ rash progressed around and down his arm; This case was reported by a consumer via call center representative and described the occurrence of tinea in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2018, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 2 years after receiving Shingrix, the patient experienced tinea and blistery rash. The patient was treated with antifungals for topical use (Antifungal Cream). On an unknown date, the outcome of the tinea and blistery rash were recovered/resolved.   It was unknown if the reporter considered the tinea and blistery rash to be related to Shingrix.  Additional details were provided as follows: The patient reported for himself. The patient received dose of Shingrix in anunknown arm at a Clinic. The patient experienced a rash with blisters just below the injection site on left arm that progressed around and down his arm. The patient was treated with an antifungal cream in case it was a ringworm infection. The patient stated, it was resolved but that the clinic declined to give him 2nd dose due to concerns about the reaction. The patient then changed clinics in 2019 and received 2nd dose of Shingrix. For tolerance of 2nd dose, refer case US2019AMR162633. The patient consented to follow up and provided contact details of clinic.",,,,,,,,,Y,05/01/2018,,,,OTH,,,,,,USGLAXOSMITHKLINEUS201915,2,09/17/2019,,,,
0834036,09/17/2019,ID,52.0,52,,F,,"Incorrect storage of drug; Product Complaint; nodule at site of injection; This case was reported by a pharmacist via call center representative and described the occurrence of injection site nodule in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number 9H524, expiry date 22nd October 2021) for prophylaxis. This case was associated with a product complaint.   On 5th September 2019, the patient received Shingrix (intramuscular) .5 ml. On 5th September 2019, immediately after receiving Shingrix, the patient experienced injection site nodule. On an unknown date, the patient experienced incorrect storage of drug and pharmaceutical product complaint. On an unknown date, the outcome of the injection site nodule was recovering/resolving and the outcome of the incorrect storage of drug and pharmaceutical product complaint were unknown.   It was unknown if the reporter considered the injection site nodule to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left arm. The pharmacist reported last 7 adjuvants of box appear to be thicker and difficult to withdraw. He noted the one he gave on the day before reporting was of this consistency, without particulate but the patient immediately developed a nodule at the site of injection. The reporter called today to report the difference with the remaining 7 adjuvants. He noted these have a clunkier flow and thick. They had been stored in a fridge that doesn't have a freezer attached, the temps have been at 41 and 42 degrees Fahrenheit, which led to incorrect storage of drug and pharmaceutical product complaint. The reporter also noted a ""jelly like"" consistency to the adjuvant. He would return the box and remaining vials of adjuvant and powder. The credit of 7 doses to direct GlaxoSmithKline account.  The patient nodule was reducing in size per the pharmacist. The reporter consented to follow up.",,,,,,,,,N,09/05/2019,09/05/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0834037,09/17/2019,TX,,,,M,,"experienced neuropathy; experienced neuropathy (tingling and pain) in extremities; experienced neuropathy (tingling and pain) in extremities; Heat with extremities; This case was reported by a pharmacist via call center representative and described the occurrence of neuropathy in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included neuropathy (the patient had neuropathy due to B12 deficiency and was disappeared for 7 years) and vitamin b12 deficiency.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 21 days after receiving Shingrix, the patient experienced neuropathy (serious criteria GSK medically significant), pain in extremity, tingling of extremity and extremities hot feeling of. On an unknown date, the outcome of the neuropathy, pain in extremity, tingling of extremity and extremities hot feeling of were unknown.   It was unknown if the reporter considered the neuropathy, pain in extremity, tingling of extremity and extremities hot feeling of to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced neuropathy (tingling and pain) in extremities 3 weeks after 1st dose of Shingrix vaccine. The reporter reported that the patient had neuropathy before but was due to a B12 deficiency then disappeared for 7 years and now reappeared after shingrix vaccination. The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Neuropathy (the patient had neuropathy due to B12 deficiency and was disappeared for 7 years); Vitamin B12 deficiency,,USGLAXOSMITHKLINEUS201916,2,09/16/2019,,,,
0834040,09/17/2019,IA,25.0,25,,M,,"pain, redness and swelling in right arm from shoulder to elbow.",,,,,,,,,Y,09/12/2019,09/13/2019,1,none,PVT,,None,Asthma without complications,Asthma without complications,,,2,09/17/2019,,,,No Known Allergies
0834041,09/17/2019,SC,65.0,65,,F,,"Severe muscle aches, headache, chills for @ 24 hours, then weakness, malaise for next 24 hours",,,,,,,,,,09/14/2019,09/15/2019,1,,PHM,,"Levothyroxine, vitamins, tumeric",none,"hypothyroidism, osteoarthritis","Shringrx, may 20, 2019",,2,09/17/2019,,,,
0834042,09/17/2019,FL,36.0,36,,F,,"Client stated she noticed a headache, chills, fever 100.2, sleepy, legs twitching,  restless and unable to sleep, Client stated she had 2 glasses of wine and had stopped taking antidepressants Sunday 9/15/19 and Monday 9/16/19.  Client stated fever is gone but is unable to sleep. after not sleeping the night before.",,,,,,,,,Y,09/16/2019,09/16/2019,0,Advised client to contact the doctor that prescribed the venlafaxine. Provided phone numbers for local clinics for client to follow up.,PUB,,venlafaxine.,DENIES,DENIES,,,2,09/17/2019,,Y,,NKA
0834043,09/17/2019,TN,8.0,8,,F,,Patient was ordered polio IM but given rotarix mixed with MMR diluent and given IM. No adverse effects seen yet,,,,,,,,,U,09/14/2019,09/14/2019,0,,PVT,,n/a,n/a,n/a,,,2,09/17/2019,,Y,,n/a
0834044,09/17/2019,NJ,52.0,52,,F,,"A few hours after vaccination, patient states she had extreme soreness in the upper arm and it  started to turn very red and hot. When she presented back to the Pharmacy 3 days later, the redness and edema was still present on her entire upper arm from the top of deltoid, down to the elbow and on the under side of the arm as well. She was counseled to take Benadryl and to seek medical attention if the swelling did not go down some in the morning or spread further. I asked her to mark the area so she could compare in the morning.",,,,,,,,,U,09/14/2019,09/14/2019,0,n/a,PHM,,Unknown,No known,None,,,2,09/17/2019,,Y,,No known
0834045,09/17/2019,FL,67.0,67,,F,,"patient claims symptoms started 12 hours after receiving the vaccine- she stated she had severe muscle aches, chills, skin hypersensitivity, headache, shaking, fever",,,,,,,,,N,09/16/2019,09/16/2019,0,,PHM,,amlodipine 5mg tab,,High blood pressure,,,2,09/17/2019,,,,no know allergies other than possibly Fluad
0834046,09/17/2019,CO,72.0,72,,F,,"Vaccine Saturday 12:30pm. Side effects: muscle ache, stomach ache, headache, nausea, fever, shivers. Began about 3am Sunday morning; Sunday, day after vaccine was height of side effects; 99.9 fever after Tylenol; fever did not return to normal until day 3 (Tuesday).",,,,,,,,,Y,09/14/2019,09/15/2019,1,none,PHM,,Trazadone; comprehensive vitamins/supplements,none,"arthritis, spinal stenosis; degenerative disc",,,2,09/17/2019,,,,codeine; aspartame
0834053,09/17/2019,FL,40.0,40,,F,,"Patient claimed she felt tingling and swelling of throat and her eyes watered.  She was counseled to take a Benadryl and call her doctor, no visible signs, just her feeling.  She said she had to take another Benadryl later that day. She felt better the next day at lunch, about 24 hours after the immunization. Her doctor was notified.",,,,,,,,,Y,09/11/2019,09/11/2019,0,none,WRK,,,,,,,2,09/17/2019,,,,
0834055,09/17/2019,MI,11.0,11,,M,,"no ADVERSE effect, vaccine administered in error, patient was due for MCV-4 at this office visit.",,,,,,,,,Y,07/09/2019,07/09/2019,0,NA,PVT,,Vyvanse 40 mg,none known,none known,,,2,09/17/2019,,,,none known
0834056,09/17/2019,MI,51.0,51,,F,,About twelve hours after receiving vaccination I had. Chills and 100 degree fever. Even with a fever I felt very cold.i took two 500 mg acetaminophen gelcaps around one a.m.,,,,,,,,,Y,09/16/2019,09/16/2019,0,None,PUB,,Synthroid 25mcg.  Nutrisystem essentials multivitamin system,None,None,,,2,09/17/2019,,,,None
0834057,09/17/2019,IN,17.0,17,,F,,"patient reports that on 9/13/2019 after the office visit she began a rash, described as erythematous, inflamed and itchy. with associated symptoms of headache, painful rash, pruritus, dizziness and vision changes.",,,,,,,,,U,09/13/2019,09/13/2019,0,none,PVT,,Nexplanon,depression,depression,,,2,09/17/2019,,Y,,NKA
0834061,09/17/2019,IL,4.0,4,,U,,"no adverse effect; patient received an improperly stored PROQUAD; This spontaneous report was received from a nurse and refers to an approximately 4-year-old patient of unknown gender. The patient's drug reactions or allergies, medical history and concomitant medications were not reported.       The vaccine underwent two temperature excursion of -14 degree Celsius to -10 degree Celsius (also reported as ""-11.91 C, multiple"") for 8 hours, one on 12-AUG-2019, and one on 13-AUG-2019. There was no previous temperature excursion. Data logger was involved. On 21-AUG-2019, the patient was vaccinated with a dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) (lot # R026722, expiration date 17-MAR-2020 or lot # R023499, expiration date 13-FEB-2020) (dose, route of administration were not reported) which was reconstituted with properly stored sterile diluent for prophylaxis. No adverse effect was reported. No product quality complains involved.",,,,,,,,,U,08/21/2019,08/21/2019,0,,UNK,,sterile diluent,Prophylaxis,,,US0095075131909USA003184,2,09/17/2019,,,,
0834062,09/17/2019,NY,,,,F,,"recently had a ""titer test"" and physician recommended that she have the MMR II administered as her "" ""titers were low""/ lack of efficacy; she have the MMR II administered as her "" ""titers were low""; This spontaneous report refers to a 55-year-old female patient reporting on herself. The patient's historical condition included allergic reaction to a unspecified tentnus vaccine. The patient's current condition included allergy to neomycin. There was no information about the patient's concomitant therapies. On an unknown date (reported as on a unspecified date in the late fifties or early sixties), the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) in the unspecified arm (dose, route of administration, lot # and expiration date were not reported) for prophylaxis. On an unknown date, the patient had a titer test and the physician recommended that the patient had the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) administered as her titers were low. The patient did not receive any treatment for the events. Due to response and lack of efficacy the adverse event was filed as a precaution. The patient didn't sought medical attention.  The outcome of the events and the causality assessment between the events and suspect therapy was not provided.",,,,,,,,,U,,,,,UNK,,,Allergic reaction to antibiotics,Medical History/Concurrent Conditions: Allergy to vaccine,,US0095075131909USA003731,2,09/17/2019,,,,
0834063,09/17/2019,TX,,,,U,,"Medical Assislant confirmed route of administration was intramuscular.; No adverse effects reported.; Medical Assistant reports that one dose of an improperly stored vaccine, VARIVAX was administered to one patient.; This spontaneous report was received from a Medical Assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On 09-SEP-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter intramuscular route (Strength, dose, frequency, and anatomical location were unknown) with lot # S002877 and expiration date 29-JAN-2021 for prophylaxis reconstituted with sterile diluent(MERCK STERILE DILUENT) with possible Lot# S000130 and possible Expiration Date: 23-AUG-20219 that was stored in the correct storage temperature range.   The administered dose of vaccine experienced the temperature excursion of 8.1 F degrees Fahrenheit for 20 minutes. There was a digital data logger invloved, and also a previous temperature excursion of 8.1 F degrees Fahrenheit for 17 minutes and 9.5 F degrees Fahrenheit 21 minutes . No adverse effects were reported.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,MERCK STERILE DILUENT,,,,US0095075131909USA005633,2,09/17/2019,,,,
0834064,09/17/2019,TX,,,,U,,"No adverse effects reported.; improperly stored vaccine; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 09-SEP-2019, the patient was vaccinated with one improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter, once, intramuscularly, lot # S002877, expiration date: 29-JAN-2021, for prophylaxis. Sterile diluent used to reconstitute the varicella virus vaccine live (oka/merck)(VARIVAX) was stored in the correct storage temperature range. The vaccine underwent temperature excursion of 8.1 degrees Fahrenheit for 20 minutes. There were previous temperature excursions of 8.1 degrees Fahrenheit for 17 minutes and 9.5 degrees Fahrenheit for 21 minutes. The digital data logger was involved in recording excursion details. No adverse effects were reported.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA006063,2,09/17/2019,,,,
0834065,09/17/2019,MA,57.0,57,,F,,"High Fever 102  lasting 3 days, body and  muscle aches 3 days,  painful joints 5 days",,,,,,,,,Y,09/10/2019,09/11/2019,1,N/A,PHM,,Daily Multi Vitamin,N/A,History Of Cancer,,,2,09/17/2019,,,,IVP Dye
0834066,09/17/2019,VA,64.0,64,,M,,Large knot on spot of injection occurred with a hour.  The next day I had flu like symptoms that lasted all day.  Fever ranging from 99.9 to 100.8.  Tired all day and took three naps.  Face felt flush.  Both arms and legs ached.  Lethargic.,,,,,,,,,Y,09/14/2019,09/15/2019,1,,PHM,,"Medication for high blood pressure, high cholesterol.  Daily vitamin and Ocuvite for eyes.",None,None,,,2,09/17/2019,,,,Allergic to Norvasc which is a high blood pressure medicine.
0834067,09/17/2019,NC,67.0,67,,F,,"PATIENT REPORTED SHE HAD CHILLS, FEVER, AND VOMITING THE NIGHT IMMEDIATELY AFTER RECEIVING THE VACCINE AND FELT BETTER AGAIN AFTER 1 DAY. ALSO REPORTS INJECTION SITE WAS SWOLLEN AND PAINFUL.",,,,,,,,,Y,09/07/2019,09/07/2019,0,,PHM,,NONE THAT REPORTER IS AWARE OF,NONE THAT REPORTER IS AWARE OF,NONE THAT REPORTER IS AWARE OF,,,2,09/17/2019,,,,DEMEROL
0834068,09/17/2019,VA,66.0,66,,F,,"Rash, Swollen right neck gland.",,,,,,,,,N,08/13/2019,08/26/2019,13,Doctor visit only.,OTH,,HydrOXYzine HCl 25 MG Tablet Start 10 days 40 Tablet 0 09/13/2019     Triamcinolone Acetonide 0.5 % Cream Start 10 days 30 Gram 0 09/13/2019     NovoFine 32G1/4 Miscellaneous Taking 90 days 2 Box 4    Aspirin Adult Low Strength 81 MG Tablet,None,Diabetes,,,2,09/17/2019,,Y,,Bactrim - Vomiting
0834069,09/17/2019,CA,62.0,62,,M,,"Severe pain in shoulder at upper arm, radiating to neck and head. Began 2-3 hours following injection,  lasted three days before easing up. Rapid pulse first two days. Nausea and stomach discomfort, loss of appetite.   Tiredness and lack of strength in limbs. Considered ER visit but decided to wait it out. These are listed as normal reactions but I felt they were way too severe and disrupted my ability to do anything for three days. Today is day five and arm/shoulder pain is gone, pulse ok now, but still have fatigue, headache, low fever and hot flashes. I am reporting the incident to my healthcare provider and the pharmacy itself.",,,,,,,,,Y,09/13/2019,09/13/2019,0,NA,PHM,,Lipitor.  Dorzolomide (Glaucoma eyedrops),"Cold and bronchitis, February 2019 (six months ago)",Glaucoma,Shingrix. 1st Dose last May 2019. But reactions then were mild.,,2,09/17/2019,,,,None known.
0834070,09/17/2019,MI,72.0,72,,F,,"PATIENT HAD SEVERE BODY ACHES THROUGH THE NIGHT, THE NIGHT OF THE VACCINATION. LASTED APPROXIMATELY 12 HOURS. NO MEDICATIONS WERE TAKEN FOR THIS. PATIENT SAID THIS SUBSIDED IN THE MORNING",,,,,,,,,Y,09/14/2019,09/14/2019,0,NONE,PHM,,UNKNOWN,UNKNOWN,UNKNOWN,,,2,09/17/2019,,,,UNKNOWN
0834071,09/17/2019,MA,78.0,78,,F,,"it started one hour after injections. painful, red and swallow. about 4x6 wide. warm and hard.",,,,,,,,,N,09/16/2019,09/16/2019,0,,PHM,,none,none,"hypertension, high cholesterol","last year flu shots, but the adverse effect was smaller in sizes",,2,09/17/2019,,,,"cipro, iodine, based dye"
0834072,09/17/2019,NJ,65.0,65,,F,,PATIENT STATES HE HAS RANDOM TWITCH IN LEFT FOREARM WHICH STARTED A FEW DAYS AFTER VACCINE. NO PAIN OR DISCOMFORT HOWEVER CERTAIN WAYS HE MOVES HIS ARM IT WILL BE SORE BUT HE IS NOT SURE IF THAT IS DUE TO PAST ROTATER CUFF  INJURY. HE DOES LIFT WEIGHTS. STATES INJECTION SITE WAS NOT RED OR SWOLLEN OR ANY MORE SORE THEN NORMAL AFTER A VACCINE,,,,,,,,,U,08/20/2019,08/23/2019,3,,PHM,,tamsulosin metformin,unaware,pt states did have rotater cuff issues in that shoulder in past,,,2,09/17/2019,,Y,,NKDA
0834073,09/17/2019,WI,66.0,66,,F,,"Patient developed a rash down both arms and on upper chest.  Rash itched and blistered.  Itching and blistering resolved, but redness is still clearly visible approx. 2 months later.",,,,,,,,,U,07/16/2019,07/16/2019,0,,PHM,,,,,,,2,09/17/2019,,,,
0834074,09/17/2019,GA,6.0,6,,F,,patient started coughing/wheezing/nausea difficulty breathing- throat sore- face and eyes turned red. Pulse ox taken- Dr notified- breathing treatment albuterol given. o2 stat was 91 immediately upon symptoms  . After treatment o2 was 96-97.  patient observed for 2 hours after vaccine.,,,,,,,,,Y,09/17/2019,09/17/2019,0,,PVT,,none,none,Asthma,,,2,09/17/2019,,Y,,none
0834075,09/17/2019,MA,67.0,67,,M,,"Due to the bee sting the previous day I took 50mg of Benadryl 9/14 in the afternoon. Began feeling nauseous,  at dinner time, could not eat, vomited, passed out and hit my head (laceration that did not need stitches).  Experienced the chills and went to bed and felt better the next morning.",,,,,,,,,Y,09/14/2019,09/14/2019,0,Did not go to ER or receive treatment.,PHM,,Asulfazine -  81mg aspirin,Important info.     -  was stung by a bee on 9/13/2019 and was experiencing swelling. Did not need to go to ER or use epipen and as  a day had passed I thought I would be ok.,"Very mild, well managed case of colitis. No flare ups for years",,,2,09/17/2019,,,,Allergic to bee stings!
0834077,09/17/2019,VA,19.0,,,F,,"no adverse effect; pediatric VAQTA were administered to a nineteen yera old patient; This spontaneous report was received from a Medical assistant regarding to a 19-year-old female patient. The patient's medical history, concurrent condition and concomitant medications were not reported. On 13-SEP-2019, (also reported as today) the patient was vaccinated with pediatric hepatitis a vaccine, inactivated (VAQTA) 2 doses of 0.5ml vials(route was not reported) lot # S002505 and expiry date 04-APR-2020, for prophylaxis (product administered to patient of inappropriate age). No product quality issue and no adverse effect reported.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,,,,,US0095075131909USA005808,2,09/17/2019,,,,
0834078,09/17/2019,MO,,,,U,,"Ill; Body aches; Extreme fatigue; Headaches; Low grade fever; This case was reported by a consumer via call center representative and described the occurrence of unwell in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th September 2019, the patient received the 2nd dose of Shingrix. On 6th September 2019, 1 days after receiving Shingrix, the patient experienced unwell. In September 2019, the patient experienced general body pain, fatigue, headache and low grade fever. On an unknown date, the outcome of the unwell, general body pain, fatigue, headache and low grade fever were recovering/resolving.   It was unknown if the reporter considered the unwell, general body pain, fatigue, headache and low grade fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was ill and less than a week after vaccination experienced body aches, extreme fatigue, headaches and low grade fever. The patient asked whether is this normal for the 2nd dose. This case has been linked with case US2019AMR163561, reported by the same reporter.",,,,,,,,,N,09/05/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/17/2019,,,,
0834079,09/17/2019,MO,,,,F,,"Ill; Body aches; Extreme fatigue; Headaches; Low grade fever; This case was reported by a consumer via call center representative and described the occurrence of unwell in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th September 2019, the patient received the 2nd dose of Shingrix. On 6th September 2019, 1 days after receiving Shingrix, the patient experienced unwell. In September 2019, the patient experienced general body pain, fatigue, headache and low grade fever. On an unknown date, the outcome of the unwell, general body pain, fatigue, headache and low grade fever were recovering/resolving.   It was unknown if the reporter considered the unwell, general body pain, fatigue, headache and low grade fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was ill and less than a week after vaccination experienced body aches, extreme fatigue, headaches and low grade fever. The patient asked whether is this normal for the 2nd dose. This case has been linked with case US2019AMR163558, reported by the same reporter.",,,,,,,,,N,09/05/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/17/2019,,,,
0834080,09/17/2019,FL,66.0,66,,F,,"Within a couple of hours the area began to itch.  Pain at injection site in deltoid area of left arm started within 4-5 hours of the injection..  Became hot to touch.  Over next 12-24 hours redness progressed to entire upper left arm.  Area was swollen.  Area remained swollen and very painful through evening of September 16.  The Pharmacy suggested taking Advil and using ice to the area.  I only took the Advil.  I felt the ice would be too uncomfortable so did not use it.  As of today, September 17, the area remains red, less swollen and less painful.  It is itching again.",,,,,,,,,U,09/15/2019,09/15/2019,0,,PHM,,"Oral compounded hormone replacement, Juice Plus Fruits, Juice Plus Vegetables, Juice Plus Omega 3, Vitamin D3, Vitamin B12,.",None,,,,2,09/17/2019,,Y,,"Codeine, morphine, adhesives."
0834081,09/17/2019,NC,23.0,23,,F,,"Both daughter 23 and my son 19 began have symptoms the next day starting to resemble a severe head cold and overall feeling bad, my son symptoms remain consistent with head cold. My daughter however, progressive got worse, with headache, severe head congestion, throat feels thick, heavy chest , asthma reaction, said feels like throat is closing up, diarrhea , vomiting. The vomiting and diarrhea started last night and worse today. We called several time to doctor his morning and then at 1130 I was finally able to reach someone and they called in Zovoran for her, but as of yet they have not and still waiting to for Doctor office to call this medicine , so we can pick it up. Due to making her asthmas worse she has taking two puffs of albuterol inhaler and 1 puff on Advair disk 30 mins ago. She also took Alkezelzer cold and flu medicine  30 min ago in hopes to help loosen up congestion and headache. . If Breathing gets worse and albuterol doesn't help we will take her to clinic or ER.",,,,,,,,,N,09/13/2019,09/14/2019,1,"None at this time, Reactions on going will take to ER if worsens.",PVT,,"Cholestyramine , Prozac, wellbutrin,  previcid, Claritin, birth control pill",none,"Celiac disease, IBS, ADHD, anxiety, Asthma",,,2,09/17/2019,,Y,,"morphine, milk products, gluten"
0834085,09/17/2019,TX,,,,U,,"no adverse event; improperly stored vaccine administered intramuscularly; confirmed route of administartation was intramuscular; This spontaneous report was received from a medical assistant regarding a patient of unknown demographics. Information on patient's pertinent medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) lot # S002877, expiry date: 29-JAN-2021) (dose details, strength unknown) via intramuscular route for prophylaxis (incorrect route of product administration). The administered varicella virus vaccine live (oka/merck) (VARIVAX) was stored at a temperature of 8.1 degree fahrenheit within time frame of 20 minutes (product storage error). The varicella virus vaccine live (oka/merck) (VARIVAX) was reconstituted with sterile diluent (possible lot # S000130, expiry date: 23-AUG-2021) which was stored in correct temperature. The previous temperature excursions included were 8.1 degree fahrenheit for 17 minutes and 9.5 degree fahrenheit for 21 minutes. The digital data logger was involved. No adverse effect was reported.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005770,2,09/17/2019,,,,
0834086,09/17/2019,,,,,F,,"Pain in arm; Redness around the injection site area; Felt bad for about 2 days; This case was reported by a consumer via call center representative and described the occurrence of feeling bad in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd September 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced feeling bad, pain in arm and injection site erythema. In September 2019, the outcome of the feeling bad was recovered/resolved. On an unknown date, the outcome of the pain in arm was recovering/resolving and the outcome of the injection site erythema was not recovered/not resolved.   It was unknown if the reporter considered the feeling bad, pain in arm and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, however the patient could be 58 or 57 years old at time of vaccination. The patient received 1st dose of Shingrix and she felt bad for about 2 days and that resolved. In September 2019, the patient experienced pain in arm that had improved but not totally resolved. In September 2019, the patient also experienced redness around the injection site area that had not cleared up yet. The reporter did not consent to follow-up. The reporter declined to provide demographics. This case has been linked with US2019164588, having same reporter.",,,,,,,,,N,09/03/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/17/2019,,,,
0834087,09/17/2019,MD,,,,M,,"Flu Like Symptoms; Chills; Fever; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms, chills and fever. On an unknown date, the outcome of the influenza-like symptoms, chills and fever were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, chills and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced flu like symptoms, chills and fever that lasted for about 3 days after receiving Shingrix. No further details were provided.  The patient was reporting event for herself, her friend, and her friends husband.  This case was 1 of 3 cases, reported by same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/17/2019,,,,
0834090,09/17/2019,,,,,F,,"Received the first dose of Shingrix and then a few weeks later developed a case of shingles; This case was reported by a physician via call center representative and described the occurrence of shingles in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, couple of weeks after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age vaccination was not reported but was selected as adult as per vaccine indication. The healthcare professional (HCP) reported that a patient had an outbreak of Shingles after receiving the 1st dose. The reporter did not consent to follow-up. The reporter asked that If i had patient who received the first dose of Shingrix and then a few weeks later developed a case of shingles, do I need to restart the entire vaccination series for her or can I just proceed with the second dose after confirming the appropriate amount of time has elapsed and the acute episode has resolved. The reporter disconnected without giving contact or patient information.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/17/2019,,,,
0834091,09/17/2019,,,,,M,,"rash on torso; This case was reported by a consumer via call center representative and described the occurrence of rash in a 86-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, however the patient could be 86 or 85 years old at time of vaccination. The reporter was daughter of patient who received first dose of Shingrix in Aug 2019. The reporter stated that patient experienced rash on his torso that had not resolved. The reporter did not consent to follow-up. The reporter declined to provide demographics or follow up. This case has been linked with US2019164591, having same reporter.",,,,,,,,,N,08/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/17/2019,,,,
0834092,09/17/2019,,,,,M,,"Chills; Aching; Nausea; Fatigue; Weakness; This case was reported by a consumer via call center representative and described the occurrence of chills in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th September 2019, the patient received Shingrix. On 10th September 2019, 1 days after receiving Shingrix, the patient experienced chills, pain, nausea, fatigue and weakness. On an unknown date, the outcome of the chills, pain, nausea, fatigue and weakness were not recovered/not resolved.   It was unknown if the reporter considered the chills, pain, nausea, fatigue and weakness to be related to Shingrix.  Additional details were provided as follows: Information obtained via webchat. The reporter was the wife of this patient.  The age at vaccination was not reported. The patient received Shingrix and was currently experiencing chills, aching, nausea, fatigue and weakness. The reporter did not consent to follow up. The reporter did not provide any demographic details and disconnected chat when asked for any demographic information to complete safety reporting.",,,,,,,,,N,09/09/2019,09/10/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/17/2019,,,,
0834093,09/17/2019,AR,72.0,72,,F,,"Rash on both Ankles; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number AS479, expiry date 25th September 2021) for prophylaxis.   On 9th September 2019, the patient received the 2nd dose of Shingrix. On 9th September 2019, less than a day after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The pharmacist asked any information on this type of reaction after 2nd dose Shingrix. The healthcare professional (HCP) stated that patient experienced rash on both ankles within 5 hours after 2nd dose administration. The HCP stated that no fever, chills or pain.  The reporter did not consent to follow-up.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/17/2019,,,,
0834094,09/17/2019,CO,,,,F,,"Suspected vaccination failure; Acute episode of shingles; This case was reported by a other health professional via call center representative and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On 10th September 2019, less than 2 years after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.  Additional details were provided as follows: This case was reported by the pharmacy intern. The age at vaccination was not reported. After vaccination, the patient experienced an acute episode of shingles. This case was considered as suspected vaccination failure as details regarding vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting. The reporter consented to follow up.",,,,,,,,,U,,09/10/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/17/2019,,,,
0834095,09/17/2019,MD,,,,F,,"Flu Like Symptoms; Chills; Fever; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms, chills and fever. On an unknown date, the outcome of the influenza-like symptoms, chills and fever were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, chills and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced flu like symptoms, chills and fever that lasted for about 3 days after receiving dose of Shingrix. No further details were provided.  The patient was reporting event for herself, her friend, and her friends husband. This was 1 of the 3 cases, reported by same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/17/2019,,,,
0834097,09/17/2019,,30.0,,,F,,"Low lying placenta; Vaccine exposure during pregnancy; This is an observational study case initially received from other health professional on 31-Oct-2018, concerning a 30-year-old female, pregnant subject (race and ethnicity: not reported), with unknown body weight, height and body mass index (BMI), enrolled in a prospective observational safety study on pregnancy outcomes in women immunized with Afluria QIV, a seasonal quadrivalent vaccine, during pregnancy.  The subject's obstetrical history noted that the subject had no previous pregnancies. The subject had no history of offspring with major congenital malformation. Also, the subject had no maternal or paternal history with major congenital malformations. The father did not receive any medications prior to conception. The subject did not have a prior history of use of tobacco, alcohol or illicit drugs during pregnancy.  The subject's medical history was not reported. The subject's concomitant medications included Citra Natal Bloom as prenatal vitamin.  The subject's last menstrual period was on 03-Apr-2018 and estimated delivery date (EDD) was reported as 08-Jan-2019. The type of pregnancy was singleton.  On 28-Jun-2018, nuchal translucency and first trimester screen was performed, and no major congenital malformation was found.   On 27-Jul-2018, ultrasound was performed and no major congenital malformation was found.  On 08-Oct-2018, the pregnant subject was administered Flu Vaccine Cell Subunit QIV NVD (batch number: YF40208, expiry date, dose, route of administration, and anatomical location: not reported) for immunization for influenza virus (explicitly considered as vaccine exposure during pregnancy). The pregnancy status of the subject was collected, and pregnancy complications included Rh negative (risk factor) and low-lying placenta.  On 05-Jan-2019, 89 days after vaccination, the subject delivered a full-term male neonate at 39.6 weeks gestation. Delivery method was vaginal. The neonate's birth weight was 3560 grams and no data was provided for head circumference and body length. The appearance, pulse, grimace, activity, and respiration (APGAR) scores were 8 (one minute) and 9 (five minutes). APGAR score was not reported for 10 minutes. There were no pregnancy complications and no major congenital malformation was identified at birth.  The outcome of low lying placenta was not reported.  Significant follow up report received from other health professional on 10-Apr-2019: The delivery date (05-Jan-2019), delivery type (vaginal), birth type (live birth), fetal outcome (normal) weight (3560 grams), APGAR score (8 and 9) and delivery notes were updated in the patient tab. The narrative and case comment were amended accordingly.  Significant follow up received from other health professional on 11-Sep-2019: Laboratory data and relevant tests were updated in the relevant fields. It was provided that no major congenital malformation was identified on birth. Event of Low lying placenta was added. Therefore, the case was upgraded to serious (per medical judgement). Narrative was amended accordingly.  Company comment: A 30-year-old, pregnant female subject was administered suspect vaccine Flu Vaccine Cell Subunit QIV NVD (coded as vaccine exposure during pregnancy). The subject was diagnosed placenta previa on an unknown date after vaccination. The decision to administer a vaccine during pregnancy is related to medical decision making by the subject and her physician and is not related to any property of the medication. The event of vaccine exposure during pregnancy was assessed as not related considering the intended use of the vaccine, while for placenta previa causality is assessed as related.; Reporter's Comments: A 30-year-old, pregnant female subject was administered suspect vaccine Flu Vaccine Cell Subunit QIV NVD (coded as vaccine exposure during pregnancy). The subject was diagnosed placenta previa on an unknown date after vaccination. The decision to administer a vaccine during pregnancy is related to medical decision making by the subject and her physician and is not related to any property of the medication. The event of vaccine exposure during pregnancy was assessed as not related considering the intended use of the vaccine, while for placenta previa causality is assessed as related.",,,,,,,,,U,10/08/2018,10/08/2018,0,Test Date: 20180628; Test Name: First trimester screen; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20180628; Test Name: Nuchal Translucency; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20180727; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.,UNK,,CITRANATAL BLOOM,Rh-negative,,,USSEQIRUS201805224,2,09/17/2019,,,,
0834100,09/17/2019,CA,80.0,80,,F,,"Pt experienced pain in the evening after administration, with redness and puffiness about 4 inch area. Pt came into pharmacy a few days later and still showed redness which had extended to wider area but less puffiness with no pain. Pt stated she did not feel she needed to see her MD but would continue to monitor symptoms. Pt did not feel this needed attention but spouse recommeded she notify pharmacy.",,,,,,,,,,09/05/2019,09/05/2019,0,,PHM,,"Amlodipine, ASA 81mg, Atorvastatin, Benazepril, Rivastigmine, Famotidine, Melatonin, Namenda, Gabapentin, Primidone, Propranolol, Sodium Chloride eye drops. Temazepam, Tramdol, Systane eye drops, Calcium with Vit D, Vitamin D, Co-Q-10, Lute",,,,,2,09/17/2019,,,,"Percodan-stomach upset, Latex bandages"
0834101,09/17/2019,MN,13.0,13,,F,,"Child present for immunization clinic with her family.  Following administration of IPV and Hep A vaccinations, she experienced a syncopal episode.  Child was seated at the table and was caught by parent and RN as she fainted.  Child quickly began to rouse from syncopal episode, parent picked her up and then sat with her on a row of chairs so child?s head could be lowered and feet elevated above her heart.  VS taken while laying down-BP 110/70, HR 68 and RR 18.  After a few minutes, client reported feeling nauseous and requested to sit upright.  Once seated, she was able to take some sips of water.  Parent reported child had last eaten at lunch time.  Nausea subsided, and child continued to sip water and reported a slight headache.  Parents requested for child to receive Varicella vaccination after syncopal incident.  Following administration of final vaccination, client able to ambulate independently to the Public Health lobby space where family remained for an additional 10 minutes for parents and staff to observe child for any effect from additional vaccination.",,,,,,,,,Y,09/16/2019,09/16/2019,0,,PUB,,NK,NK,NK,,,2,09/17/2019,,,,NKA
0834102,09/17/2019,WA,77.0,77,,M,,"O V ZOSTER/HERPES VIRUS,  BENADRYL-MAALOX-XYLOCAINE,  KENALOG IN ORABASE",,,,,,,,,Y,07/31/2019,07/31/2019,0,"O FUNGUS CULTURE, O V ZOSTER/HEREPES VIRUS PCR",PHM,,,,,,,2,09/17/2019,,,,penicillin
0834103,09/17/2019,MA,13.0,13,,M,,"Per order of N.P. Pt to receive HPV #2 and Flu vaccine today.  When pt was approached to receive the same,he stated, ""Wait, can I go to the bathroom first?""  Pt went to bathroom to void.  Upon returning to exam room, pt stated, ""I don't want any shots.  I'm scared.  I don't like shots.""  Reassurance given to pt.  Offered this pt to have his dad present now, because initially he did not want dad present.  Pt states, ""Yes.  Can you get my dad?""  Summoned pt's dad.  He presented into exam room and told pt to relax.  Dad informed me that pt 'gets worked up' prior to any experience that he does not want to do.  Dad states, ""He even gets this way when his mother reprimands him.  He gets all worked up and like a panic attack.  He breathes fast and everything.""  Reassurance given.  Dad held pt so that he could safely receive his Flu and HPV #2 vaccine.  Flu vaccine was given as ordered in right deltoid.  Pt let out a scream and said, ""Ow.  That hurts me.  It's burning!""  At this point, pt's sister had entered the room and told pt to relax and settle down.  Pt began to use foul language and his sister told him that his language was inappropriate.  Dad was still holding pt and pt told him that his right arm was now ok.  Dad then informed pt that he would now get his second vaccine and then they would go home.  Pt began to cry and said that he didn't want any more shots.  Dad said to pt, ""You're a big boy and you're getting just one more shot.  Don't be a baby.""  Dad then informed me that he had a good hold on this pt and that I could go ahead and give the HPV vaccine.  Informed dad that pt would need to sit after receiving his HPV vaccine to assess for any side effects.  Dad stated compliancy regarding the same.  At 1615 HPV vaccine was given into pt's left deltoid area.  Pt again let out an outburst of crying.  Pt then states, ""I can't breathe.  I can't breathe.""  pt had a near syncopal episode.  Pt did not have any loss of consciousness.   VS:  110/76-86-26.  O2 sat 100 %.  I then assisted this pt with slowing down his breathing.  Pt was somewhat compliant and diaphoretic at this time.  Cool cloth applied to pt's forehead and neck area. RN was then in to see pt.  She attempted to give pt O2 via mask. N.P. presented and assessed pt's O2 sat still at 100%.  She stated that O2 not necessary at this time.  Pt was not responding well at this time.  Positioned pt in left side lying position.  110/80-84-24  O2 sat 100%. Per N.P., RN placed Ammonia Salts Ampule under pt's nose.  Pt immediately sat up and was combative, stating, ""What happened?""  Reassurance given to pt and his dad. Informed pt that he had a near syncopal episode. M.D. In to see pt.  She heard wheezing throughout all lung fields of this pt.  Per order of M.D. Albuterol Neb was given at 1625 to pt.120/66-84-22 O2 sat 100%.  At 1633, pt was reassessed by M.D. No audible wheeze was present per M.D. At 1645:  110/60-83-20 O2 sat 100%.  Pt resting in room.  Pt then sat up and stated that he was feeling better.  Pt was alert and oriented to time, place, person and situation.  Pt told me and his dad, ""I'm better now.  I want to go home.""  Reassurance given to pt.  Told pt that he would be reassessed in 15"" and then N.P. would determine if pt were able to go home.  At 1700, pt was breathing well with good respiratory rate.  Lung sounds clear to auscultation.  Coloring good.  Skin warm and dry.  110/60-80-18 O2 sat 100%.  Pt was then reassessed by N.P. And was then released home by the same.  Pt stood on the floor, holding his dad's hand.  Pt denied any lightheadedness or vertigo.  Pt states, ""I'm just tired.""  Pt was alert and oriented to time, place, person and situation.  Pt's gait was slow, but steady.  Pt ambulated to his dad's car, with the assist of his dad and his sister.",,,,,,,,,Y,09/16/2019,09/16/2019,0,,PVT,,focalin xr 20 mg  zoloft 25 mg,none,"ASD, ADHD, Asthma",,,2,09/17/2019,,,,none
0834104,09/17/2019,ID,1.58,1,.6,M,,Pt was given Varivax dose after being reconstituted in the fridge for greater than 30 minutes. No adverse reaction noted.,,,,,,,,,,09/16/2019,09/16/2019,0,,PVT,,,,,,,2,09/17/2019,,,,
0834105,09/17/2019,PA,31.0,31,,F,,The patient right arm  which is Pneumovax shot was swelling and red.  She said she had fever.,,,,,,,,,Y,09/11/2019,09/13/2019,2,n/a,PHM,,"Lamotrigine er 100mg. Patient received Fluarix quad, Boostrix, and Pneumovax on 09/11/2019",none.,Biolar,,,2,09/17/2019,,,Y,Codeine
0834106,09/17/2019,FL,82.0,82,,M,,Peeling of both hands starting the day after vaccine was received.  He states the first layer of skin is coming off on both hands.,,,,,,,,,N,09/11/2019,09/12/2019,1,none,PHM,,nothing out of the ordinary,diabetes,diabetes and high cholesterol,,,2,09/17/2019,,,,penicillin and sorbitol
0834107,09/17/2019,AR,6.0,6,,F,,"Started throwing up in the night on 9/11.  On 9/12, she started breaking out on her back and it quickly spread to different parts of the body.  By the 13th, it was all over her body including her face and scalp.  Took to a walk in clinic on the 12th and said to give Benadryl and come back if got worse.  As of today, Sept 17th, it is mostly gone and she has returned to school.",,,,,,,,,Y,09/09/2019,09/11/2019,2,Walk in clinic did a strep test due to her being exposed to it but came back negative,PUB,,None,None,None,,,2,09/17/2019,,Y,,None
0834109,09/17/2019,IL,4.0,4,,U,,"No adverse effect reported.; one patient received an improperly stored V ARlV AX; This spontaneous report was received from a nurse and refers to a 4-year-old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 28-AUG-2019, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) lot # R006221, expiration date: 29-FEB-2020 (or lot # R029517, expiration date: 14-OCT-2020)(dose, route of administration and anatomical location were not reported) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent. The nurse reported that the varicella virus vaccine live (oka/merck)(VARIVAX) experienced two temperature excursions: one on 12-AUG-2019 and one on 13-AUG-2019. Neither were reported to the nurse until 06-SEP-2019. The nurse did not have the specific lot or expiration administered to the patient but it was one of the two reported. The vaccine underwent temperature excursion of minus 14 Celsius degrees to minus 10 Celsius degrees (-11.91 Celsius degrees, multiple) for 8 hours. There were no previous temperature excursions. The digital data logger was involved in recording excursion details. No adverse effect was reported.",,,,,,,,,U,08/28/2019,08/28/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA003308,2,09/17/2019,,,,
0834110,09/17/2019,SC,65.0,65,,M,08/16/2019,"pt here for routine f/u; Pt received pneumovax 23 IM in lt deltoid. After administration had erythema noted to lt shoulder with itching reported. Pt denies SOB, throat swelling sensation or diffuse body itching. No edema or hives noted to body. Lungs sound clear equal B/L anteriorly and posteriorly. Pt given prophylitically IM of Solu-medrol 125mg, and Benadryl 25 mg PO TID. Benadryl to be taken at home due to sedative effects",,,,,,,,,,06/06/2019,06/06/2019,0,,OTH,OTH,,,,,,1,,,,,
0834111,09/17/2019,CA,4.0,4,,F,,Patient complained of soreness at injection site about 7 hours after shot.  Injection site was slightly red and warm to touch.  By evening patient would not move her right leg and dragged it was she walked because of extreme pain when bending leg. Slight fever of 100 or so the day after shot.  Limping continued for 3 days (Friday - Sunday).,,,,,,,,,Y,08/30/2019,08/30/2019,0,n/a,PVT,,n/a,,,,,2,09/17/2019,,,,"Amoxicillin, Dairy, and sensitive to wheat"
0834112,09/17/2019,MA,16.0,16,,F,,"1am day after vaccination pt awoke and could not move her L arm.  Around 5am went to parents and entire L upper arm spreading to axilla, shoulder and upper back with significant swelling.  Due to swelling and pain went to ER, had eval to r/o DVT which was negative, felt swelling 2/2 vaccine reaction.",,,,,Y,1,,,N,09/13/2019,09/14/2019,1,US Doppler LUE- negative for DVT,PVT,,"levonorgestrel-ethinyl estradiol, novolog, focalin XR",none,"diabetes type I, ADHD",,,2,09/17/2019,,,Y,"penicillins, cephalosporins"
0834113,09/17/2019,,40.0,40,,F,,"high fever, severe body aches (9 on the scale of 1-10) and crying.",,,,,,,,,,09/16/2019,09/16/2019,0,,UNK,,,,,"fever, body aches. Type of vaccine Hep A, flu shot. Age at the time received 38",,2,09/17/2019,,,,
0834114,09/17/2019,UT,24.0,24,,F,,"Site redness, edema, induration, reported fever, malaise, body aches.  Reported started with malaise on 8/19 by 8/21 felt body aches , fever and sore throat.  Seen my MD on 8/23 the day she reported symptoms.  Dr Prescribed prednisone. Follow up on 9/5/2019 symptoms resolved.",,,,,,,,,Y,08/12/2019,08/19/2019,7,None,WRK,,none,None,None,,,2,09/17/2019,,Y,,None
0834115,09/17/2019,OH,69.0,69,,F,,"Pt's husband explained that her arm swelled up, and is warm to the touch. She does not have a fever. Explained to husband to let us and dr know of any changes, if pain/warmness increases, she develops a fever, or if it is still warm/painful after 24 hours.",,,,,,,,,N,09/16/2019,09/17/2019,1,,PHM,,,,,,,2,09/17/2019,,,,"Iodine, morphine, penicillin"
0834116,09/17/2019,OR,17.0,17,,F,,"Patient called on 9/17/19 to report possible adverse event to vaccines. She said on 09/13/19, about 9 days after receiving her first dose of 6 different vaccines, she started to get body aches and fevers. Fevers were between 102-104' F for 4 days. She also had significant joint pain. She was in bed the whole 4 days. Then the fever broke this morning , 09/17/19, and she started to get a rash. She described the rash as bumpy, red, itchy, and almost burning sensation. The rash is on her face, neck, shoulders, and chest. She thought it might be hives.",,,,,,,,,U,09/04/2019,09/13/2019,9,None,PUB,,Unknown,Unknown,none,,,2,09/17/2019,,,,NKDA
0834117,09/17/2019,NC,57.0,57,,F,,"Localized red, swollen, warm reaction",,,,,,,,,U,09/13/2019,09/17/2019,4,,PUB,,,,,,,2,09/17/2019,,,,
0834118,09/17/2019,OR,70.0,70,,F,,"Pt received shingrix shot on 9/14/19.  This is second shot, was sore for about 4 days.  Received 2nd shot.  Within 24 hours got red, about 3 inch diameter red spot.  Warm to the touch.  The redness is bright red and the red part is swollen.  Pt has taken ibuprofen and Tylenol to relieve discomfort.",,,,,,,,,N,09/14/2019,09/15/2019,1,none,PHM,,,,,,,2,09/17/2019,,,,
0834119,09/17/2019,NY,59.0,59,,F,,"Client called on 9/12/19. C/o fatigue, increase temp (100.3), starting on 9/11/19 and going into 9/12/19. She also had no appetite and was ""out of it"" at times. The swelling of a half dollar coin started on left arm at the injection site growing into a little larger in size and painful to touch. No rash.I explained to her that this is normal per VIS sheet. I instructed her to put a cool compress on it and to take Tylenol or Motrin to help with discomfort. 9/13/19 Called client today. She said that she still has fatigue, but the red spot (injection site) is less red and she can move her arm better. She also said she had some diarrhea during the night, but its probably not from the shot. She is feeling better.",,,,,,,,,,09/10/2019,09/11/2019,1,NONE,PUB,,None,NONE,NONE,,,2,09/13/2019,,,,NKDA
0834120,09/17/2019,NJ,61.0,61,,M,,flu like sxs,,,,,,,,,U,09/16/2019,09/17/2019,1,N/A,PVT,,,,,,,2,09/17/2019,,,,
0834121,09/17/2019,RI,40.0,40,,F,09/11/2019,"onset dizziness, fatigue, (L) arm swelling, pain, fever, chills, nausea, muscle pain back, knew, arms, bilat hand tingling, bilat foots discomfort",,,,Y,,,,,,09/09/2019,09/10/2019,1,,PUB,PUB,,none,depression,,,1,,,,,
0834122,09/17/2019,CA,56.0,58,,U,,Hives from #2,,,,,,,,,Y,09/27/2019,04/20/2018,,,PVT,,estradiol patch,none,n/a,,,2,09/16/2019,,,,Hep A antigen
0834128,09/17/2019,NY,12.0,,,M,,"after an unspecified amount of time the patient fainted; This spontaneous report was received from a physician via company representative, referring to a 12 year old male patient. The patient's concurrent conditions, past medical history and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, frequency, route, lot/batch # and expiration date were not provided) for the prevention of Human Papillomavirus (HPV) related disease. During, the same office visit the patient also received a meningococcal conj vaccine (unspecified) (dose, frequency, route, indication, lot/batch # and expiration date were not provided). After an unspecified amount of time, the patient fainted (syncope). The outcome of syncope was unknown.     The causal relationship between syncope and the suspect therapies was not provided.   Upon internal review, the event of syncope was considered to be medically significant.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA005094,2,09/17/2019,,,,
0834129,09/17/2019,GA,16.0,16,,M,,"Rigth arm swollen / right arm with hard bump; Rigth arm red; Rigth arm tender, painful; Rigth arm warm to touch; Labelled drug-drug interaction medication error; vaccine administered at inappropriate site; This case was reported by a nurse via sales rep and described the occurrence of extensive swelling of vaccinated limb in a 16-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) (batch number 7AR35, expiry date 30th June 2020) for prophylaxis.   Co-suspect products included Men B NVS (Bexsero) (batch number ABX6C1AA, expiry date 30th June 2020) for prophylaxis.   On 3rd September 2019, the patient received Fluarix Quadrivalent 2019-2020 season .5 ml and Bexsero .5 ml. On 3rd September 2019, unknown after receiving Fluarix Quadrivalent 2019-2020 season and Bexsero, the patient experienced labeled drug-drug interaction medication error and vaccine administered at inappropriate site. On 5th September 2019, the patient experienced extensive swelling of vaccinated limb, erythema of extremities, pain in arm and skin warm. On an unknown date, the outcome of the extensive swelling of vaccinated limb, erythema of extremities, pain in arm, skin warm, labeled drug-drug interaction medication error and vaccine administered at inappropriate site were unknown.   The reporter considered the extensive swelling of vaccinated limb, erythema of extremities, pain in arm and skin warm to be possibly related to Fluarix Quadrivalent 2019-2020 season and Bexsero.  Additional details were provided as follows: The patient received dose of Fluarix  tetra and Bexsero in the right deltoid on same day, at same site, which led to labeled drug-drug interaction medication error and inappropriate site of vaccine administration. The reporter stated that, the patient went to urgent care on 5th September 2019 for right arm swollen, red, tender, painful and warm to touch. The  patient follow up on 6th September 2019 at primary care provider for right arm swollen, red, tender and now with hard bump. The patient was seen and treated by provider. There was discrepancy in the suspect reported. The supect vaccine was updated as per sale's data sheet.",,,,,,,,,U,09/03/2019,09/03/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/17/2019,,Y,Y,
0834130,09/17/2019,CA,,68,,M,,"pain in hand/pain in arm; body pain; heard a whistling sound in his ear.; breathing problems/shortness of breath; vision problems; Generalized pruritus; feels like something in the throat; pain in hand; pain in head; upper back pain; neck pain; shoulder pain; could not move his hand; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2019, the patient received the 1st dose of Shingrix. On 10th July 2019, less than a day after receiving Shingrix, the patient experienced pain in hand, headache, upper back pain, neck pain and shoulder pain. In July 2019, the patient experienced injected limb mobility decreased. On an unknown date, the patient experienced injection site pain, general body pain, ear noises, difficulty breathing, abnormal vision, generalized pruritus and lump feeling in throat. On an unknown date, the outcome of the injection site pain, ear noises, abnormal vision, pain in hand, headache, upper back pain, neck pain, shoulder pain, generalized pruritus, lump feeling in throat and injected limb mobility decreased were unknown and the outcome of the general body pain was not recovered/not resolved and the outcome of the difficulty breathing was recovered/resolved.   It was unknown if the reporter considered the injection site pain, general body pain, ear noises, difficulty breathing, abnormal vision, pain in hand, headache, upper back pain, neck pain, shoulder pain, generalized pruritus, lump feeling in throat and injected limb mobility decreased to be related to Shingrix.  Additional information received were as follows: The case US2019126010 was found to be duplicate of case US2019126012. Hence case US2019126012 would be deleted and all the information of this case will be added in case US2019126010 which is the case of record for this patient. The age at vaccination was not reported. In the 2nd week of May 2019, the patient received Shingrix on left arm. Less than a day after receiving Shingrix, the patient experienced pain at the injection site, which one week later spread throughout the body. Less than a year after receiving Shingrix, the patient also experienced breathing problems, vision problems and heard a whistling sound in his ear. In the morning one day before the reporting date, the patient experienced pain in his left hand, left shoulder and upper back, neck and head. Less than a day after receiving Shingrix, the patient could not move his left hand and had pain in the left arm and shoulder. The patient stated that he experienced this pain off and on since the 1st day that he received the vaccine. The patient stated that he had also developed itching all over the body and pain in the back of the head. The patient stated that he experienced shortness of breath and that had resolved, however now each morning, he feels like there is something in his throat. The patient said that he reported his side effects to the pharmacy manager and she called Glaxosmithkline. The reporter was unable to locate a case history for that call as he could only provide a first name and attempted to call the pharmacy manager during the call with the patient but she was not available. The reporter documented what I could understand. It was extremely difficult to understand the patient due to a language barrier. The reporter cannot clarify any information reported from the patient and documented what he could understand.  The reporter requested to contact the pharmacy manager for follow up. The patient stated that the pharmacist reported this to Glaxosmithkline, however, adverse event report could not be located and patient did not have the pharmacist's full name. The reporter consented to follow up.",,,,,,,,,N,05/01/2019,07/01/2019,61,,PHM,,,,,,USGLAXOSMITHKLINEUS201912,2,09/17/2019,,,,
0834131,09/17/2019,MA,0.25,0,.3,M,,"Pentacel Vaccine was given to patient on 09/09/19 however, Pentacel was not reconstituted to include HIB. Patient has no signs and symptoms of an adverse event but this is considered an error. Outcome is that we are contacting mom to give HIB portion of vaccine separately.",,,,,,,,,,09/09/2019,09/09/2019,0,,PVT,,,,,,,2,09/17/2019,,,,
0834132,09/17/2019,WI,1.25,1,.3,F,,"R thigh with possible cellulitis. Erythema, induration, warmth up to 4-5cm in length (3cm wide). Started on antibiotics (cephalexin) due to concern of infection. Improving by 9/17/19, but area still palpable on R thigh, not tender.",,,,,,,,,Y,09/12/2019,09/14/2019,2,,PVT,,none,none,none,,,2,09/17/2019,,Y,,none
0834133,09/17/2019,WI,10.0,10,,F,,"Localized swelling of thigh, increasing over 2 days. Improved within 5 days after immunization.",,,,,,,,,Y,07/31/2019,08/01/2019,1,,PVT,,"Unknown OTC ""allergy medication""",none,none,,,2,09/17/2019,,,,none
0834134,09/17/2019,SC,77.0,77,,F,,Pt came in with complaint of body rash and pain associated with rash.  She stated that she has not started anything new since the vaccination.,,,,,,,,,Y,09/09/2019,09/15/2019,6,N/A,PHM,,Eliquis 5mg,N/A,N/A,,,2,09/17/2019,,,,Sulfa
0834135,09/17/2019,WI,81.0,81,,F,,"Patient and husband received flu shot at the pharmacy. The patient went first and then waited in the room while her husband received his vaccine. At that time there were no complaints of feeling dizzy or unwell. About 15 minutes after receiving the vaccine, the patient left the store and passed out, hitting her head on the sidewalk. A nearby customer called 911, and the EMT's were caring for the patient at the time the pharmacist and store manager were notified and made it outside. She was moved to the ambulance and subsequently taken to the hospital where admitted.",,,,,Y,,,,U,09/16/2019,09/16/2019,0,,PHM,,Unknown,,,,,2,09/17/2019,,,,None
0834136,09/17/2019,OH,17.0,17,,F,,"Patient was given her vaccine and seemed fine. She  left the pharmacy area with both of her parents. I followed them to let them know that for the school we may need to print a form for her to show proof of the vaccine. When I turned to go print the form, her mom yelled for help that patient is passing out. We all lowered patient to the floor. I told her dad to call 911. I checked for breathing and she was breathing. I rubbed by her collar bone and said her name for her to wake up(while always having my face by her face checking her breathing)  and after maybe 20 seconds, she woke up. We kept her on the floor for a while. She said that she had nothing to eat all day. He mother then told me that patient passed out when she got her last tatoo. Management brought her an orange juice and 911 checked her out. She said she was fine and they let her go on her with her patents.",,,,,,,,,Y,09/17/2019,09/17/2019,0,N/A,PHM,,none,none,none,,,2,09/17/2019,,,,none
0834137,09/17/2019,OH,4.0,4,,F,,"Patient seen and diagnosed with Varicella  without complications on 3/15/2019. Symptoms included rash, on face , torso, arms, for 1 day.",,,,,,,,,Y,02/10/2011,03/14/2019,2954,none,PVT,,unknown,unknown,none,,,2,09/17/2019,,Y,,No  known food or drug or other product allergies
0834138,09/17/2019,NJ,13.0,13,,M,,"* not sure what strand of the influenza was given, my son got his immunizations and shortly after turned gray/white in the face, eyes rolled back and his head dropped, he started to shake and the medical assistant and I helped him down to the ground, the doctor then came into the room, we propped his legs up, his blood went back, color got slightly better, he started to regain consciousness.",,,,,,,,,Y,09/16/2019,09/16/2019,0,,PVT,,Xyzal,no,no,,,2,09/17/2019,,Y,,"Motrin allergy, seasonal allergies"
0834139,09/17/2019,FL,62.0,62,,F,,After immunizaion of prevnar in right arm had numbness and tingling that extended from the right side of her neck all the way down her arm and extending the right torso and down the right low back to the right knee.  Currently aching in the upper arm and numbness from the right shoulder to the right elbow.  The rash is characterized by pain and redness,,,,,,,,,,09/10/2019,09/10/2019,0,,PVT,,none,none,Chronic Maxillary Sinusitis,,,2,09/17/2019,,Y,,NKA
0834140,09/17/2019,,69.0,69,,F,,she noticed that her arm was itchy so she removed the bandage. then she noticed it was red and slightly swollen on down her arm. It was slightly warm to the touch.,,,,,,,,,,09/16/2019,09/16/2019,0,,UNK,,,,,,,2,09/17/2019,,,,
0834141,09/17/2019,CA,64.0,64,,F,,"Fever, shivers, couldn't get warm.  Shivered all night curled into a tight ball trying to stay warm.  I tend to be very warm at night, so shivering from cold on a mild evening was an extreme reaction for me.  Overall body aches and pain, fatigue and weakness.  Could barely walk to the bathroom.",,,,,,,,,Y,09/16/2019,09/16/2019,0,,PHM,,"Olmesartan/Amlod/HCTZ, Exetimibe, Atorstatin, Valacylovier, Vitamin C, Vitamin D, Kitamin K-2, Omega 3,  Flax Seed Oil, Tuemric & Bromelain, Garlic, Calcium",None,None,,,2,09/17/2019,,,,Tetracycline
0834142,09/17/2019,OH,67.0,67,,F,,Patient called and spoke with Pharmacist Monday 9/16/19 and told her that she didn't feel good and that her arm was sore.  Today she came in and said that she feels better but her arm is still soar and a little red.  I told her that since she is feeling better than she was yesterday to give it a few more days and that unfortunately this type of reaction is normal.  I told her to watch her arm and that if it starts to hurt more or swell then to go to urgent care or make a dr appointment.,,,,,,,,,U,09/15/2019,09/16/2019,1,,PHM,,,,,,,2,09/17/2019,,Y,,
0834143,09/17/2019,TX,4.0,4,,M,,"Pt with likely anaphylactic reaction to vaccine given today.  Mom reports pt received vaccines and developed vomiting, drooling, lethargy and swollen lips within minutes of discharge.  On arrival pt appeared pale, was drooling, was sticking his hand into his mouth, and had wheezing on exam.  0.3 mg of epinephrine given and 911 was called.",,,,,,,,,Y,09/13/2019,09/13/2019,0,n/a,PUB,,n/a,n/a,n/a,,,2,09/17/2019,,,Y,n/a
0834144,09/17/2019,NY,48.0,48,,F,,"24 hours later she developed R sided facial numbness, that side of her face felt ""paralyzed"".  She states she has only drooping of her eyelid no other muscle drooping.  Also feels discomfort swallowing.  Sx continue to worsen",,,,,,,,,N,09/12/2019,09/13/2019,1,went to ED Also saw Dr who she states ordered a lyme titer,PVT,,UNKNOWN,DENIES ANY,NONE,,,2,09/17/2019,,Y,Y,UNKNOWN
0834145,09/17/2019,NY,72.0,72,,F,,"Fever, ongoing  nerve pain",,,,,,,,,N,08/05/2019,08/05/2019,0,,PHM,,,none,,,,2,09/17/2019,,Y,,none
0834146,09/17/2019,TX,84.0,84,,M,,"Patient came into the pharmacy on 9/16/19 complaining of redness, soreness, and swelling of his arm. Upon inspection, patient's arm was swollen from shoulder to hands. Pharmacist on duty advised patient to visit an urgent care and get it checked out. The following day, pharmacist called patient to check up. Patient stated he did not end up seeking attention but did take ibuprofen and applied ice to the spot which improved his symptoms greatly.",,,,,,,,,Y,09/13/2019,09/14/2019,1,None,PHM,,"Dofetilide, gabapentin, furosemide, clopidogrel, carvedilol",Unknown,Unknown,,,2,09/17/2019,,,,Penicillin
0834147,09/17/2019,UT,69.0,69,,F,,Red area where injection was given.  Two other raised hives close to the injection site.  Very itchy and sore.  Hives are lightening but the itchiness is still ongoing at 4 days post.,,,,,,,,,N,09/13/2019,09/14/2019,1,,PVT,,"Advair, Amlodipine, Losartan/HCTZ, Omeprazole",,Asthma/COPD,,,2,09/17/2019,,,,Penicillin VenaSeal Closure system glue
0834149,09/17/2019,WA,33.0,33,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 33-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's past medical history included one previous pregnancy resulting in a normal birth of a full-term infant with no defects.  The subject had not been using contraception prior to becoming pregnant.   On 7 September 2011 at 10:45 the subject received a booster dose of Boostrix (.5 unknown units, intramuscular, left arm), and experienced vaccine exposure during the third trimester of her pregnancy.  The conception was reported to be normal.  The subject was approximately 28 weeks gestation at the time of vaccination.  Date of last menstrual period was 22 February 2011 and estimated delivery date was 29 November 2011.  Prenatal testing including ultrasounds performed on 25 April 2011 and 12 July 2011, and maternal serum alpha-fetoprotein on 08 June 2011 had revealed no evidence of a defect.  Upon internal review done on 17th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasounds performed on 25 April 2011 and 12 July 2011 revealed no evidence of a defect. Maternal serum alpha-fetoprotein on 08 June 2011 revealed no evidence of a defect.",,,,,,,,,U,09/07/2011,09/07/2011,0,,UNK,,,,Medical History/Concurrent Conditions: Live birth; No adverse event (There was no relevant maternal or paternal medical history.),,USGLAXOSMITHKLINEA0944824,2,09/17/2019,,,,
0834150,09/17/2019,WA,34.0,,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 34-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's medical history included two previous pregnancies resulting in normal births of two full-term infants.  Prior to becoming pregnant the subject had not been using contraception.  On an unspecified date the subject received a dose of Boostrix (details unknown), and experienced vaccine exposure during pregnancy.  Gestational age at the time of vaccination was unknown.  The conception was reported to be normal.  Date of last menstrual period was 12 January 2011 and estimated date of delivery was 19 October 2011.  Prenatal testing including ultrasound on 29 March 2011 and maternal serum alpha-fetoprotein on 04 May 2011 had revealed no evidence of a defect.   Upon internal review done on 17th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound on 29 March 2011 and maternal serum alpha-fetoprotein on 04 May 2011 revealed no evidence of a defect.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Live birth,,USGLAXOSMITHKLINEA0946034,2,09/17/2019,,,,
0834151,09/17/2019,CA,63.0,63,,M,,"Suspected vaccination failure; Shingles; Warm shooting pains which spread up his back to the should blades; Nerve pain; Muscle pain; welts on neck; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis and VARICELLA ZOSTER VIRUS VACCINE, LIVE, OKA STRAIN (ZOSTAVAX) for prophylaxis.   The patient's past medical history included chickenpox (the patient experienced chickenpox as a child and then again around age of 32 years).   On 11th April 2018, the patient received the 1st dose of Shingrix. On 23rd August 2019, the patient received the 2nd dose of Shingrix. On an unknown date, the patient received ZOSTAVAX at an unknown dose. In August 2019, between 1 and 2 years after receiving Shingrix and less than 2 years after receiving Shingrix, the patient experienced welts. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain, nerve pain and muscle pain. The patient was treated with antivirals nos, antivirals nos, antivirals nos, antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the vaccination failure, welts, nerve pain and muscle pain were unknown and the outcome of the shingles and pain were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles, welts, pain, nerve pain and muscle pain to be related to Shingrix and Shingrix.  Additional details were provided as follows: The patient received 1st and 2nd dose of Shingrix on an unknown arm (right or left unknown). The reporter did not sure if the injection was in the muscle or just under the skin (subcutaneous) as he did not look at the length of the needle. About a month before the date of reporting (August 2019), the patient noticed welts on his neck. He went to the physician because he thought he might have poison oak. The doctor diagnosed him with shingles. The welts were also on his right shoulder. He was prescribed unspecified antiviral tablets which he took for about a week and the shingles resolved. The patient stated that the shingles outbreak was brief and not bad perhaps because he caught it early. It had fully resolved. The patient also mentioned that occasionally he got warm shooting pains which spread up his back to the should blades. The pain was nerve or muscle pain and was very mild and it came occasionally. It was happening before the shingles outbreak. The patient stated that he had been exercising lately so he was not sure if it could be related to exercising but not had the shingles rash in that area. It was unknown if the reporter considered the vaccination failure, shingles and welts to be related to Shingrix and Shingrix. It was unknown if the reporter considered the pain, nerve pain and muscle pain to be related to Zostavax as well. The reporter consented to follow up.",,,,,,,,,Y,04/11/2018,08/01/2019,477,,PHM,,,,Medical History/Concurrent Conditions: Chickenpox (the patient experienced chickenpox as a child and then again around age of 32 years),,USGLAXOSMITHKLINEUS201916,2,09/17/2019,,Y,,
0834152,09/17/2019,SD,28.0,,,F,,"Fluzone High-Dose was given to a 28 year old that was 22 weeks pregnant/ No AE; Fluzone High-Dose was given to a 28 year old that was 22 weeks pregnant/ No AE; Fluzone High-Dose was given to a 28 year old that was 22 weeks pregnant/ No AE; Fluzone High-Dose was given to a 28 year old that was 22 weeks pregnant/ No AE; Initial information received on 09-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 28 years old female patient who received 0.5 mL dose of vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ238AB, Expiry date-14-Apr-2020 via intramuscular route in the left arm, while she was 22 weeks pregnant on 06-Sep-2019.  Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known.  The date of last menstrual period was not reported. The estimated due date was not reported.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was case of vaccine exposure during pregnancy. The patient was 22 weeks pregnant when she received vaccine.  It was also the case of actual medication error due to inappropriate age at vaccine administration, product use in unapproved population and overdose.  At the time of report, no adverse event was reported.  Pregnancy outcome was unknown at the time of report.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender- none.",,,,,,,,,U,09/06/2019,,,,UNK,,,,,,USSA2019SA252818,2,09/17/2019,,,,
0834153,09/17/2019,CT,0.33,,,M,,"ActHIB vaccine that had been reconstituted with sterile water rather than 0.4 % saline, no AE; Initial information and additional information received on 10-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a four months old male patient who received 0.5 ml second dose of vaccine HIB (PRP/T) VACCINE [ACT-HIB] (lot UJ055AAA, Exp. Date 20-Apr-2022) via intramuscular route in the right vastus lateralis on 10-Sep-2019 that had been reconstituted with sterile water rather than 0.4 % saline.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR), ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) and DIPHTHERIA VACCINE TOXOID, HEPATITIS B VACCINE RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (PEDIARIX) for Immunisation.  It was a case of actual medication error due to wrong solution used in drug reconstitution.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/10/2019,,,,UNK,,PREVNAR; ROTAVIRUS VACCINE; PEDIARIX,,,,USSA2019SA254960,2,09/17/2019,,,,
0834154,09/17/2019,MI,4.0,4,,M,,"Adacel was given to a 4 years old male patient/No AE; Initial information received on 10-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a four years old male patient who received a 0.5 ml fifth dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] lot U6401AA, expiry date: 26-Jul-2021 via intramuscular route in the left deltoid on 10-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No other vaccine was administered.   It was an actual medication error due to inappropriate age at vaccine administration.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/10/2019,,,,UNK,,,,,,USSA2019SA255329,2,09/17/2019,,,,
0834155,09/17/2019,VA,81.0,81,,F,,"pt arm red and painful, reddness starts at upper arm extending to lower arm started Saturday 09/14/2019",,,,,,,,,U,09/10/2019,09/14/2019,4,,PVT,,"meloxicam, eliquis, fluocinonide, mupirocin, mirtazapine, furosemide, vitamin d3, simvastatin, gabapentin, donepezil, memantine, levothyroxine",,"hypothyroidism, htn, vitamin d def, neuropathy",,,2,09/17/2019,,Y,,heparin
0834156,09/17/2019,TX,1.17,1,.2,M,,"9/14: ""Mom called stating pt received some vaccines last week and now pt has some redness around the injection site about a quarter size. Mom was concerned that it was more toward the inner thigh. She did notice redness the day of the vaccine. He is not showing any signs of distress related to his heart and is otherwise well. He is on a pulse ox and has has no issues. Mom does feel like his more fussy than normal but she also believes he is getting some teeth. He has had no fever and no breathing difficulty.""F 9/16: ""Mom called back.  Reports the following: Patient developed a bruise with circumscribed redness to the injection site on the right inner thigh."" 9/17: 1 cm x 1.5 cm bruise noted around vaccine insertion site; no redness or swelling noted, skin is not warm to the touch.  Parents have been monitoring.",,,,,,,,,U,09/11/2019,09/14/2019,3,,PVT,,,,"Patient is a 11 m.o. male with Hypoplastic left heart (Aortic atresia, severe hypoplastic mitral valve) s/p Norwood/Sano, PA banding,  and s/p Bidirectional Glenn, hx of cardiac arrest and VA ECMO. He is also known to have a large veno-venous collateral. He has a hx of arterial thrombosis of his right hand that led to auto amputation of digits 2-5 of his right hand. He later had bilateral femoral vein thromboses.  He has a hx of seizures and congenital hypothyroidism. He has GERD and is  s/p g-tube placement for nutrition",,,2,09/17/2019,,Y,,"Milk: intolerance, cause bloody stool"
0834157,09/17/2019,MT,43.0,43,,F,,"Patient came into the Health Clinic for a TB read on 9/13/19.  She reported to RN that she had received the pneumonia, influenza and TDaP vaccines at store on 9/11/19 following her TB placement.  She stated her right arm which she received 2 vaccines in was red, swollen and warm to the touch from her deltoid and almost down to her elbow.  She stated she had attempted to contact store but did not receive any help.  She stated she had taken some Tylenol and used an ice pack which seemed to help.  She planned to take Benedryl and use ice pack again and she will contact MD if symptoms do not improved or get worse.",,,,,,,,,U,09/11/2019,09/12/2019,1,NA,PHM,,"Oral birth control, vitamins, allergy medication",Unknown,Asthma,,,2,09/17/2019,,,,No
0834158,09/17/2019,MI,1.0,1,.0,F,,Patient was accidentally given an MMRV and Varicella. So patient received an extra Varicella.,,,,,,,,,U,09/17/2019,09/17/2019,0,none,PVT,,none,none,none,,,2,09/17/2019,,,,none
0834159,09/17/2019,FL,78.0,78,,M,,Patient received two vaccines.  He was seated as he received the vaccines.  A couple of minutes after he started feeling dizzy.  He sat down but then got back up too soon.  He walked a few steps then passed out.  He fell backwards and hit his head on the floor.  He was bleeding from the back of his head.  He passed out for about two minutes.  He did not stop breathing.  Then he came to but was very confused.  He seemed to be in a lot of pain from his head injury.  911 was called immediately.  He was taken to the hospital.,,,,,,,,,U,09/17/2019,09/17/2019,0,,PHM,,NONE,NONE,NONE,,,2,09/17/2019,,,Y,NO KNOWN ALLERGIES
0834160,09/17/2019,OH,62.0,62,,F,,"Patient called pharmacy 3 days post vaccination and reported symptoms of dizziness, leg pain (more clearly described as pins and needles type pain), low grade fever and general malaise. She indicated that it wasn't severe enough for a doctor visit.",,,,,,,,,U,09/13/2019,09/16/2019,3,"Patient reported on the questionnaire that there was no asplenia and no spleen damage. However upon reporting the adverse effects, the patient stated that she has had her spleen removed for 2 years.",PHM,,,,asplenia,,,2,09/17/2019,,,,
0834161,09/17/2019,TX,25.0,25,,M,,Patient felt light headed.  Fainted for a little bit. Patient was ok after a little while.,,,,,,,,,Y,09/17/2019,09/17/2019,0,,PHM,,,,,,,2,09/17/2019,,,,
0834162,09/17/2019,AZ,35.0,35,,F,,"Patient presents clinic for mild swelling and pain with a rash in her left upper arm after getting tetanus shot 4 days ago.      States the swelling has improved slightly over the last couple  days but wanted to make sure she was okay. She denies any      fevers or chills. She reports having tetanus injections in the past without reaction. arm and dry; has  erythematous rash of left upper arm 10x14cm marked with skin marker, no induration, or nodules; normal turgor; some warmth to touch, no lymphatic streaking.",,,,,,,,,U,08/15/2019,08/19/2019,4,None,PVT,,Lo-ogestrel 1 tab po qday,Abnormal Vaginal bleeding,None,,,2,09/17/2019,,,Y,Multivitamins - intolerance (exact intolerance not listed)
0834163,09/17/2019,CA,51.0,51,,M,,"strong headache, coughing and sneezing for a week. very low energy.",,,,,,,,,N,09/11/2019,09/11/2019,0,no,WRK,,no,no,no,,,2,09/17/2019,,,,no
0834164,09/17/2019,NJ,21.0,21,,M,,After receiving MMR #1 that night he developed severe hives all over his body and face but it  disappeared in the morning . He could not sleep and took Benadryl,,,,,,,,,Y,08/15/2019,08/15/2019,0,,SCH,,none,none,none,,,2,09/17/2019,,,,none
0834165,09/17/2019,IL,5.0,5,,F,,"Runny nose, fever, measles/rubella rash over entire body, mumps-swollen neck amd armpit.  Neck is still swollen as of 9-17-19",,,,,,,,,N,08/16/2019,08/30/2019,14,Negative for strep,PUB,,None,None,None,,,2,09/17/2019,,Y,Y,None
0834166,09/17/2019,PA,72.0,72,,F,,"Body aches, chills, warm, and swollen at site; bruised and red",,,,,,,,,Y,09/12/2019,09/12/2019,0,,PHM,,,,,high dose flu vaccine,,2,09/17/2019,,,,
0834167,09/17/2019,TX,1.0,1,.1,M,,Head to Toe Rash. No treatment. went away in 2 weeks.,,,,,,,,,Y,03/04/2019,03/14/2019,10,n/a,PVT,,Montelukast,Flu on 02/11/2019,n/a,,,2,09/17/2019,,Y,,"Trees, mold, grass, weeds"
0834168,09/17/2019,WI,78.0,78,,F,,"Red blistery rash in patches.   Dr. said it resembled shingles, but was spreading to more areas when treated.",,,,,,,,,Y,07/02/2019,08/14/2019,43,Only bllod test not skin test.,PHM,,"Multivitamin supplements, Folic Acid, Vitamin  B1",none,osteoarthris,,,2,09/17/2019,,Y,,"Malarone,  Nitrofurantin, Cipro"
0834169,09/17/2019,MI,13.0,13,,M,,No Adverse reactions patient fine and tolerated well.  Patient was given a TDAP and a Menveo  before it was due to give.  Mother was informed and aware.,,,,,,,,,Y,09/01/2019,09/17/2019,16,,SCH,,none,none,none,,,2,09/17/2019,,,,none
0834170,09/17/2019,AK,5.0,5,,U,,about an hour after vaccine administration (at 4:30pm) client began having a fever. Mother medicated with Tylenol. At 6pm the same day child refused dinner and Tylenol didn't break fever. Mother medicated with ibuprofen. child began complaining of stomach pain and inability to eat. At 10pm he complained of neck pain and inability to turn neck. At 2:30 AM on 9.15.19 he began vomiting and crying unconsolably. He was taken to local ER and later released same day. Mother reports when fever drops his stiff painful neck goes way and when fever spikes it hurts again. Highest temp 102.2 F. Client currently managed on Tylenol every four hours and out of school 9.16.19.,,,,,,,,,,09/14/2019,09/14/2019,0,none reported,UNK,,none,reports new anaphylaxis reaction to LATEX,none reported,,,2,09/17/2019,,,,LATEX
0834171,09/17/2019,TX,58.0,58,,M,,"Donor returned to center on 9/17/19 stating that he started feeling sick to his stomach, weak, nausea, belching, leg spasms, tired and exhausted, and lightheadedness on 9/14/19 around 12:00 pm after receiving the vaccine at 9:29 am on 9/14/19.  Donor stated that this feeling lasted until 9/16/19 around 12:00 pm and that he felt like a million dollars on 9/17/19.",,,,,,,,,Y,09/14/2019,09/14/2019,0,N/A,OTH,,"Lisinopril, Musinex DM, Ibuprofen",N/A,HTN,,,2,09/17/2019,,Y,,N/A
0834172,09/17/2019,NY,58.0,58,,F,,cellulitis in arm. put on cefadroxil,,,,,,,,,U,09/15/2019,09/16/2019,1,,PHM,,,,,,,2,09/17/2019,,Y,,
0834173,09/17/2019,CA,6.0,6,,F,,"Local injection site adverse events : symptoms of redness, swelling, warm to the touch, hardening  or area around injection site occurred about 4-5 hours after receiving the vaccine.  The size of irritation is approximately 2 inches wide. Patient is fine and  had no other adverse events from this particular influenza vaccine.  We put ice on the irritated area and gave one age appropriate dose of motrin.  Two other children siblings received the same vaccine at the same time and they did NOT have any adverse event.",,,,,,,,,Y,09/16/2019,09/17/2019,1,,PVT,,"Montelukast 5mg once daily, kirkland children's gummy multi-vitamin, lil critters omega-3 ,vitamin c, Loratidine 10mg once daily",asthma exacerbation 2 weeks prior to vaccine,Asthma,,,2,09/17/2019,,,,"peanuts, dairy"
0834174,09/17/2019,AZ,4.0,4,,F,,"Right arm: swollen, red, hot, hard, pain and  fever for 48 hrs",,,,,,,,,Y,09/13/2019,09/14/2019,1,"No laboratory done, but doctor said it was probably  a reaction to the tetanus vaccination which was one of many she received that day.",PVT,,none,none,none,,,2,09/17/2019,,Y,,none
0834175,09/17/2019,CO,30.0,30,,M,,"Redness, swelling, pain at injection site. High fever, elevated blood glucose, dehydration, nausea, fatigue. Saw MD, given IM and Oral antibiotics due to infection at injection site. Symptoms still present 7 days later.",,,,,,,,,N,09/10/2019,09/11/2019,1,,PHM,,,,type 1 diabetes,,,2,09/17/2019,,Y,Y,
0834176,09/17/2019,NV,83.0,83,,F,,Patient's husband called stating that the patient had neck pain/ throat pain and they think they see the start of a red line.,,,,,,,,,U,09/13/2019,09/17/2019,4,,PHM,,Metoprolol on medication history. No other medications filled at this pharmacy,,,,,2,09/17/2019,,,,NKDA
0834177,09/17/2019,PA,85.0,85,,F,,"Patient complained of ""excrutiating pain"" followed by difficulty breathing",,,,,,,,,U,09/16/2019,09/17/2019,1,,PHM,,,,,,,2,09/17/2019,,,,
0834178,09/17/2019,OR,62.0,62,,F,,"Patient reported ""large"" swelling around vaccine site, bruising and bleeding ""for 2 weeks""",,,,,,,,,Y,07/29/2019,07/29/2019,0,none,PHM,,acyclovir,none,none,,,2,09/17/2019,,,,nkda
0834179,09/17/2019,UT,63.0,63,,F,,"Right lateral upper arm with approx 10cm of well-demarcated circular, erythematous patch that is indurated in the center and slightly warm to touch. No red streaks or fluctuance.",,,,,,,,,U,09/11/2019,09/12/2019,1,none,PHM,,Vitamin B Complex Calcium Vitamin D Multivitamin,,,,,2,09/17/2019,,Y,,Penicillins Sulfa
0834180,09/17/2019,OH,67.0,67,,F,,Patient called and complained of increased pain in administration arm. Tried moving arm around but no improvement. nothing done in addition to increase movement noted by patient.,,,,,,,,,U,09/13/2019,09/17/2019,4,n/a,PHM,,"Lipitor, ABilify, Prozac, xanax",N/a,n./a,,,2,09/17/2019,,Y,,N/a
0834181,09/17/2019,CA,64.0,64,,M,,"Patient report severe body ache and severe pain at the injection site. Patient was unable to lie down without feeling pain resulting in insomnia for 2 days,  fever of 100F. He had had shingle before and what he experienced with the vaccine is the exact symptoms of shingle minus the lesions. He felt like the vaccine might had trigger his body to have shingle like symptoms. He was in so much pain that he wanted to go to the emergency room but he did not end up going there. On the third day after the vaccine was administered, patient is feeling a little bit better, no longer having fever but still having residual pain.",,,,,,,,,Y,09/13/2019,09/14/2019,1,,PHM,,lamisil 250 mg,Fungal infection,N/A,he had pain and fever but only for a day,,2,09/17/2019,,,,no known allergy
0834182,09/17/2019,,85.0,85,,M,,"Patient received Pneumovax and Flu in same arm. Once patient received Pneumovax, stated he was having trouble breathing and chest tightness, which then subsided. He then had lower back pain that was pulsating and radiating across his whole back. I called 911 and EMS was sent to the pharmacy. Patient was alert the whole time. Once EMS came, patients pain was lessening. Vitals taken. EMS and patient felt he was okay to go.",,,,,,,,,Y,09/15/2019,09/15/2019,0,,PHM,,Unsure,"Unknown, patient does have pacemaker and defibrillator",Hx of kidney cancer,,,2,09/17/2019,,,,Unsure
0834183,09/17/2019,UT,57.0,57,,F,,"presenting to clinic for arm pain, redness and swelling - Cellulitis of right upper extremity  Ceftriaxone 250 mg IM injection ordered and given to patient   ?rx written and sent for her to start Keflex 500 mg PO QID for seven days, with food   ?Advised on care instructions for cellulitis and strict ER and return precautions",,,,,,,,,U,09/11/2019,09/12/2019,1,,PHM,,Omeprazole biotin artificial tears Restasis,,,,,2,09/17/2019,,Y,,NKDA
0834184,09/17/2019,CA,27.0,27,,F,,shot recieved to left deltoid - left arm slightly swollen and painful - approx 2cm inderation to injection site,,,,,,,,,U,09/11/2019,09/12/2019,1,,PHM,,none,none,none,,,2,09/17/2019,,,Y,none
0834185,09/17/2019,CA,52.0,52,,F,,"7:30 pm Client noticed a painful lump at injection site with heat. Client iced 30 min on and off for approx. 3 hours without relief. Client c/o pain all night and disrupted sleep. next morning client c/o all over body aches and joint pain. IBU 800 mg Q6hours on following day with minor relief. Troubled sleep 09/14/2019 with pain. 09/15/2019 entire Lt. arm was hurting more than the rest of her body. IBU taken with no relief. 09/15/19 client slept better. 09/16/2019 full body aches were gone, but left arm still experiencing pain. Pain did not subside until 09/16/2019 in the evening. 09/17/2019 injection site still sore, warm, and swollen.",,,,,,,,,Y,09/13/2019,09/13/2019,0,none,PUB,,"propranolol, metformin, IBU, vitamin D-2, Lexapro, and vitamin suppliments",N/A,"asthma, DM II, obesity",,,2,09/17/2019,,,,NKA
0834186,09/17/2019,TN,40.0,40,,F,,"Hot, swollen , aching at injection sight",,,,,,,,,N,09/17/2019,09/17/2019,0,,PVT,,"Estradiol,  lexapro",None,None,,,2,09/17/2019,,,,None
0834187,09/17/2019,CO,8.0,8,,M,,No adverse reaction. This was just administered to a pediatric patient. Several days worth of follow up calls reported no adverse reaction.,,,,,,,,,Y,09/13/2019,09/13/2019,0,None,PVT,,None,None,None,,,2,09/17/2019,,,,None
0834188,09/17/2019,NY,56.0,56,,F,,"Patient came into the pharmacy today with a left arm that had redness  of varying degrees in splotches in her left arm between her elbow and shoulder. and said it was because of the shingles shot she had received 18 days earlier. I thought it was possibly infected and recommended that she see her primary care md for treatment. Pt was taking doxycycline, but she said it was for another reason.",,,,,,,,,U,08/31/2019,08/31/2019,0,"None known, recommendation was made for her to seek medical care from her physician",PHM,,"mucinex er 600mg, doxycycline monohydrate, 100 mg cap, folic acid, 1 mg, senna 8.6 mg, famotidine 40 mg, quetiapine 100 mg, atorvastatin 40 mg, perphenaziine 4 mg",none reported,unknown,,,2,09/17/2019,,,,Bupropion
0834189,09/17/2019,MA,36.0,36,,F,,Immediate shooting pain in upper arm and shoulder that continues even at rest and has now been 5 hours since injection and there is throbbing pain in left wrist as well. Tylenol and Aleve do not alleviate pain at all. Pain so severe it causes nausea (even before taking any OTC pain relievers).,,,,,,,,,N,09/17/2019,09/17/2019,0,No doctor?s visit yet as it has only been 5 hours but will be going if not resolved soon as SIRVA is highly suspected and pain is not tolerable.,WRK,,"Apri, adderall, multivitamin, probiotics, ginkgo biloba, amitriptyline, topiramate",None,None,,,2,09/17/2019,,,,NKDA
0834190,09/17/2019,TX,61.0,61,,M,,"ON 9/16/2019, PT RETURNED TO PHARMACY AND TOLD US THAT ON THE DAY HE RECEIVED THE VACCINE HE HAD TO GO THE EMERGENCY ROOM DUE TO SEVERE PAIN IN LEFT DELTOID, AND SAID THAT HE THOUGHT HE WAS HAVING A HEART ATTACK, AFTER BEING ADMITTED ER DOCTOR TOLF HIM THAT WHAT HE WAS EXPERIENCING WAS A RESULT OF THE VACCINE HITTING A NERVE.",,,,,Y,2,,,N,09/11/2019,09/11/2019,0,NOT KNOWN,PHM,,"TOPROL XL, COLCHICINE, METFORMIN, ARNUITY ELLIPTA, LISINOPRIL, ATORVASTATIN, VENTOLIN, ALLOPURINOL, NORCO 7.5/325, CHLORTHALIDONE",NOT KNOWN,"DIABETES, GOUT, HIGH BLOOD PRESSURE , CHRONIC PAIN, HIGH CHOLESTEROL , LUNG PROBLEMS",,,2,09/17/2019,,,Y,NO ALLERGY TO MEDICINE
0834191,09/17/2019,MA,56.0,56,,F,,extreme irritation and pain at injection site (abnormal),,,,,,,,,U,09/08/2019,09/09/2019,1,,PHM,,,,,,,2,09/17/2019,,Y,,
0834192,09/17/2019,TX,24.0,24,,M,,"patient started to feel warm, ringing in ear, blurred visions, signs of syncope with no true fainting, Patient monitored given ice pack, fan and water until cooled down. pt did not need to go to emergency room or call 911",,,,,,,,,Y,09/17/2019,09/17/2019,0,,PHM,,,,,,,2,09/17/2019,,,,
0834193,09/17/2019,NH,84.0,84,,M,,Brusing at site of injection,,,,,,,,,U,09/10/2019,09/11/2019,1,,PHM,,"finasteide, omeprazole, doxycycline, trazodone,lasix,lipitor, cozaar,amlodipine, clonidine",,,Patient reported that bruising has occurred before,,2,09/17/2019,,,,
0834194,09/17/2019,VA,76.0,76,,F,,"redness, warmth at site of injection.  Used a warm compress and bendaryl.",,,,,,,,,U,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/17/2019,,Y,,
0834195,09/17/2019,OH,12.0,12,,M,,"Fainting reaction: occurred 1-2 minutes after vaccine administration. Non-responsive for a few seconds, then brief response. Cold paper towels were applied to face and patient responded to questions. Patient drank some bottled water. Time from initial reaction  to recovery was approximately 20 minutes.",,,,,,,,,U,09/17/2019,09/17/2019,0,Unknown,PHM,,None listed,Unknown,Unknown,,,2,09/17/2019,,,,No known allergies
0834196,09/17/2019,AZ,60.0,60,,M,,"Patient call me today at 5:45pm and stated that today after eating lunch he experienced hives all over his bodyand his watch showed his heart rate to be low. He stated that it wasn't his lunch because he eats the same thing each day: a salad and sardines.  At the time of the call he stated his heart rate returned to normal but he still had hives on his arms.  I recommended that he go to urgent care if the reaction worsen or he felt hypotensive, shortness of breath, etc. He agreed. I also told him the PIC who administered his IMZ would contact his PCP in the morning and then follow up with the patient. I also recommended him to call back tonight and consult with me if anything worsened.",,,,,,,,,N,09/13/2019,09/17/2019,4,,PHM,,N/A,,"HYPERCHOLESTEREMIA, GASTROINTESTINAL PROBLEMS, ERECTILE DYSFUNCTION",,,2,09/17/2019,,,,"TETRACYCLINES, CELECOXIB"
0834197,09/17/2019,MI,64.0,64,,F,,"Extreme muscle pain, nausea,",,,,,,,,,N,09/16/2019,09/16/2019,0,,PHM,,"Humalog insulin, lasix, atovastin, cymbalta, aspirin, norvasc, amolodypine, ropinorole, Lipitor, melatonin, gas x, ibuprofen",None,"Gerd, type 1 diabetic, psoriatic arthritis, pernicious anemia, fibromyalgia",,,2,09/17/2019,,,,Sulfa drugs
0834198,09/17/2019,AL,61.0,61,,F,,Experienced fever and redness and tenderness in arm starting 72 hours after receiving vaccinations,,,,,,,,,U,09/11/2019,09/13/2019,2,,PHM,,,,,,,2,09/17/2019,,,,
0834199,09/17/2019,,78.0,78,,F,,"Patient received her first Shingrix vaccine on 9/16/19 at about 230pm.  Immediately after administration (after ban aid application) the patient stated she felt dizzy.  She remained seated and was given water and continued to be observed by the RPH for about 10-15 minutes before the patient told the RPH she was feeling better a able to walk to the front of the pharmacy to pay and then drive home.    The next morning  (9/17/19) the patient called the pharmacy stating that about 2 hours after the vaccine, at home, she started experiencing severe pain in her left arm and shoulder.  The pain had her screaming, becoming short of breath and lead to uncontrollable shaking of her arm and head.  She was taken to the local ED where she was given 2 doses of pain medication.  She had many tests that ruled out a seizure, but she did have multiple x-rays that the MD ruled may have shown that the vaccine was administered too high in the arm.   The patient then discharged from the ED at 930pm on 9/16/19.   During her call to the pharmacy at 1030am on 9/17/19 she was still had a lot of pain in her arm and shoulder and was awaiting her spouse to return from the pharmacy with her pain meds.  She stated that the ED MD attributed her SOB and shaking all to the pain she had been feeling.  Her plan was to rest.  Her chart was documented with the reaction and it was advised that for now, she does not plan to receive the 2nd dose of the Shingirx vaccine.",,,,,,,,,U,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/17/2019,,,Y,
0834200,09/17/2019,OH,87.0,87,,M,,"Patient stated that his arm was sore on the day of the vaccine and for two weeks after. He denies needing medical care or any other adverse reaction. He said he had the same reaction after the first dose, which was already reported.",,,,,,,,,Y,08/27/2019,08/27/2019,0,,PHM,,,,,,,2,09/17/2019,,,,
0834201,09/17/2019,CA,61.0,61,,F,,"swollen neck, severe rash on her legs since Thursday. Tried over the counter Benadryl, cortisone 10. Symptoms haven't resolved till Tuesday 09/17/2019",,,,,,,,,N,09/12/2019,09/12/2019,0,,PHM,,,,,,,2,09/17/2019,,Y,Y,
0834202,09/17/2019,KS,83.0,83,,F,,Patient received this shot one month too early.  She did not mention she had any side effects from this,,,,,,,,,Y,09/16/2019,09/17/2019,1,,PHM,,,,,,,2,09/17/2019,,,,
0834203,09/17/2019,CO,63.0,63,,F,,Patient developed Shingles- diagnosed by nurse practioner at the little clinic. Patient believed it may have been from the vaccine.,,,,,,,,,Y,08/27/2019,09/17/2019,21,,PHM,,patient does not take any prescription medications on file,,,,,2,09/17/2019,,Y,,NKDA
0834204,09/17/2019,MO,36.0,36,,F,,Fever 103.1 approximately 12 hours after administration  Body aches and pain (moderate),,,,,,,,,N,09/17/2019,09/17/2019,0,,WRK,,"Celebrex: 200 mg BID Vitamin D: 5,000 IU twice weekly Potassium Gluconate: 550 mg QDay Flonase nasal spray: 1 spray/nostril QDay",None,Vitamin D deficiency  Chronic joint inflammation,,,2,09/17/2019,,,,"NKDA, seasonal allergies"
0834205,09/17/2019,NY,8.0,8,,M,,My son developed edema that was diagnosed as Nephrotic Syndrome Minimal Change Disease. He was hospitalized 9/3/19. The first NP who saw him said ?this is a vaccine reaction?. He was transferred to hospital and put under the care of a Pediatric Nephrologist. He said the disease manifested ?2-4m? ago and it is ?idiopathic ? so we cannot pin point to the MMR date. But no virus happened and he said it?s viral triggered Or vaccine.,,,,,Y,3,,Y,N,05/03/2019,08/23/2019,112,Ultrasounds  X-ray  Bloodwork  Medication,PVT,,Omega 3-6-9 Probiotics  Vitamin D3 Vitamin C Multi,None remembered.,Gut issues and food allergies partially grown out of. Eczema when too much allergy food.,,,2,09/17/2019,,Y,Y,"Previous history of dairy, egg and soy allergy. Keep to1-2 servings per day."
0834206,09/17/2019,CA,20.0,20,,F,,"AFTER ADMINISTERING BOTH SHOTS  PATIENT SAID TO HER MOTHER SHE WANTED TO GO EAT.. PATIENTS MOTHER WAS ASKING QUESTIONS TO PHARMACIST  EVERYONE WAS STANDING AND DURING THAT TIME PATIENT FAINTED.. SHE DID NOT LOSE COMPLETE CONSCIOUSNESS  HER EYES WERE OPEN . MOTHER AND RPH TOOK PATIENT TO BENCH WHERE SHE WAS GIVEN WATER AND CANDY BAR. SHE SEEMED TO BE BECOMING MORE ALERT. MOM DID STATE PATIENT HAS FAINTED WHEN NERVOUS ETC AND MAYBE DID NOT EAT THE WHOLE DAY. . PATIENT DID NOT WANT US TO CALL DR OR ANY MEDICAL ASSISTANCE. AND AFTER RESTING FOR 15 TO 20 MINS  SHE LEFT WITH MOM. DID CALL PATIENT 9/17/19 LEFT MESSAGE BUT NO REPLY BACK FORM PATIENT YET,",,,,,,,,,Y,09/16/2019,09/16/2019,0,PT REFUSED FOR US TO CALL DR OR ANY EMERGENCY HELP,PHM,,NONE KNOWN,REPORTED NO ILLNESS,NONE,,,2,09/17/2019,,,,NO ALLERGIES
0834207,09/17/2019,CA,44.0,44,,F,,PATIENT IS STATING THE DAY SHE RECEIVED THE VACCINE SHE FELT PAIN IN HER RIGHT ARM AND IT KEPT GETTING WORSE WITH SOME FEELING OF NUMBNESS AND TINGLING AND COULD BARELY MOVE HER ARM. WENT TO HOSPITAL AND RECVIED A PAIN MEDICATION AND WAS ADVISED TO PUT COLD COMPRESSES THEN WENT TO AN ORTHOPEDIC WHICH GAVE HER A STEROID SHOT ON 9/10/2019  AND PATIENT IS STATING SHE IS A LITTLE BIT BETTER BUT STILL IN PAIN WHICH IS LIMITING HER FROM PERFORMING A LOT OF ACTIVITIES,,,,,,,,,N,08/20/2019,08/20/2019,0,,PHM,,,,,,,2,09/17/2019,,Y,Y,
0834249,09/17/2019,MO,70.0,70,,F,,PATIENT CAME IN ON MONDAY TO SHOW ME HER ARM. IT HAD REDNESS TWO TO THREE INCHES LOWER THAN THE INJECTION SITE. THERE WAS A BRUISE ON THE INJECTION SITE AND REDNESS LOWER. THE RED AREA WAS WARM TO THE TOUCH. MYSELF AND ANOTHER PHARMACIST LOOKED AT HER ARM ON TUESDAY AFTER TELLING HER TO TAKE BENADRYL AND APPLY ICE OR COLD WASH CLOTH TO THE AREA. IT HAD IMPROVED SINCE THE DAY BEFORE.,,,,,,,,,,09/15/2019,09/15/2019,0,,PHM,,,,,,,2,09/17/2019,,,,
0834250,09/17/2019,AZ,,62,,M,,Pt respresently called to say pt felt sick and having hard time getting out of bed. Was told to call MD if pt Sx were severe. MD then called And stated they administered Flu and Boostrix earlier that day. MD stated the were working with pt and to fill out VAERS. Pt dosed twice on Flu + TDP in same day.,,,,,,,,,U,09/16/2019,09/17/2019,1,N/A,PHM,,"Diazepam 5mg, Furosemide, Losartan, Azithromycin, Prometh/Codeine",Cold,HTN,,,2,09/17/2019,,Y,,N/A
0834251,09/17/2019,TX,66.0,66,,F,,Pt immediately complained of dizziness. She then felt back pain and numbness in her hands. I called 911 and EMS arrived. They checked her vitals and stayed with her for about 30 minutes. She then began to feel better. Her daughter-in-law came to pick her up. She instructed to follow up with healthcare provider.,,,,,,,,,Y,09/06/2019,09/06/2019,0,,PHM,,,,,,,2,09/10/2019,,,,None
0834255,09/17/2019,KS,74.0,74,,F,,"Patient reported swelling and warmth the next day after receiving vaccine. Patient applied cool compresses to the site, and swelling and warmth have decreased. She is also still experiencing headache and nausea. I contacted her physician and was informed to have patient come to office if symptoms worsen.",,,,,,,,,Y,09/14/2019,09/15/2019,1,N/A,PHM,,"Alprazolam, cetirizine, januvia, atenolol, fluticasone nasal spray, simvastatin, furosemide",,,,,2,09/17/2019,,,,
0834261,09/17/2019,KS,16.0,16,,M,,Right lower quadrant pain - started abruptly,,,,,,,,,U,09/16/2019,09/16/2019,0,"CBC, Urinalysis, CT abd/pelvis - 9/17/19",PVT,,"Duloxetine, HCTZ, Methylphenidate",Unknown,"ADHD, HTN",,,2,09/17/2019,,Y,Y,NKDA
0834262,09/17/2019,NY,7.0,7,,M,09/17/2019,"local redness, warmth + induration @ (L) deltoid",,,,,,,,,U,09/13/2019,,,,PVT,PUB,,none,reaction to DTaP in infancy,,,1,,,,,
0834263,09/17/2019,AZ,10.0,10,,F,,Patient has received DTAP & yearly Flu vaccine w/o adverse reaction in the past. 5 min after administration had hives on face without angioedema/wheezing/respiratory distress/stomach pain. Diphenhydramine administered and observed for 25 minutes,,,,,,,,,Y,09/16/2019,09/16/2019,0,Lipid panel drawn prior to hives Silver nitrate applied to nose for nosebleed,PVT,,NO,Nose bleed,None,,,2,09/16/2019,,Y,,NO
0834264,09/17/2019,OH,12.0,12,,M,09/17/2019,"Pt was given 4 vaccinations, Pt was seated after all were given pt laid his head down on his arm, This RN shook pt and said his name and he did not respond for 10 seconds. He responded after 10 seconds and was pale + Nauseous. Squad was called to evaluate. Left Health Dept with mother not squad. Was not taken to hospital.",,,,,,,,,Y,09/17/2019,09/17/2019,0,Pulse - 102  B/P 107/79 (88),PUB,UNK,,None,None,,,1,,,,,
0834265,09/17/2019,AK,5.0,5,,U,,"9/13/19 onset sleeplessness, waking up crying, cold symptoms, diarrhea, fever 9/17/19 called public health for advice, advised to seek MD care, MD treated child for ear infection with antibiotics 9/18/19 bilateral hearing loss persists, mom states her concern VIS states MMR can result in deafness",,,,,,,,,N,09/05/2019,09/13/2019,8,,PUB,,,,,,,2,09/17/2019,,Y,,
0834266,09/17/2019,CA,24.0,24,,F,09/17/2019,"sore throat, headache, to fever for 4 days.",,,,,,,,,U,09/13/2019,09/14/2019,1,,OTH,PVT,No,No,No,,,1,,,,,
0834318,09/17/2019,KS,63.0,63,,F,09/17/2019,"pt received 1st dose of Shingrix on Sept 8, 2019, developed shingle (one spot near shoulder on her back) on Sept. 9, 2019. also low grade fever, fatigue, red dots around injection site. Currently taking Valtrex for the singles. Pt had a shingle episode in July 2019, recovered, dr. sent her to get shingle shot.",,,,,,,,,,09/08/2019,09/09/2019,1,,OTH,OTH,,,,,,1,,,,,
0834208,09/18/2019,CA,2.0,2,.8,M,,"24 HOURS after vaccine was given, it was noticed that the patient's injection site was very red, irritated, swollen, hard and warm  to the touch, and appeared bruised.  The area was approximately 3 inches wide. Patient did not have any other concerns  other than local irritation. Patient was given motrin and cold compresses to the swollen /affected area.",,,,,,,,,U,09/16/2019,09/17/2019,1,,PVT,,none,none,none,,,2,09/18/2019,,,,none
0834209,09/18/2019,AZ,32.0,32,,F,,"Patient reported soreness, redness, and swelling where the shot was given.",,,,,,,,,U,09/16/2019,09/17/2019,1,,PHM,,,,,,,2,09/18/2019,,,,
0834210,09/18/2019,CA,76.0,76,,F,,"REDNESS, SWELLING, HIGH TEMPERATURE. PER PATIENT PNEUMOVAX WAS GIVEN ON LEFT ARM.",,,,,,,,,U,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/18/2019,,,,
0834211,09/18/2019,OR,37.0,37,,F,,"full body itching onset approximately 6 or 7 pm, lasting until after I took Benedryl and fell asleep around midnight. Felt weak with weak pulse.",,,,,,,,,Y,09/16/2019,09/16/2019,0,,PVT,,"vitamin d, vitamin b, cbd, zoloft",coming down with cold,,,,2,09/18/2019,,,,intolerance to oxycodone
0834212,09/18/2019,FL,1.08,1,.1,F,,"Fever, Febrile Seizures",,,,,,,,,N,08/25/2019,08/25/2019,0,"Er visit: Vomiting (09/13), Fever, Increased Heart Rate (170bpm), Febrile Seizure",PVT,,None,None,None,,,2,09/18/2019,,Y,Y,Milk protein allergy
0834213,09/18/2019,MA,58.0,58,,F,,"headache, body aches, chills, nausea, feeling so sick that I had to go to bed last night and still not feeling right this morning",,,,,,,,,N,09/17/2019,09/17/2019,0,none (not yet anyway),PVT,,none,none,none,,,2,09/18/2019,,,,walnuts
0834214,09/18/2019,PR,1.0,1,.1,F,,Grandmother refers that the child had a fever and was vomiting with phlegm.,,,,,Y,1,,,N,09/03/2019,09/03/2019,0,WBC and it was elevated,OTH,,No,No,No,,PR-06-2019,2,09/18/2019,,,,No
0834215,09/18/2019,VA,54.0,53,,F,,"my arm was a little sore on monday, and the site of injection was red... Tuesday the red area had grown to about 3"" in diameter.  Tuesday about 5 pm, I started having chills and felt like I was freezing, muscle aches, head aches, exhausted but was not able to sleep.  Wednesday, I feel like someone hit me with a baseball bat, and  the injection site is red and inflamed.",,,,,,,,,N,09/16/2019,09/17/2019,1,none,PHM,,none,none,none,,,2,09/18/2019,,,,contrast die
0834216,09/18/2019,OH,0.58,0,.6,M,,Kinrix was given to a 7 mo old new patient for her Dtap/IPV immunization requirement.  The child was behind on his shots though the kinrix is only approved for kids at least 4 yo.  Mom notified 9/18/19.  No unusual local reaction.  No fever.  Doing well.  Have had contact with the CDC regarding this error - this dose of the Dtap & IPV do not need to be repeated.,,,,,,,,,Y,09/12/2019,09/16/2019,4,,PVT,,None,None,None,,,2,09/18/2019,,,,None
0834223,09/18/2019,OR,,,,U,,"No adverse effects; a patient was administered an improperly stored ROTATEQ.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.     On 22-AUG-2019 the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # S010702, expiration date 16-JAN-2021; strength, route, dose and frequency were not reported) for prophylaxis (improper storage of product in use)and no adverse effects. The outcome of the event was unknown.",,,,,,,,,U,08/22/2019,08/22/2019,0,,UNK,,,,,,US0095075131908USA011075,2,09/18/2019,,,,
0834224,09/18/2019,,,24,,F,,"The menstrual cycle as being ""normal at first"".However, the patient continued bleeding and is still bleeding at the time of the report The patient reported that the bleeding is ""mainly at night with some clotting""; The patient does not normally have a menstrual cycle that lasts 2.5 weeks; This spontaneous report was received from the medical assistant, referring to a 25-year-old female patient. The patient's pertinent history was not provided, it was reported that the patient did not have previously drug reactions or allergies. The patient's concurrent conditions included genital herpes, and his concomitant therapies included acyclovir, anxiety, depression, and acid reflux medications.   On 18-JUN-2019 the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (lot number and expiration date were not reported), and on 19-AUG-2019 the patient received the second dose hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, lot number 1602283 has been verified to be valid for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast); expiration date 16-AUG-2019); both vaccines were administered intramuscularly, in left deltoid, as disease prevention. On 19-AUG-2019, the patient began her menstrual cycle which was on time, the patient reported that the menstrual cycle as being normal as first, however the patient continued bleeding, and the bleeding was mainly at night with some clotting (menorrhagia). The patient's menstrual cycle had lasts 2.5 weeks (menstrual disorder). It was reported that the patient did not received any treatment for the events, and neither laboratory diagnostics or studies were performed to the patient, however it was reported that the patient called to the physician for sought medical attention.   At the time of this report, the outcome of the events menorrhagia and menstrual disorder was reported as not recovered.  The relatedness between the aforementioned events and therapy with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9)  was not reported.",,,,,,,,,N,06/18/2019,08/19/2019,62,,UNK,,acyclovir,Genital herpes,,,US0095075131909USA002368,2,09/17/2019,,,,
0834225,09/18/2019,OH,,,,U,,"patients received improperly stored doses of vaccines; No adverse effects reported; This spontaneous report was received from a nurse and refers to multiple unspecified patients of unknown age and gender. Patients' s concurrent conditions, concomitant therapies, previous drug reactions, allergies, historical drugs or medical history were not reported.  Since 12-JUN-2019, on multiple unspecified dates, the patients received improperly stored doses (product storage error) of: (rha) measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot numbers R014690 and R002510 with expiration dates on 23-MAY-2020 and 25-JAN-2020 respectively; rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot numbers R035673, R015439, and R003111 with expiration dates on 19-SEP-2020, 19-APR-2020, and 12-SEP-2019 respectively; and hepatitis a vaccine, inactivated (VAQTA) lot numbers R018935, expiration date on R018935 (strength, dose, frequency, route of administration, anatomical location, and indication were not reported for all therapies). The lot number and expiration date for properly stored sterile diluent ( Merck sharp and Dhome) use to reconstitute (rha) measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) were unknown by the reporter. There was no adverse effect reported.  The administered doses of vaccine experienced a temperature of excursion of 61.5 degrees Fahrenheit and the highest above 47 degrees Fahrenheit (9 degrees Celsius) for 6 hours and 15 minutes. The previous temperature of excursion was 46.7 degrees Fahrenheit and the highest above 47 degrees Fahrenheit (9 degrees Celsius) for 1 hour. Data logger was involved.",,,,,,,,,U,,,,,UNK,,sterile diluent,,,,US0095075131909USA002391,2,09/17/2019,,,,
0834226,09/18/2019,IL,,4,,U,,"No adverse effect reported; On 27-AUG-2019, one patient received an improperly stored VARlVAX; This spontaneous report was received from a nurse and concerns to a 4 year old patient of unknown gender. The patient's historical condition, and drug reactions or allergies were not reported. Concomitant therapies included sterile diluent.     On 27-AUG-2019,  the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) (dosage schedule, route, anatomical location were not reported)(it can not be determined which lot number was vaccinated the patient (R006221 and expiration date 29-FEB-2020 or R029517 and expiration date 14-OCT-2020)) for prophylaxis. The administered dose of the vaccine experienced a temperature excursion of -14 degrees Celsius to -10 degrees Celsius for 8 hours as recorded by a data logger. No previous temperature excursion was reported. There was no adverse effect reported.; Sender's Comments:  US-009507513-1909USA006332: US-009507513-1909USA006331: US-009507513-1909USA006333: US-009507513-1909USA006330: US-009507513-1909USA006334: US-009507513-1909USA006329: US-009507513-1909USA006328:",,,,,,,,,U,08/27/2019,08/27/2019,0,,UNK,,STERILE DILUENT,Prophylaxis,,,US0095075131909USA002960,2,09/17/2019,,,,
0834227,09/18/2019,ID,,11,,F,,"No adverse effect reported.; received improperly stored PROQUAD; Information has been received from a medical assistant referring to a 11 year old female patient. Concomitant therapy included sterile diluent. Information about concurrent condition, drug reactions/allergies and medical history was not provided.  On 16-AUG-2019, the patient received improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (therapy type was rHA, lot # was R015741, expiration date was 02-DEC-2019; strength and route were not reported) for prophylaxis; reconstituted with properly stored sterile diluent (lot # and expiration were unknown by the reporter). No adverse effects were reported.  The vaccine had temperature excursion of 6 Fahrenheit (F) degree to 14F degree (14F degree) for 1 hour and 8 minutes. Previous temperature excursion of 15F degree to 46F degree (42.8F degree) for 37 hours and 7 minutes. The call was due to the digital data logger.",,,,,,,,,U,08/16/2019,08/16/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA004011,2,09/18/2019,,,,
0834228,09/18/2019,,,,,F,,"Not able to move her arm; This spontaneous report was received from a consumer refers to a female patient of unknown age. The patient's medical history, concurrent conditions, historical dugs and concomitant medications were not reported. On an unknown date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (strength, dose, frequency, route, lot # and expiration date not reported) for prophylaxis. On an unknown date, the patient was not able to move her arm (injected limb mobility decreased). The outcome of injected limb mobility decreased was unknown. The causality assessment was not provided by the reporter.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA005356:",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA004907,2,09/18/2019,,,,
0834229,09/18/2019,TX,,,,U,,"No adverse effects reported; Improperly stored vaccine was administered to one patient; Assistant confirmed route of administration was ""intramuscular""; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported.  On 13-SEP-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 ml, once, intramuscularly, lot No. S002736, expiration date 28-JAN-2021, for prophylaxis (strength was not reported). Varicella virus vaccine live (Oka/Merck) (VARIVAX) was reconstituted with a properly stored sterile diluent (MERCK STERILE DILUENT), possible lot # S000130, expiration date reported as 23-AUG-2021.  The temperature excursion was of 8.1 Fahrenheit degrees (F), during 20 minutes. However, a previous temperature excursion of 8.1F for 17 minutes and 9.5F for 21 minutes were also reported. A digital data logger was involved. No adverse effects were reported.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,MERCK STERILE DILUENT,,,,US0095075131909USA005681,2,09/17/2019,,,,
0834230,09/18/2019,NY,,,,U,,"No adverse symptoms reported; the patient was vaccinated with expired VAQTA (R021233 exp 9/5/2019); This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported.  On 16-SEP-2019, the patient was vaccinated with an expired dose of  hepatitis a vaccine, inactivated(VAQTA) lot# R021233, expiration date 05-SEP-2019, for prophylaxis (strength, dose, route and frequency were not reported). No adverse symptoms reported.  The nurse stated that hepatitis a vaccine, inactivated(VAQTA) did not have any temperature excursions prior to vaccination.",,,,,,,,,U,09/16/2019,09/16/2019,0,,UNK,,,,,,US0095075131909USA006193,2,09/17/2019,,,,
0834234,09/18/2019,IL,,5,,U,,"No adverse effect reported; one patient received an improperly stored VARlVAX; This spontaneous report was received from a nurse and concerns to a 5 year old patient of unknown gender. The patient's historical condition, and drug reactions or allergies were not reported. Concomitant therapies included sterile diluent.   On 21-AUG-2019,  the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (Oka-Merck) Virus Vaccine Live (PROQUAD)(dosage schedule, route, anatomical location were not reported)(it can not be determined with which lot number was vaccinated the patient (R026722 and expiration date 17-MAR-2020 or R023499 and expiration date 13-FEB-2020)) for prophylaxis. The administered dose of the vaccine experienced a temperature excursion of -14 degrees Celsius to -10 degrees Celsius for 8 hours as recorded by a data logger. No previous temperature excursion was reported. There was no adverse effect reported.; Sender's Comments:  US-009507513-1909USA002960: US-009507513-1909USA006332: US-009507513-1909USA006333: US-009507513-1909USA006330: US-009507513-1909USA006334: US-009507513-1909USA006329: US-009507513-1909USA006328: US-009507513-1909USA006341:",,,,,,,,,U,08/21/2019,08/21/2019,0,,UNK,,STERILE DILUENT,Prophylaxis,,,US0095075131909USA006331,2,09/17/2019,,,,
0834235,09/18/2019,IL,,4,,U,,"No adverse effect reported; one patient received an improperly stored VARlVAX; This spontaneous report was received from a nurse and concerns to a 4-year-old patient of unknown gender. The patient's historical condition, and drug reactions or allergies were not reported. Concomitant therapies included sterile diluent.    On 21-AUG-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (Oka-Merck) Virus Vaccine Live (PROQUAD)(dosage schedule, route, anatomical location were not reported)(it cannot be determined with which lot number was vaccinated the patient (R026722 and expiration date 17-MAR-2020 or R023499 and expiration date 13-FEB-2020)) for prophylaxis. The administered dose of the vaccine experienced a temperature excursion of -14 degrees Celsius to -10 degrees Celsius for 8 hours as recorded by a data logger. No previous temperature excursion was reported. There was no adverse effect reported.; Sender's Comments:  US-009507513-1909USA002960: US-009507513-1909USA006331: US-009507513-1909USA006333: US-009507513-1909USA006330: US-009507513-1909USA006334: US-009507513-1909USA006329: US-009507513-1909USA006328: US-009507513-1909USA006341:",,,,,,,,,U,08/21/2019,08/21/2019,0,,UNK,,STERILE DILUENT,Prophylaxis,,,US0095075131909USA006332,2,09/17/2019,,,,
0834236,09/18/2019,WA,25.0,25,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 25-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's past medical history included two previous pregnancies resulting in normal births of two full-term infants with no defects.  Prior to becoming pregnant the subject had not been using contraception.  On 7 September 2011 at 12:00 the subject received a booster dose of Boostrix (o.5 unknown units, intramuscular, left arm), and experienced vaccine exposure during the third trimester of her pregnancy.  The conception was reported to be normal.  The subject was approximately 28 weeks gestation at the time of vaccination.  Date of last menstrual period was 25 January 2011 and estimated delivery date was 27 November 2011.  Prenatal testing including ultrasounds on 11 April 2011 and 20 June 2011, and maternal serum alpha-fetoprotein on 10 June 2011, had revealed no evidence of a defect.   Upon internal review done on 17th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound tests on 11 April 2011 and 20 June 2011 revealed no evidence of a defect. Maternal serum alpha-fetoprotein on 10 June 2011 revealed no evidence of a defect.",,,,,,,,,U,09/07/2011,09/07/2011,0,,UNK,,,,Medical History/Concurrent Conditions: Live birth; No adverse event (There was no relevant maternal or paternal medical history.),,USGLAXOSMITHKLINEA0944817,2,09/17/2019,,,,
0834237,09/18/2019,WA,24.0,,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 24-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's past medical history included one previous pregnancy resulting in normal birth of a full-term infant with no defects.  The subject had not been using contraception prior to becoming pregnant.  On an unspecified date the subject received a dose of Boostrix (intramuscular, unknown site), and experienced vaccine exposure during pregnancy.  Gestational age at the time of vaccination was unspecified.  Date of last menstrual period was 03 March 2011 and estimated date of delivery was 08 December 2011.  The conception was reported to be normal.  Prenatal testing including ultrasound on 26 July 2011 and maternal serum alpha-fetoprotein on 29 June 2011 had revealed no evidence of a defect.   Upon internal review done on 17th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound on 26 July 2011 and maternal serum alpha-fetoprotein on 29 June 2011 revealed no evidence of a defect.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Live birth; No adverse event (There was no relevant maternal or paternal medical history.),,USGLAXOSMITHKLINEA0945871,2,09/17/2019,,,,
0834238,09/18/2019,WA,19.0,19,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 19-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's past medical history included no previous pregnancies.  The subject had not been using contraception before becoming pregnant.  On 21 September 2011 the subject received booster dose of Boostrix (.5 ml, intramuscular, unknown site), and experienced vaccine exposure during the third trimester of her pregnancy.  The conception was reported to be normal.  The subject was approximately 28 weeks gestation at the time of vaccination.  Date of last menstrual period was 05 March 2011 and estimated date of delivery was 10 December 2011.  Prenatal testing including ultrasound on 14 June 2011 and maternal serum alpha-fetoprotein on 22 July 2011 had revealed no evidence of a defect.   Upon internal review done on 17th September 2019, the pregnancy outcome was updated to lost to follow-up.       Lab Comments: Lab Tests: Ultrasound on 14 June 2011 and maternal serum alpha-fetoprotein on 22 July 2011 revealed no evidence of a defect.",,,,,,,,,U,09/21/2011,09/21/2011,0,,UNK,,,,,,USGLAXOSMITHKLINEA0945873,2,09/17/2019,,,,
0834239,09/18/2019,WA,34.0,,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 34-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's medical history included drug abuse, and four previous pregnancies resulting in one elective abortion, one spontaneous abortion, and two normal births of infants.  Concurrent medical conditions included drug abuse on methadone.  The subject was not using contraception prior to becoming pregnant.  On an unspecified date the subject received a dose of Boostrix (intramuscular, unknown site), and experienced vaccine exposure during pregnancy.  Gestational age at the time of vaccination was unknown.  The conception was reported to be normal.  Date of last menstrual period was 19 January 2011 and estimated date of delivery was 26 October 2011.  Prenatal testing including ultrasounds on 22 April 2011 and 28 June 2011 and sequencial screening had revealed no evidence of a defect.   Upon internal review done on 18th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound on 22 April 2011 and 28 June 2011 revealed no evidence of a defect. Sequencial screen revealed no evidence of a defect.",,,,,,,,,U,,,,,UNK,,,Drug abuse,Medical History/Concurrent Conditions: Drug abuse; Induced abortion; Live birth; No adverse event (The father of the baby had a history of drug use.); Spontaneous abortion,,USGLAXOSMITHKLINEA0946035,2,09/18/2019,,,,
0834240,09/18/2019,WA,20.0,20,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 20-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's past medical history included no previous pregnancies.  The subject was not using contraception prior to becoming pregnant.  On 22 September 2011 the subject received a dose of Boostrix (.5 unknown units, intramuscular, unknown site), and experienced vaccine exposure during the second trimester of her pregnancy.  The subject was approximately 26 weeks gestation at the time of vaccination.  The conception was reported to be normal.  Date of last menstrual period was 19 March 2011 and estimated date of delivery was 24 December 2011.  Prenatal testing including ultrasound on 16 August 2011 had revealed no evidence of a defect.  Maternal serum alpha-fetoprotein had been declined.   Upon internal review done on 18th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound on 16 August 2011 had revealed no evidence of a defect.",,,,,,,,,U,09/22/2011,09/22/2011,0,,UNK,,,,,,USGLAXOSMITHKLINEA0946038,2,09/18/2019,,,,
0834241,09/18/2019,WA,35.0,35,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 35-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's medical history included two previous pregnancies resulting in two spontaneous abortions.  Prior to becoming pregnant the subject was not using contraception.  On 31 August 2011 the subject received booster dose of Boostrix (.5 unknown units, intramuscular, unknown site), and experienced vaccine exposure during the second trimester of her pregnancy.  The subject was approximately 21 weeks gestation at the time of vaccination.  The conception was reported to be normal.  Date of last menstrual period was 02 April 2011 and estimated date of delivery was 07 January 2012.  Prenatal testing including ultrasound and maternal serum alpha-fetoprotein on 01 August 2011 had revealed no evidence of a defect.   Upon internal review done on 18th September 2019, the pregnancy outcome was updated to lost to follow-up.       Lab Comments: Lab Tests: Ultrasound and maternal serum alpha-fetoprotein on 01 August 2011 revealed no evidence of a defect.",,,,,,,,,U,08/31/2011,08/31/2011,0,,UNK,,,,Medical History/Concurrent Conditions: No adverse event (There was no relevant maternal or paternal medical history.); Spontaneous abortion,,USGLAXOSMITHKLINEA0946040,2,09/18/2019,,,,
0834242,09/18/2019,FL,,,,U,,"soreness; nausea; headache; body ache; flu like symptoms; not feeling well; diarrhea; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm, nausea, headache, general body pain, influenza-like symptoms, feeling unwell and diarrhea. On an unknown date, the outcome of the pain in arm, nausea, headache, general body pain, influenza-like symptoms, feeling unwell and diarrhea were unknown.   It was unknown if the reporter considered the pain in arm, nausea, headache, general body pain, influenza-like symptoms, feeling unwell and diarrhea to be related to Shingrix.  Additional details were provided as follows: This case was reported by the pharmacist on behalf of her co-worker who spoke about another patient who had similar side effects, however, her co-worker had no details to provide. The patient demographic details were not provided. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The age at vaccination was not reported. The patient experienced pain in arm, nausea, headache, general body pain, influenza-like symptoms, feeling unwell and diarrhea, after vaccination with dose of Shingrix. The reporter consented to follow up. This case has been linked with case US2019158433, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/18/2019,,,,
0834243,09/18/2019,NE,,,,M,,"Nausea; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date, refer case US2019AMR167659).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced nausea. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the nausea was recovered/resolved.   It was unknown if the reporter considered the nausea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, her friend's husband received dose of Shingrix and next day after vaccination experienced nausea. The nausea recovered in 1 days. The reporter did not provide additional details. This was 4th of 4 reports described by the reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834244,09/18/2019,PA,0.5,0,.5,M,,"Medical Assistant forgot to mix the ActHIB and the Ipol and the DTAP and only injected the Ipol and DTAP/ No AE; Initial information received on 26-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 6 months old male patient for whom it was reported that Medical Assistant forgot to mix the ActHIB and the Ipol and the DTAP and only injected the Ipol and DTAP (Inappropriate reconstitution technique) while received vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] 0.5 mL dose, lot C5426AA via intramuscular route in the left thigh on 26-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccinations included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for Immunisation; and HEPATITIS B VACCINE (HEPATITIS B VACCINE) for Immunisation.  It was a case of actual medication error due to inappropriate reconstitution technique.  The patient did not have any AE as a result of this event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,08/26/2019,,,,UNK,,PREVNAR; HEPATITIS B VACCINE,,,,USSA2019SA239522,2,09/17/2019,,,,
0834245,09/18/2019,LA,,4,,F,,"Quadracel administered to patient inadvertently on 10/16/2018 and 08/09/2019, no AE; Initial information received on 09-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 4 years old female patient who was inadvertently given 0.5 ml DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] (lot C5500CA, expiry date: 16-Aug-2020 via intramuscular route in the left deltoid) on 16-Oct-2018 and on 09-Aug-2019.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3), VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (PROQUAD) for Immunisation.  It was an actual medication error due to extra dose administered.  It was unknown if any adverse event occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,10/16/2018,,,,UNK,,PROQUAD,,,,USSA2019SA254158,2,09/16/2019,,,,
0834246,09/18/2019,CT,72.0,,,F,,"consumer felt the wetness, sprayed some of the injection out upon removing the needle from the consumer arm, no AE; plunger was more difficult than usual, no AE; Initial information received on 10-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 72 years old female patient who was vaccinated with a dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (frequency once) lot UJ221AB, expiry date: 01-Apr-2020 via intramuscular route in the left deltoid on 10-Sep-2019.  The patient's past medical history, medical treatment(s), concomitant medications and family history were not provided.  It is an actual medication error case due to vaccine under dose and it is also a case of syringe issue. It was reported that having difficulty while pressing down the plunger, the plunger was more difficult than usual and nurse reported that may have sprayed some of the injection out upon removing the needle from the consumer arm.  At the time of this report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/10/2019,,,,UNK,,,,,,USSA2019SA254198,2,09/17/2019,,,,
0834247,09/18/2019,PA,,,,M,,"a 15 months old patient received a dose of Pentacel which had a temperature excursion below zero/No AE; Initial information received and additional information received on 10-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case is linked to cases 2019SA255196, 2019SA254282 and 2019SA255195 (same reporter).  This case involves a 15 months old male patient who received a 0.5 ml fourth dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] which had a temperature excursion below zero/ lot UJ135AA, expiry date: 26-Feb-2021 via intramuscular route in the left thigh on 12-Jul-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccination included MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR).  It was an actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,07/12/2019,,,,UNK,,MMR,,,,USSA2019SA255155,2,09/17/2019,,,,
0834248,09/18/2019,PA,,,,M,,"a patient received a 0.5 ml second dose of Pentacel vaccine which had a temperature excursion below zero, no adverse event; Initial information received on 10-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case is linked to cases 2019SA255196, 2019SA255155 and 2019SA254282 (same reporter).  This case involves a four months old male patient who received a 0.5 ml second dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/ IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] vaccine which had a temperature excursion below zero lot UJ135AA, expiry date: 26-Feb-2021 via intramuscular route in the left thigh on 12-JUL-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccinations included a dose of PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE).  It was an actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,07/12/2019,,,,UNK,,PREVNAR; ROTAVIRUS VACCINE,,,,USSA2019SA255195,2,09/17/2019,,,,
0834252,09/18/2019,IL,61.0,61,,F,,"Pt stated that she thought the placement was not into the muscle.  She was getting radiating nerve pain down the back of her arm.  She came in with the bandaid still intact and it looked to be more towards the back of her arm, almost subcutaneously.",,,,,,,,,U,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/18/2019,,,,
0834253,09/18/2019,,67.0,67,,F,,"REDNESS SIZE OF BASEBALL, HOT TOTOUCH, PATIENT STATES VERY SWOLLEN THE DAY BEFORE BUT THAT SEEMS TO HAVE RESOLVED, INJECTION SITE MIDWAY DOWN ARM NOT IN DELTOID",,,,,,,,,,08/19/2019,08/21/2019,2,,UNK,,,,,,,2,09/18/2019,,Y,,
0834254,09/18/2019,FL,61.0,61,,F,,"Arm very swollen, red and hot to touch.",,,,,,,,,U,09/15/2019,09/15/2019,0,Visited minute clinic and was prescribed an antibiotic and steroid. will follow up with the patient again today - wed,PHM,,,,,,,2,09/18/2019,,Y,,
0834267,09/18/2019,IA,71.0,71,,M,,"Extreme dizziness, chills, vomiting, diarrhea",,,,,,,,,Y,09/17/2019,09/17/2019,0,,PHM,,,,,70yrs flu vaccine,,2,09/18/2019,,,,
0834268,09/18/2019,LA,16.0,16,,M,,"POST VACCINATION PATIENT REPORTED NOT FEELING WELL, TURNED PALE AND CLAMMY BUT DID NOT LOSE CONSCIOUSNESS. PATIENT DID NOT FALL D/T NEAR SYNCOPE EPISODE. BP 114/66 RIGHT ARM LYING DURING EPISODE. HR 66. PATIENT WAS SITTING IN A CHAIR W/HIS HEAD DOWN, BETWEEN HIS KNEES WHEN I ENTERED THE ROOM. DAD REPORTED HE DID NOT FEEL GOOD. PATIENT INSTRUCTED TO LAY DOWN ON EXAM TABLE, FEET ELEVATED X 5 MINUTES W/COOL CLOTH PLACED ON FOREHEAD. ABOUT 3 MINUTES AFTER LYING DOWN, PATIENT BEGAN FEELING BETTER. AFTER 5 MINUTES OF LYING DOWN W/FEET ELEVATED HE SAT UP FOR A 5-7 MINUTES AND HE WAS GIVEN A BOTTLE OF WATER, A PACKAGE OF FRUIT SNACKS, AND SOME CANDY TO DRINK/EAT. HE THEN STOOD UP FOR A FEW MINUTES AND THEN WAS D/C FEELING NORMAL AFTER 15 MINUTES OF OBSERVATION. DISCUSSED W/PATIENT AND DAD PATIENT HAD A VASOVAGAL RESPONSE TO THE VACCINATION WHICH IS NOT AN ADVERSE REACTION TO VACCINATION. UNDERSTANDING VOICED",,,,,,,,,Y,09/17/2019,09/17/2019,0,NONE,PVT,,NONE,NONE,WELL CHILD. NO CHRONIC HEALTH CONDITIONS.,,,2,09/18/2019,,,,NONE
0834269,09/18/2019,GA,0.75,0,.8,F,,"The patient was flush and felt warm to the touch. She didn't register a fever that day but temperature was taken multiple times. She was very fussy (crying and didn't want to eat) around dinner time and I took her upstairs to get her ready for bed around 6:30pm. I gave her the bottle while I changed her diaper and put on pajamas. When I took the bottle away, she stared blankly and I picked her up. Her body went limp and her eyes rolled back. I immediately patted her back and yelled her name and she came back to consciousness within a couple of seconds. She cried for a little while and I gave her a pacifier to help soothe her. This all happened between 6:30 and 6:40pm.",,,,,,,,,Y,09/16/2019,09/17/2019,1,I took the patient to the ER and they ran an EKG on her. They said it looked normal.,PVT,,Probiotic,,Acid Reflux; Heart Murmur,,,2,09/18/2019,,,Y,N/A
0834270,09/18/2019,NC,35.0,35,,F,,"By the next morning had painful quarter size knot, red and hot to the touch. Throbbing pain radiating down right arm from knot. Fatigue, headache.",,,,,,,,,U,09/16/2019,09/17/2019,1,None,WRK,,esomeprazole 40mg ranitidine 150mg,none,GERD,,,2,09/18/2019,,,,"Cipro tendon inflammation. Latex sensitivity. Lactose intolerance,"
0834271,09/18/2019,NJ,84.0,84,,M,,Patient experienced swelling at the injection site that would not subside with ice and benadrul,,,,,,,,,Y,09/11/2019,09/12/2019,1,Patient went to urgent care and was prescribed an antiobiotic,PHM,,,,,,,2,09/18/2019,,Y,,
0834272,09/18/2019,TX,32.0,32,,F,,"Pt started to have swelling in throat, and swelling in hands complained of mouth dry at 15 mins after receiving flu shot. Pt was seen by nurse practitioner and given Epi Pen, Benadryl 25 mg IM, and non-rebreather was applied. V/S was monitored and EMS was intiated and arrived to pick up patient to take her to the ER.",,,,,,,,,Y,09/17/2019,09/17/2019,0,None,WRK,,None,None,None,,,2,09/18/2019,,Y,Y,"Mango, Peanuts, Bananas, Latex"
0834273,09/18/2019,KY,4.0,4,,M,,Received a call form parent and said they had a local reaction,,,,,,,,,U,09/06/2019,09/06/2019,0,none,PVT,,unsure,none,,,,2,09/18/2019,,,,NKDA
0834274,09/18/2019,OH,62.0,62,,F,,"Extreme Pain in arm and shoulder burning of forearm and thumb and first finger,  I am not able to lift my arm because of the pain it is so extreme. Fever of 100, headache, flush, breathing is shallow and rapid heart rate all night long.",,,,,,,,,U,09/17/2019,09/17/2019,0,I am waiting to hear back from the Dr.,PHM,,"Synthroid Crestor Ambien Mirtazapine Vitamin D, Magnesium, Throne, Biotin, Preserve airids two, vitamin b6, Vitamin","arthritis, Migraine,  back and neck pain from injury, foot pain from arthritis,","Neck and back pain, corpectomy c5-7,  Arthritis, H-pylori, migraine, Hypothroid, postlaminect synd cerv,PTSD, reflux,",,,2,09/18/2019,,Y,,"PNC, cephalexin,"
0834275,09/18/2019,IN,55.0,55,,F,,"The patient received an MMR and had difficulty breathing, skin rash, and itching.  She stated immediately after the shot she had a burning feeling on her nose.  After a few hours the shortness of breath and tight chest started.  She had itching on her chest, legs and a rash on chest only.  She admits to her lips and tongue feeling tight.",,,,,,,,,Y,09/06/2019,09/06/2019,0,,WRK,,Ozempic subq losartan potassium oral glimepiride oral  metformin hcl oral,,,Influenza vaccine,,2,09/18/2019,,,Y,"Betadine,penicillins"
0834276,09/18/2019,MI,0.17,0,.2,M,,The nurse did not mix the liquid vial (DTap and IPV) with the powder vial (Hib) for the combination of Pentacel. The patient only received DTap and IPV instead of all 3.,,,,,,,,,,09/16/2019,09/16/2019,0,,PVT,,,,,,,2,09/18/2019,,,,
0834277,09/18/2019,OH,,,,F,,"shingles; Information has been received from a lawyer and a female patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On or about 13-FEB-2009, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a healthcare provider at a physician office for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The lawyer considered shingles to be related to zoster vaccine live (ZOSTAVAX).",,,,,Y,,,,U,02/13/2009,,,,PVT,,,,,,US0095075131909USA005326,2,09/18/2019,,Y,,
0834278,09/18/2019,FL,,,,U,,"anaphylaxis; This is a spontaneous report from a contactable other healthcare professional on behalf of a physician. A patient of unspecified age and gender received meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration from an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient experienced anaphylaxis after the administration of meningococcal group b rlp2086 on an unspecified date. Outcome of the event was unknown.  Information on the batch number has been requested.; Sender's Comments: The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, as appropriate. The case will be reassessed if additional information becomes available.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2019393352,2,09/18/2019,,,,
0834279,09/18/2019,UT,,,,F,,"Drug allergies: Prevnar, Hydrocodone, Nickel; This is a spontaneous report from a Pfizer sponsored program. A contactable other hcp reported that a 45-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) (PREVNAR 13), via an unspecified route of administration from an unspecified date at single dose for immunization, hydrocodone (manufacturer unknown), via an unspecified route of administration from an unspecified date at unknown dose for an unspecified indication, nickel (manufacturer unknown), via an unspecified route of administration from an unspecified date at unknown dose for an unspecified indication. The patient medical history and concomitant medications were not reported. The patient experienced drug allergies with pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein), hydrocodone, and nickel on an unspecified date. The action taken in response to the event for hydrocodone and nickel was unknown. Outcome of the event was unknown.   Information on the batch number has been requested.",,,,,,,,,U,,,,,UNK,,HYDROCODONE; NICKEL,,,,USPFIZER INC2019395727,2,09/18/2019,,,,
0834280,09/18/2019,MD,25.0,25,,F,,"cellulitis at vaccination site, ~ 2x2 inches",,,,,,,,,U,09/17/2019,09/18/2019,1,none,MIL,,Effexor and buspar,none,none,,,2,09/18/2019,,Y,,IV contrast
0834281,09/18/2019,KY,4.0,4,,F,,erythematous  warm to touch no drainage Linear vesicular Left groin groin area has a papular lesion with localized erythema no drainage from the tick bite,,,,,,,,,,08/20/2019,08/23/2019,3,,PVT,,unsure,,,,,2,09/18/2019,,Y,,
0834282,09/18/2019,CA,70.0,70,,F,,Aches and pain from head to toe.  Severe pain all over for 3 days.  4th a little better. 5th day was able to get out of bed. Worse then the shingles that I had in the past. Left arm is still sore.,,,,,,,,,U,09/14/2019,09/14/2019,0,none,PHM,,"OMEPRAZOLE, CITALOPRAM, EFFEXOR, ALPRAZOLAM",NONE,DEPRESSION,,,2,09/18/2019,,,,NONE
0834283,09/18/2019,NY,10.0,10,,M,,"A minute or so after receiving both vaccinations, my son said he started blacking out, was dizzy and wanted to vomit. He tried walking over to the sink to throw up, but he fainted. He was carried over by his mother and a nurse to the bed and he was in and out of consciousness for a couple minutes. Doctor came in to assess and he was pale, sweating and his BP was 62/47 with a pulse of 58. Doctor gave him pedialyte and he stayed lying down for about 30 minutes. He was better, but had a headache for a few hours.",,,,,,,,,Y,09/16/2019,09/16/2019,0,none,PVT,,multi-vitamins probiotic cod liver oil vitamin c vitamin d,none,none,,,2,09/18/2019,,Y,,none
0834284,09/18/2019,KY,4.0,4,,F,,Localized reaction,,,,,,,,,,08/21/2019,08/22/2019,1,,PVT,,,,,,,2,09/18/2019,,,,
0834285,09/18/2019,KS,67.0,67,,M,,"Nausea, cough, diarrhea, joint pain, muscle pain ,throat irritation.  Lasting 5 days  Still not totally resolved   Utilized Tylenol (OTC) around clock every 3.5 hours.",,,,,,,,,N,09/12/2019,09/13/2019,1,None,WRK,,Meloxicam for joint pain and BP medication prescribed in Community,none,Hypertension controlled by medication,,,2,09/18/2019,,,,Statin meds-hypersensitivity
0834286,09/18/2019,KY,4.0,4,,F,,localized reaction,,,,,,,,,,08/21/2019,08/22/2019,1,,PVT,,,,,,,2,09/18/2019,,,,
0834287,09/18/2019,MI,60.0,60,,M,,My left eye started swelling like I had the shingles again. I had the shingle previously in the same location.,,,,,,,,,Y,09/11/2019,09/12/2019,1,Follow up with Doctor on 09/13/2019,PVT,,Advair 500/50 Celexa20mg Omeprazole 20mg Trazadone 100mg Proair inhaler as needed,none,Asthma and COPD,,,2,09/18/2019,,,,Penicillin
0834288,09/18/2019,WI,67.0,67,,M,,"Patient had a headache, chills, aches, and sore arm. He did not receive any additional treatment, and is doing ok now.",,,,,,,,,Y,08/27/2019,08/27/2019,0,,PHM,,,none,,,,2,09/18/2019,,Y,,No known drug allergies
0834289,09/18/2019,LA,17.0,17,,F,,"reported headache, fever of 103 on night of vaccine administration and lasted for the next 2 days and then was gone",,,,,,,,,Y,09/03/2019,09/03/2019,0,Negative Flu Test on 09/6/19,PVT,,Pro-Air HFA PRN,Unknown,Asthma,,,2,09/18/2019,,Y,,"NKDA, NKFA"
0834290,09/18/2019,NY,5.0,5,,M,,"Extreme dizziness, migraine headaches for 3+ weeks, difficulty focusing",,,,,,,,,U,08/28/2018,08/29/2018,1,None,PVT,,None,None,None,,,2,09/18/2019,,,,None
0834291,09/18/2019,WI,75.0,75,,M,,"Later that night patient had symptoms of abdominal pain, nausea, rhinorrhea and fevers. Patient described dry heaving as well. Patient states that similar symptoms occurred after the first shot but less severe.",,,,,,,,,Y,08/22/2019,08/22/2019,0,,PHM,,"Metoprolol succinate 25 mg, Pravastatin 20 mg,",,"CAD, hypercholesteremia, GERD,",,,2,09/18/2019,,,Y,Atorvastatin/Rosuvastatin/Simvastatin - muscle aches Codeine - GI Upset
0834292,09/18/2019,LA,16.0,16,,F,,Mother called reporting fever of 101 with chills and sever body aches and headache on the night after the vaccine was given. The fever and symptoms lasted for 2 days and then was gone.,,,,,,,,,Y,09/09/2019,09/09/2019,0,"Mother reports negative flu test at PCP office, but was told that the student had the Flu because of her symptoms.",SCH,,"Citrizine, Depo-Provera,",unknown,none known,,,2,09/18/2019,,Y,,"NKDA, NKFA"
0834293,09/18/2019,NC,43.0,43,,F,,"Localized redness and swelling at sights of injection. Itching, burning and redness to left upper extremity reported by patient. No SOB, but slight cough present. Denies nausea, throat swelling or difficulty swallowing. No angioedema and no anaphylaxis. Patients received vaccinations on 09/16 @ 12:50p symptoms developed during 09/17 leading to presentation morning of 09/18. Treated with diphenhydramine 25mg capsule PO once, famotidine 20mg tablet PO once, and prednisone 60mg tablet (3x20mg) PO once. Patient discharged after short observation post-administration of the above medications.",,,,,,,,,Y,09/16/2019,09/18/2019,2,N/A,PVT,,"Wellbutrin XL 300mg, QAM Zovia 1-50 mg-mcg QD, zestoretic 10-12.5mg QD, naproxen 500mg BID",Evaluating dysmenorrhea at time of vaccination.,"PMH: Hodgkin lymphoma, abnormal pap smear, HTN, HLD, and depression.",,,2,09/18/2019,,,,NKDA
0834294,09/18/2019,MI,28.0,28,,M,,"No adverse effect, patient given adolescent dose",,,,,,,,,,07/25/2019,07/25/2019,0,,PVT,,,,,,,2,09/18/2019,,,,"shellfish, gabapentin"
0834295,09/18/2019,,13.0,13,,F,,"The morning following vaccination, patient reported a splitting headache and a severely sore neck. This persisted for 2 days. Patient's mother gave ibuprofen, which seemed to help. Upon follow up on Day 5, symptoms have almost completely subsided and now reporting a mildly sore neck.",,,,,,,,,Y,09/13/2019,09/14/2019,1,,PHM,,Hormonal birth control,,,,,2,09/18/2019,,,,Sulfa
0834296,09/18/2019,NJ,61.0,61,,F,,"This was for the Shingrix shot. First shot I had a 4"" diameter welt that was itchy and painful. The welt lasted 3 weeks.  Second shot I experienced congestion, bad headache, fever of 101, nausea, body aches, lethargy, sore throat in less than 24 hours after the shot. Could not go to work. Day 2 I have cold-like symptoms, lethargy.",,,,,,,,,U,09/16/2019,09/17/2019,1,none,PVT,,"lexapro, allegra, multi-vite, vit. D3, calcium",none,none,,,2,09/18/2019,,,,"wheat, peanuts, nuts in general, pollens - all, cats, dust"
0834302,09/18/2019,WV,,,,U,,"the patient inadvertently received an expired dose of VARlVAX on 9/13/2019. No adverse effects reported.; the patient inadvertently received an expired dose of VARlVAX on 9/13/2019. No adverse effects reported.; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 13-SEP-2019, the patient inadvertently received an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot# N022996 with expiration date of 23-AUG-2019, for prophylaxis (route and frequency were not reported). Concomitant therapies included sterile diluent (DILUENT MRK INJ) with lot# N021894 with expiration date of 28-NOV-2019.      No adverse effects were reported. No additional information provided.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA006200,2,09/18/2019,,,,
0834303,09/18/2019,MA,,,,U,,"one patient was administered a dose of PNEUMOVAX 23 which was improperly stored. No adverse effects reported.; one patient was administered a dose of PNEUMOVAX 23 which was improperly stored. No adverse effects reported.; This spontaneous report was received from a pharmacy manager and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On an unknown date, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # R027299 with expiration date of 09-APR-2020, for prophylaxis (route and frequency were not reported). No adverse effects were reported.    It was stated that the vaccines underwent a temperature excursion above 47F (degrees Fahrenheit): 57F 59 minutes. The call was because of a ""data logger"". No further information was provided. There was no Product Quality Complaint (PQC) involved in this case.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA006301,2,09/18/2019,,,,
0834304,09/18/2019,VA,72.0,,,U,,"""72-year-old patient was administered GARDASIL 9 today."" No adverse effects reported.; ""72-year-old patient was administered GARDASIL 9 today."" No adverse effects reported.; This spontaneous report was received from an administrator and refers to a 72 year old patient of unknown gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 16-SEP-2019, reported as ""today"", the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (route, frequency, lot/batch # and expiration date were not reported). No adverse effects were reported. No further information provided.",,,,,,,,,U,09/16/2019,09/16/2019,0,,UNK,,,,,,US0095075131909USA006310,2,09/18/2019,,,,
0834305,09/18/2019,IL,,4,,U,,"No adverse effect reported; one patient received an improperly stored VARlVAX; This spontaneous report was received from a nurse and concerns to a 4 year old patient of unknown gender. The patient's historical condition, and drug reactions or allergies were not reported. Concomitant therapies included sterile diluent.     On 13-AUG-2019,  the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) (dosage schedule, route, anatomical location were not reported)(it can not be determined with which lot number was vaccinated the patient (R006221 and expiration date 29-FEB-2020 or R029517 and expiration date 14-OCT-2020)) for prophylaxis. The administered dose of the vaccine experienced a temperature excursion of -14 degrees Celsius to -10 degrees Celsius for 8 hours as recorded by a data logger. No previous temperature excursion was reported. There was no adverse effect reported.; Sender's Comments:  US-009507513-1909USA002960: US-009507513-1909USA006331: US-009507513-1909USA006332: US-009507513-1909USA006330: US-009507513-1909USA006334: US-009507513-1909USA006329: US-009507513-1909USA006328: US-009507513-1909USA006341:",,,,,,,,,U,08/13/2019,08/13/2019,0,,UNK,,STERILE DILUENT,Prophylaxis,,,US0095075131909USA006333,2,09/18/2019,,,,
0834307,09/18/2019,PA,,,,U,,"rash; This case was reported by a consumer via call center representative and described the occurrence of red rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th July 2019, the patient received the 1st dose of Shingrix. In July 2019, 1 day after receiving Shingrix, the patient experienced red rash. On an unknown date, the outcome of the red rash was unknown.   It was unknown if the reporter considered the red rash to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. About 24 hours after the vaccine the patient had a red rash across patients torso.  The patient reported to the pharmacy the patient received it from they informed me that it was not a side effect. For tolerance after 2nd dose refer case US2019AMR166978.",,,,,,,,,U,07/10/2019,07/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/18/2019,,,,
0834308,09/18/2019,MA,77.0,77,,M,,"therapy non-responder; This case was reported by a consumer via call center representative and described the occurrence of therapy non-responder in a 77-year-old male patient who received HAV (Havrix adult) (batch number 37RY4, expiry date 6th March 2021) for prophylaxis.   On 17th June 2019, the patient received Havrix adult. In July 2019, less than 3 weeks after receiving Havrix adult, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown.   It was unknown if the reporter considered the therapy non-responder to be related to Havrix adult.  Additional details were provided as follows: The patient received a dose of Havrix in the right arm had his blood work done about 2 and a half weeks later and it was negative for hepatitis A antibodies. The physician recommended to get revaccinated after 7th September 2019. The patient consented to follow up.      Lab Comments: On an unknown date lab test was performed",,,,,,,,,U,06/17/2019,07/01/2019,14,"Test Date: 201907; Test Name: Hepatitis A antibodies; Result Unstructured Data: Test Result: negative, Test Result Unit: unknown",PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834309,09/18/2019,TX,51.0,51,,F,,"fatigue; muscle aches; fever; lump at the injection site; swollen at the injection site; red at the injection site; hot at the injection site; This case was reported by a pharmacist via call center representative and described the occurrence of fatigue in a 51-year-old female patient who received Herpes zoster (Shingrix) (batch number 59EA2, expiry date 13th September 2021) for prophylaxis.   On 19th July 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced fatigue, muscle pain, fever, injection site lump, injection site swelling, injection site erythema and injection site warmth. On an unknown date, the outcome of the fatigue, muscle pain, fever, injection site lump, injection site swelling, injection site erythema and injection site warmth were recovered/resolved.   It was unknown if the reporter considered the fatigue, muscle pain, fever, injection site lump, injection site swelling, injection site erythema and injection site warmth to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient experienced fatigue, muscle aches and fever. The patient was concerned because she also experienced a lump underneath the injection site that got swollen, red and hot. All the events lasted for 7 to 10 days.",,,,,,,,,Y,07/19/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834310,09/18/2019,FL,78.0,78,,F,,"Soreness at the injection site; Injection site was red; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th September 2019, the patient received the 1st dose of Shingrix. On 6th September 2019, 1 days after receiving Shingrix, the patient experienced injection site pain. In September 2019, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site pain was recovering/resolving and the outcome of the injection site erythema was recovered/resolved.   It was unknown if the reporter considered the injection site pain and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and developed soreness at the injection site. Also, the injection site was red and the redness extended approximately three inches down from the injection site. She said that at the time of reporting the redness was almost gone. Her arm was still sore, but it was less sore than it was initially. The reporter consented to follow up. The reporter gave permission for her physician to be contacted.",,,,,,,,,N,09/05/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834311,09/18/2019,WI,,,,F,,"fever; headache; shivering; muscle pain; dizziness; weakness; itchiness; This case was reported by a consumer via call center representative and described the occurrence of fever in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th September 2019, the patient received the 2nd dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced fever, headache, shivering, muscle pain, dizziness, weakness and pruritus. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the fever, headache, shivering, muscle pain, dizziness, weakness and pruritus were unknown.   It was unknown if the reporter considered the fever, headache, shivering, muscle pain, dizziness, weakness and pruritus to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but would be between 77 and 78 years. The patient experienced fever, headache, shivering, muscle pain, dizziness, weakness and itchiness. The patient was not been seen by her doctor and that she had been taking Tylenol to help with the side effects. The patient consented to follow up.",,,,,,,,,U,09/07/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834312,09/18/2019,CA,71.0,71,,F,,"flu like symptoms; body aches; Dizziness; brain fog; malaise; This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number 53RF3, expiry date 17th October 2021) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 2nd July 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 2nd July 2019, immediately after receiving Shingrix, the patient experienced influenza-like symptoms, general body pain, dizziness, foggy feeling in head and malaise. On an unknown date, the outcome of the influenza-like symptoms, general body pain, dizziness, foggy feeling in head and malaise were resolved with sequelae.   It was unknown if the reporter considered the influenza-like symptoms, general body pain, dizziness, foggy feeling in head and malaise to be related to Shingrix.  Additional details were provided as follows: On 14th April 2019, the patient received the 1st dose of Shingrix. The patient immediately after receiving 2nd dose of Shingrix in the right deltoid experienced flu-like symptoms, body aches, dizziness, brain fog, and malaise lasting for one month. At the time of reporting all the events had resolved. The reporter did not consent to follow up.",,,,,,,,,N,07/02/2019,,,,UNK,,Shingrix,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834313,09/18/2019,GA,,,,M,,"a fib; Cholesterol high; This is a spontaneous report from a contactable Nurse via Pfizer sales representative. This non- contactable Nurse reported that a 69-year-old male patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported.  It was reported that the patient experienced Cholesterol high and a fib on an unspecified date. Events took place after use of product. Outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information currently available, Cholesterol high and fib represent intercurrent medical condition representing common cardiovascular occurrences in the patient with 69 years of age.  No known biological plausibility and close time association speak for the relatedness of the events with the vaccination.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,,,,Test Name: Cholesterol; Result Unstructured Data: Test Result: High,UNK,,,,,,USPFIZERINC2019396513,2,09/18/2019,,,,
0834314,09/18/2019,GA,,,,M,,"Cellulitis-arm turned red in about 15-20 minutes after immunization and the redness ran down the arm; Cellulitis-arm turned red in about 15-20 minutes after immunization and the redness ran down the arm; This is a spontaneous report from a contactable nurse via Pfizer sales representative. A 69-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history included cholesterol high and atrial fibrillation (a fib). Concomitant medications were not reported. The patient experienced cellulitis-arm turned red in about 15-20 minutes after immunization and the redness ran down the arm on an unspecified date. The outcome of events was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.; Sender's Comments: Based on the information currently available, the vaccination with PREVNAR might play a contributory role in triggering the occurrence of cellulitis in arm.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,,,,Test Name: Blood cholesterol; Result Unstructured Data: Test Result: High,UNK,,,,Medical History/Concurrent Conditions: Atrial fibrillation; Cholesterol high,,USPFIZER INC2019399825,2,09/18/2019,,,,
0834315,09/18/2019,RI,,,,F,,"moderate to severe redness, pain at injection site; moderate to severe redness, pain at injection site; Swelling; Decreased range of motion.; This is a spontaneous report from a contactable physician via a Pfizer sales representative. A female patient of an unspecified age (reported as age: 69, unit: unknown) received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13, lot number: X62332), via an unspecified route of administration on the left deltoid on 08May2019 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. It was reported that 5 days after in office infection, patient contacted office for moderate to severe redness, pain at injection site on an unspecified date in 2019. Swelling, decreased range of motion were also reported on an unspecified date in 2019. The patient was seen in the office on 13May2019 and was prescribed Keflex (unspecified for which event). No other 5 injections were given. The outcome of the events was unknown.",,,,,,,,,U,05/08/2019,,,,UNK,,,,,,USPFIZERINC2019401576,2,09/18/2019,,,,
0834316,09/18/2019,NC,59.0,59,,F,,"Patient reports that she got the first Shingrix vaccine Friday Sept 13, 2019 around 2pm, and around 10pm suddenly got cold, ""felt like I had the flu"" - no energy, whole body ached, had a headache; she's not sure if she had a temp, did not check; the last symptom to resolve was the headache, which was gone around 5pm on Saturday the 14th. No N/V. She also had soreness at the injection site. She did have 3 allergy shots around noon that day, 2 in right arm, 1 in left; the Shingrix was given in the left deltoid.",,,,,,,,,Y,09/13/2019,09/13/2019,0,none,PVT,,"Aubagio, montelukast, Linzess, fexofenadine, MVI, vit D, glucosamine, ginger root; allergy shots",0,"multiple sclerosis, asthma, osteopenia, allergic rhinitis",,,2,09/18/2019,,,,Latex (mouth swelling); Gilenya (chronic resp infxn); watermelon (mouth sores)
0834317,09/18/2019,DC,53.0,53,,F,,"Pt reports rash, swelling of the (L) upper arm 14 days after the 2nd vaccine. Used OTC NSAIDS + Benedryl. Feeling better now.",,,,,,,,,Y,08/24/2019,09/07/2019,14,,PHM,,Citrical,cold prior,None,,,2,09/18/2019,,Y,,Cats
0834319,09/18/2019,CT,65.0,65,,F,,"Later that night after patient received shingrix, she couldn't feel her face and started drooling. She woke up the next morning and couldn't feel anything. She ended up in the hospital the following day.  She also reports that she ended up with shingles, but she's not sure if this was from vaccine or if it was already in her body. She has missed 2 months of work.  2 months later she is slightly better but not 100%.",,,,,,,,,N,07/14/2019,07/14/2019,0,,PHM,,,,,,,2,09/18/2019,,,Y,
0834320,09/18/2019,CO,29.0,29,,F,,"At the time of reaction, I was 10 weeks and 4 days pregnant, estimated deliver April 6, 2020.  Around 30 minutes after the shot, my arm became extremely swollen, red, itchy, and hard.  Around 6-7 hours later, my neck became extremely stiff and painful.  The pain was localized in my spine from between my shoulder blades up to the base of my head.  I could not move my neck or sit up because the pain and stiffness were so awful.  I continued to have these symptoms for two days.  On the third day (Monday September 18, 2019), the swelling mostly subsided and the redness disappeared.  The hardness on my arm was still present.  The stiffness in my neck went away at this point, but I am still currently experienced some pain in my neck.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,UNK,,Smarty Pants Organic Prenatal Gummies,none,none,,,2,09/18/2019,,,,none
0834321,09/18/2019,MD,73.0,73,,M,,"ROUGHLY 8 HRS POST INJECTION, SORE SHOULDER.  12 HRS POST INJECTION ACHY FLU-LIKE SYMPTOMS BACK, LOWER BACK, BOTH SHOULDERS, CHILLS, SHAKING, NO FEVER, GENERAL MALAISE.   IBUPROFEN HELPED SOME BUT AWAKE MUCH OF THE NIGHT.  MASSAGER IN THE MORNING HELPED SOME WITH MUSCULAR SORENESS BUT STILL FEEL LETHARGIC WITH SYMPTOMS.",,,,,,,,,N,09/17/2019,09/18/2019,1,NONE,PHM,,"ATORVASTATIN, TAMSULOSIN, VITAMINS - B-COMPLEX, CALCIUM, FISH OIL, C, D, ALLEVE, IBUPROFEN, ASPIRIN",NONE,NONE,,,2,09/18/2019,,,,NONE
0834322,09/18/2019,FL,70.0,70,,F,,"Fever, shivering, chills, unwell feeling",,,,,,,,,N,09/17/2019,09/18/2019,1,None,PHM,,"Aprison, pravastatin, propranolol, fluoxitine, Vitamin C, Vitamin D3, Vitamin B-12",None,Crohn's Disease,,,2,09/18/2019,,,,None
0834323,09/18/2019,NM,68.0,68,,F,,"redness, swelling, warmth, felt bad enough to leave work, saw pcp diagnosed with cellulitis, prescribed cephalexin",,,,,,,,,N,09/16/2019,09/17/2019,1,,PHM,,,,,,,2,09/18/2019,,Y,,penicillins
0834324,09/18/2019,PA,67.0,67,,F,,"+nausea, +feeling gassy, +runny nose +left throat itchiness/irritated +dry cough, +itchy/painful left upper arm, left upper arm swelling - these symptoms started after the shot.",,,,,,,,,N,09/17/2019,09/17/2019,0,,PHM,,Synthroid 112 MCG Tablet take one tablet by mouth every morning on an empty stomach Orally Once a day      Metoprolol Tartrate 50 MG Tablet 1 tablet with food Orally Twice a day      Losartan Potassium 100 MG Tablet 1 tablet Orally Once a d,none,hypothyroidism      hypertension      hypercholesterolemia      anxiety      depression      irritable bowel disease      rosacea      shingles-2007,,,2,09/18/2019,,Y,,Augmentin: Allergy - hives      Prozac: Side Effects - suicidal thoughts      Bactrim DS: Allergy - hives      Penicillin G Sodium: Allergy - hives
0834325,09/18/2019,NY,1.25,1,.3,M,,"Hives only .  Local site reaction.  Red, swollen and warm to touch.",,,,,,,,,Y,09/13/2019,09/14/2019,1,None,PVT,,No over the counter medications nor any dietary supplements were being taken.,No illnesses,none,,,2,09/18/2019,,Y,Y,No known allergies to food nor medications noted
0834326,09/18/2019,IA,1.0,1,.0,F,,No known events at this time Possible fever could happen,,,,,,,,,,09/18/2019,09/18/2019,0,,PVT,,None,Acute Suppur Left Otitis Media w/o Spontan Rupture Tympanic Membrane,No Known,,,2,09/18/2019,,Y,,None
0834327,09/18/2019,WI,62.0,62,,F,,"After both injections I developed wheezing and shortness of breath which led to chest x-rays at Urgent Care.  Doctor prescribed fluticasone HFA 110 MCG/ACT Inhaler.  I was still on the inhaler when I had the second vaccination, so symptoms did not show up until after I ran out of the prescription.  Before I got a refill (delayed in the mail) the symptoms became extremely severe.  Treatment for that visit was as follows: 2 AIRWAYINHALATION TREATMENT Procedures   ALBUTEROL SULFATE .O83% INJ Immunization/Injection,  ALBUTEROL SULFATE .O83% INJ Immunization/Injection",,,,,,,,,Y,05/07/2019,05/10/2019,3,X-ray showed no lung disease,PHM,,"paroxetine,hydrochlorothiazid,omenaproxen,Trazodone, naproxene",None,None,anaphylactic reaction to Pennicillin age 28,,2,09/18/2019,,,Y,penicillin
0834328,09/18/2019,AZ,66.0,66,,F,09/17/2019,"Vaccines administered 9/10/19 at 3PM. Morning of 9/11/19, inside of left arm pink, by early afternoon of 9/11/19, arm swelling, more pink & worse. Pain about 7 out of 10. Felt hard (approx 4PM) Dr visit on 9/12/19. Prescribed prednisone 20mg Q AM x 5 days, plus hydroxyzine 25mg Q12 for rash. On 9/13/19 redness swelling improved Cleared by 9/16/19",,,,Y,,,,,Y,09/10/2019,09/11/2019,1,None,OTH,PVT,,N/A,N/A,,,1,,,,,
0834329,09/18/2019,ND,37.0,37,,F,,"Patient reported that the flu shot was given too high on the arm causing shoulder pain. She reports shoulder pain all night, numbness and tingling in the arm down to the fingers",,,,,,,,,U,09/10/2019,09/11/2019,1,None,WRK,,Transderm scop. ondansetron = prn Folic acid Methotrexate Proair inhaler - prn prednisone Duloxetine lidocaine ointment - prn imitrex - prn Topiramate Hydroxychloroquine Hydroquinone cream Belsomra - prn Lorazepam - prn/dental cyclobenzapri,joint pain,"Migraines, lupus",,,2,09/11/2019,,Y,,"oxycodone, sulfa, Doxycycline"
0834330,09/18/2019,FL,1.0,0,1,M,,"Bumps appeared on back, chest, right ear, and right eye 09/17/2019",,,,,,,,,,05/15/2019,09/17/2019,125,,PVT,,,,,,,2,09/18/2019,,Y,,NKDA. ?egg
0834332,09/18/2019,SC,3.0,,,M,,"mottle skin and welts; an unspecified illness; lab work done to determine immunity to chicken pox and was found to have low titers; mottle skin and welts; shingles rash; This spontaneous report was received from a nurse practitioner referring to a 3 years old male patient. The patient's drug reaction/allergies included several unspecified antibiotics and ""Zith"". The patient had no concomitant medications.  On an unknown date (reported as at 3 years old age), the patient received varicella virus vaccine live (oka/merck) (VARIVAX) with sterile diluent (MERCK STERILE DILUENT) (both dose, unit, lot#, and expiration date were not reported), subcutaneously for prophylaxis. A few days later, he developed a shingles rash and was treated with diphenhydramine hydrochloride (BENADRYL). The second dose of varicella virus vaccine live (oka/merck) (VARIVAX) was not given due to the shingles rash.  On an unspecified date, the patient also developed mottle skin and welts after taking azithromycin in elementary school for an unspecified illness. He had had similar skin reactions to several other unspecified antibiotics in his childhood. The reporter did not know any lot number or expiration information or the manufacturer of either product due to how long ago these reactions occurred. The patient had lab work done to determine immunity to chicken pox for his Program and was found to have low titers. In order to continue in his program, he would need another dose of varicella virus vaccine live (oka/merck) (VARIVAX). The outcome of all events was reported as recovered. The causality assessment was not provided.",,,,,,,,,Y,,,,,UNK,,Sterile diluent,Allergic reaction to antibiotics; Prophylaxis; Skin reaction,,,US0095075131908USA008077,2,09/18/2019,,,,
0834333,09/18/2019,PA,,,,F,,"She received her first dose of the GARDASIL 9 series on 10-AUG-2019, and shortly after she found out she was pregnant/she thinks he pregnancy gestation is about one week; This spontaneous prospective pregnancy report was received from a a female patient of unknown age, who was reporting on herself. The patient's concomitant therapies included an unspecified hepatitis a virus vaccine.  The patient had no pertinent medical history or drug reactions/allergies.  On 19-AUG-2019, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 1.5 milliliter for prophylaxis (route of administration, anatomical location, lot number and expiration date were not provided).   The patient's estimated date of LMP (last menstrual period) was 19-AUG-2019. On approximately 05-SEP-2019 (reported as ""about one week""), the patient became pregnant with EDD (estimated date of delivery) of 28-MAY-2020. On 09-SEP-2019, she patient carried out a pregnancy test, which result was positive. No treatment was given and the patient did not seek medical attention.",,,,,,,,,U,08/19/2019,08/19/2019,0,,UNK,,hepatitis A virus vaccine (unspecified),,,,US0095075131909USA005070,2,09/18/2019,,,,
0834334,09/18/2019,OK,,,,F,,"trigeminal herpes zoster; Information has been received from a lawyer and a female patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In 2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a healthcare provider at a physician office for trigeminal herpes zoster. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.",,,,,Y,,,,U,,,,,PVT,,,,,,US0095075131909USA005821,2,09/18/2019,,Y,,
0834335,09/18/2019,NY,,,,U,,"bubble at injection site; This spontaneous report was received from a pharmacist via vaccine employee regarding a patient of unknown demographics. Information on patient's pertinent medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported. On an unknown date in 2018 (over one year ago), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) or pneumococcal 13v conj vaccine (crm197) (PREVNAR 13) in the deltoid via intramuscularly (dose, strength, lot #, expiry date unknown) for prophylaxis (the pharmacist did not remember which product it was). On an unknown date, the patient developed a bubble at the injection site (injection site reaction). The outcome of injection site reaction was unknown. Causality assessment was not provided.",,,,,,,,,U,,,,,UNK,,,Prophylaxis,,,US0095075131909USA006388,2,09/18/2019,,,,
0834336,09/18/2019,PA,,,,U,,"rash; This case was reported by a consumer via call center representative and described the occurrence of red rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix with an associated reaction of rash erythematous (1st dose received on 10th July 2019, refer case US2019AMR166975).   On 10th September 2019, the patient received the 2nd dose of Shingrix. On 10th September 2019, less than a day after receiving Shingrix, the patient experienced red rash. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the red rash was unknown.   It was unknown if the reporter considered the red rash to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. within 24 hours the patient had the same exact side effect.",,,,,,,,,U,09/10/2019,09/10/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/18/2019,,,,
0834337,09/18/2019,MD,59.0,59,,M,,"numbness in right arm; tingling in right arm; Limb mobility decreased; This case was reported by a pharmacist via call center representative and described the occurrence of numbness of upper extremities in a 59-year-old male patient who received Herpes zoster (Shingrix) (batch number 3LL4P, expiry date 19th October 2021) for prophylaxis.   On 13th August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced numbness of upper extremities, tingling of extremity and mobility decreased. On an unknown date, the outcome of the numbness of upper extremities, tingling of extremity and mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the numbness of upper extremities, tingling of extremity and mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient experienced numbness and tingling in his right arm to where he cannot raise his hand fully. The events were ongoing. The reporter consented to follow up.",,,,,,,,,N,08/13/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834338,09/18/2019,MS,76.0,76,,F,,"Patient developed headache, sore throat, body aches, and significant redness of eyes a few hours after receiving the high dose flu vaccine. Patient was treated at outpatient clinic and it was recommended that patient take otc antihistamine.",,,,,,,,,Y,09/17/2019,09/17/2019,0,,PVT,,,,,,,2,09/18/2019,,Y,,
0834339,09/18/2019,MO,50.0,50,,M,,Patient described pain as severe at the time on injection and followed up a week later with pain in arm that was only a little better,,,,,,,,,N,09/11/2019,09/11/2019,0,,PHM,,Lexapro 5mg,,immune deficient,,,2,09/18/2019,,,,"egg, sulfites"
0834340,09/18/2019,,69.0,69,,F,,Per patient - she noticed some itching of her right arm the day following her vaccine then it proceeded to get red and have some warmth to her right arm exclusively.  She said she applied some cortisone to control the affected area.,,,,,,,,,N,09/13/2019,09/14/2019,1,,UNK,,,,,,,2,09/18/2019,,,,
0834341,09/18/2019,OH,69.0,69,,F,,"between half hour and hour after getting first shingrix vial kit I experienced such exhaustion, weakness  and dizziness I have never felt before.  I sat down before I fell, I was that dizzy.  I also experienced slight breathlessness but that didn't last as long as the extreme weakness, exhaustion and dizziness.  It lasted a couple hours before I was able to stand up.",,,,,,,,,Y,06/11/2019,06/11/2019,0,,PHM,,,,,,,2,09/18/2019,,,,
0834342,09/18/2019,OR,23.0,23,,M,,"Patient received a routine blood draw (fasting) and immunization with MMR at aprox 0940 on date of incident. Patient described feeling  nauseous, sat down, and doesn't remember anything until being woken up by medical staff asking how he was doing. No difficulty breathing, normal heart rate, lungs clear to auscultation. Vitals steadily increased over time. Pt had not eaten breakfast. Pt was given water and banana, oxygen via nasal cannula. Discharged after 20 minutes to place of work, with improved symptoms.   Vitals at 0948: Pulse 59,, weak; 16 breaths per minute, shallow, BP: 98/78; Vitals at 1008: Pulse 72, Breaths 14 per minute; BP: 122/90, Temp: 97.7",,,,,,,,,Y,09/18/2019,09/18/2019,0,Fasting Blood Draw,MIL,,None,None,PPD Converter,,,2,09/18/2019,,,,NKDA/NKA
0834343,09/18/2019,TX,66.0,66,,F,,Patient broke out with rash on left torso. Rash was painful and contained blisters. Diagnosed as shingles outbreak by visit to primary care physician. Patient was given prescription for Valacyclovir 1000 mg to be taken 3 times per day for the next 7 days.,,,,,,,,,U,09/08/2019,09/17/2019,9,,PHM,,,,,,,2,09/18/2019,,Y,,
0834344,09/18/2019,CA,72.0,72,,F,,"Hives and rash with pruritus. Went to ED x2 on 9/14 and 9/15 reportedly received steroid injection and prescribed prednisone, famotidine, and diphenhydramine. Came to office on 9/17/19 for f/u with ongoing sx. Steroid course extended, added cetirizine. No sx of anaphylaxis.",,,,,,,,,N,09/13/2019,09/13/2019,0,,PHM,,,,,,,2,09/18/2019,,Y,Y,
0834345,09/18/2019,MA,33.0,33,,F,,"concerns regarding sx's of ""clammy, waves of hot flashes, night sweats, achy and no appetite"". She has low grade fever of 99.6.",,,,,,,,,Y,09/10/2019,09/13/2019,3,None,PVT,,"albuterol inhaler, zyrtec, yasmin, concerta, Ritalin, Zoloft, spironolactone",none,"mild asthma, ADD, anxiety, thyroglossal duct cyst",,,2,09/18/2019,,,,sulfa
0834346,09/18/2019,NY,15.0,15,,M,,"Within a half an hour after injection, Patient complained that the left side of his tongue was numb and tingly and he felt off. It last an hour.   July 12, 2004 Patient had a polio, lot # O340N within several hours of injection his whole leg blew up and he was inconsolable for over an hour, with high pitch screams.",,,,,,,,,Y,09/02/2019,09/02/2019,0,none,PVT,,"Multi-vitamins, vit. c, probiotics",none,none,Polio,,2,09/18/2019,,,,none
0834347,09/18/2019,NC,22.0,22,,M,,"Employee came in the next morning for work and stated he was feeling nausea, chills, and body aches. He states he  had not eaten this date, and was given oral fluids and crackers. VS were obtained and found to be normal for the individual. He states this made him feel some better. After speaking with Agency, employee states he has previously had the Hep B vaccination with his prior job site. These were giving to him in May 2019, and June 2019. This was not disclosed to the center at the time the employee signed his consent for immunization. Employee left early  and Medical supervisor will follow up with employee by close of business today.",,,,,,,,,U,09/17/2019,09/18/2019,1,none,OTH,,n/a,none,none,,,2,09/18/2019,,,,n/a
0834348,09/18/2019,MT,58.0,58,,M,,Friday 9/13/19 woke up in AM torso was covered in a Rash. not itchy - PT had Fever (didn't take temp) Skin was sensitive had a bad headache. on Sunday Rash was gone. Headache gone on SAT. 9/14. Patient recovered.,,,,,,,,,Y,09/12/2019,09/13/2019,1,,PUB,,baby Aspirin - multi vit.,none,none,,,2,09/17/2019,,,,none
0834349,09/18/2019,ND,37.0,37,,F,,"Patient stated that she had pain, numbness and tingling of fingers and left arm, due to flu shot. Possibly given too high in the deltoid. Denies any redness, fever or chills.",,,,,,,,,U,09/10/2019,09/10/2019,0,None,UNK,,,,,,,2,09/11/2019,,Y,,
0834350,09/18/2019,MS,0.33,0,.3,M,09/18/2019,"Fever, Chills and bumps and Tylenol was give at the ER",,,,Y,,,,,Y,09/17/2019,09/17/2019,0,"Flu, RSV and chest xray all normal @ ER",PVT,PUB,Texacort 2.5% topical solution,Seborrhea Capitis,N/A,,,1,,,,,
0834358,09/18/2019,IA,71.0,71,,M,,"Shoulder pain; This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th September 2019, the patient received Shingrix. On 10th September 2019, 1 hr after receiving Shingrix, the patient experienced shoulder pain. On an unknown date, the outcome of the shoulder pain was recovering/resolving.   It was unknown if the reporter considered the shoulder pain to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's wife. The reporter stated that the patient experienced shoulder pain. On the day of reporting the reporter called for treatment recommendations but was referred to a Healthcare provider. The reporter noted that the pain had gotten worse over the night. This case is 1 of the 2 linked cases, reported by the same reporter.",,,,,,,,,N,09/10/2019,09/10/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834359,09/18/2019,,,,,U,,"Too many side effect; This case was reported by a consumer and described the occurrence of adverse reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. It was reported that the patient would never get the Shingrix shot again too many side effect started the moment the patient received the Shingrix shot 1.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/18/2019,,,,
0834360,09/18/2019,AL,,,,U,,"flu like symptoms; This case was reported by a nurse via sales rep and described the occurrence of influenza-like symptoms in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not was reported. The age group selected as per vaccine specification.  The patient reported flu like symptoms after receiving a dose of shingrix. This case was linked with cases US2019AMR165394 and US2019AMR165395, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/18/2019,,,,
0834361,09/18/2019,AL,,,,U,,"flu like symptoms; This case was reported by a nurse via sales rep and described the occurrence of influenza-like symptoms in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not was reported. The age group selected as per vaccine specification.  The patient reported flu like symptoms after receiving a dose of shingrix. This case was linked with cases US2019AMR165394 and US2019AMR165390, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/18/2019,,,,
0834362,09/18/2019,,,,,U,,"Tiredness; Feeling Weak; This case was reported by a other health professional via interactive digital media and described the occurrence of tiredness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced tiredness and feelings of weakness. On an unknown date, the outcome of the tiredness and feelings of weakness were recovered/resolved.   It was unknown if the reporter considered the tiredness and feelings of weakness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient had a bad reaction to the shinrix vaccine which has lasted over 3 weeks. The patient had a reaction to shinrix in the form of tiredness feeling weak at times.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/18/2019,,,,
0834364,09/18/2019,DE,66.0,,,F,,"Wrong Route of Administration; redness at injection site; tenderness at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 66-year-old female patient who received Herpes zoster (Shingrix) (batch number K1T3C2 ?, expiry date 5th December 2021) for prophylaxis.   On 4th September 2019, the patient received the 1st dose of Shingrix (subcutaneous). On 4th September 2019, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. In September 2019, the patient experienced injection site erythema and injection site tenderness. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the injection site erythema and injection site tenderness were recovered/resolved and the outcome of the intramuscular formulation administered by other route was unknown.   It was unknown if the reporter considered the injection site erythema and injection site tenderness to be related to Shingrix.  Additional details were provided as follows: The reported batch number was not available in sales data sheet, hence it was captured as  K1T3C2 ?. The pharmacist reported that a 66 year old female received the initial dose of Shingrix subcutaneously and experienced redness and tenderness at the injection site, which led to intramuscular formulation administered by other route.  The patient took Tylenol and the redness and tenderness had resolved.",,,,,,,,,Y,09/04/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834365,09/18/2019,UT,62.0,62,,M,,"Night Sweats; This case was reported by a consumer via call center representative and described the occurrence of night sweat in a 62-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 5th September 2019, 1 days after receiving Shingrix, the patient experienced night sweat. On an unknown date, the outcome of the night sweat was not recovered/not resolved.   It was unknown if the reporter considered the night sweat to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left arm. The patient stated the day after vaccination he experienced night sweats, and he was still experiencing night sweats. No further details were provided. The reporter consented to follow up.",,,,,,,,,N,09/04/2019,09/05/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834366,09/18/2019,PA,64.0,64,,F,,"chills; This case was reported by a consumer via call center representative and described the occurrence of chills in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th September 2019, the patient received the 2nd dose of Shingrix. On 9th September 2019, 1 days after receiving Shingrix, the patient experienced chills. On an unknown date, the outcome of the chills was unknown.   It was unknown if the reporter considered the chills to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine on left arm. The patient received the second dose of the Shingrix vaccine and, after about 24 hours, on day of reporting she started to experienced chills. The reporter consented to follow up.",,,,,,,,,U,09/08/2019,09/09/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834367,09/18/2019,CA,62.0,62,,F,,"Inappropriate Schedule of Vaccine; Swelling; Blotchy Extremeties; Redness/redness occurred on face downward to neck/arm redness; Fever/feeling feverish; This case was reported by a consumer via call center representative and described the occurrence of erythema in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 19th February 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On 21st February 2019, 2 days after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced erythema and feeling hot. On 22nd February 2019, the patient experienced swelling and blotchy. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the erythema, feeling hot, swelling and blotchy were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the erythema, feeling hot, swelling and blotchy to be related to Shingrix.  Additional details were received as follows:  The patient received Shingrix in right arm . At physician's office and was debating whether or not to receive 2nd dose 2 to6 month window expired. This led to incomplete course of vaccination.  The reporter reported that, approximately 2 days following vaccination redness occurred on face downward to neck.  That evening caller reports feeling feverish, and after waking the next morning reports swelling along with redness on face that last a couple days. Lastly, caller reports extremities, mostly arms, were blotchy and red for several days. The reporter consented to follow up.",,,,,,,,,Y,02/19/2019,02/21/2019,2,,PVT,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834368,09/18/2019,OH,,80,,F,,"Shoulder pain; So tired and didn't want to do anything/Laid in bed; Extra doses administered; Extra doses administered; This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 2 doses in last year from the reporting date ).   In April 2019, the patient received the 3rd dose of Shingrix (intramuscular). In September 2019, the patient received the 4th dose of Shingrix. In April 2019, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced extra dose administered. In September 2019, the patient experienced shoulder pain, tiredness and extra dose administered. On an unknown date, the outcome of the shoulder pain, tiredness, extra dose administered and extra dose administered were unknown.   It was unknown if the reporter considered the shoulder pain and tiredness to be related to Shingrix.  Additional details were received as follows: The age vaccination was not reported. The patient again received both doses of Shingrix this year, which led to extra dose administered. The reporter couldn't remember the dates of her first injections last year, however, she received one dose this past week and then five months prior she received the other dose.  When the reporter inquired if she remembered the dates of the vaccination from last year, she stated that she was losing her memory a little and couldn't remember.  She also reported that after the second dose of the Shingrix this year, she laid in bed the next day from shoulder pain and she was in bed all day and was so tired and she didn't want to do anything but then the issues resolved.   The reporter consented to follow up. The patient requested to remain anonymous.",,,,,,,,,U,04/01/2019,04/01/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834369,09/18/2019,GA,,,,F,,"Injection Site Swelling; Injection Site Redness; Heat at the Injection Site; Feel achy; Low grade fever; Sore Throat; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 83-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th September 2019, the patient received the 1st dose of Shingrix. On 11th September 2019, less than a day after receiving Shingrix, the patient experienced injection site swelling, injection site erythema, injection site warmth, pain, low grade fever and sore throat. On an unknown date, the outcome of the injection site swelling, injection site erythema, injection site warmth, pain, low grade fever and sore throat were recovering/resolving.   It was unknown if the reporter considered the injection site swelling, injection site erythema, injection site warmth, pain, low grade fever and sore throat to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but may be between 82 or 83 years. The reporter stated that, the patient experienced swelling, redness, and heat at the injection site. The patient also felt achy, had a low grade fever, and a sore throat. The reporter stated that, the patient at the time of reporting was having these symptoms. The reporter was unable to obtain additional details because her mother was not with her at the time of reporting. This case is 1 of the 2 linked cases, reported by the same reporter.",,,,,,,,,N,09/11/2019,09/11/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/18/2019,,,,
0834370,09/18/2019,SC,42.0,42,,F,,Patient reports persistent radiating pain down left arm to fingers starting 09/13/19 after receiving vaccine on 09/10/2019,,,,,,,,,N,09/10/2019,09/13/2019,3,,OTH,,,,,,,2,09/18/2019,,,Y,
0834371,09/18/2019,KY,23.0,23,,F,,"Local Allergic Reaction. 3"" diameter circle rash with stiffness, swelling, and pain.",,,,,,,,,N,09/16/2019,09/16/2019,0,,SCH,,"Humalog, Tresiba, Yaz, Protonix, Paxil, Topomax, Losartan, Allegra",,"Type 1 Diabetes, Fibromyalgia, Anxiety, Depression","MMR vaccine, 18 mo, Febrile Seizure",,2,09/18/2019,,,,"Seasonal Allergies, Mild Food Intolerances"
0834372,09/18/2019,MI,30.0,30,,M,,Patient was injected into left bursa and has ongoing pain since injection,,,,,,,,,U,09/15/2019,09/15/2019,0,,PHM,,singulair,,,,,2,09/18/2019,,,,
0834373,09/18/2019,OR,70.0,70,,F,,"Right arm of patient where she received the pneumovax 23 showing erythema and swelling of the lower arm near elbow. No redness or swelling at the injection site. Per patient, the swelling has gone down in the past 2 days.  I advised patient to keep monitoring the symptoms and see her primary care provider. I will also check with patient in the next couple of days to monitor her symptoms.",,,,,,,,,U,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/18/2019,,,,
0834374,09/18/2019,VA,67.0,67,,M,,"patient developed fevers, chills myalgia headache fatigue",,,,,,,,,Y,09/16/2019,09/17/2019,1,none,PVT,,"metoprolol, omega fatty acids, omeprazole oxycodone sildenafil pravastatin  gabapentin losartan",none,prediabetes and orthopedic problems PUD,,,2,09/18/2019,,Y,,gabapentin and Lyrica
0834375,09/18/2019,NY,76.0,76,,F,,"Patient was very cold, couldn't get warm.  Around midnight felt like she had a very high fever.  Blood pressure went to around 198/108 with HR of 100.  Patient cycled through hot and cold.  Next day the upper part of her arm was red.  Two days later the redness has subsided but remains itchy. Contacted medical doctor who said that was a normal reaction and that she would be fine.",,,,,,,,,Y,09/14/2019,09/14/2019,0,,PHM,,nothing,nothing,nothing,,,2,09/18/2019,,,,NKA
0834376,09/18/2019,GA,62.0,62,,F,,Skin red esa and inflamation,,,,,,,,,Y,08/27/2019,08/29/2019,2,Clindamicyn 150 3 capsules two times a day,PHM,,Not known,,,,,2,09/18/2019,,Y,,None
0834377,09/18/2019,CA,41.0,41,,F,,Patient state she had a white color bump 1cm away from injection site.  She states over the weekend there was red swelling with a white hard bump in the middle of the swollen area.,,,,,,,,,U,09/14/2019,09/14/2019,0,,PHM,,N/A,N/A,N/A,,,2,09/18/2019,,,,N/A
0834378,09/18/2019,PA,51.0,51,,F,,Constant palpitations,,,,,,,,,N,07/27/2019,07/31/2019,4,EKG Holter Echo Bloodwork,PHM,,None,None,None,,,2,09/18/2019,,Y,,None
0834379,09/18/2019,IA,9.0,9,,M,,Suspected Localized Cellulitis Of Upper Left Extremity 14cm X 14.5cm - Patient placed on Augmentin,,,,,,,,,N,09/16/2019,09/16/2019,0,,PVT,,loratadine (Claritin) 10mg tablet,None,Enviromental Allergies,"Same reaction, just less intense - 9/2018",,2,09/18/2019,,Y,,Enviromental Allergies
0834381,09/18/2019,PA,57.0,57,,F,,"Event started with chills and fever, progressed to nausea, loss of appetite, and exhaustion. I slept for 11 hours and woke with a headache and brain fog. Appetite did not return until early afternoon. Continue to be tired on 2nd day.",,,,,,,,,Y,09/16/2019,09/17/2019,1,None,PHM,,Synthroid 75 mcg Lomaira 8 mg,None,Hypothyroidism,,,2,09/18/2019,,,,None
0834382,09/18/2019,PA,18.0,18,,F,,"Patient received trumenba vaccination on 09/12/2019 and said soon after vaccination she developed a headache and low grade fever.  ER on Monday 9/16 with a headache with a pain 10/10 unrelieved with acetaminophen, ibuprofen as well as a family members oxycodone. In the ED  medication received was  diphenhydrAMINE (BENADRYL) tablet 25 mg,metoclopramide (REGLAN) tablet 10 mg , naproxen (NAPROSYN) tablet 500 mg and butalbital-acetaminophen-caffeine (FIORICET,ESGIC) 50-325-40 mg per tablet 1 tablet. Discharge home with rx for naproxen and to follow up with PCP. Fever has resolved she came back to the office on 09/18/2019 and said she still has a consistent headache.",,,,,,,,,N,09/12/2019,09/12/2019,0,,PVT,,unknown,,costochonchondritis; constipation; vitamin d deficiency; hernia of abdominal wall; gastro esophageal reflux disease; hemorrhage of anus; patellofemoral disorder of left knee; psosa tendinitis of both sides; tear of right acetabular labrum,,,2,09/18/2019,,Y,Y,no known allergies
0834383,09/18/2019,OR,16.0,16,,M,,"Mom reports in the early afternoon following his morning vaccines listed above, patient began complaining of headache, nausea and malaise so he went to his room to lay down.  She heard him making strange noises, so she went to check on him.   He was laying on his bed moaning with b/l arms flexing and extending at elbows and shoulders shrugging - she spoke to him and he was awake and able to respond, so she went to him and held him and his arms stopped moving.  She reports his arms were moving for ~1 minute while she was there but was unsure how long they'd been moving prior to her entering the room.  She asked him if he was moving his arms because his head hurt, and he denied moving his arms intentionally.  He complained it felt like someone was ""kicking him in the head,"" and indicated his forehead.  She noted his temperature was 100.8 at this time.  She reports she gave him ibuprofen prior to the episode listed above, but timing is not quite clear.  Mom put a cool cloth on his forehead, his fever came down and he was able to sleep a bit throughout the night.  He continues to have b/l upper arm and shoulder twitching that is involuntary.  He still has headache this morning, but it is less severe.    Patient reports headache last night was 8/10, today is 4/10.",,,,,,,,,N,09/17/2019,09/17/2019,0,None,PVT,,None,None,None,,,2,09/18/2019,,Y,,None
0834384,09/18/2019,PA,62.0,62,,F,,"L arm sore and swollen,  flu-like symptoms, fever, chills, sore throat, runny nose, sinus pain. Missed 2 days of  work after vaccination.  Feeling better by 5 days after vaccination.",,,,,,,,,Y,09/06/2019,09/06/2019,0,None,PVT,,"Alprazolam, Amlodipine, Carisoprodol, Ceterizine, Chlorthalidone; Coreg, Cyanocobalamin, Diclofenac, Doxazosin, Flovent HFA, Ibandronate, Ibuprofen, Methenamine, Montelukast, Nadolol, Omeprazole, Osphena, K Chloride, Prednisone, Pro-Air HFA",None,HTN,,,2,09/18/2019,,,,"Doxycycline, PCN, Sulfa ABX"
0834385,09/18/2019,CA,0.25,0,.3,M,,"1. Baby stopped making eye contact with people 2. Stopped smiling 3. Erections ceased 4.  Stopped reacting to things such as toys, peek-a-boo, tv 5. Didn't urinate for over 12 hours (this happened 2 times in in the 2 days following the vaccination)",,,,,,,,,U,06/21/2017,06/22/2017,1,None.  Called and let the advice nurse know about the urination and erection issue.  Wrote to  child's physician to let her know of reactions.  She requested I find a new doctor.,PVT,,None,None,None,,,2,09/18/2019,,Y,,None
0834386,09/18/2019,NY,12.0,12,,M,,Nausea and headache within 5 minutes of vaccine administration.,,,,,,,,,Y,09/18/2019,09/18/2019,0,,PVT,,NONE,NONE,NONE,,,2,09/18/2019,,,,NONE
0834387,09/18/2019,CA,0.42,0,.4,M,,"1. Cease of cooing/screaming/""talking""  2. Cries no longer a strong vocals; instead it's now a low grunt 3. Constantly has feces in diaper from the pressure of the low grunts  4. Extreme diaper rash; raw skin 5. Loss of fine motor skills 6. Loss of erections 7. No longer able to swallow solid foods.  Now pushes food out with tongue instead of swallowing. 8. Eczema rash all over torso",,,,,,,,,U,08/23/2017,08/24/2017,1,None.,PVT,,None,None,None,Age: 3 months Vaccine Type: DTaP Brand: Infarix Date: 06/21/2017  VAERS report #: 175051,,2,09/18/2019,,Y,,None
0834388,09/18/2019,AZ,4.0,4,,M,,"raise 3-4 cm papular rash about 10 minutes after injection MMR vaccine, didn't get any larger after 30 minutes, no other symptoms",,,,,,,,,U,09/18/2019,09/18/2019,0,none,PVT,,about 5 min,none,none,,,2,09/18/2019,,,,none
0834389,09/18/2019,NY,58.0,58,,F,,Patient called pharmacy complaining of pain at site of vaccination.,,,,,,,,,U,09/18/2019,09/18/2019,0,,PHM,,valsartan 80mg diltiazem er 240mg ezetimibe 10mg isosorbide mononitrate er 30mg rosuvastatin calcium 10mg,None disclosed,None on file,,,2,09/18/2019,,,,No known allergies
0834390,09/18/2019,LA,,,,F,,"unable to lift her arm/patient's difficulty in lifting lasted 3 days; red stripe that appeared 5 inches below and 5 inches above injection site; injection site was hot, swollen, there was pain; injection site was hot, swollen, there was pain; injection site was hot, swollen, there was pain; This spontaneous report was received from an office manager referring to a 38-year-old adult female patient. The patient's concurrent condition included rheumatoid arthritis and immunodeficiency. The patient's medical history and drug allergies were not reported. The patient's concomitant therapy included methotrexate. On 12-SEP-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) via intramuscular route for immunodeficiency (lot/batch number and expiry date were reported as S009945 and 10-AUG-2020 respectively) (strength and dose were not reported). On 13-SEP-2019, the patient had complaints of being unable to lift her arm (arm where dose was administered) which lasted for 3 days as her range of motion was limited with swelling (movement disorder), there was a red stripe that appeared 5 inches below and 5 inches above injection site (injection site erythema), injection site was hot (injection site warmth), swollen (injection site swelling) and there was pain to touch (injection site pain). The patient was treated for the events with Benadryl, compresses and ibuprofen and sought medical attention. There was no overdose and product quality complaint reported. The adverse event was not cancer and the patient did not die. The outcome of the events were reported as recovering. The causality of the events with respect to pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.",,,,,,,,,N,09/12/2019,09/13/2019,1,,UNK,,methotrexate,Immunocompromised; Rheumatoid arthritis,,,US0095075131909USA006444,2,09/18/2019,,,,
0834391,09/18/2019,WA,31.0,31,,F,,"VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a physician and described the occurrence of vaccine exposure during pregnancy in a 31-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   Concurrent medications included Iron salt (Iron), Vitamin D, Prenatal vitamins and Docusate sodium (Colace).   On 24 August 2011 at 09:30 the subject received a dose of Boostrix (details unknown), and experienced vaccine exposure during pregnancy.  The subject received the vaccine during her 32nd week of pregnancy.  The estimated delivery date was 16 October 2011.  Date of last menstrual period was not provided.   Upon internal review done on 13th September 2019, the pregnancy outcome was updated to lost to follow-up.",,,,,,,,,U,08/24/2011,08/24/2011,0,,PVT,,Iron; Vitamin D; Prenatal vitamins; Colace,,Medical History/Concurrent Conditions: No adverse event (There were no concomitant vaccinations and no relevant medical history.  The subject had not experie),,USGLAXOSMITHKLINEA0943033,2,09/18/2019,,,,
0834392,09/18/2019,PA,,,,M,,"4 months old  patient who received a dose of Pentacel which had a temperature excursion below zero/No AE; Initial information received and additional information received on 10-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case is linked to cases 2019SA255196, 2019SA255155 and 2019SA255195 (same reporter).  This case involves a 4 months old male patient who received a 0.5 ml dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot UJ135AA, expiry date- 26-02-2021 via unknown route in unknown administration site on 12-Jul-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,07/12/2019,,,,UNK,,,,,,USSA2019SA254282,2,09/17/2019,,,,
0834393,09/18/2019,IA,,0,.2,F,,"patient got Adacel instead of Pentacel; they do not get a 4th dose of Pentacel at 18 months; Initial information received on 11-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional.  This case involves a 17.5 months old female patient who received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] instead of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] and reported that patient got Adacel instead of Pentacel (wrong product administered) and they do not get a 4th dose of Pentacel at 18 months (product dose omission).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HAEMOPHILUS TYPE B (HIB) VACCINE (ACT-HIB).  On 06-Sep-2019, the patient received a dose of suspect 0.5 ml DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot U6213AA via intramuscular route in the right thigh. On 06-Jun-2018, 08-Aug-2018 and 09-Oct-2018, the patient received 1st, 2nd and 3rd dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot number not reported via unknown route in unknown administration site.  It was a case of actual medication error due to Wrong vaccine administered and missed dose.  It was unknown if the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,06/06/2018,,,,UNK,,ACT-HIB,,,,USSA2019SA254929,2,09/18/2019,,,,
0834394,09/18/2019,PA,11.0,,,M,,"an 11 years old  patient who received a dose of Adacel and Menactra which had a temperature excursion below zero/No AE; Initial information received and additional information received on 10-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case is linked to cases 2019SA255155, 2019SA255195 and 2019SA254282 (same reporter).  This case involves a 11 years old male patient who received a 0.5 ml first dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] lot U6214AA, expiry date: 14-Mar-2021 via intramuscular route in the left arm on 12-Jul-2019 and 0.5 ml first dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] lot U6365AA, expiry date: 24-Sep-2020 via intramuscular route in the right arm on 12-Jul-2019 which had a temperature excursion.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to incorrect product storage.  At the time of reporting, adverse event was not reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,07/12/2019,,,,UNK,,,,,,USSA2019SA255196,2,09/17/2019,,,,
0834395,09/18/2019,MN,4.0,,,M,,"Dtap and IPV component of the Pentacel was administered to the patient and not the ActHib component of pentacel, no AE; Initial information received on 11-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 4 years old male patient who received 0.5 ml dose of DTAP AND IPV component and not ACT-HIB component of the IPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (batch number: U6327AA and expiry date: 19-Sep-2020) via intramuscular route in right leg, on 11 Sep 2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) for Immunisation.  It was an actual medication error due to inappropriate reconstitution technique. It was reported that 4 year-old patient came in and the Dtap and IPV component of the Pentacel was administered. The ActHib component was not administered. It was 4th IPV and 5th Dtap dose.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/11/2019,,,,UNK,,VARICELLA VACCINE,,,,USSA2019SA255648,2,09/18/2019,,,,
0834396,09/18/2019,TX,,,,F,,"the vaccines were mistakenly given to 8 year female patient / no AE; Initial information received on 11-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case is linked to case 2019SA256338.  This case involves a 08 years old female patient who mistakenly received vaccine 0.5 ml INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot QFAA1906 (Expiry date 22-May-2020) via intramuscular route in the left arm on 10-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error case due to inappropriate age at vaccine administration.  It was unknown if any adverse event occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/10/2019,,,,UNK,,,,,,USSA2019SA256298,2,09/18/2019,,,,
0834397,09/18/2019,TX,,,,F,,"the vaccines were mistakenly given to 10 year female patient/No AE; Initial information received on 11-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case is linked to case 2019SA256298.  This case involves a 10 years old female patient who mistakenly received vaccine 0.5 ml INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot QFAA1906 (Expiry date 22-May-2020) via intramuscular route in the left arm on 10-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error case due to inappropriate age at vaccine administration.  It was unknown if any adverse event occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/10/2019,,,,UNK,,,,,,USSA2019SA256338,2,09/18/2019,,,,
0834398,09/18/2019,NC,,61,,U,,"administered in the arm subcutaneous instead of intramuscular/no AE; Initial information received on 10-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 61 years old patient who received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No concomitant therapy was reported.   On 10-Sep-2019, the patient received a single 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot QSAA1907 via subcutaneous route in the right deltoid.   It was of actual medication error due to Inappropriate route of vaccination..  It was unknown whether adverse event was experienced..  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,09/10/2019,,,,UNK,,,,,,USSA2019SA256464,2,09/17/2019,,,,
0834399,09/18/2019,TN,0.58,0,.6,M,,"Measles type rash, full body",,,,,,,,,N,09/16/2019,09/17/2019,1,,PVT,,none,Common cold 7 days prior,none,,,2,09/18/2019,,Y,,no know allergies
0834400,09/18/2019,PA,2.0,2,.6,M,,"Hepatitis A Vaccine, Nose bleeds suddenly, has never had a nose bleed before, has had 2 within an hour lasting 10-15 minutes each",,,,,,,,,,09/17/2019,09/18/2019,1,,PVT,,none,none,none,,,2,09/18/2019,,,,none
0834401,09/18/2019,NY,61.0,61,,F,,"The patient called and said she had experienced severe flu like symptoms (fatigue, headache, chills) and pain and tenderness in armpit area for 2 days after the vaccine was given. Symptoms were improving when she called to report them but they were still present.",,,,,,,,,N,09/13/2019,09/14/2019,1,N/A,PHM,,not known,None,None,,,2,09/18/2019,,,,No Known Allergies
0834402,09/18/2019,CA,37.0,37,,M,,"Felt weak around 5pm, around 6pm I was pale and very weak, had to sit/lie down, tingling in hands. Slight wheezing, but not serious. Wanted to seek Urgen Care, but SO told me to just deal with it. At 7pm a fever with shivers came on, 101.3F, which went down around 11pm. Now, the next day, I'm still feeling under the weather, but not completely knocked out any more.",,,,,,,,,Y,09/17/2019,09/17/2019,0,,WRK,,None,None,Hypertonia,,,2,09/18/2019,,,,None known
0834403,09/18/2019,CT,76.0,76,,F,,"Approximately 2 inches below the site of injection patient experiences swelling, redness extending down to the elbow.  Red area is about 1/3 of arm area.  Onset was within 6 hours of administration.  Over the past 48 hours the swelling and redness have reduced but not returned to normal baseline.  No pain except for typical soreness at injection site.  There was an area that was palpable and hard to the touch.  That has softened somewhat but not yet disappeared.",,,,,,,,,N,09/16/2019,09/16/2019,0,None,PHM,,hydrochlorothiazide lisinopril multivitamin  vitamin d,nothing,hypertension,,,2,09/18/2019,,,,No known allergies
0834404,09/18/2019,PA,74.0,74,,F,,"Patient called on 9/17/19 reporting swelling at the site of injection. She stated that it was raised, swollen, and hot to the touch on the date of injection. When she woke up on 9/17 the swelling had gone down at the injection site, but the whole upper arm was significantly swollen, red, and tender to touch.",,,,,,,,,N,09/12/2019,09/12/2019,0,,PHM,,,,,,,2,09/18/2019,,,,Macrolides Pollen Cats
0834405,09/18/2019,AR,1.0,1,.1,M,,"Running a fever, loss of appetite.",Y,09/22/2018,,,,,,,N,09/19/2018,09/19/2018,0,,PVT,,None.,None.,None.,,,2,09/18/2019,,,,None.
0834406,09/18/2019,IL,50.0,50,,F,,"Patient received her second dose of Shingrix vaccination on 9/10/19.  By the time she was at home she had to use the bathroom almost every 5 minutes,  started to develop a migraine, felt nauseous, groggy, fatigue and extreme pain upon touch.  The next morning, 9/11/19, she decided to work from home from 8am but had to stop working at 11am because she did not feel well.  She decided to take a nap and woke up with a fever drenched in sweat.  Today, 9/12/19, she did not feel well enough to drive or work and  called in for work today as well.  She is still experiencing headaches and extreme fatigue.  She will be making an appointment to be seen by a physician.",,,,,,,,,,09/06/2019,09/06/2019,0,,UNK,,,,,,,2,09/12/2019,,Y,,
0834407,09/18/2019,TX,31.0,31,,F,,"Difficulty breathing, shortness of breath",,,,,,,,,Y,09/16/2019,09/16/2019,0,9/16/19  -,PVT,,,,,,,2,09/18/2019,,,Y,Bactrim
0834408,09/18/2019,WA,21.0,21,,M,,"local cellulitis. Treated as possible contaminated needle, injection site with IM antibiotic and follow on po antibiotic. To seek Emergent treatment at ER if symptoms flare",,,,,,,,,U,09/17/2019,09/18/2019,1,N/A,MIL,,none,none,none,,,2,09/18/2019,,,,none
0834409,09/18/2019,WI,76.0,76,,M,,"Worsened, severe post-herpetic neuralgia in prior T1-T2 distribution.  Starting on treatment with gabapentin and topical lidocaine.",,,,,,,,,N,07/22/2019,08/01/2019,10,None,PVT,,"Hydrochlorothiazide, tamsulosin, hydroxychloroquine, sulfasalazine, simvastatin, lisinopril, olodaterol/tiotropium, carvedilol, fish oil, coenzyme Q10, cholecalciferol, melatonin, multivitamin, baby aspirin",None,"Coronary artery disease, COPD, past history of urothelial bladder cancer, lung ground glass opacities, plantar fasciitis, hypertension, hyperlipidemia, anxiety, rheumatoid arthritis, mild postherpetic neuralgia",,,2,09/18/2019,,Y,,None
0834410,09/18/2019,AZ,68.0,68,,M,,"BACK SEIZED AND PATIENT COULD NOT MOVE ABOUT 4 TO 6 HOURS AFTER VACCINE, ALSO HAD UPSET STOMCK, HEADCHE AND NOT FEELING WELL. CALLED 911, TRANPORTED TO ER, AFTER SOME TESTING AND EXAMINATION PATIENT WAS TOLD THAT IT WAS BAD REACTION TO VACCINE. BACK GOT BETTER WITHIN 6 HOURS, OTHER SYMPTOMS TOOK LONGER TO RESOLVE.",,,,,,,,,Y,09/06/2019,09/06/2019,0,,PHM,,"CLOPIDOGREL, TRESIBA, MS CONTIN, GLIMPEPRIDE, METOPROLOL SUCC., LISINOPRIL, SIMVASTATIN",no,"high blood pressure, diabetes, chronic pain,",,,2,09/18/2019,,,Y,none know
0834411,09/18/2019,WA,67.0,67,,M,,2.5 hrs after the vaccine I started having a problem in my left eye. it turned out to be a detached retina which required surgery on 6-20-19,,,,,,,,Y,Y,06/14/2019,06/14/2019,0,,PVT,,Atorvastatin Lisinopril,None,None,,,2,09/18/2019,,,,None
0834412,09/18/2019,WA,1.25,1,.3,F,,"at 3 PM patient developed a tactile fever with shaking, chills, rolling her eyes to the back of her head. the seizure lasted 1 minute and family called 911. Patient stopped breathing and turned cyanotic. CPR was performed (2 breaths and 3 chest compressions) prior to spontaneous breathing resumed. Patient was taken to emergency department and Tylenol was given. Patient was seen in the office by dr. on 09/18/19.",,,,,,,,,Y,09/17/2019,09/17/2019,0,none,PVT,,none,viral up[per respiratory infection,none,,,2,09/18/2019,,,,none
0834413,09/18/2019,MO,77.0,77,,M,,"Muscle aches, fatigue, momentary flushing, slight nausea, slight dizxyness for three days.",,,,,,,,,Y,09/14/2019,09/15/2019,1,None reported,PVT,,Metoprolol 50 mg (ER) Naproxen 500mg Simvastatin 20mg Vitamin D 2000mg Vit C 1000 mg  Flonase as needed,Drainage (from allergies?),None,,,2,09/18/2019,,,,"Dust, mold"
0834414,09/18/2019,,65.0,65,,F,,Patient reports experiencing a high fever (103 F) for 3 days.,,,,,,,,,Y,08/02/2019,08/03/2019,1,,PHM,,,,,,,2,09/18/2019,,Y,,
0834415,09/18/2019,CA,12.0,12,,F,,"Patient attending immunization clinic at Public Health Department to catch up on school required vaccinations. Patient had received two vaccines listed above, when administering nurse realized patient also needed a polio vaccine. She stopped administering vaccines to draw up polio vaccine, and at that time the patient's aunt called out to patient. Nurse looked at patient, who had turned pale and appeared to be starting to pass out. Nurse assisted patient's aunt and mother in  holding patient in chair, when patient began to have seizure like episode including both arms shooting out and up and in front of patient. Patient then relaxed, but almost immediately went into second episode of seizure like activity. Nurse called for help from other nurse in clinic, patient was moved to the floor, 911 was called. Patient recovered from both seizure like episodes, but continued to look pale and state she felt bad.  No loss of consciousness after being moved  to floor. Blood pressure remained stable,  breathes even and unlabored.  Patient and family Spanish speaking. Spanish speaking staff member translated for nurses. Patient history to include epilepsy. Last seizure two years ago. Was on seizure medications when living in another country (mother didnt know exact name but had magnesium in it), but moved from another country and last had medications about six months ago. Hasn't seen a doctor since moving here as she did not have insurance and hadnt had any seizures or other health issues. Patient transported by ambulance to local hospital. Outcome unknown.",,,,,,,,,U,09/17/2019,09/17/2019,0,Immunizations x2 just prior to event.,PUB,,unknown,History of epilepsy,History of epilepsy,,,2,09/18/2019,,,Y,NKDA
0834416,09/18/2019,AZ,21.0,21,,F,,"Patient complained of itchiness to site, area was hot to the touch and had a red bump. symptoms started the same day of vaccine a couple of hours later. she is an employee and was sent to a different healthcare professional  office to seek medical attention.",,,,,,,,,Y,09/12/2019,09/12/2019,0,,PVT,,Zyrtec,Sjorens Syndrome,Sjorens Syndrome,,,2,09/18/2019,,Y,,"dogs, cats, grass"
0834417,09/18/2019,VA,6.0,6,,F,,Very red and swollen at injection site. Not sensitive or painful to the touch. Spread very fast,,,,,,,,,U,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/18/2019,,Y,,
0834418,09/18/2019,VA,7.0,7,,F,,"Red, swollen, inflammation at injection site",,,,,,,,,U,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/18/2019,,Y,,
0834419,09/18/2019,TX,52.0,52,,F,,"from the patient   I was offered the shingles vaccine on Thursday. I always knew I'd get one bc my mom got shingles. It was an awful experience and I had no idea that there were going to be side effects. I did no research, which was dumb on my part. So, with no questions or more info, I got the shot at about 10 am on Thursday. I started to feel different that evening with tired muscles which usually means I'm getting sick. I felt agitated at bedtime about 12 hours later. about 14 hours after the shot,  I awoke out of a sound sleep with electric shock type feelings in my stomach (the feeling you get if you are looking down at something when someone slams on the breaks - the surge of anxiety you get all at once). When I stood up, I felt like I'd been hit by a train.  I guess you'd say flu-like symptoms. My arm was swollen and super sore too. I was sick for two days and super tired on the third. I felt exhausted again last night. I am telling you all this in case it is supposed to be reported (CDC?) or putting in my record or something. That was horrible and I'm am not looking forward to the second shot!! Should I even get it if it made me sick?",,,,,,,,,U,09/12/2019,09/12/2019,0,none,PVT,,"xanax 0-5, flexeril 5, zofran 4 , wellbutrin 150, valtrex prn only.",none,migraine headaches,,,2,09/18/2019,,,,sulfa
0834420,09/18/2019,VA,9.0,9,,M,,"Intense redness, swelling, and inflammation at injection site",,,,,,,,,U,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/18/2019,,Y,,
0834421,09/18/2019,CA,,0,.0,F,,Jaundice within 6 hours.  Lasted 3 weeks,,,,,,,Y,,Y,03/08/2007,03/08/2007,0,,PVT,,,,,,,2,09/18/2019,,,,
0834422,09/18/2019,CA,61.0,61,,M,,"Shoulder Pain   The pain is present in the left shoulder. This is a new problem. Episode onset: 11 days. There has been no history of extremity trauma (had shingrix shot 9/5/19). The problem occurs constantly. The problem has been gradually worsening. The quality of the pain is described as sharp and pounding. The pain is at a severity of 9/10. The pain is severe. Associated symptoms include an inability to bear weight and a limited range of motion. Pertinent negatives include no fever, itching, joint locking, joint swelling, numbness or tingling. The symptoms are aggravated by activity. He has tried rest for the symptoms. The treatment provided mild relief.  Nausea  The primary symptoms include nausea. Primary symptoms do not include fever, abdominal pain, vomiting, diarrhea or rash. The illness began more than 7 days ago. The onset was sudden. Progression since onset: comes and goes.  Associated with: occurs randomly, lasts a few seconds. Exacerbated by: nothing.  The illness does not include chills, anorexia, dysphagia, odynophagia, bloating, constipation, tenesmus, back pain or itching.  Shortness of Breath  This is a new problem. The current episode started in the past 7 days. The problem occurs intermittently. The problem has been waxing and waning. Pertinent negatives include no abdominal pain, chest pain, claudication, coryza, ear pain, fever, headaches, hemoptysis, leg pain, leg swelling, neck pain, orthopnea, rash, rhinorrhea, sore throat, sputum production, vomiting or wheezing.    11 days ago pt got his second shingrix immunization. That night he got all achy, nauseous, felt terrible for 24 hours. The area of injection had pain and swelling, x 5 days. Then it's still a little tender by day 8. Then last 3-4 days it's worse.  Today it's at 9/10, making him nauseous again.  Per pt nausea still coming and going.  Also noted he's feeling more easily winded when walking around.    Patient to MD  9/17/19 12:11 PM  Hi Dr,  I visited the Ortho this morning about my shoulder pain. I asked Dr about the Shingrix vaccine and if there was a possibility of the vaccine being the culprit for the shoulder pain flare up. He said there are others who have come in with this same condition and he believes is related to the vaccine.  Proposed diagnosis: The vaccine initial shoulder pain went away after 6 days but only for a day or two then came back more powerful and painful until I couldn't stand it anymore. The vaccine most likely caused shoulder pain as inflammation to the subacrominal bursa causing a painful bursitis condition. This has been treated with a cortisone to expedite healing coupled with a two week follow up with Dr who suggested cancelling the appointment if I have made a full recovery within two weeks.",,,,,,,,,U,09/05/2019,09/12/2019,7,,PVT,,Lisinopril Aspirin 81 mg,no,benign hypertension,,,2,09/18/2019,,Y,,NKDA
0834423,09/18/2019,SC,72.0,72,,F,,"Patient reported extreme swelling and redness in the days after the vaccine, for which she was seen at her primary care physician's office.  She received no treatment; the physician referred her back to the pharmacy to report the adverse event.",,,,,,,,,Y,09/12/2019,09/13/2019,1,,PHM,,,,,,,2,09/18/2019,,Y,,
0834424,09/18/2019,OH,68.0,68,,F,,Sore arm on day post vaccination. Two days post vaccination she developed a red rash under left breast and in the groin area. The areas were sweating profusely. Her arthritis also flared up and she could not go to work for two days she was so sore all over.,,,,,,,,,Y,09/10/2019,09/12/2019,2,,PHM,,"POTASSIUM 10 MEQ, LOSARTAN-HCTZ 100/12.5, METFORMIN 500",,,,,2,09/18/2019,,,,"ADHESIVE, ZITHROMAX, PENICILLIN, METOPROLOL, CLEOSIN, ALTACE"
0834425,09/18/2019,OK,42.0,42,,F,,"Patient says she has a numbing sensation in her right jaw. She claims it is like when you go to dentist and they numb the area, but it has been numb for several hours and she cannot drink out of a cup, etc.",,,,,,,,,U,09/17/2019,09/18/2019,1,,PVT,,,,,,,2,09/18/2019,,,,
0834426,09/18/2019,VA,62.0,62,,F,,"patient experienced arm swelling, redness, hot to the touch, and itching which was noticed when they woke up the day after vaccination. Patient went to the doctor and was told there was no cellulitis and could only relate the symptoms to the vaccine.",,,,,,,,,Y,09/17/2019,09/18/2019,1,none,PHM,,,,,,,2,09/18/2019,,Y,,PENICILLIN
0834427,09/18/2019,KS,64.0,64,,F,,"Arm starting hurting and swelling before leaving doctors office, at 11:00 pm started chilling got up the next morning with headache, joint and body aches this lasted for two days.  On third day my left arm turned red  at site of injection and by the fourth day redness and swelling had grown to 10 centimeters by 20 centimeters.  Doctor gave me a steroid shot and prescribed an antibiotic and steroid pills, steroid shot took the redness and swelling down by day five, but by end of day it was back even worse.  Day six I picked up the steroid pills (did not want these) started on them now redness and swelling has gone done, but now all of this has started me with hot flashes and just feeling like I have a touch of the flu.",,,,,,,,,N,09/12/2019,09/12/2019,0,9/16/19 went to the doctors office where they diagnosed my left arm with cellulitis in the upper left arm.,PVT,,None,None,None,,,2,09/18/2019,,Y,,Mucinex
0834428,09/18/2019,CA,70.0,70,,F,,"According to patient, approximately 4-5 days after receiving the Shingrix vaccination, she developed two lesions on her face (on the right side, near nose and mouth) and one on her trunk (left side). She described them as itchy, hot, fluid-filled lesions which eventually crusted over.",,,,,,,,,Y,09/06/2019,09/10/2019,4,,PHM,,levothyroxine,unknown,unknown,,,2,09/18/2019,,,,latex
0834429,09/18/2019,CA,0.08,0,.2,F,,Inconsolable screaming crying that evening.   Head size swelling .  Increased from 30 percentile to 80 percentile by next well visit.  Left eye crusted and discharge.,,,,,,,,,N,05/04/2007,05/04/2007,0,None.  Doctor said to wait and see.,PVT,,,,,"Hep B, 3/08/2007, at birth,",,2,09/18/2019,,,,
0834430,09/18/2019,KS,62.0,62,,M,,"Pt reported 1 week after receiving vaccine developed red rash with small speckled dots 1/8-1/4 inch in diameter. Rash on the upper chest about 12 inches across and 8 inches tall. Pt stated rash developed overnight and did not heal for 6 weeks. Only complaint from pt was that it was very itchy. Rash did not spread, was not painful, and did not scab.",,,,,,,,,Y,07/16/2019,07/23/2019,7,n/a,PHM,,zyrtec 10 mg hs: seasonal allergies,none,none,,,2,09/18/2019,,,,none
0834431,09/18/2019,IN,88.0,88,,F,,"Pharmacist administered vaccine, Patient started to have difficulty breathing and was turning red, pharmacist administered Epipen. Pharmacy called 911, Ambulance/EMTs took her to the ER.",,,,,,,,,U,09/18/2019,09/18/2019,0,,PHM,,"Anticoagulation medicine, indicated on consent form, medication history unknown.",Unknown,"Long-term health problem indicated on consent form, specific conditions not listed",,,2,09/18/2019,,,Y,"No Known Allergy indicated on consent form, also no allergys listed"
0834432,09/18/2019,CT,71.0,71,,F,,"redness and inflammation at injection site, pt claim injection was not deep enough and into the muscles",,,,,,,,,N,09/16/2019,09/18/2019,2,,PHM,,n/a,n/a,n/a,,,2,09/18/2019,,Y,,n/a
0834433,09/18/2019,WY,66.0,66,,M,,"redness and swelling that wrapped around bicep, also a bruise at injection site over the course of 1 to 2 days",,,,,,,,,N,09/16/2019,09/17/2019,1,,PHM,,none,none,none,,,2,09/18/2019,,,,nkda
0834434,09/18/2019,,57.0,57,,F,,severe pain at injection site and bicept area,,,,,,,,,N,09/18/2019,09/18/2019,0,,UNK,,none,frozen shoulder; same side as vac given; started 2 months after 1st shot,,same,,2,09/18/2019,,,,
0834435,09/18/2019,MO,69.0,69,,F,,Arm  became  hot and feverish.    Arm  became  swollen.   Arm  was throbbing and  continuously  itchy.   There  was  raised  spots on  arm. Could  not  sleep  at  night.    lasted  for about  a week.    My concern  is  with  the affect  of the SECOND  shot  that I might  experience,,,,,,,,,Y,07/10/2019,07/11/2019,1,no tests,PHM,,"losatran ,  metformin, lipitor , amalodipine",none,"diabetes,  arthritis,",,,2,09/18/2019,,,,"strawberries, maybe"
0834436,09/18/2019,ME,21.0,21,,F,,"2 minutes after receiving a flu shot, patient told her father she was  dizzy, then fainted immediately.  Her father stated this had happened many times before, due to anxiety.  Her father,  tried to rouse her,and we applied cold packs and cloths to her head.  She briefly came around and spoke to her father, but continued to be pale and dizzy.  After about 5 minutes she fainted again.  She was responsive after a couple more minutes, and started to feel better.  Her father thought she would do best to go home but I asked them to stay for further monitoring, as she was not able to walk or support herself.  I took her blood pressure at approximately 15 and 25 minutes after the initial fainting, with readings of 116/75 P96 and 114/76 P87, respectively.  Normal breathing and absence of allergic signs such as hives, rash, and angioedema were noted, and she gradually became less pale and more responsive.  She left with her family with assistance, and her called me 1 our later to let us know that she was better, and walked for the vehicle to her home unassisted, and had no new symptoms.",,,,,,,,,Y,09/18/2019,09/18/2019,0,none,PHM,,"methylphenidate, levothyroxine, fluoxetine",none,"hypothyroidism, anxiety",,,2,09/18/2019,,,,latex
0834437,09/18/2019,WA,68.0,68,,F,,"Pt came in today and told me her arm was red and swollen from injection site to her elbow (left arm.) She'd gotten shingrix and pneumovax in left arm (and got fluzone hd in right arm which had no rxn.) She also said she was feeling hot last night but now not feeling hot. Pt had an ice pack on her arm when she came in, which i recommended to keep using, along with ibuprofen. Pt said she ""wasn't complaining"" that she just wanted to notify us. I thanked her and said i'd fill out vaers.",,,,,,,,,N,09/17/2019,09/17/2019,0,,PHM,,"atorvastatin, metformin, meloxicam",n/a,"dm, hld",,,2,09/18/2019,,,,"penicillin, hydantoin"
0834438,09/18/2019,WA,68.0,68,,F,,"Pt came in today and told me her arm was red and swollen from injection site to her elbow (left arm.) She'd gotten shingrix and pneumovax in left arm (and got fluzone hd in right arm which had no rxn.) She also said she was feeling hot last night but now not feeling hot. Pt had an ice pack on her arm when she came in, which i recommended to keep using, along with ibuprofen. Pt said she ""wasn't complaining"" that she just wanted to notify us. I thanked her and said i'd fill out vaers.",,,,,,,,,N,09/17/2019,09/17/2019,0,,PHM,,"atorvastatin, metformin, meloxicam",,"hld, dm",,,2,09/18/2019,,,,"pcn's, hydantoins"
0834439,09/18/2019,OH,54.0,54,,F,,pt says she has swollen area by breast and underarm. a little painful. pt is taking motrin to help with pain/inflammation.,,,,,,,,,,09/17/2019,09/17/2019,0,,PHM,,unknown,no known,"fibromyalgia, smoker",,,2,09/18/2019,,,,no known drug allergies
0834440,09/18/2019,NY,72.0,72,,F,,"The vaccine area became significantly swollen, very red, not to the touch, and extremely painful in that area. It's been a week since I received the first of two Shingrex shots and the swelling has gone down, but the skin is still red, the area is still much warmer than the rest of my arm. Initially, the swelling and redness covered an area of about three inches. Now, the swelling is reduced, but covers an area of about six inches long by three inches wide. and the area has started to itch.",,,,,,,,,N,09/12/2019,09/12/2019,0,none were taken. I've been taking  Tylenol for the pain.,PHM,,"Metformin, Atorvastatin, Preservision, Move Free, calcium,, Vitamin D3, B12, Bcomplex,",none,"Type 2 diabetes, macular degeneration",,,2,09/18/2019,,,,"Shellfish, Amoxicillin, Lyrica, Codeine"
0834441,09/18/2019,CA,0.33,0,.3,F,,"Inconsolable crying and screaming first night. Next few days listless, Head size swelled.  Increased from 80th percentile to 90th percentile.  Failed to reach milestones..  Left eye discharge.",,,,,,,,Y,N,07/13/2007,07/13/2007,0,None. Dr. said to wait and see.,PVT,,,Eye discharge and crusting.  Rx Tobrex 3 x day,,"same vaccines from 2 month well visit.  same symptoms and reactions  DTaP, HiB, Prevar, annd IPV",,2,09/18/2019,,,,
0834442,09/18/2019,OR,73.0,73,,F,,We did not mix the vaccine and only injected the patient with adjuvant suspension component.,,,,,,,,,Y,09/18/2019,09/18/2019,0,n/a,PHM,,unknow,none,High Blood Pressure and Insomnia,,,2,09/18/2019,,,,NKA
0834443,09/18/2019,GA,65.0,65,,F,,pt called days later with large bruise on arm where shot was given does not hurt is not red,,,,,,,,,U,09/13/2019,09/18/2019,5,,PHM,,"pt also takes plavix, tramadol, lisinopril, isosorbide, atorvastatin, mobic, zantac, atorvastatin, celexa, coreg",none,none,,,2,09/18/2019,,,,no allergies
0834444,09/18/2019,TX,66.0,66,,F,,Pt received her PPSV23 on 9/14/19.  She states her arm was red on the morning of 9/15/19.  She showed me her arm today which was a little red and she said the redness was almost all gone.,,,,,,,,,N,09/14/2019,09/15/2019,1,n/a,PHM,,"metoprolol tartrate, hydralazine",none,hypertension,Prevnar 13 - redness/swelling (She spoke with her dr and her dr was aware and wanted her to get PPSV23.),,2,09/18/2019,,,,none
0834445,09/18/2019,IL,53.0,53,,F,,"Patient got 2 immunizations (1 Flublok on right arm and 1 Pneumovax 23 on left arm) on 09/16/19.  I tell every single customer that most common side effect with immunization is hot to touch, red to see and painful at injection for couple days.   She came back to pharmacy on 09/18/19 and complaining  about soreness, redness and hot area on triceps area of left arm which is away from injection site.  There was no sign of any visual adverse effect on injection site. She also complain about shoulder pain.  Patient also took ibuprofen 200 mg, 1 tablet by mouth 3 times a day yesterday.  I did call her doctor office and spoke to staff for follow up appointment.  There was not sign of infection, but md is treating her with antibiotic for skin infection.",,,,,,,,,N,09/16/2019,09/17/2019,1,I called MD office to follow up on antibiotic prescription which i received electronically. Staff refused to provide me with more information without patient consent.  All i was told that MD is processed with skin infection treatment.,PHM,,NOT THAT I KNOW,NOTHING WAS REPORTED AT TIME OF QUESTIONNAIRE PRIOR TO ADMINISTRATION OF VACCINE,ASTHMA,,,2,09/18/2019,,Y,,NKDA PER PATIENT
0834446,09/18/2019,WA,66.0,66,,M,,"Chills, body aches, headache, fever, blood in urine, frequent bowel movements",,,,,,,,,Y,09/17/2019,09/17/2019,0,,PHM,,none,none,none,"chills, body aches - 1st dose of Shingrix vaccine",,2,09/18/2019,,,,none
0834447,09/18/2019,CA,0.5,0,.5,F,,"Crying and screaming that evening.   Loss of eye contact.  Lethargic for the next few days.  No new milestones. Won't eat solid foods..  No crawling , clapping babbling.  gross motor skills delay.   Swollen head.",,,,,,,,Y,N,09/13/2007,09/13/2007,0,None.  Dr said to wait and see.,PVT,,,,,"DTaP, Hib, Prevnar  same reactions at previous doses",,2,09/18/2019,,,,
0834448,09/18/2019,PA,24.0,24,,F,,"Time Course:  1) Flu Shot - 11 am  2) Reaction/Hives - Noon (same day as the flu injection)  3) Reported to Health Clinic 2pm 4) Left Health Clinic 3pm   Signs:  1) Notice of Hives  2) Warmness  3) Tightness and Soreness in Arm Received Injection   Symptoms:  1) Severe Hives Both Front and Back of Arms Spread of Hives From Shoulders to Wrists  2) Area of Injection Swollen - Left Arm  3) Area Below Injection - Location of Start of Hives - Severe Redness and Warm - Left Arm  4) No Hives in Area of Injection  5) Hives On Leg Shins - After Returning From Health Clinic   Outcomes: 1) Recommended From Health Clinic Doctor - Report to Emergency Room to Receive Injection, etc. - Did Not Report to Emergency Room  2) Health Clinic Doctor - Provided a Benadryl for the Second Option - Oral Pill  3) Health Clinic Doctor - Provided Ice Pack for Swelling  4) Took 25 MG Benadryl with Water Departing From Clinic  5) Returned Directly Back to Work  6) Returned Home After Work  7) Reaction Gone Down Since Taking Medication 8) Tiredness - Bed Early From Benadryl",,,,,,,,,Y,09/18/2019,09/18/2019,0,Pulse Check - 9/18/2019 (day of injection and treatment)  Blood Pressure Check (pressure cuff) - 9/18/2019 (day of injection and treatment) Temperature -Thermometer Under Tongue - 9/18/2019 (day of injection and treatment),WRK,,1) Junel FE 1 MG/20 - Birth Control  2) Drysol 20%,None,None,,,2,09/18/2019,,Y,,None
0834449,09/18/2019,CA,1.0,1,.0,F,,Developed hives the next day.   Came and went intermittently over the next few months.   2 weeks later developed sinus infection and rash and chest and belly.    Over sensitive to light and sound.  Refused eye contact.,,,,,,,,,U,03/13/2008,03/14/2008,1,"None. When called into office, Dr said to wait and see,   Came back to office on March 31, 2008 because of sinus and infection and rash.",PVT,,Fluoride Rx  drops .25mg  daily,"cold, sinus infection, cough Feb 14 - 20, 2008","Delayed gross motor skills,","Prevnar, Hib, DTaP, Hep B, IPV",,2,09/18/2019,,Y,,
0834450,09/18/2019,FL,84.0,84,,F,,"PATIENT CAME TO PHARMACY ON 09/11/19 TO GET FLUZONE HD ADMINISTERED. SHE CAME IN ON 09/18/19 CLAIMING SHE WAS BLEEDING AT THE INJECTION SITE THE EVENING OF 09/11/19 ONLY AND THAT HER ARM WAS HURTING  ALOT SINCE AND WAS LEFT WITH A BRUISE AROUND THE INJECTION SITE WHICH COULD STILL BE SEEN AS OF 09/18/19 WHEN SHE CAME TO THE PHARMACY.  I, PHARMACIST WHO SHE HAD CONTACTED ON 09/18/19 COULD SEE THE BRUISE AND ASKED IF SHE WAS TAKING ANY BLOOD THINNERS WHICH COULD POTENTIALLY LEAD TO BLEEDING AT THE INJECTION SITE BUT SHE REPLIED NO.  SHE CLAIMED SHE NEVER TOOK ANY MEDICATION SINCE APPLYING THE VACCINE AND THERE WAS NO ALLERGIC REACTION OR AT LEAST FROM WHAT I COULD SEE ON 09/18/19, BUT I DID SEE A BRUISE AROUND THE INJECTION SITE. IN MY OPINION I BELIEVE THIS IS NOT A TRUE ADVERSE EVENT BUT I AM FILLING THE FORM AS A LIABILITY PRECAUTION AND ALSO BECAUSE I WAS ADVISED BY MY MARKET HEALTH AND WELLNESS DIRECTOR TO DO SO, AGAIN, FOR LIABILITY PRECAUTION.",,,,,,,,,U,09/11/2019,09/11/2019,0,NONE,PHM,,NONE,NONE PER PATIENT,HIGH BLOOD PRESSURE AND CHOLESTEROL,,,2,09/18/2019,,,,NO KNOWN DRUG ALLERGIES
0834451,09/18/2019,WA,69.0,69,,F,,Pt reported on 9/18 big rash at site of injection and felt really painful in her back describing as like a really bad sunburn Says symptoms are worsening also I told her to try to take a Benadryl and if doesn't improve in 48 hours to go to doctor to get checked out,,,,,,,,,U,09/16/2019,09/16/2019,0,N/A,PHM,,Don't know,Don't know,,,,2,09/18/2019,,,,No Known Drug Allergy
0834452,09/18/2019,OK,54.0,54,,F,,"symptoms include pain at area of injection, loss of ability to move arm at injection. both injections, flu and pneumvox, were given on same arm as requested by the patient. one injection was given higher than the other. it is believed to be the flu shot but it is not certain that it is the flu shot that was given higher and may have caused pain and loss of mobility of arm at shoulder joint.",,,,,,,,,N,09/16/2019,09/16/2019,0,none,PHM,,"metformin, metoprolol, furosemide, spironolactone, flexeril, warfarin, iron",unknown,unknown,,,2,09/18/2019,,Y,,unknown
0834453,09/18/2019,IL,62.0,62,,F,,oN 9-17-2019 EVENING SHE STARTED FILLING CHILLS AND BODY ACHES ALL OVER. SHE DRESSED UP WARM CLOTHES AND WENT TO BED. IN MIDDLE OF NIGHT SHE WAKE UP WITH HEAVY SWEATING AND ALL HER CLOTHES WERE WET. SOMETIME IN NITE SHE DEVELOPED RASH WITH ITCHING. IT FEELS HOT AND BY TOUCHING IS ITS HOT. AT THIS TIME MEDICAL ATTENTION NOT NECESSARY. SHE CAME TO STORE ON 9-18-2019 AROUND 530PM TO TALK TO PHARMACIST. I SUGGESTED COLD COMPRESS WILL DO THE JOB. I HAVE TAKE A PICTURE OF RASH INCASE ANY ONE INTERESTED,,,,,,,,,N,09/16/2019,09/17/2019,1,NONE,PHM,,Not Known. Customer will not go in detail,Not Known,"Glaucoma, seizure, migraine headache, RLS , b12 deficiency",,,2,09/18/2019,,,,No known allergy. Previous year had a flu shot. no reaction
0834454,09/18/2019,CA,1.25,1,.3,F,,"Swelling of face, crying screaming that night.  Loss of eye contact.  Will not eat solid foods. no responsiveness,  ear infection,  no progression in any milestones.",,,,,,,,Y,N,06/13/2008,06/14/2008,1,"None,  Dr. said to wait and see.",PVT,,Fluoride drops,,"Gross motor delay, chronic sinus infections, ear infections.","DTaP, IPV, Hib, Prevnar,5/4/07, 7/13/07, 9/13/07.  2, 4 and 6 moths of age.  Aventis, Sanofi, Wyeth.",,2,09/18/2019,,,,
0834455,09/18/2019,WA,83.0,83,,M,,"A few moments after the vaccination was administered to the patient, the patient begin to turn red in the face and then his body was shaking and he said he was experiencing some kind of muscle spasms and finally his heart rate was palpitating. 10 minutes later, all the symptoms went away and patient returned back to normal state",,,,,,,,,Y,09/13/2019,09/13/2019,0,None done at this pharmacy but EMT and pharmacist recommended that patient go to urgent clinic to get further testing done.,PHM,,"Glycopyrrolate, Prednisone, Carvedilol",None,"Thyroid Overactive, Urinary Incontinence,",,,2,09/18/2019,,Y,,None
0834456,09/18/2019,FL,77.0,77,,F,,"Fatigue, ""flushed"", warm feeling in face and body. No treatment",,,,,,,,,N,09/08/2019,09/09/2019,1,None,PHM,,"Low strength aspirin, Diltiazem, Duloxetine, Loratadine, calcium citrate, mature multivitamin, B complex, B1, B6, B12, probiotics, Aleve",,"Spinal stenosis, arthritis and torn rotator cuff in left shoulder,",,,2,09/18/2019,,,,"Tramadol, Codeine, Prednisone"
0834457,09/18/2019,CA,13.0,13,,M,,"Shot given 9/3/19, hives started 9/6/19 no fever and mild itching with hives over entire body but more pronounced on hands, mom went to clinic 9/14 and was told hives were from vaccines. Put on benadryl for 3 days, resolved. Saw patient today no hives or rash seen. No other complaints or adverse effects",,,,,,,,,Y,09/03/2019,09/06/2019,3,None done,SCH,,None known,None,Down's Syndrome. Mom states heart problems and convulsions as a baby,,,2,09/18/2019,,Y,,None
0834458,09/18/2019,AZ,78.0,78,,F,,"The next day after vaccination patient called to report extremely red and sore arm around injection site and extending around into armpit. Patient had taken some tylenol, It was recommended to apply ice and take some benadryl as well.",,,,,,,,,U,09/13/2019,09/14/2019,1,unknown,PHM,,amlodipine celebrex reglan diprolene oint,,hypertension rheumatoid arthritis,,,2,09/18/2019,,,,codeine sulfa tramadol
0834459,09/18/2019,IL,3.0,3,,M,,"My son had an open wound and received stitches at Hospital on 3/10/19.  The emergency room doctor urged us to give my son his Dtap vaccine and the nurse administered the Dtap shot in my son's left thigh on 3/10/19 at hospital.  Two days later, I noticed a rash behind my son's left knee.  I took him to the pediatrician and he was diagnosed with Eczema. He did not have eczema prior to receiving the Dtap vaccine.   He still has an active eczema outbreak in the same location today. It never went away.",,,,,,,,,N,03/10/2019,03/13/2019,3,"I visited my pediatrician and was given a diagnosis of Eczema. I do not have lab results for this because it was diagnosed by the doctor, via seeing the rash behind his knee.",PVT,,No Medications taken at time of vaccination.,No illnesses at time of vaccine or one month prior.,None before vaccine.,,,2,09/18/2019,,,,No none allergies at the time of vaccine.
0834460,09/18/2019,TX,30.0,30,,F,,"Fever, chills, arm soreness, muscle soreness, headache. Took ibuprofen p",,,,,,,,,U,09/01/2019,09/18/2019,17,,WRK,,,,Asthma,,,2,09/18/2019,,,,
0834463,09/18/2019,ND,35.0,35,,F,,"Patient stated that she had pain, numbness and tingling of right arm, due to flu shot. Possibly given too high in the deltoid. Denies any redness, fever, or chills.",,,,,,,,,Y,09/10/2019,09/10/2019,0,N/A,WRK,,N/A,N/A,N/A,,,2,09/19/2019,,Y,,N/A
0834464,09/18/2019,TX,11.0,11,,F,,Left upper arm swelling 4 x 4 cm. Reaction to Menveo vaccine,,,,,,,,,N,09/09/2019,,,,PVT,,,,,,,2,09/12/2019,,Y,,
0834465,09/18/2019,NC,65.0,64,,F,09/10/2019,Extreme (R) arm swelling post shingrix #1 given on 8-6-2019 that continued thru 8-13-19,,,,,,,,,Y,08/06/2019,08/07/2019,1,N/A,OTH,OTH,,None,None,,,1,,,,,
0834466,09/18/2019,TX,12.0,12,,F,09/18/2019,"As per mother, pt had fever, headaches, vomiting after HPV #2 vaccine was adminastered.",,,,,,,,,Y,09/16/2019,09/17/2019,1,,UNK,PUB,pp,,"Hypertension, acanthosis nigricans.",,,1,,,,,
0834467,09/18/2019,FL,17.0,17,,F,,"Dyspnea, SOB, increased heart rate, pale mottled skin Treated with: benadryl and 1 dose of steroid in ER.",,,,,,,,,Y,08/28/2019,08/28/2019,0,"CBC, Chest xray, ECG on 8/28/19 - all normal",PVT,,0,0,0,,,2,09/18/2019,,Y,Y,0
0834468,09/18/2019,PA,57.0,57,,M,09/18/2019,"Patient received 2nd dose of shingles vaccine in March of 2019. On July 23, 2019 contacted provided with the following complaint. Patient believes that he has shingles. Has had shingles in the past, this seems worse. Pain started 1.5weeks. Rash developed over the weekend. Rash to left buttocks and spreading down his legs. +red patches, +fluid filled blisters, +drainage, +tender to touch, +burning sensation, +5-8/10 pain, +abdominal pain and +body aches. Denies fever, nausea, fatigue, weakness, or HA.",,,,,,,,,Y,03/13/2019,07/23/2019,132,,OTH,OTH,Omeprazole Cyclobenzaprine Meloxicam,,,,,1,,,,,
0834469,09/18/2019,NY,9.0,9,,M,09/18/2019,Pt with 3-4cm pale pink area on (L) deltoid. Symptoms started Monday night and pt improved compared to picture taken Thursday.,,,,,,,,,Y,09/16/2019,09/17/2019,1,,PVT,UNK,,N/A,N/A,,,1,,,,,
0834514,09/18/2019,CA,0.33,0,.4,F,,Rash on face & head about 15 minuts post vaccination. No urticaria or wheezing. Observed in clinic for 1 hour with fading of macular rash. Left in good condition,,,,,,,,,Y,09/17/2019,09/17/2019,0,None,UNK,,,,,,,2,09/18/2019,,Y,,
0834527,09/18/2019,WA,2.75,2,.8,F,,"Found in bed having a seizure & Vomiting EMT called Versed Administered, taken to ED. Dx Complete Febrile Seizure Todd's paralysis",,,,,,,,,Y,09/12/2019,09/12/2019,0,"Chest x-ray - probable Agarhem Head CT - normal CBC normal, urinalysis normal",PVT,,none,none,none,,,2,09/18/2019,,,Y,none
0834608,09/18/2019,CO,12.0,12,,M,09/18/2019,(L) arm deltoid red + swollen - spreading down arm - itchy,,,,,,,,,U,09/16/2019,09/17/2019,1,,PVT,PUB,,None,None,,,1,,,,,
0834765,09/18/2019,FL,17.0,17,,F,,Intermittent dizziness that has lasted 7 days thus far. She is being treated with increased hydration and a trial of antihistamine. She is avoiding driving for now.,,,,,,,,,N,09/11/2019,09/12/2019,1,Orthostatic BP's,PVT,,Lexapro Oral contraceptive pills,"Restless sleep, sweating, tired",Anxiety,,,2,09/18/2019,,Y,,Apple juice; no known drug allergies
0834461,09/19/2019,WA,8.0,8,,F,,"Gave the patient a flu shot and she did really well. As I was giving the mother her flu shot, she said, ""mom that wasn't bad"" and then when the mother bled a little and the daughter saw and passed out. She passed out, fell and hit her head. She regained conscience right away, and the mother started asking her questions to make sure she didn't have a concussion. She was able to recall everything. I offered to call 911 but the mother said that wasn't necessary. Ice was provided and she sat for a bit while the mother and I talked. The daughter had never gone through this before but the mother has experienced this where she faints at the sight of blood. We asked patient if it was because it was the sight of blood that caused her to faint and she said yes. The mother carried her and she felt better. I reached out later in the day to see how patient was doing and the mother said she was resting and was going to give Tylenol for the bruise on her head. Expressed that her family consists of multiple healthcare professionals and they had everything under control.",,,,,,,,,Y,09/18/2019,09/18/2019,0,,PHM,,,,,,,2,09/19/2019,,,,
0834462,09/19/2019,KS,71.0,71,,F,,"Pain at shot site on day 1. Following day pain was worse, body temp elevated 2 degrees, fasting blood sugar was 170 (it has NEVER been that high before), headache, body aches, nausea, fatigue. The flu-like symptoms lasted more than 2 weeks.  My fasting blood sugar continues to be about  20 points higher than it was prior to the Shingrix  -- after 2 1/2 months. Body aches continue to be bad enough to make it difficult to sleep.",,,,,,,,,N,07/01/2019,07/01/2019,0,,PHM,,"amlodipine 2.5 mg before bed, hydrocortisone 15 mg in am , levothyroxine .025 mcg before bed, NP Thyroid 60 mg 3x/day, Estring  325 mg aspirin, 400 mg tylenol, 1000 mg vitamin C, Vitamin D3 4000 IU, 5 mg Methylcobalamin (B12), calcium citra",none,"Pan-hypo-pituitary,  secondary hypothyroidism, type 2 diabetes",,,2,09/19/2019,,Y,,"Bee Sting  Cephradine(Velosef) - rash on back, syncope. **This is a discontinued 1st generation cephalsoporin.**  Cefazolin - severe asthma reaction - vivid nightmares - night terrors  Chlorhexidine and Hexachlorophene, skin breaks open and bleeds.  Chromic Gut Suture - tissue broke ..down where it contacted suture  and I ""unzipped""  Depo-Provera - swelling, discoloration, pain (depo component -- can take oral provera)  Dulera (mometasone fumarate/fomoterol fumarate dihydrate) sinusitis, headache, profuse thick mucus production  Flovent HFA  (Fluticasone) Asthma inhaler sore throat, ear ache  Lovastatin - Elevated liver enzymes + fatty liver  Seldane - vertigo  Tramadol - nightmares and night terrors  Optimark MRI Contrast (gadolinium contrast die)  Opiates Including: Morphine, Dilaudid, Demerol - agitation and hysteria with no pain control oxycodone(Percocet) - agitation and full body itching with no pain control  Sensitivity to Sulfa"
0834470,09/19/2019,VA,56.0,56,,M,,"1.  Fatigue, general weakness, headache noticed on waking approx. 15 hours after vaccine. Milder at day 2 (40 hours) but still tired. 2.  Arm muscle soreness accompanied by 2"" diameter circular red mark at site of injection. Tender to touch. Slightly swollen. Noticed on second day after vaccination at approx. 40-42 hours. Was not there at 15 hours.",,,,,,,,,N,09/17/2019,09/18/2019,1,None,MIL,,10 mg Zocor eq daily 81mg aspirin daily,None,None,,,2,09/19/2019,,,,NKA
0834471,09/19/2019,PA,5.0,5,,M,,"Injection site started to get red with a small area around it red as well. Red area continued to grow in diameter and was warm to the touch, hard, and sensitive. This all was noticed Saturday morning and continued through the day. Sunday night at bath time, dad noticed the area had grown to a red area around his right groin area, which promoted a visit to urgent care.",,,,,,,,,N,09/13/2019,09/14/2019,1,,PVT,,Taking Allegra for allergies.,None,None,,,2,09/19/2019,,,,None
0834480,09/19/2019,MI,19.0,,,U,,"No adverse effects; a 19 year old patient received a pediatric/adolescent dose of VAQTA; This spontaneous report has been received from a physician via field representative referring to a 19-year-old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant therapies and drug allergy or reactions were not reported.             On 21-AUG-2019, the patient was vaccinated with a pediatric/adolescent dose of hepatitis a vaccine, inactivated (VAQTA) (strength: 25/0.5 (unit not provided); dose, route, lot number and expiration date were not reported) for prophylaxis (Product administered to patient of inappropriate age). No adverse effects were reported in the patient. No product quality complaint (PQC). No other information was available.",,,,,,,,,U,08/21/2019,08/21/2019,0,,UNK,,,,,,US0095075131908USA008794,2,09/19/2019,,,,
0834481,09/19/2019,OR,,,,U,,"No adverse effects.; a patient was administered an improperly stored ROTATEQ.; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medication and drug reactions/allergies were not reported.  On 22-AUG-2019, the patient received improperly stored rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (batch/lot# S010702 with expiration date 16-JAN-2021; dose, frequency, route of administration were not reported) for prophylaxis (Product storage error). The temperature and time frame were unknown (late shipment). Information of previous temperature excursion was not provided. No adverse effects were reported. Data logger was not involved.",,,,,,,,,U,08/22/2019,08/22/2019,0,,UNK,,,,,,US0095075131908USA010845,2,09/19/2019,,,,
0834482,09/19/2019,OR,,,,U,,"No adverse effects; a patient was administered an improperly stored ROTATEQ.; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medication and drug reactions/allergies were not reported.  On 22-AUG-2019, the patient received improperly stored rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (batch/lot# S010702 with expiration date 16-JAN-2021; dose, frequency, route of administration were not reported) for prophylaxis (Product storage error). The temperature and time frame were unknown (late shipment). Information of previous temperature excursion was not provided. No adverse effects were reported. Data logger was not involved.",,,,,,,,,U,08/22/2019,08/22/2019,0,,UNK,,,,,,US0095075131908USA010893,2,09/19/2019,,,,
0834483,09/19/2019,OR,,,,U,,"No adverse effects; a patient was administered an improperly stored ROTATEQ.; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medication and drug reactions/allergies were not reported.  On 22-AUG-2019, the patient received improperly stored rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (batch/lot# S010702 with expiration date 16-JAN-2021; dose, frequency, route of administration were not reported) for prophylaxis (Product storage error). The temperature and time frame were unknown (late shipment). Information of previous temperature excursion was not provided. No adverse effects were reported. Data logger was not involved.",,,,,,,,,U,08/22/2019,08/22/2019,0,,UNK,,,,,,US0095075131908USA011072,2,09/19/2019,,,,
0834484,09/19/2019,OR,,,,U,,"No adverse effects; a patient was administered an improperly stored ROTATEQ.; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medication and drug reactions/allergies were not reported.  On 22-AUG-2019, the patient received improperly stored rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (batch/lot# S010702 with expiration date 16-JAN-2021; dose, frequency, route of administration were not reported) for prophylaxis (Product storage error). The temperature and time frame were unknown (late shipment). Information of previous temperature excursion was not provided. No adverse effects were reported. Data logger was not involved.",,,,,,,,,U,08/23/2019,08/23/2019,0,,UNK,,,,,,US0095075131908USA011074,2,09/19/2019,,,,
0834485,09/19/2019,MD,,,,F,,"pneumonia; the vaccine did not prevent shingles; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 06-APR-2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for its intended purpose: the prevention of shingles.         On an unknown date, ""few months"" of receiving zoster vaccine live (ZOSTAVAX), the patient developed and was diagnosed with pneumonia. The vaccine did not prevent shingles, but rather caused the patient to contract pneumonia. As a direct and proximate result of the defective Zoster Vaccine Live (ZOSTAVAX), the patient suffered painful injuries and damages, and required extensive medical care and treatment. The patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. As a result of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The outcome of the event was considered to be not recovered.  Pneumonia was considered to be disabling.  Upon internal review pneumonia was considered to be medically significant.",,,,,,,,Y,N,04/06/2016,,,,PHM,,,,,,US0095075131909USA005059,2,09/18/2019,,Y,,
0834486,09/19/2019,,18.0,,,U,,"confirmed VZV infection by PCR of skin lesions on 8/30; patient was diagnosed with leukemia; vesicular lesions; This spontaneous report was received from a physician via former company representative refers to a 18 year old patient. The patient's concurrent condition included leukaemia. Information on medical history, concomitant mediactions were not reported.  On 30-JUL-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose, frequency, anatomical location, route, lot # and expiry date not reported) for prophylaxis. On 02-AUG-2019, the patient experienced leukaemia. The patient started chemo including a 28-day course of prednisone. Subsequently, on an unknown date in August 2019, the patient experienced rash vesicular, which started out on the neck and was initially considered as a possible case of acne (vesicular lesions). On 30-AUG-2019, the patient experienced varicella infection (VZV infection) and it was confirmed by polymerase chain reaction (PCR) of skin lesions. It was also reported that it would be helpful to confirm that this was vaccine strain. The former company representative suggested the physician, if he would test the sample or would suggest another hospital physician. The reporter also stated that the patient was doing well after the course of prednisone. The rash had resided and there were no longer any lesions from which to obtain a sample. The only available sample was the one used for PCR testing. The outcome of rash vesicular was considered as not recovered. The outcome of leukaemia was considered to be recovering and the outcome of varicella was unknown. Causality assessment was not provided.  Upon internal review, the event leukaemia was determined to be medically significant.",,,,,,,,,N,07/30/2019,08/01/2019,2,,UNK,,,,,,US0095075131909USA005369,2,09/18/2019,,,,
0834487,09/19/2019,,42.0,42,,F,,"The patient developed unspecified swelling at the injection site; This spontaneous report was received from a nurse referring to a 42-year-old female patient. Her pertinent medical history included hypertension (considered concurrent condition). On an unspecified time in the past, the patient received lisinopril (LISlNOPRlL) (considered an historical drug), to which she developed an unspecified drug reaction (also considered a concurrent conditions) (captured on MARRS # 1909USA005728). The patient had no concomitant medications.  On 10-SEP-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) intramuscular route for prophylaxis (strength and dose were not provided; lot number S021740 has been verified to be a valid number; expiration date 25-MAR-2021, and upon internal validation established as the same date).         On 12-SEP-2019, the patient developed unspecified swelling at the injection site (injection site swelling). The outcome of injection site swelling was reported as not recovered. The patient stated that she sought for medical attention and was treated by the physician with diphenhydramine (BENADRYL) 25 milligram (mg) tablet and Acetaminophen (TYLENOL) (unspecified dose). Laboratory diagnostics or studies were not performed.   The causality assessment between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and the injection site swelling was not reported.  This is one of two same patient cases.; Sender's Comments:  US-009507513-1909USA005728:",,,,,,,,,N,09/10/2019,09/12/2019,2,,UNK,,,Hypertension,Medical History/Concurrent Conditions: Drug hypersensitivity,,US0095075131909USA005607,2,09/18/2019,,,,
0834488,09/19/2019,IN,15.0,15,,F,,"no adverse effect; expired dose administered; This spontaneous report was received from a licensed practical nurse and refers to a 15-year-old female patient. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On 13-SEP-2019, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) one dose via intramuscular route, lot # R027431, expiration date 08-SEP-2019 (injection site was not reported) for prophylaxis. There was no adverse effects reported.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,,,,,US0095075131909USA005949,2,09/19/2019,,,,
0834489,09/19/2019,NY,,,,M,,"bell's palsy; Information has been received from a lawyer referring to a male patient of unknown age. The patient's medical history, concurrent condition and concomitant therapy were not reported.  In 2017, the patient was vaccinated with Zoster Vaccine Live (ZOSTAVAX) (strength, dose, frequency, route, lot# and expiration date were unknown) for the long-term prevention of shingles and/or zoster-related conditions.  On an unknown date, the patient experienced bell's palsy. The outcome of the event was unknown. As per the reporter, the patient has suffered and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of pre-existing conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.  The event of bell's palsy was determined to be disabling and medically significant. The reporter considered the event was related to Zoster Vaccine Live (ZOSTAVAX).",,,,,,,,Y,U,,,,,UNK,,,,,,US0095075131909USA006366,2,09/18/2019,,,,
0834490,09/19/2019,NY,,,,M,,"shingles; Information has been received from a lawyer and a male patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On or about 23-DEC-2008, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a physician for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.",,,,,Y,,,,U,12/23/2008,,,,OTH,,,,,,US0095075131909USA006371,2,09/19/2019,,Y,,
0834491,09/19/2019,IN,,,,F,,"shingles; Information has been received from a lawyer and a female patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In 2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a healthcare provider at a physician office for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.",,,,,Y,,,,U,,,,,OTH,,,,,,US0095075131909USA006376,2,09/19/2019,,,,
0834492,09/19/2019,AZ,,,,M,,"shingles; Information has been received from a lawyer and a male patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In 2008, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a healthcare provider for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.",,,,,Y,,,,U,,,,,OTH,,,,,,US0095075131909USA006386,2,09/19/2019,,,,
0834493,09/19/2019,CT,,,,F,,"supraclavicular lymphadenopathy; This spontaneous report was received from a nurse practitioner regarding a 12-year-old female patient. The patient did not have any medical history, concurrent conditions, drug reactions/allergies and concomitant medications. The patient was not pregnant.  On an unknown date, the patient was vaccinated with first and second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) and on 05-SEP-2019, the patient finished hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) series (strength, dose, lot number and expiry date were not provided) which were given via intramuscular route in the left deltoid region for prophylaxis (reported as for prevention). On an unknown date in September 2019, also reported as shortly after last dose administration, the patient experienced supraclavicular lymphadenopathy. The patient sought medical attention and treatment was given for adverse event. On an unknown date in September 2019, blood work cancer markers were performed and showed negative result. The outcome of lymphadenopathy was reported as not recovered. The reporter's causality assessment was not reported. No product quality complaints (PQC) were involved.",,,,,,,,,N,,09/01/2019,,,UNK,,,,,,US0095075131909USA006462,2,09/18/2019,,,,
0834494,09/19/2019,CO,,,,F,,"felt bad for about a day; This case was reported by a consumer via call center representative and described the occurrence of feeling bad in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad was recovered/resolved.   It was unknown if the reporter considered the feeling bad to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that her pharmacist told her that she herself had the Shingrix shot and felt bad for about a day afterwards and then it resolved. No further details were provided. The reporter did not consent to follow up. This case is 1 of the 3 linked cases, reported by the same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834495,09/19/2019,FL,60.0,60,,M,,"Headache; Aching muscle at injection site; This case was reported by a consumer and described the occurrence of headache in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced headache and injection site muscle pain. On an unknown date, the outcome of the headache and injection site muscle pain were not recovered/not resolved.   It was unknown if the reporter considered the headache and injection site muscle pain to be related to Shingrix.  Additional details were provided as follows: The patient reported that, after vaccination with dose of Shingrix, experienced headache and muscle pain at the injection site. The reporter wanted to know how long does side effects would last.",,,,,,,,,N,09/09/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/19/2019,,,,
0834496,09/19/2019,CA,,,,M,,"Stress is Mild; This case was reported by a consumer and described the occurrence of stress in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced stress. On an unknown date, the outcome of the stress was recovered/resolved.   It was unknown if the reporter considered the stress to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported that, after vaccination with dose of Shingrix, experienced stress. The patient reported that, the stress was mild, and it was comes and goes.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/19/2019,,,,
0834497,09/19/2019,NY,67.0,67,,F,,"Pain in her legs; Feeling Tired; nausea; This case was reported by a consumer via call center representative and described the occurrence of leg pain in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st April 2019, the patient received the 1st dose of Shingrix. In April 2019, couple of days after receiving Shingrix, the patient experienced tiredness and nausea. In July 2019, the patient experienced leg pain. On an unknown date, the outcome of the leg pain was recovering/resolving and the outcome of the tiredness and nausea were resolved with sequelae.   It was unknown if the reporter considered the leg pain, tiredness and nausea to be related to Shingrix.  Additional details were provided as follows: The patient experienced pain in her legs but mostly her left leg. The pain was on the back of her legs and was worse at night. The patient also experienced feeling tired and had nausea. The patient consented to follow up.",,,,,,,,,N,04/01/2019,07/01/2019,91,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834498,09/19/2019,OK,,,,F,,"blood pressure over 200 systolic; eyes turned red; Initial information received on 12-Sep-2019 regarding an unsolicited valid serious case received from a nurse.  This case involves a 39 years old female patient who experienced blood pressure over 200 systolic (blood pressure systolic increased) and red eyes (ocular hyperaemia), while she received vaccine INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE [FLUZONE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, in 2013, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE lot UH906AE expiry date: 30-Jun-2014.  On an unknown date, in 2013, the patient had blood pressure over 200 systolic (blood pressure systolic increased) and red eyes (ocular hyperaemia) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE. The patient was admitted in a hospital at an emergency clinic. She was declining immunization on adverse events.  Relevant laboratory test results included: On an unknown date, the blood pressure systolic was over 200.   Final diagnosis was increased systolic blood pressure and ocular hyperaemia.   It was not reported if the patient received a corrective treatment.  The patient outcome was reported as unknown for increased systolic blood pressure and ocular hyperaemia.  List of document held by sender: none.; Sender's Comments: This case concerns a 39 years old female patient who had increased systolic blood pressure and ocular hyperaemia following the vaccination with FLUZONE. Exact time to onset was unknown. The patient's past medical history, concomitant medications and lab data ruling out other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.",,,,,Y,,,,U,,,,Test Name: Blood pressure systolic increased; Test Result:  200 {DF}; Result Unstructured Data: increased,UNK,,,,,,USSA2019SA257108,2,09/18/2019,,,Y,
0834499,09/19/2019,FL,69.0,69,,M,,Patient started receiving severe pain in left arm after vaccine and cannot lift arm.  He has arm in sling and slight movement today.  He took hydrcodone/apap for the pain.  Contacted Dr. and waiting for call back.,,,,,,,,,N,09/17/2019,09/17/2019,0,Paitent had torn rotator cuff surgery in 2008 on both shoulders.,PHM,,"montelukast, omeprazole, alprazolam, simvastatin, lisinopril, symbicort, viteyes",,"left and right torn rotater cuff surgery 2008, asthma, hypertension, hypercholesterolemia, insomnia, GERD",,,2,09/19/2019,,,,flagyl
0834500,09/19/2019,NH,69.0,69,,F,,"Headache, trouble swallowing, hoarseness, Redness in both eyes and muscus, muscle aches, chills, drank plenty of fluids and stayed in bed.",,,,,,,,,Y,09/16/2019,09/16/2019,0,none,PHM,,"Advil, Querctin, Tumeric, Vitamin D, Quanol, Omega 3, Ashwangandha, Probiotic,Papaya Enzyme, CBD Oil",None,None,,,2,09/19/2019,,,,Seasonal allergies and cosmetics
0834501,09/19/2019,MN,25.0,24,,F,,"Patient was given the hepatitis A vaccine by RN in the left deltoid.  After given the vaccine and sitting for approximatly 5 minutes aferwards she indicated she felt fine and stood against a wall and was talking with a coworker.  Patient lost consciousness about two minutes later and slid down the wall and employee heard and observed her bumping her head lightly.  Patient lay on her right side while tended to by employee and nurse.  She had some jerking body movements which lasted a few seconds.  Regained consciousness in about 5 seconds.  Employee asked her where she was, her name and what the last thing she remembered was.   fully alert.  Nurse took vital signs while patient sat against the wall; pulse 56, blood pressure 102/66, temp 98.6 F, O2 sats 98%.  patient sat under observation for 30 minutes, drank some water, reported feeling fine and was escorted out of the programs room. Follow up done by health services per their protocol.Patient answered all of these questions appropriately and was",,,,,,,,,Y,09/12/2019,09/12/2019,0,,OTH,,,,,,,2,09/12/2019,,,,
0834502,09/19/2019,FL,1.0,1,.0,M,,"The day after patient received his vaccines I noticed bumps on his body, mainly his thighs and arms. The next day, two days after the vaccines the bumps started to spread pretty bad. By three days after the vaccines his body was covered in red bumps all over his body. His face, armpits, back, stomach, legs, feet and his butt.",,,,,,,,,N,09/10/2019,09/11/2019,1,"He had no test done to him, but he did see two different doctors.",PVT,,,No I?ll ess or sickness prior to vaccinations,,,,2,09/19/2019,,Y,Y,
0834503,09/19/2019,TX,19.0,19,,M,,19yo M presents to clinic c/o chest pain since 0330 this morning. Member states that he woke up with an ''intense pressure and a sharp pain upon inhalation.'' Member denies any SOB or wheezing. He denies any trauma. Patient denies chest being induced by physical activity. Member notes that he had a small pox vaccine last Friday.,,,,,Y,1,,,U,09/06/2019,09/17/2019,11,ECG completed in clinic. ECG showed some abnormalities and he was sent to the ER and subsequently admitted with pericarditis.,MIL,,No medications were reported on 09/17/2019. I am unaware if patient is/was taking any dietary supplements or herbal remedies.,The day of vaccination. No known medical illnesses or conditions were reported based off the medical screening questionnaire.,No known conditions,,,2,09/19/2019,,,,No known allergies
0834504,09/19/2019,NJ,58.0,58,,M,,"Swollen glands left super clavicle starting 48 hours after injection, pain at injection site (2 hours)",,,,,,,,,N,09/16/2019,09/18/2019,2,,PHM,,"benicar, Lipitor, vitamin D, Align, Fish oil, low dose aspirin,",none,mild hypertension (BP 140/85 unmedicated); cholesterol,pain at injection site,,2,09/19/2019,,,,none
0834505,09/19/2019,TX,3.0,3,,M,,"Patient had previously received Fluzone 0.25 in previous seasons without reaction. He was given Fluzone 0.5 IM on 9/5/19 and was initially noted to have some pain with refusal to bear weight on the left leg about 4 hours after the immunization was given. The following evening 9/6/19 about 29 hours after the immunization was given he was noted to have significant circumferential swelling of the left leg. There was no notable warmth or erythema concerning for cellulitis or type I sensitivity reaction, only extensive limb swelling in the same leg as the injection was given. He was able to move move and use leg well, and swelling was notably improved the following day.",,,,,,,,,Y,09/05/2019,09/06/2019,1,none,PVT,,"None, however started on Amoxicillin orally within 24 hours of being given the vaccination.",Diagnosed with acute otitis media bilaterally on the day of immunization being given.,Mild persistent asthma,,,2,09/19/2019,,,,"No known drug allergies.  Food allergies to milk, egg, flax seed managed by allergist. Cleared for flu vaccine by allergist."
0834506,09/19/2019,NE,11.0,11,,M,,"Gardasil and menactra given in the right arm, and tolerated well.  Tdap given in the left arm and promptly after vaccine delivered, patient leans forward and his body tenses.  I am able to prevent him from falling and help him up onto the examination table, where he arouses with some mild confusion.  The incident lasted about 5-10 seconds.  He states he was really nervous about getting the vaccines today.  I examine him and find everything WNL.  Provide him with some water and graham crackers (from the school nurse), and he starts to feel better.  Mother states that has never happened before.  After some more rest, he feels well and mother opts to take him home.",,,,,,,,,Y,09/18/2019,09/18/2019,0,None,SCH,,None,None,He is underweight with BMI at 0 percentile,,,2,09/19/2019,,Y,,None
0834507,09/19/2019,VA,64.0,64,,M,,"Chills and shivering that lasted about an hour and a half, piled blankets on and eventually warmed up again",,,,,,,,,Y,09/16/2019,09/16/2019,0,None,PHM,,"Telmisarten, diltiazem, melatonin",None,None,,,2,09/19/2019,,,,Broad beans
0834508,09/19/2019,NY,77.0,77,,F,,"fever (100.3), headache,backache,chills,shaking,nausea  approx. 5.5 hours after dose. morning after fever (99.0), no shaking, no chills, back still sore.",,,,,,,,,U,09/18/2019,09/18/2019,0,none,PHM,,"pravastatin,furosemide,",none,bundle branch block,,,2,09/19/2019,,,,none
0834509,09/19/2019,CO,62.0,62,,F,,"Evening of the vaccine I had achiness in both shoulders and neck, but then got chills in the night and body aches , fatigue with headache the next day.  Body aches, fatigue, headache and chills continues into Day 2 with Temp of 100.4 and then felt some swollen neck glands.  Day 3 with Temp 100.2, headache, body aches and fatigue are improving but neck/throat glands more swollen (no nasal congestion but feels like a sinus headache), Day 4- chills (did not check temp), body aches improved, headache continues with swollen sore throat. *I had traveled and flight was 2 days before receiving the vaccine.",,,,,,,,,U,09/15/2019,09/15/2019,0,did not notify my PCP,PHM,,"SamE, Tumeric, Ginger Root, Vit B Complex w/C, Calcium/VitD/Magnesium, Omega3/6/9 Acyclovir 400mg daily, flonase nasal spray, melatonin 5mg hs, Mag Glycinate 400mg hs",cannot recall any,Iritis OD with herpes simplex involvement on Pred Forte Eyes gtts and the Acyclovir,,,2,09/19/2019,,,,no
0834510,09/19/2019,TX,69.0,69,,F,,Patient developed a large 3-4 inch diameter redness around the injection site and complainted heavily that her arm was so sore and could hardly move it.  Adverse reaction stayed localized within 3-4 inches of the injection site.,,,,,,,,,N,09/16/2019,09/17/2019,1,,PHM,,,,,,,2,09/19/2019,,,,
0834511,09/19/2019,NY,11.0,11,,M,,"Patient developed redness in the evening after administration of Menactra in morning, then seen in clinic the following day (9/18/19) with concern for cellulitis vs allergic reaction at injection site, recommended follow-up in ED, seen at ED (9/18/19) and currently admitted for cellulitis.",,,,,Y,1,,,N,09/17/2019,09/17/2019,0,,PVT,,None.,None.,"None, BMI >95%.",,,2,09/19/2019,,,,No known allergies.
0834512,09/19/2019,,72.0,72,,F,,"persistent atrial fibrillation over a period of about 2 weeks, eventually requiring cardioversion.",,,,,,,,,Y,08/13/2019,08/14/2019,1,,UNK,,metronidazole 0.75% cream apixaban 5 mg  rosuvastatin 10 mg clobetasol 0.05% cream metoprolol succinate 50 mg docusate 100 mg Benefiber OTC Multivitamin  calcium carbonate with vitamin D3,,,"MMR vaccine, rash on cheeks, upper chest and arms",,2,09/19/2019,,Y,,"atorvastatin (muscle aches) erythromycin (unknown reaction) inhaled anesthetics (halogen based) (upset stomach) MMR vaccine (rash on cheeks, chest and arms)"
0834513,09/19/2019,PA,67.0,67,,F,,Patient stated her arm was sore and red,,,,,,,,,Y,09/10/2019,09/11/2019,1,,PHM,,unknown,Unknown,no,,,2,09/19/2019,,Y,,None known
0834515,09/19/2019,,13.0,13,,F,,"about thirty seconds after the vaccination her daughter started to ""pass out""; had a headache later that night and went to bed early; This spontaneous report was received from a patient's mother via a company representative and refers to a 13-year-old female patient. The patient did not have any pertinent medical history, concomitant therapies, drug reactions or allergies. On an unknown date in April 2019 (reported as about five months ago), the patient was vaccinated with a first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (exact dose, route of administration, lot # and expiration date were not reported) to prevent Human Papillomavirus (HPV). About thirty seconds after the vaccination, the patient started to pass out, she was caught by a nurse and, according to the reporter, she was ""okay"". On that same day (reporter as later that night), the patient experienced a headache and she went to bed early. On an unknown date in April 2019 (reported as the next day), the patient recovered from the event (reported as ""she woke up and she was fine""). The patient did not sought medical attention and had no lab diagnostics or studies performed. She did not receive any treatment for the events.  The causality assessment was not provided.  Upon internal review, the event of ""started to pass out"" was determined to be medically significant.",,,,,,,,,Y,04/01/2019,04/01/2019,0,,UNK,,,,,,US0095075131909USA005484,2,09/19/2019,,,,
0834516,09/19/2019,HI,,,,U,,"No adverse effects; patient received VARIVAX via intramuscular route; This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported.  On 14-SEP-2019, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) intramuscularly into left deltoid, lot# R010469, expiration date: 10-APR-2020 (exact dose and frequency were not reported), reconstituted with sterile diluent. No adverse effects were reported.",,,,,,,,,U,09/14/2019,09/14/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA007114,2,09/19/2019,,,,
0834517,09/19/2019,CO,,,,F,,"felt bad for a day; This case was reported by a consumer via call center representative and described the occurrence of feeling bad in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad was recovered/resolved.   It was unknown if the reporter considered the feeling bad to be related to Shingrix.  Additional details were provided as follows: This case was reported by the consumer for her sister in law. The age at vaccination was not reported. IT was reported that the patient received dose of Shin US2019163768 No further details were available. The reporter did not consent to follow-up.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834518,09/19/2019,MN,69.0,,,F,,"redness at injection site; Pain at injection site.; This case was reported by a physician via call center representative and described the occurrence of injection site erythema in a 69-year-old female patient who received Herpes zoster (Shingrix) (batch number K9M5N, expiry date 7th November 2021) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site erythema and injection site pain. On an unknown date, the outcome of the injection site erythema and injection site pain were unknown.   It was unknown if the reporter considered the injection site erythema and injection site pain to be related to Shingrix.  Additional details were provided as follows: The emergency room physician called to report that the patient received Shingrix, and had pain and reddness, demarcated area approximately 7cm, on deltoid, for 5 days. The Shingrix was given at another location listed in adverse event.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834519,09/19/2019,WV,63.0,63,,M,,"Redness at the injection site had spread from the injection site down the arm to near the elbow; Arm soreness; pain at injection site; shivering; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 6th September 2019, less than a day after receiving Shingrix, the patient experienced injection site pain and shivering. On 7th September 2019, the patient experienced erythema of extremities and pain in arm. On an unknown date, the outcome of the injection site pain, erythema of extremities, shivering and pain in arm were unknown.   It was unknown if the reporter considered the injection site pain, erythema of extremities, shivering and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received dose one of Shingrix and experienced injection site pain.  The patient also reports shivering and arm soreness.   The patient reported that one day after, the redness at the injection site had spread from the injection site down the arm to near the elbow. The reporter had consented to follow up.",,,,,,,,,U,09/06/2019,09/06/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834520,09/19/2019,IN,,,,F,,"Headache; Nausea; Vomiting; Fatigue/ Tired; Difficulty standing; This case was reported by a nurse via sales rep and described the occurrence of headache in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On 3rd September 2019, the patient received Bexsero. In September 2019, less than a day after receiving Bexsero, the patient experienced headache, nausea, vomiting, fatigue and difficulty in standing. On an unknown date, the outcome of the headache, nausea, vomiting, fatigue and difficulty in standing were recovering/resolving.   It was unknown if the reporter considered the headache, nausea, vomiting, fatigue and difficulty in standing to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that within 12 hours of receiving the Bexsero patient experienced headache, nausea, vomited once, felt fatigue and tired that she could not even stand up. The patients condition was slowly improving. No further details were provided.",,,,,,,,,N,09/03/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834521,09/19/2019,NY,6.0,6,,M,,"Facial Drooping; Eye, facial and then shoulder twitching, his neck, nose and legs twitch as well.; facial and then shoulder twitching, his neck, nose and legs twitch as well; Eyes blink repeatedly; This case was reported by a consumer via call center representative and described the occurrence of facial droop in a 6-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2018-2019 season) (batch number YZ7TR, expiry date 30th June 2019) for prophylaxis.   On 27th September 2018, the patient received the 1st dose of Fluarix Quadrivalent 2018-2019 season (intramuscular) .5 ml. On an unknown date, 5 days after receiving Fluarix Quadrivalent 2018-2019 season, the patient experienced facial droop (serious criteria GSK medically significant), blepharospasm, twitching and excessive eye blinking. On an unknown date, the outcome of the facial droop and blepharospasm were not recovered/not resolved and the outcome of the twitching and excessive eye blinking were unknown.   It was unknown if the reporter considered the facial droop, blepharospasm, twitching and excessive eye blinking to be related to Fluarix Quadrivalent 2018-2019 season.  Additional details were provided as follows: The case was reported by patient's father. The patient had eye, facial and then shoulder twitching.  The patient's eyes blink repeatedly and that his neck, nose and legs twitch as well. The patient also experienced facial drooping. The patient was referred to health care professional (HCP) and provided medical information (MI) phone number for HCP reference. The reporter inquired about post-marketing experience regarding how many patients reported nervous system disorders and how symptoms were managed. The reporter consented to follow up.",,,,,,,,,N,09/27/2018,10/02/2018,5,,PVT,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834522,09/19/2019,IL,62.0,62,,F,,"tired; mild flu; temp 100; nausea; sore throat; congestion and everything; cough; bronchitis; This case was reported by a other health professional via call center representative and described the occurrence of tiredness in a 62-year-old female patient who received Flu Seasonal QIV (FluLaval Tetra 2019-2020 season) (batch number 2277M, expiry date 24th June 2020) for prophylaxis.   On 6th September 2019, the patient received FluLaval Tetra 2019-2020 season (intramuscular). On 6th September 2019, less than a day after receiving FluLaval Tetra 2019-2020 season, the patient experienced tiredness, influenza, fever, nausea, sore throat, nasal congestion, cough and bronchitis. On 7th September 2019, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the tiredness, nausea, sore throat, nasal congestion, cough and bronchitis were not recovered/not resolved and the outcome of the influenza was unknown.   It was unknown if the reporter considered the tiredness, influenza, fever, nausea, sore throat, nasal congestion, cough and bronchitis to be related to FluLaval Tetra 2019-2020 season.  Additional details were provided as follows: The case was reported by patient herself who was a health care worker. The patient had received FluLaval Tetra 2019-2020 season on left deltoid. The patient felt tired, had mild flu, temp 100, nausea ,sore throat ,congestion and everything, cough, bronchitis. On the day of reporting, it was her first day she did not have fever. The reporter did not consent to follow-up.",,,,,,,,,N,09/06/2019,09/06/2019,0,"Test Date: 20190906; Test Name: Body temperature; Result Unstructured Data: Test Result: 100, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834523,09/19/2019,AZ,72.0,72,,F,,"hearing loss; Drug dose administration interval too short; This case was reported by a pharmacist via call center representative and described the occurrence of hearing loss in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received sometime in May).   In July 2019, the patient received the 2nd dose of Shingrix. In July 2019, less than 2 months after receiving Shingrix, the patient experienced hearing loss (serious criteria GSK medically significant) and drug dose administration interval too short. On an unknown date, the outcome of the hearing loss and drug dose administration interval too short were unknown.   It was unknown if the reporter considered the hearing loss to be related to Shingrix.  Additional details were provided as follows: The reporter had no information regarding lot numbers or expiration dates for the two doses of Shingrix. The patient experienced a sporadic loss of hearing, which she described as her hearing goes in and out. The patient received 2nd dose of Shingrix earlier than the recommended schedule, which led to shortening of vaccination schedule. The patient's doctor had an MRI done. The reporter consented to follow up. It was reported that the patient had not received Shingrix from her pharmacy.",,,,,,,,,U,07/01/2019,07/01/2019,0,"Test Date: 2019; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: unknown, Test Result Unit: unknown",PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834524,09/19/2019,VA,,,,U,,"claims they had a Prevnar 13 reaction that was/at the placement/administration site; Symptoms included pain, swelling, etc. at the placement/administration site.; Symptoms included pain, swelling, etc. at the placement/administration site.; This is a Spontaneous report based on the information received from a contactable consumer by Pfizer.  A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, Lot # X91013) via an unspecified route of administration at single dose on an unspecified date for immunisatio.   The patient medical history and concomitant medications were not reported.  The patient experienced PREVNAR 13 reaction and symptoms included as pain, swelling, etc. at the placement/administration site on 26Jun2019. The outcome of the events was unknown.",,,,,,,,,U,,06/26/2019,,,UNK,,,,,,USPFIZER INC2019401047,2,09/19/2019,,,,
0834525,09/19/2019,RI,,,,F,,"Excessive redness, pain after 2 days of injection; Excessive redness, pain after 2 days of injection; This is a spontaneous report from a contactable physician via a sales representative. A female patient of an unspecified age (reported as 65, unit unknown) received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13, lot number: W62465, expiry date not reported), via an unspecified route of administration on 15Apr2019 at a single dose for immunization. Medical history and concomitant medications were not reported. On 17Apr2019, the patient experienced excessive redness, pain after 2 days of injection. The patient had to come to office for acute visit on 19Apr2019. It was reported that the patient was prescribed with cefalexin (KEFLEX). No other vaccines were given on the day of shot. Clinical outcome of the events was unknown.",,,,,,,,,U,04/15/2019,04/17/2019,2,,UNK,,,,,,USPFIZER INC2019401631,2,09/19/2019,,,,
0834526,09/19/2019,RI,,,,F,,"Redness , left deltoid; This is a spontaneous report from a contactable physician received via a Pfizer sales representative. A female patient of an unspecified age (reported as 71, unknown unit) received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13, lot number: W62465), via an unspecified route of administration on 26Feb2019 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced redness, left deltoid on an unspecified date. Nurse practitioner prescribed Keflex.",,,,,,,,,U,02/26/2019,,,,UNK,,,,,,USPFIZERINC2019401649,2,09/19/2019,,,,
0834528,09/19/2019,TN,36.0,36,,F,,"Patient called office next day states that she has been sweating every 30 minutes after receiving TDap and hurting under her armpit. Also states that the injection site was red, swollen, and warm to touch. Patient also states that she has taken Ibuprofen and Tylenol for pain. Patient was informed to go to the ER if any signs or symptoms of an allergic reaction occurs. Phone call to patient to inform her to go to her PCP or the ER.  9/5/19 Patient states that she was still not feeling well from receiving the injection. inquired if she went to urgent care, PCP or ER as instructed on 9.4.19, to be evaluated. Patient states that there was nothing wrong with the injection site but that her body is in pain and wants this reported to the FDA. Phone number was provided to the patient per her request. Also on 9/5/19 patient reports ti the ER and reports she had body aches, joint pain, and had red bumps to her forearms. States that she feels generally weak and fatigue, ""not myself"" and that she took 2 doses of 50mg of Benedryl and rash has resolved.  Per ER: ""suspect immune reaction to recent immunization. no signs/symptoms of anaphylaxis. UA negative for infection as this was a concern because patient felt like it was her kidneys were hurting. Decadron give possibility of allergic rash itching.""",,,,,,,,,Y,09/03/2019,09/03/2019,0,,PVT,,ADDERALL; SYNTHROID,,,,,2,09/19/2019,,,Y,ADHESIVE TAPE; SILICONES; SULFA
0834529,09/19/2019,VA,60.0,60,,M,,"Fever, headache, loss of appetite. 3 days for headache, 2 days for fever, 1 day for loss of appetite. Treated with 400 mg Ibuprofen. Resolved on its own.",,,,,,,,,Y,09/11/2019,09/12/2019,1,,PHM,,"Humira, Aspirin (81mg), Eye health vitamins",None,Psoriasis,,,2,09/19/2019,,,,"Sulfa, hickory trees"
0834530,09/19/2019,TX,49.0,49,,F,,"On 9/18, 5 hrs after injection: Dizziness (vertigo), rapid heart beat, nausea, hot/cold, a little difficulty breathing (chest tightening) On 9/19 most symptoms have subsided, just a little dizziness remains. No treatment",,,,,,,,,Y,09/17/2019,09/18/2019,1,None,PHM,,"Advair, nasicort, Claritin D",,Asthma,,,2,09/19/2019,,,,Hydrocodone
0834531,09/19/2019,CA,42.0,42,,F,,"localized swelling, pain, itching, redness at injection site.  Painful facial lesions on same side that injection was give that developed redness and pus, later scabbing and scarring. Swelling on side of face where lesions were present, ear pain.",,,,,,,,,N,08/14/2019,09/10/2019,27,none,WRK,,"vitamin D-mag-calcium, b vitamin complex, vitamin c, probiotic",no,no,,,2,09/19/2019,,Y,,no known allergies
0834532,09/19/2019,GA,28.0,28,,F,,"Patient arrives via EMS for post cardiac arrest CPR per EMS, patient was at work and received a flu shot from Pharmacist, Immediately after vaccine was administration patient collapsed and went unresponsive, EMS states initial rhythm on their arrival was VFIB, patient was shocked and rhythm was then Torsades, EMS states the patient was shocked 5 additional times, 2 grams magnesium IVPB given, 300mg amiodarone, and 2mg Narcan given by EMS prior to arrival at Hospital Emergency Room. Patient arrives with IO to right lower distal Tib Fib and nasal trumpet in place being bagged by EMS. Patient has a history of hypertension (taking hydralazine), EMS brought flu vaccine information that was being administered by the pharmacist at the patient's place of employment.",,,Y,,Y,2,,,N,09/18/2019,09/18/2019,0,The patient is currently in critical condition and has had numerous labs drawn since arrival.,PVT,,unknown,None known,Hypertension,,,2,09/19/2019,,,Y,NKDA
0834533,09/19/2019,NJ,69.0,69,,F,,"Fever of over 103 degrees, shivering, joint paint, severe headache, sensitivity to light",,,,,,,,,N,09/18/2019,09/18/2019,0,,PHM,,Tamoxifen,,diabetes,,,2,09/19/2019,,,,"Penicillin, tetanus serum, eggs"
0834534,09/19/2019,GA,11.0,11,,F,,"Left arm red, firm, and swollen",,,,,,,,,U,09/17/2019,09/19/2019,2,none,PVT,,none,none,none,,,2,09/19/2019,,Y,,Penicillin
0834535,09/19/2019,KS,12.0,12,,F,,Mother called clinic approximately 15 min. after leaving clinic  (10:00 am) and reported child is not feeling well with symptoms including feeling clammy and vision is going black. Advised mother to seek medical treatment at nearest emergency room for child symptoms as we do not have a physician on staff.,,,,,,,,,U,09/19/2019,09/19/2019,0,Unknown at this time.,PUB,,None reported by mother,None reported by mother,None reported by mother,,unknown.,2,09/19/2019,,,Y,Gluten
0834536,09/19/2019,MD,34.0,34,,F,,"Weakness, fever, vomit, no appetite, extreme pain in my entire body.  Soreness at injection site.",,,,,,,,,U,08/30/2019,08/30/2019,0,,PVT,,Prenatal vitamines,none,mitral valve prolapse,,,2,09/19/2019,,,,none
0834537,09/19/2019,MA,1.33,1,.3,F,,Mom reported small lump at injection site left leg 13 days after immunizations given. No redness or pain at site.,,,,,,,,,Y,09/06/2019,09/19/2019,13,,PVT,,,,,,,2,09/19/2019,,,,
0834538,09/19/2019,MI,69.0,69,,F,,Bad headache at top of the skull; stiff neck; shivering  that kept me up several hours at night; fatigue the next day.,,,,,,,,,U,09/18/2019,09/18/2019,0,none,PHM,,none,none,none,,,2,09/19/2019,,,,none
0834539,09/19/2019,OR,58.0,58,,F,,"This was the 2nd vaccine of the 2 part series, the first being ~10/3/18.  I developed a mild case of shingles on the left side of my body primarily in the exact location that I had shingles the previous January 2018.  They resolved quickly.  The injection site erupted  2 times since the vaccination with a large sore that itched and scabbed like a shingles sore.  The 2nd time the injection site erupted in June I broke out with another case of shingles this time in 2 dermatomes on my face with a bit of random scattering on other places of my body (chest, back).  I have been on 3000 mg of Acyclovir for over 6 weeks now and am still having new blisters erupt 3 1/2 months after the breakout on 6/9/19.",,,,,,,,,N,01/03/2019,01/10/2019,7,I have been to 3 MD's and 1 dermatologist.,PHM,,synthroid,,Graves disease,,,2,09/19/2019,,,,"PCN, sulfa, inderal"
0834540,09/19/2019,MI,64.0,64,,F,,At checkout patient had a vasovagal episode and passed out.  No trauma was noted.  She may have lost consciousness for a few seconds but awoke immediately upon falling on the ground.  She was placed in a exam room and was hemodynamically stable.  No trauma noted.  Most likely this was a vasovagal episode due to getting her flu and shingles vaccine.  She was observed for 10 minutes with normal hemodynamics and felt well.  Random blood sugar was 107.,,,,,,,,,Y,08/27/2019,08/27/2019,0,Random blood sugar was 107.,PVT,,"Effexor 150, Effexor 75, xanax .25, ambien 10mg, synthroid 75. are on her current medication list",,"Fatigue, Depression, Insomnia, weight changes",,,2,09/19/2019,,,,NKDA
0834541,09/19/2019,OH,4.0,4,,F,,Rash on scalp.  Resulted in itchy scalp.  Treated with oral diphenhydramine and topical menthol shampoo.,,,,,,,,,Y,09/17/2019,09/18/2019,1,none,PVT,,none,none,none,,,2,09/19/2019,,,,none
0834542,09/19/2019,WI,71.0,71,,M,,"Patient called stating that he thinks he may have had a reaction to the oral typhoid vaccine that he started taking yesterday.  He states that he took the first dose as instructed (on empty stomach, swallowed whole and with cool water) and approximately 45 minutes later, he experience dizziness, felt faint and he noted facial numbness.  He states that he laid down and his symptoms resolved within approximately 15 minutes but he is now wondering if he should continue the subsequent doses or if he should not take any more.  He denies that he had any fever, rash, facial swelling, fast heart beat, difficulty swallowing or difficulty breathing.   Patient did not get any other vaccines yesterday (9/18/19).  The most recent vaccination was administered on 9/5/19 (Td)",,,,,,,,,Y,09/18/2019,09/18/2019,0,none,PVT,,"dulera, albuterol, vitamin C, aspirin, tenoretic, Lipitor, cholecalciferol, coenzyme q 10, centrum silver, zinc,  flonase","9/13/19 transperineal biopsy of the prostate ,  9/4/19 reported low back pain, upper respiratory infection, tinnitus,  and had a skin biopsy","#1 Hypertension #2 Hyperlipidemia #3 BMI 35 #4 Impaired fasting glucose. #5 Low back pain #6 Asthma #7 Allergic rhinitis    #9 Asymmetrical hearing loss #10 Tinnitus He was evaluated by ENT again in January, there was no changes on his hearing. Recommended to check it again in 3 years.  #11 Prostate adenocarcinoma gleason 3+3 He is followed closely in Urology, he had HoLEP for urinary retention in January, he is not using a catheter since then.   His PSA is mildly elevated comparing to April.  He will have a new prostate MRI and will be evaluated by Urology for treatment options.  #12 Multiple nevi #13 Seborrheic keratosis He was evaluated in Dermatology today, a lesion was biopsied in his right lateral back. ",,,2,09/19/2019,,,,"cat dander, animal dander, pollen extracts"
0834543,09/19/2019,FL,72.0,72,,F,,"Symptoms of cold/flu within 24 hours of vaccination which included slight increase  in body temp, coughing, nasal congestion, restless sleep and sense of uneasiness.",,,,,,,,,N,09/17/2019,09/18/2019,1,None...no medical assistance sort.  Symptoms continue to date but seem to be slowly diminishing.,PHM,,None,Moderate allergy symptoms  from mowing lawn for which took 25 mg liquid benedryl,None,,,2,09/19/2019,,,,None known
0834544,09/19/2019,MT,60.0,60,,F,,"headache, flu like, red rash, hives, dizzy, very weak, itchy when the hives start to go away, NOT GOOD!!!",,,,,,,,,U,09/13/2019,09/13/2019,0,,PHM,,"Synthroid, vitamin D",none,none,,,2,09/19/2019,,,,"eggs, dairy, soy, wheat"
0834549,09/19/2019,,,,,U,,"Feeling very tired; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th September 2019, the patient received the 2nd dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced tiredness. On an unknown date, the outcome of the tiredness was not recovered/not resolved.   It was unknown if the reporter considered the tiredness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as an adult as per vaccine indication. On the last Thursday, the patient received Shingrix. Till the time of reporting, the patient was feeling very tired and the patient asked was this normal.",,,,,,,,,N,09/05/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/19/2019,,,,
0834550,09/19/2019,GA,8.0,8,,F,,"Redness at injection site; Swelling at injection site; This case was reported by a nurse via sales rep and described the occurrence of injection site erythema in a 8-year-old female patient who received Flu Seasonal QIV (FluLaval Quadrivalent 2018-2019 season) (batch number 2277M, expiry date 24th June 2020) for prophylaxis.   On 26th August 2019, the patient received the 1st dose of FluLaval Quadrivalent 2018-2019 season (intramuscular) .5 ml. On an unknown date, less than 2 weeks after receiving FluLaval Quadrivalent 2018-2019 season, the patient experienced injection site erythema and injection site swelling. The patient was treated with amoxicillin trihydrate (Amoxicillin). On an unknown date, the outcome of the injection site erythema and injection site swelling were unknown.   It was unknown if the reporter considered the injection site erythema and injection site swelling to be related to FluLaval Quadrivalent 2018-2019 season.  Additional case details were reported as follows: The patient received vaccine in right deltoid. The patient received private dose of FluLaval. The patient experienced redness and swelling at injection site. No co-administration of other vaccines. The reporter stated that adverse event was a result of vaccine. The reporter denied permission to follow up. This case has been linked with case US2019AMR164466 reported by the same reporter.",,,,,,,,,U,08/26/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/19/2019,,,,
0834551,09/19/2019,FL,,,,U,,"Rotavirus detected after having received the first dose of Rotarix; This case was reported by a other health professional via sales rep and described the occurrence of rotavirus test positive in a infant patient who received Rota (Rotarix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Rotarix (oral). On an unknown date, unknown after receiving Rotarix, the patient experienced rotavirus test positive. On an unknown date, the outcome of the rotavirus test positive was unknown.   It was unknown if the reporter considered the rotavirus test positive to be related to Rotarix.  Additional details were provided as follows: The age at vaccination was not reported. The patient's age group was not reported but was captured as infant as per vaccine indication. The patient recently had rotavirus detected after vaccination with Rotarix. This case has been linked to US2019AMR164484, reported by the same reporter.      Lab Comments: On an unknown date, lab test was perfomed",,,,,,,,,U,,,,"Test Name: Rotavirus test; Result Unstructured Data: Test Result: Positive, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/19/2019,,,,
0834552,09/19/2019,FL,,,,U,,"Rotavirus detected after having received the first dose of Rotarix; This case was reported by a other health professional via sales rep and described the occurrence of rotavirus test positive in a infant patient who received Rota (Rotarix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Rotarix (oral). On an unknown date, unknown after receiving Rotarix, the patient experienced rotavirus test positive. On an unknown date, the outcome of the rotavirus test positive was unknown.   It was unknown if the reporter considered the rotavirus test positive to be related to Rotarix.  Additional details were provided as follows: The age at vaccination was not reported. The patient's age group was not reported but was captured as infant as per vaccine indication. The patient recently had rotavirus detected after vaccination with Rotarix. This case has been linked to US2019AMR164474, reported by the same reporter.      Lab Comments: On an unknown date, lab test was perfomed",,,,,,,,,U,,,,"Test Name: Rotavirus test; Result Unstructured Data: Test Result: Positive, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/19/2019,,,,
0834553,09/19/2019,,,,,F,,"Rash on her entire body with mild itching; Rash seems to have spread into an entire mass of red; This case was reported by a pharmacist via sales rep and described the occurrence of itchy rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for an unknown indication.   The patient's past medical history included rash (experienced rash on an unknown date when she had a virus).   On 5th September 2019, the patient received the 1st dose of Shingrix and Influenza vaccine Quadrivalent 2019-2020 season. On 6th September 2019, 1 days after receiving Shingrix and Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced itchy rash and generalized erythema. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the itchy rash and generalized erythema were recovering/resolving.   It was unknown if the reporter considered the itchy rash and generalized erythema to be related to Shingrix and Influenza vaccine Quadrivalent 2019-2020 season.  Additional details were provided as follows: The age at vaccination was not reported. The patient after receiving 1st dose of Shingrix experienced rash on her entire body with mild itching. The patient on the same day received Flu vaccine and experienced injection site extremely red and rash. The patient took Benadryl and felt little better on the day of reporting. The patient did not experienced any trouble breathing. The reporter asked whether patient had a stronger reaction because she received the flu and shingles vaccines on the same day. The reporter asked whether patient should receive the 2nd dose if Shingrix in November or wait longer. The reporter thought that the patient might be little afraid to get the 2nd dose at all after the reactions.",,,,,,,,,N,09/05/2019,09/06/2019,1,,UNK,,,,Medical History/Concurrent Conditions: Rash (experienced rash on an unknown date when she had a virus),,USGLAXOSMITHKLINEUS2019AM,2,09/19/2019,,,,
0834554,09/19/2019,TX,70.0,70,,M,,"couldn't walk; leg has atrofied; shingles; back pain; leg pain; bump; prevented him from sleeping; unable to work; Couldn't stand; This case was reported by a consumer via call center representative and described the occurrence of unable to walk in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   In July 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, 21 days after receiving Shingrix, the patient experienced unable to walk (serious criteria disability), atrophy (serious criteria disability), shingles, back pain, leg pain, swelling, sleep decreased, inability to work and difficulty in standing. The patient was treated with ibuprofen and gabapentin. On an unknown date, the outcome of the unable to walk, shingles, back pain and leg pain were recovered/resolved and the outcome of the atrophy, swelling, sleep decreased, inability to work and difficulty in standing were unknown.   It was unknown if the reporter considered the unable to walk, atrophy, shingles, back pain, leg pain, swelling, sleep decreased, inability to work and difficulty in standing to be related to Shingrix.  Additional details were provided as follows: A little over 2 months before the time of reporting, the patient received a 2nd dose of Shingrix on an unknown arm. Less than three weeks after vaccination, the patient experienced back pain and shingales. Three weeks after vaccination, the patient experienced left leg hurt so bad that the patient could barely walk. The patient saw his physician and she saw the bump on his back that looked like a spider or insect bite. The patient did not develop a rash. The physician diagnosed it as shingles and prescribed him Gabapentin and Ibuprofen. The patient had pain in his left leg from his knee to his hip that was so bad and the patient could not stand or walk. The patient was unable to work because of the pain and it prevented him from sleeping. At the time of reporting, the patient was on his third month of having shingles and the pain was resolved, but his leg had atrophied so the patient had to build it back up.",,,,,,,,Y,Y,07/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834555,09/19/2019,,,,,M,,"Flu-like symptoms; Low Grade Fever; Feeling of not wanting to do anything; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms, fever and feeling unwell. On an unknown date, the outcome of the influenza-like symptoms, fever and feeling unwell were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, fever and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The patient reported for himself. The age at vaccination was not reported. After receiving Shingrix, the patient experienced flu-like symptoms including a low grade fever. These symptoms resolved within 2 to 3 days. However he had the lingering feeling of not wanting to do anything for about one week. The patient also stated that, his physician told him that he had 10 patients with flu-like symptoms.  The patient would not provide any additional details.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834556,09/19/2019,MD,,,,U,,"Experienced a reaction to Shingrix; This case was reported by a physician via call center representative and described the occurrence of adverse drug reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, immediately after receiving Shingrix, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Shingrix.  Additional details were provided as follows: The patient demographic details were not provided. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The physician stated that, the patient's friend experienced a reaction to Shingrix and as a result got a lower dose, which led to underdose. No further details were provided, since it was reporter's patient's friend.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834557,09/19/2019,,69.0,69,,M,,"redness at injection site; soreness at injection site; muscle pain; tiredness; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In July 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 2 months after receiving Shingrix, the patient experienced injection site erythema, injection site pain, muscle pain and tiredness. On an unknown date, the outcome of the injection site erythema, injection site pain, muscle pain and tiredness were recovered/resolved.   It was unknown if the reporter considered the injection site erythema, injection site pain, muscle pain and tiredness to be related to Shingrix.  Additional details were provided as follows: The patient reported the case for himself. The patient received Shingrix about 2 months before the reporting date. The patient experienced redness at injection site, soreness at injection site, muscle pain, tiredness. All of these events were resolved in about one week. The patient consented to follow up and provided his doctor's details.",,,,,,,,,Y,07/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834558,09/19/2019,,71.0,71,,F,,"Flu like symptoms; arm pain; achy; vomiting; diarrhea; Fatigue; inappropriate Schedule of Vaccine; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2018, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced influenza-like symptoms, pain in arm, pain, vomiting, diarrhea, fatigue and incomplete course of vaccination. On an unknown date, the outcome of the influenza-like symptoms, pain in arm, pain, vomiting, diarrhea, fatigue and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the influenza-like symptoms, pain in arm, pain, vomiting, diarrhea and fatigue to be related to Shingrix.  Additional details were provided as follows: The patient demographic details were not provided. The age group of the patient was not reported, but selected as an adult as per vaccine indication. After vaccination with dose of Shingrix, the patient experineced flu like symptoms consisting of fatigue, aching, vomiting, diarrhea and arm pain. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient consented to follow up.",,,,,,,,,U,11/01/2018,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834559,09/19/2019,NJ,58.0,58,,F,,"rash on arms, back and legs/ rash was itchy; rash looks and feels like chickenpox/spots look like pimples; This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th August 2019, the patient received the 1st dose of Shingrix. On 7th September 2019, 25 days after receiving Shingrix, the patient experienced itchy rash and varicella-like rash. On an unknown date, the outcome of the itchy rash and varicella-like rash were not recovered/not resolved.   It was unknown if the reporter considered the itchy rash and varicella-like rash to be related to Shingrix.  Additional details were provided as follows: The reporter was patient.  The patient received Shingrix in her left arm.  The patient stated that on Saturday, she developed a rash on her arms, back and legs. The rash was itchy and looked and felt like chickenpox. She also stated that, the spots looked like pimples. The patient consented to follow up and provide details of her physician. The patient did not provide any additional information.",,,,,,,,,N,08/13/2019,09/07/2019,25,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834560,09/19/2019,OH,,,,F,,"Shingles; Rash / rash on face; This case was reported by a consumer via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In July 2019, the patient received the 1st dose of Shingrix. On 3rd September 2019, less than 2 months after receiving Shingrix, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles and rash were not recovered/not resolved.   It was unknown if the reporter considered the shingles and rash to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient had first dose of Shingrix about 7 weeks ago.  Last Tuesday patient thought she had a rash on her face, believed to be from antibacterial cleaner she placed on her face while visiting friend in hospital. The reporter's friend referred the patient to see a physician after having seen the rash.  The patient was seen by dermatologist on day of reporting and diagnosed with Shingles. The patient was prescribed three different medications she stated, but names were not provided. It was reported that emergency room visit was required. The reporter consented to follow up. In the XML document outcome of events was reported as recovering, but in system its mentioned as not recovered, so kept as reported in system.",,,,,,,,,N,07/01/2019,09/03/2019,64,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,Y,
0834561,09/19/2019,AZ,73.0,73,,F,,"flu-like symptoms; This case was reported by a nurse via call center representative and described the occurrence of influenza-like symptoms in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In June 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The report was via chat  The reporter was a family nurse practitioner student. The patient experienced flu like symptoms after receiving Shingrix. The reporter did not have the batch number and expiry date or the exact date of vaccination. The report was via chat and the reporter did not elaborate on what exact flu like symptoms were experienced by the patient.",,,,,,,,,U,06/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834563,09/19/2019,,,,,F,,"Not able to sleep; Trouble breathing; Throat closed up; Tired all day; Coughing; Feeling achy; This is a spontaneous case, initially received from other non-health professional via Communications (reference number: SEQ19-02681) on 13-Sep-2019, concerning a 65-year-old, female patient.   The patient's medical history included Augmentin (amoxicillin, clavulanic acid) for unknown indication.   On 12-Sep-2019, the patient was administered Fluad [Influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, MF59, dose, route of administration, anatomical location, batch number and expiration date: not reported] as protection against seasonal influenza.  On the same day, 12 hours after vaccination, the patient's throat closed up and she had trouble breathing. The patient was not able to sleep, had been tired all day, along with coughing and feeling achy. As reported, the patient had a reaction similar to this after taking Augmentin years ago, but at that time, she also had a rash, which she did not have now.   The patient did not seek medical treatment, but it was unknown if she received any treatment.  At the time of initial reporting, the outcome of the events was not resolved (reported as ongoing).  The reporter assessed the case as serious and did not provide causality assessment.  The reporter did not give consent to be contacted for further information.  Company comment: A 65-year-old, female patient experienced insomnia, dyspnoea, throat tightness, fatigue, cough and pain after vaccination with the suspect product Fluad (TIV). Chronology is plausible. Reportedly, the patient had a reaction similar to this after taking Augmentin years ago. Patient medical history of reported Augmentin reaction with similar events suggest presence of allergic predisposition which was not reported. Presence of adjuvants in vaccine (egg-derivates) may have triggered some sort of allergic reaction in the patient. Medical data of the patient is necessary for the assessment of causality. For now, considering provided information, causality is assessed as related to the product for the events of dyspnoea, throat tightness, fatigue, cough and pain, however not related to insomnia due to physiological inconsistency.; Reporter's Comments: A 65-year-old, female patient experienced insomnia, dyspnoea, throat tightness, fatigue, cough and pain after vaccination with the suspect product Fluad (TIV). Chronology is plausible. Reportedly, the patient had a reaction similar to this after taking Augmentin years ago. Patient medical history of reported Augmentin reaction with similar events suggest presence of allergic predisposition which was not reported. Presence of adjuvants in vaccine (egg-derivates) may have triggered some sort of allergic reaction in the patient. Medical data of the patient is necessary for the assessment of causality. For now, considering provided information, causality is assessed as related to the product for the events of dyspnoea, throat tightness, fatigue, cough and pain, however not related to insomnia due to physiological inconsistency.",,,,,,,,,N,09/12/2019,09/12/2019,0,,UNK,,,,,,USSEQIRUS201904631,2,09/19/2019,,,,
0834564,09/19/2019,,,,,U,,"Cleft palate; Foetal exposure during pregnancy; This is a spontaneous case, initially received from other non-health professional via Med Communications (reference number: SEQ18-02462) on 13-Sep-2019, concerning a neonate patient of unspecified sex.  The mother was an adult, female patient, whose medical history and concomitant medications were not reported.   On an unspecified date, the patient's mother was administered Afluria Quadrivalent [influenza vaccine; dose, route of administration, anatomical location, batch number and expiry date: not reported] (explicitly coded as 'Foetal exposure during pregnancy') for an unknown indication.  On 09-Jul-2019, the mother delivered neonate through caesarean delivery. The neonate was born with cleft palate. It was also reported that the neonate did not have any other problem, and there were no problems during delivery. No further details regarding neonate were provided.   At the time of initial reporting, the outcome of the event cleft palate was not reported.   This case is linked to 201905290, the corresponding mother case.  Company Comment: Reportedly, the neonate subject of unspecified sex was delivered with cleft palate after foetal exposure during pregnancy with the suspect product Afluria Quadrivalent. Chronology is unclear but plausible. No medical history and concomitant medications were provided. Foetal exposure during pregnancy is assessed as not related. For event cleft palate, causal role of the suspect product cannot be totally excluded and is assessed as related.; Reporter's Comments: Reportedly, the neonate subject of unspecified sex was delivered with cleft palate after foetal exposure during pregnancy with the suspect product Afluria Quadrivalent. Chronology is unclear but plausible. No medical history and concomitant medications were provided. Foetal exposure during pregnancy is assessed as not related. For event cleft palate, causal role of the suspect product cannot be totally excluded and is assessed as related.",,,,,,,,,U,,,,,UNK,,,,Comments: None,,USSEQIRUS201904632,2,09/19/2019,,,,
0834565,09/19/2019,FL,0.17,0,.2,M,,"Child screamed (high-pitched) for 4 hours and then shook/tremored starting approximately 4 hours after he received a Comvax vaccine. Parents elected to discontinue all vaccines for the child after this event, and he is now a healthy neurotypical 6-year old boy.",,,,,,,,,,10/16/2013,10/16/2013,0,,UNK,,None,"No illness since birth, including up to the time of vaccination.  Healthy full-term infant.",None,,,2,09/19/2019,,,,No Known Allergies
0834566,09/19/2019,FL,74.0,74,,F,,"Six hours after injection headache, muscle aches, nausea and hot and cold feelings developed lasting throughout the night into next day.  Several bouts of diarrhea also . General malaise and lethargy for one full day after shot into second day. Finally third day symptoms subsided except for a tired feeling.  Took Advil several times for headache and muscle aches.....some relief.",,,,,,,,,Y,09/16/2019,09/16/2019,0,,PHM,,Triamterene/hctz 37.5/5.25 L-thyroxine 100mcg Baby Aspirin,None,None,,,2,09/19/2019,,,,No Known
0834567,09/19/2019,NY,76.0,76,,F,,"Patient reported to me today 09/19/2019.  She said at first it was very sore especially when she was lifting her arms where she got the injection.  Today she reported  she the injection site is red, hot, and swollen and planning to see her Doctor tomorrow.  She is also thinks that the pharmacist might have given the shot too high ( she said she is a former nurse and kind knows if it is high or low).",,,,,,,,,N,09/17/2019,09/17/2019,0,none so far,PHM,,NOT AWARE,"high blood pressure, arthritis, thyroid, lung disease",see above,,,2,09/19/2019,,,,"quinolones, cephalosporins, SMZ"
0834568,09/19/2019,NC,41.0,41,,F,,"within two hours flushed, sneezing, very hot, fever, headache, and felt ""off"". plus stiff and very sore right arm. had to take benadryl to stop reaction.",,,,,,,,,U,09/19/2019,09/19/2019,0,none yet,WRK,,Lamotrigine and sertraline,none,"migraines, carcinoma in situ cervix",,,2,09/19/2019,,,,"wasp/bee stings, wheat, latex(hives)"
0834569,09/19/2019,PA,86.0,86,,F,,"chills, dizzy, nauseous, funny filling in chest feeling",,,,,,,,,Y,09/18/2019,09/19/2019,1,,PHM,,,,,,,2,09/19/2019,,,,
0834570,09/19/2019,OR,23.0,23,,F,,"Ears burning, chest and neck got itchy, diffuse hives, wheezing, swelling around the eyes, itchy throat.",,,,,,,,,Y,09/17/2019,09/17/2019,0,None,WRK,,None,None,Asthma,,,2,09/19/2019,,,,NKDA
0834571,09/19/2019,RI,40.0,40,,F,,"Patient called my work cell to report that she thought she was having a bad reaction to the vaccine she received in her left arm yesterday.  She feels like there is a ""rock"" under her skin where the vaccine was given and it is slightly warm to the touch. No redness. Localized swelling reported over injection area. Sore at injection site. Used marker to draw circle around swollen area so she could monitor. Not noticing progression since this morning.",,,,,,,,,U,09/18/2019,09/18/2019,0,n/a,PVT,,"albuterol inhaler, entocort, fluoxetine, hydrocortisone enema, lorazepam, melatonin, mesalamine capsule, omeprazole",no acute illnesses,"asthma, anxiety, depression, GERD, ulcerative proctitis, vertigo",,,2,09/19/2019,,,,"prochlorperazine,  IV contract (iohexol)"
0834572,09/19/2019,NM,85.0,85,,F,,"can't move her arm, seen by urgent care,",,,,,,,,,N,09/18/2019,09/18/2019,0,using lidocan 4% patch,PHM,,,,,,,2,09/19/2019,,Y,Y,
0834573,09/19/2019,IL,71.0,71,,F,,Injection site reaction - warm to touch - went to doctor and prescribed doxycycline hyclate 100mg twice daily for 7 days as prevention,,,,,,,,,Y,08/17/2019,08/19/2019,2,,PHM,,,,,,,2,09/19/2019,,Y,,
0834574,09/19/2019,CO,80.0,80,,F,,rash on arm below injection site,,,,,,,,,N,09/12/2019,09/16/2019,4,,PHM,,,,,,,2,09/19/2019,,,,
0834576,09/19/2019,IL,70.0,70,,F,,Injection site reaction warm to touch- pt did see doctor which stated to just monitor and to get 2nd dose and the reaction should decrease within 5 days - pt is monitoring reaction,,,,,,,,,N,09/16/2019,09/17/2019,1,,PHM,,,,,,,2,09/19/2019,,Y,,
0834577,09/19/2019,NY,22.0,22,,F,,"Patient presented to the pharmacy 9/19/19 with a sore left arm. She said it hurt to move it and that the pain woke her up in the middle of the night. The injection sites appeared normal, but there were two small red bumps on the inside of the patients arm that appeared to be a rash. Patient was told to try ice, benadryl, and alternate ibuprofen and tylenol. Patient presented back to the pharmacy 9/19/19, she said the arm was still very sore and the rash had enlarged and spread. She was instructed to follow up with her doctor at this point.",,,,,,,,,U,09/16/2019,09/18/2019,2,,PHM,,Medroxyprogesterone 150mg/ml,None,None,,,2,09/19/2019,,Y,,Penicillins
0834578,09/19/2019,GA,1.33,1,.4,M,,"Diffuse body rash that appeared to be papular vs small discrete hives.  Total body surface.  Rash started at Non the day following vaccines (9/18/19), persisted through the night and resolved by evaluation at 10 AM on 9/19/19.",,,,,,,,,Y,09/17/2019,09/18/2019,1,No labs performed,PVT,,None,"Dtap, MMR, Varicella, Influenza 2019-20",None,,,2,09/19/2019,,Y,,None
0834579,09/19/2019,NJ,88.0,88,,F,,UPON ADMINISTRATION THE CONTENTS OF THE SYRINGE ALMOST COMPLETELY SPILLED OUT THE SIDE OF SYRINGE AND DRIPPED DOWN HER ARM.,,,,,,,,,,09/18/2019,09/18/2019,0,,PHM,,,,,,,2,09/19/2019,,,,
0834580,09/19/2019,FL,43.0,43,,F,,"Vertigo starting at ~7 hours after the vaccine, continuing > 24 hours.",,,,,,,,,N,09/18/2019,09/18/2019,0,"ED visit - nystagmus, fluid behind the ear drum",PVT,,"Breo, Zyrtec, Nasonex, Singulair",,asthma,,,2,09/19/2019,,,Y,"Penicillin, sulfa"
0834581,09/19/2019,OH,74.0,74,,F,,"Cough, Headache, Sore Throat, Weak, Unable to sleep, and Acid reflux starting around 2 am the morning after vaccines were given",,,,,,,,,N,09/18/2019,09/19/2019,1,NA,PHM,,"Losartan, Celebrex, levothyroxine, Percocet, melatonin, baking soda in water (took once for relief of heartburn)",No,Lung Disease,,,2,09/19/2019,,,,Penicillins
0834582,09/19/2019,TN,0.75,0,.8,M,,"Extremes irritability, began crying uncontrollably the morning of June 6th and that lasted for weeks. Sometimes crying 15 hrs long during the day. He was then  later diagnosed with Transverse Myelitis on August 14, 2017",,,,,Y,35,,Y,N,06/05/2017,06/06/2017,1,"Spinal tap, X-ray, MRI, blood work",MIL,,,,,4 month vaccine,,2,09/19/2019,,Y,,
0834583,09/19/2019,MA,75.0,75,,M,,PT HAD HIVES AND ANGIOEDEMA. DID NOT STATE TREATMENT. PT IS CURRENTLY HEALTHY,,,,,,,,,Y,09/03/2019,09/19/2019,16,UNKNOWN,PHM,,UNKNOWN,NONE,NONE,,,2,09/19/2019,,Y,,NKA
0834584,09/19/2019,TX,15.0,15,,F,,"Administered MCV4 and Hep A vaccine in client's Rt arm IM.  Client conversing with me and her mother throughout but showing some anxiety.  Lt arm vaccines given after were HPV and Tdap.  Shortly after completed with Lt arm, client's eyes rolled back and she appeared to be having a mild seizure. She laid back on table.  Around 15 secs passed and she sat up with help but was very lethargic. Said she was nauseated.  Client's mother went to waiting room to get family member while I stayed with client.  On return we discussed her going to her Dr or the ER.   Client family member attempted to carry her out and she passed out again in hallway.  Held and eased down to floor by family.  No harm to client during transfer.  I called 911 to have client evaluated  for safety purposes. No allergic reaction evident/ no redness, hives or breathing issues, just what appeared as a mild initial seizure and fainting episodes.  Client evaluated by EMS. Blood sugar and vitals within normal limits. Mother verbalized no known previous reactions to any vaccines.  Client transported to local ER for evaluation.  My vaccination info provided to client's mother and my contact information given.",,,,,,,,,U,09/19/2019,09/19/2019,0,,PUB,,UNKNOWN,N/A,N/A,,,2,09/19/2019,,,,NONE PER PARENT
0834595,09/19/2019,SC,,,,U,,"No adverse effect; Improperly stored dose; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapy details were not reported.     On 12-SEP-2019, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # S005874 expiry date 31-OCT-2020 (strength, route of administration were not reported) for prophylaxis (Product storage error). No adverse event was reported. The vaccines was exposed to a lowest temperature of below2 degree Celsius (1.2 Celsius) for a time frame of 24 hours and 36 minutes. No previous temperature excursion was reported. The call was due to digital data logger. No product quality complaint (PQC) was associated with this report.",,,,,,,,,U,09/12/2019,09/12/2019,0,,UNK,,,,,,US0095075131909USA006618,2,09/19/2019,,,,
0834596,09/19/2019,MA,55.0,55,,F,,"Pain during injection / Injection site pain; Weakness in arm; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 55-year-old female patient who received Herpes zoster (Shingrix) (batch number BY2Y4, expiry date 13th November 2021) for prophylaxis.   On 11th September 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 11th September 2019, immediately after receiving Shingrix, the patient experienced injection site pain and weakness of arms. On an unknown date, the outcome of the injection site pain and weakness of arms were unknown.   It was unknown if the reporter considered the injection site pain and weakness of arms to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported that, the patient experienced injection site pain and weakness in arm, during the injection.",,,,,,,,,U,09/11/2019,09/11/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834597,09/19/2019,FL,65.0,65,,M,,"Arm pain; arm pain as intermittent only when the arm was moved in an upward motion; Redness; This case was reported by a physician via call center representative and described the occurrence of erythema in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th June 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced erythema, pain in arm and pain upon movement. On an unknown date, the outcome of the erythema was recovered/resolved and the outcome of the pain in arm was not recovered/not resolved and the outcome of the pain upon movement was unknown.   It was unknown if the reporter considered the erythema, pain in arm and pain upon movement to be related to Shingrix.  Additional details were reported as follows: The physician reported the patient had experienced redness and arm pain with abduction. HCP describes arm pain as intermittent only when the arm was moved in an upward motion. HCP describes redness as erythema lasting only four or five days after receipt of dose one of Shingrix.  HCP could not provide lot number or expiration date for the dose administered.  No additional details provided. The reporter consented to follow up.",,,,,,,,,N,06/07/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834598,09/19/2019,IN,,,,M,,"shingles; Inappropriate schedule of vaccine; This case was reported by a physician via call center representative and described the occurrence of shingles in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The reported that the patient received the 1st dose of Shingrix on an unknown date last year. About 6 to 8 weeks ago, the patient developed shingles. The patient would like to get the 2nd dose, which led to incomplete course of vaccination. The healthcare professional (HCP) was the patient's son. The reporter did not had the exact date of vaccination or lot/exp.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/19/2019,,,,
0834599,09/19/2019,WV,,,,F,,"4 month old was given ActHIB and Pentacel on same day; Initial information received on 05-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 4 months old female patient who received 0.5 ml dose of HIB (PRP/T) VACCINE [ACT-HIB] (lot UJ033AA, expiry date 07-Oct-2020) via intramuscular route in thigh and 0.5 ml dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL]  (lot number and Expiry date unknown) via intramuscular route in thigh.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error case due extra dose administered.   It was reported that that 4 month old was given ActHIB and Pentacel on same day.  At the time of vaccination no adverse events were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number of Pentacel was requested.  List of documents held by sender: none.",,,,,,,,,U,09/04/2019,,,,UNK,,,,,,USSA2019SA251379,2,09/19/2019,,,,
0834600,09/19/2019,NY,,43,,F,,"but missed her second dose (day 7) that was scheduled for yesterday,; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 43 years old female patient who was vaccinated with a first 1 mL dose of vaccine RABIES (HDC) VACCINE [IMOVAX RABIES] lot P1E521M, expiry date: 30-Oct-2020 via unknown route in unknown administration site on 04-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. No other concomitant vaccination was given to the patient.  It is an actual medication error case due to missed dose as the patient missed her second dose (day 7) that was scheduled for 11 Sep 2019.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/04/2019,,,,UNK,,,,,,USSA2019SA256773,2,09/19/2019,,,,
0834601,09/19/2019,WA,,,,U,,"red, swollen right deltoid; red, swollen right deltoid; red, swollen right deltoid; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 11 years old patient who experienced red, swollen right deltoid, while he/she received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MENINGOCOCCAL VACCINE A/C/Y/W (MENINGOCOCCAL VACCINE A/C/Y/W); HEPATITIS A VACCINE (HEPATITIS A); and HPV VACCINE (HPV VACCINE) for Immunisation.  On 10-Sep-2019, the patient received a 0.5 ml dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot: U6321AA, expiry date: 07-Jun-2021) via intramuscular route in the right deltoid.  On 12-Sep-2019, the patient had red, swollen right deltoid (vaccination site inflammation, vaccination site swelling and vaccination site erythema) two days following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  Lab data was not reported.  Final diagnosis was red, swollen right deltoid.   The patient was treated with and Tylenol (acetaminophen).  The patient outcome was not reported (unknown).  List of document held by sender: none.",,,,,,,,,U,09/10/2019,,,,UNK,,MENINGOCOCCAL VACCINE A/C/Y/W; HEPATITIS A; HPV VACCINE,,,,USSA2019SA256986,2,09/19/2019,,,,
0834602,09/19/2019,PA,4.0,,,F,,"administered Quadracel that expired 08/21/2019 to a patient, no AE; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 4 years old female patient who received an expired dose of vaccine DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] (lot: C5248AA expiry date: 21-Aug-2019) via intramuscular route in the arm NOS on 12-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccinations included MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) and VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) for Immunisation.  It was an actual medication error due to expired vaccine used.  At the time of reporting the no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/12/2019,,,,UNK,,MMR; VARICELLA VACCINE,,,,USSA2019SA257018,2,09/19/2019,,,,
0834603,09/19/2019,VA,,0,.4,F,,"a patient received the DTaP-IPV diluent separately and did not receive Hib/ no AE; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA261800 and 2019SA261801.   This case involves a 12 months old female patient who received DTaP-IPV diluent separately and did not receive Hib (inappropriate reconstitution technique) of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [Pentacel] Lot  UJ060AAA, ActHIB- Lot  UJ060AA (Expiry date 04-Oct-2020) on 28-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccinations included ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) and PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13).  It was a case of actual medication error due to inappropriate reconstitution technique.  At a time of reporting no adverse event reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,08/28/2019,,,,UNK,,ROTAVIRUS VACCINE; PREVNAR 13,,,,USSA2019SA257163,2,09/19/2019,,,,
0834604,09/19/2019,,,,,F,,"Stinging when entering the arm; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a non-hcp (office staff).  This case involves Adult female patient who experienced stinging when entering the arm, while she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history included Pain with Stinging when entering the arm more than in previous years. The patient's past medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot QFAA1915 via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious stinging when entering the arm (pain) (Unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  (Other relevant tests included no lab data.) Final diagnosis was stinging when entering the arm.  It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for stinging when entering the arm.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Stinging (Stinging when entering the arm more then in previous years),,USSA2019SA257276,2,09/19/2019,,,,
0834605,09/19/2019,CA,,,,U,,"deemed to have an allergic reaction; localized swelling of the injection site; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from other healthcare professional.  This case is linked to cases 2019SA257583 and 2019SA257582 (same reporter).  This case involves patient (with unknown demographics) who was deemed to have an allergic reaction (hypersensitivity) and localized swelling of the injection site (vaccination site swelling), while he/she received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a 0.5 ml dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via intramuscular route in unknown administration site.  On an unknown date, the patient had deemed to have an allergic reaction (hypersensitivity) and localized swelling of the injection site (vaccination site swelling) (unknown latency) following the administration of INFLUENZA VACCINE. The swelling was larger compared to any other reactions the staff member has had in the previous years.  Other relevant tests not reported.   Final diagnosis was hypersensitivity.  Ice pack was applied as corrective treatment.  The patient recovered from the events.  Information on the batch number was requested.  Documents held by sender: none.",,,,,,,,,Y,,,,,UNK,,,,,,USSA2019SA257467,2,09/19/2019,,,,
0834606,09/19/2019,CA,,,,U,,"deemed to have an allergic reaction; localized swelling of the injection site, The swelling was larger; localized swelling of the injection site, The swelling was larger; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from other healthcare professional.  This case is linked to case 2019SA257467 and 2019SA257582  (same reporter).  This case involves patient (with unknown demographics) who was deemed to have an allergic reaction (hypersensitivity) and localized swelling of the injection site (localized oedema), while he/she received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via intramuscular route in unknown administration site.  On an unknown date, the patient had localized swelling of the injection site. The swelling was larger compared to any other reactions the staff member has had in the previous years (localized oedema). Upon evaluation by hospital staff physician, the employee was deemed to have an allergic reaction (hypersensitivity). Ice pack was applied (unknown latency) following the administration of INFLUENZA VACCINE.  Other relevant tests not reported.   Final diagnosis was hypersensitivity.  Ice pack was applied as corrective treatment.  The patient recovered from the events.  Information on the batch number was requested.  Documents held by sender: none.",,,,,,,,,Y,,,,,UNK,,,,,,USSA2019SA257583,2,09/19/2019,,,,
0834607,09/19/2019,TX,,,,F,,"injection site was extremely itchy; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional (medical assistant).  This case involves an elderly female patient (age not reported) who experienced injection site was extremely itchy (vaccination site pruritus), while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious injection site was extremely itchy (vaccination site pruritus), unknown latency following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. It was reported that this happened during the 2018-19 season and unclear during which month.  Other relevant tests were not reported.  Final diagnosis was injection site was extremely itchy.  It was not reported if the patient received a corrective treatment.  The outcome of the event was not reported.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA260127,2,09/19/2019,,,,
0834609,09/19/2019,FL,,,,M,,"After getting a Pneumovax 0.5 ML shot from Pharmacy I noticed swelling, redness, itching and muscle pain in the area of the injection. No other symptoms have been observed.",,,,,,,,,,09/15/2019,09/16/2019,1,,UNK,,"None; Metformin, Metoprolol Tartrate tabs, Lisinopril, Jardiance, Trulicity",,"Type II diabetes, high blood pressure",,,2,09/17/2019,,,,Morphine
0834610,09/19/2019,MD,38.0,,,F,,1 week after receiving the first dose of Shingrix (given concurrently with first Humira dose) she developed sacral shingles around the anus.,,,,,,,,,,07/29/2019,09/06/2019,39,,UNK,,"Humira, Start 29-Jul-2019, Stop 29-Jul-2019",,"Psoriatic arthritis, history of Zoster of R flank (age 17yo)",,,2,09/16/2019,,,,
0834611,09/19/2019,KY,72.0,,,F,,Received Shingrix injection. Had previous shingles vaccine 10 years ago.9 days developed shingles and had to seek medical help. Presently taking Acyclovir 800 mg 4xdaily to try to prevent continued nerve problems.,,,,,,,,,,,08/28/2019,,,UNK,,"Lisinopril 20 mg day. Multivitamin , fish oil, magnesium",None,Hep C. presently eradicated from blood after treatment.,,,2,09/17/2019,,,,
0834612,09/19/2019,,,,,U,,"When medical assistant was removing sticker from shingrix vial, it was discovered the vial was broken. PCP and onsite LVN were notified immediately when incident occurred.",,,,,,,,,,,,,,UNK,,,,,,,2,09/18/2019,,,,
0834613,09/19/2019,CA,26.0,,,M,,"I took the Gardasil 9 vaccine september 3rd, and 6 days later i started suffering headaches and dizziness also on the night of september 11th i suffered from muscle tightness and numbness at the same time plus weakness i ended up at the emergency room it is now the night of september 16 and the headache is still going on its been a week now of headaches and im really worried now and some answers if this is normal or will it go away. I also want to add i had never suffered any migraine problem for a complete week till now wich is why I'm really worried. Thanks",,,,,,,,,,09/03/2019,09/09/2019,6,,UNK,,,,,,,2,09/17/2019,,,,
0834614,09/19/2019,OH,83.0,83,,F,,ACHE FULL BODY BODY HAD BURNING FEELING  FEAVER.,,,,,,,,,,08/04/2019,08/04/2019,0,,PHM,,HYDROXYUREA - ATENOLOL - ASPIRIN  PANTOPRAZOLE SOD. DR -,N/A,LYMPHOMA,,,2,,,,,N/A
0834615,09/19/2019,KY,0.5,0,.4,F,,"08/09/2019 2:30pm presented for 4 month immunizations. I gave patient rotatec, Pneumonccal and Pentacel. When I came back to triage room I saw I did not mix the Hib powder with the Dtap and IPV liquid. I saw the powder in the vial as I was dropping the vials into the sharps container. I took the sharps container and showed it to lpn and lpn the vial Hib in the sharps container. lpn called Sanofi and lpn told me Sanofi said to give Hib vaccine. I gave patient Hib 0.5ml in the right thigh. APRN notified when this occurred.",,,,,,,,,,08/09/2019,08/09/2019,0,,PVT,,,,,,,2,09/19/2019,,,,
0834616,09/19/2019,MN,68.0,68,,F,,Bumps roof of mouth numbness right side lips rash right arm 15 min. after injection went to ER still on Benedral 9/13/19,,,,,,,,,N,09/11/2019,09/11/2019,0,,UNK,,,,,,,2,09/13/2019,,,Y,
0834617,09/19/2019,AZ,70.0,70,,M,,"RECEIVED THE MUMPS/MEASLES & RUBELLA VACCINE ON 08/27/2019.  AN ADVERSE REACTION OCCURED 09/08/2019 - FLU SYMPTOMS. ON 09/09/2019 - RASH & NECK LUMPS DEVELOPED.  09/10/2019 - RED BUMPS, WRIST, NECK AND KNEE STIFFNESS, DIAGNOSED WITH MACULOPAPULAR RASH. 09/11/2019 - ITCHING, MINOR WRIST PAIN, 2 FINGERS ON THE RIGHT HAND SWOLLEN, STIFF JOINTS AND NICK, MORE BUMPS ON THE CHEST & BACK, LUMPS UNDER THE EAR ARE TENDER, AND LUMP UNDER THE LEFT ARM PIT IS ALSO TENDER.  THE RIGHT BIG TOE JOINT STARING TO HURT, LIMITS ABILITY TO WALK CORRECTLY.",,,,,,,,,U,08/27/2019,09/10/2019,14,,UNK,,N/A,N/A,"BILATERAL GLAUCOMA, AGE-RELATED EXUDATIVE MACULAR DEGENRATION OF LEFT EYE, ASTIGMATISM, PRESBYOPIA",,,2,09/18/2019,,,Y,N/A
0834618,09/19/2019,VA,66.0,66,,F,,Headache. I took ibuprofen for the past 20 hours but headache and sore arms did not go away completely. Now I have just taken excedrin.,,,,,,,,,N,09/18/2019,09/18/2019,0,None,PVT,,Prozac Wellbutrin  Q-10 Centrum over 50 multivitamin  Fish oil Magnesium  B-5,None other than strained muscle and nerve in arm,Depression  Degenerative disk disease Diverticulosis,,,2,09/19/2019,,,,None but I get sick on codeine
0834619,09/19/2019,NY,77.0,77,,M,,Pt's arm was swollen and painful.,,,,,,,,,Y,09/13/2019,09/13/2019,0,"none so far. We had advised patient to put ice, and take 1 tab of 25mg Benadryl. Spoke to pt this afternoon and pt have said that swelling has gone down and he is much better. Pt said he may go to the Dr. if he doesn't feel good after taking Benadryl.",PHM,,NONE THAT WE KNOW.,PT  is on high blood pressure medicine.,HBP,,,2,09/19/2019,,,,NONE
0834620,09/19/2019,KY,,0,.0,F,,Infant received Tdap immediately after birth due to medication error.  No adverse effects noted in the first 24 hours.,,,,,,,,,,09/18/2019,09/18/2019,0,N/A,PVT,,"Erythromycin Ophthalmic Ointment, Vitamin K",N/A,N/A,,,2,09/19/2019,,Y,,NKA
0834621,09/19/2019,MI,4.0,4,,F,,No adverse events noted.  Patient should have received DTaP at age 4. Tdap was given in error,,,,,,,,,Y,09/16/2019,09/16/2019,0,NONE,OTH,,None,NONE,NONE,,,2,09/19/2019,,,,NKA
0834622,09/19/2019,CA,74.0,74,,F,,"PER PATIENT, SHE AWOKE THE NEXT MORNING WITH RED BUMPS FROM HER LEFT HAND UP HER LEFT ARM THAT LASTED FOR 2 DAYS.  DID NOT GO TO ER/UC, DID NOT REPORT TO CLINIC.",,,,,,,,,Y,08/13/2019,08/14/2019,1,NONE,PVT,,"Pravastatin 20mg, Acetaminophen 325mg PRN, Sertraline 100mg, Benazepril 10mg, Meclizine 25mg, Clonidine 0.2mg, Metformin 500mg, Calcium Carbonate 500mg, Loratadine 10mg, Fluticasone nasal 0.05%, Ranitidine 150mg, Gabapentin 100mg, Multivita",NONE,"DMII, HTN, HYPERLIPIDEMIA, MORBID OBESITY, SEASONAL ALLERGIC RHINITIS",,,2,09/19/2019,,,,NKDA
0834623,09/19/2019,NH,57.0,57,,F,,"Fever, chills x 1 day (so far)",,,,,,,,,U,09/18/2019,09/19/2019,1,Checked temperature (verified mild fever),PHM,,None,None,Asthma,,,2,09/19/2019,,,,"Latex, polymixin, neomycin, cats, cigarette smoke"
0834624,09/19/2019,AZ,43.0,43,,F,,within 3-4 hours i felt a  huge soreness under my left armpit and yesterday  a lump formed i think its my lymph node. is a side affect of the flu shot your lymph nodes get inflamed. it hurts if i press on it or press my arm against my side. i have been using heating pad at home and motrin but im concerned.,,,,,,,,,U,09/17/2019,09/17/2019,0,,WRK,,Unknown,Unknown,Unknown,,,2,09/19/2019,,Y,,Unknown
0834625,09/19/2019,OK,12.0,12,,F,,NP had ordered and was administering the HPV9 and Flu vaccine to the child.  The sibling was also with the parent and the parent decided she wanted the flu vaccine for the other child also. The flu vaccines were in different compartments but when NP started administering the vaccines she inadvertantly administerd the other flu vaccine to the same patient.  The first flu vaccine was given in the left arm and the other in the right arm.  The parent was told and educated on what had happened.  She was told to contact our office if any adverse effects were noted.  She was watched for 15 minutes in our office without any adverse effects as of yet.,,,,,,,,,Y,09/19/2019,09/19/2019,0,,PVT,,,,,,,2,09/19/2019,,,,
0834626,09/19/2019,NY,50.0,50,,F,,Patient states onset of severe pain and tenderness from Left shoulder blade to Left wrist on Wednesday 09/18/2019. Unrelieved by extra strength Tylenol or lidocaine patch. States unable to raise Left arm above ear level.,,,,,,,,,,09/16/2019,09/18/2019,2,,PUB,,,,,,,2,09/19/2019,,,Y,
0834627,09/19/2019,FL,4.0,4,,M,,"Rash is located on the legs and is described as red, flat, nondraining.  Treatments tried at home are Benadryl- 17.5 hours ago Antihistamine cream- 17.5 hours ago  HPI - Additional information: Felt well until 1 night ago. Sx began with red, swollen, nontender, non itchy area on right  lateral thigh that was hot to touch and rough on palpation.",,,,,,,,,N,09/17/2019,09/18/2019,1,,PVT,,NONE KNOWN,"COUGH, RUNNY NOSE, STUFFY NOSE",,,,2,09/19/2019,,Y,,AUGMENTIN
0834628,09/19/2019,TN,57.0,57,,F,,"Swollen arm, red rash at injection site on left arm, hypotension (70/50), 102.4 fever",,,,,,,,,Y,09/14/2019,09/15/2019,1,,PHM,,"Flonase nasal spray, carisoprodol 350 mg,  gabapentin 300 mg, losartan 50 mg, propranolol 20 mg, montelukast 10 mg.,",none,"asthma, allergies, chronic pain, high blood pressure",,,2,09/19/2019,,,,none
0834629,09/19/2019,CA,32.0,32,,F,,"Patient received vaccination at flu clinic. Symptoms developed 10 minutes after vaccination of syncope and nausea and blurry vision. Vision became normal after 10 minutes. Patient remained in sitting position while awaiting for paramedics to get there. Blood pressure checked at 130/100, told patient to take deep breaths, 911 was called and paramedics arrived shortly after. Patient refused to go with paramedics for full follow up. Patient educated about reporting this event with primary care doctors and for future flu shots to go to the doctor's office. Patient seemed fine after paramedics left.",,,,,,,,,U,09/19/2019,09/19/2019,0,,OTH,,,,,,,2,09/19/2019,,,,PENICILLIN
0834630,09/19/2019,TN,8.0,8,,F,,"Patient received vaccinations and then was sitting in chair watching younger brother get his vaccinations, patient passed out and fell on floor, lips were cyanotic, clammy.  Patient was assessed by MD and RN at bedside, patient did not hit head. Blood pressure slightly low upon initial check of 78/50. Patient's legs were raised above heart , patient  started to get color in  face. Patient given Sprite to drink and Blood pressure improved to 90/52 and 90/60 when rechecked. Patient had pulse of 60 and 66 with O2 sats 98-99% after incident. Patient had no complaints of pain or any concerns. Patient was observed for 30 min after incident and had returned to baseline vital signs, Mom was confident that she was back to baseline and patient left the clinic in the care of mom.",,,,,,,,,Y,09/19/2019,09/19/2019,0,None,PUB,,unknown,none,unknown,,,2,09/19/2019,,,,none
0834631,09/19/2019,MD,80.0,80,,F,,Patient reported heart racing and blood pressure rising rapidly - she noticed about 4 hours after and it got increasingly worse in the early afternoon - she called Dr. to report it and ask if she should go to the ER because she was becoming very worried about it.The Dr. told her to calm down and continue monitoring at home for a few more hours by 9pm it had resolved.,,,,,,,,,Y,03/20/2019,03/20/2019,0,,PHM,,,,,,,2,09/19/2019,,Y,,
0834632,09/19/2019,WI,6.0,6,,F,,Vaccine was given after it had been stored in  temperature was out of range (-5F),,,,,,,,,Y,09/17/2019,09/17/2019,0,N/A,SCH,,N/A,None,None,,,2,09/19/2019,,,,No
0834633,09/19/2019,MO,23.0,23,,F,,red and painful at the site of injection,,,,,,,,,U,09/16/2019,09/17/2019,1,,WRK,,,,,,,2,09/19/2019,,Y,,
0834634,09/19/2019,NC,75.0,75,,M,,"CHICKEN POX LIKE RASH , HIVES STRTING THE NEXT DAY OF GETTING THE VACCINE.",,,,,,,,,N,09/04/2019,09/05/2019,1,,PHM,,"GABAPENTIN, CIPROFLOXACIN,AMLODIPINE",NONE,NONE,,,2,09/19/2019,,Y,,NONE
0834635,09/19/2019,WI,9.0,9,,M,,Vaccine was given after it had been stored in  temperature was out of range (-5F),,,,,,,,,Y,09/17/2019,09/17/2019,0,N/A,SCH,,Unknown,No,No,,,2,09/19/2019,,,,No
0834637,09/19/2019,CA,,,,F,,"Shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On 13-APR-2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dosage and route of administration were not provided) for routine health maintenance and for  the prevention of shingles (herpes zoster). On 14-SEP-2017, the patient was diagnosed with shingles after experiencing extreme pain and an outbreak of blisters on her legs, arms and ribcage which resulted in medical treatment. This outbreak lasted for at least three weeks. On or about 02-NOV-2017, the patient was diagnosed with a second shingles outbreak. On 25-NOV-2017, the patient was diagnosed with a third outbreak of shingles after reporting to her physician with lesions on her side and a feeling like ""something was biting her from inside"". The patient continued to have reoccurring shingles outbreaks throughout the end of 2017 and throughout 2018 as a result of the zoster vaccine live (ZOSTAVAX), including extreme pain and numbness in her left leg which all resulted in medical treatment. Pain and tingling sensations in her skin, as a result of zoster vaccine live (ZOSTAVAX), were permanent and continued at the time of the report. It was also specified that the patient suffered serious, progressive, permanent, and incurable disfiguring injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life and physical impairment. the event shingles was considered to be related to zoster vaccine live (ZOSTAVAX) vaccination.  Herpes zoster was considered to be disabling due to the severe, permanent and incurable injuries.",,,,,,,,Y,N,04/13/2017,09/14/2017,154,,PHM,,,,,,US0095075131909USA004541,2,09/19/2019,,,,
0834639,09/19/2019,,,,,M,,"chills; kidney soreness; body aches; muscle cramps; joint pain; Injection site swelling andd redness; Injection site swelling andd redness; Injection site swelling andd redness; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves Adult male patient who experienced chills, kidney soreness, body aches, muscle cramps, joint pain and injection site swelling andd redness, while he received vaccine DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (TDap).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a Dose of suspect DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE produced by unknown manufacturer lot number not reported.  The patient developed a non-serious chills, kidney soreness, body aches, muscle cramps, joint pain and injection site swelling and redness (Unknown latency) following the administration of DIPHTHERIA and TETANUS AND ACELLULAR PERTUSSIS VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was vaccination site inflammation, joint pain, muscle cramps, body aches, kidney soreness and chills.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for all the events.  Information on the batch number was requested.  List of documents held by the sender: none",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA258469,2,09/19/2019,,,,
0834640,09/19/2019,WI,8.0,8,,F,,Vaccine was given after it had been stored in  temperature was out of range (-5F),,,,,,,,,Y,09/17/2019,09/17/2019,0,N/A,SCH,,No,No,No,,,2,09/19/2019,,,,No
0834641,09/19/2019,OR,30.0,30,,M,,"Employee reported onset of headache 24 hours later, with additional tension near the TMJ b/l. Additionally, employee feels his blood pressure is labile.",,,,,,,,,N,09/14/2019,09/15/2019,1,n/a,OTH,,Nothing,Cold,Sphenoid tumor,,,2,09/19/2019,,,,Morphine
0834642,09/19/2019,MT,85.0,85,,F,,Severe allergic reaction affecting the central nervous system.  Severe muscle weakness over the course of several days.  Testing done and linked reaction to Shingrix vaccine.,,,,,Y,,,,Y,08/26/2019,08/27/2019,1,See above,PUB,,,,,influenza vaccine (reported),,2,09/19/2019,,,Y,
0834643,09/19/2019,WI,15.0,15,,F,,Vaccine was given after it had been stored in  temperature was out of range (-5F),,,,,,,,,Y,09/17/2019,09/17/2019,0,N/A,SCH,,No,Slight cold symptoms,No,,,2,09/19/2019,,,,No
0834644,09/19/2019,OR,39.0,39,,F,,"approx 24 hours after injection I became lethargic and spiked a fever for almost 24 hours of 101.8, not effected by acetaminophen.  My left arm became extremely painful and extremely hard to extend up or lean/lay on .",,,,,,,,,Y,09/16/2019,09/17/2019,1,,PHM,,none,none,none,,,2,09/19/2019,,,,"sulfa,  penicillin and cyclovir meds for shingles"
0834645,09/19/2019,WA,11.0,11,,M,,Varicella was given IM instead of Sq. Patient's mom presented to clinic on 8/23/19 with her son (the patient) and stated that her son had developed pain and a bump on the arm in injection site. A provider within the clinic examed the patient and determined it was given incorrectly and with ice/heat he would be okay. The mom was advised to call back if it did not improve. To my knowledge they did not call back or present to clinic again for this concern.,,,,,,,,,Y,08/13/2019,08/13/2019,0,,PVT,,cetirizine Flonase Allergy Relief fluoride (sodium),,,,,2,09/19/2019,,,,
0834646,09/19/2019,NY,78.0,78,,F,,Vaccine leaked out between the Luer Lok and barrel of syringe during administration so patient did not receive full dose.  The pharmacist contacted the clinical to advise but received a response the following day and therefore patient needs to be re-vaccinated in 4 weeks to make up dose.,,,,,,,,,,09/18/2019,09/18/2019,0,,PHM,,,,,,,2,09/19/2019,,,,
0834647,09/19/2019,MI,66.0,66,,F,,"Patient complaining  of skin rash located on the anterior arms, anterior and posterior upper legs and anterior and posterior lower legs. Patient describes the rash as red, raised and itchy. The rash has been occurring/present for 1 day and has been unchanged. Patient notes exposure to A flu shot.",,,,,,,,,N,09/17/2019,09/18/2019,1,None,PVT,,none,none,"hypertension, and GERD",,,2,09/19/2019,,Y,,Darvocet and Tramadol
0834648,09/19/2019,UT,4.0,4,,F,,Less than 24 hours after injections the patient began vomiting. Vomiting lasted 24 hours. 48 hours after injections patient developed a fever of 103.1.,,,,,,,,,U,09/17/2019,09/18/2019,1,Flu test came back negative. Strep throat test came back negative.,PVT,,Olly kids multi vitamin with probiotic. Little Critters Fiber,N/A,N/A,,,2,09/19/2019,,Y,,"Dairy, raw egg white"
0834649,09/19/2019,NV,65.0,65,,F,,"fatigue and chills. Right arm was red, itching, warm, sore.",,,,,,,,,U,09/17/2019,09/17/2019,0,Pt want to MD 9/19/2019. DX: possible cellulitis. Pt claims MD said said it may have been a result of too many vaccines at one time.,PHM,,unknown,unknown,unknown,,,2,09/19/2019,,Y,,Wellbutrin xr
0834650,09/19/2019,CA,66.0,66,,F,,Patient had severe inflammation in the pectoralis muscle and redness and inflammation in the elbow/forearm area.,,,,,,,,,,09/16/2019,09/18/2019,2,,PHM,,,,,,,2,09/19/2019,,,,
0834651,09/19/2019,IL,63.0,63,,M,,"starting 1 day after 2nd shot, red rash and inflammation appeared on pt's neck and chest, including a few bumps - today is 8 days after shot and rash is still there. he also ran a fever and had chills/aches for about 24 hours the day after administration.",,,,,,,,,N,09/11/2019,09/12/2019,1,,PHM,,,,,,,2,09/19/2019,,Y,,
0834652,09/19/2019,WI,7.0,7,,F,,Vaccine was given after it had been stored in  temperature was out of range (-5F),,,,,,,,,Y,09/17/2019,09/17/2019,0,N/A,SCH,,No,No,No,,,2,09/19/2019,,,,No
0834653,09/19/2019,WA,57.0,57,,F,,"Pain, redness and swelling at site, muscle aches",,,,,,,,,U,09/17/2019,09/17/2019,0,none,PVT,,"Minocycline, Metranidazole gel, DoTerra Lifelong Vitality Pack and bone suppliment",none,none,,,2,09/19/2019,,,,none
0834654,09/19/2019,OH,74.0,74,,F,,Patient reported to the pharmacy with a large circular black and blue mark at injection site and red skin that is warm to the touch extending from injection site down the arm toward the elbow.,,,,,,,,,,09/17/2019,09/18/2019,1,,UNK,,"Risedronate sodium 150mg, potassium citrate ER 1080mg, metoprolol succinate 50mg, hydroxychloroquine sulfate 200mg, quetiapine fumarate 25mg, folic acid 1mg, atorvastatin 10mg, amitriptyline 100mg",none stated,,,,2,09/19/2019,,Y,,no known allergies
0834655,09/19/2019,CO,64.0,64,,F,,"pt apporached pharmacy 9/19 @2:25 pm, she states her arm has a red rash after an injection. Redness is about 4 inches in all directions from injection site, pt states she experienced headache and fever for about 18 hours post immunization starting 2 hours post injection. Pulled release form and found left arm to be site of shingrix injection, no other raised rash anywhere on her body other than surrounding injection site. Explained to pt that the redness at injection site is normal also fever and soreness normal per VIS.",,,,,,,,,N,09/15/2019,09/15/2019,0,none reporeted,PHM,,"fish oil ,  vitamin d3, calcium,",no illness reported,hypothyroid and vitamin d deficiency,,,2,09/19/2019,,,,"penicillin allergy,"
0834656,09/19/2019,AZ,75.0,75,,F,,"Pt presented to pharmacy today (9/19/19), stating that her arm is swollen, red, and warm to the touch. She showed the pharmacist the area. It was as patient stated. She said that it hurt a lot the first 2 days after the shot, but the pain has since subsided. Pt is going to take Ibuprofen and try cool compresses to see if swelling goes down and/or away. She will follow up with MD if the arm gets worse in any way.",,,,,,,,,U,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/19/2019,,,,"Sulfa, ACE Inhibitors"
0834657,09/19/2019,WA,31.0,31,,F,,"Guillian Barre Syndrome   Paralysis, painful pins and needles, super cold from inside out, breathing, speaking, hearing",,,,,,,Y,,N,11/20/2000,12/25/2000,35,"spinal fluid confirmed Guillian Barre Syndrome, IVG, Plasma",PVT,,Primarin,no,,,,2,09/19/2019,,,Y,"penicillin, amoxicillin, erythromycin"
0834658,09/19/2019,AZ,28.0,28,,F,,hives on neck and one hive on face with dry mouth. Redness and swelling around site of injection,,,,,,,,,N,09/18/2019,09/19/2019,1,,PVT,,"Advair Diskus 100-50 mcg/dose, Albuterol Sulfate HFA 108 (90base) mcg/act, bupropion HCl ER 300 mg, fluvoxamine maleate 100 mg",no other illnesses reported.,anxiety with depression listed.,,,2,09/19/2019,,Y,,
0834659,09/19/2019,,90.0,90,,F,,patient is complaining of all over neuralgia that started the day after administration. patient is able to control pain with tylenol regular strength,,,,,,,,,N,09/17/2019,09/18/2019,1,,PHM,,,,,,,2,09/19/2019,,,,
0834660,09/19/2019,CA,72.0,72,,F,,Pt called that she had shingrix and flu vaccines on the same day but on the arm with the shingrix is red and swollen and she had some nausea earlier today. Rec. pt to take some Aleeve and ice the area and will check check with her later on. Rec. also if needed pt can go see her doctor or go to the urgent care. A few hours later called to check on the patient but patient did not answer.,,,,,,,,,U,09/17/2019,09/19/2019,2,,PHM,,,,,,,2,09/19/2019,,,,
0834661,09/19/2019,KS,54.0,54,,F,,"Pain in side under rib approximately 20 minutes after immunization , fever, frequent bowel movements. all symptoms lasting four days.",,,,,,,,,,09/09/2019,09/09/2019,0,,PHM,,,,,,,2,09/19/2019,,,,
0834662,09/19/2019,,55.0,55,,M,,"Pain in side under rib approximately 20 minutes after immunization , fever, frequent bowel movements. all symptoms lasting four days.",,,,,,,,,,09/09/2019,09/09/2019,0,,PHM,,,,,,,2,09/19/2019,,,,
0834663,09/19/2019,PA,41.0,41,,F,,"patient received shot in left arm around 9:30 am about 2 hours later started having pain on left side of body, pain and numbness of arm, pain in neck and even jaw.  She was seen by the school nurse.  Patient started taking naproxen for pain.",,,,,,,,,U,09/19/2019,09/19/2019,0,None,SCH,,None,None,None,,,2,09/19/2019,,,,None
0834665,09/19/2019,AZ,11.0,11,,F,,"Skin redness and swelling resolved, with continued underlying texture and color change.",,,,,,,,,Y,08/01/2019,08/02/2019,1,no,PVT,,none,no,mild asthma,,,2,09/19/2019,,,,none
0834666,09/19/2019,,49.0,49,,M,,"After vaccination, pt developed swelling on hands in several hours later.",,,,,,,,,,09/19/2019,09/19/2019,0,,PHM,,,,,,,2,09/19/2019,,,,
0834667,09/19/2019,WA,1.25,1,.3,F,,"9/12/19 Fever of 102deg and stopped walking an standing 9/13/19 Fever of 100.7 with regular Tylenol, still not standing or walking and noticeable reduced movement of the legs , crying with passive movement of her legs. Took her in to PCP where she had absent reflexes and was sent home with instruction to use motrin. 9/14/19 Fever 100.6 with regular Tylenol, very fussy and now not crawling in addition to standing or walking. Went to ER where imaging ruled out any hip dysfunction or LE fractures. Absent reflexes. Performed an enema due to stool being seen on abdominal x-ray. Was sent home with instruction to return in 24 hours if not resolved. 9/15/19 Now unable to roll over, sit up independently and control her head. Went back to ER due to progression of weakness and she was admitted to the hospital. Absent reflexes. Lumbar puncture was negative. Presentation consistent with guillain barre syndrome and Physicians got approval to use IVIG treatment. 1st dose administered of IVIG.  9/16/19 No change in muscle tone or movement. No more fever. Spinal/brain MRI with and without contrast completed and was normal. Treated with 2nd dose of IVIG and started antibiotic for UTI as well.  9/17/19 Improvement in her movement with head control and kicking her legs. Beginning to be able to roll to her side. Continues use of antibiotic for UTI. 9/18/19 More improvement in movement, now able to roll and briefly bear weight on her legs with support. Good head control and pushing up from prone into crawl position. Discharged from hospital to home. 9/19/19 More improvement in movement, now able to crawl and pull to stand.",,,,,Y,4,,,N,09/11/2019,09/12/2019,1,9/14/19 X-ray imaging ruled out any hip or LE fractures. Normal hip ultrasound bilaterally. Absent reflexes. Blood draw showing elevated CRP and WBC. 9/15/19 Absent reflexes. Lumbar puncture was negative.  9/16/19  Spinal/brain MRI with and without contrast completed and was normal.,PVT,,multivitamin,none,none,,,2,09/19/2019,,Y,Y,lactose intolerant
0834668,09/19/2019,OH,73.0,73,,F,,"Patient said she doesn't even know if her symptoms are related to the vaccine, but she said she's felt ""lousy"" for quite some time and specifically stated her left arm is ""sore"" near the injection site. She also reports right shoulder and wrist pain and left wrist pain. She is not sure if the symptoms started around the time of vaccination, but she thinks they may have... She was advised to follow up with her doctor.",,,,,,,,,N,07/15/2019,07/15/2019,0,,PHM,,,,,,,2,09/19/2019,,,,
0834669,09/19/2019,NH,68.0,68,,F,,"patient had vaccine on 9/5, had arm pain x48 hours, called md to report discomfort, went in for xray on 9/13, recommended use of OTC anti-inflamatories and stretches, still significant arm pain, going to Physical therapy starting 9/23",,,,,,,,,N,09/05/2019,09/05/2019,0,xray on 9/13 accompanied by office visit with PCP,PHM,,"levothyroxine, ibandronate, yuvafem",unknown,hypothyroidism/ osteoperosis,,,2,09/19/2019,,Y,,penicillin
0834670,09/19/2019,CA,64.0,64,,F,,pt presented today 9/19 with a swollen arm- swollen from shoulder down to half way down the lower part of arm.  A bit red and warm to the touch.,,,,,,,,,U,09/16/2019,09/17/2019,1,"no test, pt taking benadryl",PHM,,"soma, percocet, propranolol, plavix, cymbalta, fenofibrate, simvstatin, metformin",,"chronic pain, diabetes, depression, cholestserol",pneumovax was apparently give at md office about 4 months ago according to patient and she had the same reaction at that time to,,2,09/19/2019,,Y,,no known
0834671,09/19/2019,NH,63.0,63,,M,,"fever for 2 to 3 days following vaccination , reported 9-2019",,,,,,,,,Y,05/31/2019,05/31/2019,0,none reported,PHM,,,none reported,,,,2,09/19/2019,,,,tetracycline allergy
0834672,09/19/2019,NH,63.0,63,,F,,fever for 2 to 3 days,,,,,,,,,Y,05/31/2019,05/31/2019,0,,PHM,,,,,,,2,09/19/2019,,,,sulfa allergy
0834673,09/19/2019,FL,69.0,69,,F,,The patient woke up in the middle of the night with severe pain in her left arm and nausea which kept her up for three hours. She later noticed swelling in her left arm.,,,,,,,,,N,09/18/2019,09/19/2019,1,,PHM,,,,,,,2,09/19/2019,,,,
0834674,09/19/2019,NY,76.0,76,,M,,"Patient reports pain in left shoulder following flu shot so severe it has prevented/disturbed sleeping and inability to lift his arm. Reports pain starting a few hours following the shot on Sunday. Today, Thursday he reports minor improvement in ability to move arm and pain. Reports taking ibuprofen with only minimal relief. States that he felt shot was given higher in arm then usual. Advised patient that shoulder joint can be irritated if shot was given too high in the muscle and can continue ibuprofen and ice but should follow up with regular doctor as only they can diagnosis the problem. States he will wait through the weekend to see if further improvement and will seek followup.",,,,,,,,,N,09/15/2019,09/15/2019,0,,PHM,,"escitalopram, advair, diazepam, losartan",,"asthma, hypertension",,,2,09/19/2019,,Y,,nka
0834675,09/19/2019,MA,81.0,81,,M,,"Patient states that he (and his wife) never recovered from the flu shot they received from us last year. He states that he has muscle pain and weakness. He states that he is unable to raise his arms above his head. When questioned whether the effect is only in the vaccinated arm or in both arms, he responded both arms.",,,,,,,,,N,09/27/2018,09/27/2018,0,,PHM,,Alprazolam 0.5mg TID PRN Omeprazole 10mg QD PRN,,,,,2,09/19/2019,,Y,,
0834676,09/19/2019,CA,3.0,3,,M,,"fever, febrile seizure, cyanotic episode over several minutes",,,,,,,,,Y,09/18/2019,09/19/2019,1,"flu swab test (9/19/2019), urine test (9/19/2019), EKG (9/19/2019)",PVT,,None,None,Tetralogy of Fallot (congenital heart defect),,,2,09/19/2019,,,Y,None
0834677,09/19/2019,CA,72.0,72,,F,,"Fluzone High-dose around 230pm. Per pt - woke up from pain, body ache , chills around 3 am -- was feeling better around 10am when she called.",,,,,,,,,U,09/01/2019,09/01/2019,0,,PHM,,"Norco, Triamternen/Hctz, Atorvastatin, Estrogen/methyltestosterone, Levothyroxine, Bupropion",,,,,2,09/19/2019,,,,Sulfa-drugs
0834678,09/19/2019,MA,74.0,74,,F,,"As described by patients husband, she has general muscle pain and weakness, not restricted to injection site/arm which has lasted approximately a year so far.",,,,,,,,,N,09/27/2018,09/27/2018,0,,PHM,,Hydrocodone APAP 7.5/325 TID PRN Amitriptyline 10mg HS Atenolol 50mg QD Omeprazole 10mg QD,,"Hypertension, inferred Depression, inferred Chronic Pain, inferred Acid Reflux, inferred",,,2,09/19/2019,,Y,,Buspirone Codeine Lorazepam Prozac Wellbutrin
0834679,09/19/2019,FL,24.0,24,,F,,"Patient has a red circle about the size of a half dollar, warm to the touch",,,,,,,,,N,09/17/2019,09/18/2019,1,,PHM,,,,,,,2,09/19/2019,,,,
0834680,09/19/2019,MS,56.0,56,,F,,"Pharmacy providing vaccination services to a local medical clinic received notification (via email) two days after on-site flu clinic of a patient that presented with the following: severe arm pain, warm to touch, and very swollen at injection site",,,,,,,,,U,09/17/2019,09/19/2019,2,,PVT,,,,,,,2,09/19/2019,,,,"lomotil, penicillin, keflex"
0834681,09/19/2019,MO,72.0,72,,F,,"Patient states that the first week after injection her left arm was swollen, she had a fever and chills.  Patient states that after about a week, her temperature started to run low (97 degrees) for her.  She ask her doctor if she could get a flu shot and was told not until her temperature was back to her normal.",,,,,,,,,N,09/07/2019,09/15/2019,8,none,PHM,,,,,,,2,09/19/2019,,,,
0834682,09/19/2019,NJ,61.0,61,,F,,"Body itch with rash on chest, back, and shoulder",,,,,,,,,Y,09/05/2019,09/16/2019,11,,PHM,,,,,,,2,09/19/2019,,Y,,
0834683,09/19/2019,OH,24.0,24,,F,,"About ~10 minutes after receiving the flulaval intramuscularly in the right deltoid, patient reported that their entire right arm from shoulder to fingertip was numb to the touch. She says she's never experienced this before with any shot. There was no pain or decrease in range of motion. They reported difficulty holding a coffee cup in that hand because of the numbness. I had her wait in the pharmacy waiting area for another 10-15 minutes to reassess, at which time she reported no improvement. I advised her to closely monitor herself and to call the pharmacy with any developments. I heavily recommended she seek out her primary care provider and told her I'd fax a copy of this VAERS report to her PCP.",,,,,,,,,U,09/19/2019,09/19/2019,0,,PHM,,,,,,,2,09/19/2019,,Y,,
0834684,09/19/2019,MT,68.0,68,,F,,"Patient presented to the pharmacy on 9/19/19.  She said that after she got the shingrix shot on 9/12/19 her arm was very sore, but 3-4 days after she developed a roughly 4 inch by 3 inch warm, ""tight feeling"",  red splotch on her left arm, about 4 inches below the injection site.  Upon looking at it on 9/19/19, it does not appear to be raised, or a rash, and patient reports it does not itch. She says it is still tender to the touch, but the arm pain has improved.  She reports no other symptoms, it appears to be local to that one red area.",,,,,,,,,U,09/12/2019,09/15/2019,3,,PHM,,UNKNOWN,UNKNOWN,UNKNOWN,,,2,09/19/2019,,,,NO KNOWN ALLERGIES
0834685,09/19/2019,OH,66.0,66,,M,,"Patient called and stated that he had severe flu like symptoms. Chills, fever, and vomiting. Enough symptoms that his wife was going to take him to the Emergency Room. Patient waited it out and symptoms subsided after a couple days.",,,,,,,,,Y,09/17/2019,09/17/2019,0,,PHM,,,,,,,2,09/19/2019,,,,
0834686,09/19/2019,NC,64.0,64,,F,,"She developed Nausea,Chills,Fever lasting for about 7 days.Her Appetite had gotten worst.Body aches increased,Constipation got bad,increased severity of Head aches.",,,,,,,,,N,09/11/2019,09/11/2019,0,Didn't mention any as of now.,PHM,,Not Known,Liver Cirrhosis,Liver Cirrhosis,,,2,09/19/2019,,,,Penicillins
0834687,09/19/2019,IL,69.0,69,,F,,"Patient was given Fluzone HD on 8/31/19, she came into the pharmacy on 9/5/19 after going to ER stating that her lips and face were swollen. She was given prednisone, famotidine and cephalexin (which she did not want the cephalexin so she did not pick it up).",,,,,,,,,U,08/31/2019,09/05/2019,5,,PHM,,,,,,,2,09/19/2019,,,Y,
0834688,09/19/2019,FL,65.0,65,,M,,"Patient said he was fine after shot and he had no issues. He went home and decided to paint a room and used his left hand to reach in a corner to paint, He later became in pain that night and went to ER in the morning. Patient was given Flexeril and Norco to help with pain. Doctor did not see that the shot was related to his issue.",,,,,,,,,,09/18/2019,09/18/2019,0,,UNK,,,,,,,2,09/19/2019,,,Y,
0834689,09/19/2019,IN,17.0,17,,F,,"she was given the hep A shot first , then the HPV in the left arm, then I switched to give her the men B shot in the right arm, she said that she felt light headed.  She was given the Men B shot  she said she felt really light headed and we noticed that she was becoming very pale.  about 1 minute after receiving the Men B shot she went rigid  this lasted a minute or 2.  When she came around she knew where she was but did not remember after receiving the injections.  She said that she still felt very light headed and she had a bad headache.",,,,,,,,,U,09/16/2019,09/16/2019,0,,UNK,,,,,,,2,09/19/2019,,,Y,
0834690,09/19/2019,FL,68.0,68,,F,,"Uncontrollable vomiting @ 6:00pm, 2 (?) injunctions on 2 different anti nausea/vomiting drugs: worked well within approximately 15-30 minutes Seizures producing uncontrollable shaking; through the next 11-12 hours until I was discharged I was given intravenously multiple meds to stop seizures...including but not limited to Ativan, morphine, injectable form of Xanax, and other that I do not remember.  I got intermittent relief from shaking for maybe 30 minutes and then shaking would return and another med would be injected. Intense headache was relieved by seizure meds. Sent hom with prescription of hydroxyzine and zofran.",,,,,,,,,N,09/18/2019,09/18/2019,0,"CT scan head and abdomen Multiple blood work to check dehydration , highlactic acid and white blood cell count",PHM,,"Lorsartan,  amlodipine besylatr, levocetirizine, metoprolol ER",None,"High blood pressure, high cholesterol, sinus problems, IBS",,,2,09/19/2019,,,Y,"Rifampin, sulfa drugs"
0834691,09/19/2019,TX,63.0,63,,F,,"approximately 10 minutes after receiving the vaccine the patient started experiencing intense itching all over her body.  It also appeared that she was turning red, unsure if that was part of the reaction or due to the patient scratching.  Following up with the patient, she states that the reaction subsided after taking benadryl and has fully recovered.",,,,,,,,,Y,09/19/2019,09/19/2019,0,,PHM,,,,,,,2,09/19/2019,,,,sulfa containing medications
0834692,09/19/2019,NJ,87.0,87,,M,,"Patient came in with a swollen interior arm and redness. Counseled to take benadryl, consult primary.  Followed up with PT and MD reaction has gone down and no further follow up needed per pt.",,,,,,,,,Y,09/15/2019,09/16/2019,1,,PHM,,"Simvastatin, metoprolol, tamsulosin, hctz",Unknown,known,,,2,09/19/2019,,,,KNDA
0834693,09/19/2019,MO,65.0,65,,M,,Pt said that there was a red mark or line on his arm going around his arm below the deltoid muscle. He said the line was about 1.5 inches by 1/2 inch in size. It was red & itchy and sensitive to the touch. This first started several days after the shot was given and stayed for 2 days.,,,,,,,,,Y,09/03/2019,09/07/2019,4,,PHM,,,,,,,2,09/19/2019,,,,nkda
0834694,09/19/2019,NE,76.0,76,,F,,"Started next morning with nausea, vomitting  (unlike normal), light headed, temperature drowsiness.  Everything but vomitting continued with slight temp for 1 week, then vomitting again, and same symptoms.  Went to Dr. on 14th day, and he was certain that it was from the vaccine.  Continued with symptoms and went back to Dr, after another two weeks, and he gave me prednisone and finally after about six more days , I began to feel better.",,,,,,,,,Y,07/26/2019,07/27/2019,1,"No tests were done, but two visits to the Dr.",PHM,,"Amlodipine,  Lovastatin,  Sertraline, Omeprazole, Symbicort, Fish oil, B-complex",None,None,,,2,09/19/2019,,,,None
0834695,09/19/2019,NC,4.0,4,,F,,Idk what type flu shot it was but my daughter has a huge red mark the size of and egg on her thigh.and its hard,,,,,,,,,N,09/17/2019,09/18/2019,1,,PVT,,None,None,None,,,2,09/19/2019,,,,None
0834696,09/19/2019,TX,73.0,73,,F,,Patient said she threw up twice since she got the shot.,,,,,,,,,U,09/19/2019,09/19/2019,0,,PHM,,Ibuprofen,"Patient was just released from hospital for possible food poisioning. Pt was throwing up over the weekend, but hasn't thrown up since Monday.",,,,2,09/19/2019,,,,
0834697,09/19/2019,PA,36.0,36,,F,,"Numbness in arms, fingers, legs, toes  (all extremities)",,,,,,,,,N,09/17/2019,09/18/2019,1,none,PHM,,Zyrtec 10mg QD Mirena IUD,None - Just seasonal allergies,None,,,2,09/19/2019,,,,None
0834698,09/19/2019,AL,6.0,6,,M,,"warm, raised, reddened area about the size of 1 to 1.5 inch.",,,,,,,,,U,09/18/2019,09/18/2019,0,None,SCH,,Unknown,Unknown,Unknown,,,2,09/19/2019,,,,Unknown
0834701,09/19/2019,NY,0.5,0,.5,M,,"About a week after vaccination, a rash erupted over the majority of the body.  It has never resolved- has been present for the last 7 years.  Only in 2016 was it finally diagnosed after biopsy as Pityriasis Rubra Pilaris .",,,,,,,,Y,N,02/28/2012,03/08/2012,9,pediatric dermatology referral 3/16/2012- multiple follow up visits- inconclusive.  New dermatology referral  9/13/2016.  Skin biopsy 9/28/2016.,PVT,,NONE,NONE,LARYNGOMALACIA,,,2,09/19/2019,,Y,,NONE
0834702,09/19/2019,GA,82.0,82,,F,,patient reported muscle soreness that went all the down her arm on the first day.  second day patient developed a rash that was tender to touch.  third day patient went to see pcp and was diagnosed with a shingles outbreak.  patients daughter will keep pharmacy up to date with patient's progress.,,,,,,,,,U,09/12/2019,09/12/2019,0,unknown,PHM,,"no meds listed on file, no drug allergies or heath conditions listed either",none listed,none listed,,,2,09/19/2019,,Y,Y,none listed
0834703,09/19/2019,NY,4.0,4,,F,,"The day after patient was immunized she came down with diarreah & a fever of about 101 F. I called her pediatrician right away & she told me to give her over the counter fever reducing medicatons. She continued having moderate fever for the next few days. By 9/15/19 her temperature went down to 99.8 F. Then on Monday 9/16/19, her temperature spiked to 104.5 F. On Tuesday, 9/17/19, her fever was still very highest point of 104.2 F. I took her to the doctor & she did a troat culture which came up negative. Wednesday 9/18 she was very lethargic & was still having fever all day & in the evening her fever went up to 105.3 F. I gave her OTC fever medication & called the doctor right away  & Made an appointment for the following day. This morning 9/9/19 she was still having fever of about 101F. My doctor took bloodwork for a cbc & perscribed antibiotics.",,,,,,,,,N,09/08/2019,09/09/2019,1,,PVT,,None,,,,,2,09/19/2019,,Y,Y,none
0834704,09/19/2019,CO,81.0,81,,F,,"Pt came by the pharmacy on Sept 18, 2019, to report that her left arm bruised. She received Fluzone HD on left arm and Shingrix 1st dose on right arm. She reported her left arm swell with bruising for more than a week. Her bruise size was 2 inches in diameter when she came to the pharmacy on sept 18, 2019.",,,,,,,,,Y,09/10/2019,09/11/2019,1,none,PHM,,,Pt state that she is currently being treated with chemotherapy and radiation,Pt state that she is currently being treated with chemotherapy and radiation,,,2,09/19/2019,,,,none
0834705,09/19/2019,CA,,0,.0,M,,"Seizures, absent seizure, autism, gut issues, food allergies/sensitivities, tics, loss of speech, loss of eye contact, fatigue, diarrhea, constipation, hand flapping, inconsolable high pitch screaming,",,,,,,,,Y,N,09/17/2010,09/18/2010,1,autism evaluation 2012,PVT,,none,none,none,,,2,09/19/2019,,Y,Y,none
0834706,09/19/2019,CA,25.0,25,,F,,"30 mins after vaccination patients was driving and foot slammed on gas pedal. Patient began to have severe back pain, leg pain, pain in uterus, fatigue, nausea, bruising on legs, headaches. brain fog, gut issues.",,,,,,,,Y,N,05/01/2007,05/01/2007,0,,PVT,,none,none,none,Flu Vaccines,,2,09/19/2019,,Y,,none
0834720,09/19/2019,NE,55.0,55,,M,,- Patient Believes it was administered caregiver to high in arm. Patient reports pain. Patient taking IBU & ice.,,,,,,,,,U,09/18/2019,09/18/2019,0,not aval - tried to call pt. to F/U,PHM,,N/A,N/A,N/A,,,2,09/19/2019,,,,NKDA
0834742,09/19/2019,GA,17.0,17,,F,,"large red patch on the upper arm with a blue center, Nodule felt underneath the skin at the center. Painful when touched and warm to touch.",,,,,,,,,U,09/12/2019,09/13/2019,1,Vital signs; Pt started on oral abxs for cellulitis; Post injection inflammation,PVT,,None,None,,,,2,09/19/2019,,Y,,None
0834743,09/19/2019,NY,16.0,16,,M,,"LAST NIGHT AT 12:45AM HE GOT UP TO GO TO THE BATHROOM, FELT QUEEZY, WEAK, BLACKED OUT, FELL TO THE FLOOR, WOKE UP ON THE FLOOR. DENIES ANY SPINNING DIZZINESS. EVEN SITTING IN CHAIR FEELS WEAK LIKE HE IS GOING TO FALL OVER. REPORTS HEADACHE, BANDLIKE WRAPPING AROUND BACK TO SIDES OF HEAD. HAS BEEN GOING ON SINCE YESTERDAY WHEN HE RECEIVED VACCINES. NO DOCUMENTED FEVER BUT DID HAVE CHILLS LAST NIGHT, HE IS FEELING BETTER THAN HE DID LAST NIGHT. FEELING BETTER BUT NOT COMPLETELY WELL.",,,,,,,,,U,09/18/2019,09/19/2019,1,,PVT,,"VITAMIN D 50,000 UNIT WEEKLY BENZOYL PEROXIDE 10% GEL DAILY AT HS",NONE,NONE,,,2,09/19/2019,,Y,,SEASONAL
0834744,09/19/2019,CO,32.0,32,,F,,"PATIENT DEVELOPED HIVES ""ALL OVER"" LATER IN THE EVENING, AFTER GETTING PNEUMOCOCCAL VACCINE. (AM) ""ITCHY"" PO BENADRYL PO CLARITIN BENADRYL CREAM",,,,,,,,,U,09/16/2019,09/16/2019,0,N/A,PVT,,BUPRPION - 150MG PO BID FOR 30 DAYS FLUOXETINE 20MG PO QD OMEPRAZOLE MG PO QD,NO,NONE,,,2,09/19/2019,,Y,,AUGMENTIN - N+V
0834745,09/19/2019,CO,,66,,F,,"72 hours after her second Shingrix vaccination, patient had to access the ER for hives and throat swelling where she received epinephrine, Benadryl and ""something else""  The pharmacy used Shingrix Lot 52R7X, with adjuvant Lot 92NA4, on 9.13.2019. Patient reported incident to pharmacy today, 9.19.2019.",,,,,Y,,,,,09/13/2019,09/16/2019,3,,UNK,,levothyroxine,,,,,2,09/19/2019,,,,
0834746,09/19/2019,CA,34.0,34,,F,,Upper arm swollen & itchy at site of injection. Swollen 10cm x 5 - red & hot to touch. Seen by provider given shot of Kenalog 40mg IM. incident started 1 HR after administration or vaccine. Cold compress given. After several Hrs after Kenalog site & swelling Administered got better No more itch less redness patient was prescribed steroid by mouth & loratadine for Allergic reaction.,,,,,,,,,Y,09/10/2019,09/16/2019,6,,PVT,,None,None,None,,,2,09/19/2019,,Y,,NKDA
0834747,09/19/2019,TX,82.0,82,,F,,Patient came to the pharmacy on 9/18/19 indicating to the pharmacist on duty that their right upper arm had swollen from their shoulder to their elbow and it had been worse prior to coming into the pharmacy. The pharmacist on duty instructed the patient to take Benadryl for the swelling.,,,,,,,,,U,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/19/2019,,,,codeine allergy
0834749,09/19/2019,CA,6.0,6,,F,,Mother states 4-5 hours after receiving vaccination she noticed redness around injection site. Patient has been complaining of soreness and pain. Mother states over night redness spread and swelling around site appeared.,,,,,,,,,N,09/18/2019,09/08/2019,,No test were needed at the moment pt advised to RTC tomorrow,PVT,,Ibuprofen / Benadryl,No,No,,,2,09/19/2019,,Y,,No Known allergies
0834751,09/19/2019,CA,49.0,49,,M,,"Patient had a gen rash over arms & legs 2 days after vaccine with MMR/menactra He came to clinic 8 days after rash, by while rash had cleared mostly. Rash was papular very discrete, looked like insect bites. No SOB or anaphylaxis or any other Sx.",,,,,,,,,Y,08/27/2019,08/29/2019,2,"Topical caladryl, 1% Hydrocortisone given for itching.",PVT,,"Biktarvy, Cymbalta, Folic Acid, Vit D, Cyanocobalamin",,HIV,,,2,09/11/2019,,,,Erythromycin
0834766,09/19/2019,MN,76.0,76,,M,,Patient felt no symptoms/pain. Right arm began to swell at injection site. Instructed Patient's wife to take patient to the urgent care center across the street.,,,,,,,,,U,09/19/2019,09/19/2019,0,,PHM,,No know medications,Unknown,Diabetes,,,2,09/19/2019,,,Y,NKDA
0834767,09/19/2019,TN,47.0,47,,M,,"Pt got flu vaccination, then his wife was vaccinated. We chatted for several minutes afterwards & then they walked off. He was drinking a Capri Sun that I discarded for him. Several moments later his wife came back & said he fainted. We rolled him on his side & called 911. When he came to, he said this hadn't happened in about 15 years He was extremely pale, not disoriented. He said he had once fainted watching his wife get an injection and had fainted with other vaccinations but not the flu vaccine. We placed a towel under his head and used wet sponges to cool him down. He was clammy & sweating. His Blood pressure was 140/84 Pulse 58 He never mentioned prior to vaccination that he had previously fainted with other vaccines or that he had previously fainted watching his wife. EMS came and took over. I do not know if he actually went to the hospital or not.",,,,,,,,,U,09/19/2019,09/19/2019,0,,PHM,,Unknown,,,But do not know details.,,2,09/19/2019,,,,NKA
0834768,09/19/2019,FL,76.0,76,,M,,"patient given flu shot at pharmacy at 8:00 pm on 9-11-19. Woke up following morning (9-12-19) with left sided numbness, mild nausea, unsteady gait",,,,,,,,,U,09/11/2019,09/12/2019,1,CT Brain - normal 9/12/19,UNK,,Finasteride Oral Tablet 5 MG Isosorbide Mononitrate ER Oral Tablet Extended Release 24 Hour 30 MG Fluticasone Propionate Nasal Suspension 50 MCG/ACT Calcium  Ferrous Fumarate Oral Tablet 325 (106 Fe) MG NovoLIN 70/30 ReliOn Subcutaneous Sus,,,,,2,09/12/2019,,Y,,"Cipro, IV contrast dye"
0834769,09/19/2019,MA,17.0,17,,M,,Patient vomited shortly after Receiving Fluarix QUAD vaccination.,,,,,,,,,Y,09/19/2019,09/19/2019,0,Patient left for emergency room after 1 vomiting episode,UNK,UNK,,None,None,,,1,,,,,
0834770,09/19/2019,VA,33.0,33,,F,,R deltoid pain and swelling worsening in 2 days after vaccination  Rx Benadryl and epi pen PRN,,,,,,,,,U,09/11/2019,,,,PVT,,,Acute Upper Respiratory Infection,,,,2,09/19/2019,,Y,Y,
0834776,09/19/2019,CA,48.0,49,,F,,"Pt called to discuss reaction after flu vaccine today. C/o (L) shoulder itching with hives. Hives starting to go away + area red; no swelling, no pain, no SOB, no swelling of lips/tongue or throat.",,,,,,,,,Y,09/19/2019,09/19/2019,0,,PVT,,,,,,,2,09/19/2019,,,,Zithromax
0834783,09/19/2019,IA,63.0,63,,M,,"Woke up one morning about 7-10 days after receiving vaccine and could not walk. Intense pain in both feet. Joints in both hands, elbows, and knees also greatly affected. Saw Podiatrist who sent me to Rheumatologist who made diagnosis after blood test. Presently on methotrexate and prednisone.",,,,,,,,,N,03/01/2019,03/09/2019,8,Blood test confirmed diagnosis-Rheumatologist performed other tests. I am not aware of what they were,PVT,,SIMVASTATIN 40mg ASPIRIN 81mg LISINOPRIL 20mg,None,Hypertension OSTEO ARTHRITIS,,,2,09/17/2019,,Y,,PENICILLIN SULFA DRUGS TRAMADOL
0834784,09/19/2019,WV,40.0,40,,F,09/17/2019,"Headache, chills, body aches, vomiting for 12 hours then hands (and feet) turned red + numb. Red rash up to mid-shen",,,,Y,,,,,Y,09/11/2019,09/13/2019,2,"Urineanalysis, blood work, X-ray- UTI found",OTH,PVT,,,None,,,1,,,,,
0834785,09/19/2019,GA,11.0,11,,M,09/19/2019,"redness at injection site, swelling of left arm. applied heat, swelling went down.",,,,,,,,,Y,09/17/2019,09/18/2019,1,,PVT,PUB,,none.,none noted.,,,1,,,,,
0834786,09/19/2019,NM,71.0,71,,F,,Patient said so deathly ill refused to get 2nd recommended shot in the series.,,,,,,,,,Y,07/09/2019,07/09/2019,0,none,PHM,,Unknown,,Diabetes HTN hyperlipidemia,,,2,09/19/2019,,,,Penicillins cephalosporins
0834789,09/19/2019,PA,,22,,F,09/19/2019,"Quarter sized raised area, warm to touch. Itching, localized to site",,,,,,,,,Y,09/17/2019,09/18/2019,1,,PVT,UNK,,None,None,,,1,,,,,
0834790,09/19/2019,NY,12.0,12,,F,09/19/2019,N & V after injection  Fever T=102.1 the following morning resolved w/ advil 200mg x 1 dose frontal headache,,,,,,,,,U,09/18/2019,09/18/2019,0,none ordered,PVT,UNK,,none,rash w/ DTaP,,,1,,,,,
0834791,09/19/2019,AZ,38.0,38,,F,,"The next morning after receiving the vaccine, she began to experience facial swelling and redness that progressed to severe swelling, itching in her neck, chest and face by the next day.",,,,,,,,,N,09/16/2019,09/17/2019,1,,PVT,,Pepcid,,,,,2,09/19/2019,,Y,Y,"Cipro, carbamix, thyramix"
0834792,09/19/2019,FL,79.0,69,,F,09/19/2019,"Red swollen arm (left arm), 100 degree temp, pain in left arm  Pt told to use Tylenol, ice packs, & Benadryl to reduce pain/swelling",,,,,,,,,U,09/18/2019,09/19/2019,1,,OTH,PVT,,No,,,,1,,,,,
0834707,09/20/2019,IL,18.0,18,,F,,Patient's mother came to pharmacy in the drive thru to pick up antibiotic for daughter on 9/18/19.  During consultation with RPH mom expressed concern over daughter's vaccination.  She said daughter had immediate pain in her arm after vaccine was administered and her shoulder and arm hurt for days.  She had never had a reaction to a vaccine before.  After a few days patient was seen by her doctor and may have been told that vaccine was administered incorrectly.  Patient's pain has gotten better but will come back at times and be very painful again.,,,,,,,,,U,09/08/2019,09/08/2019,0,,PHM,,Isibloom birth control,none,tendonitis,,,2,09/20/2019,,Y,,none
0834708,09/20/2019,CO,68.0,68,,F,,"Within 30 minutes of receiving the vaccine she began feeling very sick to her stomach. Upon returning home she began vomiting. The vomiting has not completely resolved after 24 hours, but she is able to keep small amounts of food and fluid down, after 18 hours. Her arm is red and sore, as expected, but the redness and swelling appear to be spreading upward, toward the shoulder. If it continues, medical advice/intervention will be sought. Her eyes are puffy and burning, which she describes as being unlike anything she has experienced before. The arm that received the injection shook uncontrollably for ~12-16 hours, and the tremor has not completely resolved after 31 hours. She describes the stomach pain as severe, describing an 8/10 jumping to a 10/10 when vomiting and several minutes after. Total number of vomiting episodes ~10",,,,,,,,,N,09/18/2019,09/18/2019,0,None at this time.,PHM,,Levothyroxine Metoprolol Eliquis Montelukast Protonix Oxycodone Tizanidine,Pneumonitis/pneumonia Atelactasis,COPD/asthma Chronic migraine Atrial Fibrillation Chronic Pain Degenerative bone/disc disease Fibromyalgia Myalgia Ulcer,,,2,09/20/2019,,,,Penicillan Toradol Ultram Reglan Ceftinir Ceclor
0834709,09/20/2019,MD,41.0,41,,M,,Pain on left side of neck radiating to lower left wrist and hand.,,,,,,,,,Y,09/16/2019,09/16/2019,0,NA,PVT,,Flonase,None,None,,,2,09/20/2019,,,,Soft Shell Crabs
0834710,09/20/2019,NC,16.0,16,,M,,patient received vaccine and got a rash all over body the next day that did not go away for about a month,,,,,,,,,Y,08/16/2019,08/17/2019,1,none,PVT,,zyrtec,none,asthma,,,2,09/20/2019,,,,none
0834721,09/20/2019,PA,,,,F,,"lab values for HSV-2 were less than 0.9 values which is negative value; the male patient received ZOSTAVAX, then had oral sex with wife (unspecified date) and wife thought she had Herpes Simplex 2.; Herpes Simplex 2.; This spontaneous report was received from a pharmacist referring to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, concomitant therapies and drug reactions/allergies were not provided.  On an unspecified date in 2019 (reported as recently), her husband was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, unit, batch/lot#, expiration date and route were not reported) for prophylaxis. On an unspecified date in 2019 (reported as recently), her husband had lip swelling and hives after received zoster vaccine live (ZOSTAVAX) (captured in MARRS# 1908USA008686).   Then She had oral sex with her husband on an unspecified date (Exposure via semen) and she thought she had herpes simplex 2. The patient was treated with valacyclovir hydrochloride (VALTREX). The patient's lab values for herpes simplex viruses (HSV)-2 were less than 0.9 values which was negative value. It was unknown if her lab values for HSV-2 were negative before or after treatment with valacyclovir hydrochloride (VALTREX). The outcome of events was not reported.  Causality between the events and zoster vaccine live (ZOSTAVAX) was not reported.; Sender's Comments:  US-009507513-908USA008686:",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA000568,2,09/20/2019,,,,
0834722,09/20/2019,VA,,,,U,,"Improperly stored dose of PEDVAXHIB was administered to the patient; No adverse effect; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug allergies/ reactions and concomitant medications were not provided.   On 21-AUG-2019, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB), 1 dosage form (strength, formulation, frequency, route were unknown) ( lot# S000352 and expiration date 17-OCT-2021) for prophylaxis. On an unknown date, the patient was administered with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) (product storage error) and no adverse event was reported.  The temperature excursion was 1.2 degrees Celsius for 41 minutes; however, the vaccine did not have a previous temperature excursion and this call was not a data logger.",,,,,,,,,U,08/21/2019,,,,UNK,,,,,,US0095075131909USA003884,2,09/20/2019,,,,
0834723,09/20/2019,IN,,,,M,,"Visoon loss; Transient vision disturbance; Information has been received from a lawyer regarding a case in litigation, referring to a male pt of unknown age. Information regarding the pt's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. On or about 01-AUG-2017, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (route of administration, strength, dose, lot # and expiration date were not provided) at a pahrmacy for its intended purpose: the prevention of shingles. On an unknown date, the pt suffered and was diagnosed with transient vision disturbance of right eye and vision loss. As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, pt suffered painful, serious, progressive, permanent, and incurable injuries and damages, and required extensive medical care and treatment. The pt also suffered significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The pt had incurred and would continue to incur medical expenses and other economic harm . At the time of the report, the outcome of blindness and visual impairment was considered as not recovered. The lawyer considered visual impairment and blindness to be related to Zoster Vaccine Live (ZOSTAVAX).   Upon internal review, blindness was determined to be medically significant and all the pt experiences were considered as disabling due to the severe and permanent incurable injuries.",,,,,,,,Y,N,04/01/2017,,,,PHM,,,,,,US0095075131909USA004502,2,09/19/2019,,,,
0834724,09/20/2019,FL,,,,F,,"shingles; Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medications. On or about 07-NOV-2012, the patient was inoculated with the zoster vaccine live (ZOSTAVAX) (lot number, dosage and route of administration not provided) for the long-term prevention of shingles and zoster-related injuries. On an unspecified date, the patient was treated by a healthcare provider for shingles. The outcome of the events was unknown. As a direct and proximate result of Plaintiff's use of the zoster vaccine live (ZOSTAVAX) vaccine, Plaintiff had and would continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The event shingles was considered to be related to zoster vaccine live (ZOSTAVAX) vaccination.",,,,,Y,,,,U,11/07/2012,,,,UNK,,,,,,US0095075131909USA005664,2,09/19/2019,,,,
0834725,09/20/2019,TX,,,,U,,"No adverse effects reported; one dose of an improperly stored vaccine, VARIVAX, was administered to one patient; Assistant confirmed route of administration was ""intramuscular"" .; This spontaneous report was received from a medical assistant and refers to an identifiable patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On 11-SEP-2019, the patient was vaccinated with one dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX), 0.5 ml, intramuscularly, lot # S002877, expiration date 29-JAN-2021, for prophylaxis. The sterile diluent (lot # S000130, expiration date 23-AUG-2021) used to reconstitute the vaccine was stored in the correct storage temperature range. No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion of 8.1 Fahrenheit degrees for 20 minutes. The digital data logger was involved in recording the temperature excursion details. There were previous excursions of 8.1 Fahrenheit degrees for 17 minutes and 9.5 Fahrenheit degrees for 21 minutes reported.",,,,,,,,,U,09/11/2019,09/11/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005981,2,09/20/2019,,,,
0834726,09/20/2019,CA,,5,,U,,"No adverse effects reported; The patient received improperly stored VARIVAX; This spontaneous report was received from a medical assistance concerning to a 5 year old patient. The patient medical history, concurrent conditions and concomitant medications were not reported.     On 15-JUL-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (lot # R023513 has been verified to be a valid lot number for varicella virus vaccine live (oka/merck) expiration date reported and establish as 16-AUG-2020) (strength, dose, frequency and route of administration were not reported); it was reported that a sterile diluent properly stored was used to reconstituted the varicella virus vaccine live (oka/merck) (VARIVAX).        The administered dose of the vaccine experienced a temperature of -14 to -10 Celsius (C) for 46 minutes. There was a digital data logger involved, but there was no previous temperature excursion. No adverse effect was reported.; Sender's Comments:  US-009507513-1909USA006939: US-009507513-1909USA007177: US-009507513-1909USA007118:",,,,,,,,,U,07/15/2019,07/15/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA007312,2,09/19/2019,,,,
0834727,09/20/2019,VA,,,,M,,"minor tenderness, swelling and reddness at the injection site; minor tenderness, swelling and reddness at the injection site; minor tenderness, swelling and reddness at the injection site; This spontaneous report was received from a pharmacist via company representative referred to an approximately 66-year-old male patient. The patient's pertinent medical history, and drug reactions/allergies were not reported. The concomitant medications included zoster rge vaccine (mammalian)(SHINGRIX) and flu vaccine (not specified). On an unknown date in August 2019 (reported as 3 or 4 weeks ago from the date of reporting), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) injection (lot # R033079 has been verified to be a valid lot number, expiration date reported as June 2020, but upon internal validation established as 06-JUN-2020) for prophylaxis (route, dose, were not reported). On 18-SEP-2019, the patient experienced minor tenderness, swelling and reddness at the injection site (vaccination site pain, vaccination site erythema and vaccination site swelling) after receiving suspect product along with concomitant medications. The patient saw the pharmacist. The patient did not receive any treatment for the events. The outcome of vaccination site pain, vaccination site erythema and vaccination site swelling was reported as recovered/resolved (on 18-SEP-2019). The reporter did not provide any causality assessment. Product quality complaint was not involved.",,,,,,,,,Y,08/01/2019,09/18/2019,48,,UNK,,SHINGRIX,,,,US0095075131909USA007560,2,09/20/2019,,,,
0834728,09/20/2019,CA,,,,U,,"laryngospasms; Bronchospasm; laryngospasms; Bronchospasm; This spontaneous report was received from a nurse prescriber refers to a patient of unknown demographics. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On an unknown date approximately in MAY-2019 (about 5 months ago), the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (strength, dosage information, lot# and expiration date were unknown) first dose, via oral route for prophylaxis. On the same day after the first dose, the patient experienced laryngospasms that changed to bronchospasm while in office. The patient received albuterol dose likely through a nebulizer as a treatment and the patient recovered while in office. The nurse referred the patient to a pulmonary doctor, but the parent decided not to take patient to pulmonary doctor and they felt patient was recovered. On an unknown date approximately in July 2019 (also reported as ""about 2 to 3 months ago""), the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (strength, dosage information, lot# and expiration date was unknown) second dose, via oral route for prophylaxis. experienced laryngospasm and bronchospasm. On the same day after the second dose, the patient again experienced laryngospasms that changed to bronchospasm while in office. The patient received albuterol dose likely through a nebulizer as a treatment and the patient recovered while in office. The outcome of laryngospasm and bronchospasm was resolved. The reporter's causality was unknown. No product quality complaint (PQC) reported.",,,,,,,,,Y,05/01/2019,05/01/2019,0,,UNK,,,,,,US0095075131909USA007628,2,09/20/2019,,Y,,
0834729,09/20/2019,PA,68.0,68,,U,,"fever; chills; sweating; This case was reported by a consumer via call center representative and described the occurrence of fever in a 68-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   In July 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced fever, chills and sweating. On an unknown date, the outcome of the fever, chills and sweating were recovered/resolved.   It was unknown if the reporter considered the fever, chills and sweating to be related to Shingrix.  Additional details were provided as follows: The patient reported that, after vaccination with dose of Shingrix, had severe reaction as fever, chills and sweating. The patient had fever of 105 to 106 and went down to 100 by day 5. The patient had  chills and sweating for the period of 5 days. The patient ask to doctor, if he or she could receive the 2nd dose of Shingrix. The patient's doctor said, it was up to him or her( the patient).",,,,,,,,,Y,07/01/2019,,,"Test Date: 201907; Test Name: Body temperature; Result Unstructured Data: Test Result: 105-106, Test Result Unit: degree F; Test Date: 201907; Test Name: Body temperature; Result Unstructured Data: Test Result: 100, Test Result Unit: degree F",UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834730,09/20/2019,NE,,,,F,,"Nausea; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced nausea. On an unknown date, the outcome of the nausea was recovered/resolved.   It was unknown if the reporter considered the nausea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter's friend received dose of Shingrix and next day after vaccination experienced nausea. The reporter stated that, the nausea resolved within 1 day. The reporter did not provide additional details. For the tolerance of 2nd dose, refer case US2019167041, reported by same reporter. This was 3 of 4 reports provided by the same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834731,09/20/2019,CT,,,,F,,"Sick feeling; fever; Up all night because of the fever; Left arm soreness; Headache; Wild dreams; This case was reported by a nurse via call center representative and described the occurrence of feeling unwell in a female patient who received Herpes zoster (Shingrix) (batch number 9X374, expiry date 10th October 2021) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced feeling unwell, fever, sleeplessness, pain in arm, headache and abnormal dreams. On an unknown date, the outcome of the feeling unwell, fever, sleeplessness, pain in arm, headache and abnormal dreams were unknown.   It was unknown if the reporter considered the feeling unwell, fever, sleeplessness, pain in arm, headache and abnormal dreams to be related to Shingrix.  Additional information received were as follows: The nurse also stated that she administered the vaccine to other employees on the day before reporting, who she had called on the reporting date and 7 of the 10 had reported the exact same issues. The nurse did not had the specifics of the individuals other than 4 were females and 3 were males. They all received the same lot and expiration date of the product she received and it was the first dose of Shingrix for all. This case is 1 of the 8 cases, reported by the same reporter.",,,,,,,,,U,09/09/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834732,09/20/2019,MA,,,,M,,"Shingles; This case was reported by a nurse via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. Chat with RN how long should a person wait with active shingles to get their 2nd shingrix. The reporter didn't have facts with this patient, this was only what he was telling me. The patient might be confusing the zostavax with the shingrix, the reporter would be looking into that. HCP disconnected from the chat and therefore no permission given to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834733,09/20/2019,CA,81.0,80,,M,,"pain; This case was reported by a physician via call center representative and described the occurrence of pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 5 months after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was resolved with sequelae.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were reported as follows: MD states he experienced slight pain following Shingrix administration in May 2019 that lasted for a day or so then subsided.  He states it was probably administered in his left arm and believes it was adminstered IM. The reporter consented to follow up.  No lot number or expiration date available.  This case has been linked with US2019165617, reported by same reporter.",,,,,,,,,N,05/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834734,09/20/2019,,,,,F,,"Hearing issue; Inappropriate schedule of vaccine; This case was reported by a consumer via call center representative and described the occurrence of hard of hearing in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced hard of hearing and drug dose administration interval too long. On an unknown date, the outcome of the hard of hearing and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the hard of hearing to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient thought she might had been over the 6 month window for her 2nd dose of Shingrix, which led to lengthening of the vaccination schedule. The patient was experiencing some issues with her hearing. The reporter was in a rush and did not want to provide any information in regards to the adverse event and address.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834735,09/20/2019,NE,,,,F,,"Nausea; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date, refer case US2019AMR167670).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced nausea. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the nausea was recovered/resolved.   It was unknown if the reporter considered the nausea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter's friend received dose of Shingrix and next day after vaccination experienced nausea. The nausea recovered within 1 days. The reporter did not provide additional details. This was 3rd of 4 reports provided by the reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834736,09/20/2019,KS,,,,F,,"Torn ligament in left arm; Fall; This case was reported by a pharmacist via call center representative and described the occurrence of ligament tear in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included breast cancer (due to that could not received injections to the right arm).   On 14th June 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced ligament tear and fall. On an unknown date, the outcome of the ligament tear and fall were unknown.   It was unknown if the reporter considered the ligament tear and fall to be related to Shingrix.  Additional details were provided as follows: This case was reported by the pharmacy student. The age at vaccination was not reported. The patient received 1st dose of Shingrix on an unknown arm, but since that time, the patient fell and tore a ligament in her left arm and had been instructed to also avoid injections to the left arm. The reporter stated that, the patient did not share the date of the fall and adds the patient's arm would be out for at least 6 months. Upon call back to the pharmacy, the pharmacist came to the line and confirms details as reported by the pharmacy student. Further details not provided and specialist neglected to asked whether safety had permission to follow up.",,,,,,,,,U,06/14/2019,,,,UNK,,,,Medical History/Concurrent Conditions: Breast cancer (due to that could not received injections to the right arm),,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834738,09/20/2019,MA,69.0,69,,F,,"Inappropriate Schedule of Vaccine; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 13th September 2019, the patient received the 2nd dose of Shingrix. On 13th September 2019, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were received as follows: the patient inadvertently was administered second dose of Shingrix less than 4 week after dose one, which led to Shortening of vaccination schedule. The reporter did not consented to follow up.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834739,09/20/2019,WI,,,,F,,"inappropriate schedule of; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 88-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in November 2018 ).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were received as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient not yet receive the second dose, which led to incomplete course of vaccination. The VAERS details were reported for the 1st dose.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834740,09/20/2019,MD,1.5,,,F,,"burned going in; This is a spontaneous report from a contactable other hcp.   A 18-months-old female patient received the fourth dose of pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, lot number not provided) intramuscular in the thigh right on 02Aug2019 13:30 at single dose for immunisation. The patient medical history was none. On 02Aug2019 the patient received also the first dose of influenza vaccine (FLU VACCINE VII, Sanofi Lot number: UT6647JA expiry date: 30Jun2020) intramuscular in the left thigh, and the fourth dose of diphtheria vaccine toxoid, hib vaccine conj (tet tox), pertussis vaccine acellular 5-component, polio vaccine inact 3v (mrc 5), tetanus vaccine toxoid (PENTACEL, Sanofi, Lot number: UJ017AAA expiry date: 26Oct2020) intramuscular in the left thigh both for immunisation. The patient previously received the first dose of pneumococcal 13-val conj vac (dipht crm197 protein) (Lot number: W09943; Expiration: 30Apr2020) intramuscular in the right thigh on 02Aug2018 (a little over 2 months), the second dose (Lot number: W51762; expiry date: 30Jun2020) intramuscular in the left thigh on 03Oct2018 at 4 months old, the third dose (Lot number: X11327; expiry date: 30Sep2020) intramuscular in the right thigh on 03Dec2018 at 6 months old all at single dose; on the same dates she received also diphtheria vaccine toxoid, hib vaccine conj (tet tox), pertussis vaccine acellular 5-component, polio vaccine inact 3v (mrc 5), tetanus vaccine toxoid all at single doses for immunisation. The medical assistant reported that a first product (Batch/lot number: AG8356, NDC number: 0005197101), Expiry Date: May2021), was not administered as the product needle was injected into the patient's leg but the whole top of the syringe was cracked so the medication shot all over the bed and the patient didn't get any of it. Reporter went to administer the vaccine, while in the child leg, whole top of syringe was cracked, defective vial, and by vial the reporter means prefilled syringe, where the needle attaches on to the top of the syringe was cracked. Reporter did not notice before placing the needle on because they have to push up to get air out, the crack must've been farther up in the syringe. The patient was successfully re-dosed and the successful dose of pneumococcal 13-val conj vac (dipht crm197 protein) burned going in. The outcome of the event was not reported. Information on the batch number has been requested.",,,,,,,,,U,08/02/2019,08/02/2019,0,,PVT,,FLU VACCINE VII; PENTACEL,,"Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none, Comment:",,USPFIZER INC2019399763,2,09/19/2019,,,,
0834741,09/20/2019,NJ,,,,U,,"a child under the age of 4 received the Quadracel vaccine, no adverse event; Initial information received on 26-Aug-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves a under four years old child patient who was vaccinated with a dose of vaccine DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] (batch number, Exp. Date. Dose, route and site of administration not reported) on an unknown date.  The patient's medical history and concomitant medications were not reported.  It was an actual medication error case due to inappropriate age at vaccine administration.  No adverse event was reported post vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA241994,2,09/19/2019,,,,
0834748,09/20/2019,MD,17.0,17,,F,,Patient had adverse reaction to HPV. Vitals was taken. BP 112/78 pulse 86 RR 16 Temp 97.6 denies pain. Patient was stabilized and monitored for 30 minutes. She was discharged stable,,,,,,,,,Y,09/19/2019,09/19/2019,0,,PUB,,no known,no illness,,,,2,09/20/2019,,,,no known
0834750,09/20/2019,WI,12.0,12,,F,,"Patient had a vasovagal syncope response upon standing after injections (both given in left deltoid, +1 inch apart. Hep A was the first given in the upper deltoid, HPV second in the lower deltoid). Writer had patient sit down, and she then passed out for 5-10 seconds. RN and provider were called into the exam room to evaluate her. Writer took her blood pressure and it was 54/34. Writer elevated patients legs on provider's chair, as she was not able/willing to transfer to the exam table. Patient was given orange juice, water, and crackers as she reported she had not eaten since noon, nor had she had anything to drink all day. Blood sugar was 102. Second blood pressure reading was 64/36. Patient then went to the restroom  with her mother, had a BM, and went back into exam room. Her final blood pressure was 94/64 and she was feeling much better, less pale and clammy. She walked to check out with RN and was given permission to go from RN and provider.",,,,,,,,,Y,09/18/2019,09/18/2019,0,Blood glucose was taken shortly after and result was 102.,PVT,,None,None known. Patient had started her period that day.,None.,,,2,09/20/2019,,,,No known allergies
0834752,09/20/2019,,0.33,0,.3,F,,High fever of 102 degrees F. Red bumps on cheeks and limbs two days after.,,,,,,,,,Y,09/16/2019,09/17/2019,1,None,PVT,,None,Cold - two weeks prior,None,,,2,09/20/2019,,,,None known
0834753,09/20/2019,,80.0,80,,M,,"Fever and Chills, self resolved over 24-48 hours",,,,,,,,,,03/20/2019,03/21/2019,1,,PHM,,"aspirin 81mg, centrum cewable",,"HTN, BPH, Hyperlipidemia, GERD, ED, Hernia",,,2,09/20/2019,,,,"Lipitor,cipro, pravastatin"
0834754,09/20/2019,CO,55.0,55,,F,,"Fever, severe chills, headache, muscle aches",,,,,,,,,N,09/19/2019,09/19/2019,0,None,PVT,,Zyrtec,,,,,2,09/20/2019,,,,
0834755,09/20/2019,NY,72.0,72,,F,,"Pt states she heard or ""felt""  a popping ( I as the pharmacist do not recall hearing a popping) she states that she felt as if her nose was then about to bleed (this was not communicated the day of) Pt states she had chills the following tuesday (3 days later) and her arm began to swell. Pt also receives a bone marrow shot in the same arm. at presentation on friday 9/20 patient does not present with swelling, some slight redness however her skin turgor and condition of skin makes most of her skin appear dry brittle and slighlty red. Pt denies pain, limited motion, and appears to be doing fine. she states she just wanted us to know that she had a reaction. she did inform her md. I instructed her to talk with her doctor next year as to whether or not she should receive the vaccine. Pt is not angered at the pharmacy and or immunizer just wanted us to know.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,PHM,,"Folic acid, dexamethasone, ""chemo meds""",Cancer,Cancer,,,2,09/20/2019,,,,"Vistaril, penicillin, sertraline, piperazine"
0834756,09/20/2019,NJ,1.0,1,.0,F,,"On Tuesday, 09/03/2019 I took my healthy 1 year old daughter for her 12-month visit where she received the recommended dose of Varicella. The injection was administered by her Pediatrician to the left upper thigh. By Wednesday, 09/04 evening my daughter became febrile with a fever that spike to its highest 104F by Thursday 09/05/2019 which was associated with shivering and loss of appetite. The fever persisted despite of oral Tylenol and Motrin given to my daughter. Finally, her pediatrician administered a rectal suppository in the office on 09/05 which helped to reduce the fever, however, it did spike again that evening. The fever lasted until Saturday 09/07 and my daughter began to show signs of improvement by Sunday 09/08. Monday 09/09 my daughter developed what I thought were cold symptoms which included cough, congestion and runny nose; this lasted a week. On Sunday 09/15/2019 I noticed some inflammation at the site of her injection which I began to keep an eye on throughout the day; by Monday 3 vesicles were formed on her left thigh and one in the center of her chest. By Monday evening the vesicles continued to appear and the swelling at the injection site became more prominent. I took my daughter to an after hour Urgent Care on Tuesday 09/17 evening to express my concerns and all they could say was its viral. Keeping in mind that my daughter did not have nor has she developed any vesicles on her hands or feet, therefore, the prognosis of coxsackie would not apply. Additionally we co-sleep and I have not developed any symptoms throughout this entire time and coxsackie is extremely contagious. It is now September 20, 2019 and finally some of the vesicles on my daughter?s body are beginning to heal especially the ones at the site of injection. I will continue to monitor and keeping a diary along with photos to further assist with any information needed regarding this matter.",,,,,,,,,N,09/03/2019,09/04/2019,1,,PVT,,NONE,NONE,NONE,,,2,09/20/2019,,Y,Y,N.K.D.A with a history of  lactose intolerance
0834759,09/20/2019,CA,,,,U,,"no adverse effects; patient administered the 1st dose of recombivax HB on 5/4/2019 and a 2nd dose on 7/8/2019; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 04-MAY-2019, the patient was vaccinated with 1st dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (dosing details not reported) for prophylaxis. On 08-JUL-2019, the patient was vaccinated with second dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) ( lot/batch# R031052, expiry date # 03-JUN-2021, strength, dose and route, therapy type not reported) for prophylaxis (inappropriate schedule of product administration). There were no adverse effects. There was no product quality complaint (PQC).",,,,,,,,,U,05/04/2019,07/08/2019,65,,UNK,,,,,,US0095075131909USA004062,2,09/20/2019,,,,
0834760,09/20/2019,FL,,,,F,,"Arm was red; Arm was swollen; This case was reported by a consumer and described the occurrence of erythema of extremities in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced erythema of extremities and swelling arm. On an unknown date, the outcome of the erythema of extremities and swelling arm were unknown.   The reporter considered the erythema of extremities and swelling arm to be possibly related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient asked if there any discounts/coupons that could be applied to the Shingrix vial shot for Shingles. The patient reported that she and her husband they had different insurance options. The patient received 1 of 2 shots, and she paid 45 (co-pay) and her husband paid the total cost of 170. They were still facing these costs to receive a 2nd shot in 2 to 4 months. The patient reported that her arm was red and swollen. The patient reported that it was strange that insurance did not help out with vaccinations, just the flu shot!  The patient did not want to come down with Shingles and was thankful you have a vaccination as a remedy.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834761,09/20/2019,LA,,,,F,,"Rash; This case was reported by a physician via sales rep and described the occurrence of rash in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was in her 80's. It was reported that the patient experienced rash after the dose of Shingrix.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834762,09/20/2019,MA,,,,F,,"Red spot at injection site; Flaky skin at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included herpes zoster.   In June 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced injection site erythema and injection site exfoliation. The patient was treated with topical steroid nos (Steroid Cream). On an unknown date, the outcome of the injection site erythema was not recovered/not resolved and the outcome of the injection site exfoliation was recovered/resolved.   It was unknown if the reporter considered the injection site erythema and injection site exfoliation to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 76 years or 77 years. Injection site had redness and flaky skin, about the size of a pencil eraser. The redness was not raised. The patient was seen by her dermatologist who prescribed a steroid cream and after treatment, the red, flaky skin resolved. At the time of reporting the patient returned to the pharmacy and states the redness recurred.  The date of recurrence was unknown to pharmacist, but as of the time of this call the redness was ongoing.  The patient denied itching and pain, and states that at the time of reporting the reddened skin was not flaky. The reporter consented to follow up. The pharmacist did not provide further details.",,,,,,,,,N,06/01/2019,,,,UNK,,,Herpes zoster,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,Y,,
0834763,09/20/2019,CA,56.0,56,,F,,"blacked out; vertigo; she states if was like her knees buckled; fell asleep; rubbing below her ear on her neck, slightly behind the ear and just under her skull bone, equilibrium was off; double vision; This case was reported by a consumer via call center representative and described the occurrence of blackout in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included vertigo (experienced earlier before receiving Shingrix, in yoga class when she tilted her head back.). Concurrent medical conditions included multiple myeloma (received infusion treatments for the same).   On 27th August 2019, the patient received the 1st dose of Shingrix. On 28th August 2019, 1 days after receiving Shingrix, the patient experienced double vision, sleepiness and balance disorder. On 12th September 2019, the patient experienced blackout (serious criteria GSK medically significant), vertigo and joint disorder. On an unknown date, the outcome of the blackout, vertigo, joint disorder, sleepiness and balance disorder were unknown and the outcome of the double vision was recovered/resolved.   It was unknown if the reporter considered the blackout, vertigo, double vision, joint disorder, sleepiness and balance disorder to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix at the infusion center where she receives her infusion treatments for multiple myeloma.  On the 2nd day after receiving Shingrix, the patient was lying on the floor with her dog. She felt asleep and when she went to get up her equilibrium was off and she had double vision for about 2 hours.  The day before reporting, she was at her counter, and reached up to put something away and then she felt like her knees buckled and she was not sure but believed she might have been blacked out.  The patient remembered thinking like what had happened.  The patient also experienced vertigo the night before the date of reporting. The patient rubbed below her ear on her neck, slightly behind the ear and just under her skull bone when she experienced vertigo. The patient was encouraged to continue to express the events to her physician. On the day of receiving Shingrix, the patient was in the infusion center having her port flushed, which was because she received infusion treatments for Multiple Myeloma. The reporter consented to follow up. The reporter was willing to get authorization form. She notified her PCP via email about the events, but she was under the care of her hematologist/ oncologist who was the doctor that recommended her to receive Shingrix.",,,,,,,,,Y,08/27/2019,08/28/2019,1,,PVT,,,Multiple myeloma (received infusion treatments for the same),"Medical History/Concurrent Conditions: Vertigo (experienced earlier before receiving Shingrix, in yoga class when she tilted her head back.)",,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,Y,,
0834764,09/20/2019,GA,,,,U,,"pain in arm; a fever of 103 degrees; received 1st dose of Trumenba in 2018/nurse reported the incident late in the afternoon on 17Sep2019 and has requested information regarding the completion of the Trumenba series; This is a spontaneous report from a contactable nurse via a Pfizer sales representative. A patient of unspecified age and gender received meningococcal group b rlp2086 (TRUMENBA; lot number and expiration date were unknown), via an unspecified route of administration on 2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The nurse reported that the patient received the 1st dose of meningococcal group b rlp2086 in 2018, and within 48 hours the patient complained of pain in arm and reported a fever of 103 degrees to the office. The nurse reported the incident late in the afternoon on 17Sep2019 and has requested information regarding the completion of the meningococcal group b rlp2086 series. The nurse was asking if it was safe and recommended to complete the series with this patient following the adverse events that occurred following the first dose in 2018. The outcome of the events was unknown.  Information on the batch/lot number has been requested.",,,,,,,,,U,,,,Test Name: Body temperature; Result Unstructured Data: Test Result: 103; Comments: body temperature (unknown date): 103 degrees,UNK,,,,,,USPFIZER INC2019406945,2,09/20/2019,,,,
0834771,09/20/2019,RI,75.0,75,,F,,"hot red and swollen arm after receiving vaccine in the same arm, patient was seen in a walk in and received an antibiotic scipt",,,,,,,,,,09/18/2019,09/18/2019,0,,PHM,,,,,,,2,09/20/2019,,Y,,
0834772,09/20/2019,MO,66.0,66,,F,,"I had flu like symptoms (fatigue, muscles aches) the evening of the shot and most of the following day. Then 3 days after the shot, I developed a line of burning/itching at the base of my neck on the left side. This was intermittent for about a week. I would call them flares that were very intense for about 30 seconds and then the feeling would stop.  It was in a line about 4 inches long. I looked for a rash but I could not see anything on the skin. I had no symptoms after my 1st Shingrix shot. I am a pharmacist.",,,,,,,,,Y,07/10/2019,07/13/2019,3,None,PHM,,levothyroxine; hydrochlorothiazide; cetirizine; senior vitamin; Lutein & Zeaxanthin,None,hypothyroid; hypertension,,,2,09/20/2019,,,,None
0834773,09/20/2019,CA,5.0,5,,M,,"Patient received MMR, Varicella, and Influenza vaccines at Public Health Immunization Clinic. Patient tolerated vaccines well, returned to the waiting room to wait while sister's immunizations were drawn up, and per patient's mom and aunt, fainted.  Per patient's mother, patient was standing in front of her as she was seated in a chair, complained of a headache, and then started to fall forward. Mother caught patient before he fell and no injury sustained. Patient then had moments of lethargy, whining, and crying for three to four minutes. No difficulty breathing. Face pale according to vaccinating nurse.  Patient was laid supine on mom and aunt's laps for a couple minutes, when it was determined he had not eaten in 7 hours.  A small candy bar, a bottle of Boost drink, and a bottle of water given. No prior history of syncope. Patient's sister reacted in same manner on 9/17/19 (VAERS report also submitted) with two short seizures afterwards (this child with history of Epilepsy). Reassessment after candy and Boost started showed improvement in color, activity, and symptoms.  Patient and family remained in the waiting area for another 10 minutes without further incidence. Instructed mother and aunt that children to be vaccinated with PCP for a more controlled environment.",,,,,,,,,Y,09/19/2019,09/19/2019,0,None,PUB,,Unknown,unknown,unknown,,,2,09/20/2019,,,,NKDA
0834774,09/20/2019,CO,66.0,66,,F,,"Patient said she was shopping later on that day and passed out. Didn't feel that way at all right after vaccine for earlier in the day. No signs of allergic rxn, simply fainted then was fine.",,,,,,,,,Y,09/18/2019,09/18/2019,0,None,PHM,,Unknown,NO,"Kidney, DM",,,2,09/20/2019,,,,NO
0834775,09/20/2019,MI,15.0,15,,M,,Give Meningoccal immunization on 09/17/2019. Immunization was not due until 11/12/2019 which is slightly under 2 months from now.  Last Dose 06/25/2015 - No adverse reactions,,,,,,,,,Y,09/17/2019,09/20/2019,3,none,PVT,,none,none known,none known,,,2,09/20/2019,,,,none
0834777,09/20/2019,CA,1.33,1,.4,M,,"Starting the following day of the injections given, swelling and warmth began along with slight fever. Tylenol was given for fever and cool wash cloth was used for swelling. Next day Thursday the 19th of September 2019 around 8:30 am I noticed extreme swelling and blisters forming.  I called office and they said to bring him in. They saw him and prescribed antibiotics, steroids, pain reliever, and a cream for the site. Also drew a line surrounding the swollen site and said if swelling went outside of border to take baby to the ER or if a fever of 100.4 or higher was present. Made follow up visit for 1 week. Later in that same day around 6:00 pm the swelling had worsened and went outside of lines. Took baby to ER and and said to give double dose of antibiotics and to bring him back the following day to check up.  It is the 20th day of September while I write this and still early in the morning. The swelling has gone even farther outside of the line almost wrapping around the entire thigh but redness has slightly subsided.",,,,,,,,,N,09/17/2019,09/18/2019,1,,PVT,,None,Small cold a week prior to visit.,None,Unknown name of vaccine. Age 6-9 months at time of reaction,,2,09/20/2019,,,,NKDA
0834778,09/20/2019,AL,11.0,11,,M,,"Swelling, tender, large knot at injection site",,,,,,,,,U,09/17/2019,09/17/2019,0,none,SCH,,Unknown,Unknown,Unknown,,,2,09/20/2019,,,,Unknown
0834779,09/20/2019,IA,78.0,78,,F,,"Pt received Shingrex vaccination on Monday, Sept. 16, 2019 at pharmacy.  (pt originally reported she received the vaccination on the 17th, pharmacy then pt confirmed it was Monday, Sept 16, 2019).  Pt called her doctor's office on Friday, Sept. 20, 2019 to report her symptoms.  Reports by noon on the day she received the vaccine noted left arm soreness, by mid afternoon developed chills, excessive thirst, nausea, fatigue, required sips of water to help her swallow.  Symptoms continued all night, next AM awoke with headache, chills continued with nausea, and excessive fatigue. Tylenol relieved the headache. Next day chills decreased, fatigue started to improve, arm soreness left. Next day developed sores and pain under her tongue, developed bumps on her tongue.  Symptoms continued to improve, except for tongue and mouth sores and spots.  Chills were gone on day 4, fatigues improving, no nausea and thirst improved.   Today, Friday 9-20-19 chills, fatigue gone, soreness remains in mouth and tongue.  Denies ever experiencing a rash, itching, difficulty breathing or chest pressure/pain, no facial swelling.   First Shingrex received was at pharmacy (same) on 7-9-19 and experienced no adverse reactions.",,,,,,,,,U,09/16/2019,09/16/2019,0,NONE as of yet,PVT,,NONE,NONE,"HX NON MELANOMA SKIN CANCER, HYPERTENSION, POSITIVE ANA, OSTEOPOROSIS, OSTEOARTHRITIS, HYPERLIPIDEMIA",,,2,09/20/2019,,,,PENICILLINS
0834780,09/20/2019,,68.0,68,,M,,"Fever (100.6) for 2 days, chills, sore arm, redness at injection site",,,,,,,,,Y,09/17/2019,09/17/2019,0,,UNK,,,,,,,2,09/20/2019,,,,
0834781,09/20/2019,WA,75.0,75,,F,,"The night of the injection the patient had a violent 12 hour reaction to the shingles shot. Dry heaves, teeth chattering chills, headache, body aches, nausea and vomiting. The next day she was very exhausted. She coincidentally had an appointment with Dr., her ophthalmologist, glaucoma specialist on 8/8/2019. Her eye pressures had soared from 10 each to 15 and 24.  Due to the high IOP she was placed on numerous medications. She was seen again on 8/22/2019 by Dr as a followup to her 8/8/19 appointment.",,,,,,,,,N,07/30/2019,07/30/2019,0,8/8/2019 Ophthalmic testing revealing high IOP.,PVT,,,NONE,"DEPRESSION, HTN, OSTEOPENIA, HYPERLIPID",,,2,09/20/2019,,Y,,"SULFA, LOTREL, LATEX, PREDNISONE, LIPITOR"
0834782,09/20/2019,NV,71.0,71,,M,,"REDNESS, SWOLLEN, AND PAINFUL HOURS AFTER INJECTION. IS  IMPROVING 2 DAYS LATER",,,,,,,,,Y,09/18/2019,09/18/2019,0,,PHM,,LEVOTHYROXINE 100MCG  DAILY PREDNISONE 5 MG DAILY,,,,,2,09/20/2019,,,,NONE
0834793,09/20/2019,FL,17.0,17,,M,,"Severe headache with photosentitivity, phonophobia, fever 104, deteriorated rapidly in clinic with + Kernigs sign and nystagmus, sluggish pupils",,,,,Y,2,,,Y,09/17/2019,09/17/2019,0,hospitalization,PVT,,None,None,None,,,2,09/20/2019,,,,Sulfa drugs
0834794,09/20/2019,,67.0,67,,F,,"rash, swollen injection site and swelling down to elbow, pain in arm, headache, all resolved by day 4.",,,,,,,,,,09/16/2019,09/16/2019,0,,UNK,,,,,,,2,09/20/2019,,,,
0834795,09/20/2019,FL,75.0,75,,F,,"The shingrix vaccine was administered manufacturer GlaxoSmithKline  Body ache, headache, fever of 101.6 on Sept 18, shivering",,,,,,,,,Y,09/17/2019,09/17/2019,0,None,PHM,,"Lisinopril, simvastatin ,carvedilol, D3, calcium, vitamin c, bioting",Nonr,"hypertension, high cholestrol",fever,,2,09/20/2019,,,,"Flagel, floxin, sulpha"
0834796,09/20/2019,MO,72.0,72,,F,,"Patient came in today after getting flu shot yesterday. Patient had localized redness (approx 2-3 in across x ~1.5 in tall oval on arm around where shot was given). Pt stated the area was itchy, but no fever, no chills, no pain. Only reaction was redness and itching. Pt had flu shot in the past and had used the bandaid in the past with no reaction. Patient stated the shot did not hurt at all when given and still wasn't sore or painful (also mentioned that significant other had gotten injection yesterday as well with no reaction). Confirmed that we cleaned the area with alcohol pad and that the shot was given in the correct location. Area was slightly warm to touch, so instructed patient any signs of illness (fever, chills, etc) or if the area gets worse (starts to hurt, etc) or spreads, that pt should contact the doctor.",,,,,,,,,,09/19/2019,09/20/2019,1,,PHM,,,,,,,2,09/20/2019,,,,
0834797,09/20/2019,MO,65.0,65,,F,,Pt had a very large red circle on her left deltoid.  She said it appeared a few hours after the immunization and it became larger and deeper purple over time.  She said there was a dull persistent pain and she felt a little nauseated.  Today is 9/20.  Three days have past.  She is feeling better but the erythema is still present (very large circle over her left deltoid).,,,,,,,,,N,09/17/2019,09/17/2019,0,,PHM,,effexor xr 150mg + ranitidine 300mg + hctz 25mg + cozaar 100mg,,high blood pressure,,,2,09/20/2019,,,,codeine
0834798,09/20/2019,,10.0,10,,F,,"Dtap, given after the maximum age",,,,,,,,,,09/18/2019,09/18/2019,0,,UNK,,,,,,,2,09/20/2019,,,,
0834799,09/20/2019,,15.0,15,,F,,MMRV given after the maximum age.,,,,,,,,,,09/18/2019,09/18/2019,0,,UNK,,,,,,,2,09/20/2019,,,,
0834800,09/20/2019,MN,52.0,52,,F,,"Headache, dizziness, nausea, tired, fatigue, loopy feeling & mild fever At injection sight: muscle ache & tenderness in upper arm",,,,,,,,,N,09/17/2019,09/18/2019,1,N/A,PHM,,Topiramate MIrtazapine Quetiapine Fetzima Xiidra Multivitamin Omeprazole Cetirizine Hydrochloride allergy tabs  Magnesium,vestibular migraines,vestibular migraines,,,2,09/20/2019,,,,Penicillin Sulfas Nortriptyline
0834801,09/20/2019,AZ,78.0,78,,M,,"Developed fevers, chills, cold sweats, rapid heart beat, and shortness of breath approx 6:30 pm after 11 am vaccination.  Admitted to hospital for 5 days.  Cultures negative.  Dx at discharge COPD exacerbation",,,,,,,,,Y,09/11/2019,09/11/2019,0,"available from hospital, not to me today",PVT,,"atorvastatin, blilinta, fluticason, omeprazole, spiriva, wixela, proair, asa, vitamin d","Myocardial infarct with stent  august 11, 2019","CAD, CHF, COPD, Hypertension, hyperlipidemia, mild pulmonary hypertension",,,2,09/20/2019,,,,None known
0834808,09/20/2019,IL,,,,U,,"No adverse effect reported; one patient received an improperly stored PROQUAD; This spontaneous report was received from a registered nurse and refers to a 4-year-old patient of unknown age. No information regarding the patient's pertinent medical history, drug reactions and allergies was provided. Concomitant therapies included properly stored sterile diluent (STERILE DILUENT). On 13-AUG-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin (rHA)) (PROQUAD) (lot# R026722, expiry date 17-MAR-2020 or lot # R023499, expiry date13-FEB-2020) for prophylaxis. The nurse did not have the specific lot number/ expiration date administered to the patient but it was one of the two listed. The vaccine experienced two storage temperature excursions (on 12-AUG-2019 and on 13-AUG-2019) from -14 Celsius degrees to -10 Celsius degrees (-11.91 Celsius degrees, multiple) for 8 hours. The data logger was involved. No adverse events were reported.  The outcome of product storage error and no adverse event was unknown.",,,,,,,,,U,,08/13/2019,,,UNK,,STERILE DILUENT,,,,US0095075131909USA003325,2,09/20/2019,,,,
0834809,09/20/2019,FL,,,,F,,"Hearing loss; Shingles; Information has been received from a lawyer regarding a case in litigation, referring to a female pt of unknown age. Information regarding the pt's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. In or about 2015, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (route of administration, strength, dose, lot # and expiration date were not provided) by a healthcare provider at a pharmacy for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date, the pt was treated at a physician office for shingles and hearing loss. As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, had and would continued to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, included but not limited to medical losses and costs which included care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. At the time of the report, the outcome of deafness and herpes zoster was considered as not recovered. The lawyer considered herpes zoster and deafness to be related to zoster vaccine Live (ZOSTAVAX).     Upon internal review, deafness was determined to be medically significant.",,,,,Y,,,,N,,,,,PHM,,,,,,US0095075131909USA005680,2,09/20/2019,,Y,,
0834810,09/20/2019,NY,,,,M,,"shingles; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On or about 03-FEB-2016, pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot # and expiration date were not provided), as prescribed and/or administered by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. Subsequent to pt's zoster vaccine live (ZOSTAVAX) inoculation, pt was treated by a healthcare provider for shingles. As a direct and proximate result of pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, pt has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).",,,,,Y,,,,N,02/03/2016,,,,UNK,,,,,,US0095075131909USA007258,2,09/20/2019,,,,
0834811,09/20/2019,UT,67.0,67,,F,,"Extreme Pain; Affected my immune system; Throwing up; Fever; Can't eat; Headache; Feels like every bone is inflamed; This case was reported by a consumer and described the occurrence of pain in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included fibromyalgia.   On 6th September 2019, the patient received the 1st dose of Shingrix. On 6th September 2019, less than a day after receiving Shingrix, the patient experienced pain, immune system disorder, vomiting, fever, unable to eat, headache and bone inflammation. On an unknown date, the outcome of the pain was unknown and the outcome of the immune system disorder, vomiting, fever, unable to eat, headache and bone inflammation were not recovered/not resolved.   It was unknown if the reporter considered the pain, immune system disorder, vomiting, fever, unable to eat, headache and bone inflammation to be related to Shingrix.  Additional details were provided as follows: The patient experienced extreme pain, fever, thrown up after receiving Shingrix. The patient stated her immune system was affected. The patient had history of severe fibromyalgia, which she had kept on sheet. The patient asked how long would the symptoms would last or if she would have them for the rest her life. The patient had researched it online and felt she should not have had the vaccine with the autoimmune problems. The patient was unable to eat since she had received Shingrix. The patient felt like every bone was inflamed. She wanted the company to know that they should have a warning with patients with a history of auto-immune disease not to receive Shingrix. The reporter permitted to contact her physician.",,,,,,,,,N,09/06/2019,09/06/2019,0,,UNK,,,Fibromyalgia,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834812,09/20/2019,AL,,,,F,,"Significant pain at site of injection; This case was reported by a nurse via sales rep and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. On first shot the patient had significant pain at site of injection.  The patient used heating pad that night to sleep.  No further information, but patient stated she did subsequently get the 2nd dose shot. The reporter denied permission to follow up.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834813,09/20/2019,NY,87.0,87,,U,,"pain in shoulder; This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a 87-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th August 2019, the patient received Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced shoulder pain. The patient was treated with dermatologicals nos, dermatologicals nos, dermatologicals nos, dermatologicals nos (Ointment). On an unknown date, the outcome of the shoulder pain was unknown.   It was unknown if the reporter considered the shoulder pain to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in unknown arm. The patient had pain in shoulder and did not lie on that side. It was been almost a month. (It was been three and a half weeks). The patient talked to his/her primary, said pain would eventually go away. The patient had applied ice and muscle pain ointment. The patient worried that this might become a chronic condition and patient want to know if other people have complained about the same. The reporter consented to follow up.",,,,,,,,,U,08/15/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834814,09/20/2019,OK,,,,F,,"felt bad; felt Tired; Muscle aches; Headaches; This case was reported by a physician via sales rep and described the occurrence of tiredness in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced tiredness, muscle pain, headache and feeling bad. On an unknown date, the outcome of the tiredness, muscle pain and headache were recovered/resolved and the outcome of the feeling bad was unknown.   The reporter considered the tiredness, muscle pain, headache and feeling bad to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and felt tired, had muscle aches & had headaches consistent with the label. The patient felt bad for 2 days and then went sailing. The reporter agreed to follow up. This case linked with US2019AMR167048, reported by same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834815,09/20/2019,IL,53.0,53,,U,,"nausea; weakness; headache; pain; swelling; Health issues; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 53-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain (1st dose received on an unknown date, for tolerance refer case US2019AMR167033).   On 11th September 2019, the patient received the 2nd dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced nausea, weakness, headache, pain, swelling and adverse reaction. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the nausea, weakness, headache, pain, swelling and adverse reaction were not recovered/not resolved.   It was unknown if the reporter considered the nausea, weakness, headache, pain, swelling and adverse reaction to be related to Shingrix.  Additional details were provided as follows: On the day before the reporting date, the patient received Shingrix. The patient had many other health issues and was not sure if this was a reaction to the shot or something else and the patient would check it with primary health care provider. The patient asked about the duration of these side effects and how long they last. The call center representative provided general information of side effects that the patient could experience and also advised to contact primary health care provided. The patient made a call to the primary health care provider and was waiting for a reply.",,,,,,,,,N,09/11/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834816,09/20/2019,OK,,,,M,,"Tired; Muscle aches; Headaches; Felt bad; This case was reported by a physician via sales rep and described the occurrence of tiredness in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced tiredness, muscle pain, headache and feeling bad. On an unknown date, the outcome of the tiredness, muscle pain, headache and feeling bad were recovered/resolved.   The reporter considered the tiredness, muscle pain, headache and feeling bad to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was a health care professional and had received Shingrix dose. The patient felt tired, had muscle aches and had headaches (these were consistent with the label). The patient felt bad for 2 days and then he went for sailing. The reporter stated, patient's wife also received Shingrix and experienced adverse events, refer case US2019AMR167044.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834817,09/20/2019,OR,,,,F,,"heart rate; light headed; This case was reported by a other health professional via sales rep and described the occurrence of heart rate increased in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, 40 min after receiving Bexsero, the patient experienced heart rate increased and light headedness. On an unknown date, the outcome of the heart rate increased and light headedness were unknown.   It was unknown if the reporter considered the heart rate increased and light headedness to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. After 40 min of Bexsero administration, the patient felt light headed and experienced heart rates between 78 to 118 beats per min.  Clinic stated they did report this to VAERS as well. The reporter agreed to follow up from GlaxoSmithKline.      Lab Comments: on an unknown date, lab test was done",,,,,,,,,U,,,,"Test Name: Heart rate; Result Unstructured Data: Test Result: between 78 to118, Test Result Unit: beats/min",OTH,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834818,09/20/2019,,,,,M,,"injection site ache / dull pain at the site of the injection; ache all over the body; This case was reported by a pharmacist and described the occurrence of injection site pain in a elderly male patient who received Herpes zoster (Shingrix) (batch number 4H9G2, expiry date 25th September 2021) for prophylaxis.   On 16th July 2019, the patient received Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced injection site pain and generalized aching. On an unknown date, the outcome of the injection site pain and generalized aching were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain and generalized aching to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number of the Shingrix was updated as 4H9G2 from 4H952, as per sales's data sheet. On 16th July 2019, the patient got NDC shot 58160-08232 11 The patient stated that, currently remodeling the house, so did get ache all over the body, but the ache at the site of the injection lingers on. The reporter consented to fiollow up.",,,,,,,,,N,07/16/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834819,09/20/2019,NE,,,,M,,"Nausea; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced nausea. On an unknown date, the outcome of the nausea was recovered/resolved.   It was unknown if the reporter considered the nausea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter reported that, her friend's husband received dose of Shingrix and next day after vaccination experienced nausea. The reporter stated that, the nausea resolved in 1 day. The reporter did not provide additional details. For the tolerance of 2nd dose, refer case US2019167038, reported by same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834820,09/20/2019,,,,,F,,"Weakness; Chills; Aching; Nausea; Fatigue; This case was reported by a consumer via call center representative and described the occurrence of chills in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th September 2019, the patient received Shingrix. On 10th September 2019, 1 days after receiving Shingrix, the patient experienced chills, pain, nausea, fatigue and weakness. On an unknown date, the outcome of the chills, pain, nausea, fatigue and weakness were unknown.   It was unknown if the reporter considered the chills, pain, nausea, fatigue and weakness to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient. The patient demographic details were not provided. The age at vaccination was not reported. The patient reported that, after vaccination with dose of Shingrix, currently experienced chills, aching, nausea, fatigue and weakness. The reporter did not consent to follow up.",,,,,,,,,U,09/09/2019,09/10/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834821,09/20/2019,OH,,77,,F,,"Localized swelling; Flu Like Symptoms; Headache; Fugue like reaction for about 4 hours where she could not remember anything; This case was reported by a physician via call center representative and described the occurrence of swelling in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced swelling, influenza-like symptoms, headache and fugue state. On an unknown date, the outcome of the swelling, influenza-like symptoms, headache and fugue state were recovered/resolved.   It was unknown if the reporter considered the swelling, influenza-like symptoms, headache and fugue state to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported, but it could be 77 or 78 years. The patient received her first dose of Shingrix about 3 weeks ago at pharmacy.  The patient experienced localized swelling, flu like symptoms, headache and fugue like reaction for about 4 hours where she could not remember anything.  The patient recovered from everything within 24 hours, except the swelling which was almost gone. No further details were provided. The reporter gave permission to follow up.",,,,,,,,,Y,08/01/2019,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834822,09/20/2019,IA,60.0,60,,F,,"shoulder pain; This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th September 2019, the patient received Shingrix. On 10th September 2019, 1 hr after receiving Shingrix, the patient experienced shoulder pain. On an unknown date, the outcome of the shoulder pain was not recovered/not resolved.   It was unknown if the reporter considered the shoulder pain to be related to Shingrix.  Additional details were provided as follows: The patient reported for the case for herself. The patient received dose of Shingrix in the right arm last night. About an hour later, the patient experienced shoulder pain. On the day of reporting, the patient called, seeking treatment recommendations but was referred to a health care provider. The patient stated that, pain had gotten worse over the night. The health care professional did not asked. This case was linked with the case US2019165574, reported for patient's husband.",,,,,,,,,N,09/10/2019,09/10/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834823,09/20/2019,NM,64.0,64,,F,,"burning; burning on whole body; This case was reported by a consumer via call center representative and described the occurrence of injection site burning in a 64-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) for prophylaxis.   Previously administered products included Flu vaccine (Several years ago the patient had a reaction to a flu vaccine that caused a skin crawling sensation. This lasted for almost one year before resolving. At that time she thought it might be due to the thimerosal in the vaccine).   On 22nd August 2019, the patient received Fluarix Quadrivalent 2019-2020 season (intramuscular). On 22nd August 2019, less than a day after receiving Fluarix Quadrivalent 2019-2020 season, the patient experienced injection site burning and burning sensation. On an unknown date, the outcome of the injection site burning and burning sensation were not recovered/not resolved.   It was unknown if the reporter considered the injection site burning and burning sensation to be related to Fluarix Quadrivalent 2019-2020 season.  Additional case details were reported as follows: The patient received vaccine in unknown arm. On evening of 22nd August 2019, the patient started having a burning sensation in her arm around the injection site. The burning later spread to the whole side of her body, and then to her whole body. The reporter did not consent to follow up.",,,,,,,,,N,08/22/2019,08/22/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834824,09/20/2019,NY,80.0,80,,M,,"Pain; This case was reported by a consumer via call center representative and described the occurrence of pain in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th August 2019, the patient received the 1st dose of Shingrix. On 16th August 2019, immediately after receiving Shingrix, the patient experienced pain. Shingrix was continued with no change. On 19th August 2019, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional case details were reported as follows: The reporter was patient's wife. The patient received vaccine in right arm. The patient developed pain shortly after receiving the vaccine.  The pain resolved after 3 days. The contact information was not available at the time of the call. The reporter did not provide any additional details. The reporter consented to follow up. This case had been linked to the case US2019166402, reported by same reporter.",,,,,,,,,Y,08/16/2019,08/16/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834826,09/20/2019,,,,,M,,"fever; chills; fatigue; sore arm; This case was reported by a consumer via call center representative and described the occurrence of fever in a 51-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever, chills, fatigue and pain in arm. On an unknown date, the outcome of the fever, chills, fatigue and pain in arm were unknown.   It was unknown if the reporter considered the fever, chills, fatigue and pain in arm to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported.  The reporter did not wish to provide demographics or participate in a safety report. The patient received vaccine in unknown arm. The patient experienced fever, chills, fatigue and a sore arm. The reporter did not consent to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834827,09/20/2019,KY,55.0,54,,M,,"fever; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 54-year-old male patient who received Herpes zoster (Shingrix) (batch number YE53N, expiry date 7th November 2021) for prophylaxis.   On 11th September 2019, the patient received Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional case details were reported as follows: The patient reported having fever of 103 degree Fahrenheit. The reporter consented to follow up.",,,,,,,,,U,09/11/2019,09/01/2019,,"Test Date: 201909; Test Name: Body temperature; Result Unstructured Data: Test Result: 103, Test Result Unit: degree F",UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834828,09/20/2019,FL,69.0,69,,F,,"arm  sore; fatigue; muscle aches; redness at injection site; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE).   On 11th September 2019, the patient received the 1st dose of Shingrix. On 11th September 2019, 7 hrs after receiving Shingrix, the patient experienced pain in arm, fatigue, muscle pain and injection site erythema. On an unknown date, the outcome of the pain in arm, fatigue, muscle pain and injection site erythema were unknown.   It was unknown if the reporter considered the pain in arm, fatigue, muscle pain and injection site erythema to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in unknown arm. About 7 hours later, the patient experienced a sore arm, fatigue, muscle aches and redness at the injection site.  The redness at the site was described as about 3 inches in diameter.  The patient did receive an unspecified pneumonia shot in the opposite arm at the same time as Shingrix. The reporter did not consent to follow up.",,,,,,,,,U,09/11/2019,09/11/2019,0,,PHM,,PNEUMONIA VACCINE,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834829,09/20/2019,DE,,,,M,,"fever/high fever; severe headache; urobilinogen and ketones in his urine; urobilinogen and ketones in his urine; urine was also dark in color; This is a spontaneous report from a contactable physician.    A male patient of an unspecified age received the first dose of  meningococcal group b rlp2086 (TRUMENBA) , via an unspecified route of administration on an unspecified date at single dose for immunisation , the second dose of meningococcal vaccine a/c/y/w (MENINGOCOCCAL VACCINE A/C/Y/W) , via an unspecified route of administration on an unspecified date at single dose for immunisation .  The patient medical history and concomitant medications were not reported.  The patient previously took the first dose of meningococcal vaccine a/c/y/w for immunisation on an unknown date.  The patient experienced high fever  on an unspecified date with outcome of unknown , severe headache on an unspecified date with outcome of unknown , urobilinogen and ketones in his urine on an unspecified date with outcome of unknown , urine was also dark in color on an unspecified date with outcome of unknown. The reported events were considered non serious. The patient underwent lab tests and procedures which included urine analysis: urobilinogen and ketones    on unknown date,  body temperature: pyrexia on an unknown date.  His urine was also dark in color.  The information on the batch number has been requested",,,,,,,,,U,,,,Test Name: Urinalysis; Result Unstructured Data: Test Result: urobilinogen and ketones in his urine; Comments: urinalysis (Unknown); urobilinogen and ketones in his urine.  His urine was also dark in color.; Test Name: Body temperature; Result Unstructured Data: Test Result: pyrexia; Comments: urinalysis (Unknown); urobilinogen and ketones in his urine.  His urine was also dark in color.,UNK,,,,,,USPFIZER INC2019401279,2,09/20/2019,,,,
0834830,09/20/2019,MI,70.0,70,,F,,"patient described little to no reaction following  FIRST shingrix dose, however, following second dose, on the same day as the dose was given, in the afternoon patient reports feeling very ill - enough to be on the couch and unable to do normal daily activities until 48 hours later. Also, patient reports the appearance of a rash on her trunk and upper arm resembling chicken pox. the rash she said was very itchy and she used hydrocortisone cream to help. She reports recalling chickenpox as a child - a very severe case - in the summertime. The rash that came following the vaccination appeared approximately 2 weeks after her second dose of shingrix which was given 8/20/2019.",,,,,,,,,Y,08/20/2019,08/20/2019,0,none.,PHM,,citalopram 10mg daily,none,none,,,2,09/20/2019,,,,no known allergies
0834831,09/20/2019,MS,6.0,6,,F,,"HPI: erythematous site to RT thigh after receiving immunizations 2 days ago. Pt received MMR/VAR and DTAP/IPV on 9/17/19 and has since developed a pruritic, warm and red lesion to site where INJ were given. Mother has not given an antihistamines in response to reaction. Mother denies any angioedema, difficulty breathing or swallowing. PLAN:  pt may take prednisone <20 mg day <14 days for adverse reaction to live virus vaccine. Will treat adverse reaction with prednisone 5 mg daily x 5 days. Instructed mother to continue Benadryl as needed. Monitor reaction site and notify clinic if borders increase or systemic reaction occurs. Apply cool compresses to site. Encouraged mother to continue with Hep B immunization in one month. Risks vs benefits discussed. Adverse reaction reported to vaccine manufacturer. Mother v/u.",,,,,,,,,N,09/17/2019,09/19/2019,2,none,PVT,,NONE,NONE,NONE,,,2,09/20/2019,,Y,,AUGMENTIN OMNICEF
0834832,09/20/2019,OK,67.0,67,,F,,"Right arm was very sore after receiving shot. Took some Tylenol and went to bed at approximately 10:00pm. Did not sleep well as my arm hurt. About 4:00 am I woke up shivering uncontrollably, had a horrible headache and could not move right arm at all.  Husband brought me another Tylenol and some water. After a while I dozed off and woke up approximately 6:30. I have had a headache all morning but my arm is not as bad as it was earlier.",,,,,,,,,Y,09/19/2019,09/20/2019,1,None,PVT,,"Tylenol, Paxil cr,  generics Lipitor, biotin, aspirin, pantoprazole, levothyxine",None,None,,,2,09/20/2019,,,,Codeine Prilosec
0834833,09/20/2019,WV,77.0,77,,F,,"red, swollen, arm.  on day of vaccination  dr prescribed a steroid cream and doxycycline 2 days later",,,,,,,,,U,09/18/2019,09/18/2019,0,,PHM,,"on furosemide, cephalexin, synthroid, ativan, cartia, warfarin, advair",cellulitis of the leg,n/a,,,2,09/20/2019,,Y,,"lisinopril, pcn, celestone, sulfa allery"
0834834,09/20/2019,LA,65.0,65,,F,,I gave the patient the Shingrix shot. She complained of pain as I gave it but she expected it to hurt. After receiving her flu shot and Prevnar 13 in the opposite arm she felt dizzy. She sat down and I gave her a water. Within a few minutes she felt okay to leave and her husband drove her home. Her husband called the pharmacy and said the patient's arm was hurting very badly and pulsating. He said she already had a primary care doctor appointment within 2 hours and they would let the doctor look at it.,,,,,,,,,U,09/20/2019,09/20/2019,0,,PHM,,,,,,,2,09/20/2019,,Y,,
0834835,09/20/2019,TN,0.17,0,.1,M,,"Mottled skin which worsened with heat or precise crying, diagnosed 9/20/19 as Post-Inflammatory Hyperpigmentation   Development of ?silent? reflux",,,,,,,,,N,11/01/2017,11/01/2017,0,"Check up around 6 months of age, misdiagnosed as rosella  Checkup around 1 year of age, misdiagnosed as eczema   Dermatologist appointment 9/20/19, diagnosed post inflammatory hyperpigmentation",PVT,,None,None,None,,,2,09/20/2019,,Y,,None
0834836,09/20/2019,WA,47.0,47,,F,,"The evening of receiving the flu vaccine, the individual developed soreness in her left arm. Now, 9 days later, the arm is still sore, approximately 2"" posterior to the injection site. The pain covers are area of near her left shoulder to her left elbow. The individual states that she has used hot packs and Tylenol for discomfort, but that she cannot sleep on the arm. She states that she can raise her arm to the side and back, but it is too painful to lift her arm forward. She has not experienced this pain following an injection before, and states that it feel like pain in the joint to the bone. There is no redness, swelling, warmth or hardness around the injection site.",,,,,,,,,N,09/11/2019,09/11/2019,0,,OTH,,Antihypertensive and Ibuprofen,None,Hypertension,,,2,09/20/2019,,,,"Cipro, CT Contrast"
0834837,09/20/2019,CT,0.5,0,.5,F,,"Pt. received immunizations including Flu, mother arrived home approximately 20 mins later where it was noted that she was covered with hives and had facial swelling diarrhea and lethargy. EMS called and administer Epi .15mg and 7mg of Benadyl. Patient was transported to ED where she was observed for 4 hours and discharged home",,,Y,,,,,,Y,09/19/2019,09/19/2019,0,,PVT,,,N/A,Mesenteric cyst,,,2,09/20/2019,,,Y,NKDA
0834838,09/20/2019,CA,19.0,19,,F,,"After the administration of both influenza and PPD, patient felt dizzy then loss just this briefly. fell into the arms of the MA for 5-10 second. when I enter the room I witnessed patient's arms and legs clench and shaking involuntarily for about 5 seconds Her eyes were closed. No drooling, no bowel or urinary incontinence. When patient regained consciousness she answered all questions appropriately, but felt dizzy with 7 out of 10 headache and nausea. She vomiting and office x 4. She reports history of LOC while given blood 2 years ago, denies   seizures in the past. Never saw a neurologist in the past before. She was sento into the ER for suspected seizures - like activity further evaluation -",,,,,,,,,,09/16/2019,09/16/2019,0,,PVT,,None,None,None,,,2,,,Y,Y,None
0834839,09/20/2019,GA,2.0,2,.0,F,09/20/2019,"Vomiting, leg pain -> Resolved",,,,,,,,,Y,09/19/2019,09/20/2019,1,None,PUB,PUB,,None,heart murmur,,,1,,,,,
0834840,09/20/2019,PA,43.0,43,,M,09/10/2019,"Received Tdap 9/3/19 - developed pain, swelling, within several hours increased pain & swelling 9/4/19. Seen in ED 9/6/19 - treated with Tylenol, ibuprofren, ice.",,,,Y,,,,,Y,09/03/2019,09/03/2019,0,None,PVT,PVT,None,None,None,,,1,,,,,
0834841,09/20/2019,WI,78.0,78,,U,,Red Hot RAsh,,,,,,,,,N,09/19/2019,09/20/2019,1,,PVT,,yes,NONe,Acute Diastolic CHF,,,2,,,Y,,NONe
0834842,09/20/2019,AZ,92.0,92,,F,,"R Arm became painful, tender to touch, red, warm and swollen. Was treated with ice, Benadryl and hydrocodone. Pain and tenderness lasted 2 days, redness and swelling lasted another 4 days.",,,,,,,,,Y,09/13/2019,09/13/2019,0,none,PHM,,"levothyroxine, lovastatin, furosemide, lisinopril, omeprazole, Duloxetine, Flonase, Pro Air, Symbicort, MTX, Preservision, Caltrate, Vit, Hydrocodone, Voltaren gel",none,"cad, copd, pulmonary htn, gerd, chf, depression, ckd, afib, hypothyroid",,,2,09/20/2019,,Y,,"sulfa, pcn, demerol, cipro, macrobid, terazosin, taztia, hydralazine"
0834843,09/20/2019,MD,61.0,61,,F,09/20/2019,"9/10/19 vaccinated. Initially had fatigue + aches 9/14/19 burning, itchy rash (R) back 9/18/19 office exam - Diagnosed with Shingles",,,,,,,,,,09/10/2019,09/14/2019,4,None,PVT,UNK,,,"Allergic to NSAIDs, Bupoprion, Goiter, Asthma, Anxiety, HTN",,,1,,,,,
0834844,09/20/2019,CA,4.0,4,,M,,Vaccine admin @ approx 1430 on 9/11/19 and at 1730 9/11/19 noticed Hives + intermittent fever (TMaX 101.7) Hives resolved (self resolved w/o tx) evening of 9/12/19 + Fevers resolved 9/17/19. Pt. now asymptomatic.,,,,,,,,,Y,09/11/2019,09/11/2019,0,N/A,PVT,,N/A,N/A,N/A,,,2,09/20/2019,,,,NKDA
0834847,09/20/2019,FL,,,,U,,"no adverse effect; Varivax was administered via intramuscular instead of subcutaneous; Varivax was given 20 minutes after receiving a properly administered dose of M-M-R II; This spontaneous report was received from a pharmacist refers to a patient of unknown age. There was no information about the patient's concurrent conditions, medical history, drug reactions, allergies or concomitant medication.   On 28-AUG-2019, the patient was vaccinated at an unspecified retail location with varicella virus vaccine live (oka/merck)(VARIVAX) (Lot # S002877 expiration date not reported, but upon internal validation established as 29-JAN-2021), intramuscular instead of subcutaneous for prophylaxis (strength and dosage schedule were not reported). The reporter also stated that the vaccine was given 20 minutes after receiving a properly administered dose of measles virus vaccine live (enders-edmonston), mumps virus vaccine live (jeryl lynn), rubella virus vaccine live (wistar ra 27/3) (M-M-R II) for prophylaxis (strength, dosage schedule, route of administration, lot number and expiration date were not reported) at a different unspecified retail location. No adverse effects were reported.",,,,,,,,,U,08/28/2019,08/28/2019,0,,UNK,,,,,,US0095075131908USA011709,2,09/20/2019,,,,
0834848,09/20/2019,NH,,,,U,,"No adverse effects reported; two patients were administrated an improperly stored dose of PNEUMOVAX 23; This spontaneous report was received from a nurse and refers to an identifiable patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On 16-SEP-2019, the patient was vaccinated with improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), lot # S013489, expiration date 06-MAR-2021 (strength, route of administration and exact dose were not reported) for prophylaxis. No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion of above 9 Celsius degrees (also reported as 16.8 Celsius degrees) for 3 hours. The digital data logger was involved in recording the temperature excursion details. There were no previous excursions reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA008031:",,,,,,,,,U,09/16/2019,09/16/2019,0,,UNK,,,,,,US0095075131909USA007126,2,09/20/2019,,,,
0834849,09/20/2019,NH,,,,U,,"No adverse effects reported; two patients were administrated an improperly stored dose of PNEUMOVAX 23; This spontaneous report was received from a nurse and refers to an identifiable patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On 16-SEP-2019, the patient was vaccinated with improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), lot # S013489, expiration date 06-MAR-2021 (strength, route of administration and exact dose were not reported) for prophylaxis. No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion of above 9 Celsius degrees (also reported as 16.8 Celsius degrees) for 3 hours. The digital data logger was involved in recording the temperature excursion details. There were no previous excursions reported.; Sender's Comments:  US-009507513-1909USA007126:",,,,,,,,,U,09/16/2019,09/16/2019,0,,UNK,,,,,,US0095075131909USA008031,2,09/20/2019,,,,
0834851,09/20/2019,FL,,,,U,,"Redness at injection site; Pain at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced injection site erythema and injection site pain. On an unknown date, the outcome of the injection site erythema and injection site pain were unknown.   It was unknown if the reporter considered the injection site erythema and injection site pain to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. The registered pharmacist reported that the patient received FluLaval Quadrivalent and had redness and pain at the injection site. The reporter consented to follow up. The registered pharmacist had no further details but was agreeable to recontact. This case was linked with the cases US2019AMR165268 and US2019164595, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834852,09/20/2019,FL,,,,U,,"Redness at injection site; Pain at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced injection site erythema and injection site pain. On an unknown date, the outcome of the injection site erythema and injection site pain were unknown.   It was unknown if the reporter considered the injection site erythema and injection site pain to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. The registered pharmacist reported that the patient received FluLaval Quadrivalent and had redness and pain at the injection site. The reporter consented to follow up. The registered pharmacist had no further details but was agreeable to recontact. This case was linked with the cases US2019AMR165268 and US2019164595, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834853,09/20/2019,AL,,,,U,,"Significant redness; Significant swelling; This case was reported by a physician via sales rep and described the occurrence of erythema in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced erythema and swelling. On an unknown date, the outcome of the erythema and swelling were recovered/resolved.   The reporter considered the erythema and swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The physician stated he had about 3 patients with significant redness and swelling after receiving Shingrix and it has resolved on its own in a couple of days. The reporter did not consent to follow up.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834854,09/20/2019,MD,,,,U,,"Cold; This case was reported by a consumer and described the occurrence of cold in a elderly patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced cold. On an unknown date, the outcome of the cold was recovering/resolving.   It was unknown if the reporter considered the cold to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that the patient experiencing a cold since receiving the first dose. The patient asked whether the patient could received 2nd shot if the patient recovering from a cold.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834855,09/20/2019,CA,56.0,56,,F,,"Rash looked like hives on the top half of the arm; Rash on left arm; This case was reported by a physician via sales rep and described the occurrence of hives in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number 454S2, expiry date 5th November 2021) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Shingrix. On 10th September 2019, 1 days after receiving Shingrix, the patient experienced hives and injection site rash. On an unknown date, the outcome of the hives and injection site rash were unknown.   The reporter considered the hives and injection site rash to be possibly related to Shingrix.  Additional details were provided as follows: The patient received 1st dose of Shingrix in left arm and 24 hours later the patient returned to office with a rash.  The patient did not have any pain but after work went home and notice the rash on her left arm. Rash looked like hives on the top half of the arm. The patient not aware of any allergies. Looked like a localized reaction from vaccine. The physician thought this could be related to the vaccine based on the time after the vaccine and the location vaccine given. The reporter agreed to follow up.",,,,,,,,,U,09/09/2019,09/10/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834856,09/20/2019,GA,70.0,70,,M,,"Weak; Tired; Dizzy; Difficulty Sleeping; Dragging as if he could not walk to go to the bathroom; Being uncomfortable; Lethargic; This case was reported by a pharmacist via call center representative and described the occurrence of weakness in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for an unknown indication.   The patient's past medical history included stroke (stroke survivor from 1997).   On 9th September 2019 09:00, the patient received Shingrix and Influenza vaccine Quadrivalent 2019-2020 season. On 9th September 2019 22:00, 13 hrs after receiving Shingrix and Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced weakness, tiredness, dizziness, difficulty sleeping, unable to walk, discomfort and lethargy. On an unknown date, the outcome of the weakness, tiredness, dizziness, difficulty sleeping, unable to walk, discomfort and lethargy were not recovered/not resolved.   It was unknown if the reporter considered the weakness, tiredness, dizziness, difficulty sleeping, unable to walk, discomfort and lethargy to be related to Shingrix and Influenza vaccine Quadrivalent 2019-2020 season.  Additional details were provided as follows: The patient received Shingrix vaccine in his left arm as well as an unknown manufacturer of the flu vaccine in an unspecified arm.  The patient was going to the bathroom, caller reports he was very weak, tired, dizzy, and dragging as if he could not walk to go to the bathroom.  The caller reports it was difficult for her husband to sleep last night due to being uncomfortable.  The patient was currently sleeping although he usually wakes up around 7:30 AM. The caller reports he did not seem as lethargic at the time of reporting compared to day before. The reporter did not consent to follow up. The caller was wife of the patient.  The caller had limited information about vaccines since she did not go with him to the pharmacy for vaccination.  The caller currently did not consent to health care professional follow up, but might call back later and consent if symptoms did not subside within the next day or two.",,,,,,,,,N,09/09/2019,09/09/2019,0,,PHM,,,,Medical History/Concurrent Conditions: Stroke (stroke survivor from 1997),,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834857,09/20/2019,FL,,,,U,,"Redness at injection site; Pain at injection site; Blistering; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced injection site erythema, injection site pain and blister. On an unknown date, the outcome of the injection site erythema, injection site pain and blister were unknown.   It was unknown if the reporter considered the injection site erythema, injection site pain and blister to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. The registered pharmacist reported that the patient received FluLaval Quadrivalent and had redness, blister and pain at the injection site. The reporter consented to follow up. The Registered Pharmacist has no further details but was agreeable to recontract. This case linked with US2019AMR165267and US2019AMR165268, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834858,09/20/2019,MO,79.0,79,,F,,"Spider web like sensation on her face; Irritation; Short temper; Headache; This case was reported by a consumer via call center representative and described the occurrence of crawling sensation of skin in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included TETANUS TOXOID (TETANUS VACCINE) for prophylaxis.   On 26th August 2019, the patient received the 1st dose of Shingrix and TETANUS VACCINE. On an unknown date, less than a week after receiving Shingrix and an unknown time after receiving TETANUS VACCINE, the patient experienced crawling sensation of skin, irritability, short tempered and headache. On an unknown date, the outcome of the crawling sensation of skin, irritability, short tempered and headache were recovering/resolving.   It was unknown if the reporter considered the crawling sensation of skin, irritability, short tempered and headache to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix vaccine and on the same day she also received tetanus vaccine on her other arm. Within a week after she experienced a spider web like sensation on her face. She also experienced irritation, short temper and headaches.  All the side effects were still present. The reporter did not consent to follow up. No further details were provided. It was unknown if the reporter considered the crawling sensation of skin, irritation skin, short tempered and headache to be related to tetanus vaccine as well.",,,,,,,,,N,08/26/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834859,09/20/2019,TN,67.0,67,,F,,Patient said she had noticed a red rash on her arm on 9/20/19. She also said she wasn't sure how long it had been there. She said it wasn't bothering her.,,,,,,,,,N,09/18/2019,09/20/2019,2,,PHM,,,,,,,2,09/20/2019,,,,
0834860,09/20/2019,SC,65.0,65,,F,,Patient has dark and rough and peeling skin around injection site. Some redness extending up to 6 inches from injection site. Patient has been taking prednisone for 3 days to reduce symptoms. Appears to be resolving. Advised patient to get rechecked if no improvement or worsening of area occurs.,,,,,,,,,U,09/10/2019,09/11/2019,1,,PHM,,,,,,,2,09/20/2019,,Y,,"Aminothiols, Aztreonam, Carbapenem, Cephalosporins, Penicillins"
0834861,09/20/2019,NY,66.0,66,,F,,"Within 2 hour, allergic reaction started: swollen, puffy  and red eyes, airway irritated, voice hoarse, tremors and fever.  Took 2 Motrin and eventually fell sleep around 1am.   Today, throat is not as irritate, eyes are still puffy and red, and voice hoarse.   Contacted the pharmacy and they confirmed that the vaccine was Thimerosol-free and that it was possible that she reacted to vaccine. Per patient she was not asked which vaccine she wanted; she would have chosen the regular as she has never had a problem with that one. It would be helpful if patients are given the choice.",,,,,,,,,U,09/19/2019,09/19/2019,0,,PHM,,"Baby aspirin, Norvasc, Prednisone, Vitamin D","no, no",Auto-immune disease,,,2,09/20/2019,,,,"Penicillin, Thimerosol"
0834862,09/20/2019,UT,56.0,56,,F,,"Around 9/2/19 She started with quarter size welts on right arm and chest/breast,  central belly, inner thighs (started with right thigh now she says it's on both thighs) and excruciating pain in right arm. Internal pain in back, but but no breakouts on back. Breaking out on face. Broken out everywhere on scalp.  She saw lady about it and she said it was mosquito bites or spider bites.  Patient disagrees and thinks it's the vaccine.",,,,,,,,,N,08/09/2019,09/02/2019,24,"Staff ran a bunch of other tests 9/5/19 on thyroid,  diabetes, etc.. but none related to the rash/sores",PHM,,"melatonin, Vit D, multi-vit, citracel, immodium, topiramate, gabapentin, trazodone, cyancobalamin, clonazepam, synthroid, sumatriptan, quetiapine, , twinrix, adacel, amitriptyline","Crohn's, asthma, migraines, fibromyalgia, low thyroid,  insomnia, anxiety, depression","Crohn's, asthma, migraines, fibromyalgia, low thyroid,  insomnia, anxiety, depression",,,2,09/20/2019,,Y,Y,"Belsomra, marcobid, nitrofurantoin"
0834863,09/20/2019,PA,35.0,35,,F,,Patient stated feels dizzy today (day after administration). Her MD sent her in a prescription for meclizine to help with dizziness.,,,,,,,,,U,09/19/2019,09/20/2019,1,n/a,OTH,,lexapro,,,,,2,09/20/2019,,,,
0834864,09/20/2019,CA,64.0,64,,M,,"According to patient, 4 hrs later after receiving vaccine, patient blacked out, went to ER. Blood pressure dropped severely. Unclear the connection.",,,,,,,,,Y,09/17/2019,09/17/2019,0,,PHM,,"Tamsulosin, 0.4mg, Lisinopril 10mg, Carvedilol 3.125mg, Metformin 500mg, naproxen 500mg",unknown,,,,2,09/20/2019,,,Y,n/a
0834865,09/20/2019,PA,55.0,55,,M,,"Severe rigors, fever, headache, starting 7 hours after dosing. Temperature to 103F. Took naproxen 2 tablets. Went to bed. Around 3 AM next day (15 hours after vaccination), woke up with heavy sweat. Still had headache. In the AM, had muscle pain from the previous day's rigors. Felt shakey and febrile. Took two more naproxen at 8 AM. Now, at 26 hours post-vaccination, no fever, rigors, or headache finally!  Also,severe pain, left arm (injection site), that became worse over 2 hours, limiting mobility. Then, after a few hours, pain subsided. It is still present now (26 hours after injection) but at lower level.",,,,,,,,,Y,09/19/2019,09/19/2019,0,None,PVT,,Baby Aspirin Simvastatin Sertraline Omeprazole,None,High Cholesterol,,,2,09/20/2019,,,,Penicillin
0834866,09/20/2019,UT,76.0,76,,F,,"Two days after receiving second dose of Shingrix, patient reports developing welts down her left arm and experiencing pain on the trunk of her body below her left armpit .  She later developed shooting pains about every 30 seconds on the right side of her head that later moved to her right jaw and ear canal which lasted approximately 12 hours.  Five days after her vaccination, a red blister-like sore developed on the middle finger of her right hand.  When a second blister developed on the same finger, she was given a prescription for Valtrex from her provider.",,,,,,,,,U,09/09/2019,09/11/2019,2,,PHM,,,,,,,2,09/20/2019,,Y,,
0834867,09/20/2019,CA,76.0,76,,M,,"At about 9pm, patient reports fever 100.6, headache minor, nausea, sweating, and racing heart.  Symptoms lasted 3 hours and disappeared--went to back to normal.  Patient did not take any other medicine than usual. Patient has received Flu vaccines with no problems for years so can only relate symptoms to vaccine.",,,,,,,,,Y,09/19/2019,09/19/2019,0,,MIL,,"lopidine Bezylate, Esomeprazole Mg, Simvastatin, Acamprosate Calcium, Tamsulosin hydroclhoride","No, No","Blood Pressure, Acid reflux, Cholesterol",,,2,09/20/2019,,,,No
0834868,09/20/2019,NY,3.0,3,,M,,Rash developed on posterior aspect of leg immunized,,,,,,,,,Y,09/19/2019,09/19/2019,0,,PVT,,,,,,,2,09/20/2019,,Y,,NKDA
0834869,09/20/2019,NY,4.0,4,,F,,red raised area developed at injection site. Size of a pancake,,,,,,,,,Y,08/30/2019,08/01/2019,,,PVT,,,,,,,2,09/20/2019,,,,NKDA
0834870,09/20/2019,MI,69.0,69,,F,,"Rapid Heartbeat, severe headache, swelling at injection site,",,,,,,,,,N,09/19/2019,09/19/2019,0,,PHM,,olmesartan 20mg levothyroxine 100 mcg amlodipine 5 mg,high blood pressure,High blood pressure hypothyroidism,,,2,09/20/2019,,,,sulfa
0834871,09/20/2019,NY,67.0,67,,F,,"The vaccine was the second dose of Shingrix. The first was uneventful other than a very sort left arm. The second resulted again in a very sore left arm and a low grade fever the next day. The other symptoms came about three weeks later and now, on September 21, have not subsided: on the inner thighs and the back of the thighs. Sensitive to clothes rubbing, even skin on skin, and sensitive when sitting. Symptoms have variously been burning, irritation, and what feels like heightened nerve endings. There has never been a rash. I was first prescribed a topical steroid which I took for about a week, and then a dermatologist told me to stop it because I did not have signs of a rash. It was triamcinolone acetonide 0.1%. . After around two weeks, I saw a neurologist who prescribed gabapentin - 100 mg twice a day which I could increase to the same dosage three times I day. I started that yesterday.",,,,,,,,,N,07/31/2019,08/21/2019,21,"None to date. Exams by an urgent care doctor, an internist, two dermatologists and a neurologist have so far been unable to diagnose the condition. The urgent care doctor thought I had shingles, but everyone else disagreed, and wanted me to take an antiviral medication. I have filled the RX but have never taken it. I am thinking now that I should.",PVT,,Alendronate - once a week,"Lingering symptoms of bad head cold - post nasal drip, cough, throat irritation although not sore",,"Very sore left arm, unusually for a shot, after the first vaccine. Same with the second plus a low grade fever the next day",,2,09/20/2019,,,,dust mites grass sensitive to fragrances and adhesive tape
0834872,09/20/2019,TX,43.0,43,,F,,"Expected soreness but at around 9-10pm area was red, was wheezing and coughing. Affected area spread to the top of the arm.  Took Tylenol and Benadryl to help with the the cold-like symptoms.   The medicine helped for the cold like symptoms developed swollen hives all over arm the size of tennis ball. Used some Mentholatum on area an left it alone.  Patient hast not checked in with doctor yet",,,,,,,,,U,09/17/2019,09/17/2019,0,,PVT,,"Metoprolol, Ultram, Gabapentin, Tizanidine, Benadryl as needed , Aspirin","No, No","High blood pressure, back problems",,,2,09/18/2019,,,,"Penicillin, Bactrim"
0834873,09/20/2019,VA,72.0,72,,M,,"experienced severe side effects afterwards, pain,  vomiting/ weakness.  He ended up in the emergency room and based on the Band-Aid placement and further evaluation, the doctor determined that the vaccine was administered in the shoulder joint.  Her dad is now receiving cortisone shots and is unable to move that arm.",,,,,,,,,N,09/13/2019,09/13/2019,0,,PHM,,,,,,,2,09/20/2019,,,Y,
0834874,09/20/2019,IA,83.0,83,,M,,"pt received PPSV23 and Fluzone-HD on 9/17/19. That evening he noticed feeling weak in bed. The following morning he experienced weakness and instability and fell several times at home.  He also developed redness, inflammation, and pain around the injection sites on his arm.  Pt also states he was mentally foggy and had some disorientation on the morning of 9/18. His caretaker took him to the hospital 9/18 where he was admitted overnight.  Pt was monitored and released the afternoon of 9/19 after improvement in strength and mental clarity. Pt states he continues to improve but still has pain, tenderness, redness in arm",,,,,Y,1,,,U,09/17/2019,09/17/2019,0,multiple lab inpatient,PHM,,,,,,,2,09/20/2019,,,Y,
0834875,09/20/2019,NC,66.0,66,,F,,Pain and redness below the injection site,,,,,,,,,N,09/18/2019,09/18/2019,0,,PHM,,,,,,,2,09/20/2019,,,,
0834876,09/20/2019,MA,32.0,32,,M,,"erythema, warmth, swelling and tenderness of right upper extremity at the site of pneumonia vaccine. On exam today: It is around 4 inches in size and is spreading medially    was seen in the office today by provider; cellulitis  prescribed Keflex 500mg twice daily for 5 days follow up at visit in 1-1/2 week for reeval",,,,,,,,,N,09/17/2019,09/18/2019,1,none,PVT,,"Flovent, albuterol",mild asthma exacerbation and URI Symptoms in the beginning of Sept. 9/7/19,asthma,,,2,09/20/2019,,Y,,"Bactrim, Sulfadiazine"
0834877,09/20/2019,PA,64.0,64,,F,,"Raised rash that occurred 1 day after injection, rash lasted at least 2 weeks, significant arm weakness which onset the day after vaccination and is still occurring, although there has been some improvement.",,,,,,,,,N,02/11/2019,02/12/2019,1,No,PHM,,Anastrozole 1mg Citalopram 30mg Pantoprazole 40mg Glucosamine Acyclovir 800mg Clobetasol 0.05% Liquid Triamcinolone 1% Cream Meloxicam 15mg  Eszopiclone 2mg,,Breast Cancer,,,2,09/20/2019,,,,Metoclopamide
0834878,09/20/2019,NY,9.0,9,,F,,Child became light-headed approximately 5 minutes after receiving vaccines.  She seemed to recover from this approximately 20 minutes later.  She developed a headache about 1 hour later and became very fatigued.  Tylenol was administered.  Child then proceeded to vomit multiple times.,,,,,,,,,U,09/20/2019,09/20/2019,0,Vital signs remained within normal limits the entire time.,SCH,,None,None,Dental caries,,,2,09/20/2019,,,,None
0834879,09/20/2019,AK,56.0,56,,F,,"Patient called the morning of 9/20/19 .   Patient reports that late last night she noticed that her arm was really sore and painful.  She also states that on the same side (left) she has a significant lump under her clavicle that she believes to be a swollen lymph node.  I advised patient to call her Humira doctor, to take Benadryl, and to call me with questions.",,,,,,,,,U,09/18/2019,09/19/2019,1,,PHM,,"humira, singulair, levothyroxine, estradiol, prednisone","autoimmune disorder, patient takes humira",autoimmune disorder:  Crohn's .  Patient recently switched from Remicade to Humira,,,2,09/20/2019,,Y,,"budesonide, cephalsosporins, penicillins, sulfa antibiotics"
0834883,09/20/2019,MD,59.0,,,F,,"Pain in left shoulder; Chills; Rash associated with itching on the right side at midsection of the body about 7 to 8 inches in size from bra area to the waistband, and towards the back; This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced shoulder pain, chills and itchy rash. The patient was treated with ibuprofen (Motrin). On an unknown date, the outcome of the shoulder pain and chills were recovered/resolved and the outcome of the itchy rash was unknown.   It was unknown if the reporter considered the shoulder pain, chills and itchy rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced pain in her left shoulder and chills that lasted for couple days and took motrin for it.  About 5 days after vaccination, she broke out in a rash associated with itching on the right side at midsection of the body about 7 to 8 inches in size from her bra area to the waistband, and towards the back.  She had reached out to her doctor via email portal. The reporter did not consent to follow up. No further details were provided.  The patient was reporting event for herself, her friend, and her friends husband. This report 1 of 3 reported by the same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,Y,,
0834884,09/20/2019,GA,,,,M,,"Injection Site Swelling; Injection Site Redness; Heat at the injection site; Feel Achy; Low grade fever; Sore Throat; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 83-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th September 2019, the patient received the 1st dose of Shingrix. On 11th September 2019, less than a day after receiving Shingrix, the patient experienced injection site swelling, injection site erythema, injection site warmth, pain, low grade fever and sore throat. On an unknown date, the outcome of the injection site swelling, injection site erythema, injection site warmth, pain, low grade fever and sore throat were recovering/resolving.   It was unknown if the reporter considered the injection site swelling, injection site erythema, injection site warmth, pain, low grade fever and sore throat to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but may be between 82 or 83 years. The reporter stated that, the patient experienced swelling, redness, and heat at the injection site. The patient also felt achy, had a low grade fever, and a sore throat. The reporter stated that, the patient at the time of reporting was having these symptoms. The reporter was unable to obtain additional details because her mother was not with her at the time of reporting. This case is 1 of the 2 linked cases, reported by the same reporter.",,,,,,,,,N,09/11/2019,09/11/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834885,09/20/2019,NE,,58,,F,,"Nausea; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In March 2019, the patient received the 2nd dose of Shingrix. In March 2019, 1 day after receiving Shingrix, the patient experienced nausea. On an unknown date, the outcome of the nausea was recovered/resolved.   It was unknown if the reporter considered the nausea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received vaccine in right arm. The patient received the second dose of the Shingrix vaccine 6 months ago. The patient experienced nausea the day after receiving the vaccine that lasted for one day. The reporter was unable to provide additional information. The reporter consented to follow up. This was 2 of 4 linked cases reported by the same reporter.",,,,,,,,,Y,03/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834886,09/20/2019,IN,57.0,57,,U,,"headache; sore joints; arm hurts; felt like hit by a truck; This case was reported by a consumer via call center representative and described the occurrence of headache in a 57-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th September 2019 16:00, the patient received the 2nd dose of Shingrix. In September 2019, less than a day after receiving Shingrix, the patient experienced headache, soreness of joint, pain in arm and feeling abnormal. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the headache, soreness of joint, pain in arm and feeling abnormal were unknown.   The reporter considered the headache, soreness of joint and pain in arm to be related to Shingrix. It was unknown if the reporter considered the feeling abnormal to be related to Shingrix.  Additional details were provided as follows: On 10th September 2019 at 9:50 AM, the patient reported that, the patient felt like hit by a truck, headache, sore joints and arm hurts as expected. The patient took Tylenol. The patient asked if there was anything else to do regarding these events.",,,,,,,,,U,09/09/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834887,09/20/2019,TX,53.0,53,,F,,"abdominal pain; colitis; This case was reported by a other health professional via sales rep and described the occurrence of colitis in a 53-year-old female patient who received Herpes zoster (Shingrix) (batch number 454S2, expiry date 5th November 2021) for prophylaxis.   On 27th August 2019, the patient received the 1st dose of Shingrix. On 2nd September 2019, 6 days after receiving Shingrix, the patient experienced colitis. On an unknown date, the patient experienced abdominal pain. On an unknown date, the outcome of the colitis and abdominal pain were unknown.   The reporter considered the colitis and abdominal pain to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient went to hospital on 2nd September 2019, because of abdominal pain and diagnosed with colitis. The reporter stated that, the patient does not want to take second dose of Shingrix when due. The reporter was agree to follow up from GlaxoSmithKline.",,,,,,,,,U,08/27/2019,09/02/2019,6,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834888,09/20/2019,WA,76.0,76,,U,,"Reddened area; Whenever I rest left wrist on a keyboard, get an electrical-like shock that goes from elbow to end of fingers; Gave injection somewhat forward of the deltoid muscle; This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a 76-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th July 2019, the patient received the 2nd dose of Shingrix. On an unknown date, 7 days after receiving Shingrix, the patient experienced erythema of extremities, electric shock sensation and vaccine administered at inappropriate site. On an unknown date, the outcome of the erythema of extremities, electric shock sensation and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the erythema of extremities and electric shock sensation to be related to Shingrix.  Additional details were provided as follows: The patient stated that the pharmacist gave the injection somewhat forward of the deltoid muscle, which led to inappropriate route of vaccination. The patient had a reddened area about 6x8 inches toward the inner aspect of upper arm and got an electrical like shock that goes from elbow to the end of fingers. The patient asked could it hit a nerve.",,,,,,,,,U,07/18/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834889,09/20/2019,MS,,,,U,,"Fever; Chills; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever and chills. On an unknown date, the outcome of the fever and chills were recovered/resolved.   It was unknown if the reporter considered the fever and chills to be related to Shingrix.  Additional details were provided as follows: The patient demographic details were not provided. The reporter stated that, the patient had fever and chills, that lasted for 1 week. The reporter did not consent to follow up. This case has been linked with case US2019166363, reported by the same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834890,09/20/2019,FL,,,,F,,"Flu-like symptoms; This case was reported by a consumer and described the occurrence of influenza-like symptoms in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On 12th September 2019, less than 2 months after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional setails were provided as follows: The age at vaccination was not reported. The reporter reported for his wife. The reporter reported that, the patient received dose of Shingrix 5 weeks ago and on the date of reporting had flu like symptoms.",,,,,,,,,U,,09/12/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834891,09/20/2019,OH,66.0,66,,U,,"Extreme  Tiredness; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 66-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced tiredness. On an unknown date, the outcome of the tiredness was unknown.   It was unknown if the reporter considered the tiredness to be related to Shingrix.  Additional details were provided as follows: The patient demographic details were not provided. The patient received dose of Shingrix, on monday at about 3pm. The patient asked, an average how long would the fatigue continue and also ask if need to really get for the 2nd dose.",,,,,,,,,U,09/09/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834892,09/20/2019,,,,,U,,"side effects; This case was reported by a consumer and described the occurrence of adverse reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had side effects. The reporter asked how long could the side effects last from the Shingrix.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834893,09/20/2019,IL,,,,U,,"pain; redness; swelling; This case was reported by a consumer via call center representative and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain, erythema and swelling. On an unknown date, the outcome of the pain, erythema and swelling were unknown.   It was unknown if the reporter considered the pain, erythema and swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient after receiving 1st dose experienced extreme pain, redness, and swelling. This case has been linked with case US2019AMR167047, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834894,09/20/2019,PA,60.0,60,,F,,"Fever; Feel Sick; Arm hurts a lot; This case was reported by a consumer and described the occurrence of fever in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced fever, feeling unwell and pain in arm. On an unknown date, the outcome of the fever, feeling unwell and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the fever, feeling unwell and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix vaccine and had fever, feel sick and her arm hurts a lot. The patient asked when would I feel better and would I be allowed to get the 2nd dose.",,,,,,,,,N,09/11/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834895,09/20/2019,GA,,,,F,,"Shingles; Cold sores; Fatigue; Shooting nerve pain from the corner of my eye to just below my nose; Shooting nerve pain from the corner of my eye to just below my nose/ pain; Just blow my nose I developed a Red blister/ blister; Just blow my nose I developed a Red blister/ blister; Tingling; This case was reported by a consumer via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included cold sores.   In August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced shingles, cold sores, fatigue, nerve pain, shooting pain, blister, localized erythema and tingling. The patient was treated with acyclovir. On an unknown date, the outcome of the shingles, cold sores, fatigue, nerve pain, shooting pain, blister, localized erythema and tingling were unknown.   The reporter considered the shingles, cold sores, nerve pain, shooting pain, blister, localized erythema and tingling to be unrelated to Shingrix. The reporter considered the fatigue to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported that, she received her 1st dose of Shingrix in the mid August 2019. The patient had expected fatigue reaction, but in addition she developed a shooting nerve pain from the corner of eye to just below her nose and just below nose she developed a red blister. She then quickly took acyclovir which had been prescribed for a cold sore and it went away. The patient enquired hat, whether she should take acyclovir prophylactically before receiving 2nd Shingrix dose. The patient further stated, this reaction was not listed anywhere and since Shingrix was not a live vaccine, she did not understand how she could have a case of shingles, since there was no denying that she had tingling, pain or blister. To answer patient's question, the call center representative provided information that, Shingrix does not contain any live virus, so it can not cause Shingles. Also there were no known interactions between Shingrix and acyclovir. The patient then asked, could Shingrix cause an outbreak of oral herpes in a new location, might be just from whacking the immune system but the call center representative denied it by explaining her that, shingles and herpes are two different infections caused by two different viruses. Shingles is caused by the varicella zoster virus (VZV), the same virus that causes chickenpox. Herpes is caused by the herpes simplex virus.",,,,,,,,,U,08/01/2019,,,,UNK,,,,Medical History/Concurrent Conditions: Cold sores,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834896,09/20/2019,,,,,F,,"allergic; Covered in hives; Swelling in my face; This case was reported by a consumer via interactive digital media and described the occurrence of drug allergy in a female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   The patient's past medical history included cold and influenza. Previously administered products included Proair.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced drug allergy, hives and facial swelling. Rechallenge with Influenza vaccine Quadrivalent unspecified season was positive. On an unknown date, the outcome of the drug allergy, hives and facial swelling were unknown.   It was unknown if the reporter considered the drug allergy, hives and facial swelling to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient stated that, had only pro air and nebulizer to fall back on and tried to avoid cols and flu. The patient reported that, after vaccination had very allegic to flu shot and covered in hives, and swelling on face past 2 times.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Cold; Influenza,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834897,09/20/2019,,,,,F,,"arm pain; fall asleep; Discomfort; General body pain; feeling like a truck ran you over and over and over; This case was reported by a pharmacist via sales rep and described the occurrence of pain in arm in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included DIPHTHERIA TOXOID + TETANUS TOXOID (TD) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and TD. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm, sleeplessness, discomfort, general body pain and feeling abnormal. The patient was treated with paracetamol (Tylenol) and ibuprofen (Advil). On an unknown date, the outcome of the pain in arm, sleeplessness, discomfort, general body pain and feeling abnormal were recovering/resolving.   It was unknown if the reporter considered the pain in arm, sleeplessness, discomfort, general body pain and feeling abnormal to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient both arms were achy but right arm hurt worse, hard to fall asleep with the discomfort. The patient stated that what was worse was the all over body ache I had when I awoke. The patient felt like a truck ran you over and over and over from top to bottom. The reporter was did not agree to follow up from GlaxoSmithKline.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834898,09/20/2019,,,,,F,,"allergic; Covered in hives; Swelling in my face; This case was reported by a consumer via interactive digital media and described the occurrence of drug allergy in a female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   The patient's past medical history included cold and influenza. Previously administered products included Proair.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced drug allergy, hives and facial swelling. On an unknown date, the outcome of the drug allergy, hives and facial swelling were unknown.   It was unknown if the reporter considered the drug allergy, hives and facial swelling to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient stated that, had only pro air and nebulizer to fall back on and tried to avoid cold and flu. The patient reported that, after vaccination had very allegic to flu shot and covered in hives, and swelling on face past 2 times. This case has been linked with case US2019AMR167075, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Cold; Influenza,,USGLAXOSMITHKLINEUS2019AM,2,09/20/2019,,,,
0834899,09/20/2019,PA,89.0,89,,F,,"Rash that is red, itchy, warm to touch; rash itchy; warm to touch; developed another rash on the left elbow; Raised rash; This case was reported by a consumer via call center representative and described the occurrence of red rash in a 89-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included osteoporosis. Concomitant products included denosumab (Prolia).   On 1st September 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 3 days after receiving Shingrix, the patient experienced red rash, itchy rash, heat rash, rash and raised rash. On an unknown date, the outcome of the red rash was not recovered/not resolved and the outcome of the itchy rash, heat rash and raised rash were unknown and the outcome of the rash was recovered/resolved.   It was unknown if the reporter considered the red rash, itchy rash, heat rash, rash and raised rash to be related to Shingrix.  Additional details were provided as follows: The patient received the Shingrix and 3 days later she developed a raised itchy area on the side of her left hand. Once this rash resolved, the patient developed another rash on the left elbow. This rash resolved and then the patient developed a rash on the right elbow that was red, itchy, warm to touch and 3 inches in diameter. The reporter consented to follow up.  The caller did not provide any additional details.",,,,,,,,,N,09/01/2019,,,,PHM,,PROLIA,,Medical History/Concurrent Conditions: Osteoporosis,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834901,09/20/2019,CA,76.0,76,,F,,"Redness; Arm swelling; Severe Pain; Unable to use Left arm for a couple of days; This case was reported by a physician via call center representative and described the occurrence of erythema of extremities in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included measles virus vaccine live attenuated (Measles Vaccine) for prophylaxis.   In May 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient started Measles Vaccine at an unknown dose and frequency. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced erythema of extremities, swelling arm, pain in arm and injected limb mobility decreased. On an unknown date, the outcome of the erythema of extremities, swelling arm, pain in arm and injected limb mobility decreased were recovered/resolved.   It was unknown if the reporter considered the erythema of extremities, swelling arm, pain in arm and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The reporter asked how to proceed with the 2nd dose. The patient after receiving 1st dose experienced local reaction of redness, swelling, severe pain and unable to use her Left Arm for a couple days. The patient 2 weeks prior received a measles vaccination. The reporter asked for any information available to continue series or any drug interaction with the measles vaccination. The reporter consented to follow up. This case has been linked with case US2019165633, reported by the same reporter.",,,,,,,,,Y,05/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834902,09/20/2019,AZ,69.0,69,,M,,"blister below his belly button; This case was reported by a consumer via call center representative and described the occurrence of blister in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st September 2019, the patient received the 1st dose of Shingrix. On 8th September 2019, 7 days after receiving Shingrix, the patient experienced blister. On an unknown date, the outcome of the blister was unknown.   It was unknown if the reporter considered the blister to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and she developed a blister below his belly button. She reported that he was going to see his physician this week and would inform about the blister. The reporter consented to follow up.",,,,,,,,,U,09/01/2019,09/08/2019,7,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834903,09/20/2019,OH,81.0,81,,F,,"She sometimes couldn't sleep because of the arm pain; Swollen bicep muscle; The vaccine may have been given in the bicep muscle and not up higher where it normally should be; Soreness in the arm; malaise; swelling in the area where she received the shingrix shot\lump in arm; It was red and painful; It was red and painful; she couldn't hardly move her arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 81-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included denosumab (Prolia) for osteoporosis.   Previously administered products included Prolia with an associated reaction of pain.   On 1st August 2019, the patient received the 1st dose of Shingrix. On 12th August 2019, the patient started Prolia (subcutaneous) at an unknown dose and frequency. On 1st August 2019, less than a day after receiving Shingrix, the patient experienced pain in arm, malaise and vaccine administered at inappropriate site. In August 2019, the patient experienced extensive swelling of vaccinated limb, injection site pain, injection site erythema and injected limb mobility decreased. On an unknown date, the patient experienced difficulty sleeping and muscle swelling. On 2nd August 2019, the outcome of the pain in arm and malaise were recovered/resolved. On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site pain, injection site erythema and injected limb mobility decreased were recovering/resolving and the outcome of the difficulty sleeping, muscle swelling and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the pain in arm, malaise, extensive swelling of vaccinated limb, injection site pain, injection site erythema, injected limb mobility decreased, difficulty sleeping and muscle swelling to be related to Shingrix.  Additional details were provided as follows: The reporter stated that the patient experienced soreness in the arm and malaise for about a day and then it resolved. On  12th October 2019, the patient went into receive her 14th dose of Prolia, which she did in the left arm also but in the subcutaneous tissue on the back upper side of her left arm.  The patient developed swelling in the area where she received the shingrix shot, it was red and painful.  The patient noted it was so swollen she looked like a football player.  it was down to the elbow. The patient returned to her Endocrinologist where she received the Prolia on 8/19, because that was the last shot and it was so far after the Shingrix shot. An MRI and ultrasound of her arm were done to rule out blood clot and ruptured muscle.  The patient was told Prolia shot wouldn't cause that reaction and she was referred to a bone doctor.  Blood tests were also performed and negative along with the Ultrasound and MRI.   The patient saw the bone doctor on 30th August 2019,  she states she could not hardly move her arm to dress herself and the pain was worse. The patient noted she sometimes could not sleep because of the arm pain. The patient also noted lump in the arm. The bone doctor showed her on the MRI that she had a very swollen bicep muscle. The patient was concerned when she saw the MRI film as she believes the vaccine may have been given in the bicep muscle and not up higher where it normally should be, which led to vaccine administered at inappropriate site. The patient believes it was given on the front of the arm, in the middle between her shoulder and elbow. The patient noted the Prolia was given to the back of the arm but appeared a little higher than normal.  The patient noted she had improved significantly,  she still had difficulty holding her arm up and out but the pain is about 95 percent better.   The patient stated the bone doctor has her doing arm exercises and recommended she receive the shingrix second shot in her right arm, which she stated she would not do. The patient states she would not be able to go that lone with her dominant arm in pain or with decreased mobility. The patient plans to discuss the second shot with her  Endocrinologist and her primary care physician. The reporter consented to follow up.      Lab Comments: on an unknown date MRI, ultrasound and blood test was done",,,,,,,,,N,08/01/2019,08/01/2019,0,"Test Name: Blood test; Result Unstructured Data: Test Result: negative, Test Result Unit: unknown; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: swollen bicep muscle, Test Result Unit: unknown; Test Name: Diagnostic ultrasound; Result Unstructured Data: Test Result: unknown, Test Result Unit: unknown",PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,Y,Y,
0834904,09/20/2019,FL,78.0,78,,F,,"redness at injection site; swelling at injection site; lump at injection site; Full body rash (from head to toe).; Rash looks a little like chickenpox; This case was reported by a physician via call center representative and described the occurrence of injection site erythema in a 78-year-old female patient who received Herpes zoster (Shingrix) (batch number 5TH3L, expiry date 19th November 2021) for prophylaxis.   On 5th September 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In September 2019, less than a week after receiving Shingrix, the patient experienced injection site erythema, injection site swelling, injection site lump, generalized rash and varicella. The patient was treated with paracetamol (Tylenol) and benadryl (nos) (Benadryl). On an unknown date, the outcome of the injection site erythema, injection site swelling, injection site lump, generalized rash and varicella were recovering/resolving.   It was unknown if the reporter considered the injection site erythema, injection site swelling, injection site lump, generalized rash and varicella to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient experienced redness, swelling and a lump at the injection site. The patient also experienced full body rash (from head to toe). The reporter stated that the rash looked a little like chickenpox. The patient was taking over the counter Tylenol and Benadryl for the symptoms. The emergency room visit was required. The reporter did not provide any additional information.",,,,,,,,,N,09/05/2019,09/01/2019,,,PVT,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,Y,
0834905,09/20/2019,PA,67.0,67,,F,,"Sunburn feeling of her skin; This case was reported by a consumer via call center representative and described the occurrence of burning sensation skin in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th June 2019, the patient received the 1st dose of Shingrix. On 8th June 2019, less than a day after receiving Shingrix, the patient experienced burning sensation skin. The patient was treated with valaciclovir hydrochloride (Valtrex). On an unknown date, the outcome of the burning sensation skin was recovering/resolving.   It was unknown if the reporter considered the burning sensation skin to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient had sunburn feeling of her skin after receiving vaccine. The patient had no redness, rash or bumps, just a feeling of a sunburn on her back. The reporter consented to follow up. For tolerance to the VALTREX, refer case US2019166358.",,,,,,,,,N,06/08/2019,06/08/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834906,09/20/2019,NY,,,,F,,"Severe Back Pain; This case was reported by a consumer via call center representative and described the occurrence of back pain in a adult female patient who received Flu unspecified (Flu vaccine) for prophylaxis.   The patient's past medical history included open heart surgery. Previously administered products included Flu vaccine with an associated reaction of malaise (received flu vaccine in 1976 and reaction ill ). Concurrent medical conditions included allergy to antibiotic (allergic to neomycin) and penicillin allergy.   On an unknown date, the patient received Flu vaccine. On an unknown date, several years after receiving Flu vaccine, the patient experienced back pain. On an unknown date, the outcome of the back pain was resolved with sequelae.   It was unknown if the reporter considered the back pain to be related to Flu vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient stated that approximately 10 years before the reporting date, she received a flu vaccine and experienced severe back pain that lasted 48 hours. The patient did not consent to follow up. The patient did not provide any additional details.",,,,,,,,,N,,,,,UNK,,,Allergy to antibiotic (allergic to neomycin); Penicillin allergy,Medical History/Concurrent Conditions: Open heart surgery,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834907,09/20/2019,MS,,,,U,,"Goose Egg; This case was reported by a pharmacist via call center representative and described the occurrence of swelling in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced swelling. On an unknown date, the outcome of the swelling was recovered/resolved.   It was unknown if the reporter considered the swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The healthcare professional stated that, the patient had a goose egg that lasted for 2 to 3 days. The reporter did not consent to follow up. The healthcare professional declined to provide any additional information. The healthcare professional declined follow up regarding the case. This case is 1 of the 2 linked cases, reported by the same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834908,09/20/2019,NY,57.0,57,,M,,"Up and down red sports and the spots are raised; Raised rash; This case was reported by a consumer via call center representative and described the occurrence of erythromacular rash in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd September 2019, the patient received the 1st dose of Shingrix (intramuscular). In September 2019, 3 days after receiving Shingrix, the patient experienced erythromacular rash and raised rash. On an unknown date, the outcome of the erythromacular rash and raised rash were recovering/resolving.   It was unknown if the reporter considered the erythromacular rash and raised rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix on left arm. The patent developed a rash on both of his legs. The rash was on the entire legs and the patient described it as up and down red sports and the spots are raised. The patient consented to follow up.",,,,,,,,,N,09/02/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834909,09/20/2019,ND,,,,M,,"Shingles after Shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 62-year-old male patient who received Herpes zoster (Shingrix) (batch number AC79X, expiry date 17th October 2021) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient developed shingles after first dose of Shingrix. The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834910,09/20/2019,NE,,,,M,,"Nausea; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 81-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced nausea. On an unknown date, the outcome of the nausea was recovered/resolved.   It was unknown if the reporter considered the nausea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter's father experienced nausea the next day after receiving the first dose of the Shingrix vaccine.  The nausea resolved within one day. The reporter unable to obtain additional details. The reporter was unable to provide additional details. This was 1 of 4 linked cases reported by the same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834911,09/20/2019,NY,78.0,77,,F,,"Sharp pain in both arms,  and by the neck; Sharp pain in both arms,  and by the neck; headache; nausea; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included ibuprofen (Advil) for pain.   On 16th August 2019, the patient received the 1st dose of Shingrix. In August 2019, the patient started Advil at an unknown dose and frequency. In August 2019, less than 2 months after receiving Shingrix, the patient experienced nausea. On 19th August 2019, the patient experienced pain in arm, neck pain and headache. The action taken with Advil was unknown. On an unknown date, the outcome of the pain in arm, neck pain, headache and nausea were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, neck pain, headache and nausea to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left arm. The patient stated that approximately 3 days after receiving the vaccine, she developed sharp pain in both arms, and by the neck.  The patient also developed a headache. Patient stated that she went to see her doctor and received acupuncture to help with the pain, however, this did not resolve the pain.  The patient stated that she was also taking Advil and other pain medications for the pain, which were not helping. On an unknown date, less than 2 months after receiving a dose of Shingrix, Advil and pain medications, the patient was also experiencing nausea that she believed was caused by the pain medications. The reporter considered the nausea to be related to Advil and pain medication as well. It was reported that emergency room visit required. The contact information not available at the time of the call. The reporter did not provided any additional information. The reporter consented to follow up. This case had been linked to the case US2019166404, reported by same reporter. In the XML document outcome of events was reported as recovering, but in Argus its mentioned as not recovered, so kept as reported in Argus.",,,,,,,,,N,08/01/2019,08/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,Y,,
0834912,09/20/2019,NY,67.0,67,,F,,"fever; tachycardia; fatigue; headache; difficulty getting out of bed; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number 2G2T7, expiry date 15th November 2021) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Shingrix (intramuscular). In September 2019, less than a week after receiving Shingrix, the patient experienced fever, tachycardia, fatigue, headache and mobility decreased. In September 2019, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the tachycardia, fatigue, headache and mobility decreased were unknown.   It was unknown if the reporter considered the fever, tachycardia, fatigue, headache and mobility decreased to be related to Shingrix.  Additional case details were reported as follows: The patient experienced fever, which was resolved, and had tachycardia, fatigue, headache, difficulty getting out of bed. The reporter consented to follow up.",,,,,,,,,Y,09/09/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834913,09/20/2019,OK,,,,F,,"diarhea; loss of balance; disoriented; food allergy; nausea; feeling faint; low grade fever; stomach pain; tired/sleepy; Sleepiness; malaise; hives; Itchy; This case was reported by a consumer via call center representative and described the occurrence of food allergy in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In August 2019, 3 days after receiving Shingrix, the patient experienced hives and pruritus. On 27th August 2019, the patient experienced food allergy, nausea, felt faint, low grade fever, stomach pain, tiredness, sleepiness and malaise. On 9th September 2019, the patient experienced diarrhea, loss of balance and disorientation. The patient was treated with benadryl (nos) (Benadryl), topical steroid nos (Steroid Cream) and eucerin (nos) (Eucerin Cream). On 6th September 2019, the outcome of the low grade fever was resolved with sequelae. On an unknown date, the outcome of the food allergy was unknown and the outcome of the nausea, felt faint, hives, stomach pain, tiredness, sleepiness, malaise, diarrhea, loss of balance and pruritus were recovering/resolving and the outcome of the disorientation was resolved with sequelae.   It was unknown if the reporter considered the food allergy, nausea, felt faint, hives, low grade fever, stomach pain, tiredness, sleepiness, malaise, diarrhea, loss of balance, disorientation and pruritus to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient developed nausea, faintness, low grade fever, stomach pain, tired/sleepy, malaise. The patient developed itchy hives 3-4 days after her dose 1 and they are still ongoing and in a variety of locations. The patient went to the doctors regarding these symptoms on 9/6/19 and was diagnosed with food allergies, patient disagrees with this diagnosis. The patient was prescribed benadryl at bedtime, and a steroid cream for the hives. The patient stated that had diarrhea, loss of balance and disorientation. The patient did not consent to follow up.",,,,,,,,,N,08/26/2019,08/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,Y,,
0834914,09/20/2019,NC,,,,M,,"Shingles (that are scabbed over); developed shingles (that were scabbed over); This case was reported by a nurse via call center representative and described the occurrence of shingles in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included knee operation.   In January 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix, the patient experienced shingles and scab. On an unknown date, the outcome of the shingles and scab were unknown.   It was unknown if the reporter considered the shingles and scab to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported but could be 74 or 75 years. The patient was unable to receive the 2nd dose at the recommended time frame due to surgery with complications.  The patient had since developed shingles (that were scabbed over) and reporter was inquiring when he should receive the 2nd dose or if he should restart the series. The patient had knee surgery, which she states was unrelated to him receiving Shingrix.  The reporter consented to follow up.",,,,,,,,,U,01/01/2019,,,,UNK,,,,Medical History/Concurrent Conditions: Knee operation,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0834915,09/20/2019,LA,55.0,54,,F,,"positive complement titer; swelling; Lip swelling; swelling on eyelids; ankle swelling; positive ANA titer; angeoedema; urticaria; rash; This case was reported by a consumer via sales rep and described the occurrence of angioedema in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 11th January 2019, the patient received the 1st dose of Shingrix (intramuscular). On 18th June 2019, the patient received the 2nd dose of Shingrix (intramuscular). In February 2019, less than 2 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced angioedema (serious criteria GSK medically significant), chronic urticaria and rash. In May 2019, the patient experienced antinuclear antibody positive. On an unknown date, the patient experienced complement fixation test positive, facial swelling, lip swelling, swelling of eyelid and ankle swelling. On an unknown date, the outcome of the angioedema, chronic urticaria and rash were not recovered/not resolved and the outcome of the antinuclear antibody positive, complement fixation test positive, facial swelling, lip swelling, swelling of eyelid and ankle swelling were unknown.   It was unknown if the reporter considered the angioedema, chronic urticaria, rash, antinuclear antibody positive, complement fixation test positive, facial swelling, lip swelling, swelling of eyelid and ankle swelling to be related to Shingrix. It was unknown if the reporter considered the complement fixation test positive to be related to Shingrix.  Additional details were provided as follows: The case was reported by the field representative, who was also the patient. At the end of February 2019, the patient experienced a rash and chronic urticaria with angioedema. Her face, lips, eyelids and ankles swell and this happened daily.  In May 2019, she saw an allergist and had a positive antinuclear antibody (ANA) titer. The patient also saw a rheumatologist, but all the tests for autoimmune diseases were negative except for a positive complement factor, which she expected with the reaction she had.      Lab Comments: on an unknown date, all the tests for autoimmune diseases were negative",,,,,,,,,N,01/11/2019,02/01/2019,21,"Test Date: 201905; Test Name: Antinuclear antibody positive; Result Unstructured Data: Test Result: positive, Test Result Unit: unknown; Test Date: 201905; Test Name: Complement fixation test positive; Result Unstructured Data: Test Result: positive, Test Result Unit: unknown; Test Name: Laboratory test; Result Unstructured Data: Test Result: negative, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,Y,Y,
0834916,09/20/2019,TX,56.0,56,,M,,Noticed very high pitched ringing in both ears about 3.5 hours after injection. Ringing in both ears persists 22 hours after injection.,,,,,,,,,N,09/19/2019,09/19/2019,0,,PHM,,"None the day prior or day of vaccination. But a few hours after the reaction symptoms a ""Nature Made"" Stress B-Complex tablet was taken.",None,None,,,2,09/20/2019,,,,"Penicillin,  erythromycin, V-cillin K, Bactrim"
0834917,09/20/2019,CA,1.5,1,.5,M,,"Severe Rash on Sept 15, vomiting and refusal to eat, diarrhea. It is now 15 days after the vaccine and the rash is looking better but the vomiting and diarrhea continue. We have been to urgent care and also the Pediatrician who are recommending just treating the symptoms.",,,,,,,,,N,08/05/2019,09/14/2019,40,MMR and Varicella Vaccine,PVT,,,,,,,2,09/20/2019,,Y,Y,
0834918,09/20/2019,OH,68.0,68,,F,,"Red bullseye around vaccination site 1.5-2 hours after, swollen and red next morning",,,,,,,,,N,09/19/2019,09/19/2019,0,"None, but Dr wrote prescription for patient for prednisone 10 mg BID x 7 days on 9/20/19",PHM,,"Latanoprost eye drops, ezetimibe, multivitamin, ventolin HFA",None,asthma,,,2,09/20/2019,,Y,,"Latex, soy, sulfa/sulfites, MSG"
0834919,09/20/2019,NE,84.0,84,,F,,"Patient's right arm is red, swollen, hot, and hard to the touch.",,,,,,,,,U,09/11/2019,09/17/2019,6,immunization Prevnar 13 given to patient in the right deltoid IM route,PVT,,"Tylenol, alendronate, aspirin, refresh eye drops, carvedilol, cetirizine, losartan, simvastatin, dyazide, vitamin c, multivitamin",none,"osteoporosis, arthritis, CF, diabetes (pre), hypercholestermia, hypertension, macular degeneration disease, osteoprosis",,,2,09/20/2019,,Y,,ace inhibitors captopril sulfa cefadroxil
0834920,09/20/2019,NC,64.0,64,,F,,OUTSIDE OF FDA APPROVED AGE RANGE,,,,,,,,,,09/06/2019,,,,PHM,,,,,,,2,09/20/2019,,,,
0834921,09/20/2019,NC,64.0,64,,F,,OUTSIDE OF FDA APPROVED AGE RANGE,,,,,,,,,,09/06/2019,,,,PHM,,,,,,,2,09/20/2019,,,,
0834922,09/20/2019,ID,16.0,16,,M,,"Mother brought in patient for flu vaccine and 2nd dose of Trumenba. Mother called in the afternoon concerned for son. Mother states that he has malaise, joint pain specifically to knees and ankles. Has trouble walking because they ache.",,,,,,,,,U,09/01/2019,09/20/2019,19,None,OTH,,None.,None,None,,,2,09/20/2019,,,,None
0834923,09/20/2019,GA,65.0,65,,F,,"Patient called pharmacy on Tuesday 9-10-2019 to report severe fatigue, nausea, malaise and following vaccination on the morning of 9-9-19. Per follow-up conversations, symptoms took about seven days to resolve.",,,,,,,,,Y,09/09/2019,09/09/2019,0,,PHM,,Folic acid; Vit D; Vit B-12,,"Difficulty breathing, but no diagnosis",,,2,09/20/2019,,,,NKDA
0834924,09/20/2019,FL,79.0,79,,M,,"Severe rash extendind from right shoulder, across chest and to the left shoulder. Also rash spots on both hands and inbetween index fingers and middle fingers. Patient states it came up about one month after the vaccine. States it itches, but does not give a burning sensation. Doctor is treating with Valcyclovir 1 gram by mouth twice a day for 7 days.",,,,,,,,,U,08/16/2019,09/19/2019,34,Unknown,PHM,,,,,,,2,09/20/2019,,Y,,
0834925,09/20/2019,IL,69.0,69,,F,,"24 hours later felt nauseated, projectile vomited down to yellow vile. Called the doctor and told to take Tylenol and rest. Took some Emetrol and Pedialyte.  Arm was swollen from deltoid halfway down; it was hard, hot, red and couldn't move arm.  Used ice/gel packs and took 2 Ibuprofen tablets 400mg but did not help.  Slept a lot.  Can move arm a little bit but it is warm and not as swollen on deltoid.  Will follow-up with doctor in 1 month.   Recovery at 85%",,,,,,,,,U,09/10/2019,09/11/2019,1,,PVT,,"Multivitamin, GasX, Calcium and D3, Vitamin C, Anoro Ellipta, 25 per inhalation/1 daily, Lisinopril-HCTZ 20/25mg,  EpiPen as needed, Estrace, Zetia, Fenofibrate Micronized, B-12 injections, Klonopin, Lotemax 0.5 ophthalmic suspension, Predn","No, No","Fribromyalgia, AIP +, Tb, COPD, Arthritis, Osteoarthritis, Cholesterol, Triglycerides, hormone replacement therapy GERD, Gastritis, Retinosis",Flu vaccines: redness and swelling every year because it is egg based,,2,09/17/2019,,,,"Eggs, mold, yellow dye"
0834926,09/20/2019,VA,21.0,21,,M,,"Onset of ageusia, neck pain and headache within 12 hours of receipt of vaccine dose.  Symptoms persisted and within 48 hours unilateral facial paralysis noted.  Evaluated via an emergency department and given diagnosis of Bell's Palsy.",,,,,,,,,N,09/13/2019,09/13/2019,0,CT and MRI without findings consistent with CVA.,MIL,,Bictegravir/Emtricitabine/Tenofovir Alafenamide,None,Human immunodeficiency virus,,,2,09/20/2019,,,Y,No known allergies.
0834927,09/20/2019,MN,40.0,40,,F,,"09/16/19 pain on right side of face and chest, shortness of breath around 11pm 09/17/19 swelling in right arm, pain in right side of chest and torso. Temp 100.8 Tylenol was taken and  ice packs were applied to arm 09/18/19 Tylenol taken for pain and ice packs applied to right arm 09/19/19 No Tylenol take. Arm was red slightly swollen with induration",,,,,,,,,U,09/16/2019,09/16/2019,0,na,OTH,,Fluoxetine 20mg 1 tablet by mouth daily.,na,anxiety/depression  migraines,,,2,09/20/2019,,Y,,metamizol hydrocodone
0834928,09/20/2019,KY,64.0,64,,F,,PATIENT STATES SHE EXPERIENCED EXTRA ERYTHEMA AT THE INJECTION SITE THAT SPREAD DOWN HER ARM. SHE IS GOING TO A MEDICAL PHYSICIAN FOR FURTHER EVALUATION.,,,,,,,,,U,09/13/2019,09/14/2019,1,PHYSICIAN APPOINTMENT.,PHM,,,,DIABETES,,,2,09/20/2019,,Y,,"CONTRAST MEDIA (IODINATED), NSAIDS, ACE INHIBITORS, CELEBREX."
0834929,09/20/2019,OH,59.0,59,,F,,"nausea, muscle soreness, shivers, fever, headache, starting about 24 hours after injection, continuing into day 2",,,,,,,,,N,09/18/2019,09/19/2019,1,,PHM,,"omeprezol, metoprolol succinate, losartan",2 weeks prior upper respiratory infection,high blood pressure,,,2,09/20/2019,,,,morphine
0834930,09/20/2019,TX,70.0,70,,F,,"Patient stated had hives, redness, fever, itching, swelling in left arm from shoulder to elbow.  The symptoms lasted for 3 weeks.  She is fine now and just ""stuck it out"".",,,,,,,,,Y,07/15/2019,07/16/2019,1,none done,PHM,,NONE,none,none,,,2,09/20/2019,,,,Penicillins and Codeine
0834931,09/20/2019,NJ,36.0,36,,F,,Bleeding at site of injection but resolved.  Then pain at sight of injection following day .,,,,,,,,,Y,09/19/2019,09/19/2019,0,None,PHM,,None,None,None,,,2,09/20/2019,,,,None
0834932,09/20/2019,SC,73.0,73,,F,,"Pt came with Swollen right arm,  rash, and fever. Treatment included: tylenol, Benadryl QHS, and cold compressions.",,,,,,,,,Y,09/17/2019,09/18/2019,1,,PHM,,,,,,,2,09/20/2019,,Y,,PCN
0834933,09/20/2019,FL,76.0,76,,F,,"Patient developed redness, heat, pain, and swelling at injection site. Did not seek any medical treatment and tolerated the effects on her own.",,,,,,,,,U,09/15/2019,09/15/2019,0,,PHM,,,,,,,2,09/20/2019,,,,
0834934,09/20/2019,IN,71.0,71,,F,,"Started to itch at the site around 5pm the day of the injection.  The site was red and swollen mid bicep on 9/20/19 slightly warm to touch.  Called doctor's office and they told patient to take benadryl, & use cold compress for 15 to 30 minutes every 1 to 2 hours.",,,,,,,,,U,09/18/2019,09/18/2019,0,None,PHM,,"Lexapro, Vitamin D (otc), Zantac",None,None,,,2,09/20/2019,,,,"NKDA, no food allergies"
0834935,09/20/2019,MS,7.0,7,,M,,"localized hives at injection site, appeared at 24 hours post vaccination. worsening at 48h.  treated for allergic rxn with decadron, benadryl, ranitidine",,,,,,,,,U,09/17/2019,09/19/2019,2,,PUB,,none,none,none,,,2,09/20/2019,,Y,,no known allergies
0834936,09/20/2019,OR,66.0,0,.0,F,,"2-3 hours after receiving vaccine, patient reported having headache, chills, nausea, and diarrhea.",,,,,,,,,U,01/04/1953,09/19/2019,24364,,PHM,,,,,,,2,09/20/2019,,,,
0834937,09/20/2019,IN,72.0,72,,F,,"Patient got pustular red bumpy rash on arms and stomach after 2nd dose. It appeared a few days after receiving vaccine. After 1st dose, patient's arm swelled at the site of injection. Patient did not go to MD and self treated with benadryl.",,,,,,,,,Y,09/02/2019,09/07/2019,5,N/A,PHM,,,,,,,2,09/20/2019,,,,
0834938,09/20/2019,NV,38.0,38,,M,,"Increased seizure frequency beginning one day after vaccination. Per patient, typically experiences 1 seizure per month; increased to 3 within a 48 hour period",,,,,,,,,Y,09/04/2019,09/05/2019,1,,PHM,,"aripiprazole 5mg tab, ibuprofen 800mg tab, briviact 50mg tab, citalopram 20mg tab, omeprazole 20mg cap, lamotrigine 200mg tab, topiramate 200mg tab",,epilepsy,,,2,09/20/2019,,Y,,sulfa drugs
0834939,09/20/2019,AL,5.0,4,,M,,He developed fever with 2-3 hours and began stating that he could not walk.  We put him to bed and called the doctor.  He said that his neck and head hurt.  He coughed a few times and later went to sleep.,,,,,,,,,Y,03/21/2019,03/21/2019,0,,PVT,,Flintstones Vitamins with Iron,None,None,,,2,09/20/2019,,Y,,None
0834940,09/20/2019,CT,69.0,69,,F,,"Patient reports acute onset fever to 104, drenching sweats and intense myalgias hours after vaccine.  9 wks later, intense muscle pain, fatigue and low grade fever, occasional sweats persist.",,,,,,,,,N,07/03/2019,07/03/2019,0,"CBC , BC, CXR",WRK,,"Calcium/magnesium supplement,  coenzyme Q10, vitamin D, folic acid, glucosamine complex,  red yeast rice, synthroid, zinc, zetia",none,"Psoriatic arthritis, remote history of small cell lung cancer, hypothyroidism, TIA, dyslipidemia, abnormal pap smear with HPV",,,2,09/20/2019,,Y,,casein
0834941,09/20/2019,PA,67.0,67,,F,,Bruised arm and redness,,,,,,,,,,09/16/2019,09/17/2019,1,,PHM,,,,,,,2,09/20/2019,,Y,,
0834942,09/20/2019,CO,62.0,62,,F,,Patient called to report raised hot area after vaccination. Came up about 2 inches below vaccination site.,,,,,,,,,N,09/18/2019,09/19/2019,1,none,PHM,,"Diltiazem, spironolactone, baclofen, nystatin, Flovent, Ventolin, thyroid meds",n/a,"hypothyroidism, allergic rhinitis, asthma, chronic rhinitis, esophagitis",,,2,09/20/2019,,Y,,"beta-blockers, lansoprazole, macrolides, ranitidine, sulfonamide antibiotics, tetracycline"
0834943,09/20/2019,CA,26.0,26,,F,,"26 year old year old female who developed pain and swelling at the immunization site in her left arm after receiving the varicella vaccine two days ago.  The pain and swelling have begun to dissipate, but she is now having a rash on the left arm.  Her pain is now 2/10, located in left tricep area and is described as dull in nature.  Denies paresthesia, numbness, or motor weakness.",,,,,,,,,U,09/17/2019,09/17/2019,0,,SCH,,"Klonopin, Levonogestrel",None,,,,2,09/20/2019,,Y,,Aspirin
0834944,09/20/2019,ME,52.0,52,,F,,Patient broke out in a rash on the back of both elbows and the back of both knees. She contacted her prescriber and was using hydrocortisone,,,,,,,,,Y,09/09/2019,09/10/2019,1,,PHM,,,,,,,2,09/20/2019,,,,
0834945,09/20/2019,ME,61.0,61,,F,,"Patient had large red spot at injection site, had flu-like symptoms that lasted 5 days after the injection. Patient had similar reaction with the first dose as well",,,,,,,,,Y,07/31/2019,08/01/2019,1,,PHM,,,,,,,2,09/20/2019,,,,
0834946,09/20/2019,,,,,U,,"Limited range of motion in arm, constant pain in arm (at/around injection site, down through arm, around shoulder and upper back); growing  red ""halo"" around injection site; flu like symptoms.",,,,,,,,,N,,,,None at this time but if symptoms persist will seek treatment at Hospital; consulted command today regarding symptoms.,MIL,,,,,,,2,09/20/2019,,Y,,
0834947,09/20/2019,ME,57.0,57,,F,,Patient had redness and pain at the injection site along with flu-like symptoms that lasted 3 days. Patient's husband received the same dose on the same day and did not have any reaction,,,,,,,,,Y,09/13/2019,09/14/2019,1,,PHM,,,,,,,2,09/20/2019,,,,
0834948,09/20/2019,NH,68.0,68,,F,,red round rash that is itchy,,,,,,,,,U,09/17/2019,09/17/2019,0,,PHM,,,,,,,2,09/20/2019,,Y,,
0834949,09/20/2019,WI,68.0,68,,F,,"Chills, headache, fever, muscle pain,, lethargy, nausea, lack of energy, general malaise",,,,,,,,,N,09/19/2019,09/19/2019,0,,PHM,,,,,,,2,09/20/2019,,,,
0834950,09/20/2019,MA,37.0,37,,F,,Patient mention that the area is red. She does not have any pain but the skin is warm to touch and red,,,,,,,,,U,09/18/2019,09/20/2019,2,,PHM,,seroquel  amitriptylin clonazepam buspar efffexor,na,,,,2,09/20/2019,,,,abilify  penicillin
0834951,09/20/2019,MA,0.33,0,.4,F,,"This patient received her 4 month vaccines per protocol. One day after receiving vaccines, she developed vomiting and diarrhea. 5 days after receiving vaccines, she was diagnosed with ileocolic intussusception which was reduced with air contrast enema under fluoroscopy on 9/3/19 with no complications or sequelae.",,,,,Y,1,,,Y,08/28/2019,09/03/2019,6,Diagnostic and therapeutic air contrast enema on 9/3/19.,PVT,,"None, only infant formula.",Vomiting and diarrhea starting on 8/29/2019.,None.,,,2,09/20/2019,,Y,Y,None known.
0834952,09/20/2019,CA,51.0,51,,M,,"I felt sore muscles, fatigue, and slight chills, elevated heart rate (up to 110s) and a restless sleep.  Symptoms resolves by the middle of the next day (about 24 hours after the injection.",,,,,,,,,Y,09/18/2019,09/18/2019,0,No tests were done.,PHM,,Atorvastatin 10MG taken 12 hours prior to vaccination Dymista (one pump) taken 10 hours prior to vaccination,none,"no issues, in good health",,,2,09/20/2019,,,,penicillin (hives after 4 days of dosage)
0834953,09/20/2019,PA,71.0,71,,F,,"Inner arm swollen, red and warm to touch. Not near injection site. Stated started 1 day after vaccine.  Pt. does not believe due to injection, just wanted RPH to look at it. Says might have bumped arm somewhere. Informed pt. to go to MD to have looked at.",,,,,,,,,,09/16/2019,09/17/2019,1,,UNK,,,,,,,2,09/20/2019,,,,
0834954,09/20/2019,NC,52.0,52,,F,,"Sore injection site, bruised, warm, red  3"" around site, all-over itching",,,,,,,,,N,09/19/2019,09/19/2019,0,None,PVT,,"Warfarin, metoprolol. Aspirin, Celexa,  coq10, multivitamin, neurontin",None,"Depression, heart issues",,,2,09/20/2019,,,,Nothing notablw
0834955,09/20/2019,KS,66.0,66,,F,,Patient said she felt dizzy and had her blood pressure taken and it was really high so she went to emergency room and they couldn't find anything wrong. She went to her primary care physician and he was not sure if it could have been caused by the vaccine. She is to monitor her blood pressure with the possibility of increasing her blood pressure medication,,,,,,,,,U,09/06/2019,09/09/2019,3,,PHM,,,,"High Blood Pressure, High Cholestrol",,,2,09/20/2019,,Y,Y,
0834956,09/20/2019,TX,24.0,24,,F,,No adverse events reported yet. Md aware. Said it's fine,,,,,,,,,U,09/19/2019,09/19/2019,0,,PHM,,Norg-ee-0.18-0.215-0.25/0.035,Unknown,Unknown,,,2,09/20/2019,,,,Nkda
0834957,09/20/2019,IN,70.0,70,,F,,"local reaction to the site. Swelling, redness, and warm to touch. Patient came to pharmacy 8/20/19 to show reaction. Pharmacist advised patient to use ice packs for the swelling, ibuprofen for the pain and swelling, and benadryl at night.  Primary Dr. has been contacted and advised same course of action as the pharmacist",,,,,,,,,U,09/18/2019,09/19/2019,1,,UNK,,,,,,,2,09/20/2019,,Y,,latex
0834958,09/20/2019,FL,62.0,62,,F,,"on 3rd day after shot, patient experienced sweating, shivers, dizziness, incoordination, ""TIA""",,,,,,,,,U,09/10/2019,09/13/2019,3,,PHM,,"Amphetamine Salts 20mg, Clonazepam 0.5mg, Lithium Carb 300mg, Rosuvastatin 20mg",,,,,2,09/20/2019,,,,Amoxicillin
0834959,09/20/2019,NY,15.0,15,,M,,"Respiratory Infection, Fever, tirdness",,,,,,,,,N,09/01/2019,09/19/2019,18,,PVT,,Daily Vitamin,None,None,,,2,09/20/2019,,,,No
0834960,09/20/2019,MS,26.0,26,,F,,"LARGE RED, WARM, RAISED AREA",,,,,,,,,,09/16/2019,09/17/2019,1,,WRK,,,,,STATES SHE HAD A SIMILAR REACTION TO THE FLU SHOT LAST YEAR,,2,09/20/2019,,Y,,
0834961,09/20/2019,,67.0,67,,M,,"Patient became extremely dizzy, reported back to pharmacy then vomited. Symptoms began approximately 10 minutes after receiving the vaccine. He was given meclizine 25mg x2 for dizziness/unsteadiness. Approximately 20 minutes after this initial symptoms patient vomited again but stated he was less dizzy than initially.  Symptoms gradually resolved and patient left the store feeling mostly normal approximate 70 minutes after receiving the vaccine.",,,,,,,,,Y,09/20/2019,09/20/2019,0,,PHM,,,,,,,2,09/20/2019,,,,
0834963,09/20/2019,NY,14.0,14,,F,,"09/09/2019-present,  persistent headache Motrin/Advil (provided minimal relief) ,fatigue, swollen glands, fevers on & off",,,,,,,,,N,09/09/2019,09/09/2019,0,"09/11/2019 throat culture negative for strep at MD 09/19/2019 complete blood work, monocytosis present; lumbar puncture performed as MD expressed concerns of ""vaccine induced meningitis or encephalitis"" results WNL, however, MD stated aspirating spinal fluid relieved some pressure in her head as she felt relief from her headache shortly after.  Although, it became worse again later that night, she continues to have a headache & fatigue.",PVT,,none,none,none,,,2,09/20/2019,,,Y,none
0834964,09/20/2019,AR,50.0,50,,F,,"muscle aches in BLE, dull ache behind eyes, general  malaise",,,,,,,,,N,09/18/2019,09/19/2019,1,,SCH,,none,none,none,,,2,09/20/2019,,,,none
0834965,09/20/2019,CO,15.0,15,,F,,"Patient received immunization in a seated position. After the immunization, patient stood around the immunization area for approximately 10 minutes when the patient experienced syncope and collapse. Patient was caught prior to making contact with the floor. No apparent physical injuries were present.",,,,,,,,,Y,09/20/2019,09/20/2019,0,,PHM,,,,,,,2,09/20/2019,,,,
0834966,09/20/2019,CA,22.0,22,,F,,"AFTER RECIEVING THE SHOT, WITHIN 5-7 MINS, PATIENT EXPERIENCED SYNCOPY AND FELL TO THE FLOOR. ON THE WAY, SHE HIT HER HEAD AGAINST THE WALL.  SHE WAS TURNED OVER AND SHE STARTED TO SEIZURE FOR ABOUT 10 - 15 SECONDS THEN SHE REGAINED CONCIOUSNESS WITHIN 5 MINUTES.  911 WAS CONTACTED AND SHE WAS TAKEN TO ER FOR FURTHUR EVALUATION.",,,,,,,,,Y,09/20/2019,09/20/2019,0,N/A,PHM,,none,none,none,,,2,09/20/2019,,,Y,none
0834967,09/20/2019,CA,26.0,26,,F,,"Per patient had episode where she felt light headed and ""blacked out"" but remained conscious. Noted left arm was twitching uncontrollably. Had abnormal sensation on left side for several minutes after with confusion for at least 1 hour after completion of episode.",,,,,,,,,U,09/19/2019,09/19/2019,0,EKG NSR 9/20/19,PVT,,Adderall,,,,,2,09/20/2019,,Y,,nkda
0835204,09/20/2019,NC,,63,,F,,Arm pain - could not reach Back with that arm to attach Bra. She can reach up but not Back. No reddness noted.,,,,,,,,,,05/10/2019,05/13/2019,3,none,PHM,,none noted,none,none,,,2,09/20/2019,,,,none
0835205,09/20/2019,CA,1.58,1,.6,F,,"Vaccine admit @ approx 1430 pm on 9/11/19 + next day developed ""rash"" to upper body shoulder area + intermittent fevers (99.5 - 99.7) fevers resolved 9/14/19 + rash has improved but still present. No other sx. But see ER or UC/ED for urticaria Monday if not resolved.",,,,,,,,,N,09/11/2019,09/12/2019,1,N/A to date,PVT,,N/A,N/A,N/A,,,2,09/20/2019,,,,NKDA
0835227,09/20/2019,WY,65.0,65,,M,09/05/2019,Pt with varicose veins received Shingrix 6/28/19. Started getting pain + firmness in varicose veins about 4-6 wks later. This progressively worsened. He got his second dose 8/29/19. The pain was getting worse so he decided to be scan. DVT was found with US and he was started on Eliquis. No other identified changes that would cause DVT.,,,,,,,,,U,06/28/2019,,,US showed DVT,OTH,PVT,"allopurinol, fenofibrate, finasteride, meloxicam, omeprazole",None,Varicose Veins,,,1,,,,,
0835289,09/20/2019,OH,59.0,59,,F,,Patient has a rash on the left fore arm (same side of her body as the flu shot we gave yesterday). She said her doctors office told her to get benadryl and hydrocortisone cream to be used until she can be seen. She has an appointment with MD for further guidance. Looked like possible poisen ivy to me but she denied any contact with plants. She's following up with MD to see what she should be doing. Rash was about the size of a deck of cards. We sold her the benadryl and hydrocortisone and referred her to follow up with her doctor.,,,,,,,,,N,09/19/2019,09/20/2019,1,none,PHM,,,,"Diabetes, hypothyroid, HTN, high chol.",,,2,09/20/2019,,,,NKDA
0835459,09/20/2019,AK,41.0,41,,F,,"(L) arm pain, Redness, Swelling + tingling gradually improving over last 24 hrs",,,,,,,,,N,09/18/2019,09/18/2019,0,None,PVT,,10 mg Fluoxetine,None,None,,,2,09/20/2019,,Y,,Azithromycin
0835460,09/20/2019,OH,68.0,68,,M,,Pt called 9/20 + said he has had a radiating pain down his arm + is now residing in wrist area. His gout medication (colchicine) didn't work. He will see PCP if it continues.,,,,,,,,,,09/14/2019,,,,PHM,,,,Gout,,,2,09/20/2019,,Y,,
0835464,09/20/2019,WA,62.0,62,,F,,"Severe migraine, temperature, nausea",,,,,,,,,N,09/19/2019,09/20/2019,1,N/A,PHM,,"metformin, methimazole, vit D",N/A,,,,2,09/20/2019,,,,"Morphine, NSAID"
0835493,09/20/2019,NY,65.0,65,,F,09/20/2019,Pronounced lump at the injection site with erythema started day after with pain at axilla 24 HR after onset of pain. (+) swelling at both axilla + (R) deltoid with lump.,,,,,,,,,U,09/17/2019,,,,PUB,PUB,,None,Diabetes (diet controlled) HLD,,,1,,,,,
0834969,09/21/2019,NY,63.0,63,,M,,"Flue like, with chills which lasted throughout the day and pain at the injection site.  Next day, arm still sore but flu symptoms are gone.  Took aspirin several times.",,,,,,,,,Y,09/19/2019,09/20/2019,1,,PHM,,Rosuvastatin 5mg; Amlodipine Besylate 5mg; Centrum multi-vitamin.,none,dry skin,,,2,09/21/2019,,,,none
0834970,09/21/2019,PA,59.0,59,,M,,"redness, warmth, pain.  antibiotics required",,,,,,,,,U,09/18/2019,09/19/2019,1,,PHM,,"jardiance, trulicity, creon, metformin, glipizide",none,"AODM, colitis",,,2,09/21/2019,,,,nkda
0834971,09/21/2019,PA,56.0,56,,F,,"redness, pain, warmth-  started on antibiotics prophylactically",,,,,,,,,Y,09/18/2019,09/19/2019,1,none,PHM,,none,none,none,,,2,09/21/2019,,,,none
0834972,09/21/2019,NY,17.0,17,,M,,"He actually got his first round of: Hep B, Polio, Varicella, Meningicoccal, MMR and TDAp on the first day because our right to religious freedom was stripped from us. prior to 8/23/2019, he never had any...on 8/30/2019 his neck started to feel very stiff and his ran a high temperature, felt nauseated and couldn't eat. He slept for 48 hours getting up only to go to the restroom and drink some water",,,,,,,,,Y,08/23/2019,08/30/2019,7,none,PVT,,none,none,none,,,2,09/21/2019,,,,none
0834973,09/21/2019,TX,67.0,67,,M,,"Flu-like symptoms: diaphoretic, clammy, headache, GI disturbance (frequent bouts of gas/small amount of stool), sneezing, runny nose, body aches (marked), eyes sting (but not red or itchy), poor appetite, inability to sleep, restless leg syndrome, marked fatigue/malaise.  Symptoms lasted 3 days (past 3 days the worst: September 18/19/20) then began to resolve. I was unable to attend the Meeting on Sept 19/20 due to needed to stay in bed.  Feeling somewhat better today (Sept 21) so will attempt to go to the medical meeting. I am a physician. I have not seen my doctor. I thought I had a virus at first so was going to let it run it's course but after 3 days I am feeling better (too short for a viral illness). Benadryl taken for runny nose helped as well as Ibuprofen. I'm retired and had not been in the public since Sept 1, 2019.",,,,,,,,,Y,09/04/2019,09/18/2019,14,None,PHM,,"Low dose ASA, Adderall, Clonazepam, Lexapro, Tramadol, Advil, Seroquel, Xyzal, Benadryl at bedtime, Fish Oil, Centrum Silver multivitamins.",None,"Fibromyalgia, OCD, ADHD, anxiety, depression, nasal allergies (environmental)",,,2,09/21/2019,,,,None
0834974,09/21/2019,CT,71.0,71,,F,,Severe chills for about five hours Very sore injection site (unable to lift arm) slowly improving as of third day after vaccination Pain in both kidneys for several hours Leg pain and general muscle weakness for 18 hours,,,,,,,,,Y,09/19/2019,09/19/2019,0,,PHM,,"Levothroxine .88 Vitamin D, 2000 IU Vitamin B, complete Magnesium, 300mg",,Low thyroid,"Pneumonia vaccine, localized reaction, red swollen area 3'x3"" at injection site, unable to use are for five days due to pain.",,2,09/21/2019,,,,Codeine Amoxicillin Soy
0834975,09/21/2019,GA,0.33,0,.4,F,,"Projectile vomiting 24hrs after vaccines; Eyes rolled back, possible seizure.",,,,,,,,,Y,09/19/2019,09/20/2019,1,CMP; CBC,PVT,,none,croup on 8/16/2019,,,,2,09/21/2019,,Y,Y,none
0834976,09/21/2019,NY,82.0,82,,F,,"Patient came in Saturday, 9/21/19 complaining of pain, redness, and swelling on her left arm. Patient says it is warm to touch and the redness started on Wed 9/18/19 and has not improved. Patient was advise to take Benadryl &  apply cool compress",,,,,,,,,U,09/14/2019,09/18/2019,4,not applicable,PHM,,UNKNOWN,none,none,,,2,09/21/2019,,Y,,no known allergies
0834977,09/21/2019,PA,2.0,2,.4,M,,Localized redness and swelling,,,,,,,,,Y,09/18/2019,09/19/2019,1,,UNK,,none,none,speech delay,,,2,09/21/2019,,Y,,none
0834978,09/21/2019,FL,59.0,59,,M,,"Weeks of fatigue, sore joints, lack of motivation, headache.  Where they injected the vaccine stayed sore for well over a week.  Still feeling the effects of the vaccine.  Patient information said to expect two or three days of reactions but, it has been a month and the reactions are still strong.  It makes me hesitant to followup with the booster that is recommended within six months.  I had shingles when I was 35 years old and don't know if that made the side effects of the vaccine stronger.",,,,,,,,,N,08/22/2019,08/22/2019,0,None,PHM,,"descovy, tivicay, finesteride, levothyroxine, ambien",None,HIV,Mild reaction to flu and tetanus,,2,09/21/2019,,,,Asprin
0834979,09/21/2019,SD,24.0,24,,F,,Painful swelling of cervical lymph node chain and supraclavicular lymph node. Isolated to the left side. First noticed around 12 hours after administration of influenza vaccine.,,,,,,,,,N,09/20/2019,09/21/2019,1,,SCH,,Vyvanse,no,no,,,2,09/21/2019,,,,no
0834980,09/21/2019,CA,80.0,80,,F,,"Pneumovax and FluAD given around 2pm. Pneumovax was in the left arm. Patient was having a lot of pain in the left arm. Also increased blood pressure, after which patient took amlodipine 5mg. Patient experiencing chills and fever as the evening continues. Daughter takes her to the ER and patient is diagnosed with CELLULITIS. She takes an antibiotic at the ER and is discharged with an cephalexin for 10 days.",,,,,,,,,,09/19/2019,09/19/2019,0,,PHM,,,,,,,2,09/21/2019,,,Y,
0834981,09/21/2019,MN,61.0,61,,F,,I  got very ill with a bad headache and constant nausea. The injection site is so painful  still I can barely lift my arm all the way up   I was sick for 6 weeks. With nausea etc.  but my arm is a big concern. I cannot sleep well always just a nagging  pain.   I was prescribed nausea medication but that barely helped me.  Then I started on NOW NAB supplement 2 times a day and I still am taking it.,,,,,,,,Y,N,08/19/2019,08/19/2019,0,,PVT,,Extensive list,I deal with CRPS and have had it for 15 yrs,Refer above,,,2,09/21/2019,,Y,,Allergic to bees
0834982,09/21/2019,CA,53.0,53,,F,,Fever of 101.4. Body Aches. Shivering. Headache.  Pain at injection site.,,,,,,,,,N,09/20/2019,09/21/2019,1,,PHM,,None,None,None,pain at injection site following flu vaccines,,2,09/21/2019,,,,None
0834983,09/21/2019,,52.0,52,,M,,"Chills, aches and pains, general mild flu-like symptoms, difficulty sleeping.  Symptoms subsided within 48 hours.",,,,,,,,,Y,09/19/2019,09/19/2019,0,,PVT,,"Fenofibrate, nicotinamide, Vitamin B supplement, Flonase, Saw Palmetto",None,High cholesterol,,,2,09/21/2019,,,,None
0834984,09/21/2019,MA,77.0,77,,F,,Patient reported having fever and shakes,,,,,,,,,Y,09/20/2019,09/20/2019,0,"Patient reported to ER for treatment, but was never actually scene. She waited for over 2 hours and started to feel better so she left without seeing a provider",PHM,,losartan levothyroxine vitamin d aspirin low dose,none,hypertension hypothyroidism,,,2,09/21/2019,,,Y,cipro
0834985,09/21/2019,OH,44.0,44,,F,,"regular patient of pharmacy came in on 09/21/19 to receive her yearly flu vaccination. We are aware of and patient disclosed diagnosis of epilepsy and states that she has always received her influenza vaccine and has never had an issue. Vaccine was administered with no difficulty. After patient ambulated she began to speak to the pharmacy staff about various topics. After approximately 5 minutes she proceeded to fall to the ground due to a seizure. Patient was turned on her side and kept safe while an ambulance was called. After approximately 5 minutes, patient became conscious and was kept seated and calm until paramedics arrived. They took over care and took her to a local hospital. Patient called 60 minutes later inquiring as to the details of what happened and asking for her complete med list to provide to the ER staff.",,,,,,,,,Y,09/21/2019,09/21/2019,0,unknown,PHM,,"alprazolam er 2mg , vimpat 50mg, gabapentin 600mg, aripiprazole 2mg, duloxetine 60mg, unknown injection given at providers office 24 hour prior to vaccine administration.",unknown,"epilepsy, anxiety, depression, substance abuse",,,2,09/21/2019,,,Y,nkda
0834986,09/21/2019,NC,68.0,68,,F,,"redness, swelling, hot area around shot, localized reaction",,,,,,,,,N,09/13/2019,09/13/2019,0,none,PHM,,,,"HIGH BLOOD PRESSURE, DIABETES, KIDNEY CANCER (ONE KIDNEY REMOVED), THYROID, acid reflux",,,2,09/21/2019,,,,LIPITOR
0834987,09/21/2019,AK,58.0,58,,F,,Later in the afternoon after receiving the vaccine the patient experienced pain and swelling in the left arm. This has continued from Wednesday the 18th until the 21st.  The patient states that the pain feels like its coming from her bone and is radiating from the vaccine injection site to the shoulder. The patient has used ibuprofen and ice to manage symptoms.,,,,,,,,,N,09/18/2019,09/18/2019,0,,PHM,,ibuprofen,none,asthma.,,,2,09/21/2019,,Y,,n/a
0834988,09/21/2019,MI,67.0,67,,F,,"Sever. Hills, nausea, muscle aches.  Felt like the worst case of flu ever. Had the adverse reactions for five days",,,,,,,,,Y,09/09/2019,09/10/2019,1,,PHM,,"Allergy shots for molds, nuts, cat, dog, seasonal allergies",None,"Allergies, Factor 5",,,2,09/21/2019,,,,"Nuts, soy, molds like grapes, figs, etc"
0834989,09/21/2019,CA,60.0,60,,M,,"Shingrix #1 Fever, chills, muscle aches, and left arm pain for 24 hours after vaccine. Resolved the next day without any meds. Pt did not have any symptoms for Shingrix #2 administered on 09/17/2019",,,,,,,,,Y,07/15/2019,07/15/2019,0,None,OTH,,Amlodipine Valsartan,None,HTN Arthritis Tendonitis Lymphatic depletion syndrome,,,2,09/21/2019,,,,Lisinopril
0834990,09/21/2019,OH,64.0,64,,F,,"Patient woke up the morning after her vaccination with a severe headache, fever of 100.5, weakness, upset stomach, and diarrhea. The headache lasted for 7 days, and the diarrhea persisted for 5 days. The fever dropped below 100 degrees later that day and she stopped monitoring.",,,,,,,,,Y,09/05/2019,09/06/2019,1,None. Did not seek medical care,PHM,,"Losartan 100mg, meloxicam 15mg, metoprolol succ 100 mg, hydrochlorothiazide 12.5mg, montelukast 10mg, omeprazole 20mg, atorvastatin 10mg, aspirin 81mg, multi-vitamin, calcium supplement",None,"High blood pressure, pre-diabetic",,,2,09/21/2019,,,,None
0834991,09/21/2019,TN,15.0,15,,F,,PATIENT WAS GIVEN FLUBLOK AND IS UNDER THE AGE OF 18,,,,,,,,,Y,09/21/2019,09/21/2019,0,,PHM,,,,,,,2,09/21/2019,,,,
0834992,09/21/2019,NY,8.0,8,,M,,"09/13   headache , felt dizzy and tired and injection site was very sore ,   09/14 back of head hurt even hurt to turn his neck side to side , are still extremely sore eyes hurt   90/15 same arm hurt,  headaches , dizzy very tired  Low grade fever in the evening 100.3   09/16 arm still very sore , extremely exhausted, dizzy spells , feels his eyes can?t focus on something very long , headache low grade fever again in the evening 100.1",,,,,,,,,,09/01/2019,09/13/2019,12,,PVT,,No,No,No,,,2,09/21/2019,,Y,,No
0834993,09/21/2019,GA,76.0,76,,F,,Patient stated that injection hit her bone.She also stated pharmacist had to use alternate arm to get shot in,,,,,,,,,Y,09/11/2019,09/12/2019,1,,PHM,,,,,,,2,09/21/2019,,,,
0834994,09/21/2019,ID,73.0,73,,F,,"given vaccine about 6 PM from Pharmacy  Arm was itching by the time I got to the grocery store-within 15 minutes BUT THE WORST WAS YET TO COME WHEN I WOKE UP NEXT MORNING & MY LEFT ARM WAS RED, SWOLLEN, HARD FROM INSIDE ELBOW UP TO RIGHT BELOW SHOT ENTRANCE--ABOUT 6 INCHES BY 6 INCHES / BUT DUMMY ME DID NOT GO TO ER UNTILL THE 8th of Sept where they gave me prescription for Prednisone-20 mg-twice daily for 5 days. Today (09/21/19) arm is looking normal.",,,,,,,,,Y,09/06/2019,09/06/2019,0,09/08/19--ER-OBSERVED & GAVE PRESCRIPTION FOR PREDNISONE,PHM,,Losartan - 50 mg (green pill)-Blood pressure - 1 pill twice daily Tylenol as needed.,HIGH BLOOD PRESSURE (September 2019),High Blood Pressure Pneumonia? Bronchitis? (finished Symbicort about 2 months ago)Used for about 3 months),,,2,09/21/2019,,,,Allergic to LATEX-red & hurts                          CODEINE makes me itch                           Milk?-lactose intolerant
0834995,09/21/2019,FL,68.0,,,F,,rash around waist,,,,,,,,,N,09/12/1950,09/21/2019,25211,none,PHM,,"no otc, no herbs, no supplements, metformin, olmesartan/hctz, atorvaststin, pantoprazole, escitalopram, cbd topical cream",none,"HBP, diabetes, high cholesterol",,,2,09/21/2019,,Y,,none
0834996,09/21/2019,FL,72.0,72,,F,,PATIENTS ARM WAS INFLAMMED AND RED.,,,,,,,,,N,09/19/2019,09/20/2019,1,,PHM,,,,,,,2,09/21/2019,,Y,,
0834997,09/21/2019,WA,59.0,59,,F,,Pain at injection site on upper left arm; high part of shoulder; pain radiated down entire left arm for 5 days including pain in muscle of left arm above the elbow; including pain in left wrist; all of the side effects were not present prior to the vaccine which I received at medical center.,,,,,,,,,N,09/16/2019,09/17/2019,1,None,UNK,,None,None,None,,,2,09/21/2019,,,,None
0834998,09/21/2019,GA,66.0,66,,M,,"Received the shot in the afternoon and close to bedtime he said he felt like someone had hit him in his nose.  Went to bed and got up the next morning feeling awful. It was on a Sunday and Patient did not feel like going to church.  I (his spouse) went to church without him and when I returned, his nose and cheeks were red and sore. The next day we went to the doctor because his nose and cheeks were real red and he had blisters on his nose.  Dr's office took a skin graph of his nose that tested negative for Flesh  Eating Bacteria.",,,,,,,,,N,08/10/2019,08/10/2019,0,skin graph of his nose antibiotic shot steriod shot,PHM,,Losartan Potassium 25mg tab; Rosuvastatin Calcium 20mg tab; Mexiletine 150mg cap; Bayer 325 mg; Carvedilol 6.25mg tab; Furosemide 40mg tab; Klor-Con 10meq tab,none,heart disease,,,2,09/21/2019,,Y,,
0834999,09/21/2019,TX,0.33,0,.4,F,,"Redness and discharge at injection site, treated with topical antibiotics for skin infection",,,,,,,,,U,09/16/2019,09/16/2019,0,NA,PVT,,NA,None known,None,,,2,09/21/2019,,Y,,NKDA
0835000,09/21/2019,IN,11.0,11,,F,,After receiving both vaccines around 12:23 pm the patient lost consciousness and urinated herself. The patient passed out for approximately  2 minutes. She was placed in a chair and given some water. EMT's arrived when the patient was already conscious; they evaluated her and told her mom that she was fine. Patient left the store shortly after EMT's left.,,,,,,,,,Y,09/21/2019,09/21/2019,0,None,PHM,,"Pt was given the Tdap and the Menactra vaccine. Pt received the Menactra in the left arm, and the Tdap in the right arm. Pt received the menactra first; after receiving it she looked a bit nervous. I stopped to ask her if she was doing ok;",None,None,,,2,09/21/2019,,,,NA
0835001,09/21/2019,LA,65.0,65,,F,,"Patient has confirmed cellulitis - swelling, redness, pain",,,,,,,,,N,09/17/2019,09/18/2019,1,,PHM,,"omeprazole 20mg, ibandronate 150mg, myrbetriq er 50mg, atorvastatin 10mg",none,,,,2,09/21/2019,,Y,,sulfur
0835002,09/21/2019,NY,75.0,75,,F,,"sweeling/ redness/hot/itching on bicep, on left arm but below injection site",,,,,,,,,N,09/19/2019,09/20/2019,1,,PHM,,,,,,,2,09/21/2019,,Y,,
0835003,09/21/2019,MS,59.0,59,,F,,"PATIENT COMPLAINED OF RASH /HIVES ON NECK AND BACK, NO SOB OR WHEEZING.  PATIENT SAID SHE TOOK BENADRYL BUT NO RELIEF.",,,,,,,,,N,09/19/2019,09/20/2019,1,,PHM,,FLEXERIL,N/A,N/A,,,2,09/21/2019,,,,N/A
0835004,09/21/2019,PR,1.5,1,.5,F,,Seizures several times throughout the day.,,,,,,,,,N,09/09/2019,09/13/2019,4,"No test or Laboratory have been made. Appointment for an EEG on October 22, 2019.",PUB,,Children's Panadol,N/A,N/A,,,2,09/21/2019,,,,N/A
0835005,09/21/2019,VA,63.0,63,,F,,"On 9/8/19 to 9/9/19  Exhaustion. 9/10 to 9/12  seemed to have recovered.  9/12 taken to ER with severe joint pain, pain in left shoulder, back, stomach, legs, behind the knees and finger joints (both hands).  Diagnosed by ER as serum sickness. Around 9/14 admitted to ICU with severe chest pain. As of 9/21 patient is still in the ICU",,,,,Y,8,,,N,09/07/2019,09/08/2019,1,,UNK,,,,,,,2,09/21/2019,,,,"WALNUTS, PLANTAIN,GRASS POLLEN"
0835006,09/21/2019,IL,57.0,57,,F,,"Patient received the shot on 9/15/19 and next day she experienced, fever, swelling, redness ,and site of injection was hard, hot and and red and had it for 6 days and just about healing according to the patient. She experienced a stinging feeling upon receiving the shot.",,,,,,,,,Y,09/15/2019,09/16/2019,1,Patient had routine  blood work done on 9/17/19 same arm but blood was only drawn and no shot given that day.,PHM,,"diatiazem, sertraline, pravastatin, toprol, allegra, exedrine, gabapentin, norco, exemestane, vitamin d2",,"COPD, neuropathy,",,,2,09/21/2019,,,,"omnicef, levaquin,"
0835007,09/21/2019,CO,58.0,58,,M,,Fever and neasua,,,,,,,,,Y,09/19/2019,09/20/2019,1,None,PVT,,Melatonin,None,ED,,,2,09/21/2019,,,,None
0835008,09/21/2019,GA,42.0,42,,F,,"fever, chills, body aches within one hour.  Unable to move right arm.  Symptoms worsening throughout next 48 hours to include chest pain, chest tightening, weakness, nausea, dry heaving,  diarrhea, elevated heart rate, tremors, blurred vision and confusion,  inability to swallow leading to trip to urgent care for allergic reaction and transport to ER by ambulance  for tachycardia and allergic reaction to flu shot. ER DR advised upon DC to follow up with PCP and said each reaction would become more severe and not to take the flu vaccine ever again",,,,,,,,,U,09/16/2019,09/16/2019,0,09/18/2019 full work up at local ER Chest Xray,PVT,,none,none - I was there getting my annual exam and in perfect health,none,"every year I feel ill when taking the flu vaccine, this was the first time I was unable to breathe with cardiac and pulmonary ma",,2,09/21/2019,,Y,Y,none
0835009,09/21/2019,KY,39.0,39,,F,,"Pt here today for possible allergic reaction to varicella vaccine. vaccine given in left arm 9/19, also had a PPD on the left arm same day, and a MMR vaccine on the right arm the same day. The next afternoon noted soreness at the injection site of the varicella and achiness to enitire left arm and shoulder. Took  800mg of ibuprofen, but did not seem to improve at all. this morning worke up and noticed swelling and redness at the injection site and now entire left arm is throbbing, aching with intermittwnt sharp pains to the shoulder. pain 8/10.  Patient returned to clinic today 9/21 with complaints. Prednisone given to help with imflammation. Pt refused to go to ER or urgent care for imaging,",,,,,,,,,N,09/19/2019,09/20/2019,1,none,OTH,,"nexium, ibuprofen, montelukast; PPD",none,none,,,2,09/21/2019,,Y,,none
0835010,09/21/2019,FL,77.0,77,,F,,Arm was swollen and red and hot to touch patient had reaction for about 5 days after vaccination. Patient did go to urgent care and instructed to keep ice on arm,,,,,,,,,Y,08/13/2019,08/13/2019,0,,PHM,,,,,,,2,09/21/2019,,,Y,sulfa
0835011,09/21/2019,TX,63.0,63,,F,,"Patient reports having fever and inflammation and itchiness on the right forearm about 24 hours after receiving the vaccines. pt states she tried using cortizone cream and it helped alittle with the itchiness. Pt states she took ibuprofen for the fever and it subsided but she still feels a little feverish. Upon reporting patient states all of her symptoms have improved except the redness on the forearm and the pharmacist on duty recommended she take some benadryl at night and report any changes in symptoms. Pt was contacted 24 hours and was unreached, pt will be contacted again at next business day for follow-up",,,,,,,,,U,09/17/2019,09/19/2019,2,,PHM,,Cetirizine,None,"Hypertension, Diabetes",,,2,09/21/2019,,,,None
0835012,09/21/2019,FL,74.0,74,,M,,"FLUAD WAS GIVEN IN PATIENT'S LEFT ARM, NO REACTION. PNEUMOVAX 23 WAS GIVEN IN RIGHT ARM. INSTANTLY, PATIENT'S LOWER CENTER BACK STARTED SPASMING AND RADIATING SHOOTING PAIN UP HIS BACK, LEADING TO FURTHER PAINFUL MUSCLE SPASMS. 911 WAS CALLED AND EMT ARRIVED MINUTES LATER. HE WAS ADMINISTERED A BENADRYL INJECTION PROPHYLACTICALLY. HIS VITALS WERE TAKEN AND EVERYTHING WAS STABLE. HE WAS RELEASED BY EMT.",,,,,,,,,,09/21/2019,09/21/2019,0,,PHM,,,,,,,2,09/21/2019,,,,NKA
0835013,09/21/2019,OR,73.0,73,,F,,extreme hair loss,,,,,,,,,N,06/28/2019,07/01/2019,3,None,PHM,,"MultiVitamin w/o iron, Omega 3 fish oil, Vitamin D, Vitamin B12, CO Q10. Irbesartan, Clonidine, Furoesemide, Atorvastatin, Spironlactone, Metoprolol Tartrate, Allopurinol, Doxycycline (60 days on - 60 days off)",None,"High blood pressure, dry eye, high uric acid",,,2,09/21/2019,,,,"Penicillin, Codeine, Aspirin, Advil"
0835014,09/21/2019,,67.0,67,,M,,Patient came in to pharmacy the following day after receiving vaccine and the entire upper arm was red and hot to the touch.,,,,,,,,,,09/16/2019,09/16/2019,0,,UNK,,,,,,,2,09/21/2019,,,,
0835015,09/21/2019,CA,68.0,68,,F,,severe redness and inflammation with warm to touch,,,,,,,,,N,09/19/2019,09/19/2019,0,none,PHM,,"losartan, levothyroxine, ozempic, atorvastatin, metoformin,",no,diabetes,,,2,09/21/2019,,,,no
0835016,09/21/2019,,79.0,79,,F,,Patient called pharmacy the day after receiving vaccine stating she could not lift the arm the vaccine was administered in and she fell ill later that night and was unable to get out of bed,,,,,,,,,,09/19/2019,09/19/2019,0,,UNK,,,,,,,2,09/21/2019,,,,
0835017,09/21/2019,MA,48.0,48,,M,,Patient called me stating that he got his flu shot at an event on 9/20/19. He was fine until he noticed a bump and it seems to be getting worse and not better. I made sure he could move his arm and had no other pain. He stated the only thing was he felt a bump and it is painful to the touch. I told him I would start a report and if it continued to get worse to go to an urgent care facility.,,,,,,,,,,09/20/2019,09/21/2019,1,N/A,UNK,,,,,,,2,09/21/2019,,,,
0835018,09/21/2019,OH,12.0,12,,M,,"The patient recieved the fluzone quadrivalent vaccine and seemed to be fine.  He then walked around the store and did some shopping with his parents.  About 5- 10 minutes after receiving the vaccine, his father returned with him stating he felt faint and skin was clammy.  He was also very pale.  After drinking some orange juice and  sitting in a lounge chair for 10 minutes he felt much better and felt fine to go ahead and walk.",,,,,,,,,Y,09/21/2019,09/21/2019,0,,PHM,,,,,,,2,09/21/2019,,,,
0835019,09/21/2019,NJ,85.0,85,,F,,"Patient called and said she was having chest pain, buckeling legs, fever, diarrhea, dizziness, and soreness in the left arm where both shots were administered. Patient called her MD and her doctor advised her to take tylenol.",,,,,,,,,N,09/20/2019,09/21/2019,1,none that I know of,PHM,,"spiriva, omeprazole, levothyroxine, bisoprolol, hydrocortisone, raloxifene, meloxicam, gabapentin",none,unknown,,,2,09/21/2019,,Y,,penicillins
0835020,09/21/2019,OK,8.0,8,,M,,"Mom reported that he seemed fine the day of treatment (09/19).  The next day, he complained that his arm was sore and stiff.  She examined the arm and found that it was swollen, red, and warm to the touch.  She marked the boundaries of the swelling with a marker on Friday (09/20) to keep track of it.  The next day, she did note that it had spread some.  I did advise her to get him examined when she called today (09/21), especially since the affected area seemed to be spreading.  I have not heard more since then.",,,,,,,,,U,09/19/2019,09/20/2019,1,Unknown as of today (09/21).,PHM,,The patient has SABA rescue inhalers and nebulizer vials for breathing difficulties.  Also oral steroid for potential allergic reactions.,Unknown aside from keeping rescue inhalers handy.,Breathing difficulties.,,,2,09/21/2019,,Y,,"The mom mentioned his allergy panel showing some sensitivity to peanuts/soy/legumes, but nothing that should be relevant to a flu shot.  No egg or latex allergies known specifically."
0835021,09/21/2019,NV,64.0,64,,F,,"Patient stated she started feeling extremely tired, run down, and had a fever and chills and had to leave work early on Wednesday 9/18/19 due to how terrible she felt. She presented on Friday 9/20/19 with a welt on her left arm about 4-5 inches below the injection site. The welt was warm to the touch and spanned the entire front of the bicep and was approximately 6 inches wide and 3 inches tall. Patient was instructed to use cold compress and take acetaminophen/ibuprofen for any fever or pain. Patient was also instructed to return to pharmacy if the reaction worsened over the next 2 days.",,,,,,,,,U,09/17/2019,09/18/2019,1,,PHM,,,,,,,2,09/21/2019,,,,
0835022,09/21/2019,UT,74.0,74,,F,,Both shot were given in left arm due to polio in the past. Her whole upper arm was swollen and red and painful. She saw a dr. who prescribed a pain medication and cephalexin incase the her arm gets worse,,,,,,,,,U,09/19/2019,09/20/2019,1,,PHM,,,,,,,2,09/21/2019,,Y,,
0835023,09/21/2019,NY,54.0,54,,F,,Two days after the vaccination patient noticed a rash on the upper chest.  She called the ER but they said to just use benadryl (the rash was mild).  She did not visit the ER and the rash is improving.,,,,,,,,,,09/18/2019,09/20/2019,2,,PHM,,,,,,,2,09/21/2019,,,,
0835024,09/21/2019,IL,82.0,82,,F,,"redness, significant swelling of her upper arm, hot,fluid filled, mild pain, head ache, fluid is slowly leaving arm 1 week later.",,,,,,,,,Y,09/12/2019,09/12/2019,0,none,PHM,,unknown,none,"hypertension, thyroid, GERD,",,,2,09/21/2019,,,,NKA
0835025,09/21/2019,TX,50.0,50,,F,,"Pain/soreness at injection site, worst on 9/20, better on 9/21. 101 degree fever lasting one day, all day, on 9/20. Small splotchy rash starting around injection site 9/21.",,,,,,,,,U,09/19/2019,09/20/2019,1,,SCH,,B12 shot at same time,None,None,,,2,09/21/2019,,,,None
0835026,09/21/2019,TX,1.25,1,.3,F,,"large area of redness at site with possible early skin infection, started on topical antibiotics",,,,,,,,,N,09/19/2019,09/20/2019,1,,PVT,,miralax,"Abscess, constipation",Abscesses,,,2,09/21/2019,,Y,,NKDA
0835027,09/21/2019,NJ,61.0,61,,M,,"Patient reported having extreme pain at the site of the injection a ""couple days"" after receiving his shot.  He said he did not have any redness, heat, or swelling and that the pain didn't start to go away for a ""couple weeks"".  He said it was now improving.",,,,,,,,,Y,09/10/2019,09/12/2019,2,,PHM,,"Gemfibrozil, novolin n, lisinopril, metformin",,"dm, htn",,,2,09/21/2019,,,,"pcn, asa"
0835028,09/21/2019,NY,79.0,79,,M,,Psychological reaction to flu vaccine.,,,,,,,,,U,08/22/2019,08/22/2019,0,,PHM,,One dose of 1000 mg of acetaminophen,,,,,2,09/21/2019,,,Y,
0835029,09/21/2019,PA,71.0,71,,F,,large red warm area of deltoid and below  towards elbow,,,,,,,,,Y,09/19/2019,09/19/2019,0,,PHM,,none,none,depression,,,2,09/21/2019,,,,"sulfonamides, penicillin, clindamycin"
0835030,09/21/2019,AZ,51.0,51,,F,,Patient said she got a high fever and had a small seizure at work and they called an ambulance and her blood pressure 150/100.  The recommended that she go to the ER but she did not.  She came to the Pharmacy the next day and said she felt better.,,,,,,,,,U,09/19/2019,09/20/2019,1,,PHM,,"metformin, glimepride, atorvastatin, estrace",none reported,Diabetis,,,2,09/21/2019,,,,None reported
0835031,09/21/2019,,19.0,19,,F,,"Patient PASSED OUT. CAME BACK AFTER A FEW SECONDS. THEN 5 MINUTES LATER, PASSED OUT AGAIN. THEN PATIENT HAD A CONVULSION LASTING 3 SECONDS. AND THEN VOMITTED. 911 WAS CALLED",,,,,,,,,Y,09/21/2019,09/21/2019,0,,PHM,,,,,,,2,09/21/2019,,,Y,
0835032,09/21/2019,TX,66.0,66,,F,,Pain and redness around injection site near deltoid muscle present along with redness farther from injection site running down arm.,,,,,,,,,U,09/18/2019,09/20/2019,2,,PHM,,,,,,,2,09/21/2019,,,,
0835033,09/21/2019,MI,50.0,50,,F,,"Day after the injection the area was very inflamed (red, swollen, hot, and painful) at site of injection and very painful.  Unable to raise arm overhead.  Day after the injection I felt nauseous, fatigued, had an elevated temperature of about 99.7 degrees F.   Two days after injection I still felt off and on nauseous, arm was still very inflamed at the site of injection.   Site appeared larger (8 cm in diameter), but not quite as sore or painful.  Still very red and hot to the touch.   Feel generally unwell still two days after the injection, but not quite as bad as the day after.  I treated the 1st day after with aleve and tylenol and zyrtec.  I also iced the injection site.  The 2nd day after I took aleve and have iced the injection site.",,,,,,,,,N,09/19/2019,09/20/2019,1,None,PHM,,metoprolol succinate XL 25 mg 24 hr tablet hydroCHLOROthiazide 25 mg tablet cyclobenzaprine 10 mg tablet PRN melatonin 3 mg tablet,none,"cardiac PVCs, left ventricular non-compaction cardiomyopathy, back pain due to muscle spasms (had a lumbar discectomy in 2001).",,,2,09/21/2019,,,,"morphine causes vomiting  food sensitivity (itchy mouth/throat) to raw fruits & vegetables (e.g. carrots, celery, apple peel, watermelon, etc.) environmental allergies (mostly spring pollen/grass)"
0835034,09/21/2019,TX,9.0,9,,F,,"Patient received the vaccine in the left deltoid at 11:22:23 am and she said it didn't hurt and she seemed totally fine.  She stood up and was talking as I gave her brother his vaccine and she was watching him get his shot and she just suddenly fell forward.  She fainted and fell towards her father.  We laid her on the floor and she was very rigid with twitching like behavior.  I asked the father if she had any reaction like this to a vaccine or and history of seizure and he said no.  I am not sure how long she was unresponsive-perhaps a minute.  When she began to wake up she didn't remember falling, but said that as she watched her brother get his shot everything got blurry.  Her eyes were very dilated.  The patient also threw up once she was awake and sitting in a chair.  EMS was called and the family refused transport via ambulance but they went to the emergency room afterwards.",,,,,,,,,U,09/21/2019,09/21/2019,0,I'm not sure of the medical tests done once she went to the ER,PHM,,unknown,none listed,none listed,,,2,09/21/2019,,,Y,none listed
0835035,09/21/2019,OK,20.0,20,,F,,"After receiving her vaccine for the flu, patient watched her father receive his flu vaccine, and as her mother was about to receive her vaccine she started to not feel well and fainted in her chair and urinated. I used an Ammonia inhalant and she was alert within 30 seconds. She was monitored over the next  20 to 30 minutes and felt better before leaving with her parents.",,,,,,,,,Y,09/21/2019,09/21/2019,0,N/A,PHM,,N/A,n/a,n/a,"has felt faint in the past, usually associated with needles.",,2,09/21/2019,,,,no known allergies
0835036,09/21/2019,OH,53.0,53,,F,,"Patient reports feeling ""dizzy"", ""achy"", ""clammy"", and having a ""fever"", which can all be typical side effects. However, she also reports having ears that are ""stuffed up"" and pain in both ears that continues through today after vaccination yesterday.",,,,,,,,,N,09/20/2019,09/20/2019,0,,PHM,,,,,"Patient reports experiencing a similar situation in the ""90s"" after receiving a flu vaccine, but they were only known side effec",,2,09/21/2019,,,,
0835037,09/21/2019,CA,53.0,53,,F,,"Flu vaccine, further information about dosage and type unavailable. Severe lower intestinal cramping and diarreah, sudden onset 5.5 hours after vaccine. Profuse sweating and low body temperature (95.5 degrees) for approx 2 to 3 hours after onset. Extreme weakness, fatigue, dizziness, and mental fog. Temperature returned to normal by midnight. Diarreah continues as of time of submitting this form, as does weakness. Cramping has subsided and mental clarity has returned, but still a general feeling of extreme fatique and general body aches. No side effects such as swelling of lips or impaired breathing. No treatment at this time except for fluids, rest, tylenol.  Have regularly had flu shot with same provider with no reactions of note, except for some localized pain at site of injection.",,,,,,,,,N,09/20/2019,09/20/2019,0,,PHM,,"Levothyroxine 50mcg, Vyvanse 40mg, Aspirin 81mg",None,Asthma,"Shingrix, 2nd dose, approximately one year ago. Flu-like body aches and fatigue for three days.",,2,09/21/2019,,,,None
0835038,09/21/2019,MO,66.0,66,,M,,"patient complained of runny nose, headache, fatigue, cough from post nasal drip at around 4:00pm , vaccine was given that morning at 10:45am.",,,,,,,,,U,09/21/2019,09/21/2019,0,,PHM,,,,Asthma per patient,,,2,09/21/2019,,,,
0835039,09/21/2019,GA,68.0,68,,F,,"from small swelling at vaccine site, to incredible swollen arm and lots of redness pain and heat. returned to Doctors office nest morning to show, and doctor said it was an infection, put me on antibiotics ""cephalexin 500 mg ""4 times a day. started antibiotics evening of 20 September  for most of September 21 it every symptom increased",,,,,,,,,N,09/19/2019,09/19/2019,0,return to Doc office on September 20,PVT,,"calcium, fish oil, aspirin, 25 mg metoprolol, 2000 biotin",no,"a-fib,  have been in sinus rhythm for almost since February 2016",tetanus _+4 years ago,,2,09/21/2019,,,,none known
0835040,09/21/2019,MA,58.0,58,,F,,"Within 24 hours, as expected: fever  of 99.3, overall body aches,  head ache, sore arm at injection site (bruised feeling), incapacitated, lasted a day.    4 days later I have an unexpected 4"" wide warm to the touch red rash around the injection site--oddly not at the site of the former bandage covering the injection (which was removed the same day after the shot was administered). No blisters.",,,,,,,,,N,09/16/2019,09/20/2019,4,,PHM,,None,None,None,,,2,09/21/2019,,,,None
0835041,09/21/2019,OH,25.0,25,,F,,"Hard raised area, spreading redness, numbness to back of arm, non-blanching skin",,,,,,,,,,09/19/2019,09/20/2019,1,,PVT,,"Cymbalta, Lexapro",Bronchitis,Depression and Generalized Anxiety Disorder,,,2,09/21/2019,,,,N/a
0835042,09/21/2019,IA,26.0,26,,F,,I received a quadrivalent influenza vaccine but am unsure exactly which one. I developed a headache around 3 PM later in the day after receiving the flu shot. That night I developed a fever of 99.98 degrees F. I experienced a headache and total body achiness throughout the morning and into the afternoon/early evening the next day.,,,,,,,,,Y,09/20/2019,09/20/2019,0,,WRK,,Postnatal vitamin; Rho (D) Immune Globulin,No illness. Delivered a baby.,None,,,2,09/21/2019,,,,None
0835043,09/21/2019,VA,56.0,56,,F,,"Approximately 3 days after the vaccine, I began to have irregular heartbeats throughout the day.  After about 2 weeks the irregular heartbeats began to feel more like heavy fluttering and gradually as the weeks went on turned to light fluttering.  Today, 5 weeks after the vaccine, I felt no fluttering at all for the entire day, for the first time.",,,,,,,,,U,08/17/2019,08/20/2019,3,"Went to the doctor twice who took my blood pressure and listened to my lungs and heart.  He is recommending that I go back to my cardiologist for a follow up, since some of the heart beats I felt when exercising, hurt a bit, but only for the one heartbeat. The pain did not continue and did not radiate anywhere.",PHM,,"Diltiazem 120 MG Vitamin D3 2000 IU Centrum Silver, women's formula Fish oil 1000 mg",None,HBP,,,2,09/21/2019,,Y,,Penicillin
0835044,09/21/2019,IL,76.0,76,,M,,"trouble standing,  very weak, fell in bathroom, chills sweating",,,,,,,,,Y,09/19/2019,09/20/2019,1,none,PHM,,"Lipitor 20mg ,  400 Vitamin E, Latanoprost eye medicine, Azelastine nasal spray, coated aspirin",none,none,,,2,09/21/2019,,,,none
0835463,09/21/2019,AL,78.0,78,,F,09/21/2019,- patient had allergic reaction - arm swollen from injection site to elbow.,,,,,,,,,Y,09/20/2019,09/21/2019,1,,OTH,OTH,,-No,-No,,,1,,,,,
0835465,09/21/2019,CO,5.0,5,,M,09/21/2019,pt seen 2 days after vaccine with redness with harder core at injection site total area of redness > than softball size started on cephalexin for ? cellulitis,,,,,,,,,,09/19/2019,09/20/2019,1,,PVT,PUB,,0,0,,,1,,,,,
0835467,09/21/2019,IL,67.0,67,,F,,Patient came in on 9/17/2019 to get a rx for Cephalexin and she told me that the Urgent Care Doctor said that it was from the flu shot. Patient said redness in area of injection site was getting worse and that is why she went to the doctor. Left message with patient on 9/21/2019 to follow up.,,,,,,,,,U,09/14/2019,09/15/2019,1,unknown,PHM,,Unknown,Unknown,Unknown,,,2,09/21/2019,,Y,,NKA
0835480,09/21/2019,WA,71.0,71,,F,,"Patient had extensive swelling, redness, pain, and heat around injection site. Says she was sick in bed for 2 days and had to miss work.",,,,,,,,,U,09/18/2019,09/18/2019,0,,PHM,,,,,,,2,09/21/2019,,,,
0835045,09/22/2019,,26.0,26,,F,,Shoulder pain.,,,,,,,,,,07/06/2019,07/13/2019,7,,PHM,,,,,,,2,09/22/2019,,,,
0835046,09/22/2019,NY,44.0,44,,F,,"Rabies vaccine- human immoglobin and rabies vaccine series.  First week had fever, felt like body sunburn, tongue started prickly, flu ish, achiness.  2nd week sunburn feeling over body, prickly tongue, slight fever, soreness/pain, and arm heaviness.  3rd shot day after third shot got really fatigued during day and felt like needed to sleep, so took daytime nap and had body jerks, unable to get self up but half awake and biting tongue/like humming, then was really tired when got out of it and headache; week 3 body felt like sunburn, achy, prickly tongue, fatigue, right arm joints sore, rash on right side of stomach; and week 4 last shot within hour after shot right cheek swelling, rash on arms, itchy, lips numb swelling on right side, tongue prickly and felt right side swelling throat; later evening difficulty swallowing, diarrhea and same symptoms.  Since vaccinations I continue to have prickly tongue, fatigue, headaches, itchiness on arm and right cheek, swelling on right cheek and tongue issues like biting tongue while eating. I take 24hr Claritin or Zyrtec every 12 hrs because otherwise my cheek starts to swell and get itchy, and my tongue feels prickly.",,,,,,,,,U,08/01/2019,08/01/2019,0,I have scheduled allergy testing and ENT.,OTH,,"daily Claritin or Zyrtec, vitamins, probiotics and Motrin or aspirin; and occasional Benadyrl.","allergies, headaches","allergies, venous insufficiency, headaches, anemia",,,2,09/22/2019,,Y,,"sensitive/or/allergic to: codeine, latex, cats, grasses, trees, dust mites, corn syrup/modified corn preservative, strawberries, tomatoes, kiwi, wheat."
0835047,09/22/2019,NY,42.0,42,,M,,Patient experienced severe chills and body aches from 2am - 6am the next morning after receiving the vaccine the day prior.  Patient believed he had a fever.  Patient took Ibuprofen and found symptom relief.  Symptoms lasted from 2am - 6am.,,,,,,,,,Y,09/20/2019,09/21/2019,1,,PHM,,,,,,,2,09/22/2019,,,,
0835048,09/22/2019,MA,63.0,63,,F,,"Achy muscles and joints, chills, headache, nausea.  Took Motrin. Chills subsided but nausea continued. Morning now and  still have headache and achy muscles and joints but chills and nausea is gone. Plan to take Motrin after breakfast.",,,,,,,,,Y,09/21/2019,09/21/2019,0,None,PHM,,"Calcium, vitamin d3, multi vitamin, miralax.",None.,,,,2,09/22/2019,,,,"Yogurt, hydrocortisone cream."
0835049,09/22/2019,MI,28.0,28,,F,,"Employee was given her second dose of her HEP B vaccine.  She shows redness, swelling, and sensitivity at the injection sites.  No current fevers or illnesses.",,,,,,,,,N,09/19/2019,09/19/2019,0,None at this time but the employee is being sent to occupational medical care.,OTH,,None,None,No medical history or diagnosis,,,2,09/22/2019,,Y,,None
0835050,09/22/2019,,53.0,53,,M,,"Pt presented a week later with complaining about rash on his body. It looked like mosquito bite on his legs and back of trunk, and pt was having itchiness, but no pain or any discharge.",,,,,,,,,Y,08/02/2019,08/07/2019,5,,PHM,,no,unknown,unknown,,,2,09/22/2019,,,,nkda
0835051,09/22/2019,NC,71.0,71,,M,,"I felt like I literally had flu, based on he one time  I had it during my 20s.",,,,,,,,,Y,09/20/2019,09/21/2019,1,,PHM,,"Nucynta 125mg, 1 every 4 hrs Etodolac 400 mg  1 twice a day Amphetamine salts 30 mg ER 1 every morning Amphetamine salts 10 mg 1 tab. 4 times a day Metoprolol Succ ER 50 mg 1 a day Duloxetine HCL DR 30 mg 3 per day Lisinopril - HCTZ 20-25 m","Intestinal cramps, saw my PCP and have a colonoscopy scheduled",Chronic pain in my hips,,,2,09/22/2019,,,,None
0835052,09/22/2019,,67.0,67,,F,,"Body aches, headache, chills, fatigue, nausea.  I had these same reactions to the first shot but this second shot was worse.",,,,,,,,,Y,09/18/2019,09/18/2019,0,None,PHM,,"Losartan Potassium, Carvedilol, Montelukast Sodium, Calcium, Vitamin D3",None,High blood pressure,"Body aches, chills, headache, fatigue, nausea;  age 67;  vaccination date 07/02/2019;  First Shingrix;  Unknown brand name",,2,09/22/2019,,,,None
0835053,09/22/2019,WA,61.0,61,,F,,Uncontrollable shivering and high fever ( with its accompanying aches and pains),,,,,,,,,N,09/21/2019,09/21/2019,0,,PHM,,"levothyroxine 100 MCG, Cytomel 5 MCG. Fluoxetine 80 mg omeprazole 20 mg",none,"asthma,",,,2,09/22/2019,,,,none
0835054,09/22/2019,AR,66.0,66,,F,,Nausea swelling Joint pain Headache Fever Chills Vomiting Swelling,,,,,,,,,U,09/21/2019,09/21/2019,0,,PHM,,Amlodapine Xanax Prozac Lisinopril zestoretic Zanaflec Miralax Vitamin d3 Levothyroxine Baby aspirin,Vertigo High blood pressure,Hypertension Thyroid low Kidney disease,,,2,09/22/2019,,,,Sulfa  Beta blockers
0835055,09/22/2019,CA,26.0,26,,F,,"Chest tightness, rash on BL upper arms, right about inner elbow",,,,,,,,,N,09/20/2019,09/20/2019,0,none,PVT,,none,none,none,,,2,09/22/2019,,Y,,none
0835056,09/22/2019,,31.0,31,,F,,chest tightness/pressure/palpitations/dizziness,,,,,,,,,N,09/01/2019,09/21/2019,20,,WRK,,none,none,none,,,2,09/22/2019,,Y,,none
0835057,09/22/2019,OH,73.0,73,,M,,arm swelled soreness bicep front of arm,,,,,,,,,Y,09/19/2019,09/22/2019,3,went to dr ran test catscan could not find anything  wbc was up,PHM,,nexium,no,chronic lymphocytic leukemia,,,2,09/22/2019,,,,pcn allergy
0835058,09/22/2019,MI,61.0,61,,M,,"A few hours after shot, patient complained of very sore arm.  2 days later he came back in stating after he got home and the whole next day he felt ""like crap"", entire body was aching and weak.  He took ibuprofen and felt better.  Today he says he feels better but his arm is still sore.",,,,,,,,,N,09/20/2019,09/20/2019,0,none,PHM,,none known,none known,none,,,2,09/22/2019,,,,none
0835059,09/22/2019,NY,73.0,73,,F,,"Patient reports injection site reaction of redness and swelling at injection site, starting around 24 hours after administration and improving at 48 hours after administration.",,,,,,,,,Y,09/19/2019,09/20/2019,1,,PHM,,,,,,,2,09/22/2019,,,,
0835060,09/22/2019,GA,68.0,68,,M,,"One day post vaccine, I could not rise from the bed or chair without assistance. I could not walk without holding onto walls. I felt very weak. Incontinent. Confused. These were all symptoms I had not had before.",,,,,,,,,U,09/20/2019,09/21/2019,1,,PVT,,Recombinant Zoster Vaccine,neuropathy,neuropathy,,,2,09/22/2019,,Y,,Ancef
0835061,09/22/2019,TN,65.0,65,,F,,eyes and chest affected - patient went to clinic - obtained steroid,,,,,,,,,U,09/21/2019,09/21/2019,0,tests and labs  unknown from 9/21/2019 clinic visit,PHM,,"levothyroxine 75mcg;  amlodipine 5mg; ergocalciferol 50,000 units a week; ziac 10/6.25",none,"thyroid, blood pressure","Pneumovax 23 on 9/22/2015, age 61, same allergic reaction symptoms as this adverse event",,2,09/22/2019,,,Y,"sulfa, codeine, morphine"
0835062,09/22/2019,NY,12.0,12,,M,,"7/20:  Sore throat, headache, photo sensitivity, sore neck, lethargic, no appetite. 7/22:  In addition to the above symptoms, developed petechiae rash on cheeks, torso, back, groin, buttocks, and upper thighs. 7/26:  In addition to the above symptoms that occurred on 7/20 and 7/22, developed flare of petechiae rash and painfully, swollen left, cervical lymph node.",,,,,,,,,Y,07/10/2019,07/20/2019,10,"Component Results Component Your Value Standard Range WBC  4.4 THOU/uL  4.2 - 9.1 THOU/uL RBC  4.3 MIL/uL  4.6 - 6.1 MIL/uL Hemoglobin  12.1 g/dL  13.7 - 17.5 g/dL Hematocrit  37 %  40 - 51 % MCV  85 fL  79 - 92 fL MCH  28 pg/cell  26 - 32 pg/cell MCHC  33 g/dL  32 - 37 g/dL RDW  12.0 %  11.6 - 14.4 % Platelets  158 THOU/uL  150 - 330 THOU/uL Seg Neut %  37.5 %  % Lymphocyte %  43.7 %  % Monocyte %  7.1 %  % Eosinophil %  3.6 %  % Basophil %  0.9 %  % Neut # K/uL  1.7 THOU/uL  1.8 - 5.4 THOU/uL Lymph # K/uL  2.2 THOU/uL  1.3 - 3.6 THOU/uL Mono # K/uL  0.3 THOU/uL  0.3 - 0.8 THOU/uL Eos # K/uL  0.2 THOU/uL  0.0 - 0.5 THOU/uL Baso # K/uL  0.0 THOU/uL  0.0 - 0.1 THOU/uL Nucl RBC %  0.0 /100 WBC  0.0 - 0.2 /100 WBC Nucl RBC # K/uL  0.0 THOU/uL  0.0 - 0.0 THOU/uL General Information Collected:  07/26/2019 3:09 PM Resulted:  07/26/2019 8:47 PM Ordered By:  NP  Result Status:  Final result  CRP - Details  Component Results Component Your Value Standard Range CRP  8 mg/L  0 - 10 mg/L General Information Collected:  07/26/2019 3:09 PM Resulted:  07/26/2019 7:07 PM Ordered By:  NP Result Status:  Final result CYTOMEGALOVIRUS IGG&IGM - Details  Component Results Component Your Value Standard Range CMV IgG  NEG      Test performed with bio Merieux VIDAS CMV IgG EIA CMV IgM  NEG    NEGATIVE TEST METHOD: EIA General Information Collected:  07/26/2019 3:09 PM Resulted:  07/29/2019 2:43 PM Ordered By:  NP Result Status:  Final result DIFF MANUAL - Details  Component Results Component Your Value Standard Range Bands %  1 %  0 - 10 % React Lymph %  6 %  0 - 6 % Manual DIFF  RESULTS      Diff Based On  112 CELLS  CELLS General Information Collected:  07/26/2019 3:09 PM Resulted:  07/26/2019 8:47 PM Ordered By:  NP Result Status:  Final result EBV DNA PCR, QUANTITATIVE - Details  Study Result Narrative  Test performed on plasma Negative for Epstein-Barr Virus Nucleic Acid Assay Range: 49 IU/ml to 1.69x10e8 IU/ml The limit of quantitation (LOQ) is 49 IU/ml. EBV DNA detected below the LOQ will be reported as Positive for Epstein-Barr Virus Nucleic Acid, Quantitative Result: <49 IU/ml. As of April 22, 2013, results for quantitative EBV testing are resulted in International Units (IU). One IU is equal to 0.59 copies of EBV. Test Method: Nucleic Acid Amplification by PCR Component Results Component Your Value Standard Range EBV DNA PCR,Quantitative  .      General Information Collected:  07/29/2019 12:48 PM Resulted:  07/31/2019 10:49 AM Ordered By:  NP Result Status:  Final result EBV PCR QUANTITATIVE - Details  Component Results Component Your Value Standard Range EBV PCR Qnt,Log  NEG IU/mL  IU/mL EBV PCR Qnt  NEG IU/mL  IU/mL Lower Limit of Detection: 500 IU/mL Dynamic Range: 3.0 - 6.0 log IU/mL Dynamic Range: 1,000 - 1,000,000 IU/mL  Accurate quantification not possible at < 500 IU/mL. Specimens in the 500 - 999 IU/mL range are reported qualitatively as POS<1000.   Method: PCR  This test was developed and its performance characteristics determined by Labs. It has not been cleared or approved by the Food and Drug Administration. The methodology used for this test is approved by the  Department of Health. The results should not be used as a sole diagnostic or therapeutic criterion. General Information Collected:  07/26/2019 3:09 PM Resulted:  08/01/2019 9:17 AM Ordered By:  NP Result Status:  Final result MONONUCLEOSIS SCREEN - Details  Component Results Component Your Value Standard Range Mono (Heterophile)  NEG    NEGATIVE TEST METHOD: Chromatographic Immunoassay  Normal Value: Negative General Information Collected:  07/26/2019 3:09 PM Resulted:  07/27/2019 10:27 AM Ordered By:  NP Result Status:  Final result  SEDIMENTATION RATE, AUTOMATED - Details  Component Results Component Your Value Standard Range Sedimentation Rate  20 mm/hr  0 - 15 mm/hr General Information Collected:  07/26/2019 3:09 PM Resulted:  07/26/2019 8:23 PM Ordered By:  NP Result Status:  Final result  VITAMIN D - Details  Component Results Component Your Value Standard Range 25-OH VIT D2  <4 ng/mL  ng/mL 25-OH VIT D3  33 ng/mL  ng/mL Methodology: Liquid Chromatography-Tandem Mass Spectrometry Test developed and characteristics determined by Labs 25-OH Vit Total  33 ng/mL  30 - 60 ng/mL Reference Ranges:  < 20 ng/mL Moderate Risk of Deficiency 20-29 ng/mL Low Risk of Deficiency 30-60 ng/mL Adequate > 60 ng/mL Potentially Harmful The Total Vitamin D result is the sum of the two forms of 25-hydroxyvitamin D (D2, from plant sources, and D3 from animal sources or endogenous synthesis). General Information Collected:  07/26/2019 3:09 PM Resulted:  07/29/2019 10:41 AM Ordered By:  NP Result Status:  Final result",PVT,,Fluoxetine HCL 40mg capsule / once daily Vitamin D 2000 IU / once daily Ferrous Sulfate 65 mg tablet / once daily,None,Autism Spectrum Disorder Anemia Ear infections Low muscle tone,,,2,09/22/2019,,Y,Y,None
0835063,09/22/2019,PA,73.0,73,,F,,"Patient described redness around injection site in right arm the day after vaccination which is gone at this point.  Patient developed red raised rash on both arms, trunk, and back of neck.  Rash still present when arriving at pharmacy 6 days after vaccination on 9/22. Patient was treating with hydrocortisone cream, but did not want to take Benadryl or Claritin as she has also had negative reactions to these medications.  Pharmacist recommended seeing a physician if rash does not improve. Patient stated she thinks the rash is getting better. Patient also said she had a sore throat for a few days afterwards but that is improved.",,,,,,,,,N,09/16/2019,09/17/2019,1,,PHM,,,,,,,2,09/22/2019,,Y,,"mafenide, penicillin, salicylates, sulfa antibiotics, sympathomimetics,"
0835064,09/22/2019,NY,89.0,89,,M,,Patient's daughter called due to language barrier and stated that her father had more pain at injection site than last year and he had an elongated bruise at the sire of injection.,,,,,,,,,U,09/18/2019,09/20/2019,2,,PHM,,Lyrica 50mg Capsule Toprol XL 100mg tab Jalyn 0.5/0.4 capsule Cyclobenzaprine 5mg tab Namenda xr 14mg capsule Aricept 10mg tab Pataday 0.2% eye drops Qnasl 80mcg Nasal spray Ramipril 10 mg capsule Nexium DR 40 mg capsule,None,Alzheimer's Disease Diabetes High blood pressure,,,2,09/22/2019,,,,No known allergies
0835065,09/22/2019,GA,67.0,67,,F,,extreme pain and limited ability to lift or use left arm; continue to have minimal although perceptible discomfort in left arm from elbow down,,,,,,,,,N,06/23/2019,06/23/2019,0,,PHM,,,none,,,,2,09/22/2019,,,,rabbit (food) sumac in food
0835066,09/22/2019,CA,76.0,76,,M,,"Patient filled out pre-screening form in complete and all questions were answered ""no"".  Pt wife called to inquire regarding the questions on the form and how he answered because he is having full body severe myalgias after obtaining his flu and Shingrix dose.  pt is paraplegic and she informed us that he should have answered ""yes"" to a couple of the questions.  Advised pt wife to take pt to seek further diagnostic care with a physician.  She will monitor his pain level to decide if she will take him in urgently to ER or wait to call me/neurologist on Monday if they don't have on call #.  Called pt wife to follow up on pt's condition on 9/22 - pt wife, has informed me that she did not end up taking him in yesterday and today he is doing just fine.",,,,,,,,,Y,09/20/2019,09/21/2019,1,,PHM,,,Pt is paraplegic,Pt is paraplegic,,,2,09/22/2019,,,,peanut
0835067,09/22/2019,NC,71.0,71,,F,,"Patient states she woke up at night vomiting, with cold chills, feverish, and fatigued.  Patient stated that adverse events resolved at 10am the next morning.",,,,,,,,,Y,09/09/2019,09/09/2019,0,,PVT,,"Fluoxetine, Methimazole, Meloxicam, Pantoprazole, Atorvastatin, Aspirin low dose, Biotin, Trazodone, Gabapentin, Alprazolam",none,,,,2,09/22/2019,,,,no allergies
0835068,09/22/2019,NC,36.0,36,,F,,"Fever around 100, chills, joint ache, headache, nausea, watery diarrhea, stomach pain, loss of appetite",,,,,,,,,Y,09/21/2019,09/21/2019,0,,PHM,,,,"Celiac, asthma",,,2,09/22/2019,,,,Wheat
0835069,09/22/2019,CA,39.0,39,,M,,"Fever 102 (normally 97.7), Elevated resting heart rate, 90 (normally 50) peaking at 120 BPM, Hypertension 181/97 (normally 130/73). Shaking and shivering.",,,,,,,,,U,09/21/2019,09/21/2019,0,,PHM,,"Multi Vitamin, Omega-3",,Mild hypertension,,,2,09/22/2019,,,,Penicillin
0835070,09/22/2019,FL,72.0,72,,F,,"Left arm sore, red and swollen from elbow to shoulder. Body shivering and feeling cold. No fever, no rash. Currently treating with Tylenol. Symptoms currently not resolved.",,,,,,,,,N,09/19/2019,09/19/2019,0,,PHM,,,,,,,2,09/22/2019,,Y,,
0835071,09/22/2019,FL,65.0,65,,F,,Patient came in and stated that last month she was vaccinated (8/16/19) after 24 hrs her arm started swelling up. After 3 days not getting better she went to urgent care and was advised to go to E.R. Patient was experiencing adverse reaction (face is swelling and tongue; rapid heart beat) she was discharge on the same day. She is feeling better now.,,,,,,,,,Y,08/16/2019,08/17/2019,1,unknown,PHM,,bimatoprost eyelash solution;np thyroid; pravastatin;cetirizine;pantoprazole;synthroid; ranitidine,,,,,2,09/22/2019,,Y,Y,unknown
0835072,09/22/2019,TX,67.0,67,,F,,"Patient reported swelling, rash and pain around injection site that remained for 4 days. causing inability to move arm comfortably",,,,,,,,,Y,09/19/2019,09/20/2019,1,none stated,PHM,,none stated,none stated,none stated,,,2,09/22/2019,,,,codeine
0835073,09/22/2019,MA,26.0,26,,F,,Patient had pain down whole arm and hand with some swelling of the hand on side of vaccination,,,,,,,,,U,09/21/2019,09/22/2019,1,,PHM,,,,,,,2,09/22/2019,,,,
0835074,09/22/2019,PA,66.0,66,,F,,"At5p.m. I felt fatigued and got weaker,by 7 p.m. I felt severe muscle pain along with shivering ,fever and sweating . It felt like full blown flu symptoms.This continued until 7a.m. The next morning and symptoms slowly declined,but a headache along with tiredness continued until the morning of September 20. As of this date all symptoms have subsided.",,,,,,,,,Y,09/18/2019,09/18/2019,0,,PHM,,,,,,,2,09/22/2019,,,,
0835075,09/22/2019,,73.0,73,,F,,"Patient experienced redness, swelling, tenderness and pain at the injection site and the surrounding area which also spread around the bicep to the back of the arm. She has been icing and taking tylenol for the pain.",,,,,,,,,,09/19/2019,09/20/2019,1,,UNK,,,,,,,2,09/22/2019,,Y,,
0835076,09/22/2019,PA,30.0,30,,M,,"Patient states that he experienced joint pain, swelling, warmth at the site and his arm was immobile.",,,,,,,,,U,09/11/2019,09/13/2019,2,"Patient went to the emergency room. they ran multiple tests and took scans and concluded that either it was a ""bad batch"" or the patient had an allergic reaction to the vaccine. Due to it being the patients first flu shot and no other reported incidents from the manufacture or other patients using this lot, the assumption is that it may be an allergic reaction to the vaccine.",PHM,,none aware of,none that patient was aware of,none that patient was aware of,,,2,09/22/2019,,,Y,patient stated only seasonal allergies
0835077,09/22/2019,FL,50.0,,,F,,Patient presented 2 days post-vaccines with right facial paralysis. Advised urgent care after looking for signs and symptoms of stroke.,,,,,,,,,N,,09/19/2019,,,PHM,,,,,,,2,09/22/2019,,,Y,Opiods
0835078,09/22/2019,NJ,52.0,52,,F,,"Shortly after patient received flu vaccine, she experienced hot flashes, heavy breathing, dizziness, sudden back spasms. Patient received flu vaccine at pharmacy in the past but has never had this type of reaction before. When police and EMS arrived, patient recovered and felt better. Patient refused transport to hospital. Patient was well when she left the pharmacy.",,,,,,,,,Y,09/22/2019,09/22/2019,0,,PHM,,"Synthroid, per patient",None,,,,2,09/22/2019,,Y,,None
0835079,09/22/2019,CT,55.0,55,,F,,Muscle ached whole body low  grade fever naseua Headache,,,,,,,,,N,09/21/2019,09/22/2019,1,None,PHM,,Clonazapam sinthroid seraquel effexor lispordril,None,Migraines,,,2,09/22/2019,,,,Amoxicillian
0835080,09/22/2019,MT,72.0,72,,F,,"Patient stated that on Friday 9/20 she started getting chills and a headache. On Saturday 9/21 she developed a red rash looking area below the injection site roughly palm sized, it was red, hot, and sore to the touch. By Sunday 9/22, the rash was still present and was still warm, but she was able to touch it.",,,,,,,,,U,09/20/2019,09/20/2019,0,,PHM,,none known of,none known of,none known of,,,2,09/22/2019,,,,none known of
0835081,09/22/2019,NY,72.0,72,,M,,"itching bilaterally in antecubital fossa, sides, stomach with onset of a few days after shot and continuing to present...attempted neosporin...advised to use cortisone at this time",,,,,,,,,N,09/09/2019,09/11/2019,2,,PHM,,"metoprolol tartrate 25mg daily, simvastatin 40mg at bedtime, multivitamin daily",nka,cardiovascular,,,2,09/22/2019,,,,nka
0835082,09/22/2019,NC,33.0,33,,F,,"Red circle around injection site (about 3 inches diameter), pain/tenderness at injection site, nausea",,,,,,,,,N,09/20/2019,09/21/2019,1,,PHM,,,,,,,2,09/22/2019,,Y,,
0835083,09/22/2019,OH,65.0,65,,F,,"Patient received vaccine on 9/18/19  on 9/20/19 morning patient noticed 4"" round circle  2"" below injection site, circle was red, raised and warm to touch. Patient's whole are was painful to touch. Patient called physican and was seen the afternoon of 9/20/19. Physician said cellulitis or allergic reaction. Patient used bacitracin and swelling has gone down.",,,,,,,,,Y,09/18/2019,09/20/2019,2,,PHM,,,,patient is on pain medications,,,2,09/22/2019,,Y,,"penicillins, quinolones, sulfa antibiotic, tetracycline"
0835084,09/22/2019,CA,61.0,61,,F,,"Fast heart beat, light headed and weak in the morning, headache.",,,,,,,,,Y,09/12/2019,09/13/2019,1,,PVT,,"Amaryl, atorvastatin, candesartan, carbamazepine, diltiazem, farcical, metformin,  sotalol, warfarin.",,"Diabetes, High blood pressure,  Afib.",,,2,09/22/2019,,,,No.
0835085,09/22/2019,NJ,75.0,75,,F,,Patient states that she was give the Fluzone HD on 9/10/19  then on 9/13/19 she experienced  hives and lost her voice. On 9/21/19 she experienced swelling in her face. During this time period she was administered Synvisc injections on 9/11/19 and 9/18/19 . Patient is not getting worse with her symptoms but was counseled and advised to speak to her physician if symptoms worsen or persist.,,,,,,,,,N,09/10/2019,09/13/2019,3,,PHM,,Patient received Fluzone HD on 9/10/19 then received Synvisc injection on 9/11/19 and 9/18/19,,,,,2,09/22/2019,,,,
0835086,09/22/2019,TX,55.0,55,,M,,Patient received the Shingrix dose 1 shot on 7/17/19.  He got a reaction a week later.  He had welts on his right side of this face.  He came back to the pharmacy on 7/31/19 to tell the pharmacist on duty.,,,,,,,,,Y,07/17/2019,07/24/2019,7,,PHM,,sertraline 25mg hydroxyzine 10mg montelukast 10mg atorvastatin 40mg Prasugrel 10mg,No,,,,2,09/22/2019,,Y,,Penicillin
0835087,09/22/2019,TX,66.0,66,,F,,"Patient stated that within 30 minutes she became dizzy/lightheaded.  Her lips started burning like they were on fire and there was ""white stuff"" oozing from her eyes.",,,,,,,,,Y,09/20/2019,09/20/2019,0,Patient went to emergency room.  Unknown to pharmacy what tests were performed.,PHM,,Unknown,Unknown,Unknown,,,2,09/22/2019,,,Y,None
0835088,09/22/2019,NY,75.0,75,,M,,patient came to pharmacy 2 days later complaining about fever and night sweats. also complained about rash on right side of arm. site of injection for both vaccines was put in the system as the left arm when patient states he received one shot on each arm. so dont know which vaccine he actually got on right arm that caused reaction,,,,,,,,,U,09/18/2019,09/18/2019,0,,PHM,,"fenofibrate,omeprazole,amlodipine,zocor,atenolol",,,,,2,09/22/2019,,,,nkda
0835090,09/22/2019,IL,61.0,61,,F,,MMR was administered intramuscularly as opposed to subcutaneously as recommended.,,,,,,,,,U,09/22/2019,09/22/2019,0,,PHM,,n/a,n/a,n/a,,,2,09/22/2019,,,,n/a
0835091,09/22/2019,MO,60.0,60,,F,,Patient reported pain and swelling on right upper arm the day after the immunization. She said that swelling occurred almost within a couple of hours after the injection.,,,,,,,,,Y,09/19/2019,09/19/2019,0,,PHM,,,,,,,2,09/22/2019,,,,
0835092,09/22/2019,OH,69.0,69,,M,,The next day after receiving Shingrix the patient stated he became nauseous and developed a fever. He said she felt this way for two days.,,,,,,,,,Y,09/16/2019,09/17/2019,1,,PHM,,,,,,,2,09/22/2019,,,,
0835093,09/22/2019,OH,68.0,68,,F,,The patient stated she experienced nausea and a fever the day after receiving Shingrix. The symptoms lasted for four days.,,,,,,,,,Y,09/16/2019,09/17/2019,1,,PHM,,,,,,,2,09/22/2019,,,,
0835094,09/22/2019,IN,63.0,63,,F,,"PATIENT CAME TO PHARMACY 9/21/19 TO REPORT SHE HAD EXPERIENCED A LARGE AREA OF REDNESS ON HER UPPER RIGHT ARM, SURROUNDING THE AREA WHERE SHE RECEIVED PNEUMOVAX 23.  THE AREA OF REDNESS WAS HOT AND SLIGHTLY RAISED, WITH AN IRREGULAR OVAL SHAPE, APPROXIMATELY 3 OR 4 INCHES IN DIAMETER.  I DREW A BORDER AROUND THE AREA OF REDNESS. WHEN I CALLED TO CHECK IN WITH THE PATIENT ALMOST 24 HOURS LATER, SHE REPORTED THE TOP OF THE AREA OF REDNESS HAD RECEDED AN INCH OR TWO, BUT AT THE BOTTOM THE REDNESS HAD MOVED BEYOND THE LINE BY AN INCH OR TWO.  PATIENT REPORTED THE SPOT APPEARED TO BE ""MOVING DOWN HER ARM.""  PATIENT WILL BE SEEING HER DOCTOR TUESDAY 9/24/19 FOR AN UNRELATED ISSUE, AND WILL CONSULT WITH HIM THEN.   SHE WILL SEEK URGENT MEDICAL CARE IF HER SYMPTOMS WORSEN SIGNIFICANTLY PRIOR TO THAT PLANNED APPOINTMENT.",,,,,,,,,N,09/20/2019,09/20/2019,0,,PHM,,,,,,,2,09/22/2019,,Y,,
0835095,09/22/2019,WA,62.0,62,,F,,swollen and red at the site started 2 days after shot.,,,,,,,,,U,09/11/2019,09/13/2019,2,unknown,PHM,,"losartan, crestor, hydroxychloroquine, jentadueto, propranol er",nothing reported,"type 2 diabetes, rheumatoid arthritis, hypertension, hypercholesteremia",,,2,09/22/2019,,,Y,sulfas
0835096,09/22/2019,AL,57.0,57,,F,,"Reaction:  Sore arm, severe headache, joint and muscle pain, fever, fatigue, red swollen spots on arm. Treatment:  Rest and ibuprofen. Resolved with treatment after 48 hours.",,,,,,,,,Y,09/17/2019,09/18/2019,1,,PHM,,"Multi-vitamin, calcium supplement, collagen protein.",None,None,,,2,09/22/2019,,,,No known allergies
0835097,09/22/2019,OH,51.0,51,,F,,Lumps in the left armpit and groins area. Bumps that turned into sores on both legs.,,,,,,,,,N,08/12/2019,08/24/2019,12,,PVT,,"I am participating in an on-line class that required up-to-date immunization vaccines. I though the the University simply wanted you to have a physical to start the program. I was required to have TB vaccines, MMR vaccines, Hepatitis B vacc",No,No,,,2,09/22/2019,,Y,,Augmentin
0835098,09/22/2019,SC,64.0,64,,F,,"Within an hour or so of the vaccine, I felt dizzy, short of breath and pains in my head.  Not really a headache, but pains in my head.  I started running a fever that night.  A call to the pharmacist advised me to take an antihistamine, which helped.  I ran a fever the next day, all day, and slept all day.  The second day I felt better, but still a bit dizzy.  About the 4th day after the shot, at night, my skin was hyper sensitive all over.  It itched where my head touched the pillow and the sheet on top of my body was irritating.  More antihistamine helped me to sleep eventually.  Have had some lingering dizziness.",,,,,,,,,Y,09/09/2019,09/09/2019,0,"No test.  I had the shot on Monday.  Later in the week I visited the doctor because I was concerned about the hyper- sensitivity of my skin. My throat hurt and the inside of my ears itched, but he said I had no visible signs of inflammation.",PHM,,latanoprost,none,none,"Penicillin.  It was when I was an infant, so I don't remember.  But my mother said I should never have it again.",,2,09/22/2019,,Y,,"penicillin, sulfa drugs, honey dew mellon, Brazil nuts"
0835099,09/22/2019,CA,48.0,48,,M,,"Fever 102 degrees,  muscle pains, joint pains, dizziness, chills",,,,,,,,,N,09/21/2019,09/21/2019,0,None,PVT,,"Insulin, metformin, lisinopril","Diabetes, strep throat in August  2019","Diabetes, High blood pressure,  kidney cancer (Partial Nephrectomy 09/28/2019)",,,2,09/22/2019,,,,Allergy to Statins
0835100,09/22/2019,AL,59.0,59,,M,,"Reaction: sore arm, fever,  body aches, fatigue. Treatment: Ibuprofen and rest. Resolved with in 48 hours.",,,,,,,,,Y,09/17/2019,09/17/2019,0,None,PHM,,"Metformin, Vascepa, Mag-Oxide, Losartan, Januvia,  Chlorthalidone,  Pravastatin,  Glipizide,  Dye-Free Aspirin 81,  Coenzyme Q10 supplement, Collagen protein.",None,"Type 2 diabetes, high cholesterol, high blood pressure",Sore arm with 1st series of Shingrix vaccine,,2,09/22/2019,,,,No known allergies
0835101,09/22/2019,VA,57.0,57,,F,,"0700 - Nausea, vomiting, febrile (101.2), lethargy, malaise, headache, chills. 0700 - Promethazine 25 mg, Tylenol 1,000 mg. 1100 - Remained febrile. 1100 - Ibuprofen 400 mg . 1400 -  Nausea, vomiting, fever, headache, & chills resolved.",,,,,,,,,Y,09/21/2019,09/22/2019,1,N/A,PHM,,Prozac,Conjunctivitis,"Fibromyalgia, Sjogren's Syndrome, Raynaud's Syndrome, splenectomy",Adverse reaction to influenza vaccine 3 times (including this event) since 1981. This is the event with the most severe symptoms,,2,09/22/2019,,,,"PCN, ASA"
0835102,09/22/2019,,81.0,81,,F,,Patient said her arm was hurting for about 7 days which is unusual for her,,,,,,,,,,08/29/2019,08/29/2019,0,,UNK,,,,,,,2,09/22/2019,,,,
0835103,09/22/2019,NM,58.0,58,,F,,"ABOUT 18 HOURS AFTER VACCINATION, PATIENT DEVELOPED FEVER.  MEASURED AT ONE POINT AS 100.5 UNDER THE ARM.  LATER DEVELOPED LOCAL REACTION. APPROXIMATELY 3 INCH AREA AT INJECTION SITE (ON RIGHT ARM) AND ANOTHER AREA ABOUT 1 1/2 INCHES BELOW SITE BECAME RED, HOT & TENDER.  FEVER RESOLVED AFTER 3 DAYS.  LOCAL REACTION MUCH IMPROVED ON 9/22",,,,,,,,,U,09/18/2019,09/19/2019,1,NONE,PHM,,"FUROSEMIDE, LISINOPRIL,LEVOTHYROXINE, METFORMIN,PRAVASTATIN, POTASSIUM CITRATE, MAGNESIUM, VITAMIN D",MILD ALLERGY/COLD SYMPTOMS ABOUT 1 MONTH PRIOR,"KIDNEY DISEASE, PRE-DIABETES, HYPERTENSION, HIGH CHOLESTEROL, THYROID DISEASE",,,2,09/22/2019,,,,NONE
0835104,09/22/2019,CA,57.0,57,,F,,"pain next day after immunization then bruising appeared, bruising as of this date visible approximate  2inch by 1inch area",,,,,,,,,U,09/13/2019,09/13/2019,0,none,PHM,,blood pressure medication,none,hyper tension,,,2,09/22/2019,,,,none
0835105,09/22/2019,WA,54.0,54,,F,,Chills and fever that went up to 102 during the day,,,,,,,,,Y,09/14/2019,09/15/2019,1,,PHM,,None,None,None,,,2,09/22/2019,,,,penicillin
0835107,09/22/2019,FL,42.0,42,,F,,"The day I received the flu shot I started to feel tired and got a headache. The next day I took Advil for the headache. The next two days I felt  fine. However day four I woke up with a severe sore throat/burning, with many more symptoms and side effects until today. I came down with flu like symptoms and other side effects such as follows: fever, vomiting, headache, chills, body aches, tired, weakness, numb hands and face, dizzy, congestion, runny nose, sneezing, chest pain, heavier period, delirious, and nauseous.",,,,,,,,,N,09/09/2019,09/09/2019,0,None,OTH,,None,None,Seasonal allergies,,,2,09/22/2019,,Y,,Sulfa
0835108,09/22/2019,MN,54.0,54,,M,,"About 13 hours after the vaccination, I developed chills and a fever.  This persisted, along with body aches and fatigue for about 13 hours.   I felt back to normal about 48 hours after the vaccination.",,,,,,,,,Y,09/20/2019,09/20/2019,0,,PVT,,,,,,,2,09/22/2019,,,,
0835109,09/22/2019,FL,45.0,45,,F,,allergic reaction swelling/hives. given steroid and antibiotic,,,,,,,,,U,09/20/2019,09/22/2019,2,,PHM,,"clonazepam, topamax, proair",,,,,2,09/22/2019,,,Y,beta lactams
0835110,09/22/2019,IL,29.0,29,,F,,"I had the flu shot given on 9/10/2019. I still have moderate arm pain with limited range of motion as of today, 9/22/2019. I contacted my physician who said I need to take Advil for two weeks, do physical therapy, and have possible steroid injections done.",,,,,,,,,N,09/10/2019,09/10/2019,0,None,PVT,,None,None,Mitral Valve,,,2,09/22/2019,,,,None
0835111,09/22/2019,WA,56.0,56,,M,,"Second shot.  At 3 am started  feeling body aches, muscle soreness, nausea, tiredness that is still present at 8:40 pm.",,,,,,,,,N,09/21/2019,09/22/2019,1,,PHM,,"Lisinopril, rosuvastatin, hydrochlorothiazide, fluoxetine,",None.  Received flu vaccination on 9/20/19.,None,,,2,09/22/2019,,,,None
0835198,09/22/2019,WI,24.0,24,,F,,"9/11/19 Pain, redness, swelling (golf ball size), and warm to touch at sight of injection. Itchy also. 9/12/19 Visit with provider and given Hydroxizine and Hydrocertisone topical. 9/13/19 Symptoms improving noted by nurse call.",,,,,,,,,Y,09/09/2019,09/10/2019,1,NA,PVT,,"Tylenol, Benadryl, Ventolin HFA, Biotin, Cyclobenzaprine, Ibuprofen, Novolog, Levemir",N/A,Type 2 diabetes,,,2,09/18/2019,,Y,,"Amoxicillin, Risperidone, Bee Stings"
0835226,09/22/2019,CA,77.0,77,,F,,"- vaccinated on 9/17/19 around 5 pm - Side effects became noticeable on 9/18/19 and are still there today on 9/18/19. Symptoms stay the same, not getting worse.  -2"" x 2"" inflamed area about 3 - 4"" below injection site.  - Recommended pt to go to urgent care for evaluation",,,,,,,,,N,09/17/2019,09/18/2019,1,,PHM,,,,,ABcess iN (R) ARM Following FLU SHot SEVEral years ago.,,2,09/20/2019,,,,
0835288,09/22/2019,MN,60.0,60,,M,,"Patient states that he awoke ""convulsing"" and was able to get to a sitting position at end of bed. Put ice pack on injection site. Had no other problems.",,,,,,,,,Y,09/19/2019,09/19/2019,0,None,PHM,,,none,,,,2,,,,,"naproxen, aspirin, cephalosporins, penicillins"
0835482,09/22/2019,MI,,,,F,09/21/2019,"Shingles per MD. Rashes, pain left side of the the body Valacyclovir 1 gm TABlet 3x a day for 7 DAYS",,,,,,,,,Y,08/26/2019,09/12/2019,17,,OTH,OTH,,NONE,,,,1,,,,,
0835495,09/22/2019,AZ,72.0,72,,F,,"flu-like symptoms Thursday am - Friday pm redness, swelling, erythema at injection site Saturday - Sunday Urgent Care prescribed hydroxyzine 12.5mg",,,,,,,,,N,09/19/2019,09/20/2019,1,,PHM,,,none,,,,2,,,Y,,
0835496,09/22/2019,PR,22.0,22,,M,09/22/2019,"After patient leaving the immunization room, he apparently fell to the floor. His mother helped him to sit down and he said he felt dizzy and was pale and sweating. Patient did not report any other complaints.",,,,,,,,,Y,09/22/2019,,,Blood Presure: 81/48 mmHg (7:10pm) 65 bpm 151/83 mmHg (7:19pm) Pulse 62 bpm 135/91 mmHg (7:21pm) 58 bpm 153/89 mmHg (7:35pm) 59 bpm 146/94 mmHg (7:37pm) 59 bpm,OTH,PVT,,none,allergy to latex,,,1,,,,,
0835112,09/23/2019,CA,13.0,13,,M,,"Patient developed fever (101.6 degrees), chills and aches about eight hours after injection.  He could not eat for the next 24 hours because of nausea and malaise.  On 9-21 he started getting bad headaches especially when he moved.  On 9-22 he developed a runny nose and red, watery eyes.  The symptoms have not yet subsided.",,,,,,,,,N,09/20/2019,09/20/2019,0,,PVT,,None,None,None,,,2,09/23/2019,,,,Allergic to Amoxicillin
0835113,09/23/2019,MI,54.0,54,,F,,"Urticaria noted on back areas from shoulders to mid-thigh,; red, slightly raised itchy patches; itch relieved by diphenhydramine but patches remain today. Wondering if unusual pattern on body is due to increased circulation to back area due to use of car seat warmer.",,,,,,,,,N,09/17/2019,09/18/2019,1,None,OTH,,Ibuprofen,None,None,,,2,09/23/2019,,,,Penicillin (rash as a child)
0835114,09/23/2019,MI,55.0,55,,F,,severe shoulder pain,,,,,,,,,N,09/17/2019,09/20/2019,3,,WRK,,"Atorvastatin, Aspirin, Metoprolol Tartrate, Hydrochlorothiazide",none,none,,,2,09/23/2019,,Y,Y,none
0835115,09/23/2019,CO,65.0,65,,F,,"Toothache starting with pain, then severe pain swollen sore glands red irritated gums all on right side of mouth and base of tongue  a few small blisters that broke",,,,,,,,,N,09/20/2019,09/21/2019,1,Went to dentist got stay nothing,PUB,,Levothyroxine tramadol naproxen omeprazole terpinafine,None,"Arrhritis , rheumatoid /osteo",,,2,09/23/2019,,Y,,None
0835116,09/23/2019,AR,24.0,24,,F,,"immediately after the immunization every muscle in my body severely hurt. Within an hour of the immunization, I had sudden extreme  exhaustion and fatigue  to the point I feel asleep while eating and I had nausea, vomiting, diarrhea, stomach cramps and 103 degree fever. My skin also turned pink all over my body. I am still this many days out in extreme pain. All my muscle in my body hurt severely to the point my muscle pain wakes me up from sleeping. Last night I was again awaken from all of my muscles hurting. The pain was so bad that I felt I needed to an ER for pain control. The only reason that I did not go to an ER is because I do not live close to an ER. I am I so much pain and have so many GI symptoms and such bad fatigue that I do not feel that I can drive to my nearest ER which is far away from me. I considered calling for an ambulance but I was not sure if this is the type of thing you call an ambulance  for since I was not having an life threatening issue. I was not sick prior to this immunization. In fact, I have a berry healthy lifestyle and diet and I was feeling very well prior to this immunization.  Now that it is amiss business hours, I am going to see if I can get someone to drive me to the doctor today. I normally can drive but I have been too sick to drive since this immunization.",,,,,,,,,N,09/19/2019,09/19/2019,0,,PUB,,Prescription birth control,No,Autism Neurological hypersensitivity,,,2,09/23/2019,,,,"Serotonin drugs, penicillin"
0835117,09/23/2019,SC,80.0,80,,F,,"muscle weakness, itching, pain, ,swelling",,,,,,,,,N,09/18/2019,09/18/2019,0,,PHM,,"metformin, asa, vit.D,tramadol, ranitidine, montelukast, losartan",none,"diabetes hypertensuon, DJD",,,2,09/23/2019,,,,"sulfer, codiene"
0835127,09/23/2019,,19.0,20,,M,,"Neurodermatitis; Seasonal allergy; This case (DE-PEI-PEI2019005917) was received from a consumer via health authority (EMA) on 09-Sep-2019. It described a 19-year-old male consumer who developed neurodermatitis (PT: neurodermatitis) and pollinosis (PT: seasonal allergy) after administration of Typhoral L, Pocken and Telanol for prophylactic vaccination.  Case report: The consumer took a dose of Typhoral-L on 14-Jul-1976, along with Pocken on 18-Aug-1976 and Tetanol on 02-Jul-1976. Subsequently, he developed pollinosis and neurodermitis in 1976 & 1977, respectively. The consumer showed disabling/incapacitating.  Action taken with Typhoral L with respect to the event pollinosis was unknown, while with respect to the event neurodermatitis was not applicable while that with Pocken, and Tetanol with respect to the events pollinosis. The consumer had recovered with sequelae from the reported events.  Company's Comment: In this case, it was reported that a 19-year-old adult male consumer developed neurodermatitis and pollinosis after the administration of Typhoral L, Pocken, and Tetanol. There is lack of information regarding start date of events, course of events, medical history and concomitant medications. Hence, the causality is assessed as not assessable for the reported events with respect to intake of Typhoral-L.; Sender's Comments: Company's Comment: In this case, it was reported that a 19-year-old adult male consumer developed neurodermatitis and pollinosis after the administration of Typhoral L, Pocken, and Tetanol. There is lack of information regarding start date of events, course of events, medical history and concomitant medications. Hence, the causality is assessed as not assessable for the reported events with respect to intake of Typhoral-L.",,,,,,,,Y,N,07/02/1976,,,,OTH,,,,Comments: None,,DEE2B_00003974,2,09/23/2019,,,,
0835140,09/23/2019,NJ,,,,U,,"No adverse effects reported; a patient received unspecified dose of PEDVAXHIB that was improperly stored/experienced excursion on 5/10/2018.; Information has been received from a nurse referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.  On 10-MAY-2018, the haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot # N003536, expiration date wasreported as November 2019, but upon internal validation established as 02-NOV-2019) was improperly stored. The stored temperature was 8.72 degree Celsius. The time frame was 1 hours and 35 minutes. There was more than 1 previous temperature excursion. The temperature excursion was detected by a data logger.    On 23-JUL-2018, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot # N003536, expiration date was reported as November 2019, but upon internal validation established as 02-NOV-2019, strength, dose, frequency and route were unknown) for prophylaxis (improper storage of product in use).  No adverse effects were reported.",,,,,,,,,U,07/23/2018,07/23/2018,0,,UNK,,,,,,US0095075131908USA012329,2,09/21/2019,,,,
0835141,09/23/2019,NY,0.08,0,.1,M,,"No adverse event; one male patient received improperly stored ROTATEQ; Information has been received from an office manager referring to a 6-week-old male patient. The patient's pertinent medical history, concurrent condition and concomitant therapy were not reported.        On 25-JUL-2019, the patient was vaccinated with received improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot S000945, expiration date: 13-JUL-2020; strength, dose and route were not reported) for prophylaxis (product storage error). The call was because of data logger. Total time and lowest temperature below 2 degrees Celsius (""-0.2 C"") for 1 hour and 12 minutes and total time and highest temperature above 9 degrees Celsius (""11 C"") for 2 hours and 44 minutes. There was no previous temperature excursion. No adverse effect reported.",,,,,,,,,U,07/25/2019,07/25/2019,0,,UNK,,,,,,US0095075131909USA000636,2,09/21/2019,,,,
0835142,09/23/2019,CA,,74,,F,,"injection site pain, redness, and swelling traveling to her wrist; injection site pain, redness, and swelling traveling to her wrist; injection site pain, redness, and swelling traveling to her wrist; injection site pain, redness, and swelling traveling to her wrist; injection site pain, redness, and swelling traveling to her wrist; Information has been received from a medical assistant, referring to a 74 years old female patient. The patient had none concomitant therapy, pertinent medical history or drug reactions/allergies. It was also reported on an unknown date, the patient received pneumococcal 13v conj vaccine (CRM197)(PREVNAR 13).  On 28-AUG-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # R034248, expiration date: 07-AUG-2020, 1 dosage form, strength and frequency were unknown) intramuscularly in the left arm for prophylaxis.         On the same day, the patient called to report ""injection site pain, redness, and swelling traveling to her wrist"". The medical assistant told the patient to ""apply ice to her wrist"". On 30-AUG-2019 (or 31-AUG-2019), the patient returned to the office and was prescribed unspecified oral steroids. Treatments were given for the events. None lab diagnostics or studies were performed. The patient had sought medical attention. The outcome of the events was unknown. The causality assessment was not provided by the reporter.",,,,,,,,,U,08/28/2019,08/28/2019,0,,UNK,,,,,,US0095075131909USA000681,2,09/21/2019,,,,
0835143,09/23/2019,NY,,,,U,,"No adverse affects reported; an improperly stored dose of PEDVAX HIB administered to patient on 8/20/2019; Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history, drug reactions or allergies were not reported.  On 20-AUG-2019, the patient was administered a dose of improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(PEDVAXHIB) ( Lot No. R027326 has been verified to be a valid lot number, expiration date not reported, but upon internal validation established as 10-JUL-2021; strength and dose were not reported), intramuscularly for prophylaxis. No adverse events were reported. The temperature of storage was below 36 degrees Fahrenheit/ 2 degrees centigrade (35.4 F) for 27 minutes. There was no previous temperature excursion. Data logger was involved.",,,,,,,,,U,08/20/2019,08/20/2019,0,,UNK,,,,,,US0095075131909USA000713,2,09/21/2019,,,,
0835144,09/23/2019,KY,,,,U,,"a patient received improper stored vaccine; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history, drug reactions or allergies were not reported.      On 17-APR-2019, the patient was vaccinated with improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot # R021078, expiration date 12-JUN-2021; one dose; route and dose number were unknown) for prophylaxis.        The storage temperature of the vaccine was reported as 52.5 degrees Fahrenheit (F) for a time frame of 4 hours and 40 minutes. There was no previous temperature excursion. No product quality complaint (PQC) was involved. The call was due to a data logger.",,,,,,,,,U,04/17/2019,04/17/2019,0,,UNK,,,,,,US0095075131909USA000737,2,09/21/2019,,,,
0835145,09/23/2019,CO,,0,1,U,,"no adverse effects reported; an unspecified patient with date of birth 7/31/2016, received a dose of MMR II (M035388, expiration 8/2/2018) on 7/25/2017 ""5 days before they turned one year old""; Information has been received from a nurse referring to a 11 months old patient with unknown gender. The patient's concomitant drug included sterile diluent. The patient's pertinent medical history, drug reactions or allergies were not reported.  On 25-JUL-2017 (5 days before turning one year old), the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (lot number: M035388; expiration date: 02-AUG-2018; strength and route were not reported) for prophylaxis (Inappropriate age at vaccine administration). No adverse effects reported. The outcome of the event was unknown.",,,,,,,,,U,07/25/2017,07/25/2017,0,,UNK,,sterile diluent,,,,US0095075131909USA000826,2,09/21/2019,,,,
0835146,09/23/2019,KY,,,,U,,"a patient received improperly stored vaccine on 4/24/2019; Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history, drug reactions or allergies were not reported.  On 24-APR-2019, the patient was administered a dose of improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(PEDVAXHIB) (lot number: R021078; expiration date: 12-JUN-2021; strength and route were not reported) and a dose improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot number: R028189; expiration date: 06-JUN-2020; strength and route were not reported) for prophylaxis. The temperature of storage was 52.5 degrees Fahrenheit for 4 hours and 40 minutes. There was no previous temperature excursion. Data logger was involved. The outcome of the event was unknown.",,,,,,,,,U,04/24/2019,04/24/2019,0,,UNK,,,,,,US0095075131909USA000842,2,09/21/2019,,,,
0835149,09/23/2019,IL,5.0,5,,U,,"No adverse effect reported; one patient received an improperly stored Proquad; This spontaneous report was received from a nurse and refers to a 5-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 21-AUG-2019, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin) (PROQUAD), injection, lot # R026722 and expiration date 17-MAR-2020 or lot # R023499 and expiration date 13-FEB-2020 (dose and route of administration were not reported) for prophylaxis. Concomitant therapies included properly stored sterile diluent. The temperature was from -14C to -10C (-11.91 C, multiple) for 8 hours. There was no previous temperature excursion reported. Digital data logger was involved. No adverse effect was reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA003212:",,,,,,,,,U,08/21/2019,08/21/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA003218,2,09/21/2019,,,,
0835150,09/23/2019,MD,,,,U,,"No adverse symptoms reported.; patient was vaccinated with expired VARIVAX; Information has been received from a medical assistant referring to a patient of unknown age and gender. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided.     On 05-SEP-2019, the patient was vaccinated with expired varicella virus vaccine live (oka/merck) (VARIVAX) (lot #: N021318, expiration date: 07-AUG-2019, frequency, route and dose details were unknown) for prophylaxis. The varicella virus vaccine live (oka/merck) (VARIVAX) did not have any temperature excursions prior to administration. No adverse symptoms reported.",,,,,,,,,U,09/05/2019,09/05/2019,0,,UNK,,,,,,US0095075131909USA004046,2,09/23/2019,,,,
0835151,09/23/2019,PA,,,,M,,"No adverse effects; one dose of improperly stored GARDASIL 9 was inadvertently administered to the one 11-year-old male patient; This spontaneous report was received from a healthcare business professional referring to a 11 years old male patient. The patient's concurrent conditions, pertinent medical history, drug reactions/allergies and concomitant therapies were not reported.    On 12-JUL-2019, the patient was inadvertently vaccinated with one dose of improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # 1602283, expiration date: 16-AUG-2021, but upon internal validation established as 18-AUG-2021 (dose, unit, and route were not reported) for prophylaxis (Product storage error). There was no previous temperature excursion. The vaccine was exposed at the temperature below 2 degree Celsius (C) (-0.6 C) for 50 minutes. Data digital logger was involved. No adverse effects were reported.",,,,,,,,,U,07/12/2019,07/12/2019,0,,UNK,,,,,,US0095075131909USA004048,2,09/23/2019,,,,
0835152,09/23/2019,NJ,,,,U,,"No known adverse effects; A patient received a dose ofGARDASIL 9 into the gluteal area on an unknown date in September 2018 and in December 2018; A patient received a dose ofGARDASIL 9 into the gluteal area on an unknown date in September 2018 and in December 2018; This spontaneous report has been received from a registered nurse and referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug allergy or reactions were not reported.        The patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route, lot number and expiration date were not reported) into the gluteal area for prophylaxis on an unknown date in September 2018 and in December 2018 (vaccine administered at inappropriate site). No known adverse effects were reported. There was no product quality complaint involved.",,,,,,,,,U,09/01/2018,09/01/2018,0,,UNK,,,,,,US0095075131909USA004054,2,09/21/2019,,,,
0835153,09/23/2019,NM,,,,U,,"no adverse effects reported; patient received unspecified dose of ROTATEQ on 09/09/2019 after temperature excursion; This spontaneous report as received from a medical assistant refers to a patient of an unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 09-SEP-2019, the patient was vaccinated with improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), lot # R026541, expiration date 11-JUL-2020, for prophylaxis (dose, frequency, route of administration and anatomical location were not provided). The vaccine underwent a temperature excursion of 34.1 degree Fahrenheit for 20 minutes and 47.6 degrees Fahrenheit for 40 minutes on 30-AUG-2019. There were no previous temperature excursion. The call was made because of digital data logger. There were no adverse effects reported. The outcome of product storage error and no adverse event was unknown.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,US0095075131909USA004229,2,09/21/2019,,,,
0835154,09/23/2019,TX,,,,U,,"patients that were over 15 weeks of age received their first dose of ROTATEQ; No known adverse effects; This spontaneous report was received from a physician and refers to an unknown number of patients of unknown age and gender. The patient's concurrent conditions, pertinent medical histories, drug reactions/allergies and concomitant medications were not reported.  On unknown dates, the patients were vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) vial (strength, dose, route of administration, lot number and expiry date were not reported) for prophylaxis.   At the time of vaccination, the patients were over 15 weeks of age. There were no known adverse effects.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA004725,2,09/21/2019,,,,
0835155,09/23/2019,PR,1.0,,,M,,"'This Monday, the patient came to the office with a mild rash; This spontaneous report has been received from a physician via a company representative referring to a 1-year-old male patient. The patient's concurrent conditions, medical history, concomitant therapies and drug allergy or reactions were not reported.       On 06-SEP-2019 (reported as last Friday), the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, route, lot number and expiration date were not reported) for prophylaxis (reported as routine vaccine) along with all vaccines related to the one year old visit (no further details).         On 09-SEP-2019 (reported as this Monday), the patient came to the office with a mid rash. The outcome of rash was unknown. The causality between rash and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was not reported.",,,,,,,,,U,09/06/2019,09/09/2019,3,,UNK,,,,,,US0095075131909USA005282,2,09/21/2019,,Y,,
0835156,09/23/2019,CA,1.25,1,.3,U,,"no adverse event; a patient received improperly stored VARIVAX; This spontaneous report was received from a medical assistant and refers to a 15-month-old patient of unknown gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 04-SEP-2019, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # S002874, expiration date: 29-JAN-2021 (exact dose, frequency and route of administration were not reported) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent. The vaccine experienced a temperature excursion between 6 to 14 degrees Fahrenheit (F) (10.2 F, multiple) for 50 minutes. There was no previous temperature excursion reported. Digital data logger was involved to capture the temperature excursion. No adverse effect was reported. This is one of 14 reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA005231: US-009507513-1909USA005525: US-009507513-1909USA005468: US-009507513-1909USA005424: US-009507513-1909USA005375: US-009507513-1909USA005139: US-009507513-1909USA005134: US-009507513-1909USA005129: US-009507513-1909USA005124: US-009507513-1909USA005119: US-009507513-1909USA005078: US-009507513-1909USA005220: US-009507513-1909USA005223:",,,,,,,,,U,09/04/2019,09/04/2019,0,,UNK,,sterile diluent,Prophylaxis,,,US0095075131909USA005365,2,09/23/2019,,,,
0835157,09/23/2019,PA,,,,U,,"No adverse affects reported; patient received an extra dose of VARN AX after receiving PROQUAD; Information has been received from a nurse referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/ allergies was not provided.       On 07-AUG-2019, the patient an extra dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot number R008394, expiration date 20-MAR-2020; frequency and route of administration were not reported) for prophylaxis after receiving measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot number, expiration date, frequency and route of administration were not reported) for prophylaxis also on 07-AUG-2019 (extra dose administered). No adverse affects were reported.",,,,,,,,,U,08/07/2019,08/07/2019,0,,UNK,,,,,,US0095075131909USA006504,2,09/20/2019,,,,
0835159,09/23/2019,FL,,,,U,,"No adverse effrct; the patient was inadvertently administered a dose of PNEUMOV AX 23 (LOT#S02l 740/EXP:3/25/202l) that was improperly stored; This spontaneous report has been received from a registered nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug allergy or reactions were not reported.     On 17-SEP-2019, the patient was inadvertently vaccinated with a dose of improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # S021740, expiration date: 25-MAR-2021; dose and route were not reported) for prophylaxis (product storage error).  The vaccine underwent temperature excursion of 12 Celsius for 1 hour 5 minutes. There were no previous temperature excursions. The digital data logger was involved in recording excursion details. No adverse effect was reported.",,,,,,,,,U,09/17/2019,09/17/2019,0,,UNK,,,,,,US0095075131909USA006907,2,09/23/2019,,,,
0835160,09/23/2019,NV,11.0,,,F,,"had syncope episode; This spontaneous report was received from a medical assistant via a company representative and refers to an 11-year-old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 16-SEP-2019, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot# 1614897, expiration date 20-SEP-2021, intramuscularly (exact dose and site of administration were not reported) for prophylaxis. On the same day, the patient had a syncope episode. The patient was already lying down and was given crackers and water. The outcome of syncope was reported as recovered/resolved on the same day after receiving the treatment. The patient sought medical attention. It was unknown whether the patient had any laboratory tests performed. The relatedness between the event and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.  Upon internal review, syncope was determined to be medically significant.",,,,,,,,,Y,09/16/2019,09/16/2019,0,,UNK,,,,,,US0095075131909USA007204,2,09/23/2019,,,,
0835161,09/23/2019,WA,,,,F,,"post herpetic neuralgia following chronic pain after the shingles outbreak; erythematous macular rash noted over her right face with burning pain/ diagnosed with shingles; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. On or around 20-MAY-2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiry date were not provided) for routine health maintenance and the prevention of shingles (herpes zoster). On an unknown date in 2016 (reported as within two weeks after vaccination), she suffered from an erythematous macular rash noted over her right face with burning pain. The patient was ultimately diagnosed with shingles and later diagnosed with post herpetic neuralgia following chronic pain after the shingles outbreak. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccination, the patient's symptoms resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). She also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the zoster vaccine live (ZOSTAVAX), the patient suffered severe and permanent personal injuries. Further, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccination, she suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.  The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX). The events were considered to be disabling.",,,,,,,,Y,N,05/20/2016,,,,UNK,,,Routine health maintenance,,,US0095075131909USA007253,2,09/21/2019,,,,
0835162,09/23/2019,NY,,,,F,,"shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unspecified age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2008, the patient was inoculated with zoster vaccine live (ZOSTAVAX) for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to patient's zoster vaccine live (ZOSTAVAX) inoculation, patient was treated by a physician for shingles. As a direct and proximate result of patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.",,,,,Y,,,,U,,,,,OTH,,,,,,US0095075131909USA007259,2,09/21/2019,,,,
0835163,09/23/2019,IN,,,,M,,"postherpetic neuralgia; trigeminal neuralgia; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications.  On an unknown date, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, exact dose, dose# and route not specified) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unspecified date, reported as shortly after zoster vaccine live (ZOSTAVAX) vaccination, the patient suffered severe sudden pain on the right side of his forehead and right temple region. The patient presented to his medical provided and was diagnosed with postherpetic neuralgia and trigeminal neuralgia. Despite receiving treatment, the patient continued suffering from postherpetic neuralgia and trigeminal neuralgia. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine use, the patient symptoms resulted in physical limitation not present prior to zoster vaccine live (ZOSTAVAX). The patient also experienced mental and emotional distress due to resulting physical limitation and seriousness of the patient's conditions. The patient sustained severe and permanent personal injuries. Further, the patient suffered serious, progressive permanent and incurable injuries as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the patient had suffered and incurred damages, included medical expenses; loss of accumulation; and other economic and non-economic damages. The outcome of the events was not recovered. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).  The events of postherpetic neuralgia and trigeminal neuralgia were considered to be disabling.",,,,,,,,Y,N,,,,,UNK,,,Routine health maintenance,,,US0095075131909USA007281,2,09/23/2019,,Y,,
0835164,09/23/2019,CA,0.33,,,F,,"patient regurgitated one dose of ROTATEQ; second dose of ROTATEQ due to the regurgitated dose being viewed as an incomplete dose; This spontaneous report was received from a registered nurse via company representative, referring to a 4 month old female patient. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were unknown by the reporter.  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent(ROTATEQ), orally, for routine vaccination (strength, dose, frequency, lot# and expiration date were not reported).   On an unknown date, the patient regurgitated one dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (infantile spitting up). It was reported that the patient did not seek medical attention and was unknown if diagnostic laboratories were performed.  On an unknown date (reported as ""one week after initial dose""), the patient received a second dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) due to the regurgitated dose (extra dos administered), which was viewed as an incomplete dose.   At the time of reporting, the outcome of infantile spitting up was reported as resolved on an unknown date. The causality assessment was not provided.",,,,,,,,,Y,,,,,UNK,,,Routine immunisation,,,US0095075131909USA007385,2,09/20/2019,,,,
0835165,09/23/2019,CT,,67,,F,,"No adverse effect; Improper storage conditions during shipping; This spontaneous report was received from a nurse refers to a 67 year old female patient. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported.  On 16-SEP-2019, the product was received and stored appropriately in the refrigerator. On 17-SEP-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) injection of lot # S012246 with expiry date 10-FEB-2021 (strength, dose, frequency, route of administration, date unspecified) for prophylaxis, which was deemed by the wholesaler to have been shipped outside of appropriate shipping temperature conditions (product storage error). The office was notified on 18-SEP-2019 about the improper temperature conditions during shipping. No adverse effects reported (no adverse event). There was no previous temperature excursion reported. Digital data logger was not involved. The outcome of the event was unknown.  This is one of two reports received from the same reporter.",,,,,,,,,U,09/17/2019,09/17/2019,0,,UNK,,,,,,US0095075131909USA007909,2,09/23/2019,,,,
0835166,09/23/2019,CA,,,,U,,"No adverse effect; multiple unspecified patient have received improperly stored vaccines; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions, or allergies was provided.  On 25-JUN-2019, the patient received improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (0.5 ml, one dose; lot# N028744, expiration date: 11-MAR-2020; route of administration was not provided). No adverse effects were reported. Hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was stored in refrigerator and experienced temperature excursion of 28.2 degrees Fahrenheit (F) (1 cycle) for 19 hours. There was no previous temperature excursion. Digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA005979: US-009507513-1909USA008230: US-009507513-1909USA008228: US-009507513-1909USA008229:",,,,,,,,,U,06/25/2019,06/25/2019,0,,UNK,,,,,,US0095075131909USA008227,2,09/21/2019,,,,
0835167,09/23/2019,CA,,,,U,,"No adverse effect; multiple unspecified patient have received improperly stored vaccines; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions, or allergies was provided.  On 30-MAY-2019, the patient received improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (0.5 ml, one dose; lot# N028744, expiration date: 11-MAR-2020; route of administration was not provided). No adverse effects were reported. Hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was stored in refrigerator and experienced temperature excursion of 28.2 degrees Fahrenheit (F) (1 cycle) for 19 hours. There was no previous temperature excursion. Digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA008227: US-009507513-1909USA005979: US-009507513-1909USA008230: US-009507513-1909USA008229:",,,,,,,,,U,05/30/2019,05/30/2019,0,,UNK,,,,,,US0095075131909USA008228,2,09/21/2019,,,,
0835168,09/23/2019,CA,,,,U,,"No adverse effect; multiple unspecified patient have received improperly stored vaccines; This spontaneous report as received from a medical assistant refers to multiple patients of unknown age and gender. No information regarding the patients' pertinent medical history, concomitant medications, drug reactions, or allergies was provided.  On 24-MAY-2019, the patient received improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (0.5 ml, one dose; lot# N028744, expiration date: 11-MAR-2020; route of administration was not provided). No adverse effects were reported. Hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was stored in refrigerator and experienced temperature excursion of 28.2 degrees Fahrenheit (F) (1 cycle) for 19 hours. There was no previous temperature excursion. Digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA005979: US-009507513-1909USA008228: US-009507513-1909USA008230: US-009507513-1909USA008227:",,,,,,,,,U,05/24/2019,05/24/2019,0,,UNK,,,,,,US0095075131909USA008229,2,09/21/2019,,,,
0835169,09/23/2019,CA,,,,U,,"No adverse effect; multiple unspecified patient have received improperly stored vaccines; This spontaneous report as received from a medical assistant refers to a patient of unspecified age and gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions, or allergies was provided.  On 15-MAY-2019, the patient received improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (0.5 ml, one dose; lot# N028744, expiration date: 11-MAR-2020; route of administration was not provided US-009507513-). No adverse effects were reported. Hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was stored in refrigerator and experienced temperature excursion of 28.2 degrees Fahrenheit (F) (1 cycle) for 19 hours. There was no previous temperature excursion. Digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA008229: US-009507513-1909USA008228: US-009507513-1909USA005979: US-009507513-1909USA008227:",,,,,,,,,U,05/15/2019,05/15/2019,0,,UNK,,,,,,US0095075131909USA008230,2,09/21/2019,,,,
0835170,09/23/2019,WA,,,,M,,"extreme migraine; This spontaneous report was received from a medical assistant via company representative referred to a 17-year-old male patient.  The patient's pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On an unknown date the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection for Human Papilloma Virus (HPV) infection prevention (prophylaxis) (dose, route, lot # and expiry date were not reported). The patient was also concurrently vaccinated with meningococcal b rfhbp vaccine (e. coli) (TRUMENBA) for prophylaxis (dose, route, lot # and expiry date were not reported). On an unknown date, after the administration of suspect products, the patient's mother contacted the facility to inform that, the patient was experiencing extreme migraines (sought medical attention). The outcome of the event was not reported. The reporter did not provide any causality assessment. The product quality complaint was not involved.",,,,,,,,,U,,,,,UNK,,,Prophylaxis,,,US0095075131909USA008243,2,09/23/2019,,,,
0835171,09/23/2019,MO,,,,U,,"No adverse events; Expired vaccine used; This spontaneous report was received from a pharmacist refers to a patient of unknown demographics.The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 19-SEP-2019, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (strength, dosage information, route of administration and anatomical locations were unknown) of lot # N034512 with an expiry date of 13-SEP-2019 for prophylaxis (expired product administered). No adverse events reported. The outcome of expired product administered was unknown. No product quality complaint (PQC) reported.",,,,,,,,,U,09/19/2019,09/19/2019,0,,UNK,,,,,,US0095075131909USA008373,2,09/23/2019,,,,
0835172,09/23/2019,AZ,51.0,51,,M,,"nausea; tingling on lips; bad taste in mouth; This case was reported by a other health professional via call center representative and described the occurrence of nausea in a 51-year-old male patient who received HAB (Twinrix adult) (batch number 9355D, expiry date 14th March 2022) for prophylaxis.   On 27th August 2019, the patient received the 1st dose of Twinrix adult. On 27th August 2019, 1 hr after receiving Twinrix adult, the patient experienced nausea, tingling lips and dysgeusia. On an unknown date, the outcome of the nausea, tingling lips and dysgeusia were recovered/resolved.   It was unknown if the reporter considered the nausea, tingling lips and dysgeusia to be related to Twinrix adult.  Additional case details were reported as follows: The patient experienced nausea, tingling in lips, and bad taste in mouth. The events were resolved. The reporter consented to follow up. This is 2 of the 3 linked cases reported by the same reporter.",,,,,,,,,Y,08/27/2019,08/27/2019,0,,PVT,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835173,09/23/2019,AZ,47.0,47,,M,,"Lightheadedness; Sweating on palm of hands; Face felt numb; This case was reported by a other health professional via call center representative and described the occurrence of light headedness in a 47-year-old male patient who received HAB (Twinrix adult) (batch number 9355D, expiry date 14th March 2022) for prophylaxis.   On 27th August 2019, the patient received the 1st dose of Twinrix adult. On 27th August 2019, 1 hr after receiving Twinrix adult, the patient experienced light headedness, sweating increased palms and numbness facial. On an unknown date, the outcome of the light headedness, sweating increased palms and numbness facial were recovered/resolved.   It was unknown if the reporter considered the light headedness, sweating increased palms and numbness facial to be related to Twinrix adult.  Additional case details were reported as follows: The patient experienced lightheadedness, sweating on palm of hands, and face felt numb.  The events began about 1 hour after injection. The events were resolved. The reporter consented to follow up. This is 3 of the 3 linked cases reported by the same reporter.",,,,,,,,,Y,08/27/2019,08/27/2019,0,,PVT,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835174,09/23/2019,NJ,,,,U,,"Swelling in the bicep; This case was reported by a pharmacist via call center representative and described the occurrence of muscle swelling in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than a day after receiving Shingrix, the patient experienced muscle swelling. On an unknown date, the outcome of the muscle swelling was unknown.   It was unknown if the reporter considered the muscle swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but was selected as per the vaccine indication. The reporter stated that the patient experienced swelling in the bicep. The doses were given within the past 2 months from the time of reporting and the swelling started within day after the vaccination. The reporter did not have any further information about the patient. This case has been linked with case US2019167103, reported by the same reporter.",,,,,,,,,U,,,,,PHM,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/23/2019,,,,
0835175,09/23/2019,FL,56.0,56,,F,,"Fever; Headache; Chills; Achy; Slept all morning; Little nausea; This case was reported by a consumer and described the occurrence of fever in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date and had no problem).   On 12th September 2019, the patient received the 2nd dose of Shingrix. On 12th September 2019, less than a day after receiving Shingrix, the patient experienced fever, headache, chills, pain, daytime sleepiness and nausea. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the fever, headache, chills, pain, daytime sleepiness and nausea were unknown.   It was unknown if the reporter considered the fever, headache, chills, pain, daytime sleepiness and nausea to be related to Shingrix.  Additional information received were as follows: A day before the reporting date, the patient received Shingrix and started experiencing symptoms that night. The patient experienced fever, headache, chills, achy, and a little nausea. On the reporting date, the patient did not went to work. The patient slept all morning for 4 hours and started to feel a little better compared to the morning on the reporting date. The patient had been taking Tylenol every 4 to 6 hours and thought that had helped. The patient had not reported these events to her doctor. The patient asked that how long would the side effects of the shingles shot last.",,,,,,,,,U,09/12/2019,09/12/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/23/2019,,,,
0835176,09/23/2019,GA,,,,F,,"Itchy Rash; Burning/lips burning/Lips were burning/sides of mouth were burning; Mouth Blisters; feeling sunburned/ear burning; Rash across chest/on shoulders/on arm/on back/on face/on earlobe; lips rash; rash on external genitalia; genitalia burning; blisters on tip of tongue/blister on underneath tongue; Lips were peeling; side of mouth were cracking; difficulty in brushing; Redness on her arm; Swelling on arm; Sore Arm; This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (thrice). Previously administered products included Beta-blocker. Concurrent medical conditions included drug allergy (allergy to an unspecified beta blocker).   On 20th August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 21st August 2019, 1 days after receiving Shingrix, the patient experienced erythema of extremities, swelling arm and pain in arm. On an unknown date, the patient experienced itchy rash, oral discomfort, blistering of mouth, burning sensation skin, rash, rash lips, genital rash, genital burning, tongue blistering, peeling lips, cracked lips and activities of daily living impaired. The patient was treated with benadryl (nos) (Benadryl). On 3rd September 2019, the outcome of the erythema of extremities, swelling arm and pain in arm were recovered/resolved. On an unknown date, the outcome of the itchy rash was recovering/resolving and the outcome of the oral discomfort and blistering of mouth were recovered/resolved and the outcome of the burning sensation skin, rash, rash lips, genital rash, genital burning, tongue blistering, peeling lips, cracked lips and activities of daily living impaired were unknown.   It was unknown if the reporter considered the erythema of extremities, swelling arm, pain in arm, itchy rash, oral discomfort, blistering of mouth, burning sensation skin, rash, rash lips, genital rash, genital burning, tongue blistering, peeling lips, cracked lips and activities of daily living impaired to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in her right arm, and the following day having redness, swelling and soreness on her arm.  The redness described as being as wide as a softball as far as area, but not raised as high as a softball. Local reactions reported to have lasted approximately 2 weeks.  The patient had itchy rash developed that comes and then goes away following oral Benadryl 50mg that is taking throughout the day.  The rash has appeared across chest, shoulders, arm, back, lips, earlobes, external genitalia, and face.  The caller still has bouts of recurrent rash that was suppressed following oral Benadryl.  The caller reported lips, earlobes and genitalia as burning or feeling sunburned, and caller also reports blisters in mouth on the tip of tongue and underneath tongue.  The lips were burning and peeling and the sides of mouth were cracking and burning.  The caller describes difficulty in brushing teeth due to burning sensitivity in mouth from toothpaste.  The burning sensations and oral blisters resolved in approximately 1 week. The reporter consented to follow up. In the mix of events, the caller reports discovering an allergy to an unspecified beta blocker that has at the time of reporting been stopped and switched to a different therapy. The caller unsure if side effects are from Shingrix vaccine or something else.  The caller inquires if she should receive 2nd dose.Referred to health care professional.  The caller has appointment tomorrow with her dermatologist about ongoing rash. There is discrepancy between the outcome reported in the structured field of system (recovered) for redness, swelling and soreness on her arm and the outcome reported in the source document (recovered with sequel); outcome for itchy rash in the structured field of system (recovering) while in source document it is reported as fatal.",,,,,,,,,N,08/20/2019,08/21/2019,1,,PHM,,,,Medical History/Concurrent Conditions: Drug allergy (allergy to an unspecified beta blocker); Shingles (thrice),,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0835177,09/23/2019,CA,,,,F,,"Severe pain; Swelling at the site; Bruising; Shoulder pain; Not back to normal activities; Extreme fatigue; No strength; dizziness; Foggy head; Couldn't sleep; diarrhea; freezing; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th September 2019 01:00, the patient received the 1st dose of Shingrix (intramuscular). On 5th September 2019, less than a day after receiving Shingrix, the patient experienced diarrhea, feeling cold, fatigue, weakness, dizziness, foggy feeling in head and sleeplessness. On 5th September 2019 05:00, the patient experienced pain in arm, injection site swelling, injection site bruising, shoulder pain and activities of daily living impaired. On an unknown date, the outcome of the pain in arm, injection site swelling, injection site bruising, shoulder pain, sleeplessness and activities of daily living impaired were unknown and the outcome of the diarrhea, fatigue and weakness were not recovered/not resolved and the outcome of the feeling cold was recovered/resolved and the outcome of the dizziness and foggy feeling in head were recovering/resolving.   It was unknown if the reporter considered the pain in arm, injection site swelling, injection site bruising, diarrhea, feeling cold, fatigue, weakness, shoulder pain, dizziness, foggy feeling in head, sleeplessness and activities of daily living impaired to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and had severe pain and swelling at the site with bruising. She noted these began about 5pm and her vaccine received on at 1pm. She noted these also extended up into her shoulder area.  She does believe the vaccine was given in the muscle but noted she was only 4 feet 11 inches and 95 pounds.     She noted she did report these events to her physician via a message portal but has not been seen by her physician, who noted these did not require follow up.The patient states also on Thursday evening she had diarrhea, that has improved but not resolved. She was freezing but that resolved after 24 hours. She had extreme fatigue and no strength, which has gotten better but not resolved. She noted she had to cancel a vacation. She also had dizziness and what foggy head that continue but have improved.She noted she couldn't sleep due to the pain in her arm and shoulder. She was not back to normal activity but feels she is about 80 percent better.    The patient noted the continued issues are occurring longer than expected and was concerned about the long term effects would be.   The patient was referred to her physician and shared the information from post marketing adverse event reports from the prescribing Information.That document was also being emailed to the consumer. The reporter consented to follow up.",,,,,,,,,N,09/05/2019,09/05/2019,0,,PVT,,,,,,USGLAXOSMITHKLINEUS201916,2,09/20/2019,,,,
0835178,09/23/2019,NJ,,,,U,,"Swelling in the bicep; This case was reported by a pharmacist via call center representative and described the occurrence of muscle swelling in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, less than a day after receiving Shingrix, the patient experienced muscle swelling. On an unknown date, the outcome of the muscle swelling was unknown.   It was unknown if the reporter considered the muscle swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The reporter stated that the patient experienced swelling in the bicep. The doses were given within the past 2 months from the time of reporting and the swelling started within day after the vaccination. The reporter did not have any further information about the patient. This case has been linked with case US2019AMR167772, reported by the same reporter.",,,,,,,,,U,,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835179,09/23/2019,,,,,M,,"Felt like had the flu; Rash at injection site; Warmth at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th September 2019, the patient received Shingrix. On 10th September 2019, 1 days after receiving Shingrix, the patient experienced influenza-like symptoms, injection site rash and injection site warmth. On an unknown date, the outcome of the influenza-like symptoms, injection site rash and injection site warmth were unknown.   It was unknown if the reporter considered the influenza-like symptoms, injection site rash and injection site warmth to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  The patient felt like he had the flu and developed a rash and warmth at the injection site. The healthcare professional reported via chat and the conversation was dropped before any additional details could be given. The reporter stated follow up not required.",,,,,,,,,U,09/09/2019,09/10/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835180,09/23/2019,AZ,35.0,35,,M,,"Tongue swelling; This case was reported by a other health professional via call center representative and described the occurrence of swollen tongue in a 35-year-old male patient who received HAB (Twinrix adult) (batch number 9355D, expiry date 14th March 2022) for prophylaxis.   On 27th August 2019, the patient received the 1st dose of Twinrix adult. On 27th August 2019, 1 hr after receiving Twinrix adult, the patient experienced swollen tongue. Twinrix adult was continued with no change. On an unknown date, the outcome of the swollen tongue was recovered/resolved.   It was unknown if the reporter considered the swollen tongue to be related to Twinrix adult.  Additional case details were reported as follows: The patient experienced tongue swelling about 1 hour after the injection. The event was resolved. The reporter consented to follow up. This is 1 of the 3 linked cases reported by the same reporter.",,,,,,,,,Y,08/27/2019,08/27/2019,0,,PVT,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835181,09/23/2019,FL,73.0,73,,F,,"Inappropriate route of vaccination; Arm bruised; Arm swelled; This case was reported by a pharmacist via call center representative and described the occurrence of bruising of arm in a 73-year-old female patient who received Herpes zoster (Shingrix) (batch number 774SY, expiry date 2nd October 2021) for prophylaxis.   On 9th September 2019, the patient received the 2nd dose of Shingrix (subcutaneous). On 9th September 2019, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. In September 2019, the patient experienced bruising of arm and swelling arm. On an unknown date, the outcome of the bruising of arm and intramuscular formulation administered by other route were unknown and the outcome of the swelling arm was not recovered/not resolved.   It was unknown if the reporter considered the bruising of arm and swelling arm to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in unknown arm, subcutaneously which led to an incorrect route of product administration. The patient's arm bruised and swelled.  The swelling was going down and the patient felt fine.  At the time of this report, the swelling has not completely resolved. The reporter agreed to recontact but said she was not always at the store.  Patient safety could call if details were needed. The reporter consented to follow up. In the XML document outcome of swelling arm was reported as recovering, but in system its mentioned as not recovered, so kept as reported in system.",,,,,,,,,N,09/09/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835182,09/23/2019,CT,,,,F,,"nausea; vomiting; soreness/ sore arm at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 17th September 2019, less than a day after receiving Shingrix, the patient experienced injection site pain. On 18th September 2019, the patient experienced nausea and vomiting. On an unknown date, the outcome of the injection site pain was recovering/resolving and the outcome of the nausea and vomiting were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, nausea and vomiting to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. On the day before the reporting date, the patient received Shingrix in her left arm. The patient had a sore arm at the injection site. The soreness had mostly resolved on 18th September 2019 but she was experiencing nausea and vomiting which was unresolved. The patient consented to follow up. There was a discrepancy in the reported outcomes of the events tenderness nausea and vomiting. In XML, outcome was mentioned as recovering/resolving and in case narrative, it was reported as not recovered. However outcome of these events is captured as per narrative.",,,,,,,,,N,09/17/2019,09/17/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/20/2019,,,,
0835183,09/23/2019,TX,5.0,,,U,,"Ipol was given yesterday to a patient, but it expired on August 2nd 2019, no AE; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 5 years old patient who was inadvertently vaccinated with an expired dose of 0.5 mL IPV (VERO) [IPOL] lot N1G511M via intramuscular route in unknown administration site (right dosterm was reported) on an unknown date which was expired in 02-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication included- VARICELLA ZOSTER VACCINE (Flu vaccine) and VARICELLA ZOSTER VACCINE (Varicella).  It is an actual medication error case due to expired vaccine used.  At the time of reporting, the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,FLU VACCINE VII; VARICELLA VACCINE,,,,USSA2019SA256818,2,09/19/2019,,,,
0835184,09/23/2019,CA,1.5,,,U,,"patient was given a 5th dose of Pentacel, no AE; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 18 months old patient of an unknown gender who received a fourth and fifth doses of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot number, expiry date, dose, route and site of administration were not reported) on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to extra dose administered. It was reported that the interval between the 4th and 5th administrations was 12 weeks and 3 days.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA257161,2,09/19/2019,,,,
0835185,09/23/2019,DC,,0,.2,F,,"9-week-old patient that received a dose of Fluzone Quadrivalent; Initial information received on 13-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 9 weeks old female patient who received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] and reported that 9-week-old patient that received a dose of Fluzone Quadrivalent (product administered to patient of inappropriate age).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13); ROTAVIRUS VACCINE (ROTAVIRUS VACCINE); and DIPHTHERIA VACCINE TOXOID, HIB VACCINE CONJ (TET TOX), PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, POLIO VACCINE INACT 3V (MRC 5), TETANUS VACCINE TOXOID (PENTACEL).  On 13-Sep-2019, the patient received a dose of suspect 0.5 ml INFLUENZA QUADRIVAL A-B VACCINE lot UJ209AA and expiry date: 30-Jun-2019 via intramuscular route in the left thigh.  It was a case of actual medication error due to inappropriate age at vaccine administration.  It was unknown if the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,PREVNAR 13; ROTAVIRUS VACCINE; PENTACEL,,,,USSA2019SA257510,2,09/20/2019,,,,
0835186,09/23/2019,AZ,,,,F,,"extreme temperature for an unknown cumulative time of exposure; Initial information received on 13-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional.  This case involves an 8 years old female patient who received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] and reported that extreme temperature for an unknown cumulative time of exposure (product storage error).  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On 12-Sep-2019, the patient received one dose of suspect 0.5 ml INFLUENZA QUADRIVAL A-B VACCINE lot UJ237AB and expiry date: 30-Jun-2020 via unknown route in the right arm.  It was a case of actual medication error due to incorrect product storage.  It was unknown if the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/12/2019,,,,UNK,,,,,,USSA2019SA257511,2,09/20/2019,,,,
0835187,09/23/2019,OR,,,,M,,"Pharmacist stated a flu shot (Fluzone HD) may have been mis-administered outside of the target area/ No AE; Initial information received on 13-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 72 years old male patient who received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ232AA, expiry date- 10-04-2020 via unknown route in the arm (bicep) on an unknown date, may have been mis-administered outside of the target area.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to vaccine administered at inappropriate site.  It was unknown whether the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA257545,2,09/20/2019,,,,
0835188,09/23/2019,MI,,2,.2,F,,"2 years patient was given Fluzone High Dose by mistake/ No AE; 2 years patient was given Fluzone High Dose by mistake/ No AE; Initial information received on 13-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case is linked to case 2019SA257558 same reporter.  This case involves a 2 years old female patient who received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ246AA via intramuscular route in the right thigh on 09-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No other vaccines received.  It was a case of actual medication error due to inappropriate age at vaccine administration and overdose.  It was unknown whether the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/09/2019,,,,UNK,,,,,,USSA2019SA257547,2,09/20/2019,,,,
0835189,09/23/2019,OR,,,,M,,"patient stated that his arm turned yellow; patient thinks he has not been getting the vaccine in the right place and thinks he has gotten it too low; Initial information received on 13-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves male patient of an unknown age who experienced arm turned yellow (yellow skin), while he received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past vaccination(s) included Fluzone High Dose. The patient's medical history, medical treatment(s) and family history were not provided.  On 04-SEP-2019, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious his arm turned yellow (yellow skin) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  It was also the case of actual medication error due to vaccine administered at inappropriate site. The patient thinks he has not been getting the vaccine in the right place and thinks he has gotten it too low.  (Other relevant tests included no lab data.)  Final diagnosis was his arm turned yellow after the vaccine.   It was not reported if the patient received a corrective treatment.  The outcome of the event was reported as Unknown for arm turned yellow after the vaccine.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  Documents held by sender: none.",,,,,,,,,U,09/04/2019,,,,UNK,,,,,,USSA2019SA257548,2,09/20/2019,,,,
0835190,09/23/2019,MI,7.0,7,,F,,"7 years old patient was given Fluzone High Dose by mistake/ No AE; 7 years patient was given Fluzone High Dose by mistake/ No AE; Initial information received on 13-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case is linked to case 2019SA257547 same reporter.  This case involves a seven years old female patient who received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ246AA via intramuscular route in the right thigh on 09-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No other vaccines received.  It was a case of actual medication error due to inappropriate age at vaccine administration and overdose.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/09/2019,,,,UNK,,,,,,USSA2019SA257558,2,09/20/2019,,,,
0835191,09/23/2019,CA,,,,U,,"deemed to have an allergic reaction; localized swelling of the injection site, the swelling was larger; localized swelling of the injection site, the swelling was larger; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from other healthcare professional.  This case is linked to cases 2019SA257583 and 2019SA257467 (same reporter).  This case involves patient (with unknown demographics) who was deemed to have an allergic reaction (hypersensitivity) and localized swelling of the injection site, swelling was larger (localized oedema), while he/she received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via intramuscular route in unknown administration site.  On an unknown date, the patient had deemed to have an allergic reaction (hypersensitivity) and localized swelling of the injection site, swelling was larger (localized oedema) following the administration of INFLUENZA VACCINE. The swelling was larger compared to any other reactions the staff member has had in the previous years.  Other relevant tests not reported.   Final diagnosis was hypersensitivity.  Ice pack was applied as corrective treatment.  The patient recovered from the events.  Information on the batch number was requested.  Documents held by sender: none.",,,,,,,,,Y,,,,,UNK,,,,,,USSA2019SA257582,2,09/19/2019,,,,
0835192,09/23/2019,FL,0.08,0,.1,F,,"A patient was given ActHib in the left thigh when 4 weeks old instead of the intended vaccine which was hepatitis B, no AE; A patient was given ActHib in the left thigh when 4 weeks old instead of the intended vaccine which was hepatitis B, no AE; Initial information received on 13-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 4 weeks old female patient received vaccines HIB (PRP/T) VACCINE [ACT-HIB] (lot: UI965AAA, expiry date: 13-Mar-2020, via unknown route in the left thigh) instead HEPATITIS B VACCINE, on 09-Sep-2019. It was reported that ACT-HIB was the first time administered to the patient.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to inappropriate age at vaccine administration and wrong vaccine administered.   At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of document held by sender: none.",,,,,,,,,U,09/09/2019,,,,UNK,,,,,,USSA2019SA257699,2,09/20/2019,,,,
0835193,09/23/2019,NY,,,,U,,"Ipol reached a temperature of 61F for an hour and a half.; Initial information received on 13-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves 2 patient who received vaccine IPV (VERO) [IPOL] (batch and expiry date was not reported via unknown route in unknown administration site), which reached a temperature of 61 F for an hour and a half. It was reported that IPOL vaccines were to be discard.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of document held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA257729,2,09/20/2019,,,,
0835194,09/23/2019,NC,,,,M,,"Menactra was delivered them the next day.; Initial information received on 13-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 12 years old male patient who received 0.5 ml dose of  MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot: U6522AA and expiry date: 29-Jan-2021), via intramuscular route in the left deltoid on 12-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, TETANUS VACCINE TOXOID (BOOSTRIX) for Immunisation.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of document held by sender: none.",,,,,,,,,U,09/12/2019,,,,UNK,,BOOSTRIX,,,,USSA2019SA257815,2,09/20/2019,,,,
0835195,09/23/2019,,,,,U,,"severe arm swelling; Initial information received on 13-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a patient (demographics unknown) who experienced severe arm swelling (peripheral swelling), when received vaccines PNEUMOCOCCAL VACCINE POLYSACCH 23V [PNEUMOVAX] and INFLUENZA VACCINE (QUADRIVALENT).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (QUADRIVALENT) produced by unknown manufacturer lot number not reported via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect PNEUMOCOCCAL VACCINE POLYSACCH 23V [PNEUMOVAX] not produced by Sanofi Pasteur lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient experienced a non-serious severe arm swelling (peripheral swelling) (Unknown latency) following the administration of INFLUENZA VACCINE (QUADRIVALENT) and PNEUMOCOCCAL VACCINE POLYSACCH 23V [PNEUMOVAX].  (Other relevant tests included no lab data.)  Final diagnosis was severe arm swelling.   It was not reported if the patient received a corrective treatment.  The patient outcome was not reported for severe arm swelling.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA258471,2,09/20/2019,,,,
0835196,09/23/2019,,,,,U,,"wrong vaccine (Quadracel) for the patients age last month, no AE; Initial information received on 13-Sep-2019 regarding an unsolicited valid non-serious case received from a non-health care professional.  This case involves patient (with unknown demographics) who received vaccine DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] (lot number and Exp. Date not reported) via unknown route in unknown administration site that was wrong vaccine for the patient's age last month.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to inappropriate age at vaccine administration.  It was reported that RMA's gave a patient the wrong vaccine (Quadracel) for the patients age last month. She called Sanofi to make sure there was no harm to the patient and was told there should be no harm.  The patient did not experience any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA259995,2,09/20/2019,,,,
0835199,09/23/2019,IN,1.25,1,.3,M,,"Child developed Alopecia Areata in December 2017, 2 months after  injections. Visited dermatologist on 2/26/18 who determined diagnosis. Prescribed Lidex to apply to area to help with irritation since child was pulling at the hair.",,,,,,,,,Y,10/16/2017,12/29/2017,74,,PVT,,None,None,None,,,2,09/23/2019,,Y,,None
0835200,09/23/2019,,72.0,72,,M,,Patient reported hives after receiving the injection,,,,,,,,,Y,09/20/2019,09/20/2019,0,,PHM,,,,,,,2,09/23/2019,,,,
0835201,09/23/2019,TX,60.0,60,,F,,"Large swelling, redness, pain, muscle pain, nausea, shivering. 109.1 temperature",,,,,,,,,N,09/01/2019,09/22/2019,21,N/A,PHM,,None,None,None,TDap,,2,09/23/2019,,,,"Tdap codiene, morphine"
0835202,09/23/2019,IN,1.5,1,.5,M,,"Child had a non-febrile seizure on 2/4/19 that lasted for several minutes. No prior symptoms other than child complaining of being tired. Paramedic arrived and administered oxygen until ambulance arrived. Hospital did EEG and MRI and all came back normal. They said this was just a fluke and if another happened again, they would discuss the possibility of epilepsy.  We were at hospital for about 22 hours.",,,,,Y,1,,,Y,01/09/2018,02/04/2019,391,EEG 2/5/19 normal MRI 2/5/19 normal,PVT,,none,none,none,,,2,09/23/2019,,,Y,none
0835203,09/23/2019,IL,52.0,52,,M,,"chills, fever, muscle aches/pains, nausea over the course of 2+ days",,,,,,,,,Y,09/21/2019,09/21/2019,0,N/A,PHM,,Multi-vitamins,,Celiac,,,2,09/23/2019,,,,
0835206,09/23/2019,NM,66.0,66,,F,,"Pain, redness and swelling: 3.5 inches x 5.5 inches on left arm.",,,,,,,,,Y,09/12/2019,09/12/2019,0,None,SCH,,Progesterone 100 mg QD Estradiol 0.5 mg QD Citalopram  Propranolol for hand tremors,None,Bicuspid Aortic Valve,,,2,09/23/2019,,,,Penicillin
0835207,09/23/2019,NH,66.0,66,,M,,"Patient reported fever, chills and tremor starting approximately 4 and 1/2 hours after the flu shot and lasted for 2 days. Starting 3 days after shot(Sunday night) pt started itching and today(Monday) reports a rash and hives on wrists, arms, shoulder and chest.",,,,,,,,,N,09/19/2019,09/19/2019,0,,PHM,,,,"hypertenson, hypercholesteremia,gout",,,2,09/23/2019,,,,none
0835208,09/23/2019,AL,84.0,84,,M,,"Vaccine given 9/19/19.  Patient began itching on right rib cage morning of 09/21/19.  Broke out in rash by same afternoon.  Patient presented to local ER 0830 on 9/22/19 and was diagnosed with shingles.  Prescribed Gabapentin, Hydrocodone and Acyclovir.",,,,,,,,,,09/19/2019,09/21/2019,2,,MIL,,"Glyburide, Levothyroxine, Lisinopril, Janumet, Canagliflozin, Rosuvastatin",N/A,Diabetes Hypertension,,,2,09/23/2019,,Y,,Tetracyclines Vibramycin
0835209,09/23/2019,MI,63.0,63,,F,,"Muscle aches, Joint pain (all), Chills, fever, Headache, Extreme fatigue, lightheadedness, complete loss of appetite. Localized pain and redness at Bilateral injection sites.  All symptoms lasted 48 hours",,,,,,,,,Y,09/20/2019,09/21/2019,1,None,PHM,,"Losartan/HCTZ 50-12.5,  Atorvastatin 10 mg,, Magnesium, Melatonin, Multivitamin",None,"Asthma, HBP",,,2,09/23/2019,,,,Augmentin
0835210,09/23/2019,NY,71.0,71,,F,,"She experienced soreness; This case was reported by a consumer via call center representative and described the occurrence of pain in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th March 2019, the patient received the 1st dose of Shingrix. On 5th March 2019, less than a day after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were provided as follows: The patient reported that, after vaccination with dose of Shingrix, experienced soreness. The patient planned to follow up with physician on an unknown date. The reporter consented to follow up. For tolerence of 2nd dose, refer case US2019167113..",,,,,,,,,Y,03/05/2019,03/05/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/23/2019,,,,
0835211,09/23/2019,MD,,,,M,,"Fever; Chills; Feeling very run down; Pain at injection site; Swelling at the injection site; This case was reported by a physician via sales rep and described the occurrence of fever in a 18-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced fever, chills, fatigue, injection site pain and injection site swelling. On an unknown date, the outcome of the fever, chills, fatigue, injection site pain and injection site swelling were recovered/resolved.   It was unknown if the reporter considered the fever, chills, fatigue, injection site pain and injection site swelling to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Bexsero and had fever, chills feeling very run down for a couple days.  The pain and swelling at the injection site.  More severe of these reactions than normal. The reporter agreed to follow up. This case linked to the case US2019AMR170807, reported by same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/23/2019,,,,
0835212,09/23/2019,,,,,U,,"Cough; Headache; Body aches; Arm pain; Chills; This case was reported by a consumer and described the occurrence of cough in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced cough, headache, general body pain, pain in arm and chills. On an unknown date, the outcome of the cough was recovering/resolving and the outcome of the headache, general body pain, pain in arm and chills were unknown.   It was unknown if the reporter considered the cough, headache, general body pain, pain in arm and chills to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was selected as an adult as per vaccine indication. The patient received Shingrix and had headache, body aches, arm pain and chills. The patient had various reactions after Shingrix vaccination, not including a cough. However, 1-2 days after those side effects improved the patient began coughing.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/23/2019,,,,
0835213,09/23/2019,LA,0.5,5,,F,09/19/2019,9/19/19 (R) arm swollen at immunization site & rash temp-normal per mother Spoke with Dr. office 9/20/19 child okay went to school.,,,,,,,,,Y,09/17/2019,09/19/2019,2,0 reactions with previous immunizations,PUB,PUB,N/A,None,Na,,,1,,,,,
0835214,09/23/2019,NY,45.0,45,,F,,Left axillary nod swelling,,,,,,,,,Y,09/20/2019,09/21/2019,1,,WRK,,,,,bilateral  axillary lymph node swelling: 10/5/18: influenza:Fluarix,,2,09/23/2019,,Y,,
0835215,09/23/2019,PA,17.0,17,,M,,"Patient felt ""distant"" with blurry vision.",,,,,,,,,Y,09/23/2019,09/23/2019,0,None,PVT,,None,None,None,,,2,09/23/2019,,Y,,None
0835216,09/23/2019,VA,74.0,74,,F,,Patient received vaccines listed above around 06:15pm. She states she started chilling around 09:30pm. She states around 11:30 pm her stomach was hurting and to up to take some medication. She then passed out and her husband found her passed out in the floor. He then took her to the emergency room. She states the ER doctor examined her with no significant findings.,,,,,,,,,Y,09/18/2019,09/18/2019,0,,PHM,,,,,,,2,09/23/2019,,,Y,
0835217,09/23/2019,NV,1.0,1,.1,M,,"recurrent loose, NM,NBS stools for 4 days with the appearance of red rash all over the face, trunk and extremeties and low grade fever since 2 days ago. he has had recurrent diarrhea for 2 weeks, about 4 bouts. Attends daycare with 2 siblings in school. has been on whole cows milk since birth.",,,,,,,,,N,09/10/2019,09/19/2019,9,none,PVT,,none,"recurrent loose, NM,NBS stools for 4 days with the appearance of red rash all over the face, trunk and extremeties and low grade fever since 2 days ago. he has had recurrent diarrhea for 2 weeks, about 4 bouts.",none,,,2,09/23/2019,,Y,,none
0835218,09/23/2019,NC,0.33,0,.4,M,,"Baby started having bellyaches within 24 hours. Inconsolable crying for 72 hours following vaccine. Bowel movements became orange, mucus-y, and foul smelling (remained that way for last 4 days) - normally yellow and odorless from exclusive breastfeeding. Bowel movements became painful. Back arching during feedings followed by vomiting. Basically appears baby contracted rotavirus from rotavirus ""vaccine""",,,,,,,,,N,09/18/2019,09/19/2019,1,,PVT,,none,none,none,,,2,09/23/2019,,Y,,none known
0835219,09/23/2019,TX,54.0,54,,F,,"Left arm has warm, reddened sore area at sight of injection; fever of 99 on 9/22/19.  Treated with rest and ibuprofen.  Reddened area still present on 9/23/19, and still treating with ibuprofen.",,,,,,,,,N,09/21/2019,09/22/2019,1,,PHM,,"Levothyroxine, Propranolol",None,None,,,2,09/23/2019,,,,Sulfa
0835220,09/23/2019,AR,4.0,4,,M,,"Swelling, redness and heat to left Deloitte 24 hours after receiving vaccines, from clavicle  area to elbow and around upper arm with blisters also.",,,,,,,,,Y,09/13/2019,09/14/2019,1,none,PUB,,none,none,none,,AR1922,2,09/23/2019,,,,NKDA
0835221,09/23/2019,WV,17.0,17,,F,,"the day after the vaccine, she began having multiple symptoms: pain at injection site, fatigue, knot on arm with swelling, rib pain/lung pain-bilateral- left more than right, headache, fever for 1st 2 days.",,,,,,,,,N,09/13/2019,09/14/2019,1,strep screen & culture 9/16/19- negative,PUB,,ogestrel 0.5mg-50mcg tablet,,"congenital leg length discrepancy, hemihypertropy of muscle, constipation, precocious puberty, breast pain",,,2,09/23/2019,,Y,,nkda
0835222,09/23/2019,CO,62.0,62,,M,,"Confusion, blurred vision, lips and tongue swollen, burning sensation in mouth",,,,,,,,,Y,09/19/2019,09/19/2019,0,None,WRK,,"Losartan, Metformin, Baclofen, Atorvastatin, Celebrex, Gabapentin, multivitamin, fish oil",None,"pre-diabetes, Celiac Disease, Hypothyroidism, High BP, Lumbar spine issue",,,2,09/23/2019,,,,Codiene
0835223,09/23/2019,MN,77.0,76,,M,,"After receiving my 2nd shot of the Shingles vaccine, I got the shingles rash on the right T5 dermatome and extends under my right arm and across the right side of my chest.  I still have the virus as of 09/23/2019",,,,,,,,,N,08/06/2019,08/12/2019,6,none,MIL,,"Jakafi, metoprolol, hydroxyurea, lisinopril, aspirin",none,myelopybrosis,,,2,09/23/2019,,,,none
0835224,09/23/2019,VA,59.0,59,,F,,"Fever blister on upper lip: (9/20/2019 at 6:30am) started Abreva on  9/20/2019 at 4:30pm: Currently healing  Swollen Round, hot red inflamation about 1 inch below site of vaccination: Started on 9/19/2019 at approximately 9:30pm.  Taking OTC Naproxin Sodium to treat on 9/19/2019 at 10:00 pm. Continued to grow to the size of a baseball.  Remained that size through Sunday, 9/22/2019. Now, on 9/23/2019 it is the size of a plum, still hot, red, and raised, with small white dots on it. Still hot to the touch, painful and swollen. Unresponsive to Naproxen Sodium.  Joint and muscle aches and pains: Started on 9/20/2019. Treated with OTC Naproxin Sodium 250 mg. BID. Unresponsive to treatment. Worsened through 9/21/2019. Patient went to bed with severe muscle and joint aches and pains on 2/21/2019 at approximately 4:30pm. Muscle and joint aches and pains have lessened, but continue as of 9/23/2019 at 11:30 am.  Low grade fever, 99.7 F: Started on 9/21/2019 at approximate 6:30 pm. Treated with OTC Naproxin Sodium 250 mg. BID. Fever broke in the middle of the night sometime between 9/21/19 at 6:30pm to 9/22/19 at 7:00am.",,,,,,,,,N,09/19/2019,09/20/2019,1,None,PHM,,"Naproxin Sodium 250 mg. Vitamin D 5,000 IU Daily Esomeprazole Magnesium DR 40 mg Daily Fluoxetine HCL 10 mg daily",Arthritis,Shotsky's Ring,,,2,09/23/2019,,,,latex erythromycin
0835225,09/23/2019,VA,64.0,64,,M,,"Large, red knot at injection site",,,,,,,,,N,09/21/2019,09/22/2019,1,Unknown,PHM,,unknown,None,None,States milder site reaction after 1st dose of Shingrix,,2,09/23/2019,,Y,,No known allergies
0835228,09/23/2019,FL,,,,M,,"No adverse effects; a male patient was administered two live vaccines less than 28 days apart; This spontaneous report as received from a pharmacist refers to a male patient of unknown age. Pertinent medical history, drug reactions and allergies were not reported.  On 19-JUL-2019, the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck)(VARIVAX) injection (lot number: R030610, expiration date: 23-OCT-2020; dose and route of administration were not reported). On 13-AUG-2019, he was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection (lot number, expiration date, dose and route of administration were not reported). Therefore, the patient was administered two live vaccines less than 28 days apart (inappropriate schedule of vaccine administered). Sterile diluent (lot number: S005075, expiration date: 08-AUG-2021) was used as a concomitant medication. No adverse effects were reported.",,,,,,,,,U,07/19/2019,08/13/2019,25,,UNK,,sterile diluent,,,,US0095075131908USA011348,2,09/23/2019,,,,
0835229,09/23/2019,GA,15.0,,,U,,"no adverse event; 15-years-old patient received VARIVAX and PROQUAD on 9/13/2019; 15-years-old patient received VARIVAX and PROQUAD on 9/13/2019; This spontaneous report was received from a physician and refers to a 15-year-old patient of unknown gender. The patient's pertinent medical history, concomitant medications and drug reaction or allergies were not reported.  On 13-SEP-2019, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (strength, dose, route of administration, lot# and expiration date were not reported for both vaccines); (product administered to patient of inappropriate age, incorrect dose administered). It was reported that sterile diluent (STERILE DILUENT) injection was used with suspect vaccines. No adverse effects were reported.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA006012,2,09/23/2019,,,,
0835230,09/23/2019,,,,,U,,"Was quite ill; Felt as baf bad as I did during Chemo; This case was reported by a consumer and described the occurrence of unwell in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chemotherapy (Felt bad).   On 10th September 2019, the patient received Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced unwell and feeling bad. On an unknown date, the outcome of the unwell and feeling bad were not recovered/not resolved.   It was unknown if the reporter considered the unwell and feeling bad to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was selected as an adult as per vaccine indication. The patient was quite ill after shingrix and felt bad as during Chemotherapy. The reporter asked was this an allergic reaction. The reporter asked would it be better if 2nd shot could be administered in buttocks.",,,,,,,,,N,09/10/2019,09/01/2019,,,UNK,,,,Medical History/Concurrent Conditions: Chemotherapy (Felt bad),,USGLAXOSMITHKLINEUS2019AM,2,09/23/2019,,,,
0835231,09/23/2019,MD,,,,M,,"Fever; Chills; Feeling very run down; Pain at injection site; Swelling at the injection site; This case was reported by a physician via sales rep and described the occurrence of fever in a 18-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   Previously administered products included Bexsero with an associated reaction of pyrexia (1st dose received on an unknown date, refer linked case US2019AMR167943).   On an unknown date, the patient received the 2nd dose of Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced fever, chills, fatigue, injection site pain and injection site swelling. Rechallenge with Bexsero was positive. On an unknown date, the outcome of the fever, chills, fatigue, injection site pain and injection site swelling were unknown.   It was unknown if the reporter considered the fever, chills, fatigue, injection site pain and injection site swelling to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Bexsero and had fever, chills feeling very run down for a couple days.  The pain and swelling at the injection site.  More severe of these reactions than normal. The reporter agreed to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/23/2019,,,,
0835232,09/23/2019,GA,,,,U,,"Suspected vaccination failure; Pertussis; Pneumonia; Sepsis; Encephalopathy; Cough; Respiratory Failure; This case was reported in a literature article and described the occurrence of vaccination failure in a 48-year-old patient who received DTPa (Reduced antigen) (dTpa vaccine) for prophylaxis.   Concurrent medical conditions included hiv infection.   On an unknown date, the patient received dTpa vaccine at an unknown dose. On an unknown date, more than a week after receiving dTpa vaccine, the patient experienced vaccination failure (serious criteria death, hospitalization and GSK medically significant), pertussis (serious criteria death, hospitalization and GSK medically significant), pneumonia (serious criteria death, hospitalization and GSK medically significant), sepsis (serious criteria death, hospitalization and GSK medically significant), encephalopathy (serious criteria death, hospitalization and GSK medically significant), cough (serious criteria death and hospitalization) and respiratory failure (serious criteria death and GSK medically significant). On an unknown date, the outcome of the vaccination failure, pertussis, pneumonia, sepsis, encephalopathy, cough and respiratory failure were fatal. The reported cause of death was pertussis, pneumonia, sepsis, encephalopathy, respiratory failure, vaccination failure and cough.   It was unknown if the reporter considered the vaccination failure, pertussis, pneumonia, sepsis, encephalopathy, cough and respiratory failure to be related to dTpa vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the suspected vaccination failure, sever pertussis infection, pneumonia, sepsis, encephalopathy in an adult patient of 48-year-old of unspecified gender who was vaccinated with unspecified tetanus, diphtheria & acellular pertussis (Tdap) vaccine (manufacturer unknown) for prophylaxis. This case corresponds to result section reported in this literature article. The patient was the part of the Enhanced Pertussis Surveillance (EPS) as part of the Emerging Infections Program Network. The aim of the study was to characterize severe pertussis cases, defined as those that require hospitalization, and compare hospitalized and non-hospitalized pertussis patients, identify risk factors for hospitalization, and describe the clinical course and underlying health conditions of hospitalized pertussis patients. The patient had a concurrent history of human immunodeficiency virus infection. No information on patient's family history or concomitant medication. On unspecified date, at least 14 days prior to cough onset, the patient had received unspecified tetanus, diphtheria & acellular pertussis (Tdap) vaccine (administration route and site unspecified, dosage unknown; batch number not provided). The age of vaccination was not provided. [In this study, 15942 cases of pertussis were reported in the surveillance area, patients aged more or equal to 12 years were considered up to date if they had received Tdap. For this analysis, only documented vaccine doses administered at least 14 days prior to cough onset. Fewer hospitalized patients were up to date on pertussis-containing vaccines]. On unspecified date in between 1st January 2011 and 31st December 2015, at least 14 days after vaccination, the patient had the onset of cough and was admitted. The patient had an infection which was laboratory confirmed by culture or polymerase chain reaction (PCR). During the admission, the patient had diagnosed with the pneumonia, sepsis (not further described), and encephalopathy. The patient had the normal white blood cell (WBC) of 8.71  109/L. The patient had a respiratory failure that required mechanical ventilation. On an unspecified date, the hospitalized pertussis patients died from their infection. It was unknown, whether the autopsy was performed or not. [In this study, pertussis cases were classified according to the Council of State and Territorial Epidemiologists case definition. For hospitalized pertussis patients, defined as those admitted to an inpatient care facility, observation unit, or emergency department for more or equal to 24 hours as a result of pertussis infection. Among these cases, 15 427 occurred in patients treated as an outpatient and 515 occurred in patients who were hospitalized; 107 hospitalized patients required admission to the intensive care unit (ICU). Overall, the most common hospital admission diagnoses included cough, ""pertussis"", respiratory distress and or failure, bronchiolitis or bronchitis, and pneumonia. Among all hospitalized patients (515), the median length of time from onset to hospitalization was 11 days, ranging from 7 days in infants aged less than 2 months to 17 days in persons aged equal or more than 65 years. The median length of hospital stay was 3 (1.7-6.9 days) and ICU stay was 4 (2-9 days). The hospitalized patients received a macrolide antibiotic within 14 days of symptom onset, and had an infection that was laboratory confirmed by culture or polymerase chain reaction (PCR). Traditional pertussis clinical symptoms were more commonly reported in hospitalized patients symptoms included paroxysmal cough, post-tussive vomiting, whoop, cyanosis and apnea. Among patients who were tested during their hospitalization, 31 of 350 had a maximum white blood cell (WBC) count that surpassed 30  109/L (previously associated with an increased risk of pertussis-related infant deaths and 54 of 271 had a viral codetection (diagnosed through PCR, direct fluorescent antibody testing, culture, or rapid antigen tests). Overall, 127 of hospitalized pertussis patients developed pneumonia, developed new-onset seizures, and developed encephalopathy]. This case was considered as suspected vaccination failure as the vaccination schedule and time to onset were unknown. This case was considered as serious due to suspected vaccination failure and death. The author commented, ""Pertussis vaccination according to Advisory Committee on Immunization Practices (ACIP) recommendations is not only effective at preventing disease but has also been shown to reduce the clinical severity of pertussis illness. Although high amounts of missing vaccination information in adolescents and adults precluded our ability to fully assess this association in older age groups, a recent publication suggested that adolescents and adults vaccinated with Tdap have reduced incidence of post-tussive vomiting, a marker of more clinically significant illness. Thus, although vaccinated persons may still remain at risk for pertussis infection, these data highlight the role that pertussis vaccination plays in the prevention of severe and potentially life-threating infections, suggesting an added benefits of vaccination that goes beyond disease prevention. We are unable to determine whether certain underlying conditions are risk factors for severe pertussis or, rather, whether persons with these conditions are hospitalized at greater rates due to a perception of increased risk for severe disease"". The author concluded, ""Our analysis shows that severe pertussis infections that require hospitalization are not limited to infants; certain risk factors, such as key underlying medical conditions, may predispose an individual to more severe infections. Continued monitoring of pertussis hospitalizations through enhanced surveillance systems such as EPS will help better define populations at increased risk of severe disease in order to appropriately target and prioritize current and future pertussis prevention and control strategies. Individuals at the extreme ends of life may be the most vulnerable to severe pertussis infections, though hospitalization was reported across all age groups. Continued monitoring of severe pertussis infections will be important to help guide prevention, control, and treatment options"".      Lab Comments: Lab test done on an unspecified date between 1st January 2011 and 31st December 2015.  The patient had an infection which was laboratory confirmed by culture or polymerase chain reaction (PCR).; Reported Cause(s) of Death: Pertussis; Pneumonia; sepsis (not further described); Encephalopathy; Respiratory failure; Suspected Vaccination failure; Cough",Y,,,,Y,,,,N,,,,"Test Name: White blood cell count; Result Unstructured Data: Test Result: 8.71, Test Result Unit: x 10^9/L",UNK,,,HIV infection,,,USGLAXOSMITHKLINEUS2019GS,2,09/23/2019,,,,
0835234,09/23/2019,MO,68.0,68,,M,,"severe pain located proximal to the injection site; Can't move arm; This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced injection site pain and injected limb mobility decreased. On an unknown date, the outcome of the injection site pain and injected limb mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in an unknown arm. The reporter reported that, after vaccination, the patient developed severe pain located proximal to the injection site. The pain was not relieved by over the counter medication and the patient stated that, could not move their arm. The physician was at home at the time of the report and did not have specific records. The reporter consented to follow up.",,,,,,,,,N,08/26/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835235,09/23/2019,IL,66.0,66,,M,,"arm swelling at injection site and soreness, followed by that evening fever to 100.2 , bp 140/80 pulse 85. (usually bp around 120/80 with 60 pulse, really bad headache, skin sensitivity,  significant fatigue,  unable to sleep well, chills lasting until Monday  morning 9/23/19.  As of this report right arm at injection site is still very sensitive to touch and when flexing muscle.",,,,,,,,,Y,09/21/2019,09/21/2019,0,none,PHM,,"Methotrexate  15mg once per week on Wednesdays, Lisinopril 10 mg daily, Folic Acid 2 mg daily, Naproxin Sodium 220 mg daily",Rheumatoid Arthritis diagnosed with markers,Rheumatoid Arthritis diagnosed with markers,First dose of Shingrix  two months prior,,2,09/23/2019,,,,sulfa
0835236,09/23/2019,NC,38.0,38,,F,,"All this was reported to RN by the Patient and Leader notified us of her hospitalization. Appears to be Guillian Barre Syndrome.  Numbness in foot started within 24 hours of vaccination and proceeded up her legs over several days, in contact with her provider over time, when it got to her belly button she was advised by her provider to proceed to the ED.  She was hospitalized for at least 5 days and received IVIG.  She did get to the point she could not walk.  Prior to discharge she did walk with help and a physical therapist.  She was still having arm tingling and leg tingling prior to discharge.",,,,,Y,7,,,N,09/05/2019,09/06/2019,1,You will need to request medical records.,WRK,,unknown,unknown,unknown,,,2,09/23/2019,,Y,Y,unknown
0835237,09/23/2019,OH,89.0,89,,M,,I developed a macular type of lesion in the medial aspect of left axilla( about 3-4 mm in diameter) 3 days ago. It is a single lesion which has now developed into a papule.  Before that I developed mild flu-like symptoms with muscle aches and slight fever(which lasted a few hours) The papule itself is mildly tender and it had a reddish base which has disappeared now. The constitutional symptoms are gone now.,,,,,,,,,Y,09/16/2019,09/20/2019,4,,PHM,,"Vitamin tablets, Garlic tablet, Metoprolol 150mgm OD,Amlodipine 10mgmOD, Ezetimibe 10mgm OD, Clopidogrel 75mgm OD, Simvastatin 10 mgm OD, Tamsulosin 10mgmOD, Finasteride 5mgm OD, ASA 81mgm OD, Vit D3 2000 IU OD",None,CAD and CA Prostate,,,2,09/23/2019,,,,Cardizem and Floxin
0835238,09/23/2019,CA,73.0,73,,M,,"on 9/13/19, I was administered a flu shot That night I came down with very severe flu symptoms. Fever, sweats, strong nausea, loss of energy and severe vertigo This lasted through the night and periodically through the weekend.  It was so serious that I considered going to the ER.  I reported this to the clinic was told that this was normal and that it is impossible for live viruses to remain  in the serum.  I have has many flu shots and am not allergic ---- this was very unusual and frightening.  I can't help but surmise that there was either live viruses remaining or that there were QC issues associated with the formulation.  Can you please investigate.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,MIL,,"Vorapamil, Atorvastatin, , Lisinopril",None,None,,,2,09/23/2019,,Y,,P0ossible Shellfish
0835239,09/23/2019,MO,64.0,64,,M,,"Patient first noticed left deltoid soreness upon laying down in bed on Friday (9/20/19) night. Upon awakening the next morning, the patient then noticed patchy spots on his left deltoid that displayed some redness and swelling. The patient's wife informed pharmacy staff of this adverse event, and upon further questioning, it was discovered that the patient has been experiencing some pain, which is tolerable, and some itching at injection site. Patient and his wife have been closely monitoring this adverse reaction and stated that they will go to the doctor if the patient's condition worsens at any time. Patient's wife has used some benadryl (oral and topical cream) to relieve some of the itching.",,,,,,,,,N,09/18/2019,09/20/2019,2,,PHM,,Levothyroxine 100mcg,None,"Hypothyroidism, Previous History of Shingles",,,2,09/23/2019,,,,No Known Allergies
0835242,09/23/2019,PA,79.0,79,,M,,"Shingles; This case was reported by a nurse via sales rep and described the occurrence of shingles in a 79-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th August 2019, the patient received the 1st dose of Shingrix. On 6th September 2019, 8 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The nurse reported that, after vaccination with dose of Shingrix, the patient diagnosed with shingles. The reporter had concerned because it happened to another patient, which would report after completion of this report. This case has been linked with case US2019AMR167067, repored by same reporter.",,,,,,,,,U,08/29/2019,09/06/2019,8,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/23/2019,,,,
0835243,09/23/2019,PA,66.0,66,,M,,"Shingles; This case was reported by a nurse via sales rep and described the occurrence of shingles in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd July 2019, the patient received the 1st dose of Shingrix. On 27th July 2019, 4 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The reporter reported that, after vaccination the patient had shingles, and this was the 2nd patient in their practice with same story. Thie case has been linked with case US2019AMR167063, reported by same reporter",,,,,,,,,U,07/23/2019,07/27/2019,4,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/23/2019,,,,
0835244,09/23/2019,,,,,M,,"Slight rash at injection site; Warmth at injection site; Flu-like symptoms; This case was reported by a other health professional via call center representative and described the occurrence of influenza-like symptoms in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th September 2019, the patient received Shingrix. On 10th September 2019, 1 days after receiving Shingrix, the patient experienced influenza-like symptoms. On 13th September 2019, the patient experienced injection site rash and injection site warmth. On an unknown date, the outcome of the influenza-like symptoms, injection site rash and injection site warmth were unknown.   It was unknown if the reporter considered the influenza-like symptoms, injection site rash and injection site warmth to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication. On 13th September 2019, 4 days after receiving Shingrix, the patient had slight rash and warmth at injection site. The adverse event was captured via webchat and visitor didn't respond after chat opened and initial question received from visitor. Chat visitor indicated that they were a pharmacy technician. The reporter denied permission to follow up.",,,,,,,,,U,09/09/2019,09/10/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835245,09/23/2019,MO,,,,U,,"Patient was inadvertently given Trumenba instead of Menatra at the 10 year old visit.; severe headache; fever; This is a spontaneous report from contactable physician via Pfizer Sales Representative.  A 10-year-old patient of an unspecified gender received meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration on an unspecified date at single dose for immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient was inadvertently given meningococcal group b rlp2086 instead of meningococcal vaccine a/c/y/w conj (dip tox) (MENACTRA). The patient experienced severe headache and fever. The events were non serious with outcome of unknown.  The information on the batch/lot number has been requested.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2019407025,2,09/23/2019,,,,
0835246,09/23/2019,AR,55.0,55,,F,,Patient developed itchy rash on lower abdomen that began with red bumps and developed into bleeding blisters. Patient self-treated at home with hydrocortisone cream without improvement. Patient then went to urgent care and received steroid cream. Patient reports rash is improving but not completely resolved.,,,,,,,,,N,09/12/2019,09/15/2019,3,n/a,PHM,,"Allegra D, valsartan/HCTZ, fenofibrate, citalopram, gabapentin, lovastatin",n/a,"depression, high cholesterol",,,2,09/23/2019,,,Y,some cholesterol medications
0835247,09/23/2019,PA,81.0,81,,F,,patient had sore arm and body aches... patient said she may have had chest wall pain but those went away ... patent was advised to follow up with dr today on 9/23/19,,,,,,,,,U,09/22/2019,09/23/2019,1,none,OTH,,"osteo bilfex, vit d , citracal, mag ox, xarelto 15mg, metoprolol 25mg, zoloft 25mg, metotrxate 2.5, synthroid 50mcg, protonix 40mg, zocor 20mg, folic acid 1mg",neck pain,ra and afrib,,,2,09/23/2019,,,,none
0835248,09/23/2019,NC,68.0,68,,F,,"I awoke around 1 am  and I was freezing, and I had muscle ache and joint pain all over my body. Went into closet and found heaviest blanket I had and put over me. Was same when I woke in morining and took my temp, it was 101.2. I called pharmacy that gave me shot and they said to take aleve and I did. Fell asleep and was ok when I woke up about 2-3 hours later.",,,,,,,,,Y,08/14/2019,08/15/2019,1,N/A,PHM,,"Levothyroxine, Venlafaxine, Loratadine, Probiotics",N/A,"Asthma, Rhinitis",,,2,09/23/2019,,,,N/A
0835249,09/23/2019,WY,40.0,40,,F,,"County Public Health Nurses make visits to the County Detention Center to inmates who request STD/TB/Pregnancy testing and/or immunizations. 9/6/19: Patient seen at County Detention for testing and desired immunizations. Hep B virus panel drawn, Hep A vaccine (LDIM) and Tdap (RDIM) given. 9/9/19: Negative Hep B virus panel, not immune. 9/17/19 PM:  Heplisav given at County Detention Center by Public Health Nurse. 9/19/19 approx 1530:  Call from detention center staff nurse, reports pt c/o redness, swelling, warmth, and itching in area of Heplisav injection. Red raised area marked with a sharpie, topical hydrocortisone applied to area at approx 1540. 9/20/19 AM: Visit with patient at County Detention Center by Public Health Nurse, redness is slightly larger than marked area, area of raised, warm, redness measures 3"" from top to bottom and 4"" across with a 1-1.5"" area in the center that is not red, raised, or warm. Pt reports slight itch today, better than yesterday, no pain unless touched, pain level 3 of 10 when touched. No blister(s) or pustule(s) noted, no other complaints. Reports no problems with Hep A or Tdap vaccines given 9/6/2019.",,,,,,,,,U,09/17/2019,09/19/2019,2,None,PUB,,Ibuprofen PRN,None,History of +TB and treatment as a child. History of drug use. History of unprofessional tattoo.,,,2,09/23/2019,,Y,,Wheat
0835250,09/23/2019,TX,66.0,66,,F,,"Patient had a Pneumovac 23 immunization given on 09/20/2019 at the time of the visit.  Pt called to report to provider at 8:00 pm Friday evening that she had started to have excruciating pain  to her RT arm.  Pt stated to the provider she had minimal redness noted to the area and had applied ice and took some OTC pain medication .  Pt stated after she left the clinic after getting her immunization she headed back to work and did 3 pedicures as she works in a beauty salon.  Pt then indicated that later that evening she was unable to lift her arm to eat.   Provider recommend to have the pt take Benadryl and continue to ice that arm.   Provider requested to have the pt contact her the next day to report how she was doing.  The next morning the patient stated to provider that she had no worsening of symptoms , but no change.  Later that evening the pt stated she was able to attend an event where she was scheduled to serve food and was able to participate in the activity.  The provider requested to have pt continue to notify her how she was doing.  Monday am the provider attempted to contact her to have pt schedule a follow up to be reassessed and provider was unable to reach the pt at the time.  She made several attempts to contact her by phone and by text message.  Provider states the pt did mention to her that her landline was out of service for the last few months .  Provider states that pt lives in a rural area that cell service does not always work.",,,,,,,,,U,09/20/2019,09/20/2019,0,None,PVT,,None,UTI at the time of visit.  Patient reports at the time of visit that she was having complaints of cramps to feet and back. Patient had complaints of fatigue for 2 months.,None reported at the time of visit.,,,2,09/23/2019,,Y,,None
0835251,09/23/2019,NY,56.0,56,,F,,Hives/ rashes/blisters,,,,,,,,,U,09/20/2019,09/20/2019,0,,PHM,,,,,,,2,09/23/2019,,Y,Y,
0835252,09/23/2019,MI,12.0,12,,M,,Redness with swelling and pain in right upper arm developed 5-6 hours after the shot. Went to ER on 9/13/2019  given Decadron 10 mg oral once and discharged. Symptoms resolved over 2 days. Father did not want to bring child for follow up as he was better.,,,,,,,,,Y,09/12/2019,09/12/2019,0,No,PVT,,,,"Right jaw swelling, resolved 6 months ago",Localization to influenza shot age 11 date 12/10/2018,,2,09/23/2019,,,Y,
0835253,09/23/2019,NJ,41.0,41,,M,,9/4/19 1PM SORE THROAT DEVELOPED.  9/4/19 11PM BODY ACHES OCCURRED.  9/5/19 2AM BODY CHILLS WITH JOINT ACHES AND FEVER OF 102F WERE RECORDED.  9/5/19 9AM FEVER OF 100 WITH JOINT ACHES AND BODY ACHES AND NASAL PRESSURE.  DECREASE IN APPETITE.  9/6/19 9AM BODY TEMP WAS 99 WITH CONTINUED JOINT PAIN. 9/7/19 FEVER WAS ABSENT AND NO BODY PAIN BUT SORE THROAT WORSENING.  WENT TO SEE URGENT CARE ON 9/7 11AM AND GIVEN AMOXICILLIN FOR POSSIBLE STREP THROAT INFECTION,,,,,,,,,Y,09/03/2019,09/04/2019,1,9/9/19 GOT STREP CULTURE BACK AND WAS NEGATIVE,PHM,,none,none,none,,,2,09/23/2019,,Y,,food allergy to pineapple
0835254,09/23/2019,RI,,1,.3,F,,"Patient received both vaccines in left thigh on 9/9/19. She returned to office on 9/20/19 with large swollen lump on left thigh. No fevers. Area with no redness or tenderness. Ultrasound obtained, result suggested cellulitis with small amount of free fluid. Patient started treatment with keflex on 9/23/19.",,,,,,,,,N,09/09/2019,09/20/2019,11,"US done on 9/23/19, suggested cellulitis with small amount of free fluid.",PVT,,No,No,None,,,2,09/23/2019,,Y,,No
0835261,09/23/2019,MN,,,,M,,"sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that the patient received dose of Shingrix and experienced sore arm that had not resolved.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835262,09/23/2019,,66.0,66,,F,,"Right shoulder soreness; Right axillary lymph node swelling; This case was reported by a nurse via call center representative and described the occurrence of shoulder soreness in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th September 2019, the patient received the 1st dose of Shingrix. On 13th September 2019, 1 days after receiving Shingrix, the patient experienced shoulder soreness and enlargement of lymph nodes. On an unknown date, the outcome of the shoulder soreness and enlargement of lymph nodes were unknown.   It was unknown if the reporter considered the shoulder soreness and enlargement of lymph nodes to be related to Shingrix.  Additional information received were as follows: The nurse reported that she was the patient and experienced right shoulder soreness and right axillary lymph node swelling. The healthcare professional described sore shoulder as sore arm.  The healthcare professional noted that the soreness and swelling began the day after she received dose one of Shingrix.  The reporter was unable to query healthcare professional for lot number, expiration date, consent to follow up, and physician contact details due to healthcare professional's abrupt end to conversation.  The healthcare professional did not provide phone number and address when queried.",,,,,,,,,U,09/12/2019,09/13/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835263,09/23/2019,IN,74.0,74,,F,,"urticarial rash on her abdomen and her legs; This case was reported by a pharmacist via call center representative and described the occurrence of urticarial rash in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number AC79X, expiry date 17th October 2021) for prophylaxis.   On 6th September 2019, the patient received the 1st dose of Shingrix .5 ml. On 10th September 2019, 4 days after receiving Shingrix, the patient experienced urticarial rash. On an unknown date, the outcome of the urticarial rash was not recovered/not resolved.   It was unknown if the reporter considered the urticarial rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and developed an urticarial rash on her abdomen and her legs. The reporter consented to follow up. The caller did not provide any additional information.",,,,,,,,,N,09/06/2019,09/10/2019,4,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835264,09/23/2019,NJ,88.0,88,,F,,"fever; This case was reported by a consumer via call center representative and described the occurrence of fever in a 88-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th April 2019, the patient received the 1st dose of Shingrix. In April 2019, less than a day after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The patient stated that she got the first dose of the Shingrix vaccine and that night she experienced the fever which lasted for 24 hours.  The patient did not provide additional information. The reporter did not consent to follow-up.",,,,,,,,,Y,04/25/2019,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835265,09/23/2019,NC,65.0,65,,F,,"felt like had the flu; This case was reported by a consumer via call center representative and described the occurrence of influenza like illness in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th September 2019, the patient received the 1st dose of Shingrix (intramuscular). In September 2019, less than a day after receiving Shingrix, the patient experienced influenza like illness. On an unknown date, the outcome of the influenza like illness was recovered/resolved.   It was unknown if the reporter considered the influenza like illness to be related to Shingrix.  Additional details were provided as follows: The patient reported that, after vaccination she felt like flu. Next day after vaccination, the influenza like illness was resolved. The reporter did not consent to follow up.",,,,,,,,,Y,09/11/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835266,09/23/2019,CA,,,,U,,"INJECTION SITE PAIN; Radiating pain; pain in arm / Feet pain; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site pain, radiating pain and pain in arm. On an unknown date, the outcome of the injection site pain, radiating pain and pain in arm were unknown.   It was unknown if the reporter considered the injection site pain, radiating pain and pain in arm to be related to Shingrix.  Additioanl details were provided as follows: The age at vaccination was not reported. The age group of the patient was not reported but selected as an adult as per vaccine indication. The pharmacist reported that, there were number of patients(over 10) experienced injection site pain after vaccination with dose of Shingrix. The reporter stated that, some of the patients reported that, the pain radiates over the arm and feet. No additional information provided. The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835267,09/23/2019,NC,78.0,78,,F,,Rash - spotty rash about 2 inches in diameter (circular presentation) several different ones on abdomen /underarm  started 09/21 reported to pharmacy 09/22 - rash is not itching or painful - pharmacist got a second opinion from Nurse practioner on duty at clinic recommended benadryl . Pharmacist reached out to patient later in the evening and pt did say that benadryl was helping,,,,,,,,,N,09/16/2019,09/21/2019,5,,PHM,,"pantoprazole, levothytroxine, pravastatin,clopidogrel",,,,,2,09/23/2019,,,,
0835268,09/23/2019,FL,1.25,1,.3,M,,"Today, the patient returned to the clinic 3 days after injection. Yesterday mom noticed a mass under his skin/on top of muscle. No further symptoms.",,,,,,,,,N,09/20/2019,09/22/2019,2,,PVT,,Amoxicillin 400mg/5ml Oral Suspension 7 mL PO BID for 10 days. ;  Brompheniramine/Dextromethorphan/Pseudoephedrine 2mg/10mg/30mg per 5ml Syrup 1.25 mL Q6 hours PRN cough/congestion. ;  Polyethylene Glycol 3350 Powder for Oral Solution 1/2 t,Bilateral AOM; constipation,reoccurring AOM (3 this year),,,2,09/23/2019,,Y,,NKA
0835269,09/23/2019,MI,65.0,65,,M,,Stomach and chest felt uncomfortable. Next chills and shaking for about 30 to 45 min. Approximately a hour and half later had fever and sweating for about 45 min. Checked temp about 30 min later was weak and not eating for a total  36 hours. Body aches all joints,,,,,,,,,Y,09/18/2019,09/19/2019,1,None,PHM,,None,None,None,,,2,09/23/2019,,,,None
0835270,09/23/2019,DE,75.0,75,,F,,"Left facial and left upper lip angioedema, uncertain if related. Started 9/18/19 at 12 noon after having ricola cough drop denies any other changes",,,,,,,,,U,09/17/2019,09/18/2019,1,None,PVT,,"Ricola Cough drop, amlodipine-benazepril, asa, atorvastatin, zetia, omeprazole, toprol XL",None reported,"hiatal hernia, esophageal stricture, GERD, ETOH above recommended intake, hyperkalemia, IFG, HTN, hyperlipidemia, elevated LFT",,,2,09/23/2019,,Y,,no known allergies
0835271,09/23/2019,IN,41.0,41,,M,,A bruising of the left upper lateral side of arm with some redness around it. size of a egg some tingling felt when it was given.,,,,,,,,,Y,09/19/2019,09/19/2019,0,,PVT,,no,,,With first Varicella (8/16/2019)  flu like symptoms.,,2,09/23/2019,,Y,,seasonal allergies
0835272,09/23/2019,GA,83.0,83,,M,,patient returned to pharmacy 11 days after immunization to report that he is still experiencing arm soreness/pain upon moving arm,,,,,,,,,U,09/09/2019,09/09/2019,0,,PHM,,"coreg 3.125mg ; vit d 50,000iu",,,,,2,09/23/2019,,,,
0835273,09/23/2019,GA,56.0,56,,F,,"raised red area with bumps, instructed to treat with ibuprofen and ice pack, ongoing",,,,,,,,,U,09/20/2019,09/23/2019,3,,PHM,,"temazepam, symbicort, gabapentin, metoprolo, cyclobenzaprine, losartan, esopmeprazole, atorvastatin",bacterial infection,"htn, hypercholesterolnemia, GERD, insomnia",,,2,09/23/2019,,,,"metronidazole, sulfa"
0835274,09/23/2019,FL,77.0,77,,F,,"On Monday, right foot broke out and patient was not sure what it was.  Went to the pharmacist and they were not sure what it was either.  On Tuesday, went to the ER on Tuesday (ER) and they were not sure what it was either so just gave patient injection for pain and released them.  Patient kept trying to go to work, wore slipper on foot but could not stand pain.  On Friday went to Hospital and it was diagnosed as shingles. Hospitalized for 11-12 days.  Patient was in isolation since also had chickenpox on back.  An MRI was done in the hospital.  Patient had to file for disability since have not been able to work since 7/5; first could not go to work because sore were open and then after they healed could not go because of the pain. On 7/18 visit with primary for follow-up; filled up paperwork for disability. After hospitalization, visit with RA specialist had her stop weekly Norco injections and just restarted them last week. This is the doctor that prescribes Gabapentin, Norco injections and folic acid. On 7/25 visit with Pain Management doctor prescribes the hydrocodone/Norco and Tizanidine. He increased Gabapentin dose because patient could not take weekly Norco injections.  On 7/25 went to Dr, neurologist, who treated patient at hospital to follow-up on tremors that got worse. In hospital patient received Valacyclovir on a drip and then prescribed Valacyclovir 1 gram.   On 8/12, Dr did an EMG.  Visit with Dr on 8/15 and 8/19 because foot was still so bad that it felt like if walking on lump.  On 8/20 visit with Dr  (podiatrist) who specified it is just related to shingles.   On 8/22 had follow-up visit with Dr.  On 9/10, Dr told patient to go back on Norco injections.  On 9/16 visit with Dr and Dr for follow-up.  On 9/23 visit with Dr for back injection.  In terms of recovery, outbreak has healed but now dealing the pain. Patient is in so much pain that cannot put shoes to or drive to go back to work. She puts foot in a bucket of water to help ease the pain. Recovery at 40%.  In terms of recovery, outbreak has healed but now dealing the pain. Patient is in so much pain that cannot put shoes to or drive to go back to work. She puts foot in a bucket of water to help ease the pain. Recovery at 40%.   Patient had chickenpox when she was little.   She participated in shingles study in 90s; she was in the placebo group but received vaccine for free for participating.",,,,,Y,11,,Y,,06/29/2019,07/01/2019,2,,PHM,,"Gabapentin,  Methotrexate, Tizanidine 4mg, Folic acid,  Calcium. Norco injections",No.  No,"Back pain, Laminectomy, gall bladder removed, hysterectomy, rotator cuff left arm surgery, Rheumatoid arthritis",,,2,09/23/2019,,Y,Y,None
0835275,09/23/2019,WI,30.0,30,,M,,"Patient calls the clinic on 9/23 to report symptoms which developed after receiving the Pneumococcal vaccine.   He felt there was no problems with the initial injection. Everything seemed fine."" nothing out of the ordinary""  A few hours after returning home he developed Fever of 102, chills, Sweats, diarrhea  and vomiting and pain at the injection site. He later developed swelling of the arm and "" Hematoma"" Described bruising extending up to shoulder and upper collar bone and down to the forearm. Felt like he could not move his muscle. On 9/22 he was going to seek medical attention if it continued to get worse however the symptoms subsided. Today he is much better and feels the "" worst is over"" . No further concerns with fever , vomiting /diarrhea . Swelling has gone down with bruising fading.",,,,,,,,,U,09/20/2019,09/20/2019,0,none,PVT,,none,none,"Alcohol dependence,Anxiety,Pancreatitis , Irritable Bowel Syndrome ,",,,2,09/23/2019,,,,"Pineapple, Carbamazepine"
0835276,09/23/2019,PA,58.0,58,,M,,patient said he was very nauseous. Also felt cramping across his body.,,,,,,,,,Y,09/20/2019,09/21/2019,1,none,PHM,,"Synvisc, Synthroid, tramadol, etodolac, plaquenil, lisinopril, airduo, albuterol, Pepcid, Flonase, allopurinol, gabapentin, prednisone, b12,",patient has auto-immune disorder,,,,2,09/23/2019,,,,none
0835277,09/23/2019,FL,63.0,63,,F,,pt presented with a swollen hand  joint at forefinger and middle finger was swollen and hot to touch and painful,,,,,,,,,N,09/21/2019,09/21/2019,0,,PHM,,cucurimin,n/a,n/a,,,2,09/23/2019,,Y,,n/a
0835278,09/23/2019,PA,46.0,46,,F,,"Three hours after vax: extreme fatigue, flu symptoms, nausea, dizziness, extreme headache, vomiting lasting 24 hours. One month after vax:  viral infection/bronchial infection. Coughing, phlegm, swollen glands lasting one month.",,,,,,,,,N,07/17/2019,07/17/2019,0,No tests - only treatment. Dr. did not respond to email on the infection.,PUB,,None.,None.,I developed a massive flu-like illness just hours after the vaccine. Lung/bronchial infection directly after lasting into September.,,,2,09/23/2019,,Y,,"Penicillin, Z-pac, shellfish, quinoa, broccoli and anything that raises the heart rate."
0835279,09/23/2019,NY,54.0,54,,F,,Pt arm started to swell right away popping bandaids  off. She took Benadryl and put ice pack on and waited for a bit. I checked no trouble breathing or hives or any other reactions. Pt had to leave so I called her later that night to check but not home so I left message. Pt called next day and said still swollen even more and bruised possible slight fever that night but she wasn?t positive.,,,,,,,,,U,09/01/2019,09/18/2019,17,,PHM,,Not available,Not available,Not available,,,2,09/23/2019,,,,Codeine red dye
0835280,09/23/2019,PA,1.25,1,.3,M,,"He was acting like he was on a ""sugar high"" for a few hours.  He was running around and very hyper and loud.  This lasted a few hours and self resolved. Grandma was watching and said she also gets like this after the flu shot and was concerned.  He was back to normal behavior after a few hours",,,,,,,,,Y,09/21/2019,09/21/2019,0,non,PVT,,NONE,NONE,NO,,,2,09/23/2019,,,,NONE
0835281,09/23/2019,MD,4.0,4,,F,,"Within 5 minutes of receiving vaccine began sneezing abdundantly, then became lethargic, which progressed to listlessness and decreased responsiveness. Retracting, wheezing, hypoxic (sats dropped into 60s), arms and face flushed, grunting. Received oxygen, albuterol and atrovent via nebulizer, epinephrine 0.15 mg IM then 0.3 mg IM 10 minutes later, oral dexamethasone, IM benadryl and transported to Emergency Room. By time transported, oxygen saturations had improved to low 90s. Report from ER that was sitting up, alert and interactive within an hour. Kept overnight for observation.",,,,,Y,1,,,Y,09/23/2019,09/23/2019,0,Will refer to allergist after recovered from this event,PVT,,None,mild nasal congestion discussed at time of visit thought to be possible seasonal allergies,asymmetric crying facies,,,2,09/23/2019,,,Y,None known
0835282,09/23/2019,TX,64.0,64,,F,,"Feeling unwell began a few hours later. Tired, no energy,  body aches Woke up next morning feeling much worse. Fever started going up. Max measured was 101.7 Chills, body aches, headache, no energy, felt like I couldn?t even move. Stayed in bed all day.",,,,,,,,,Y,09/21/2019,09/21/2019,0,,PHM,,"Enbrel, cytomel, synthroid, omeprazole, losarton, Victoza, dymista, qvar, gabapentine, Allegra, multi-vitamin, iron (blood builder supplement), vit d, allergy shots",Sinus infection - finished antibiotics 10 days prior to vaccine,"Arthritis, hypothyroid, asthma, allergies",,,2,09/23/2019,,,,"Mycin antibiotics, amlodipine, statins, levaquin"
0835283,09/23/2019,HI,69.0,69,,M,,"4-6 WEEKS AFTER RECIEVING SECOND DOSE OF SHINGRIX, PATIENT STARTED TO NOTICE 5 SMALL RED ""CHICKEN POX"" LIKE DOTS APPEARED  ON HIS RIGHT FORE ARM.  5 DAYS AFTER IT'S APPEARANCE,  IT BURSTED AND BECAME 5 LITTLE SORES THAT ITCHES ALL THE TIME. THE SMALL RED DOTS HAVE MIGRATED TO ALL OF HIS RIGHT ARM, TO HIS LEFT ARM, TOP OF SHOULDERS, AND BELLLY BUTTON. THESE SMALL RED DOTS TURNS INTO BLISTERS THAT BURSTS, HEALS UP, AND ITCHES ALL THE TIME.",,,,,,,,,N,04/30/2019,06/01/2019,32,"PATIENT REPORTED THAT MD OFFICE DID NOT PERFORM ANY TESTS, ONLY RECOMMENDED HIM TO USE OVER THE COUNTER ITCH CREAM TO HELP WITH THE ITCHING.",PHM,,N/A,N/A,N/A,,,2,09/23/2019,,Y,,N/A
0835284,09/23/2019,AK,41.0,41,,F,,IM right deltoid region. Right shoulder pain after receiving injection that has progressively worsened since. Difficulty with abduction/internal rotation of the right shoulder. Suspect injection placed into subacromial space.,,,,,,,,,N,09/13/2019,09/13/2019,0,,MIL,,,None,,,,2,09/23/2019,,Y,,NKA
0835285,09/23/2019,FL,65.0,65,,F,,"APPROXIMATELY 7 1/2 months later on 8/7/2016 Admitted TO MEDICAL CTR FOR SHORTNESS OF BREATH AND PNEUMONIA TO THE EMERGENCY ROOM THEN ADMITTED OVERNIGHT. On 12/15/2015 - patient received the Zostavax vaccine in the doctor office. Interestingly, the insurance companies, or the supplemental insurance would not cover the vaccine, the vaccine from Merck pharma has been removed from public use. Subsequently, patient had developed pneumonia 7 1/2 mo. later, in the summer, as well as shortness of breath. These were unusual occurrences in a short span of time, occurring in the summer & no prior history of pneumonia; After a follow up visit with the pulmonologist in November 2017, he advised an inflamation of the pancreas which led to a further diagnosis of cancer. I believe this accelerated patient's condition, whereby, there was no family history on her side of any cancer.",,,Y,,Y,2,,,,12/15/2015,08/07/2016,236,,PVT,,multivitamin,NONE,,,,2,09/15/2019,,,Y,SULFA
0835286,09/23/2019,CA,71.0,71,,M,,"Diarrhea, vomiting, loss of apetite, no energy. Mostly recovered by 9/13.",,,,,,,,,,04/09/2019,09/11/2019,155,N.A.,PHM,,Lutein Vit. D3 & B12,None,None,,,2,09/13/2019,,,,None
0835287,09/23/2019,NY,8.0,8,,F,,"During administration, the patient pulled her arm away and she received only part of the vaccine. The rest went to the outside of her arm. Slight scrape from needle on the outside of her arm where she pulled away. Contacted the pediatrician to determine if an additional dose is needed and emailed her the information on I found from the CDC.",,,,,,,,,U,09/22/2019,09/22/2019,0,N/A,PHM,,none known,none known,nothing reported,,,2,09/23/2019,,,,NKA
0835292,09/23/2019,ID,,0,.2,M,,"No adverse effect reported; received improperly stored PEDVAXHIB; This spontaneous report was received from a nurse refers to a 9 week old male patient. The patient's concurrent condition, concomitant medication and medical history were unknown. On 06-SEP-2019, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) of lot # S000353 with expiry date 09-SEP-2021 (strength, dose, frequency, route of administration date unspecified) for prophylaxis (product storage error). On an unknown date, the vaccine was exposed above 47 Degree Fahrenheit (47.4 F) temperature for 23 hours. There was no previous excursion reported. Digital data logger was involved and no adverse effects reported (no adverse event). The outcome of the events was unknown.  This is one of three reports received from the same reporter.",,,,,,,,,U,09/06/2019,09/06/2019,0,,UNK,,,,,,US0095075131909USA008497,2,09/23/2019,,,,
0835294,09/23/2019,MD,,,,U,,"Guillain Barre syndrome; Fisher syndrome; Limb weakness; This case was reported in a literature article and described the occurrence of guillain barre syndrome in a elderly patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, less than 2 months after receiving Flu vaccine, the patient experienced guillain barre syndrome (serious criteria hospitalization and GSK medically significant), fisher syndrome (serious criteria hospitalization and GSK medically significant) and weakness of limbs. On an unknown date, the outcome of the guillain barre syndrome, fisher syndrome and weakness of limbs were unknown.   The reporter considered the guillain barre syndrome, fisher syndrome and weakness of limbs to be related to Flu vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of guillain-barre syndrome (GBS) and fisher syndrome (FS) in a patient aged more or equal to 65-year-old of unspecified gender who was vaccinated with unspecified 2015-2016 seasonal of influenza vaccine (manufacturer unknown) for prophylaxis. This case corresponds to result section reported in this literature article The patient was the part of the near real-time surveillance for GBS claims after influenza vaccination of insurance fee-for-service (FFS) beneficiaries using the updating sequential probability ratio test throughout the influenza seasons and SCRI analyses at the end of the 2015-2016 and 2016-2017 seasons. The aimed of this study was to evaluate this signal by conducting chart reviews in the 2015-2016 season followed by self-controlled risk interval (SCRI) analyses of chart-confirmed and imputed cases. [In this study, for the 2015-2016 season SCRI analysis, they used chart-confirmed GBS cases. In 2016-2017 season they conducted SCRI analyses of the claims-based GBS cases and attributed GBS cases (based on the positive predictive value (PPV) of the GBS diagnoses obtained by chart reviews in the previous season). Of the 95 chart-confirmed GBS cases, they noted a history of antecedent respiratory or gastrointestinal illness within six weeks prior to onset of GBS symptoms in 47 charts, one of which had a documented history of Campylobacter jejuni. They identified claims for influenza vaccines and vaccines administered concomitantly (pneumococcal, hepatitis B, and tetanus toxoid-containing vaccines) using Healthcare Common Procedure Coding System (HCPCS) and Current Procedural Terminology (CPT) codes. They conducted influenza infection adjustment using high"" and low"" influenza weeks, which were assigned as such using weekly oseltamivir prescription rates as well as use rates of rapid influenza tests (RIT) followed by an oseltamivir prescription within the subsequent two days]. On unspecified date, the patient had received unspecified 2015-2016 seasonal influenza vaccine (administration route and site unspecified, dosage unknown; batch number not provided). The age of vaccination was not provided. [In this study, the vaccine type (high dose (HD) and standard dose (SD)), and presence of concomitant vaccination. The only HD vaccine administered in both seasons was the inactivated trivalent high dose vaccine (60 mg hemagglutinin per strain). The SD group included inactivated trivalent and quadrivalent (15 mg hemagglutinin per strain) vaccines A total of 13,366,005 insurance FFS influenza-vaccinated beneficiaries were observed for our SCRI analyses. Of these, 6,936,021 received the HD vaccine, 6,218,036 received the SD vaccines, and the remaining received other influenza vaccines (recombinant, intradermal, and cell-culture based) or only had general influenza vaccine codes but no specific codes for a vaccine type.]. On unspecified date between 2015 and 2016, in between the 1 and 42 days risk window, the patient had diagnosed with the guillain-barre syndrome (GBS) and fisher syndrome (FS) as per the Brighton case definition. [In this study, the primary and secondary risk windows were 1-42 and 8-21 days post-vaccination respectively. They defined exposure as a beneficiary's first influenza vaccination during the season, and outcome as the first occurrence of GBS in the inpatient setting during the post-vaccination window of interest. They used Brighton Collaboration's case definitions for GBS and Fisher Syndrome (FS), a variant of GBS, to classify these cases and considered cases classified as Brighton Level 1, 2, or 3 as chart-confirmed"" GBS cases. For the 2015-2016 season, our claims-based near real-time surveillance using the Updating Sequential Probability Ratio Test (USPRT) first revealed a GBS signal in week 16 of surveillance (as of 29th November 2015) among HD vaccines aged more or equal than 65 years as a risk of GBS in the 0 to 42 day window and as a risk of GBS in the 7 to 21 day window. Of note, in the 2015-2016 season, the 0 to 42 day and 7 to 21 day risk windows were used for near real-time surveillance; however, they changed the risk windows to 1 to 42 and 8 to 21 days post-vaccination for the SCRI analyses and near real-time surveillance for subsequent seasons to better align with the existing literature. In the subsequent weeks they observed a GBS signal in week 26 (as of February 2, 2016) for all beneficiaries vaccinated with all seasonal vaccines as a risk of GBS cases in the 0 to 42 day window. The demographic characteristics of the influenza-vaccinated beneficiaries and the GBS cases in the 2 risk windows. They obtained 133 charts. They found 158 claims-based GBS cases in the 84 days post-vaccination that met our study criteria. All cases except one were identified with the ICD-10 code. Three cases were observed after the January 22, 2016 cut-off, and they requested medical charts for the remaining 155 cases. They obtained 133charts. Of these, they confirmed 95 by chart review as GBS cases. Our analysis showed a PPV of an inpatient diagnosis of GBS in ICD-10. By chart abstraction they found that seven cases identified as GBS by claims had FS noted in the charts. However, none of these seven cases met the criteria for FS and four did not meet the criteria for GBS. Of the remaining three cases, they excluded one due to the subject being noted as less than 65 years of age. They included the remaining two cases in the SCRI analysis. Both cases occurred in the 1 to 42 day risk window; one also occurred in the 8 to 21 day window. Even though these two remaining cases were diagnosed by the physicians as FS, they both had limb weakness in addition to FS features and were thus classified as GBS.].  This case has been considered as serious due to the hospitalization. Treatment was unknown. The outcome of the event was not provided. The authors commented, ""Our SCRI results did not show an excess GBS risk in the 1-42 day risk window either in the overall analysis or in any of the sub-analyses by vaccine type. For the secondary 8-21 day risk window, we found a statistically significant increased GBS for all seasonal vaccines. Our chart-confirmed analysis showed that the attributable risk in the secondary (8-21 day) risk window for all seasonal vaccines was slightly less than one excess GBS case per million vaccines, and that for the HD vaccine was slightly less than two excess cases of GBS per million vaccines. These findings are consistent with the risks noted on the package insert of influenza vaccines distributed in specific country. Our secondary analysis finding of a higher GBS risk among males and individuals aged more or equal to 75 years who received seasonal vaccines is consistent with existing literature. We considered the possibility that the difference may be related to egg-based versus recombinant influenza vaccine, which was included in our SD vaccine group"". The author concluded, ""we did not find an excess GBS risk in our primary analysis. The excess risk in some of our secondary analyses was close to what was expected; however, the slightly elevated GBS risk after all seasonal and HD vaccines, but not after standard dose vaccines is hypothesis-generating. This difference between HD and SD vaccines may be related to vaccine factors such as the amount of antigen or the antigen strains in various seasons or related to host factors. The risk of GBS after influenza disease is estimated to be much greater than the potential risk following influenza vaccine, ranging from four to almost 16 times higher, and the benefits of influenza vaccines in preventing morbidity and mortality heavily outweigh this risk. Influenza vaccines continue to be our best defense against influenza disease and the morbidity and mortality associated with it."" This is 1 of the 4 valid cases reported in this literature article.",,,,,Y,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019GS,2,09/23/2019,,,,
0835295,09/23/2019,CA,67.0,66,,F,,"brain shut down; This case was reported by a pharmacist via call center representative and described the occurrence of disorientation in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th August 2019, the patient received Shingrix (intramuscular) .5 ml. On 20th August 2019, 1 days after receiving Shingrix, the patient experienced disorientation. On an unknown date, the outcome of the disorientation was recovering/resolving.   It was unknown if the reporter considered the disorientation to be related to Shingrix.  Additional details were provided as follows: The patient experienced a brain shut down. She would run a stop light or walk into a room and not realize she was in that room. The pharmacist referred to it as a possible loss of time.  At the time of reporting, the patient started to get better. The pharmacist was transferred to medical information for additional assistance.",,,,,,,,,N,08/19/2019,08/20/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835296,09/23/2019,MD,,,,U,,"Guillain Barre syndrome; Fisher syndrome; Limb weakness; This case was reported in a literature article and described the occurrence of guillain barre syndrome in a elderly patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, between 1 and 3 weeks after receiving Flu vaccine, the patient experienced guillain barre syndrome (serious criteria hospitalization and GSK medically significant), fisher syndrome (serious criteria hospitalization and GSK medically significant) and weakness of limbs. On an unknown date, the outcome of the guillain barre syndrome, fisher syndrome and weakness of limbs were unknown.   The reporter considered the guillain barre syndrome, fisher syndrome and weakness of limbs to be related to Flu vaccine.  Additional details were reported as follows: This case was reported in a literature article and described the occurrence of guillain-barre syndrome (GBS) and fisher syndrome (FS) in a patient aged more or equal to 65-year-old of unspecified gender who was vaccinated with unspecified 2015-2016 seasonal of influenza vaccine (manufacturer unknown) for prophylaxis. This case corresponds to result section reported in this literature article The patient was the part of the near real-time surveillance for GBS claims after influenza vaccination of insurance fee-for-service (FFS) beneficiaries using the updating sequential probability ratio test throughout the influenza seasons and SCRI analyses at the end of the 2015-2016 and 2016-2017 seasons. The aimed of this study was to evaluate this signal by conducting chart reviews in the 2015-2016 season followed by self-controlled risk interval (SCRI) analyses of chart-confirmed and imputed cases. [In this study, for the 2015-2016 season SCRI analysis, they used chart-confirmed GBS cases. In 2016-2017 season they conducted SCRI analyses of the claims-based GBS cases and attributed GBS cases (based on the positive predictive value (PPV) of the GBS diagnoses obtained by chart reviews in the previous season).Of the 95 chart-confirmed GBS cases, they noted a history of antecedent respiratory or gastrointestinal illness within six weeks prior to onset of GBS symptoms in 47 charts, one of which had a documented history of Campylobacter jejuni. They identified claims for influenza vaccines and vaccines administered concomitantly (pneumococcal, hepatitis B, and tetanus toxoid-containing vaccines) using HCPCS and Current Procedural Terminology (CPT) codes. They conducted influenza infection adjustment using high"" and low"" influenza weeks, which were assigned as such using weekly oseltamivir prescription rates as well as use rates of rapid influenza tests (RIT) followed by an oseltamivir prescription within the subsequent two days]. On unspecified date, the patient had received unspecified 2015-2016 seasonal influenza vaccine (administration route and site unspecified, dosage unknown; batch number not provided). The age of vaccination was not provided. [In this study, the vaccine type (high dose (HD) and standard dose (SD)), and presence of concomitant vaccination. The only HD vaccine administered in both seasons was the inactivated trivalent high dose vaccine (60 mg hemagglutinin per strain). The SD group included inactivated trivalent and quadrivalent (15 mg hemagglutinin per strain) vaccines A total of 13,366,005 Insurance FFS influenza-vaccinated beneficiaries were observed for our SCRI analyses. Of these, 6,936,021 received the HD vaccine, 6,218,036 received the SD vaccines, and the remaining received other influenza vaccines (recombinant, intradermal, and cell-culture based) or only had general influenza vaccine codes but no specific codes for a vaccine type.]. On unspecified date between 2015 and 2016, in between the 8 and 21 days risk window, the patient had diagnosed with the guillain-barre syndrome (GBS) and fisher syndrome (FS) as per the Brighton case definition. [In this study, the primary and secondary risk windows were 1-42 and 8-21 days post-vaccination respectively. They defined exposure as a beneficiary's first influenza vaccination during the season, and outcome as the first occurrence of GBS in the inpatient setting during the post-vaccination window of interest. They used Brighton Collaboration's case definitions for GBS and Fisher Syndrome (FS), a variant of GBS, to classify these cases and considered cases classified as Brighton Level 1, 2, or 3 as chart-confirmed"" GBS cases. For the 2015-2016 season, our claims-based near real-time surveillance using the Updating Sequential Probability Ratio Test (USPRT) first revealed a GBS signal in week 16 of surveillance (as of 29th November 2015) among HD vaccines aged more or equal than 65 years as a risk of GBS in the 0 to 42 day window and as a risk of GBS in the 7 to 21 day window. Of note, in the 2015-2016 season, the 0 to 42 day and 7 to 21 day risk windows were used for near real-time surveillance; however, they changed the risk windows to 1 to 42 and 8 to 21 days post-vaccination for the SCRI analyses and near real-time surveillance for subsequent seasons to better align with the existing literature. In the subsequent weeks they observed a GBS signal in week 26 (as of February 2, 2016) for all beneficiaries vaccinated with all seasonal vaccines as a risk of GBS cases in the 0 to 42 day window. The demographic characteristics of the influenza-vaccinated beneficiaries and the GBS cases in the 2 risk windows. They obtained 133 charts. They found 158 claims-based GBS cases in the 84 days post-vaccination that met our study criteria. All cases except one were identified with the ICD-10 code. Three cases were observed after the January 22, 2016 cut-off, and they requested medical charts for the remaining 155 cases. They obtained 133charts. Of these, they confirmed 95 by chart review as GBS cases. Our analysis showed a PPV of an inpatient diagnosis of GBS in ICD-10. By chart abstraction they found that seven cases identified as GBS by claims had FS noted in the charts. However, none of these seven cases met the criteria for FS and four did not meet the criteria for GBS. Of the remaining three cases, they excluded one due to the subject being noted as less than 65 years of age. They included the remaining two cases in the SCRI analysis. Both cases occurred in the 1 to 42 day risk window; one also occurred in the 8 to 21 day window. Even though these two remaining cases were diagnosed by the physicians as FS, they both had limb weakness in addition to FS features and were thus classified as GBS.].  This case has been considered as serious due to the hospitalization. Treatment was unknown. The outcome of the event was not provided. The authors commented, ""Our SCRI results did not show an excess GBS risk in the 1-42 day risk window either in the overall analysis or in any of the sub-analyses by vaccine type. For the secondary 8-21 day risk window, we found a statistically significant increased GBS for all seasonal vaccines. Our chart-confirmed analysis showed that the attributable risk in the secondary (8-21 day) risk window for all seasonal vaccines was slightly less than one excess GBS case per million vaccines, and that for the HD vaccine was slightly less than two excess cases of GBS per million vaccines. These findings are consistent with the risks noted on the package insert of influenza vaccines distributed. Our secondary analysis finding of a higher GBS risk among males and individuals aged more or equal to 75 years who received seasonal vaccines is consistent with existing literature. We considered the possibility that the difference may be related to egg-based versus recombinant influenza vaccine, which was included in our SD vaccine group"". The author concluded, ""we did not find an excess GBS risk in our primary analysis. The excess risk in some of our secondary analyses was close to what was expected; however, the slightly elevated GBS risk after all seasonal and HD vaccines, but not after standard dose vaccines is hypothesis-generating. This difference between HD and SD vaccines may be related to vaccine factors such as the amount of antigen or the antigen strains in various seasons or related to host factors. The risk of GBS after influenza disease is estimated to be much greater than the potential risk following influenza vaccine, ranging from four to almost 16 times higher, and the benefits of influenza vaccines in preventing morbidity and mortality heavily outweigh this risk. Influenza vaccines continue to be our best defense against influenza disease and the morbidity and mortality associated with it."" This is 1 of the 4 valid cases reported in this literature article.",,,,,Y,,,,U,,,,,UNK,,,,,,USIDBIOMEDICALCORPORATION,2,09/23/2019,,,,
0835297,09/23/2019,VA,60.0,60,,M,,Neuromuscular loss of dexterity of lower extremities occurring the morning after vaccine and following evening resulting in fall with laceration of multiple sites on face. Admitted to Hospital. Admitting physician Dr.,,,,,Y,1,,,Y,09/16/2019,09/17/2019,1,"CTA Neck Head Brain Chest 1V, MRI Brain, CT 3D Recom C Spine, Blood Lab",PHM,,None,None,None,,,2,09/23/2019,,,Y,Caffiene
0835298,09/23/2019,TX,64.0,64,,F,,"INJECTION WAS STARTED IN LEFT ARM, NEEDLE ON HUB WAS LOOSE AND LEAKED OUT THE SIDE.  IMMUNIZATION WAS REGIVEN ON RIGHT ARM.  PATIENT STATES BOTH ARMS ARE SORE AND THERE FEELS LIKE A ""BALL"" IN HER LEFT ARM.",,,,,,,,,U,09/23/2019,09/23/2019,0,,PHM,,,,,,,2,09/23/2019,,,,
0835300,09/23/2019,CA,53.0,53,,M,,"Patient was given influenza shot and pneumonia vaccine.  (pt does not know which pneumonia vaccine) in a different facility. Pt had visit with our provider after going to the ER and leaving before being seen due to wait time. Pt states about 4 hours after receiving the vaccines he had arm pain, headaches, shivers and had a temp of 104 that has since resolved. The back of his head is sore with general headache. His left arm where the injection was has been red and feels a lump, but no spreading red skin rash or pus. No current signs of cellulitis. Pt referred to follow up with primary care provider as well as Doctor on Demand provider. Pt to seek immediate medical attention if persistent temp above 100.6, nausea and vomiting, or severe worsening of your skin condition.",,,,,,,,,N,09/18/2019,09/18/2019,0,N/A,UNK,,Excedrin and Ibuprofen,Unknown,unknown,,,2,09/23/2019,,Y,Y,No allergies
0835301,09/23/2019,VA,41.0,41,,M,,Hard knot (golf ball sized) 1 - 2 hours after injection. Next morning upper left arm swelled to twice normal size. Bicep muscle clearly outlined in red itchy rash moving down forearm. That evening urgent care clinic diagnosed with allergic reaction and infection - steroids and antibiotics prescribed to clear out infection and reaction. 3 days later rash still visible and bicep muscle outlined in bruising of skin.,,,,,,,,,N,09/20/2019,09/01/2019,,,PHM,,"Omneprazole 40mg, culturelle probiotic, vegan multi-vitamin, environmental allergy shots to dust mites, pollen, dog dander",n/a,,,,2,09/23/2019,,Y,Y,"Alpha-gal mammalian meat allergy,"
0835302,09/23/2019,OH,4.0,4,,M,,"Mother noticed redness,swelling posterior left arm at injection site day after vaccines given  when she picked him up from Daycare.  Symptoms became worse over the following 12 hours.  Does have insect bites on L side of trunk and on L forearm.  2 indurated ares noted L posterior upper arm",,,,,,,,,U,09/19/2019,09/20/2019,1,none,PVT,,Lactulose Solution,"cough, insect botes",Autissm,,,2,09/23/2019,,Y,,Amoxicillin
0835303,09/23/2019,MD,72.0,72,,F,,"A KNOT AT SITE OF INJECTION, RED, HOT AND ITCHY.  PT NOTICED WHEN SHE AWOKE NEXT MORNING, STILL HAS IT 4 DAYS LATER. RECOMMENDED ANTIHISTAMINE BUT PT HAD NOT TRIED ANYTHING YET",,,,,,,,,N,09/19/2019,09/20/2019,1,NONE,PHM,,"PANTOPRAZOLE, HCTZ, LOSARTAN, ROSUVASTATIN, VITAMIN D,  ASPIRIN 81MG",NONE,"HIGH BLOOD PRESSURE, CHOLESTEROL","RED, SORE, SWELLING",,2,09/23/2019,,,,NO KNOWN ALLERGIES
0835304,09/23/2019,KY,10.0,10,,F,,"CONCERNS WITH IMMUNIZATION REACTION FROM FLU SHOT, RECEIVED ON WEDNESDAY   an hour later ARM RED, SWOLLEN, BRUISED AND WARM TO THE TOUCH    HURTS WHEN SHE MOVES OR TOUCHES IT    no fevers, no other sick symptoms  Denies any trouble breathing   cool compress to area  no concerns for cellulitis at this time, if redness continues to spread would consider antibiotic",,,,,,,,,U,09/18/2019,09/18/2019,0,N/A,PVT,,No medications.,ALLERGY SYMPTOMS; HAVING TROUBLE IN P.E. W/ ASTHMA  - wheezing,Obesity; Mild Persistent Asthma; Insufficient Sleep Syndrome; Major Depressive Disorder (single episode).,,,2,09/23/2019,,Y,,No allergies.
0835305,09/23/2019,MD,66.0,66,,F,,Nerve pain in the left arm,,,,,,,,,U,09/19/2019,09/20/2019,1,,PHM,,"Esomeprazole, Lipitor, Celebrex",None,"Cholesterol, pain, acid reflux",,,2,09/23/2019,,Y,,Codeine
0835306,09/23/2019,AZ,60.0,60,,F,,"Achiness, chills, fever (101.6), lack of appetite, painful injection site, underarm (nerve?) pain, small pimples at hairline, exhaustion",,,,,,,,,Y,09/19/2019,09/19/2019,0,None,PHM,,"Calcium, Vitamin D, Glucosamine",None,None,,,2,09/23/2019,,,,None
0835307,09/23/2019,NC,12.0,12,,M,,Red area and hot to touch,,,,,,,,,N,09/20/2019,09/21/2019,1,,PVT,,"Zyrtec, Flonase, Lotrisone, Singular, Proair inhaler",none,none,,,2,09/23/2019,,Y,,none
0835308,09/23/2019,CO,66.0,66,,F,,Rapid heartbeat  Weakness  Dizziness Fainting  Difficulty breathing,,,,,,,,,U,08/22/2019,09/22/2019,31,None,PHM,,Levothyroxine Hydrochlorathiazide,None,None,,,2,09/23/2019,,,,Penicillin
0835309,09/23/2019,MI,62.0,62,,F,,"""Pt had the shingles vaccination on the 13th. Last night she noticed her lymph nodes on her L neck feel swollen. She has been feeling body aches and tenderness in her lymph node.""",,,,,,,,,,11/13/2018,11/15/2018,2,,UNK,,"aspirin, Flonase, trandate, creon, anivert, Zofran, imitrex, zanaflex",,,,,2,09/23/2019,,Y,,"codeine sulfate, Lisinopril, sulfa"
0835310,09/23/2019,AZ,63.0,63,,F,,Woke up with ringing in the ears and hot flashes without fever,,,,,,,,,N,09/18/2019,09/19/2019,1,None reported s/s to MD,PUB,,Advil prn,None,None,Reports flu like s/s after flu vaccine age 16; Reports rubella 1 week after MMR,,2,09/23/2019,,,,"Dicloxacillin, Penicillin, dairy,pollen,"
0835311,09/23/2019,MA,68.0,68,,F,,"Initial small rash, size of about 2"" x 2"" south of injection site, increased rash area over the day to eventually a 3-1/2"" x 5"" area with a very small raised ""dot"" kind of near the middle of the initial rash appearance.  Mild headache began around 9:30 pm. the same day.  Increased headache next morning and a feeling of being not quite right.  Mid-afternoon, around 3 pm, felt tired, and really overall sick feeling, but no temperature ? not exactly nausea, but just feeling very tired, sleepy and sick with no appetite. Shooting pains in bottom of feet started in the evening around 6:30 pm,  also aches in right leg bone and both arms.",,,,,,,,,Y,09/15/2019,09/15/2019,0,"Did not contact doctor because 1st dose gave me a small rash, but no other symptoms. Figured the greater reaction was antibodies recognizing the vaccine.  Would have called doctor in morning if symptoms worsened overnight, but in morning, except for the headache and rash, other symptoms mostly subsided and I was not tired anymore.",PHM,,Vitamin D3,No illnesses or colds.,"None other than some mild arthritis, and occasional knee pain associated with two knee operations decades ago.",,,2,09/23/2019,,,,"Allergic to strawberries, melons except watermelon.  Calcium supplements, particularly prescription ones, result in severe heartburn and acid re-flux.  Very sensitive to an array of prescription pain relievers - brings on vertigo.  Very sensitive to anesthesia."
0835312,09/23/2019,WA,16.0,16,,F,,"A couple minutes after the patient received the vaccine, she reported that she ""didn't feel well"" and that she ""could not see"". Pt laid down on the exam table and feet were elevated. Patient became pale and clammy. Vitals were taken and patient was monitored. After about 10 minutes, patient reported she felt better. Color returned to her skin and she returned to normal.",,,,,,,,,Y,08/17/2019,08/17/2019,0,,PVT,,Patient reported not taking any medications at visit,None reported at visit,None reported at visit,,,2,09/23/2019,,,,Patient reported no allergies at visit
0835313,09/23/2019,IA,80.0,80,,F,,Severe redness and swelling at the injection site.,,,,,,,,,U,09/22/2019,09/23/2019,1,NA,PHM,,NA,NA,NA,,,2,09/23/2019,,Y,,NA
0835314,09/23/2019,NJ,70.0,70,,F,,"pt received vaccine 9/17, came in pharmacy 9/23 to show bruised right arm (as result of immunization per patient). pt claimes day after immnuization (9/18) arm was sore and bruised, and has not resolved as of 9/23. c/o soreness, pain, no numbness,tingling, or ""frozen"" feeling.",,,,,,,,,N,09/17/2019,09/23/2019,6,,PHM,,"Baby  Aspirin, breo inhaler, metformin 500mg, pravastatin 40 mg, citalopram 20 mg, amlodipine 10 mg",none,hypertension,,,2,09/23/2019,,,,none
0835315,09/23/2019,FL,77.0,77,,F,,"Patient indicated that Dizziness, Headache, and Blurred Vision started after receiving the flu shot",,,,,,,,,U,09/19/2019,09/19/2019,0,n/a,PHM,,"omeprazole, simvastatin, levothyroxine, enalapril,",n/a,n/a,,,2,09/23/2019,,Y,,nkda
0835316,09/23/2019,MA,72.0,72,,F,,"Temperature for day and a half, achy all over, sore left arm-couldn't move it",,,,,,,,,Y,09/16/2019,09/16/2019,0,n/a,PHM,,,,,,,2,09/23/2019,,Y,,
0835317,09/23/2019,IL,37.0,37,,F,,Numbness/loss of range of motion in arm/shoulder of arm receiving the injection lasting 6-12 hours; weakness in injection arm lasting 2+ days Acute otitis media (bilateral) Diarrhea,,,,,,,,,,09/19/2019,09/20/2019,1,,OTH,,,,,,,2,09/23/2019,,,,DMSO
0835318,09/23/2019,SC,79.0,79,,F,,The patient came into the pharmacy today stating she had been in bed the past two days with little strength. Her left arm was red about 2 inches below the injection site and she stated it was sore to the touch. She said she was feeling a lot better now than she had the last few days.,,,,,,,,,N,09/20/2019,09/20/2019,0,,PHM,,,,,,,2,09/23/2019,,,,
0835319,09/23/2019,GA,55.0,55,,F,,"Patient says she felt very faint and weak about 2 hours after the vaccine was given, and the area around the vaccine became very swollen.",,,,,,,,,Y,09/17/2019,09/17/2019,0,,PHM,,,,,,,2,09/23/2019,,,,Demerol
0835320,09/23/2019,FL,70.0,70,,F,,"Pt states 3-4 weeks after getting shot, she got pustules in right mid section (looked like pimples) that had intense itch, this has persisted till today. pt thought this was not due to shot so she   got  the 2 nd shot 8-21 which made this worse the condition worse.  Pt saw PMD today 9-23, dr feels this is side effect of shot pt received. Pt wrote script for Medrol dose pack",,,,,,,,,N,05/07/2019,06/01/2019,25,none,PHM,,"Plavix, simvastatin, fish oil, b vitamins, MVI (gummy bears)",none,PT had TIA maybe 2-3 years ago,,,2,09/23/2019,,Y,,"NKDA, possible seasonal allergies"
0835321,09/23/2019,WI,82.0,82,,F,,Patient has about a 5 inch red circle around the injection site and heat in that area. She said it was not painful.,,,,,,,,,,09/17/2019,09/17/2019,0,,PHM,,,,,,,2,09/23/2019,,,,
0835322,09/23/2019,NY,63.0,63,,F,,"Pt said she felt a little warm, burning and numb for a few seconds after receiving the flu vaccine but it went away. Later on that night, she felt pain & could not move her arm. She went to see her doctor on 9/23/19 in am. She said she was diagnosed with adhesive capsulitis (frozen shoulder) & due to incorredt flu shot.administration site. She said she would need to see a physical therapist. She was prescribed meloxicam, tylenol & ice pack for her current treatment.",,,,,,,,,N,09/21/2019,09/21/2019,0,Unknown -pt went to see her doctor on 9/23/19 in am,PHM,,Unknown,Unknown,Unknown,,,2,09/23/2019,,,,No known allergies listed
0835336,09/23/2019,OH,,,,U,,"No adverse effects were reported.; the patient received a dose of MMRII which was reconstituted with expired STERILE DILUENT; This spontaneous report was received from a pharmacy technician referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, previously drug reactions, allergies or concomitant therapies were not provided.  On 13-SEP-2019, the patient was vaccinated with a dose of  measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) a dose, for prophylaxis (concentration, dose, frequency and route of administration were not reported; lot number reported as R031679, valid upon internal review, and expiration date reported and determined on 01-NOV-2020). It was reported that the vaccine was reconstituted with expired sterile diluent (MERCK STERILE DILUENT) (concentration, dose, frequency and route of administration were not reported; lot number reported as N011475, valid upon internal review, and expiration date reported and determined on 08-AUG-2019) (expired product administered). No adverse effects were reported.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,,,,,US0095075131909USA005551,2,09/23/2019,,,,
0835337,09/23/2019,AR,,,,F,,"The patient experienced chronic inflammatory demylenating polyneuropathy, Idiopathic Tbrombocytopenic Purpurn(ITP), and gastric bleed after receiving ZOSTAVAX vaccine in 2016"". The patient was hospitalized; The patient experienced chronic inflammatory demylenating polyneuropathy, Idiopathic Tbrombocytopenic Purpurn(ITP), and gastric bleed after receiving ZOSTAVAX vaccine in 2016"". The patient was hospitalized; The patient experienced chronic inflammatory demylenating polyneuropathy, Idiopathic Tbrombocytopenic Purpurn(ITP), and gastric bleed after receiving ZOSTAVAX vaccine in 2016"". The patient was hospitalized; Information has been received regarding a case in litigation involving an approximately 68 year old female patient (pt), reporting herself, with plantar fasciitis and drug reaction/allergy to nalidixic acid (NEGGRAM). Concomitant therapies included eltrombopag olamine (PROMACTA), gabapentin  and pantoprazole (indications not reported).     ""Sometime on 2016"", the pt was vaccinated with a dose of zoster vaccine live (ZOSTAVAX), for singles, in her arm (unspecified) (route, lot/batch # and expiration date were not reported).     It was reported that the pt experienced chronic inflammatory demylenating polyneuropathy (chronic inflammatory demyelinating polyradiculoneuropathy), Idiopathic Thrombocytopenic Purpurn (ITP) (immune thrombocytopenic purpura), and gastric bleed (gastric haemorrhage) after receiving zoster vaccine live (ZOSTAVAX) in 2016. Subsequently, the pt was hospitalized for about two weeks (unspecified date in 2016). The pt had a routine blood work on an unknown date, results not reported. She received immunoglobulin infusion as treatment on an unknown date.   The outcome of chronic inflammatory demyelinating polyradiculoneuropathy, gastric haemorrhage and immune thrombocytopenic purpura was reported as not resolved.  The causality assessment between chronic inflammatory demyelinating polyradiculoneuropathy, gastric haemorrhage and immune thrombocytopenic purpura with zoster vaccine live (ZOSTAVAX) was not reported.   The reporter considered chronic inflammatory demyelinating polyradiculoneuropathy, gastric haemorrhage and immune thrombocytopenic purpura as disabling and life threatening, however, it was also reported that no intervention was need to prevent serious criteria.   Upon internal review, chronic inflammatory demyelinating polyradiculoneuropathy, gastric haemorrhage and immune thrombocytopenic purpura were determined to be medically significant events.",,,Y,,Y,,,Y,N,,,,,UNK,,PROMACTA; gabapentin; pantoprazole,Drug hypersensitivity; Plantar fasciitis,,,US0095075131909USA005703,2,09/23/2019,,Y,,
0835338,09/23/2019,AZ,,17,,F,,"dizziness; vomiting; queasiness; This spontaneous report was received from a pharmacist and refers to a 17 year old female patient. The patient did not have any known allergy, medical history or concomitant medications. On 24-JUL-2019, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) route intramuscular for prophylaxis(lot # and expiration date were not provided). Subsequently, the patient developed dizziness, queasiness with vomiting. No treatment was administered for the adverse event and all symptoms resolved within about 15 minutes with no further sequelae. The reporter did not provide the causality assessment between the aforementioned events and therapy with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL).",,,,,,,,,Y,07/24/2019,07/24/2019,0,,PVT,,,,,,US0095075131909USA008755,2,09/23/2019,,,,
0835339,09/23/2019,NY,71.0,71,,F,,"Sensation of the vaccine running down her arm on the inside of her arm; She experienced soreness; rash near injection site; Possibly some of the vaccine may not have be injected correctly into her muscle; Wrong technique in device usage process; This case was reported by a consumer via call center representative and described the occurrence of injection site leaking in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (1st dose received on 5th March 2019, refer linked case US2019AMR167804).   On 21st May 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 21st May 2019, less than a day after receiving Shingrix, the patient experienced injection site leaking, injection site pain, injection site rash, accidental underdose and wrong technique in device usage process. On an unknown date, the outcome of the injection site leaking, injection site pain and injection site rash were recovered/resolved and the outcome of the accidental underdose was not recovered/not resolved and the outcome of the wrong technique in device usage process was unknown.   It was unknown if the reporter considered the injection site leaking, injection site pain and injection site rash to be related to Shingrix.  Additional information received were as follows: The patient reported that she experienced a sensation of the vaccine running down her arm on the inside of her arm, no medication was visible on the outside of her arm, and believed that possibly some of the vaccine may not have be injected correctly into her muscle, which led to injection site leaking, wrong technique in device usage process and accidental underdose. The patient experienced soreness at injection site and rash near injection site. The patient planned to follow-up with her physician and pharmacy on an unknown date.  The reporter consented to follow up.",,,,,,,,,N,05/21/2019,05/21/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835340,09/23/2019,NC,65.0,65,,M,,"weird in stomach; heavy chest; This case was reported by a pharmacist via call center representative and described the occurrence of upset stomach in a 65-year-old male patient who received Herpes zoster (Shingrix) (batch number 249DB, expiry date 8th November 2021) for prophylaxis.   Co-suspect products included INFLUENZA VIRUS VACCINE INACTIVATED (FLUZONE HIGH DOSE) for prophylaxis.   On 13th September 2019, the patient received the 1st dose of Shingrix (intramuscular) and FLUZONE HIGH DOSE. On 13th September 2019, less than a day after receiving Shingrix and FLUZONE HIGH DOSE, the patient experienced upset stomach and chest heaviness. On an unknown date, the outcome of the upset stomach and chest heaviness were unknown.   It was unknown if the reporter considered the upset stomach and chest heaviness to be related to Shingrix.  Additional information received were as follows: The caller was a pharmacist who administered first dose of Shingrix along with hi-dose flu shot and experienced stomach feeling weird and heavy chest. The caller unable to further define feeling weird in stomach or heavy chest that patient described to her.",,,,,,,,,U,09/13/2019,09/13/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835341,09/23/2019,MN,65.0,65,,F,,"sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In July 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 2 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received first dose of Shingrix about 8 weeks ago and she experienced arm pain that had not resolved. The patient had been seen by her physician due to the pain. Emergency room visit required. The outcome of the event was reported as recovering/resolving in source document but as per narrative the outcome of the event was taken as not recovered/not resolved.",,,,,,,,,N,07/01/2019,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,Y,,
0835342,09/23/2019,PA,18.0,18,,M,,"a lump in his left arm pit; Extra dose administered; This case was reported by a nurse via call center representative and described the occurrence of axillary lump in a 18-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   Previously administered products included Menactra (had Menactra 2 years ago).   On 9th September 2019, the patient received the 1st dose of Menveo (intramuscular). On 9th September 2019, less than a day after receiving Menveo, the patient experienced axillary lump and extra dose administered. On an unknown date, the outcome of the axillary lump was recovering/resolving and the outcome of the extra dose administered was unknown.   It was unknown if the reporter considered the axillary lump to be related to Menveo.  Additional details were provided as follows: The reporter was the mother of the patient. The patient had Menactra 2 years ago from the date of reporting and did not had any issue. The patient received dose of Menveo in the left arm. The reporter stated that, the patient received dose of Menveo past monday of the date of reporting, and developed a lump in his left arm pit, in the night of the day of vaccination. The patient received Menactra 2 years ago and again received Menveo, which led to extra dose administered. The reporter reported that, the lump was decreased some in size. The reporter stated that, the patient needed another dose of Menveo. The patient's mother did call in the event to the physician but hasn't been seen by the doctor. The reporter did not consent to follow up, but open to authiorization form sent later.",,,,,,,,,N,09/09/2019,09/09/2019,0,,PVT,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835343,09/23/2019,TX,70.0,70,,M,,"left arm pain / arm pain at the injection site; pain spread around shoulder; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 70-year-old male patient who received Herpes zoster (Shingrix) (batch number 95XF7, expiry date 29th October 2021) for prophylaxis.   On 22nd August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 22nd August 2019, 1 hr after receiving Shingrix, the patient experienced pain in arm and shoulder pain. On an unknown date, the outcome of the pain in arm and shoulder pain were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and shoulder pain to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. The reporter reported that, after vaccination, the patient experienced pain at the injection site. On 12th September 2019, the patient informed to pharmacist that, the arm pain continued and had spread to the back of the arm and around the shoulder and still persisted The reporter consented to follow up.",,,,,,,,,N,08/22/2019,08/22/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835344,09/23/2019,CT,85.0,85,,F,,"Lyme disease; Supply issue; This case was reported by a pharmacist via call center representative and described the occurrence of lyme disease in a 85-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 30th November 2018, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced lyme disease (serious criteria hospitalization and GSK medically significant) and product supply issue. On an unknown date, the outcome of the lyme disease was recovered/resolved and the outcome of the product supply issue was unknown.   It was unknown if the reporter considered the lyme disease to be related to Shingrix.  Additional details were provided as follows: The pharmacist stated that the patient received the first dose of Shingrix and she had not yet received the second dose, partly due to the supply issue and partly due to hospitalized for about 15 days due to Lyme disease. Lot number was not available at the time of reporting. No further information was provided.  The reporter consented to follow up.",,,,,Y,,,,Y,11/30/2018,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/23/2019,,,,
0835345,09/23/2019,KY,,,,M,,"broke out in flat rashes in the back of his neck and right ear; This is a spontaneous report from a contactable physician.   An infant male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), at single dose, diphtheria vaccine toxoid, hib vaccine conj (tet tox), pertussis vaccine acellular 5-component, polio vaccine inact 3v (mrc 5), tetanus vaccine toxoid (PENTACEL), in right thigh and hepatitis b vaccine in right thigh, all via an unspecified route of administration on an unspecified date for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced broke out in flat rashes in the back of his neck and right ear on an unspecified date with outcome of unknown.  The information on the lot number has been requested.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2019408218,2,09/23/2019,,,,
0835346,09/23/2019,IN,,,,M,,"patient received expired Ipol vaccine; Initial information received on 23-Aug-2019 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 19 years old male patient who received vaccine IPV (VERO) [IPOL] and reported that patient received expired Ipol vaccine (expired product administered).  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A); MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR); and MENINGOCOCCAL VACCINE B RFHBP/NADA/NHBA OMV (BEXSERO).  On 02-Aug-2019, the patient received 1st dose of suspect 0.5 ml IPV (VERO) lot N1F181M and expiry date: 23-Jun-2019 via unknown route in the left deltoid.  It was reported that the vaccine was approximately 5 weeks expired when it was administered.  It was a case of actual medication error due to expired vaccine used.  It was unknown if the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/02/2019,,,,UNK,,HEPATITIS A; MMR; BEXSERO,,,,USSA2019SA239145,2,09/21/2019,,,,
0835347,09/23/2019,IL,,,,U,,"mixed the DTaP/IPV component but did not mix the Acthib portion of this vaccine and administered to a patient, no AE; Initial information received on 26-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a patient of an unknown demographics who received a dose of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot: UJ071AA, expiry date: 13-Jun-2020, route and site of administration were not reported) which was reconstituted incorrectly on an unknown date.  The patient's medical history and concomitant medications were not reported.  It was a case of actual medication error due to inappropriate reconstitution technique. It was reported patient received a dose of Pentacel but did not mix the powder. Only administered the liquid portion from the vial. Mixed the DTaP/IPV component but did not mix the Acthib portion of this vaccine.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA239523,2,09/23/2019,,,,
0835348,09/23/2019,FL,,,,M,,"ActHIB diluent was administered without the Hib lyophilized powder/ No AE; Initial information received on 27-Aug-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case involves a male patient of an unknown age who received 0.5 mL dose of ActHIB diluent without the Hib lyophilized powder (Product preparation error) of vaccine HIB (PRP/T) VACCINE [ACT-HIB] lot UJ112AAC, expiry date- 21-06-2020 via unknown route in unknown administration site on 26-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to Product preparation error.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,08/26/2019,,,,UNK,,,,,,USSA2019SA241924,2,09/23/2019,,,,
0835349,09/23/2019,IL,,,,F,,"Consumer is pregnant and received the Adacel vaccine, no AE; Initial information received on 27-Aug-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves female patient of an unknown age who was received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (batch number, expiry date, dose, route and site of administration were unknown) on an unspecified date, while she was pregnant.  Data regarding this pregnancy were received prospectively i.e. before pregnancy outcome was known.  The date of last menstrual period was not reported.  The estimated due date is 27-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Reporter did not know the dose. She did not receive any other medication or vaccinations.  It was case of vaccine exposure during pregnancy. The patient was pregnant when she received vaccine.  It was unknown whether patient experienced any adverse reaction after the injection.  Pregnancy outcome was unknown at the time of report.  Information on the batch number was requested.  List of documents held by sender- none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA242203,2,09/23/2019,,,,
0835350,09/23/2019,MD,,18,,F,,"flare of mass cell activiation syndrome; Initial information received on 27-Aug-2019 regarding an unsolicited valid serious case received from a non-health care professional  This case involves a 18 years old female patient who experienced flare of mass cell activation syndrome (Condition aggravated), while she received vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] and TUBERCULIN TEST (TUBERSOL).  The patient was found to have an egg and corn allergy and mass cell activation syndrome (mast cell activation syndrome.).  The patient's past medical treatment(s), vaccination(s) and family history were not provided.  On 30-Jul-2019, the patient received a 0.5 ml booster dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6208AB and Exp. Date 08-Jul-2020) via intramuscular route in unknown administration site and was treated with TUBERCULIN TEST (TUBERSOL) (lot number, expiry date, dose, route and site of administration were not reported).  On an unknown date, the patient developed flare of mass cell activation syndrome (condition aggravated) (Unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and TUBERCULIN TEST.   Details of lab data not reported.  Final diagnosis was flare of mass cell activiation syndrome and flare of mass cell activiation syndrome.   It was not reported if the patient received any corrective treatment.  At the time of reporting, the patient did not recover from the event.  Batch number of Tubersol was requested.  List of documents held by sender: none.; Sender's Comments: This case concerns a 18 years old female patient with history of egg and corn allergy and mast cell activation syndrome who developed flare of mast cell activation syndrome after vaccination with MENACTRA and Tubersol. The time to onset is unknown. However, Lab tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.",,,,,,,,,N,07/30/2019,,,,UNK,,TUBERSOL,Egg allergy; Food allergy; Mast cell activation syndrome,,,USSA2019SA242214,2,09/23/2019,,,,
0835351,09/23/2019,OH,,17,,M,,"they gave a 17 yr old FluBlok/ no AE; Initial information received on 27-Aug-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 17 years old male patient who received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] and reported that they gave a 17 year old Flublok/ no AE (product administered to patient of inappropriate age).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MENINGOCOCCAL VACCINE A/C/Y/W CONJ (DIP TOX) (MENACTRA).  On 20-Aug-2019, the patient received a dose of suspect 0.5 ml INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot QFAA1901 and expiry date: 17-May-2020 via intramuscular route in the right arm.  It was a case of actual medication error due to inappropriate age at vaccine administration.  No adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/20/2019,,,,UNK,,MENACTRA,,,,USSA2019SA242420,2,09/21/2019,,,,
0835352,09/23/2019,LA,39.0,39,,M,,"Patient received the vaccine which had been shipped more than 2 days/ No AE; Initial information and additional information received on 27-Aug-2019 regarding an unsolicited valid non-serious case received from  other health professional.  This case is linked to case 2019SA241338 and 2019SA243238 (same reporter).  This case involves a 39 years old male patient who received 0.5 mL dose of vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] lot number UJ211AA expiry date 30-JUN-2020 not reported via intramuscular route in the left deltoid on 27-Aug-2019 the vaccine that was shipped more than 2 days.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to incorrect product storage.  There were no Side Effects.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,08/27/2019,,,,UNK,,,,,,USSA2019SA243159,2,09/23/2019,,,,
0835353,09/23/2019,LA,,74,,M,,"a 74 years old male patient received a dose of Fluzone HD which had been shipped more than 2 days thus not valid/No AE; Initial information received on 27-Aug-2019 and additional received on 28-Aug-2019 regarding an unsolicited valid non-serious case received from an other health care professional.  This case is linked to cases 2019SA243159 and 2019SA241338 (same reporter).  This case involves a 74 years old male patient who a 0.5 ml received a dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HD] which had been shipped more than 2 days thus not valid lot UJ221AB, expiry date: 01-APR-2020 via intramuscular route in the left deltoid on 26-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to incorrect product storage.  No side effects.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/26/2019,,,,UNK,,,,,,USSA2019SA243238,2,09/23/2019,,,,
0835354,09/23/2019,AK,49.0,49,,M,,"a patient received IPOL intradermally instead of Tubersol as intended, no AE; Initial information received on 27-Aug-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 49 years old male patient who received 0.1 mL dose of vaccine IPV (VERO) [IPOL] lot P1A171M via intradermal route in the left arm on 26-Aug-2019 instead of TUBERCULIN TEST [TUBERSOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  no other vaccines received.  It was a case of actual medication error due to wrong vaccine administered. Medical assistant stated that a vial of IPOL was in a bin with Tubersol and administered interdermally to the patient instead of Tubersol.  It was unknown whether the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,08/26/2019,,,,UNK,,,,,,USSA2019SA243340,2,09/23/2019,,,,
0835355,09/23/2019,NY,18.0,,,F,,"student received 2 dose, 6 weeks apart, no AE; Initial information received on 27-Aug-2019 regarding an unsolicited valid non-serious case received from other health professional.  This case involves an 18 years old female patient who received vaccine DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] and reported that student received 2 dose, 6 weeks apart (inappropriate schedule of product administration).  The patient's past medical history, medical treatment(s), vaccination(s), and family history were not provided.  Concomitant medication included TUBERCULIN PPD.   On 16-Jul-2019, the patient received 1st dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT lot number not reported via unknown route in unknown administration site. On 27-Aug-2019 she also received 2nd dose of the same vaccine 0.5 ml DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT lot U6021AA and expiry date: 29-Jul-2020 via unknown route in the right deltoid.  It was a case of actual medication error due to inappropriate schedule of vaccine administered.  It was unknown if the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,07/16/2019,,,,UNK,,PPD DISPOSABLE,,,,USSA2019SA243353,2,09/23/2019,,,,
0835356,09/23/2019,MO,0.33,0,.3,M,,"a four months old male patient was received the liquid DTaP and IPV of the Pentacel vaccine with out Lyophilizing ActHIB powder/No AE; Initial information received on 27-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a four months old male patient who received the liquid DTAP and IPV of the DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] vaccine without lyophilizing ACT-HIB powder dose (Product preparation issue): 0.5ml, lot UJ014AAA, expiry date: 10-OCT-2020 via intramuscular route in the right thigh on 26-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVENAR 13) and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ).  It was an actual medication error due to inappropriate reconstitution technique (Product preparation issue).  It was unknown if adverse event occurred or not.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/26/2019,,,,UNK,,PREVENAR 13; ROTATEQ,,,,USSA2019SA243362,2,09/23/2019,,,,
0835357,09/23/2019,MA,,,,F,,"left arm pain; limited mobility; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a female patient of unknown demography who experienced left arm pain (pain in extremity) and limited mobility (mobility decreased), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, following the vaccination the patient experienced left arm pain (pain in extremity) and limited mobility (mobility decreased).  (Other relevant tests included no lab data.)  Final diagnosis was pain in arm and mobility decreased.  It was not reported if the patient received a corrective treatment.  The outcome of the events was unknown at the time of reporting.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA249967,2,09/21/2019,,,,
0835358,09/23/2019,NY,,0,.4,M,,"expired dose of Pentacel was inadvertently administered to a patient, no AE; Initial information received on 16-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 4 months old male patient who inadvertently administered with 0.5 ml dose of expired vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot: C5466AB, Expiry Date: 05-Sep-2019) via intramuscular route in the right thigh on 16-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccinations included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) for Immunisation.  It was an actual medication error due to expired vaccine used.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/16/2019,,,,UNK,,PREVNAR; ROTATEQ,,,,USSA2019SA259790,2,09/23/2019,,,,
0835360,09/23/2019,TX,,29,,F,,"oozing at site, it was like an open wound; bump at injection site larger than usual; bruising at injection site; pregnant patient vaccinated with Adacel; Initial information received on 16-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to case 2019SA260889 (same reporter).  This case involves a 20 years old female patient who experienced oozing at site, it was like an open wound (Vaccination site discharge), bump at injection site larger than usual (vaccination site mass) and bruising at injection site (vaccination site bruising), while she received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] in pregnancy.  Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known.  The reported events occurred at unknown gestation period. The date of last menstrual period was not reported but reported as 31 weeks ago. The estimated due date is 10-Nov-2019.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 10-Sep-2019, the patient received a 0.5 mL first dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot C5602AA, expiry date: 19-Mar-2021 via intramuscular route in the left deltoid.  On an unknown date, the patient developed a non-serious oozing at site, it was like an open wound (Vaccination site discharge), bump at injection site larger than usual (vaccination site mass) and bruising at injection site (vaccination site bruising) (Unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  It was also a case of vaccine exposure during pregnancy.  Other relevant tests were not reported.  Final diagnosis was oozing at site, it was like an open wound (Vaccination site discharge), bump at injection site larger than usual (vaccination site mass) and bruising at injection site (vaccination site bruising).  Patient was advised to keep site clean and dry and take Benadryl. Keep eye on sute in case fever, growing in size and then go to ER if needed.  The outcome of the events was not reported.  Additionally, at time of reporting, the outcome of the pregnancy was unknown.  List of documents held by sender: none.",,,,,,,,,U,09/10/2019,,,,UNK,,,,,,USSA2019SA260880,2,09/23/2019,,,,
0835361,09/23/2019,TX,,20,,F,,"oozing at site, it was like an open wound; bump at injection site larger than usual; bruising at injection site; pregnant patient vaccinated with Adacel; Initial information received on 16-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to case 2019SA260880 (same reported).  This case involves a 29 years old female patient who experienced oozing at site, it was like an open wound (Vaccination site discharge), bump at injection site larger than usual (vaccination site mass) and bruising at injection site (vaccination site bruising), while she received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known.  The reported events occurred at unknown gestation period. The date of last menstrual period was not reported but reported as 27 weeks ago. The estimated due date is 04-Dec-2019.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 10-Sep-2019, the patient received a 0.5 mL first dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot C5602AA, expiry date:19-Mar-2021 via intramuscular route in the left deltoid.  On an unknown date, the patient developed a non-serious oozing at site, it was like an open wound (Vaccination site discharge), bump at injection site larger than usual (vaccination site mass) and bruising at injection site (vaccination site bruising)  (Unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  It was also a case of vaccine exposure during pregnancy.  Other relevant tests were not reported.  Final diagnosis was oozing at site, it was like an open wound (Vaccination site discharge), bump at injection site larger than usual (vaccination site mass) and bruising at injection site (vaccination site bruising).  It was not reported if the patient received a corrective treatment.  The outcome of the events was not reported.  Additionally, at time of reporting, the outcome of the pregnancy was unknown.  List of documents held by sender: none.",,,,,,,,,U,09/10/2019,,,,UNK,,,,,,USSA2019SA260889,2,09/23/2019,,,Y,
0835362,09/23/2019,CA,1.5,,,M,,"delayed in transit/no AE; Initial information received on 16-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked with 2019SA260949.  This case involves a 18 month old male patient who received 0.5 ml dose vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (lot: UT6645LA, expiry date:30-Jun-2020) via intramuscular route in the left thigh), on 13-Sep-2019 which was delayed in transit.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Contamination therapy included Pentacel on 13-Sep-2019.   It was an actual medication error due to Incorrect product storage.  It was unknown if any adverse event occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,PENTACEL,,,,USSA2019SA265062,2,09/23/2019,,,,
0835363,09/23/2019,MI,50.0,50,,F,,"redness, hardness, hotness in a large circle around the injection site",,,,,,,,,U,09/19/2019,09/01/2019,,,PHM,,,,,,,2,09/23/2019,,,,
0835364,09/23/2019,MA,65.0,65,,F,,"After vaccine administration, patient was bleeding from site and a bump under the skin was left on deltoid muscle.",,,,,,,,,U,09/23/2019,09/23/2019,0,,PHM,,,,,,,2,09/23/2019,,,,
0835365,09/23/2019,MO,73.0,73,,F,,"Patient received Tdap vaccination and had fever for a day then the fever went away.  The day after vaccination she had arm pain and had limitation in range of motion til today, 9/23/19.",,,,,,,,,N,09/14/2019,09/15/2019,1,,PHM,,Patient received Tdap vaccination on 9/14/2019.  She came back to pharmacy to report the adverse reaction on 9/23/19.  She had fever the day after vaccination for a day.  She also complains that her vaccinated arm has limitation in range of,Patient says that she did not have issue before vaccination,,,,2,09/23/2019,,,,
0835366,09/23/2019,MD,34.0,34,,F,,"Within 5 minutes of injection, Dr. complained of a sensation of coldness going down the arm to the hand.  When checked on roughly 15 minutes later, reported numbness that started at anterior crease of the elbow that continued to the palm of the hand and the posterior aspect of the hand.  Mobility not affected.  Followed up roughly one hour post injection.  Reported no change.",,,,,,,,,,09/23/2019,09/23/2019,0,,OTH,,Uncertain,,,,,2,09/23/2019,,,,
0835367,09/23/2019,SC,73.0,73,,F,,"patient felt feverish, had a red, tender and inflamed area a little smaller than the size of a baseball at injection site. Patient went to urgent care 9/22/19 and was given triamcinolone cream and told to mark red area and contact primary care doctor if it enlarged and also to come tell us.",,,,,,,,,N,09/20/2019,09/21/2019,1,,PHM,,atorvastatin,,,,,2,09/23/2019,,,Y,nka
0835368,09/23/2019,KS,57.0,57,,F,,"Patient said that she developed a hive about 3-4 inches in size that was warm, red, and gradually growing late Saturday evening. Today (Monday) she reported that it had grown to about 5-6 inches. She was going to the doctor today for an appointment and was going to have it checked out. Patient also reported a low grade fever that she was taking advil for.",,,,,,,,,U,09/21/2019,09/21/2019,0,none available,PHM,,"Lipitor, metoprolol, pantoprazole, hydrochlorothiazide, flublok quad (given same day)",none reported but patient did take zpak 24 days ago,patient did not report any,,,2,09/23/2019,,Y,,"latex, nitrofurantoin, sulfa"
0835369,09/23/2019,FL,59.0,59,,F,,"patient reporting redness, warness, and difficulty raising arm over head. Called pharmacy to report adverse event. Informed patient needed to seek treatment if does not improve.",,,,,,,,,N,09/22/2019,09/22/2019,0,Dr appointment tomorrow 9/24 with dr,PHM,,"albuterol hfa, pantoprazole, levothyroxinem, fluticasone-salmeterol, losartan",none,n/a,,,2,09/23/2019,,Y,,"qbrelis, ace inhibitors"
0835370,09/23/2019,PA,56.0,56,,F,,"tingling and prickling on skin,  doctor confirmed shingles",,,,,,,,,Y,09/21/2019,09/22/2019,1,,PHM,,,,,,,2,09/23/2019,,Y,,
0835371,09/23/2019,,54.0,54,,F,,"Arm tenderness, arm ache (dull ache), loss of strength in arm, very limited range of motion. Loss of sleep due to ache.",,,,,,,,,N,09/10/2019,09/10/2019,0,,PVT,,,,,,,2,09/23/2019,,,,
0835372,09/23/2019,MI,52.0,52,,F,,"Patient perceived about shore arms, shorness of breath and chest pain and feeling very uncomfort",,,,,,,,,Y,09/21/2019,09/21/2019,0,none,PHM,,not known,not known,"Thyroid Disorder, Asthma,",,,2,09/23/2019,,Y,,not known
0835373,09/23/2019,KY,30.0,30,,F,,"SOME RED AND SLIGHTLY SWOLLEN AT THE INJECTION SITE THE NEXT MORNING. NO DISCOMFORT REPORTED. I ASKED THE PATIENT TO CONTACT ME THE NEXT DAY IF THE AREA HAS NOT IMPROVED. I DID NOT RECEIVE A CALL BACK FROM HER. I REACHED OUT TO HER TODAY AGAIN, BUT WAS UNABLE TO SPEAK WITH HER.",,,,,,,,,U,09/18/2019,09/19/2019,1,N/A,PHM,,N/A,CONFIRMED NO ILLNESS,CONFIRMED NONE,,,2,09/23/2019,,,,CONFIRMED NO ALLERGIES
0835374,09/23/2019,OR,13.0,13,,F,,"Pt looked like she had fallen asleep and slumped in the chair. After arousing her, her skin turned green/grey. She reported dizziness, ringing in her ears, and nausea. Pt was given water to sip, a sucker, and observed for approximately 20-30 minutes. Mother took pt home after observation period. I followed up on 9/21/19 with a phone call. Mom was not home but pt was reported to be fine.",,,,,,,,,Y,09/20/2019,09/20/2019,0,,PHM,,,,,,,2,09/23/2019,,,,amoxicillin
0835375,09/23/2019,AZ,82.0,82,,M,,"Patient reported experiencing arm redness that started at the upper arm where the vaccine was given and spread down to the elbow. He said that it felt warm to the touch, but was not overly painful. He denied having a fever or any sort of open sores on the arm.  Pharmacist told patient to go see his doctor for follow up to monitor",,,,,,,,,U,09/21/2019,09/22/2019,1,none as of this time,PHM,,"EZETIMIBE 10MG, TRIAMT/HCTZ 37.5-25 MG, GABAPENTIN 300MG",NONE,"HYPERTENSION, HYPERCHOLESTEREMIA",,,2,09/23/2019,,Y,,NONE
0835376,09/23/2019,VA,34.0,34,,F,,"Pt was given Tdap (unknown manufacturer however above field was required. Pt will call  hospital for specific manufacturer.) the day after delivering her child at Hospital. She woke the next morning with complaint of inability to use L arm. States she couldn't move her L arm and had severe shooting pain into L arm for ADLs. States this severity lasted about 2 months then use of arm slightly improved. Now complains of diffuse pain, weakness and fatigue throughout B hips and lower extremities. Continues with sharp pain and weakness in L shoulder. Complains about constant aching in wrists and arm as well as generalized fatigue.  After consultation with primary care, orthopedics, and rheumatologist pt was referred to Physical Therapy to address shoulder pain and weakness.",,,,,,,,Y,N,04/07/2019,04/08/2019,1,L shoulder MRI- negative for tear in shoulder  however demonstrated inflammation   (per patient report) and supraspinatus tendinosus.  X-Ray - negative,PVT,,Pre-Natal Vitamin,,,,,2,09/23/2019,,Y,,Sulfa
0835377,09/23/2019,OR,54.0,54,,F,,"2 hours after receiving the vaccine, patient complained of right shoulder pain and immobility, and tingling in right arm",,,,,,,,,U,09/23/2019,09/23/2019,0,,PVT,,"levothyroxine, metformin",n/a,"Diabetes type II, hypothyroidism, Coronary artery disease",,,2,09/23/2019,,Y,,Penicillins
0835378,09/23/2019,NJ,71.0,71,,F,,"Immediate swelling in arm and mild bruising. Had the patient sit for 20 minutes or so to ensure she was okay.  Followed up with patient the following day and  the patient explained she had some nausea, headache, and vomiting after eating dinner that night. The headache persisted for 2 days as well. Other than bruising, all other side effects were gone when I followed up on 9/23/19. Her arm was feeling fine just bruising at injection site remained.",,,,,,,,,Y,09/18/2019,09/18/2019,0,"Nothing necessary, just follow up by pharmacy",PHM,,,,,,,2,09/23/2019,,,,
0835379,09/23/2019,CA,56.0,56,,F,,"local redness, soreness, swelling, warmth inside the body, diarrhea.",,,,,,,,,Y,09/20/2019,09/21/2019,1,,PHM,,"Proventil, Symbicort, Tramadol,  Metformin, Cyclobenzaprine, Atorvastatin.",No,No,,,2,09/23/2019,,,,Fibrates Codeine Gabapentin
0835380,09/23/2019,AK,69.0,69,,M,,Patient came in today and mentioned that his right arm felt sore and warm after receiving the Flu-HD vaccine on the 17th. He also reported that a few days later that arm felt even more sore at the joint especially when he tried to raise his arm.,,,,,,,,,N,09/17/2019,09/21/2019,4,,PHM,,"metformin, lisinopril, gabapentin, Lipitor, lantus",,"DM, HBP",A pneumonia vaccine,,2,09/23/2019,,,,"Thimerosal, Latex"
0835381,09/23/2019,CA,68.0,68,,F,,"The patient states she has raised and ""blood red"" skin from right upper shoulder down to elbow area.  It is hot to the touch.  The left arm is sore but has no swelling or redness (Adacel only).  The patient states she got the same reaction last year, but included more swelling.  Last year she received the flu vaccine from the doctor's office.  She noted this prior to receiving the shot but thought perhaps it was the doctor's office that was the issue as she received it before, multiple times, from another pharmacy, with no issues.  The patient has been taking Benadryl for the swelling.   It has now been 5 days from the injections.",,,,,,,,,N,09/19/2019,09/20/2019,1,N/A,PHM,,Topiramate 100 mg/day.,N/A,"Hypothyroidism, Hypertension, Hormone deficiency, Rhinitis, muscle spasms, ulcers, depression, pain.","Last year, she states she got a reaction from the flu shot from the doctor's office.  The brand is unknown but she states it was",,2,09/23/2019,,,,"Sulfa antibiotics, corticosteroids, penicillins, NSAIDs, codeine, quinolone antibiotics, acetaminophen.  All were listed as ""mild allergy"" by the patient."
0835382,09/23/2019,WV,72.0,72,,F,,"Patient reported high fever (did not take her temp), chills, flushing, vomiting, diarrhea, muscle aches.  Lasted approximately 36 hours.  No medical treatment was sought.  The symptoms were gradual onset and gradual increase in intensity.",,,,,,,,,Y,09/17/2019,09/18/2019,1,,PHM,,"Lovastatin, lisinopril, valacyclovir, lotemax",,,,,2,09/23/2019,,,,
0835383,09/23/2019,MI,61.0,61,,F,,Patient received Fluad for 65+ when not over 65 yo.,,,,,,,,,,09/23/2019,09/23/2019,0,,PHM,,,,,,,2,09/23/2019,,,,
0835384,09/23/2019,IN,26.0,26,,F,,"Employee has erythema and warmth at site of second Hep-B immunization, some localized pain and tenderness.",,,,,,,,,N,09/21/2019,09/22/2019,1,None,OTH,,Zolmitriptan,None,"IBS, Migraines, Psoriasis",,,2,09/23/2019,,,,"Tramadol, Cinnamon"
0835385,09/23/2019,WA,63.0,63,,F,,Patient showed up and showed us her arm today 9/23/2019.  It was red at the location of the shot. She said it was itchy and hot.  She was advised to follow up with Dr whose information was provided in this form (her primary care doctor). We do not know if the patient will follow up with the doctor or not. We do not know the outcome.,,,,,,,,,U,09/17/2019,09/18/2019,1,,PHM,,,,hypertension,,,2,09/23/2019,,,,
0835386,09/23/2019,MA,47.0,47,,F,,"Immediate severe dizziness, lightheaded, weakness, couldn?t stand, turned pale. Had to sit down and wait 20 minutes before I could leave the store. Felt weak and general malaise for 24 hours.",,,,,,,,,Y,09/18/2019,09/18/2019,0,None,PHM,,"Acetazolamide, Aczone, Concerta ER, Pristiq, Lunesta, Gabapentin, Lamotrigine, Linzess, Methocarbamol, Lopressor, Omeprazole,  Zofran, Fiber",Common Cold,"Fibromyalgia, IBS, acid reflux, ADHD, depression, anxiety, migraines, GIST, heart palpitations",,,2,09/23/2019,,,,"Minocycline, Restoril,  Ceftriaxone"
0835387,09/23/2019,ME,61.0,61,,F,,Rash developed about 1 - 2 inches below the site of injection,,,,,,,,,,09/19/2019,09/21/2019,2,,PHM,,,,,,,2,09/23/2019,,,,
0835389,09/23/2019,,56.0,56,,F,,"Moderate arm pain, chills, nausea, tiredness, low-grade fever - within 24 hours",,,,,,,,,Y,09/22/2019,09/22/2019,0,,PHM,,"Levothyroxin, pravastatin, acetazolimide, aspirin",None,Hypothyroidism,"Headache, muscle pain, tiredness, chills, nausea, fever, 56, Jun 25, 2019, Shindrix vaccine #1",,2,09/23/2019,,,,None
0835390,09/23/2019,GA,69.0,69,,F,,"Patient states that very early the next morning she had extreme chills.  When she woke up the next AM she had aches everywhere.  She said after taking Tylenol, the aches were tolerable.  What she was most concerned about was that early Monday AM ( 1 and 1/2 days post vaccination)  she had lots of itchy red spots on her chest and arm.  She also said her lips felt very rough and a little bit tingly. She said that they were not swollen and that her tongue was not involved.  She presented at the pharmacy 9/23/19 at 6PM and had multiple red, blotchy spots on her left arm about 3 inches below the injection site. She asked if she could take Benadryl and I said yes that she should take.   Patient did not want to run to urgent care and said thought not getting worse but I did tell her if her tongue or any part of her face was to start to swell to seek immediate help./",,,,,,,,,U,09/21/2019,09/22/2019,1,,PHM,,"diclofenac, paxil, protonix",no,none,,,2,09/23/2019,,,,NKDA
0835391,09/23/2019,MT,37.0,37,,F,,"The patient elected to have the flu shot in her left arm, which has been amputated just below the elbow.  The patient is reporting nerve pain in the entire arm following the flu shot.  She also uses a diabetic freestyle libre sensor on this arm as well.",,,,,,,,,U,09/12/2019,09/12/2019,0,Patient went to walk in clinic on 9-19/20-2019 and was told it was just painful from the immunization.  She visited primary care provider on 9-23-19 and was told it was SIRVA and given voltaren for the pain.  She has consults with PT and ortho pending establishment at this point for further follow up.,PHM,,"Freesyle libre, letrozole, progesterone, fioricet",,Amputee of left arm,,,2,09/23/2019,,Y,,"gabapentin, morphine, penicillin, tetracycyline"
0835392,09/23/2019,NH,45.0,45,,F,,"Patient received flu shot.  A few minutes later while waiting to check out at register, she fainted.  When she fell she bumped her head above her eye.  She was unaware she had fainted, but she immediately regained consciousness.  She then claimed to feel ""queezy"". Patient was brought into back and laid down for around 30 minutes.  Was given water and an ice pack for her head wound.  Her pulse was normal and her blood pressure was normal.  She later explained she felt a pain in her arm before fainting.  She was planning to go to an urgent care facility to be checked when she left.",,,,,,,,,U,09/23/2019,09/23/2019,0,,PHM,,None apparent,None,None,,,2,09/23/2019,,Y,,NKDA
0835393,09/23/2019,,70.0,70,,F,,"The patient described a rash that was warm to the touch, and spread from arm to neck and breast areas. She gets the flu shot every year and never had a reaction in the past, so she believes it may be due to Boostrix. She will be following up with her PCP tomorrow to have rash checked.",,,,,,,,,,09/21/2019,09/23/2019,2,,PHM,,,,,,,2,09/23/2019,,Y,,
0835394,09/23/2019,NJ,78.0,78,,M,,Patient reported that he is having a hard time/discomfort raising his left arm when the vaccination was administered and having a soreness at the site of injection.,,,,,,,,,N,09/15/2019,09/15/2019,0,None,PHM,,"Xarelto 20mg, latanoprost 0.0005%, dutasteride 0.5mg, tamsulosin 0.4mg, levothyroxine 25mcg, metformin ER 500mg, lisinopril 5mg, allopurinol 300mg",Not known,"heart condition, prostate condition, glaucoma, hypothyroidism, diabetes, high blood pressure, gout, arthritis",,,2,09/23/2019,,,,None
0835395,09/23/2019,HI,15.0,15,,F,,"About 1/2 after receiving the shots my daughter started to complain that she was experiencing traveling numbness.  First her arm, then her leg.  She said the sensations kept moving around her body. Within an hour she was having blotches in her vision and felt extremely nauseated and was struggling to walk.  She became very weak and achy.   A doctor friend said it was somewhat normal and that she should lay down for a bit.  After about another hour she started to feel somewhat normal again.  She did complain of her hand bothering her several times on several different days.  Two months later she was at the ER 3 times for seizures and then hospitalized for 2 weeks.  Her diagnoses was anti-NMDA receptor encephalitis.  She is still in recovery.  The doctors do not know why or how the encephalitis occurred.  several of the symptoms mimicked what occurred after the vaccines were given but on a much more intense scale.",,,,,Y,14,,,U,05/07/2019,05/07/2019,0,,PVT,,,,,,,2,09/23/2019,,,Y,
0835396,09/23/2019,GA,67.0,67,,F,,"Redness, rash, warm to the touch, soreness all the way to the armpit. Patient was told to put a cold compress on the site as well as take Benadryl.",,,,,,,,,U,09/21/2019,09/23/2019,2,,PHM,,N/A,N/A,Dyslipidemia Hypertension,,,2,09/23/2019,,Y,,NKDA
0835397,09/23/2019,AZ,61.0,61,,F,,"patient presented to pharmacy 9-23-19 concerned with reaction having after vaccine.  She reported and showed visible signs of left arm swelling, pain and hot to the touch of vaccinated arm.  She also reported experiencing itching to arm vaccinated and left side of upper back.  I counseled patient that she appeared to be having an adverse event from the vaccination and should see a doctor to confirm as well as get further possible treatment.  Patient was seen in office at urgent care, given steroid injection and prescription for 5 day course of steroids.  I phoned patient to follow up and she informed me that the doctor believed she was having an allergic reaction to the vaccine as well and informed me of treatment.  As of now her symptoms remain the same, patient only received injection a few hours ago.",,,,,,,,,N,09/21/2019,09/22/2019,1,,PHM,,none that aware of,none,Asthma,,,2,09/23/2019,,Y,,none
0835398,09/23/2019,WV,66.0,66,,M,,"Patient got bad 4.5 inch bruise in arm that he got a fluzone HD in. He could move his arm, but the pain made it hard to sleep. Pain is improving now. He ran a low grade fever for about a week which is gone now.",,,,,,,,,Y,09/16/2019,09/16/2019,0,N/A,PHM,,"indomethacin 25mg, olmesartan 40, allopurinol 300mg, triamcinolone 0.1%, ketoconazole 2%.",N/A,"gout, hypertension, rash.",,,2,09/23/2019,,,,N/A
0835399,09/23/2019,KS,68.0,68,,F,,"Patient reported severe chills (described by patient as ""shaking the bed""), fever, headache, nausea, fatigue starting about 6 hours after administration of Shingrix and Fluzone High dose.  The  fatigue, fever and headache continued into the following day. The patient treated symptoms with over-the-counter ibuprofen.",,,,,,,,,Y,09/11/2019,09/11/2019,0,,PHM,,"Levothyroxine 25mcg daily, Simvastatin 20mg daily",No illnesses,None,,,2,09/23/2019,,,,No known allergies
0835400,09/23/2019,AL,72.0,72,,F,,Rectangular red and puffy underneath injection site of Pneumovax 23 beginning 2 inches below injection site and ending 1 inch above the elbow crease. Slightly warm to the touch.,,,,,,,,,U,09/21/2019,09/22/2019,1,None,PHM,,Digoxin  125mcg daily Omeprazole  10mg Daily,None,Arrhythmias Acid reflux,,,2,09/23/2019,,,,Phenazopyridine
0835401,09/23/2019,AL,65.0,65,,F,,Large eyrthematous rash covering the entire deltoid area of the right arm. Upper area clearing up with the lower area still beefy red.,,,,,,,,,N,09/18/2019,09/19/2019,1,,PHM,,,,,,,2,09/23/2019,,,,"latex, cipro"
0835402,09/23/2019,FL,72.0,72,,F,,Patient had no adverse reaction to the first Shingrix vaccine which was 1 year ago.  Her arm was very sore on Day 1 after the vaccine but no other symptoms.  On day 2 she noticed that it itched about 1 inch below and to the left of where the vaccine was given.  When she stopped by to see us today on day 3 the area was red and warm and was approximately 2 inches wide by 3 inches long.  It was itching and burning.  Advised her to use ice/cool pack on it and possibly try some topical hydrocortisone.  Will call her to follow up again in 2 days.  Explained that although this is not terribly common it is in the package literature.,,,,,,,,,N,09/20/2019,09/22/2019,2,,PHM,,Did not confim,none,did not confirm,,,2,09/23/2019,,,,acetaminophen
0835403,09/23/2019,NJ,87.0,87,,M,,"Patient experienced erythema and swelling from his shoulder all the way down to his knuckles.  He said his shoulder was tender and he had a burning sensation.  When he came today (9-23-19), there was mild erythema with swelling;  the swelling near the wrist and hand was very pronounced.  The patient said he had the shot on 9-19-19 and the side effect occurred on 9-20-19.    He started an antibiotic on 9-21-19.   Today, he was evaluated by his pcp and they started him on a Medrol dose pack.  If his arm is not better tomorrow, he will be getting a Doppler done.",,,,,,,,,N,09/18/2019,09/19/2019,1,9-21-19  Patient started an antibiotic 9-23-19 Patient was seen by a primary care md and prescribed a Medrol dose pack with instructions to get a Doppler tomorrow if the swelling is not improved.,PHM,,"dicylomine 10, furosemide 20",,"copd, heart disease, lung disease, has a pacemaker",,,2,09/23/2019,,Y,,"penicillin, iodine, doxycycline"
0835404,09/23/2019,FL,67.0,67,,M,,"09/20/2019 vaccine was delivered. 09/21/2019 patient noticed dark spots on the same arm but not at the injection site. About 7 dark spots looking like  burn spots dime to quarter size. No pain, no itching. Patient reported to the pharmacy on 09/23/2019. The spots did not change in size but started to become look not as dark as first day. Pharmacist recommended to call PCP. I am not sure if it is a side effect of vaccination or co-incidence. Injection site looks normal, no skin reaction, may be slightly swollen but it is hard to say because skin of the deltoid muscle looks absolutely normal.",,,,,,,,,N,09/20/2019,09/21/2019,1,NA,PHM,,"vaccination , Shingrix Vaccine",Diabetes,Diabetes,,,2,09/23/2019,,Y,,No
0835405,09/23/2019,TX,75.0,75,,M,,Patient complained of rash on back that itches when in hot climate/setting for the past four days.  They look like 4 red bug bites.  I strongly recommended that he follow-up with his physician to determine if it is possibly something un-related to the vaccine components since he has been working outside.,,,,,,,,,U,09/16/2019,09/19/2019,3,,PHM,,,,,,,2,09/23/2019,,,,none on file
0835406,09/23/2019,TX,72.0,72,,F,,"Fever, muscle pain, stomach pain, headache Tiredness",,,,,,,,,N,09/22/2019,09/22/2019,0,,PHM,,Levothyroxine,,,,,2,09/23/2019,,,,Codeine
0835407,09/23/2019,GA,58.0,58,,F,,Sharp and throbbing pain upon certain  movement that has lasted from 8/8/19 till present time,,,,,,,,,N,08/08/2019,08/08/2019,0,N/a,PHM,,N/a,N/a,N/a,,,2,09/23/2019,,,,N/a
0835408,09/23/2019,LA,34.0,34,,F,,Bumpy blister type rash at injection site,,,,,,,,,U,09/12/2019,09/23/2019,11,None. Visual test conducted by the Urgent Care,MIL,,"Xanax, BC Powder Arthritis, allergy medicine off brand claritin","Aug 21 steroid injections in both shoulders for pain, burning, numbness in shoulders and neck.  MRI -Neck pain buldged disc, degenerative disc and bone surrounding disc, arthritis in spine, Depression, Anxiety, welbutrin, gabapentin, flexeril, prescription. Restricted blood flow to brain(aspirin, prescribed plavix- did not take) knee pain arthritis.","Both shoulders- pain, burning, numbness in shoulders and neck.  MRI -Neck pain buldged disc, degenerative disc and bone surrounding disc, arthritis in spine,(steroid injections in spine 3times) Depression, Anxiety. Restricted blood flow to brain.  knee pain arthritis.",,,2,09/23/2019,,Y,,Codeine
0835409,09/23/2019,CO,62.0,62,,F,,REDNESS AND SWELLING,,,,,,,,,N,09/21/2019,09/22/2019,1,,PHM,,,NO,,,,2,09/23/2019,,,,
0835410,09/23/2019,NC,68.0,68,,F,,"Both my knees have swollen to a point where it is very painful to walk. Fever of 101.8 Sore throat. Mental confusion. Loss of sense of balance, seeing items that are not really there.",,,,,,,,Y,N,09/22/2019,09/23/2019,1,None yet. I have unable to drive.,PHM,,Levothyroxin. .100 Nexium 40 Wellbutrin Escolitapram Seroquel Vitamin B12 Multivitamin Advair,No illness,Asthma (controlled),,,2,09/23/2019,,,,None
0835411,09/23/2019,UT,57.0,57,,F,,"The patient came in today to pick up a cephalexin antibiotic.  She was already at her dr's office today, and her arm was slightly swollen and red.  The dr. wasn't sure if she was developing an infection or not, so he just prescribed her the cephalexin to be safe.  The patient wasn't upset or bothered.",,,,,,,,,,09/21/2019,09/23/2019,2,,PHM,,,sulfa antibiotics,,,,2,09/23/2019,,Y,,
0835412,09/23/2019,,32.0,32,,M,,"1 day after vaccination, the patient developed symptoms of severe fatigue, nausea, and malaise. The following morning, the patient awoke complaining of shortness of breath and chest pain. He also developed a red, angry rash that spread to cover most of the surface area of his upper arm around the injection site. The rash persisted for about 7-8 days after vaccination.",,,,,,,,,Y,09/16/2019,09/17/2019,1,,UNK,,,,,,,2,09/23/2019,,,,
0835413,09/23/2019,CA,20.0,20,,F,,I haven't had my period since I took the third shot after my HPV vaccine. And the medical report also shows that I have premature ovarian failure.d,,,,,,,,Y,,01/01/2019,02/01/2019,31,,SCH,,None,None,Good health conditions,,,2,09/23/2019,,Y,,Pineapple
0835458,09/23/2019,MI,59.0,59,,F,,"redness, pain, itchy, heat in arm where injection was given, headache body aches all over",,,,,,,,,U,09/14/2019,09/16/2019,2,,PHM,,,,,,,2,09/23/2019,,,,no known allergies
0835466,09/23/2019,NY,64.0,64,,F,,"This patient received her second vaccine 13 days too soon. I have contacted GSK, the patient and the physician Per the CDC, the second dose is only considered invalid if it is given at less than 1 weeks after the first. This was 6-7 weeks after the first so the dose will not be repeated.",,,,,,,,,U,08/25/2019,08/25/2019,0,None,PHM,,"Amitriptyline, Citalopram, Diclofenac, Hydroxycine, Lamotrigin, Lyrica, Nucynta, Prazosin, Quetiapine, Zolpidem",None known,Unknown,,,2,09/23/2019,,,,NKA
0835488,09/23/2019,MA,20.0,20,,M,,Noted fever to 102.5 that night came down with tylenol. 2 days later noted (R) sided neck pain,,,,,,,,,Y,09/20/2019,09/20/2019,0,None,SCH,,"MVI, Vit D3",No,None,,,2,09/23/2019,,Y,,NKDA
0835489,09/23/2019,OH,72.0,72,,F,,"Says she believes she is having allergic reaction to Shingrix. Says that on 09/16/2019 she received the Shingrix  in her left arm and flu shot in her right arm at pharmacy. She said that the next day the area where she had this Shingrix injected became red, warm, and swollen. She was seen for this at urgent care on 09/18/2019. She was diagnosed with irritation of injection site. Shortly after that, she developed generalized itching with a rash on her trunk and extremities. She said that the redness in local reaction at the injection site has improved but the rash has worsened. She said she can think of nothing else new that she has come into contact with. She has had flu shots many times without problems. She denies any new foods, beverages, soaps, shampoos, laundry detergents, or dryer sheets. She denies any difficulty breathing or swallowing. No wheezing.",,,,,,,,,N,09/16/2019,,,,PHM,,TYLENOL PACERONE NORVASC  ELIQUIS VITAMIN C VITAMIN D3 ferrous sulfate 325 LASIX ORAL  HYDRALAZINE ORAL MAG-OX TOPROL XL ZANTAC  SANCTURA XR  VITAMIN B COMPLEX ORAL,"Iron deficiency anemia Arthritis Chronic diastolic heart failure  Colon polyp Diarrhea Diverticulosis of large intestine Gastroesophageal reflux disease Dysfunction of eustachian tube History of peptic ulcer Hyperlipidemia Hypomagnesemia Irritable bowel syndrome Adiposity  Overactive bladder Sleep apnea Urinary incontinence Vitamin D deficiency Asteotosis cutis Depression Diverticulosis of intestine Gastric ulcer Hypertension Spinal stenosis of lumbar region Atrial fibrillation  Body mass index 40.0-44.9, adult Rotator cuff impingement syndrome of right shoulder Benign essential hypertension Coronary artery stenosis Abnormal electrocardiography  History of arthritis Persistent atrial fibrillation Ventricular premature beats Chronic kidney disease On amiodarone therapy Diabetes mellitus Sinus bradycardia PAF (paroxysmal atrial fibrillation) Hypothyroidism","Iron deficiency anemia Arthritis Chronic diastolic heart failure  Colon polyp Diarrhea Diverticulosis of large intestine Gastroesophageal reflux disease Dysfunction of eustachian tube History of peptic ulcer Hyperlipidemia Hypomagnesemia Irritable bowel syndrome Adiposity  Overactive bladder Sleep apnea Urinary incontinence Vitamin D deficiency Asteotosis cutis Depression Diverticulosis of intestine Gastric ulcer Hypertension Spinal stenosis of lumbar region Atrial fibrillation  Body mass index 40.0-44.9, adult Rotator cuff impingement syndrome of right shoulder Benign essential hypertension Coronary artery stenosis Abnormal electrocardiography  History of arthritis Persistent atrial fibrillation Ventricular premature beats Chronic kidney disease On amiodarone therapy Diabetes mellitus Sinus bradycardia PAF (paroxysmal atrial fibrillation) Hypothyroidism",,,2,09/20/2019,,Y,Y,Dofetilide  Iodinated Contrast Media (IVP dye) Iodine-131 (Xray contrast dye) Codeine Iodine Lisinopril Nsaids Shingrix Tramadol
0835490,09/23/2019,UT,63.0,63,,F,,"Headache, nausea, Earache, sore throat, eye pain, severe Body aches.",,,,,,,,,U,09/19/2019,09/20/2019,1,,PVT,,N/A,Dizziness,,,,2,09/23/2019,,,,"Adhesive, chlorhexidine, iodides, oxycodone"
0835491,09/23/2019,IL,82.0,82,,M,09/19/2019,"Patient became flushed, hot, and lightheaded. Slumped to side but did not pass out. Symptoms resolved about 10 minutes after start.",,,,,,,,,Y,09/18/2019,09/18/2019,0,,OTH,PUB,,,,,,1,,,,,
0835492,09/23/2019,VA,68.0,68,,M,,"Reports that 24 hrs after inj. of Pneumonia he had redness, warmth, swelling of upper arm down to elbow. Called Pharmacy was told to apply ice",,,,,,,,,,09/19/2019,09/21/2019,2,,PHM,,"Effexor, carbamazepine, celexa, pulmicort, Zyrtec","COPD, depression",see above,,,2,09/21/2019,,Y,,NKA
0835494,09/23/2019,FL,66.0,66,,F,,"Patient stated her right arm was red and swollen after vaccine and there was pain. Patient applied ice pack and the redness did go down, but there was redness and warmth on interior side of arm starting from elbow and extending up to under arm area.",,,,,,,,,,09/19/2019,09/19/2019,0,,PHM,,"Pantoprazole 40 mg, Montelukast 10 mg, Simvastatin 20 MG, Stiolto, Dueneb",,COPD and bronchiectasis,,,2,09/21/2019,,,Y,Penicillin
0835512,09/23/2019,CA,66.0,66,,F,,"Cellulitis, swelling, severe tenderness to touch, and warmth. Symptoms started approximately 30-45 minutes after injection, worse at 11 pm per patient. Started having chills the next morning.",,,,,,,,,U,08/29/2019,08/29/2019,0,"Gave decadron, ketonolac, and Benadryl in office was inform would call to check on her that evening but no answer, told to go to ER if no improvement",PVT,,"Naproxen, diclofenac, albuterol, allopurinol, aspirin, vit D, Colace, Flonase, gabapentin, Lisinopril, meloxicam, metformin, simvastatin","Sinusitis, neck pain, constipation, gout flare","COPD, hypertension, hyperlipidemia, osteoarthritis",,,2,08/30/2019,,Y,,Vicodin
0835513,09/23/2019,FL,71.0,71,,M,09/09/2019,"Since taking shot, patient has experienced chills. Patient took temperature morning after shot, at 1:15 pm, and 99.1 degree F, chills resolved 9/10/19 Wed night.",,,,,,,,,U,09/09/2019,09/09/2019,0,N/A,OTH,PUB,"Pravastatin, metformin, glimepiride, Lisinopril, omeprazole",At time of shot,No,,,1,,,,,
0835514,09/23/2019,MD,53.0,53,,F,,"After midnight, I felt chills, headache and feverish. Then I had Fast heart rate. On Sept. 6, 2019 I called my doctor's office + reported on my situation. Nurse advised me to take Tylenol for headache that morning. No more chills, fever and fast heart rate in the morning of SepT. 6.",,,,,,,,,Y,09/05/2019,09/06/2019,1,,PVT,,multi-vitamins asthma - inhaler,none,,,,2,09/17/2019,,,,none that I know
0835639,09/23/2019,MI,51.0,51,,F,09/23/2019,"Talk to pt. She had flu like symptoms, body pain. Shivering after 3-4 hrs of vaccination on 9/22/19. on 9/23/19 at 2:30 PM she is feeling ok. No shivering, just body pain, Dr told to take Tylenol",,,,,,,,,Y,09/22/2019,09/22/2019,0,None,UNK,UNK,,None,None,,,1,,,,,
0835640,09/23/2019,NJ,90.0,70,,F,,"Red circular Rash, Raised, itchy, warm to touch treatment: tylonal, ice, hydrocortisone Cream, Benadryl for the itch.",,,,,,,,,U,09/17/2019,09/18/2019,1,N/A,PVT,,See attached,,,,,2,09/23/2019,,Y,,See attached
0835641,09/23/2019,OR,68.0,62,,F,09/23/2019,"5 min after injection pt got hot and very sweaty and faint. I had pt lay down. Checked blood pressure 100/50, strong pulse, called 911, EMT determined pt had anxiety rxn. husband took pt home",,,,,,,,,Y,09/23/2019,09/23/2019,0,BP 100/50,OTH,PVT,Synthroid; Amlodipine; Atenolol; zolpidem,None,?,,,1,,,,,
0835642,09/23/2019,IA,80.0,80,,M,,"Patient's daughter called stating her father has been having a really bloody nose for the past 30 minutes and was not stopping. He had received the Fluzone HD the day before. She believed it could have been the flu shot he got the previous day that was causing it, he usually does not get bloody noses. Recommended to call hospital to see if they would want him to come to be seen.",,,,,,,,,U,09/17/2019,09/18/2019,1,,PHM,,,,,,,2,09/23/2019,,,,None
0835643,09/23/2019,WI,60.0,60,,F,08/29/2019,fEVER,,,,,,,,,Y,07/05/2019,,,0,PVT,OTH,,No,No,,,1,,,,,
0835644,09/23/2019,WA,18.0,18,,M,,Patient was accidently given a 3rd dose of the meningococcal Vaccine - Menactra.,,,,,,,,,Y,08/05/2019,08/05/2019,0,N/A,PVT,,"No known meds, vitamins, or OTCs",None,Pectus excavatum,,,2,09/23/2019,,,,Mold-wheezy
0835645,09/23/2019,NY,61.0,61,,F,,"Pt experience, pain, fever and swelling of the entire arm and hand. Pt has difficulty moving her hand.",,,,,,,,,N,09/13/2019,09/14/2019,1,,PHM,,Losartan 25 mg,Hypertension,None,,,2,09/23/2019,,Y,,No
0835414,09/24/2019,IL,36.0,36,,M,,"Patient experienced pain in arm immediately following vaccine. Pain radiating down arm to hand. No swelling, or redness near or around injection site. Fingers feel good ok to move as well as hand. Has ""funny"" feeling in hand, can't describe what it seems like but thinks its slight tingle in fingers. A little pain in axilla. No fevers or other symptoms. Instructed patient to takes tylenol & ibuprofen for pain. If tingle persists or if symptoms progress instructed patient to seek medical attention.",,,,,,,,,N,09/21/2019,09/21/2019,0,n/a,PHM,,n/a,none,none,,,2,09/24/2019,,,,no known drug allergies
0835415,09/24/2019,UT,19.0,19,,M,,"Aggression and worsened mental status, several episodes of incontinence. Aggression was treated with restraint and IM injections of Haldol",,,,,,,Y,,N,09/23/2016,09/24/2016,1,The family suspected a vaccine injury so had a hair metals test run the day after patient was discharged from this hospital. The hair metals test came back positive for a significant mercury spike (which would indicate a mercury containing vaccine was used). A lyme and H pylori test were also run and came back positive.,PVT,,"Multivitamin, magnesium, vitamin C,  phosphatidyl serine, methylation pathway supplements","High functioning autism, anxiety, hearing voices,  SIBO (new onset anxiety started after a two week course of Flagyl for SIBO treatment)","Patient had been experiencing unusual foot pain, joint pain and fatigue for over one year prior to the vaccinations.  He developed a sudden onset psychosis during  his second semester in college and had to withdraw from school to seek treatment (March 2016).  He responded well to treatment and was back in school part time by fall of 2016, but began to experience shortly after a two-week course of Flagyl.","03/02/1997 HEP B,  MMR (age 1 and 4)",,2,09/24/2019,,Y,,"Thimerisol (previous vaccine adverse reactions as a child), gluten."
0835416,09/24/2019,LA,0.5,0,.5,M,,"Fever, redness, swelling at injection site, hard lump. 24 hours later cellulitis formed.",,,,,,,,,Y,08/20/2019,08/20/2019,0,,PVT,,0,0,0,,,2,09/24/2019,,Y,,0
0835417,09/24/2019,CA,52.0,52,,F,,I developed lymphadenitis right over my left collar bone on day after the vaccine. This never happened before with any vaccine.,,,,,,,,,N,09/22/2019,09/23/2019,1,,PHM,,Angeliq,None,None,,,2,09/24/2019,,,,Sulfa allergy
0835418,09/24/2019,VA,67.0,67,,M,,"Fever of 104.2 rectal at 00:26, chills, weakness, vomiting and diarrhea.",,,,,Y,,,,N,09/23/2019,09/23/2019,0,"UA, CBC, CMP, Blood cultures, Lactic acid, Chest X-ray and EKG 9/24/2019.",PVT,,None,None,None,,,2,09/24/2019,,,,None
0835419,09/24/2019,MI,36.0,36,,F,,"Patient describes that she developed hives, facial redness, difficulty breathing, some redness at injection site.",,,,,,,,,N,09/23/2019,09/23/2019,0,None,WRK,,Unknown,None,Unknown,,,2,09/24/2019,,,,Egg allergy
0835420,09/24/2019,NC,79.0,79,,M,,"Pain at injection site, muscle pain across shoulders involving previously stressed arm on opposite shoulder 24-36 hours after injection, muscle pain occurring in arm of original site of injection beginning 3-4 days after injection.  Pain was severe enough that it precluded sleep.  It tapered off beginning several days after onset.  At this time, a week after injection, pain is still quite noticeable and not responding well to acetaminophen.",,,,,,,,,N,09/17/2019,09/19/2019,2,none,PHM,,"Eliquis,  Verapamil, multivitamin, 600 iu Calcium (tid),  OTC stool softener,",none,Afib,Shinglex,,2,09/24/2019,,,,
0835436,09/24/2019,AR,,,,F,,"reported the patient fell while ice skating with her ""arms out-stretched; tender to touch but is not warm to touch; 1 inch by 1 inch seroma at the injection site; Medical Assistant reported the patient developed a walnut size swelling at the injection site.; soreness at the injection site for a few days / tender to touch but is not warm to touch; lump/mass/spot; This spontaneous report was received from a medical assistant and the physician, referring to a female patient of unknown age. Her concomitant medications included terbinafine hydrochloride (LAMISIL). The patient did not have any pertinent medical history, drug reactions or allergies.  On 01-AUG-2019, the patient was vaccinated with the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, intramuscularly in the lateral deltoid (exact dose dose and anatomical location were unknown) (lot # R017624 has been verified to be a valid lot number, expiration date 17-MAR-2021) to finish the dosing schedule. On an unknown date in August 2019, the patient fell with her arms out-stretched while ice skating. On an unknown date in August 2019, after the fall, the patient noted swelling at the injection site (also reported as walnut size swelling at the injection site). The patient sought medical attention and was seen by the physician, however she did not receive any treatment and had no lab diagnostics or studies performed. The physician informed that the patient developed 1 inch by 1 inch seroma at the injection site. According to the reporter the area was tender to touch, but it was not warm to touch and it seemed to be getting smaller. It was reported, that on an unspecified date, the patient would have an ultrasound performed.  The outcome of the events soreness at the injection site, area tender to touch and fall was unknown. The outcome of the other events was recovering. The causality assessment was not provided.  Follow up information has been received form the reporting physician on 04-SEP-2019, regarding the patient.  According to the physician, on 30-AUG-2019, the patient was doing fine and the spot went down.  On 04-SEP-2019, the physician contacted the patient and the mass was completely gone.",,,,,,,,,Y,08/01/2019,08/01/2019,0,,UNK,,LAMISIL (terbinafine hydrochloride),,,,US0095075131908USA012996,2,09/24/2019,,,,
0835438,09/24/2019,SC,,,,U,,"a patient received an improperly stored dose of ROTATEQ on 09/12/2019. No adverse effect reported.; a patient received an improperly stored dose of ROTATEQ on 09/12/2019. No adverse effect reported.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 12-SEP-2019, the patient was vaccinated with and improperly storage rotavirus vaccine, live, oral, pentavalent (ROTATEQ), orally, for prophylaxis, lot# S005874 with expiration date of 31-OCT-2020.  No adverse effects were reported.   It was stated that the vaccines underwent a temperature excursion lowest temperature below 2 degrees Celsius (1.2 C) for 24 hours 36 minutes. No previous temperature excursion was reported The call was not because of a ""data logger"".  No further information was provided. There was no Product Quality Complaint (PQC) involved in this case.",,,,,,,,,U,09/12/2019,09/12/2019,0,,UNK,,,,,,US0095075131909USA005687,2,09/23/2019,,,,
0835439,09/24/2019,CA,,11,,U,,"No adverse effects; the Patient received improperly stored VARIVAX; This spontaneous report was received from a medical assistant referring to a 11 year old patient of unknown gender. The patient's pertinent medical history, concomitant medication and drug reactions/allergies were not provided.  On 10-JUL-2019 the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (lot # R023513 with expiration date 16-AUG-2020; dose, frequency and route of administration were not reported) for prophylaxis (product storage error), which was reconstituted with properly stored sterile diluent (lot# reported as S000130 & expiration 23-AUG-2021). No adverse effects were reported.  The temperature excursion was ranged from -14 Celsius Degree to -10 Celsius Degree (-13.2 C) for 46 minutes. There was not previous temperature excursion. Data logger was involved. ; Sender's Comments:  US-009507513-1909USA007177: US-009507513-1909USA007512: US-009507513-1909USA007118:",,,,,,,,,U,07/10/2019,07/10/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA006939,2,09/23/2019,,,,
0835440,09/24/2019,PA,1.0,,,U,,"no adverse effect; patient inadvertently received Proquad and varivax instead of the intended Varivax and MMR II; This spontaneous report was received from a licensed practical nurse refers to a 12 month old patient. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 20-SEP-2019, the patient had inadvertently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) and varicella virus vaccine live (oka/merck)(VARIVAX) instead of the intended varicella virus vaccine live (oka/merck)(VARIVAX) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (anatomical location, route, lot# and expiry date were not reported for all the vaccines) for prophylaxis (wrong product administered). The nurse stated that the person administering the vaccines thought the measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) was measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II). Other suspect therapies included sterile diluent(STERILE DILUENT). No adverse effects were reported.",,,,,,,,,U,09/20/2019,09/20/2019,0,,UNK,,Sterile Diluent,,,,US0095075131909USA008870,2,09/24/2019,,,,
0835441,09/24/2019,CA,,,,F,,"small bruise; This case was reported by a other health professional via sales rep and described the occurrence of contusion in a female patient who received Men B NVS (Bexsero) for prophylaxis.   Previously administered products included Bexsero with an associated reaction of contusion (1st dose received on an unknown date and experienced small bruise).   On an unknown date, the patient received the 2nd dose of Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced contusion. On an unknown date, the outcome of the contusion was unknown.   It was unknown if the reporter considered the contusion to be related to Bexsero.  Additional information received were as follows: The age at vaccination was not reported. The patient experienced small bruise.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/24/2019,,,,
0835442,09/24/2019,CA,,,,F,,"small bruise; This case was reported by a other health professional via sales rep and described the occurrence of contusion in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced contusion. On an unknown date, the outcome of the contusion was unknown.   It was unknown if the reporter considered the contusion to be related to Bexsero.  Additional information received were as follows: This case was reported by the Medical assistant (MA). The age at vaccination was not reported. The patient had a small bruise. For tolerance to 2nd dose refer linked case US2019AMR150929.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/24/2019,,,,
0835443,09/24/2019,NY,65.0,65,,F,,"Shingles on her back; This case was reported by a pharmacist and described the occurrence of shingles in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number MX2LT, expiry date 29th May 2021) for prophylaxis.   Co-suspect products included INFLUENZA VACCINE (FLUAD) (batch number 260385, expiry date 30th April 2020) for prophylaxis.   On 7th September 2019, the patient received the 1st dose of Shingrix (intramuscular) and FLUAD. In September 2019, less than a week after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left deltoid and Fluad in the right deltoid. Within less than a week after vaccination, the patient experienced shingles on back. The reporter stated that, the patient was upset and asked explaination to the reporter. The reporter gave permission to follow up. It was unknown if the reporter considered the shingles to be related to Fluad as well.",,,,,,,,,U,09/07/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/24/2019,,,,
0835444,09/24/2019,NC,65.0,65,,U,,"SIDE EFFECTS; This case was reported by a consumer via call center representative and described the occurrence of adverse drug reaction in a 65-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th September 2019, the patient received Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Shingrix.  Additional details were provided as follows: The patient experienced side effects after receiving the Shingrix vaccine.",,,,,,,,,U,09/18/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/24/2019,,,,
0835447,09/24/2019,FL,66.0,66,,M,,"Body aches; Severe headache; Chills; Both of arms are sore; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included INFLUENZA VIRUS VACCINE INACTIVATED (FLUZONE QUADRIVALENT (INFLUENZA VIRUS VACCINE)) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received about 2 months and 1 week ago, refer linked case US2019AMR163388).   On 5th September 2019, the patient received the 2nd dose of Shingrix and FLUZONE QUADRIVALENT (INFLUENZA VIRUS VACCINE). On 5th September 2019, less than a day after receiving Shingrix, the patient experienced general body pain, headache and chills. In September 2019, the patient experienced pain in arm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm was unknown and the outcome of the general body pain was not recovered/not resolved and the outcome of the headache and chills were recovered/resolved.   It was unknown if the reporter considered the pain in arm, general body pain, headache and chills to be related to Shingrix.  Additional information received were as follows: A day before reporting date, the patient received Shingrix on unknown arm and Fluzone. At night before the reporting date, the patient started having body aches, a severe headache and chills overnight. The patient was still experiencing body aches at the reporting date. Both of his arms were also sore, where he got Shingrix and Fluzone. The Shingrix arm ached more than it did after the first dose.  The Fluzone arm ached more than he usually experiences after a flu vaccine. It was unknown if the reporter consider the events body aches, a severe headache, chills and arm aches to be related to the Fluzone as well. The reporter consented to follow up.",,,,,,,,,N,09/05/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/24/2019,,,,
0835448,09/24/2019,MN,69.0,69,,F,,"itching at injection site; chills; fatigue; Injection site warmth; redness surrounding injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously experienced adverse reactions included spondylolysis. Concomitant products included phentermine, topiramate (Qsymia).   On 4th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 5th September 2019, 1 days after receiving Shingrix, the patient experienced injection site erythema, chills, fatigue and injection site warmth. On 8th September 2019, the patient experienced injection site itching. On an unknown date, the outcome of the injection site erythema was not recovered/not resolved and the outcome of the injection site itching, chills, fatigue and injection site warmth were unknown.   It was unknown if the reporter considered the injection site erythema, injection site itching, chills, fatigue and injection site warmth to be related to Shingrix.  Additional information received were as follows: At around noon, the patient received Shingrix. The day after vaccination, the patient experienced redness at the injection site. The day after vaccination, the patient experienced chills and fatigue. The patient reported that the redness surrounding the injection has become larger, described as about 4 by 4 inches. The site had become itchy. The patient reported that she was given Symia loading doses in May 2019 but stopped in the summer, around June with her new physician. The redness was not improved and becoming worse at time of report. The reporter consented to follow up.",,,,,,,,,N,09/04/2019,09/05/2019,1,,UNK,,QSYMIA,,Medical History/Concurrent Conditions: Spondylolysis,,USGLAXOSMITHKLINEUS201916,2,09/24/2019,,,,
0835449,09/24/2019,MI,73.0,73,,M,,"at the injection site and below the injection site, there was redness and warmth; at the injection site and below the injection site, there was redness and warmth; soreness at injection site; fatigue; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 11th September 2019, immediately after receiving Shingrix, the patient experienced injection site pain. On 14th September 2019, the patient experienced injection site warmth and injection site erythema. In September 2019, the patient experienced fatigue. On an unknown date, the outcome of the injection site pain, injection site warmth and injection site erythema were recovering/resolving and the outcome of the fatigue was resolved with sequelae.   It was unknown if the reporter considered the injection site pain, injection site warmth, injection site erythema and fatigue to be related to Shingrix.  Additional details were provided as follows: The patient stated that he developed soreness at the injection site shortly after receiving the vaccine. The patient also noticed that at the injection site and below the injection site, there was redness and warmth and experienced fatigue that lasted for 1-2 days. The patient consented to follow up.",,,,,,,,,N,09/11/2019,09/11/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/24/2019,,,,
0835450,09/24/2019,,,,,U,,"Area of induration; Area of induration described as large and red; Wrong route of Administration; This case was reported by a nurse via call center representative and described the occurrence of injection site induration in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix (subcutaneous). On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site induration, injection site erythema and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site induration, injection site erythema and intramuscular formulation administered by other route were unknown.   It was unknown if the reporter considered the injection site induration and injection site erythema to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. Nurse reported Shingrix was administered subcutaneously, which led to incorrect route of vaccine administration. Nurse reports an area of induration noted following dose two of Shingrix series. Area of induration described as large and red.  HCP declined to provide demographic or contact details. HCP declined to complete full report. This was a medication error with harm.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/24/2019,,,,
0835451,09/24/2019,FL,,,,M,,"Shooting pain in arm; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd July 2019, the patient received the 1st dose of Shingrix. On 5th July 2019, 2 days after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovering/resolving.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient had experienced shooting pain in his arm since two days after the injection. The pain shoots down the patients left arm when he raises the arm. The reporter stated that the pain resolves when the arm is lowered, but returns when arm is raised again. The patient had not sought treatment from a physician as of the time of reporting. The reporter consented to follow up.",,,,,,,,,N,07/03/2019,07/05/2019,2,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/24/2019,,,,
0835452,09/24/2019,,,,,U,,"severe allergic reaction to TYPHOID VACCINE; Initial information received on 18-Sep-2019 regarding an unsolicited valid serious case received from Nurse via other company Merck (Non Licensed Partner) in the form of courtesy.  This case involves an unspecified patient of an unknown age who experienced severe allergic reaction to typhoid vaccine (allergy to vaccine), while he/she received vaccine TYPHOID VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect TYPHOID VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a serious severe allergic reaction to typhoid vaccine (allergy to vaccine) (Unknown latency) following the administration of TYPHOID VACCINE. The patient required hospitalization for this event.  (Other relevant tests included no lab data.)  Final diagnosis was severe allergic reaction to typhoid vaccine.  It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for severe allergic reaction to typhoid vaccine.  Information on the batch number was requested.  Documents held by sender: none.; Sender's Comments: This case concerns an unspecified patient of an unknown age who experienced allergy to TYPHOID VACCINE produced by unknown manufacturer. The time to onset is unknown. Additional information regarding patient's past medical history, condition at the time of vaccination, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.",,,,,Y,,,,U,,,,,UNK,,,,,,USSA2019SA263855,2,09/24/2019,,,,
0835453,09/24/2019,OH,5.0,5,,M,,"Redness to injection site of left thigh, noticed 9/18/2019.  Mild warmth to the area, tender to the area as well reported by family. Provider notes from 9/19/2019: positive erythematous lesion approximately 9 cm in diameter upper lateral region of left thigh, two small injection sites noted central of lesion approximately 1 inch apart. No induration noted, very mild warm to touch, no tenderness noted with palpation.",,,,,,,,,U,09/17/2019,09/18/2019,1,N/A,PVT,,N/A,"Stomach virus 2 days prior to day of visit. Symptoms including fever, vomiting, and diarrhea.",N/A,,,2,09/24/2019,,,,N/A
0835454,09/24/2019,PA,67.0,67,,F,,"Extreme chills & shaking - lasted for an hour Killer headache - lasted all night Aches in hips & knees I felt like I had to throw up, but didn't. Ears were itchy inside.",,,,,,,,,Y,09/23/2019,09/23/2019,0,,PVT,,"Xarelto, simvastatin, levothyroxine, benazepril",none,none,,,2,09/24/2019,,,,none
0835455,09/24/2019,VA,67.0,67,,M,,"Swelling , redness and warmth in left arm down to the elbow",,,,,,,,,N,09/23/2019,09/23/2019,0,,PHM,,Xarelto,,,,,2,09/24/2019,,Y,,
0835456,09/24/2019,OH,51.0,51,,F,,"Arm soreness began last night. This morning I woke up with flu like symptoms, soreness, headache, lethargy, chills.",,,,,,,,,N,09/23/2019,09/23/2019,0,,PHM,,armour thyroid 45 mg,,pulmonary stenosis,"Shingrix, May 7, 2019, Redness, swelling and arm pain for 2 weeks",,2,09/24/2019,,,,
0835461,09/24/2019,VT,1.25,1,.3,F,09/19/2019,Patient developed hives that resolved over the course of 36 hours without treatment. Patient developed swelling and induction at injection site on left thigh 0.5 cm x 0.5 cm. Resolved without tx.,,,,,,,,,Y,09/16/2019,09/17/2019,1,,PVT,UNK,,None,None,,,1,,,,,
0835468,09/24/2019,NC,12.0,12,,F,,"No adverse event reported by pt, error found in facility vaccine stock indicating a probable administration of two liquid components of Menveo vaccine with no dry component mixed in.  Unable to determine which documented  pt may have received the erroneous dose.  Will re-vaccinate patient to ensure appropriate immunity.",,,,,,,,,Y,09/19/2019,09/19/2019,0,N/A,PVT,,N/A,N/A,N/A,,,2,09/24/2019,,Y,,NKA
0835469,09/24/2019,NC,11.0,11,,M,,"No adverse event reported by pt.  Likely erroneous dose on menveo containing two liquid components administered from this box, unable to determine which pt received the probably erroneous dose.  All patients to be re-vaccinated to ensure appropriate immunity.",,,,,,,,,Y,09/18/2019,09/18/2019,0,N/A,PVT,,"Budesonide, formoterol/mometasone inh, albuterol, ipratropium bromide, montelukast",N/A,Asthma,,,2,09/24/2019,,Y,,N/A
0835470,09/24/2019,NC,12.0,12,,M,,"No adverse event reported by pt.  Likely erroneous dose on menveo containing two liquid components administered from this box, unable to determine which pt received the probably erroneous dose.  All patients to be re-vaccinated to ensure appropriate immunity.",,,,,,,,,Y,09/17/2019,09/17/2019,0,N/A,PVT,,N/A,N/A,N/A,,,2,09/24/2019,,Y,,PCN
0835471,09/24/2019,RI,35.0,35,,F,,Patient has developed insomnia,,,,,,,,,N,09/13/2019,09/13/2019,0,,PHM,,,,,,,2,09/24/2019,,,,
0835472,09/24/2019,NC,41.0,41,,F,,"headache, nausea, neck and back pain that progressed into full body pain, chills, fever of 102, chest pain for a period of roughly 30 min",,,,,,,,,Y,09/23/2019,09/23/2019,0,none,WRK,,"methylphenidate 40 MG 24 hr capsule, mometasone 50 MCG/ACT nasal spray, candesartan 16 mg tablet, GRALISE 300 MG Tab, lamoTRIgine 100 mg tablet, buPROPion HCl 150 mg 24 hr tablet, doxycycline 100 MG tablet, cetirizine 10 mg tablet",none,"asthma, allergies, migraine, add, mitral valve prolapse",,,2,09/24/2019,,,,"Fentanyl, Morphine, Sulfa Drugs, Keflex"
0835473,09/24/2019,LA,16.0,16,,F,,Fever went up to 104.7 Welts /bumps all over her face Dizziness/weakness Took her to urgent care then to the hospital...she never gets a fever.  Her fever went up quickly...within a couple of hours and she got welts all over her face (I have pictures).  Urgent care had us take her to the hospital.  They tested her for a bunch of stuff which turned out negative.  They gave her IV's and released her a few hours later when her fever came down.    In the end we believe it was the HPV shot.  A few OB/GYNs tell us that they have seen this with the HPV Vaccinations.,,,,,,,,,Y,06/12/2019,06/13/2019,1,Flu/Strep Emergency Department Visit Urgent Care Visit,PVT,,None,None,None,,,2,09/24/2019,,Y,Y,None
0835474,09/24/2019,MI,64.0,64,,M,,"This patient only at our location for Shingrix.  By phone message, states developed shingles approx 2 weeks following injection requiring antiviral treatment by his physician.  Will contact patient and ask him to contact VAERs to give more detailed personal info.",,,,,,,,,U,07/24/2019,09/04/2019,42,,PHM,,"UNKNOWN, ONLY AT OUR PHARMACY FOR THIS VACCINATION",UNKNOWN,"UNKNOWN,",,,2,09/24/2019,,Y,,UNKNOWN
0835475,09/24/2019,PA,0.42,0,.3,F,,"Infantile Spasms, drop head seizures, stare seizures,",,,Y,,Y,10,,Y,N,03/01/2014,04/01/2014,31,ERG,PVT,,None,None,"Asthma, Cerebral Palsy, Epilepsy, ADHD, Developmental Delays (Global) , heart issues for the first 3 years of life-Currently.",,,2,09/24/2019,,Y,Y,Eggs
0835478,09/24/2019,RI,,,,F,,"no adverse effect; administered a dose of VARIVAX today via intramuscular injection; This spontaneous report was received from a pharmacist (patient) of unknown age referring to herself. The patient's concurrent condition, medical history and concomitant therapy details were not reported.  On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX), 1 dosage form, intramuscularly (lot# and expiry date were not reported) for prophylaxis (Incorrect route of product administration). No adverse events were reported. No product quality complaint was involved.",,,,,,,,,U,,09/18/2019,,,UNK,,,,,,US0095075131909USA007889,2,09/24/2019,,,,
0835479,09/24/2019,CO,65.0,65,,F,,"Eruption of Herpes Simplex; cold sores; This case was reported by a pharmacist via call center representative and described the occurrence of herpes simplex in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included cold sores (are usually brought on by sun exposure or a fever).   On 22nd August 2019, the patient received Shingrix. On 26th August 2019, 4 days after receiving Shingrix, the patient experienced herpes simplex and cold sores. On an unknown date, the outcome of the herpes simplex and cold sores were unknown.   It was unknown if the reporter considered the herpes simplex and cold sores to be related to Shingrix.  Additional information received were as follows: The pharmacist reported that the patient experienced an eruption of herpes simplex four days after Shingrix vaccine.  The reporter stated that cold sores are usually brought on by sun exposure or a fever but patient experienced followed Shingrix vaccination. The reporter consented to follow up.  Clarification has been raised for event onset date for eruption of herpes simplex whether it is 28th August 2019 or 26th August 2019.",,,,,,,,,U,08/22/2019,08/26/2019,4,,UNK,,,,Medical History/Concurrent Conditions: Cold sores (are usually brought on by sun exposure or a fever),,USGLAXOSMITHKLINEUS201915,2,09/24/2019,,,,
0835481,09/24/2019,NJ,69.0,69,,F,,soreness developed within 2 hours  .  Muscle spasms developed shortly after a.c. well as a frozen shoulder and severe pain.  Called pharmacist around 3:00 and suggested ibuprofen as a ice.  24 hours and sleepiness painful night spasms are less but frozen shoulder. Pain persists.,,,,,,,,Y,N,09/23/2019,09/23/2019,0,none done at this point,PHM,,metroprolol  celebrex    protein drink  evista  provastin,,arthritis.,,,2,09/24/2019,,Y,,latex
0835483,09/24/2019,NC,12.0,12,,F,,"lethargy, nausea, blurred vision, headache, abdominal pain, throwing up, numbness/tingling/pain in legs  Injections given on 8/4/2016 and 11/23/2016.  Headache and lethargy began after first injection, but remaining symptoms began after 2nd injection.  The pain in her legs and blurred vision resolved, but the remaining symptoms persist.  We are now nearly 3 years later and she is vomiting at least 2 days each week, sometimes more.  She has frequent headaches and is tired often.  She has missed many days of school each year - enough that we get letters from the school about her attendance.",,,,,,,,,N,11/23/2016,11/24/2016,1,Saw doctor on 11/30/2016 for symptoms but were told that it was not related to vaccine.,PVT,,Adderall XR,none,none,"First injection of HPV on 8/4/16 were mild, increased with 2nd injection",,2,09/24/2019,,Y,,none
0835484,09/24/2019,GA,19.0,19,,F,,"Approximately 3 hours after receiving Gardasil vaccine, patient's mother reports patient is hallucinating.  Denies chest pains, shortness of breath, palpitations or vomiting.  Patient was taken to the nearest ED for assessment.  Patient was seen in PCP's office for follow up 2 days later.",,,,,,,,,Y,09/17/2019,09/17/2019,0,"CT Head without Contrast 9/19/19, normal Toxicology screen in ED 9/19/19, normal per patient's mother",PVT,,None,Rash,None,,,2,09/24/2019,,Y,Y,Bee pollen
0835485,09/24/2019,WI,66.0,66,,U,,"Sore arm at injection site all the way around to arm pit, still sore after 3 days,  chills, fever of 102.5, muscle aches and pains, head ache, lasted for 24 hours",,,,,,,,,Y,09/20/2019,09/20/2019,0,,PVT,,"Pantoprazole,  Ranitidine, Cholestyramine, acetaminophen, aspirin, fish oil, B-complex, C, multivitamin, cranberry, D, Calcium,",None,acid reflux,"sore arm,  65, 9/19/2018, pneumococcal pneumonia, Prevnar13",,2,09/24/2019,,,,None
0835486,09/24/2019,NC,58.0,58,,F,,"Within 2 hrs of injection - extreme fatigue Within 8 hrs - fever/chills/nausea/body aches/lightheadness, arm became so stiff/sore that I could barely lift it  It has been 48 hrs and the chills have stopped Treatment - Acetaminophen, drinking lots of water, bed rest (24 hrs)",,,,,,,,,N,09/22/2019,09/22/2019,0,,PHM,,100 mcg levothyroxine 1/day; 50 IU Vitamin D 1/week; multivitamin; 50 mg magnesium 1/day; Reclast 1/year (last infusion 10/2018),None,"Graves Disease, Osteoporosis Note:  had mild case of shingles in Aug 2018",,,2,09/24/2019,,,,None
0835487,09/24/2019,CA,11.0,11,,M,,"Parent report patient experienced a rash the evening of 9/12/19. He was given vaccines on 9/11/19. Rash was on his trunk, front and back, extending down to groin. Rash spared arms, face, buttocks and lower extremities.",,,,,,,,,Y,09/11/2019,09/12/2019,1,Negative rapid strep test.,SCH,,None reported,None reported,None reported,,,2,09/24/2019,,Y,,No known allergies
0835497,09/24/2019,CA,20.0,20,,F,,"CHILLS, FEVER,  SHE CANNOT HOLD HER ARM UP",,,,,,,,,U,09/23/2019,09/23/2019,0,NONE,PHM,,BIRTH CONTROL PILL (ENKYCE),UNKNOWN,NONE PER SCREENING PAPER,,,2,09/24/2019,,Y,,ALLERGIC TO PINEAPPLE
0835498,09/24/2019,SC,62.0,62,,F,,"Fever; Flu-like symptoms (including upset stomach,, headache, muscle aches, and sore throat), Pain at injection site that radiated under arm all the way down to hand; bruising from left armpit down left side of left breast; extreme pain in armpit; ""fluid pocket"" between armpit and left breast; lymph node inflammation under left arm.",,,,,,,,,,09/20/2019,09/21/2019,1,"Physician visual exam only; follow up MRI scheduled Monday, Sept 30 and possible ultrasound on Oct 15, 2019",PHM,,Synthroid,,Post-ablative hypothyroid,,,2,09/24/2019,,Y,Y,"Bactrim, Pyridium, Prednisone"
0835499,09/24/2019,CA,1.75,1,.8,F,,redness and warmth,,,,,,,,,U,09/19/2019,09/21/2019,2,N/A,PUB,,N/A,N/A,N/A,,,2,09/24/2019,,Y,,N/A
0835500,09/24/2019,NY,76.0,76,,F,,"Patient received the flu shot on 09/12/2019, and 5 hours later after getting the shot the patient experienced violent tremors over the whole body. She also experienced significant nausea without vomiting and dry heaving. Patient almost called the ambulance  but instead took 1mg of ativan. Her symptoms seemed to resolve. On the next day she was fine during the day but at night she developed a high fever.",,,,,,,,,Y,09/12/2019,09/12/2019,0,,PHM,,,,,,,2,09/24/2019,,,,
0835501,09/24/2019,TX,39.0,39,,F,,Started off with a heavy chest and dry cough.  Then nausea and chills began.  Around 4pm my eyes began to swell and became extremely blood shot.  Both of my eyes still look like I have double pink eye and burn.,,,,,,,,,N,09/23/2019,09/23/2019,0,none,PVT,,"None; Tuberculin, PPD test",None,None,,,2,09/24/2019,,,,None
0835502,09/24/2019,AZ,48.0,48,,F,,Patient said that night after the flu shot she started losing her hearing.  It got worse the next day.  She went to the doctor and said she now has a viral infection in the ear damaging,,,,,,,,Y,N,09/21/2019,09/21/2019,0,She went to the dr office... he is prescribing prednisone 9/23 but he says it may cause permanent ear loss,PHM,,birth control -microgestin fe,no,no,,,2,09/24/2019,,Y,,no
0835503,09/24/2019,MI,67.0,66,,F,,"Eyelids red and burning, fever and chills, coughing, vomiting, headache.",,,,,,,,,Y,09/23/2019,09/23/2019,0,,PHM,,"Synthroid, vitamin D3, Calcium,  D-Mannose, Ellura.",None,"Neurogenic bladder, hypothyroidism,.",,,2,09/24/2019,,,,"Morphine, Codeine, Quinolones, Cipro."
0835504,09/24/2019,LA,54.0,54,,F,,"Acute pain in left elbow (tendinitis) followed by stiffness in left shoulder; joint achy/stiffness in left wrist, ankle and knee.  By morning, left arm stiff and painful",,,,,,,,,Y,09/17/2019,09/17/2019,0,"No medical tests ordered; Dr. recommended that maybe by evening time, to take Benadryl (since side effect is drowsiness)",WRK,,"Prempro, Losartan, Allegra, bupropion, zafirlukast",none,Asthma,,n/a,2,09/24/2019,,Y,,none
0835507,09/24/2019,FL,,,,M,,"Gardasil used for condyloma accuminata; This literature marketed report was received from the authors of a published literature article, titled as stated below, and refers to a 9-year-old male patient. On an unreported date, the previously healthy boy presented to dermatology with his mother for a lesion on his penis with a recent history of itching and bleeding. On exam, there was a 6x7 mm brown papule on the shaft of his penis surrounded by smaller papules. The area was biopsied and pathology reported condyloma accuminata positive for Human Papillomavirus (HPV) 6 and 11, and negative for HPV 16 and 18. Upon further questioning, the patient's mother reported that she was serum positive for HPV; however, she and the patient's siblings were not clinically affected. The mother was educated on routes of transmission of HPV and denied any knowledge of prior sexual abuse. Laboratory Sexually Transmitted Infection (STI) studies were ordered and the patient was returned to primary care for further care and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccination.   A copy of the published article is attached as further documentation of the patient's experience.",,,,,,,,,U,,,,,UNK,,,Condyloma accuminata recurrent; Human papilloma virus serology test positive (mother),,,US0095075131908USA012788,2,09/24/2019,,,,
0835508,09/24/2019,AL,,,,F,,"Extra dose administered; weakness; fatigue; Inappropriate Schedule of vaccine administered; This case was reported by a nurse via sales rep and described the occurrence of weakness in a female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   Co-suspect products included Men ACWY-CRM NVS (Menveo) for prophylaxis and Men B NVS (Bexsero) for prophylaxis.   Previously administered products included Menveo (received 1st dose in 2015.). Concomitant products included Men B NVS (Bexsero).   On 15th July 2019, the patient received the 2nd dose of Menveo. On 16th August 2019, the patient received the 3rd dose of Menveo and the 2nd dose of Bexsero. On 15th July 2019, unknown after receiving Menveo, not applicable after receiving Menveo and Bexsero and an unknown time after receiving Bexsero, the patient experienced drug dose administration interval too long. In August 2019, the patient experienced weakness and fatigue. On 16th August 2019, the patient experienced extra dose administered. The patient was treated with steroids nos (Steroid Pack (Nos)). On an unknown date, the outcome of the weakness, fatigue, drug dose administration interval too long and extra dose administered were unknown.   It was unknown if the reporter considered the weakness and fatigue to be related to Menveo and Bexsero.  Additional case details were reported as follows: The age at vaccination was not reported. On 15th July 2019, the patient received 2nd dose of Menveo which led to lengthening of vaccination schedule. The patient received 3rd dose of Menveo by accident, which led to extra dose administered. The patients mom reported weakness and fatigue. The blood drawn to check for infection and gave patient steroid pack to reduce reaction to vaccines. The reporter gave permission to follow up.",,,,,,,,,U,07/15/2019,07/15/2019,0,"Test Name: Blood test; Result Unstructured Data: Test Result: to check for infection, Test Result Unit: unknown",UNK,,Bexsero,,,,USGLAXOSMITHKLINEUS2019AM,2,09/24/2019,,,,
0835509,09/24/2019,IL,69.0,69,,F,,"Drug dose administration interval too long; Injection site whelp; This case was reported by a consumer via call center representative and described the occurrence of injection site wheal in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of herpes zoster (received 1st dose in September 2018 and experienced a slight shingles outbreak).   In August 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced injection site wheal and drug dose administration interval too long. On an unknown date, the outcome of the injection site wheal was not recovered/not resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the injection site wheal to be related to Shingrix.  Additional details were provided as follows: The patient received the 2nd dose of Shingrix in August 2019, which led to lengthening of vaccination schedule. The patient experienced a 3 inch whelp on her arm at site of injection that has improved but not completely resolved after 3 weeks. The patient consented to follow up. This case has been linked with case US2019159147, reported by the same reporter.",,,,,,,,,N,08/01/2019,08/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/24/2019,,,,
0835510,09/24/2019,NV,,,,U,,"Reactions at the site of Injection; This case was reported by a other health professional via call center representative and described the occurrence of injection site reaction in a patient who received DTPa (Reduced antigen) (Boostrix) (batch number 43E4T, expiry date 1st September 2021) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, less than 6 months after receiving Boostrix, the patient experienced injection site reaction. On an unknown date, the outcome of the injection site reaction was unknown.   It was unknown if the reporter considered the injection site reaction to be related to Boostrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient had reactions at the site of injection with Boostrix. The batch number reported for Boostrix(43E47) did not exist and was updated to 43E4T, as per sales database. The reporter consented to follow up. This was one of the 6 cases, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/24/2019,,,,
0835511,09/24/2019,VA,,,,F,,"Swelling; red at the injection site; flu like symptoms; This is a spontaneous report from a contactable Physician via Pfizer Sales Representative.  A 16-year-old female patient received meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration on an unspecified date at single dose for immunisation.  The patient medical history and concomitant medications were not reported.  On an unspecified date the patient experienced swelling, red at the injection site and flu like symptoms. The events were non-serious with outcome of unknown.  The information on the batch number has been requested",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2019408537,2,09/24/2019,,,,
0835515,09/24/2019,WA,30.0,30,,M,,You will need to contact pharmacy for vaccine information.,,,,,,,,,Y,09/09/2019,09/18/2019,9,,PHM,,"None, just the MMR he received on the 9th of September.  Patient received his vaccine at pharmacy.",None,None,,,2,09/24/2019,,,,Amoxicillin and PCN
0835516,09/24/2019,MI,73.0,73,,M,,"vomiting, passed out, extended (3-days) pain, headache, lethargic and bedridden   Could not continue clinic visit.",,,,,,,,,Y,09/20/2019,09/20/2019,0,"No additional testing due to reaction.  EKG was done to determine if something else was wrong, or if another unrelated event was happening",MIL,,flu shot,diabetes,diabetes,,,2,09/24/2019,,,,none
0835517,09/24/2019,TX,15.0,15,,F,,"STARTED WITH SYMPTOMS ON 9/13/2019: REPORTS PULSATING B/L ARMS WITH PAIN, FATIGUE & HA'S AFTER RECEIVING VACCINE",,,,,,,,,,09/09/2019,09/13/2019,4,,PVT,,,,,,,2,09/24/2019,,Y,Y,
0835518,09/24/2019,CA,12.0,12,,M,,"developed a petechial rash ~ 1 week after vaccines, diagnosed with Idiopathic thrombocytopenic purpura (HCC)",,,,,Y,7,,,Y,04/12/2019,04/18/2019,6,platelets at zero on 4/23/19,PVT,,"singulair, Flonase, zyrtec",none,"asthma, allergic rhinitis",,,2,09/24/2019,,Y,,none
0835519,09/24/2019,MO,59.0,59,,F,,"Patient woke up in night with arm in extreme pain when she rolled over on it. Left arm was swollen from shoulder to elbow. By the following morning she had swelling in her lymphnodes under the left arm and towards her left breast. She had no pain with movement of the arm but it was painful to touch.  She went to see her primary care provider on Monday, September 23rd. They decided to prescribe an oral steroid and as nsaid for the swelling, They determined it was a localized reaction to the vaccine. Dr has recommended patient come to office for prophylactic steroid prior to administration of second dose.",,,,,,,,,Y,09/19/2019,09/20/2019,1,none,PHM,,NONE,NONE,NONE,patient does occassionally experience vasovagal response after shot administration.,,2,09/24/2019,,Y,,NONE
0835520,09/24/2019,CO,52.0,52,,M,,Pt went septic.,,,,,Y,,,,U,09/09/2019,09/10/2019,1,,PVT,,Bupropion XL 150 mg 24 hr tablet tadalifil 5 mg tablet,cirrhosis of liver,n/a,,,2,09/24/2019,,,Y,nkda
0835521,09/24/2019,WI,41.0,41,,F,,"According to my after visit summary, I received the Infuenza Quadrivalent P-Free flu shot.  At approximately 6:50 p.m., my hands started itching and burning.  Within 20 minutes, it went from 0 to 100.  I had hives from my head to my feet, swollen face, lips, ears, nose, neck and was red as a tomato.  After about 20 minutes, it affected my breathing and I started throwing up.  I went to the ER which is one block away from my home.  I was seen the ER doctor in the trauma room.  I was given epinephrine, steroids, benadryl, and a breathing treatment.  Today I pickup up prescriptions prednizone, benadryl, and two epi pens that were prescribed by ER doctor.  I am missing work today because I feel like I had a heart attack last night, not to mention I almost died.  Today suffering from chest pain, throat pain, and an awful headache.",,,,,,,,,N,09/23/2019,09/23/2019,0,Had blood drawn yesterday at my doctor appointment during the same visit of the flu shot.  Blood drawn because I take high blood pressure meds and they wanted to check my potassium and electrolytes.,PVT,,Atelolol 25 mg two times a day and  HCZ hydrochlorizide 25mg 2 times a day (both for high blood pressure),N/A,high blood pressure,,,2,09/24/2019,,,Y,N/A
0835522,09/24/2019,MN,65.0,65,,F,,"I took ibuprofen 15 minutes after the vaccine to minimize any reaction. 4 hours later my eyes started to feel like I had dirt under the eyelids. I also started to get a headache. Shortly thereafter I started to get an irritated throat and swelling at the back of my tongue. Next my sinus became so swollen that I couldn't breathe through my nose and my frontal sinuses became swollen as well. Next my lungs became involved and I started to have asthma symptoms.  I called the emergency triage nurse line for my clinic and as told to take more ibuprofen, an antihistamine and use my albuterol. If symptoms continued to get worse, I was to go to the ER. about 4-5 hours after the symptoms started, they stabilized and I was able to go to sleep. I wolk up this morning with aching muscles a headache ringing ears and a slightly swollen throat. I'm taking tylenol and ibuprofen to control the symptoms.  This is the first time I've ever reacted tot e flu vaccine. This is also the first high dose vaccine I've had. I do get serioius asthma symptoms with a cold or flu.",,,,,,,,,N,09/23/2019,09/23/2019,0,,PVT,,"Daily multi-vitamin, vitamin D 4000iu, Vitamin B12, VItamin C",None. Was very healthy.,Mild asthma controlled with clinic anti-inflammatory diet.,,,2,09/24/2019,,Y,,"Shellfish, Mango, Kiwi, penicillin, Macrodantin, Sulfa, MSG"
0835525,09/24/2019,,,,,F,,"Polycystic kidney; Anhydramnios (and oligohydramnios); (Anhydramnios and) oligohydramnios; Fetal exposure during pregnancy; Preterm birth; Infant passed away 10 minutes shy of being 24 hours old; This is an observational serious study case, initially received from other health professional on 20-Sep-2019, concerning a 24-hour-old female neonate subject. The mother was a 30-year-old subject (Ethnicity: Not reported) of body weight: 197 lbs, height: 65 inches and body mass index (BMI): 32.8, enrolled in a prospective observational safety study on pregnancy outcomes in women immunized with seasonal cell culture influenza trivalent (TIVc) or quadrivalent (QIVc) vaccine during pregnancy.  The mother's historical condition included neurofibromatosis. The mother's current conditions included yeast, HSV 2, anxiety and migraines. Concomitant medication included prenatal vitamins (unspecified vitamins), terconasole and Zoloft (sertraline hydrochloride).  The subject's mother obstetrical history noted that the mother had five previous pregnancies with 2 full term live birth, 2 preterm live birth and 1 elective abortion. The subject's mother had no maternal or paternal history with major congenital malformations. The mother did not have a prior history of use of illicit drugs during pregnancy. The subject's mother had a prior history of using alcohol (reported as 2 or less). The mother's last menstrual period (LMP) date was 25-Jun-2018 and the pregnancy was singleton. The estimated delivery date (EDD) and the corrected estimated date of delivery (CEDD) were 01-Apr-2019.  On 21-Aug-2018, 04-Sep-2018 and 02-Oct-2018, the subject's mother underwent Ultrasound scan and no major congenital malformation noted.  On 16-Oct-2018, at gestation age of 16 weeks, the subject's mother was administered Flucelvax QIVc [influenza vaccine, subunit influenza virus vaccine polyvalent, batch number: 252664, dose, expiration date, route of administration, and anatomical location: not reported] (explicitly coded as Fetal exposure during pregnancy'] for influenza immunisation.  On 18-Oct-2018, the subject's mother underwent ultrasound scan and quad screen and no major congenital malformation noted.  On 09-Jan-2019, the subject's mother underwent ultrasound scan and non stress test and polycystic kidneys, oligohydramnios and anhydramnios noted.  On 22-Jan-2019, the subject's mother underwent non stress test and polycystic kidneys, oligohydramnios and anhydramnios noted.  On 23-Jan-2019, the subject's mother underwent ultrasound scan and polycystic kidneys, oligohydramnios and anhydramnios noted.  On 25-Jan-2019, the subject's mother underwent non stress test and polycystic kidneys, oligohydramnios and anhydramnios noted.  On 29-Jan-2019, the subject's mother underwent ultrasound scan and polycystic kidneys, oligohydramnios and anhydramnios noted.  On 07-Feb-2019, the subject's mother underwent genetic testing and no major congenital malformation noted. Ultrasound scan was performed on the same day and the results showed polycystic kidneys, oligohydramnios and anhydramnios noted.  On 13-Feb-2019, the subject's mother underwent non stress test and polycystic kidneys, oligohydramnios and anhydramnios noted.  On 14-Feb-2019, 21-Feb-2019 and 01-Mar-2019, the subject's mother underwent biophysical profile and polycystic kidneys, oligohydramnios and anhydramnios noted.  At gestational age of 36.3 weeks, the mother delivered live birth, female neonate by Caesarean section (explicitly coded as Premature baby'). The neonate's birth weight was 2780 g, head circumference and length were not reported. The appearance, pulse, grimace, activity, and respiration (APGAR) scores were 1 at one minute, 3 at five minutes and 5 at ten minutes.  Major congenital malformations (MCM) identified at birth were oligohydramnios, anhydramnios and polycystic kidneys. Other factors contributing to the MCM were unknown. As reported: ""Baby passed away 10 minutes shy of being 24 hours old.""(outcome: fatal). Information regarding autopsy was not reported.  This case is linked to 201904743, corresponding mother case.  Company Comment: Reportedly, the female neonate subject was delivered as premature baby with congenital cystic kidney disease, oligohydramnios and anhydramnios after foetal exposure during pregnancy, at gestation age of 16 weeks, with the suspect product Flucelvax QIV. Chronology is plausible. The neonate died at 24 h and 10 minutes of age. Mother's medical history of HSV 2 and neurofibromatosis may have contributed to development of the events. Causality was confounded by therapy with multiple concomitant medications.  Foetal exposure during pregnancy is assessed as not related. For all other events, causal role of the suspect product cannot be totally excluded and is assessed as related.; Reporter's Comments: Reportedly, the female neonate subject was delivered as premature baby with congenital cystic kidney disease, oligohydramnios and anhydramnios after foetal exposure during pregnancy, at gestation age of 16 weeks, with the suspect product Flucelvax QIV. Chronology is plausible. The neonate died at 24 h and 10 minutes of age. Mother's medical history of HSV 2 and neurofibromatosis may have contributed to development of the events. Causality was confounded by therapy with multiple concomitant medications.  Foetal exposure during pregnancy is assessed as not related. For all other events, causal role of the suspect product cannot be totally excluded and is assessed as related.; Reported Cause(s) of Death: Unknown",Y,03/01/2019,,,,,,,N,10/16/2018,03/01/2019,136,"Test Date: 20190214; Test Name: Biophysical profile; Result Unstructured Data: Polycystic kidneys, oligohydramnios, anhydramnios.; Test Date: 20190221; Test Name: Biophysical profile; Result Unstructured Data: Polycystic kidneys, oligohydramnios, anhydramnios.; Test Date: 20190301; Test Name: Biophysical profile; Result Unstructured Data: Polycystic kidneys, oligohydramnios, anhydramnios.; Test Date: 20190109; Test Name: Non stress test; Result Unstructured Data: Polycystic kidneys, oligohydramnios, anhydramnios.; Test Date: 20190122; Test Name: Non stress test; Result Unstructured Data: Polycystic kidneys, oligohydramnios, anhydramnios.; Test Date: 20190125; Test Name: Non stress test; Result Unstructured Data: Polycystic kidneys, oligohydramnios, anhydramnios.; Test Date: 20190213; Test Name: Non stress test; Result Unstructured Data: Polycystic kidneys, oligohydramnios, anhydramnios.; Test Date: 20190109; Test Name: Ultrasound; Result Unstructured Data: Polycystic kidneys, oligohydramnios, anhydramnios.; Test Date: 20190123; Test Name: Ultrasound; Result Unstructured Data: Polycystic kidneys, oligohydramnios, anhydramnios.; Test Date: 20190129; Test Name: Ultrasound; Result Unstructured Data: Polycystic kidneys, oligohydramnios, anhydramnios.; Test Date: 20190207; Test Name: Ultrasound; Result Unstructured Data: Polycystic kidneys, oligohydramnios, anhydramnios.",UNK,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; ZOLOFT; TERCONAZOLE,,Medical History/Concurrent Conditions: Neurofibromatosis; Comments: None,,USSEQIRUS201904742,2,09/24/2019,,,,
0835526,09/24/2019,PA,5.0,5,,F,,"At daycare the day after vaccines were given, child had an episode where she vomited after becoming pale. Her knees buckled and she fell to the floor from a standing position. She did not have loss of consciousness.  She was alert.",,,,,,,,,Y,09/23/2019,09/24/2019,1,,PVT,,none,none,none,,,2,09/24/2019,,,,none
0835527,09/24/2019,CA,40.0,40,,F,,PATIENT REPORTS INTNESE ITCHING AND HIVE-LIKE WELTS ON AREA SURROUNDING VACCINE SITE. SYMPTOMS STARTED SEVERAL HOURS AFTER RECEIPT OF VACCINE; STATES NO CONCERNS ABOUT PROCESS OF VACCINATION. TOOK BENADRYL AND APPLIED HYDROCORTIZONE CREAM TO AFFECTED AREA. STATES SYMPTOMS RESOLVE BY MORNING AND HAVE NOT RETURNED.,,,,,,,,,Y,09/20/2019,09/20/2019,0,NONE,MIL,,"BENZOYL PEROXIDE 10% LOTION, TOPICAL ACETAMINOPHEN 325 MG TABLET",NONE REPORTED,CARDIAC MURMUR EHLERS-DANLOS SYNDROME TRAUMATIC BRAIN INJURY ALLERGIC RHINITIS,,,2,09/24/2019,,,,CEFAZOLIN CEPHALOPSPORINS CETIRIZINE ERYTHROMYCIN NAFCILLIN PENCILLINS VANCOMYCIN ZYRTEC
0835528,09/24/2019,OR,56.0,56,,F,,"swelling in right hand and wrist, severe itching, sores, and bruising.",,,,,,,,,N,09/20/2019,09/20/2019,0,N/A,PHM,,"buPROPion 150mg, lamoTRIgine 25mg, DULoxetine 90mg, atorvaSTATin 40mg, multi-vitamin, calcium-magnesium, aspirin 81mg, vitamin D-3,",N/A,Sinusitis,,,2,09/24/2019,,,,Oxycontin
0835529,09/24/2019,SC,2.0,2,.5,F,,"Patient was given Kinrix, she is only 2 years old and Kinrix is a vaccine for 4-6 years.",,,,,,,,,,09/24/2019,09/24/2019,0,n/a,PVT,,"Childrens ibuprofen, 5mL",no,no,,,2,09/24/2019,,,,no
0835530,09/24/2019,WI,38.0,38,,M,,Vaccine given out of licensure age range.,,,,,,,,,Y,09/23/2019,09/23/2019,0,none,PUB,,,none,none,,,2,09/24/2019,,,,none
0835531,09/24/2019,AZ,69.0,69,,F,,"Upset stomach, nausea, vomiting, diarrhea, severe headache",,,,,,,,,Y,09/23/2019,09/23/2019,0,,PHM,,Myrbetriq Medroxyprogesterone Estradiol Collagen,None,Charcot Marie Tooth,,,2,09/24/2019,,,,None known
0835532,09/24/2019,ME,63.0,63,,M,,"Injection was very painful. Over the following several hours I experienced severe aching in my left shoulder, to the extent I could not raise my left arm. During the night I had fever and chills and continuing pain in the shoulder. The following day I suffered from fatigue, headaches and continued pain in my shoulder. I still do not have full range of motion in my left arm.",,,,,,,,,N,09/23/2019,09/23/2019,0,,PHM,,None,None,Von Willebrands and seasonal asthma,,,2,09/24/2019,,,,Allergic to nuts and legumes
0835533,09/24/2019,MI,21.0,21,,F,,Vaccine given out of licensure age range.,,,,,,,,,Y,09/19/2019,09/19/2019,0,none,PUB,,,none,none,,,2,09/24/2019,,,,none
0835534,09/24/2019,NC,72.0,72,,M,,"Patient got the second Shringrix shot on September 21 around 6 p.m. at our local pharmacy where we got the first one on June 21, 2019. On Sept. 22, his arm was sore, but he did not take off his Tshirt or notice if it was red at the time. On Sept. 23, he went to see a physical therapist in the morning and when she saw his arm, she told him to go to an ER immediately because it was red, hot to the touch and in a rectangular shape. She thought it was either cellulitis or MRSA. We went to the ER around 1 p.m. and the PA there, sent patient home with a cellulitis diagnosis and a prescription for Cephalexin 500 mg four times a day for seven days. Today is Tuesday, and he has taken the antibiotic five times. His upper arm is still red and warm to the touch, but the redness it seems to have faded a tiny bit. He had a low grade fever on Sunday but not now.",,,,,,,,,N,09/21/2019,09/23/2019,2,None.,PHM,,"Rivastigmine 13.3 mg, Eliquis 5 mg, Flecainide 100 mg, Trintellix 5mg, Zetia 10 mg, Flomax .4 mg, Pantoprazole 40 mg Cholestyramine, Vitamin D 1000IU, Vitamin B12 1000 mg, Melatonin",,"atrial fibrillation, gerd, sleep apnea, high cholesterol, mild depression",,,2,09/24/2019,,,Y,"statins, atenolol, contrast dyes"
0835535,09/24/2019,AK,66.0,66,,F,,"Flu-like symptoms +: Achy, fever, diarrhea, nausea",,,,,,,,,Y,09/02/2019,09/02/2019,0,none,PHM,,Amlodipine Besylate 5 mg Losartan Potassium -HCTZ 50-12.5 Metoprolol Succinate ER24 HR 50,none,none,,,2,09/24/2019,,,,sulfa  penicillin aspirin NSAIDs
0835536,09/24/2019,MD,55.0,55,,F,,"Redness, swelling , pain and ""hot"" area around injection site.",,,,,,,,,N,09/21/2019,09/22/2019,1,None,PVT,,"simvastatin 40 MG, gabapentin 600 MG, cyclobenzaprine 5 MG, ranitidine 300 MG, DULoxetine 60 MG, LEVOthyroxine 100 MCG, clindamycin-benzoyl peroxide gel, dicyclomine 10 MG, meclizine 25 mg, pantoprazole 40 MG EC, meloxicam 15 MG, cholecalci","hypothyroidism, Fibromyalgia, bursitis, Idiopathic polyneuropathy",,,,2,09/24/2019,,,,"Penicillin,"
0835537,09/24/2019,AZ,75.0,75,,F,,"Patient called in 09/24/19 that last night 09/23/19 she was having trouble walking and had to force her legs to move. Is better this morning, but is having some redness and heat on location of both vaccine sites. Patient reports using a cold pack and benadryl.",,,,,,,,,Y,09/23/2019,09/23/2019,0,,PVT,,Albuterol Sulfate (2.5 MG/3ML) 0.083% Nebulization Solution   Cholecalciferol 4000 UNIT Capsule   ProAir HFA 108 (90 base) MG/ACT Aerosol  Fluticasone Propionate 50 MCG/ACT Suspension   Diltiazem HCl ER Coated Beads 180 MG Capsule Extended,,"Diabetes, Paroxysmal a-fib, Hypertension, chronic lower back pain, and chronic kidney disease.",,,2,09/24/2019,,,,Penicillin V Potassium: blisters and trouble breathing       Droperidol       Codeine       sulfa drugs       Meclofenamate Sodium       Avelox       Cefdinir       Demerol       Fish       Shellfish       tree nuts: hives       doxycycline: cramp and burn in stomach        meperidina : ITCHING       iodine topical: DIB       CHERRY       NITROFURANTONIN: SKIN REACTION       ASA: GI UPSET       NONSTEROIDAL ANTI INFLAMMATORY AGENTS       Kissing bug: hives
0835538,09/24/2019,SC,19.0,19,,F,,"Patient called this morning at approximately 10am and stated she had pain in her left arm and upon taking off her Band-Aid, she saw a large amount of blood on the Band-Aid. I reassured her I didn't see much when I did give her the vaccine, but it could have occurred after she left. She stated she felt some tingling down her arm to her fingers and has pain up towards the clavicle bone (she stated more towards the muscle near the clavicle area). She stated she has no fever and there is no redness around the injection site. She described the pain around the clavicle as ""tight"" like a sprained ankle. I told patient she could call her primary care physician for any pain medication she needed and rehabilitation of the shoulder if needed.",,,,,,,,,U,09/23/2019,09/24/2019,1,,PHM,,"Fluticasone 50mcg nasal spray, naproxen 500mg tablets, escitalopram 10mg tablets, medroxyprogesterone 10mg tablets",,,,,2,09/24/2019,,,,Red Dye
0835539,09/24/2019,CA,46.0,46,,F,,"Reported approximately 20-30 minutes after vaccine injection experienced facial flushing, upper extremity tingling feeling, itching and redness to injection site. Resolved by the next day. Denied shortness of breath.",,,,,,,,,Y,09/19/2019,09/19/2019,0,,OTH,,,none,none,,,2,09/24/2019,,,,HPV vaccine - rash
0835540,09/24/2019,MI,2.0,2,.0,M,,The nurse administered TDap instead of DTap.,,,,,,,,,,09/23/2019,09/23/2019,0,none,PVT,,None,,,,,2,09/24/2019,,Y,,NKDA
0835541,09/24/2019,MI,77.0,77,,F,,Pain developed 3 days after injection in left upper arm. More severe than anticipated. Still experiencing significant pain near injection site. Painful just to lift arm off her lap.,,,,,,,,,,09/18/2019,09/21/2019,3,,PVT,,"Aspirin, pravastatin, Tylenol, motrin, omega-3, vit D, B complex","(L) shoulder pain, chest pain","Hyperlipidemia, back pain, knee pain",,,2,09/23/2019,,Y,,Nitrofurantoin
0835549,09/24/2019,CA,,1,.1,U,,"No adverse effect reported; Patient received improperly stored VARIVAX; This spontaneous report was received from a certified medical assistant and refers to a 56 week old patient of unknown gender. The patient's medical history and concurrent conditions were not reported.   On 05-SEP-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX), lot # S002874, expiration date 29-JAN-2021, for prophylaxis (dose, dose number, and route were not provided). The varicella virus vaccine live (oka/merck) (VARIVAX) was reconstituted with properly stored sterile diluent. No adverse effect reported.   The temperature excursion was from 6F to 14F (10.2F, multiple) for 50 minutes. There were no previous temperature excursions. Digital data logger involved.   This is one of several cases received from the same reporter.; Sender's Comments:  US-009507513-1909USA005231: US-009507513-1909USA005078: US-009507513-1909USA005119: US-009507513-1909USA005129: US-009507513-1909USA005134: US-009507513-1909USA005139: US-009507513-1909USA005220: US-009507513-1909USA005223: US-009507513-1909USA005365: US-009507513-1909USA005375: US-009507513-1909USA005424: US-009507513-1909USA005468: US-009507513-1909USA005525:",,,,,,,,,U,09/05/2019,09/05/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005124,2,09/24/2019,,,,
0835550,09/24/2019,WI,,,,U,,"suspected vaccination failure; Shingles; This case was reported by a other health professional via sales rep and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The reporter stated that the patient post vaccination developed shingles disease post vaccination. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. The reporter agree to follow up from GlaxoSmithKline. This case has been linked with US2019AMR169849 reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/24/2019,,,,
0835551,09/24/2019,NY,,,,U,,"variceal hemorrhage; Abdominal pain; This case was reported in a literature article and described the occurrence of fever in a 9-year-old patient who received Haemophilus influenzae type b vaccine for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PCV13) for prophylaxis, PPSV23 PNEUMOCOCCAL VACCINE for prophylaxis, piperacillin for prophylaxis and tazobactam for prophylaxis.   The subject's past medical history included varicose veins ligation. Concurrent medical conditions included portal hypertension (etiology was biliary atresia), biliary atresia and varicosity.   On an unknown date, the patient received Haemophilus influenzae type b vaccine at an unknown dose, PCV13 at an unknown dose, PPSV23 PNEUMOCOCCAL VACCINE at an unknown dose, piperacillin (intravenous) at an unknown dose and frequency and tazobactam at an unknown dose and frequency. On an unknown date, more than a week after receiving Haemophilus influenzae type b vaccine, the patient experienced fever (serious criteria hospitalization) and abdominal pain (serious criteria hospitalization). The action taken with piperacillin was unknown. The action taken with tazobactam was unknown. On an unknown date, the outcome of the fever and abdominal pain were unknown.   It was unknown if the reporter considered the fever and abdominal pain to be related to Haemophilus influenzae type b vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of fever and abdominal pain in a 9-year-old patient of unspecified gender who was vaccinated with unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (manufacturer unknown for all) for prophylaxis.  The patient was a part of cohort study that aimed to determine whether Partial Splenic Embolization (PSE) was safe and effective in the pediatric population.  The study was a retrospective review of a single-center experience for all patients ages 0 to 21 who underwent PSE for the management of portal hypertension (PHTN) between January 2010 and August 2017. The study presented the experience with the use of this modality in different pediatric populations with PHTN to better understand the rationale for safe and appropriate application of this treatment. [In this study, [In this study, recommended PSE to patients with bleeding tendencies that were not optimal candidates for an open surgical shunt or repeated endoscopies. This includes the following patient populations: Patients with baseline compromised respiratory function (ie, cystic fibrosis [CF]). 2. Patients with significant synthetic dysfunction that may progress to liver failure after shunting. 3. Patients with early signs of encephalopathy that could potentially worsen with increased portal systemic shunting. 4. Patients with abnormal right heart function that could develop cardiac decompensation or shunt failure. 5. Patients deemed to be marginal candidates for repeated anesthesia. 6. Patients with splenic vein thrombosis. 7. Patients with characteristics predicting poor wound healing or other surgical complications. 8. Patients with unfavorable anatomy, increased transhepatic resistance, or elevated right heart pressures to permit mesoportal shunting (Rex shunt)]. The patient had thrombocytopenia and/or recurrent variceal bleeding. The patient had portal hypertension, whose etiology was biliary atresia (BA), and the patient also noted to have evidence of varices before PSE which required endoscopic intervention. For this, the patient underwent endoscopic variceal ligation (EVL) before PSE. The patient had significant splenomegaly before PSE. The decision to proceed with PSE was determined by the primary hepatologist and surgeon after careful discussion with both patient and family members regarding alternative approaches. No information on patient's family history or concomitant medication was provided.   On an unspecified date, at least 2 weeks before PSE, the patient received unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (administration route and site unspecified, dosage unknown, batch number not provided for all), in order to reduce the risk of future infection by encapsulated organisms, should the procedure lead to a complication necessitating total splenectomy. The age of vaccination was not provided. It was reported that the patient received broad-spectrum intravenous antibiotic prophylaxis, typically with piperacillin/tazobactam, before the procedure to prevent infection of infarcted splenic tissue. This was continued for 5 to 7 days. On an unknown date, before PSE, the patient's platelet count was noted at 3510E9/L (normal range not provided).   On an unspecified date between January 2010 and August 2017, at least 2 weeks after vaccination, the patient underwent PSE by interventional radiology under general anesthesia via percutaneous femoral artery approach under sterile conditions utilizing guidelines based on the Spigos technique to minimize complications. At the time of PSE, the patient was not actively bleeding. Diagnostic angiographies of the celiac axis and splenic arteries were obtained to determine the target splenic arterial branches, to identify accessory branches to other tissues from the splenic artery and to determine baseline splenic volume. Abdominal sonograms with doppler analysis of hepatic and splenic vessels were performed post procedure to assess vessel patency and the degree of intra-abdominal-free fluid. Arteriograms of partial splenic embolization (PSE), pre-embolization with capillary blush demonstrated splenomegaly and post-embolization with capillary blush revealed multiple defects before and after esophageal varices.   Information regarding patient's blood transfusions was not available. The patient was admitted to hospital after PSE for further observation and management. [In this study, patients received patient-controlled analgesia for pain control and to prevent splinting and associated pulmonary complications such as atelectasis and pneumonia]. The patient did not develop infection with encapsulated organisms. Post-PSE, the patient's platelet count was 15410E9/L. the antibiotics were converted to an oral regimen before hospital discharge. [In this study, criteria for hospital discharge included adequate control of abdominal pain with oral medications, adequate oral intake/hydration, and absence of post procedure infection. Magnetic resonance imaging (MRI) showed splenomegaly and postembolization with necrotic areas surrounding the spleen. Three patients demonstrated complete resolution of varices. An additional 7 patients were noted to have a decrease in variceal grade].  On an unknown date, the patient was discharged fulfilling the criteria for hospital discharge that included (adequate control of abdominal pain with oral medications), adequate oral intake/hydration, and absence of post procedure infection. The patient was followed-up in the outpatient hepatology clinic. Hematologic indices including white blood cell (WBC) and platelet counts were monitored. Imaging was repeated as indicated. The patient developed fever and abdominal pain and the patient was re-hospitalized. [In this study, 7 patients required readmission after initial discharge 2 of these patients were discharged only 1 day after PSE and returned the following day with fevers and abdominal pain with an unremarkable diagnostic evaluation].  Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.  This case has been considered as serious due to hospitalization.  The outcome of the event was not reported.  The author did not comment on the relationship between the event of fever and abdominal pain and Unspecified Haemophilus influenza type B vaccine, unspecified meningococcal vaccine and unspecified pneumococcal (PCV13 followed by PPSV23) vaccine. The author stated ""The Centers for Disease Control and Prevention recommends immunoprophylaxis against Streptococcus pneumoniae, H influenzae and Neisseria meningitidis in all splenectomized patients. Complications of PHTN such as hypersplenism, variceal hemorrhage, and ascites can lead to significant morbidity and mortality in children. Surgical interventions include shunting or splenectomy; however, overwhelming sepsis postsplenectomy is a pressing concern. PSE addresses portal hypertension regardless of etiology as definitive therapy. Most adverse effects following PSE are expected and can be managed conservatively. In our cohort we commonly observed fever, abdominal pain, and leukocytosis without evidence of infection. Pain was effectively controlled with intravenous and oral analgesics. Nonsteroidal anti-inflammatory drugs were avoided to minimize hemorrhage. In our experience, prophylactic antibiotics and limiting splenic reduction to no greater than 70% have avoided serious morbidity and mortality. In particular, there was no significant difference in the preprocedure platelet count between patients with and without recurrent thrombocytopenia. After PSE we noted a significant increase in platelets but to a lesser degree in patients who had recurrent hypersplenism. In our patients with esophageal varices, the combination of endoscopic ligation and PSE has been successful in controlling the progression of varices and decreasing the incidence of variceal hemorrhage.""  The author concluded ""our study supports that PSE is a safe, effective, semi-invasive alternative to splenectomy in pediatric patients with PHTN. The combination of EVL and PSE is effective treatment for esophageal and gastric varices (not amenable to simple band ligation). Reduced splenic volume and splenic venous return effectively decreased portal flow and pressure. PSE can be successfully performed in pre- and post-transplant transplant patients, and select cirrhotic and noncirrhotic pediatric patients. PSE appears to preserve functional spleen mass and avoids postprocedure accelerated liver disease or encephalopathy. In contrast to shunting, PSE can be effective even in the setting of elevated right-sided heart pressures. Further multicenter collaborative studies with larger and varied patient populations will need to be performed to substantiate our approach and better define patient populations that would benefit most from PSE, sequential PSE or combined interventions. Liver transplantation remains the ideal intervention for anyone with significant decompensated PHTN or advanced hepatic dysfunction"".  This is 1 of the 9 valid cases reported in this article.      Lab Comments: Lab test were performed on an unspecified date,The patient's hematologic indices including white blood cell (WBC) and platelet counts were monitored (result not provided). Imaging was repeated as indicated  (result not provided). Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.",,,,,Y,,,,U,,,,"Test Name: Endoscopy; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Platelet count; Result Unstructured Data: Test Result: 35 (before PSE), Test Result Unit: x10e9/L; Test Name: Platelet count; Result Unstructured Data: Test Result: 154(Post PSE), Test Result Unit: x10e9/L; Test Name: White blood cells; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown",UNK,,PIPERACILLIN; TAZOBACTAM,Biliary atresia; Portal hypertension (etiology was biliary atresia); Varicose veins ligation; Varicosity,,,USGLAXOSMITHKLINEUS2019GS,2,09/24/2019,,,,
0835552,09/24/2019,NY,,,,U,,"Dehydration; This case was reported in a literature article and described the occurrence of dehydration in a 16-year-old patient who received Haemophilus influenzae type b vaccine for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PCV13) for prophylaxis, PPSV23 PNEUMOCOCCAL VACCINE for prophylaxis, piperacillin for prophylaxis and tazobactam for prophylaxis.   The subject's past medical history included varicose veins ligation and splenomegaly. Concurrent medical conditions included portal hypertension (etiology was autoimmune hepatitis), autoimmune hepatitis, varicosity (before PSE) and hemorrhage.   On an unknown date, the patient received Haemophilus influenzae type b vaccine at an unknown dose, PCV13 at an unknown dose, PPSV23 PNEUMOCOCCAL VACCINE at an unknown dose, piperacillin (intravenous) at an unknown dose and frequency and tazobactam (intravenous) at an unknown dose and frequency. On an unknown date, more than a week after receiving Haemophilus influenzae type b vaccine, the patient experienced dehydration (serious criteria hospitalization). The action taken with piperacillin was unknown. The action taken with tazobactam was unknown. On an unknown date, the outcome of the dehydration was unknown.   It was unknown if the reporter considered the dehydration to be related to Haemophilus influenzae type b vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of dehydration in a 16-year-old patient of unspecified gender who was vaccinated with unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (manufacturer unknown for all) for prophylaxis. This case corresponds to supplemental table 1 (patient 11) reported in this literature article.  The patient was a part of cohort study that aimed to determine whether Partial Splenic Embolization (PSE) was safe and effective in the pediatric population.  The study was a retrospective review of a single-center experience for all patients ages 0 to 21 who underwent PSE for the management of portal hypertension (PHTN) between January 2010 and August 2017. The study presented the experience with the use of this modality in different pediatric populations with PHTN to better understand the rationale for safe and appropriate application of this treatment. [In this study, [In this study, recommended PSE to patients with bleeding tendencies that were not optimal candidates for an open surgical shunt or repeated endoscopies. This includes the following patient populations: Patients with baseline compromised respiratory function (ie, cystic fibrosis [CF]). 2. Patients with significant synthetic dysfunction that may progress to liver failure after shunting. 3. Patients with early signs of encephalopathy that could potentially worsen with increased portal systemic shunting. 4. Patients with abnormal right heart function that could develop cardiac decompensation or shunt failure. 5. Patients deemed to be marginal candidates for repeated anesthesia. 6. Patients with splenic vein thrombosis. 7. Patients with characteristics predicting poor wound healing or other surgical complications. 8. Patients with unfavorable anatomy, increased transhepatic resistance, or elevated right heart pressures to permit mesoportal shunting (Rex shunt)]. The patient had thrombocytopenia and/or recurrent variceal bleeding. The patient had portal hypertension, whose etiology was autoimmune hepatitis (AIH) and started bleeding. The patient also noted to have evidence of varices before PSE which required endoscopic intervention. For this, the patient underwent endoscopic variceal ligation (EVL) before PSE. The patient had significant splenomegaly before PSE. The decision to proceed with PSE was determined by the primary hepatologist and surgeon after careful discussion with both patient and family members regarding alternative approaches. No information on patient's family history or concomitant medication was provided.   On an unspecified date, at least 2 weeks before PSE, the patient received unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (administration route and site unspecified, dosage unknown, batch number not provided for all), in order to reduce the risk of future infection by encapsulated organisms, should the procedure lead to a complication necessitating total splenectomy. The age of vaccination was not provided. It was reported that the patient received broad-spectrum intravenous antibiotic prophylaxis, typically with piperacillin/tazobactam, before the procedure to prevent infection of infarcted splenic tissue. This was continued for 5 to 7 days. On an unknown date, before PSE, the patient's platelet count was noted at 4510E9/L (normal range not provided).   On an unspecified date between January 2010 and August 2017, at least 2 weeks after vaccination, the patient underwent PSE by interventional radiology under general anesthesia via percutaneous femoral artery approach under sterile conditions utilizing guidelines based on the Spigos technique to minimize complications. At the time of PSE, the patient was not actively bleeding. Diagnostic angiographies of the celiac axis and splenic arteries were obtained to determine the target splenic arterial branches, to identify accessory branches to other tissues from the splenic artery and to determine baseline splenic volume. Abdominal sonograms with doppler analysis of hepatic and splenic vessels were performed post procedure to assess vessel patency and the degree of intra-abdominal-free fluid. Arteriograms of partial splenic embolization (PSE), pre-embolization with capillary blush demonstrated splenomegaly and post-embolization with capillary blush revealed multiple defects before and after esophageal varices.   Information regarding patient's blood transfusions was not available. The patient was admitted to hospital after PSE for further observation and management. [In this study, patients received patient-controlled analgesia for pain control and to prevent splinting and associated pulmonary complications such as atelectasis and pneumonia]. The patient did not develop infection with encapsulated organisms. Post-PSE, the patient's platelet count was 32910E9/L. the antibiotics were converted to an oral regimen before hospital discharge. [In this study, criteria for hospital discharge included adequate control of abdominal pain with oral medications, adequate oral intake/hydration, and absence of post procedure infection. Magnetic resonance imaging (MRI) showed splenomegaly and postembolization with necrotic areas surrounding the spleen. Three patients demonstrated complete resolution of varices. An additional 7 patients were noted to have a decrease in variceal grade].  On an unknown date, the patient was discharged fulfilling the criteria for hospital discharge that included (adequate control of abdominal pain with oral medications), adequate oral intake/hydration, and absence of post procedure infection. The patient was followed-up in the outpatient hepatology clinic. Hematologic indices including white blood cell (WBC) and platelet counts were monitored. Imaging was repeated as indicated. The patient developed dehydration and the patient was re-hospitalized. [In this study, 7 patients required readmission after initial discharge 2 of these patients were discharged only 1 day after PSE and returned the following day with fevers and abdominal pain with an unremarkable diagnostic evaluation].  Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.  This case has been considered as serious due to hospitalization.  The outcome of the event was not reported.  The author did not comment on the relationship between the event of recurrent dehydration and Unspecified Haemophilus influenzae type B vaccine, unspecified meningococcal vaccine and unspecified pneumococcal (PCV13 followed by PPSV23) vaccine. The author stated ""The Centers for Disease Control and Prevention recommends immunoprophylaxis against Streptococcus pneumoniae, H influenzae and Neisseria meningitidis in all splenectomized patients. Complications of PHTN such as hypersplenism, variceal hemorrhage, and ascites can lead to significant morbidity and mortality in children. Surgical interventions include shunting or splenectomy; however, overwhelming sepsis postsplenectomy is a pressing concern. PSE addresses portal hypertension regardless of etiology as definitive therapy. Most adverse effects following PSE are expected and can be managed conservatively. In our cohort we commonly observed fever, abdominal pain, and leukocytosis without evidence of infection. Pain was effectively controlled with intravenous and oral analgesics. Nonsteroidal anti-inflammatory drugs were avoided to minimize hemorrhage. In our experience, prophylactic antibiotics and limiting splenic reduction to no greater than 70% have avoided serious morbidity and mortality. In particular, there was no significant difference in the preprocedure platelet count between patients with and without recurrent thrombocytopenia. After PSE we noted a significant increase in platelets but to a lesser degree in patients who had recurrent hypersplenism. In our patients with esophageal varices, the combination of endoscopic ligation and PSE has been successful in controlling the progression of varices and decreasing the incidence of variceal hemorrhage.""  The author concluded ""our study supports that PSE is a safe, effective, semi-invasive alternative to splenectomy in pediatric patients with PHTN. The combination of EVL and PSE is effective treatment for esophageal and gastric varices (not amenable to simple band ligation). Reduced splenic volume and splenic venous return effectively decreased portal flow and pressure. PSE can be successfully performed in pre- and post-transplant transplant patients, and select cirrhotic and noncirrhotic pediatric patients. PSE appears to preserve functional spleen mass and avoids postprocedure accelerated liver disease or encephalopathy. In contrast to shunting, PSE can be effective even in the setting of elevated right-sided heart pressures. Further multicenter collaborative studies with larger and varied patient populations will need to be performed to substantiate our approach and better define patient populations that would benefit most from PSE, sequential PSE or combined interventions. Liver transplantation remains the ideal intervention for anyone with significant decompensated PHTN or advanced hepatic dysfunction"".  This is 1 of the 9 valid cases reported in this article.      Lab Comments: Lab test were performed on an unspecified date,The patient's hematologic indices including white blood cell (WBC) and platelet counts were monitored (result not provided). Imaging was repeated as indicated  (result not provided). Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.",,,,,Y,,,,U,,,,"Test Name: Endoscopy; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Platelet count; Result Unstructured Data: Test Result: 45 (before PSE), Test Result Unit: x10e9/L; Test Name: Platelet count; Result Unstructured Data: Test Result: 329 (Post PSE), Test Result Unit: x10e9/L; Test Name: White blood cells; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown",UNK,,PIPERACILLIN; TAZOBACTAM,Autoimmune hepatitis; Hemorrhage; Portal hypertension (etiology was autoimmune hepatitis); Varicosity (before PSE),Medical History/Concurrent Conditions: Splenomegaly; Varicose veins ligation,,USGLAXOSMITHKLINEUS2019GS,2,09/24/2019,,,,
0835553,09/24/2019,NY,,,,U,,"Bacteremia; This case was reported in a literature article and described the occurrence of bacteremia in a 7-year-old patient who received Haemophilus influenzae type b vaccine for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PCV13) for prophylaxis, PPSV23 PNEUMOCOCCAL VACCINE for prophylaxis, piperacillin for prophylaxis and tazobactam for prophylaxis.   The subject's past medical history included splenomegaly. Concurrent medical conditions included portal hypertension (etiology was portal vein thrombosis ), portal vein thrombosis (PVT) and varicosity.   On an unknown date, the patient received Haemophilus influenzae type b vaccine at an unknown dose, PCV13 at an unknown dose, PPSV23 PNEUMOCOCCAL VACCINE at an unknown dose, piperacillin (intravenous) at an unknown dose and frequency and tazobactam (intravenous) at an unknown dose and frequency. On an unknown date, more than a week after receiving Haemophilus influenzae type b vaccine, the patient experienced bacteremia (serious criteria hospitalization and GSK medically significant). The subject was treated with amoxicillin trihydrate (Amoxicillin) and clavulanic acid (Clavulanate). The action taken with piperacillin was unknown. The action taken with tazobactam was unknown. On an unknown date, the outcome of the bacteremia was unknown.   It was unknown if the reporter considered the bacteremia to be related to Haemophilus influenzae type b vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of bacteremia in a 7-year-old patient of unspecified gender who was vaccinated with unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (manufacturer unknown for all) for prophylaxis. This case corresponds to supplemental table 1 (patient 15) reported in this literature article.  The patient was a youngest patient of a cohort study that aimed to determine whether Partial Splenic Embolization (PSE) was safe and effective in the pediatric population.  The study was a retrospective review of a single-center experience for all patients ages 0 to 21 who underwent PSE for the management of portal hypertension (PHTN) between January 2010 and August 2017. The study presented the experience with the use of this modality in different pediatric populations with PHTN to better understand the rationale for safe and appropriate application of this treatment. [In this study, [In this study, recommended PSE to patients with bleeding tendencies that were not optimal candidates for an open surgical shunt or repeated endoscopies. This includes the following patient populations: Patients with baseline compromised respiratory function (ie, cystic fibrosis [CF]). 2. Patients with significant synthetic dysfunction that may progress to liver failure after shunting. 3. Patients with early signs of encephalopathy that could potentially worsen with increased portal systemic shunting. 4. Patients with abnormal right heart function that could develop cardiac decompensation or shunt failure. 5. Patients deemed to be marginal candidates for repeated anesthesia. 6. Patients with splenic vein thrombosis. 7. Patients with characteristics predicting poor wound healing or other surgical complications. 8. Patients with unfavorable anatomy, increased transhepatic resistance, or elevated right heart pressures to permit mesoportal shunting (Rex shunt)]. The patient had thrombocytopenia and/or recurrent variceal bleeding. The patient had portal hypertension, whose etiology was portal vein thrombosis (PVT) (no underlying liver disease) and the patient had a bleeding. The patient also noted to have varices before PSE. The patient had significant splenomegaly before PSE. The patient underwent surgical shunt before PSE. The decision to proceed with PSE was determined by the primary hepatologist and surgeon after careful discussion with both patient and family members regarding alternative approaches. No information on patient's family history or concomitant medication was provided.   On an unspecified date, at least 2 weeks before PSE, the patient received unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (administration route and site unspecified, dosage unknown, batch number not provided for all), in order to reduce the risk of future infection by encapsulated organisms, should the procedure lead to a complication necessitating total splenectomy. The age of vaccination was not provided. It was reported that the patient received broad-spectrum intravenous antibiotic prophylaxis, typically with piperacillin/tazobactam, before the procedure to prevent infection of infarcted splenic tissue. This was continued for 5 to 7 days. On an unknown date, before PSE, the patient's platelet count was noted at 5610E9/L (normal range not provided).   On an unspecified date between January 2010 and August 2017, at least 2 weeks after vaccination, the patient underwent PSE by interventional radiology under general anesthesia via percutaneous femoral artery approach under sterile conditions utilizing guidelines based on the Spigos technique to minimize complications. At the time of PSE, the patient was not actively bleeding. Diagnostic angiographies of the celiac axis and splenic arteries were obtained to determine the target splenic arterial branches, to identify accessory branches to other tissues from the splenic artery and to determine baseline splenic volume. Abdominal sonograms with doppler analysis of hepatic and splenic vessels were performed post procedure to assess vessel patency and the degree of intra-abdominal-free fluid. Arteriograms of partial splenic embolization (PSE), pre-embolization with capillary blush demonstrated splenomegaly and post-embolization with capillary blush revealed multiple defects before and after esophageal varices.   Information regarding patient's blood transfusions was not available. The patient was admitted to hospital after PSE for further observation and management. [In this study, patients received patient-controlled analgesia for pain control and to prevent splinting and associated pulmonary complications such as atelectasis and pneumonia]. The patient did not develop infection with encapsulated organisms. Post-PSE, the patient's platelet count was 18110E9/L. The antibiotics were converted to an oral regimen before hospital discharge. [In this study, criteria for hospital discharge included adequate control of abdominal pain with oral medications, adequate oral intake/hydration, and absence of post procedure infection. Magnetic resonance imaging (MRI) showed splenomegaly and postembolization with necrotic areas surrounding the spleen. Three patients demonstrated complete resolution of varices. An additional 7 patients were noted to have a decrease in variceal grade].  On an unknown date, the patient was discharged fulfilling the criteria for hospital discharge that included (adequate control of abdominal pain with oral medications), adequate oral intake/hydration, and absence of post procedure infection. The patient was followed-up in the outpatient hepatology clinic. Hematologic indices including white blood cell (WBC) and platelet counts were monitored. Imaging was repeated as indicated. The patient developed bacteremia and re-admitted 1 day after discharge secondary to Staphylococcus warneri treated with a change in oral antibiotic from amoxicillin/clavulanate to levofloxacin after sensitivities were reported.  [In this study, 7 patients required readmission after initial discharge 2 of these patients were discharged only 1 day after PSE and returned the following day with fevers and abdominal pain with an unremarkable diagnostic evaluation].  Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.    This case has been considered as serious due to hospitalization.  The outcome of the event was not reported.  The author did not comment on the relationship between the event of bacteremia and Unspecified Haemophilus influenzae type B vaccine, unspecified meningococcal vaccine and unspecified pneumococcal (PCV13 followed by PPSV23) vaccine. The author stated ""The Centers for Disease Control and Prevention recommends immunoprophylaxis against Streptococcus pneumoniae, H influenzae and Neisseria meningitidis in all splenectomized patients. Complications of PHTN such as hypersplenism, variceal hemorrhage, and ascites can lead to significant morbidity and mortality in children. Surgical interventions include shunting or splenectomy; however, overwhelming sepsis postsplenectomy is a pressing concern. PSE addresses portal hypertension regardless of etiology as definitive therapy. Most adverse effects following PSE are expected and can be managed conservatively. In our cohort we commonly observed fever, abdominal pain, and leukocytosis without evidence of infection. Pain was effectively controlled with intravenous and oral analgesics. Nonsteroidal anti-inflammatory drugs were avoided to minimize hemorrhage. In our experience, prophylactic antibiotics and limiting splenic reduction to no greater than 70% have avoided serious morbidity and mortality. In particular, there was no significant difference in the preprocedure platelet count between patients with and without recurrent thrombocytopenia. After PSE we noted a significant increase in platelets but to a lesser degree in patients who had recurrent hypersplenism. In our patients with esophageal varices, the combination of endoscopic ligation and PSE has been successful in controlling the progression of varices and decreasing the incidence of variceal hemorrhage.""  The author concluded ""our study supports that PSE is a safe, effective, semi-invasive alternative to splenectomy in pediatric patients with PHTN. The combination of EVL and PSE is effective treatment for esophageal and gastric varices (not amenable to simple band ligation). Reduced splenic volume and splenic venous return effectively decreased portal flow and pressure. PSE can be successfully performed in pre- and post-transplant transplant patients, and select cirrhotic and noncirrhotic pediatric patients. PSE appears to preserve functional spleen mass and avoids postprocedure accelerated liver disease or encephalopathy. In contrast to shunting, PSE can be effective even in the setting of elevated right-sided heart pressures. Further multicenter collaborative studies with larger and varied patient populations will need to be performed to substantiate our approach and better define patient populations that would benefit most from PSE, sequential PSE or combined interventions. Liver transplantation remains the ideal intervention for anyone with significant decompensated PHTN or advanced hepatic dysfunction"".  This is 1 of the 9 valid cases reported in this article.      Lab Comments: Lab test were performed on an unspecified date, The patient's hematologic indices including white blood cell (WBC) and platelet counts were monitored (result not provided). Imaging was repeated as indicated  (result not provided). Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.",,,,,Y,1,,,U,,,,"Test Name: Bacterial test; Result Unstructured Data: Test Result: Staphylococcus warneri, Test Result Unit: unknown; Test Name: Endoscopy; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Platelet count; Result Unstructured Data: Test Result: 56 (before PSE), Test Result Unit: x10e9/L; Test Name: Platelet count; Result Unstructured Data: Test Result: 181 (Post PSE), Test Result Unit: x10e9/L; Test Name: White blood cells; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown",UNK,,PIPERACILLIN; TAZOBACTAM,Hemorrhage; Portal hypertension (etiology was portal vein thrombosis); Portal vein thrombosis (PVT); Varicosity,Medical History/Concurrent Conditions: Splenomegaly,,USGLAXOSMITHKLINEUS2019GS,2,09/24/2019,,,,
0835554,09/24/2019,NY,,,,U,,"Abdominal pain; This case was reported in a literature article and described the occurrence of abdominal pain in a 19-year-old patient who received Haemophilus influenzae type b vaccine for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PCV13) for prophylaxis, PPSV23 PNEUMOCOCCAL VACCINE for prophylaxis, piperacillin for prophylaxis and tazobactam for prophylaxis.   The subject's past medical history included varicose veins ligation and splenomegaly. Concurrent medical conditions included portal hypertension (etiology was cystic fibrosis), cystic fibrosis, hemorrhage and varicosity (before PSE).   On an unknown date, the patient received Haemophilus influenzae type b vaccine at an unknown dose, PCV13 at an unknown dose, PPSV23 PNEUMOCOCCAL VACCINE at an unknown dose, piperacillin (intravenous) at an unknown dose and frequency and tazobactam (intravenous) at an unknown dose and frequency. On an unknown date, more than a week after receiving Haemophilus influenzae type b vaccine, the patient experienced abdominal pain (serious criteria hospitalization). The action taken with piperacillin was unknown. The action taken with tazobactam was unknown. On an unknown date, the outcome of the abdominal pain was unknown.   It was unknown if the reporter considered the abdominal pain to be related to Haemophilus influenzae type b vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of abdominal pain in a 19-year-old patient of unspecified gender who was vaccinated with unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (manufacturer unknown for all) for prophylaxis. This case corresponds to supplemental table 1 (patient 24) reported in this literature article.  The patient was a part of cohort study that aimed to determine whether Partial Splenic Embolization (PSE) was safe and effective in the pediatric population.  The study was a retrospective review of a single-center experience for all patients ages 0 to 21 who underwent PSE for the management of portal hypertension (PHTN) between January 2010 and August 2017. The study presented the experience with the use of this modality in different pediatric populations with PHTN to better understand the rationale for safe and appropriate application of this treatment. [In this study, [In this study, recommended PSE to patients with bleeding tendencies that were not optimal candidates for an open surgical shunt or repeated endoscopies. This includes the following patient populations: Patients with baseline compromised respiratory function (ie, cystic fibrosis [CF]). 2. Patients with significant synthetic dysfunction that may progress to liver failure after shunting. 3. Patients with early signs of encephalopathy that could potentially worsen with increased portal systemic shunting. 4. Patients with abnormal right heart function that could develop cardiac decompensation or shunt failure. 5. Patients deemed to be marginal candidates for repeated anesthesia. 6. Patients with splenic vein thrombosis. 7. Patients with characteristics predicting poor wound healing or other surgical complications. 8. Patients with unfavorable anatomy, increased transhepatic resistance, or elevated right heart pressures to permit mesoportal shunting (Rex shunt)]. The patient had thrombocytopenia and/or recurrent variceal bleeding. The patient had portal hypertension, whose etiology was cystic fibrosis (CF), and had bleeding. The patient also noted to have evidence of varices before PSE which required endoscopic intervention. For this, the patient underwent endoscopic variceal ligation (EVL) before PSE. The patient had significant splenomegaly before PSE. The decision to proceed with PSE was determined by the primary hepatologist and surgeon after careful discussion with both patient and family members regarding alternative approaches. No information on patient's family history or concomitant medication was provided.   On an unspecified date, at least 2 weeks before PSE, the patient received unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (administration route and site unspecified, dosage unknown, batch number not provided for all), in order to reduce the risk of future infection by encapsulated organisms, should the procedure lead to a complication necessitating total splenectomy. The age of vaccination was not provided. It was reported that the patient received broad-spectrum intravenous antibiotic prophylaxis, typically with piperacillin/tazobactam, before the procedure to prevent infection of infarcted splenic tissue. This was continued for 5 to 7 days. On an unknown date, before PSE, the patient's platelet count was noted at 5010E9/L (normal range not provided).   On an unspecified date between January 2010 and August 2017, at least 2 weeks after vaccination, the patient underwent PSE by interventional radiology under general anesthesia via percutaneous femoral artery approach under sterile conditions utilizing guidelines based on the Spigos technique to minimize complications. At the time of PSE, the patient was not actively bleeding. Diagnostic angiographies of the celiac axis and splenic arteries were obtained to determine the target splenic arterial branches, to identify accessory branches to other tissues from the splenic artery and to determine baseline splenic volume. Abdominal sonograms with doppler analysis of hepatic and splenic vessels were performed post procedure to assess vessel patency and the degree of intra-abdominal-free fluid. Arteriograms of partial splenic embolization (PSE), pre-embolization with capillary blush demonstrated splenomegaly and post-embolization with capillary blush revealed multiple defects before and after esophageal varices.   Information regarding patient's blood transfusions was not available. The patient was admitted to hospital after PSE for further observation and management. [In this study, patients received patient-controlled analgesia for pain control and to prevent splinting and associated pulmonary complications such as atelectasis and pneumonia]. The patient underwent EVL intervention. The patient did not develop infection with encapsulated organisms. Post-PSE, the patient's platelet count was 13610E9/L. The patient reported to improve respiratory mechanics post-PSE presumably secondary to reduction in spleen size and avoiding the negative impact of additional anesthesia. The antibiotics were converted to an oral regimen before hospital discharge. [In this study, criteria for hospital discharge included adequate control of abdominal pain with oral medications, adequate oral intake/hydration, and absence of post procedure infection. Magnetic resonance imaging (MRI) showed splenomegaly and postembolization with necrotic areas surrounding the spleen. Three patients demonstrated complete resolution of varices. An additional 7 patients were noted to have a decrease in variceal grade].  On an unknown date, the patient was discharged fulfilling the criteria for hospital discharge that included (adequate control of abdominal pain with oral medications), adequate oral intake/hydration, and absence of post procedure infection. The patient was followed-up in the outpatient hepatology clinic. Hematologic indices including white blood cell (WBC) and platelet counts were monitored. Imaging was repeated as indicated. The patient developed abdominal pain and the patient was re-hospitalized. [In this study, 7 patients required readmission after initial discharge 2 of these patients were discharged only 1 day after PSE and returned the following day with fevers and abdominal pain with an unremarkable diagnostic evaluation].  Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.  This case has been considered as serious due to hospitalization.  The outcome of the event was not reported.  The author did not comment on the relationship between the event of abdominal pain and Unspecified Haemophilus influenza type B vaccine, unspecified meningococcal vaccine and unspecified pneumococcal (PCV13 followed by PPSV23) vaccine. The author stated ""The Centers for Disease Control and Prevention recommends immunoprophylaxis against Streptococcus pneumoniae, H influenzae and Neisseria meningitidis in all splenectomized patients. Complications of PHTN such as hypersplenism, variceal hemorrhage, and ascites can lead to significant morbidity and mortality in children. Surgical interventions include shunting or splenectomy; however, overwhelming sepsis postsplenectomy is a pressing concern. PSE addresses portal hypertension regardless of etiology as definitive therapy. Most adverse effects following PSE are expected and can be managed conservatively. In our cohort we commonly observed fever, abdominal pain, and leukocytosis without evidence of infection. Pain was effectively controlled with intravenous and oral analgesics. Nonsteroidal anti-inflammatory drugs were avoided to minimize hemorrhage. In our experience, prophylactic antibiotics and limiting splenic reduction to no greater than 70% have avoided serious morbidity and mortality. In particular, there was no significant difference in the preprocedure platelet count between patients with and without recurrent thrombocytopenia. After PSE we noted a significant increase in platelets but to a lesser degree in patients who had recurrent hypersplenism. In our patients with esophageal varices, the combination of endoscopic ligation and PSE has been successful in controlling the progression of varices and decreasing the incidence of variceal hemorrhage.""  The author concluded ""our study supports that PSE is a safe, effective, semi-invasive alternative to splenectomy in pediatric patients with PHTN. The combination of EVL and PSE is effective treatment for esophageal and gastric varices (not amenable to simple band ligation). Reduced splenic volume and splenic venous return effectively decreased portal flow and pressure. PSE can be successfully performed in pre- and post-transplant transplant patients, and select cirrhotic and noncirrhotic pediatric patients. PSE appears to preserve functional spleen mass and avoids postprocedure accelerated liver disease or encephalopathy. In contrast to shunting, PSE can be effective even in the setting of elevated right-sided heart pressures. Further multicenter collaborative studies with larger and varied patient populations will need to be performed to substantiate our approach and better define patient populations that would benefit most from PSE, sequential PSE or combined interventions. Liver transplantation remains the ideal intervention for anyone with significant decompensated PHTN or advanced hepatic dysfunction"".  This is 1 of the 9 valid cases reported in this article.       Lab Comments: Lab test were performed on an unspecified date, The patient's hematologic indices including white blood cell (WBC) and platelet counts were monitored (result not provided). Imaging was repeated as indicated  (result not provided). Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.",,,,,Y,,,,U,,,,"Test Name: Endoscopy; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Platelet count; Result Unstructured Data: Test Result: 50 (before PSE), Test Result Unit: x10e9/L; Test Name: Platelet count; Result Unstructured Data: Test Result: 136 ( Post PSE), Test Result Unit: x10e9/L",UNK,,PIPERACILLIN; TAZOBACTAM,Cystic fibrosis; Hemorrhage; Portal hypertension (etiology was cystic fibrosis); Varicosity (before PSE),Medical History/Concurrent Conditions: Splenomegaly; Varicose veins ligation,,USGLAXOSMITHKLINEUS2019GS,2,09/24/2019,,,,
0835555,09/24/2019,MI,,,,F,,"Painful lump in arm pit; Pain in her whole upper arm/ Pain at injection site; very painful to touch; This case was reported by a physician via call center representative and described the occurrence of axillary lump in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th September 2019, the patient received Shingrix (intramuscular). In September 2019, 3 days after receiving Shingrix, the patient experienced axillary lump, injection site pain and tenderness. The patient was treated with levomenthol (Icy Hot Patch). On an unknown date, the outcome of the axillary lump, injection site pain and tenderness were not recovered/not resolved.   It was unknown if the reporter considered the axillary lump, injection site pain and tenderness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient had the Shingrix in right deltoid three days later physician noted the lump in the right arm pit, in the anterior aspect of her upper right arm. The lump was about one and a half to two inches in diameter. Physician states she also has injection site pain and pain in her whole upper arm. She notes the arm was still very painful to touch now.  The patient put Icy Hot pain patches on it for the last week and it helped. The whole upper arm was still sore to touch. The lump, the pain at the injection site, and upper arm pain are ongoing as of the time of this call.  The reporter consented to follow up. No further details were provided.  The physician consents to follow up.",,,,,,,,,N,09/11/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/24/2019,,,,
0835556,09/24/2019,LA,78.0,78,,F,,"Cardiac arrhythmia; This case was reported by a pharmacist via call center representative and described the occurrence of cardiac arrhythmia in a 78-year-old female patient who received Herpes zoster (Shingrix) (batch number 9JG52, expiry date 27th September 2021) for prophylaxis.   Concomitant products included INFLUENZA VIRUS VACCINE INACTIVATED (FLUZONE HD).   On 16th September 2019 09:26, the patient received the 1st dose of Shingrix .5 ml. On 17th September 2019, 1 days after receiving Shingrix, the patient experienced cardiac arrhythmia (serious criteria GSK medically significant). On an unknown date, the outcome of the cardiac arrhythmia was recovered/resolved.   It was unknown if the reporter considered the cardiac arrhythmia to be related to Shingrix.  Additional details were provided as follows: The patient also received Fluzone HD vaccine at the same time as Shingrix. The patient received Shingrix on left arm. The patient experienced cardiac arrhythmia.  The patient had experienced the event for 2 and half hours when the pharmacist called GSK.  The reporter consented to follow up.",,,,,,,,,Y,09/16/2019,,,,PHM,,FLUZONE HD,,,,USGLAXOSMITHKLINEUS201916,2,09/24/2019,,,,
0835557,09/24/2019,WA,72.0,72,,F,,"Suspected vaccination failure; Shingles flare up; Rash and Shingles flare up; This case was reported by a pharmacist via call center representative and described the occurrence of suspected vaccination failure in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th August 2019, the patient received Shingrix. On 17th September 2019, 35 days after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and rash. On an unknown date, the outcome of the vaccination failure, shingles and rash were unknown.   The reporter considered the vaccination failure, shingles and rash to be unrelated to Shingrix.  Additional case details were reported as follows: The patient had rash and shingles flare up after taking Shingrix. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles and laboratory confirmation for herpes zoster were not provided.",,,,,,,,,U,08/13/2019,09/17/2019,35,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/24/2019,,,,
0835558,09/24/2019,MN,,1,.3,M,09/20/2019,"3"" diameter AREA of ERYTHEMA, WARMTH, & FULLNESS",,,,Y,,,,,,09/09/2019,09/18/2019,9,None,PVT,PVT,,NONE,EGGS ALLERGY,,,1,,,,,
0835559,09/24/2019,,35.0,35,,F,,"Patient experienced a rash/hives on the back of her neck roughly an hour or so after receiving the vaccination. She took diphenhydramine 25mg  to help with the itching, which helped to decrease the rash and itching.",,,,,,,,,,09/24/2019,09/24/2019,0,,UNK,,,,,,,2,09/24/2019,,,,
0835560,09/24/2019,MN,68.0,68,,F,,Patient experienced a large red injection site reaction. Was warm to touch. Mildly itchy. Covered about a hand sized area of the upper arm.,,,,,,,,,U,09/13/2019,09/14/2019,1,,PHM,,,,,,,2,09/24/2019,,,,
0835561,09/24/2019,FL,58.0,58,,F,,"patient reports arm to be red, in pain, swollen. also, patient reports fever of 101",,,,,,,,,,09/22/2019,09/22/2019,0,,UNK,,,,,,,2,09/24/2019,,,Y,
0835562,09/24/2019,PA,71.0,71,,F,,"Patient reported 9-24-19 for a flu shot and showed her left arm which had a dime sized rash on it, about 2.5 to 3 inches from top of arm. She said it tingles for alittle bit and then it hurts in that area in what she calls a nerve type pain. It lasts around thirty minutes and goes away. When the tingling comes, the rash shows up. The dime size of rash never goes away but it gets redder when the tingling happens which is followed by the pain. It happens maybe once a month.",,,,,,,,,Y,12/18/2018,01/01/2019,14,,PHM,,,,,,,2,09/24/2019,,,,
0835563,09/24/2019,WV,47.0,47,,F,,Tinnitus occurred at 0400 the day after administration. Tinnitus not accompanied by any other complaints or symptoms. No deafness. Tinnitus intermittent in nature.,,,,,,,,,N,09/23/2019,09/24/2019,1,none - pending. patient wants to watch and wait x 2-3 days before coming in for an appt,PVT,,"losartan, kariva",HTN,HTN,,,2,09/24/2019,,,,NKDA
0835564,09/24/2019,PR,43.0,43,,F,,"Patient presented with erythema, pain redness and rash on the area where the vaccine was administered. She has been on panadol so doesn't  know if she has been on fever. Medical evaluation was recommended as soon as possible.",,,,,,,,,U,09/11/2019,09/13/2019,2,none,PHM,,,None reported,None,,,2,09/24/2019,,Y,,NKDA
0835565,09/24/2019,,67.0,67,,F,,"3-4 inch diameter rash on left arm around injection site. Not raised, itchy, or hot.",,,,,,,,,,09/20/2019,09/21/2019,1,,PHM,,,,,,,2,09/24/2019,,,,NKDA
0835566,09/24/2019,,17.0,17,,F,,"Mother called with concerns about side-effects from vaccines (nausea, dizziness).  She stated that she told her child to ""sleep it off"" and is checking on her periodically throughout the day.  I asked if child had high fever or unusual behavior, which mom denied. I told her that while it is not uncommon to have side effects to vaccines, that she should seek medical attention if they persist or become worse.  I asked her whether the child had a family doctor to seek attention.  Mom stated ""she is fine.  Have a nice day.""  That was the end of the call.  I will F/U with VAERS report.",,,,,,,,,,09/23/2019,09/23/2019,0,,UNK,,Parent stated none.,Parent stated none.,Parent stated none.,,,2,09/24/2019,,,,Parent stated none.
0835567,09/24/2019,CA,77.0,77,,M,,"Reported on 9-20-2019 that beginning 1-2 days after receiving flu vaccine on 9-13-2019, of gradual spread to overall torso and extremities pinhead to pinpoint sized raised reddened bumps, with slight itchiness. Stated was diagnosed by own dermatologist with ""angry skin"". Bumps remain 1 week after injection but diminishing.",,,,,,,,,U,09/13/2019,09/14/2019,1,,OTH,,,,"DM II, HTN, CAD",,,2,09/24/2019,,Y,,nka
0835568,09/24/2019,OH,54.0,54,,F,,"Severe hives reaction starting in left arm (shingrix, heplisav site) and then spreading to entire abdomen, torso, trunk.  Required visit to ED to receive prednisone, antihistamines and monitoring.  Pt did not report and other symptom and was discharged without any other incidents.  Will finish steroid course and antihistamines at home.",,,,,,,,,Y,09/17/2019,09/17/2019,0,none disclosed.,PHM,,Glipizide  Losartan atorvastatin metformin,no acute illness,diabetes coclear implants hypertenstion,"Pneumovax 23-fatigue, fevers, chills",,2,09/24/2019,,,Y,kelfex (cephalosporins)
0835569,09/24/2019,IL,77.0,77,,F,,Patient is experiencing swelling and redness to the touch at and around the area of the injection site. Has been progressively getting worse since time of administration,,,,,,,,,N,09/22/2019,09/22/2019,0,,PHM,,"Losartan/HCTZ 100/25, fluoxetine 20mg,  Multivitamin, vegetable supplement, b12",,,,,2,09/24/2019,,Y,,penicillin allgery
0835570,09/24/2019,NY,86.0,86,,F,,soon after receiving patient felt faint and fell,,,,,,,,,U,09/24/2019,09/24/2019,0,,PHM,,"flomax, xarelto, liptor, ferrous gluconate, amlodipine, levothyroxine, metoprolol, aricept",,"bph, hbp,",,,2,09/24/2019,,,Y,
0835571,09/24/2019,MI,4.0,4,,M,,The nurse administered TDap instead of DTap,,,,,,,,,,09/23/2019,09/23/2019,0,none,PVT,,None,,,,,2,09/24/2019,,Y,,"NKDA, peanuts"
0835572,09/24/2019,,30.0,30,,F,,Right after receiving the injection patient was sweaty and c/o feeling dizzy.,,,,,,,,,Y,09/24/2019,09/24/2019,0,,PUB,,,,,,,2,09/24/2019,,,,
0835573,09/24/2019,MI,61.0,61,,M,,"The patient's mother contacted pharmacy on 9/23/19 at 1:30pm to report after receiving immunizations on 9/13/19 the patient arrived home about 1 pm and was fine but at about 5pm later the same day the patient began experiencing exasperated symptoms of his M.S. According to mother, patient's neurologist was contacted on Saturday 9/14 and recommended patient proceed to hospital. The patient refused to go to the hospital until Sunday 9/15 when he was transported and hospitalized. The patient was discharged ""Wednesday or Thursday"" per mother.",,,,,Y,4,,,U,09/13/2019,09/13/2019,0,N/A,PHM,,N/A,multiple sclerosis,multiple sclerosis,,,2,09/24/2019,,,,NKA
0835574,09/24/2019,MI,16.0,16,,F,,"Mother called??patient started with hives-like rash on 9/21 on the upper and lower back. No fever, no other symptoms. No changes in soaps, detergents, fabric softeners. Concerned about association with vaccine??Menactra given. No local injection site symptoms. With Benadryl, hives are dissipating.  Recommended Zyrtec 10 mg daily until rash is gone.",,,,,,,,,U,09/17/2019,09/21/2019,4,,PVT,,,none,none,,,2,09/24/2019,,Y,,NKA
0835575,09/24/2019,AR,54.0,54,,F,,"Patient received vaccination on 11/12/2018. She contacted the office on 11/19/2019 stating she was having shoulder pain in the same arm she received the vaccination. Patient was seen for follow up in the clinic. X-rays were negative. She was treated with steroids and advised if not better would consider MRI. Patient completed steroids and continued to have pain. She was sent for MRI Left Shoulder on 11/29/2018 which revealed tendonitis. Patient was given the options of Physical therapy, Orthopedic referral or treatment with oral NSAIDs. Patient requested to think it over and call back with decision. On 12/3/18 patient called back stating that she would like to see an orthopedist and a referral was started.",,,,,,,,,N,11/12/2018,11/13/2018,1,Physical exam and Xray on 11/13/2018 MRI Left Shoulder 11/29/2018,PVT,,? aspirin 81 mg EC tablet Take 81 mg by mouth daily.   ? IBUPROFEN ORAL Take 200 mg by mouth as needed.   ? multivitamin tablet Take 1 tablet by mouth daily.   ? Omega-3 Fatty Acids (FISH OIL) 300 mg Capsule Take  by mouth daily,Sinobronchitis and conjunctivitis 10/18/2018,Hyperlipidemia,,,2,09/24/2019,,Y,,NKA
0835576,09/24/2019,IN,76.0,76,,F,,"Weakness and fatigue, muscle and joint aches so bad she couldn't get up.",,,,,,,,,Y,09/23/2019,09/23/2019,0,none,PVT,,Dyazide Proventil Lipitor D3 Spiriva Zanaflex protonix Percocet Ativan atarax Lasix Advair Flonase Lexapro Voltaren Nopramin Fosamax ASA Flulaval given at same time as Shingrix,none,"Copd,   gerd,  hypothyroidism, osteoarthritis, osteoporosis, Hypertension, urticaria, insomnia, anemia",,,2,09/24/2019,,,,Talwin codeine hydrocodone
0835577,09/24/2019,TX,23.0,23,,F,,"left arm in which the vaccine was administered began to swell and experienced pain in her chest. Also, a rash began to develop around the injection site. Patient instructed to take Benadryl and Motrin. Instructed to go to urgent care as she later stated she has a pork allergy (gelatin in vaccine is of porcine derivate)",,,,,,,,,U,09/23/2019,09/23/2019,0,,PHM,,none listed,none listed,none listed,,,2,09/24/2019,,,Y,pork allergy
0835578,09/24/2019,OH,80.0,80,,F,,Patient came in and showed us her arm. She had a huge bruise going 4 inches below the injection site saying that she had more pain than usual after the injection. She also stated it was hard for her to sleep on that side for a day or two after.,,,,,,,,,,09/20/2019,09/21/2019,1,,PHM,,aspirin 81mg,,,,,2,09/24/2019,,,,
0835579,09/24/2019,OR,67.0,67,,M,,Patient reports severe burning in mid section after 2nd Shingrix vaccination.  Patient stated it started at least 2 weeks ago (~9-1-19).  Patients primary care physician treated patient (unknown treatment) and sent him to us (pharmacy) to report to VAERS.,,,,,,,,,N,06/13/2019,09/01/2019,80,,PHM,,,,,,,2,09/24/2019,,Y,,
0835580,09/24/2019,NC,60.0,60,,F,,"On Friday 9/20/19 pt and RN discussed if pt should get varicella vaccine because pt reported having disease as a child and also having shingles as an adult so it was decided to not give and just give mmr and tdap and get blood drawn for varicella antibodies for pre-employment. When nurse went to ddraw up vaccines she grabbed the varicella instead of the mmr and worote the varicella lot # under the mmr on the inventory tracking list. Later when inventory was being counted it was found that there was 1 extra dose of mmr and short a dose of varicella and the nurse checked the lot she wrote and found it was for varicella. Pt was then contacted and she came in to get the mmr she needed. Called pt on Tues 9/24/19 and she reports she had been very ill over weekend reporting severe flu like symptoms including malaise, fatigue, nausea, body aches severe joint pain, warm, red swollen left arm at site of Varicella injection. Pt reports she took ibuprofen multiple times throughout the weekend but helped very little but does not think she ran a fever. She reports now she is feeling fine and inflammation improved at site. of injection",,,,,,,,,Y,09/20/2019,09/21/2019,1,,PUB,,NONE REPORTED,NONE REPORTED,NONE REPORTED,,,2,09/24/2019,,,,NONE REPORTED
0835581,09/24/2019,CO,44.0,44,,F,,"Pt. vaccinated  with the Flu vaccine on 9/23/2019 at 1515, noted itching and ""skin crawling"" in all her extremities and stomach at approximately 2230 symptoms continued through the night and until the next morning.  Denies any visible rash.  Reported to Occupational Heath the next morning 9/24/2019.",,,,,,,,,Y,09/23/2019,09/23/2019,0,none,PVT,,,None reported,,,,2,09/24/2019,,,,Hay fever
0835582,09/24/2019,AR,11.0,11,,M,,"After receiving vaccines patient fainted for approx. 5-10 seconds. Client was assisted to lying position. Client quickly started talking and following at commands. Vital sign: B/P=112/71, HR=53, pulse ox 99%. Client given water and snack. Client stated he was nervous and was holding his breath. 2nd set of Vital signs taken 10 minutes after 1st set: B/P=10/68, HR=50, pulse ox=99%.  Mother present and child left with mother.",,,,,,,,,Y,09/23/2019,09/23/2019,0,"Vital signs. Alert, Awake and following all given commands. Moving all extremities,",PVT,,no known,no,no,,,2,09/24/2019,,,,no
0835583,09/24/2019,WA,67.0,66,,F,,"Deep pain in right arm, Diarrhea, up set stomach, vomiting, fever.",,,,,,,,,N,09/23/2019,09/23/2019,0,"ER visit, Lab test, medications given",PVT,,none,none,Knee problem,,,2,09/24/2019,,,Y,none
0835584,09/24/2019,NM,81.0,81,,F,,Large rash developed with bruising in the center. Patient reports sensitivity on skin as well as slightly irritation and itchiness.,,,,,,,,,N,09/21/2019,09/22/2019,1,,PHM,,Unknown,,,,,2,09/24/2019,,,,None
0835585,09/24/2019,OK,20.0,20,,F,,Patient said about a minute after receiving vaccine that she felt like she was going to faint. She put her head down and then fainted. I caught her and lowered her to ground. She tensed up and shook a little and was unconscious. I called 911 and she became conscious in less than a minute. Paramedics arrived and took over.,,,,,,,,,Y,09/24/2019,09/24/2019,0,,PHM,,Oral contraceptive,,Asthma,,,2,09/24/2019,,,,No known
0835586,09/24/2019,IL,53.0,53,,F,,"Patient reported redness, swelling, and itching below the injection site that developed 3 days after the vaccination.  She stated that she took Benadryl for the symptoms.  2 days later, the redness and swelling subsided, but some itching remained if she did not take the Benadryl.",,,,,,,,,U,09/10/2019,09/13/2019,3,None,PHM,,None known,None known,None known,,,2,09/24/2019,,,,No
0835587,09/24/2019,GA,51.0,51,,F,,Tingling in all limbs and both hands and feet. Parenthesis in both hands and feet,,,,,,,,,U,09/20/2019,09/21/2019,1,,PHM,,"Rantindine,levothyroxine, claritine, glimperide, gabapentin, amitriptolinemetformin, trulicity, levimir,",Weakened vertibrae,"High blood pressure, obesity, hypothyroide",,,2,09/24/2019,,Y,,"Originators,  all pain medicine, acitametafin"
0835588,09/24/2019,PA,46.0,46,,F,,"no initial reaction.  24 hours post vaccination bruising present at injection site spreading to swelling which spread from the shoulder to the elbow.  patient stated the entire surface of the arm was raised, red and swollen.  1 week after there is no residual swelling and minor bruising left.  no bursitis, no tingling, no pain currently.  injection site based on bruised area was correct.",,,,,,,,,Y,09/18/2019,09/19/2019,1,,PHM,,,,,,,2,09/24/2019,,,,
0835589,09/24/2019,VA,72.0,72,,F,,"PATIENT stated she experienced nausea, vomiting, dizziness, joint ache, tachycardia, blurred vision, chills, she stated she wanted to die",,,,,,,,,U,09/19/2019,09/22/2019,3,,PHM,,"Ezetimibe, Ipatropium,Olopatadine (patient stated)",n/a,n/a,,,2,09/24/2019,,,,nkda
0835590,09/24/2019,ND,20.0,20,,F,,"I was given the shot at approximately 8:30 am. I left the clinic and was driving home. At approximately 8:45 am, I had to pull over because I felt very drowsy. As soon as I pulled over, I got very tingly and blacked out. I?m unsure how long I was unconscious. I woke up and I decided to try to make it home. I parked in the parking lot at my apartment building where I blacked out again, this time having severe shakes. I managed to take a Zofran as I felt like I was going to vomit. I called 911 because I kept falling in and out of unconsciousness. I managed to tell the dispatcher where I was at and what car I was in, but again, I fell unconscious. I woke up to paramedics banging on my car windows because my car door was locked. I unlocked it before starting to pass out again. My blood sugar and blood pressure was taken. My blood sugar was 96, and I cannot remember my blood pressure. I had a weak pulse so they had to use a stethoscope to take my pulse. I do not remember what my pulse was either. I cannot afford a hospital visit so I asked the paramedics to just take my to my bedroom, and help me lie down. I have been in bed since. During these black out events, I was tingling all over my body, I could hear - but it sounded like I was underwater, I had very dry mouth and I was very sick to my stomach. As of right now, it?s been 7 hours since receiving the vaccine and I have a strong headache, and feel generally unwell and lethargic. I am 26 weeks pregnant with an expected due date of December 26th, 2019. I have not noticed any issues with my baby. He is moving around normally.",,,,,,,,,Y,09/24/2019,09/24/2019,0,Blood sugar test: 96  Blood pressure and heart rate were taken but I cannot remember the results.,PUB,,"Omeprazole, Zofran, Flintstone vitamins",None,Ehlers Danlos Syndrome,,,2,09/24/2019,,,,Pineapple
0835596,09/24/2019,CO,,,,M,,"This pharmacist reports giving the patient the MMR II vaccine which was reconstituted with expired diluent; Route: Subdermic; This spontaneous report was received from a pharmacist and refers to a 59 year old male patient. The patient's past medical history, concurrent conditions and concomitant medications were unknown. On 30-AUG-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), lot # M044952 (expiration date not reported), subdermally for prophylaxis. The vaccine was reconstituted with an expired sterile diluent.  Lot numberM044952 is an invalid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live.",,,,,,,,,U,08/30/2019,08/30/2019,0,,UNK,,Sterile diluent,Prophylaxis,,,US0095075131909USA001425,2,09/24/2019,,,,
0835597,09/24/2019,NY,,,,M,,"Shingles; Information has been received from a lawyer regarding a case in litigation, referring to a male pt of unknown age. Information regarding the pt's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. In 2014, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (route of administration, strength, dose, lot # and expiration date were not provided) by a healthcare provider at a physician's office for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date, the pt was treated at a physician office for shingles. As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, had and would continued to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, included but not limited to medical losses and costs which included care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. At the time of the report, the outcome of herpes zoster was considered as not recovered. The lawyer considered herpes zoster to be related to zoster vaccine Live (ZOSTAVAX).",,,,,Y,,,,N,,,,,OTH,,,,,,US0095075131909USA006320,2,09/24/2019,,Y,,
0835598,09/24/2019,IL,,,,F,,"Shingles; Information has been received from a lawyer regarding a case in litigation, referring to a female pt of unknown age. Information regarding the pt's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. In or about 2014, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (route of administration, strength, dose, lot # and expiration date were not provided) by a physician at a medical center for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date, the pt was treated at a physician office for shingles. As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, had and would continued to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, included but not limited to medical losses and costs which included care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. At the time of the report, the outcome of herpes zoster was considered as not recovered. The lawyer considered herpes zoster be related to zoster vaccine Live (ZOSTAVAX).",,,,,Y,,,,N,,,,,OTH,,,,,,US0095075131909USA006321,2,09/24/2019,,Y,,
0835599,09/24/2019,GA,,,,F,,"pregnant when she received a dose of MMR Il; This spontaneous retrospective pregnancy report was received from a nurse regarding a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, when the patient was pregnant, she was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, strength, route of administration, lot number and expiration date were not reported) for prophylaxis (exposure during pregnancy). The vaccine was reconstituted with a sterile diluent. The Last Menstrual Period (LMP) and Estimated Date of Delivery (EDD) was unknown. On an unknown date, the patient delivered a child (live birth). The child had unspecified developmental delays. The outcome of exposure during pregnancy was recovered.  This case is cross referenced with 1909USA008792 (child case).",,,,,,,,,Y,,,,,UNK,,Sterile diluent,,,,US0095075131909USA006681,2,09/24/2019,,,,
0835600,09/24/2019,OK,,,,F,,"The Patient had two previous doses in unspecified date in 2007 or 2008 and on an unspecified date in 2013 or 2014 with only minor pain and low grade fever.; The Patient had two previous doses in unspecified date in 2007 or 2008 and on an unspecified date in 2013 or 2014 with only minor pain and low grade fever.; she could not lift her left arm / the left arm felt weak / ""no strength in that arm""; around 2 pm developed increasing pain; fever of 100 F; general malaise; ""She had a reaction to the PNEUMOVAX 23 shot""; she could not lift her left arm / the left arm felt weak / ""no strength in that arm""; pain with lifting her arm-needed to use the right arm to hold the left arm / The pain is reported as extreme.; finger numbness; This spontaneous report was received from a 56-year-old female patient referring to herself.  The patient's concurrent conditions included asthma, drug hypersensitivity and food allergy. The patient's medical history included herpes zoster. Previous drug reactions/allergies included allergy to ibuprofen, soy and peanuts. Concomitant therapies included fluticasone furoate (+) vilanterol trifenatate (BREO), beclomethasone dipropionate (QNASL), olopatadine hydrochloride (PATANASE), albuterol sulfate (PROAIR) and vitamins (unspecified).  On unspecified dates in 2007 (reported as 2007 or 2008) and in 2013 (reported as 2013 or 2014), the patient was vaccinated with the first and second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), respectively; (strength, dose, frequency, lot # and expiration date were not reported) intramuscularly. On unspecified dates after those vaccinations, she experienced minor pain and low-grade fever. On 18-SEP-2019 in the morning, the patient was vaccinated with a third dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, frequency, lot # and expiration date were not reported) in the left arm, intramuscularly, for prophylaxis (indication reported as asthma).  On the same date, the patient went to work and around 14:00, she developed a reaction to the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) shot (vaccination complication), which included increasing pain (injection site pain) and finger numbness in the left hand (hypoaesthesia). She left work early and while changing, she found that she could not lift her left arm, her arm felt weak and without strength (injected limb mobility decreased and muscular weakness). Then, she contacted the physician and spoke with the Nurse Manager, who sent her to the minor emergency clinic. At the emergency clinic, she reported fever of 100 Farenheit degrees (F) (pyrexia), extreme pain with lifting her arm (she needed to use the right arm to hold the left arm) (pain in extremity) and general malaise (malaise). As treatment for the events, she was placed on acetaminophen (TYLENOL) and ice. It was reported that there were no flair-up of asthma symptoms, the patient was not hospitalized and there were no laboratories/studies performed yet. The outcome for the events of minor pain and low-grade fever was not reported. At the reporting time, the patient was not recovered from vaccination complication, injection site pain, hypoaesthesia, injected limb mobility decreased, muscular weakness, pyrexia (onset date: 18-SEP-2019), pain in extremity and malaise.   Relatedness between all the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not provided.",,,,,,,,,N,,09/18/2019,,,UNK,,BREO; QNASL; PATANASE; PROAIR (albuterol sulfate); vitamins (unspecified),Asthma; Drug hypersensitivity; Peanut allergy; Soy allergy,Medical History/Concurrent Conditions: Shingles,,US0095075131909USA007386,2,09/24/2019,,,Y,
0835601,09/24/2019,TX,,,,U,,"no adverse event; The patient received a dose of improperly stored PROQUAD; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concurrent conditions or drug reactions/allergies.     On 19-SEP-2019, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), via subcutaneous for vaccination lot number S013715 and expiration date 01-NOV-2020 (strength, dose and frequency) (product storage error). The vaccine was reconstituted with Merck sterile diluent that did not experience a temperature excursion (lot number and expiration date were not reported).  The administered dose of the vaccine experienced a temperature excursion range of 6F to 14F(14F) for 3 hours and a range of range of 15F to 46F (27F) for 11 hours. The vaccine experienced a previous temperature excursion of 15F to 46F (38F) for 51 hours.  There was no adverse effect reported.",,,,,,,,,U,09/19/2019,09/19/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA008127,2,09/24/2019,,,,
0835602,09/24/2019,GA,,,,U,,"the child has unspecified developmental delays; patient was pregnant when she received a dose of MMR Il. Patient gave birth to a child; This spontaneous report was received from a nurse regarding a child patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. The mother of the patient was pregnant. Her last menstrual period (LMP) and Estimated date of delivery (EDD) was not reported. On an unknown date, when the mother of the patient was pregnant, she was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, strength, lot number and expiration date unknown) and the patient was exposed to the vaccine via transplacental route (foetal exposure during pregnancy). The vaccine was reconstituted with a sterile diluent. On an unknown date, the child was born and had some unspecified developmental delays. The outcome of developmental delay was unknown. The outcome of foetal exposure during pregnancy was recovered.   This case is cross referenced with 1909USA006681 (mother case).",,,,,,,,,Y,,,,,UNK,,Sterile diluent,,,,US0095075131909USA008792,2,09/24/2019,,,,
0835603,09/24/2019,,,,,U,,"Suspected vaccination failure; influenza A(H3N2); acute respiratory illness; This case was reported in a literature article and described the occurrence of suspected vaccination failure in a adult patient who received Flu Seasonal QIV Dresden (Flu Seasonal QIV Dresden) for prophylaxis.   On an unknown date, the patient received Flu Seasonal QIV Dresden at an unknown dose. On an unknown date, less than a year after receiving Flu Seasonal QIV Dresden, the patient experienced vaccination failure (serious criteria hospitalization and GSK medically significant), h3n2 influenza (serious criteria hospitalization) and respiratory disorder (serious criteria hospitalization). On an unknown date, the outcome of the vaccination failure, h3n2 influenza and respiratory disorder were unknown.   It was unknown if the reporter considered the vaccination failure, h3n2 influenza and respiratory disorder to be related to Flu Seasonal QIV Dresden.  Additional details were reported as follows: This case was reported in a literature article and described the suspected vaccination failure in a patient aged between 22 and 63 years of unspecified gender, who was vaccinated with unspecified quadrivalent influenza vaccine (manufacturer GlaxoSmithKline) for prophylaxis.   The patient was a part of the study that aimed was to compare antibody titers against both circulating influenza A (H3N2) strains and egg-adapted influenza A (H3N2) strains in acute specimens from individuals with and those without influenza virus infection in the 2017-2018 season. During the severe 2017-2018 influenza season, a study of the effectiveness of influenza vaccine among inpatients with acute respiratory illness as part of the Centers for Disease Control and Prevention (CDC) sponsored Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) was performed. No information on patient's medical history, family history, concurrent condition or concomitant medication was provided. On unspecified date, during 2017-2018 influenza season, the patient received unspecified quadrivalent influenza vaccine (administration route and site unspecified; dosage unknown; batch number not provided). The age at vaccination was not provided. [In this study, there were 18 individuals who had been vaccinated, and the specific influenza vaccine they received could be confirmed for 15. All 15 individuals with confirmed vaccine product information received vaccines containing inactivated egg grown virus; 10 received quadrivalent standard dose vaccines (9 vaccines were produced by GlaxoSmithKline, and 1 was produced by Seqirus), 3 received trivalent high dose vaccines (produced by Sanofi Pasteur), 1 received trivalent adjuvanted vaccine (produced by Seqirus), and 1 received trivalent unadjuvanted vaccine (produced by Seqirus)]. On an unspecified date, during 2017-2018 influenza season, between 27 November 2017 and 31 January 2018, an unknown period after the vaccination, the patient developed acute respiratory illness and subsequently hospitalized. The patient was enrolled less than or equal to 10 days after illness onset during active influenza virus circulation. The patient's throat and nasal swab specimens were collected shortly for influenza virus identification by reverse transcription polymerase chain reaction (RT-PCR) analysis. The patient was found influenza A(H3N2) Positive The patient's antibody titers were also measured with neuraminidase-inhibition (NAI) and Microneutralization (MN) assays was determined. The microneutralization (MN) egg propagated A/HongKong/4801/2014 (HK-egg) antibody titer was found 20, MN MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 20, MN MDCK-SIAT1 propagated A/Washington/16/2017 (WA) antibody titer was found 10, MN MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was 10, MN MDCK-SIAT1 propagated A/Maryland/53/2017 (MD) antibody titer was found 10, MN MDCK-SIAT1 propagated A/Wisconsin/327/2017 (WI) antibody titer was found 10, neuraminidase-inhibition (NAI) MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 80 and NAI MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was found 160 in patient. The genetic characterization of Influenza A(H3N2) virus strains circulating in patient sample was also determined (results not provided). This case has been considered as suspected vaccination failure being the time to onset was unknown. This case has been considered as serious due to suspected vaccination failure and hospitalization. Treatment was unknown. The outcome of the event was not reported. The author did not comment on the relationship between the event of influenza A (H3N2) infection and unspecified Quadrivalent influenza vaccine. However, the authors stated, ""This analysis of specimens from adults hospitalized with influenza A(H3N2) virus infection during the 2017-2018 influenza season demonstrated an antibody response specific to egg-adapted strains that was significantly higher among vaccinated individuals. In our study sample, this suggests that the antibody responses to vaccination in this population are highly specific to the egg-adapted strain, with little cross-reactivity to the circulating virus. Additionally, antibody titers against cell grown influenza A/HongKong/4801/2014(H3N2) virus were similar to those in unvaccinated individuals. In this study sample, this suggests that the antibody responses to vaccination in this population are highly specific to the egg adapted strain, with little cross-reactivity to the circulating virus. In this study, antibody against the neuraminidase of influenza A/HongKong/4801/2014 virus and influenza A/Singapore/INFIMH-16-0019/2016 virus was not associated with protection against infection. Although neuraminidase content was not standardized in influenza vaccines, it was observed that anti neuraminidase antibody titers were higher among vaccinated individuals, suggesting that some of the existing anti neuraminidase antibody in this population resulted from vaccination. The serum specimens in this study were collected at a single time point early during acute illness."" The authors concluded, ""The conclusions were limited by the inclusion of a small number of specimens from a single hospital. Because the severity of the 2017-2018 epidemic was evident early in the season, it was prioritized rapid serologic testing of the specimens that were available to date during the first half of the season. These 2 factors may limit the broad generalizability of the results; however, the influenza viruses that circulated locally overall and during the analysis period were similar to those that predominated nationwide during the same season. The small sample size also precluded the ability to perform additional subanalyses, to assess whether results might vary within specific age groups or by history of prior vaccination. In one sense, the 2017-2018 influenza vaccine appears to have worked as intended: vaccinated individuals had high antibody titers against the influenza virus strain included in the vaccine. The study adds to the evidence that egg adaptations in the 2017-2018 influenza vaccine strain elicited antibodies to epitopes not conserved in circulating strains. The degree to which this contributed to the marked severity of the 2017- 2018 season remains to be determined. Several vaccine products have been introduced into the vaccine market that are produced in cells and do not have the same emergent egg adaptations seen in recent influenza A(H3N2) vaccine strains. At this time, evidence for the effectiveness of these vaccines relative to those produced in eggs is limited because few head to head trials have been performed. Early data suggest that cell based vaccines have somewhat improved protection in clinical trials and in the community. Unfortunately, these vaccines are still dependent on selecting viruses that are close antigenic matches to those that will circulate and are subject to the limitations of annual strain selection time lines. This underscores the need for the development of the next generation of influenza vaccines that provide better, broader, and longer lasting protection."" This is 1 of the 4 valid cases reported in the same literature article.      Lab Comments: On an unspecified date, during 2017-2018 influenza season, between 27 November 2017 and 31 January 2018, the lab test were performed. The patient's antibody titers were also measured with neuraminidase-inhibition (NAI) and Microneutralization (MN) assays was determined. The microneutralization (MN) egg propagated A/HongKong/4801/2014 (HK-egg) antibody titer was found 20, MN MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 20, MN MDCK-SIAT1 propagated A/Washington/16/2017 (WA) antibody titer was found 10, MN MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was 10, MN MDCK-SIAT1 propagated A/Maryland/53/2017 (MD) antibody titer was found 10, MN MDCK-SIAT1 propagated A/Wisconsin/327/2017 (WI) antibody titer was found 10, neuraminidase-inhibition (NAI) MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found  80 and NAI MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was found 160 in patient. The genetic characterization of Influenza A(H3N2) virus strains circulating in patient sample was also determined (results not provided).",,,,,Y,,,,U,,,,"Test Name: Gene sequencing; Result Unstructured Data: Test Result: See text, Test Result Unit: unknown; Test Name: Polymerase chain reaction; Result Unstructured Data: Test Result: influenza A(H3N2) Positive, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS2019GS,2,09/24/2019,,,,
0835604,09/24/2019,KS,,,,F,,"was given HRIG in one gluteal muscle, rabies vaccine is not recommended to be administered in the gluteal muscle; On 22 Jul 2019, the patient was given HRIG and in one gluteal muscle and rabies vaccine; Initial information received on 26-Jul-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a female patient of unknown age who was vaccinated with a dose of HUMAN RABIES IMMUNOGLOBULIN [HUMAN ANTIRABIES IMMUNOGLOBULIN] and RABIES VACCINE (lot number and exp. Date not reported) in the gluteal muscle on 22-Jul-2019  for animal bite as patient's rabies exposure consists of saliva exposure to mucus membrane (no wound).  The patient's medical history not reported.  It was an actual medication error case due to vaccine administered at inappropriate site and Extra dose administered.  It was reported that, the hospital then decided that the first dose of HRIG that was administered to the patient was invalid, for a reason that was not clear. It might have been that since rabies vaccine is not recommended to be administered in the gluteal muscle they thought that HRIG should not be administered in the gluteal muscle either, or since HRIG and rabies vaccine should be administered distant to one another that the two gluteal muscles were not distant enough. Hence as corrective on the same evening (22 Jul 2019) they administered a second dose of HRIG in the patient's left and right thighs.  It was unknown whether the patient experienced any adverse event post vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,07/22/2019,,,,UNK,,Human Anti rabies Immunoglobulin,,,,USSA2019SA206012,2,09/24/2019,,,,
0835605,09/24/2019,OR,1.25,,,F,,"one patient received expired ActHIB/ No AE; Initial information received on 27-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to case 2019SA242256 same reporter.  This case involves a 15 months old female patient who received 0.5 mL dose of expired vaccine HIB (PRP/T) VACCINE [ACT-HIB] Lot UI859AAA via intramuscular route in the right thigh on 26-Jan-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to Expired vaccine used.  It was unknown whether the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,01/26/2019,,,,UNK,,,,,,USSA2019SA242244,2,09/24/2019,,,,
0835606,09/24/2019,MN,,25,,F,,"side of her face went numb; she woke up and felt funny; wanted to say but the words would not come out right; feel dizzy and faint; Initial information received on 16-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 25 years old female patient who experienced side of her face went numb (hypoaesthesia), feel dizzy and faint (dizziness), she woke up and felt funny (feeling abnormal) and wanted to say but the words would not come out right (dysarthria), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No concomitant therapies were reported.  In January 2019, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient experienced a non-serious side of her face went numb (hypoaesthesia), feel dizzy and faint (dizziness), she woke up and felt funny (feeling abnormal) and wanted to say but the words would not come out right (dysarthria), unknown latency, following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was wanted to say but the words would not come out right, she woke up and felt funny, feel dizzy and faint and side of her face went numb.   It was not reported if the patient received a corrective treatment. The patient sat with her head between her legs for a couple of minutes and she felt better  The patient outcome is reported as Unknown for side of her face went numb, she woke up and felt funny and for wanted to say but the words would not come out right and as recovering for feel dizzy and faint.  List of document held: none; Sender's Comments: This case involves a 25 years old female patient who experienced syncope, numbness in face and dizziness after vaccination. Exact time to onset was unknown. More details regarding patient's medical history, previous vaccination history, history of similar episode, etiological workup and investigation reports to identify alternative etiology are needed for complete assessment of the case. Based on the available information the role of vaccine cannot be assessed",,,,,,,,,N,01/01/2019,,,,UNK,,,,,,USSA2019SA259793,2,09/23/2019,,,,
0835607,09/24/2019,CA,,,,U,,"expired dose of Daptacel was inadvertently administered to a patient, no adverse event; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves an unknown demographic patient who was vaccinated with a dose of expired vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot number C5202AA and Exp. Date May-2019) on an unknown date.   The patient's medical history and concomitant medications were not reported.  It was an actual medication error case due to expired vaccine used.  It was not reported at the time of reporting whether the patient experienced any adverse event post vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA260894,2,09/24/2019,,,,
0835608,09/24/2019,CA,,2,.1,F,,"Fluzone Quadrivalent pre-filled 0.5mL syringes were administered that was delayed in transit, no AE; Initial information received on 16-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked with 2019SA265062 (18 month old patient administered with another dose).  This case involves a 2 years old female patient who received 0.5 ml dose vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (lot: UT6645LA, expiry date:30-Jun-2020) via intramuscular route in the left thigh), on 13-Sep-2019 which was delayed in transit.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to Incorrect product storage.  It was unknown if any adverse event occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA260949,2,09/23/2019,,,,
0835609,09/24/2019,CA,,63,,M,,"receiving an expired dose of Fluzone Quadrivalent; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 63 years old male patient who received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] and reported that receiving an expired dose of Fluzone Quadrivalent (expired product administered).  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On 17-Sep-2019, the patient received a dose of suspect 0.5 ml INFLUENZA QUADRIVAL A-B VACCINE lot UI996AB and expiry date: 30-Jun-2019 via intramuscular route in the right deltoid.  It was a case of actual medication error due to expired vaccine used.  It was unknown if the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none",,,,,,,,,U,09/17/2019,,,,UNK,,,,,,USSA2019SA260951,2,09/24/2019,,,,
0835610,09/24/2019,NY,,3,,M,,"3 year old consumer getting a partial dose of Fluzone Quadrivalent; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 3 years old male patient who received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] and reported that 3 year old consumer getting a partial dose of Fluzone Quadrivalent (accidental underdose).  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On 15-Sep-2019, the patient received a dose of suspect 0.5 ml INFLUENZA QUADRIVAL A-B VACCINE lot UJ243AD and expiry date: 30-Jun-2020 via intramuscular route in the left deltoid.  It was a case of actual medication error due to accidental underdose.  It was unknown if the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none",,,,,,,,,U,09/15/2019,,,,UNK,,,,,,USSA2019SA260952,2,09/24/2019,,,,
0835611,09/24/2019,NY,60.0,,,U,,"Menactra vaccine has been dispensed for the use on a 60 year old consumer, no AE; Initial information received on 16-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 60 years old patient who was dispensed vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot number and Exp. Date not reported), on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a potential medication error case due to product dispensing error.  It was reported that the Menactra vaccine has been dispensed for the use on a 60 year old consumer.   It was unknown if the consumer has been administered this vaccine at the time of this report.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA260984,2,09/23/2019,,,,
0835612,09/24/2019,,,,,U,,"2 patients received an expired flu from  last year, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a non-health care professional.  This case involves two patients of an unknown demographics who received a dose of vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] expired from  last year on an unknown date (dose, route and site of administration, expiry date not reported).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA261063,2,09/24/2019,,,,
0835613,09/24/2019,WV,12.0,12,,U,,"12 year old that received  Dtap instead of Tdap/ No AE; 12 year old that received  Dtap instead of Tdap/ no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 12 years old patient who received 0.5 ml dose of vaccines DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot C5254AB and expiry date: 18-Sep-2019) instead of DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE on 22-Jul-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccination included MENINGOCOCCAL VACCINE A/C/Y/W CONJ (DIP TOX) (MENACTRA) for Immunisation.   It was an actual medication error due to wrong vaccine administered and Inappropriate age at vaccine administration.  At the time of reporting no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,07/22/2019,,,,UNK,,MENACTRA,,,,USSA2019SA261987,2,09/24/2019,,,,
0835614,09/24/2019,DE,11.0,11,,M,,"by mistake gave Daptacel to an 11 yr old instead of Adacel, no AE; by mistake gave Daptacel to an 11 yr old instead of Adacel, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 11 years old patient who received 0.5 ml dose of vaccines DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot U5798AB and expiry date: 15-Nov-2019) instead of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] via intramuscular route in the arm NOS by mistake on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included MENINGOCOCCAL VACCINE B (MENINGOCOCCAL VACCINE B) for Immunisation.  It was an actual medication error due to wrong vaccine administered and inappropriate age at vaccine administration.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,MENINGOCOCCAL VACCINE B,,,,USSA2019SA261994,2,09/24/2019,,,,
0835615,09/24/2019,CA,0.5,0,.5,M,,"only Diluent diluent DTap/IPV of the Pentacel was received instead of Reconstituting with the HIB Powder, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked with case 2019SA266039 (same reporter).   This case involves a 6 months old male patient received a dose of DTap/IPV from DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] instead of Reconstituting with the HIB Powder on 13-Sep-2019 via intramuscular route in right thigh while receiving his third dose of the series. The reported Lot numbers were for a Vial DTap/IPV (Lot: U6469AB, Expiration Date: 11-Oct-2020), Pentacel Box (Lot UJ134AAA, Expiration Date: 11-Oct-2020) and HIB Vial (Lot: UJ134AA, Expiration Date: 11-Oct-2020).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13), ROTAVIRUS VACCINE (ROTAVIRUS VACCINE); HEPATITIS B VACCINE (HEPATITIS B VACCINE) and INFLUENZA VACCINE INACT SPLIT VIRION 4V (FLUZONE QUADRIVALENT) for Immunisation on 13-Sep-2019.  It was an actual medication error due to inappropriate reconstitution technique.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,PREVNAR 13; ROTAVIRUS VACCINE; HEPATITIS B VACCINE; FLUZONE QUADRIVALENT,,,,USSA2019SA262075,2,09/24/2019,,,,
0835616,09/24/2019,OR,14.0,,,F,,"expired dose of Menactra was inadvertently administered to patient, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case involves a 14 years old female patient who was inadvertently administered with an expired dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot number not reported, expiry date: 30-Jun-2019), via unknown route in an unknown site on 15-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error due to expired vaccine used.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,08/15/2019,,,,UNK,,,,,,USSA2019SA262158,2,09/24/2019,,,,
0835617,09/24/2019,IL,,,,F,,"given expired Fluzone Quadrivalent administered to patient / no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case is linked to case 2019SA262280.  This case involves a 4 years old female patient who was administered an expired INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot UT6375LA (Expiry date JUN-2019) via intramuscular route in the left thigh on 13-Sep-2019.  The patient's past medical history, vaccination(s) and family history were not provided.   It was a case of actual medication error due to expired vaccine used.  At a time of reporting No adverse reactions reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA262273,2,09/24/2019,,,,
0835618,09/24/2019,IL,,,,F,,"given expired Fluzone Quadrivalent / no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case is linked to case 2019SA262273.  This case involves a 7 years old female patient who was administered an expired INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot UT6375LA (Expiry date JUN-2019) via intramuscular route in the left thigh on 13-Sep-2019.  The patient's past medical history, vaccination(s) and family history were not provided.   It was a case of actual medication error due to expired vaccine used.  At a time of reporting No adverse reactions reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA262280,2,09/24/2019,,,,
0835619,09/24/2019,PA,,,,F,,"tightness in the chest similar to when she has reactions to shellfish or peanuts; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a non-health care professional.  This case involves a 65 years old female patient who experienced tightness in the chest similar to when she has reactions to shellfish or peanuts, while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history included allergy to shellfish and peanuts, tightness in the chest . The patient's past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX) for Immunization.  On 16-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot UJ232AB and Exp. Date 10-Apr-2020) via unknown route in the upper deltoid.  On an unknown date, the patient developed tightness in the chest similar to when she has reactions to shellfish or peanuts (chest discomfort) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  The patient had a hospital visit.  Details of lab data not reported.  Final diagnosis was tightness in the chest similar to when she has reactions to shellfish or peanuts.   It was not reported if the patient received any corrective treatment.  On an unknown date, the patient had recovered from event.  List of documents held by sender: none.",,,,,,,,,Y,09/16/2019,,,,UNK,,SHINGRIX,Peanut allergy; Shellfish allergy,Medical History/Concurrent Conditions: Tightness in chest,,USSA2019SA262285,2,09/24/2019,,,Y,
0835620,09/24/2019,TX,,56,,F,,"56 year age of patient receive Fluzone High Dose/ no AE; 56 year age of patient receive Fluzone High Dose/ no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 56 years old female patient who received vaccine 0.5 ml INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ238AA (Expiry date 14-Apr-2020) via intramuscular route in the right deltoid on 07-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history and concomitant therapies were not provided.  It was an actual medication error case due to inappropriate age at vaccine administration and overdose.  It was reported that patient who is 56 years of age received the Fluzone HD.  The patient did not experience any adverse reaction.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/07/2019,,,,UNK,,,,,,USSA2019SA262286,2,09/24/2019,,,,
0835621,09/24/2019,VA,,86,,F,,"administration of Fluzone HD to patient that incurred a delayed transit / no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a non-hcp (Office Staff).  This case involves a 86 years old female patient who received 0.5 ml vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UJ242AA) via intramuscular route in the right deltoid, on 16-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error case due to Incorrect product storage.  It was reported that administration of Fluzone HD that incurred a delayed transit time on 16Sep2019. Caller reports product was shipped on 12Sep2019 and was not received until 16Sep2019.  At the time of reporting none adverse event symptoms were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/16/2019,,,,UNK,,,,,,USSA2019SA262288,2,09/24/2019,,,,
0835622,09/24/2019,ID,,,,F,,"patient was given last year's Fluzone HD; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case involves Elderly female patient who was administered an expired INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot number and Expiry date unknown) via unknown route in unknown administration site on an unknown date.  The patient's past medical history, vaccination(s) and family history were not provided.   It was a case of actual medication error due to expired vaccine used.  At a time of reporting No adverse reactions reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA262289,2,09/24/2019,,,,
0835623,09/24/2019,IL,4.0,,,M,,"expired vaccines was inadvertently left in the refrigerator and was administered to 2 children, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from other healthcare professional.  This case is linked to case 2019SA262370 (same reporter).  This case involves a four years old male patient who received 0.5 ml dose of expired vaccine QUADRIVALENT INFLUENZA VACCINE (FLUZONE QUADRIVALENT) (lot UT6375LA, Exp. Date 30-Jun-2019) via intramuscular route in the left vastus lateralis on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  It was reported that a box of expired vaccines was inadvertently left in the refrigerator and was administered to 2 children on 9/13/2019.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA262365,2,09/24/2019,,,,
0835624,09/24/2019,TN,1.42,1,.5,M,,"nurse accidentally gave Fluzone Quadrivalent to a patient, that expired on 30Jun2019, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a non-healthcare professional.  This case involves a 17 months old male patient who received 0.25 ml dose of expired vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (Prefilled syringe, lot UT6259LA, Exp. Date 30-Jun-2019) via intramuscular route in the left thigh on 17-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13), HIB VACCINE CONJ (OMPC) (PEDVAXHIB) and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP) for Immunisation.  It was a case of actual medication error due to expired vaccine used.  It was reported that a nurse accidentally gave Fluzone Quadrivalent to a patient, that expired on 30-Jun-2019.  The patient did not experience any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/17/2019,,,,UNK,,PREVNAR 13; PEDVAXHIB; DTAP,,,,USSA2019SA262368,2,09/24/2019,,,,
0835625,09/24/2019,IL,7.0,,,F,,"expired vaccines was inadvertently left in the refrigerator and was administered to 2 children, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from other healthcare professional.  This case is linked to case 2019SA262365 (same reporter).  This case involves a seven years old female patient who received 0.5 ml dose of expired vaccine QUADRIVALENT INFLUENZA VACCINE (FLUZONE QUADRIVALENT) (lot UT6375LA, Exp. Date 30-Jun-2019) via intramuscular route in left deltoid on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  It was reported that a box of expired vaccines was inadvertently left in the refrigerator and was administered to 2 children on 9/13/2019.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA262370,2,09/24/2019,,,,
0835626,09/24/2019,CT,12.0,12,,M,,"Fainted about 5 minutes after receiving vaccine (fell, hit head) - vagal response per paramedic Able to get up and leave, feeling better about 35 minutes after event.",,,,,,,,,Y,09/23/2019,09/23/2019,0,,PUB,,,,none,,,2,09/24/2019,,Y,,none
0835627,09/24/2019,TN,60.0,60,,M,09/14/2019,"Patient experienced low grade fever, erythema, bone pain for 36 hours and fatigue for 84 hours after vaccination.",,,,,,,,,Y,08/31/2019,08/31/2019,0,,UNK,PVT,,none,Asthma,,,1,,,,,
0835628,09/24/2019,MN,57.0,57,,M,,"Swollen, painful lymph glands in the neck and face",,,,,,,,,N,09/18/2019,09/22/2019,4,,PHM,,"Monteleukast 10MG PO HS, Ranitidine 300MG PO HS, Xyzal 5mg PO HS, Azelastine 2 puffs each nostril HS, Flonase 2 puffs each nostril QAM, Multivitamin QAM, Omega 3-6-9 2 capsules QAM, Milk Thistle- 2 capsules QAM, Naltrexone 25mg QAM",,,,,2,09/24/2019,,,,
0835629,09/24/2019,NY,65.0,65,,M,,"Severe headache,fever.lower back pain,general all over body pain,coughing,thick secretions and mucus out of lungs[grayish-green color]",,,,,,,,,U,09/18/2019,09/19/2019,1,"inr ,influenza a pcr ,influenza b pcr, RSV PCR .",PHM,,"methadone,spiriva,eplerenome,warfarin,allopurinol, omeprazole,citracal ,centrum silver, vitamins a, c, and e","gout,chf",,,,2,09/24/2019,,,Y,"Otezla ,gabapentindemorol"
0835630,09/24/2019,MI,10.0,10,,F,,"Localized rash, itching, redness and pain starting the day following vaccination. This lasted for 3 days, during which pt developed pain shooting down her arm to her wrist from vaccination site. Progressed to wrist pain and weakness that is gradually improving after 10 days.  Also c/o some aches and pains to legs but no weakness.",,,,,,,,,,09/14/2019,09/15/2019,1,,UNK,,None,None,None,,,2,09/24/2019,,Y,,None
0835631,09/24/2019,TX,0.33,0,.2,F,,These were typical four month shots given. Our baby woke up the next morning with a 104.5 fever. She screamed for two days straight unless she fell asleep. She was admitted to Hospital due to refusing bottles for two days. She lost almost a whole pound and went into the ?Failure to thrive? and ?Malnourished? category.,,,,,Y,4,,,N,08/01/2019,09/05/2019,35,,PVT,,None,None,None,,,2,09/24/2019,,,,None
0835632,09/24/2019,MI,77.0,77,,M,,Patient reported dry mouth and difficulty swallowing at 20 minutes after the vaccination.  The patient was monitored for 5 minutes and then it was determined to call EMS.  EMS arrived about 5 minutes after being called and took the patient to the hospital and assessing the patient.  No epinephrine was administered here at the pharmacy due to patient not presenting with difficulty breathing.,,,,,,,,,U,09/24/2019,09/24/2019,0,none known at this time,PHM,,"Azopt eye drops, Imdur ER 30mg, Levemir Flextouch, Digoxing 250mcg, Coumadin 5mg, Lipitor 80mg, Captopril 25mg, Diltiazem Er 180mg, Trulicity,",none known,diabetes high blood pressure,,,2,09/24/2019,,,Y,No Known Drug Allergies
0835633,09/24/2019,ID,7.0,7,,U,,I thought that i had picked up the MMR that is what i read on it but it was MMRV  I did not see the varicella on the box when i read it. so the patient was given varicella and extra dose.,,,,,,,,,,09/20/2019,,,NONE,OTH,,None,None,None,,,2,09/24/2019,,,,None
0835634,09/24/2019,NE,71.0,71,,M,,"Fever, achiness, nausea, dizziness, headache",,,,,,,,,N,09/23/2019,09/24/2019,1,,PHM,,"Losartan, asa, omeprozole",,,,,2,09/24/2019,,,,"Penicillin, sulfa"
0835635,09/24/2019,CA,36.0,36,,F,,"Vomiting, chills, and body aches began the morning after receiving the vaccine (about 20 hours after receiving). Vomiting resolved spontaneously after 1 hour. Chills and body aches for the remainder of the morning/afternoon, treated with Tylenol.",,,,,,,,,U,09/23/2019,09/24/2019,1,,PVT,,Prenatal vitamins,None,None,,,2,09/24/2019,,,,None
0835636,09/24/2019,MA,49.0,49,,M,,patient reported a high fever of up to 105 degrees F. on both Sunday and Monday. patient did not go to see a doctor . Patient reported still a fever on Tuesday but better than Monday and still did not want to go to see a doctor,,,,,,,,,N,09/21/2019,09/22/2019,1,,PHM,,,pneumonia,"mixed connective tissue disease, rheumatoid arthritis, diabetes, heart disease, high cholesterol",,,2,09/24/2019,,,,none
0835637,09/24/2019,PA,14.0,14,,F,,left arm swelling with pink color and itchy 13x16 cm size; flushing of cheeks; given Benadryl at school and improved with less itching afterwards.,,,,,,,,,Y,09/23/2019,09/24/2019,1,n/a,PVT,,,,,,,2,09/24/2019,,Y,,shellfish; amoxicillin
0835638,09/24/2019,NE,70.0,70,,F,,"Fever, headache, achiness, arthralgias, photosensitivitu",,,,,,,,,N,09/23/2019,09/23/2019,0,,PHM,,None,,,,,2,09/24/2019,,,,None
0835646,09/24/2019,MA,62.0,,,F,,"Pt. presented to clinic 3 days after (9/20/19) with (R) arm swelling & fever. Tx'ed with cool packs, ibuprofen",,,,,,,,,U,,,,None,PVT,,Lipitor,,DM2; Adenoma of colon; cataracts; Hyperlipidemia; alpha thalassemia,,,2,09/24/2019,,,,Lipitor
0835647,09/24/2019,IN,35.0,35,,F,,"Approximately 12 hours post injection the patient complained of itching of elbows, knees and hands.  Patient complained of pain in joints (specifically knees, elbows) and edema of hands which began on 9/20/19 at 6:00 am.  Patient presented with hives of knees, elbows and wrists on 9/20/19 at 1:00 pm.  Treated with diphenhydramine 50 mg Q 6 hours, ranitidine 150 mg QD and cetirizine 10mg QD. 9/21/19 the patient reported the symptoms had worsened (pain in joints worse, hives worse and spreading, edema of hands was worse.  Continued with the above treatment and also prednisone 40 mg one dose. The symptoms completely resolved by 9/22/19 at 2 pm.",,,,,,,,,Y,09/19/2019,09/20/2019,1,N/A,PVT,,None,None,Irritable Bowel Syndrome,,,2,09/24/2019,,Y,,Fish
0835648,09/24/2019,PA,58.0,58,,F,,pt had a flu shot 09/21/2019. Her daughter called 09/24/2019 stating that mom has been throwing up since 09/23/2019 and her temp 99.4 she thinks it is related to shot. Pt will go to urgent care,,,,,,,,,U,09/21/2019,09/23/2019,2,unknown,PHM,,na,not known,not known,,,2,09/24/2019,,,Y,NKDA
0835649,09/24/2019,MD,56.0,56,,F,,"Rash, subjective fever",,,,,,,,,Y,09/20/2019,09/21/2019,1,n/a,PVT,,"Metformin, Glipizide",N/A,Diabetes Mellitus,,,2,09/24/2019,,Y,,Naproxen
0835650,09/24/2019,SC,73.0,73,,F,,"Patient states she experienced flu-like symptoms for 2 weeks after being immunized (8/27/19) with Shingrix. Aching, chills. Then she felt better for a while until 9/23/19. On the evening of 9/23, she states she starting experiencing facial drooping, difficulty talking. She went to ER, and after extensive tests, diagnosed her with Bell's Palsy.  She stated on the phone today that they discharged her last night, and she is on prednisone. Some of the symptoms have improved, but she still has some drooping and difficulty talking.",,,,,,,,,N,08/27/2019,09/23/2019,27,CT scans on 9/23,PHM,,"Gabapentin 100mg, Vitamin D2, Relion Novolin 70/30, amoxicillin 500mg, cyclobenzaprine 10mg, fluconazole 100mg",,Diabetes,,,2,09/24/2019,,,Y,"Tetracyclines, codeine, sulfa drugs, macrolides"
0835651,09/24/2019,,81.0,81,,F,,"The patient had a large red area just under where the immunization was given, the area was warm to the touch, but did not itch or burn.",,,,,,,,,,09/23/2019,09/24/2019,1,,PHM,,,,,,,2,09/24/2019,,,,
0835652,09/24/2019,FL,31.0,31,,F,,"Had Flu symptoms 4 days after vaccination, soreness on the injection site and persisting up to this date.",,,,,,,,,N,08/28/2019,08/28/2019,0,none,PHM,,Multivitamins,Undifferentiated connective tissue disorder (2008),Connective tissue disorder,,,2,09/24/2019,,,,No known allergies
0835653,09/24/2019,WI,37.0,37,,F,,"Unsure if this was Adacel or Boostrix (only know ""Tdap"")  - great pain in arm, difficulty moving for a couple days - nausea, chills, headache, weakness",,,,,,,,,Y,08/13/2019,08/13/2019,0,none,PVT,,multivitamin/mineral Vit D,none,none,"pain at site, but to a lesser degree",,2,09/24/2019,,,,none
0835654,09/24/2019,CO,5.0,5,,F,,"Approximately 20 minutes after vaccine administration, patient developed generalized urticarial.  No respiratory or GI symptoms.  Re-evaluated in the office, normal cardiac and lung exam.  Diffuse urticarial and pruritus.  Given 5mg PO chewable Claritin and applied topical triamcinolone.  MOC called back about 3 hours later and symptoms had resolved.",,,,,,,,,Y,09/24/2019,09/24/2019,0,None,PVT,,None,None,"Complex coarctation of the aorta, multiple VSD, s/p surgical repair",,,2,09/24/2019,,Y,,None
0835655,09/24/2019,CA,84.0,84,,M,,Rash,,,,,,,,,N,09/09/2019,09/10/2019,1,None,PVT,,ASA Simvastatin Lisinopril-Hydrochlorothiazide Ditropan,None,HTN Prostate Cancer AV Black/ Bradycardia s/p Pacemaker Umbilical Hernia Back Pain,,,2,09/24/2019,,Y,,None
0835656,09/24/2019,MI,89.0,89,,F,,"Shortly after receiving her flu shot (~within 5 minutes of receiving it), a patient came back and reported that she was feeling flushed and asked if she appeared red.  She seemed normal in appearance, but then she started complaining of severe lower back pain.  At this point, I asked her if she would like us to call an ambulance to which she responded, ""yes.""  I asked my technician to call 911, while I continued to assess the patient. I went out of the pharmacy to see if I could aid the patient to a chair in the nearby waiting area (5 steps away), but she complained her back was in too much pain, and she remained hunched over a shopping cart for support. Patient did not report difficulty breathing, dizziness, or nausea. I grabbed a chair and put it directly behind the patient so that she could sit down.  After sitting, patient reported the pain in her back moved to her legs.  And after a few more minutes of waiting, patient began to report she was experiencing chest pain.  Shortly after this, the paramedics arrived and took the patient to the hospital.",,,,,Y,,,,U,09/24/2019,09/24/2019,0,Unknown,PHM,,"Eliquis, Amlodipine, Levetiracetam, Digitek",Unknown,"Hypertension; AFib; Localization-related idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epiepticus;",,,2,09/24/2019,,,,No known allergies
0835657,09/24/2019,CA,63.0,63,,F,,swollen upper lip,,,,,,,,,Y,09/19/2019,09/19/2019,0,,PVT,,Lisinpril HCTZ 10/12   tab once day albuterol when needed advar 250 twice day Estring 2 mg,none,asthma high blood pressure,,,2,09/24/2019,,,,no
0835658,09/24/2019,CA,67.0,67,,F,,The vaccination was administered subcutaneously rather than intramuscularly.  There was no immediate reaction noted.  The patient was consulted to contact the pharmacy if any reactions did occur and the prescriber was notified of the error.,,,,,,,,,U,09/24/2019,09/24/2019,0,None as of the time of reporting.,PUB,,"Clobetasol prop 0.05% cream, fluticasone 50 mcg nasal spray, levocetirizine 5mg tablet.",None known.,"Alopecia, rhinitis, seborrhea/keratolytic condiytion, spine disorders, topical inflammation, upper respiratory problems.",,,2,09/24/2019,,,,"Ceclor, Penicillin VK, Bactrim DS."
0835659,09/24/2019,OR,4.0,4,,M,,"rash on face, trunk, back and legs, fever",,,,,,,,,,09/09/2019,09/20/2019,11,,PVT,,,,,,,2,09/24/2019,,Y,,
0835660,09/24/2019,FL,75.0,75,,M,,Patient received Flu and Pneumovax in right arm and then he got a large red knot at sight of injection. Patient went to emergency room and the doctor draw a circle of the red area and said it was 9 inch around. The doctor said if the red area went outside the circle to get script filled. The next morning the patient was not any better (red had not gotten bigger) and he decided to get script filled.,,,,,,,,,U,09/21/2019,09/23/2019,2,,PHM,,,,,,,2,09/24/2019,,,Y,
0835661,09/24/2019,WA,59.0,59,,M,,"Early the morning following the vaccination had acute headache that lasted through Sunday. I rarely get headaches. Also, general ache and flu-like symptoms accompanied. Monday morning, I had a episode of Transient Global Amnesia and went to the emergency room for a quick onset and intense loss of memory. This lasted for about 2-3 hours and subsided, returning to normal by late day.",,,,,,,,,Y,09/20/2019,09/21/2019,1,"I had a full battery of blood tests, a CT scan, MRI and XRays. All tests came back normal or negative. I was visited and tested by a neurologist in ER and was released shortly after with the diagnosis of Transient Global Amnesia.",PVT,,"Sildenafil (Occasionally), Zantac (daily)",None,None,,,2,09/24/2019,,Y,Y,None
0835662,09/24/2019,IA,43.0,43,,F,,"I have been having upper right arm pain for a while now, this has happened in the past, I cannot remember the exact year, but it was about  10 years ago, maybe. That pain lasted about 6 months and just went away on it's own. At the time I had mentioned it to my PCP but she said that she had never heard of arm pain after so many months  as a reaction to a flu shot. At that time, I could not even lift my arm to dress myself, it was very painful but like I said it went away. This time, I felt it again and thought oh no, before when I would tell people of my reaction to it before they looked at me like I was weird. This time I googled it and found that there is such a thing now.  This is where I got the information to this site. The deltoid muscle can get pinched and can be very painful. I knew I was not crazy. I am having pain now everyday, as the day goes on my arm just gets painful, there are times when I have to literally lift my arm up with my other arm to move it while I'm in bed. I have muscle relaxers that I was given by my PCP for my lower back pain that I use when the pain is so bad on my arm  and then I can get some sleep.  I have read articles on it and have found that a MRI can be helpful in determining how bad it is. I have not gone to my Dr yet regarding this and it's just because I do not want to take the time to do all the visits that will probably be involved and also the cost of the MRI. I have medical insurance but I'm sure there will be a deductible that I have to meet.",,,,,,,,,N,10/04/2018,10/01/2018,,I have not had any done yet.  But I will be scheduling soon to see my PCP.,WRK,,Paroxetine HCL 20 mg tablet Larissa- 28 tablet Bupropin HCL XL 300 mg Pantoprazole SOD DR 40 mg Cyclobenzaprine 10 MG prn,lower back pain,,A flu shot many years ago.,,2,09/24/2019,,Y,,NKA
0835663,09/24/2019,CA,76.0,76,,F,,patient experience some raise rash like localized to the right arm were injection was given 2 days after injection. heat would increase the itcheness,,,,,,,,,Y,09/06/2019,09/08/2019,2,,PHM,,,,,,,2,09/24/2019,,,,
0835664,09/24/2019,NY,14.0,14,,M,,Excessive tics following vaccine,,,,,,,,,N,09/01/2019,09/01/2019,0,Appointment made with neurologist,UNK,,,Very minor tic association of Tourette?s noticed by father but mother unaware,Severe increase in tic noticed by all observers following vaccines,Polio,,2,09/24/2019,,,,
0835665,09/24/2019,NY,50.0,50,,F,,RASH AT INJECTION SITE WHICH CAUSE A DISCOLORATION,,,,,,,,,N,09/10/2019,09/11/2019,1,NONE,UNK,,NONE,NONE,NONE,,,2,09/24/2019,,,,NONE
0835666,09/24/2019,CA,62.0,62,,F,,"Patient noticed redness, pain, and injection site was warm to the touch on Saturday the day after the injection.  She also said that the area felt hard.  This information was reported to the pharmacist on 9/16/19 and patient subsequently went to the physician's office on 9/17/19,",,,,,,,,,Y,09/13/2019,09/14/2019,1,Patient did go to her physician office on 9/17/19 and was given an rx for an antibiotic in case of infection.,PHM,,"Pantoprazole, sotalol, lipitor, eliquis",none,"Arrythimia, Hypercholesteremia, Gerd",,,2,09/24/2019,,Y,,NKA
0835667,09/24/2019,TX,24.0,24,,F,,Patient fainted due to severe anxiety,,,,,,,,,Y,09/24/2019,09/24/2019,0,none,PHM,,none,none,none,,,2,09/24/2019,,,,none
0835668,09/24/2019,FL,32.0,32,,M,,"Patient was given shot and walked away to go get food, then came back within 5 minutes and sat in the waiting area. When approached he was pale and sweating. When asked if he was ok, he stated he felt like he was going to pass out. After sipping on some water and sitting on the floor, he never lost consciousness and spoke with us the entire time. After 10-15 minutes he was back up and feeling better, but still sweating. He was able to contact his fianc who was waiting for him in the parking lot. He wanted to go grab food again and was last seen standing in line to purchase that food about 30 minutes after vaccination.",,,,,,,,,Y,09/24/2019,09/24/2019,0,,PHM,,unknown,none that we are aware of,patient did not indicate any on consent form,"pertussis, he said it occurred when he was young, when asked what the reaction was, he did not know",,2,09/24/2019,,,,pertussis vaccine
0835670,09/24/2019,SC,68.0,68,,F,,"Patient reported sharp pain radiating from neck to r. shoulder blade that she believes is from the vaccine.  FLUHD in R ARM, pneumovax23 in left arm.  Pt notified pharmacy of reaction, gave her suggestions of icing area, treating with APAP and follow up with her primary care physician.  Additionally, I contacted DR office and let them know of the reaction (4pm 9/24/19).  Will be filing VAERS today.",,,,,,,,,N,09/19/2019,09/23/2019,4,N/A,PHM,,N/A,UNKNOWN,UNKNOWN,,,2,09/24/2019,,Y,,NONE
0835671,09/24/2019,IN,50.0,50,,F,,"Patient awakened after midnight on 9/10/19 with a swollen tongue.  She reported her heart was ""beating out of her chest"".  Patient had experienced nightmares leading up to the awakening.  She also reported having had nightmares during at least 1 night since the vaccination, but had not had any other symptoms until the 9/10/19 effects.  Patient reported skin blotches, primarily on her front & back.  She went to the ER after awakening with a swollen tongue.  The ER physician did not administer any treatments, although the nurse told the patient that ""she has seen a lot of patients with reactions to the pneumo-23 vaccine"".  Patient was not prescribed any medication to treat her reported symptoms.  As of 9/24/19, she does not report any lingering symptoms.",,,,,,,,,Y,09/06/2019,09/10/2019,4,No tests performed or reported,PHM,,Pt started 2 antibiotics on 9/6/2019 (with 1st dose of each in the evening) ... SMZ/TMP DS 800/160 (1 tablet twice daily for 10 days) AND metronidazole 500mg  (1 tablet 3 times daily for 10 days).   She completed both over the next 10 days.,Diverticulitis with antibiotics being prescribed on 9/6/19,None listed,,,2,09/24/2019,,,Y,"Aspirin allergy on file ... no details about the nature of reported ""allergy"""
0835672,09/24/2019,FL,72.0,72,,F,,Red swollen area on arm where vaccine was given. Patient will followup with medical provider.,,,,,,,,,N,09/22/2019,09/23/2019,1,,PHM,,,unknown,,,,2,09/24/2019,,,,none
0835673,09/24/2019,MI,12.0,12,,M,,"Developed redness with a 6 inch round induration around site with obvious edges around 1/2 inch high same evening of injection. Entire upper arm became red and swollen. Left arm measured at 15 inches compared to right at 12 1/2 inches.  Arm was painful and difficult to move for several days.  At 3 days later, arm is no longer red but arm is firm/swollen but getting better",,,,,,,,,N,09/21/2019,09/21/2019,0,,PHM,,none,none,none,,,2,09/24/2019,,,,none
0835674,09/24/2019,GA,28.0,28,,F,,"Flushing in the face, shaking, heartbeat racing, and difficulty breathing. EMT took vitals, 92 heartbeat and 140/95 blood pressure. Drank water and rested. Symptoms decreased significantly within 30-45 minutes.",,,,,,,,,Y,09/24/2019,09/24/2019,0,None,PUB,,None,Costochondritis and finished 6 day steroids a week prior to flu shot.,None,,,2,09/24/2019,,Y,,None
0835675,09/24/2019,,60.0,60,,F,,"chills, severe arm pain",,,,,,,,,,09/23/2019,09/23/2019,0,,PVT,,,,,,,2,09/24/2019,,Y,,
0835676,09/24/2019,IN,63.0,63,,F,,"Soreness,  redness Flu-like symptoms  (body aches, fatigue) Low grade fever- 100 degrees Muscle pain Headaches",,,,,,,,,Y,09/20/2019,09/21/2019,1,N/A,PHM,,"Montelukast, Pravastatin",N/A,Sinus problems,,,2,09/24/2019,,,,Lactose intolerant
0835677,09/24/2019,WA,17.0,17,,F,,patient experienced severe pain in the shoulder due to possibility of nerve was hurt by the needle during immunization. patient reporting pain referring back to shoulder blade and she said she is unable to lift her arm above shoulder level,,,,,,,,,N,09/08/2019,09/08/2019,0,Advised patient to visit primary care provider or local doctor. Patient to follow up soon as possible,PHM,,paxil 10 mg 1 qd,none,depression,,,2,09/24/2019,,,,no  known allergies
0835678,09/24/2019,AL,42.0,42,,F,,"Patient received 2 immunizations on 9/23/19, flu in her right arm and pneumovax in her left arm. Patient came back to pharmacy 24 hours later and reported swelling and pain in her left arm. Suggested to patient  to ice area, take benadryl and ibuprofen. Patient will try those suggestions.",,,,,,,,,U,09/23/2019,09/24/2019,1,none as of 9/24/2019,PHM,,"estradiol, valacyclovir",none,none known,,,2,09/24/2019,,,,Macrolides/ketolides
0835679,09/24/2019,MO,67.0,67,,F,,"Pt received shingrix vaccine mid July through pharmacy.  Within two weeks, she experienced shortness of breath and vesicular rash on her face.  She had been able to walk 3 miles a day and now unable to walk across the room without SOB.  Pt had not had an asthma flare up in 40 years.  Using allergist as her PCP, allergiest  and diabetic resource.  Pt came two  Urgent Care after having difficulties for almost two months. She was hypoxic 88% and sent to hospital, admitted and a few days later having CABG",,,Y,,,,,,N,07/01/2019,07/01/2019,0,No,OTH,,"Adderall, ""Dexadrine"", Duloxetine, Metformin, Lantus Solostar, Ambien, Rosuvastatin, Invokana, Multiple Vitamins, Trelegy Ellipta, Proventil handheld inhaler.",No,"Uncontrolled T2DM (last A1C 11 3 weeks ago), hx MI, Asthma, Sleep disorder, HTN, Environmental allergies",,,2,09/24/2019,,,Y,"Environmental allergies, NKDA"
0835680,09/24/2019,FL,66.0,66,,F,,"Patient reports pain in both arms that radiates to her back and up to her neck. She says she has difficulty lifting her arms. Said she has not experienced and fever, chills, rash, or other symptoms. Patient says her physician told her to take Benadryl, and she reports also taking Aspirin.",,,,,,,,,,09/23/2019,09/23/2019,0,,PHM,,,,,,,2,09/24/2019,,,,
0835681,09/24/2019,ID,61.0,61,,M,,"RASH ON BOTH ARMS ON THE INSIDE OF THE ELBOW, PETICHAE ITCHY RASH",,,,,,,,,U,09/20/2019,09/22/2019,2,GAVE BENADRYL FOUR TIMES DAILY FOR 3 DAYS. DRAWING A LINE AROUND THE SPOTS TO SEE IF CLEARING UP OR GETTING WORSE,PHM,,,,,,,2,09/24/2019,,Y,,
0835682,09/24/2019,AZ,69.0,69,,F,,Extreme GI upset with diarrhea,,,,,,,,,Y,09/23/2019,09/23/2019,0,,PHM,,"Estradiol, Myrbetriq",N/A,,,,2,09/24/2019,,,,N/A
0835683,09/24/2019,GA,66.0,66,,F,,Pt went to the hospital and was diagnosed with cellulitis.,,,,,,,,,,09/01/2019,09/01/2019,0,,PHM,,"Gabapentin, zantac, zocor",,High cholesterol,,,2,09/24/2019,,,Y,nsaids
0835684,09/24/2019,GA,72.0,72,,M,,"Around 3:15 pm , patient was given immunization of prevnar and fluzone high dose both in left deltoid as agreed to by the patient. about 5:20 pm patient's wife called rather frantic because he had become pale and shaky. Instructed her to lie him on his backs and rest his legs on the couch to help regain circulation to the upper portion of the body. A few minutes later the daughter got on the phone and said he was starting to have trouble breathing, so I instructed them to call 911 or got to the nearest emergency room due to the presentation of shortness of breath as I could not rule out some sort of reaction to the vaccination causing this.",,,,,,,,,,09/24/2019,09/24/2019,0,,PHM,,,,,,,2,09/24/2019,,,Y,
0835685,09/24/2019,FL,13.0,13,,F,,"Tachycardia, rapid resp, ha, nausea, body aches, o skin painful to touch, fever",,,,,,,,,Y,09/17/2019,09/18/2019,1,None,PVT,,None,None,None,,,2,09/24/2019,,,,None
0835686,09/24/2019,GA,76.0,76,,F,,"Patient called pharmacy saying arm was bruised, swollen, red  and was hot to the touch .",,,,,,,,,U,09/23/2019,09/24/2019,1,,PHM,,,,,,,2,09/24/2019,,Y,,
0835687,09/24/2019,FL,82.0,82,,M,,"Patient immediately developed a large, raised, red welt about the size of a quarter. Patient was not experiencing any relief from the swelling but experienced no pain or itching at 10:54a diphenhydramine 25 mg one by mouth once was administered with water. The patient then waited tell 11:06a to go to their doctor's office in which they had seen their physician and the physician noted no significant change in condition but for the patient to monitor the situation and alert both pharmacy and doctor if any change in condition occurred.",,,,,,,,,Y,09/23/2019,09/23/2019,0,Physical observation at time of administration through 11:06 a.m. at the pharmacy.,PHM,,"Pravastatin 40mg, bupropion xl 300mg, amlodipine 5 mg, carvedilol 12.5 mg,",None noted,"Hypertension, unspecified heart condition, hypercholesterolemia, depression",,,2,09/24/2019,,Y,,No known allergies
0835688,09/24/2019,OH,0.75,0,.8,M,,"Patient was sick for three days and slept for those three days. He recieved the vaccination on a thursday and didnt come back around tp normal until that monday. He didnt eat, drink, or move for those three days. All he did was sleep",,,,,,,,,Y,03/28/2019,03/28/2019,0,"None, dr said it was normal",PVT,,None,"None, was completely health until vaccinated",None,,,2,09/24/2019,,,,None
0835689,09/24/2019,IA,69.0,69,,F,,"By the morning of 9-22-19, there was a red hot welt around the injection site. It was about four and a half inches long and about  3 inches wide. It was not symmetrical. It itches a lot.  That morning I returned to the pharmacy to see if this was a normal expected reaction. I showed the pharmacist my arm. The pharmacist said I could use something to stop the itching and that I should report this as a n adverse reaction.  It is now the evening of 9-24-19 and my arm  is still red and itches, but not nearly as bad as it was. I continue to use something for the itching.",,,,,,,,,Y,09/21/2019,09/21/2019,0,,PHM,,None,None,None,,,2,09/24/2019,,,,Penicillin
0835690,09/24/2019,,71.0,71,,F,,"patient reported feeling fine during and immediately after vaccine, after signing for vaccine as she was walking to her cart the patient felt lightheaded and dizzy, patient asked to sit down, as patient was resting she starting feeling a pain in her neck and up her arm, patient also said that she had a headache after vaccine.  - paramedics checked patient out - vitals were normal and they believe that she just had an episode of syncope -patient refused to go to the hospital  -checked in with patient at 4:00pm and she was resting at home and feeling better",,,,,,,,,Y,09/23/2019,09/23/2019,0,,PHM,,,,,,,2,09/24/2019,,,,
0835691,09/24/2019,CA,28.0,28,,F,,On Sept 24th at approximately  2:15 pm Staff patient received Flulaval flu vaccine with Lot # 60442 Manufactured by GSK with Expiration date 6-30-20 Pre-filled vaccine was given IM via Left Arm. At approximately 2:20 pm she complained  to the stahat she is hot and itching.  Staff was assesses by 2 RN's After few minutes mild rashes was noted to neck region and scattered mild rash on the posterior trunk and mild redness to left arm noted.  NO Shortness of breath during the assessment . Staff was alert and oriented and ambulatory. Staff Was referred to urgent care. Per RN of Urgent care patient was noted with nausea and vomiting.  Was given oxygen therapy and was referred to hospital for further treatment,,,,,,,,,U,09/24/2019,09/24/2019,0,None reported,OTH,,Info not available,Not sick per completed report,not reported during the completion of FLu vaccination form,,,2,09/24/2019,,,Y,per completed Flu vaccination form - NONE
0835734,09/24/2019,PA,4.0,4,,M,,No adverse events noted. Pt was administered Td vs DT which was ordered.,,,,,,,,,Y,07/22/2019,07/22/2019,0,,PVT,,None,None,None,,,2,09/24/2019,,Y,,None
0835752,09/24/2019,NC,78.0,78,,M,,patient began having raspy voice/sore throat approximately 4 hours after receiving vaccine He also had conjunctivitis-like symptoms in both eyes which he did not have prior to receiving vaccine,,,,,,,,,U,09/24/2019,09/24/2019,0,,PHM,,"atenolol, amlodipine, multivitamin, B12, vitamin D3, allopurinol, atorvastatin",tooth extract on 9/16/19,"hypertension, hyperlipidemia, gout",,,2,09/24/2019,,,Y,nkda
0835765,09/24/2019,,68.0,68,,M,09/24/2019,Rash & UrticariaPruritus,,,,,,,,,,09/09/2019,09/14/2019,5,,OTH,OTH,,,,,,1,,,,,
0835766,09/24/2019,VA,68.0,68,,F,,"1 shot - body shaking , fever 2 shot - no reaction  2nd vaccine was not available several months  Got shingles - 7-12-2019",,,,,,,,,,07/30/2018,11/06/2018,99,,PHM,,No,No,No,,,2,,,,,No
0835790,09/24/2019,MI,6.0,6,,U,,"-Following the vaccination, client became ILL + had a Emesis. at no time was the clients breathing compromised. I assisted with a Emesis bucket + cool compresses to the client forehead. The Emesis was full of food + other liquids.  -TX: I Made sure Client was safe at all time + did take vitals, following (Vitals: 2:30 114/68, 64, 20, 97.8/ 2:45 110/64, 68, 18, 97.6 LOC: A&O x 3.",,,,,,,,,Y,09/24/2019,09/24/2019,0,NONe,PUB,,NoNe,Last Week allergic Reaction to food,NONe,,,2,09/24/2019,,,,food: Watermelon
0835791,09/24/2019,,81.0,81,,M,,"Patient came to the pharmacy on September 24, 2019 at approximately 11:15 AM and stated that he had a reaction from the Shingrix vaccine he received. He brought pictures of his break out- pictures showed patient's arm with red, blistering spots. Pictures were of patient's arms, but patient stated he also had blistering spots on both legs. Patient stated he went to his primary care provider where they gave him a prescription for an antiviral and the blistering spots have since cleared. The primary care provider instruction him not to receive the 2nd dose of the Shingrix vaccine.",,,,,,,,,Y,07/23/2019,07/29/2019,6,,UNK,,,,,,,2,09/24/2019,,Y,,
0835792,09/24/2019,OK,55.0,55,,M,09/23/2019,Narrative: Symptoms: Seizures Treatment: SODIUM CHLORIDE ONCE NS x 1 liter,,,,,,,,,,09/20/2019,09/20/2019,0,,OTH,OTH,Fluarix Quadrivalent vaccine,,,,,1,,,,,
0835820,09/24/2019,MA,5.0,5,,F,,Hive x1 at injection site approximately 24 hrs after injection given; treated with Benadryl & cool compress.,,,,,,,,,Y,09/23/2019,09/24/2019,1,none,PVT,,"EPiPen 0.15 (PRN), Fluoride",Unknown,,,,2,,,Y,,"Dairy, Egg, Peanut, tree nut"
0835821,09/24/2019,PR,68.0,68,,F,09/24/2019,"Fever Swelling arms, red and warm area, pain both arms.",,,,Y,,,,,Y,09/21/2019,09/22/2019,1,Cellulitis,OTH,PVT,,No,No,,,1,,,,,
0835832,09/24/2019,NY,55.0,55,,F,09/18/2019,"Raised area of redness over (R) upper arm. Blotchy skin over UES, upper chest - no frank hives",,,,,,,,,N,09/17/2019,09/17/2019,0,N/A,PVT,PVT,"Losartan Potassium, Klonopin, Bactrim, Ibuprofen Ventolin, Advair, Spiriva",,"Allergic: Coconut, naproxen, Wellbutrin, Zestoretic Hx-COPD, HTN, smoker",,,1,,,,,
0835692,09/25/2019,,83.0,83,,M,,patient reported swelling of the injection arm and hand.,,,,,,,,,,09/11/2019,09/12/2019,1,,UNK,,,,,,,2,09/25/2019,,Y,,
0835693,09/25/2019,,57.0,57,,F,,"pt reported swelling, redness, pain of injection arm",,,,,,,,,,09/06/2019,09/07/2019,1,,UNK,,,,,,,2,09/25/2019,,,,
0835694,09/25/2019,,68.0,68,,F,,"I started with a headache and strong body aches that disturbed my sleep the night of the vaccine. The next day I experienced continued headaches and bothersome dizziness, like vertigo. Dizziness and headaches continued into the third day, the tapered off the fourth day after the injection. I stayed in bed a lot for a couple days because of the side effects.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,PHM,,"Citalopram HBR 40mg;  Bupropion HCL XL 150mg; Magnesium Taurate 400mg; Vitamin D3  2,000mg twice per day; L-Methionine 500mg; Dry Vitamin E Succinate 400 IU; Grape Seed Extract Complex with Resveratrol 100mg/ Vit C  250mg/ Calcium 25mg/Japa",,Benign irregular heartbeat; tinnitus (single sided deafness); arthritis in joints; double full knee replacements.,,,2,09/25/2019,,,,"Some medical tape (blistered with radiation therapy); Bacitracin (caused stitches to be infected); Hydrocodone, Codeine (if don't eat enough with it, get dizzy nauseous."
0835695,09/25/2019,MI,55.0,55,,M,,Headache.  Body ache.  Feverish feeling.   Insomnia.  Racing/confusing thoughts.  Trouble concentrating.,,,,,,,,,U,09/23/2019,09/24/2019,1,None,WRK,,None,None,None,Similar reaction to flu vaccine annually,,2,09/25/2019,,,,None known
0835696,09/25/2019,IL,67.0,67,,F,,"Patient reported the arm where both vaccines were injected was very tender to touch, and warm.  Patient felt weak the following couple of days and had fever 101.   On 09/23/19 she felt better but injection site was still sore.",,,,,,,,,Y,09/19/2019,09/20/2019,1,n/a,PHM,,n/a,n/a,n/a,,,2,09/25/2019,,,,n/a
0835711,09/25/2019,TN,,,,F,,"No adverse effect; A 28 week pregnant female patient received GARDASIL 9 on 11-SEP-2019; This spontaneous prospective pregnancy report was received from a medical assistant via a company representative referring to a female patient of unknown age who were 28 weeks pregnant. There was no information about patient's concomitant medications, past drug reactions, allergies or pertinent medical history. Her last menstrual period was in 28-FEB-2019.   On 11-SEP-2019, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (strength, dose number, dose route, anatomical site of vaccination, lot number and expiration date were not reported) (exposure during pregnancy). In addition, no adverse effect was reported.    At the moment of the report, the pregnancy was on going.",,,,,,,,,U,09/11/2019,09/11/2019,0,,UNK,,,Pregnancy,,,US0095075131909USA004992,2,09/24/2019,,,,
0835712,09/25/2019,CA,1.17,1,.2,U,,"No adverse effects reported; a patient received improperly stored Varivax; This spontaneous report was received from a medical assistant and refers to a 14-month-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 09-SEP-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot # S002874 and expiration date 29-JAN-2021 (dose and route of administration were not reported) for prophylaxis. The temperature was from 6F to 14F (10.2 F, multiple) for 50 minutes. There was no previous temperature excursion reported. Digital data logger was involved. Concomitant therapies included properly stored sterile diluent. No adverse effects were reported.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA005231: US-009507513-1909USA005223: US-009507513-1909USA005220: US-009507513-1909USA005078: US-009507513-1909USA005119: US-009507513-1909USA005124: US-009507513-1909USA005129: US-009507513-1909USA005134: US-009507513-1909USA005139: US-009507513-1909USA005365: US-009507513-1909USA005525: US-009507513-1909USA005424: US-009507513-1909USA005468:",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005375,2,09/25/2019,,,,
0835713,09/25/2019,WI,,,,F,,"sudden hearing loss and significant tinnitus where she was ultimately diagnosed with sudden idiopathic hearing loss of right ear; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. In or around 01-JUN-2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dosage and route of administration were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after received zoster vaccine live (ZOSTAVAX), the patient suffered sudden hearing loss and significant tinnitus where she was ultimately diagnosed with sudden idiopathic hearling loss or right ear. It was also specified that the patient suffered serious, progressive, permanent and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a result of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. At the time of reporting, the outcome of the event was not recovered. The event sudden hearing loss was considered to be related to zoster vaccine live (ZOSTAVAX) vaccination.  The event sudden hearing loss was considered medically significant.   The sudden hearing loss was considered to be disabling.",,,,,,,,Y,N,06/01/2016,,,,UNK,,,,,,US0095075131909USA006303,2,09/24/2019,,,,
0835714,09/25/2019,NC,,,,F,,"Shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. In 2011, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dosage and route of administration were not provided) for the long-term prevention of shingles and/or zoster-related conditions. On an unspecified date, subsequent to the patient's vaccination with zoster vaccine live (ZOSTAVAX), the patient was treated by a physician for shingles. It was also specified that the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The event shingles was considered to be related to zoster vaccine live (ZOSTAVAX) vaccination.",,,,,Y,,,,N,,,,,OTH,,,,,,US0095075131909USA006317,2,09/24/2019,,,,
0835715,09/25/2019,NE,,,,F,,"Shingles; Information has been received from a lawyer regarding a case in litigation, referring to a female pt of unknown age. Information regarding the pt's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. On or about 30-SEP-2014, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (route of administration, strength, dose, lot # and expiration date were not provided) by a healthcare provider at a pharmacy for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date, the pt was treated at a medical center for shingles. As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, had and would continued to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, included but not limited to medical losses and costs which included care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. At the time of the report, the outcome of herpes zoster was considered as not recovered. The lawyer considered herpes zoster to be related to zoster vaccine Live (ZOSTAVAX).",,,,,Y,,,,N,09/30/2014,,,,PHM,,,,,,US0095075131909USA006323,2,09/24/2019,,Y,,
0835716,09/25/2019,NJ,,14,,F,,"Her ""calves started swelling and then progressively got worse""/While admitted was diagnosed with Myositis; This spontaneous report has been received from a pharmacist who is also the patient's father referring to a 14 year old female patient. The patient did not have pertinent medical history, drug reactions or allergies. Concomitant therapies included loratadine (CLARITIN) and cetirizine hydrochloride (ZYRTEC).       On 07-AUG-2019, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) intramuscularly, for prophylaxis (lot # and expiration date were not reported).     On 30-AUG-2019, the patient's calves started swelling and progressively got worse, therefore, the patient went to the physician's office, then to urgent care and finally, on 07-SEP-2019, was hospitalized. On an unspecified date in September 2019, an ultrasound of calves, unspecified blood work, and urianalysis tests were taken but no results were provided. Afterwards, while being hospitalized, the patient was diagnosed with myositis and received furosemide (LASIX) intravenously for 3 days, as well as fluid and sodium restrictions. On 11-SEP-2019 (reported as 5 days later), the patient recovered from the event and was discharged from hospital.  The reporter's causality assessment between myositis and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was not provided.",,,,,Y,5,,,Y,08/07/2019,08/30/2019,23,,UNK,,CLARITIN; ZYRTEC,,,,US0095075131909USA008159,2,09/24/2019,,Y,Y,
0835717,09/25/2019,ID,1.08,1,.1,M,,"no adverse effect; received improperly stored PEDVAXHIB; This spontaneous report was received from a nurse refers to a 13 month old male patient. The patient's medical history, concurrent conditions, historical drugs, drug reactions/ allergies and concomitant medications were not reported. On 06-SEP-2019, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) injection, lot # S000353 and expiration date 09-OCT-2021 (strength, dose, frequency and route not reported) for prophylaxis (product storage error). Storage temperature was reported as above 47 degree Fahrenheit (F) (47.4 F) with timeframe of 23 hours. There was no previous temperature excursion. The call was made because of a data logger. No adverse effects reported. No product quality complaint (PQC) present.  This is one of three reports received from the same reporter.",,,,,,,,,U,09/06/2019,09/06/2019,0,,UNK,,,,,,US0095075131909USA008239,2,09/25/2019,,,,
0835718,09/25/2019,ID,0.33,0,.4,M,,"No adverse effect; received improperly stored PEDVAXHIB; This spontaneous report was received from a nurse refers to a 4 month old male patient. The patient's medical history, concurrent conditions, historical drugs, drug reactions/ allergies and concomitant medications were not reported. On 09-SEP-2019, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) injection, lot # S000353 and expiration date 09-OCT-2021 (strength, dose, frequency and route not reported) for prophylaxis (product storage error). Storage temperature was reported as above 47 degree Fahrenheit (F) (47.4 F) with timeframe of 23 hours. There was no previous temperature excursion. The call was made because of a data logger. No adverse effects reported. No product quality complaint (PQC) present.  This is one of three reports received from the same reporter.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,US0095075131909USA008364,2,09/25/2019,,,,
0835719,09/25/2019,FL,12.0,12,,F,,"patient was hospitalized again and was again diagnosed with nephrotic syndrome; patient developed ""swollen legs"". The patient was hospitalized at unknown facility in an unspecified city/state on 22-AUG-2012 with flu and was diagnosed with nephrotic syndrome; patient developed ""swollen legs"". The patient was hospitalized at unknown facility in an unspecified city/state on 22-AUG-2012 with flu and was diagnosed with nephrotic syndrome; This spontaneous report was received from a physician via a company representative regarding a 12 years old female patient. Patient's past medical history and drug reactions/allergies were reported as unknown. Concomitant medications included diphtheria toxoid, pertussis acellular 5-component vaccine, tetanus toxoid (ADACEL) and meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA).   On 25-JUL-2012, the patient received first dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL), intramuscular for prevention of certain HPV related cancers (dose, lot# and expiry dates were not reported).   On 02-AUG-2012, the patient developed ""swollen legs"". The patient was hospitalized at unknown facility in an unspecified city/state on 22-AUG-2012 with flu and was diagnosed with nephrotic syndrome. On 03-JAN-2013, the patient received 2nd dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) and received 3rd dose on 26-APR-2013. On 13-MAY-2013, the patient was hospitalized again and was again diagnosed with nephrotic syndrome.   On unspecified dates, the patient recovered from the events nephrotic syndrome and flu. On an unknown date in 2017, the patient recovered from the event nephrotic syndrome. Causality of the events were not reported.  It was reported that the patient was suffering an incapacity due to being hospitalized and diagnosed with Nephrotic syndrome twice (disability).   Upon internal review, the event ""Nephrotic syndrome"" was determined to be medically significant.",,,,,Y,,,Y,Y,07/25/2012,08/01/2012,7,,UNK,,ADACEL; MENACTRA,,,,US0095075131909USA008431,2,09/25/2019,,,,
0835720,09/25/2019,NY,,,,M,,"her son had trouble breathing; severe allergic reaction; negative titers to mumps; This spontaneous report was received from a consumer, referring to her son, a male patient of unknown age. The patient's pertinent medical history, concurrent conditions, concomitant therapies, previous drug reactions or allergies were not reported.     On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (strength, dose, frequency, route of administration, anatomical injections site, lot # and expiration date were not disclosed).         Afterwards, on an unknown date, the patient experienced trouble breathing (dyspnea) and had other unspecified but severe allergic reaction (allergy to vaccine). The patient's mother also reported that her son had negative titers to mumps (mumps antibody test negative) after receiving the vaccine.  At the time of this report, the outcome of dyspnoea, mumps antibody test negative and allergy to vaccine was unknown.    The event of allergy to vaccine was considered to be related to Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II). However, the causality assessment between Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) and the events dyspnea and mumps test negative, was not provided.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA008653,2,09/24/2019,,,,
0835721,09/25/2019,CA,,,,F,,"Ataxia; This spontaneous report was received from a physician via a company representative refers to a 13 year old female patient. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported.  On an unknown date, the patient was vaccinated with first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, frequency, lot #, expiry date and route were not reported) for prophylaxis. On an unknown date, (reported as: approximately 5 days after vaccination with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), the patient experienced ataxia. The outcome of ataxia was reported as recovered/resolved, on an unknown date. The causality of event was not reported.",,,,,,,,,Y,,,,,UNK,,,,,,US0095075131909USA009128,2,09/25/2019,,,,
0835722,09/25/2019,CA,,,,U,,"an improperly stored dose of Pedvax was administered to the patient; no adverse effects; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's medical history, concomitant medications, previous drug reactions or allergies, and concurrent conditions were not disclosed.  On an unknown date, the patient was vaccinated with a dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) for prophylaxis (strength, dose, route of administration, anatomical injection site were not disclosed), lot # N024570 and expiration date 01-MAY-2020.  It was reported that this vaccine had been on a temperature excursion and was stored below 36 F (32.1 F) during 8 hours; but it was also noted that there had not been a previous temperature excursion.  At the time of this report, there were no adverse events reported. Digital data logger was involved.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009285,2,09/24/2019,,,,
0835723,09/25/2019,TX,,,,F,,"cellulitis; post herpetic neuralgia; left ear pain; recurrent outbreaks of herpes zoster dermatitis; Information has been received from a lawyer referring to a female patient of unknown age. Information about concurrent condition, history condition and concomitant medication was not reported. On or around 18-SEP-2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live (ZOSTAVAX) (date not reported), the patient suffered painful rash on right arm and has been diagnosed with recurrent outbreaks of herpes zoster dermatitis, left ear pain, cellulitis and post herpetic neuralgia. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the vaccine. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events recurrent outbreaks of herpes zoster dermatitis, left ear pain, cellulitis and post herpetic neuralgia was considered to be not recovered and causal relationship was assessed as related.   The lawyer considered the events recurrent outbreaks of herpes zoster dermatitis, left ear pain, cellulitis and post herpetic neuralgia to be disability.  Upon internal review, the event cellulitis was determined to be medically significant event.",,,,,,,,Y,N,09/18/2017,,,,UNK,,,Routine health maintenance,,,US0095075131909USA009446,2,09/24/2019,,,,
0835724,09/25/2019,WA,76.0,,,U,,"facial pain radiating to eye, ear and Rsideof the face; Incomplete course of vaccination; This case was reported by a consumer via call center representative and described the occurrence of facial pain in a 76-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In February 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced facial pain and incomplete course of vaccination. The patient was treated with antivirals nos, antivirals nos, antivirals nos, antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the facial pain and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the facial pain to be related to Shingrix.  Additional details were provided as follows: The patient had vaccine and experienced facial pain radiating to eye ear and right side of face. The patient took antiviral pill which alleviated the sx. At the time of reporting did not receive the 2nd dose, which led to incomplete course of vaccination. The patient asked whether it is safe to have the follow up vaccine suggested after 6 months.",,,,,,,,,U,02/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/25/2019,,,,
0835725,09/25/2019,NY,67.0,,,F,,"Sore arm; This case was reported by a physician via call center representative and described the occurrence of pain in arm in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included foot pain and breast cancer.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received a dose of Shingrix in the right arm. The patient experienced sore arm for few days after receiving 1st dose of Shingrix. The reporter consented to follow up. This case has been linked with case US2019168158 reported by the same reporter.",,,,,,,,,Y,,,,,UNK,,,Breast cancer; Foot pain,,,USGLAXOSMITHKLINEUS2019AM,2,09/25/2019,,,,
0835726,09/25/2019,NY,,,,U,,"variceal hemorrhage; bleeding; This case was reported in a literature article and described the occurrence of bleeding varicose vein in a 18-month-old patient who received Haemophilus influenzae type b vaccine for prophylaxis.  Co-suspect products included PNEUMOCOCCAL VACCINE (PCV13) for prophylaxis, PPSV23 PNEUMOCOCCAL VACCINE for prophylaxis, piperacillin for prophylaxis and tazobactam for prophylaxis.   The subject's past medical history included hemorrhage, bleeding varicose vein, splenomegaly (before PSE) and sclerotherapy (for management of variceal hemorrhage). Concurrent medical conditions included portal hypertension (whose etiology was portal vein thrombosis), portal vein thrombosis (PVT) and varicosity.   On an unknown date, the patient received Haemophilus influenzae type b vaccine at an unknown dose, PCV13 at an unknown dose, PPSV23 PNEUMOCOCCAL VACCINE at an unknown dose, piperacillin (intravenous) at an unknown dose and frequency and tazobactam (intravenous) at an unknown dose and frequency. On an unknown date, more than a week after receiving Haemophilus influenzae type b vaccine, the patient experienced bleeding varicose vein (serious criteria hospitalization) and hemorrhage (serious criteria hospitalization and GSK medically significant). The action taken with piperacillin was unknown. The action taken with tazobactam was unknown. On an unknown date, the outcome of the bleeding varicose vein and hemorrhage were unknown.   It was unknown if the reporter considered the bleeding varicose vein and hemorrhage to be related to Haemophilus influenzae type b vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of recurrent variceal hemorrhage in a 18-month-old patient of unspecified gender who was vaccinated with unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (manufacturer unknown for all) for prophylaxis. This case corresponds to supplemental table 1 (patient 13) reported in this literature article.  The patient was a youngest patient of a cohort study that aimed to determine whether Partial Splenic Embolization (PSE) was safe and effective in the pediatric population.  The study was a retrospective review of a single-center experience for all patients ages 0 to 21 who underwent PSE for the management of portal hypertension (PHTN) between January 2010 and August 2017 at New York. The study presented the experience with the use of this modality in different pediatric populations with PHTN to better understand the rationale for safe and appropriate application of this treatment. [In this study, [In this study, recommended PSE to patients with bleeding tendencies that were not optimal candidates for an open surgical shunt or repeated endoscopies. This includes the following patient populations: Patients with baseline compromised respiratory function (ie, cystic fibrosis [CF]). 2. Patients with significant synthetic dysfunction that may progress to liver failure after shunting. 3. Patients with early signs of encephalopathy that could potentially worsen with increased portal systemic shunting. 4. Patients with abnormal right heart function that could develop cardiac decompensation or shunt failure. 5. Patients deemed to be marginal candidates for repeated anesthesia. 6. Patients with splenic vein thrombosis. 7. Patients with characteristics predicting poor wound healing or other surgical complications. 8. Patients with unfavorable anatomy, increased transhepatic resistance, or elevated right heart pressures to permit mesoportal shunting (Rex shunt)]. The patient had thrombocytopenia and/or recurrent variceal bleeding. The patient had portal hypertension, whose etiology was portal vein thrombosis (PVT)(no underlying liver disease) and the patient had a bleeding. The patient also had variceal hemorrhage and the patient also noted to have varices before PSE. For the management of variceal hemorrhage, the patient underwent sclerotherapy rather than endoscopic variceal ligation before PSE. The patient had significant splenomegaly before PSE. The decision to proceed with PSE was determined by the primary hepatologist and surgeon after careful discussion with both patient and family members regarding alternative approaches. No information on patient's family history or concomitant medication was provided.   On an unspecified date, at least 2 weeks before PSE, the patient received unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (administration route and site unspecified, dosage unknown, batch number not provided for all), in order to reduce the risk of future infection by encapsulated organisms, should the procedure lead to a complication necessitating total splenectomy. The age of vaccination was not provided. It was reported that the patient received broad-spectrum intravenous antibiotic prophylaxis, typically with piperacillin/tazobactam, before the procedure to prevent infection of infarcted splenic tissue. This was continued for 5 to 7 days. On an unknown date, before PSE, the patient's platelet count was noted at 1510E9/L (normal range not provided).   On an unspecified date between January 2010 and August 2017, at least 2 weeks after vaccination, the patient underwent PSE by interventional radiology under general anesthesia via percutaneous femoral artery approach under sterile conditions utilizing guidelines based on the Spigos technique to minimize complications. At the time of PSE, the patient was not actively bleeding. Diagnostic angiographies of the celiac axis and splenic arteries were obtained to determine the target splenic arterial branches, to identify accessory branches to other tissues from the splenic artery and to determine baseline splenic volume. Abdominal sonograms with doppler analysis of hepatic and splenic vessels were performed post procedure to assess vessel patency and the degree of intra-abdominal-free fluid. Arteriograms of partial splenic embolization (PSE), pre-embolization with capillary blush demonstrated splenomegaly and post-embolization with capillary blush revealed multiple defects before and after esophageal varices.   Information regarding patient's blood transfusions was not available. The patient was admitted to hospital after PSE for further observation and management. [In this study, patients received patient-controlled analgesia for pain control and to prevent splinting and associated pulmonary complications such as atelectasis and pneumonia]. The patient was noted to have recurrent variceal hemorrhage after PSE and started bleeding and subsequently underwent EVL intervention. The patient did not develop infection with encapsulated organisms. Post-PSE, the patient's platelet count was 18810E9/L. The antibiotics were converted to an oral regimen before hospital discharge. [In this study, criteria for hospital discharge included adequate control of abdominal pain with oral medications, adequate oral intake/hydration, and absence of post procedure infection. Magnetic resonance imaging (MRI) showed splenomegaly and postembolization with necrotic areas surrounding the spleen. Three patients demonstrated complete resolution of varices. An additional 7 patients were noted to have a decrease in variceal grade].  On an unknown date, the patient was discharged fulfilling the criteria for hospital discharge that included (adequate control of abdominal pain with oral medications), adequate oral intake/hydration, and absence of post procedure infection. The patient was not re-hospitalized. The patient was followed-up in the outpatient hepatology clinic. Hematologic indices including white blood cell (WBC) and platelet counts were monitored. Imaging was repeated as indicated. Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Additionally, the patient underwent surgical shunt after post PSE and reason of surgical shunt was due to recurrent variceal hemorrhage. The time range from PSE to surgical shunt was 7.56 -27.72 months. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.  This case has been considered as serious due to hospitalization.   The outcome of the event was not reported.  The author did not comment on the relationship between the event of recurrent variceal hemorrhage and Unspecified Haemophilus influenza type B vaccine, unspecified meningococcal vaccine and unspecified pneumococcal (PCV13 followed by PPSV23) vaccine. The author stated ""The Centers for Disease Control and Prevention recommends immunoprophylaxis against Streptococcus pneumoniae, H influenzae and Neisseria meningitidis in all splenectomized patients. Complications of PHTN such as hypersplenism, variceal hemorrhage, and ascites can lead to significant morbidity and mortality in children. Surgical interventions include shunting or splenectomy; however, overwhelming sepsis postsplenectomy is a pressing concern. PSE addresses portal hypertension regardless of etiology as definitive therapy. Most adverse effects following PSE are expected and can be managed conservatively. In our cohort we commonly observed fever, abdominal pain, and leukocytosis without evidence of infection. Pain was effectively controlled with intravenous and oral analgesics. Nonsteroidal anti-inflammatory drugs were avoided to minimize hemorrhage. In our experience, prophylactic antibiotics and limiting splenic reduction to no greater than 70% have avoided serious morbidity and mortality. In particular, there was no significant difference in the preprocedure platelet count between patients with and without recurrent thrombocytopenia. After PSE we noted a significant increase in platelets but to a lesser degree in patients who had recurrent hypersplenism. In our patients with esophageal varices, the combination of endoscopic ligation and PSE has been successful in controlling the progression of varices and decreasing the incidence of variceal hemorrhage.""  The author concluded ""our study supports that PSE is a safe, effective, semi-invasive alternative to splenectomy in pediatric patients with PHTN. The combination of EVL and PSE is effective treatment for esophageal and gastric varices (not amenable to simple band ligation). Reduced splenic volume and splenic venous return effectively decreased portal flow and pressure. PSE can be successfully performed in pre- and post-transplant transplant patients, and select cirrhotic and noncirrhotic pediatric patients. PSE appears to preserve functional spleen mass and avoids postprocedure accelerated liver disease or encephalopathy. In contrast to shunting, PSE can be effective even in the setting of elevated right-sided heart pressures. Further multicenter collaborative studies with larger and varied patient populations will need to be performed to substantiate our approach and better define patient populations that would benefit most from PSE, sequential PSE or combined interventions. Liver transplantation remains the ideal intervention for anyone with significant decompensated PHTN or advanced hepatic dysfunction"".  This is 1 of the 9 valid cases reported in this article.      Lab Comments: On an unspecified date, Lab test were per formed. The patient's hematologic indices including white blood cell (WBC) and platelet counts were monitored (result not provided). Imaging was repeated as indicated (result not provided). . Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Additionally, the patient underwent surgical shunt after post PSE and reason of surgical shunt was due to recurrent variceal hemorrhage. The time range from PSE to surgical shunt was 7.56 -27.72 months. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.",,,,,Y,,,,U,,,,"Test Name: Endoscopy; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Platelet count; Result Unstructured Data: Test Result: 15 (before PSE), Test Result Unit: x10e9/L; Test Name: Platelet count; Result Unstructured Data: Test Result: 188, Test Result Unit: x10e9/L; Test Name: White blood cells; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown",UNK,,,Bleeding varicose vein; Hemorrhage; Portal hypertension (whose etiology was portal vein thrombosis); Portal vein thrombosis (PVT); Varicosity,Medical History/Concurrent Conditions: Sclerotherapy (for management of variceal hemorrhage); Splenomegaly (before PSE),,USGLAXOSMITHKLINEUS2019GS,2,09/25/2019,,,,
0835727,09/25/2019,NY,,,,U,,"recurrent variceal hemorrhage; bleeding; This case was reported in a literature article and described the occurrence of bleeding varicose vein in a 11-year-old patient who received Haemophilus influenzae type b vaccine for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PCV13) for prophylaxis, PPSV23 PNEUMOCOCCAL VACCINE for prophylaxis, piperacillin for prophylaxis and tazobactam for prophylaxis.   The subject's past medical history included hemorrhage, bleeding varicose vein, splenomegaly (significant before PSE) and varicose veins ligation. Concurrent medical conditions included portal hypertension (etiology was hepatoportal sclerosis) and varicosity (before PSE.).   On an unknown date, the patient received Haemophilus influenzae type b vaccine at an unknown dose, PCV13 at an unknown dose, PPSV23 PNEUMOCOCCAL VACCINE at an unknown dose, piperacillin (intravenous) at an unknown dose and frequency and tazobactam (intravenous) at an unknown dose and frequency. On an unknown date, more than a week after receiving Haemophilus influenzae type b vaccine, the patient experienced bleeding varicose vein (serious criteria hospitalization) and hemorrhage (serious criteria hospitalization and GSK medically significant). The action taken with piperacillin was unknown. The action taken with tazobactam was unknown. On an unknown date, the outcome of the bleeding varicose vein and hemorrhage were unknown.   It was unknown if the reporter considered the bleeding varicose vein and hemorrhage to be related to Haemophilus influenzae type b vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of recurrent variceal hemorrhage in a 11-year-old patient of unspecified gender who was vaccinated with unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (manufacturer unknown for all) for prophylaxis. This case corresponds to supplemental table 1 (patient 23) reported in this literature article.  The patient was a part of cohort study that aimed to determine whether Partial Splenic Embolization (PSE) was safe and effective in the pediatric population.  The study was a retrospective review of a single-center experience for all patients ages 0 to 21 who underwent PSE for the management of portal hypertension (PHTN) between January 2010 and August 2017. The study presented the experience with the use of this modality in different pediatric populations with PHTN to better understand the rationale for safe and appropriate application of this treatment. [In this study, [In this study, recommended PSE to patients with bleeding tendencies that were not optimal candidates for an open surgical shunt or repeated endoscopies. This includes the following patient populations: Patients with baseline compromised respiratory function (ie, cystic fibrosis [CF]). 2. Patients with significant synthetic dysfunction that may progress to liver failure after shunting. 3. Patients with early signs of encephalopathy that could potentially worsen with increased portal systemic shunting. 4. Patients with abnormal right heart function that could develop cardiac decompensation or shunt failure. 5. Patients deemed to be marginal candidates for repeated anesthesia. 6. Patients with splenic vein thrombosis. 7. Patients with characteristics predicting poor wound healing or other surgical complications. 8. Patients with unfavorable anatomy, increased transhepatic resistance, or elevated right heart pressures to permit mesoportal shunting (Rex shunt)]. The patient had thrombocytopenia and/or recurrent variceal bleeding. The patient had portal hypertension, whose etiology was hepatoportal sclerosis (HPS), and the patient had a bleeding. The patient also had variceal hemorrhage and the patient also noted to have evidence of varices before PSE. For the management of variceal hemorrhage, the patient underwent endoscopic variceal ligation (EVL) before PSE. The patient had significant splenomegaly before PSE. The decision to proceed with PSE was determined by the primary hepatologist and surgeon after careful discussion with both patient and family members regarding alternative approaches. No information on patient's family history or concomitant medication was provided.   On an unspecified date, at least 2 weeks before PSE, the patient received unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (administration route and site unspecified, dosage unknown, batch number not provided for all), in order to reduce the risk of future infection by encapsulated organisms, should the procedure lead to a complication necessitating total splenectomy. The age of vaccination was not provided. It was reported that the patient received broad-spectrum intravenous antibiotic prophylaxis, typically with piperacillin/tazobactam, before the procedure to prevent infection of infarcted splenic tissue. This was continued for 5 to 7 days. On an unknown date, before PSE, the patient's platelet count was noted at 4810E9/L (normal range not provided).   On an unspecified date between January 2010 and August 2017, at least 2 weeks after vaccination, the patient underwent PSE by interventional radiology under general anesthesia via percutaneous femoral artery approach under sterile conditions utilizing guidelines based on the Spigos technique to minimize complications. At the time of PSE, the patient was not actively bleeding. Diagnostic angiographies of the celiac axis and splenic arteries were obtained to determine the target splenic arterial branches, to identify accessory branches to other tissues from the splenic artery and to determine baseline splenic volume. Abdominal sonograms with doppler analysis of hepatic and splenic vessels were performed post procedure to assess vessel patency and the degree of intra-abdominal-free fluid. Arteriograms of partial splenic embolization (PSE), pre-embolization with capillary blush demonstrated splenomegaly and post-embolization with capillary blush revealed multiple defects before and after esophageal varices.   Information regarding patient's blood transfusions was not available. The patient was admitted to hospital after PSE for further observation and management. [In this study, patients received patient-controlled analgesia for pain control and to prevent splinting and associated pulmonary complications such as atelectasis and pneumonia]. The patient was noted to have recurrent variceal hemorrhage after PSE and started bleeding and subsequently underwent EVL intervention. The patient did not develop infection with encapsulated organisms. Post-PSE, the patient's platelet count was 10710E9/L. The patient did not have a sustained platelet response and underwent Splenectomy which was performed for recurrent variceal hemorrhage after PSE. the antibiotics were converted to an oral regimen before hospital discharge. [In this study, criteria for hospital discharge included adequate control of abdominal pain with oral medications, adequate oral intake/hydration, and absence of post procedure infection. Magnetic resonance imaging (MRI) showed splenomegaly and postembolization with necrotic areas surrounding the spleen. Three patients demonstrated complete resolution of varices. An additional 7 patients were noted to have a decrease in variceal grade].  On an unknown date, the patient was discharged fulfilling the criteria for hospital discharge that included (adequate control of abdominal pain with oral medications), adequate oral intake/hydration, and absence of post procedure infection. The patient was not re-hospitalized. The patient was followed-up in the outpatient hepatology clinic. Hematologic indices including white blood cell (WBC) and platelet counts were monitored. Imaging was repeated as indicated. Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.  This case has been considered as serious due to hospitalization.  The outcome of the event was not reported.  The author did not comment on the relationship between the event of recurrent variceal hemorrhage and Unspecified Haemophilus influenza type B vaccine, unspecified meningococcal vaccine and unspecified pneumococcal (PCV13 followed by PPSV23) vaccine. The author stated ""The Centers for Disease Control and Prevention recommends immunoprophylaxis against Streptococcus pneumoniae, H influenzae and Neisseria meningitidis in all splenectomized patients. Complications of PHTN such as hypersplenism, variceal hemorrhage, and ascites can lead to significant morbidity and mortality in children. Surgical interventions include shunting or splenectomy; however, overwhelming sepsis postsplenectomy is a pressing concern. PSE addresses portal hypertension regardless of etiology as definitive therapy. Most adverse effects following PSE are expected and can be managed conservatively. In our cohort we commonly observed fever, abdominal pain, and leukocytosis without evidence of infection. Pain was effectively controlled with intravenous and oral analgesics. Nonsteroidal anti-inflammatory drugs were avoided to minimize hemorrhage. In our experience, prophylactic antibiotics and limiting splenic reduction to no greater than 70% have avoided serious morbidity and mortality. In particular, there was no significant difference in the preprocedure platelet count between patients with and without recurrent thrombocytopenia. After PSE we noted a significant increase in platelets but to a lesser degree in patients who had recurrent hypersplenism. In our patients with esophageal varices, the combination of endoscopic ligation and PSE has been successful in controlling the progression of varices and decreasing the incidence of variceal hemorrhage.""  The author concluded ""our study supports that PSE is a safe, effective, semi-invasive alternative to splenectomy in pediatric patients with PHTN. The combination of EVL and PSE is effective treatment for esophageal and gastric varices (not amenable to simple band ligation). Reduced splenic volume and splenic venous return effectively decreased portal flow and pressure. PSE can be successfully performed in pre- and post-transplant transplant patients, and select cirrhotic and noncirrhotic pediatric patients. PSE appears to preserve functional spleen mass and avoids postprocedure accelerated liver disease or encephalopathy. In contrast to shunting, PSE can be effective even in the setting of elevated right-sided heart pressures. Further multicenter collaborative studies with larger and varied patient populations will need to be performed to substantiate our approach and better define patient populations that would benefit most from PSE, sequential PSE or combined interventions. Liver transplantation remains the ideal intervention for anyone with significant decompensated PHTN or advanced hepatic dysfunction"".  This is 1 of the 9 valid cases reported in this article.      Lab Comments: On an unspecified date Lab test were performed. The patient's hematologic indices including white blood cell (WBC) and platelet counts were monitored (result not provided). Imaging was repeated as indicated (result not provided).. Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.",,,,,Y,,,,U,,,,"Test Name: Endoscopy; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Platelet count; Result Unstructured Data: Test Result: 48(before PSE), Test Result Unit: x10e9/L; Test Name: Platelet count; Result Unstructured Data: Test Result: 107 (Post PSE), Test Result Unit: x10e9/L; Test Name: White blood cells; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown",UNK,,PIPERACILLIN; TAZOBACTAM,Portal hypertension (etiology was hepatoportal sclerosis),Medical History/Concurrent Conditions: Bleeding varicose vein; Hemorrhage; Splenomegaly (significant before PSE); Varicose veins ligation; Varicosity (before PSE.),,USGLAXOSMITHKLINEUS2019GS,2,09/25/2019,,,,
0835728,09/25/2019,NY,,,,U,,"Fever; Abdominal pain; This case was reported in a literature article and described the occurrence of fever in a 12-year-old patient who received Haemophilus influenzae type b vaccine for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PCV13) for prophylaxis, PPSV23 PNEUMOCOCCAL VACCINE for prophylaxis, piperacillin for prophylaxis and tazobactam for prophylaxis.   The subject's past medical history included splenomegaly (for varices) and varicose veins ligation. Concurrent medical conditions included portal hypertension (etiology was primary sclerosing cholangitis), primary sclerosing cholangitis (PSC), thrombocytopenia, bleeding varicose vein and varicosity (Before PSE).   On an unknown date, the patient received Haemophilus influenzae type b vaccine at an unknown dose, PCV13 at an unknown dose, PPSV23 PNEUMOCOCCAL VACCINE at an unknown dose, piperacillin (intravenous) at an unknown dose and frequency and tazobactam (intravenous) at an unknown dose and frequency. On an unknown date, more than a week after receiving Haemophilus influenzae type b vaccine, the patient experienced fever (serious criteria hospitalization) and abdominal pain (serious criteria hospitalization). The action taken with piperacillin was unknown. The action taken with tazobactam was unknown. On an unknown date, the outcome of the fever and abdominal pain were unknown.   It was unknown if the reporter considered the fever and abdominal pain to be related to Haemophilus influenzae type b vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of fever and abdominal pain in a 12-year-old patient of unspecified gender who was vaccinated with unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (manufacturer unknown for all) for prophylaxis.   The patient was a part of cohort study that aimed to determine whether Partial Splenic Embolization (PSE) was safe and effective in the pediatric population.  The study was a retrospective review of a single-center experience for all patients ages 0 to 21 who underwent PSE for the management of portal hypertension (PHTN) between January 2010 and August 2017. The study presented the experience with the use of this modality in different pediatric populations with PHTN to better understand the rationale for safe and appropriate application of this treatment. [In this study, [In this study, recommended PSE to patients with bleeding tendencies that were not optimal candidates for an open surgical shunt or repeated endoscopies. This includes the following patient populations: Patients with baseline compromised respiratory function (ie, cystic fibrosis [CF]). 2. Patients with significant synthetic dysfunction that may progress to liver failure after shunting. 3. Patients with early signs of encephalopathy that could potentially worsen with increased portal systemic shunting. 4. Patients with abnormal right heart function that could develop cardiac decompensation or shunt failure. 5. Patients deemed to be marginal candidates for repeated anesthesia. 6. Patients with splenic vein thrombosis. 7. Patients with characteristics predicting poor wound healing or other surgical complications. 8. Patients with unfavorable anatomy, increased transhepatic resistance, or elevated right heart pressures to permit mesoportal shunting (Rex shunt)]. The patient had thrombocytopenia and/or recurrent variceal bleeding. The patient had portal hypertension, whose etiology was primary sclerosing cholangitis (PSC), and the patient also noted to have evidence of varices before PSE which required endoscopic intervention. For this, the patient underwent endoscopic variceal ligation (EVL) before PSE. The patient had significant splenomegaly before PSE. The decision to proceed with PSE was determined by the primary hepatologist and surgeon after careful discussion with both patient and family members regarding alternative approaches. No information on patient's family history or concomitant medication was provided.   On an unspecified date, at least 2 weeks before PSE, the patient received unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (administration route and site unspecified, dosage unknown, batch number not provided for all), in order to reduce the risk of future infection by encapsulated organisms, should the procedure lead to a complication necessitating total splenectomy. The age of vaccination was not provided. It was reported that the patient received broad-spectrum intravenous antibiotic prophylaxis, typically with piperacillin/tazobactam, before the procedure to prevent infection of infarcted splenic tissue. This was continued for 5 to 7 days. On an unknown date, before PSE, the patient's platelet count was noted at 6610E9/L (normal range not provided).   On an unspecified date between January 2010 and August 2017, at least 2 weeks after vaccination, the patient underwent PSE by interventional radiology under general anesthesia via percutaneous femoral artery approach under sterile conditions utilizing guidelines based on the Spigos technique to minimize complications. At the time of PSE, the patient was not actively bleeding. Diagnostic angiographies of the celiac axis and splenic arteries were obtained to determine the target splenic arterial branches, to identify accessory branches to other tissues from the splenic artery and to determine baseline splenic volume. Abdominal sonograms with doppler analysis of hepatic and splenic vessels were performed post procedure to assess vessel patency and the degree of intra-abdominal-free fluid. Arteriograms of partial splenic embolization (PSE), pre-embolization with capillary blush demonstrated splenomegaly and post-embolization with capillary blush revealed multiple defects before and after esophageal varices.   Information regarding patient's blood transfusions was not available. The patient was admitted to hospital after PSE for further observation and management. [In this study, patients received patient-controlled analgesia for pain control and to prevent splinting and associated pulmonary complications such as atelectasis and pneumonia]. Post PSE, the patient again underwent EVL intervention. The patient did not develop infection with encapsulated organisms. Post-PSE, the patient's platelet count was 9210E9/L. the antibiotics were converted to an oral regimen before hospital discharge. [In this study, criteria for hospital discharge included adequate control of abdominal pain with oral medications, adequate oral intake/hydration, and absence of post procedure infection. Magnetic resonance imaging (MRI) showed splenomegaly and postembolization with necrotic areas surrounding the spleen. Three patients demonstrated complete resolution of varices. An additional 7 patients were noted to have a decrease in variceal grade].  On an unknown date, the patient was discharged fulfilling the criteria for hospital discharge that included (adequate control of abdominal pain with oral medications), adequate oral intake/hydration, and absence of post procedure infection. The patient was followed-up in the outpatient hepatology clinic. Hematologic indices including white blood cell (WBC) and platelet counts were monitored. Imaging was repeated as indicated. The patient developed fever and abdominal pain and the patient was re-hospitalized. [In this study, 7 patients required readmission after initial discharge 2 of these patients were discharged only 1 day after PSE and returned the following day with fevers and abdominal pain with an unremarkable diagnostic evaluation].  Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. The patient underwent orthotopic liver transplantation. The time range from PSE to OLT was 10-55 months. [In this study, Indications for OLT included worsening liver synthetic function and concern for hepatocellular carcinoma in a patient with underlying cirrhosis. The indications for OLT were not related to hypersplenism]. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.  This case has been considered as serious due to hospitalization.  The outcome of the event was not reported.  The author did not comment on the relationship between the event of fever and abdominal pain and Unspecified Haemophilus influenza type B vaccine, unspecified meningococcal vaccine and unspecified pneumococcal (PCV13 followed by PPSV23) vaccine. The author stated ""The Centers for Disease Control and Prevention recommends immunoprophylaxis against Streptococcus pneumoniae, H influenzae and Neisseria meningitidis in all splenectomized patients. Complications of PHTN such as hypersplenism, variceal hemorrhage, and ascites can lead to significant morbidity and mortality in children. Surgical interventions include shunting or splenectomy; however, overwhelming sepsis postsplenectomy is a pressing concern. PSE addresses portal hypertension regardless of etiology as definitive therapy. Most adverse effects following PSE are expected and can be managed conservatively. In our cohort we commonly observed fever, abdominal pain, and leukocytosis without evidence of infection. Pain was effectively controlled with intravenous and oral analgesics. Nonsteroidal anti-inflammatory drugs were avoided to minimize hemorrhage. In our experience, prophylactic antibiotics and limiting splenic reduction to no greater than 70% have avoided serious morbidity and mortality. In particular, there was no significant difference in the preprocedure platelet count between patients with and without recurrent thrombocytopenia. After PSE we noted a significant increase in platelets but to a lesser degree in patients who had recurrent hypersplenism. In our patients with esophageal varices, the combination of endoscopic ligation and PSE has been successful in controlling the progression of varices and decreasing the incidence of variceal hemorrhage.""  The author concluded ""our study supports that PSE is a safe, effective, semi-invasive alternative to splenectomy in pediatric patients with PHTN. The combination of EVL and PSE is effective treatment for esophageal and gastric varices (not amenable to simple band ligation). Reduced splenic volume and splenic venous return effectively decreased portal flow and pressure. PSE can be successfully performed in pre- and post-transplant transplant patients, and select cirrhotic and noncirrhotic pediatric patients. PSE appears to preserve functional spleen mass and avoids postprocedure accelerated liver disease or encephalopathy. In contrast to shunting, PSE can be effective even in the setting of elevated right-sided heart pressures. Further multicenter collaborative studies with larger and varied patient populations will need to be performed to substantiate our approach and better define patient populations that would benefit most from PSE, sequential PSE or combined interventions. Liver transplantation remains the ideal intervention for anyone with significant decompensated PHTN or advanced hepatic dysfunction"".  This is 1 of the 9 valid cases reported in this article.      Lab Comments: On an unspecified date Lab test were performed. The patient's hematologic indices including white blood cell (WBC) and platelet counts were monitored (result not provided). Imaging was repeated as indicated (result not provided).. Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.",,,,,Y,,,,U,,,,"Test Name: Endoscopy; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Platelet count; Result Unstructured Data: Test Result: 66 (before PSE), Test Result Unit: x10e9/L; Test Name: Platelet count; Result Unstructured Data: Test Result: 92 (Post PSE), Test Result Unit: x10e9/L; Test Name: White blood cells; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown",UNK,,PIPERACILLIN; TAZOBACTAM,Bleeding varicose vein; Portal hypertension (etiology was primary sclerosing cholangitis); Primary sclerosing cholangitis (PSC); Thrombocytopenia; Varicosity (Before PSE),Medical History/Concurrent Conditions: Splenomegaly (for varices); Varicose veins ligation,,USGLAXOSMITHKLINEUS2019GS,2,09/25/2019,,,,
0835729,09/25/2019,NY,,,,U,,"Fever; Abdominal pain; This case was reported in a literature article and described the occurrence of fever in a 17-year-old patient who received Haemophilus influenzae type b vaccine for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PCV13) for prophylaxis, PPSV23 PNEUMOCOCCAL VACCINE for prophylaxis, MENINGOCOCCAL VACCINES (NOS) (MENINGOCOCCAL VACCINE) for prophylaxis, piperacillin for prophylaxis and tazobactam for prophylaxis.   The subject's past medical history included orthotopic liver transplant (Before PSE lead to biliary complications) and splenomegaly. Concurrent medical conditions included portal hypertension (PHTN) and varicosity.   On an unknown date, the patient received Haemophilus influenzae type b vaccine at an unknown dose, PCV13 at an unknown dose, PPSV23 PNEUMOCOCCAL VACCINE at an unknown dose, MENINGOCOCCAL VACCINE at an unknown dose, piperacillin at an unknown dose and frequency and tazobactam at an unknown dose and frequency. On an unknown date, more than a week after receiving Haemophilus influenzae type b vaccine, the patient experienced fever (serious criteria hospitalization) and abdominal pain (serious criteria hospitalization). The action taken with piperacillin was unknown. The action taken with tazobactam was unknown. On an unknown date, the outcome of the fever and abdominal pain were unknown.   It was unknown if the reporter considered the fever and abdominal pain to be related to Haemophilus influenzae type b vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of fever and abdominal pain in a 17-year-old patient of unspecified gender who was vaccinated with unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (manufacturer unknown for all) for prophylaxis. This case corresponds to supplemental table 1 (patient 25) reported in this literature article.  The patient was a part of cohort study that aimed to determine whether Partial Splenic Embolization (PSE) was safe and effective in the pediatric population.  The study was a retrospective review of a single-center experience for all patients ages 0 to 21 who underwent PSE for the management of portal hypertension (PHTN) between January 2010 and August 2017. The study presented the experience with the use of this modality in different pediatric populations with PHTN to better understand the rationale for safe and appropriate application of this treatment. [In this study, [In this study, recommended PSE to patients with bleeding tendencies that were not optimal candidates for an open surgical shunt or repeated endoscopies. This includes the following patient populations: Patients with baseline compromised respiratory function (ie, cystic fibrosis [CF]). 2. Patients with significant synthetic dysfunction that may progress to liver failure after shunting. 3. Patients with early signs of encephalopathy that could potentially worsen with increased portal systemic shunting. 4. Patients with abnormal right heart function that could develop cardiac decompensation or shunt failure. 5. Patients deemed to be marginal candidates for repeated anesthesia. 6. Patients with splenic vein thrombosis. 7. Patients with characteristics predicting poor wound healing or other surgical complications. 8. Patients with unfavorable anatomy, increased transhepatic resistance, or elevated right heart pressures to permit mesoportal shunting (Rex shunt)]. The patient had thrombocytopenia and/or recurrent variceal bleeding. The patient underwent orthotopic liver transplantation (OLT) before PSE which lead to biliary complications. The patient had portal hypertension. The patient also noted to have varices before PSE. The patient had significant splenomegaly before PSE. The decision to proceed with PSE was determined by the primary hepatologist and surgeon after careful discussion with both patient and family members regarding alternative approaches. No information on patient's family history or concomitant medication was provided.   On an unspecified date, at least 2 weeks before PSE, the patient received unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (administration route and site unspecified, dosage unknown, batch number not provided for all), in order to reduce the risk of future infection by encapsulated organisms, should the procedure lead to a complication necessitating total splenectomy. The age of vaccination was not provided. It was reported that the patient received broad-spectrum intravenous antibiotic prophylaxis, typically with piperacillin/tazobactam, before the procedure to prevent infection of infarcted splenic tissue. This was continued for 5 to 7 days. On an unknown date, before PSE, the patient's platelet count was noted at 6510E9/L (normal range not provided).   On an unspecified date between January 2010 and August 2017, at least 2 weeks after vaccination, the patient underwent PSE by interventional radiology under general anesthesia via percutaneous femoral artery approach under sterile conditions utilizing guidelines based on the Spigos technique to minimize complications. At the time of PSE, the patient was not actively bleeding. Diagnostic angiographies of the celiac axis and splenic arteries were obtained to determine the target splenic arterial branches, to identify accessory branches to other tissues from the splenic artery and to determine baseline splenic volume. Abdominal sonograms with doppler analysis of hepatic and splenic vessels were performed post procedure to assess vessel patency and the degree of intra-abdominal-free fluid. Arteriograms of partial splenic embolization (PSE), pre-embolization with capillary blush demonstrated splenomegaly and post-embolization with capillary blush revealed multiple defects before and after esophageal varices. The patient underwent PSE more than 3 years after OLT. [In this study, there was no difference in management, adverse events, or complications in patients who had previously undergone OLT as compared to non-transplanted patients. Of the 4 patients who had PSE after OLT, 3 were on low-dose tacrolimus and 1 had a history of post-transplant lymphoproliferative disorder and was off immunosuppression.  Information regarding patient's blood transfusions was not available. The patient was admitted to hospital after PSE for further observation and management. [In this study, patients received patient-controlled analgesia for pain control and to prevent splinting and associated pulmonary complications such as atelectasis and pneumonia]. The patient did not develop infection with encapsulated organisms. Post-PSE, the patient's platelet count was 14010E9/L. The antibiotics were converted to an oral regimen before hospital discharge. [In this study, criteria for hospital discharge included adequate control of abdominal pain with oral medications, adequate oral intake/hydration, and absence of post procedure infection. Magnetic resonance imaging (MRI) showed splenomegaly and postembolization with necrotic areas surrounding the spleen. Three patients demonstrated complete resolution of varices. An additional 7 patients were noted to have a decrease in variceal grade].  On an unknown date, the patient was discharged fulfilling the criteria for hospital discharge that included (adequate control of abdominal pain with oral medications), adequate oral intake/hydration, and absence of post procedure infection. The patient was followed-up in the outpatient hepatology clinic. Hematologic indices including white blood cell (WBC) and platelet counts were monitored. Imaging was repeated as indicated. The patient developed fever and abdominal pain and the patient was re-hospitalized. [In this study, 7 patients required readmission after initial discharge 2 of these patients were discharged only 1 day after PSE and returned the following day with fevers and abdominal pain with an unremarkable diagnostic evaluation].  Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.  This case has been considered as serious due to hospitalization.  The outcome of the event was not reported.  The author did not comment on the relationship between the event of fever and abdominal pain and Unspecified Haemophilus influenza type B vaccine, unspecified meningococcal vaccine and unspecified pneumococcal (PCV13 followed by PPSV23) vaccine. The author stated ""The Centers for Disease Control and Prevention recommends immunoprophylaxis against Streptococcus pneumoniae, H influenzae and Neisseria meningitidis in all splenectomized patients. Complications of PHTN such as hypersplenism, variceal hemorrhage, and ascites can lead to significant morbidity and mortality in children. Surgical interventions include shunting or splenectomy; however, overwhelming sepsis postsplenectomy is a pressing concern. PSE addresses portal hypertension regardless of etiology as definitive therapy. Most adverse effects following PSE are expected and can be managed conservatively. In our cohort we commonly observed fever, abdominal pain, and leukocytosis without evidence of infection. Pain was effectively controlled with intravenous and oral analgesics. Nonsteroidal anti-inflammatory drugs were avoided to minimize hemorrhage. In our experience, prophylactic antibiotics and limiting splenic reduction to no greater than 70% have avoided serious morbidity and mortality. In particular, there was no significant difference in the preprocedure platelet count between patients with and without recurrent thrombocytopenia. After PSE we noted a significant increase in platelets but to a lesser degree in patients who had recurrent hypersplenism. In our patients with esophageal varices, the combination of endoscopic ligation and PSE has been successful in controlling the progression of varices and decreasing the incidence of variceal hemorrhage.""  The author concluded ""our study supports that PSE is a safe, effective, semi-invasive alternative to splenectomy in pediatric patients with PHTN. The combination of EVL and PSE is effective treatment for esophageal and gastric varices (not amenable to simple band ligation). Reduced splenic volume and splenic venous return effectively decreased portal flow and pressure. PSE can be successfully performed in pre- and post-transplant transplant patients, and select cirrhotic and noncirrhotic pediatric patients. PSE appears to preserve functional spleen mass and avoids postprocedure accelerated liver disease or encephalopathy. In contrast to shunting, PSE can be effective even in the setting of elevated right-sided heart pressures. Further multicenter collaborative studies with larger and varied patient populations will need to be performed to substantiate our approach and better define patient populations that would benefit most from PSE, sequential PSE or combined interventions. Liver transplantation remains the ideal intervention for anyone with significant decompensated PHTN or advanced hepatic dysfunction"".  This is 1 of the 9 valid cases reported in this literature article.      Lab Comments: Lab test were performed on an unspecified date, The patient's hematologic indices including white blood cell (WBC) and platelet counts were monitored (result not provided). Imaging was repeated as indicated  (result not provided). Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.",,,,,Y,,,,U,,,,"Test Name: Endoscopy; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Platelet count; Result Unstructured Data: Test Result: 65 (before PSE), Test Result Unit: unknown; Test Name: Platelet count; Result Unstructured Data: Test Result: 140 (post PSE), Test Result Unit: unknown; Test Name: White blood cells; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown",UNK,,piperacillin; tazobactam,Portal hypertension (PHTN); Varicosity,Medical History/Concurrent Conditions: Orthotopic liver transplant (Before PSE lead to biliary complications); Splenomegaly,,USGLAXOSMITHKLINEUS2019GS,2,09/25/2019,,,,
0835731,09/25/2019,MO,70.0,70,,F,,"Injection Site Redness; Injection Site Swelling; Injection Site Warmth; Injection Site Pain; Injection Site Itching; It was tender but then worsened; Couldn't sleep; Slight discomfort at injection site; Inappropriate Schedule of Vaccine; Fever; Chills; Headache; Knots in the muscle that moved throughout the muscle area; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 70-year-old female patient who received Herpes zoster (Shingrix) (batch number B4772, expiry date 20th November 2021) for prophylaxis.   Previously administered products included Zostavax and Shingrix (received 1st dose in May 2018).   On 13th September 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 13th September 2019, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On 14th September 2019, the patient experienced injection site erythema, extensive swelling of vaccinated limb, injection site warmth, injection site pain, injection site itching, tenderness, sleeplessness and injection site discomfort. In September 2019, the patient experienced fever, chills, headache and muscle mass. On an unknown date, the outcome of the injection site erythema, extensive swelling of vaccinated limb, injection site warmth, injection site pain, injection site itching, tenderness, sleeplessness, fever, chills, headache, muscle mass, injection site discomfort and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the injection site erythema, extensive swelling of vaccinated limb, injection site warmth, injection site pain, injection site itching, tenderness, sleeplessness, fever, chills, headache, muscle mass and injection site discomfort to be related to Shingrix.  Additional details were reported as follows: On 13th September 2019, the patient received the 2nd dose of Shingrix, which led to lengthening of vaccination schedule. The patient stated that had redness, swelling, warmth, pain and itching at the site. The area was about 4 x 6 and the whole upper arm. The patient stated that it was tender but then worsened , it was painful to lay on and she could not sleep. The patient also had fever, chills and headache. The patient also saw knots in the muscle that moved throughout the muscle area. On the time of reporting the patient still had slight discomfort, itching and warmth at the site. The patient has not reported the event to the physician because everything she read is her events were common. The patient wondered if the events to the second dose had anything to do with the fact that she was so late receiving the second dose.",,,,,,,,,U,09/13/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,09/25/2019,,,,
0835732,09/25/2019,TN,47.0,47,,F,,loss of range of motion in shoulder and severe pain in shoulder,,,,,,,,,N,09/09/2019,09/09/2019,0,none yet,PHM,,estrogen patch,none,kidney issues,,,2,09/25/2019,,Y,,tetracycline and shell fish
0835733,09/25/2019,NY,49.0,49,,F,,"Symptoms included metallic taste, hot sensation over entire body, blurry vision, rash on upper body, chills, sensation of throat ""getting full"" . Noted symptoms approx. 20 minutes after receiving vaccination. Called 911, given epinephrine 1mg/ml 0.3ml IM. Taken to ER via ambulance. Outcome, symptoms resolved after treatment in the ER.",,,,,,,,,Y,09/20/2019,09/20/2019,0,,PVT,,"multi vitamin, enzymes",none,none,,,2,09/25/2019,,,Y,lactose intolerant
0835735,09/25/2019,TX,4.0,4,,F,,"Clinic note from 9/24-- ""Pt got flu vaccine Friday morning. Friday evening, pt c/o pain and itching at site. Mom treated with tylenol. Saturday, Pt developed small bruising at puncture site with a small red ring around it. Pt still c/o itching and pain. Mom gave zyrtec, tylenol and applied ice. Saturday evening, the red ring was approx 2 inches big and mom called the RN line and was told to watch for 48 hrs and seek care if it was worse when she wakes up. On Sunday morning, area of redness was approx 5 inches and bruised area in the center was larger. Pt was seen at UC and was thought to have an injection site reaction as well as an infection and was started on Keflex. Mom continued with zyrtec, tylenol for comfort and applied ice and hydrocortisone. Pt took 2 doses of keflex on Sunday. Area looked alot better on Monday morning. Today in office, pt is much improved. Area appears normal - no swelling, redness, pain. Pt remained afebrile throughout weekend. This is pt's 4th year to get the flu vaccine. """,,,,,,,,,Y,09/20/2019,09/20/2019,0,,PVT,,,,,,,2,09/25/2019,,Y,Y,
0835736,09/25/2019,MN,67.0,67,,F,,Employee reports shortness of breath approximately 4 hours post vaccine with little relief from inhaler and continued to report shortness of breath the next day (though milder than the day of the vaccine).,,,,,,,,,N,09/24/2019,09/24/2019,0,,OTH,,Unknown,,Asthma (uses inhaler),,,2,09/25/2019,,,,Unknown
0835737,09/25/2019,KY,70.0,70,,F,,"Patient reported to pharmacy next day with redness around the injection site approximately 3 inches in diameter. Told patient to monitor the area and if it got any larger or no  improvement to seek medical attention. Patient was seen that evening at after hours care where the site had spread to the whole upper arm with itching, swelling and redness. Prescriber treated pt for possible cellulitis and allergic reaction with antibiotic and steroid dose pack.",,,,,,,,,U,09/23/2019,09/24/2019,1,None reported,PHM,,,,,,,2,09/25/2019,,Y,,Keflex
0835738,09/25/2019,WI,1.5,1,.5,F,,Golf ball size swelling and warm to touch. Hard knot at injection site that is very itchy and hasn't gone away. The knot is about the size of a quarter.,,,,,,,,,N,04/12/2018,04/12/2018,0,,PVT,,NA,NA,NA,,,2,09/25/2019,,,,NA
0835739,09/25/2019,TX,40.0,40,,F,,"Numbness and tingling to left side on arm, jaw and hand,  and left sided swollen tongue.",,,,,,,,,N,09/13/2019,09/13/2019,0,"9/17/19 MRI, chest X-ray, multiple labs all negative. , 9/19/19 Spinal tap, multiple lab tests all negative.",WRK,,Celexa,none,bulging disks history of arthritis,,,2,09/25/2019,,,Y,Tetracycline
0835740,09/25/2019,FL,90.0,90,,F,,"Next day at 7: 30am woke up like usual and ate breakfast.  Around 8am, took shower and got chills that is out of norm.  Started to get dress, went down, started to vomit, and could not get up.  Tried to crawl but could not get footinglegs felt like spaghetti.  Patient was able to get up and felt supper shaky; laid on bed gradually got better.  Patient started to sweat and it took about 24 hours to stop shaking.  Patient has never had an experience like that so was very surprised. She ate the same dinner as the night before to make sure that it was not food poisoning and was not.  Patient has received vaccines in the past with no problem besides a sore arm.  Patient has taken same medicine for years; there was no change. Patient lives by herself.  Today went for a walk as usual but did not walk as many hours as usual.   Patient did not call doctor because it was the weekend.  Patient has follow-up with doctor on Thursday in preparation for surgery to replace pacemaker. Patient is almost back to normal.",,,,,,,,,Y,09/20/2019,09/21/2019,1,,PHM,,"Metoprolol (25mg, 3 x day), Gabapentin 600 mg, Cranberry pills","No, No","Non-Hodgkin's lymphoma for the last 10 years, pacemaker,",arm with aches but nothing else,,2,09/23/2019,,,,Antiobiotic (maybe Bactrim)
0835741,09/25/2019,NY,65.0,65,,F,,"A few hrs after shot,  suddenly had both significant difficulty breathing and significant chills, trembling. Super hot steamy bath with menthol, heavy robe, electric blanket on high dissipated in a couple hours. ScareyKindsscarey!",,,,,,,,,Y,09/24/2019,09/24/2019,0,,PHM,,Occaisional vitamin and iron,None,Smoker. Possible COPD,Couple yrs ago slight breathing a couple hrs later,,2,09/25/2019,,,,Sulfa
0835742,09/25/2019,IL,0.33,0,.3,M,,shrilling inconsolable cry,,,,,,,,,U,07/16/2019,07/16/2019,0,none,PVT,,none,none,none,,,2,09/25/2019,,,,none
0835743,09/25/2019,FL,55.0,55,,F,,LOCALIZED RASH AND SWELLING,,,,,,,,,N,09/21/2019,09/25/2019,4,NONE,PHM,,None,None,None,,,2,09/25/2019,,,,No known allergies
0835744,09/25/2019,GA,73.0,73,,F,,"Patient called on 9/20/19 and said that her arm was swollen, red, painful and inflammed where she had received the vaccines. When I asked if she was running a fever she said yes. I advised her to alternate between ibuprofen and tylenol and to call me the next day to update me on how she was feeling. I called her back on Saturday and she said she felt much better and that her fever had gone down but her arm was still swollen and red. I advised her if she was still concerned to contact her doctor. She mentioned that it could have also triggered a fibromylagia attack.",,,,,,,,,Y,09/18/2019,09/18/2019,0,,PHM,,Ibuprofen,fibromyalgia,fibromyalgia,,,2,09/25/2019,,,,sulfa
0835748,09/25/2019,CA,40.0,40,,F,,"The Patient was known to be pregnant prior to having the vaccines; inadvertently administered properly stored VARIVAX  (lot R029519 & expiration date 10/14/2020 and properly stored M-M-R Il; This spontaneous prospective pregnancy report was received from a nurse regarding a 40-year-old female patient. The patient's medical history and concomitant medications was unknown. The patient's concurrent condition included diabetes. The patient did not have any drug allergy or drug reaction. The patient was pregnant and last menstrual period was approximately on August 2019.   On 06-SEP-2019, the patient was inadvertently vaccinated with properly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # R029519, Expiration date:14-OCT-2020), rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin (rHa) (M-M-R II) lot No. R010713 has been verified to be a valid lot number, expiration date reported as 12-APR-2020, but upon internal validation established as 11-APR-2020 (strength, dose number, dose, anatomical location were not reported) subcutaneously for prophylaxis use (reported as immigration purposes) (contraindicated product administered). Both vaccines were reconstituted with properly stored sterile diluent. Other suspect therapy included insulin. The patient was known to pregnant prior to administration of the vaccines (exposure during pregnancy). The gestation period at exposure was at 5 weeks. On an unknown date in September 2019, a Quanti feron- Tuberculosis (TB) gold test was performed and the result was unknown. The patient did not seek medical attention and no treatment was given for adverse events. The Estimated Date of Delivery (EDD) was unknown. The pregnancy outcome was pending. The fetal outcome was unknown. No product quality complaints (PQC) were involved.",,,,,,,,,U,09/06/2019,09/06/2019,0,,UNK,,Sterile diluent; Insulin,Diabetes,,,US0095075131909USA009092,2,09/25/2019,,,,
0835749,09/25/2019,,,,,U,,"Pertussis; This case was reported by a consumer via interactive digital media and described the occurrence of pertussis in a child patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced pertussis (serious criteria GSK medically significant). On an unknown date, the outcome of the pertussis was unknown.   It was unknown if the reporter considered the pertussis to be related to DTPa vaccine.  Additional details were provided as follows: The case has been reported by patient's mother. The age at vaccination was not reported. Till the time of reporting, the patient had not received the final TDaP and had contracted. The case was considered as mild because, the patient had been received the vaccination upto the point. This case has been linked with case US2019AMR167031 reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/25/2019,,,,
0835750,09/25/2019,,,,,U,,"Pertussis; This case was reported by a consumer via interactive digital media and described the occurrence of pertussis in a child patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced pertussis (serious criteria GSK medically significant). On an unknown date, the outcome of the pertussis was unknown.   It was unknown if the reporter considered the pertussis to be related to DTPa vaccine.  Additional details were provided as follows: The case has been reported by patient's mother. The age at vaccination was not reported. Till the time of reporting, the patient had not received the final DTPa and had contracted. The case was considered as mild because, the patient had been received the vaccination upto the point. This case has been linked with case US2019AMR167025 reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/25/2019,,,,
0835751,09/25/2019,,,,,M,,"Fever; Achiness; This case was reported by a consumer via call center representative and described the occurrence of fever in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever and pain. On an unknown date, the outcome of the fever and pain were unknown.   It was unknown if the reporter considered the fever and pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced fever and achiness after first dose of Shingrix vaccine. The reporter denied to provide any additional information. The reporter did not want to provide his address. The reporter denied permission to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/25/2019,,,,
0835753,09/25/2019,FL,66.0,66,,M,,"Apparent shoulder injury.  Felt the needle hit somethin solid (assuming it was bone) during the injection.  No visible signs of redness or bruising on the skin.  Pain was increasing as usual for a flu shot but then it continued until I could not lift my arm above my shoulder.  Woke with shoulder pain in the middle of the night and applied cold packs to the shoulder. This morning, the pain has started to subside.   I am continuing cold pack administration today in hopes that the issue will resolve.  Will seek medical treatment with primary care physician if issue does not resolve within a few days.",,,,,,,,,U,09/24/2019,09/24/2019,0,None,PHM,,"Eliquis, Pravastatin, Atenolol, Triamterene-HCTZ, Finasteride",None,High blood pressure - under control with medication,,,2,09/25/2019,,,,None
0835754,09/25/2019,VT,81.0,81,,F,,"No pain or abnormalities upon administration.  Pharmacist covered with bandage.  The next day the patient noticed a bruse underneath the bandage.  It was a little achy and slightly warm.  It didn't bother her otherwise had no pain or sensation.  Kept moving her arm.  Has no pain/sensation like a normal bruise.  Bowling didn't irritate it.  Just has a visual bruise and it feels a little bit warm.   Patient has tried icing but it didn't change the size.  It is however turning yellow (healing) and starting to get slightly smaller.  As long as it continues to get smaller, no further medical action is necessary.  If patient develops a fever, or experiences pain/tenderness advised her to be checked out.",,,,,,,,,N,09/18/2019,09/18/2019,0,none,PHM,,"carvedilol, lisinopril (due to stent)",Has stent,stent,,,2,09/25/2019,,,,no known allergies
0835755,09/25/2019,IN,66.0,66,,F,,"fever, body aches. 24 hours",,,,,,,,,Y,05/22/2019,06/23/2019,32,none,PHM,,"vit d, vit b12, calcium, collagen",none,none,,,2,09/25/2019,,,,none
0835756,09/25/2019,DE,81.0,81,,F,,"PATIENT FELT LIKE HER THROAT WAS GETTING ITCHY AND HER TONGUE WAS SWELLING,  WITHIN 5 MINS OF RECEIVING VACCINE ,  PT WAS GIVEN 25MG BENEDRYL BY MOUTH, WITH NO SIGNS OF IMPROVEMENT, PT WAS  GIVEN 75MG OF SLOUMEDROL BY IV,  10 MINS LATER SHE WAS GIVEN 50MG OF BENADRYL BY IV.  HER SYMPTOMS DID APPROVE AFTER 30 MINS OF OBSERVATION PT WAS ABLE TO LEAVE.  PATIENT'S CAREGIVER CALLED  THE OFFICE AT 2:14PM STATING THAT THE PATIENT'S SYMPTOMS HAVE RETURNED AND THEY HAVE GOTTEN WORSE PT WAS TOLD TO GO THE ER. PATIENT WAS ADMITTED TO HOSPITAL",,,,,Y,2,,,,09/24/2019,09/24/2019,0,,PVT,,,,,,,2,09/25/2019,,Y,Y,
0835757,09/25/2019,KS,17.0,17,,F,,"Mother states around 1600 that evening she starting to get red and warm to touch to injection site.  By 1830 that evening she was sick feeling with a headache and the arm was very tender, red, swollen and hot.   She did take Benadryl, Tylenol and Motrin for symptoms.   09/24/2019- Her Dr. was out of the office.  Left message to return phone call. 09/25/2019- 0920- Dr.'s nurse called and updated on above information.  Will notify Dr.   09/25/2019- 0930- Pt's mother called and states she is better but her arm is still red, warm and swollen and very tender.  States she still doesn't feel great but is getting better feeling every day.",,,,,,,,,N,09/23/2019,09/23/2019,0,,PUB,,"Levothyroxine qd, Amitriptyline q hs.",,"Hypothyroidism, anxiety, IBS.",Menactra and Bexsero,,2,09/25/2019,,,,None
0835758,09/25/2019,MA,75.0,75,,F,,"9/16/19: Patient noted fatigue and nausea, a tingling sensation across the abdominal wall which  improved within 48 hours.  Left sided headache, worse on 9/16 evening-gradually resolved within 48 hours.  Insomnia.  Nocturia and frequency developed on the night of 9/18/19.  Symptoms resolved spontaneously on 9/22/19.  She experienced transient increas in her chronic peripheral neuropathy which resolved back to baseline by 9/23/19",,,,,,,,,Y,09/16/2019,09/16/2019,0,9/19/19:  Urinalysis-benign 9/19/19:  Urine Culture-negative 9/21/19,PHM,,"Clonazepam, Co-Enzyme Q-10, Gabapentin, Magnesium, Miralax, Primidone, Propranolol",,"Lumbar Stenosis, Chronic Constipation, Tremor, Arthritis, Neuropathy, Gastric Ulcer",,,2,09/25/2019,,Y,,"Bee Venom, Morphine Percocet"
0835759,09/25/2019,MI,37.0,37,,F,,"PATIENT HAD FLU LIKE SYMPTOMS (BODY ACHES, FEVER, SORE THROAT) THAT STARTED MORNING AFTER VACCINATION.",,,,,,,,,U,09/23/2019,09/24/2019,1,NONE,PHM,,UNKNOWN,NONE KNOWN,NONE WE ARE AWARE OF,,,2,09/25/2019,,,,NONE WE WERE TOLD OF
0835760,09/25/2019,VA,0.5,0,.5,M,,"Knot developed in right leg and patient had ""jerky-like"" movements for 2 weeks after vaccination.",,,,,,,,,Y,08/26/2019,08/26/2019,0,none,PVT,,none,none,none,,,2,09/25/2019,,Y,,none
0835761,09/25/2019,,72.0,72,,F,,"Patient states that she has had swelling start in her knee that is bothering her.  She had normal adverse reactions to the injection site, but nothing significant.  She is not sure if this is due to Shingrix, but is unaware of what else could cause this for her.  Recommended to follow up with MD.",,,,,,,,,U,09/23/2019,09/25/2019,2,,UNK,,,,,,,2,09/25/2019,,Y,,nkda
0835762,09/25/2019,ME,0.33,0,.3,F,,6 days after vaccination she became fussy.  This progressed and by 8 days after vaccination she had projectile vomiting and bloody/mucosy diarrhea.  She was seen in our office and subsequently admitted where intussception was confirmed and treated.,,,Y,,Y,1,,,Y,09/12/2019,09/18/2019,6,Labs - CMP and CBC - 9/21/2019 Abdominal u/s - 9/21/2019,PVT,,None,None,None,,,2,09/25/2019,,Y,Y,None
0835763,09/25/2019,NY,1.17,1,.2,M,,"2x3cm pale erythematous flat rash with central raised red mac-pap rash 1.5x1.5cm; non tender, no increase in warmth, no edema.  No meds needed, expected to improve over the next 1-2 weeks",,,,,,,,,U,09/09/2019,09/17/2019,8,n/a,PVT,,None,None,None,,,2,09/25/2019,,Y,,N.K.D.A
0835764,09/25/2019,MI,53.0,53,,M,,"Fever, headache, muscle aches, joint pain, sore throat, pain at injection site, pain throughout arm, weakness",,,,,,,,,N,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,09/25/2019,,,,
0835767,09/25/2019,NC,7.0,7,,M,,"Local reaction last year and needed oral steroids. This year he had local reaction, larger than last year, pretreated with benadryl . Fever for 1.5 days, body aches",,,,,,,,,Y,09/16/2019,09/17/2019,1,,PVT,,"Vyvanse, SIngulair",Dysuria 4 days after vaccine,"ODD, ADD, Eczema, Allergies, tympanosclerosis","Flu vaccine 10/16/2018 , 7 years old , flulaval",,2,09/25/2019,,Y,,NKDA
0835768,09/25/2019,AL,9.0,9,,F,,Child started feeling dizzy. Redness and swelling began at injection site about 5 minutes after administering.  Benedryl was administered at the school per the parents request.,,,,,,,,,U,09/17/2019,09/17/2019,0,unknown,SCH,,Unknown,Unknown,Unknown,,,2,09/25/2019,,,,Unknown
0835769,09/25/2019,SD,0.08,0,.2,M,,"Started with severe constipation in a breastfed baby. Sever enough he would have fevers until passing it with assistance (stimulation, suppository, etc). From then on he got worse with every injection. Diagnosed with GERD and eventually suggested to put him on Zyrtec for allergies. Had severe protective vomiting several times per day and some weight loss. Eczema. Has been in the ER mulitple times due to breathing issues, has now (5yrs) been diagnosed with mild to severe persistent asthma.",,,,,,,,Y,N,07/10/2014,07/18/2014,8,"At 2yrs allergy testing was done and came back severely positive for almost everything tested.  Was given an Eppi Pen. Went on to see a Gastro and she stated he had too many allergies, that he likely has Mast Cell Activation Disease/Disorder. Specialist ran blood work but does not believe he hast MSA. Limiting toxin exposures in our home and environment helped. Still didnt eat much, was eating mostly eggs until his 18m shots and then stopped eating them. When older I asked why, he said his mouth itched when he ate them. He had ""spiders in his ears"". Had chronic ear infections until getting tubes at 2yrs. Easily sick, strep multiple times, croup, etc.  He is on Allegra 2x/day as Zyretec gave him night terrors. He is on a steroid for his asthma 2x/day and a rescue inhaler/nebulizer. To this day was have no difinatave answers as to why his body has so many issues/allergies. We just have to deal with the symptoms. After discovering Vax Injury to be a thing, that is the only real explication to his issues as all are side effects to being vaccinated.",PVT,,None,None,"Asthma, constant histamine reactions sometimes the cause is unknown due to the number of sensitivities both known and unknown. He has to be on Allegra full time to keep reactions to a minimal level",,,2,09/25/2019,,Y,Y,"None known at the time of starting vaccinations. Now Amoxicillin, peaches, and has tested positive for numerous food and environmental allergies"
0835770,09/25/2019,NC,1.0,1,.0,F,,"Head drop with shoulder shrug with full cognition several times a day and it escalated to several times an hour.  Symptoms worsened significantly by 1 month post vaccine and resolved completely 2 months post vaccine.  No vomiting, no diarrhea, no seizures, no fever, no illnesses after vaccine.  No loss of developmental milestones.  Growth NL.",,,,,,,,,Y,03/12/2019,03/18/2019,6,none,PVT,,Vitamin D3/K2 Probiotic - infant 1 scoop daily,none,none,,,2,09/25/2019,,Y,,"Dairy, Soy, Gluten"
0835771,09/25/2019,ME,4.0,4,,F,,"Patient had redness and pain. Vomited liquid once on 8/30. No fever, chills or decreased appetite.",,,,,,,,,Y,08/28/2019,08/29/2019,1,n/a,PVT,,none,none,none,,,2,09/25/2019,,Y,,none
0835772,09/25/2019,CA,23.0,23,,F,,"Approximately 20 minutes after receiving the vaccinations, patient reported urticaria on her thighs, bilateral.   Patient also reported feeling ""tightness"" in her throat.    Patient given Epipen in clinic at approximately 12:40pm and Benadryl 50mg PO.    After administration of EPIpen patient reported throat symptoms resolved.  Approximately 30minutes post Benadryl and Epipen Urticaria resolving.     Patient left clinic AMA.",,,,,,,,,U,09/24/2019,09/24/2019,0,,PVT,,none,None,None,,,2,09/25/2019,,Y,,Penicillin  Mango Pineapple Chili
0835773,09/25/2019,NY,65.0,65,,F,,red raised rash  allergic reaction at site of injection  treated with prednisone and hydroxyzine for itch and cefdinir for infection,,,,,,,,,Y,09/18/2019,09/21/2019,3,unknown,PHM,,"furosemide, dexamethasone. tramadol. metoprolol, montelukast, valacyclovir",unknown,,,,2,09/25/2019,,Y,,"pen, morphine,  latex"
0835774,09/25/2019,OK,5.0,5,,F,,"Patient was given vaccines on 09/23/2019. Patient was given Dtap/IPV and Varcella in the left thy.  Patient presented to the clinic  on 09/25/2019 with a noted swelling, redness, and tenderness the sizes of the palm  around were the vaccines were given on the left thy.  Provider instructed the patients parents to apply warm compresses , Tylenol and antihistamines .",,,,,,,,,N,09/23/2019,09/24/2019,1,,PVT,,None,had ringworm on her neck.,none,,,2,09/25/2019,,Y,,none
0835775,09/25/2019,CO,65.0,65,,F,,"My right upper arm began aching  more than just from the initial injection a few days from getting the flu shot. I was told this was a better flu shot. The pain just kept getting worse and for the last two weeks I haven?t been able to sleep through the night. It?s been very hard to work as I have to lift some objects that are heavy and some that are not so heavy but now cause me very much pain. I had to leave work yesterday after two hours. Today is my day off, but I don?t know what I?m going to do about tomorrow. Working and  using my arm is excruciating and makes it worse. I have used Aleve in large doses and ice and heating pad for a little relief, but no change.",,,,,,,,,N,08/28/2019,08/30/2019,2,,PHM,,,,,,,2,09/25/2019,,,,
0835776,09/25/2019,ME,25.0,25,,F,,"Pt states her lips were tingling after the vaccine. Took benedryl. Went to ER on the evening of 9/24. Had dizziness but no itching, swelling, or trouble swallowing. Experience mild breathing difficulties. Symptoms started 5-10 minutes after shot was given. Once going to ER the next day, Pt informed staff she has had anaphylaxis in the past (7-10 years ago).",,,,,,,,,Y,09/23/2019,09/23/2019,0,n/a,PVT,,"Albuterol Sulfate HFA, Ambien 5mg, Levothyroxine 50mcg,  Lorazepam 0.5mg",Post Concussion Syndrome,"Hypothyroidism, GAD","7-10 years ago, anaphylaxis to flu shot",,2,09/25/2019,,,Y,"Sulfa, Penicillin"
0835777,09/25/2019,UT,45.0,45,,F,,I don't know if I marked the right vaccine.  Al I know is that I received a flu shot.  Severe facial swelling of lips and left eye and cheek.  Swelling started in the middle of the night after the day in which I received the vaccine.  I had the vaccine around lunchtime and woke in the night and felt swelling on my face.,,,,,,,,,N,09/24/2019,09/25/2019,1,,WRK,,Birth control pills Doxycycline,perioral facial rash,none,,,2,09/25/2019,,,,cantaloupe avocado
0835778,09/25/2019,IA,8.0,8,,M,,"body itching, at 9:30pm covered in hives armpits, stomach, underwear line, growing, rapidly spreading",,,,,,,,,Y,09/21/2019,09/21/2019,0,,PHM,,childrens multivitamin gummy,had a cold weeks before vaccination,,,,2,09/25/2019,,,Y,
0835779,09/25/2019,AL,1.25,1,.2,M,,"When the skin discoloration first began it was also accompanied by red target-like rings on the discoloration marks which led my husband and I to believe that he had gotten ring worm some how. They didn't seem to itch our son though, and we put Miconazole from the local store on it every day. It didn't seem to help though. He didn't run a fever or fall ill from it. We didn't take him to his doc appointment sooner due to those things and his next appointment was 03/18/2019. When we got to his appointment, I asked about what the ash and discoloration was. Dr. said it was eczema, not ring worm and that's why Miconazole didn't work. I asked how he could pick up eczema because that doesn't run on either side of our families. He was not sure. I looked within the vaccine insert under post market-experience on page 17 and found that his last visit and vaccine DTap/IPV/hib fit the time frame perfect.   Eczema is a particular type of inflammatory reaction of the skin in which there is erythema (reddening), edema (swelling), papulles (bumps), and crusting of the skin followed  finally, by lichenification (thickening) and scaling of the skin. Erythema occurs with any skin injury, infection, or inflammation.   Erythema multiforme is most often caused by Herpes Simplex Virus. He received the Varicella vaccine 09/24/2018.",,,,,,,,,N,12/18/2018,03/01/2019,73,"none. Dr. just had told us it was eczema, not ring worm. The red rings have since gone about May, but the skin discoloration has remained as well as rough patches of skin.",PVT,,none,none,none,,,2,09/25/2019,,,,none
0835780,09/25/2019,NY,66.0,66,,F,,"The injection itself was extremely painful.  Felt like a nerve was being hit.  Within hours, had bad pain in my right arm and could not move it.  Range of motion was limited.  Could not lift arm above shoulder level.  Next morning, same.  Called pharmacy and spoke with pharmacist, who said that is normal and to call him in another 2 days if no better.  He said if no better, he would contact my physician.  Range of motion is a bit better, but still painful to raise arm above shoulder level, and still painful to try to put on clothing.  I am concerned and worried that this may not get better.  It is now 12 days since the vaccine was administered.  I just tried to contact the pharmacy again, but I cannot get a ""human.""",,,,,,,,,N,09/13/2019,09/13/2019,0,,PHM,,Atorvastatin,None,High Cholesteral,,,2,09/25/2019,,,,None
0835781,09/25/2019,CT,76.0,76,,F,,Patient complains of pain in the arm and she has hard time lifting her arm up. MD said the needle might have hit a nerve to cause the pain and it will eventually go away over time,,,,,,,,,N,09/17/2019,09/18/2019,1,NA,PHM,,"Tramadol,",N/A,nerve pain and anxiety,,,2,09/25/2019,,,,cephalexin 125 mg Penicillin Codeine and related
0835782,09/25/2019,MN,5.0,5,,F,,PAINFUL SWOLLEN ARM PATIENT REPORT OF DIFFICULTY LIFTING ARM,,,,,,,,,N,09/24/2019,09/25/2019,1,NONE,PUB,,NONE,NONE,NONE,,,2,09/25/2019,,Y,,NONE
0835789,09/25/2019,FL,59.0,59,,F,,"Couldn't get out of bed; Was Achy / Pain throughout her body/Pain upon movement; Crying with the achiness; Light headed; Nausea; Vomiting; Fever; Chills; Hot feeling; Diarrhea; Incapacitated for 2 days; This case was reported by a consumer via call center representative and described the occurrence of disability in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Afluria quadrivalent with an associated reaction of nausea (received the year before the date of reporting and experienced nausea, vomiting,  itching, fatigue, flu like symptoms and achiness) and Benadryl (pre-medicate with 50mg.). Concurrent medical conditions included chronic idiopathic urticaria. Concomitant products included cetirizine hydrochloride (Zyrtec) and fexofenadine hydrochloride (Allegra).   On 18th August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced disability (serious criteria GSK medically significant), bedridden, pain, crying, light headedness, nausea, vomiting, fever, chills, feeling hot and diarrhea. On an unknown date, the outcome of the disability was recovered/resolved and the outcome of the bedridden, pain, crying, light headedness, nausea, vomiting, fever, chills, feeling hot and diarrhea were unknown.   It was unknown if the reporter considered the disability, bedridden, pain, crying, light headedness, nausea, vomiting, fever, chills, feeling hot and diarrhea to be related to Shingrix.  Additional details were provided as follows: The patient was incapacitated for 2 days. The patient could not get out of bed.  The patient was achy, cried with achiness, light headed, nausea, vomiting, fever, chills, hot feeling, diarrhea, pain throughout her body. It was reported that  it hurted upon movement. For tolerance of 2nd dose of Shingrix, refer case US2019AMR165478.",,,,,,,,,Y,08/18/2019,,,,PHM,,Zyrtec; ALLEGRA,Chronic idiopathic urticaria,,,USGLAXOSMITHKLINEUS201916,2,09/25/2019,,,,
0835793,09/25/2019,MN,45.0,45,,M,,"Pt became light headed, BP dropped from 128/74 to 70/48",,,,,,,,,Y,09/25/2019,09/25/2019,0,,PUB,,vistaril and claritin,,,,,2,09/25/2019,,Y,,N/A
0835794,09/25/2019,TX,73.0,73,,F,,Patient states that her left arm had red streaks stemming from the injection site all the way to her armpit. She also feels slightly nauseous and feverish.,,,,,,,,,,09/23/2019,09/24/2019,1,,PHM,,"omeprazole, ranitidine, Diovan HCT, Flu Ad, Shingrix",,"GERD, Hypertension",,,2,09/25/2019,,Y,,NKDA
0835795,09/25/2019,IL,66.0,66,,F,,"Patient received pneumonia and flu vaccine both given in the left upper arm on 9.20.19--at pharmacy.  Both injections were given in the left deltoid.  Later on Saturday evening  her left upper arm was painful and started to swell and turn red, she states she ""was swollen from the elbow to the armpit.""  That resolved partially on Monday, but she was unable to lift her arm, it was still very stiff and pain was rated at ""15 of 10"" on the pain scale.  In addition, pain  had travelled into the left neck and clavicle. She also developed low grade temp on 9/21/19 weekend that increased to 100.0  by 9/24/19.   Patient called Dr.'s office and explained the circumstances, she was advised to see her PCP's office and report the issue to the pharmacy that gave her the vaccines. (Rheumatologist then called the Pharmacy to advise them.) Patient saw her pcp, DR. and patient called Rheumatology on 9/25/19 to report that she did in fact have SIRVA injury related to the vaccine administration.",,,,,,,,,N,09/21/2019,09/21/2019,0,"Exam by her primary care MD, Dr. on 9/24/2019 confirmed SIRVA (Shoulder Injury Related to Vaccine Administration) due to vaccine entering the shoulder bursa.",PVT,,1. Ativan 0.5 MG Oral Tablet; TAKE 1 TABLET DAILY AS NEEDED;  Therapy: (Recorded:17Oct2011) to Recorded  2. Centrum Silver TABS; TAKE 1 TABLET DAILY;  Therapy: (Recorded:27May2015) to Recorded  3. Citracal + D TABS; TAKE 2 TABLET DAILY;  Th,n/a,Rheumatoid Arthritis,,,2,09/25/2019,,Y,,Asprin: Bleeding NSAIDS: GI Bleeding
0835796,09/25/2019,WA,10.0,10,,M,,"Provider ordered MA to give DTap due to the patient not ever having vaccines. The patient was to get TDap. I helped with these vaccines and entered them into the chart.  The provider was notified, this event was reported and there were NO adverse reactions.",,,,,,,,,,09/05/2019,09/05/2019,0,NONE,PVT,,N/A,n/A,N/A,,,2,09/25/2019,,,,N/A
0835797,09/25/2019,NC,59.0,59,,F,,"Morning after receiving vaccine, I was nauseous, injection site was very sore, had headache, back of neck hurt, occasional stomach pain and fatigue. Stayed in bed all day until 5:00 p.m. Following morning I feel fine but have a rash on chest and under breasts.",,,,,,,,,Y,09/23/2019,09/24/2019,1,None,PHM,,Calcium with Vitamin D & Magnesium,None,None,On 4/17/19 received first dose of this same vaccine and had same reaction,,2,09/25/2019,,,,Penicillin
0835798,09/25/2019,AL,25.0,25,,F,,"Short explanation: DEVELOPED ALL HORRIBLE SYMPTOMS OF SKOGREN'S SYNDROME, AN AUTOIMMUNE DISEASE-  FLUMIST MADE ME HAVE AN AUTOIMMUNE RESPONSE/REACTION.  ALSO DEVELOPED FIBROMYALGIA",,,,,Y,20,,Y,N,10/03/2008,10/28/2008,25,Ana positive for immune response-sjogrens syndrome. FIBROMYALGIA- doctor diagnosed,PVT,,"Multivitamin, b12 sublingual",NONE,3 WEEKS AFTER FLUMIST VACCINE STARTED SYMPTOMS ..ENDED UP DEVELOPING SHOGREN'S SYNDROME (A HORRIBLE AUTO IMMUNE DISEASE---GET IT..AN IMMUNE RESPONSE)AND FIBROMYALGIA,,,2,09/25/2019,,Y,Y,None! NONE BEFORE FLUMIST VACCINE WAS GIVEN TO ME
0835799,09/25/2019,GA,58.0,58,,M,,Patient experiences itching and swelling around the mouth/face. Treated at urgent care clinic.,,,,,,,,,Y,09/22/2019,09/22/2019,0,,PHM,,,None,,,,2,09/25/2019,,,Y,None
0835800,09/25/2019,WI,69.0,69,,F,,"Red, swelling and hot to touch at injection site. I'm taking ibuprofen, this is the day after the injection. I'm hoping it will get better.",,,,,,,,,N,09/24/2019,09/25/2019,1,none,PHM,,"Levothyroxine, Metformin,  Pravastatin,  Meloxicam, Symbicort, calcium, vitamin D3, daily multi-vitamin, fish oil, tumeric",none,"asthma, arthritis",,,2,09/25/2019,,,,none
0835801,09/25/2019,NC,65.0,65,,F,,"patient woke up with vasculitis in her lower right leg.  She said she got it a few years ago, but not after a flu shot.",,,,,,,,,U,09/24/2019,09/25/2019,1,,PHM,,"levothyroxine, atorvastatin, furosemide",,,,,2,09/25/2019,,,,NKA
0835802,09/25/2019,MA,57.0,57,,F,,"itchy sensation in abdomen and head, headache, nausea, and facial flushing",,,,,,,,,Y,09/23/2019,09/23/2019,0,,WRK,,,,,,,2,09/25/2019,,Y,,
0835803,09/25/2019,PA,53.0,53,,F,,"Approximately 6 to 8 hours after injection the injection was raised and swollen, red, and hot to the touch  Patient has arm pain at injection site",,,,,,,,,N,09/24/2019,09/24/2019,0,,PHM,,"Levothyroxine , Simvastatin, Fluoxetine Multi-vitamin , Vitamin C, Cranberry, eye vitamins, Glucosamine Chondritin , B12, fish oil,  iron,  Probiotic ,   Estroven  Hair skin and Nails,  Coconut oil",,Chronic Lymphocytic Leukemia,,,2,09/25/2019,,,,Allergic to sulfa drugs like Bactrim
0835804,09/25/2019,NC,9.0,9,,M,,Blisters noted at or near injection site,,,,,,,,,Y,09/17/2019,09/19/2019,2,none,PVT,,none,none,Asthma,,,2,09/25/2019,,,,NKA
0835805,09/25/2019,NJ,72.0,72,,F,,"Within 12 hours experienced fever, chills general feeling of illness.  Felt exhaustion the next day and slept most of the next 24 hours. The site of injection became red, (a circle approx. 3 inches round.)  A large, hard lump appeared and took almost a week to dissipate.  The injection area was also very itchy.",,,,,,,,,Y,09/17/2019,09/17/2019,0,None,PHM,,Low dose aspirin daily.  Synthroid .100 once daily.  Keppra 250 mg. once daily. Keppra 500 mg once daily.  itamin D3 3x week,None,None,,,2,09/25/2019,,,,None
0835806,09/25/2019,NY,12.0,12,,F,,Lethargic 12 hour periods of sleeping reduced appetite and reduced activity level extreme difficulties being woke up,,,,,,,,,U,09/12/2019,09/13/2019,1,,PVT,,None,None,Vsd hear murmur,,,2,09/25/2019,,Y,,Maple tree pollen
0835807,09/25/2019,MO,5.0,5,,F,,"Phone call from mother, stated child had a fever of 101.2 on 9/24/2019 and had to be picked up from school.  Patient had not had any antifebrile medication today.  Child states head hurting and arm hurting.  No seizures or any other symptoms noted.  Encouraged Tylenol or Motrin for symptoms along with ice pack to arm.  Instructed mother to call pediatrician if patient becomes worse or if symptoms do not improve.",,,,,,,,,U,09/24/2019,09/24/2019,0,none,PUB,,na,poison ivy,na,,,2,09/25/2019,,,,penicillin
0835808,09/25/2019,LA,81.0,80,,F,,LOCAL SKIN IRRITATION. RED AND LITTLE SORE WHEN SHE MOVES ARM.,,,,,,,,,N,09/01/2019,09/01/2019,0,VISITING DOCTOR LATER TODAY,PHM,,NONE REPORTED,HYPERTENSION,HYPERTENSION,,,2,09/25/2019,,Y,,NONE REPORTED
0835809,09/25/2019,ID,76.0,76,,M,,"Altered mental status. Unresponsiveness. Moans to any stimulus. Symptoms started upon awakening on 9/23/19. Labs including CBC, CMP, lumbar puncture, PCR for viral meningitis, CSF culture all normal. No evidence for infectious etiology. Venous blood gas normal. Provided supportive care and he improved over a period of 24-36 hours. Has no recollection of the event or day following.",,,,,Y,2,,,Y,09/16/2019,09/23/2019,7,,PVT,,Aspirin 81mg daily Lipitor 20mg QHS Vitamin D3 daily Krill oil daily Lisinopril 20mg daily Metformin XR 500mg daily Toprol XL 50mg daily Prilosec 40mg daily,None,"Hypertension, hyperlipidemia",,,2,09/25/2019,,Y,Y,No known allergies
0835815,09/25/2019,CA,,,,U,,"Improperly stored dose of GARDASIL 9 was administered to the patient on an unknown date; no adverse effect; This spontaneous report was received from a medical assistant regarding a patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection lot # N022952, expiration date: 14-JUN-2020 (exact dose, strength and route of administration were unknown) for prophylaxis (product storage error). The vaccine underwent temperature excursion below 36-degree Fahrenheit: 32.1 Fahrenheit for a duration of 8 hours. There was no previous temperature excursion. There was an involvement of data logger. No product quality complaints (PQC) were involved.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009519,2,09/25/2019,,,,
0835816,09/25/2019,CA,,,,U,,"Improperly stored dose of GARDASIL 9 was administered to the patient on an unknown date; No adverse effect; This spontaneous report was received from a medical assistant regarding a patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # N022952, expiration date: 14-JUN-2020 (exact dose, strength and route of administration were unknown) for prophylaxis (product storage error). The vaccine underwent temperature excursion below 36-degree Fahrenheit: 32.1 Fahrenheit for a duration of 8 hours. There was no previous temperature excursion. There was an involvement of data logger. No product quality complaints (PQC) were involved.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009529,2,09/25/2019,,,,
0835817,09/25/2019,CA,,,,U,,"Improperly stored dose of GARDASIL 9 was administered to the patient on an unknown date; no adverse effects; This spontaneous report was received from a medical assistant regarding a patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # N022952, expiration date: 14-JUN-2020 (exact dose, strength and route of administration were unknown) for prophylaxis (product storage error). The vaccine underwent temperature excursion below 36 degree Fahrenheit: 32.1 Fahrenheit for a duration of 8 hours. There was no previous temperature excursion. There was an involvement of data logger. No product quality complaints were involved.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009809,2,09/25/2019,,,,
0835818,09/25/2019,NJ,,,,U,,"rash; shingles; hurts; This case was reported by a consumer and described the occurrence of rash in a 55-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included painful rash (experienced couple years before the reporting).   In June 2019, the patient received the 1st dose of Shingrix. In August 2019, between 2 and 3 months after receiving Shingrix, the patient experienced rash, shingles and pain. The patient was treated with valaciclovir hydrochloride (Valacyclovir Hcl). On an unknown date, the outcome of the rash, shingles and pain were unknown.   It was unknown if the reporter considered the rash, shingles and pain to be related to Shingrix.  Additional information received were as follows: The patient started to experience rash on rear about 5 days ago from the reporting date. The patient blamed it on adult diaper rash because the patient had been outside sweating a lot on the weekends. On Wednesday, the patient decided to get 2nd dose of Shingrix. On Friday, on the reporting date, the patient finally went to the doctor and he looked at my rash.  The patient told him it did not itch, it hurts, and had something like this a couple years ago, which took about 3 or 4 weeks or more to heal, though did not go to the doctor for it years ago.  On the reporting date, the patient was diagnosed with Shingles. The patient was put on Valacyclovir HCl 1gm tablet, every 8 hours, for 7 days. The patient know that it is not supposed to get a Shingrix shot when you have Shingles. But the patient did not even know that the patient had Shingles. The patient asked that would being on the Valtrex (Valacyclovir), reduce the effectiveness of my second Shingrix shot. The patient asked whether do need to consider getting a third shot when the patient do not had Shingles.",,,,,,,,,U,06/01/2019,08/01/2019,61,,UNK,,,,Medical History/Concurrent Conditions: Painful rash (experienced couple years before the reporting),,USGLAXOSMITHKLINEUS2019AM,2,09/25/2019,,,,
0835819,09/25/2019,OH,10.0,10,,M,09/25/2019,9 AM Flu Vaccine administered. 1015 AM In class at school - felt confused + jittery. Was in Math Class + couldn't answer question as he Normally would. Went to Nurses STation. BP slightly Elevated. Mom Took Home after 2 hrs. Felt Normal.,,,,,,,,,Y,09/24/2019,09/24/2019,0,,PUB,PVT,,NoNe,0,,,1,,,,,
0835822,09/25/2019,NY,63.0,63,,F,,"Bruising, severe pain, blisters and then subsequent ulcers that needed to be debrided.",,,,,,,,,N,07/16/2019,07/25/2019,9,None,PVT,,"Loratadine, Letrozole, probiotic, famtodine, Gabapentin, Naproxen, Toremide , vitamin D, duloxetine, clear-x","breast cancer, peripheral neuropathy, tobacco use, vitamin D insufficiency, allergic rhinitis","Breast cancer, peripheral neuropathy",,,2,09/25/2019,,Y,,NKDA
0835823,09/25/2019,MI,30.0,30,,M,,Employee had anaphylaxis reaction to the flu vaccine within 5 minutes of receiving dose. Treated with IM  EPI and taken to ER for further evaluation.,,,,,,,,,Y,09/25/2019,09/25/2019,0,,WRK,,none,none,none,,,2,09/25/2019,,,,none
0835824,09/25/2019,PA,37.0,37,,F,,"Approximately 6 to 8 hours after the injection, the injection site and upper arm got raised and swollen, red  and hot to the touch   Patient said arm hurt at injection site",,,,,,,,,N,09/24/2019,09/24/2019,0,,PHM,,None,None,None,,,2,09/25/2019,,,,None
0835825,09/25/2019,NJ,72.0,72,,M,,"Diagnosed with Shingles on 9/23/2019 by Dr.   Valtrex,  started on 9/21/2019.   Pamelor, Flomax started on 9/23/2019.    Lab work on 9/23/2019      Pain and soreness at injection site on 9/17/2019 No symptoms until 9/20/2019  Rash with blisters,  burning pain, Low grade fever, malaise--on right upper groin area, right flank, and right back.",,,,,,,,,N,09/17/2019,09/19/2019,2,Draw on 9/23/2019 by physician.  I do not have results as yet.,PHM,,"Amlopidine,  Xyzal,  Rovastatin, Vitamin D3, CQ 10, Multi-vitamin",None,Cancerous polyp removed 12/19/2018.  All follow up colonoscopies( 3)  and MRI's have been negative.,,,2,09/25/2019,,,,NKA
0835826,09/25/2019,CA,4.0,4,,M,,"09/11/2019 swelling and redness 09/12/2019 swelling and redness expanded 09/13/2019 swelling and redness expanded 09/13/2019 took him to urgent care. I  was told it was a skin reaction, not vaccine reaction.  He was prescribed Hydrocortisone Cream, 2.5% and Cetirizine Hydrochloride Oral Solution 1 mg/ml. Neither one seemed to reduce the swelling.  09/15/2019 took him again to urgent care. This time the Dr agreed that it may be a reaction to the vaccine, not skin allergy. 09/19/19 He broke into 101.9 fever 09/20/19 voice became hoarse and developed croup cough. Fever came back 101.3. 09/21/19 cough worsened. Tylenol reduced fever.  09/22/19 cough sounded more like whooping 09/23/19 took him back to facility. He was diagnosed with croup.",,,,,,,,,N,09/10/2019,09/11/2019,1,,PVT,,None,None,None,,,2,09/25/2019,,Y,Y,None
0835827,09/25/2019,GA,51.0,51,,F,,"patient has been experiencing a redness at the injection site, swelling, and hot to the touch sensation. she has used ibuprofen and ice but it has lasted about 2 days so far",,,,,,,,,N,09/23/2019,09/23/2019,0,,WRK,,none,none noted,none noted,,,2,09/25/2019,,,,none noted
0835828,09/25/2019,IL,73.0,68,,U,,"Fever [temp 100.6], chills, sclerae reddened, purulent drainage from both eyes, lump in throat, difficulty swallowing, chest tightness.  Duration unknown.",,,,,,,,,,09/23/2019,09/23/2019,0,,UNK,,,,,,,2,09/25/2019,,,,
0835829,09/25/2019,IN,86.0,86,,F,,"That day patient prescribed Cipro for urinary tract infection; doctor said vaccine was ok to receive as long as there was no fever.   Tetanus received at ER in hospital maybe within last month.    Patient took antibiotics around 5pm and arm felt funny.  Patient started to get chills and shaking and could not control it.  Patient fell down when tried to move to get blanket and scraped arm on table on the way down. Patient wet herself, sat down for a while.  Finally got up and went to bed; not sure at what time this was.   On Sunday, did not feel the best went got up, spent afternoon with kids. On Monday felt like got tired easily.  Today feels chills and aches but feels better now.  Patient called pharmacist today, VAERS number given, and encouraged to follow-up with doctor; will not go to the doctor since doesn't feel as bad now.   Patient at 80% recovery.",,,,,,,,,U,09/21/2019,09/21/2019,0,,PHM,,"Atenolol, Lisinopril, Simvastatin, One-a-Day Vitamins,",Urinatry track infection. No.,"Blood pressure, cholesterol",,,2,09/24/2019,,,,"Macrobid, Novocain, Iodine, Sulfa sensitivity, Probiotic, fish oil, Iron,"
0835830,09/25/2019,SC,64.0,64,,F,,red swollen area with pain and cant raise arm much behind her and cant reach behind you and pain is radiating,,,,,,,,,N,05/08/2019,05/08/2019,0,blood work on 09-25-2019,PHM,,chantix 1mg continued pack on 5-14-2019 and ammonium lactate lotion on 04-24-2019,none that i am aware of,none that i am aware of,,,2,09/25/2019,,Y,,no known allergies in computer
0835831,09/25/2019,WA,66.0,66,,F,,"Pt had a sore arm night of 9/21 and had flu like symptoms on 9/22. She started feeling better by Monday 9/23, however by the evening of Tuesday 9/24 her arm was more sore. She took Tylenol and went to bed but woke up at 2am Wed 9/25 with an extremely painful arm. Her arm is extremely painful with any movement and she has limited mobility in the arm. She also reports shooting pain with any sudden movements and is concerned about nerve issues. Patient reports her arm is tender to touch above the injection site, but states there is no swelling/bump/redness. She does have RA, which has manifested with the same symptoms, and she thinks that it may have been triggered by the shot but we are not sure at this point. I counseled patient to take some more Tylenol and recommended she go to an urgent care or see her physician so that they can take a look at her arm more closely.",,,,,,,,,N,09/21/2019,09/25/2019,4,,PHM,,,,,,,2,09/25/2019,,Y,,Penicillin
0835838,09/25/2019,TX,70.0,,,M,,"Shingles on forehead; This case was reported by a physician via sales rep and described the occurrence of shingles in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced shingles. The patient was treated with valaciclovir hydrochloride (Valtrex). On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient experienced shingles within one week of receiving Shingrix. The patient received Valtrex as a treatment for herpes zoster on forehead and not in eye. This case has been linked with cases US2019AMR167873, US2018GSK096361 and US2019AMR084177 reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/25/2019,,,,
0835839,09/25/2019,TX,70.0,,,M,,"Shingles; This case was reported by a physician via sales rep and described the occurrence of shingles in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced shingles. The patient was treated with valaciclovir hydrochloride (Valtrex). On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient experienced shingles within one week of receiving Shingrix. The patient received Valtrex as a treatment for herpes zoster on forehead and not in eye. This case has been linked with cases US2019AMR167862, US2018GSK096361 and US2019AMR084177 reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/25/2019,,,,
0835840,09/25/2019,SC,,,,U,,"Chicken pox outbreak; This case was reported by a consumer and described the occurrence of chickenpox in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, 12 days after receiving Shingrix, the patient experienced chickenpox. On an unknown date, the outcome of the chickenpox was not recovered/not resolved.   It was unknown if the reporter considered the chickenpox to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient broke out with Chickenpox after receiving Shingrix vaccine.  The patient trying to ascertain if it's contagious. The patient had approximately 40-50 pox sores at various degrees or healing and still breaking out with new pox places daily. Initially started breaking out 12 days after the vaccination. The reporter asked if was there any treatment other the over the counter meds such as antihistamines and asked how long can expect this to continue.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/25/2019,,,,
0835841,09/25/2019,,,,,U,,"Suspected vaccination failure; influenza A(H3N2); acute respiratory illness; This case was reported in a literature article and described the occurrence of suspected vaccination failure in a adult patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, less than a year after receiving Flu vaccine, the patient experienced vaccination failure (serious criteria hospitalization and GSK medically significant), h3n2 influenza (serious criteria hospitalization) and respiratory disorder (serious criteria hospitalization). On an unknown date, the outcome of the vaccination failure, h3n2 influenza and respiratory disorder were unknown.   It was unknown if the reporter considered the vaccination failure, h3n2 influenza and respiratory disorder to be related to Flu vaccine.  Additional details were reported as follows: This case was reported in a literature article and described the suspected vaccination failure in a patient aged between 22 and 63 years of unspecified gender, who was vaccinated with unspecified influenza vaccine (manufacturer unknown) for prophylaxis. This case corresponds to supplementary table 2 (subject 7) in this literature article. The patient was a part of the study that aimed was to compare antibody titers against both circulating influenza A (H3N2) strains and egg-adapted influenza A (H3N2) strains in acute specimens from individuals with and those without influenza virus infection in the 2017-2018 season. During the severe 2017-2018 influenza season, a study of the effectiveness of influenza vaccine among inpatients with acute respiratory illness as part of the Centers for Disease Control and Prevention (CDC)-sponsored program was performed. No information on patient's medical history, family history, concurrent condition or concomitant medication was provided. On unspecified date, during 2017-2018 influenza season, the patient received unspecified influenza vaccine (administration route and site unspecified; dosage unknown; batch number not provided). The age at vaccination was not provided. [In this study, there were 18 individuals who had been vaccinated, and the specific influenza vaccine they received could be confirmed for 15. All 15 individuals with confirmed vaccine product information received vaccines containing inactivated egg-grown virus; 10 received quadrivalent standard-dose vaccines (9 vaccines were produced by GlaxoSmithKline, and 1 was produced by Seqirus), 3 received trivalent high dose vaccines (produced by Sanofi Pasteur), 1 received trivalent adjuvanted vaccine (produced by Seqirus), and 1 received trivalent unadjuvanted vaccine (produced by Seqirus)]. On an unspecified date, during 2017-2018 influenza season, between 27 November 2017 and 31 January 2018, an unknown period after the vaccination, the patient developed acute respiratory illness and subsequently hospitalized. The patient was enrolled less than or equal to 10 days after illness onset during active influenza virus circulation. The patient's throat and nasal swab specimens were collected shortly for influenza virus identification by reverse transcription polymerase chain reaction (RT-PCR) analysis. The patient was found influenza A(H3N2) Positive. The patient's antibody titers were also measured with neuraminidase-inhibition (NAI) and Microneutralization (MN) assays was determined. The microneutralization (MN) egg propagated A/HongKong/4801/2014 (HK-egg) antibody titer was found 320, MN MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 57, MN MDCK-SIAT1 propagated A/Washington/16/2017 (WA) antibody titer was found 20, MN MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was 20, MN MDCK-SIAT1 propagated A/Maryland/53/2017 (MD) antibody titer was found 20, MN MDCK-SIAT1 propagated A/Wisconsin/327/2017 (WI) antibody titer was found 57, neuraminidase-inhibition (NAI) MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 160 and NAI MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was found 160 in patient. The genetic characterization of Influenza A(H3N2) virus strains circulating in patient sample was also determined (results not provided). This case has been considered as suspected vaccination failure being the time to onset was unknown. This case has been considered as serious due to suspected vaccination failure and hospitalization. Treatment was unknown. The outcome of the event was not reported. The author did not comment on the relationship between the event of influenza A (H3N2) infection and unspecified influenza vaccine. However, the authors stated, ""This analysis of specimens from adults hospitalized with influenza A(H3N2) virus infection during the 2017-2018 influenza season demonstrated an antibody response specific to egg-adapted strains that was significantly higher among vaccinated individuals. In our study sample, this suggests that the antibody responses to vaccination in this population are highly specific to the egg-adapted strain, with little cross-reactivity to the circulating virus.Additionally, antibody titers against cell-grown influenza A/HongKong/4801/2014(H3N2) virus were similar to those in unvaccinated individuals. In this study sample, this suggests that the antibody responses to vaccination in this population are highly specific to the egg-adapted strain, with little cross-reactivity to the circulating virus. In this study, antibody against the neuraminidase of influenza A/HongKong/4801/2014 virus and influenza A/Singapore/INFIMH-16-0019/2016 virus was not associated with protection against infection. Although neuraminidase content was not standardized in influenza vaccines, it was observed that anti-neuraminidase antibody titers were higher among vaccinated individuals, suggesting that some of the existing anti-neuraminidase antibody in this population resulted from vaccination. The serum specimens in this study were collected at a single time point early during acute illness."" The authors concluded, ""The conclusions were limited by the inclusion of a small number of specimens from a single hospital. Because the severity of the 2017-2018 epidemic was evident early in the season, it was prioritized rapid serologic testing of the specimens that were available to date during the first half of the season. These 2 factors may limit the broad generalizability of the results; however, the influenza viruses that circulated locally overall and during the analysis period were similar to those that predominated nationwide during the same season. The small sample size also precluded the ability to perform additional subanalyses, to assess whether results might vary within specific age groups or by history of prior vaccination. In one sense, the 2017-2018 influenza vaccine appears to have worked as intended: vaccinated individuals had high antibody titers against the influenza virus strain included in the vaccine. The study adds to the evidence that egg adaptations in the 2017-2018 influenza vaccine strain elicited antibodies to epitopes not conserved in circulating strains. The degree to which this contributed to the marked severity of the 2017- 2018 season remains to be determined. Several vaccine products have been introduced into the US vaccine market that are produced in cells and do not have the same emergent egg adaptations seen in recent influenza A(H3N2) vaccine strains. At this time, evidence for the effectiveness of these vaccines relative to those produced in eggs is limited because few head-to-head trials have been performed. Early data suggest that cell-based vaccines have somewhat improved protection in clinical trials and in the community. Unfortunately, these vaccines are still dependent on selecting viruses that are close antigenic matches to those that will circulate and are subject to the limitations of annual strain selection time lines. This underscores the need for the development of the next-generation of influenza vaccines that provide better, broader, and longer-lasting protection."" This is 1 of the 4 valid cases reported in the same literature article.      Lab Comments: On an unspecified date, during 2017-2018 influenza season, between 27 November 2017 and 31 January 2018, the lab test were performed. The patient's throat and nasal swab specimens were collected shortly for influenza virus identification by reverse transcription polymerase chain reaction (RT-PCR) analysis.  The patient was found influenza A(H3N2) Positive. The patient's antibody titers were also measured with neuraminidase-inhibition (NAI) and Microneutralization (MN) assays was determined. The microneutralization (MN) egg propagated A/HongKong/4801/2014 (HK-egg) antibody titer was found 320, MN MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 57, MN MDCK-SIAT1 propagated A/Washington/16/2017 (WA) antibody titer was found 20, MN MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was 20, MN MDCK-SIAT1 propagated A/Maryland/53/2017 (MD) antibody titer was found 20, MN MDCK-SIAT1 propagated A/Wisconsin/327/2017 (WI) antibody titer was found 57, neuraminidase-inhibition (NAI) MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found  160 and NAI MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was found 160 in patient. The genetic characterization of Influenza A(H3N2) virus strains circulating in patient sample was also determined (results not provided).",,,,,Y,,,,U,,,,"Test Name: Gene sequencing; Result Unstructured Data: Test Result: See text, Test Result Unit: unknown; Test Name: Polymerase chain reaction; Result Unstructured Data: Test Result: influenza A(H3N2) Positive, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS2019GS,2,09/25/2019,,,,
0835842,09/25/2019,TX,59.0,59,,M,,"positive hepatitis B test; This case was reported by a consumer via call center representative and described the occurrence of hepatitis b test positive in a 59-year-old male patient who received HAB (Twinrix adult) for prophylaxis.   Previously administered products included Hepatitis B vaccine (unknown hepatitis B vaccine received 10-15 years before the date of reporting).   On 11th June 2019, the patient received the 1st dose of Twinrix adult (intramuscular). On 14th June 2019, 3 days after receiving Twinrix adult, the patient experienced hepatitis b test positive. On an unknown date, the outcome of the hepatitis b test positive was unknown.   It was unknown if the reporter considered the hepatitis b test positive to be related to Twinrix adult.  Additional details were provided as follows: The had blood work done. It was reported that, the patient tested positive for Hepatitis B, however, the health department believed it was detected in his blood due to him receiving the vaccine 3 days prior to testing.",,,,,,,,,U,06/11/2019,06/14/2019,3,"Test Date: 20190614; Test Name: Hepatitis B surface antibody; Result Unstructured Data: Test Result: hepatitis B positive, Test Result Unit: unknown",PHM,,,,,,USGLAXOSMITHKLINEUS201911,2,09/25/2019,,,,
0835843,09/25/2019,CA,,,,F,,"swelling at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2018, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced extensive swelling of vaccinated limb. On an unknown date, the outcome of the extensive swelling of vaccinated limb was recovered/resolved.   It was unknown if the reporter considered the extensive swelling of vaccinated limb to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After vaccination with dose of Shingrix, the patient experienced swelling at the injection site to about the size of an orange.",,,,,,,,,Y,09/01/2018,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201912,2,09/25/2019,,,,
0835844,09/25/2019,CA,83.0,,,F,,"Rash; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 83-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced rash. The patient was treated with prednisone. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number was not reported. The pharmacist called to report that the patient has rash. The patient was scheduled for 2nd dose of Shingrix. Doctor gave Shingrix and prednisone for the rash.  The reporter stated that she did not have Shingles.  The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/25/2019,,,,
0835845,09/25/2019,FL,,,,U,,"Pain; Myalgia; Fatigue; This case was reported by a pharmacist via call center representative and described the occurrence of pain in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain, myalgia and fatigue. On an unknown date, the outcome of the pain, myalgia and fatigue were unknown.   It was unknown if the reporter considered the pain, myalgia and fatigue to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  The reporter did not reported a specific number of patients, did not have information regarding lot or expiry date or patient specific details. The reporter reported pain, fatigue, myalgia from Medical Information requested for a different inquiry, from lot of patients. The reporter denied permission to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/25/2019,,,,
0835846,09/25/2019,PA,48.0,48,,F,,"Site of injection is very swollen (3-4 inches in diameter), red, raised, and warm/hot to the touch. It is very painful for patient to lift her arm. Symptoms began last night and remain unresolved with ice and ibuprofen.",,,,,,,,,,09/24/2019,09/24/2019,0,,PHM,,,,,,,2,09/25/2019,,,,
0835847,09/25/2019,OR,19.0,19,,F,,cellulitis,,,,,,,,,,09/23/2019,09/24/2019,1,,PVT,,,,,,,2,09/25/2019,,,,
0835848,09/25/2019,,60.0,60,,F,,"My left hand started itching so much that it woke me repeatedly during the night. It continued to itch throughout the day after the vaccination. In addition to itching, there was a burning sensation and sometimes a tingling.  The itching has subsided, but tingly sensation persists a little.",,,,,,,,,Y,09/23/2019,09/24/2019,1,,PHM,,"No prescriptions, Turmeric, Calcium +D supplement, B-complex",,Celiac disease,,,2,09/25/2019,,,,
0835849,09/25/2019,NC,29.0,29,,F,,"Employee has previously received a three shot series of the Hepatitis B vaccine in 2009. Employee received first injection of  Hepislav-B on 9/23/2019 by trained staff. Employee states that she had only a slight headache when she received the vaccination. Roughly 8 hours after receiving the vaccination employee noted the injection site was sore, raised, red and warm to the touch. Roughly 12 hours after the shot employee states that she had a migraine, itching at the injection site, tingling in the right arm, nausea, fatigued, loss of appetite, and with chills. Employee took Excedrin Migraine and baclofen.  Employee presented to work to complete form. States that the injection site pain has stopped. The tingling in her arm and stopped but the redness remains. Employee now denies nausea and loss of appetite. Employee continues to complain of chills and  fatigue.",,,,,,,,,Y,09/23/2019,09/25/2019,2,"Blood pressure at this time 116/78, heart rate 76 and oral temperature 99.0",PVT,,"Excedrin Migraine, Womens One a day, toperomate, levothyroxine, citalopram and zyrtec are all daily medications.",None,"Migraines, chronic UTI",Flu shot causes flu symptoms,,2,09/25/2019,,,,Azithromycin
0835850,09/25/2019,NC,10.0,10,,M,,Severe local reaction measuring 2.5 inches in diameter of induration.  Prescription for Pramoxine-Hydrocortisone 2.5-1% cream prescribed.,,,,,,,,,U,09/19/2019,09/19/2019,0,Allergy testing and CBC done.,PVT,,"Albuterol inhaler, Cetirizine, Montelukast",None,"Mild Persistent Asthma, Flexural Eczema, Osgood-Schlatter's- left knee",,,2,09/25/2019,,Y,,Shrimp
0835851,09/25/2019,NY,67.0,67,,F,,Right arm very sore from shoulder to elbow for 3 days (8/26-8/28/2019).  For 4 days migraine headaches (8/29-9/1/2019).,,,,,,,,,Y,08/26/2019,08/26/2019,0,,PHM,,"Vitamin D3, Flax Seed, Calcium, Hair, Skin & Nails tablets, Amlodipine Besylate 5mg tablets,",,"Osteoporosis/penia, high blood pressure, osteo arthritis",From flu shot chills and sweating overnight - 10 yrs ago.  Age:57,,2,09/21/2019,,,,"HCTZ, Zestril, Maxide, Sulpha Drugs, Demerol, Metoprolol, Atenolol"
0835852,09/25/2019,OH,18.0,18,,F,,"Employee reported burning sensation at the site of IM injection Left Deltoid immediately after administration at 1555 on 09/23/2019.  Employee started to complain of feeling ""dizzy"" at 1600 Blood pressure obtained 104/70mmHg , HR 89bpm , regular respiration rate , no signs of respiratory compromise  or distress noted. Employee stated she had nothing to eat today 09/23/19. Employee provided with cheese crackers x6 and 12 ounces of electrolyte fluid. Employee remained in office #2 for observation , at 1618 employee now reports abdominal cramping rates a 9 out of 10  on a 0-10 scale with 10 being the most pain. At 1620 Blood pressure obtained 100/67 mmHg and HR 87bpm , no changes in respiration pattern. No signs of anaphylatic reaction ,no facial swelling, no hives, no swelling throat noted, employee denies difficulty breathing. Employee states ""dizziness feeling is only when she lifts her head up and not when my head is lying down ""Employee reports no other symptoms experienced and no changes in intensity for symptoms of dizziness, abdominal cramping. employee requested ibuprofen for pain for abdominal cramps employee and reports no changes with cramping with food and fluid. employee did consume all of the crackers and electrolyte drink provided . Employee did stated burning sensation to left arm at IM site stopped . 1630 after re-evaluation of employee's response to treatment the employee took medication two 200 mg tablets of Ibuprofen by mouth provided from first aid kit .  Employee remains under MSA /MCS observation post administration of Hepatitis B  vaccine.  1720 BP 98/61 mmHg HR 84 bpm Respiratory rate 20 breaths per minute. employee remains awake and alert.  No redness or swelling noted to site.  CMD notified and stated for employee to transfer to the hospital.  911 dispatched at 1750. 1755 EMS arrived, employee walked independently to ambulance with paramedic to go to Hospital ED.",,,,,,,,,Y,09/23/2019,09/23/2019,0,,OTH,,none,no,none,,,2,09/23/2019,,,Y,"NKA ,NKDA"
0835853,09/25/2019,MI,86.0,86,,F,,Starting 2 days after injection the arm became very sore from injection site all the way to tips of fingers. Fingers became numb and couldn't hold things. Very severe body pain at night that is lingering. Skin on middle fingers is sore to touch. Gradually able to grasp things again after 2 weeks.  Primary care physician appointment 9/9/19.,,,,,,,,Y,N,08/12/2019,08/14/2019,2,Having  a test done where electrodes are placed on the fingers.,PHM,,"Advair, Basal insulin, Carvedilol, Digoxin, Lasix, Thyroid, Lipitor, Losartan, Xanax, Relive (nutritional drink)",Tightening of lung but not COPD,Cardiac and lung problems,,,2,09/25/2019,,Y,,NKA
0835854,09/25/2019,GA,44.0,44,,M,,hives and neck pain,,,,,,,,,Y,09/16/2019,09/16/2019,0,,PVT,,Amlodipine/Losartan/HCTZ,High Blood Pressure,,,,2,09/25/2019,,,,Penicillin
0835855,09/25/2019,NY,76.0,76,,M,,"The vaccines were administered on 9/23. On 9/25, pt came in with a rash on his arm.",,,,,,,,,U,09/23/2019,09/24/2019,1,,PHM,,,,,,,2,09/25/2019,,,,No known allergies
0835856,09/25/2019,UT,66.0,66,,F,,Extreme itching and rash over entire body began day after injection and lasted at least 5 days,,,,,,,,,N,09/20/2019,09/21/2019,1,,PHM,,,,,,,2,09/25/2019,,,Y,
0835857,09/25/2019,MI,65.0,65,,F,,Swollen left arm from shoulder to elbow area,,,,,,,,,,09/24/2019,09/24/2019,0,n/a,PHM,,"Nabumetone 500 mg, Celecoxib 200 mg, Pregabalin 75 mg, Citalopram 20 mg, Atorvastatin 10 mg",None stated,,,,2,09/25/2019,,Y,,NKDA
0835858,09/25/2019,,33.0,33,,F,,"Pain and tingling throughout arm, cellulitis",,,,,,,,,U,09/10/2019,09/18/2019,8,,PHM,,,,,,,2,09/25/2019,,Y,,
0835859,09/25/2019,,71.0,71,,F,,tachycardia flu like symptoms,,,,,,,,,,09/07/2019,09/07/2019,0,,PHM,,,,,,,2,09/25/2019,,,Y,
0835860,09/25/2019,MI,17.0,17,,M,,"Menveo brand by GlaxoSmithKline is given as the second dose. 17 year old male discharged from appointment in pediatrics. Nurse alert called to outside front lobby. Patient was found to be lying on ground with purse under his head and mother by his side. Per mother, as he left our clinic, he walked outdoors and verbalized that it was blurry and bright to see and passed out immediately. When nurse arrives, patient was found alert, oriented to place, person and time. Initial vital signs while supine at 1145 am, B/P 110/74, AHR 59, blood chemstix 85, pulse oximetry 99% on room air. He was closely monitored for the next 15 minutes outdoors then transferred back to the pediatric treatment room at noon via wheelchair. The primary care provider was notified of incident immediately. It was noted that he had received his meningococcal vaccine prior to leaving his appointment and had not had anything to eat or drink before his visit today.  He was monitored until 1230 pm as vital signs remained stable. He was also given apple juice, crackers and 24 ounces of water while being monitored. Dr. (PCP) evaluated him and  was cleared to be discharged home. Nurse accompanies him by walking him outside as mother had car pulled up and escorted to car. He denied any further symptoms upon discharge.",,,,,,,,,Y,09/25/2019,09/25/2019,0,n/a,PVT,,unaware,None noted,None noted,,,2,09/25/2019,,,,None noted
0835861,09/25/2019,AZ,66.0,66,,F,,"My left upper arm turned red and swollen at the/from the site of the injection  to my elbow all the way around the entire circumference of my upper left arm. It became very hot and remained so for at least 4 to 5 days with the swelling continuing to this day; it has slowly improved along with the redness but both symptoms still linger. At about the 3rd day post-injection I was awoken from sleep with a deep pain in my elbow and upper & lower arm -- my arm was black and blue, especially at the vein areas and now the arm was swollen. This went into the second week and though it has improved I am still in moderate discomfort. I had/have difficulty lifting my arm during time and still have the same problem. Along with the above I have felt sick: breaking out in chills and cold sweats and shaking, very tired and trouble concentrating. The cold sweats began about a week post injection and still continue (at just over 2 weeks). And, now my left leg is having vein pain/discomfort same as my left arm. I am still tired, my left arm still hurts and I have been to the doctor and may need to go ahead. I am trying to avoid the Emergency Room, if at all possible.",,,,,,,,,N,09/07/2019,09/07/2019,0,"CBC blood panel taken Friday, September 20, 2019. Results: Normal.",PHM,,Levothyroxine 50 mcg daily (hypothyroidism) Spironolactone 12.5 mg daily (hypertension),None,None,,,2,09/25/2019,,Y,,Erythromycin
0835862,09/25/2019,FL,62.0,62,,F,,"Patient felt stinging in injection area which progressed to pain in left arm. Patient also began to feel faint and dizzy. Vision became blurred momentarily. Nurse from facility's urgent care came to take vitals. Vitals were normal. Gave patient water and allowed her to sit and let the reaction wear off. Patient waiting about 20 minutes before becoming mobile again. No further treatment was given and patient felt okay to go home, but still was too anxious to walk back to car on her own. Husband wheeled her out.",,,,,,,,,U,09/25/2019,09/25/2019,0,Patient recently had surgery (unspecified) in right arm after breast cancer diagnosis. She seemed very anxious and overwhelmed before shot.,PHM,,n/a,,breast cancer,,,2,09/25/2019,,,Y,shellfish and oxycodone
0835863,09/25/2019,ID,73.0,73,,M,,Localized redness and pain,,,,,,,,,N,09/19/2019,09/20/2019,1,none,MIL,,"atorvastatin 20mg, losartan 100mg, aspirin 81mg, dulaglutide",none,"DM type 2, OSA, HTN, hereditary hemochromatosis, LUTS, peripheral neuropathy, RLS",,,2,09/25/2019,,Y,,metformin (nausea/vomiting)
0835864,09/25/2019,MN,85.0,85,,F,,"red rash, warm to touch and inflammed",,,,,,,,,N,09/23/2019,09/24/2019,1,,PHM,,na,no,,,,2,09/25/2019,,,,penicillin
0835865,09/25/2019,IL,58.0,58,,M,,"Body aches, fever as high as 102 by 9/21/2019 - 8 PM.  Significant lack of energy. Took over the counter medication to combat fever and body aches. Symptoms subsided by 2 PM on 9/22/2019.",,,,,,,,,Y,09/20/2019,09/21/2019,1,,PHM,,Multi-vitamin,None,,,,2,09/25/2019,,,,None
0835867,09/25/2019,CO,67.0,67,,F,,hives,,,,,,,,,U,09/19/2019,09/20/2019,1,,PHM,,,,,,,2,09/25/2019,,,,
0835868,09/25/2019,CO,1.5,1,.5,F,,"About 7 hours post-immunization, child was getting out of a warm bath when her legs collapsed and she slide face down into the water. Mother immediately scooped her up and noted her to have a blue-grey appearance and that she was limp in parents arms.  EMS called and child returning to baseline on their arrival, MOC estimated event lasted about 8 minutes.",,,,,,,,,Y,09/24/2019,09/24/2019,0,CXR done in ED 9/24- hazy oppacities,PVT,,None,URI 9/11/2019,None,"After 2 month immunizations, infant had a similar hypotonic/hyporesponsive episode that only lasted 2 minutes and self-resolved ",,2,09/25/2019,,Y,Y,None
0835869,09/25/2019,TX,69.0,69,,M,,"About 3 inches below the injections site, pt presented with redness and slight swelling of the skin on his arm. It started the day after he received the vaccine. He didn't experience any pain, fever, or body aches. He was told if it gets any worse or doesn't improve to contact his dr. He was also told to place ice on the site.",,,,,,,,,,09/23/2019,09/24/2019,1,,UNK,,,,,,,2,09/25/2019,,,,
0835870,09/25/2019,AZ,71.0,71,,F,,Reddiness around shot area. Itching  times 4 days. No treatment was necessary.,,,,,,,,,Y,09/16/2019,09/18/2019,2,None,PVT,,None,NONE,"COPD, Pulmonary Arterial Hypertension, Fibromyagia and Systemic Lupus.",,,2,09/25/2019,,,,Vanacomycin and Tape
0835871,09/25/2019,MO,62.0,62,,M,,Patient stated they had arm pain the day of the injection.  The pain continued to last and the patient went to the doctor's office today complaining of the pain and shoulder/joint pain.,,,,,,,,,N,08/26/2019,08/26/2019,0,unknown,PHM,,unknown,unknown,unknown,,,2,09/25/2019,,Y,,unknown
0835872,09/25/2019,CO,66.0,66,,M,,"diffuse welt-like rash, erythematous. Sporadic body sites/locations",,,,,,,,,Y,08/14/2019,08/18/2019,4,n/a,PVT,,Simvastatin 20 mg - 1 tablet once daily qhs,"prediabetes, hyperlipidemia, GERD",see above,,,2,09/25/2019,,Y,,no known drug allergies
0835873,09/25/2019,NY,52.0,52,,F,,Patient came in 1 week after receiving both vaccines in the same arm approximately 2 inches apart. She reports a raw rash on the posterior arm and swelling on the entire arm and fingers on the right side. She also reported a similar rash under her breast. Patient also stated that she started sweating profusely after the vaccines were administered. No reports of any pain or redness at the injection site. Patient states that she receives the flu vaccine yearly with no reaction therefore she thinks that this reaction is from the boostrix vaccine,,,,,,,,,N,09/18/2019,09/18/2019,0,,PHM,,"Lantus, Humalog, furosemide, symbicort, spironolactone, pantoprazole, lisinopril, proair, cyclobenzaprine, gabapentin, loratidine,  singulair, albuterol nebulized solution","diabetes type 2, hypertension, asthma, pain, was on a course of antibiotics 10 days prior to vaccination","diabetes type 2, hypertension, asthma, pain",,,2,09/25/2019,,,,none reported to pharmacy
0835874,09/25/2019,LA,53.0,53,,M,,"During a flu clinic at a local business a patient was administered a pneumovax and fluzone. The pharmacist. The patient requested that he get a pneumonia shot because he had revieved one in 2014 and needed another  and when the pharmacist asked if he was over 65, the technician that was helping out and going over patient questionaires with the pharmacist  at the flu clinic said 66. The pharmacist then administered the pneumovax and fluzone to the patient thinking the patient was over 65.  The prescriber and patient was then notified of the error.",,,,,,,,,,09/24/2019,09/24/2019,0,No adverse event reported,PHM,,,,,,,2,09/25/2019,,,,
0835875,09/25/2019,FL,73.0,73,,F,,Patient experienced significant pain in the right arm and could not raise arm. Patient was advised to take any pain medication she normally is allowed to take by primary care physician. Pain subsided over several days.,,,,,,,,,Y,09/18/2019,09/18/2019,0,,PHM,,"Sertraline, Losartan HCTZ, Amlodipine, Rosuvastatin, Celecoxib",,"High blood pressure, arthritis, high cholesterol",,,2,09/25/2019,,,,"Doxycycline, Penicillin, Sulfa"
0835876,09/25/2019,PA,,0,.5,M,,"Intussusception- crying, pain, fatigue",,,,,,,,,Y,05/25/2018,07/09/2018,45,"Ultrasound, air enema",PVT,,,,,,,2,09/25/2019,,Y,Y,
0835877,09/25/2019,IN,57.0,57,,F,,"Patient reports right should and area around the injection site got itchy and she got a few hives within a couple hours of the injection. Pt states that she took Benadryl and went to bed, and when she woke this morning, it was fine.",,,,,,,,,Y,09/24/2019,09/24/2019,0,,PUB,,,,,,,2,09/25/2019,,,,"SULFA, LEVAQUIN"
0835878,09/25/2019,CA,68.0,68,,F,,Redness and warmth spreading down her arm past her elbow,,,,,,,,,U,09/23/2019,09/24/2019,1,,PVT,,,,,,,2,09/25/2019,,Y,,
0835879,09/25/2019,PA,63.0,63,,F,,patient has redness and swelling radiating down left arm,,,,,,,,,N,09/19/2019,09/22/2019,3,none,PHM,,"rizartriptan, gabapentin",Urinary Tract Infection,,,,2,09/25/2019,,Y,,no allergies
0835880,09/25/2019,CT,61.0,61,,F,,"Feels like I have a really bad case of the Flu - fever, chills, aches, tired, dizzy, bad headache  - arm only hurts a little so that is not an issue.  Day after vaccine was the worse and I had to leave work - on day two now and much better but still really tired and have a slight headache.",,,,,,,,,Y,09/23/2019,09/23/2019,0,None,PHM,,None,None,None,"Same as the first Shingrix dose  April 6, 2019",,2,09/25/2019,,,,None
0835882,09/25/2019,,27.0,,,F,,"Inappropriate age at vaccine administration; This spontaneous report as received from a registered nurse refers to a 27 year old female patient.    The patient's pertinent medical history, drug reactions, allergies or concomitant medications were not provided.  On 04-JUN-2019, the 27 year old patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (dose, route of administration, lot# and expiration date were not provided) (product administered to patient of inappropriate age). On 17-SEP-2019, the patient went back to receive the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9).",,,,,,,,,U,06/04/2019,06/04/2019,0,,UNK,,,,,,US0095075131909USA008213,2,09/25/2019,,,,
0835883,09/25/2019,,2.0,,,U,,"No adverse effects; patient was administered an expired VAQTA; This spontaneous report was received from a consumer and office manager refers 26 month old patient. The patient's concurrent conditions, medical history and concomitant medications were not provided. On 21-SEP-2019, the patient was administered an expired hepatitis a vaccine, inactivated (VAQTA) (expired product administered) for prophylaxis (lot # R018935, Expiry date: 05-SEP-2019). No adverse effect reported. No PQC involved. No additional information provided.",,,,,,,,,U,09/21/2019,09/21/2019,0,,UNK,,,,,,US0095075131909USA009537,2,09/25/2019,,,,
0835884,09/25/2019,,,,,U,,"Suspected vaccination failure; influenza A(H3N2); acute respiratory illness; This case was reported in a literature article and described the occurrence of suspected vaccination failure in a adult patient who received Flu Seasonal QIV Dresden (Flu Seasonal QIV Dresden) for prophylaxis.   On an unknown date, the patient received Flu Seasonal QIV Dresden at an unknown dose. On an unknown date, less than a year after receiving Flu Seasonal QIV Dresden, the patient experienced vaccination failure (serious criteria hospitalization and GSK medically significant), h3n2 influenza (serious criteria hospitalization) and respiratory disorder (serious criteria hospitalization). On an unknown date, the outcome of the vaccination failure, h3n2 influenza and respiratory disorder were unknown.   It was unknown if the reporter considered the vaccination failure, h3n2 influenza and respiratory disorder to be related to Flu Seasonal QIV Dresden.  Additional details were reported as follows: This case was reported in a literature article and described the suspected vaccination failure in a patient aged between 22 and 63 years of unspecified gender, who was vaccinated with unspecified quadrivalent influenza vaccine (manufacturer GlaxoSmithKline) for prophylaxis.   The patient was a part of the study that aimed was to compare antibody titers against both circulating influenza A (H3N2) strains and egg-adapted influenza A (H3N2) strains in acute specimens from individuals with and those without influenza virus infection in the 2017-2018 season. During the severe 2017-2018 influenza season, a study of the effectiveness of influenza vaccine among inpatients with acute respiratory illness as part of the Centers for Disease Control and Prevention (CDC)-sponsored Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) was performed. No information on patient's medical history, family history, concurrent condition or concomitant medication was provided. On unspecified date, during 2017-2018 influenza season, the patient received unspecified quadrivalent influenza vaccine (administration route and site unspecified; dosage unknown; batch number not provided). The age at vaccination was not provided. [In this study, there were 18 individuals who had been vaccinated, and the specific influenza vaccine they received could be confirmed for 15. All 15 individuals with confirmed vaccine product information received vaccines containing inactivated egg-grown virus; 10 received quadrivalent standard-dose vaccines (9 vaccines were produced by GlaxoSmithKline, and 1 was produced by Seqirus), 3 received trivalent high dose vaccines (produced by Sanofi Pasteur), 1 received trivalent adjuvanted vaccine (produced by Seqirus), and 1 received trivalent unadjuvanted vaccine (produced by Seqirus)]. On an unspecified date, during 2017-2018 influenza season, between 27 November 2017 and 31 January 2018, an unknown period after the vaccination, the patient developed acute respiratory illness and subsequently hospitalized. The patient was enrolled less than or equal to 10 days after illness onset during active influenza virus circulation. The patient's throat and nasal swab specimens were collected shortly for influenza virus identification by reverse transcription polymerase chain reaction (RT-PCR) analysis. The patient was found influenza A(H3N2) Positive. The patient's antibody titers were also measured with neuraminidase-inhibition (NAI) and Microneutralization (MN) assays was determined. The microneutralization (MN) egg propagated A/HongKong/4801/2014 (HK-egg) antibody titer was found 160, MN MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 80, MN MDCK-SIAT1 propagated A/Washington/16/2017 (WA) antibody titer was found 40, MN MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was 40, MN MDCK-SIAT1 propagated A/Maryland/53/2017 (MD) antibody titer was found 40, MN MDCK-SIAT1 propagated A/Wisconsin/327/2017 (WI) antibody titer was found 40, neuraminidase-inhibition (NAI) MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 80 and NAI MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was found 160 in patient. The genetic characterization of Influenza A(H3N2) virus strains circulating in patient sample was also determined (results not provided). This case has been considered as suspected vaccination failure being the time to onset was unknown. This case has been considered as serious due to suspected vaccination failure and hospitalization. Treatment was unknown. The outcome of the event was not reported. The author did not comment on the relationship between the event of influenza A (H3N2) infection and unspecified Quadrivalent influenza vaccine. However, the authors stated, ""This analysis of specimens from adults hospitalized with influenza A(H3N2) virus infection during the 2017-2018 influenza season demonstrated an antibody response specific to egg-adapted strains that was significantly higher among vaccinated individuals. In our study sample, this suggests that the antibody responses to vaccination in this population are highly specific to the egg-adapted strain, with little cross-reactivity to the circulating virus. Additionally, antibody titers against cell-grown influenza A/HongKong/4801/2014(H3N2) virus were similar to those in unvaccinated individuals. In this study sample, this suggests that the antibody responses to vaccination in this population are highly specific to the egg-adapted strain, with little cross-reactivity to the circulating virus. In this study, antibody against the neuraminidase of influenza A/HongKong/4801/2014 virus and influenza A/Singapore/INFIMH-16-0019/2016 virus was not associated with protection against infection. Although neuraminidase content was not standardized in influenza vaccines, it was observed that anti-neuraminidase antibody titers were higher among vaccinated individuals, suggesting that some of the existing anti-neuraminidase antibody in this population resulted from vaccination. The serum specimens in this study were collected at a single time point early during acute illness."" The authors concluded, ""The conclusions were limited by the inclusion of a small number of specimens from a single hospital. Because the severity of the 2017-2018 epidemic was evident early in the season, it was prioritized rapid serologic testing of the specimens that were available to date during the first half of the season. These 2 factors may limit the broad generalizability of the results; however, the influenza viruses that circulated locally overall and during the analysis period were similar to those that predominated nationwide during the same season. The small sample size also precluded the ability to perform additional subanalyses, to assess whether results might vary within specific age groups or by history of prior vaccination. In one sense, the 2017-2018 influenza vaccine appears to have worked as intended: vaccinated individuals had high antibody titers against the influenza virus strain included in the vaccine. The study adds to the evidence that egg adaptations in the 2017-2018 influenza vaccine strain elicited antibodies to epitopes not conserved in circulating strains. The degree to which this contributed to the marked severity of the 2017- 2018 season remains to be determined. Several vaccine products have been introduced into the vaccine market that are produced in cells and do not have the same emergent egg adaptations seen in recent influenza A(H3N2) vaccine strains. At this time, evidence for the effectiveness of these vaccines relative to those produced in eggs is limited because few head-to-head trials have been performed. Early data suggest that cell-based vaccines have somewhat improved protection in clinical trials and in the community. Unfortunately, these vaccines are still dependent on selecting viruses that are close antigenic matches to those that will circulate and are subject to the limitations of annual strain selection time lines. This underscores the need for the development of the next-generation of influenza vaccines that provide better, broader, and longer-lasting protection."" This is 1 of the 4 valid cases reported in the same literature article.      Lab Comments: On an unspecified date, during 2017-2018 influenza season, between 27 November 2017 and 31 January 2018, the lab test were performed. The patient's throat and nasal swab specimens were collected shortly for influenza virus identification by reverse transcription polymerase chain reaction (RT-PCR) analysis.  The patient was found influenza A(H3N2) Positive. The patient's antibody titers were also measured with neuraminidase-inhibition (NAI) and Microneutralization (MN) assays was determined. The microneutralization (MN) egg propagated A/HongKong/4801/2014 (HK-egg) antibody titer was found 160, MN MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 80, MN MDCK-SIAT1 propagated A/Washington/16/2017 (WA) antibody titer was found 40, MN MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was 40, MN MDCK-SIAT1 propagated A/Maryland/53/2017 (MD) antibody titer was found 40, MN MDCK-SIAT1 propagated A/Wisconsin/327/2017 (WI) antibody titer was found 40, neuraminidase-inhibition (NAI) MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found  80 and NAI MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was found 160 in patient. The genetic characterization of Influenza A(H3N2) virus strains circulating in patient sample was also determined (results not provided).",,,,,Y,,,,U,,,,"Test Name: Gene sequencing; Result Unstructured Data: Test Result: See text, Test Result Unit: unknown; Test Name: Polymerase chain reaction; Result Unstructured Data: Test Result: influenza A(H3N2) Positive, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS2019GS,2,09/25/2019,,,,
0835885,09/25/2019,CA,3.0,3,,F,,"3 year old girl came into ED -Emergency Department on 9/1/19 due to right upper thigh swelling and redness for the past 3 days.  Prior to coming into our ED, the girl was also seen in urgent care  for the same swelling and started on antibiotic- Cephalexin.   Mother stated that her daughter received flu vaccination in pediatrician's office 3 days ago (on 8/29/19).      Swelling involved anterior right thigh, circle of erythema, and additional symptoms also include abdominal pain. Patient was admitted to our pediatric unit for IV antibiotic and close observation.    Patient rec'd IV fluid,  Rocephin IVPB,  oral Benadryl,    Patient discharged the following day on 9/2/19  and to follow up with her pediatrician Dr.",,,,,Y,1,,,Y,08/29/2019,08/30/2019,1,,PVT,,unknown,patient had pink eye 2 days prior to getting her flu vaccine and was treated by her PCP,none,,,2,09/25/2019,,,,none
0835886,09/25/2019,MA,17.0,17,,F,,"Became dizzy, pale, diaphoretic and fainted within minutes of receiving injection.  Seizure like arm movements for 3-5 seconds after. Opened eyes right after seizure like movement.  Placed head between knees x5 minutes. Drank 2 glasses apple juice and ate crackers.  Then placed on stretcher to lie flat for 10 minutes. Gradually and incrementally raised HOB to sitting position. Pt remained without further dizziness.  VS remained stable throughout.  Pt states that she didn't eat breakfast.",,,,,,,,,Y,09/20/2019,09/20/2019,0,none,PVT,,Ethinyl Estradiol-Norgestimate BCP,None,None,,,2,09/25/2019,,,,None
0835887,09/25/2019,MA,64.0,64,,F,,Headache.  Muscle ache.  Sore throat. Tired.,,,,,,,,,U,09/23/2019,09/24/2019,1,,PHM,,None,None,None,,,2,09/25/2019,,,,None
0835888,09/25/2019,FL,75.0,75,,F,,"about 12 hours after injection, patients upper arm became very sore/painful. Swelled, turned red, and was hot to the touch. She used ice packs over next 2 days until symptoms subsided. She did not require additional treatment and only reported it upon a return trip to pharmacy on 9/25/19. Area was still slightly red but for most part all symptoms resolved",,,,,,,,,Y,09/21/2019,09/22/2019,1,,PHM,,,,,,,2,09/25/2019,,,,
0835889,09/25/2019,MI,1.0,1,.0,M,,"Patient received dose of IPV 11/28/18, 02/01/2019, 6/24/19 and 09/25/2019.  Received dose on 9/25/19 when not due.  Currently no documented adverse reactions.",,,,,,,,,U,09/25/2019,09/25/2019,0,,PVT,,None,None,None,,,2,09/25/2019,,,,NKDA
0835890,09/25/2019,MI,35.0,35,,F,,"Onset tremor, cold sweat and dizziness at 1645 after receiving injection at 1215.   Ate breakfast and had a bagel w cream cheese and sweet drink at 12:45, so unlikely to be intake related, no history of DM or hypoglycemia.....   Tried eating snack but dizziness persisted such that I have to lie down and couldn?t drive to pick up my kids",,,,,,,,,N,09/25/2019,09/25/2019,0,Did not seek medical lab,WRK,,Bupropion xr,None,ADHD,,,2,09/25/2019,,,,Never
0835891,09/25/2019,OH,55.0,55,,M,,"The patient called the pharmacy on 9/19/19 and told me he had a rash of small bumps that itched over most of his body - more concentrated in the trunk area of his body along his beltline and sock line. He said these bumps were also on his scalp. I instructed the patient to take Benadryl throughout the day and at bedtime as directed on the bottle and to go to the ER if any signs of anaphylaxis - difficulty breathing, swelling of face/mouth. I also advised him to call us or the doctor with any questions. I told him I would call him back to check in. 9/25/19 - I called back and the patient said his rash has improved but is not entirely gone - but he feels better and is still taking the Benadryl every day. He said he would call me back in a few days for another update.",,,,,,,,,N,09/11/2019,09/13/2019,2,none,PHM,,Atorvastatin 40mg and amlodipine 5mg,None reported,high cholesterol and HTN,,,2,09/25/2019,,,,No know allergies reported
0835892,09/25/2019,,72.0,72,,F,,patient stated that upper arm is swollen. This is 5 hours after vaccination,,,,,,,,,,09/25/2019,09/25/2019,0,,UNK,,,,,,,2,09/25/2019,,,,
0835893,09/25/2019,GA,68.0,68,,M,,"AROUND 11 am ON 9/25/19, pt called said that he have sore on his shoulder the day after his shot,  we ask him how is it site of injection, he said it was fine except muscle sore on shouders, so i told pt to take some tylenol but he said he as ibuprofen, so he took ibu. I told him to call me back in afternoon for follow up. At 1p.m, pt called and said that he felt itchy and had fever. I ask him   was he just  itching  or felt  any difficult of breathing or tounge swelling, he said he just itched. So i told him to  take benadryl ( he got nightime benadryl) and tylenol, and i will call to check on him about lucnh. I also told him if he cant breathe, he has to go to hospital. after 2pm, i called him back he said he was ok ( but still had sores on shoulders)",,,,,,,,,Y,09/24/2019,09/24/2019,0,n/a,PHM,,n/a,n/a,n/a,,,2,09/25/2019,,,,n/a
0835894,09/25/2019,IN,51.0,51,,F,,"Patient developed malaise, extreme fatigue, myalgias, headache, lack of appetite, and nausea approximately 12 hours after receiving the Shingrix and PPV 23 vaccinations. Patient received vaccinations on 9/23 and was reevaluated on 9/25 due to symptoms thought to be related to an adverse reaction to vaccinations. Patient symptoms have been improved and were abating by late morning on 9/25. No anaphylaxis or angioedema reported. There were no rashes/hives.",,,,,,,,,Y,09/23/2019,09/23/2019,0,None preformed,WRK,,ACTIVE MEDICATION LIST amlodipine 5 mg tablet take 1 tablet (5MG)  by oral route  every day for high blood pressure atorvastatin 10 mg tablet take 1 tablet by oral route  every day Bayer Aspirin 325 mg tablet take 1 tablet (325MG)  by oral,None reported,PROBLEM LIST:  Benign essential hypertension Anxiety Heart disease/CVD Mixed hyperlipidaemia Tobacco use Upper extremity edema,,,2,09/25/2019,,Y,,GABAPENTIN Itching SULFA (SULFONAMIDE ANTIBIOTICS) dry mouth IODINATED CONTRAST MEDIA shakes
0835895,09/25/2019,TX,12.0,12,,F,,After about five minutes of receiving Tdap and MCV patient began to have violent movements of arms and legs for a few seconds.  The patient was placed on a bed with her legs upright for fifteen minutes. When the fifteen minutes had past the patient was doing well and answering all questions.,,,,,,,,,Y,09/13/2019,09/13/2019,0,Blood Pressure 90/60,PVT,,None,None,None,,,2,09/25/2019,,Y,,None
0835896,09/25/2019,PA,1.0,1,.0,F,,"The night of the vaccination patient threw up and ran a fever of 103.4. The vomitting continued through the next 2 days along with extreme lethargy and the inability to walk. For the next week patient would not/could not hold her head upright, she was sleeping for 20hours a day and when she was awake she stared into space. She refuse to eat. She could not walk or climb which she had been doing for the last 4 months at that point. I took patient to the hospital about a week and a half after vaccination due to episodes of hypothermia, cyanosis, and the extreme lethargy. She also began having stomach distention shortly after discharge which continued for a month along with the cyanosis. The lethargy lifted after 2 weeks she began holding her head up again and slowly walking again. We began noticing personality trait differences as well. Increased appetite and mood swings which have not gone away",,,,,,,,,Y,04/05/2019,04/05/2019,0,Lumbar puncture to rule out gullian-barre and meningitis. Xray to look at her leg since she wasn't walking,UNK,,,,,,,2,09/25/2019,,,,Lactase
0835897,09/25/2019,NH,61.0,61,,F,,"Fever (102), chills, aches",,,,,,,,,N,09/24/2019,09/25/2019,1,,UNK,,None,None,None,Shingrix #1,,2,09/25/2019,,,,Sulfa
0835898,09/25/2019,OH,68.0,68,,F,,PATIENT RETURNED TO PHARMACY AFTER RECEIVING VACCINE APPROX 5 MINUTES PRIOR STATING SHE FELT LIGHT HEADED AND HAD AN UNUSUAL TASTE/COLDNESS IN HER MOUTH.  SHE SAT DOWN FOR 10-15 MINUTES UNTIL THE FEELING SUBSIDED THEN LEFT.,,,,,,,,,Y,09/25/2019,09/25/2019,0,,PHM,,"PROTONIX, THYROID REPLACEMENT MEDICATION, AND ANTIHISTAMINE AS NEEDED.",N/A; SEASONAL ALLERGIES,THYROID,,,2,09/25/2019,,,,PENICILLIN ONLY
0835899,09/25/2019,AZ,77.0,77,,F,,"Soon after immunization was administered pt's arm swelled at injection site. redness and swelling. pt did not complain of any pain. I called RN into exam room to examine site. Ice pack was placed on site to help with swelling, vitals were rechecked and pt was monitored by myself and RN until provider came into exam room. Pt complained of lightheadedness/feeling faint and sob. prior to injection pt complained of anxiety that was addressed in office visit wtih provider.",,,,,,,,,Y,09/25/2019,09/25/2019,0,,PVT,,"Metoprolol Succinate ER, Flonase, Metformin, Januvia, Voltaren Gel 1%, Zolpidem",dysphasia,"Diabetes, Thyroid Nodule, Hypertension, Hyperlipidemia, low TSH, Angina, Seasonal Allergies",,,2,09/25/2019,,Y,,"Codeine, Metformin ER"
0835900,09/25/2019,AR,62.0,62,,F,,"REDNESS AND SWELLING AT INJECTION SITE. UPPER ARM ON SIDE OF INJECTION HAD REDNESS STREAKING DOWN TO ELBOW, SWELLING UPPER ARM TO ELBOW, AND ""FEVER"". INJECTION WAS ON SATURDAY 9/21, REACTION WAS TUESDAY 9/24. WAS BETTER IN APPEARANCE ON WEDNESDAY 9/24 (LOOKED NORMAL TO ME ON INSPECTION). PATIENT SAID THIS DID NOT HAPPEN WITH FIRST INJECTION. DID NOT HAVE ANY OTHER REACTION ELSEWHERE ON BODY.",,,,,,,,,Y,09/21/2019,09/24/2019,3,,PHM,,,,,,,2,09/25/2019,,,,
0835901,09/25/2019,IL,61.0,61,,F,,"PT  HAD FEVER AND INJECTION SITE REACTION; SWELLING ON LEFT ARM. RECOMMENDED TO USE TYLENOL AND IBUPROFEN OTC; BENADRYL,25 AT BEDTIME AND CORTISONE CREAM.",,,,,,,,,N,09/20/2019,09/22/2019,2,N/A,PHM,,"TYLEONOL 500MG,IBUPROPFEN 200MG;BENADRYL 25MG; CORTISONE CREAM",N/A,N/A,,,2,09/25/2019,,,,ERYTHROMYCIN
0835902,09/25/2019,CO,82.0,82,,F,,Patient got red over entire body for 10 to 15 hours,,,,,,,,,Y,09/23/2019,09/23/2019,0,,PHM,,,,,,,2,09/25/2019,,,,
0835903,09/25/2019,TX,12.0,12,,M,,PATIENT FAINTED AFTER VACCINATION AND MOTHER STATED HE CONVULSED FOR A COUPLE OF SECONDS. PATIENT DID NOT SUSTAIN A HEAD INJURY AND REGAINED CONSCIOUSNESS ALMOST IMMEDIATELY.  PATIENT WAS TREATED AND TRIED TO GET UP ON FEET AFTER ABOUT 10 MINUTES BUT FAINTED AGAIN. MOTHER OPTED TO CALL AMBULANCE AND CHILD WAS TAKEN TO HOSPITAL.,,,,,,,,,U,09/24/2019,09/24/2019,0,NONE KNOWN,PUB,,NONE,NONE,NONE,,,2,09/25/2019,,,Y,NONE
0835904,09/25/2019,CO,36.0,36,,F,,After getting both the tdap and not sure which one and the flu vaccine I began to have extreme entire leg swelling daily.,,,,,,,,,N,09/19/2019,09/20/2019,1,,PVT,,None,None,None,,,2,09/25/2019,,,,None
0835905,09/25/2019,,59.0,59,,M,,Patient is under the age of 65 and was given a dose of Fluzone HD,,,,,,,,,,09/24/2019,09/24/2019,0,,UNK,,,,,,,2,09/25/2019,,,,
0835906,09/25/2019,NC,69.0,69,,F,,"Patient got the Pneumovax23 in her right arm. Per patient, her arm swelled up from her elbow to her shoulder and turned bright red and was warm to the touch. She also experienced headache, fatigue, and coughing. As of 9/25/19, symptoms are improving.",,,,,,,,,Y,09/22/2019,09/23/2019,1,none,PHM,,unknown,none,none,,,2,09/25/2019,,,,codeine - upset stomach
0835907,09/25/2019,KY,52.0,52,,F,,"Patient's left arm became red, swollen, warm to the touch, and had a rash form.",,,,,,,,,U,09/21/2019,09/24/2019,3,,UNK,,,,,,,2,09/25/2019,,Y,,
0835908,09/25/2019,VA,76.0,76,,F,,Patient's arm was red and swollen almost to the the elbow,,,,,,,,,N,09/23/2019,09/23/2019,0,Patient went to her primary care provider and he prescribed her antibotics,PHM,,None,None,None,,,2,09/25/2019,,Y,,None
0835909,09/25/2019,WV,75.0,75,,F,,"patient reported that a couple hours after the immunization, she started to eat a salad.  she then began to feel that her throat was swelling, tongue swelling and it was hard to breathe.  patient took a Benadryl capsule.   she didn't report to the pharmacy or the dr office until another day she called the pharmacy on 09/23 and I called the dr on 09/25",,,,,,,,,Y,09/22/2019,09/22/2019,0,none,PHM,,none,,,,,2,09/25/2019,,,,none
0835910,09/25/2019,MA,63.0,63,,M,,Gave HD dose to 63 year old patient inadvertedly,,,,,,,,,Y,09/22/2019,09/22/1956,,na,PHM,,na,na,na,,,2,09/25/2019,,,,na
0835911,09/25/2019,MO,64.0,64,,M,,"Pt reports eyes shifting really fast, eyes jumping, sleepy, fever, dizziness, jitters with flu shot.  He also recieved Boostrix and Pneumovax but attributes these side effects to the flu shot as they are similar to what he experienced years ago.   He is better today and expects to be fully recovered by tomorrow.",,,,,,,,,N,09/23/2019,09/24/2019,1,none,PHM,,"Carvedilol 6.25mg, chlorthalidone, valsartan 160mg, warfarin 1mg, atorvastatin 40mg.  Pt not available at time of reporting.",none that were reported.,pt not available at time of reporting.,"Flu shot, many years ago, had dizziness and jitters.",,2,09/25/2019,,,,none
0835912,09/25/2019,DC,8.0,8,,F,,Patient was nervous about getting her flu shot but did calm down to receive it while holding her moms hand.  I administered the shot and asked if she was ok and she said she was then I walked away.  Another patient in line told me that we had a problem and I walked over to her and she was laying on the floor and had urinated herself.  She was breathing but in and out of responsiveness.  She never stopped breathing nor did she show signs of anaphylaxis so I did not administer epinephrine.  I called 911 and they arrived and she alert and oriented and able to talk to them and they took her to the ER.,,,,,,,,,U,09/25/2019,09/25/2019,0,none,PHM,,unknown,None noted,None Noted,,,2,09/25/2019,,,Y,No allergies checked on consent form
0835913,09/25/2019,OH,85.0,85,,F,,Approximately 10 days following vaccination patient began to have nerve and mobility issues. Per the patient she was eventually diagnosis with Guillian-Barre syndrome.,,,,,Y,,,,Y,07/17/2019,07/27/2019,10,unknown,PHM,,"Levothyroxine, Lisinopril/Hydrochlorothiazide",Unknown,Unknown,,,2,09/25/2019,,,,"Aspirin, Macrobid"
0835914,09/25/2019,NC,75.0,75,,F,,Pain and redness at injection site on day of injection followed by significant swelling  and redness of elbow on same arm as injection site one day later. Patient reported no pain at elbow but only redness and swelling.,,,,,,,,,,09/24/2019,09/24/2019,0,,UNK,,,,,,,2,09/25/2019,,,Y,
0835915,09/25/2019,NM,70.0,70,,M,,"Mouth/throat tingling, chills/rigors, heart palpitations",,,,,,,,,Y,09/24/2019,09/24/2019,0,None,PHM,,"Xarelto, Metoprolol, Flecainide",None,Atrial fibrillation,,,2,09/25/2019,,,,None
0835916,09/25/2019,GA,72.0,72,,M,,"Patient states that the following day he noticed redness, numbness, and tightness in the arm but it has been improving. Patient still experiences some tightness and an ""unusual"" feeling.",,,,,,,,,N,09/18/2019,09/19/2019,1,,PHM,,"Ranitidine, atorvastatin",None,"Indigestion, partial arterial blockage",,,2,09/25/2019,,,,None
0835917,09/25/2019,,2.0,2,.8,M,,Fever of 100-101F and rash with irritability that lasted for three days.,,,,,,,,,,07/01/2019,07/06/2019,5,,UNK,,,,,,,2,09/25/2019,,,,
0835918,09/25/2019,AZ,38.0,38,,F,,Patient received vaccination on Sunday and called the pharmacy Wednesday morning reporting severe pain and difficulty lifting arm. Site was red/swollen and hot. Patient had to have assistance getting dressed as the pain was too severe to do on her own. She stated the pain began Tuesday evening and woke her from sleep due to severity.,,,,,,,,,U,09/22/2019,09/24/2019,2,Unknown. Patient was referred to her PCP for further care.,PHM,,unknown,none,unknown,,,2,09/25/2019,,Y,,No known
0835919,09/25/2019,,71.0,71,,F,,Redness and swelling,,,,,,,,,,09/22/2019,09/22/2019,0,,PHM,,,,,,,2,09/25/2019,,,Y,
0835920,09/25/2019,FL,71.0,71,,F,,joint and muscle pain in the arm of the vaccine for 1 day,,,,,,,,,Y,09/22/2019,09/22/2019,0,,PHM,,,,,,,2,09/25/2019,,,,
0835921,09/25/2019,NY,36.0,36,,F,,"lightheaded, nauseous, dizziness, rush of heat, throat swelling, congestion",,,,,,,,,Y,09/25/2019,09/25/2019,0,none,PHM,,"metformin, cyclosporine, zyrtec, levothyroxine, ranitidine",none,"VKH, diabetes, thyroid disease",,,2,09/25/2019,,,,none
0835922,09/25/2019,IN,55.0,55,,F,,PATIENT RECEIVED VACCINE ON 09/20/2019. PATIENT STATES FLU-LIKE SYMPTOMS AND AN ENLARGED INJECTION SITE REACTION THAT WORSENED UNTIL SHE VISITED HER PHYSICIAN ON 09/25/2019. PATIENT STATES THAT SHE RECEIVED PREDNISONE AND WAS ADVISED TO TAKE BENADRYL. SHE ALSO HAS A PRESCRIPTION FOR HYDROXYZINE IF NEEDED. PATIENT CONTACTED PHARMACY TO INFORM THEM OF ADVERSE REACTION. PHARMACIST HAS OFFERED ASSISTANCE TO PATIENT IF NEEDED. ALLERGY TO SHINGRIX HAS BEEN ADDED TO PATIENT PROFILE. PATIENT HAS BEEN ADVISED NOT TO RECEIVE THE SECOND DOSE OF SHINGRIX UNLESS DIRECTED BY PHYSICIAN.,,,,,,,,,U,09/20/2019,09/25/2019,5,,PVT,,,,,,,2,09/25/2019,,Y,,NO KNOWN DRUG ALLERGIES
0835923,09/25/2019,,54.0,54,,F,,"Patient had severe tenderness, swelling, hand 'shingle' looking hives come out on her body the same day as the injection.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,UNK,,Butorphanol Oxycodone,n/a,Chronic pain,,,2,09/25/2019,,,Y,Sulfasalazine
0835925,09/25/2019,TX,53.0,53,,F,,"Severe joint pain where I currently have arthritis, severe headache, flu-like muscle aches, chills, fatigue for approximately 24 hours.",,,,,,,,,Y,09/23/2019,09/24/2019,1,None,PHM,,"Centrum multi-vitamin, biotin, bupropion hcl, cyclobenzaprine",None,neck pain due to a fall,,,2,09/25/2019,,,,None
0835926,09/25/2019,AZ,66.0,66,,F,,"Nausea, terrible headache, feverish and very congested",,,,,,,,,Y,09/24/2019,09/25/2019,1,"none, did not seek medical attention",PHM,,No other drugs taken at time of vaccination,none,"arthritis, gout",09/2018  Prevnar 13,,2,09/25/2019,,,,None known
0835927,09/25/2019,GA,43.0,43,,F,,"At time of injection patient reports not feeling sick. Patient reports feeling pain and aches the next day after immunization at site of injection and around body. Patient reports symptoms of fever, headaches, and cramps. Patient later went to care clinic and was told she had symptoms of the flu and given a prescription for Tamiflu. Time course: 9/24/2019 immunization given at 11:47am. Patient reports symptoms started on 9/25/2019 at 6:00am and did not resolve. Patient went to prompt care around 6pm and given tamiflu prescription.",,,,,,,,,N,09/24/2019,09/25/2019,1,,PHM,,"Phentermine, Oxycodone, Alprazolam",,chronic ortho pain,,,2,09/25/2019,,,Y,no
0835928,09/25/2019,AZ,82.0,82,,F,,"Very sore upper left arm, nausea, very tired",,,,,,,,,Y,09/23/2019,09/23/2019,0,None,PHM,,"Multi vitamin, OTC allergy, fish oil",None,None,,,2,09/25/2019,,,,None
0835929,09/25/2019,GA,84.0,84,,F,,"Patient called the pharmacy on 9/25/19 and said she has been sick since the day she received her flu shot(9/19/19). She reported  nausea, vomiting, fever, chills, severe soreness at injection site, headache, and fatigue. She said shortly after she arrived home, the headache began (~1 hr after vaccination) then the others followed and lasted for days. She said she is feeling better now and ""on the mend."" She didn't reach out to her primary doctor, the pharmacist recommended for her to contact her doctor.",,,,,,,,,Y,09/19/2019,09/19/2019,0,Patient hasn't reached out to her doctor.,PHM,,"ASPIRIN, CRESTOR, LOSARTAN, & ATENOLOL",NO KNOWN ILLNESSES,BLOOD PRESSURE AND HIGH CHOLESTEROL,,,2,09/25/2019,,,,NKDA
0835930,09/25/2019,TX,82.0,82,,F,,"Patient Called reporting an ""itchy raised tangerine sized welp""  with itching radiating down to her left elbow.  She tried to apply an ice pack which helped a little with the swelling but not the itching.  She stated that she gets a pneumo shot every year and has never had a reaction before.",,,,,,,,,U,09/25/2019,09/25/2019,0,,PHM,,"ProAir Respiclick, Symbicort, Zyrtec","asthma, diabetes, COPD","Asthma, Diabetes, COPD",,,2,09/25/2019,,Y,,"Penicillin, Tree Pollen, and Grass"
0835931,09/25/2019,WA,52.0,52,,F,,"At about 11 pm I started shivering uncontrollably, couldn't get warm, took a hot bath, turned on my heater in bed and just kept shivering. In the morning I woke up with muscle aches, fatigue, wobbly legs and just overall exhaustion continuing throughout the day. Got shivery again mid-day and it's subsided for a while. Took OTC Tylenol and Advil.",,,,,,,,,N,09/24/2019,09/24/2019,0,,PHM,,20 mg. Citalopram multivitamin vitamin D Fish Oil Vitamin B12,a mild cold one week earlier for just one day.,Chronic pericarditis (in remission right now) Bicuspid aortic valve,,,2,09/25/2019,,,,Penicillin
0835932,09/25/2019,TX,59.0,59,,M,,"There hasn't been any adverse event reported.  This is to report to VAERS that the patient was given a High Dose vaccine at the age of 59.  Upon completion of the Flu Clinic it was discovered that a High Dose flu shot was given to a patient under the age of 65.  A patient aged 59 was given the High Dose.  We tried reaching out to the patient multiple times  but kept going to a voice mailbox that was not set up. Called patient around 12:20pm 9/25/19, 12:45pm  9/25/19, 1:20pm 9/25/19 and then again at 4:35pm on 09/25/2019.  We reached out to his MD and informed them of the situation. They said they would call if any questions.",,,,,,,,,U,09/25/2019,09/25/2019,0,"See Item 18, no adverse event reported",WRK,,Unknown.,N/A,Did indicate long term health condition but not specific,,,2,09/25/2019,,,,None listed
0835933,09/25/2019,MN,50.0,50,,F,,"I have been experiencing headache, ear pain, swollen glands, extreme fatigue, eye nerve pain, weakness, and dizziness for nearly 6 months beginning the day following the Shingrix booster.  I had Pleurisy for about a month about two weeks after the booster.  I had several months of not being able to control my body temperature.  I had several weeks of thyroid gland pain, even though an ultrasound was normal.   I have had numerous labs, imaging, doctor and specialist appointments plus the one ER visit for pleurisy.  I tested positive for the Epstein Barr Virus (negative Mono) and even though I've been on Prednisone for the past 5 weeks, my inflammation markers are still high and it only seems to be suppressing my symptoms for a bit until they increase the dose again.  There seems to be no hope in sight.",,,,,,,,Y,N,04/09/2019,04/10/2019,1,Same as above,PVT,,"Flonase, Zyrtec, Venlafaxine, Melatonin, Calcium with Vitamin D, Magnesium, Vitamin C",None,"Fibromyalgia, Arthritis",,,2,09/25/2019,,Y,Y,Almonds
0835934,09/25/2019,SD,57.0,57,,F,,"Patients arm became sore on the evening of the vaccination 9/23. Her arm was very sore on 9/24 and she could hardly move it. On 9/25/19, she noticed it started bruising; however, the soreness started to subside",,,,,,,,,U,09/23/2019,09/23/2019,0,none,PHM,,omeprazole 20- 2 qam; multivitamin; phentermine 37.5 qd; atorvastatin 10qd; diclofenac 1% gel,none,none,,,2,09/25/2019,,,,no known allergies
0835935,09/25/2019,WA,31.0,31,,F,,Patient complained of dizziness and feeling warm after immunization was administered. Patient passed out in chair.,,,,,,,,,Y,09/25/2019,09/25/2019,0,None,PHM,,Unknown,Unknown,Unknown,,,2,09/25/2019,,,,"Sulfa drugs, ciprofloxacin, naproxen, sumatriptan, sulfasalazine"
0836022,09/25/2019,,87.0,87,,F,,upset stomach                           dizzy                                        right arm hurt                            eye problem  HEADACHE today is 9/23/19 & my right arm is still black and blue where injected!,,,,,,,,,,08/31/2019,09/01/2019,1,,UNK,,,,,,,2,09/23/2019,,,,
0836023,09/25/2019,NJ,1.17,1,.2,F,,"Received vaccinations 9/10/19. On ~9/12/19 started losing her balance ""walking like a drunkard"" as per mother. falling, staggering. resolved slowly over the next 2 weeks. was only seen at PCP's office 9/25/19 when history was told. at that point she's almost totally resolved, so monitoring was recommended.",,,,,,,,,Y,09/10/2019,09/12/2019,2,,PVT,,0,teething,0,,,2,09/25/2019,,Y,,Soy / Milk sensitive (dairy)
0836024,09/25/2019,MN,35.0,35,,M,,"About 45 min after vaccine was given, patient felt dizzy, lightheaded & states ""not ok"".  an hour later feels more lightheaded & almost fainted,  was pale & diaphoretic.  Given Benadryl 50mg P.O. & to be followed on the next shift. Benadryl order 3x daily for 3 days  patient was called to medical but refused to be seen",,,,,,,,,U,09/23/2019,09/23/2019,0,None,OTH,,Remeron Buspar Omeprazole Pro-Air Sertraline,N/A,N/A,,,2,09/25/2019,,,,"Codiene, Vicodine"
0836041,09/25/2019,FL,10.0,10,,F,,Mom stated child had a rash all over x 48 hrs after vaccine was administered.,,,,,,,,,Y,05/13/2019,05/13/2019,0,None - Mom did not report till Sept,OTH,,Loratadine 10 MG QD,None,Allergic Rhinitis,,,2,09/25/2019,,,,Codeine
0836043,09/25/2019,CA,38.0,38,,F,,pt was sitting and given the injection.  She then complained that she had a hot sensation in her body which moved up to her head.   I laid her down and the sensation passed  vital signs remained normal  Unable to enter Manufacture GSK,,,,,,,,,Y,08/23/2019,08/23/2019,0,,OTH,,none,,ovarian cysts  back pain,,,2,09/20/2019,,Y,,denies
0836054,09/25/2019,FL,45.0,45,,F,,Cellulitis on Right Arm. Redness Around site. Reaction occurred on 9/22/19 (Adverse Reaction to Pneumovax 23),,,,,,,,,Y,09/21/2019,09/22/2019,1,Dr. visit,PVT,,NONE,NONE,Asthma,,,2,09/25/2019,,Y,,NONE
0836085,09/25/2019,MA,4.0,4,,M,09/18/2019,Large area of Redness on Entire (L) thigh spreading to entire thigh - hot to touch and swelling,,,,,,,,,,09/16/2019,09/17/2019,1,,PVT,PUB,,none,none,,,1,,,,,
0836086,09/25/2019,CA,62.0,,,F,09/18/2019,"Pain, redness and swelling on right arm. Rt eye swelling. Rt leg pain, rt cald and rt thigh aches.",,,,,,,,,Y,,,,PENDING,OTH,UNK,,N/A,N/A,,,1,,,,,
0836087,09/25/2019,NY,67.0,67,,F,,"Patient present to office on 9/25/19 with Redness, swelling and pain to Left upper arm.",,,,,,,,,U,09/23/2019,09/23/2019,0,N/A,PVT,,"Calcium + Vit D 600-800, naproxen, ezopiclone, citalopram, cyclobenzapine",,"Ostepoina, BL Hearing loss, Sciatica, insomnia, dressive disorder, GI reflux disease",,,2,09/25/2019,,,,N.K.D.A
0836088,09/25/2019,TN,41.0,41,,F,09/25/2019,Red Swollen area on Left Deltoid Warm to touch size of a Small orange. Use cool compresses. Take antihistamine etc Benadryl. Ibuprofen or Tylenol as needed.,,,,,,,,,Y,09/23/2019,09/24/2019,1,,PVT,PVT,,None,,,,1,,,,,
0836108,09/25/2019,PA,9.0,9,,M,,"Systemic rash, hives Started about 12 hrs after injections treated with Benadryl otc",,,,,,,,,,09/24/2019,09/24/2019,0,,PVT,,Albuterol PRN,none,Asthma,,,2,09/25/2019,,Y,,none
0836121,09/25/2019,IL,57.0,57,,F,,"3 DAYS AFTER iMMUNiZATiON, PT SAiD SiTE DEVELOPED A GOLF BALL SiZED LUMP ON THE RiGHT SiDE OF HER NECK AND A SMALLER LUMP ON THE LEFT SiDE. BUMPS ARE 3"" UNDER EACH EAR AND PAiNFUL. PT SOUGHT MEDiCAL ATTENTiON AND REPORTED THAT MD WAS UNSURE OF CAUSE BUT THOUGHT LYMPH NODES MiGHT BE iNVOLVED. NO TREATMENT GiVEN AT THAT TIME.",,,,,,,,,N,09/20/2019,09/23/2019,3,,PHM,,,,,,,2,09/25/2019,,Y,,
0836122,09/25/2019,WV,1.08,1,.1,F,,None stated.,,,,,,,,,,09/25/2019,,,,PVT,,,,,,,2,09/25/2019,,,,
0836124,09/25/2019,AZ,24.0,24,,F,,Redness/Swelling & Itchy on site area where vaccine was given. Also Right ear was itchy starting 09/25/2019 @ 10:00 AM.,,,,,,,,,,09/24/2019,09/24/2019,0,None,OTH,,None,None,None,,,2,09/25/2019,,Y,,None
0836125,09/25/2019,CA,71.0,71,,F,09/25/2019,Patient complained of pain after shot (immunization) could not lift her arm the night and had a,,,,,,,,,U,09/24/2019,09/24/2019,0,,OTH,OTH,,None,None,,,1,,,,,
0836126,09/25/2019,WI,72.0,72,,F,,Patient reported arm and shoulder pain that night of vaccine. Patient went to her doctor's clinic 9/25/19 and was told pain was probably from vaccine and should take OTC pain medication. Doctor says vaccine was probably given too close to shoulder. She came to the pharmacy today and told us about the visit.,,,,,,,,,N,09/10/2019,09/10/2019,0,,PHM,,,,,,,2,09/25/2019,,Y,,
0835936,09/26/2019,WA,67.0,67,,M,,Patient states that he has had ongoing pain and difficulty raising his arm following vaccination,,,,,,,,Y,,01/25/2019,01/25/2019,0,,PHM,,,,,,,2,09/26/2019,,Y,,
0835937,09/26/2019,MA,0.42,0,.4,M,,Influenza vaccine administered to patient under 6 months of age.,,,,,,,,,Y,09/24/2019,09/24/2019,0,none,PVT,,None,none,none,,,2,09/26/2019,,,,none
0835938,09/26/2019,,53.0,53,,F,,"Previously documented redness and pain at injection site, but had additional symptoms of pain upon raising arm above head, and neck pain as same side as injection.  Three days out, symptoms still exist, although I am able to raise arm above head without pain.",,,,,,,,,N,09/23/2019,09/23/2019,0,None,WRK,,"Restasis, Claritin, Acyclovir, Lysine, Lemon Bioflavinoids, VSL #3 (probiotic), D-5000, Selenium, Fish Oil, Detox Nutrients, FemGuard + Balance, Deproloft, Chlorophyll, Cal-Mag-Zinc, Wild Yam, Iron-C, Ashwaganda",None,"Hashimotos, Meinier's Disease",,,2,09/26/2019,,,,No
0835974,09/26/2019,VA,,,,U,,"No adverse effects reported; patient was administered two live vaccines outside of the minimum interval; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The concomitant medications included sterile diluent. Information about the patient's pertinent medical history, concurrent conditions and previous drug reactions or allergies was not provided.   On 15-JUN-2017, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) for prophylaxis (strength, route of administration, anatomical location, lot number and expiration date were unknown by the reporter).   On 06-JUL-2017, the patient was vaccinated with measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) for prophylaxis (strength, route of administration, anatomical location, lot number and expiration date were unknown by the reporter).  It was reported that the patient was vaccinated with two live vaccines outside of the minimum interval (inappropriate schedule of product administration).  No adverse effects were reported.",,,,,,,,,U,06/15/2017,07/06/2017,21,,UNK,,sterile diluent,,,,US0095075131909USA005029,2,09/25/2019,,,,
0835975,09/26/2019,IN,,,,M,,"Shortly after receiving Zostavax vaccine, suffered a stroke, hearing loss, and shingles.; Shortly after receiving Zostavax vaccine, suffered a stroke, hearing loss, and shingles.; Shortly after receiving Zostavax vaccine, suffered a stroke, hearing loss, and shingles.; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a male patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided.     In or around 2012, the pt was inoculated with a dose of zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, frequency, lot/batch # and expiration date were not reported).     On an unknown date, reported as ""shortly after receiving zoster vaccine live (ZOSTAVAX)"", the pt suffered a stroke (cerebrovascular accident), hearing loss (deafness), and shingles (herpes zoster). As a direct and proximate result of zoster vaccine live (ZOSTAVAX), pt symptoms had resulted in physical limitations not present prior to using it. Pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition.  As a result of the manufacture, marketing, advertising, promotion, distribution, and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.    The reporter considered the events to be related to zoster Vaccine Live (ZOSTAVAX).  The reporter considered the events to be disabling. Upon internal review, stroke, hearing loss were determined to be medically significant events.",,,,,,,,Y,N,,,,,UNK,,,Routine health maintenance,,,US0095075131909USA007255,2,09/25/2019,,,,
0835976,09/26/2019,IL,,,,U,,"On 11-SEP-2019, the patient was administered the second dose of MMR II after first dose of MMR II was administered on 20-AUG-2019; No adverse effect; On 11-SEP-2019, the patient was administered the second dose of MMR II after first dose of MMR II was administered on 20-AUG-2019; This spontaneous report has been received from nurse referring to a patient of unknown age and gender. The patient's concomitant medications included sterile diluent. The patient's current condition, pertinent medical history, drug reactions/allergies were not reported. On 20-AUG-2019, the patient was administered with first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (dose, strength, lot number, expiry date, frequency, route of administration were not reported) for prophylaxis. On 11-SEP-2019, the patient was administered with second dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) lot number R030806, expiry date 24-OCT-2020, therapy type rHA (dose, strength, frequency, route of administration were not reported) for prophylaxis (inappropriate schedule of product administration) (circumstance or information capable of leading to medication error). No adverse effects were reported. There was no product quality complaint present.",,,,,,,,,U,08/20/2019,09/11/2019,22,,UNK,,sterile diluent,,,,US0095075131909USA008370,2,09/26/2019,,,,
0835977,09/26/2019,WI,,,,F,,"no adverse effects; Received a dose of GARDASIL 9 on 8/26/2019 and discovered she was pregnant on 9/7/2019; This spontaneous prospective pregnancy report was received from a medical assistant concerning to a female patient of unknown age. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported.     On 26-AUG-2019, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (strength, dose, frequency and route of administration were not reported) (lot # R009614 has been verified to be a valid lot number for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast), expiration date reported and establish as 30-NOV-2020) , the patient discovered that she was pregnant on 07-SEP-2019 (exposure during pregnancy); the last menstrual period, date of conception and estimated date of delivery were not known. The pregnancy outcome was outcome pending.    No adverse event was reported.",,,,,,,,,U,08/26/2019,08/26/2019,0,,UNK,,,,,,US0095075131909USA008812,2,09/25/2019,,,,
0835978,09/26/2019,OH,,,,U,,"No adverse effects; that patient received first dose of Hepatitis A vaccine (unspecified name and manufacturer) in 2011 and second dose of Hepatitis A vaccine in 2017; This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.          On an unspecified date in 2011, the patient received the first dose of hepatitis a vaccine, inactivated (manufacture unknown) (dosage schedule, route, anatomical location, lot number and expiration date were not reported).   On an unknown date in 2017, the patient received the second dose of hepatitis a vaccine, inactivated (manufacture unknown) (inappropriate schedule of product administration) (dosage schedule, route, anatomical location, lot number and expiration date were not reported). No adverse effects reported.    The outcome of inappropriate schedule of product administration was unknown.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009283,2,09/25/2019,,,,
0835979,09/26/2019,CA,,,,U,,"an improperly stored dose of PEDVAX was administered to the patient on an unknown date; No adverse effects; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs, drug reactions and allergies was not provided.  On an unknown date, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) lot # N024570 and expiration date on 01-MAY-2020 (strength, route and anatomical location were not provided), for prophylaxis. The vaccine was exposed to a temperature below 36 degree fahrenheit (32.1F) during 8 hours. There was not previous temperature excursion. It was reported that digital data logger was involved. No adverse effects were reported.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009374,2,09/25/2019,,,,
0835980,09/26/2019,CA,,,,U,,"Improperly stored dose of GARDASIL 9 was administered to the patient on an unknown date; No adverse effects; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug allergies/reactions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # N022952, expiration date: 14-JUN-2020 (strength, dose, schedule and route of administration were unknown) for prophylaxis (product storage error). The vaccine underwent temperature excursion below 36-degree Fahrenheit: 32.1 Fahrenheit for a duration of 8 hours. There was no previous temperature excursion. There was an involvement of data logger. No product quality complaints (PQC) were involved.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009796,2,09/25/2019,,,,
0835981,09/26/2019,MD,,,,U,,"No adverse effects reported.; Nurse reports the administration of one dose of an improperly stored vaccine, ROTATEQ, to one patient; This spontaneous report was received from a Registered Nurse referring to an unspecified patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On 16-SEP-2019, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) per oral route with lot # R030924 and expiration date 10-JUL-2020  for prophylaxis.   The administered dose of vaccine experienced the temperature excursion of (0.24 C) (multiple) degrees Celsius for 5 hours and 30 min. There was a digital data logger invloved, but there was no previous temperature excursion. No adverse effects were reported.",,,,,,,,,U,09/16/2019,09/16/2019,0,,UNK,,,,,,US0095075131909USA011074,2,09/25/2019,,,,
0835982,09/26/2019,SC,,,,U,,"No adverse effects; patient was administered VAQTA post expiration; This spontaneous report was received from a Nurse Practitioner refers to a patient of unknown age. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 24-SEP-2019, the patient was vaccinated with 0.5 milliliter one dose of hepatitis a vaccine, inactivated(VAQTA) (lot # R027431, expiration date was reported as 09-SEP-2019, but upon internal validation established as 08-SEP-2019, 25/0.5 (units unspecified), anatomical location and route were not reported) post expiration for prophylaxis (expired product administered). No adverse effects reported. No product quality complaint involved. No additional information provided.",,,,,,,,,U,09/24/2019,09/24/2019,0,,UNK,,,,,,US0095075131909USA011985,2,09/26/2019,,,,
0835983,09/26/2019,NY,,,,F,,"Respiratory infection; Information has been received from a lawyer via a case in litigation (# 1711USA002107) referring to a currently  69 year old female patient. Information about concurrent condition, medical history and concomitant medication was unknown. In 2016 the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown, reported as Pneumonia vaccine) (strength, dose, route, lot# and expiration date not reported) for prophylaxis. On an unknown date, the patient experienced adverse reaction of respiratory infection. The outcome of respiratory infection was unknown. The reporter considered respiratory infection to be related to pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown, reported as Pneumonia vaccine).      Upon internal review, the event respiratory infection was determined to be medically significant.; Sender's Comments:  US-009507513-1711USA002107:",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA012076,2,09/26/2019,,,,
0835984,09/26/2019,NY,68.0,68,,F,,"Felt tired; Arm discomfort; Limited range of motion of arm; This case was reported by a pharmacist via call center representative and described the occurrence of arm discomfort in a 69-year-old female patient who received Herpes zoster (Shingrix) (batch number JC55P, expiry date 15th November 2021) for prophylaxis.   On 15th August 2019, the patient received the 2nd dose of Shingrix. On 16th August 2019, 1 days after receiving Shingrix, the patient experienced arm discomfort and joint range of motion decreased. On an unknown date, the patient experienced tiredness. On an unknown date, the outcome of the arm discomfort and joint range of motion decreased were not recovered/not resolved and the outcome of the tiredness was unknown.   It was unknown if the reporter considered the arm discomfort, joint range of motion decreased and tiredness to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and a day after began experiencing arm discomfort and limited range of motion of her arm. It had slightly improved but had not resolved. She also felt tired but feels tired normally. The reporter consented to follow up. The registered pharmacist agreed to follow up. This case is 2 of the 2 linked cases, reported by the same reporter.",,,,,,,,,N,08/15/2019,08/16/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0835985,09/26/2019,TX,,,,U,,"Bad Reaction; This case was reported by a consumer via call center representative and described the occurrence of ill-defined disorder in an unspecified number of  adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown.   It was unknown if the reporter considered the adverse event to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not applicable. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The reporter stated that, when she was at doctor's office with her husband for his regular follow up visit, the physician mentioned that some patients had a bad reaction to the first dose of Shingrix and they denied to get the second dose of Shingrix. No further details were provided.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0835986,09/26/2019,TX,,,,U,,"Felt like had the flu; This case was reported by a consumer and described the occurrence of influenza-like symptoms in a elderly patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vacination was not reported. The patient stated that, after vaccination with dose of Shingrix, felt like had the flu. The patient asked, if it was ok, that her husband wanted to get Shingrix shot at the same time of his flu shot. The patient stated that, her husband received Pneumovax, 2 weeks ago and said to wait 4 weeks to get Shingix shot.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0835987,09/26/2019,TN,,71,,U,,"Tiredness; This case was reported by a consumer and described the occurrence of tiredness in a elderly patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th September 2019, the patient received Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced tiredness. On an unknown date, the outcome of the tiredness was unknown.   It was unknown if the reporter considered the tiredness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The day before reporting, the patient received dose of Shingrix and experienced tiredness. The patient asked, how long should tiredness side effect last.",,,,,,,,,U,09/15/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0835988,09/26/2019,,,,,U,,"Muscle soreness; This case was reported by a consumer and described the occurrence of muscle soreness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th September 2019, the patient received Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced muscle soreness. On an unknown date, the outcome of the muscle soreness was unknown.   It was unknown if the reporter considered the muscle soreness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group of the patient was not reported, but selected as an adult as per vaccine indication. In the afternoon on the day of reporting, the patient received dose of Shingrix and experienced muscle soreness. The patient asked, how long did it typically last and when was it ok to exercise.",,,,,,,,,U,09/15/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0835989,09/26/2019,IN,,,,F,,"Fever; Felt tired; This case was reported by a nurse via call center representative and described the occurrence of fever in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced fever and tiredness. On an unknown date, the outcome of the fever and tiredness were unknown.   It was unknown if the reporter considered the fever and tiredness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The nurse reported that the OBGYN on staff reported a fever of 101.6F and that they felt tired the day after receiving the 2nd dose of Shingrix. The reporter consented to follow up.  The nurse did not have any specific data to report.",,,,,,,,,U,,,,"Test Name: Body temperature; Result Unstructured Data: Test Result: 101.6, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS201915,2,09/26/2019,,,,
0835990,09/26/2019,VA,59.0,59,,M,,"Rash; This case was reported by a physician via call center representative and described the occurrence of rash in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a month after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was recovering/resolving.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient developed a rash and had developed more within the last 3 to 4 days from the time of reporting. The reporter stated that the patient did not know the exact date of the vaccination nor the expiration date and lot number.",,,,,,,,,N,08/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0835991,09/26/2019,WI,,,,M,,"diarhea; Dizzy Spells; flu-like symptoms; increased heart rate, 106 bpm; Feeling weak; increased respiratory rate; injection site pain; injection site firmness; Injection Site Swelling; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 58-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included pneumococcal immunization.   On 10th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 10th September 2019, 12 hrs after receiving Shingrix, the patient experienced influenza-like symptoms, heart rate increased, feelings of weakness, respiratory rate increased, injection site pain, injection site induration and injection site swelling. On 11th September 2019, the patient experienced diarrhea and dizzy spells. The patient was treated with antihistamine (Anti Histamine). On an unknown date, the outcome of the influenza-like symptoms, heart rate increased, respiratory rate increased and diarrhea were resolved with sequelae and the outcome of the feelings of weakness, injection site pain, injection site induration, injection site swelling and dizzy spells were recovering/resolving.   It was unknown if the reporter considered the influenza-like symptoms, heart rate increased, feelings of weakness, respiratory rate increased, injection site pain, injection site induration, injection site swelling, diarrhea and dizzy spells to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient stated that 12 hours later vaccination experienced flu like symptoms, increased heart rate, feeling weak, increased respirator rate, and injection site pain, swelling and firmness. The patient stated that after 24 hours of vaccination experienced diarrhea and dizzy spells. At the time of reporting all events resolved except feeling weak, injection site pain, injection site induration and injection site swelling. The patient stated that he went to healthcare professional regarding the events experienced and was told to take over the counter anti histamines. The healthcare professional told to avoid future pneumonia and all vaccines. The patient consented to follow up.",,,,,,,,,N,09/10/2019,09/10/2019,0,"Test Date: 20190910; Test Name: Heart rate; Result Unstructured Data: Test Result: 106 bpm, Test Result Unit: bpm",UNK,,,Pneumococcal immunization,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,Y,,
0835992,09/26/2019,WA,63.0,63,,F,,"redness at injection site; swelling at injection site / swelling; warm to the touch / warmness at injection site; fever; sore arm / arm soreness; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 63-year-old female patient who received Herpes zoster (Shingrix) (batch number 249DB, expiry date 8th November 2021) for prophylaxis.   On 11th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 12th September 2019, 1 days after receiving Shingrix, the patient experienced injection site erythema, injection site swelling, injection site warmth, fever and pain in arm. On an unknown date, the outcome of the injection site erythema, injection site swelling, injection site warmth, fever and pain in arm were recovering/resolving.   It was unknown if the reporter considered the injection site erythema, injection site swelling, injection site warmth, fever and pain in arm to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in right arm. The reporter reported that one day after receiving dose 1 of Shingrix, the patient experienced redness at injection, warmness at injection site, arm pain, arm soreness, fever, and swelling. The patient went to urgent care and was given unspecified medications. The symptoms were improving. The reporter consented to follow up.",,,,,,,,,N,09/11/2019,09/12/2019,1,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,Y,
0835993,09/26/2019,WI,,,,U,,"Bump located a couple inches below the injection site; Warm bump; Red bump; This case was reported by a nurse via sales rep and described the occurrence of injection site swelling in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 5 days after receiving Shingrix, the patient experienced injection site swelling, injection site warmth and injection site erythema. On an unknown date, the outcome of the injection site swelling, injection site warmth and injection site erythema were unknown.   It was unknown if the reporter considered the injection site swelling, injection site warmth and injection site erythema to be related to Shingrix.  Additional case details were reported as follows: The healthcare professional did not provide patient demographics, lot number, or expiration date of vaccine. The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  The patient experienced a bump approximately five days after receiving dose one of Shingrix. The healthcare professional described bump as being located a couple inches below the injection site, 1.5 inches in diameter, warm, and red.  The outcome for bump was unknown.",,,,,,,,,U,,,,,PVT,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0835994,09/26/2019,TX,62.0,61,,F,,"warmth to touch; injection site reaction; knot at injection site; body aches; This case was reported by a pharmacist via call center representative and described the occurrence of injection site reaction in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th June 2019, the patient received the 1st dose of Shingrix (intramuscular). On 27th June 2019, 1 days after receiving Shingrix, the patient experienced injection site reaction, injection site lump and general body pain. On 7th September 2019, the patient experienced skin warm. On an unknown date, the outcome of the injection site reaction, injection site lump, general body pain and skin warm were recovered/resolved.   It was unknown if the reporter considered the injection site reaction, injection site lump, general body pain and skin warm to be related to Shingrix.  Additional case details were provided as follows: The patient received Shingrix in left deltoid. On 27th June 2019 and day after Shingrix, the patient experienced injection site reaction. On 7th September 2019, the patient reported, she felt as she developed a delayed injection site reaction. All the events had resolved. The reporter did not consent to follow-up.",,,,,,,,,Y,06/26/2019,06/27/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0835995,09/26/2019,TN,69.0,69,,F,,"Inappropriate schedule of vaccine; shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 20th June 2018, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. In July 2019, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional case details were provided as follows: The patient reported for herself. In July 2019, the patient developed shingles after receiving one dose of Shingrix.  The patient forgot to receive the 2nd dose according to the recommended dosing schedule and till the time of reporting she did not receive the 2nd dose, which led to incomplete course of vaccination. The patient did not consent to follow-up.",,,,,,,,,U,06/20/2018,07/01/2019,376,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0835996,09/26/2019,OR,71.0,71,,M,,"fever; rigors; myalgia; fatigue; huddled down in bed; headaches; shaking; This case was reported by a physician via call center representative and described the occurrence of fever in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax (received vaccine on an unknown date).   On 4th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 4th September 2019, 21 hrs after receiving Shingrix, the patient experienced fever, rigors, myalgia, fatigue, bedridden, headache and tremor. On an unknown date, the outcome of the fever and rigors were unknown and the outcome of the myalgia, fatigue, bedridden, headache and tremor were recovered/resolved.   It was unknown if the reporter considered the fever, rigors, myalgia, fatigue, bedridden, headache and tremor to be related to Shingrix.  Additional details were provided as follows: The patient stated that after receiving vaccine experienced fever that felt like rigors and a lot of myalgia that was preceded by fatigue. The patient was huddled down in bed. The patient lost the whole next day because of the myalgia and fatigue. By that afternoon he went home and crawled into bed and  significant shaking and fever started. The patient also experienced headache and was gone by the next morning. The patient slept 17 hours in total. The shaking lasted about a good 3 hours. The patient consented to follow up.",,,,,,,,,Y,09/04/2019,09/04/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0835997,09/26/2019,FL,,,,U,,"Cellulitis; Welts/ welts on their arm; Swelling/ arm swelled up pretty big; allergic reaction; This case was reported by a pharmacist via call center representative and described the occurrence of cellulitis in a patient who received HAV (Havrix) for prophylaxis.   Concomitant products included PNEUMOCOCCAL VACCINE (PNEUMOVAX-23).   On 17th September 2019, the patient received Havrix. On an unknown date, less than a week after receiving Havrix, the patient experienced cellulitis (serious criteria GSK medically significant), welts, swelling arm and allergic reaction. On an unknown date, the outcome of the cellulitis, welts, swelling arm and allergic reaction were unknown.   It was unknown if the reporter considered the cellulitis, welts, swelling arm and allergic reaction to be related to Havrix.  Additional details were provided as follows: The age at vaccination not reported at time of report. The pharmacist gave a patient Pneumovax-23 and Havrix in the same arm, then the patient developed what sounds like an allergic reaction.  They had welts on their arm, cellulitis, and the arm swelled up pretty big. The patient's physician told them the reaction was due to bacteria build up because the vaccines were given in the same arm. The reporter stated that vaccines given in their own syringes in separate sites, but in the same arm.  The reporter gave the vaccines at a clinic she ran at the location indicated under vaccine facility details; however, she works out of the address for the contact profile. The reporter does not have any further information, she does not even know who the patient was at this time. Same information as passed along to her. The reporter was consented to follow up.",,,,,,,,,U,09/17/2019,,,,UNK,,PNEUMOVAX-23,,,,USGLAXOSMITHKLINEUS201917,2,09/26/2019,,,,
0835998,09/26/2019,OK,78.0,78,,M,,"seizure; This case was reported by a consumer via call center representative and described the occurrence of seizure in a 78-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th September 2019, the patient received the 1st dose of Shingrix (intramuscular). In September 2019, less than a week after receiving Shingrix, the patient experienced seizure (serious criteria hospitalization and GSK medically significant). On an unknown date, the outcome of the seizure was recovered/resolved.   It was unknown if the reporter considered the seizure to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's wife. The patient experienced a seizure for which he was hospitalized. On 20th September 2019, the patient was discharged from the hospital. The reporter consented to follow up.",,,,,Y,3,,,Y,09/17/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/26/2019,,,,
0835999,09/26/2019,CA,,,,U,,"Shingles after 1st dose of Shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The pharmacist reported that, the patient experienced Shingles after vaccination with dose of Shingrix. The reporter did not have patient information and expiry date of Shingrix at the time of call. The reporter consent to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/26/2019,,,,
0836000,09/26/2019,,,,,U,,"Suspected vaccination failure; influenza A(H3N2); acute respiratory illness; This case was reported in a literature article and described the occurrence of suspected vaccination failure in a adult patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, less than a year after receiving Flu vaccine, the patient experienced vaccination failure (serious criteria hospitalization and GSK medically significant), h3n2 influenza (serious criteria hospitalization) and respiratory disorder (serious criteria hospitalization). On an unknown date, the outcome of the vaccination failure, h3n2 influenza and respiratory disorder were unknown.   It was unknown if the reporter considered the vaccination failure, h3n2 influenza and respiratory disorder to be related to Flu vaccine.  Additional details were reported as follows: This case was reported in a literature article and described the suspected vaccination failure in a patient aged between 22 and 63 years of unspecified gender, who was vaccinated with unspecified influenza vaccine (manufacturer unknown) for prophylaxis.  The patient was a part of the study that aimed was to compare antibody titers against both circulating influenza A (H3N2) strains and egg-adapted influenza A (H3N2) strains in acute specimens from individuals with and those without influenza virus infection in the 2017-2018 season. During the severe 2017-2018 influenza season, a study of the effectiveness of influenza vaccine among inpatients with acute respiratory illness as part of the Centers for Disease Control and Prevention (CDC)-sponsored Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) was performed. No information on patient's medical history, family history, concurrent condition or concomitant medication was provided. On unspecified date, during 2017-2018 influenza season, the patient received unspecified influenza vaccine (administration route and site unspecified; dosage unknown; batch number not provided). The age at vaccination was not provided. [In this study, there were 18 individuals who had been vaccinated, and the specific influenza vaccine they received could be confirmed for 15. All 15 individuals with confirmed vaccine product information received vaccines containing inactivated egg-grown virus; 10 received quadrivalent standard-dose vaccines (9 vaccines were produced by GlaxoSmithKline, and 1 was produced by Seqirus), 3 received trivalent high dose vaccines (produced by Sanofi Pasteur), 1 received trivalent adjuvanted vaccine (produced by Seqirus), and 1 received trivalent unadjuvanted vaccine (produced by Seqirus)]. On an unspecified date, during 2017-2018 influenza season, between 27 November 2017 and 31 January 2018, an unknown period after the vaccination, the patient developed acute respiratory illness and subsequently hospitalized. The patient was enrolled less than or equal to 10 days after illness onset during active influenza virus circulation. The patient's throat and nasal swab specimens were collected shortly for influenza virus identification by reverse transcription polymerase chain reaction (RT-PCR) analysis. The patient was found influenza A(H3N2) Positive. The patient's antibody titers were also measured with neuraminidase-inhibition (NAI) and Microneutralization (MN) assays was determined. The microneutralization (MN) egg propagated A/HongKong/4801/2014 (HK-egg) antibody titer was found 160, MN MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 20, MN MDCK-SIAT1 propagated A/Washington/16/2017 (WA) antibody titer was found 10, MN MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was 10, MN MDCK-SIAT1 propagated A/Maryland/53/2017 (MD) antibody titer was found 10, MN MDCK-SIAT1 propagated A/Wisconsin/327/2017 (WI) antibody titer was found 10, neuraminidase-inhibition (NAI) MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 10 and NAI MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was found 10 in patient. The genetic characterization of Influenza A(H3N2) virus strains circulating in patient sample was also determined (results not provided). This case has been considered as suspected vaccination failure being the time to onset was unknown. This case has been considered as serious due to suspected vaccination failure and hospitalization. Treatment was unknown. The outcome of the event was not reported. The author did not comment on the relationship between the event of influenza A (H3N2) infection and unspecified influenza vaccine. However, the authors stated, ""This analysis of specimens from adults hospitalized with influenza A(H3N2) virus infection during the 2017-2018 influenza season demonstrated an antibody response specific to egg-adapted strains that was significantly higher among vaccinated individuals. In our study sample, this suggests that the antibody responses to vaccination in this population are highly specific to the egg-adapted strain, with little cross-reactivity to the circulating virus.Additionally, antibody titers against cell-grown influenza A/HongKong/4801/2014(H3N2) virus were similar to those in unvaccinated individuals. In this study sample, this suggests that the antibody responses to vaccination in this population are highly specific to the egg-adapted strain, with little cross-reactivity to the circulating virus. In this study, antibody against the neuraminidase of influenza A/HongKong/4801/2014 virus and influenza A/Singapore/INFIMH-16-0019/2016 virus was not associated with protection against infection. Although neuraminidase content was not standardized in influenza vaccines, it was observed that anti-neuraminidase antibody titers were higher among vaccinated individuals, suggesting that some of the existing anti-neuraminidase antibody in this population resulted from vaccination. The serum specimens in this study were collected at a single time point early during acute illness."" The authors concluded, ""The conclusions were limited by the inclusion of a small number of specimens from a single hospital. Because the severity of the 2017-2018 epidemic was evident early in the season, it was prioritized rapid serologic testing of the specimens that were available to date during the first half of the season. These 2 factors may limit the broad generalizability of the results; however, the influenza viruses that circulated locally overall and during the analysis period were similar to those that predominated nationwide during the same season. The small sample size also precluded the ability to perform additional subanalyses, to assess whether results might vary within specific age groups or by history of prior vaccination. In one sense, the 2017-2018 influenza vaccine appears to have worked as intended: vaccinated individuals had high antibody titers against the influenza virus strain included in the vaccine. The study adds to the evidence that egg adaptations in the 2017-2018 influenza vaccine strain elicited antibodies to epitopes not conserved in circulating strains. The degree to which this contributed to the marked severity of the 2017- 2018 season remains to be determined. Several vaccine products have been introduced into the vaccine market that are produced in cells and do not have the same emergent egg adaptations seen in recent influenza A(H3N2) vaccine strains. At this time, evidence for the effectiveness of these vaccines relative to those produced in eggs is limited because few head-to-head trials have been performed. Early data suggest that cell-based vaccines have somewhat improved protection in clinical trials and in the community. Unfortunately, these vaccines are still dependent on selecting viruses that are close antigenic matches to those that will circulate and are subject to the limitations of annual strain selection time lines. This underscores the need for the development of the next-generation of influenza vaccines that provide better, broader, and longer-lasting protection."" This is 1 of the 4 valid cases reported in the same literature article.      Lab Comments: On an unspecified date, during 2017-2018 influenza season, between 27 November 2017 and 31 January 2018, the lab test were performed. The patient's throat and nasal swab specimens were collected shortly for influenza virus identification by reverse transcription polymerase chain reaction (RT-PCR) analysis.  The patient was found influenza A(H3N2) Positive. The patient's antibody titers were also measured with neuraminidase-inhibition (NAI) and Microneutralization (MN) assays was determined. The microneutralization (MN) egg propagated A/HongKong/4801/2014 (HK-egg) antibody titer was found 160, MN MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found 20, MN MDCK-SIAT1 propagated A/Washington/16/2017 (WA) antibody titer was found 10, MN MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was 10, MN MDCK-SIAT1 propagated A/Maryland/53/2017 (MD) antibody titer was found 10, MN MDCK-SIAT1 propagated A/Wisconsin/327/2017 (WI) antibody titer was found 10, neuraminidase-inhibition (NAI) MDCK-SIAT1 propagated A/HongKong/4801/2014 (HK) antibody titer was found  10 and NAI MDCK-SIAT1 propagated A/Singapore/Infimh-16-0019/2016 (SG) antibody titer was found 10 in patient. The genetic characterization of Influenza A(H3N2) virus strains circulating in patient sample was also determined (results not provided).",,,,,Y,,,,U,,,,"Test Name: Gene sequencing; Result Unstructured Data: Test Result: See text, Test Result Unit: unknown; Test Name: Polymerase chain reaction; Result Unstructured Data: Test Result: influenza A(H3N2) Positive, Test Result Unit: unknown",UNK,,,,,,USID BIOMEDICAL CORPORATI,2,09/25/2019,,,,
0836002,09/26/2019,Fl,16.0,,,F,,"patient fainted in the room; This is a spontaneous report from a contactable nurse received via a Pfizer sales representative. A 16-year-old female patient received meningococcal group b rlp2086 (TRUMENBA, Lot# AN2721 and Exp. 20Apr2021, 1st dose), hpv vaccine and meningococcal vaccine a/c/y/w conj (dip tox) (MENACTRA); all via unspecified routes of administration on 16Sep2019 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. Three minutes after being vaccinated on 16Sep2019, the patient fainted in the room. After a few minutes of resting in the room she was allowed to walk out with parent and fainted again at checkout. Outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, as appropriate. The case will be reassessed if additional information becomes available.",,,,,,,,,U,09/16/2019,09/16/2019,0,,UNK,,,,,,USPFIZERINC2019412784,2,09/25/2019,,,,
0836003,09/26/2019,FL,17.0,,,M,,"Fainted; Shake hands; Spasm; This is a spontaneous report from a contactable nurse received via a Pfizer sales representative. A 17-year-old male patient received meningococcal group b rlp2086 (TRUMENBA, lot number and expiration date unknown), via an unspecified route of administration in late Aug2019 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient fainted within seconds of being given only meningococcal group b rlp2086 in late Aug2019, after a min or so patient woke and started to spasm and shake hands violently. He was restrained and within 30 seconds or so the patient settled down and after a few minutes of being stable was allowed to leave. The events recovered on an unspecified date.  No follow-up attempts are possible, information on the lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, as appropriate. The case will be reassessed if additional information becomes available.",,,,,,,,,Y,08/01/2019,08/01/2019,0,,UNK,,,,,,USPFIZERINC2019413054,2,09/25/2019,,,,
0836004,09/26/2019,HI,,,,U,,"exposed to 1.8 C for 1 hour 54 minutes and 1.9 C; Based on additional information received on 27-AUG-2019, case was upgraded to Valid from Non-Valid because patient was involved.  Initial information received on 06-Aug-2019 regarding an unsolicited non-valid non-serious case received from a nurse.  It was reported that vaccines DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL], DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] and HIB (PRP/T) VACCINE [ACT-HIB] exposed to 1.8 c for 1 hour 54 minutes and 1.9 c. It was reported that a patient received Act-Hib but did not produce any adverse event.  Patient's  medical history and concomitant therapies were not reported.  It was of actual medication error due to incorrect product storage..  It was reported that no adverse event was noticed post vaccination with Act-Hib.  Information on the batch number was requested  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.  Follow-up information received on 27-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  Case was upgraded to valid. Significant information in Case was updated.  Information on the batch number was requested",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA219367,2,09/25/2019,,,,
0836005,09/26/2019,,18.0,,,M,,"administered an Expired Menactra to a patient. Expired December 2018/ No AE; Based on information received on 18-SEP-2019, the report previously considered as non-valid became valid: patient identifier reported.  Initial information received on 07-Aug-2019 regarding an unsolicited valid non-serious case received from a non-health care professional (office staff).  This case involves 18 years old male patient (195 cm and 112.925 kg) who was vaccinated with 0.5 mL dose of expired vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] lot U5766AE, expiry date- 02-Dec 2018 via intramuscular route in the right arm on 07-AUG-2019.  The patient's medical history and concomitant medications were not reported.  It was an actual medication error case due to expired vaccine used.  No adverse event occurred post vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Follow-up information was received on 18-SEP-2019 from Consumer/Non-HCP (practice manager).  Case validity, patient details, lot number, expiry date, dose, route and site of administration updated in field and narrative.  List of documents held by sender: none.",,,,,,,,,U,08/07/2019,,,,UNK,,,,,,USSA2019SA224694,2,09/25/2019,,,,
0836006,09/26/2019,CA,,18,,M,,"erythema, redness and swelling that went from the upper arm into the axillary area; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 18 years old male patient who experienced erythema, redness and swelling that went from the upper arm into the axillary area (Inflammation), while he received vaccines MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] and HEPATITIS B VACCINE .  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 12-Sep-2019, the patient received a 0.5 mL dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U6179AA via intramuscular route in the left deltoid and a dose of suspect HEPATITIS B VACCINE (HEPATITIS B VACCINE) lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious erythema, redness and swelling that went from the upper arm into the axillary area (inflammation) (Unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and HEPATITIS B VACCINE.  Other relevant tests were not reported.  Final diagnosis was erythema, redness and swelling that went from the upper arm into the axillary area.  It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for erythema, redness and swelling that went from the upper arm into the axillary area.  List of documents held by sender: none.",,,,,,,,,U,09/12/2019,,,,UNK,,,,,,USSA2019SA262417,2,09/25/2019,,,,
0836007,09/26/2019,MA,,,,M,,"52 year old male had a Fluzone HD, no side effects; 52 year old male had a Fluzone HD, no side effects; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 52 years old male patient who was vaccinated with a dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (dosage form: prefilled syringe) lot UJ241AB expiry date: 18-Apr-2020 via unknown route in the left deltoid on 18-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No other vaccine was given.  It is an actual medication error case due to inappropriate age of vaccine administration and overdose.   It was reported that the patient did not had any side effects.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/18/2019,,,,UNK,,,,,,USSA2019SA262430,2,09/25/2019,,,,
0836008,09/26/2019,MA,,49,,F,,"A 49 year old patient was inadvertently given the Fluzone High Dose vaccine; A 49 year old patient was inadvertently given the Fluzone High Dose vaccine; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 49 years old female patient received 0.5 mL dose of vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ253AB via unknown route in unknown administration site on 17-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No other vaccines received.   It was a case of actual medication error due to Inappropriate age at vaccine administration and overdose.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/17/2019,,,,UNK,,,,,,USSA2019SA262432,2,09/25/2019,,,,
0836009,09/26/2019,,,,,F,,"Vaccine given outside of indication/no AE; Vaccine given outside of indication/no AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves female patient of an unknown age who received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ253AB via unknown route in unknown administration site on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to Inappropriate age at vaccine administration and overdose.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA262513,2,09/25/2019,,,,
0836010,09/26/2019,TX,9.0,9,,F,,"9 year old female patient was inadvertently administered with Flublok vaccine, no AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked with case 2019SA262697 (same reporter)  This case involves a 9 years old female patient who was inadvertently received a 0.5 ml dose of vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (lot QFAA1913, expiry date: 29-Jun-2020) via intramuscular route in the deltoid NOS on 16-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE VLP RL1 9V (YEAST) (GARDASIL 9) on 16-Sep-2019, for Immunisation.  It was an actual medication error due to inappropriate age at vaccine administration.  Flublok is not FDA-approved for use in pediatric patients. Nurse stated that neither patient has experienced any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/16/2019,,,,UNK,,GARDASIL 9,,,,USSA2019SA262695,2,09/25/2019,,,,
0836011,09/26/2019,TX,11.0,11,,F,,"11 year old patient inadvertently administered the Flublok vaccine, no AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked with case 2019SA262695 (same reporter)  This case involves a 11 years old female patient who was inadvertently received a 0.5 ml dose of vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (lot QFAA1913, expiry date: 29-Jun-2020) via intramuscular route in the deltoid NOS on 16-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE VLP RL1 9V (YEAST) (GARDASIL 9); MENINGOCOCCAL VACCINE A/C/Y/W CONJ (DIP TOX) (MENACTRA); and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, TETANUS VACCINE TOXOID (ADACEL) on 16-Sep-2019 for Immunisation.  It was an actual medication error due to inappropriate age at vaccine administration.  The patient had no adverse event at the time of this report.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/16/2019,,,,UNK,,GARDASIL 9; MENACTRA; ADACEL,,,,USSA2019SA262697,2,09/25/2019,,,,
0836012,09/26/2019,TX,70.0,70,,F,,"70 year old was given Adacel vaccination, no AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 70 years old female patient who received 0.5 ml dose vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] lot number not reported via unknown route in unknown administration site on 17-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included INFLUENZA VACCINE (INFLUENZA VACCINE) for Immunisation.  It was an actual medication error case due to inappropriate age at vaccine administration.  It was reported that a 70 year old was given Adacel vaccination because her daughter is expecting, and it was recommended that as a grandmother she receive Tdap.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,09/17/2019,,,,UNK,,INFLUENZA VACCINE,,,,USSA2019SA262847,2,09/25/2019,,,,
0836013,09/26/2019,OH,,,,M,,"a six month old male patient received only the Pentacel liquid Dtap IPVcomponent without mixing the powder HIB/No AE; Initial information and additional information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 6 months old male patient who only the pentacel liquid dtap ipv component without mixing the powder hib while receiving vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] lot U6397AA, expiry date: 29-Sep-2020, dose: 0.5 ml via intramuscular route in the left thigh on 18-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVENAR) and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE).  It was an actual medication error due to inappropriate reconstitution technique.  Symptoms: None reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/18/2019,,,,UNK,,PREVENAR; ROTAVIRUS VACCINE,,,,USSA2019SA263410,2,09/25/2019,,,,
0836014,09/26/2019,,,,,F,,"gave a tetanus shot (which did hurt); Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional.  This case involves a 72 years old female patient who gave a tetanus shot (which did hurt) (injury), while she received vaccine TETANUS TOXOID.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect TETANUS TOXOID produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date following the vaccination the patient experienced injury (injury).  It was reported that physician put her on antibiotics in the emergency room.  (Other relevant tests included no lab data.) Final diagnosis was injury.   It was not reported if the patient received a corrective treatment.  The outcome of the event was unknown at the time of reporting.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA264366,2,09/25/2019,,,Y,
0836015,09/26/2019,,,,,U,,"unable to administer full 0.5 mL to patient. Tried miltiple syringes, needles, etc. Having no trouble administering other vaccines/ No AE; unable to administer full 0.5 mL to patient. Tried multiple syringes, needles, etc. Having no trouble administering other vaccines/ No AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves patient who unable to administer full 0.5 ml vaccine INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] lot number not reported via unknown route in unknown administration site on an unknown date, tried multiple syringes, needles.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of vaccine underdose and Liquid product flow abnormal. Staff unable to administer full 0.5 mL to patient. Tried multiple syringes, needles, etc. Having no trouble administering other vaccines.  At the time of report no adverse event was reported.  Information on the batch number was requested.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA264579,2,09/25/2019,,,,
0836016,09/26/2019,,,,,U,,"high fever; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 2 months old patient who experienced high fever (pyrexia), while received vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a first  dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious high fever (pyrexia) (Unknown latency) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE.  (Other relevant tests included no lab data.) Final diagnosis was high fever.  It was not reported if the patient received a corrective treatment.  On an unknown date, the event outcome is reported as Recovered for high fever.  Information on the batch number was requested.  Documents held by sender: none.",,,,,,,,,Y,,,,,UNK,,,,,,USSA2019SA264629,2,09/25/2019,,,,
0836017,09/26/2019,,,,,F,,"feeling itchy; redness to left deltoid of injection site which then spread to left shoulder and across chest; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case involves an unknown age female patient who experienced feeling itchy (pruritus) and redness to left deltoid of injection site which then spread to left shoulder and across chest (erythema), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UJ209AA via unknown route in the left arm.  On an unknown date, the patient experienced a non-serious feeling itchy (pruritus) and redness to left deltoid of injection site which then spread to left shoulder and across chest (erythema) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Patient remained in clinic for 15 minutes after injection of DECADRON.  (Other relevant tests included no lab data.)  Final diagnosis was redness to left deltoid of injection site which then spread to left shoulder and across chest and feeling itchy.   The patient was treated with 150 mg twice daily RANITIDINE HYDROCHLORIDE (ZANTAC) and 8 mg DEXAMETHASONE ACETATE (DECADRON A) to left dorogluteal.  The patient outcome was not reported for redness to left deltoid of injection site which then spread to left shoulder and across chest and feeling itchy.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA264721,2,09/25/2019,,,,
0836018,09/26/2019,NH,74.0,74,,F,,"Patient received vaccine on 7/10/19. She reports waking up with polyarthralgias in ""all joints"" a few days later, not sure of exact date, but it was within a week of receiving vaccine. She described this as an aching feeling and stiffness, improved during day, worsened after sleeping. This lasted for 3.5 weeks, resolving in mid-August. She had no joint redness or swelling. No fever, rash or other symptoms. Aching joint pain and stiffness completely resolved, except for aching pain in her left knee. She sought medical care on 9/25/19 for her left knee. She is also an avid golfer, which may be contributing to left knee symptoms. Her exam was normal, x-ray is pending. She has been referred to physical therapy for her knee.",,,,,,,,,Y,07/10/2019,07/15/2019,5,none,PVT,,None,None,"PMH of migraines, sleep apnea, colon polyps, gilbert syndrome, uterine fibroids, cataracts, basal cell carcinoma of face",,,2,09/26/2019,,,,"Cephalosporins, Cephalexin, Pencillins"
0836019,09/26/2019,,65.0,65,,F,,"Rash, fever,chills",,,,,,,,,,09/22/2019,09/23/2019,1,,UNK,,,,,,,2,09/26/2019,,,,
0836020,09/26/2019,SC,76.0,76,,M,,PATIENT WAS UNABLE TO LIFT ARM AND HAD A FAINTING SPELL LATER THAT EVENING AT DINNER TIME,,,,,,,,,,09/19/2019,09/19/2019,0,,PHM,,,,,,,2,09/26/2019,,,Y,
0836021,09/26/2019,PA,17.0,17,,M,,"Patient received Menactra booster, HPV 9, Bexsero (MEN B) vaccines.  After HPV vaccine administered, patient became stiff and eyes became dilated; lasted approx.4-5 seconds.  Post episode patient stated he was ""fine"" and was hungry.  No other side effects were noted.  RN recommended that patient call family PCP in regards to same.",,,,,,,,,N,09/23/2019,09/23/2019,0,none,PUB,,none,none,none,,,2,09/26/2019,,,,nkda
0836025,09/26/2019,MI,59.0,59,,F,,"On Monday, 9/16/19, she had an ear ache, put some drops in it, resolved after a couple of days, but then couldn't wink w/her right eye, and right side of face was numb, felt like she had been to the dentist & she couldn't put her lips together to whistle & can't drink well from a glass.  Went to see provider on 9/19/19 and patient was diagnosed w/Bell's Palsy.  Her left eye is super sensitive to light.",,,,,,,,,N,08/21/2019,09/16/2019,26,none that I know of,OTH,,Lisinopril,unknown,unknown,,,2,09/26/2019,,Y,,unknown
0836026,09/26/2019,ME,1.5,1,.5,F,,"My daughter went from having no fear of loud noises, no issues with being wet or feeling textures, confident away from her mom, always happy.   The day of her vaccine it was like flipping a switch.   She was immediately fussier, afraid of loud noises, aggravated by wet clothing, and clingy with her mom.   This was not just a few days after her MMR shot.  It has changed her and she is only slowly getting back to her normal personality.    I am not reporting this because I want compensation.   I am reporting this because you need data.    I am pro public health and have both of my children fully vaccinated.   I am not imagining this.  It was not coincidental.   Her nervous system was adversely impacted by the MMR shot.",,,,,,,,,U,03/04/2019,03/05/2019,1,,UNK,,None,None known,None,,,2,09/26/2019,,,,None known
0836027,09/26/2019,WV,12.0,12,,M,,Patient given a Men B vaccine and should have received a MCV4 vaccine,,,,,,,,,Y,09/09/2019,09/09/2019,0,none,PUB,,none,none,none,,,2,09/26/2019,,,,none
0836028,09/26/2019,GA,22.0,22,,F,,"Almost 22 hours after receiving the shot, I started to get a sore throat. 4 hours after the sore throat I was hit with strong fatigue. An hour later I had a high fever (100.8 degrees). Took alkaselzer which only cured the runny nose and sore throat. Muscle aches and fever persisted. 48 hours after the shot, fever subsided but congestion and headache on right side of head continued. Took alkaselzer when headache was too much to sleep. This is day three, woke up with migraine, congestion and runny nose. Everything I've read said symptoms only last 1-2 days.",,,,,,,,,N,09/23/2019,09/24/2019,1,No medical tests,PHM,,"Junel Fe birth control, Midol",None -- took during menstrual cycle,None,,,2,09/26/2019,,,,None
0836029,09/26/2019,NJ,,0,.5,F,,"Vomiting after any and every type of feeding of normally tolerated Elecare formula in 6 month old infant baby girl occurred at approximately 6 hours after receiving these three vaccines. Beginning Thursday 9/19 at approximately 5PM EST.  Contacted pediatrician that administered vaccines the following day on Friday 9/20 and did not receive adequate care or medical guidance. My husband and I have thought about moving the patient to a new pediatrician and made a follow up call on Friday 9/20 to Dr. We brought patient to Dr. at 1:30PM on Friday 9/20 where she was evaluated. As this was not yet even 24 hours of the vomiting, we were sent home for monitoring. Dr remained in close contact through the next 24 hours through to Saturday 9/21 where patient continued to vomit. Saturday late afternoon/early evening 9/21 we decided in partnership with Dr to bring patient to the ER at Medical Center for the primary reason to assess dehydration levels and rule out any immediate medical or surgical emergency. We were discharged Saturday 9/21 due to no surgical emergency and to keep giving pedialyte to patient through a bottle. We continued to monitor patient Saturday night through Monday 9/23 with following up with the Doctor for medical guidance, Bringing patient to an allergist appointment Monday 9/23 to rule out an my potential allergic reactions. Throughout this entire time, patient has continued vomiting after eating. Fast forward as my form time is expiring- we went back to hospital ER Monday evening and were admitted. It is Thursday 9/26 and still here in the hospital. The doctors will have exact findings but everything is pointing to complications from a viral infection. Patient has to have many points of radiation through xrays and ultrasound and an Upper GI study.",,,,,Y,4,,,N,09/19/2019,09/19/2019,0,Referenced above,PVT,,Zantac 1.5ml twice/day,None,None,,,2,09/26/2019,,Y,Y,Milk-Soy Protein Allergy
0836030,09/26/2019,PA,28.0,28,,F,,"red, swollen and itchy area (about the size of a large grapefruit) surrounding the vaccination site.  Also caused some muscle twitching.  The next day, the area of swelling grew larger and wrapped around her bicep.  She is now taking Benadryl and has started to apply a topical steroid cream.  she will follow up with the office if her symptoms do not dissipate.",,,,,,,,,U,09/24/2019,09/24/2019,0,,PVT,,"bupropion SR, cyanocobalamin, levothyroxine, linaclotide, lo loestrin, phentermine, sertraline",fatigue,"thyroid disorder, celiac disease, anxiety, ADHD, irritable bowel",,,2,09/26/2019,,,,"iodine, gluten"
0836031,09/26/2019,MD,4.0,4,,M,,"swollen, redness",,,,,,,,,Y,09/24/2019,09/25/2019,1,N/A,PVT,,N/A,N/A,N/A,,,2,09/26/2019,,Y,,
0836038,09/26/2019,,78.0,,,M,,"Soreness; Vomiting; Fever; Became sick; This case was reported by a consumer and described the occurrence of pain in a 78-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th September 2019, the patient received the 2nd dose of Shingrix. On 13th September 2019, less than a day after receiving Shingrix, the patient experienced pain, vomiting, fever and sickness. On an unknown date, the outcome of the pain, vomiting, fever and sickness were unknown.   It was unknown if the reporter considered the pain, vomiting, fever and sickness to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and experienced soreness and became sick with fever and vomiting on the same day as the vaccine was administered. The outcome of the events was unknown. The GSK employee who reported the event noted that the patient exercised in the gym regularly and appeared to be in good health. The GlaxoSmithKline employee would request the patient contact GlaxoSmithKline with additional information.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0836039,09/26/2019,NY,72.0,72,,M,,"arm discomfort; limited range of motion of arm; This case was reported by a pharmacist via call center representative and described the occurrence of arm discomfort in a 72-year-old male patient who received Herpes zoster (Shingrix) (batch number JC55P, expiry date 15th November 2021) for prophylaxis.   On 15th August 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 16th August 2019, 1 days after receiving Shingrix, the patient experienced arm discomfort and joint range of motion decreased. On an unknown date, the outcome of the arm discomfort and joint range of motion decreased were recovering/resolving.   It was unknown if the reporter considered the arm discomfort and joint range of motion decreased to be related to Shingrix.  Additional details were provided as follows: The reporter stated that the patient experienced arm discomfort and limited range of motion of his arm. The reporter stated that the events had slightly improved but has not resolved at the time of reporting. The reporter consented to follow up. This case is 1 of the 2 linked cases, reported by the same reporter.",,,,,,,,,N,08/15/2019,08/16/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836040,09/26/2019,CO,41.0,41,,F,,"joint pain; sensitive skin; Trouble sleeping; This case was reported by a pharmacist via call center representative and described the occurrence of joint pain in a 41-year-old female patient who received Rabies NVS (RabAvert) (batch number ARBA181A, expiry date 30th September 2022) for prophylaxis.   On 14th September 2019, the patient received the 2nd dose of RabAvert. On 15th September 2019, 1 days after receiving RabAvert, the patient experienced joint pain, sensitive skin and difficulty sleeping. On an unknown date, the outcome of the joint pain, sensitive skin and difficulty sleeping were recovering/resolving.   It was unknown if the reporter considered the joint pain, sensitive skin and difficulty sleeping to be related to RabAvert.  Additional details were reported as follows: The reporter stated that, the patient experienced joint pain, sensitive skin and trouble sleeping after the 2nd dose of Rabavert.",,,,,,,,,N,09/14/2019,09/15/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836042,09/26/2019,MA,17.0,17,,F,,"Since receiving vaccine, directly after Patient has had moderate Pain from injection site to upper neck, and down to elbow, and in left shoulder blade. Patient took ibuprofen today, throughout day with no relief, Patient has to keep arm still due to movement of shoulder hurts.",,,,,,,,,N,09/24/2019,09/24/2019,0,none,PVT,,none,Seen on 9/20/19 for (L) wrist injury,N/A,,,2,09/28/2019,,Y,,NKDA; ? lactose-intolerance
0836044,09/26/2019,IN,13.0,13,,F,,"My daughter fainted 15 minutes after the vaccination as we were checking out at the doctors office.  We had difficulty getting her to become conscious, it took over 30 minutes before I could even get her to the car and then the nurse used a wheelchair.  My daughter slept for hours after that incident and felt foggy.  She did not act the same for months after and began having panic attacks within 48 hrs of the vaccine, which we had never experienced before.  She would experience shortness of breath, severe crying, nausea, headaches, and said she just felt foggy for months.  We began therapy after as she could not walk into or talk about going to a doctors office without having a panic attack.  She still, over a year later, experiences anxiety and panic attacks.",,,,,,,,Y,N,05/01/2018,05/01/2018,0,None suggested by her physician.,PVT,,Xyzal OTC allergy medication,N/A,N/A,,,2,09/26/2019,,Y,,N/A
0836045,09/26/2019,VA,58.0,58,,M,,"On the 13th, I felt lethargic and ""out of it"" all day, more specifically -  weak and dizzy when up and walking around.  I felt very warm all day, and because of the other symptoms, I didn't think to take my temperature until later that afternoon. I didn't have a  proper thermometer, so I took my temperature under my arm with a scientific field thermometer - it registered approximately 104.5 degrees - between 104-105 degrees Fahrenheit. This was the best measurement I could get as the thermometer is graduated every 2 degrees (i.e., I was reading between 104-106). My regular ""medical"" thermometer had a dead battery.  I didn't seek treatment, but took 2-200mg tablets of ibuprofen every 4 hours  (4pm, 8pm, then again at 8am the next day).  The second day (9/14), I took my temperature again and it had come down to a little over 100 degrees. I took the last ibuprofen dose of 400mg at that time.",,,,,,,,,Y,09/12/2019,09/13/2019,1,none requested,PHM,,hydrochlorothiazide 50mg; amlodipine 5mg; potassium citrate 1080mg (2x/day); gabapentin 400mg (2x/day); amitriptyline HCl 25mg; cetirizine 10mg; multivitamin (male senior type).  All above are 1x/day unless otherwise noted.,hay fever,"Kidney stones, high blood pressure, tinnitus, trigeminal neuralgia",,,2,09/26/2019,,,,penicillin (anaphylaxis); macadamia nuts (vomiting); chicory root (pruritis); seasonal hay fever/pollen allergies
0836046,09/26/2019,FL,47.0,47,,F,,"Body aches, rigors",,,,,,,,,N,09/25/2019,09/25/2019,0,,PVT,,Sestraline,none,none,,,2,09/26/2019,,Y,,none
0836047,09/26/2019,NJ,55.0,55,,F,,"Approximately 12 hours after the injection I awoke with fever, chills, severe pain wherever I was touched, nausea, and severe abdominal pain. After 24  hours the fever, chills, and severe pain wherever I was touched abated but I still had the nausea and severe abdominal pain. 4 days later I went to the emergency room with these symptoms. A CAT scan revealed a clot had blocked an artery leading to my spleen and I had a partially dead spleen. I am a heart patient and had an ejection fraction in the 40s. It was now 25-30. I also now have a pericardial effusion.",,,Y,,Y,3,,Y,N,09/17/2019,09/18/2019,1,"9/22/2019 Chest X-ray, Cat abdomen Pelvis. 9/23/2019 CT Angiogram Cardiac, Doppler vein ultrasound. 9/24/2019 CT scan cardiac, echo cardiogram.",PVT,,"Coreg, Altace, Baby Aspirin--prescriptions. Curcumin, Multi-Vitamin, Flax oil, Glucosamine/Chondroitin, Calcium, Vitamin D, Cholestoff--supplements.",None.,MI from a Peripartum coronary artery dissection 18 years prior.,,,2,09/26/2019,,,Y,None.
0836048,09/26/2019,SD,48.0,48,,M,,"swollen lips, red and blotchy chest, increased work of breathing",,,,,,,,,Y,09/24/2019,09/24/2019,0,none,PVT,,simvastatin 10 mg po QD,none,irritable bowel hyperlipidemia,,,2,09/26/2019,,,,NKA
0836049,09/26/2019,MO,59.0,59,,F,,"Started running a fever.  Site of injection was swollen. Size of a golf ball. Extreme pain.  Day two Fever, muscle cramps site growing. Size of grapefruit.  Looked like a spider bite.  Warm to the touch.  Thru the night extreme pain.  Redness and swelling was impressive.  Horrible headache with muscle cramps.   Red, swollen blistered.",,,,,,,,,N,09/24/2019,09/24/2019,0,None,PHM,,TriamterHCTZ 37.5 mg    Amlodipine 5mg.   Mobic 15mg.    Flexeril PRN. Tramodol PRN,Arthritis,Arthritis a lot of fractures,,,2,09/26/2019,,,,"Lisinopril anaphylaxis was incubated  Morphine, Nubaine Levaquin, Demerol, Dilaudid  All Short of breath"
0836050,09/26/2019,TX,70.0,70,,F,,patient states she got a huge hive and a lot of pain at the site that did not let her sleep,,,,,,,,,N,09/25/2019,09/25/2019,0,none at this time,PHM,,"ajovy, amitriptyline, chlorthalidone, celebrex, alendronate, sumatriptan",none,"migraines, osteoporosis,",,,2,09/26/2019,,,,NKDA
0836052,09/26/2019,PA,63.0,63,,M,,Patient experienced pain at the time of injection and has been feeling numbness/pins and needles in the left hand.,,,,,,,,,N,09/20/2019,09/20/2019,0,,PHM,,Multivitamin,None,None,,,2,09/26/2019,,Y,,NKA
0836053,09/26/2019,MI,25.0,25,,F,,"Skin: Inspection and palpation: right upper arm with ~7cm x 4.5cm area of erythema and warmth, tender to palpation at site of injection of Tdap. No induration. Patient Instructions Apply ice to the area, 20 minutes on and then at least 20 minutes off. Start the claritin and motrin Recheck if symptoms worsen or do not improve in 3 to 5 days.",,,,,,,,,N,09/23/2019,09/25/2019,2,None,PVT,,"FLUoxetine 40 mg capsule,LORazepam 0.5 mg tablet, zolpidem 10 mg tablet.",No,"generalized anxiety disorder,  thoracic  back pain.",,,2,09/26/2019,,,,AMITRIPTYLINE: Other (Moderate) - weight gain  BUSPIRONE: Headache (Moderate)  LEXAPRO: - vomiting  MORPHINE: - hallucinations
0836055,09/26/2019,PA,64.0,64,,F,,"Patient verbalizes ""lot of pain at the injection site, moderate swelling of the left arm, erythema (5.5 (l) x 2.5 (w)), joint pain mostly in her fingers, left hand stiffness, knots beneath the skin of her left arm.",,,,,,,,,N,09/17/2019,09/18/2019,1,None,PVT,,"Lipitor 10 daily, Metformin HCL ER 750 mg BID, Dit D 50,000u",none,"DM2, Alergy Rhinitis, Hyperlipidema, menopausal",,,2,09/24/2019,,Y,,Molds
0836057,09/26/2019,NJ,,,,U,,"On unspecified dates an unspecified number of patients may have administered improperly stored GARDASIL 9.; No adverse events reported; This spontaneous report was received from a registered nurse regarding an identifiable patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant therapies were not reported.   On an unknown date, the patient was vaccinated with improperly stored dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) for prophylaxis, lot number R020947, expiration date 04-MAY-2021 (strength, dose and route of administration was not reported). There was no adverse events reported. On 20-JUN-2019, the administered doses of vaccines experienced the temperature excursion of -13.33 Celsius degrees for 2 minutes. On 10-MAY-2019, the previous excursion of 9.12 Celsius degrees for 3 hours and 15 minutes was reported. No data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA001880: US-009507513-1909USA001305:",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA012982,2,09/26/2019,,,,
0836058,09/26/2019,PA,64.0,64,,M,,"arm pain at the site of injection; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In July 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 3 months after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient's wife reported the case. The patient received Shingrix in left arm.   The patient experienced arm pain at the site of injection that had persisted. The reporter did not consent to follow-up. This case has been linked to US2019168251, reported by the same reporter.",,,,,,,,,N,07/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836059,09/26/2019,IA,,,,U,,"Got quite sick; This case was reported by a consumer and described the occurrence of sickness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (experienced twice).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient got quite sick after receiving the 1st dose of Shingrix, but decided better to receive the 2nd dose of Shingrix or wouldnt be protected. For tolerance of 2nd dose of Shingrix, refer case US2019AMR170744.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Shingles (experienced twice),,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0836060,09/26/2019,IA,,,,U,,"I really got sick; Had to go to bed because I was weak; Had the worst headache of my life; My back hurt something terrible; Was very sick to my stomach; Ached in every bone in my body; I felt like I had the worst case of flu; This case was reported by a consumer and described the occurrence of sickness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (experienced twice). Previously administered products included Shingrix with an associated reaction of malaise (1st dose received years before the date of reporting and was quite sick, for tolerance of 1st dose refer case US2019AMR170739).   On 16th September 2019, the patient received the 2nd dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced sickness, weakness, headache, back pain, upset stomach, bone pain and influenza like illness. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the sickness, weakness, headache, back pain, upset stomach and bone pain were unknown and the outcome of the influenza like illness was recovered/resolved.   It was unknown if the reporter considered the sickness, weakness, headache, back pain, upset stomach, bone pain and influenza like illness to be related to Shingrix.  Additional details were provided as follows: The patient got sick after receiving the 2nd dose of Shingrix.  The patient was also weak, had the worst headache of life, back hurted terriblly. The patientI was very sick to the stomach and ached in every bone in the body. The patient's friends did not get sick and so the patient wondered. The patient thaught it could it be because had shingles twice and the friends never had, or it could be an allergy to the drugs in the vaccine. The patient was just curious about experiencing sick from the vaccine, and felt like had the worst case of flu that lasted 24 hrs. At the time of reporting, the patient was still  little weak yet.",,,,,,,,,Y,09/16/2019,09/01/2019,,,UNK,,,,Medical History/Concurrent Conditions: Shingles (experienced twice),,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0836061,09/26/2019,TX,50.0,50,,F,,"Feel pretty crummy; This case was reported by a consumer and described the occurrence of feeling unwell in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th September 2019, the patient received the 1st dose of Shingrix. On 18th September 2019, 1 days after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional details were provided as follows: The patient felt pretty crummy after receiving Shingrix.",,,,,,,,,U,09/17/2019,09/18/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0836062,09/26/2019,,,,,M,,"Has struggled his entire life; This case was reported by a consumer via interactive digital media and described the occurrence of activities of daily living impaired in a child male patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced activities of daily living impaired (serious criteria disability). On an unknown date, the outcome of the activities of daily living impaired was unknown.   It was unknown if the reporter considered the activities of daily living impaired to be related to DTPa vaccine.  Additional information was reported as follows: The age at vaccination was not reported. The reporter's child was injured by the DPT and had struggled his entire life as a result. But of course it was dismissed as unrelated coincidence.",,,,,,,,Y,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0836063,09/26/2019,,,,,U,,"Severe reaction; This case was reported by a consumer via interactive digital media and described the occurrence of adverse reaction in a child patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to DTPa vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced severe reaction to DTPa vaccine and was too dangerous to go back to and if the new one did not work.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0836064,09/26/2019,CA,79.0,79,,F,,"localized bruising at the site of the injection; Area is very sensitive to touch; Skin is discolored; This case was reported by a consumer via call center representative and described the occurrence of injection site bruising in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th September 2019, the patient received the 2nd dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced injection site bruising, touch sensitivity increased and injection site discoloration. On an unknown date, the outcome of the injection site bruising, touch sensitivity increased and injection site discoloration were unknown.   It was unknown if the reporter considered the injection site bruising, touch sensitivity increased and injection site discoloration to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's son. The reporter stated that, the patient had localized bruising at the site of the injection. The area was very sensitive to touch and the skin was discolored. Additional information was not provided.",,,,,,,,,U,09/13/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836066,09/26/2019,KS,63.0,,,F,,"Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 63-year-old female patient who received Herpes zoster (Shingrix) (batch number AP257, expiry date 26th November 2021) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional case details were reported as follows: The reporter was filing in at the pharmacy and had no additional information on the topic including address. The reporter did not consent to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836067,09/26/2019,PA,61.0,61,,F,,"pain during injection/ arm pain/ hurts to sleep on that side at night; tiredness; nerve pain in arm muscle where she received the injection/ nerve and muscle pain in arm; nerve pain in arm muscle where she received the injection/ nerve and muscle pain in arm; decreased mobility of arm; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (about 5 years ago) and nerve pain (due to shingles infection).   On 8th June 2019, the patient received the 1st dose of Shingrix (intramuscular). On 8th June 2019, immediately after receiving Shingrix, the patient experienced injection site pain. In June 2019, the patient experienced tiredness, nerve pain, muscle pain and injected limb mobility decreased. On an unknown date, the outcome of the injection site pain and tiredness were recovered/resolved and the outcome of the nerve pain, muscle pain and injected limb mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, tiredness, nerve pain, muscle pain and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient reported for herself. The patient received Shingrix in left arm. During the injection, the patient felt pain. Less than a week after the shot, the patient felt tired and that resolved. About one week later, she developed nerve pain in her arm muscle where she received the injection. Since then, this muscle or nerve pain had persisted and she had decreased mobility of the arm and it hurt to sleep on that side at night. The patient did not consent to follow-up. This case has been linked to US2019168255, reported by the same reporter.",,,,,,,,,N,06/08/2019,06/01/2019,,,PHM,,,,Medical History/Concurrent Conditions: Nerve pain (due to shingles infection); Shingles (about 5 years ago),,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836068,09/26/2019,FL,60.0,60,,F,,"Itchy,  hives,  blistering of hands. Treated with Solu-medrol injection, prednisone and antihistamines",,,,,,,,,Y,09/16/2019,09/16/2019,0,,PVT,,,,,,,2,09/26/2019,,Y,,
0836069,09/26/2019,AZ,65.0,65,,F,,"Fever 101.5?, burning in the eyes, sweats and chills, aches, joint pains",,,,,,,,,Y,09/25/2019,09/25/2019,0,,PHM,,Synthroid Lisinopril,,,,,2,09/26/2019,,,,
0836070,09/26/2019,NC,81.0,81,,F,,"Pt. complained of significant dizziness, nausea, and anorexia beginning 12-24 hours after the vaccination and continuing for 5 days post-vaccination. The patient visited their PCP on 09/23/2019 who diagnosed the patient with a significant immune response to the vaccination, not requiring follow-up. The PCP documented ""dizziness"" as the reason for pt. visit.",,,,,,,,,Y,09/18/2019,09/20/2019,2,,PHM,,,,,,,2,09/26/2019,,Y,,no known allergies
0836071,09/26/2019,NY,75.0,75,,F,,pt had severe pain in arm and could not lift it for a day,,,,,,,,,N,09/24/2019,09/24/2019,0,,PHM,,no,no,high blood pressure,,,2,09/26/2019,,,,no
0836072,09/26/2019,LA,36.0,36,,F,,"Day after vaccination the patient said she started to develop rash on her arms and legs, small and red, but mostly beneath the skin.  Also pretty bad joint pain in her shoulders, knees, feet, hands and neck.  At this point, the neck pain has decreased greatly and the other pains are easing up as of today. The patient has not seen at dr yet.  I was just notified of the symptoms today.  I informed her today that if the symptoms do not continue to improve or if they get worse to seek medical attention.",,,,,,,,,N,09/15/2019,09/16/2019,1,n/a,PHM,,n/a,n/a,n/a,,,2,09/26/2019,,,,no
0836073,09/26/2019,TX,43.0,43,,F,,Patient had to go to the Emergency room because she had a rash all over her arm and tingling sensation in her arm.  Patient had to follow up with 3 doctors and had to take medication.  Tingling lasted many days and still was present in hand after a couple weeks.  Rash has gone down but still present at last interaction with patient.,,,,,,,,,,09/04/2019,09/14/2019,10,,PHM,,,,,,,2,09/26/2019,,Y,Y,
0836074,09/26/2019,TN,54.0,54,,F,,"Red, swollen, warm to the touch around the injection site the morning after receiving the vaccination. Patient mentioned experiencing some nausea and loss of appetite also. Patient was seen by a doctor and received a steroid dose pack.",,,,,,,,,Y,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,09/26/2019,,Y,,No known allergies reported by patient.
0836075,09/26/2019,CA,0.33,0,.3,F,,"Mother described the adverse events as redness, swelling, hot to the touch about 1"" above the administration site. Next day on September 19, 2019 she took the baby to the ER for the symptoms and was diagnosed with ""Cellulitis"". Prescribed antibiotics treatment and benadryl on September 19, 2019 medication she had not picked up yet.",,,,,,,,,U,09/18/2019,09/18/2019,0,09/19/2019 Emergency Room physical examination.,PVT,,N/A,"Vomiting , Constipation",N/A,,,2,09/26/2019,,,Y,N/A
0836076,09/26/2019,CA,50.0,50,,F,,"Had mild vertigo that started around 09/19/19. But on Saturday 09/21/2019 the vertigo was so bad, I could not get out of bed and I was vomiting all day. I stayed in bed the whole Saturday until Sunday morning. Feeling better, no vomiting, but up until today I still have  periods of Vertigo, that have not stopped. My daughter got the same Flu shot, she had some dizziness too, but she caught the Flu symptoms and she was sick for mre than a week.",,,,,,,,,N,09/10/2019,09/19/2019,9,None,PHM,,None,None,None,,,2,09/26/2019,,,,None
0836077,09/26/2019,AR,69.0,69,,F,,"per pt's fiance/boyfriend pt started to have severe pain in diaphragm, numbness in legs and arms, couldn't speak because she was in so much pain. Her and her fiance thought she was having a heart attack. He checked her blood pressure several times before the ambulance got there. He did not tell me what her blood pressure was. Pt went in ambulance to hospital. Pt then had chills from fever, throwing up and diarrhea (at the same time per pt fiance). Per pt fiance the hospital wanted to airlift her to a larger hospital but she stabilized.",,,,,Y,1,,,U,09/25/2019,09/25/2019,0,,PHM,,"unknown. pt's fiance/boyfriend says she is ""healthy""","none per pt's boyfriend/fiance; however pt answered yes to the question ""does the person to be vaccinated have a weakened immune system, is in contact with anyone with a severely weakened immune system or in long-term treatment with drugs such as high-dose steroids?""",none per pt's fiance/boyfriend. pt answered,,,2,09/26/2019,,,Y,none per pt.
0836078,09/26/2019,FL,69.0,69,,M,,pt is currently in hospital with double pneumonia...pt wife stated that she thinks it is related to the flu shot. Pt was feeling poorly right after the flu shot was given,,,,,Y,,,,U,09/18/2019,09/19/2019,1,,PHM,,"levothyroxine, latanoprost",unknown,unknown,,,2,09/26/2019,,,,nkda
0836079,09/26/2019,GA,66.0,66,,F,,"""Got flu shot on Wed 9-18-19. On Thursday 9-19-arm sore and woke me up from sleep that night. On Friday 9-20 started numbness (SIC) inside index and middle finger up to hand and arm pain some neck and shoulder and wrist pain, neck stiffness and shoulder, thumb pain.",,,,,,,,,N,09/18/2019,09/19/2019,1,,PVT,,Pravastatin 80mg po qd Plavix 75 po qd Levothyroxine 50 po qd,None,Polycythemia Thrombocytosis,,,2,09/26/2019,,Y,,Augmentin Sulfa  Noroxin Orografin
0836080,09/26/2019,NH,78.0,78,,M,,This gentleman returned to the pharmacy 1 hour after administration of the vaccine.  His lips were very swollen and he said he felt terrible.  His face was also getting red and blotchy.  He also told us that he was having trouble seeing.  We asked him to sit down so we could call 911 but he insisted on returning to his car to be with his wife.  He was sweaty and confused.  911 arrived and took over the situation.,,,,,,,,,Y,09/24/2019,09/24/2019,0,unknown,PVT,,this patient is not a patient of ours...did not get his medication history.,not known,"not know, other than he is blind in one eye",,,2,09/26/2019,,,,none known
0836081,09/26/2019,OR,81.0,81,,F,,"Redness and swelling at injection site and limited range of motion in left arm (nothing above horizontal). As of 9-26-2019, patient states redness and swelling has subsided and full range of motion is back, but with soreness in elbow of left arm.",,,,,,,,,Y,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,09/26/2019,,,,Eucalyptus oil
0836082,09/26/2019,CA,64.0,64,,M,,"PATIENT RECEIVED 2 DOSES OF ADACEL WITHIN 3 MONTHS.  PATIENT WAS NOTIFIED ON 9/24/19 ABOUT ADDITIONAL DOSE.  UPON SPEAKING TO HIM, HE COMPLAINED OF NO ADVERSE EVENTS.  HOWEVER, HE PHONED ON 9/25/19 TO LET ME KNOW HE WAS NOT FEELING WELL THAT MORNING AND HAD GONE TO HOSPITAL TO RECEIVE CARE.  HE STATED HE HAD MUSCLE PAIN.",,,,,,,,,U,09/13/2019,09/25/2019,12,,PHM,,"ASPIRIN, LISINOPRIL, METFORMIN, LIDOCAINE TOPICAL GEL,  CAPSAICIN TOPICAL",UNKNOWN,"HTN, MUSCLE PAIN, DIABETES, GAD, NEUROPATHY, HEP C.",,,2,09/26/2019,,,Y,NONE
0836083,09/26/2019,PA,76.0,76,,F,,"red, swollen arm",,,,,,,,,N,09/23/2019,09/24/2019,1,,PHM,,,,,,,2,09/26/2019,,,,
0836084,09/26/2019,PA,63.0,63,,F,,"Swollen, red, soreness, feel exhausted, muscles ached, pinprick pain, unable to lift arm without pain, sleep disturbances, and feel tightness in the chest (may be from rain and asthma though). Not yet recovered, but it's been <2 days since vaccinated.",,,,,,,,,N,09/24/2019,09/24/2019,0,N/A,PVT,,"Synthroid 88mcg, Asprin 81mg, Benefiber. Take Ventolin as needed for asthma, but not recently.",N/A,Hashimoto's thyroiditis. Asthma.,,,2,09/26/2019,,,,Bactrim
0836106,09/26/2019,CA,14.0,14,,U,,"No adverse effects reported; received improperly stored VARIVAX; This spontaneous report was received from a medical assistant and refers to a 14-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On 13-AUG-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # R023513, expiration date 16-AUG-2020, strength, route of administration and dose were not reported) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (lot 3 S00130, expiration date 23-AUG-2021). No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion of -14 Celsius degrees (C) to -10 C (also reported as -13.2 C) for 46 minutes. The digital data logger was involved in recording the temperature excursion details. There were no previous excursions reported.    This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA007512: US-009507513-1909USA007177: US-009507513-1909USA007312: US-009507513-1909USA006939: US-009507513-1909USA007312:",,,,,,,,,U,08/13/2019,08/13/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA007118,2,09/26/2019,,,,
0836109,09/26/2019,CA,,,,U,,"An improperly stored dose of GARDASIL 9 was administered to the patient; No adverse effects; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concomitant medications, drugs reactions or allergies were not reported.  On an unspecified date, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # N022952, expiration date: 14-JUN-2020 (dose, frequency, route of administration and anatomical location were not provided) as prophylaxis. The vaccine was under a temperature below 36 fahrenheit degrees (F) of 32.1 F during a time frime of 8 hours as recorded by a data logger. No previous temperature excursion was reported as well as no adverse effects.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009404,2,09/26/2019,,,,
0836110,09/26/2019,MD,,,,U,,"No adverse effect; improperly stored vaccine administered; This spontaneous report was received from a Nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not provided. On 13-SEP-2019, the patient was adminstered one dose of improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (product storage error) for prophylaxis (lot # R030924, expiry date: 10-JUL-2020). The vaccine was stored at 0.24 C (multiple) for 5 hours 30 minute. There was no previous temprature excursion. No adverse effect reported. It was reported that, this call was because of data logger. No PQC involved. No additional information available.",,,,,,,,,U,09/13/2019,09/13/2019,0,,UNK,,,,,,US0095075131909USA012190,2,09/26/2019,,,,
0836111,09/26/2019,TX,,,,F,,"Patient developed shingles all over her body; This case was reported by a other health professional via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 2 days after receiving Shingrix, the patient experienced shingles. Shingrix was discontinued. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the vaccination at a different location so the reporter had limited information. The patient developed shingles all over her body about 2 days after receiving Shingix. She has elected not to receive the 2nd dose.The visit to this doctor was not related to Shingles.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836112,09/26/2019,,,,,F,,"injection site soreness; This case was reported by a consumer and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th September 2019, the patient received the 2nd dose of Shingrix. On 13th September 2019, less than a day after receiving Shingrix, the patient experienced injection site pain. On 16th September 2019, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. The patient was in her 70's. The patient received Shingrix and experienced injection site soreness on the same day as the vaccine was administered. The event was resolved by 16th September 2019 when the GlaxoSmithKline employee saw the patient at the gym.  The GlaxoSmithKline employee who reported the event noted that the patient exercised in the gym regularly and appeared to be in good health.  The GlaxoSmithKline employee did not have the patient's name and contact information but would request the patient contact GlaxoSmithKline with additional information.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0836113,09/26/2019,MS,,,,U,,"Fever; Lethargy; Generally just felt bad; Missed one day of work; This case was reported by a consumer and described the occurrence of fever in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced fever, lethargy, feeling unwell and activities of daily living impaired. On an unknown date, the outcome of the fever, lethargy, feeling unwell and activities of daily living impaired were unknown.   It was unknown if the reporter considered the fever, lethargy, feeling unwell and activities of daily living impaired to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient had the Shingrix 3 months ago and missed one day of work because of fever, lethargy, and generally just felt bad.  The patient need the 2nd vaccine, just trying to figure work schedule.  The reporter asked should expect the same reaction or should reaction be milder.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0836114,09/26/2019,NY,,,,U,,"extensive thrombosis; normal transhepatic pressures with massive debilitating splenomegaly; This case was reported in a literature article and described the occurrence of thrombosis in a 6-year-old patient who received Haemophilus influenzae type b vaccine for prophylaxis.  Co-suspect products included PNEUMOCOCCAL VACCINE (PCV13) for prophylaxis, PPSV23 PNEUMOCOCCAL VACCINE for prophylaxis, piperacillin for prophylaxis and tazobactam for prophylaxis.   The subject's past medical history included varicose veins ligation and splenomegaly. Concurrent medical conditions included portal hypertension (etiology was autoimmune hepatitis ), autoimmune hepatitis, hemorrhage, thrombocytosis,genetic predisposition to myelodysplastic-like syndrome and varicosity.   On an unknown date, the patient received Haemophilus influenzae type b vaccine at an unknown dose, PCV13 at an unknown dose, PPSV23 PNEUMOCOCCAL VACCINE at an unknown dose, piperacillin (intravenous) at an unknown dose and frequency and tazobactam (intravenous) at an unknown dose and frequency. On an unknown date, more than a week after receiving Haemophilus influenzae type b vaccine, the patient experienced thrombosis (serious criteria hospitalization, GSK medically significant and other: serious as per eporter) and splenomegaly (serious criteria hospitalization). The action taken with piperacillin was unknown. The action taken with tazobactam was unknown. On an unknown date, the outcome of the thrombosis and splenomegaly were unknown.   It was unknown if the reporter considered the thrombosis and splenomegaly to be related to Haemophilus influenzae type b vaccine.  Additional details were provided as follows: This case was reported in a literature article and described the occurrence of thrombosis in a 6-year-old female who was vaccinated with unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (manufacturer unknown for all) for prophylaxis.   The patient was a part of cohort study that aimed to determine whether Partial Splenic Embolization (PSE) was safe and effective in the pediatric population.  The study was a retrospective review of a single-center experience for all patients ages 0 to 21 who underwent PSE for the management of portal hypertension (PHTN) between January 2010 and August 2017. The study presented the experience with the use of this modality in different pediatric populations with PHTN to better understand the rationale for safe and appropriate application of this treatment. [In this study, [In this study, recommended PSE to patients with bleeding tendencies that were not optimal candidates for an open surgical shunt or repeated endoscopies. This includes the following patient populations: Patients with baseline compromised respiratory function (ie, cystic fibrosis [CF]). 2. Patients with significant synthetic dysfunction that may progress to liver failure after shunting. 3. Patients with early signs of encephalopathy that could potentially worsen with increased portal systemic shunting. 4. Patients with abnormal right heart function that could develop cardiac decompensation or shunt failure. 5. Patients deemed to be marginal candidates for repeated anesthesia. 6. Patients with splenic vein thrombosis. 7. Patients with characteristics predicting poor wound healing or other surgical complications. 8. Patients with unfavorable anatomy, increased transhepatic resistance, or elevated right heart pressures to permit mesoportal shunting (Rex shunt)]. The patient had thrombocytopenia and/or recurrent variceal bleeding.   The patient had portal hypertension, whose etiology was autoimmune hepatitis (AI). The patient also noted to have evidence of varices before PSE. For this, the patient underwent endoscopic variceal ligation (EVL) before PSE. The patient had significant splenomegaly before PSE. This patient was found to have a genetic predisposition to myelodysplastic-like syndrome and thrombocytosis. it was reported that Myelodysplastic-like syndrome has been associated with both thrombotic and hemorrhagic complications. The decision to proceed with PSE was determined by the primary hepatologist and surgeon after careful discussion with both patient and family members regarding alternative approaches. No information on patient's family history or concomitant medication was provided.   On an unspecified date, at least 2 weeks before PSE, the patient received unspecified Haemophilus influenzae type B, unspecified meningococcal vaccines and unspecified pneumococcal vaccine (PCV13 followed in 1 month by PPSV23 when feasible) (administration route and site unspecified, dosage unknown, batch number not provided for all), in order to reduce the risk of future infection by encapsulated organisms, should the procedure lead to a complication necessitating total splenectomy. The age of vaccination was not provided. It was reported that the patient received broad-spectrum intravenous antibiotic prophylaxis, typically with piperacillin/tazobactam, before the procedure to prevent infection of infarcted splenic tissue. This was continued for 5 to 7 days. On an unknown date, before PSE, the patient's platelet count was noted at 15310E9/L and white blood cells count (WBC) was 1.410E9/L (normal range not provided).   On an unspecified date between January 2010 and August 2017, at least 2 weeks after vaccination, the patient underwent PSE by interventional radiology under general anesthesia via percutaneous femoral artery approach under sterile conditions utilizing guidelines based on the Spigos technique to minimize complications. At the time of PSE, the patient was not actively bleeding. Diagnostic angiographies of the celiac axis and splenic arteries were obtained to determine the target splenic arterial branches, to identify accessory branches to other tissues from the splenic artery and to determine baseline splenic volume. Abdominal sonograms with doppler analysis of hepatic and splenic vessels were performed post procedure to assess vessel patency and the degree of intra-abdominal-free fluid. Arteriograms of partial splenic embolization (PSE), pre-embolization with capillary blush demonstrated splenomegaly and post-embolization with capillary blush revealed multiple defects before and after esophageal varices.   Information regarding patient's blood transfusions was not available. The patient was admitted to hospital after PSE for further observation and management. [In this study, patients received patient-controlled analgesia for pain control and to prevent splinting and associated pulmonary complications such as atelectasis and pneumonia]. The patient underwent EVL intervention post PSE. The patient did not develop infection with encapsulated organisms. Post-PSE, the patient's platelet count was 133510E9/L. the antibiotics were converted to an oral regimen before hospital discharge. [In this study, criteria for hospital discharge included adequate control of abdominal pain with oral medications, adequate oral intake/hydration, and absence of post procedure infection. Magnetic resonance imaging (MRI) showed splenomegaly and postembolization with necrotic areas surrounding the spleen. Three patients demonstrated complete resolution of varices. An additional 7 patients were noted to have a decrease in variceal grade].  On an unknown date, the patient was discharged fulfilling the criteria for hospital discharge that included (adequate control of abdominal pain with oral medications), adequate oral intake/hydration, and absence of post procedure infection. The patient was followed-up in the outpatient hepatology clinic. Hematologic indices including white blood cell (WBC) and platelet counts were monitored. Imaging was repeated as indicated. The patient developed extensive thrombosis and re-admitted to hospital. The extensive thrombosis of her splenic vein, portal vein, and inferior vena-cava (IVC) at the level of the renal veins necessitating thrombectomy and urgent splenectomy 9 days after PSE. This patient had normal transhepatic pressures with massive debilitating splenomegaly. The procedure was performed for compassionate reasons and an estimated 80% of the spleen was infarcted in a single procedure. Platelet levels peaked at an astonishing 2484E109/L in this patient after PSE necessitating chronic antiplatelet therapy.  [In this study, 7 patients required readmission after initial discharge 2 of these patients were discharged only 1 day after PSE and returned the following day with fevers and abdominal pain with an unremarkable diagnostic evaluation]. Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.  This case has been considered as serious due to hospitalization/serious per reporter. [In this study, Thrombosis included splenic vein, portal vein, and inferior vena cava at the level of the renal veins reported by the Institute.  The outcome of the event was not reported.  The author did not comment on the relationship between the event of thrombosis and Unspecified Haemophilus influenza type B vaccine, unspecified meningococcal vaccine and unspecified pneumococcal (PCV13 followed by PPSV23) vaccine. The author stated ""The Centers for Disease Control and Prevention recommends immunoprophylaxis against Streptococcus pneumoniae, H influenzae and Neisseria meningitidis in all splenectomized patients. Complications of PHTN such as hypersplenism, variceal hemorrhage, and ascites can lead to significant morbidity and mortality in children. Surgical interventions include shunting or splenectomy; however, overwhelming sepsis postsplenectomy is a pressing concern. PSE addresses portal hypertension regardless of etiology as definitive therapy. Most adverse effects following PSE are expected and can be managed conservatively. In our cohort we commonly observed fever, abdominal pain, and leukocytosis without evidence of infection. Pain was effectively controlled with intravenous and oral analgesics. Nonsteroidal anti-inflammatory drugs were avoided to minimize hemorrhage. In our experience, prophylactic antibiotics and limiting splenic reduction to no greater than 70% have avoided serious morbidity and mortality. In particular, there was no significant difference in the preprocedure platelet count between patients with and without recurrent thrombocytopenia. After PSE we noted a significant increase in platelets but to a lesser degree in patients who had recurrent hypersplenism. In our patients with esophageal varices, the combination of endoscopic ligation and PSE has been successful in controlling the progression of varices and decreasing the incidence of variceal hemorrhage.""  The author concluded ""our study supports that PSE is a safe, effective, semi-invasive alternative to splenectomy in pediatric patients with PHTN. The combination of EVL and PSE is effective treatment for esophageal and gastric varices (not amenable to simple band ligation). Reduced splenic volume and splenic venous return effectively decreased portal flow and pressure. PSE can be successfully performed in pre- and post-transplant transplant patients, and select cirrhotic and noncirrhotic pediatric patients. PSE appears to preserve functional spleen mass and avoids postprocedure accelerated liver disease or encephalopathy. In contrast to shunting, PSE can be effective even in the setting of elevated right-sided heart pressures. Further multicenter collaborative studies with larger and varied patient populations will need to be performed to substantiate our approach and better define patient populations that would benefit most from PSE, sequential PSE or combined interventions. Liver transplantation remains the ideal intervention for anyone with significant decompensated PHTN or advanced hepatic dysfunction"".  This is 1 of the 9 valid cases reported in this article.      Lab Comments: Lab test were performed on an unspecified date, The patient's hematologic indices including white blood cell (WBC) and platelet counts were monitored (result not provided). Imaging was repeated as indicated  (result not provided). Surveillance endoscopy was also performed 3 months after PSE to evaluate for persistent varices. Splenic function appeared to be preserved during years of follow-up in patient without increased incidence of infection.",,,,,Y,,,,U,,,,"Test Name: Endoscopy; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Platelet count; Result Unstructured Data: Test Result: 153 (before PSE), Test Result Unit: x10e9/L; Test Name: Platelet count; Result Unstructured Data: Test Result: 1335 (Post PSE), Test Result Unit: x10e9/L; Test Name: Platelet count; Result Unstructured Data: Test Result: peaked at an astonishing 2484, Test Result Unit: x10e9/L; Test Name: White blood cell count; Result Unstructured Data: Test Result: 1.41 (before PSE), Test Result Unit: x10e9/L",UNK,,Piperacillin; tazobactam,Autoimmune hepatitis; Portal hypertension (etiology was autoimmune hepatitis); Thrombocytosis; Varicosity,Medical History/Concurrent Conditions: Splenomegaly; Varicose veins ligation,,USGLAXOSMITHKLINEUS2019GS,2,09/26/2019,,,,
0836115,09/26/2019,TX,50.0,50,,F,,"Shingles rash on her upper right thigh; This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 14th September 2019, 3 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The reporter stated the patient has a shingles rash on her upper right thigh 3 days after receiving the Shingrix vaccine. The reporter was transferred to medical information for additional assistance including whether the patient should receive the 2nd dose.",,,,,,,,,N,09/11/2019,09/14/2019,3,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836116,09/26/2019,AZ,65.0,65,,F,,"Felt ill; fatigue that prevented her from getting out of bed; Nausea; vomiting; Red welt below the injection site; This case was reported by a pharmacist via call center representative and described the occurrence of erythema urticarial in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th June 2019, the patient received Shingrix. On 29th June 2019, 1 days after receiving Shingrix, the patient experienced erythema urticarial. On an unknown date, the patient experienced feeling unwell, fatigue, nausea and vomiting. On an unknown date, the outcome of the erythema urticarial, feeling unwell, fatigue, nausea and vomiting were unknown.   It was unknown if the reporter considered the erythema urticarial, feeling unwell, fatigue, nausea and vomiting to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient developed A red welt below the injection site a day after the first dose of Shingrix. The patient went on to feel ill, had nausea, vomiting and fatigue that prevented her from getting out of bed. The reporter consented to follow up. This case is 1 of the 2 linked cases, reported by the same reporter.",,,,,,,,,U,06/28/2019,06/29/2019,1,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836117,09/26/2019,WA,64.0,64,,F,,"swelling; red cheeks/ ruddy cheeks; cheeks were hot; chills; blotches on chest; This case was reported by a consumer via call center representative and described the occurrence of facial swelling in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th June 2019, the patient received the 1st dose of Shingrix (intramuscular). On 28th June 2019, less than a day after receiving Shingrix, the patient experienced facial swelling, red face, feeling of warmth facial, chills and blotchy. On 29th June 2019, the outcome of the facial swelling, red face, feeling of warmth facial, chills and blotchy were resolved with sequelae.   It was unknown if the reporter considered the facial swelling, red face, feeling of warmth facial, chills and blotchy to be related to Shingrix.  Additional details were provided as follows: The patient received a dose of Shingrix in the left arm. The patient stated that on the same day of vaccination experienced swelling on her face and the cheeks were hot and red and ruddy cheeks. The patient also experienced chills and blotches on her chest. The patient consented to follow up.",,,,,,,,,N,06/28/2019,06/28/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836118,09/26/2019,,32.0,,,F,,"Delivered neonate at 36.3 week of gestation; Candidiasis; Urinary tract infection; Vaccine exposure during pregnancy; This is an observational study case, initially received from other health professional on 06-Aug-2019, concerning a 32-year-old, pregnant, female subject of body weight: 199 lbs, height: 60 inches and body mass index (BMI): 38.9, enrolled in a prospective observational safety study.  The subject's obstetrical history noted that the subject had 5 previous pregnancies which included 4 full term, live births and 1 spontaneous abortion. No birth defects were reported. Also, the subject had no maternal or paternal history with major congenital malformations. The subject did not have a prior history of use of tobacco, alcohol or illicit drugs during pregnancy. The subject's medical history included history of deep vein thrombosis. The subject's concomitant medications included Prenatal Vitamins (mineral NOS, vitamin NOS) as a supplement and Lovenox (enoxaparin sodium) for deep vein thrombosis.  The subject's last menstrual period (LMP) date was 27-Aug-2018, estimated delivery date (EDD) was 03-Jun-2019 and corrected estimated date of delivery (CEDD) was 23-Jun-2019. The type of pregnancy was singleton.  On 29-Oct-2018, at gestation age of 9 weeks, the subject was administered Flucelvax QIVc [influenza vaccine, subunit influenza virus vaccine polyvalent, at a dose of 0.5 ml, batch number: 252664, expiration date, route of administration and anatomical location: not reported] (explicitly coded as vaccine exposure during pregnancy) for influenza immunisation.  On 07-Nov-2018, the subject developed urinary tract infection (UTI) and candidiasis. The subject received 0.4% terconazole, administered via vaginal route, as a corrective treatment for candidiasis, and Macrobid (nitrofurantoin) at a dose of 100mg, administered via oral route, two times per day, as a corrective treatment for UTI.   On 08-Nov-2018, the subject recovered from the event of candidiasis', and treatment with terconazole was discontinued.  On 14-Nov-2018, the subject recovered from the event of urinary tract infection', and the treatment with Macrobid was discontinued.  On 28-May-2019, at gestational age of 36.3 weeks, the subject vaginally delivered male neonate (explicitly coded as Premature delivery'). The neonate's birth weight was 3090 g, head circumference was 34.3 cm and length was 48.3 cm. Appearance, pulse, grimace, activity and respiration (APGAR) score at one minute was 7 and at five minutes was 5.  APGAR score was not reported for 10 minutes. No major congenital malformation was identified at birth. There were no pregnancy complications noted.  The case is linked to 201904408, the corresponding child case.  Follow up received by other health care professional on 17-Sep-2019: The information on ongoing use of Lovenox and APGAR score at one minute and at five minutes were provided. Action taken for Lovenox was updated. The narrative was amended accordingly.  Company comment: A 32-year-old female pregnant subject experienced candidiasis, urinary tract infection and premature delivery after receipt of Flu Vaccine Cell Subunit QIV NVD. Chronology seems plausible for the events of candidiasis and urinary tract infection while for premature delivery remains unsuggestive. UTIs are common during pregnancy, because the growing uterus makes pressure on the bladder and urinary tract. Candida infections are also frequent during pregnancy. According to one study, about 20 percent of women have Candida yeast in their vagina normally. That number goes up to 30 percent during pregnancy. Although causality was highly confounded, causal role of the suspect vaccine cannot be totally excluded and is assessed as related for all 3 events. Vaccine exposure during pregnancy assessed as unrelated per company's conventions.; Reporter's Comments: A 32-year-old female pregnant subject experienced candidiasis, urinary tract infection and premature delivery after receipt of Flu Vaccine Cell Subunit QIV NVD. Chronology seems plausible for the events of candidiasis and urinary tract infection while for premature delivery remains unsuggestive. UTIs are common during pregnancy, because the growing uterus makes pressure on the bladder and urinary tract. Candida infections are also frequent during pregnancy. According to one study, about 20 percent of women have Candida yeast in their vagina normally. That number goes up to 30 percent during pregnancy. Although causality was highly confounded, causal role of the suspect vaccine cannot be totally excluded and is assessed as related for all 3 events. Vaccine exposure during pregnancy assessed as unrelated per company's conventions.",,,,,,,,,Y,10/29/2018,10/29/2018,0,Test Date: 20181102; Test Name: Cystic fibrosis mutation analysis; Result Unstructured Data: No major congenital malformation.; Test Date: 20190110; Test Name: Quad screen; Result Unstructured Data: No major congenital malformation.; Test Date: 20181102; Test Name: Spinal muscular atrophy; Result Unstructured Data: No major congenital malformation.; Test Date: 20181029; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.; Test Date: 20181219; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.; Test Date: 20190110; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.; Test Date: 20190401; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.; Test Date: 20190502; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.,UNK,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; LOVENOX,Deep vein thrombosis,Medical History/Concurrent Conditions: Live birth; Multigravida; Spontaneous abortion,,USSEQIRUS201904358,2,09/24/2019,,,,
0836119,09/26/2019,,37.0,,,F,,"Pre-eclampsia; Gestational diabetes; Vaccine exposure during pregnancy; This is an observational study case, initially received from other health professional on 18-Sep-2019, concerning a 37-year-old, pregnant, female subject, of body weight: 191 lbs, height: 65 inches and body mass index (BMI): 31,8, enrolled a prospective observational safety study.  The subject's obstetrical history noted that the subject had three previous pregnancies which included one full-term live birth, one pre-term live birth and one spontaneous abortion. The subject had no history of offspring with major congenital malformation. Also, the subject had no maternal or paternal history with major congenital malformations. The subject did not have a prior history of use of tobacco or alcohol during pregnancy. The subject's current conditions included nausea, vomiting and use of marijuana. The subject's concomitant medication included Prenatal vitamins (mineral NOS, vitamin NOS) for pregnancy.  The subject's last menstrual period (LMP) date was 29-Sep-2018. The subject's estimated delivery date (EDD) and corrected estimated date of delivery (CEDD) were 06-Jul-2019. The type of pregnancy was singleton.  On 12-Nov-2018, at gestational age of 6 weeks, the subject was administered Flu Vaccine Cell Subunit QIV NVD [influenza vaccine, subunit influenza virus vaccine polyvalent; batch number: 252664, dose: 0.5 ml, route of administration, expiry date and anatomical location: not reported] (explicitly coded as 'Vaccine exposure during pregnancy') for influenza immunisation.   On 26-Nov-2018, the subject underwent ultrasound and no major congenital malformation was noted.   On 24-Dec-2018, the subject underwent Qnatal test and no major congenital malformation was noted.   On 24-Jan-2019, the subject underwent ultrasound and no major congenital malformation was noted.   On 31-Jan-2019, the subject underwent MSAFP / serum markers test and no major congenital malformation was noted.   On 04-Mar-2019, approximately three months after vaccination, the subject developed gestational diabetes. No further details were provided.   On an unspecified date, unknown amount of time after vaccination, at gestational age of 29 weeks, the subject developed pre-eclampsia.  At the time of initial reporting, the outcome of the events was not reported.  Company comment: The patient was administered Flu Vaccine Cell Subunit QIV NVD (Flucelvax QIVc) at approximately 6 weeks of gestational age (explicitly considered as vaccine exposure during pregnancy).  The patient experienced gestational diabetes approximately three months after vaccination and pre-eclampsia after the unknown amount of time after vaccination. Chronology seems unsuggestive.  Causality was confounded by patient's use of marijuana. The event of vaccine exposure during pregnancy is assessed as not related based on company's conventions. Causal relationship between the suspect product and events of gestational diabetes and pre-eclampsia is assessed as related.; Reporter's Comments: The patient was administered Flu Vaccine Cell Subunit QIV NVD (Flucelvax QIVc) at approximately 6 weeks of gestational age (explicitly considered as vaccine exposure during pregnancy).  The patient experienced gestational diabetes approximately three months after vaccination and pre-eclampsia after the unknown amount of time after vaccination. Chronology seems unsuggestive.  Causality was confounded by patient's use of marijuana. The event of vaccine exposure during pregnancy is assessed as not related based on company's conventions. Causal relationship between the suspect product and events of gestational diabetes and pre-eclampsia is assessed as related.",,,,,,,,,U,11/12/2018,11/12/2018,0,Test Date: 20190131; Test Name: MSAFP; Result Unstructured Data: No major congenital malformation.; Test Date: 20181224; Test Name: Qnatal; Result Unstructured Data: No major congenital malformation.; Test Date: 20181126; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.; Test Date: 20190124; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.,UNK,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS],Marijuana use,Medical History/Concurrent Conditions: Live birth; Multigravida; Nausea; Premature delivery; Spontaneous abortion; Vomiting,,USSEQIRUS201904700,2,09/25/2019,,,,
0836120,09/26/2019,,,,,F,,"Premature delivery; Yeast; Anemia; Vaccine exposure during pregnancy; This is an observational study case, initially received from other health professional on 18-Sep-2019, concerning a 29-year-old, adult female pregnant subject of body weight: 144 lbs, height: 64 inches and body mass index (BMI): 24.7 [ethnicity: not reported] enrolled in a study.  The subject's obstetrical history included seven previous pregnancies (five full term live births, one preterm live birth and one spontaneous abortion). The subject did not have history of offspring with major congenital malformation (MCM) and did not have maternal and paternal history with MCM. The subject did not consume tobacco, alcohol and illicit-drugs.  The subject's historical condition included bacterial vaginosis. The subject's historical medication included Metrogel (metronidazole). The subject's concomitant medications included Prenatal vitamin (unspecified vitamins).   The subject's last menstrual period (LMP) date was 25-Jun-2018. The subject's estimated delivery date (EDD) and corrected estimated delivery date (CEDD) were 01-Apr-2019. The type of pregnancy was singleton.  On 01-Aug-2018, the subject performed cystic fibrosis mutation analysis and spinal muscular atrophy (mother+carrier) and no MCM was noted.  On 07-Aug-2018 and 13-Aug-2018, the subject underwent ultrasound and no MCM was noted.  On 15-Oct-2018, approximately at gestational age of 16 weeks, the subject was administered Flu Vaccine Egg Split QIV NVD (Flucelvax QIVc) (influenza vaccine, subunit influenza virus vaccine polyvalent, batch number: 252664, dose: 0.5 ml, route of administration, anatomical location and expiration: not reported) (explicitly coded as Vaccine exposure during pregnancy) for Influenza immunisation.  On 15-Oct-2018, the subject performed Quad screen and ultrasound and no MCM was noted.  On 12-Dec-2018, 1 month and 27 days after vaccination, the subject developed anemia. The subject started corrective treatment with ferrous sulfate, at dose of one tablet, twice a day, orally.  On 22-Dec-2018, the subject recovered from anemia.  On 09-Jan-2019 and 31-Jan-2019, the subject underwent ultrasound and no MCM was noted.  On 14-Feb-2019, 3 months and 30 days after vaccination, the subject developed yeast. The subject started corrective corrective treatment with Metrogel (metronidazole), 0.75% gel, twice a day, vaginally.   On 21-Feb-2019, the subject underwent ultrasound and no MCM was noted.  On 24-Feb-2019, the subject recovered from yeast.  On 09-Mar-2019, at gestational age of 36.7 weeks, the subject vaginally delivered male neonate. No pregnancy complications were noted. The neonate's birth weight was 2977 g, head circumference was 33 cm and length was 52.1 cm. Appearance, pulse, grimace, activity and respiration (APGAR) score at one minute was 9, at five minutes was 9 and no data was reported for APGAR score at ten minutes. No major congenital malformation was identified at birth.  This case is linked to 201904705, the corresponding child case.  Company comment:The patient was administered Flu Vaccine Egg Split QIV NVD (Flucelvax QIVc) at approximately 16 weeks of gestational age (explicitly considered as vaccine exposure during pregnancy).  The patient experienced anaemia and fungal infection, approximately two and four months after vaccination, respectively. Chronology seems plausible. At 36.7-week gestational age, the subject gave birth to a male infant (reported as preterm delivery). The decision to administer a vaccine during pregnancy is related to medical decision making by the mother and her physician and is not related to any property of the medication. The event of vaccine exposure during pregnancy is assessed as not related considering the intended use of the vaccine. Causal relationship between the suspect product and events of anaemia, fungal infection and preterm delivery is assessed as related.; Reporter's Comments: The patient was administered Flu Vaccine Egg Split QIV NVD (Flucelvax QIVc) at approximately 16 weeks of gestational age (explicitly considered as vaccine exposure during pregnancy).  The patient experienced anaemia and fungal infection, approximately two and four months after vaccination, respectively. Chronology seems plausible. At 36.7-week gestational age, the subject gave birth to a male infant (reported as preterm delivery). The decision to administer a vaccine during pregnancy is related to medical decision making by the mother and her physician and is not related to any property of the medication. The event of vaccine exposure during pregnancy is assessed as not related considering the intended use of the vaccine. Causal relationship between the suspect product and events of anaemia, fungal infection and preterm delivery is assessed as related.",,,,,,,,,Y,10/15/2018,10/15/2018,0,Test Date: 20180801; Test Name: Cystic fibrosis mutation analysis; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20181015; Test Name: Quad screen; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20180801; Test Name: Spinal muscular atrophy (mother+carrier); Result Unstructured Data: No major congenital malformation noted.; Test Date: 20180807; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20180813; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20180827; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20181015; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20190109; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20190131; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.; Test Date: 20190221; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation noted.,UNK,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS],,Medical History/Concurrent Conditions: Bacterial vaginosis; Live birth; Multigravida; Premature delivery; Spontaneous abortion,,USSEQIRUS201904704,2,09/25/2019,,,,
0836123,09/26/2019,MO,69.0,69,,F,09/25/2019,Pt C/O allergic reaction redness and swelling believes it was accident given SC instead of IM,,,,,,,,,Y,07/08/2019,,,N/A,UNK,UNK,unknown,unknown,unknown,,,1,,,,,
0836127,09/26/2019,GA,15.0,15,,F,09/24/2019,"After receiving a HPV injection, pts. color turned pallor, pt. became non-verbal, and began to slide from her chair. Pts. mother cuddled her & she did not slide from chair - within 30 seconds, pt. was alert and oriented and again verbal. Pt. never loss consciousness. Pt. was allowed to lye down in clinic room & observed.",,,,,,,,,Y,09/09/2019,09/09/2019,0,N/A,PUB,PVT,None known,None known,None known,,,1,,,,,
0836128,09/26/2019,MA,69.0,69,,F,,"Woke up shivering, whole body felt tight, muscle pain and weakness, fever 100.5, headache not relieved with Tylenol,loss of appetite,  exhaustion.  No energy to do anything. Slept 11 hours straight last night.  Felt better when awoke at 6:30. a.m.  All symptoms gone.",,,,,,,,,Y,09/24/2019,09/25/2019,1,Did not seek medical attention. Read CDC website. Thank you. Never experienced anything like this before from vaccine.,PHM,,Paroxetine.  Indapamide Potassium,None,Hypertension,,,2,09/26/2019,,,,Sulfa
0836129,09/26/2019,MI,65.0,65,,F,,"Increased secretions, throat swelling, extreme difficulty swallowing own secretions, took Benadryl 50 mg at home. No improvement after 45-60 minutes. Treated in ED with IV steroids and Benadryl. Symptoms resolved over 1 hour Oral steroids for 3 days at home",,,,,,,,,Y,09/24/2019,09/24/2019,0,,PVT,,,None,RA,,,2,09/26/2019,,,Y,Tetracycline Plaquenil
0836130,09/26/2019,IN,6.0,6,,F,,"Patient had her vaccine on 9/22 at 3:02pm. By the next day, she came home from school and had mosquito and quarter size hives all over her upper body, and was itching. I took her into where she had her vaccine done, and they couldn?t tell me if it was a directly related to the vaccine. Told me to give her Benadryl and apply hydro cortisone cream.  By early morning (9/24), her hives had spread all the way down her legs, and the hives were raised and  severely spread all across her back and stomach. I took her to the emergency room, and they said the rash matched that of her left arm where she received her vaccine. They prescribed her Cetirizine & presnizolone, along with a prescription to take home. The next morning (9/25), she had hives again (not as severe), and we have her the prescribed medication and she was better a few hours later. We have been continuing  to take the prescribed medicine.",,,,,,,,,N,09/01/2019,09/22/2019,21,,PVT,,N/A,N/A,N/A,,,2,09/26/2019,,,,N/A
0836131,09/26/2019,CA,1.0,1,.0,F,,My infant rec'd 6 vaccines on 8/21. i have her vaccine record but do not have the specifics on the manufacturer/sites etc.  The evening of 8/21 she developed a fever. The afternoon of 8/22 she had a tonic clonic sz that was dx as febrile in nature.,,,,,,,,,Y,08/21/2019,08/22/2019,1,My infant had a blood sugar done by the ambulance personal and a straight cath for UA in the ER.,PVT,,N/A,N/A,N/A,,,2,09/26/2019,,,Y,N/A
0836132,09/26/2019,KY,49.0,49,,F,,"Employee received MMR on 9/13/2019 r/t nonimmunity to Rubella. Employee complain of rash that started on face, knots to back of head, itching, ""feeling funny in the right facial area"" on 9/25/2019, employee to see clinic provider on 9/26/2019 with rash to face, neck, trunk, BUE's, BLE's to mid-thigh area, large amount of redness to both eyes with watering, itching, soreness to bilateral lymph nodes, dizziness.",,,,,,,,,N,09/13/2019,09/25/2019,12,"Measles IgG and IgM, CBC, collected on 9/26/2019, buccal swab scheduled for 9/27/19 per Department of Public Health request.",OTH,,"Metformin, Glipizide",none,diabetes,,,2,09/26/2019,,Y,,no
0836133,09/26/2019,,16.0,16,,F,,"Pt in clinic today for raised, red area where injection was given. She reported it started the night of the injection the area was red, warm and raised. Area has been slowly going down in size, still noted today a quarter sized area that was red and raised.",,,,,,,,,Y,09/17/2019,09/17/2019,0,,PVT,,,,,,,2,09/26/2019,,Y,,
0836134,09/26/2019,WI,65.0,65,,F,,"Patient states that approximately 8-9 hours following vaccination (around 9pm), she started to develop a fever and what she reported as ""extreme"" chills.  She states that the shaking from the chills was enough that she was unable to hold a book or concentrate on anything.  She took a dose of acetaminophen and went to bed, waking midway through the night still running a fever of 100.3.  At the time she called me on 9/25/19, she stated that her fever was resolving, and she had not had any repeat episodes of the chills, but she wanted to inquire why those side effects were not listed on the VIS given at time of vaccination.",,,,,,,,,Y,09/24/2019,09/24/2019,0,none,PHM,,None reported,None reported,None reported,Patient states similar symptoms from dose 1 of Shingrix that she never reported.  Less severe and no chills.,,2,09/26/2019,,,,Penicillin
0836135,09/26/2019,CA,69.0,69,,F,,"Muscle ache, tiredness, easily chilled, slight fever (100 F),swelling/redness/inflammation at injection site.",,,,,,,,,,09/23/2019,09/24/2019,1,,PHM,,Losartan 50mg,None,High blood pressure,"Similar, but not as severe, side effects following first shingrix vaccine.",,2,09/26/2019,,,,None
0836136,09/26/2019,LA,81.0,81,,F,,BRUISED AND SORE AT INJECTION SITE BEGINNING DAY OF ADMINISTRATION. STILL EXPERIENCING SORENESS AND BRUISING TODAY 9/26/2019,,,,,,,,,N,09/09/2019,09/09/2019,0,NONE,PHM,,NONE,NONE,NONE,,,2,09/26/2019,,,,NKDA
0836137,09/26/2019,GA,71.0,71,,F,,"PATIENT CAME TO PHARMACY AND SHOWED ME HER RIGHT ARM. IT WAS RED AND INFLAMMED. LOOKED LIKE SHE HAD A SMALL BRUISE WHERE THE INJECTION WAS ADMINISTERED. SHE SAID IT STARTED ON 9-24-19, BUT HAD NOT SPREAD DOWN HER ARM AND STAYED LOCALIZED TO HER UPPER DELTOID AREA. SHE SAID SHE HAD NOT TAKEN ANY ANTIHISTAMINES OR ANTIPYRETICS. SHE STATED TO NOT HAVE A FEVER. I ADVISED HER TO TAKE EITHER TYLENOL OR IBUPROFEN IF IT WAS TENDER OR IF SHE DEVELOPED A LIGHT FEVER AND TO ALSO TAKE BENADRYL OR ANOTHER ANTIHISTAMINE TO HELP WITH THE REDNESS AND SWELLING, AND IF IT CONTINUED TO GET WORSE TO CONSULT WITH HER PRIMARY CARE PROVIDER.",,,,,,,,,N,09/24/2019,09/24/2019,0,,PHM,,"LISINOPRIL 10MG, PRAVASTATIN 80MG",NONE REPORTED,"HYPERTENSION, HYPERLIPIDEMIA",,,2,09/26/2019,,,,NONE REPORTED
0836138,09/26/2019,TN,68.0,68,,F,,"Patient called and reported severe pain in right shoulder where Pneumovax was given earlier in the day, also reported swelling at site as well. Advised patient to take benedryl in case this was an allergic reaction and to go to the emergency room or urgent care for physician's evaluation.",,,,,,,,,U,09/25/2019,09/25/2019,0,Unknown.,PHM,,"tacrolimus, primidone, furosemide, alprazolam, ezetemibe, mycophenolate, clopidogrel, pravastatin",Heart transplant patient,Heart transplant patient,,,2,09/26/2019,,,,None
0836139,09/26/2019,FL,2.0,1,1,F,,"Mom reported upper lip swelling about one hour after receiving seasonal flu vaccine in clinic. There was some fussiness but no other swelling, no hives, no difficulty or noisy breathing,  and no vomiting. Child was brought back to clinic and evaluated. She was given 12.5mg of diphenhydramine and observed for 1.5 hours without further symptoms. Strict precautions were given on symptoms and signs to look for to seek medical attention.",,,,,,,,,N,09/26/2019,09/26/2019,0,none,PVT,,None,None,none,,,2,09/26/2019,,Y,,"None reported at time of visit. Had reported previous swelling of lip and hives after eating eggs as an infant, but tolerated eggs subsequently without reaction. Reported no egg allergy on screening questionnaire."
0836140,09/26/2019,NY,70.0,70,,F,,Half dollar size bruise,,,,,,,,,,09/21/2019,09/21/2019,0,,PHM,,,,,,,2,09/26/2019,,,,
0836141,09/26/2019,SC,87.0,87,,F,,"Pt diagnosed with cellulitis and treated with steroid dose pack and doxycycline. Day 9 after shot and patient complains of redness, swelling and warm to the touch in the area of shingrix.",,,,,,,,,U,09/17/2019,09/18/2019,1,,PHM,,"Doxycycline and methylprednisolone give for cellulitis. Patient states redness, swelling, warm to the touch at sight of injection",,,,,2,09/26/2019,,Y,,
0836142,09/26/2019,AZ,54.0,54,,F,,"Started feeling body aches and a sharp pain in my ovary around 4PM the following day 9/24.  I was drinking more water than normal.  When I urinated it felt warmer than usual.  As the evening went on I the aches increased, I had a severe all over headache, had occasional  sharp pains in my right ovary,  and I was vomiting, not able to keep anything down.  I was not urinating nor did I have a BM on 9/25.  Although much better today 9/26, I am fully functioning, but still feeling weak and noticed a rash on both sides of my neck. My headache is still present but much better (from an 8 pain score to a 3), but only after I took some Aleve this morning.",,,,,,,,,,09/23/2019,09/24/2019,1,"No tests.  I reported it to my doctor this morning.   For Item 20:  I have not recoded completely, so none of the options seem to fit my current situation.",PVT,,Armour Thyroid 30mg Vyvanse 50mg SeroVital - Supplement,"No other illnesses.  However, I received a first round of  Hep A and Hep B vaccinations on  09/16/2019.",,,,2,09/26/2019,,,,Niacin
0836143,09/26/2019,GA,12.0,12,,F,,"Injections given and patient asked to lie down for 5-7 minutes since receiving  Gardisil vaccine.  Patient in room with sibling. Sibling reported that after about 5 minutes patient got up from supine position, stood, became weak and fainted.  Sibling called for help. Patient was pale, clammy and semi- alert.  Placed back on bed in supine position and attended to by physician.  After about 25 minutes skin color pinked up and she was alert and felt well.  She got up to leave and in the waiting room became weak, dizzy and almost passed out again.  Patient was pale again and alert. She felt dizzy.  Placed in supine position on bed with knees up. Blood glucose level checked and at 99. B/P was at 72/40.  Given oral fluids and pretzels to eat.  Patient observed about 45 minutes and B/P was at 98/69.  No longer pale, alert and oriented and dizziness improving.  Patient rechecked by physician  and released to home.",,,,,,,,,Y,09/24/2019,09/24/2019,0,None,PVT,,None,None,None,,,2,09/26/2019,,,,None
0836144,09/26/2019,TX,72.0,72,,F,,"4 Hours after injection the patient reported an ""egg shaped hard spot"". 6 hours after injection this area grew to 4x5 inches. Patient took 2 Tylenol 500mg at this point. The area became swollen and red hot at this time. 7 hours after injection the area grew to 6x6inches. 9 hours after injection the area began itching. At 4:30AM the next day, the entire arm was swollen from the shoulder to the elbow. Patient was given a ""steroid shot at urgent"" care this morning and a Medrol pack to follow the next day. Patient was also given hydroxyzine 10mg.",,,,,,,,,,09/25/2019,09/25/2019,0,Patient was seen at Urgent Care and treated by physician.,PHM,,"Rosuvastatin 20mg, Cetirizine 10mg",None,High Cholesterol,,,2,09/26/2019,,,Y,None
0836145,09/26/2019,CA,34.0,34,,F,,"Within 30 minutes of receiving the Boostrix Tdap shot, I suffered a severe allergic reaction. My whole body became heavy, and I was unable to move or get out of bed. I felt a wave of extreme fatigue and weakness wash over me and was in a mental fog. My mental intake and comprehension, as well as my response time was greatly slowed. I was able to finally get out of bed about an hour after the reaction, but stayed in a mental fog for weeks, if not months after that. The fatigue is overwhelming and has not gone away.",,,,,,,,,N,07/10/2017,07/10/2017,0,3 separate doctor visits to address fatigue and mental symptoms. Diagnosis and treatment ongoing.,PVT,,"Levothyroxine, Liothyronine, prenatal vitamin",n/a,Hypothyroidism,,,2,09/26/2019,,Y,,n/a
0836146,09/26/2019,VA,66.0,66,,F,,Immediately upon injection I felt like I had received an electric shock.   A few hours later I began shivering severely and uncontrollably.   This lasted for hours.    Later I developed a severe headache.   I vomited and felt weak and dizzy.   I still feel ill.  I have never had a reaction to any vaccine like this.   I was very frightened until I googled Shingrix reactions and realized my problems were common.,,,,,,,,,N,09/25/2019,09/25/2019,0,,PHM,,"Lialda, Citalopram, vitamin/mineral supplement",NONE,Ulcerative Colitis,,,2,09/26/2019,,,,NONE
0836147,09/26/2019,TN,30.0,30,,F,,"After receiving my TDAP vaccine, I experienced the expected soreness in my left arm at the injection site. But in the early morning of the 3rd day I began feeling extreme pain, which only increased daily to the point where my husband insisted on taking me to the ER.  The pain feels as though my arm is being ripped out of it's socket. It is a constant pain that is only increasing over time. My left arm is completely useless. It is not paralyzed or anything, but is immobile unless I am willing to endure extreme, excruciating pain. The ER sent me home with instructions to follow up with my clinic when they opened that morning (I checked into the ER shortly before 04:00am on the morning of September 25, 2019). My clinic suggested Motrin for 48 hours and to see them if after 48 hours the pain did not decrease. The pain increased again overnight and my clinic was able to see me today, September 26th, around 11am. They suggested 72 hours of Motrin as needed, and told me if the pain is still there on Monday they will send me to a neurologist. Therefore, we are assuming there has been nerve damage.  There was never any swelling, redness, or signs of fever. I am 28 weeks pregnant, with 2 living boys whom have both been fully vaccinated with no issues. My due date is Dec 17, 2019.",,,,,,,,,N,09/19/2019,09/22/2019,3,N/A,PVT,,"Prenatal Vitamins, iron supplements",N/A,N/A,,,2,09/26/2019,,,,N/A
0836148,09/26/2019,UT,69.0,69,,M,,"Pain reported upon insertion of needle in upper left arm.  Patient said the pharmacist saw him wince in pain and ask if he wanted to continue and patient said yes.  Pharmacist finished administering vaccine and patient reports pain has been consistent in the area of administration since the time of the injection. It is now a week later and he is still reporting pain in the area of the injection site and he is not able to fully use his arm for lifting/etc at work.  It is not red or warm to the touch, hard or inflamed in any way when we observed it today.  Advised to use ibuprofen, tylenol or ice  and if it continues to seek medical attention.",,,,,,,,Y,N,09/18/2019,09/18/2019,0,None,PHM,,N/A,NONE,NONE,,,2,09/26/2019,,,,N/A
0836149,09/26/2019,MI,59.0,59,,F,,"Immunization given 09/24 in morning, by 11am patient experienced headache. Developed fatigue, fever by 3pm. Patient called primary doctor and was advised to treat symptoms and call back if temperature was over 100. Patient woke 09/25 arm was visibly swollen and red. Arm was warm to touch and area grew as day progressed. Patient came to pharmacy after 7pm. Arm was visibly swollen, redness was approximately 5 inches in diameter. Patient was still complaining of fatigue and fever and lower back and hip pain. Patient was still wearing the band aid and it appeared to be below the deltoid",,,,,,,,,U,09/24/2019,09/24/2019,0,,UNK,,none,none,none,,,2,09/25/2019,,,,none
0836150,09/26/2019,NC,11.0,11,,M,,after receiving shoT we wenT home and I kepT an eye on him because of family hisTory he sTarTed geTTing raspy at first I said maybe he caughT someThing buT he jusT kepT geTTing worse To fasT for a cold his sTomach sTarTed to hurT I gave him some sysrazine he sounded worse as Time wenT on I Took him back to Drs and Dr. (PA had done shoT) who gave me his # and sTronger for His sTomach,,,,,,,,,Y,08/28/2018,08/28/2018,0,,UNK,,,,,,,2,01/16/2019,,Y,,
0836151,09/26/2019,OH,76.0,76,,F,,Very nauseated for 3 days - couldn't bend over I was so sick to my stomach,,,,,,,,,Y,08/31/2019,09/01/2019,1,,PHM,,Capitoday-Zocor-Lipitor-Advair-Flonase-Spiriva,None,"Asthma, COPD-Back",,,2,09/18/2019,,,,Sulpha
0836152,09/26/2019,FL,80.0,80,,F,,Pt felt fine had shingles shot Next day began to have acute abdominal pain found to have blocksage in ER,,,,,,,,,Y,09/15/2019,09/16/2019,1,CT abdomen; supportive care IV fluid's,PVT,,,Elevchol; Increase Glucose;,Hx Bladder cn Hx Merkle cell,,,2,09/26/2019,,,Y,Tolteracine
0836153,09/26/2019,NC,77.0,77,,F,,"On 05/18/19 I received the first Shingrix shot without experiencing side effects.  On 07/17/19 I received the second Shingrix shot at 9:00 a.m. at the same Pharmacy and continued with my usual daily routine. At bed time (about 10:00 p.m.) I suddenly started to shiver uncontrolably and felt ice-cold for several minutes. When the shivers finally subsided, I fell asleep. The next morning (07/18/19) I felt slightly nauseated and very sweaty but forced myself to get up and feed the cat. When I was in the process of setting his bowl on the floor, I lost consciousness and collapsed on the concrete floor. My partner heard the shattering of the food bowl and found me. When I came to he helped me back to bed and called the ER at Hospital. The doctor on duty, urged my partner to bring me to the ER, since I had experienced syncope and collapse. By the time we reached the hospital, I was feeling well again (aside from a couple of bruises from the fall). Because the tests run by the ER staff showed no abnormalities, they concluded that the episode I had experienced was attributable to the Shingrix shot.  It turned out to be a very expensive shot.",,,,,Y,,,,Y,07/17/2019,07/17/2019,0,Showed no abnormalities,PHM,,"Turmeric, Centrum Silver Women",None,None,,,2,09/23/2019,,,Y,None
0836154,09/26/2019,RI,49.0,49,,F,,"Redness, edema left arm",,,,,,,,,Y,09/20/2019,09/22/2019,2,None,PVT,,,,,,,2,09/23/2019,,,,
0836155,09/26/2019,NC,57.0,57,,F,,"-Local reaction to (L) arm vaccine site including redness, swelling, itching and burning in (L) deltoid area.  -Treated with Elocon Cream & Cold compress application -Pt. also experienced redness/flushing of skin on chest",,,,,,,,,Y,09/19/2019,,,None,PHM,,"Escitalopram, Nexium, Zolpidem",None,"GERD, Insomnia, Anxiety & Depression",,,2,09/24/2019,,Y,,"Meloxicam, Penicillin, Sulfa, Ciprofloxacin"
0836180,09/26/2019,,,,,M,,"Just one case LSIL due to 6/58; This spontaneous report was received from a physician via a company representative referring to unspecified patients, one of them a male patient of unknown age. Information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was not provided.  On an unknown date, the patient was vaccinated with a dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, route of administration, lot # and expiration date were not reported), as primary prevention of anal cancer.  Information was identified on a slide presentation. The following information was reported:  Long-term follow up studies of 4 valent human papillomavirus (HPV) vaccine in male Data 11.5 years No new cases of condilomas fue to HPV 6/11 nor external genital lesions due to 6/11/16/18 No lesion high grade squamous intraepithelial lesion (HSIL) 6/11/16/18 Just one case low grade squamous intraepithelial lesion (LSIL) due to 6/58  On an unknown date, the patient experienced (LSIL). The outcome of the event was unknown.  The causality assessment was not provided by the reporter.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909ESP008727,2,09/26/2019,,,,
0836181,09/26/2019,TX,,,,U,,"No adverse effect reported; One dose of an improperly stored vaccine, VARIVAX, was administered to one patient.; Reporter confirmed route of administration was ""intramuscular""; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications and previous drugs reactions or allergies were not provided.  On 11-SEP-2019, the patient was vaccinated with one dose of an improperly stored, varicella virus vaccine live (oka/merck) (VARIVAX) injection, at a dose of 0.5 milliliter (ml), intramuscularly, as prophylaxis (strength, number of dose, and anatomical location of vaccination were not reported; lot number S002877 has been verified to be valid for varicella virus vaccine live (oka/merck); expiration date: 29-JAN-2019) (product storage error, and incorrect route of product administration). It was reported that sterile diluent (lot number S000130 has been verified to be valid); expiration date: 23-AUG-2021 (reported as possible dates) was used to reconstitute the aforementioned vaccine , also it was reported that it was stored in the correct storage temperature range.  The temperature and time frame were 8.1 degrees Fahrenheit (F), for 20 minutes, respectively a previous temperature excursion were at  8.1 degrees Fahrenheit (F) for 17 minutes and 9.5 degrees Fahrenheit (F) for 21 minutes. A data logger was used. No adverse effect was reported.",,,,,,,,,U,09/11/2019,09/11/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005698,2,09/26/2019,,,,
0836182,09/26/2019,AZ,,,,U,,"Red welt below injection site; This case was reported by a pharmacist via call center representative and described the occurrence of erythema urticarial in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced erythema urticarial. On an unknown date, the outcome of the erythema urticarial was unknown.   It was unknown if the reporter considered the erythema urticarial to be related to Shingrix.  Additional details were provided as follows: The age group was not reported, but was selected adult as per vaccine indication. The patient developed red welt below the injection site a day after the 1st dose of Shingrix. The symptoms lasted a few days. She did not have data for the 2nd patient. The reporter consented to follow up. This case was linked with the case , reported by the same reporter.",,,,,,,,,U,,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836183,09/26/2019,IL,,,,U,,"Site of injection is hard; Site of injection is painful; Site of injection is swollen; Many side effects (flu like); Swollen lymph nodes in neck and a really painful one under arm pit/enlarged lymph node; Malaise; Muscle aches; Temperature; Headache; Pain in left armpit; This case was reported by a consumer and described the occurrence of injection site induration in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th September 2019, the patient received the 1st dose of Shingrix. In September 2019, 1 day after receiving Shingrix, the patient experienced injection site induration, injection site pain, injection site swelling, influenza-like symptoms, lymphadenopathy cervical, malaise, muscle pain, fever, headache and axillary pain. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the injection site induration, injection site pain, injection site swelling, influenza-like symptoms and malaise were unknown and the outcome of the lymphadenopathy cervical, fever, headache and axillary pain were not recovered/not resolved and the outcome of the muscle pain was recovering/resolving.   It was unknown if the reporter considered the injection site induration, injection site pain, injection site swelling, influenza-like symptoms, lymphadenopathy cervical, malaise, muscle pain, fever, headache and axillary pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient recieved shingrix and had many side effects flu like symptoms. The patient also had swollen lymph nodes in neck and a painful one under my arm pit. The patient had malaise, muscle aches, temperature, Headache, swollen lymph node in neck and pain in her left arm pit yesterday. The patient has worse arm pit pain and an enlarged lymph node. She noted the site of the injection was hard, swollen and painful. She has taken Tylenol and did not feel the muscle aches are better. She still has slight headache and temperature today. She did not believe the lymph node in her left arm pit was decreased in size. The one from her neck has resolved completely.",,,,,,,,,N,09/14/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0836184,09/26/2019,OR,,,,U,,"Severe reaction; This case was reported by a other health professional and described the occurrence of adverse reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient had a severe reaction to the Shingrix vaccination and thought that the reporter should be aware of.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0836186,09/26/2019,WA,58.0,,,F,,"Malaise; Injection site soreness; Patch of pox-like lesions on my abdomen that were raised and red; it did indeed look like shingles; raised Rash / lesion; This case was reported by a consumer and described the occurrence of malaise in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chickenpox (had chicken pox as a child).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced malaise, injection site pain, red rash, vesicular rash and raised rash. On an unknown date, the outcome of the malaise and injection site pain were unknown and the outcome of the red rash, vesicular rash and raised rash were recovered/resolved.   It was unknown if the reporter considered the malaise, injection site pain, red rash, vesicular rash and raised rash to be related to Shingrix.  Additional details were provided as follows: The patient had chicken pox as a child and was exposed to it when, the patient's children also had chicken pox. The patient never had shingles previously. The patient had no evidence of severe allergic reaction after vaccination. Less than 2 years after vaccination with dose of Shingrix, the patient experienced red rash, vesicular rash and raised rash . Few days after, the patient had patch of pox like lesions on my abdomen that were raised and red, unlike any type of rash or bug bite. The patient contacted to doctor, who asked to sent a picture of the rash confirmed that it did indeed look like shingles, even though theoretically it should not occur with a non live virus vaccine. The patient stated that, rash resolved in 10 days.",,,,,,,,,Y,,,,,UNK,,,,Medical History/Concurrent Conditions: Chickenpox (had chicken pox as a child),,USGLAXOSMITHKLINEUS2019AM,2,09/26/2019,,,,
0836187,09/26/2019,TX,72.0,72,,F,,"Injection Site Itching; Injection Site Irritation; Sore arm/Difficulty laying on her side due to the sore arm; Chills; Sleepiness; Red 3 inch circle at injection site; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (on face, about 10 years ago).   On 9th September 2019, the patient received the 1st dose of Shingrix. On 9th September 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. On 10th September 2019, the patient experienced chills and sleepiness. On 12th September 2019, the patient experienced injection site erythema, injection site itching and injection site irritation. On an unknown date, the outcome of the pain in arm, chills, sleepiness and injection site erythema were recovered/resolved and the outcome of the injection site itching and injection site irritation were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, chills, sleepiness, injection site erythema, injection site itching and injection site irritation to be related to Shingrix.  Additional case details were provided as follows: The patient received Shingrix on left arm. On the day of getting the vaccine, the patient had sore arm that lasted for about 3 days.  Due to the sore arm, she had difficulty laying on her side.  On the next day, the patient experienced chills and sleepiness that lasted for about one day.  On day 3 after vaccination, the patient noticed red 3 inch circle at injection site associated with itching and irritation. After 7 days, the redness had faded but the itching and irritation were still present periodically. The patient did not consent to follow-up. This case has been linked to US2019AMR168832, reported by the same reporter. No further details were provided.",,,,,,,,,N,09/09/2019,09/12/2019,3,,UNK,,,,"Medical History/Concurrent Conditions: Shingles (on face, about 10 years ago)",,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836188,09/26/2019,TN,76.0,76,,F,,"Vertigo; Dizziness; Nausea; Diarrhea; Fatigue; This case was reported by a nurse via call center representative and described the occurrence of fatigue in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th September 2019, the patient received Shingrix. On 15th September 2019, 1 days after receiving Shingrix, the patient experienced fatigue. On 16th September 2019, the patient experienced vertigo, dizziness, nausea and diarrhea. On an unknown date, the outcome of the fatigue, vertigo, dizziness, nausea and diarrhea were recovering/resolving.   It was unknown if the reporter considered the fatigue, vertigo, dizziness, nausea and diarrhea to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient experienced fatigue, vertigo, dizziness, nausea and diarrhea. The reporter stated that, the events were much better at the time of reporting. No further information was provided at the time of reporting regarding vaccine and events. The reporter consented to follow up.",,,,,,,,,N,09/14/2019,09/15/2019,1,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836189,09/26/2019,NY,67.0,67,,F,,"Dizzy / Dizziness; Nauseous; Vomit; Fell in bathroom a few times; Feeling hot; Muscle aches; Sore arm/feet hurt; Severe flu like symptoms; Headache; Chills; Feeling off center; vertido; hyperventilating; not able to catch her breath; feel thristy; breathing more deeply and through her mouth; This case was reported by a physician via call center representative and described the occurrence of pain in arm in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included breast cancer. Previously administered products included Shingrix (received 1st dose 2 months ago,refer case US2019AMR168728).   In September 2019, the patient received the 2nd dose of Shingrix. On 12th September 2019, less than a day after receiving Shingrix, the patient experienced pain in arm, influenza-like symptoms, headache, chills, muscle pain and feeling hot. On 13th September 2019, the patient experienced dizziness, nausea, vomiting and fall. In September 2019, the patient experienced feeling abnormal, vertigo, hyperventilation, shortness of breath, thirst and mouth breathing. The patient was treated with ranitidine, antiinflammatory/antirheumatic products (Anti-Inflammatory), non-drug therapy (Heating Pad (Nos)) and non-drug therapy (Ice Pack (No Medication)). Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm, chills, nausea, vomiting, muscle pain, fall, feeling hot, feeling abnormal, vertigo, hyperventilation and shortness of breath were recovered/resolved and the outcome of the influenza-like symptoms, thirst and mouth breathing were unknown and the outcome of the headache and dizziness were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, influenza-like symptoms, headache, chills, dizziness, nausea, vomiting, muscle pain, fall, feeling hot, feeling abnormal, vertigo, hyperventilation, shortness of breath, thirst and mouth breathing to be related to Shingrix.  Additional details were provided as follows: The patient had injections in her right arm.  The patient received Shingrix and had sore arm and experienced severe flu like symptoms. All the symptoms she experienced are listed in this report under adverse events.  The patient felt so dizzy that she fell in her bathroom a few times. The dizziness caused her to be nauseous and vomit. She has been taking Ranitidine and anti-inflammatories and they have helped with the nausea and muscle aches. All symptoms have resolved except for headache, dizziness and nausea which are still present on and off. She described it as still feeling off center. She used a heating pad and ice packs for the muscle aches. She said her feet also hurt but they always hurt. The reporter stated that the dizziness has gotten better and was more like vertigo at the time of reporting. She states she has been drinking alot and feels thirsty since receiving Shingrix. It could be that she was breathing more deeply and through her mouth, hyperventilating, not able to catch her breath when she was vomiting. The reporter consented to follow up.",,,,,,,,,N,09/01/2019,09/01/2019,0,,UNK,,,,Medical History/Concurrent Conditions: Breast cancer,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836190,09/26/2019,PA,30.0,30,,M,,"injection site pain; joint pain; swelling; Arm warm to the touch; Arm partially immobile; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 30-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) (batch number P4DN4, expiry date 30th June 2020) for prophylaxis.   On 11th September 2019, the patient received Fluarix Quadrivalent 2019-2020 season. On an unknown date, 2 days after receiving Fluarix Quadrivalent 2019-2020 season, the patient experienced injection site pain, joint pain, swelling, skin warm and mobility decreased. On an unknown date, the outcome of the injection site pain, joint pain, swelling, skin warm and mobility decreased were unknown.   It was unknown if the reporter considered the injection site pain, joint pain, swelling, skin warm and mobility decreased to be related to Fluarix Quadrivalent 2019-2020 season.  Additional details were provided as follows: The patient received Fluarix Quadrivalent 2019-2020 season and 2 days later experienced pain at the injection site, joint pain, swelling, arm was warm to the touch, and had partial immobility. The reporter did not consent to follow up.",,,,,,,,,U,09/11/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836191,09/26/2019,IL,78.0,78,,M,,"Upper and lower arm are red / very red; Blister inside the upper arm; Redness at the injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 78-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 11th September 2019, 2 days after receiving Shingrix, the patient experienced injection site erythema. On 15th September 2019, the patient experienced erythema of extremities and blister. On an unknown date, the outcome of the injection site erythema, erythema of extremities and blister were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, erythema of extremities and blister to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine on unknown arm. About 5 days later the patient visited the pharmacy and there was redness at the injection site.  The patient said the redness started about 2 days after getting the vaccine.  The patient was instructed to put an icepack on the redness.  The patient was at the pharmacy again on day before reporting and 6 days after receiving Shingrix his upper and lower arm are red and there was a blister at the injection site. It was not itchy or painful, but very red. Upon call back to healthcare professional on day of reporting, they stated that the blister was not at the injection site on arm but inside the upper arm. The reporter consented to follow up. In the document outcome of events was reported as recovering, but its mentioned as not recovered, so kept as reported.",,,,,,,,,N,09/09/2019,09/11/2019,2,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836193,09/26/2019,MI,53.0,53,,F,,"Injection site redness; Injection site swelling; Injection site warmth; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 53-year-old female patient who received Herpes zoster (Shingrix) (batch number 3FJ59, expiry date 27th November 2021) for prophylaxis.   On 14th September 2019, the patient received the 2nd dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced injection site erythema, injection site swelling and injection site warmth. On an unknown date, the outcome of the injection site erythema, injection site swelling and injection site warmth were unknown.   It was unknown if the reporter considered the injection site erythema, injection site swelling and injection site warmth to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left deltoid. The patient experienced injection site redness, warmth, and swelling. The healthcare professional reported the patient noticed the events two days later but could not provide an exact start date. The reporter consented to follow up.",,,,,,,,,U,09/14/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836194,09/26/2019,IA,79.0,79,,M,,"Slurred Speech; This case was reported by a pharmacist via call center representative and described the occurrence of slurred speech in a 79-year-old male patient who received Herpes zoster (Shingrix) (batch number AH992, expiry date 8th March 2022) for prophylaxis.   On 3rd September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than 2 weeks after receiving Shingrix, the patient experienced slurred speech. On an unknown date, the outcome of the slurred speech was unknown.   It was unknown if the reporter considered the slurred speech to be related to Shingrix.  Additional details were provided as follows: The patient developed slurred speech for days after receiving Shingrix vaccine The reporter did not consent to follow up.",,,,,,,,,U,09/03/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836195,09/26/2019,FL,97.0,97,,F,,"Sore; Difficulty lifting arm; Rash; Red; Tender; Hot to touch; Swollen to golf ball size; Inflamed; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 97-year-old female patient who received Herpes zoster (Shingrix) (batch number AP257, expiry date 26th November 2021) for prophylaxis.   On 14th September 2019, the patient received Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced rash, erythema, tenderness, feeling hot, swelling and inflammation. On 15th September 2019, the patient experienced mobility decreased. On 16th September 2019, the patient experienced pain in arm. On an unknown date, the outcome of the rash, erythema, tenderness, feeling hot, swelling, inflammation and pain in arm were unknown and the outcome of the mobility decreased was recovering/resolving.   It was unknown if the reporter considered the rash, erythema, tenderness, feeling hot, swelling, inflammation, mobility decreased and pain in arm to be related to Shingrix.  Additional case details were provided as follows: This adverse event information was collected via chat. On the first day she received Shingrix, she had difficulty lifting her arm.  On the day of reporting, the patient could lift her arm but it was sore.  The patient complained of a golf sized rash, hot to touch, red and tender but not itchy.  The reporter confirmed that, the rash was like the size of golf ball and was not raised like it but was very inflamed. The reporter consented to follow up.",,,,,,,,,N,09/14/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836196,09/26/2019,IL,76.0,76,,F,,"Reaction after Shingrix vaccination; This case was reported by a pharmacist via call center representative and described the occurrence of adverse reaction in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th August 2019, the patient received Shingrix. On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were provided as follows: The pharmacist asked any information on any cross ingredients between Boostrix and Shingrix. The health care professional stated that the patient would like Boostrix but had a previous reaction to the Shingrix. The reporter consented to follow up.",,,,,,,,,U,08/29/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/26/2019,,,,
0836197,09/26/2019,PA,,,,U,,"Suspected vaccination Failure; shingles; This case was reported by a pharmacist via call center representative and described the occurrence of suspected  vaccination failure in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax (received 3 years before the time of reporting).   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional information was reported as follows: The age at vaccination was not reported. The age group was not reported, but was selected adult as per vaccine indication. Last year, the patient completed a series of Shingrix. In 2019, the patient had a shingles outbreak. The reporter did not have any patient details to provide or dates of vaccination. This case was considered as suspected vaccination failure as details regarding, time to onset for target disease and laboratory confirmation were unknown at the time of reporting.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/26/2019,,,,
0836198,09/26/2019,IL,0.42,0,.5,F,,"Lymphoma; This case was reported by a physician via call center representative and described the occurrence of lymphoma in a 4-year-old female patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   Previously administered products included Pediarix (1 dose received on 17th February 2005). Concomitant products included DTPa-HBV-IPV (Pediarix).   On 22nd June 2005, the patient received the 3rd dose of Pediarix. On 4th September 2009, 4 years and 75 days after receiving Pediarix, the patient experienced lymphoma (serious criteria GSK medically significant). On an unknown date, the outcome of the lymphoma was unknown.   It was unknown if the reporter considered the lymphoma to be related to Pediarix.  Additional details were provided as follows: The patient received her first three doses of Pediarix in 2005, but never completed the remainder of the DTaP or IPV due to being diagnosed with lymphoma.  They went into remission, but it came back at some point.  The patient completed their treatments about a year ago and was cleared to receive live vaccines. The reporter consented for follow up.",,,,,,,,,U,06/22/2005,09/04/2009,1535,,UNK,,Pediarix,,,,USGLAXOSMITHKLINEUS201917,2,09/26/2019,,,,
0836199,09/26/2019,VA,,,,U,,"Tested and treated for lymes; This is a spontaneous report from a contactable nurse received via a Pfizer sales representative. A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date (reported as 7/10) at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient was given the vaccine on an unspecified date, reported as 7/10, and came back on an unspecified date, reported as 7/12, with fever, headache, body aches and altered mental status. The patient was tested and treated for lymes and was hospitalized. The nurse stated ""not sure if related to vaccine but started 2 days after"". The outcome of the event was recovered. It took 3 months for the patient to return to baseline.  The information on the lot number has been requested.; Sender's Comments: The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators as appropriate.",,,,,Y,,,,Y,,,,Test Name: Investigation; Result Unstructured Data: Test Result: lymes,UNK,,,,,,USPFIZER INC2019409469,2,09/26/2019,,,,
0836200,09/26/2019,CA,64.0,,,F,,"Anxiety; Aching muscles; low energy; Fatigue; Nausea; This is a spontaneous report from a contactable other healthcare professional (medical assistant). A 64-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13, lot number: AA7118, expiry: 31May2021, NDC: 00005197101), intramuscular in the left deltoid at the clinic on 16Sep2019 15:39 at 0.5 ml, single for immunization. Medical history included autoimmune disorder. There were no concomitant medications. On 20Sep2019, the patient experienced anxiety, aching muscles, low energy, fatigue and nausea. Outcome of the events was unknown. Events anxiety and aching muscles were reported as serious due to medically significant; for the other events were reported as non-serious. The patient was advised to go to the emergency room if any of her symptoms worsened.; Sender's Comments: A possible causal association between administration of PREVNAR 13 and the onset of aching muscles cannot be excluded, considering the apparent temporal association and the known adverse event profile of the suspect vaccine;  anxiety more likely represents an emotional tension arising from immunization.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,09/16/2019,09/20/2019,4,,OTH,,,,Medical History/Concurrent Conditions: Autoimmune disorder,,USPFIZER INC2019412795,2,09/26/2019,,,,
0836201,09/26/2019,,,,,F,,"Physician gave a pregnant patient Fluzone Quadrivalent which was expired on 30-Jun-2019/No AE; Physician gave a pregnant patient Fluzone Quadrivalent which was expired on 30-Jun-2019/No AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a female pregnant patient (age unknown) who was given a 0.5ml dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] which was expired on 30-Jun-2019 administered by a physician lot number not reported via unknown route in unknown administration site on an unspecified date, while she was pregnant.  The date of last menstrual period was not reported.  The estimated due date was not reported.  Data regarding this pregnancy were received prospectively.  It was a case of vaccine exposure during pregnancy.  It was an actual medication error due to expired vaccine used.  It was unknown whether patient experienced any adverse reaction after the injection.  Pregnancy outcome was unknown at the time of report.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA263212,2,09/26/2019,,,,
0836202,09/26/2019,MD,,82,,U,,"Fluzone high dose and it leaked between the syringe / no AE; Fluzone high dose and it leaked between the syringe / no AE; injection the medication leaked over the patient's arm / no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 82 years old patient who received 0.5 ml vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE]  lot UJ241AB (Expiry date Apr-2020) via intramuscular route in the right deltoid on 18-sep-2019.  It was case of syringe leak, vaccine underdose and Exposure via skin contact.  It was reported that prefilled syringes in the box were fine and this was the last one so she threw the leaking syringe and the box away after the infection therefore has limited information. States as she was giving the injection the medication leaked over the patient's arm.  At the time of reporting no adverse reaction was reported.  List of documents held by sender: none.",,,,,,,,,U,09/18/2019,,,,UNK,,,,,,USSA2019SA263291,2,09/26/2019,,,,
0836203,09/26/2019,CA,75.0,75,,F,,"patient received less than the full dose of Fluzone High-Dose due to the administering agent ""squirted"" most of the liquid out when they were removing the air from the syringe, no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 75 years old female patient who received yearly 0.5 ml dose of vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE]  (lot number and Expiry date unknown) via unknown route in unknown administration site on 27-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was case of vaccine underdose.  It was reported that Received less than the full dose of Fluzone High-Dose due to the administering agent ""squirted"" most of the liquid out when they were removing the air from the syringe.  At the time of reporting no adverse reaction was reported.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,08/27/2019,,,,UNK,,,,,,USSA2019SA263292,2,09/26/2019,,,,
0836204,09/26/2019,MA,80.0,80,,F,,"patient was administered two dose of Fluzone High-Dose / no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 80 years old female patient who received two doses of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 17 Sep 2019, patient received dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (vaccination details regarding dose, route, site, batch, exp date was not reported)  On 19 Sep 2019, Patient received 05 ml dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ253AB (Expiry date 06-May-2020) via unknown route in unknown in the left deltoid   It was an actual medication error case due to extra dose administered.   At a time of vaccination no adverse events were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,09/17/2019,,,,UNK,,,,,,USSA2019SA263293,2,09/26/2019,,,,
0836205,09/26/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked with case 2019SA267191; 2019SA267208 ; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193 (same reporter)  This case involves a female patient (elderly) who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the right deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this Flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No other vaccine was administered.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267209,2,09/26/2019,,,,
0836206,09/26/2019,NY,,,,M,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191; 2019SA267208; 2019SA267209; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves (an elderly) male patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020 via intramuscular route in the left deltoid on an unspecified date which was 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant vaccine was Pneumococcal Conjugate Vaccine 13.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,PNEUMOCOCCAL 13 VALENT VACCINE,,,,USSA2019SA267210,2,09/26/2019,,,,
0836207,09/26/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193 (same reporter)  This case involves a female patient of unknown age who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020, via intramuscular route in the left deltoid on an unspecified date which was 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant vaccine included Pneumococcal vaccine.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,PNEUMOCOCCAL VACCINE,,,,USSA2019SA267211,2,09/26/2019,,,,
0836208,09/26/2019,CO,11.0,11,,M,,"swelling hands and feet, itchy, blanching rash on legs.  macules on arms.",,,,,,,,,,09/24/2019,09/25/2019,1,,PVT,,none,viral URI,none,,,2,09/26/2019,,Y,,penicillin
0836209,09/26/2019,,34.0,34,,F,,Rash and raised bump at injection site about 2 inches. no fever. no other symptoms,,,,,,,,,N,09/25/2019,09/26/2019,1,,PHM,,,,,,,2,09/26/2019,,,,
0836210,09/26/2019,TX,53.0,53,,F,,"Started with headache, muscle aches and feeling feverish.  Truly bad event in middle of night with sweating, stomach craps, diarrhea and vomiting lasting over one hour.  After two hours, felt normal again.  Could be bad timing, but if related thought you guys would want to know.",,,,,,,,,Y,09/24/2019,09/24/2019,0,None.  Felt okay after everything out.,WRK,,"Valsartan, sertaline, synthroid",,"high blood pressure, thyroid underfunction",,,2,09/26/2019,,,,sulfa drugs
0836211,09/26/2019,AL,50.0,50,,F,,"Patient had fever, body aches, and chills on 9/5/19. Patient who is RN states that on 9/11/19 she had Varicella like rash to her left leg and arm. Rash has resolved at this time.",,,,,,,,,Y,09/04/2019,09/05/2019,1,N/A,PVT,,"Zantac, Folic Acid, Vit. D, Muti. VIt.",,,,,2,09/26/2019,,Y,,Penicillin
0836212,09/26/2019,IL,17.0,17,,F,,"Pt returned to clinic 15-20 minutes after vaccine was given with wheezing throughout lungs, extreme pruritus to eyes/nose/ears/neck, copious rhinnorrhea, and sneezing. 2.5 mg albuterol nebulizer was given with resolution of wheezing and 25 mg of benadryl was given with improvement in pruritus and rhinnitis. No vomiting, no lip swelling.",,,,,,,,,Y,09/26/2019,09/26/2019,0,,SCH,,albuterol prn,none,asthma since age 7,,,2,09/26/2019,,Y,,pollen
0836213,09/26/2019,MS,62.0,62,,F,,"Pt reported heat, rash and soreness to the arm that last for several weeks.",,,,,,,,,Y,08/23/2019,08/23/2019,0,none,PHM,,"zantac, lipitor, diflucan, nystatin, synthroid",none reported,none reported,,,2,09/26/2019,,,,none
0836214,09/26/2019,MO,4.0,4,,M,,Significant redness and swelling to left upper arm starting a few hours after receiving vaccine--took three days to improve,,,,,,,,,Y,09/20/2019,09/20/2019,0,,PVT,,n/a,n/a,asthma,,,2,09/26/2019,,Y,,Egg
0836215,09/26/2019,CA,63.0,63,,F,,"Pain, swelling, redness persistent three days after the injection, fever of 101 approximately 24 hours after injection, joint pain, muscle pain, fatigue.",,,,,,,,,Y,09/23/2019,09/24/2019,1,,PHM,,"Eliquis, Metoprolol, Atorvastatin, flecainide",,"asthma, atrial fibrilation, arthritis",,,2,09/26/2019,,,,
0836216,09/26/2019,GA,4.0,4,,F,,Rash started Tuesday afternoon after vaccines; Rash and induration at area on right thigh; 5X5cm. Area of rash 19X15cm. Erythema,,,,,,,,,Y,09/24/2019,09/24/2019,0,,PVT,,none,none,none,,,2,09/26/2019,,Y,,none
0836217,09/26/2019,MN,50.0,50,,F,,"angioedema, swollen lips",,,,,,,,,N,09/25/2019,09/25/2019,0,,PVT,,"carbotrol, Keppra, zonagram, gabapentin, vt d2,  prenatal vitamin, pravastatin, potassium chloride.",none,epilepsy,,,2,09/26/2019,,,Y,none
0836218,09/26/2019,NC,87.0,87,,F,,"Redness, pain, swelling of left arm. Began receding after two days",,,,,,,,,N,09/24/2019,09/24/2019,0,None,PVT,,"Lisinopril, prevastatin, hydrochlorothiazide, prednizone, premarin, stool softener, multivitamin, calcium with vitamin D",None,None,,,2,09/26/2019,,,,None
0836219,09/26/2019,MS,65.0,65,,F,,Patient called pharmacy on 9-26-19 complaining of pain in upper arm. She stated she has seen a physician since receiving the vaccine and was told by the physician that the vaccine was given too high in the arm.,,,,,,,,,N,09/18/2019,09/18/2019,0,none per patient,PHM,,n/a,N/A,N/A,,,2,09/26/2019,,Y,,PCN
0836220,09/26/2019,TX,82.0,82,,M,,"Patient said that he went to eat the evening in Park and after eating, he fell shaking cold with lots of headache.  His daughter in law which work for dispatching, took him to the ER.  He said the hospital took 5 pints of blood for different tests .  All came negative.    Patient came in today to the pharmacy and complained still of very red eyes.  I suggest him to see the doctor for check up today.   I was able to make apt to see doctor today at 3pm.  He just left the pharmacy to go straight to see his doctor",,,,,,,,,,09/25/2019,09/25/2019,0,n/a,PHM,,n/a,no,,,,2,09/26/2019,,Y,Y,n/a
0836221,09/26/2019,TX,50.0,50,,F,,"pt developed a rash on her neck about a day after receiving immunizations, unknown if it is related to immunizations.  She has been taking benadryl otc, and will start using hydrocortisone otc also",,,,,,,,,N,09/23/2019,09/25/2019,2,unknown,PHM,,unknown,none known,smoker,,,2,09/26/2019,,Y,,"penicillins, phenothiazines"
0836222,09/26/2019,NM,69.0,69,,F,,Patient having nerve pain down arm towards wrist and at site of injections.  Does not appear to be getting worse.  Patient following up with us this evening and knows to go to ER if worsens.,,,,,,,,,U,09/26/2019,09/26/2019,0,,PHM,,"Metformin, pravastatin,synthroid",,,,,2,09/26/2019,,,,Codeine
0836223,09/26/2019,AZ,60.0,60,,M,,patient's wife called the pharmacy and asked us to report to CDC that her husband had red purple swollen area where he got the shot,,,,,,,,,U,09/25/2019,09/26/2019,1,,PHM,,unknown,"per patient's VAR form , no","per patient's VAR form , no",,,2,09/26/2019,,,,"per patient's VAR form , there's no allergy"
0836224,09/26/2019,CA,1.0,1,.0,M,,"Fever, swelling/warmth to touch and tenderness with movement to lower right thigh (below site of injection)",,,,,,,,,U,09/24/2019,09/25/2019,1,"Evaluated in clinic 9/25, referred to ER 9/25",PVT,,Budesonide respules 0.25mg/2ml inhal suspension,viral URI,"Premature birth at 23 weeks, perinatal IVH with resulting hydrocephalus s/p VPS shunt, chronic lung disease, pulmonary hypertension, retinopathy of prematurity",,,2,09/26/2019,,Y,Y,None
0836225,09/26/2019,NY,75.0,75,,F,,Patient says her lips swelled post vaccination,,,,,,,,,Y,09/03/2019,09/03/2019,0,,PHM,,none,none,none,,,2,09/26/2019,,,,none
0836226,09/26/2019,PR,4.0,4,,F,,"Symptoms included sweat, pallor, vomiting, lethargy, cold skin.",,,,,,,,,U,09/26/2019,09/26/2019,0,,OTH,,No,No,No,,,2,09/26/2019,,,Y,No
0836227,09/26/2019,IL,55.0,55,,F,,"Patient injected with flucelvax flu shot shortly after 1pm, and called back after about an hour saying they just noticed a rash on their leg running along their calf, on their left side (same side as injection was administered) Patient instructed to take oral Benadryl, and recheck it after a couple hours. Instructed patient for warnings of more severe allergic symptoms, with directions to call 911 if they experienced and difficulty breathing. If rash did not diminish or grew in size to call back for further care instructions.",,,,,,,,,U,09/26/2019,09/26/2019,0,None,PHM,,"Amitriptyline 25mg, oxybutynin 5mg",none,Multiple sclerosis,,,2,09/26/2019,,,,none
0836228,09/26/2019,RI,72.0,72,,F,,cellulitis,,,,,,,,,Y,09/24/2019,09/25/2019,1,"clinic visit, doxycycline, triamcinolone cream",PHM,,"omeprazole 40mg, amlodipine 2.5 mg, synthroid 50mcg, alprazolam 0.25mg, atorvastatin 10mg",n/a,hypothyroid,,,2,09/26/2019,,Y,,penicillin
0836229,09/26/2019,MA,51.0,51,,F,,"shivering, very cold couldn't get warm and insomnia as well as pain at injection site",,,,,,,,,Y,08/06/2019,08/06/2019,0,,PHM,,lisinopril/hctz,,,,,2,09/26/2019,,,,
0836230,09/26/2019,PA,83.0,83,,F,,Patient received PPSV23 on 9/19/19 she reported having swelling later in the evening with redness and warmth.  She reported to the office on 09/20/2019 and the provider checked her arm and told her to take Benadryl non-drowsy and to continue using cold compresses.  She presented to the office again on 09/23/2019 showing us her arm which showed improvement.,,,,,,,,,Y,09/19/2019,09/19/2019,0,,PVT,,,,,,,2,09/26/2019,,Y,,
0836231,09/26/2019,MA,62.0,62,,F,,"Shooting neck and back pain, arm pain at injection site for a day",,,,,,,,,Y,08/07/2019,08/07/2019,0,,PHM,,,,,,,2,09/26/2019,,,,
0836232,09/26/2019,OH,80.0,80,,M,,"IN LEFT ARM: REDDNESS, SWELLING, PAIN, HOT TO TOUCH. ADVISED PATIENT TO APPLY COLD COMPRESS, TAKE IBUPROFEN AND IF ITCHING OCCURS TO TAKE BENADRYL, ADVISED IF NOT BETTER OR IS WORSE BY TOMORROW TO SEEK MEDICAL TREATMENT.",,,,,,,,,U,09/24/2019,09/25/2019,1,NONE AS OF TODAY,PHM,,FINASTERIDE,NONE,NOT SHARED,,,2,09/26/2019,,,,NONE
0836233,09/26/2019,FL,0.17,0,.2,M,,The day after all vaccines listed above were given patent developed a small rash on both inner arms. The rash continued to spread to other places on body. The rash started as a bright red speckled rash. The rash did not seem to be painful for the first week. Over the next several weeks the rash got worse. It was covering the entire body of the infant. The effected areas became sore and painful to touch.,,,,,,,,,U,04/29/2019,04/30/2019,1,,PVT,,Oral Vit. D drops,None,None,,,2,09/26/2019,,Y,Y,None
0836234,09/26/2019,MI,54.0,54,,F,,"Extreme swelling and redness at site of injection-(round circle 3"" x 4"" in diameter).  Flu like symptoms started in the middle of the night-fever, chills, body ache, nausea lasted 2 1/2 days. My mother who is eighty-one (81) also received her second dose of the vaccination the same day, and had the same symptoms.    My husband had his first dose who is sixty (60) and had these exact symptoms,   My concern is that these are not symptoms listed on the pamphlet.",,,,,,,,,U,09/23/2019,09/24/2019,1,None,PHM,,Vitamin D,None,None,,,2,09/26/2019,,,,None
0836235,09/26/2019,AZ,64.0,64,,F,,"Redness, swelling and pain at the injection site that lasted one week; lethargy/fatigue that lasted a week; muscle aches all over body that lasted 4 days; chills that lasted one day for two hours; headache that lasted one day.",,,,,,,,,Y,06/24/2019,06/24/2019,0,None.,PHM,,"Metropolol 50 mg; Levothyroxine, 88 mg; Tums 1500; Vit D 2000 mg.",None,"High blood pressure, low thyroid",,,2,09/26/2019,,,,"penicillun, rash"
0836236,09/26/2019,KY,52.0,52,,M,,"Patient experienced headache, bilateral weakness & numbness of the upper and lower extremities.  He went to a general practitioner starting in August, but was later referred to a neurologist that diagnosed as Guillian Barre syndrome.  He was admitted to the hospital for IVIG therapy and was discharged after one day to continue therapy at home.  Patient is still undergoing therapy at home, and outcome is yet to be determined.",,,Y,,Y,1,,,N,07/30/2019,08/01/2019,2,,PHM,,,,,,,2,09/26/2019,,Y,,nka
0836237,09/26/2019,ID,71.0,71,,F,,The patient had itchy hives appear on her right wrist after receiving her first Shingrix vaccine. They disappeared the following day.,,,,,,,,,Y,07/01/2019,07/01/2019,0,None,PHM,,Lisinopril 10mg daily Ibandronate 150mg once monthly,None,Hypertension Osteoporosis,,,2,09/26/2019,,,,None
0836238,09/26/2019,OK,9.0,9,,M,,"Large location reaction with associated swelling, erythema, and induration starting within several hours, worsening over first 24 hours",,,,,,,,,N,09/25/2019,09/25/2019,0,,SCH,,None,None,"ADHD, autism, generalized anxiety disorder",,,2,09/26/2019,,Y,,None
0836239,09/26/2019,NY,57.0,57,,F,,Severe headache and vomiting in the middle of the night.  Also pain at injection site.  Flu like symptoms the day after the injection.,,,,,,,,,N,09/25/2019,09/26/2019,1,,PHM,,,,,flu like symptoms after shingrix at age 57,,2,09/26/2019,,,,
0836244,09/26/2019,FL,,,,F,,"severe sepsis; altered mental status; diagnosed with an acute upper respiratory infection; pneumonia; Information has been received from a lawyer and the patient regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided.  On or about 17-SEP-2014, the patient (pt) was vaccinated with zoster vaccine live (ZOSTAVAX), (lot# and route unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).  Within one  week after receiving zoster vaccine live (ZOSTAVAX), the pt suffered altered mental status and was diagnosed with an acute upper respiratory infection, pneumonia, and severe sepsis.  As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms have resulted in physical limitations not present prior to using the product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events were considered not resolved. The events were considered related to zoster vaccine live (ZOSTAVAX).  The events of altered mental status, acute upper respiratory infection, pneumonia, and severe sepsis were determined to be disabling events.",,,,,,,,Y,N,09/17/2014,09/01/2014,,,UNK,,,,,,US0095075131909USA009258,2,09/26/2019,,,,
0836245,09/26/2019,UT,,,,U,,"no adverse effect reported; expired PNEUMOVAX 23 was administered; This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's concurrent condition, concomitant medication and medical history were unknown. On 23-SEP-2019, the patient was vaccinated with expired pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) injection (lot # N024385 with expiry date 18-MAY-2019, intramuscular; dose number and frequency unspecified) for prophylaxis (expired product administered). No adverse effects reported (no adverse event). The outcome of the events was unknown. No product quality complaint was involved.",,,,,,,,,U,09/23/2019,09/23/2019,0,,UNK,,,,,,US0095075131909USA012776,2,09/26/2019,,,,
0836246,09/26/2019,NC,17.0,17,,F,,"LEFT ARM SWELLING, REDNESS, ITCHING, HOT TO TOUCH, BURNING SENSATION AT AND AROUND INJECTION SITE, ALONG WITH HEADACHE. PATIENT ADVISED TO TAKE ZYRTEC 10ML DAILY AND PRESCRIBED PREDNISOLONE 15ML/5ML ORAL SOLUTION 10ML BY MOUTH EVERY DAY X 3 DAYS",,,,,,,,,N,09/24/2019,09/25/2019,1,NONE,PVT,,ZYRTEC 10ML,NONE,NONE,,,2,09/26/2019,,Y,,NKA
0836247,09/26/2019,LA,73.0,73,,F,,"headache, muscle aches, fever, shivering, stomach pain, nausea, fatigue, fast heartbeat, pain and redness at site",,,,,,,,,Y,09/22/2019,09/23/2019,1,,PHM,,"Premarin, Progesterone, Nexium, calcium, vitamin, MoveFree, probiotic, baby aspirin",,acid reflux,"steroid shot, not vaccination",,2,09/26/2019,,,,
0836248,09/26/2019,FL,66.0,66,,F,,"Patient was diagnosed with cellulitis from doctor's office, patient to complete a 10 day cycle of antibiotics.",,,,,,,,,U,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,09/26/2019,,Y,,
0836249,09/26/2019,GA,67.0,67,,F,,"2nd shingrix dose given within 3 weeks of 1st shingrix.I checked with patient 2 days after immunization, she reports fatigue and chills for 24 hrs, these side effects should be related to fluzone hd and shingrix. Ive submitted this because I immunized too early for 2nd shingrix.",,,,,,,,,Y,09/24/2019,09/26/2019,2,,PHM,,,,,,,2,09/26/2019,,,,
0836250,09/26/2019,NH,67.0,67,,F,,"patient called stating injection site had a raised, egg-sized, warm-to-the-touch, lump at the injection site. informed patient to call PCP, use Ibuprofen, and ice.  Within 24 hours, symptoms completely subsided",,,,,,,,,Y,09/25/2019,09/25/2019,0,None,PHM,,"Atenolol, Irbesartan, Hydrochlorothiazide, Simvastatin",no spleen,"High Cholesterol, Hypertension",,,2,09/26/2019,,,,NKDA
0836251,09/26/2019,NE,57.0,57,,F,,Patient with diplopia. Exam revealed upper extremity clonus on DTR testing of triceps and hyperreflexia on DTR testing of knees.   No other findings.   Doing well and feels well day after reported symptoms.,,,,,,,,,Y,09/24/2019,09/25/2019,1,"CBC, CMP, TSH, ESR, CRP all on 9/26/19",PVT,,Augmentin Bupropion Trazodone Lamictal Estradiol,Cellulitis due to dog bite puncture wound,"Bipolar 2 disorder, major depressive episode (Chronic) Depression (Chronic)",,,2,09/26/2019,,Y,,NKMA
0836252,09/26/2019,AZ,88.0,88,,F,,fast heartbeat that lasted for hours,,,,,,,,,Y,09/24/2019,09/24/2019,0,,PHM,,,,,,,2,09/26/2019,,,,
0836254,09/26/2019,SD,69.0,69,,F,,Arm at injection site swelled up to the size of an egg and was still swollen at 10 days later,,,,,,,,,Y,09/04/2019,09/04/2019,0,,PHM,,,,,,,2,09/26/2019,,,,progestins
0836255,09/26/2019,TX,32.0,32,,F,,"Patient stated the next afternoon she started having red dots form on the body, and still had a cough",,,,,,,,,,09/24/2019,09/25/2019,1,She went to ER to get blood transfusion and further testin,PHM,,,Patient had been sick with viral/bacterial infections for a month on and off,Heart issues,,,2,09/26/2019,,,Y,
0836256,09/26/2019,NJ,54.0,54,,F,,"Side effects - top gums, roof of mouth, throat; tingling like allergic reaction; it stopped about 5 hours later. Bad arm pain lasted 2 days. Bad headache that lasted a week. Also felt like I was getting the flu, had mild body aches",,,,,,,,,Y,09/18/2019,09/18/2019,0,,PHM,,"oxycontin, percocet, flomax, baclofen, lunesta",none,failed lumbar L5S1 fusion,,,2,09/26/2019,,,,"morphine, steroid Z pack, new antibiotics"
0836257,09/26/2019,CO,18.0,18,,U,,"Patient reports ""normal"" soreness at injection site on day of injection (Tues)  and next day (Wed). On Thursday morning woke with markedly increase pain in left, upper  arm and  irregular area of redness and induration approximately 60 mm by 70 mm on anterior aspect if left upper arm.  Area of induration reported as painful. Area is not at injection site. Pt reports took Benedryl without relief.  Referred to primary care provider for evaluation.",,,,,,,,,,09/24/2019,09/26/2019,2,,SCH,,Androderm patch; ProAir inhaler (PRN); Enbrel; methotrexate; naproxen; testosterone transdermal gel pump,No acute illness,"Asthma, anxiety disorder, rheumatoid arthritis",,,2,09/26/2019,,Y,,Penicillin
0836258,09/26/2019,CA,2.0,2,.2,M,,"Swelling within 6 hours, developed fever to 102, erythema, pain and induration of right thigh within 24 hours. Also viral URI symptoms and asthma exacerbation.",,,,,,,,,N,09/24/2019,09/24/2019,0,N/A,PVT,,"Singulair, Budesonide",None,"Asthma, Eczema, FPIES, history of GERD",,,2,09/26/2019,,Y,Y,"Milk, Soy, Egg, Peanut, Apple"
0836259,09/26/2019,SC,76.0,76,,F,,states sore arm for 2 weeks and rash that just went away.  she is concerned because had no reaction with first shot,,,,,,,,,Y,09/12/2019,09/12/2019,0,,PHM,,,,,,,2,09/26/2019,,,,
0836260,09/26/2019,AZ,40.0,40,,F,,Patient stated she developed arm swelling redness and pain in left arm as well as fever and chills. Said she has been taking ibuprofen since to help with symptoms. Patient showed her left arm and it was still noticeably red and swollen. Pt education that Benadryl/diphenhydramine may help with allergic reaction symptoms. Instructed pt to go in if symptoms do not resolve or get worse. Pt also stated she had pneumonia immunization previously about a year ago with no reaction that time.,,,,,,,,,N,09/23/2019,09/23/2019,0,,PHM,,,,,,,2,09/26/2019,,,,
0836261,09/26/2019,AZ,72.0,72,,F,,ARM WAS SWOLLEN  RED AND HOT TO TOUCH FOR ABOUT 3 DAYS,,,,,,,,,Y,09/23/2019,09/23/2019,0,NONE,PHM,,LEVOTHYROXINE,NONE,NONE,,,2,09/26/2019,,,,SULFUR
0836262,09/26/2019,WA,55.0,55,,F,,"Injection site hot to touch, swollen, hard lump the size of jawbreaker and 3 inch red spot.  Painful.",,,,,,,,,N,09/24/2019,09/24/2019,0,None,PVT,,Paroxetene,None,None,"Shingrix, swollen painful injection site 4? diameter, 08/23/2019",,2,09/26/2019,,,,None
0836263,09/26/2019,AZ,7.0,,,M,,Patient's left arm became red and swollen 1  day after receiving the flu shot. Instructed parent to apply cool compresses to area affected.,,,,,,,,,Y,,09/23/2019,,NONE,PUB,,NONE,NONE,NONE,,,2,09/26/2019,,,,NONE
0836264,09/26/2019,OR,8.0,8,,M,,"Patient developed hives on his R thigh and his back the evening after receiving the vaccine. No other symptoms.  By the next day, the hives on his back had dissipated, but the R thigh (at the location of the vaccination) persisted with an urticarial lesion.   Patient had a very similar episode (documented only by a phone call to our clinic, not a clinic visit) the year prior with the seasonal influenza vaccine (Fluzone Quad)",,,,,,,,,U,09/24/2019,09/24/2019,0,No testing done.,PVT,,None,None,Obesity,On 10/22/2018 Patient had a very similar reaction (large red reaction at site of injection) after Fluzone Quad,,2,09/26/2019,,Y,,None
0836265,09/26/2019,CA,80.0,80,,M,,"Patient received the 2nd dose of the shingrix vaccine on Saturday 6/15/19 mid-day. By Sunday 6/16/19, he developed a fever of over 100 degrees. He took some acetaminophen and went to see his doctor Monday morning who instructed him to continuing taking acetaminophen as necessary. His fever persisted and by Wednesday evening, his temperature had gone over 102 degrees. On Thursday morning, he went to see the doctor and was asked to go to the Emergency department next door at hospital. He was given many tests and was immediately admitted due to suspicious images in upper lung. He was put in isolation since they did not know the cause of the problem. By Friday, he was admitted to the ICU and by Friday afternoon, he was not able to breathe on his own and a respirator was put in. He was given different antibiotics and various anesthesia and was in an unconscious state for the next 8 plus days. By the time the respirator was removed, he was told he had ""acute respiratory distress syndrome"". His lungs were not functioning and had dark images throughout. He was discharged on 7/16/19 and has been regaining breathing and physical strength. Pulmonologist says it will probably take 1 year to recover completely.",,,Y,,Y,26,,,Y,06/15/2019,06/16/2019,1,,UNK,,,,,,,2,09/26/2019,,Y,Y,
0836266,09/26/2019,IL,65.0,65,,F,,"Patients states to have experienced a fever of 105 degrees, shaking, teeth chattering about 24 hours post immunization.  She later called back to state she may have been in a coma and did not eat, or drink for 2 days",,,,,,,,,Y,09/12/2019,09/13/2019,1,Patient did not acknowledge any medical treatment.,PHM,,"armour thyroid, alprazolam, trazodone, not sure about otc items",,,,,2,09/26/2019,,,,"penicillin, codeine, opiodes"
0836267,09/26/2019,CA,55.0,55,,F,,"patient reported experiencing mild throat, head and ears itching (internally) at 9pm 09/18/2019, which progressed to moderate itching, nasal congestion and cough for the next 2 days. States cough was productive with yellowish phlegm. Patient walked into our clinic Tuesday 09/24/2019 at 4pm to report occurrence, and stated she was feeling a lot better at this time, itching subsided, she was only experiencing a mild cough. States took Benadryl, nightquil and continued Zyrtec to help alleviate symptoms from 09/18 thru 09/23. Patient did not go to doctor for evaluation of symptoms and was instructed to follow up with Urgent care on 09/24/2019. Spoke to patient today and stated doing a lot better, currently experiencing mild non productive cough and does not feel the need to follow up with doctor for evaluation.",,,,,,,,,Y,09/18/2019,09/18/2019,0,patient was instructed to follow up with Urgent Care.,PUB,,Omeprazole Zyrtec 10mg daily,none,seasonal allergies,,,2,09/26/2019,,,,no allergies to medications allergic to pork (rash)
0836268,09/26/2019,CO,35.0,35,,F,,Donor states that right after getting in her POV that she felt short of breath. Donor left center at 13:35. Donor received immunization at 13:15.  Donor stated that she felt short of breath all day long. Didn't feel back to normal until the next morning. Donor denies taking any medicine to help with her symptoms. Donor states feeling tired and laid down once she got home.,,,,,,,,,Y,09/24/2019,09/24/2019,0,None,OTH,,"Donor occasionally takes Tylenol for minor back pain, but none was consumed around time of vaccination.  Donor also takes multivitamins occasionally.",None,None,,,2,09/26/2019,,,,NKDA.  No food allergies.  Is allergic to unknown fabric softener
0836269,09/26/2019,IN,64.0,64,,F,,"Patient had fever, chills, throbbing pain, red rash, knot in arm and hot to touch. She has been treating with ice packs and tylenol and caladryl and her rx allergy pill. This is day 4 and arm is still red and very painful.",,,,,,,,,N,09/23/2019,09/24/2019,1,none,PHM,,"ZYRTEC 10, LIPITOR 80, LISINIOPRIL 2.5, SYNTHROID 25MCG, MOBIC 15,",None,,,,2,09/26/2019,,,,NO ALLERGIES
0836270,09/26/2019,OR,66.0,66,,F,,"According to the patient, about 3 hours after receiving the vaccination she started to have a fever up to 102 degrees F, chills, body aches and rapid heart beat. The next day, the fever has subsided, but she still has some body aches and chills. She has never had this type of reaction after a vaccination  before.",,,,,,,,,Y,09/25/2019,09/25/2019,0,,PHM,,"levothyroxine, lisinopril, simvastatin, metoprolol succinate, sertraline",none,"anxiety, hyperlipidemia, hypertension, hyperthyroidism",,,2,09/26/2019,,,,none known
0836271,09/26/2019,IL,59.0,59,,M,,"Patient received a flu vaccine on the evening on 9/24/19.   Patient reported that he woke up and the area was red and itchy.   He applied Cortisone cream for the itching.   He came in to ask what else he could use for the itching.  He showed me and the area was red and looked like a whelp.  It was on a large area on the upper part of his arm.  He said it did not have any heat to it, was just itchy.  He is going to continue using the steroid cream and may take some oral Benadryl.  If that doesn't work and it is still itchy, he may see his doctor for treatment.",,,,,,,,,U,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,09/26/2019,,,,
0836272,09/26/2019,MI,25.0,25,,F,,"After obtaining the vaccination, the patient went to stand up and indicated she did not feel right. Patient lost consciousness and would have fallen to the floor but pharmacy technician was able to catch her and lower her gently to the floor. Patient was unconscious for a few  moments before coming back around. Patient vomited upon coming alert and indicated she was very hot. Cold compresses were placed on patients face and neck. Ambulance was called and transported the patient to the hospital. Per patient, the hospital indicated she had vasovagal syncope. Patient was treated with IV fluids and released the same day.",,,,,,,,,Y,09/25/2019,09/25/2019,0,,PHM,,,,Asthma,,,2,09/26/2019,,,Y,None
0836273,09/26/2019,NC,45.0,45,,F,,"Pain, swelling, heat, rash started the night after receiving the vaccine. Patient is taking ibuprofen/tylenol and icing arm.",,,,,,,,,,09/25/2019,09/25/2019,0,,PHM,,,,,,,2,09/26/2019,,,,
0836274,09/26/2019,CO,66.0,66,,F,,"Hot/raised rash at injection site beginning day after vaccine administration, ~3 inches wide spreading nearly to elbow over following 48 hours. Body wide myalgias. Ibuprofen has relived myalgias, rash has stopped spreading as of day 3, but has not yet improved.",,,,,,,,,N,09/23/2019,09/24/2019,1,,PHM,,,,,,,2,09/26/2019,,,,
0836275,09/26/2019,OH,57.0,57,,F,,"Patient received vaccines on 9/24/19. Patient presented to pharmacy on 9/26/19 with red swollen right arm, bruising around injection site, extremely swollen and red near elbow,  with upper arm being warm to the touch. Advised patient to use cool packs and to watch for any change in condition. Will follow up with patient as well. Patient instructed to follow up with doctor in 2 days if not improved or sooner if it gets worse. Patient reported trying Benadryl with no effect. Patient reported no pain just the swelling and redness.",,,,,,,,,U,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,09/26/2019,,,,morphine
0836276,09/26/2019,NC,12.0,12,,M,,"Patient started with a warm to touch, red, rash on right arm. Patient seen in office to observe the current reaction on 9/26/19.",,,,,,,,,,09/24/2019,09/25/2019,1,,PVT,,,,,,,2,09/26/2019,,Y,,tree nut allergy
0836280,09/26/2019,,87.0,87,,F,,swelling of arm and warm to touch,,,,,,,,,N,09/24/2019,09/24/2019,0,,PHM,,,,,,,2,09/26/2019,,Y,,
0836281,09/26/2019,FL,68.0,68,,F,,"patient complained of whole arm redness, hives and fever in the evening of 103.4. patient took Tylenol for fever and Benadryl for hives",,,,,,,,,Y,09/24/2019,09/24/2019,0,none,PHM,,not sure,none,not sure,,,2,09/26/2019,,,,"penicillin, salicylates"
0836282,09/26/2019,,73.0,73,,F,,"After a few hours, customer came and complained of tingling from injection site up.",,,,,,,,,,09/26/2019,09/26/2019,0,,UNK,,,,,,,2,09/26/2019,,,,
0836283,09/26/2019,VA,66.0,66,,F,,Patient returned to pharmacy 2 days after vaccine with complaint of severe arm pain  the next day following vaccination to the point of not being able to lift arm. Pain had improved by the reported time but arm was very red  from bicep down to elbow and hot to the touch. Patient did not feel the need to see PCP and will take OTC analgesic and apply ice pack.,,,,,,,,,U,09/23/2019,09/24/2019,1,,PHM,,,,,,,2,09/26/2019,,,,
0836284,09/26/2019,NC,67.0,67,,F,,"Patient  said , she developed shaking , dizziness, weakness next day after she had  vaccine",,,,,,,,,N,09/19/2019,09/20/2019,1,did not mention any  as of now,PHM,,not known,none per consent form,none,,,2,09/26/2019,,,,none as per consent form
0836285,09/26/2019,SC,84.0,84,,M,,"Days 1 and 2 after vaccine had flu-like symptoms, felt tired and had a hard time breathing. Day 3 went to emergency department and diagnosed with pleural effusion.",,,,,,,,,U,09/20/2019,09/21/2019,1,,PHM,,Unknown,,,,,2,09/26/2019,,,Y,None known
0836286,09/26/2019,TX,67.0,67,,F,,"PAIN, REDNESS, FEVER, SWELLING.",,,,,,,,,N,09/24/2019,09/24/2019,0,,PHM,,"SIMVASTATIN, HCTZ, LORAZEPAM, AMLODIPINE, LABATELOL",N/A,,,,2,09/26/2019,,Y,,PENICILLIN
0836287,09/26/2019,FL,17.0,17,,F,,"Vaccines given 2 days ago (flu and Trumenba-both left arm), yesterday with some arm soreness. This am felt like arm is swollen and noticed rash that is tender under side of left upper arm. Some hand and feet swelling today. Denies lip or tongue swelling. No SOB, dizziness. No fever.  Area photographed and marked to watch for spreading. Continue Advil prn comfort and cool compress. F/u tomorrow.     Has Nexplanon in left arm as well.",,,,,,,,,U,09/24/2019,09/26/2019,2,"Evaluated 9/26 Normal UA, normal BP",PVT,,Amoxil Zyrtec Qvar  Nexplanon implant,Sinusitis,Asthma Allergic rhinitis Migraines Femoral acetabular impingement  Dysmenorrhea,,,2,09/26/2019,,Y,,NKA
0836288,09/26/2019,NC,16.0,16,,F,,"pt was fine after shot but then within a minute or 2 said she""didn't feel too good"" then slip down to ground. Her eyes rolled back and it looked like she shook for a second then immediately came to and said ""I'm fine"". pt said her face felt warm and just felt weird.",,,,,,,,,Y,09/26/2019,09/26/2019,0,,PHM,,,,n/a,,,2,09/26/2019,,,,n/a
0836289,09/26/2019,FL,79.0,79,,F,,"nausea, vomiting and diarrhea",,,,,,,,,N,09/25/2019,09/26/2019,1,na,PHM,,"pravaststin, caltrate +d, cranberry pills, preservision, align",na,"breast cancer, c. diff in the past",,,2,09/26/2019,,,,"Cipro, Levaquin, cefdinir, penicillin"
0836290,09/26/2019,ID,24.0,24,,F,,"Patient stated having dizziness, weakness in the legs, severe body aches, decreased circulation in the legs and stiffness of the neck in the morning that resolved throughout the day.  Patient did not present with fever or injection site reactions.",,,,,,,,,N,09/23/2019,09/23/2019,0,,PHM,,"Nuva-ring,  fludricortisone, tranexamic acid, sertraline",,,,,2,09/26/2019,,Y,,No Known Allergy
0836291,09/26/2019,MD,77.0,77,,M,,Blisters and Large rush area and deep stabbing pain around the left side of the waist area.,,,,,,,,,N,09/19/2019,09/20/2019,1,Extreme reaction to the Shingles vaccine.,PHM,,Gabapentin,None,None,,,2,09/26/2019,,,,None
0836292,09/26/2019,TX,76.0,76,,F,,"TODAY 09/26/19 PATIENT CAME AND SHOWED SOME RASH LOCATED BELOW THE INJECTION SITES ABOUT 2 INCHES. IT WAS ON THE LEFT ARM . IT  LOOKS LIKE  A RED RASH PATCH ABOUT 1 TO 2  INCHES  AND SHE SAID ITCHY ON THAT AREA. THERE IS NO PAIN OR SWELLING AT INEJCTION SITE. ADVISED PATIENT TO TAKE BENADRYL OR APPLY SOME BENADRYL CREAM FOR ITCHING. IF IT DOES NOT GET BETTER IN 3 DAYS , SEE MD.",,,,,,,,,U,09/21/2019,09/22/2019,1,NONE,PHM,,NONE,NONE,NONE,,,2,,,,,NONE
0836293,09/26/2019,CA,57.0,57,,F,,patient fell unconscious a day after the vaccination. Was in the hospital for 3 days and took 2 days to completely regain consciousness,,,Y,,Y,3,,,Y,09/18/2019,09/19/2019,1,not available,PHM,,"lamotrigine, levetiracetam, levothyroxine, loratidine, lorazepam, methenamine, hydroxyurea",,seizures,mild infection,,2,09/26/2019,,,,none
0836294,09/26/2019,PA,41.0,41,,F,,"PT FELT LOW BLOOD PRESSURE APPROX 1 HOUR (3.40P) AFTER THE IMZ, OVER THE COURSE OF AN HOUR WHILE WAITING TO RECOVER AND HER HUSBAND TO PICK HER UP SHE FELT WOOZY (4.00PM) THEN SAID SHE FELT LIKE A SEIZURE WAS COMING ON , SHE EVENTUALLY SLID TO FLOOR  AT 4.20PM; BP TAKEN AT 4.26  73/58 PULSE=121 ; PARAMEDICS ARRIVED  4.36PM AND RESUMED CARE AND ADMITTED HER TO HOSPITAL ; I  FOLLOWED UP WITH THE PATIENT THE EVENING OF 9/26/19, SHE WAS FEELING BETTER BUT WAS STILL TRYING TO RECOVER HER SPEACH FROM THE SEIZURE",,,,,Y,1,,,Y,09/24/2019,09/24/2019,0,UNKNOWN - PT WAS HOSPITALIZED FROM 9/24/19 TO 9/25/19,PHM,,"sertraline, plaquenil, amlodipine, cyclobenzaprine","lupus, rheumatoid arthritis, untreated seizure history not disclosed on consent form",lupus; pt had history of seizures but never sought medical treatment for them; did not disclose that condition on the consent form,,,2,09/26/2019,,,,"sulfa, nitrofurans, duloxetine, leflunomide, adalimumab"
0836295,09/26/2019,AZ,70.0,70,,F,,"Patient complained of redness, minor discomfort,  warmth extended past injection site.",,,,,,,,,N,09/25/2019,09/26/2019,1,None,PHM,,Restoril,None Known,None reported,,,2,09/26/2019,,,,None Listed
0836376,09/26/2019,MA,71.0,71,,F,,Patient experienced swollen right arm could not eat or sleep,,,,,,,,,U,09/12/2019,09/12/2019,0,,PHM,,,,,,,2,09/18/2019,,,,
0836396,09/26/2019,NV,29.0,29,,F,,"Pain left side (arm, shoulder, back, leg) clammy; HA",,,,,,,,,U,09/25/2019,09/26/2019,1,,PHM,,None,none,none,,,2,09/26/2019,,Y,,none
0836411,09/26/2019,NC,32.0,,,F,,"Urticaria, full body. 12 hrs after flu vax, no other new exposures to my knowledge. Never happened before. Still advocate of the flu shot as a medical professional (PA).",,,,,,,,,,09/01/2019,09/18/2019,17,,UNK,,"Generic adderall, D, flax omega 3, b complex",None,Adhd,,,2,09/19/2019,,,,Sulfa
0836412,09/26/2019,CO,,75,,M,,"patient reports to pharmacy that post Shingrix vaccine, he experienced a hyperanesthesia at the bottom of his skull, unilaterally on the same side as the vaccine injection. He felt it was reportable, as it is not listed in the package insert.",,,,,,,,,,08/15/2019,08/17/2019,2,,UNK,,finasteride,,,,,2,09/19/2019,,,,
0836413,09/26/2019,FL,26.0,26,,F,,"I received my flu shot Wednesday September 18th at Pharmacy. At 1am on September 19th I woke up and had severe and uncontrollable diarrhea and vomiting every two hours. I had frequent episodes of diarrhea, vomiting, and stomach pain throughout the rest of the day, and even on September 20th I still suffered from two incidents of diarrhea. This led to severe dehydration and stomach pain, as well as a lack of appetite.",,,,,,,,,,09/18/2019,09/20/2019,2,,UNK,,"Syeda (drosoirenone and ethinyl estradiol tablets USP 3mg), Zyrtec, Stool softener, Centrum women's multi vitamin",,,,,2,09/21/2019,,,,"Dogs, cats, tree pollen"
0836414,09/26/2019,,64.0,,,F,,went for routine Shingrix shot (second part) had severe pain and stiffness that has lasted more than three weeks. Shot was done at Pharmacy. Pain/stiffness/Loss of strength has lasted more than three weeks and there has only been a very slight improvement,,,,,,,,Y,,,08/30/2019,,,UNK,,,,,,,2,09/22/2019,,,,
0836415,09/26/2019,,,1,.0,M,,"Mmr vaccine 9/12/19 to twin one year old boys. 8 days later have rash, 102 fever, projectile vomiting.",,,,,,,,,,09/12/2019,09/20/2019,8,,UNK,,,,,,,2,09/20/2019,,,,
0836438,09/26/2019,MD,78.0,78,,F,,Patients office called to report an immunization allergy. The patient was seen by her doctor in response to a 4 inch diameter raised red area near the injection site.,,,,,,,,,U,09/24/2019,09/25/2019,1,,PHM,,,,diabetes,,,2,09/26/2019,,Y,,
0836439,09/26/2019,CA,27.0,27,,M,,"After injection, pt complained of feeling light-headed and appeared pale. Pharmacist called for ambulance for pt but refused to go to hospital. Pharmacist consulted pt to sit in chair to rest while pharmacist monitor pt. 10-15 minutes later. pt states he's feeling better ( said he probably was having anxiety because he was already nervous about getting a shot) and wants to leave. Pharmacist again told pt that she can call for an ambulance to have pt monitored, and again, he refused. He states that he is well to leave",,,,,,,,,N,09/26/2019,09/26/2019,0,NA,PHM,,unknown,none,none,,,2,09/26/2019,,,,"Erythromycin, amoxicillin, sulfa antibiotics, macrolide"
0836440,09/26/2019,TX,11.0,11,,M,,"Patient was seen at Emergency room on 9-22-19, diagnose with cellulitis in Both arms near vaccines sites; He follow up with us on 9/23/19; patient was improving both arms were still swell and redness.",,,,,,,,,,09/20/2019,09/22/2019,2,none,PVT,,none,none,none,,,2,09/26/2019,,Y,Y,none
0836455,09/26/2019,MA,76.0,75,,F,,"Red swollen eye lids - Rash on forhead - got worse after 10 days. leasion from hairline to eyelid right side. face swollen - went to urgent care 9/2/19 NP prescribed ValacycloviR said I had shingles. This was my 2Nd shingles shot. I had shingles vaccine 2001 and I goet the shingles 2018 on my head and right side of my face over my forhead and right eye. 5/3/19 got 1st shot and 8/15/19 got 2ND shot, a few days later my eyelid swelled and was red, that cleared over a 10 - 11 day period I got a rash on my forhead and it got gradually worse with water blisters under the skin. On 9/2/19 I went to urgent care got the RX Valacyclovir for shingles. I started taking the pills - my face got swollen but after 2 - 3 days started to get better. after a week I was pretty much healed. Thank you for mailing the forms.",,,,,,,,,,08/21/2019,,,after week symptoms healed. I am fine now,PHM,,Calcium - Vit B Complex,NoNe,NONe,,,2,09/22/2019,,,,Predneszlone - ADVAIR - DOXYCYLIN
0836467,09/26/2019,MN,68.0,68,,F,,"First day achy bones, for 2 days.  Extreme pain starting in upper thigh, radiating around to buttocks, up to waist. Skin extremely sensitive to touch. No lesions. Some puffed up areas. This started 24-48 hours after immunization.   Dr. Visit 9/19/19 - Valtrex, gabapentin prescribed",,,,,,,,,U,09/13/2019,09/14/2019,1,,PHM,,Propranolol 20 Mg,,Diabetes,,,2,09/26/2019,,Y,,NKA
0836469,09/26/2019,FL,11.0,11,,F,,REDNESS AND SWELLING AT INJECTION SITE ABOUT 10 CM IN DIAMETER - SYMPTOMS IMPROVED AFTER 48HRS,,,,,,,,,Y,09/23/2019,09/24/2019,1,NONE,PVT,,NONE,NONE,NONE,,,2,09/26/2019,,Y,,None
0836470,09/26/2019,PA,3.0,3,,F,,Patient had induration involving Left deltoid extending up neck and into clavicle. Mild warmth to touch.,,,,,,,,,U,09/24/2019,09/25/2019,1,None,PVT,,multivitamin,None,None,,,2,09/25/2019,,Y,,None
0836473,09/26/2019,KS,84.0,84,,F,,Patient states experienced extreme pain in left arm (PREVNAR 13) with onset the same afternoon. States she had limited ROM and was unable to sleep overnight. Used TYLENOL for pain relief--is on blood thinners so only uses TYLENOL. States pain was to the point she considered going to the emergency room overnight but ended up not doing so. Requested her doctor not be contacted.. Net day states pain better but she still has compromised ROM.,,,,,,,,,,09/24/2019,09/24/2019,0,,PHM,,SOTALOL,,A-fib,,,2,09/25/2019,,,,None
0836530,09/26/2019,RI,0.17,0,.2,F,,"Patient received above vaccination at 2:48 PM, then began crying and screaming at 6:10 pm, parents gave tylenol at about 8:30 pm, patient fell asleep and rhythmic gasping while asleep noted, at first thought it was residual from crying, but it continued for 20min, they called me and I referred to ER. The rhythmic gasping type breaths continued for another 4-5 hours, and whenever she awoke during that time she went back to screaming, when she would fall asleep she begin the rhythmic gasps again. Seen at hospital by Dr., who by the time she examined her found the breathing had normalized. She spoke with me and said the episode seemed most consistent with irritability and screaming/crying which during sleep would present as gasping. After it resolved, awoke, became alert, ate well, smiled, observed for 2 hours and discharged to home. Mother describes infant as back to herself this am. She only notes mild bruising at site of pentacel injection.",,,,,,,,,Y,09/25/2019,09/25/2019,0,none,PVT,,N/A,N/A,N/A,,,2,09/26/2019,,,Y,N/A
0836531,09/26/2019,CA,4.0,4,,M,,"Patient was given Fluarix and Pneumovax 23 due to special circumstances on 09/23/2019, administered on the left deltoid per mother request. Mother stated that reaction started at 9:00PM at the same day, with itchiness, tenderness, redness, and mild swelling. Patient came to the clinic to get checked on 09/26/2019. Patient is continuing to take Tylenol for pain and antibiotic for otitis media. Rxd Benadryl as well.",,,,,,,,,N,09/23/2019,09/23/2019,0,,UNK,,"Montelukast, Loratidine, Tylenol, Augmentin",Left Otitis media/middle ear effusion,Asthma,,,2,09/26/2019,,Y,,N/A
0836532,09/26/2019,MN,,,,F,,Patient reported on 9/25/19 that she had a red bumpy rash around the circumference of her arm that appeared as a stripe,,,,,,,,,,,03/17/2019,,,UNK,,,,,,,2,09/25/2019,,,,
0836533,09/26/2019,CA,46.0,46,,F,,swollen lymphnude in Armpit Arm pain,,,,,,,,,,09/11/2019,09/12/2019,1,,UNK,,,,,,,2,09/26/2019,,Y,,
0837216,09/26/2019,NJ,33.0,,,F,,Got a bad sore throat after guardsall vaccine,,,,,,,,,,,09/25/2019,,,UNK,,Fexafenadine omeprazole ibuprofen 600,,,,,2,09/25/2019,,,,
0837218,09/26/2019,,85.0,85,,F,,"Patient had reaction to vaccines given (09/11/2019) in the same left arm (boostrix and flu) at pharmacy. Patient came back to pharmacy on the 09/20/2019 with a left red, swollen, hot, mottled, and itchy arm. Patient instructed to see primary care doctor or an urgent clinic. Primary care doctor informed of incident.",,,,,,,,,,09/11/2019,09/11/2019,0,,UNK,,,"NKDA. PMH includes hypertension, hyperlipidemia, insomnia, and urinary incontinence.",,,,2,09/20/2019,,,,
0837219,09/26/2019,CA,,80,,M,,"Side effects hours (onset within 6hrs) to days (2-3days post) after receiving 1st dose of Shinglex vaccine which included: body aces, extreme fatigue, slight headache. Also reported chills with rigors & muscle spasms in upper abdominal region, lasting 3 hours or more, oral temperature of 99.5 (this pt normally runs about 97.5). Local erythema and swelling to injection site taking up at least 1/2 of upper arm. Erythema/swelling lasted 2-3 days. Chills/rigors/spasms on day of injection. myalgias/arthralgias, and fatigue x 2-3 days.",,,,,,,,,,09/13/2019,09/13/2019,0,,UNK,,Fenofibric acid Aspirin  Bystolic  Atorvastatin  Zetia  Vitamin D3 Influenza vaccine (seasonal),,"Hx of MI 20 yrs ago, with CABG x3 at the time (1999), hx of angina. Hx of Bronchitis a few times. Pt has traveled in the distant past (1970-s and 1980s) in his religious order role, and while there had contracted dengue fever x 1 (1971) and had malarial episodes at least 3 times. He states symptoms he felt after this vaccine reminded him and felt like when he had malaria in the 1970/80's. Vaccine was administered by Pharmacy staff on 9/13/19 at about 11 am.",,,2,09/20/2019,,,,
0836296,09/27/2019,CA,0.75,0,.8,M,,High fever reaching 103.5 Diarrhea,,,,,,,,,,09/24/2019,09/24/2019,0,,PVT,,None,None,None,,,2,09/27/2019,,Y,,None
0836297,09/27/2019,TX,51.0,51,,M,,"Fever 102', lege muscle cramps, excessive sweats, a heartbeat in the chest heavy pounding, and strong headache and sound of heart beating also.  Short breath difficulty in healing.",,,,,,,,,Y,09/18/2019,09/18/2019,0,"Emergency room doctor examinations, no lab testing. Was given Tynanol two capsules to take only and over the counter Tynalol to purchase later. Dates 09/19/2019 at 12:00 AM",PVT,,N/A,N/A,Pack pain and knee Pain,,,2,09/27/2019,,,Y,N/A
0836298,09/27/2019,VA,1.5,1,.6,M,,"Slight fever, runny nose, lack of appetite, sleep issues",,,,,,,,,,09/24/2019,09/25/2019,1,,PVT,,N/A,Ear Infection,N/a,Adverse reaction to flu shot at 6 months of age,,2,09/27/2019,,,,N/A
0836300,09/27/2019,MA,52.0,52,,M,,"Pain in testicles and prostate. Headache, fever, chills, fast heart beat, stuffy nose and sinus pressure, fatigue & insomnia.",,,,,,,,,Y,09/25/2019,09/26/2019,1,,PHM,,40mg Pantoprazole Sodium  Ec one per day,none,GERD,,,2,09/27/2019,,,,IV contrast
0836301,09/27/2019,VA,62.0,62,,F,,"Patient returned to pharmacy day after immunization to report redness, warmth and itchiness below injection site on left arm. She stated she had taken diphenhydramine tablet yesterday when itching began (in afternoon a few hours after vaccination). After further questioning of patient, she asked if having an allergy to alpha-gal could contribute to her reaction. When I pulled her immunization sheet, she had not listed an allergy. I said it could be a factor in the reaction and told her that I would be reporting the reaction and advised her to watch the reaction site for any changes and to continue diphenhydramine for now. I also counseled her that if the reaction changed or got worse to see medical treatment immediately.",,,,,,,,,U,09/25/2019,09/25/2019,0,,PHM,,Epinastine 0.05% opth drops,None,,,,2,09/27/2019,,,,"Codeine, Morphine, Galactose (Alpha-gal) - disclosed only when pt came back to report reaction."
0836302,09/27/2019,,71.0,71,,M,,"Sore arm, general body ache, slight fever (99.3), accelerated heartbeat, grogginess",,,,,,,,,N,09/25/2019,09/25/2019,0,,PHM,,None,None,None,,,2,09/27/2019,,,,Nonen
0836303,09/27/2019,VA,72.0,72,,F,,"Patient called the pharmacy approximately 7 hours after vaccine administration to report itchiness at injection site. When questioned, she said the area did feel warm to the touch and described the area as slightly ""swollen"". She did not report any breathing issues or swelling of the tongue. I suggested she take a Benadryl tablet (diphenhydramine) , which she confirmed she had available at home. I instructed her if the reaction changed or got more severe to see medical attention immediately. I also informed her that I would be reporting this as an adverse reaction and incident report.  Patient had received a Fluzone High Dose vaccination on 9/13/19 and a Prevnar 13 vaccination on 9/8/2018 with no reactions to either injection.",,,,,,,,,U,09/26/2019,09/26/2019,0,,PHM,,"Not known - pt has diabetes, fills rx's elsewhere",,Diabetes,,,2,09/27/2019,,,,Nitrofurantoin (Macrobid)
0836364,09/27/2019,CA,,,,M,,"No adverse effects reported; Patient received MMR II on 8/30/2019 and then again on 9/3/2019.; This spontaneous report was received from a pharmacist referring to a male patient of unknown age.  Information about medical history and concurrent conditions was not provided.   On 30-AUG-2019, the patient was vaccinated with one dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin) (M-M-R II) (route subcutaneous; strength, dose, frequency, lot #, expiration date and were not reported) for prophylaxis with sterile diluent (STERILE DILUENT) (unknown lot number and expiration). On 03-SEP-2019 the patient was vaccinated with another dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live albumin status rHA (recombinant Human albumin) (M-M-R II) (lot # R036582, expiration date 17-DEC-2020) with sterile diluent (STERILE DILUENT) (lot #S003608, expiration date 22-NOV-2020) (inappropriate schedule of vaccine administration). No adverse effects reported.",,,,,,,,,U,08/30/2019,09/03/2019,4,,UNK,,Sterile diluent,,,,US0095075131909USA001998,2,09/26/2019,,,,
0836365,09/27/2019,WA,18.0,18,,M,,"No adverse effect reported; improperly stored PROQUAD (lot R030798 & expiration date 4/22/2020).; PROQUAD used for 18 year old patient; This spontaneous report was received from a administrator referring to a 18 year old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not provided.     On 11-SEP-2019 the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (dose and route were not provided, lot#R030798, expiration date was 22-APR-2020) (Inappropriate age at vaccine administration). The measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) was reconstituted with properly stored sterile diluent (lot# and expiration date were not provided). The temperature excursions included 6 fahrenheit degree to 14 fahrenheit degree (14 fahrenheit degree) for 200 hours and 15 fahrenheit degree to 46 fahrenheit degree (34.268 fahrenheit degree) for 18 hours (Incorrect product storage). There was no temperature previously excursion. There was a data logger involved. No adverse effects were reported.",,,,,,,,,U,09/11/2019,09/11/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA006927,2,09/27/2019,,,,
0836366,09/27/2019,LA,,,,U,,"No adverse effects; the patient was administered an improperly stored dose of PROQUAD; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reactions, allergies, medical history, and concomitant therapies provided.  On 09-SEP-2019, the patient was administered an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin(rHA)(PROQUAD)(lot#R030794, expiration date was 22-APR-2019)(exact dose and route of administration were not reported)for prophylaxis. The administered doses experienced a temperature excursion of 1 to 5 degree Celsius(reported as -14 to 10 degree Celsius(-14.37C)) for 30 minutes. There were no previous temperature excursions. The temperature excursions were detected by a data logger. The sterile diluent used to reconstitute measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin(rHA)(PROQUAD) was properly stored. No adverse effects were reported.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA007022,2,09/27/2019,,,,
0836367,09/27/2019,SC,,40,,M,,"Finger flange of the syringe broke which made a deep cut on the left pointer finger.; Finger flange of the syringe broke which made a deep cut on the left pointer finger.; the finger flange of the syringe broke/ PQC: Yes; The patient ""was using a PNEUMOV AX 23 syringe and while injecting PNEUMOVAX 23 on 9/15/2019, the finger flange of the syringe broke which made a deep cut on the left pointer finger; This spontaneous report as received from a 40 year-old male pharmacy technician who is also the patient.   The patient did not have concurrent or historical conditions, drug reactions, allergies, or concomitant medications.    On 15-SEP-2019, the patient was was using a pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # S012244 with expiry date of 09-FEB-2021) syringe and while injecting the vaccine, the finger flange (at the end towards plunger not needle) of the syringe broke (syringe issue) which made a deep cut on the left pointer finger (skin laceration). The finger was treated by washing the site and applying a bandage. Then, another syringe of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was administered without difficulty. On 16-SEP-2019, the patient was recovered from the events. There was a product quality complaint involved, but the product would not be retrieved as syringe was used. Additionally, it was reported that the syringe tip cap was attached properly prior to use, the syringe tray intact and undamaged, the cellophane cover of the syringe tray intact and completely sealed on receipt and the syringe carton was not damaged prior to use.   The causality assessment between skin laceration, product quality complaint and syringe issue with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not provided.",,,,,,,,,Y,09/15/2019,09/15/2019,0,,UNK,,,,,,US0095075131909USA007458,2,09/26/2019,,,,
0836369,09/27/2019,MD,,,,U,,"No adverse effects; improperly stored vaccine; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's current condition, concomitant medications, pertinent medical history, drug reactions/allergies were not reported. On 21-SEP-2019, the patient was administered with one dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number R030924, expiry date 10-JUL-2020 (dose, strength, frequency were unknown) via oral route (defaulted) for prophylaxis which was improperly stored (product storage error). The vaccine underwent a temperature excursion of 0.24 Celsius for time frame of 5 hours 30 minutes. Data logger was involved. There was no previous temperature excursion. There were no adverse effects reported. There was no product quality complaint involved.",,,,,,,,,U,09/21/2019,09/21/2019,0,,UNK,,,,,,US0095075131909USA011975,2,09/26/2019,,,,
0836370,09/27/2019,NJ,,,,F,,"shingles; Information has been received from lawyers referring to a female patient of unknown age. The patient's concurrent condition, medical history and concomitant therapy were not reported.  On or about 28-APR-2011, the patient was vaccinated with Zoster Vaccine Live (ZOSTAVAX) (strength, dose, frequency, route, lot# and expiration date were unknown) for the prevention of shingles (herpes zoster).  On an unknown date, the patient experienced a bad case of shingles. The patient did not recover from the event. As per the reporter, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. The event of post herpetic neuralgia was determined to be disabling.  The reporter considered the event was related to Zoster Vaccine Live (ZOSTAVAX).",,,,,,,,Y,N,,,,,UNK,,,,,,US0095075131909USA012145,2,09/27/2019,,,,
0836372,09/27/2019,GA,,,,F,,"an unspecified patient experienced swelling,redness and warmth from her shoulder to her elbow after receiving PNEUMOV AX 23 on an unspecified day.; an unspecified patient experienced swelling,redness and warmth from her shoulder to her elbow after receiving PNEUMOV AX 23 on an unspecified day.; an unspecified patient experienced swelling,redness and warmth from her shoulder to her elbow after receiving PNEUMOV AX 23 on an unspecified day.; This spontaneous report has been received from a physician via company representative referring to a 72-year-old female patient. Information about the patient's concurrent conditions, medical history, concomitant therapies and drug reaction or allergies were unknown.     On 23-JUL-2019, the patient was vaccinated with pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) (dose, dose number, route, lot number and expiration date were not reported)) for prophylaxis.         On an unknown date in July 2019 (reported as after receiving pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) on an unspecified day), the patient experienced welling, redness and warmth from her shoulder to her elbow. The patient had sought medical attention (came back to office). The patient was treated with prednisone therapy pack and benadryl. It was unknown if the lab diagnostics or studies were performed. The outcome of the events was reported as recovered. No cancer and overdose were reported. No product quality complaint (PQC) was reported. The causality between the events and pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) was not reported.",,,,,,,,,Y,07/23/2019,07/01/2019,,,UNK,,,,,,US0095075131909USA013734,2,09/26/2019,,Y,,
0836373,09/27/2019,GA,,,,M,,"urticaria lesions; Information has been received from a physician via a company representative, referring to a currently 11 years old male patient. Concurrent condition was not reported. Drug reactions/ allergies included history of environmental and food allergies. Concomitant therapies included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid and meningococcal ACYW conj vaccine (CRM197) (MENVEO).  On an unknown date, the patient received a dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (dose detail, strength, lot#, and expiration date were not reported) via intramuscular route for prophylaxis (reported as vaccination).   The patient developed erythema on neck which than spread to the trunk and the back not long after the patient received HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9), diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid and meningococcal ACYW conj vaccine (CRM197) (MENVEO) on the same unspecified date. The physician diagnosed the condition as urticaria lesions, prescribed diphenhydramine hydrochloride (BENADRYL) and cetirizine hydrochloride (ZYRTEC) for 1 day. There were no lab diagnostics/studies performed. The patient was fully recovered on an unspecified date.  Causality assessment was not reported.",,,,,,,,,Y,,,,,UNK,,diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid; MENVEO,Immunisation; Prophylaxis,Medical History/Concurrent Conditions: Environmental allergy; Food allergy,,US0095075131909USA013765,2,09/27/2019,,,,
0836374,09/27/2019,AR,,,,U,,"no adverse effect; expired dose administered; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.   On 06-SEP-2019, the patient was vaccinated with expired dose of hepatitis a vaccine, inactivated(VAQTA) 1 injection, intramuscularly (lot # R021233, Expiry date : 05-SEP-2019) for prophylaxis (expired product administered). No adverse effects were reported. Nurse declined evaluation of administered dose. There was no product quality complaint.",,,,,,,,,U,09/06/2019,09/06/2019,0,,UNK,,,,,,US0095075131909USA013811,2,09/27/2019,,,,
0836375,09/27/2019,CA,,,,U,,"Rashes to neck and trunk; Nausea; Vomiting; Red eyes; Shortness of breath; This case was reported by a nurse and described the occurrence of rash in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced rash, nausea, vomiting, eye red and shortness of breath. On an unknown date, the outcome of the rash, nausea, vomiting, eye red and shortness of breath were unknown.   It was unknown if the reporter considered the rash, nausea, vomiting, eye red and shortness of breath to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that, there was Flu immunization where the patient experienced adverse reaction reaction with rashes to neck and trunk, nausea and vomiting red eyes. The patient also experienced shortness of breath. This is 1 of the 10 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836377,09/27/2019,CA,,,,U,,"Rashes to neck and trunk; Nausea; Vomiting; Red eyes; Shortness of breath; This case was reported by a nurse and described the occurrence of rash in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced rash, nausea, vomiting, eye red and shortness of breath. On an unknown date, the outcome of the rash, nausea, vomiting, eye red and shortness of breath were unknown.   It was unknown if the reporter considered the rash, nausea, vomiting, eye red and shortness of breath to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that, there was Flu immunization where the patient experienced adverse reaction reaction with rashes to neck and trunk, nausea and vomiting red eyes. The patient also experienced shortness of breath. This is 1 of the 10 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836378,09/27/2019,CA,,,,U,,"Rashes to neck and trunk; Nausea; Vomiting; Red eyes; Shortness of breath; This case was reported by a nurse and described the occurrence of rash in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced rash, nausea, vomiting, eye red and shortness of breath. On an unknown date, the outcome of the rash, nausea, vomiting, eye red and shortness of breath were unknown.   It was unknown if the reporter considered the rash, nausea, vomiting, eye red and shortness of breath to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that, there was Flu immunization where the patient experienced adverse reaction reaction with rashes to neck and trunk, nausea and vomiting red eyes. The patient also experienced shortness of breath. This is 1 of the 10 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836379,09/27/2019,CA,,,,U,,"Adverse reaction; This case was reported by a nurse and described the occurrence of adverse reaction in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that, there was Flu immunization where the patient experienced flu adverse reaction. This is 1 of the 10 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836380,09/27/2019,CA,,,,U,,"Adverse reaction; This case was reported by a nurse and described the occurrence of adverse reaction in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that, there was Flu immunization where the patient experienced flu adverse reaction. This is 1 of the 10 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836381,09/27/2019,CA,,,,U,,"Adverse reaction; This case was reported by a nurse and described the occurrence of adverse reaction in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that, there was Flu immunization where the patient experienced flu adverse reaction. This is 1 of the 10 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836382,09/27/2019,CA,,,,U,,"Adverse reaction; This case was reported by a nurse and described the occurrence of adverse reaction in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that, there was Flu immunization where the patient experienced flu adverse reaction. This is 1 of the 10 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836383,09/27/2019,CA,,,,U,,"Adverse reaction; This case was reported by a nurse and described the occurrence of adverse reaction in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that, there was Flu immunization where the patient experienced flu adverse reaction. This is 1 of the 10 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836384,09/27/2019,CA,,,,U,,"Adverse reaction; This case was reported by a nurse and described the occurrence of adverse reaction in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that, there was Flu immunization where the patient experienced flu adverse reaction. This is 1 of the 10 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836385,09/27/2019,AZ,,,,U,,"Fever; Nausea; Chills; Headaches; Arm numbness; This case was reported by a physician via call center representative and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced fever, nausea, chills, headache and numbness of upper extremities. On an unknown date, the outcome of the fever, nausea, chills, headache and numbness of upper extremities were recovered/resolved.   It was unknown if the reporter considered the fever, nausea, chills, headache and numbness of upper extremities to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The physician on the chat reporting a patient experienced nausea, fever, chills, headaches and arm numbness the day after the first dose.  The events went away within a couple days.  The contact had a patient waiting and left the chat without providing any further information.  No other information captured.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836386,09/27/2019,DE,66.0,66,,F,,"Upset stomach; Frequent Bowel Movements; This case was reported by a consumer via call center representative and described the occurrence of upset stomach in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 15th September 2019, less than a day after receiving Shingrix, the patient experienced upset stomach and frequent bowel movements. On an unknown date, the outcome of the upset stomach and frequent bowel movements were not recovered/not resolved.   It was unknown if the reporter considered the upset stomach and frequent bowel movements to be related to Shingrix.  Additional information received were as follows: On sunday, in the early afternoon, the patient received Shingrix on right arm. Within 12 hours of receiving the vaccination, the patient began to experience an upset stomach and frequent bowel movements. The patient reported that she had 4 to 5 bowel movements in the last 24 hours and that was more than she normally experienced, The patient stated that it was not diarrhea just increased frequency of bowel movements and indicated that the symptoms were starting to lessen as the day progresses.  The reporter consented to follow up. The reporter gave permission for her physician to be contacted. The reporter was unable to provide additional information.",,,,,,,,,N,09/15/2019,09/15/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836387,09/27/2019,AZ,65.0,65,,F,,"Redness; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 9AB33, expiry date 6th December 2021) for prophylaxis.   On 11th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 11th September 2019, less than a week after receiving Shingrix, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left deltoid. The patient experienced redness 4 inches wide at the site of injection site and it had been 7 days at the reporting date the redness had still not improved.  No further details were provided.",,,,,,,,,N,09/11/2019,09/11/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836388,09/27/2019,MD,,,,U,,"fever; chills; pain/ Achiness; flu-like symptoms; headache; This case was reported by a pharmacist via call center representative and described the occurrence of fever in an unknown number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever, chills, pain, influenza-like symptoms and headache. On an unknown date, the outcome of the fever, chills, pain, influenza-like symptoms and headache were unknown.   It was unknown if the reporter considered the fever, chills, pain, influenza-like symptoms and headache to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The age group was captured as adult as per vaccine indication. The pharmacist reports that many patients had been complaining that they had worse issues after the second dose of Shingrix. She stated that she had been told by patients that after getting the second dose of Shingrix, the patients had experienced fever, chills, pain, headache, achiness, and flu like symptoms. No specific details regarding patient or products was provided at time of reporting. The reporter had consented to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836389,09/27/2019,SC,82.0,82,,F,,"trouble hearing out of left ear; complete loss of vision for short periods of time; trouble walking; extremely dizzy; vertigo; Initial information received on 20-Sep-2019 regarding an unsolicited valid serious case received from a nurse.  This case involves a 82 years old female patient who experienced trouble hearing out of left ear (hypoacusis), complete loss of vision for short periods of time (blindness), trouble walking (gait disturbance), extremely dizzy (dizziness) and vertigo (vertigo), while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 12-Sep-2019 at 2:09 pm, the patient received a 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ221AB and Exp. Date 01-Apr-2020 via intramuscular route in the left deltoid.  On 13-Sep-2019 at night around 3 am, the patient developed a serious trouble hearing out of left ear (hypoacusis), complete loss of vision for short periods of time (blindness), trouble walking (gait disturbance), extremely dizzy (dizziness) 12 hours 51 minutes following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. patient was diagnosed with vertigo. The patient was hospitalized on the same day these events occurred and discharged on 14-Sep-2019 (hospitalization duration 1 day). She was told to go to emergency room.  Other relevant tests not reported.    Final diagnosis was vertigo, hypoacusis, blindness, gait disturbance and dizziness.  It was not reported if the patient received a corrective treatment.  The patient was recovering from all the events.  List of documents held by sender: none.; Sender's Comments: This case involves a 82 years old female patient who developed vertigo, hypoacusis, blindness, gait disturbance and dizziness after vaccination with FLUZONE HIGH DOSE. Time to onset was compatible. However, patient's medical condition at the time of vaccination and lab tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of vaccine cannot be assessed.",,,,,Y,1,,,N,09/12/2019,09/13/2019,1,,UNK,,,,,,USSA2019SA265158,2,09/27/2019,,,Y,
0836390,09/27/2019,FL,69.0,69,,F,,"Light flu like symptoms, acute local reaction To arm. Redness,acute pain ,swelling from injection site to anticubital with heat and redness. Acute swelling",,,,,,,,,N,09/25/2019,09/25/2019,0,,PVT,,Levothyroxine/ 81 asa/ B12,Asthma,Asthma,,,2,09/27/2019,,,,Latex/ shrimp/ avocado/ banana/
0836391,09/27/2019,NJ,26.0,26,,M,,Sore throat.,,,,,,,,,Y,09/25/2019,09/26/2019,1,None.,UNK,,None.,None.,None.,,,2,09/27/2019,,,,None.
0836392,09/27/2019,,56.0,56,,F,,"She received vaccine in the morning of 9/26/19, yesterday evening began having some fatigue, and over night area below injection site became swollen, red, and very hot to the touch. She is taking Advil/Tylenol for swelling/pain and is going to keep an eye on swelling and redness.",,,,,,,,,,09/26/2019,09/26/2019,0,,UNK,,,,,,,2,09/27/2019,,Y,,
0836393,09/27/2019,KY,80.0,80,,F,,Patient describes facial swelling on opposite side of body where vaccine was administered.,,,,,,,,,N,09/18/2019,09/22/2019,4,None,PHM,,None,None,None,,,2,09/27/2019,,,,penicillin
0836394,09/27/2019,VA,16.0,16,,F,,"Patient presents to the pharmacy very anxious to receive the vaccine. Her mom had filled out the vaccination form without any problems (NKDA, no ill day of vaccination, etc). Quickly after administering the vaccination (about 1-2 minutes), patient said she felt like she needed to 'vomit.' She threw up, was sweating, lost consciousness for 30 seconds, urinated, and then woke up. She was unaware of the event (did not know she lost consciousness or urinated). She was provided some water and began to feel better. She sat until she felt better. Patient and her parent left without letting me know. Unknown if patient improved, called the following morning to follow up but no answer.",,,,,,,,,U,09/26/2019,09/26/2019,0,n/a,PHM,,lo-loestrin fe 1-10,acne vulgaris,acne vulgaris,,,2,09/27/2019,,,,no known drug allergies
0836395,09/27/2019,GA,59.0,59,,F,,"After less than 24 hour employee's left arm middle upper portion of tricep toward back  became swollen , red , hot to the touch. per the nurse who administered the vaccine.  After my assessment of the area involved with the reaction was not where the deltoid is located. I believe the vaccine could have been given  in the wrong site. So I recommended that ibuprofen  and benadryl be started immediately since the arm was already the size of a coke can and to reassess the arm in 24 hours.As antiboitics may need to be started . After additional 24 hours there was some improvement and the employee  agreed it had as well- we opted to start  the antibiotics given it was the same size had not gone down. The redness had improved some. Keflex 500mg  2 capsules BID x10 days",,,,,,,,,U,09/25/2019,09/26/2019,1,none,PVT,,"adderall, klonopin, sinus meds otc",sinus congestion,ADD,,,2,09/27/2019,,,,"iodine,penicillin, seafood"
0836410,09/27/2019,CA,,,,U,,"Rashes to neck and trunk; Nausea; Vomiting; Red eyes; Shortness of breath; This case was reported by a nurse and described the occurrence of rash in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced rash, nausea, vomiting, eye red and shortness of breath. On an unknown date, the outcome of the rash, nausea, vomiting, eye red and shortness of breath were unknown.   It was unknown if the reporter considered the rash, nausea, vomiting, eye red and shortness of breath to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that, there was Flu immunization where the patient experienced adverse reaction reaction with rashes to neck and trunk, nausea and vomiting red eyes. The patient also experienced shortness of breath. This is 1 of the 10 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836416,09/27/2019,MA,52.0,52,,F,,Cellulitis,,,,,,,,,N,09/23/2019,09/23/2019,0,N/A,PVT,,"OCP, zyrtec",no known,Seasonal allergy,,,2,09/27/2019,,,,Seasonal
0836417,09/27/2019,TX,45.0,45,,M,,"Patient reported that 2 hours after receiving injection, his eye started getting very red and painful along with throat irritation.  He reports that he took Ibuprofen and Zyrtec and symptoms resolved shortly after.  He denies any rash, redness at injection site, wheezing, shortness of breath or chest pain.  Notified Medical the next day.  He was then given Claritin and Zantac to take daily for one week",,,,,,,,,Y,09/24/2019,09/24/2019,0,none required,WRK,,unknown,,,,,2,09/27/2019,,Y,,unknown
0836418,09/27/2019,FL,68.0,68,,F,,patient reported arm red and still a little sore 6 days after receiving vaccination.  Also stated had chills soon after receiving vaccine.,,,,,,,,,Y,09/19/2019,09/19/2019,0,none,PHM,,"LEVOTHYROXIN, TRAMADOL, LORAZEPAM, HYDROCHLORTHIAZIDE, ATORVASTATIN,",NONE REPORTED,HYPERCHOLESTEREOLEMIA,,,2,09/27/2019,,,,NONE KNOWN
0836419,09/27/2019,MO,76.0,76,,F,,"Patient came into pharmacy on 9/26/19 with signs and symptoms of redness on injection site arm. The red area was warm to the touch and was about the size of 2 palms. Patient still had her band-aid on, it was recommended that she remove her band-aid and ice the site. Patient said that she was getting better.",,,,,,,,,U,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,09/27/2019,,,,
0836421,09/27/2019,MN,2.0,2,1,F,,Redness and hard lump at site. One medium pustule sustained and a few smaller bumps appeared and resolved in two days.,,,,,,,,,Y,09/17/2019,09/25/2019,8,,PVT,,None.,High fever and lethargy two weeks prior to vaccine lasting less than 24 hours.,None.,,,2,09/27/2019,,Y,,None.
0836422,09/27/2019,FL,66.0,66,,F,,PATIENT CALLED IN THE PHARMACY AND COMPLAINED ABOUT HAVING ITCHY AND BUMPY SKIN ON BOTH LEGS AND THIGHS. PATIENT HAVE ALREADY USED BENADRYL LIQUID.,,,,,,,,,U,09/22/2019,09/26/2019,4,NONE; PATIENT IS GOING TO THE DOCTOR OFFICE ON 09/27/2019,PHM,,NONE AT THE TIME OF VACCINATION;  PATIENT IS TAKING MELOXICAM 15 MG FOR ARTHRITIS SOMETIMES,ARTHRITIS,NONE,,,2,09/27/2019,,Y,,PENICILLIN
0836423,09/27/2019,LA,60.0,60,,F,,"Could not resume activities till 9/23/2019.  Fever as high as 101.8.  Headache, chills, severe stomach pain.  Malaise.  Sore arm.",,,,,,,,,Y,09/20/2019,09/20/2019,0,None,PVT,,Crestor and Synthroid,None,"Hypothyroid, hyperlipidemia",Shingrix December 2018,,2,09/27/2019,,,,None
0836424,09/27/2019,MA,19.0,19,,M,,Patient 19y/o was inadvertently given a state supplied pediatric dose of HepA (0.5ml). No adverse reactions noted. Patient will be revaccinated with the age appropriate adult HepA dose (1ml) as soon as possible. VAERS and Institute error reporting forms are summited. MA who gave the incorrect vaccine has been spoken to. State Board of health is aware of the situation.,,,,,,,,,U,08/29/2019,08/29/2019,0,,PVT,,,,"allergic rhinitis, lactose intolerance",,,2,09/27/2019,,Y,,
0836425,09/27/2019,GA,0.33,0,.3,F,,Anaphylactoid reaction based on postmortem tryptase level of 87.1 ng/ml. This postmortem level is elevated.,Y,09/09/2019,,,,,,,N,09/09/2019,09/09/2019,0,,PVT,,,,,,,2,09/27/2019,,,,
0836428,09/27/2019,,,,,M,,"Foetal vaccine exposure during pregnancy; Isomerism, stomach and gallbladder on left; Low birth weight baby; This is a serious observational study case, finitially received from other health care professional on 20-Sep-2019, concerning a neonate, male subject.   The mother was a 38-year-old, adult female pregnant subject of body weight: 286 lbs, height: 65 inches and body mass index (BMI): 47.6 enrolled in a study on pregnancy outcomes in women immunized with seasonal cell culture influenza trivalent (TIVc) or quadrivalent (QIVc) vaccine during pregnancy.  The mother's obstetrical history included 6 previous pregnancies with 1 full term live birth, 1 preterm birth, 2 spontaneous abortions and 2 stillbirths. The mother had no maternal or paternal history with major congenital malformations.   The mother did not use tobacco, alcohol or illicit drugs during pregnancy.   The mother's last menstrual period (LMP) was 18-Jun-2018, estimated delivery date (EDD) and corrected estimated date of delivery (CEDD) was 10-Mar-2019. The type of pregnancy was singleton.  The mother's current conditions included gestational diabetes, obesity, chronic hypertension, asthma, ADHD (attention deficit hyperactivity disorder), shortness of breath and acid reflux. The mother's concomitant medications included prenatal vitamins (minerals nos, vitamins nos) for pregnancy, Albuterol (salbutamol) for shortness of breath, Makena (hydroxyprogesterone caproate) for history of preterm birth, Clatirine (loratadine) for allergies and Zantac (ranitidine hydrochloride) for acid reflux.  On 02-Aug-2018, the mother underwent cystic fibrosis mutation analysis and spinal muscular atrophy test and no major congenital malformation (MCM) was noted.  On 06-Aug-2018, the mother underwent ultrasound scan and no MCM was noted.  On 16-Aug-2018, the mother underwent Qnatal test and no MCM was noted.  On 24-Sep-2018, the mother underwent ultrasound scan and no MCM was noted.  On 08-Oct-2018, at 16 weeks of gestation, the mother was administered with Flu Vaccine Cell Subunit QIV NVD (influenza vaccine, subunit influenza virus vaccine polyvalent, batch number: 252664, route of administration, anatomical location, expiration date: not reported) (explicitly coded as foetal exposure during pregnancy) for influenza immunisation.  On 10-Jan-2019, 17-Jan-2019, 25-Jan-2019, 31-Jan-2019 and 07-Feb-2019, the mother underwent non-stress test and no MCM was noted.  On 08-Feb-2019, the mother underwent ultrasound scan and MCM was noted.  On 11-Feb-2019 and 13-Feb-2019, the mother underwent non-stress test and no MCM was noted.  On 18-Feb-2019, the mother underwent ultrasound scan and no MCM was noted.  On 19-Feb-2019, four months and eleven days after vaccination, at 37.3 weeks gestation, the mother gave a live birth to a male neonate by vaginal delivery. The neonate's birth weight was 2268 grams (explicitly coded as low birth weight baby), head circumference 32.4 centimetres and body length 45.7cm. The appearance, pulse, grimace, activity, and respiration (APGAR) scores were 8 at one minute and 9 at five minutes. APGAR score was not reported for 10 minutes.   On the same date, major congenital malformation was noted: isomerism, stomach and gallbladder on left.   At the time of initial report, outcome of the isomerism, stomach and gallbladder on left and low birth weight baby was not reported.   The reported did not provide causality and seriousness criteria.  This case is linked to 201904749, the corresponding mother report.  Company Comment: Reportedly, the male neonate subject was delivered as low birth weight baby with heterotaxia after foetal exposure during pregnancy, at gestation age of 16 weeks, with the suspect product Flu Vaccine Cell Subunit QIV NVD. Chronology is plausible for the event low birth weight baby. For the event heterotaxia temporal relationship is implausible because product was administered after organs of digestive system have already positioned themselves. Mother's medical history of gestational diabetes, obesity, chronic hypertension and asthma may have contributed to development of the events. Causality was confounded by therapy with multiple concomitant medications. Foetal exposure during pregnancy and heterotaxia is assessed as not related. For the event low birth weight baby, causal role of the suspect product cannot be totally excluded and is assessed as related.; Reporter's Comments: Reportedly, the male neonate subject was delivered as low birth weight baby with heterotaxia after foetal exposure during pregnancy, at gestation age of 16 weeks, with the suspect product Flu Vaccine Cell Subunit QIV NVD. Chronology is plausible for the event low birth weight baby. For the event heterotaxia temporal relationship is implausible because product was administered after organs of digestive system have already positioned themselves. Mother's medical history of gestational diabetes, obesity, chronic hypertension and asthma may have contributed to development of the events. Causality was confounded by therapy with multiple concomitant medications. Foetal exposure during pregnancy and heterotaxia is assessed as not related. For the event low birth weight baby, causal role of the suspect product cannot be totally excluded and is assessed as related.",,,,,,,,,U,10/08/2018,02/19/2019,134,,PVT,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; ALBUTEROL [SALBUTAMOL]; ZANTAC; MAKENA; CLARITINE,,Comments: None.,,USSEQIRUS201904748,2,09/26/2019,Y,,,
0836429,09/27/2019,NJ,79.0,79,,M,,"chills, headache, body aches, fatigue, sore arm",,,,,,,,,Y,09/25/2019,09/25/2019,0,,PHM,,"statins, blood pressure meds",none,high cholesterol,,,2,09/27/2019,,,,none
0836430,09/27/2019,NJ,70.0,70,,F,,"headache, fatigue, red sore arm, chills, body aches",,,,,,,,,Y,09/25/2019,09/25/2019,0,none,PHM,,none,none,none,,,2,09/27/2019,,,,none
0836431,09/27/2019,NC,59.0,59,,F,,"Within hours, my arm began to ache to the point that lifting it to shoulder height was uncomfortable.  By evening, the entire upper arm was swollen (measured about 1.25 inches greater in diameter than it does today), hard to the touch, red and very warm;  the arm ached unbearably unless it was supported on a pillow, and I couldn't lift it without significant pain.  The same remained true on Friday (the next day) and to a lesser degree on Saturday.  By Sunday, I had good range of motion back, but the arm remained warm and redder than usual.  By Monday, I only noticed it when I bumped it.  I was taking 800 mg of ibuprofen (my usual dose for headache pain) three times a day Friday through Sunday.",,,,,,,,,Y,09/19/2019,09/19/2019,0,None,PHM,,Amlodipine (10 mg daily) Aspirin (81 mg daily),None,"Seasonal allergies, vision problems (multiple retinal and vitreal detachments in each eye), infertility (undiagnosed cause), high blood pressure (controlled with above), stroke in 2011 (Factor V Leyden mutation -- heterozygous)",,,2,09/27/2019,,,,Mild latex allergies
0836432,09/27/2019,KY,10.0,10,,F,,Vasovagal syncope due to immunizations. Event happened around 10:15 am and the child fainted around 10:18 am.,,,,,,,,,Y,09/27/2019,09/27/2019,0,N/A,PVT,,None,None,None,,,2,09/27/2019,,,,None
0836433,09/27/2019,MI,66.0,66,,F,,"Patient states she started to experience pain, most often in the arm and hand of the injection (left) starting about 5 days after administration. She described the pain as an aching nerve pain, usually from the elbow down to the hand, She states she also experiences pain that moves to the legs and other arms, as well as fatigue, weakness and pain to the touch in the wrist of the left arm.",,,,,,,,,N,07/27/2019,08/01/2019,5,Patient states she has seen her primary care provider who has done bloodwork that shows signs of inflammation but she was not able to provide dates or exact results of her labs. She has also taken two courses of steroids which has not resolved the pain.,PHM,,"Cartia XT, Flecainide, Eliquis, Levothyroxine, Simvastatin, Fosamax, Vitamin D and Calcium",None,"Atrial fibrillation, hypothyroidism, high cholesterol, obstructive sleep apnea, age related osteoporisis",,,2,09/27/2019,,Y,,Sulfa drugs
0836434,09/27/2019,NY,17.0,17,,F,,"sensitivity to light, headache - pain scale of 5-6 for 4 days; sore throat, dizziness on day 4; extreme fatigue for 6 days",,,,,,,,,Y,09/16/2019,09/16/2019,0,none,PVT,,"Vitamin C, multivitamin, omega 3, Chelex, immune boost supplement",none,none,,,2,09/27/2019,,,,most sunscreens
0836435,09/27/2019,VA,11.0,11,,M,,Cellulitis to right deltoid area.  Clindamycin and Cetirizine prescribed.,,,,,,,,,N,09/25/2019,09/27/2019,2,n/a,PVT,,cetirizine 10mg; Clindamycin HCI 300 mg; Kapvay 0.1 mg; loratadine 10 mg; ProAir 90mcg/actuation,,,,,2,09/27/2019,,Y,,None
0836436,09/27/2019,VA,55.0,55,,F,,Red raised rash to right and left forearms (right greater than left) with associated itching.  Employee encouraged to take benadryl unless otherwise contraindicated.  No allergy to eggs.  No reaction to previous influenza vaccines.,,,,,,,,,U,09/27/2019,09/27/2019,0,n/a,WRK,,unknown.  Under the care of a physician for chest pain and itching due to unknown causes.,Under the care of a physician for chest pain and itching due to unknown causes.,none identified.,,,2,09/27/2019,,,,none known
0836437,09/27/2019,KS,81.0,81,,F,,"Pt reports an ongoing headache and an itchy, red rash on her chest (not at her injection site)",,,,,,,,,N,09/24/2019,09/26/2019,2,,PHM,,,,,,,2,09/27/2019,,,,"baclofen, Ciprofloxacin, Codeine, Lisinopril, Morphine, Tramadol"
0836447,09/27/2019,CA,,15,,U,,"No adverse effects reported; the Patient received improperly stored VARIVAX (lot R023513 & expiration date 8/16/2020). The VARIVAX was reconstituted with properly stored STERILE DILUENT; This spontaneous report was received from a Medical Assistant and refers to a 15 year old patient of unknown gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 13-AUG-2019, the patient received an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # R023513 with expiration date of 16-AUG-2020, for prophylaxis (route and frequency were not reported), that was reconstituted with a properly stored sterile diluent (STERILE DILUENT MRK) lot# S000130 with expiration date of 23-AUG-2021. No adverse effects were reported.    It was stated that the vaccine underwent a temperature excursion of -14C (degrees Celsius) to -10c (-13.2 C) for 46 minutes No previous temperature excursion was done. The call was because of a ""data logger"".  This is one of several reports received from the same source.; Sender's Comments:  US-009507513-1909USA007312: US-009507513-1909USA007177: US-009507513-1909USA007118: US-009507513-1909USA006939:",,,,,,,,,U,08/13/2019,08/13/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA007512,2,09/27/2019,,,,
0836448,09/27/2019,,,,,F,,"VZV aseptic meningitis and zoster; VZV aseptic meningitis and zoster; VZV aseptic meningitis and zoster; This spontaneous report as received from a physician refers to a teenage female patient of unknown age. No information on patient's medical history, concurrent conditions and concomitant medications was provided.      On an unknown date, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot#, expiration date, dose and route of administration were not provided)  for prophylaxis.         On an unknown date, the patient experienced varicella zoster virus (VZV) aseptic meningitis and zoster. The reporter wanted to test her cerebrospinal fluid (CSF) for the vaccine strain. The outcome of the event was not provided. The relatedness between the event and the vaccination with varicella virus vaccine live (oka/merck) (VARIVAX) was not provided.  Upon internal review, the event of aseptic meningitis was considered to be medically significant.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA008660,2,09/27/2019,,,,
0836449,09/27/2019,GA,,,,F,,"two hours after the vaccination the patient had a ""psychotic break"" described as the patient was seeing things and hearing things; only abnormal test result was a blood sugar of 69; Orthostatic blood pressure changes; This spontaneous report was received from a physician refers to a 19 year old female patient. The patient's concurrent condition, concomitant medication and medical history were unknown. On an unknown date in September 2019 (reported as ""last week""), the patient was vaccinated with third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (frequency, route of administration, lot # and expiry date unspecified) for prophylaxis. On the same day, two hours after the vaccination the patient had a psychotic break described as the patient was seeing things and hearing things (psychotic disorder). The patient's mother took the patient to the emergency department and all tests were normal including testing for alcohol and drugs. The physician reported the only abnormal test result was a blood sugar of 69 (unit not reported) (blood glucose abnormal). The patient's computed tomography (CT) scan of head result was fine. The physician reported the patient stayed in a quiet room in the emergency department and went to sleep and when the patient awakened she was back to her normal mental baseline. The patient was seen in physician's office a couple days later and had orthostatic blood pressure changes (pressure orthostatic abnormal). The outcome of the events was reported as recovering. Causality assessment was not reported by the reporter.  This is one of two reports received from the same reporter.",,,,,,,,,N,09/01/2019,09/01/2019,0,,UNK,,,,,,US0095075131909USA012437,2,09/27/2019,,Y,Y,
0836450,09/27/2019,OK,,,,M,,"nosebleed; This spontaneous report was received from office manager via company representative refers to a male patient of unknown age. No information was provided regarding the patient's pertinent medical history, concomitant medication and drug reactions/allergies. On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (strength, dose, frequency, route, lot number, expiry date unspecified). On an unknown date, the patient had nosebleed (epistaxis) after the administration of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9). The patient never had nosebleed previously. It was unknown by reporter which dose of HPV series was received by the patient. No PQC involved. No further information provided. The outcome of epistaxis was unknown. Reporter's causality was not provided.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA013965,2,09/27/2019,,,,
0836451,09/27/2019,WI,,,,U,,"Muscle aches; Flu-like symptoms; This case was reported by a other health professional via call center representative and described the occurrence of muscle pain in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced muscle pain and influenza-like symptoms. On an unknown date, the outcome of the muscle pain and influenza-like symptoms were unknown.   It was unknown if the reporter considered the muscle pain and influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The medical assistant reported that, several patients experienced muscle ache and flu like reactions after vaccinatin with a dose of Shingrix. The medical assistant denied, she was reporting any adverse event, and refused to provide further details regarding patients, products or events. The reporter did not consent to follow up. This case has been linked with case US2019170910.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836452,09/27/2019,,30.0,,,F,,"Premature delivery; Anxiety; Yeast; Vaccine exposure during pregnancy; This is a serious observational study case, initially received from other health professional on 20-Sep-2019, concerning a 30-year-old, female pregnant subject of body weight: 197 lbs, height: 65 inches and body mass index (BMI): 32.8 enrolled in, a study on pregnancy outcomes in women immunized with seasonal cell culture influenza trivalent (TIVc) or quadrivalent (QIVc) vaccine during pregnancy.  The subject's medical history included migraine and herpes simplex virus type II (HSV2).  The subject's concomitant medication prenatal vitamins (minerals NOS, vitamins NOS) for pregnancy.   Subject had five previous pregnancy reported with full-term live birth for two pregnancies, pre-term live birth for other two pregnancies and one elective abortion. No birth defects were reported. There was no history of maternal or paternal congenital malformation. The subject had used alcohol (2 drinks or less per day) during pregnancy.   The subject's last menstrual period (LMP) date was on 25-Jun-2018. The subject's estimated date of delivery (EDD) and corrected estimated date of delivery were reported as 01-Apr-2019. The type of pregnancy was singleton.   On 21-Aug-2018, the subject underwent ultrasound and there was no major congenital malformation (MCM) noted.  On 04-Sep-2018, the subject underwent ultrasound and there was no MCM noted.  On 02-Oct-2018, the subject underwent ultrasound and there was no MCM noted.  On 16-Oct-2018, at 16-weeks of gestation, the subject was administered Flu Vaccine Cell Subunit QIV NVD (Flucelvax QIVc) [influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5 ml, batch number: 252664, route of administration, anatomical location and expiration date: not reported) (explicitly coded as ''Vaccine exposure during pregnancy'') for an influenza immunisation.  On 18-Oct-2018, the subject underwent ultrasound and quad test and there was no MCM noted.   On 29-Nov-2018, one month and 13 days after vaccination, the subject experienced yeast and on the same day started treatment with terconazole, vaginally, every day at bedtime until 08-Dec-2018.  On 08-Dec-2018, the patient recovered from yeast.  On 09-Jan-2019, the subject underwent ultrasound and non-stress test and there were polycystic kidneys, oligohydramnios and anhydramnios identified.  On 22-Jan-2019, the subject underwent non-stress test and there were polycystic kidneys, oligohydramnios and anhydramnios identified.  On 23-Jan-2019, three months and 7 days after vaccination, the subject developed anxiety and was treated with Zoloft (sertraline hydrochloride) once daily, orally.  On the same day, the subject underwent ultrasound and there were polycystic kidneys, oligohydramnios and anhydramnios identified.  On 25-Jan-2019, the subject underwent non-stress test and there were polycystic kidneys, oligohydramnios and anhydramnios identified.  On 29-Jan-2019, the subject underwent ultrasound and there were polycystic kidneys, oligohydramnios and anhydramnios identified.  On 07-Feb-2019, the subject underwent ultrasound and there were polycystic kidneys, oligohydramnios and anhydramnios identified. On the same day, the patient underwent genetic testing and there was no MCM noted.   On 13-Feb-2019, the subject underwent non-stress test and there were polycystic kidneys, oligohydramnios and anhydramnios identified.   On 14-Feb-2019, 21-Feb-2019 and 01-Mar-2019, the subject underwent biophysical profile test and there were polycystic kidneys, oligohydramnios and anhydramnios identified.   On 06-Mar-2019, at 36.3 weeks of gestation (explicitly coded as Premature delivery'), the subject delivered a live female neonate through Caesarean section. The neonate had major congenital malformation at the time of birth which included polycystic kidneys, oligohydramnios and anhydramnios. The birth weight was 2780 grams. No data regarding head circumference and length were provided. The appearance, pulse, grimace, activity, and respiration (APGAR) score was 1 at minute 1, 3 at minute 5 and 5 at minute 10. It was reported that the neonate ''passed away 10 minutes shy of being alive for 24 hours''.  The outcome for the event Anxiety' was not recovered.    This case is linked to the case 201904742, corresponding child case.  Company Comment: The subject experienced premature delivery, fungal infection and anxiety after vaccination with the suspect product Flucelvax QIVc. Reportedly, vaccination occurred during pregnancy. Chronology is plausible. Medical history of herpes simplex virus type II and alcohol use may have contributed to development of the events. Exposure during pregnancy is assessed as not related per company conventions. For all other events, causal role of the suspect product cannot be totally excluded and is assessed as related.; Reporter's Comments: The subject experienced premature delivery, fungal infection and anxiety after vaccination with the suspect product Flucelvax QIVc. Reportedly, vaccination occurred during pregnancy. Chronology is plausible. Medical history of herpes simplex virus type II and alcohol use may have contributed to development of the events. Exposure during pregnancy is assessed as not related per company conventions. For all other events, causal role of the suspect product cannot be totally excluded and is assessed as related.",,,,,,,,,N,10/16/2018,10/16/2018,0,"Test Date: 20190214; Test Name: Biophysical profile; Result Unstructured Data: Polycystic kidneys, oligohydramnios and anhydramnios identified.; Test Date: 20190221; Test Name: Biophysical profile; Result Unstructured Data: Polycystic kidneys, oligohydramnios and anhydramnios identified.; Test Date: 20190301; Test Name: Biophysical profile; Result Unstructured Data: Polycystic kidneys, oligohydramnios and anhydramnios identified.; Test Date: 20190207; Test Name: Genetic testing; Result Unstructured Data: No major congenital malformations noted.; Test Date: 20190109; Test Name: Non-stress test; Result Unstructured Data: Polycystic kidneys, oligohydramnios and anhydramnios identified.; Test Date: 20190122; Test Name: Non-stress test; Result Unstructured Data: Polycystic kidneys, oligohydramnios and anhydramnios identified.; Test Date: 20190125; Test Name: Non-stress test; Result Unstructured Data: Polycystic kidneys, oligohydramnios and anhydramnios identified.; Test Date: 20190213; Test Name: Non-stress test; Result Unstructured Data: Polycystic kidneys, oligohydramnios and anhydramnios identified.; Test Date: 20181018; Test Name: Quad test; Result Unstructured Data: No major congenital malformations noted.; Test Date: 20180821; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformations noted.; Test Date: 20180904; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformations noted.; Test Date: 20181002; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformations noted.; Test Date: 20181018; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformations noted.; Test Date: 20190109; Test Name: Ultrasound; Result Unstructured Data: Polycystic kidneys, oligohydramnios and anhydramnios identified.; Test Date: 20190123; Test Name: Ultrasound; Result Unstructured Data: Polycystic kidneys, oligohydramnios and anhydramnios identified.; Test Date: 20190129; Test Name: Ultrasound; Result Unstructured Data: Polycystic kidneys, oligohydramnios and anhydramnios identified.; Test Date: 20190207; Test Name: Ultrasound; Result Unstructured Data: Polycystic kidneys, oligohydramnios and anhydramnios identified.",UNK,,PRENATAL VITAMINS [MINERALS NOS; VITAMINS NOS],Herpes simplex type II (Start date 0 weeks prior to conception.); Migraine (Start date 0 weeks prior to conception.),Medical History/Concurrent Conditions: Alcohol use (2 drinks or less per day); Elective abortion (1 previous pregnancy ended with elective abortion); Full term baby (2 previous pregnancies ended with fullterm live birth); Multigravida (5 previous pregnancies); Preterm labour (2 previous pregnancies ended with preterm live birth); Comments: Unknown.,,USSEQIRUS201904743,2,09/27/2019,,,,
0836453,09/27/2019,,20.0,,,F,,"Dysmature placenta; Vaccine exposure during pregnancy; This is a serious observational study case initially received on 20-Sep-2019, concerning a 20-year-old adult female, pregnant subject (Ethnicity: Not reported), of body weight 265 lbs, height 65 inches and body mass index (BMI) 44.1, enrolled, a safety study.  The subject's obstetrical history noted that the subject had one previous spontaneous abortion. The subject had no history of offspring with major congenital malformation (MCM). Also, the subject had no maternal or paternal history with MCM. The subject did not use tobacco, alcohol or illicit drugs during pregnancy.   The subject's last menstrual period (LMP) date was 01-Mar-2018. The subject's estimated date of delivery (EDD) was reported as 04-Jan-2019. The type of pregnancy was singleton.   The subject's historical condition was chlamydia, while current conditions were anaemia, hypertension, nausea and vomiting. The subject's historical drug included azithromycin. The subject's concomitant medications included prenatal vitamins (unspecified vitamins) for pregnancy, Zofran (ondansetron) for nausea and vomiting, ferrous sulfate for anaemia and labetalol for hypertension.  On 14-May-2018, the subject underwent ultrasound and no MCM was noted.   On 23-Jul-2018, the subject underwent quadscreen and ultrasound, there was no MCM noted.  On 15-Oct-2018, at approximately 32 weeks of gestation, the subject was administered Flu Vaccine Cell Subunit QIV NVD [influenza vaccine, subunit influenza virus vaccine polyvalent, batch number: 252664, dose: 0.5 mL, route of administration, anatomical location, batch number and expiration date: not reported] (explicitly coded as vaccine exposure during pregnancy) for an influenza immunisation.   On the same day, the subject underwent ultrasound and no MCM was noted.  On an unknown date, the subject experienced dysmature placenta, reported as pregnancy complication.  On 29-Oct-2018 and 05-Nov-2019, ultrasound was performed, and no MCM was noted.  On 14-Nov-2018 and 19-Nov-2018, the subject underwent non-stress test and no MCM was noted.  On 06-Dec-2018, the subject underwent ultrasound and no MCM was noted.  On 11-Dec-2018 and 19-Dec-2018, the subject underwent non-stress test and no MCM was noted.  On 26-Dec-2018, at gestational age of 38.7 weeks, the subject delivered a live birth, male neonate via Caesarean section. The characteristics of the neonate included birth weight: 3147 grams, head circumference: 33 cm, length: 52 cm and appearance, pulse, grimace, activity, and respiration (APGAR) scores were 8 (one minute) and 9 (five minutes). There was no APGAR score data for 10 minutes reported. No MCM was identified at birth.   The outcome for the event of dysmature placenta was not reported.  Company comment: A 20-year-old adult female, pregnant subject experienced placental disorder associated with Flu Vaccine Cell Subunit QIV NVD. The product was given in 32nd week of gestation. Onset date of the event was unknown. Chronology needs more clarification. The subject's obstetrical history noted that the subject had one previous spontaneous abortion. Concomitant drugs ondansetron and labetalol may have contributed in development of this event. Having in mind provided information, causality is assessed as not related to the product. The event of exposure during pregnancy was assessed as unrelated per company's conventions.; Reporter's Comments: A 20-year-old adult female, pregnant subject experienced placental disorder associated with Flu Vaccine Cell Subunit QIV NVD. The product was given in 32nd week of gestation. Onset date of the event was unknown. Chronology needs more clarification. The subject's obstetrical history noted that the subject had one previous spontaneous abortion. Concomitant drugs ondansetron and labetalol may have contributed in development of this event. Having in mind provided information, causality is assessed as not related to the product. The event of exposure during pregnancy was assessed as unrelated per company's conventions.",,,,,,,,,U,10/15/2018,10/15/2018,0,Test Date: 20181114; Test Name: Non-stress test; Result Unstructured Data: No major congenital malformations were noted.; Test Date: 20181119; Test Name: Non-stress test; Result Unstructured Data: No major congenital malformations were noted.; Test Date: 20181211; Test Name: Non-stress test; Result Unstructured Data: No major congenital malformations were noted.; Test Date: 20181219; Test Name: Non-stress test; Result Unstructured Data: No major congenital malformations were noted.; Test Date: 20180723; Test Name: Quadscreen; Result Unstructured Data: No major congenital malformations were noted.; Test Date: 20180514; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformations were noted.; Test Date: 20180723; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformations were noted.; Test Date: 20181015; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformations were noted.; Test Date: 20181029; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformations were noted.; Test Date: 20181105; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformations were noted.; Test Date: 20181206; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformations were noted.,PVT,,ZOFRAN [ONDANSETRON]; FERROUS SULFATE; PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; LABETALOL,,Medical History/Concurrent Conditions: Anemia; Chlamydial infection; Hypertension; Nausea; Pregnancy; Spontaneous abortion; Vomiting,,USSEQIRUS201904745,2,09/26/2019,,,,
0836454,09/27/2019,,,,,U,,"Abnormal XYY karyotype; Foetal exposure during pregnancy; This is a serious observational study case, initially received from other health professional on 20-Sep-2019, concerning a foetal subject. The mother was 34-year-old female subject of body weight:120 Ibs, height: 64 inches and body mass index (BMI): 20.6, enrolled in, a study on pregnancy outcomes in women immunized with seasonal cell culture influenza trivalent (TIVc) or quadrivalent (QIVc) vaccine during pregnancy.  The mother' current condition included gas. The mother's concomitant medication included: Citrinatal assure (ascorbic acid, calcium citrate, colecalciferol, cupric oxide, docosahexaenoic acid, docusate sodium, eicosapentaenoic acid, folic acid, iron, nicotinamide, potassium iodide, pyridoxine hydrochloride, riboflavin, thiamine, tocopheryl acetate, zinc oxide) for healthy pregnancy, simethicone for gas and Makena (hydroxyprogesterone caproate) to reduce risk of preterm birth.  The mother's obstetrical history included two previous pregnancies with one full term live birth and one preterm live birth. The mother had no maternal or paternal history with major congenital malformations. The mother did not use tobacco, alcohol or illicit drugs during pregnancy. The mother's last menstrual period (LMP) date was on 03-Sep-2018 and the pregnancy was singleton. The estimated delivery date (EDD) was 10-Jun-2019.  On 11-Oct-2018, at five weeks of gestation, the mother was administered Flucelvax QIVc [influenza vaccine, subunit influenza virus vaccine polyvalent, batch number: 252232, dose: 0.5 ml, route of administration, anatomical location, expiry date: not reported) (explicitly coded as Foetal exposure during pregnancy') for influenza immunisation.  On 27-Nov-2018, the mother underwent First trimester screening test and risk of Down syndrome was identified.  On 06-Dec-2018, the mother underwent Non-invasive prenatal testing (NIPT) and abnormal XYY karyotype was identified.  On 11-Dec-2018, at 14.1 weeks of gestation, the mother underwent elective termination and it was reported as patient choice'. No further information was provided.  This case is linked to 201805974, corresponding mother case.  Company Comment: Foetal subject was diagnosed with XYY syndrome after foetal exposure during pregnancy, at gestation age of 5 weeks with the suspect product Flucelvax QIVc. Temporal relationship is implausible because the event occurred at the time of conception and before administration of the suspect product. The mother underwent elective termination of pregnancy. Foetal exposure during pregnancy is assessed as not related per company conventions. For the event XYY syndrome, causal role of the suspect product is assessed as not related.; Reporter's Comments: Foetal subject was diagnosed with XYY syndrome after foetal exposure during pregnancy, at gestation age of 5 weeks with the suspect product Flucelvax QIVc. Temporal relationship is implausible because the event occurred at the time of conception and before administration of the suspect product. The mother underwent elective termination of pregnancy. Foetal exposure during pregnancy is assessed as not related per company conventions. For the event XYY syndrome, causal role of the suspect product is assessed as not related.",,,,,,,,,U,10/11/2018,10/11/2018,0,Test Date: 20181127; Test Name: First trimester screening; Result Unstructured Data: Risk of Down syndrome; Test Date: 20181127; Test Name: NIPT test for abnormal karyotype XYY; Test Date: 20181206; Test Name: NIPT test for abnormal karyotype XYY; Result Unstructured Data: Abnormal XYY karyotype,UNK,,SIMETHICONE; MAKENA; CITRANATAL ASSURE,,Comments: None,,USSEQIRUS201904750,2,09/27/2019,Y,,,
0836456,09/27/2019,MA,4.0,4,,F,,"Parent states arm became swollen within an hour of the immunization.  The left shoulder is not red, swollen and warm to the touch warm to touch approximately a 3-4 inch round area.",,,,,,,,,U,09/25/2019,09/25/2019,0,N?A,SCH,,none,none,none,,,2,09/27/2019,,,,none
0836457,09/27/2019,NY,69.0,69,,F,,"Red, warm swollen upper arm which over the course of the next three days spread to entire arm.  Contacted dr. office by phone and spoke with nurse. Was told to ice and take ibuprofen 3 X a day.  Which I did, Arm did not return to normal for 7 days and shoulder pain lingers.  Incident of overall warmth, sweating, light-headedness, which went away after sitting down, deep breathing and rest.   Did not return.",,,,,,,,,Y,09/18/2019,09/18/2019,0,none,PVT,,"Trianterene-HCTZ, Crestor, baby aspirin",none,none,,,2,09/27/2019,,,,Sulfa drugs
0836458,09/27/2019,SC,72.0,72,,F,,"all symptoms started 9/25-26-2019--vomiting, chills, headache, inject site reaction (red, heat), malaise, fatigue",,,,,,,,,U,09/25/2019,09/25/2019,0,,PHM,,"melatonin 10mg, zetia 10mg, toprol xl 50mg,",no,type 2 diabetes,,,2,09/27/2019,,,,"penicillin, tetracycline, clindamycin"
0836459,09/27/2019,WI,40.0,40,,F,,"Injection site on left arm became more painful as the day went on, a patch of raised skin emerged, the raised area became warm to the touch.  The next morning, the raised area had doubled in size and was hot to the touch and very red.  A surgeon I work for looked at it and determined it was cellulitis.",,,,,,,,,N,09/25/2019,09/25/2019,0,,PVT,,"Ondansetron, multi-vitamins, Zyrtec, probiotic",none,acid reflus,,,2,09/27/2019,,Y,,latex
0836460,09/27/2019,MA,72.0,72,,F,,"1st.  Your neat system here would not let me go back to add: Not saying here they did anything wrong. 2nd.  Got Fluzone high dose in one arm and Pneumovax 23 in the other at the same time because they said I could do that.  Get flu shot yearly, no reactions.  So it's likely the Pneumovax 23.  Got the Pneumovax13 last year.  Do not recall any reaction.  This year from about two hours after the shot until the next morning, mid-morning, I felt sick.  For about 19 hours I felt dizzyish, a warm forehead, general malaise/fatigue, weakness, and some swelling in the right Pneumovax arm.  There was NO redness, muscle aches, fast heartbeat,  difficulty breathing.  I want you to know because we should be warned this may occur.  What if I had work the next day?  (Yes, I still work.)  Just tell them to tell us such a reaction MIGHT happen and we can set our schedules accordingly.",,,,,,,,,Y,09/25/2019,09/25/2019,0,None.,PHM,,"A half aspirin, 3-4 times a week.  Antihistamine pill for hay fever allergies.  No prescribed meds.",None.  Just hay fever.,None.  That's right.  72 and healthy.,,,2,09/27/2019,,,,None.
0836461,09/27/2019,MD,59.0,59,,M,,Patient developed herpes zoster rashes on 9/23/2019 and was seen by me on 9/27/2019. Raised erythematous vesicular patches extending from mid back to front along the chest wall on L side in a band. He was put on Valtrex for treatment.,,,,,,,,,U,09/20/2019,09/23/2019,3,,PVT,,"Lotrel 10/20, Vitamin D 2000 units, cinnamon, Lidex 0.05 % topical cream, Tripleflex, Anusol-HCL rectal suppository, Omega 3 acid, Crestor 20 mg,",None,"Hypertension, Obstructive sleep apnea, Allergic rhinitis, Eczema, Vitamin D deficiency, nephropathy with proteinuria, Prediabetes, mixed hyperlipidemia",,,2,09/27/2019,,Y,,NKDA
0836463,09/27/2019,NY,72.0,72,,F,,"temporary hearing loss, dizziness, dry heaving",,,,,,,,,Y,09/21/2019,09/22/2019,1,,PHM,,,,chronic vertigo,,,2,09/27/2019,,Y,,
0836464,09/27/2019,MD,65.0,65,,F,,o 2 hours after her arm swelled and e=she couldn't move her arm o Headache o Nausea o Some redness o It itched a lot o She felt light headed o Couldn't sleep  she soaked in epsom salt and the hives went away,,,,,,,,,U,09/16/2019,09/17/2019,1,N/A,PVT,,,N/A,,,,2,09/27/2019,,,,Clorzoxazone  Gabapentin  Morphine
0836465,09/27/2019,,85.0,85,,F,,redness and swelling  extending 3-4 inches away from injection site with pain and soreness extending past the injection site,,,,,,,,,N,09/25/2019,09/26/2019,1,,UNK,,,,,,,2,09/27/2019,,,,
0836466,09/27/2019,TX,31.0,31,,F,,"Flu like symptoms, nausea, itching to body, lethargy, chills",,,,,,,,,N,09/23/2019,09/24/2019,1,None,OTH,,None,None,None,,,2,09/27/2019,,,,Penicillin
0836468,09/27/2019,ID,75.0,75,,F,,"Patient came to pharmacy counter about 10 min after shot-to report a burning feeling, no redness or swelling noted. On Sat 9/22, pt came to pharmacy & the inner portion of upper arm was a bit swollen, red and warm to the touch. On 9/24/19 pt called and stated doing much better and report is no more swelling, no warmth to touch & only a bruise 2 inches past injection site yellowish in color. Pt. Did not seek Medical attention as she felt not necessary.",,,,,,,,,Y,09/20/2019,09/20/2019,0,,PHM,,,,,,,2,09/22/2019,,,,
0836471,09/27/2019,DE,35.0,35,,F,,"(L) Arm pain after given shot within 24 hrs. Also reported (L) sided facial swelling and numbness, swelling resolved but numbness persisted. Pain improved next day",,,,,,,,,,09/16/2019,09/17/2019,1,Medrol (Pak)4mg tablets dosepak/ sed rate/ C Reactive Protein/ Allergy referral,PVT,,Lisinopril 20mg Daily,NA,Hypertension,,,2,09/25/2019,,Y,,NKDA
0836472,09/27/2019,PR,17.0,17,,M,,"AFTER ADMINISTERING THE VACCINES WITH THE NECESSARY PRECAUTIONS, INTRAMUSCULARLY IN BOTH ARMS, THE PATIENT REFERS FEELING DIZZY. WHEN THE FATHER WAS TRYING TO MOVE HIM TO HAVE HIM LAY DOWN, THE PATIENT SEEMED TO HAVE A TONIC SEIZURE AND RIGIDITY, EYES ROLLED BACK AND LOSS OF BLADDER CONTROL. AFTER LAYING HIM DOWN AND LIFTING HIS LOWER EXTREMITIES, THE PATIENT RECOVERED CONSCIOUSNESS AND SLOWLY STARTS FEELING BETTER.",,,,,,,,,Y,08/22/2019,08/22/2019,0,NO,OTH,,NO,NO,NO,,,2,09/25/2019,,,,NO
0836474,09/27/2019,FL,16.0,16,,M,,"Per mom, patient experienced tight chest, rash on site of injection. Was seen at urgent care and prescribed Epipen, Prednisone, steroid medications.",,,,,,,,,Y,08/09/2019,08/13/2019,4,N/A,PVT,,Focalin XR 20 mg/Cetirizine 10mg/Singulair 10 mg,N/A,ADHD/Anaphylactic reaction Shellfish,,,2,09/27/2019,,,Y,Buscapina/Sulfa/Aspirin/Shellfish
0836475,09/27/2019,NV,3.0,3,,F,09/26/2019,Cellulitis of left leg Start clindamycin powder for reconstitution 75mg/5ml.,,,,,,,,,,09/24/2019,09/26/2019,2,,UNK,UNK,,,,,,1,,,,,
0836477,09/27/2019,OK,67.0,67,,F,,"redness and ""heat"" spreading to shoulder, subsided somewhat by now",,,,,,,,,U,09/24/2019,09/27/2019,3,,PHM,,tramadol zolpidem citalopram atorvastatin lisinopril,,,,,2,09/27/2019,,,,
0836478,09/27/2019,AR,72.0,72,,F,,"-sore are at site of injection for 2 days; then more generalized shoulder pain, progressing to limited range of motion;  then inability to lay on that side while in bed. -revisited APN at Family Clinic and was referred to Orthopaedic physician.   -Orthopaedic physician injected the shoulder and prescribed Meloxacam along with at home physical therapy. He stated I should get back to 90% functioning.  Two years after flu shot that has occurred.",,,,,,,,,Y,10/01/2017,10/01/2017,0,X-ray,PVT,,aspirin 81 mg; levothyroxine; pravastatin; hydrochlorthiazide; metoprolol; multivitamin,none,elevated cholesterol; hypothyroid; moderately elevated blood pressure,,,2,09/27/2019,,,,penicillin; bactrim
0836479,09/27/2019,GA,69.0,69,,M,,"c/p pain, in R upper arm extending to R shoulder, r proximal forearm starting morning after vaccination",,,,,,,,,N,09/20/2019,09/21/2019,1,none,PVT,,"Alprazolam, ASA, Furosemide, Gabapentin, Hydrocodone-Acetaminophen, Ibuprofen,  Klor-con, Losartan-HCTZ, Metformin, Metoprolol, Sertraline, Simvastatin, Tamsulosin",,"Type 2 Diabetes, HTN, Hyperlipidemia, Arthritis,  Vitamin d deficiency, Chronic back pain",,,2,09/27/2019,,,,Percocet
0836480,09/27/2019,VA,57.0,57,,F,,"Left upper arm red, swollen and hot to touch.  Complaints of fever and body aches.  Diagnosed with cellulitis.",,,,,,,,,N,09/18/2019,09/01/2019,,N/A,PVT,,none,none,none,Tdap/ slight redness/swelling,,2,09/27/2019,,Y,,none
0836481,09/27/2019,CA,61.0,61,,F,,"I broke out in a horrible itchy rash with welts all over my trunk.  I call the pharmacist who administered the vaccine. She told me to take benedryl and said i may need a steroid shot. The next day, 9/26/2019, when I woke it at was far worse. I phoned my dr and made an appt.  He gave me a steroid shot and had me start taking  24 hour xyzoz antihistime.  It did clear up a lot but im coming up on the dosage time and Im getting red and itchy again.",,,,,,,,,N,09/25/2019,09/25/2019,0,,PHM,,"Levothyroxine, Lexapro, melatonin",none,Hashimotos disease,,,2,09/27/2019,,Y,,none
0836482,09/27/2019,AR,68.0,68,,F,,"arm became swollen, red, and hot . also had rash down arm. went away after a week",,,,,,,,,Y,09/19/2019,09/20/2019,1,na,PHM,,,,,,,2,09/27/2019,,,,"codeine, penicillin, ambien, keflex, flonase"
0836483,09/27/2019,NY,21.0,21,,F,,"Localized redness induration measuring 4cmx5cm, pruitic Given zyrtec, advised cool compresses, symptoms improved within 48hours",,,,,,,,,Y,09/23/2019,09/24/2019,1,None,SCH,,none,None,History of intermittent mild asthma,,,2,09/27/2019,,Y,,Penicillin
0836484,09/27/2019,MD,83.0,83,,F,,"pt started with tremor RUE>LUE>legs  'shortly after' the vaccination, was improving by the time she was seen by me a couple of weeks later - no new medications or other decline in health",,,,,,,,,Y,09/04/2019,09/01/2019,,none,PVT,,"levothroid, gabapentin, losartan, warfarin, furosemide, atorvastatin, latanoprost eyedrops, MVI, Coenzyme Q10, loratadine prn",none,"DM2 with complications, HTN, CKD3, chronic afib, pacemaker, hypothyroidism (controlled), GERD, hx TIA, OA, glaucoma",,,2,09/27/2019,,Y,,"sulfa - also reactions/intolerances to amlodipine, atorvastatin, simvastatin, doxycycline, enalapril"
0836525,09/27/2019,KY,1.5,1,.5,M,,"There were no adverse reactions; patient received improperly stored vaccine; This spontaneous report as received from a medical assistant refers to an 18-month-old male patient. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 29-APR-2019, the patient was vaccinated with the improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) injection (lot number: S002460, expiration date: 15-MAY-2020; dose was not reported) administered intramuscularly. The vaccine was stored in temperature 52.5 degrees Fahrenheit for 4 hours and 40 minutes. There was no previous temperature excursion. Digital data lodger was involved.  There were no adverse reactions.",,,,,,,,,U,04/29/2019,04/29/2019,0,,OTH,,,,,,US0095075131909USA000314,2,09/27/2019,,,,
0836526,09/27/2019,WI,17.0,17,,F,,"No adverse effect; A 17 years old female patient was administered properly stored PROQUAD on 14-NOV-2018 and 19-DEC-2018; A 17 years old female patient was administered properly stored PROQUAD on 14-NOV-2018 and 19-DEC-2018; This spontaneous report was received from a pharmacist referring to a 17 years old female patient. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported.  On 14-NOV-2018, the patient was vaccinated with a dose of properly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot# R011214, expiry date: 15-OCT-2019, therapy type: rHA, dose, strength and route were not reported) for prophylaxis. On 19-DEC-2018, she was vaccinated with another dose of properly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot# R011214, expiry date: 15-OCT-2019, therapy type: rHA, dose, strength and route were not reported) for prophylaxis (inappropriate age at vaccine administration). The sterile diluent (lot# M041688, expiry date not reported, but upon internal validation established as 12-JUN-2019) used to reconstitute the vaccines was also properly stored. No adverse effects were reported.",,,,,,,,,U,11/14/2018,11/14/2018,0,,UNK,,sterile diluent,,,,US0095075131909USA005269,2,09/27/2019,,,,
0836527,09/27/2019,MD,,,,U,,"This literature marketed report has been received from authors in a published literature article titled as above.  This literature referred to 3 children patients of unknown gender. Information about concurrent condition, concomitant medication and medical history was not provided.  On unknown date(s), the patients was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(manufacturer unknown) (dose, frequency, route and lot # were not reported) for prophylaxis. On unknown date(s), the patients were diagnosed measles within 30 days of vaccine administration, which are most likely measles vaccine-associated adverse events. The outcome of the event was unknown. The causality was related.  A copy of the published article is attached as further documentation of the patient's experience.",,,,,,,,,U,,,,,OTH,,,,,,US0095075131909USA006828,2,09/27/2019,,,,
0836528,09/27/2019,WA,,,,F,,"Seizure like episode; Migraine; Vomiting; Nausea; Flu-like symptoms; Information received on 14SEP2019 from a consumer via a website.  A 35 year old female experienced seizures like episode (PT: Seizure like phenomena), flu-like symptoms (PT: Influenza like illness), nausea (PT: Nausea), vomiting (PT: Vomiting), migraine (PT: Migraine), following the administration of BioThrax.  The consumer claimed to have suffered progressively worse symptoms after anthrax vaccinations in December 2017, April 2018 and August 2018. It was reported that after the first vaccine, she experienced flu-like symptoms including headaches, sweats and coughing. After the second shot, she experienced nausea, vomiting and migraines, in addition to her prior symptoms. She also received emergency room treatment for migraines during this period.  The progressively worsening reactions to the first two vaccines led the consumer to withdraw her informed consent to the third administration of the vaccine, and she repeatedly requested a waiver from vaccination from the doctor, her patient advocate, and her chain of command. Although she received a week-long delay in vaccine, she did not obtain a waiver.  After the compulsory administration of the third anthrax vaccine, she developed nausea within a day. More symptoms developed over the course of weeks resulting in multiple overnight stints at the hospital. Medical staff instructed her and her husband, to wait out the reaction at home and avoid seeking treatment, as reported by the consumer. But when she became non-responsive during episodes of seizure-like shaking, her husband paid out-of-pocket for emergency room treatment. The seizure-like episodes continued for at least three weeks after the administration of the vaccine.   Outcome of the reported events was unknown at the time of report.   Company Comments: The described events of seizure-like episode, flu-like symptoms, nausea, vomiting and migraine have been reported with reasonable time relation to intake of Biothrax, with flu-like symptoms having recurred with repeated administration.  No medical history nor diagnostic evaluations were reported in the article, therefore causality cannot be ruled out.  That being said,  the causality assessment is considered to be probably related to the administration of vaccine.; Sender's Comments: Company Comments: The described events of seizure-like episode, flu-like symptoms, nausea, vomiting and migraine have been reported with reasonable time relation to intake of Biothrax, with flu-like symptoms having recurred with repeated administration.  No medical history nor diagnostic evaluations were reported in the article, therefore  causality cannot be ruled out.  That being said, the causality assessment is considered to be probably related to the administration of vaccine.",,,,,,,,,U,12/01/2017,,,,MIL,,,,Comments: Unknown patient history,,USEMERGENT BIOSOLUTIONS19,2,09/26/2019,,,Y,
0836529,09/27/2019,CA,,,,F,,"Having sore, redness at injection site; Having sore, redness at injection site; This is a spontaneous report from a contactable pharmacist via Pfizer sales representative.  A female patient of an unspecified age received pneumococcal 13-val conjugate vaccine (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced having sore and redness at injection site on an unspecified date. The events lasted 2 or 3 days and were non serious. The outcome of the events was resolved on unspecified date.  No follow-up attempts are possible, information about batch number cannot be obtained",,,,,,,,,Y,,,,,UNK,,,,,,USPFIZER INC2019417552,2,09/27/2019,,,,
0836534,09/27/2019,IL,60.0,60,,F,,Rash around the injection sight. About 2 inches in diameter and has begun to itch. Has not gotten worse since first noticed,,,,,,,,,N,09/24/2019,09/26/2019,2,,PHM,,,,,,,2,09/27/2019,,,,
0836535,09/27/2019,,82.0,82,,M,,"On 9/25/2019, pt received the High Dose Flu vaccine at a Clinic. No other vaccines given. Pt reported pain after injection. On 09/27/2019, pt reported to the Medical Center Injection Room. Pt reported that on the morning of 09/27/2019, he had arm swelling. Nurse assessed. Erythema that was approximately 10 cm in length and 6 cm  in width on Left lower arm. It was warm to touch. No pain on palpation. Denied fever. PCP notified via Electronic Health Record.",,,,,,,,,,09/25/2019,09/27/2019,2,,UNK,,Multivitamins,,Essential Hypertension Parkinsonism,,,2,09/27/2019,,,,Amlodipine
0836536,09/27/2019,PA,65.0,65,,F,,"1 week post administration, developed redness, swelling, warmth, and pain at injection site",,,,,,,,,N,09/18/2019,09/25/2019,7,none,PVT,,"anastrozole for breast cancer, Vitamin D High Potency  1000 Units, Metoprolol Succinate ER  100 mg , Hydrochlorothiazide  25 mg , Lisinopril 40 mg,  Lorazepam  1 mg",,"Essential hypertension, Insomnia, Anxiety state, Chronic kidney disease stage 3, Impaired fasting glycaemia, Mixed hyperlipidemia, Hypothyroidism, Vitamin D deficiency, Hyperuricemia, Taking medication, Gastroesophageal reflux disease, History of Infiltrating duct carcinoma of breast, Disorder of magnesium metabolism, Rosacea, Polyneuropathy due to chemotherapy, Long-term current use of aromatase inhibitor, Osteopenia",,,2,09/27/2019,,Y,,amlodipine
0836537,09/27/2019,VA,53.0,53,,M,,"Fever of 101.5 recorded at 6:00 pm on 9/25/2019 which was the day after the vaccination.  Throughout the day, I felt miserable at work.  I could not keep my hands warm.  I had to wear a jacket which is very unusual for me.  I had a headache and muscle aches all day.  When I got home, I slept for 12 hours and felt much better the next day.  I had these exact same reactions to the first dosage of Shringrix vaccine (101 fever) which I received on 3/7/2019 [I did not file a VAERS report for that].",,,,,,,,,Y,09/24/2019,09/25/2019,1,None,PHM,,"Lisinipril-HCTZ, Nexium, Vitamin C and TruBiotic Probiotics supplements",None.  Perfectly healthy,None,,,2,09/27/2019,,,,None
0836538,09/27/2019,FL,68.0,68,,F,,"pt cam e in today with rash/redness at site of injection. around injection site is red/black and blue and sore.  Pt said she was feeling lightheaded/dizzy at after receiving injection and reaction showed up following morning. Pt took 2 benadryl night after injection, just 1 dose.",,,,,,,,,N,09/24/2019,09/25/2019,1,none,PHM,,"Eliquis 5mg, Amlodipine 2.5mg,",none,emphysema,,,2,09/27/2019,,Y,,contact allergy to dye
0836539,09/27/2019,MI,4.0,4,,M,,"Presented to ER 2 days post vaccine with itching, red and swollen thigh.  No pain with palpation or walking.  Most likely localized reaction to vaccine, but placed on antibiotics proactively.  Spoke with parent on 9/27/2019 and redness and swelling resolving.",,,,,,,,,Y,09/24/2019,09/26/2019,2,,PVT,,none,none known,mild asthma,,,2,09/27/2019,,,Y,none
0836540,09/27/2019,CA,33.0,33,,M,,"woke up with very itchy rash to arms and legs the next day after receiving flu vaccine. Immediately after receiving the vaccine, he felt a little light headed.  Used atarax x 2 doses; triamcinolone cream, allegra x 1. It has helped someone. But still had symptoms when he presented on 9/23/19 for evaluation.  On exam he had multiform wheels, papules/macules to lower arms and legs. No angio edema or HEENT sx. No nausea/vomiting.  Rx provided for benadryl 25mg 1-2 tabs qid for the following 2 day then prn. rtc 2 days for recheck. Did not follow up as of report date",,,,,,,,,U,09/16/2019,09/17/2019,1,NA,PVT,,none,none at the time of vaccination,none,,,2,09/27/2019,,Y,,none; had 1 episode of possible shrimp allergy but has eaten it since without issue
0836541,09/27/2019,,44.0,44,,F,,"Rash on upper part of body and under arm.  She also had a headache, fever and nausea",,,,,,,,,,09/13/2019,09/13/2019,0,,UNK,,,,,,,2,09/27/2019,,,,
0836542,09/27/2019,AZ,70.0,70,,F,,noted red macular rash over LLQ and RLQ abdominal wall and lower back.  Also macular rash on R upper arm,,,,,,,,,N,09/25/2019,09/27/2019,2,none,PVT,,"lisinopril 5mg daily, atorvastatin 40mg daily, chlorthalidone 25mg daily, doxepin 3mg daily",None,"Hypertension, h/o thalamic stroke 11/18",,,2,09/27/2019,,Y,,None
0836543,09/27/2019,AZ,64.0,64,,F,,"The patient reports that a few days after her 1st Shingrix shot, she developed her usual outbreak of localized vesicular shingles in a dermatomal pattern (same distribution that she has had several times in the past) on her left shoulder; the same side as the Shringrix vaccine was administered.  She took Valtrex bid for a week after first noticing the rash and it ultimately resolved with no sequelae or symptoms of post herpetic neuralgia.  She was administered her 2nd Shingrix dose in the series 13 weeks after the first dose, but in her contralateral deltoid (right side)",,,,,,,,,Y,06/28/2019,06/30/2019,2,none,PVT,,"Rosuvastatin, Duloxetine, Mirtazapine",none,anxiety with depression history of recurrent herpes zoster outbreaks,,,2,09/27/2019,,,,none
0836544,09/27/2019,OR,11.0,11,,M,,"large red area from shoulder to elbow  with fever, itching, soreness",,,,,,,,,,09/25/2019,09/26/2019,1,,PVT,,,,,,,2,09/27/2019,,,,
0836545,09/27/2019,FL,77.0,77,,F,,Patient states she experienced severe pain that led to being admitted in hospital,,,,,Y,,,,Y,09/23/2019,09/23/2019,0,,PHM,,,,,,,2,09/27/2019,,,Y,
0836546,09/27/2019,MI,44.0,44,,F,,Pt refused flu vaccine. Was suppose to get Hep A. I drew up flu instead and administered to pt. Pt did not receive Hep A.,,,,,,,,,Y,09/27/2019,09/27/2019,0,n/a,PVT,,lisinopril meclizine  ferrous sulfate,no,htn,,,2,09/27/2019,,,,erythromycin tetracycline
0836547,09/27/2019,IL,58.0,58,,F,,swelling and pain in the arm where the shot was given. Extreme fatique next morning and feeling of fogginess and lack of concentration. The top of my right hand (shot side) hurts when I make a fist or type.,,,,,,,,,N,09/26/2019,09/26/2019,0,"None, I'm going to wait and see if it gets better on its own.",OTH,,"coreg, lisinpril, lexapro, wellbutrin, aspirin, multiviatmin with soy isoflavorne, Vitamin D3 supplement, Magnesium oxide, B12",None,"Heart disease, sleep apnea, obesity, anxiety and depression",,,2,09/27/2019,,,,"premarin, sulfa drugs, sensitivity to chemicals including perfume"
0836548,09/27/2019,TX,16.0,16,,M,,"After checking out and leaving the doctor's office after a routine well-child exam, we got in our car. Right after my son closed the door and fastened his seat belt, he reclined his seat slightly. I jokingly asked if he was already feeling lethargic. We were warned that he might be lethargic for about 3 days. He did not respond. His eyes rolled back and his upper body began shaking. His head was shaking as well. I began yelling at him and grabbed his arm, but he didn't respond to me. The movement lasted approximately 30 seconds, but could be slightly more or less. (It seemed like forever.) I was about to get out of the car and run for help inside the doctor's office when his body relaxed, and his eyes closed completely. He then opened his eyes and looked at me. He did not know what had just happened and thought he had just fallen asleep. He was slightly  disoriented,  alert, but slightly lethargic. He was extremely pale, diaphoretic and his pulse was approximately in the 40s. It had been 84 in the doctor's office. He was able to stand and walk and we went back into the doctor's office. I explained what had just happened.  They took his temperature and led us into a room for him to lie down. The doctor came out and looked at him. He explained that he just passed out and that it is common after shots and blood draws. It was a blood pressure thing and he needed to rest. No exam was done and no vital signs taken. I took his pulse and it was 70. He was told to rest there for a bit. After 15 minutes, he felt stronger and we left the doctor's office.",,,,,,,,,U,09/27/2019,09/27/2019,0,"None. Temperature was taken,",PVT,,none,none,None besides acne. Acne not treated by anything other than over-the-counter cleansers and creams.,,,2,09/27/2019,,,,none
0836549,09/27/2019,MN,49.0,49,,F,,"Patient husband called saying patient had baseball size welt under injection site.  Site was not part of injection area, and husband was concerned due to clotting issue.  Verified patient allergies and checked adverse rxn of shot.  Nothing showing corroboration with either.  They proceeded to ED for evaluation.",,,,,,,,,U,09/26/2019,09/27/2019,1,,PHM,,"Ethacrynic acid, Enoxaparin 40mg, folc acid, hydroxyurea, spironolactone, duloxetine, levothyroxine, propranolol, omeprazole",clotting disorder treated w/ enoxaparin.,,,,2,09/27/2019,,Y,,furosemide
0836550,09/27/2019,PA,67.0,67,,F,09/26/2019,"Although patient ""did not feel"" the shot, a few hours later it felt tender and looked bruised & swollen. There was also pain that went up the shoulder to the neck area. She has been using cold compress, then Ibuprofen. Today the lump is gone and pain is better (pain was worse first 24 hours). Advised patient to see her doctor if not all better; discussed hi-dose versus quad -will try quad next year and changed to right arm...left arm weak from stroke 2 yrs. ago.",,,,,,,,,U,09/22/2019,09/22/2019,0,,OTH,UNK,,,stroke (2 yrs. ago) & whiplash (years ago); weakness on left side from stoke,mild shingles~Zoster Live (Zostavax)~~64.00~Patient,,1,,,,,
0836587,09/27/2019,GA,11.0,11,,F,,"The patient passed out after leaning over to tie her shoelace; This spontaneous report was received from a physician via company representative, referring to a 11-year-old female patient. The patient's medical history, concurrent condition, drug allergies/reactions and concomitant medications were unknown. On 13-AUG-2019, the patient was vaccinated with hpv rL1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, schedule, anatomical location, lot# and expiry date was unknown) via intramuscular route for vaccination. On the same day the patient was also vaccinated with diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (manufacturer unknown) and meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA) (strengths, doses, schedules, anatomical locations, route of administrations, lot#s and expiry dates not reported) for prophylaxis. On the same day (13-AUG-2019), the patient passed out after leaning over to tie her shoelace (loss of consciousness). The patient sought medical attention. The patient did not receive any treatment or undergo any lab diagnostics/studies for the event. The physician observed the patient for about an hour and after the patient recovered completely she was sent home on the same day. There was no associated product quality complaint. Cancer and overdose were not involved. The reporter did not provide the causality assessment between the suspect therapies and the reported events.  Upon internal review, the event loss of consciousness was determined to be medically significant.",,,,,,,,,Y,08/13/2019,08/13/2019,0,,UNK,,,Prophylaxis,,,US0095075131909USA012541,2,09/27/2019,,Y,,
0836588,09/27/2019,,,,,U,,"No adverse effect reported; the patient was inadvertently administered a dose of VARIVAX that had been improperly stored; This spontaneous report was received from a vaccine coordinator (also reported as office manager), concerning a patient of unknown age and gender. The patient's pertinent medical history, and past drug reactions / allergies were not provided. The patient's concomitant therapies included sterile diluent.  On 24-SEP-2019, the patient was inadvertently administered a dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) as prophylaxis (lot # S008692, date of expiration: 21-MAR-2021, lot # S019463, date of expiration reported as 24-JAN-2021, upon internal validation established as 24-JUN-2021, and lot number R035222, date of expiration: 04-DEC-2020; all lot number have been verified to be valid lot numbers) (strength, dose, route of administration, and anatomical location were not reported), that had been improperly stored (Product storage error). All lots of varicella virus vaccine live (Oka/Merck) (VARIVAX)  were reconstituted with properly stored sterile diluent. No adverse effects were reported.   The administered dose of the vaccine experienced a temperature excursion of 27.1 Fahrenheit degrees for 40 minutes, as recorded by a data logger. There was no previous temperature excursion. No product quality complaint was filed.",,,,,,,,,U,09/24/2019,09/24/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA013113,2,09/27/2019,,,,
0836589,09/27/2019,MI,62.0,62,,M,,"flu like symptoms; Headache; Body aches; Sore arm; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 62-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th September 2019, the patient received the 2nd dose of Shingrix. On 12th September 2019, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms, headache, general body pain and pain in arm. On an unknown date, the outcome of the influenza-like symptoms, headache, general body pain and pain in arm were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, headache, general body pain and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received the 2nd dose of Shingrix and developed flu like symptoms including headache and body aches. These symptoms were resolved. The patient had sore arms but that resolved. The reporter consented to follow up. This case linked with US2019169078, reported by same reporter.",,,,,,,,,Y,09/12/2019,09/12/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836590,09/27/2019,FL,63.0,63,,F,,"Swelling of knuckles; Code Knuckles Pain/ Hip is hurting; Jaw hurt / Felt like she had a toothache; Fingers and knuckles became inflamed; Fingers and knuckles became swollen; Pain; Neck became sore; Knuckles again became red; This case was reported by a consumer via call center representative and described the occurrence of inflammation localized in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included unilateral renal agenesis, celiac disease and hypothyroidism.   On 28th August 2019, the patient received the 1st dose of Shingrix. On 6th September 2019, 9 days after receiving Shingrix, the patient experienced inflammation localized and swelling of fingers. On 14th September 2019, the patient experienced toothache. In September 2019, the patient experienced pain, neck pain and red hands. On 17th September 2019, the patient experienced pain in hip. On an unknown date, the patient experienced swollen joints. The patient was treated with naproxen (Aleve). On an unknown date, the outcome of the inflammation localized, toothache, pain in hip and swollen joints were unknown and the outcome of the swelling of fingers, pain, neck pain and red hands were not recovered/not resolved.   It was unknown if the reporter considered the inflammation localized, swelling of fingers, pain, neck pain, red hands, toothache, pain in hip and swollen joints to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and her fingers and knuckles became inflamed and swollen.  She took Alleve for 4 days and the pain got a little better but then then her neck became sore and her knuckles again became swollen, red, and painful. she said it almost felt like she had a toothache and her hip was hurting. The reporter consented to follow up. The reporter gave permission for her physician to be contacted. Unable to obtain additional details the reporter was difficult to follow she reported adverse events seen with her husband.   This case linked with US2019170058, reported by same reporter.",,,,,,,,,N,08/28/2019,09/01/2019,4,,UNK,,,Celiac disease; Hypothyroidism; Unilateral renal agenesis,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836591,09/27/2019,,,,,U,,"golf ball sized rash / very hard borders; hot to touch; skin warm; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced rash, heat rash and skin warm. On an unknown date, the outcome of the rash, heat rash and skin warm were unknown.   It was unknown if the reporter considered the rash, heat rash and skin warm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The reporter stated that, after vaccination with Shingrix, the patient experienced golf ball sized rash hot to touch and very hard borders.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836592,09/27/2019,,,,,U,,"fever; body aches; injection site reaction; injection site itching; flu-like symptoms; This case was reported by a consumer via call center representative and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever, general body pain, injection site reaction, pruritus and influenza-like symptoms. On an unknown date, the outcome of the fever, general body pain, injection site reaction, pruritus and influenza-like symptoms were unknown.   It was unknown if the reporter considered the fever, general body pain, injection site reaction, pruritus and influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The patient reported that, after vacccination with dose of Shingrix, the patient experienced fever, general body pain, injection site reaction, itching and influenza-like symptoms. The patient asked if should get 2nd dose of Shingrix.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,Y,,
0836593,09/27/2019,VA,70.0,70,,U,,"arm swollen; arm red; painful arm; felt sick; Fatigue; Headache; Shivering; Gastrointestinal symptoms; Myalgia; This case was reported by a consumer via call center representative and described the occurrence of swelling arm in a 70-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu unspecified (Flu vaccine) for prophylaxis.   On 13th September 2019, the patient received the 1st dose of Shingrix and Flu vaccine. In September 2019, less than a week after receiving Shingrix and Flu vaccine, the patient experienced swelling arm, erythema of extremities, pain in arm, feeling unwell, fatigue, headache, shivering, gastrointestinal symptom nos and myalgia. On an unknown date, the outcome of the swelling arm, erythema of extremities, pain in arm, feeling unwell, fatigue, headache, shivering, gastrointestinal symptom nos and myalgia were unknown.   It was unknown if the reporter considered the swelling arm, erythema of extremities, pain in arm, feeling unwell, fatigue, headache, shivering, gastrointestinal symptom nos and myalgia to be related to Shingrix and Flu vaccine.  Additional case details were reported as follows: The patient received vaccines in unknown arm. The patient received the first shot of Shingrix on Friday, before day of reporting and felt sick a weekend and arm was still swollen, red and painful. The patient had flu shot in other arm on the same day. The patient did not have idea that the new Shingrix had possibility of more side effects. The patient enquired whether his/her arm feels better over a few days. Less than a week after vaccination, the patient had fatigue, headache, shivering and gastrointestinal symptoms, except fever and myalgia. The patient would not look forward to the 2nd dose. The reporter consented to follow up.",,,,,,,,,U,09/13/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836594,09/27/2019,PA,,,,U,,"Arm pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The reporter stated that several patient's experienced arm pain following Shingrix vaccination. The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836595,09/27/2019,,,,,F,,"rash suspected shingles; rash suspected shingles; high fever (107F); This case was reported by a consumer via call center representative and described the occurrence of shingles in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced shingles, rash and fever. On an unknown date, the outcome of the shingles, rash and fever were unknown.   It was unknown if the reporter considered the shingles, rash and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The patient had the 1st dose vaccine and developed high fever and rash suspected shingles. The reporter asked does patient need to take the 2nd dose of Shingrix.      Lab Comments: On an unknown date body temperature was recorded",,,,,,,,,U,,,,"Test Name: Body temperature; Result Unstructured Data: Test Result: 107, Test Result Unit: degree F",UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836596,09/27/2019,TX,,,,U,,"pain of shot; This case was reported by a consumer via call center representative and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain. The patient was treated with non-drug therapy (Cold Compress). On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient asked help for pain of shot. The patient heard that, the pain was typical but wondered if anything would help like cold compress.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836597,09/27/2019,NJ,56.0,56,,U,,"arm pain; sick; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 56-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2019, the patient received Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced pain in arm and sickness. On an unknown date, the outcome of the pain in arm and sickness were unknown.   It was unknown if the reporter considered the pain in arm and sickness to be related to Shingrix.  Additional details were reported as follows: About 45 hours before the reporting date, the patient received Shingrix.  The patient asked, the duration that the side effects start after getting the vaccine. The patient had only arm pain and was wondering if this adverse event was over or could get the patient sick.",,,,,,,,,U,09/01/2019,09/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836598,09/27/2019,,,,,U,,"arm pain; swelling; This case was reported by a consumer via sales rep and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, 3 days after receiving Shingrix, the patient experienced pain in arm and swelling. On an unknown date, the outcome of the pain in arm and swelling were unknown.   It was unknown if the reporter considered the pain in arm and swelling to be related to Shingrix.  Additional details were reported as follows: The reporter was patient's spouse. The age at vaccination was not reported. The patient experienced significant arm pain and swelling after receipt of shingrix dose. The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836599,09/27/2019,WI,,,,M,,"Injection site soreness; Redness; Body aches; Fatigue; This case was reported by a other health professional via sales rep and described the occurrence of injection site pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site pain, injection site erythema, general body pain and fatigue. On an unknown date, the outcome of the injection site pain, injection site erythema, general body pain and fatigue were unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, general body pain and fatigue to be related to Shingrix.  Additional details were provided as follows: The patient date of birth was reported as 26th December. The age at vaccination was not reported. The reporter stated that, after vaccination with dose of Shingrix experienced injection site soreness, redness, body pain and fatigue. The reporter consented to follows up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836600,09/27/2019,,,,,M,,"Polymyalgia; Felt like truck hit me; Slight fever; Aches in shoulders, neck, hands and hip area; Could not get out of chair without assistance or reach above my head; Flu like feeling; This case was reported by a consumer via call center representative and described the occurrence of polymyalgia in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th July 2019, the patient received the 1st dose of Shingrix. On 18th July 2019, 1 days after receiving Shingrix, the patient experienced polymyalgia, feeling abnormal, fever, general body pain, mobility decreased and influenza like illness. The patient was treated with steroids nos (Steroids). On an unknown date, the outcome of the polymyalgia, feeling abnormal, general body pain, mobility decreased and influenza like illness were not recovered/not resolved and the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the polymyalgia, feeling abnormal, fever, general body pain, mobility decreased and influenza like illness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but could be between 72 to 73 years. The patient felt like truck hit, slight fever and aches in pains in shoulders, neck, hands and hip area. The patient could not get out of chair without assistance or reach above my head. The patient was having flu like feeling also. The patient had numerous x rays and blood work from family doctor and also Rheumatoid Specialist. The patient was diagnosed with Polymyalgia and had been on heavy steroids. The patient stated that will not be getting the booster dose of Shingrix. The patient was upset for getting the vaccine. The patient suggested to do more testing on People with arthritis and autoimmune diseases as they may not want to get it.      Lab Comments: on an unknown date numerous x rays and blood work were done",,,,,,,,,N,07/17/2019,07/18/2019,1,"Test Name: Blood test; Result Unstructured Data: Test Result: unknown, Test Result Unit: unknown; Test Name: X-ray; Result Unstructured Data: Test Result: Unknown, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836601,09/27/2019,FL,,,,U,,"Rash; Minor swelling at site of vaccine injection; Itching; This case was reported by a consumer via sales rep and described the occurrence of injection site rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included ophthalmic herpes zoster (had shingles in the eye 15 years ago from the time of reporting) and post herpetic neuralgia (had severe post herpetic for many years).   On 9th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than 2 weeks after receiving Shingrix, the patient experienced injection site rash, injection site swelling and injection site itching. On an unknown date, the outcome of the injection site rash, injection site swelling and injection site itching were unknown.   It was unknown if the reporter considered the injection site rash, injection site swelling and injection site itching to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The patient stated that had the rash and minor swelling and itching. The patient asked about how long may the rash and minor swelling at the site of vaccine injection last and is treatment needed. The patient preferred to have anonymous. The patient was advised to speak with healthcare provider for the next steps. The patient had vaccination at local pharmacy and there were no warnings on information sheet or from pharmacist that history of shingles a concern.",,,,,,,,,U,09/09/2019,09/01/2019,,,PHM,,,,Medical History/Concurrent Conditions: Ophthalmic herpes zoster (had shingles in the eye 15 years ago from the time of reporting); Post herpetic neuralgia (had severe post herpetic for many years),,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836602,09/27/2019,AL,,,,M,,"shingles/symptoms of shingles; This case was reported by a nurse via sales rep and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported showing symptoms of shingles within 2 weeks of getting shingrix. The reporter did not consent to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836603,09/27/2019,HI,71.0,71,,F,,"hives of bilateral upper and lower extremties; rash; Cbc w/ diff elevated eosinophils; This case was reported by a other health professional via sales rep and described the occurrence of hives in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 31st August 2019, the patient received the 1st dose of Shingrix. On 1st September 2019, 1 days after receiving Shingrix, the patient experienced hives, rash and eosinophil count increased. The patient was treated with steroids nos, steroids nos, steroids nos, steroids nos (Steroid (Not Specified)), benadryl (nos) (Benadryl), antihistamine, antihistamine, antihistamine, antihistamine (Antihistamine) and prednisone. On an unknown date, the outcome of the hives, rash and eosinophil count increased were unknown.   It was unknown if the reporter considered the hives, rash and eosinophil count increased to be related to Shingrix.  Additional details were provided as follows: It was reported that the patient experienced hives of bilateral upper and lower extremities started day after injection. It was reported that the rash improved with steroid injection and benedryl, stopped antihistamine, then rash reoccurred 10 days later. Benedryl was ineffective. The physician gave another steroid shot and prescribed allegation and prednisone 20mg for 10 days. The patient underwent allergy panel for eggs, nut, wheat, milk, seseme and soy results were negative. The patient's CBC w/ diff elevated eosinophils. All other counts within normal limits.      Lab Comments: The patient underwent allergy panel for eggs, nut, wheat, milk, sesemeand soy showed all negative",,,,,,,,,U,08/31/2019,09/01/2019,1,"Test Date: 201909; Test Name: Allergy test; Result Unstructured Data: Test Result: negative, Test Result Unit: unknown; Test Date: 201909; Test Name: CBC; Result Unstructured Data: Test Result: elevated eosinophils, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836604,09/27/2019,GA,72.0,72,,M,,"Classic rash on left side of abdomen only; Shingles; This case was reported by a physician via sales rep and described the occurrence of rash in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included apremilast (Otezla) for an unknown indication.   On 13th September 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient started Otezla at an unknown dose and frequency. On 17th September 2019, 4 days after receiving Shingrix, the patient experienced rash and shingles. The action taken with Otezla was unknown. On an unknown date, the outcome of the rash and shingles were unknown.   It was unknown if the reporter considered the rash and shingles to be related to Shingrix.  Additional case details were reported as follows: The patient seen at office week of 16th September 2019, showing classic rash on left side of abdomen only, patient began experienced symptoms week of September 2019, approximately 4 days after receiving Shingrix vaccine. The patient also using Otezla prescribed by rheumatologist.  The reporter did not think incidence of shingles related to use of Shingrix. The reporter consented to follow up.",,,,,,,,,U,09/13/2019,09/17/2019,4,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836605,09/27/2019,MI,79.0,79,,M,,"Redness at injection site; Pain at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 79-year-old male patient who received Herpes zoster (Shingrix) (batch number TB2PK, expiry date 5th October 2021) for prophylaxis.   On 13th September 2019, the patient received Shingrix. On 17th September 2019, 4 days after receiving Shingrix, the patient experienced injection site erythema and injection site pain. On an unknown date, the outcome of the injection site erythema and injection site pain were unknown.   It was unknown if the reporter considered the injection site erythema and injection site pain to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported that the patient had redness and pain at injection site following Shingrix vaccination. The reporter did not consent to follow up.",,,,,,,,,U,09/13/2019,09/17/2019,4,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836606,09/27/2019,MI,94.0,,,M,,"Itching all over his body/itching presented on his feet and toes; Feels a burning on his face that comes and goes; His face gets red in color; His head, back and legs are scratched; itching on his testicles; This case was reported by a consumer via call center representative and described the occurrence of generalized pruritus in a 94-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included cancer. Concomitant products included antineoplastic agents (nos) (Anticancer Agent (Nos)).   In 2019, the patient received the 2nd dose of Shingrix. On 17th September 2019, less than 9 months after receiving Shingrix, the patient experienced genital itching male. On an unknown date, the patient experienced generalized pruritus, burning sensation, red face and scratch. On an unknown date, the outcome of the generalized pruritus and red face were not recovered/not resolved and the outcome of the burning sensation, scratch and genital itching male were unknown.   It was unknown if the reporter considered the generalized pruritus, burning sensation, red face, scratch and genital itching male to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix in either March or April and following that dose he has developed itching all over his body. His head, back and legs are scratched from him scratching them.The itching presented on his feet and toes just recently and before the date of reporting he complained of itching on his testicles. He feels a burning on his face that comes and goes.When it presents, his face gets red in color. There was no rash present with this itching. The reporter consented to follow up.",,,,,,,,,N,,09/17/2019,,,UNK,,ANTICANCER AGENT (NOS),Cancer,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836607,09/27/2019,MI,60.0,60,,F,,"Rash on her face, neck and chest/spot on her neck and chest are again red; Itchy/spot on her neck and chest are again itchy; raised red, hot area about 4x2 inches on the arm; hot area on the arm; Flu like symptoms; Sore arm; Headache; Body aches; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th September 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 12th September 2019, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms, pain in arm, headache and general body pain. On 13th September 2019, the patient experienced erythema of extremities and skin warm. On 14th September 2019, the patient experienced red rash and itchy rash. On 14th September 2019, the outcome of the skin warm, red rash and itchy rash were not recovered/not resolved and the outcome of the pain in arm, headache and general body pain were recovered/resolved. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved and the outcome of the erythema of extremities was not recovered/not resolved.   It was unknown if the reporter considered the influenza-like symptoms, erythema of extremities, skin warm, red rash, pain in arm, headache, general body pain and itchy rash to be related to Shingrix.  Additional details were provided as follows: The patient received the 2nd dose of Shingrix and developed flu like symptoms including headache and body aches. These symptoms were resolved. The patient had sore arms but that resolved. 24 hours after the vaccination the patient experienced a raised red, hot area about 4x2 inches on the arm in which she got the vaccine but closer to her body than the injection site. She started getting a rash on her face, neck and chest.  This continued and then the rash on the face was pretty much gone.  It had settled down to redness and wasn't itchy or hot. After work out the patient noticed the spot on her neck and chest are again red and itchy and feels like the symptoms are returning. The reporter consented to follow up. This case linked with US2019169081, reported by same reporter.",,,,,,,,,N,09/12/2019,09/12/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836608,09/27/2019,UT,,,,F,,"All of her skin peeling off; This case was reported by a pharmacist via call center representative and described the occurrence of skin peeling in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced skin peeling. On an unknown date, the outcome of the skin peeling was unknown.   It was unknown if the reporter considered the skin peeling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number was not reported. The pharmacist reported that the patient experienced all her skin peeling off following a dose of Shingrix. The health care professional reported no additional details about the event.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836609,09/27/2019,PA,65.0,65,,F,,"Allergic reaction; Tightness in chest; This case was reported by a pharmacist via call center representative and described the occurrence of allergic reaction in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 9AB33, expiry date 6th December 2021) for prophylaxis.   Co-suspect products included INFLUENZA VIRUS VACCINE INACTIVATED (FLUZONE HIGH DOSE) for prophylaxis.   Concurrent medical conditions included shellfish allergy (reaction to allergies for shellfish and peanuts) and peanut allergy.   On 16th September 2019, the patient received Shingrix (intramuscular) and FLUZONE HIGH DOSE. In September 2019, less than a week after receiving Shingrix, the patient experienced allergic reaction and chest tightness. On an unknown date, the outcome of the allergic reaction and chest tightness were recovered/resolved.   It was unknown if the reporter considered the allergic reaction and chest tightness to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix along with Fluzone High Dose flu shot. The patient described she as an allergic reaction that included tightness in her chest like her reaction to allergies for shellfish and peanuts.   The Caller reports patient went to the hospital and issue has resolved. The emergency room visit was required.",,,,,,,,,Y,09/16/2019,09/01/2019,,,PHM,,,Peanut allergy; Shellfish allergy (reaction to allergies for shellfish and peanuts),,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,Y,Y,
0836610,09/27/2019,TX,,,,M,,"In the middle of the night he woke up to a very painful knee; This case was reported by a pharmacist via call center representative and described the occurrence of knee pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a day after receiving Shingrix, the patient experienced knee pain. On an unknown date, the outcome of the knee pain was unknown.   It was unknown if the reporter considered the knee pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number was not reported. The patient received Shingrix and in the middle of the night he woke up to a very painful knee.  The reporter consented to follow up. The caller stated it was unknown if it was related and was asking about potential side effects.  The reporter did not have further information to provide at reporting time.",,,,,,,,,U,09/15/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836611,09/27/2019,PA,59.0,59,,F,,"Not feeling good (malaise); Fever; Headache; Nausea; Feeling lightheaded over the weekend; Remaining in bed; Soreness under armpit; Stomach started to bother a little / and it feels dull; Stomach hurts a little; Soreness at the injection site/Pain in arm; Arm felt heavy lifting up; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th September 2019 06:30, the patient received the 1st dose of Shingrix (intramuscular). On 13th September 2019, immediately after receiving Shingrix, the patient experienced injection site pain and heaviness in arm. On 14th September 2019, the patient experienced malaise, fever, headache, nausea, light headedness, bedridden, axillary pain, upset stomach and stomach pain. The patient was treated with paracetamol (Tylenol) and non-drug therapy, non-drug therapy (Ice Pack (No Medication)). On 15th September 2019, the outcome of the headache was recovered/resolved. On an unknown date, the outcome of the injection site pain, heaviness in arm, malaise, fever, bedridden, axillary pain, upset stomach and stomach pain were unknown and the outcome of the nausea was not recovered/not resolved and the outcome of the light headedness was recovered/resolved.   It was unknown if the reporter considered the injection site pain, heaviness in arm, malaise, fever, headache, nausea, light headedness, bedridden, axillary pain, upset stomach and stomach pain to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and approximately 6:30 pm in her left arm and immediately had soreness at the injection site.  The caller reports her arm felt heavy lifting up. The following day the patient waking up in morning and soreness in her arm, not feeling good (malaise), having a fever of 100 F, onset of headache that was relieved Sunday, nausea that lasted throughout the day, remaining in bed throughout the weekend, feeling lightheaded over the weekend, and soreness under armpit.  The caller at the time of reporting soreness now extending down her arm and approximately half an hour prior to contacting GSK she began to feel nauseous again.  The caller reported when this nausea came her stomach started to bother her a little.  The caller reported her stomach hurts a little and it feels dull but not a feeling of needing to go to bathroom. The reporter consented to follow up.  This case linked with US2019AMR169698, reported by same reporter.",,,,,,,,,N,09/13/2019,09/13/2019,0,"Test Date: 20190914; Test Name: Body temperature; Result Unstructured Data: Test Result: 100, Test Result Unit: degree F",PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836612,09/27/2019,GA,67.0,67,,M,,"leg cramping; This case was reported by a pharmacist via call center representative and described the occurrence of leg cramps in a 67-year-old male patient who received Herpes zoster (Shingrix) (batch number E2A23, expiry date 13th September 2021) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Shingrix (intramuscular). In September 2019, less than 2 weeks after receiving Shingrix, the patient experienced leg cramps. On an unknown date, the outcome of the leg cramps was not recovered/not resolved.   It was unknown if the reporter considered the leg cramps to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on right arm and experienced leg cramping that has not resolved unclear which leg involved.",,,,,,,,,N,09/09/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836613,09/27/2019,IN,66.0,66,,M,,"Burning sensation all over body / Palms of hands and bottoms of feed were burning; Felt like they had blistered; This case was reported by a nurse via call center representative and described the occurrence of burning sensation in a 66-year-old male patient who received Herpes zoster (Shingrix) (batch number 9277N, expiry date 27th June 2021) for prophylaxis.   Concurrent medical conditions included parkinsonism.   On 16th September 2019, the patient received Shingrix (intramuscular). On 16th September 2019, less than a day after receiving Shingrix, the patient experienced burning sensation and blister. On an unknown date, the outcome of the burning sensation and blister were recovered/resolved.   It was unknown if the reporter considered the burning sensation and blister to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and in the middle of the night he woke up with a burning sensation all over his body.  The palms of his hands and bottoms of his feed were burning so badly it felt like they had blistered.  The symptoms resolved after about 4 hours.",,,,,,,,,Y,09/16/2019,,,,UNK,,,Parkinsonism,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836614,09/27/2019,MA,,68,,F,,"Pain; This case was reported by a nurse via sales rep and described the occurrence of pain in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th May 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 67 or 68 years. The field representative reported the adverse event by a nurse. The patient experienced pain with the first dose of Shingrix.  No further details were provided. The case was linked with the case US2019169171, reported by same reporter for same patient.",,,,,,,,,U,05/14/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836615,09/27/2019,GA,66.0,66,,F,,"knot at site of injection; This case was reported by a pharmacist via call center representative and described the occurrence of injection site lump in a 66-year-old female patient who received Herpes zoster (Shingrix) (batch number 4RR52, expiry date 7th December 2021) for prophylaxis.   On 20th August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 20th August 2019, less than a day after receiving Shingrix, the patient experienced injection site lump. On an unknown date, the outcome of the injection site lump was unknown.   It was unknown if the reporter considered the injection site lump to be related to Shingrix.  Additional information received were as follows: The caller was a pharmacist reporting that the patient experienced a knot at the site of the injection about the size of a dime and had not resolved.",,,,,,,,,U,08/20/2019,08/20/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836616,09/27/2019,OH,76.0,76,,F,,"Orange sized hot, painful, red, and hard injection site; Injection site hot; Injection site painful; Injection site hard; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 76-year-old female patient who received Herpes zoster (Shingrix) (batch number 227FL, expiry date 26th November 2021) for prophylaxis.   On 14th September 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 15th September 2019, 1 days after receiving Shingrix, the patient experienced injection site erythema, injection site warmth, injection site pain and injection site induration. On an unknown date, the outcome of the injection site erythema, injection site warmth, injection site pain and injection site induration were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site warmth, injection site pain and injection site induration to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. The reporter stated that, after vaccination with dose of Shingrix, the patient had orange sized hot, painful, red, and hard injection site. The reporter consented to follow up.",,,,,,,,,N,09/14/2019,09/15/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836617,09/27/2019,AZ,86.0,86,,F,,"Shingles; Redness with itching all over her body / redness of her face, eyes, eyelids, inside of her thumbs, right side torso; Itching all over her body / Itching at right ankle, back of right leg, upper back, and it may have come around to her front shoulder blade area, and right side torso; Rash on upper back and shoulder blade; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 86-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st July 2018, the patient received the 1st dose of Shingrix (intramuscular). On 31st July 2018, 10 days after receiving Shingrix, the patient experienced shingles, generalized erythema, generalized pruritus and rash. The patient was treated with cetirizine hydrochloride (Cetrizine). Shingrix was discontinued. On an unknown date, the outcome of the shingles was unknown and the outcome of the generalized erythema, generalized pruritus and rash were resolved with sequelae.   The reporter considered the shingles, generalized erythema, generalized pruritus and rash to be related to Shingrix.  Additional details were provided as follows: The patient stated that had redness with itching all over her body. The patient specifically mentioned redness of her face, eyes, eyelids, inside of her thumbs, right side torso. The patient also mention itching at injection site, right ankle, back of right leg, upper back, and it may have come around to her front shoulder blade area, and right side torso. The patient also had rash on upper back and shoulder blade. The patient had not received the second dose of shingrix because her healthcare professional told her she is not a candidate for the second dose due to the reaction she experienced with the first dose. The patient had 2 outbreaks of shingles after receiving the first dose. The patient did not consent to follow up.",,,,,,,,,N,07/21/2018,07/31/2018,10,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836618,09/27/2019,WI,,,,U,,"Cellulitis at injection site; This case was reported by a nurse via sales rep and described the occurrence of injection site cellulitis in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th August 2019, the patient received Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced injection site cellulitis. On an unknown date, the outcome of the injection site cellulitis was unknown.   It was unknown if the reporter considered the injection site cellulitis to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but as per indication of the vaccine the age group was captured as adult. The patient received Shingrix and developed cellulitis at the injection site. No patient information was provided.",,,,,,,,,U,08/29/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836619,09/27/2019,WA,85.0,85,,F,,"Headache; Was achy; Lump on her arm at the injection site; Not feeling well /  feeling awfully sick; She was tired / She feels exhausted; This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a 85-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th September 2019, the patient received the 2nd dose of Shingrix. On 17th September 2019, less than a day after receiving Shingrix, the patient experienced feeling unwell and tiredness. On 18th September 2019, the patient experienced headache, pain and injection site lump. On an unknown date, the outcome of the feeling unwell, tiredness, headache, pain and injection site lump were not recovered/not resolved.   It was unknown if the reporter considered the feeling unwell, tiredness, headache, pain and injection site lump to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in right arm.  The patient received her second dose of Shingrix, on day before reporting and last night she was not feeling well and she was tired and she felt exhausted.  The patient described her experience as feeling awfully sick on day of reporting. The patient went to bed at 8:30 PM and she awake with a headache and was achy.  The patient also reported a lump on her arm at the injection site. The reporter consented to follow up. In the XML document outcome of events was reported as recovering, but in system its mentioned as not recovered, so kept as reported in system.",,,,,,,,,N,09/17/2019,09/17/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836620,09/27/2019,TX,,,,F,,"injection site redness; Whelps; Injection site swelling; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included zostavax.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site erythema, injection site wheal and injection site swelling. On an unknown date, the outcome of the injection site erythema, injection site wheal and injection site swelling were recovered/resolved.   It was unknown if the reporter considered the injection site erythema, injection site wheal and injection site swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced redness, whelps and swelling at the injection site of her first dose.  The patient could not recall the date of the initial dose, but she added she never had issues with the Zostavax. The reporter consented to follow up. The case has been linked with the case US2019AMR170622, reported for the dose 2 of the same patient.",,,,,,,,,Y,,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836621,09/27/2019,PA,46.0,46,,M,,"Sugar starting spiking and overnight it got up into the 500s; Not feel well; This case was reported by a nurse via call center representative and described the occurrence of blood sugar increased in a 46-year-old male patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2019-2020 season) (batch number 9579P, expiry date 30th June 2020) for prophylaxis.   Concurrent medical conditions included type i diabetes mellitus.   On 17th September 2019, the patient received FluLaval Tetra 2019-2020 season (intramuscular) .5 ml. In September 2019, less than a week after receiving FluLaval Tetra 2019-2020 season, the patient experienced feeling unwell. On 17th September 2019, the patient experienced blood sugar increased. On an unknown date, the outcome of the blood sugar increased was not recovered/not resolved and the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the blood sugar increased and feeling unwell to be related to FluLaval Tetra 2019-2020 season.  Additional information received were as follows: The employee health nurse on the line with a type I diabetic employee who received a dose of FluLaval, pre-filled syringe, a day before reporting date. By 7:00 pm, less than a day after receiving Shingrix, the patient's sugar starting spiking and overnight it got up into the 500s (his monitor can not monitor levels higher than what it reached). The employee took 12 extra units of insulin, which brought their glucose into range, but it was wearing off this morning and his glucose was now back into the 300s and the employee does not felt well The reporter consented to follow up.",,,,,,,,,N,09/17/2019,09/01/2019,,"Test Date: 20190917; Test Name: Blood sugar increased; Result Unstructured Data: Test Result: 500s, Test Result Unit: unknown",UNK,,,Type I diabetes mellitus,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836622,09/27/2019,,,,,U,,"Pain after injection in underarm; Bruising; This case was reported by a physician via call center representative and described the occurrence of axillary pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced axillary pain and contusion. On an unknown date, the outcome of the axillary pain and contusion were unknown.   It was unknown if the reporter considered the axillary pain and contusion to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The reporter sated that, the patient had bruising and pain after injection in underarm.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836623,09/27/2019,FL,69.0,69,,M,,"Headache; Hurt; Fever; Nausea; Joint Pain; This case was reported by a consumer via call center representative and described the occurrence of headache in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th August 2019, the patient received Shingrix. In August 2019, less than a day after receiving Shingrix, the patient experienced headache, pain in arm, fever, nausea and joint pain. On an unknown date, the outcome of the headache, pain in arm, fever, nausea and joint pain were recovered/resolved.   It was unknown if the reporter considered the headache, pain in arm, fever, nausea and joint pain to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's wife. The patient received the Shingrix vaccine and the night after receiving the vaccine he began to experience a severe headache, arm hurt, nausea, fever, and joint pain.  These symptoms resolved after 1 to 2 days. The patient gave consent to contact the physician and provided contact details for the same. The case has been linked to the case US2019170041, reported by same reporter. There was discrepancy in the outcome of the events, in the source document outcome was reported as recovered/ resolved with sequel and in the narrative outcome reported as recovered/resolved.",,,,,,,,,Y,08/28/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836624,09/27/2019,AL,34.0,34,,M,,"aching lymph nodes; burning sensation inside of body; blisters all over right side of body; swollen lymph nodes; swelling at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 34-year-old male patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Concurrent medical conditions included factor v leiden mutation.   On 4th September 2019, the patient received the 1st dose of Boostrix (intramuscular). On 4th September 2019, less than a day after receiving Boostrix, the patient experienced injection site swelling. On 9th September 2019, the patient experienced blister, enlargement of lymph nodes, lymph node pain and burning sensation. On 9th September 2019, the outcome of the injection site swelling was recovered/resolved. On an unknown date, the outcome of the blister, enlargement of lymph nodes, lymph node pain and burning sensation were not recovered/not resolved.   It was unknown if the reporter considered the injection site swelling, blister, enlargement of lymph nodes, lymph node pain and burning sensation to be related to Boostrix.  Additional details were provided as follows: The patient received a dose of Boostrix in the right arm. On 9th September 2019, 5 days after receiving a dose of Boostirx the patient experienced blister, enlargement of lymph nodes, lymph node pain and burning sensation. The patient planned to continue follow-up with his physician on an unknown date. The reporter consented to follow up. The case was linked with the case US2019170062, reported by same reporter. There was discrepancy in the outcome of the events blister, enlargement of lymph nodes, lymph node pain and burning sensation, in the source document outcome was reported as recovering/ resolving and in the database outcome reported as not recovered/not resolved.",,,,,,,,,N,09/04/2019,09/04/2019,0,,UNK,,,Factor V Leiden mutation,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836625,09/27/2019,CA,55.0,,,F,,"shivers; This case was reported by a consumer via call center representative and described the occurrence of shivers in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included ethanol (Alcoholic Beverage) for an unknown indication.   Concurrent medical conditions included weight loss diet.   On 17th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml and Alcoholic Beverage at an unknown dose and frequency. In September 2019, less than a day after receiving Shingrix, the patient experienced shivers. On an unknown date, the outcome of the shivers was not recovered/not resolved.   It was unknown if the reporter considered the shivers to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's husband. The reporter's wife received dose 1 of Shingrix and later had some alcohol beverages. The reporter stated that the patient had been in bed since last night shivering. The reporter did not consent to follow-up. The reporter did not have vaccine information. The reporter declined HCP follow up and declined to provide any further information. It was unknown if the reporter considered the shivers to be related to Alcoholic Beverage.",,,,,,,,,N,09/17/2019,09/01/2019,,,UNK,,,,Medical History/Concurrent Conditions: Weight loss diet,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836626,09/27/2019,LA,63.0,63,,F,,"headache; sore throat; swollen lymph nodes; This case was reported by a pharmacist via call center representative and described the occurrence of headache in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th September 2019, the patient received Shingrix (intramuscular). On 11th September 2019, 1 days after receiving Shingrix, the patient experienced headache, sore throat and lymphadenopathy cervical. On an unknown date, the outcome of the headache, sore throat and lymphadenopathy cervical were unknown.   It was unknown if the reporter considered the headache, sore throat and lymphadenopathy cervical to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left arm. The patient experienced headache, sore throat, and swollen lymph nodes on the neck. The patient was seen by her physician who noted the swelling was unremarkable. The reporter consented to follow up.",,,,,,,,,U,09/10/2019,09/11/2019,1,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836628,09/27/2019,PA,61.0,61,,F,,"rash; itchy rash; bump; soreness; This case was reported by a pharmacist via call center representative and described the occurrence of pain in a 61-year-old female patient who received Herpes zoster (Shingrix) (batch number J225D, expiry date 22nd October 2021) for prophylaxis.   On 12th September 2019, the patient received the 1st dose of Shingrix. On 12th September 2019, less than a day after receiving Shingrix, the patient experienced pain. On 18th September 2019, the patient experienced red rash, itchy rash and local swelling. On an unknown date, the outcome of the pain, red rash, itchy rash and local swelling were unknown.   It was unknown if the reporter considered the pain, red rash, itchy rash and local swelling to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported that the patient experienced soreness after receiving the first Shingrix vaccination.  The patient also experienced  red, bumpy and itchy rash. The reporter consented to follow up.",,,,,,,,,U,09/12/2019,09/12/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836629,09/27/2019,WA,68.0,68,,F,,"Itching; This case was reported by a consumer via call center representative and described the occurrence of itchy upper limbs in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 24th August 2019, 2 days after receiving Shingrix, the patient experienced itchy upper limbs. The patient was treated with hydrocortisone (Hydrocortisone Cream). On an unknown date, the outcome of the itchy upper limbs was unknown.   It was unknown if the reporter considered the itchy upper limbs to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left arm. The patient experienced itching on the front of the right arm closer to her shoulder. On the reporting date, the patient's left arm had started to itch closer to her shoulder.  The itching felt like stabbing 2 inches deep into the skin.  The itching was like poison oak and felt like a lightning bolt. Due to increased scratching, the patient had started tobleed.  The patient had used hydrocortisone cream and it did not help.  The patient had applied band aid over her area where she was bleeding.  The reporter did not consent to follow-up.  No further details were provided.",,,,,,,,,U,08/22/2019,08/24/2019,2,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836630,09/27/2019,MN,78.0,78,,F,,"Headache; Nausea; Fever; This case was reported by a consumer via call center representative and described the occurrence of fever in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th September 2019, the patient received the 1st dose of Shingrix. In September 2019, 7 days after receiving Shingrix, the patient experienced fever, headache and nausea. On an unknown date, the outcome of the fever, headache and nausea were recovered/resolved.   It was unknown if the reporter considered the fever, headache and nausea to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left arm. The reporter unsure if vaccine administered intramuscularly, the volume, and lot number, expiry date of vaccine. The patient complains of 103 degree Fahrenheit fever that developed a week later that lasted approximately 5 days.  The reporter also reported less than 2 weeks after vaccination headache and nausea. The patient not considering for receiving 2nd dose. The reporter consented to follow up.",,,,,,,,,Y,09/04/2019,09/01/2019,,"Test Date: 201909; Test Name: Body temperature; Result Unstructured Data: Test Result: 103, Test Result Unit: degree F",PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836632,09/27/2019,AL,,,,U,,"drug exposure via breast milk; This case was reported by a nurse via call center representative and described the occurrence of drug exposure via breast milk in a 2-year-old patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2019-2020 season) (batch number 99CA4, expiry date 30th June 2020) for prophylaxis.   On an unknown date, the patient received Fluarix Tetra 2019-2020 season. On an unknown date, unknown after receiving Fluarix Tetra 2019-2020 season, the patient experienced drug exposure via breast milk. On an unknown date, the outcome of the drug exposure via breast milk was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient demographic details were not provided. The nurse reported that, the Fluarix vaccine was administered to the patient who was breastfeeding to child. The reporter provided the details of the patients' monther who was breastfeeding to child.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836633,09/27/2019,OH,,,,F,,"flu symptoms; This case was reported by a physician via sales rep and described the occurrence of flu symptoms in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced flu symptoms. On an unknown date, the outcome of the flu symptoms was unknown.   It was unknown if the reporter considered the flu symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The physician reported via request that the patient had Shingrix vaccine and experienced flu symptoms. The reporter consented to follow up. Other details were not provided.  It was unknown if the reporter filed an adverse event based on physician's request.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836634,09/27/2019,MI,71.0,71,,M,,"Shingles rash on his back; Shingles rash on his back; Pain; Itching; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included INFLUENZA VIRUS VACCINE INACTIVATED (FLUZONE HIGH DOSE) for prophylaxis.   Previously experienced adverse reactions included shingles (30 years ago).   On 13th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, the patient received FLUZONE HIGH DOSE (intramuscular). In September 2019, couple of days after receiving Shingrix, the patient experienced shingles, rash, pain and pruritus. On an unknown date, the outcome of the shingles, rash, pain and pruritus were unknown.   It was unknown if the reporter considered the shingles, rash, pain and pruritus to be related to Shingrix.  Additional information received were as follows: The caller was wife of the patient, and patient also came on the line to provide information for the report. A couple days after receiving Shingrix, the patient experienced shingles rash on his back with associated pain and itching. The reporter consented to follow up.",,,,,,,,,U,09/13/2019,09/01/2019,,,PHM,,,,Medical History/Concurrent Conditions: Shingles (30 years ago),,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836635,09/27/2019,VA,,,,M,,"swelling; rash ""moved and he felt it move from shoulder to stomach to legs; generalized rash / rash ""moved and he felt it move from shoulder to stomach to legs; extremely itchy; pain in bone; hives; This case was reported by a pharmacist via call center representative and described the occurrence of generalized rash in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd July 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced generalized rash, itchy rash, bone pain, hives, swelling and rash. The patient was treated with dermatologicals nos (Calamine Lotion). On an unknown date, the outcome of the generalized rash and rash were recovered/resolved and the outcome of the itchy rash, bone pain, hives and swelling were unknown.   It was unknown if the reporter considered the generalized rash, itchy rash, bone pain, hives, swelling and rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced generalised rash, for about 5 days after vaccination. The patient was treated with over the counter calamine lotion. The reporter stated that, the rash was extremaly itchy, and moved from shoulder to stomach to legs and had pain all over through the bone. The pharmacist stated that, the pain, hives and swelling lasted for 4 days. The patient was seen in his physician's office, but the rash was resolved by the time he had his appointment.",,,,,,,,,Y,07/22/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,Y,,
0836636,09/27/2019,FL,66.0,66,,M,,"Discomfort; couldn't walk; Plantar fasciitis; sore arm / foot pain; This case was reported by a consumer via call center representative and described the occurrence of pain in extremity in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 13th September 2019, immediately after receiving Shingrix, the patient experienced pain in extremity. On 15th September 2019, the patient experienced discomfort, unable to walk and plantar fasciitis. On an unknown date, the outcome of the pain in extremity, discomfort and unable to walk were recovered/resolved and the outcome of the plantar fasciitis was unknown.   It was unknown if the reporter considered the pain in extremity, discomfort, unable to walk and plantar fasciitis to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in unknown arm. The patient's arm was sore right after the injection.  Two days later, on 15th September 2019, the patient woke up with discomfort in the instep of his right foot. By the end of the day his foot was so painful that he couldn't walk on it.  The patient started off it for a couple days and the pain resolved.  The patient stated it felt like plantar fasciitis, which he has never had before. The reporter did not consent to follow up.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836637,09/27/2019,MA,61.0,61,,F,,"muscle aches; headache; weakness; fatigue; This case was reported by a pharmacist via call center representative and described the occurrence of muscle pain in a 61-year-old female patient who received Rabies NVS (RabAvert) for prophylaxis.   On 4th September 2019, the patient received the 4th dose of RabAvert. In September 2019, less than 3 weeks after receiving RabAvert, the patient experienced muscle pain, headache, weakness and fatigue. On an unknown date, the outcome of the muscle pain, headache, weakness and fatigue were not recovered/not resolved.   It was unknown if the reporter considered the muscle pain, headache, weakness and fatigue to be related to RabAvert.  Additional information received were as follows: It was unknown, whether the patient received RabAvert for preexposure or post exposure prophylaxis. The patient experienced muscle aches, headache, weakness and fatigue. The symptoms improved for a time and on the reporting date, the patient had them again.",,,,,,,,,N,09/04/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836638,09/27/2019,OK,,,,U,,"Fever; Chills; Swelling; GI symptoms; This case was reported by a physician via call center representative and described the occurrence of fever in an unspecified number adult patients who received Herpes zoster (Shingrix) for prophylaxis.  On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever, chills, injection site swelling and gastrointestinal symptom nos. On an unknown date, the outcome of the fever, chills, injection site swelling and gastrointestinal symptom nos were unknown.   It was unknown if the reporter considered the fever, chills, injection site swelling and gastrointestinal symptom nos to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not applicable for this report. The physician reported side effects for approximately 30 percent of his patients seen over several clinics. After receiving Shingrix, the patient complain of fever, chills swelling at injection site and gastrointestinal symptoms. The reporter consented to follow up. The doctor stated that he believes it is 30 percent of 30 patient administered the vaccine which were approximately 9 patients. No specific data was given at the time of call.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836639,09/27/2019,CA,28.0,28,,M,,"30 MINUTES after receiving flu vaccine he had hives to arms, neck,face, itching, and slight itchy feeling to his throat. No SOB/chest pain or nausea/vomitting. He works in ED so he was seen there. received 1 liter normal saline IV fluids. 1 gram of tylenol, benadryl 50mg IV push. Pepcid 20mg IV push. solumedrol 125mg IV push. Had improvement of rash/itchiness and was released home with. Rx for benadryl/prednisone/H2 blocker.   Was re-evaluated by me the following morning, and had not filled Rx. Still with multi form wheels to arms with itching. NO angioedema, respiratory sx, No nausea vomiting. Reinforced the importance of continuing RX for sx resolution. Has appointment followup scheduled on 9/30/19.  Patient notes that last year he received the flu blok on 10/10/18 without any issues. Previous 10/10/2017 regular influenza IIV vaccine he also experienced hives.",,,,,,,,,U,09/24/2019,09/24/2019,0,NA,PVT,,,none at the time of vaccination,has sensitive skin and will get rashes related to products he uses on his skin,Patient notes that at age 27. had hives after receiving IIV influenza vaccine on 10/10/2017. brand seq; lot# 195222. No document,,2,09/27/2019,,Y,,latex  purell hand cleaner egg
0836640,09/27/2019,TN,64.0,64,,F,,"Extreme pain at injection site at time of injection. Within 2 hours vomiting and flu-like symptoms, swelling, redness at injection site.",,,,,,,,,N,09/23/2019,09/23/2019,0,,UNK,,,,Celiac Disease,,,2,09/27/2019,,Y,,
0836641,09/27/2019,IN,57.0,57,,M,,"Medication Error:  Incorrectly given to a 57 year old.  No treatment, symptoms from patient currently.",,,,,,,,,Y,09/22/2019,09/22/2019,0,none,OTH,,"Metformin, Lisinopril, Amlodipine","Dermatitis, cellulitis","HTN, DM type 2",,,2,09/27/2019,,,,NKDA
0836643,09/27/2019,KY,50.0,50,,F,,"rash stomach, back",,,,,,,,,U,09/25/2019,09/26/2019,1,,UNK,,,,,,,2,09/27/2019,,Y,,penicillin
0836644,09/27/2019,NY,65.0,65,,F,,"Patient called pharmacy to report having a slight fever (100.2) the night she received the vaccine (9/25/19) and injection site swelling as well as redness of her entire arm from shoulder down to elbow that presented 9/25/19 in the left arm (the arm in which she received Shingrix). The redness got progressively worse that day, and has subsided and appears to be resolving today (9/27).  She works in a facility with a nurse available who evaluated her and advised her to contact us so that we could report reaction.  She'd had several shots before but never had a reaction.  We called her PCP to advise as well, though the patient didn't think that was necessary.",,,,,,,,,Y,09/25/2019,09/25/2019,0,Patient was evaluated by nurse at work who advised she may be having a slight non life threatening reaction.,PHM,,"PHENTERMINE, VITAMIN D-3",NONE,"DIABETES, LUNG DISEASE",,,2,09/27/2019,,Y,,"LATEX, CODEINE"
0836645,09/27/2019,GA,60.0,60,,F,,"Flu-like illness for 72 hours, followed by extreme weakness and dizziness. Latter has not gone away six weeks later.",,,,,,,,,N,08/16/2019,08/16/2019,0,None,PHM,,Lisinopril; Levothyroxine,None,"High blood pressure, low thyroid",Had similar reaction to dose #1 of Shingrix,,2,09/27/2019,,Y,,None
0836646,09/27/2019,MD,57.0,57,,F,,"Patient started having chills around 6:30pm, approx 4 hours after receiving vaccine. She had a fever, aches, headache, and was very cold. Patient recovered within one day.",,,,,,,,,Y,09/12/2019,09/12/2019,0,,PHM,,,,,,,2,09/27/2019,,,,
0836647,09/27/2019,NY,78.0,78,,F,,patient called on 9/27/19 stating she received the flu vaccine on 9/12/19 and that now her arm is sore. In the patient profile it shows that shingrix was administered on that date and no flu vaccine was received. The form filled out by the patient has the vaccine you would like to receive today area blank. I explained to the patient that she received the shingrix vaccine according to our records and that pain at the injection would be normal for the shingrix vaccine. She reiterated that she thought the vaccine was the flu shot. I also informed her that she was due for the shingrix and that now that she has had the first on she would be due for the booster in 2 months.,,,,,,,,,U,09/12/2019,09/27/2019,15,,PHM,,donepezil atorvastatin dicyclomine,,,,,2,09/27/2019,,,,none
0836648,09/27/2019,VA,34.0,34,,F,,"Neuro exam non focal. Etiology unclear however low concern for a demyelinating polyneuropathy, myopathy, or other acute CNS process at this point. UA positive for UTI which could be contributing",,,,,,,,Y,N,09/13/2019,09/14/2019,1,,PVT,,,none,hypothyroidism,,,2,09/27/2019,,Y,Y,NKDA
0836649,09/27/2019,VA,40.0,40,,F,,"Arm numbness that progressed to numbness in fingers and legs (intermittent, tingling); headache and light-headedness. Pt was recommended to f/u with neurology. Still at home recuperating",,,,,,,,Y,N,09/13/2019,09/13/2019,0,,PVT,,,,none,,,2,09/27/2019,,Y,Y,none
0836650,09/27/2019,CA,71.0,71,,F,,"Had my shot at 11:33. By 4:00 pm. I was having difficulty breathing, swelling in my throat. I took an antihistamine. After awhile that went away. Then that night around 8. My skin around my eyes started puffing up. And a white then yellow mucus started in my eyes. Later that night I started to have a horrible headache. In the morning I called my Dr. I was told to take Alive, I did.  I was out of pain around 11 the next day.",,,Y,,,,,,Y,09/24/2019,09/24/2019,0,,PHM,,Move Free Joint Health glucosamine + chondroitin,none,BACK PAIN,,,2,09/27/2019,,,,no
0836651,09/27/2019,NC,39.0,39,,F,,Client reports that approx. 20 min after receiving the vaccine she developed muscle spasms in her right shoulder. Client states that her arm is now swollen and 3 of her right fingers are numb. States she was seen at Urgent Care and was told to massage and apply heat to right arm. In our phone conversation today client states blood clots run in her family and she is concerned. I advised patient to go to the ER.,,,,,,,,,N,09/24/2019,09/24/2019,0,Seen at Urgent Care (see above),PUB,,none,Client reports nausea/vomiting 1 week prior,low back pain,,,2,09/27/2019,,Y,,Reglan
0836652,09/27/2019,NY,66.0,66,,M,,He came back to the pharmacy around 10 minutes after the vaccine saying he had pain in his neck and lower back and down his sides (both). He said it came on slowly and got sharper. I offered to have him take a seat and called. I offered him an ambulance and/or to call his primary care doctor. As I was talking to him and others he said it was starting to subside. After about 30 minutes he said he felt pretty good and basically no pain any longer.,,,,,,,,,Y,09/27/2019,09/27/2019,0,,PHM,,"lisin/hctz 20/12.5mg, valium 5mg, victoza 18mg/3mL, torsemide 10mg",unknown,unknown,,,2,09/27/2019,,,,none
0836654,09/27/2019,NM,14.0,14,,U,,He had a new onset of tic starting 9 hours after vaccination. This required overnight admission to the hospital for evaluation for secondary causes of acute onset tic.,,,,,Y,3,,,U,09/18/2019,09/18/2019,0,,PVT,,Tylenol as needed.  Melatonin as needed,,,,,2,09/27/2019,,,Y,
0836655,09/27/2019,GA,70.0,70,,F,,"Wife got her Fluzone HD shot first and then I gave her husband his Fluzone HD and his first Shingrix shot. Patient reported symptoms 10-15 minutes after receiving her Fluzone HD shot. Patient had some difficulty breathing, skin was clammy to touch, reported leg pain, back pain and chest pain. Before paramedics arrived she started feeling a little better with her leg pain and back pain. When husband notified of adverse event we contacted 911 immediately and asked paramedics to come to pharmacy to check patient. Patient's son arrived the same time paramedics came.",,,,,,,,,U,09/27/2019,09/27/2019,0,N/A,PHM,,"atenolol 50mg daily, atorvastatin 20mg daily, levothyroxine 100mcg daily, lisinopril/HCTZ 20/12.5mg, lovastatin 20mg.",Patient reported NOT feeling sick the day of vaccination and selected NO for all questionnaire.,"Pain, cough, respiratory problems, hypertension, hypercholesterolemia.",,,2,09/27/2019,,Y,,NKDA as of 9/26/19
0836656,09/27/2019,PA,88.0,88,,F,,Patient reports chills and fever beginning a few hours after injection and continuing for 48 hours.,,,,,,,,,Y,09/25/2019,09/25/2019,0,n/a,PHM,,"oxybutinin, hctz, tramadol, voltaren, singulair",n/a,,,,2,09/27/2019,,,,Codeine
0836657,09/27/2019,AZ,64.0,64,,F,,"Redness around injection site, patient states are itches, she experienced a headache after injection",,,,,,,,,,09/25/2019,09/25/2019,0,,PHM,,,,,,,2,09/27/2019,,,,
0836658,09/27/2019,PA,71.0,71,,F,,"Wife called and reported patient sick in bed, weak, low grade fever,  acting confused and delirious.",,,,,,,,,U,09/26/2019,09/27/2019,1,none known. not known if any other healthcare visit or clinic visit occurred,PHM,,"Symbicort, Atorvastatin, Prednisolone eye drops",none known,unknown,,,2,09/27/2019,,,,none
0836659,09/27/2019,LA,70.0,70,,F,,Patient has red rash around neck area and feels reaction through out her body.  She had no adverse reaction to first injections.  They think possibly this is an allergic reaction to 2nd injection,,,,,,,,,U,09/25/2019,09/26/2019,1,,PHM,,gabapentin  300mg    alprazolam 1mg,no,no   this is a possible drug allergy to shingrix,,,2,09/27/2019,,Y,,none known
0836660,09/27/2019,WA,57.0,57,,F,,"Throat felt like I had something stuck in it, I couldn't gargle or drink it away. I called my sister who is a nurse and she said to take Benadryl.  I also had chills and some body aches. After taking the Benadryl I slept most of the night but woke a couple of times because of a migraine. I took 50mg Sumatriptan at 2 am and again at 6 am. The following day I felt poorly, could not eat much,  but the feeling in my throat was getting better so I just stayed home from work and rested. I still have a dull headache today, two days later. A little throat irritation, but easy to swallow.",,,,,,,,,,09/25/2019,09/25/2019,0,,UNK,,"full day Vitamins, Vitamin C, biotin, magnesium, B12",None,None,Swelling at injection sight about 30 years ago from flu shot,,2,09/27/2019,,,,"Sulfites, nitrites, nitrates, MSG cortisone"
0836675,09/27/2019,NY,,,,M,,"He developed febrile seizures / hospitalized many times at unspecified times due to seizures; Developed epilepsy at age of 4; This spontaneous report was received from a consumer (patient's mother) regarding a currently 5 years old male patient. Information on patient's current conditions, drug allergies/reactions were not reported.Concomitant medications included divalproex sodium (DEPAKOTE). On an unknown date, the patient was vaccinated with first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (MMR), 1 regular injection, for prophylaxis (dose, route, lot# and expiry date was not reported).The consumer reported that the patient had received MMR (not  M-M-R II) vaccine around 12 to18 months of age. On an unknown date (reported as within 24 hours of vaccination), the patient developed febrile seizures (febrile convulsion). The consumer reported that her son had been hospitalized many times at unspecified hospitals at unspecified times due to seizures. On an unknown date (reported as at the age of 4), the patient developed epilepsy (also reported as pertinent medical history).The patient sought medical attention. The consumer stated that she was not anti-vaccine. She was against putting her son's life in danger. She also stated that she highly doubted her son would have had epilepsy if he had not gotten that first shot of MMR. The consumer stated that her son was up to date on all vaccines except MMR because he tolerated monovalent vaccines. The consumer wanted to speak to the person who made the decision to stop making MMR as a monovalent vaccine. There was no product quality complaint (PQC) was involved. The outcome of the event febrile seizures was reported as not recovered, however for epilepsy it was unknown.Causality of the events were not reported.   Upon internal review, the event febrile seizures and epilepsy were determined to be medically significant.",,,,,Y,,,,N,,,,,UNK,,DEPAKOTE,,,,US0095075131909USA008390,2,09/27/2019,,,,
0836676,09/27/2019,OH,,,,F,,"pneumonia; COPD exacerbation; herpes zoster; Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient's medical history and concomitant medications were not provided. Her concurrent condition included chronic obstructive pulmonary disease (COPD). In or around 28-MAY-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dosage, route, lot number and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).  Shortly after receiving zoster vaccine live (ZOSTAVAX) (date unknown in 2017), the patient suffered from COPD exacerbation and pneumonia, which required hospitalization. Additionally, shortly after receiving zoster vaccine live (ZOSTAVAX) (date unknown in 2017), the patient also suffered from lesions and was diagnosed with herpes zoster.  As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms had resulted in physical limitations not present prior to using the product. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the company wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the company's conduct, the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was reported as not recovered. The events were considered to be related to zoster vaccine live (ZOSTAVAX).   The events herpes zoster, COPD exacerbation and pneumonia were considered to be disabling. Upon internal review, the event pneumonia was determined to be medically significant.",,,,,Y,,,Y,N,05/28/2017,,,,UNK,,,Chronic obstructive pulmonary disease; Routine health maintenance,,,US0095075131909USA009138,2,09/27/2019,,,,
0836677,09/27/2019,GA,,,,U,,"side effects; ear ache; sore throat; headaches; aching all over; malaise; fever; CHILLS; muscle aches; This case was reported by a consumer via call center representative and described the occurrence of adverse drug reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced adverse drug reaction, ear pain, sore throat, headache, fever, chills, muscle pain, general body pain and malaise. On an unknown date, the outcome of the adverse drug reaction, ear pain, sore throat and headache were unknown and the outcome of the fever, chills and muscle pain were recovered/resolved and the outcome of the general body pain and malaise were not recovered/not resolved.   It was unknown if the reporter considered the adverse drug reaction, ear pain, sore throat, headache, fever, chills, muscle pain, general body pain and malaise to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The patient stated that had every side effect but also had ear ache, sore throat and headaches. The fever, chills and muscle aches lasted 4 days. At the time of reporting patient stated that still aching all over and just a feeling of malaise. The patient was not sure if want to take the 2nd dose if will have a reaction like this. The patient cannot take medrol dose pack due to adverse reactions. The patient asked for the suggestions. The patient asked if I do not take the 2nd shot how much of efficacy can I expect from one dose of the Shingrix.",,,,,,,,,N,09/01/2019,09/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836678,09/27/2019,,,,,U,,"Abdominal pain; This case was reported by a consumer via call center representative and described the occurrence of abdominal pain in a 60-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced abdominal pain. On an unknown date, the outcome of the abdominal pain was unknown.   It was unknown if the reporter considered the abdominal pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient did not want to provide demographic details. The patient asked call center representative to suggest over the counter treatment for abdominal pain post vaccine. The patient just want to know whether it was motrin or antacid. The reporter stated follow up not required.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836679,09/27/2019,,,,,U,,"Very high fever/Bad reaction; Sick like the flu/Bad reaction; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a child patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced fever (serious criteria hospitalization) and influenza like illness (serious criteria hospitalization). On an unknown date, the outcome of the fever and influenza like illness were not recovered/not resolved.   It was unknown if the reporter considered the fever and influenza like illness to be related to DTPa vaccine.  Additional details were received as follows: The patient never had another shot of vaccine in the past.  The age at vaccination was not reported.  After vaccination, the patient had a very high fever and sick like the flu. The patient ended up in the hospital more than once.  The patient's physician, tried cutting the dose in half and then into a quarter and the patient still had a bad reaction. The measle, smallpox also made the patient sick. The patient had 2 flu shots and ended up in the hospital. This case was linked to case US2019AMR172639, reported by the same reporter.",,,,,Y,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836680,09/27/2019,,,,,U,,"Ended up in the hospital; This case was reported by a consumer via interactive digital media and described the occurrence of adverse event in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced adverse event (serious criteria hospitalization). On an unknown date, the outcome of the adverse event was unknown.   It was unknown if the reporter considered the adverse event to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were received as follows: The patient never had another shot of vaccine in the past.  The age at vaccination was not reported.  The patient had 2 flu shots and ended up in the hospital. This case was linked to case US2019AMR172636, reported by the same reporter.",,,,,Y,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836681,09/27/2019,,,,,F,,"Seizures several times throughout the day; This case was reported by a consumer via call center representative and described the occurrence of seizure in a female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) for prophylaxis.   Co-suspect products included HAV (Havrix) for prophylaxis.   On 9th September 2019, the patient received Fluarix Quadrivalent 2019-2020 season and Havrix. On 13th September 2019, 4 days after receiving Fluarix Quadrivalent 2019-2020 season and Havrix, the patient experienced seizure (serious criteria GSK medically significant). On an unknown date, the outcome of the seizure was not recovered/not resolved.   It was unknown if the reporter considered the seizure to be related to Fluarix Quadrivalent 2019-2020 season and Havrix.  Additional details were provided as follows: The age at vaccination was not reported. After receiving Fluarix and Havrix, four days later she started having seizures several times throughout the day. On 17th September 2019, her Pediatrician refers her to a Pediatric Neurologist. She visited an emergency room (ER) on 18th September 2019, where she received no treatment or test but an appointment for next day to see the Neurologist. On 19th September 2019, she finally visited the Neurologist, she had no medication just an appointment for an EEG on 22nd October 2019. The patient's symptoms get worsened every day.",,,,,,,,,N,09/09/2019,09/13/2019,4,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,Y,Y,
0836682,09/27/2019,NJ,,,,M,,"pneumonia; fibrotic lung condition; This case was reported by a consumer via call center representative and described the occurrence of pneumonia in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included prednisone.   In April 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced pneumonia (serious criteria GSK medically significant) and pulmonary fibrosis (serious criteria GSK medically significant). On an unknown date, the outcome of the pneumonia and pulmonary fibrosis were unknown.   It was unknown if the reporter considered the pneumonia and pulmonary fibrosis to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received his 1st Shingrix dose in mid-April 2019. The patient's initial diagnosis was pneumonia, but that was under a total re-evaluation now. He might had a fibrotic lung condition. On 28th June 2019, the patient received Prednisone 10 mg 4 for 3 days and progressive fewer pills over the next week. Again, on 5th August 2019, he received the treatment drug again. The pharmacist said that the patient could have 2nd Shingrix dose on 23rd September 2019.",,,,,,,,,U,04/01/2019,,,,UNK,,PREDNISONE,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836683,09/27/2019,NC,73.0,72,,F,,"Blood glucose reading of over 300; Shacking palms; Sweaty palms; This case was reported by a pharmacist via call center representative and described the occurrence of blood glucose increased in a 73-year-old female patient who received Herpes zoster (Shingrix) (batch number 2G2T7, expiry date 15th November 2021) for prophylaxis.   Concurrent medical conditions included diabetes (was a diabetic so they monitor their blood sugar).   On 13th September 2019 10:16, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 13th September 2019 03:05, 4 hrs 49 min after receiving Shingrix, the patient experienced blood glucose increased, tremor and sweating increased palms. On an unknown date, the outcome of the blood glucose increased, tremor and sweating increased palms were recovering/resolving.   It was unknown if the reporter considered the blood glucose increased, tremor and sweating increased palms to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and at 10:16am and at 3:05pm had a blood glucose reading of over 300 despite not eating after the vaccine. The patient also reported shaking and sweaty palms. The patient was feeling better and the pharmacist plans to call at the time of reporting for follow up. The patient was a diabetic so they monitor their blood sugar.",,,,,,,,,N,09/13/2019,09/13/2019,0,"Test Date: 20190913; Test Name: Blood glucose; Result Unstructured Data: Test Result: over 300, Test Result Unit: unknown",UNK,,,Diabetes (was a diabetic so they monitor their blood sugar),,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836684,09/27/2019,WI,,,,U,,"unexpected reaction; This case was reported by a other health professional via call center representative and described the occurrence of adverse reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.  On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per the vaccine indication. The patient had unexpected reaction after receiving Shingrix vaccine. The reporter did not consent to follow up. The medical assistant denied she was reporting any adverse event, and refused to provide further details regarding patient, product or event. This case linked with US2019170906, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836685,09/27/2019,NY,56.0,56,,F,,"floaters in left eye; Flashing lights; This case was reported by a consumer via call center representative and described the occurrence of eye floaters in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th September 2019 12:00, the patient received the 1st dose of Shingrix. On 13th September 2019, 5 hrs 30 min after receiving Shingrix, the patient experienced flashing lights. On 13th September 2019 05:30, the patient experienced eye floaters. On an unknown date, the outcome of the eye floaters and flashing lights were not recovered/not resolved.   It was unknown if the reporter considered the eye floaters and flashing lights to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. The patient currently saw black floaters in her left eye. The patient consent to follow up.",,,,,,,,,N,09/13/2019,09/13/2019,0,,PVT,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836686,09/27/2019,MA,61.0,61,,M,,"Rash; pink indurated plaque / plaque on the patient's extremities trunk, legs and lower back; Lesions; Pink induration plaque; Pink induration plaque; This case was reported by a other health professional via call center representative and described the occurrence of rash in a 62-year-old male patient who received Herpes zoster (Shingrix) (batch number 9X374, expiry date unknown) for prophylaxis.   On 8th July 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 3 months after receiving Shingrix, the patient experienced rash, skin scaly, skin lesion, skin plaque and induration. On an unknown date, the outcome of the rash was not recovered/not resolved and the outcome of the skin scaly, skin lesion, skin plaque and induration were unknown.   It was unknown if the reporter considered the rash, skin scaly, skin lesion, skin plaque and induration to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in right deltoid. The CMA reported on behalf the dermatologist that a patient came in their office and reported a rash that wouldn't resolve. The physician did a biopsy and it showed no danger. They completed blood work for Lyme disease and it was negative. The reporter described the rash as 1-5 cm. pink indurated plaque; some annular and scaly on the patient's extremities, trunk, legs and lower back. The multiple smooth indurated plaque and lesions were annular and others were not. The reporter consented to follow up. The reporter provided physician contact details. In the XML document outcome of event rash was reported as recovering, but in system its mentioned as not recovered, so kept as reported in system.",,,,,,,,,N,07/08/2019,,,"Test Name: Biopsy; Result Unstructured Data: Test Result: no danger, Test Result Unit: unknown; Test Name: Blood test; Result Unstructured Data: Test Result: Negative, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836687,09/27/2019,KY,2.0,2,.3,F,,"(this is her only flu vaccine this season, she has gotten flu vaccine in the past (this is her 4th, the above question isn't clear, as to which dose in the series). Area surrounding injection site became red, warm to touch, and swollen. Not bothering patient. No affect on walking. No fever. Mom brought her in because she felt the area looked bigger today.  Area of erythema measured 14cm x 8 cm. Slightly warm to touch, some induration centrally, non-tender, no negative impact on patient.",,,,,,,,,U,09/25/2019,09/26/2019,1,none,PVT,,none,none,none,,,2,09/27/2019,,,,none
0836688,09/27/2019,MT,49.0,49,,F,,"Redness, soreness, warmth, induration, and tingling sensation ""radiating down left arm"". Body temp @ office visit on 9/26/19 was 99.3 degrees F (forehead).",,,,,,,,,U,09/24/2019,09/24/2019,0,None,WRK,,None,None,None,,,2,09/27/2019,,Y,,None
0836689,09/27/2019,OR,67.0,67,,M,,"severe dry cough for 4-5 hours, bone shaking chills, fever 101 severe headache, eyes hurt, injection site hot but not red",,,,,,,,,Y,09/26/2019,09/26/2019,0,none,PHM,,"LISINOPRIL-HCTZ,ALPRAZOLAM, TRAZODONE, SILDENAFIL,ASPIRIN,OXYCODONE,CENTRUM SILVER, VITAMIN E",NONE,HIGH BLOOD PRESSURE ERECTILE DYSFUNCTION,,,2,09/27/2019,,,,TRAMADOL
0836690,09/27/2019,NY,71.0,71,,F,,angioedema at site of injection,,,,,,,,,U,09/26/2019,09/27/2019,1,,PHM,,n/a,n/a,n/a,,,2,09/27/2019,,Y,,opoids/morphine
0836691,09/27/2019,TX,77.0,77,,F,,Patient says she had severe nausea and vomiting and weakness and diarrhea for 6-8 hours.,,,,,,,,,Y,09/21/2019,09/21/2019,0,None,PHM,,Not indicated,Not indicated,Not indicated,,,2,09/27/2019,,,,None
0836692,09/27/2019,MA,18.0,18,,M,,patient passed out/seized 15 seconds after vaccine given  - 911 was called and dispatched,,,,,,,,,Y,09/27/2019,09/27/2019,0,,PHM,,,,,,,2,09/27/2019,,,,
0836693,09/27/2019,NJ,63.0,63,,M,,reported approx 12 hours post vaccination felt swelling on left side of tongue with tingling sensation; sensation similar to that when exposed to shellfish or ibuprofen - denies having had either these or any new foods or medication  at time reporting reaction to clinic the sensation was almost completely subsided; just a slight sensation of tingling on left side of tongue,,,,,,,,,Y,09/26/2019,09/27/2019,1,none,WRK,,none,none,none,,,2,09/27/2019,,,,"shellfish, ibuprofen"
0836694,09/27/2019,MN,51.0,51,,M,,"Flu like symptoms, joint pain, muscle aches general malaise",,,,,,,,,U,09/26/2019,09/27/2019,1,,PVT,,Multi vitamin  Vitamin D Glucosamine  Omega supplements  Lisinopril HCTZ Trazadone Actorvistatin,None,Heart disease,,,2,09/27/2019,,,,NKDA
0836695,09/27/2019,SC,76.0,76,,F,,"There was no response immediately at the time of the vaccine.  The patient complained of redness, swelling on her arm.  I told her that could be a normal response to the vaccine, but she came in the show me her arm.  I noticed what appeared to be a scratch and 2 mosquito or ants bites around her left elbow.  This is the area where the inflammation was.  It was red, swollen, and warm to the touch.  I suggested she try tylenol and benadryl to see if that helps and to see an MD if it doesn't clear up in a few days.  The patient decided to see an MD where she was prescribed Keflex 500mg 1 po TID x10d",,,,,,,,,U,09/23/2019,09/24/2019,1,I'm not 100% sure of the exact visit date to the MD or any test results as my call to the MD to research wasn't responded to thus far.  I listed the MD contact info. on this form if any further investigation or questions remain for the MD.,PHM,,"Unknown, she fills at pharmacy in a different city.  She was on Vimovo and Levothyroxin at her last fill here in Jan 2019.",No known illness,The patient didn't list any on her VAR,,,2,09/27/2019,,Y,,No known allergies
0836696,09/27/2019,GA,10.0,10,,F,,"Patient received influenza vaccine on 09/23/2019 on 09/24/2019 pt started with pain, hard swollen area, with redness that was warm to the touch.",,,,,,,,,Y,09/23/2019,09/24/2019,1,none,PVT,,None,None,Atopic Dermatitis,,,2,09/27/2019,,Y,,none
0836697,09/27/2019,WA,4.0,4,,M,,Patient had a febrile seizure and was seen at the ER.   Patient was treated with Tylenol and Motrin,,,,,,,,,Y,09/04/2019,09/05/2019,1,,PVT,,Ranitidine,GERD Abdominal pain,GERD,,,2,09/27/2019,,,Y,NKA
0836698,09/27/2019,,75.0,75,,M,,Swelling  and redness,,,,,,,,,N,09/25/2019,09/25/2019,0,,PHM,,,,,,,2,09/27/2019,,,,
0836699,09/27/2019,LA,21.0,21,,F,,"Patient was planning to get 3 vaccines, these two and a flu Vaccine. After the second vaccine, the patient passed out and was shaking.  Patient came back in about 60 seconds.  The patient vomited within a few min of waking up and complained of a burning sensation in her arms and legs. Paramedics came and checked BP. BP was fine. Pt stayed here for about 30 min and then her mother picked her up to go home. Pt felt fine once she left.",,,,,,,,,Y,09/27/2019,09/27/2019,0,"BP check by paramedics. I did not see the reading, but the paramedic said it was ""fine""",PHM,,n/a,n/a,n/a,,,2,09/27/2019,,Y,,n/a
0836700,09/27/2019,CA,64.0,64,,F,,Pt experienced sweating and mild dizziness after the flu shot.  Pt  laid down of the flood for 5 to 10 minutes to rest. She recovered after  resting for 5 to 10 minutes,,,,,,,,,Y,09/27/2019,09/27/2019,0,n/a,PHM,,,She claimed she is fully recovered from the flu,"hypothyroidism, hyperlipidemia, mood disorder",,,2,09/27/2019,,,,Thimerosal
0836701,09/27/2019,PA,62.0,62,,F,,"Patient reporting shoulder, neck, back of head pain, dizziness, white of eye completely bloodshot at the top",,,,,,,,,N,09/25/2019,09/27/2019,2,,PHM,,"Amlodipine, Indapamide",,,H1N1  vaccine 2009,,2,09/27/2019,,,,Codeine
0836702,09/27/2019,,70.0,70,,M,,Patient's wife notified the pharmacy of this adverse reaction on 9/27/19. Patient's wife noticed that her husband was dizzy and had a sense of feeling off balance. Patient's wife also reported that her husband was experiencing a very rapid heart rate. Patient eventually fell down and was in a fetal position per the wife. The wife then contacted emergency services. Patient was placed on the intensive care unit for one day for treatment of a pulmonary embolism that had occurred. Patient was appropriately treated and sent home on 9/27/19.,,,,,Y,3,,,Y,09/24/2019,09/24/2019,0,,UNK,,,,,,,2,09/27/2019,,,Y,
0836703,09/27/2019,OR,65.0,65,,F,,"Patient got an unusual amount of swelling the next day.  Came back to the pharmacy that Saturday.  Pharmacist on duty gave a Benadryl with no effect.  Came in 9-25-19 swelling had gone don't, but was still red and warm to the touch.  Wanted swelling report as side effect",,,,,,,,,Y,09/04/2019,09/05/2019,1,,PHM,,none known,none known,none known,,,2,09/27/2019,,,,phenobarbital
0836704,09/27/2019,NE,63.0,63,,F,,On right arm only- patient developed hives on right arm and under the right arm the day after the vaccine. The hives itch and are warm.  Her arm is also tender and a bit swollen. The hives are continuing on Friday- 5 days post shot. Pt experienced a fever of 101 for 2 days post immunization and left very tired.,,,,,,,,,N,09/23/2019,09/24/2019,1,None,PHM,,"ASA 81mg, lisinopril-hctz 20-12.5mg, metformin er 500mg, atorvastatin 10mg, flonase, viibryd 40mg,",None,"diabetic, high blood pressure, depression",,,2,09/27/2019,,,,macrolids and opiods
0836705,09/27/2019,PA,68.0,68,,M,,"patient had a red arm that was warm to the touch, swollen, and tender within 24 hours of vaccination. patient went to an urgent care where they prescribed the patient keflex to treat",,,,,,,,,Y,09/16/2019,09/17/2019,1,,PHM,,flomax 0.4mg qd,no other illnesses,prostate,,,2,09/27/2019,,Y,,nka
0836706,09/27/2019,LA,76.0,76,,M,,"CHILLS, FEVER, REDNESS RADIATING AROUND TO OTHER SIDE OF ARM WITH RASH, SORE ARM, ACHING BONES, DECREASED APPETITE, ALL THIS LASTING FROM 9/24/19 AM TO 9/27/19 AM; 092619  SWEATING TO THE POINT OF SOAKING SHEETS AND BEDCLOTHES AND HAVING TO WAKE UP TO CHANGE ALL; OKAY FEELING ON 92719 BUT STILL RASH LARGE AND PRESENT",,,,,,,,,N,09/24/2019,09/24/2019,0,,PHM,,,,,,,2,09/27/2019,,,,
0836707,09/27/2019,NC,28.0,28,,F,,"unexplained stillbirth 10 days after vaccination, no known fetal anomalies",,,,,Y,1,,,,09/16/2019,09/26/2019,10,,PVT,,prenatal vitamin daily,none,"history of pituitary adenoma, hyperprolactinemia",,,2,09/27/2019,,,,allergy to Tamiflu
0836708,09/27/2019,NY,8.0,8,,F,,Stomachs ache every day since injection. Her ADHD has had the worst flare in years,,,,,,,,Y,N,09/17/2019,09/18/2019,1,None,PVT,,None,None,None,"Hep B 8 years old, 6/27/19 glaxosmithkline",,2,09/27/2019,,,,"Wheat, dairy,"
0836709,09/27/2019,NY,67.0,67,,M,,"The patient reports that minor headache started approximately one day after vaccination and was relieved using Tylenol. However, the patient reports an itchy, isolated rash on the wrist, which also arose after about one day after receiving the vaccination. The patient believes the rash is a result of the vaccination, but no other symptoms of allergic rxn are present (swelling, fever, hives, etc.).",,,,,,,,,N,09/24/2019,09/25/2019,1,Not applicable,PHM,,"METFORMIN, VICTOZA, RAMIPRIL, ATORVASTATIN, CABERGOLINE",N/A,DIABETES,,,2,09/27/2019,,,,NO KNOWN DRUG ALLERGIES
0836710,09/27/2019,WA,3.0,3,,M,,10cm x 6cm area of erythema with central clearing at injection site,,,,,,,,,N,09/19/2019,09/19/2019,0,NA,PVT,,Sulfasalazine 300mg BID Folic Acid 1mg qd Vitamin D 400IU qd Probiotic,None,Ulcerative Colitis,,,2,09/27/2019,,Y,,No known
0836711,09/27/2019,OR,74.0,74,,M,,Skin rash mostly on the right side of upper arm and back  Developed low case of Shingles.,,,,,,,,,,07/25/2019,07/26/2019,1,,PHM,,"Atorvastatin, Clopidogrel, low dose aspirin, Levothyroxone, Mushroom formula, Olive Leaf extract, Garlic, Oregano oil, Tumeric.",None,Arthritis,,,2,09/27/2019,,Y,,None
0836712,09/27/2019,WI,62.0,62,,F,,"She experienced redness, swelling, itching, and pain around the injection site. The redness and itching extended further down the arm.",,,,,,,,,Y,09/18/2019,09/19/2019,1,None,PHM,,None known to Pharmacist,,,,,2,09/27/2019,,,,None known to Pharmacist.
0836713,09/27/2019,WA,7.0,7,,M,,next day he noticed redness and rash and hive like bumps near vaccine site.  was about 3 inches around the whole site,,,,,,,,,Y,09/24/2019,09/25/2019,1,none,PVT,,"adderal, magnesium and fish oil",seasonal allergies,none,,,2,09/27/2019,,,,no known allergies
0836714,09/27/2019,CA,0.17,83,,F,,"red eyes, headache, cold , lack of appetite, tired,,,,,,dizzi",,,,,,,,,Y,09/21/2019,09/21/2019,0,,OTH,,,,"COPD/ ARTHRITIS, PRE-DIABETIC",,,2,09/27/2019,,,,
0836715,09/27/2019,OH,80.0,80,,F,,"patient stated that when she got home, she was very cold, shaking and had goose bumps.  later that day, she said that she fell down because she felt weak.  she has no appetite for the past 2 days",,,,,,,,,Y,09/25/2019,09/25/2019,0,,PHM,,simvastatin 10mg; alendronate 70mg;  diclofenac sod 75mg; hydrocodone/apap 5/325;,do not know,chronic pain,,,2,09/27/2019,,,,cephalosporin
0836716,09/27/2019,NV,51.0,51,,F,,Patient states their arm was swollen and had rash around the injection site. Patient also state their arm was painful and symptom lasted for 3 days.,,,,,,,,,Y,09/06/2019,09/07/2019,1,,PHM,,,,,,,2,09/27/2019,,,,
0836717,09/27/2019,NY,13.0,13,,M,,"Lethargic after a few days. Very severe eczema, less engaged.",,,,,,,,,Y,09/17/2019,09/19/2019,2,,PVT,,,None,"asthma, allergies",,,2,09/27/2019,,,,Allergic to seeds and treenuts. sensitive to nuts
0836718,09/27/2019,MA,68.0,68,,M,,he broke out in a rash across his chest,,,,,,,,,U,09/24/2019,09/25/2019,1,,PHM,,metoprolol er 50mg quinapril 10 mg pravastatin 20 mg,,"heart disease, high blood pressure",,,2,09/27/2019,,,,nka
0836719,09/27/2019,KY,74.0,74,,F,,"Started running a fever of 100.4 the day of the shot. the fever would go up and down but never below 99.4. Arm very painful  and running fever for 2 days now. I just now noticed a knot on the right side of my neck,(this was also the side of the injection). I called the Pharmacist and my family doctor about the fever and chills because I thought I may have caught the flu but they both told me it was a reaction to the shot. They are both closed for the day so I could not call them to tell them about the swelling in my neck.  I don't know if this is usual in the Shingle shot but I didn't have this reaction with the first injection back in May,2019.",,,,,,,,,N,09/25/2019,09/27/2019,2,none,PHM,,"Dyazide Vitamin D 50,000 Singular Requip Paxil Lisinipril Spiriva Symbicort Vitamin B 12 Vitamin B 6 Tylenol Duoneb Multivitam",slight cough,Lung cancer CLL Asthma COPD PAD,Arm swelled after flu shot. Age-45-Intramuscular,,2,09/27/2019,,,,Phenobarbital
0836720,09/27/2019,CA,65.0,65,,F,,"Patient experienced fever, chills, nausea, faintness, dry mouth, throat swelling, and difficulty breathing. Called paramedics who hydrated her and treated her for hypotension. ER treated the case as an allergic reaction. Patient received two vaccines the same day and believes it was the shingles vaccine. She had never experienced any issues with influenza vaccine but it was her first year of receiving the high dose for over the age of 65.",,,,,,,,,Y,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,09/27/2019,,,Y,"Compazine, MAOI, Morphine"
0836721,09/27/2019,OH,30.0,30,,F,,"Nausea, fever of 100.4, muscle aches, joint pain, fatigue",,,,,,,,,,09/25/2019,09/26/2019,1,,PVT,,Synthroid and One-A-Day Women's Prenatal Vitamin,None,Hypothyroidism and high cholesterol,,,2,09/27/2019,,,,None
0836722,09/27/2019,AZ,78.0,78,,F,,"PATIENT SAYS SHE IS EXPERIENCING FLAIR UPS OF SHINGLES BLISTERS ON HER FOREHEAD, SHOULDER, TRUNK AND LEGS. SAYS THEY FORMED BLISTERS AND SOME HAVE BROKEN OPEN AND ARE DRYING UP. SHE STATES THE SIGHTS ARE SWOLLEN AND PAINFUL.",,,,,,,,,N,09/18/2019,09/20/2019,2,,PHM,,UNKNOWN,NONE,UNKOWN,,,2,09/27/2019,,,,NONE
0836723,09/27/2019,MA,71.0,71,,F,,"Patient called on 9/27/19 stating she was experiencing a red spot, the size of a half dollar at the site of injection. Patient states that it is tender to the touch. It began on 9/24/19. It does not appear to be getting any worse. The only time she even notices it is if she bumps that area of her arm into something. I counseled her to watch it this weekend. If it gets worse or is not better by Monday, to give either us or her doctor a call.",,,,,,,,,U,09/23/2019,09/24/2019,1,,PHM,,,,,,,2,09/27/2019,,,,
0836724,09/27/2019,NY,68.0,68,,F,,"chills, fever and redness and warmth at injection site",,,,,,,,,,09/25/2019,09/26/2019,1,,PHM,,,,,,,2,09/27/2019,,,,
0836725,09/27/2019,NV,72.0,72,,F,,"Chills, fever (up to 101F), headache, muscle aches starting about 6 hours after injection, getting worse for about 36 hours, then getting better, recovered in 4 days. Had to spend most of day following injection in bed.",,,,,,,,,Y,09/09/2019,09/09/2019,0,none,PHM,,Synthyroid   Benazepril 20MG (generic for Lotensin) twice daily Hydrocholorothiazide 25 MG  Allegra,None as far as I know but it is possible that I was going to come down with a virus separately from the vaccine. I came down with a fever (101 F) for 2+ days which is as I understand not a usual reaction to the vaccine. I do not typically get fevers.,controlled high blood pressure hypothyroid,,,2,09/27/2019,,,,"oysters, hibiscus, bees"
0836726,09/27/2019,OR,30.0,30,,F,,"Donor received TDAP post plasma donation. Donor waited 15min and felt fine. Donor went to shop about 10min later and developed tunnel vision, was nauseated, pale, light headed and had a 2-3min episode of LOC. Donor then took bus to transfer station and developed the same symptoms followed by another 2-3min LOC. Later that evening while preparing for bed donor had the same symptoms again with another 2-3min LOC. Donor had had a routine amount of food and fluid before donating. Donor has never had a reaction to donating like this before. Donor has been a regular donor for about the last year. That evening donor slept well and awoke the next morning with no further symptoms except a temperature of 99.2 for two more days. Donor had no prior reactions to TDAP like this. Donor states she sometimes gets a little light headed post donation, but eating something fixes that.",,,,,,,,,Y,09/23/2019,09/23/2019,0,none,OTH,,Nexplanon,None,None,,,2,09/27/2019,,,,Unknown
0836727,09/27/2019,MA,71.0,71,,F,,"Patient called 9/27/19 stating that later in the day on 9/24/19 she began experiencing achy joints, nausea, lack of appetite, and redness in her arm (not stated which arm). As of today, she is still experiencing nausea, lack of appetite, and redness in arm (not stated which arm). Patient was counseled to monitor symptoms this weekend. If symptoms are not better by Monday or get worse during the weekend, she should contact us again or her doctor.",,,,,,,,,N,09/24/2019,09/24/2019,0,,PHM,,,,,,,2,09/27/2019,,,,
0836728,09/27/2019,,7.0,7,,F,,"My daughter received 2 vaccines on 9/16, MMR and Varicella, and 2 more vaccines on 9/20 Tdap and Polio. On 9/23 she began developing several pimple-like bumps on her body. For the next 3 days more bumps were forming. On 9/25 she developed a fever of 103 and headache. The next day 9/26 a rash developed on many parts of her body, and a few round bruises formed on her skin. I took her to the ER that night, bloodwork was performed. Doctor stated all was normal, besides a fever and rash. The next morning most of her body was covered in hives. I took her to a pediatric urgent care, doctor confirmed some pox spots and rash and hives. Stated that it appears to be a vaccine reaction.",,,,,,,,,N,09/16/2019,09/23/2019,7,"Examination and various blood work 9/26, all within normal limits, besides inflammation markers and rash 9/27  examination and negative strep test. Hives and pox spots confirmed.",UNK,,,Strep throat the month before,none,,,2,09/27/2019,,Y,Y,none
0836729,09/27/2019,AK,18.0,18,,F,,"Vasovagal response. Approximately 4-5 minutes after all vaccines administered. Extreme pallor, lowered head, moaning. Client able to verbally respond. Complained of dizziness and lightheadedness. Assisted to a supine position, cold cloth placed on forehead, water, candy, juice given. BP 110/70.  Color returned within 5 - 7 minutes. Monitored client for further reaction for approximately 30 minutes. After 30 minutes client reported no further symptoms. Able to stand and walk without issue. Follow up phone call at 1 hour post leaving clinic, client stated she felt good and made it home safely, denied further symptoms.",,,,,,,,,Y,09/27/2019,09/27/2019,0,n/a,PUB,,Birth Control,none,none,,,2,09/27/2019,,,,NKDA
0836730,09/27/2019,CA,35.0,35,,F,,"anaphylaxis, respiratory difficulty requiring epinephrine x2 doses  dose given @1130, hives w urticarial at 1315. progressed rapidly to paroxysmal cough, throat swelling, stridor and SVT hr 140's   911 called and taken to ER where pt had chest pain additional dose of epi, and breathing treatments,+ ""heart tests""",,,,,,,,,U,09/27/2019,09/27/2019,0,see above,WRK,,none,,none,,,2,09/27/2019,,,Y,seasonal environmental
0836731,09/27/2019,PA,60.0,60,,F,,"Localized redness, and irritation to right upper arm",,,,,,,,,,09/19/2019,09/21/2019,2,,PHM,,,,,,,2,09/27/2019,,Y,,
0836732,09/27/2019,NC,60.0,60,,F,,"SYMPTOMPS : NAUSEA -  PATIENT DENIED TO TAKE ANY TREATMENT AS IT WAS NOT MUCH COUGH - SUGGESTED  TUSSIN DM., DRINK LOT OF WATER, REST WAS SUGGESTED' IF WORSENS THE SX, TO CONTACT DR OFFICE .",,,,,,,,,Y,09/21/2019,09/26/2019,5,,PHM,,,,,,,2,09/27/2019,,,,
0836733,09/27/2019,TX,69.0,69,,F,,"Patient oxygen saturation dropped that night after the vaccination, husband brought patient to the ER that same night and was released. But patient oxygen saturation dropped again Friday morning down to 60% and he brought patient back to the ER.",,,,,Y,,,,N,09/11/2019,09/11/2019,0,,PHM,,"VIatmin D2, carvedilol, amitriptyline",UTI,,,,2,09/27/2019,,,Y,NKDA
0836734,09/27/2019,MI,27.0,27,,F,,"Starting about 9 pm on 9-19, I had extreme diarrhea. Then in the next hour or so, I started having really bad aches and chills. About 10:30 I threw up a lot, everything in my stomach from dinner and all that I had to drink. I was up all night throwing up and having diarrhea. I started having a fever of 102 around 3 AM on 9-20. From 9 PM on 9-19 to about 11 PM on 9-20, I threw up 12 times and had diarrhea about 8 or so times. I was not able to keep down any liquids or food and my body was aching so bad that I could not move. Because of not being able to keep down any fluids (and having a fever and sweating a lot) and also breastfeeding, I felt like I was seriously dehydrated and that I should see a doctor. I called my 24/7 nurse hotline around 8 PM on 9-20 through my insurance company, and the nurse instructed me to go into the ER within the next hour, as I was probably severely dehydrated. I told myself if I threw up in the next 2 hours, that I would go in. I was able at that point to hold down a little bit of water and didn't end up going in, although I probably should have. I felt slightly better on 9-21, but still very weak and dehydrated.",,,,,,,,,Y,09/18/2019,09/19/2019,1,,PVT,,Multi-Vitamin,None,None,"Almost every year I get the flu shot, I get a similar type of reaction - aches, chills, fever, throwing up.",,2,09/27/2019,,,,None
0836894,09/27/2019,NC,83.0,83,,F,,"If the flu shot is supposed to make some people sick why don't we be told. I was told I would have a sore shoulder. My shoulder has not bothered me. I do not be sick I worked 6 years, no sick day out of work. So I did not expect to be sick after this shot. I have had shots before but not been sick from them. Nausea, chills, hands numb weak, too weak to work in the home. I used heating pad to warm hands head aches. I felt like staying in bed 3 days. I prayed and hoped I would be better to Bowl on Wednesday.",,,,,,,,,Y,09/15/2019,,,,PHM,,yes,none,none,,,2,09/24/2019,,,,none
0836895,09/27/2019,CA,17.0,17,,M,,"Syncope and collapse (ICD10-R55). 17 y/o male who received vaccines being HPV the last one given of 3 on DOS. Pt felt light headache, body was stiff and collapsed. He was somewhat disoriented, pale and clammy, he was assisted to the bed laying down with legs held high. BP 113-43, HR variation 30s-50s at 3:45 PM; pt oriented and conscious at this time. Repeat BP at 4:00 PM 121/67 HR 55. EKG showed NSR with rate variation. His O2sats were in the 80s, w/supplemental Oxygen 8 lpm, sats up to 100%. O2 decreased to 6 lpm with sat still at 100%. Pt had 2 other HPV vaccines with no reaction. Pt continued alert and oriented, HOB raised at 45 degrees. BP at 4:12PM 123/64, HR=51 O2sat=100%. O2 removed at 4:16 PM O2 sats holding at 99% on RA. BP at 4:19 pm 108/77 with HR=64(sitting). BP standing at 4:22 PM = 109/47 with HR=63. Pt continues A/O X3. No neuro deficits; taking for a walk with no complaints; taken back to room BP at 4:25 PM = 101/35 HR=60. Neuro-exam = No deficits. Pt denies headache, dizziness, chest pain, sod, doe, vision changes, paresthesias. BP checked again = 106-56, HR=61. Pt referred to Dr, Pediatric Cardiologist. Pt currently not clear for sports, no PE or strenuous activities until cardiac evaluation. Strict ER precautions d/w patient and his fatherin any significant headaches, dizziness, disorientation, lethargy, difficult breathing, chest pain. 09/26/19=F/U on vaccine reaction. Pt denies any symptoms since 09/25/19; has an appointment with Ped. Cardiologist, Dr next week.",,,,,,,,,U,09/25/2019,09/25/2019,0,"EKG done in clinic on 09/25/19. See notes in item #18. Pt referred to Ped. Cardiology - appointment on Friday October 4, 2019.",PVT,,NONE,NONE,NONE,,,2,09/27/2019,,Y,,N.K.D.A
0836896,09/27/2019,IN,67.0,67,,F,,"18 hours after receiving injection, employee presented with small, open area to left upper arm. She stated it had been fluid-filled blister which ruptured. Advised on appropriate wound care and to follow-up with regular clinic if symptoms continue or worsen. Presented again 7 days later. Area appeared slightly improved. Employee counselled to keep area clean & open to air. Nursing coord. notified. Attempted to discover vaccination to review best practices for vaccine administration",,,,,,,,,N,09/20/2019,09/21/2019,1,,WRK,,Atenolol/coozar,N/A,myloma,,,2,09/27/2019,,Y,,N/A
0837022,09/27/2019,GA,62.0,62,,F,,Redness & swelling noted to Right deltoid. (2.5cmX3cm) C/O muscle pain and headace,,,,,,,,,,09/16/2019,09/16/2019,0,N/A,PUB,,denies any meds prior to vaccination,none,"neuropathy hypertension, thyroid disorder, anxiety",,GA1920,2,09/18/2019,,,,NKA
0837030,09/27/2019,GA,31.0,31,,F,,"Redness, swelling of injection site started 9-18-19",,,,,,,,,Y,09/17/2019,09/18/2019,1,None,PUB,,None,,,,GA1921,2,09/19/2019,,,,morphine
0837031,09/27/2019,CA,79.0,79,,F,09/22/2019,"Rt. arm red, warm to touch, swollen hard size of my palm - itching, painful, almost hot to touch. Received injection at 10AM and symptoms appear 2 hrs. after lasted 3 days.",,,,,,,,,Y,09/12/2019,09/12/2019,0,,OTH,PUB,,N/A,N/A,,,1,,,,,
0837032,09/27/2019,MN,73.0,75,,M,,Pain in shoulder left but went up back to hips and down to knees Toes fingers for over two weeks only while laying flat or in chair.,,,,,,,,,,09/05/2019,09/10/2019,5,Seen Medical Dr & Chiro.,UNK,,,,,,,2,09/23/2019,,Y,,
0837086,09/27/2019,CA,30.0,30,,M,,"Pt given Tdap 9/20/2019, Next day, developed (L) axilla swelling. No itching/redness. Resolved as of visit on 9/27/2019.",,,,,,,,,Y,09/20/2019,09/21/2019,1,None,PVT,,None,Right flank pain,None,,,2,09/27/2019,,Y,,Peaches
0837160,09/27/2019,NM,12.0,12,,M,,"After 5 mins, pt became pale, nauseated and rolling eyes up. Lied down on exam table and picked up legs due to becoming hypotensive. Place O2 at 2 liters nasal cannula, pt arouseable and opening eyes. Took VS, B/P 80/40, HR 74, Resp. 16. Provider PA evaluated pt and following simple commands. Pt able to drink fluids and drank 12 oz. Pt's mother states pt had been eating snacks prior to event. @ 04:20 Pt more alert and able to ambulate in room and hallway. Drank 6oz more of juice. Instructions given to parents on watching for any serious effects and take to ER immediately and if pt develops fever and given childrens acetaminophen. Event of vagal response lasting 5min. Pt home with parents.",,,,,,,,,Y,09/26/2019,09/27/2019,1,none,PUB,,none,none,none,,,2,09/27/2019,,,,none known
0837161,09/27/2019,CA,2.83,2,.9,M,,"the patient received by mistake the 2nd part of the flu shot 2 weeks earlier than the 4 weeks period after the first dose. Sanofi scientific department was consulted, no known history of serious complications. Mom was notified, no adverse reaction happened, the patient is doing good, mom was advised to monitor patient and return to the clinic or the ER if any new symptoms. staff recieved training to avoid that in the future.",,,,,,,,,Y,09/25/2019,09/25/2019,0,none,PVT,,,,,,,2,09/26/2019,,,,
0837162,09/27/2019,IL,75.0,75,,U,,"redness, heat, soreness",,,,,,,,,N,09/23/2019,09/25/2019,2,N/A,PHM,,unknown,N/A,unknown,,,2,09/27/2019,,,,N/A
0837220,09/27/2019,CT,58.0,58,,F,09/21/2019,Patient had a rash on arm and across chest - felt tongue tingle and went to Emergency Room,,,,Y,,,,,Y,09/19/2019,09/20/2019,1,,OTH,OTH,metformin  crestor lisinopril,no,allergic to cloves and mangoes,,,1,,,,,
0837221,09/27/2019,PA,79.0,79,,F,,"Flu-like symptoms next morning, which subsided gradually over the next week:  Felt very cold, sore muscles & joints, headache, weak and very tired. Also had diarrhea a day or so later. I felt ""unwell"" for a week or more.",,,,,,,,,U,09/06/2019,09/07/2019,1,,PHM,,"Synthroid Eliquis Multivitamin Glimepiride Metoprolol Calcium Vita B, D",,"Diabetes, A-Fib",,,2,09/23/2019,,Y,,CT Dye Iodine
0837222,09/27/2019,PA,78.0,78,,M,09/22/2019,"pt called to say after receiving vaccinations he had a fever of 102 degrees. no appetite, couldn't sleep for 5 days and had a bladder infection a few days later requiring Bactrim/Macrobid treatment",,,,Y,,,,,Y,09/13/2019,09/14/2019,1,,OTH,PUB,N/A,None,N/A,,,1,,,,,
0837235,09/27/2019,OH,66.0,66,,F,,Developed Red Swollen area around injection site that is approximately 4 inches x 6 inches. Did not start until following morning. Saw doctor was given Prednisone and Hydrocortisone topical.,,,,,,,,,,09/26/2019,09/27/2019,1,,PHM,,,,,,,2,09/27/2019,,Y,,NONE
0837236,09/27/2019,VA,52.0,52,,M,,Client given expired MMR. Physical there were no untoward veffects except having to repeat doses,,,,,,,,,,09/25/2019,,,N/A,PUB,,Unknown,0,0,,,2,09/27/2019,,,,0
0836735,09/28/2019,TX,40.0,40,,F,,"I received the vaccine on Tuesday 09/17. Later in the night I started running a fever, and nausea. The next couple of days that followed I was fighting the fever with ibuprofen and Tylenol. My arm started swelling and a lump the size of a baseball formed from fluid build-up and was very painful. I continued to treat this at home up until Saturday when I noticed a small rash on my right arm.  The following Sunday morning the rash had spread and was raised, and scattered. However, the swelling had gone down. The rash was very warm to the touch and holding heat. Later in the day, the rash spread even more. I could not sleep due to the pain in my arm and the rash was hot. I sought treatment at the ER/Urgent care and was diagnosed with Cellulitis.",,,,,,,,,Y,09/17/2019,09/18/2019,1,"The nurses took my vitals, DR did a physical exam of my arm, was given IV antibiotics Clindamycin, and Toradol for pain. Ran blood tests which noted my WBC was high as well. The DR was then able to determine it was not a hematoma, or allergic reaction. I also sent my DR the results and she asked if the injection site was cleaned. The pharmacist that administered the vaccine did not swab prior that I can recall.",PHM,,clonazapam,None,anxiety-no other chronic physical illnesses,,,2,09/28/2019,,,Y,None
0836736,09/28/2019,MN,70.0,70,,F,,"extreme chills, nausea, body aches--bedridden for the entire next day",,,,,,,,,Y,01/04/2019,01/04/2019,0,,PHM,,"Simvastatin, Vitamins C and D, Calcium, Glucosamine Condroitin, Miralax",none,none,,,2,09/28/2019,,,,Compazine
0836737,09/28/2019,OH,56.0,56,,F,,"Received vaccine 8/22/19.  I am experiencing muscle pain in the left deltoid (site of the vaccine) since then with decreased ROM and function due to burning, aching, throbbing pain if I move it in certain ways or lift heavy objects.  I cannot lay on the arm to sleep, I cannot move my arm behind me.",,,,,,,,,N,08/22/2019,08/23/2019,1,"No tests as of yet.  Completed a 14 day course of diclofenac which was effective while the medication lasted but as soon as it wore off, it was back to the same pain.  It seems to have gotten slightly worse as it is now bothering me to type whereas before the diclofenac, it didn't.",PHM,,"Metformin, Invokana, Januvia, Lisinopril, MVI, Allegra, Simvastatin, Effexor",No acute illnesses,"Diabetes, depression",,,2,09/28/2019,,Y,,None
0836738,09/28/2019,ME,51.0,51,,F,,"Patient called and said she had swelling and a rash on the area where the shot was give.  She reported no fevers, swelling in other areas, vomiting or diarrhea.   I instructed her to apply a compress as well as NSAID for swelling.  I also told her to keep an eye on the rash, use benadryl but call her provider if it doesn't start to fade in a few days.",,,,,,,,,U,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,09/28/2019,,,,morphine
0836739,09/28/2019,MA,1.0,1,.0,M,,Swelling of right parotid gland,,,,,,,,,U,09/25/2019,09/27/2019,2,,PVT,,,,,,,2,09/28/2019,,Y,,
0836740,09/28/2019,CT,60.0,60,,F,,"3 days after vaccine, developed bumps and rash on left side of neck. By 6 days had turned to blisters and rash, and was confirmed by dermatologist on 9/19 that I had developed shingles. Started Valtrax that night. On 9/26 noticed another line of red bumps on the other side of neck, almost exact same area as left side rash, and seem to be getting worse.",,,,,,,,,N,09/11/2019,09/14/2019,3,Dermatologist diagnosis shingles 9/19/2019 Dr,PHM,,"atorvastin, levoxathrine, magnesium, vitamin D, one-a-day",none,none,,,2,09/28/2019,,Y,,none
0836742,09/28/2019,GA,58.0,58,,F,,"UPON ADMINISTERING VACCINE, ARM IMMEDIATELY BEGAN TO SWELL AROUND INJECTION SITE. A HARD KNOT APPEARED BENEATH THE SKIN. PATIENT'S ARM BRUISED WITHIN 30 MINUTES AND WAS SORE FOR A FEW DAYS. PATIENT SAT FOR 30 MINUTES TO ENSURE REACTION WAS LOCAL, ADVISED TO USE ICE PACK FOR SORENESS.",,,,,,,,,Y,09/23/2019,09/23/2019,0,,PHM,,,,,,,2,09/28/2019,,,,
0836743,09/28/2019,MI,77.0,77,,F,,"Dizziness, Redness in face, Intense pain in back muscles, Shortness of breath with immediate onset.  Patient requested to lay on floor, Epi-pen was administered with patients approval. 911 was called.  Epi-pen worked well and patient was complaining of less back pain and shortness of breath.  Patient was released to go home.",,,,,,,,,Y,09/27/2019,09/27/2019,0,None,PHM,,"Xarelto, Levothyroxine, Keppra",None,"Stroke, Epilepsy",,,2,09/28/2019,,,,None
0836744,09/28/2019,NJ,70.0,70,,F,,"Extreme arm pain, from shoulder to elbow.  Couldn?t move arm.  Pain was so bad at times, it brought me to tears.  Became nauseous with pain.  Lasted for approximately 24 hours.",,,,,,,,,Y,09/23/2019,09/23/2019,0,,PHM,,"Metroprolol, 100 mg; Hydrochlorothiazide, 12.5 mg; multi-vitamin; caltrate; vitamin c",None,Palpitations,"Sore arm from 1st dose of Shingrix, but nothing like 2nd shot",,2,09/28/2019,,,,None
0836745,09/28/2019,CA,11.0,11,,F,,"She broke out in a mild ?non contagious? version of varicella. Began on leg in morning, then two on face by 5pm on 9/26, morning 9/27 woke with one on trunk under right breast, one mid neck in scalp, on way to school one popped up behind patient's ear, and in the time it took me to get to her two hours later, she had another behind her ear and three going down her back on the right side that itch. We were not around anyone with chicken pox, no one in our family has it.",,,,,,,,,N,09/12/2019,09/26/2019,14,Doctor visit with visual exam. On-hold labs for October to check titers to avoid giving the second shot.,PVT,,None,None,"None. However I didn?t want this vaccine because her little sister is immuno compromised from cardiac defects and aspirin therapy and the doctors refused to give a medical exemption, putting my youngest?s life at risk just so patient  could stay in school and not be suspended.","MMR, second booster, raised welt at injection site and fever",,2,09/28/2019,,Y,,Penicillin
0836746,09/28/2019,FL,54.0,54,,M,,Small red gives on underside of Left forearm. Tingling sensation.,,,,,,,,,N,09/27/2019,09/28/2019,1,None,PVT,,,None,"Diabetes type 2, sleep apnea, arthritis, allergic conjunctivitis",,,2,09/28/2019,,,,"Penicillin, Milk, Percocet"
0836747,09/28/2019,NJ,83.0,83,,F,,"PAtient noticed on the day of it was red, next day it was swollen, red was spreading and continuing to spread as of now, burning, itchy, warm, painful (pain scale 2)",,,,,,,,,N,09/26/2019,09/26/2019,0,,UNK,,"lisinopril, paroxetine",,hypertension,,,2,09/28/2019,,Y,Y,"iodine, penicillin, sulfur, iron, sulfa"
0836748,09/28/2019,IL,50.0,50,,F,,"Pt walked in day after vaccine to show local reaction: 5x7 area of firm redness, not overly tender or warm, do not suspect infection.  Arm is very sore but not with reduced range of motion use. Unknown how quickly the redness developed as patient did not see it until the Band-Aid was removed today.  Upon review of administrating provider's note, the pt was informed of all possible reactions and advised to wait in clinic area for 15 min for observation.",,,,,,,,,U,09/26/2019,09/27/2019,1,none needed,PHM,,none,none,none,,,2,09/28/2019,,Y,,none
0836749,09/28/2019,GA,65.0,65,,F,,"Overall body achiness, fever (max was 101 F.), depressed appetite, headache  Bed rest and aleve  Started feeling somewhat better around 6am Saturday, Sep 28  This was the second shingles shot. The first shingles shot (2018) caused similar reactions.  Additionally the 1st shot caused a very hard red reaction at the site of the shot.",,,,,,,,,Y,09/26/2019,09/26/2019,0,,PVT,,"Metformin, prilosec, simvistatin, aleve",none,"diabetes, high cholesterol,",1st Shingles shot in 2018,,2,09/28/2019,,,,"Mercurochrome, amoxicillin, ceclor"
0836750,09/28/2019,NC,84.0,84,,F,,"Patient received her 1st dose of the Shingrix series in the Left deltoid on 9/21/19, she said the next day her arm swelled up and became red and warm to touch. This then went away after about 24-36 hours but has come back on morning of 9/28/19. She came in to pharmacy to ask about reaction, her arm was red and warm to touch. I instructed her to take some NSAIDS (Ibuprofen) and an antihistamine and referred her to contact PCP to be examined for possible cellulitis infection.",,,,,,,,,U,09/21/2019,09/22/2019,1,,PHM,,Omeprazole,,,,,2,09/28/2019,,Y,,"Calcium, Celebrex abd Codeine"
0836751,09/28/2019,TN,,0,.0,F,,"Excessive sweating, respiratory distress, heart murmur, jaundice  Was in NICU for two weeks",,,,,,,Y,,N,02/05/2019,02/05/2019,0,,PVT,,VITAMIN K,,"Eczema, heart murmur, MTHFR 677, FUT2 non-secretor Norovirus immunity, Vit A deficiency, genetic marker for low B6 & B2 levels, tested positive for potential gluten intolerance, gene's associated with diabetes, insulin resistance and/or metabolic syndrome.",,,2,09/28/2019,,Y,,"Patient is Lactose intolerant, MTHFR 677 carrier"
0836752,09/28/2019,MO,50.0,50,,F,,"once I received the vaccination I didn't notice any adverse effects until about June, even then I didn't even think it had anything to do with the flu vaccination.  Symptoms, I had difficulty breathing, MAJOR muscle aches and constant fever and elevated liver enzymes.  I had my second flu inj.  a year late I got so bad liver functions elevated double. I went to see a cardiologist, I thought the shortness of breath was due to my heart also went to see a rheumatologist since my joints ached so bad. finally went to see (Dr. who is now retired) who documented my symptoms.",,,,,,,,,U,03/10/2016,06/01/2016,83,Lab work show elevated liver enzymes,PUB,,"acyclivir prn, albuterol prn, ibuprofen prn, adderall, losartan",n/a,asthma,,n/a,2,09/28/2019,,,,n/a
0836753,09/28/2019,NC,69.0,69,,M,,Patient received a flu shot at around 11:15 AM and called pharmacy at 12:00 PM stating that he was having an itchy feeling all over and swelling of face. I advised him to take Benadryl as soon as possible and get to urgent care to be evaluated. No difficulty breathing or mouth swelling at the time of speaking to him,,,,,,,,,U,09/28/2019,09/28/2019,0,,PHM,,Unknown,None,Unknown,,,2,09/28/2019,,Y,,NKDA
0836754,09/28/2019,FL,72.0,72,,F,,"The patient is complaining about a sore in the are of injection site (from the upper right arm to her elbow) starting one day after her injection. She does not have any fever, but complained about occasional headaches. She has taken ibuprofen to relieve from her pain. She still complains about her sore as of today (09/28/2019). She visited a walk-in clinic on 09/28/2019 and was prescribed doxycycline and medrol tablets.",,,,,,,,,N,09/25/2019,09/26/2019,1,N/A,PHM,,"ALPRAZOLAM, MONTELUKAST, STIOLTO, ADVAIR, DULOXETINE, VENTOLIN",N/A,N/A,,,2,09/28/2019,,Y,,NO KNOWN ALLERGIES
0836755,09/28/2019,PA,65.0,65,,F,,"Patient states that 2 days after vaccination, she experienced severe muscle and joint pain to the extent that she was unable to function or do her rehab therapy that she is doing post knee replacement.  She also experienced marked redness on the injected arm, on the forearm area.",,,,,,,,,Y,09/14/2019,09/16/2019,2,,PHM,,"Oxycodone IR 5 mg tablets, Methocarbamol 500 mg tablets",,osteoarthritis,,,2,09/28/2019,,,,NKA
0836756,09/28/2019,,53.0,53,,F,,"Major body aches,, chills and nausea. Missed 2 days of work.",,,,,,,,,,09/22/2019,09/23/2019,1,,UNK,,,,,,,2,09/28/2019,,,,
0836757,09/28/2019,,54.0,55,,M,,"Major body aches, chills, massive headache, eyeballs hurt for the next 6 days!! Missed 4 days of work. I have a massive headache today...not sure when I'm going to feel better! I will not be getting the second shot!",,,,,,,,,,09/22/2019,09/22/2019,0,,UNK,,,,,,,2,09/28/2019,,,,
0836759,09/28/2019,MA,57.0,57,,M,,Severe chills and fatigue headache,,,,,,,,,Y,09/27/2019,09/27/2019,0,,PHM,,,,,,,2,09/28/2019,,,,Sulfa
0836761,09/28/2019,AL,62.0,62,,F,,"Extreme soreness at injection site, flu-like symptoms: fatigue, significant body aches/pains, nausea, mild headache, overall malaise. Lasted evening of day 1 through day 3.  800mg ibuprofen gave nearly complete symptom relief.",,,,,,,,,U,09/26/2019,09/26/2019,0,,PVT,,,None,Ulcerative colitis,,,2,09/28/2019,,,,None
0836762,09/28/2019,CA,45.0,45,,M,,"Severe shoulder pain; complete inability to move the shoulder or any muscle in the left arm without EXTREME pain starting around 8pm (5-6 hours post injection.) Occasional numbness in pinky and ring finger. By mid morning the next day (14 hours post injection) I could move the arm but still with a good deal of pain and very limited range of motion. It is now 36 hours post injection and I cannot lift the arm to the side above 30 degrees without severe pain and I cannot reach behind me at all. I believe the nurse administered the shot into my shoulder joint, not the deltoid muscle. It was placed very high on the shoulder. I took a picture of the administration site for records at the request of medical clinic. They urged me to go to Urgent care, but I didn't want to incur the expense so I declined.",,,,,,,,,N,09/26/2019,09/26/2019,0,"None yet, I have an appointment Tuesday morning (in 2 more days.)",PVT,,Symbicort inhaler,"Asthma, well controlled. Neck pain.",only asthma and neck pain. Had both for decades.,,,2,09/28/2019,,Y,,Nexium
0836763,09/28/2019,OR,72.0,72,,F,,"varicella-zoster virus infection, abdomen; treatment = valacyclovir 1000 mg q 8 hr x 7 days began on 09/26/2019",,,,,,,,,U,09/20/2019,09/22/2019,2,"VZV PCR 09/26/2019, confirmed +VZV, sampled from vesicles at rash site",PHM,,"atorvastatin, fluoxetine, hydochlorothiazide, latanoprost ophthalmic solution, rizatriptan, timolol ophthalmic solution,",,"hypertension, high cholesterol, depression, tension headaches, migraine headaches, atrophic vaginitis",,,2,09/28/2019,,Y,,"Ciprofloxacin, nitrofurantoin"
0836764,09/28/2019,MI,69.0,69,,M,,"about 8 hrs. after the shot I contracted a fever, vomited, bowel movement, runny nose, at same time, felt as though i had the flu vert tired, and weak. could not eat or drink afterwords, went to bed, slept ok. got up this morning feeling like a ""a train ran over me"" now eating and recovering like I had the flu.",,,,,,,,,Y,09/27/2019,09/27/2019,0,n/a,PHM,,Crestor - Zetia - Hydrochlorothiazide - Omeprazole - Gabapentin  fish oil - Multivitamin - Benefiber,nothing,Chrones,,,2,09/28/2019,,,,none
0836765,09/28/2019,CA,0.33,0,.3,M,,"Sept 20- Received 4 month vaccines  had a rectal temp of 99.9  Sept 21- Went to the ER  for fussiness,  Bulging fontanelle, facial flushing, poor feeding.  temperature of 102 Sept 22- Continued fussiness, poor feeding fever all day high of 101 Sep 23- Fever over 100.5 continued fussiness poor feeding Sept  24, went to pediatrician for follow up advised to do sponge baths and tylenol. Sept 24-  fever over 101 sept 25 - return to pediatrician for fever over 100.5  for more than 2 days sept 26- went to ER for fever of 103  ER provided tylenol and fluids. babye has been fussy and crying for 3 hours straight each day",,,,,,,,,U,09/20/2019,09/20/2019,0,cbc spinal tap urine culture,PVT,,none,none,none,,,2,09/28/2019,,Y,Y,none
0836766,09/28/2019,IN,19.0,19,,F,,"4 hours after taking shot developed temperature of 106, severe headache and nausea. after taking generic Tylenol after 2 hours temperature went back to normal and headache and nausea went away.",,,,,,,,,Y,09/21/2019,09/27/2019,6,,PHM,,,,,,,2,09/28/2019,,Y,,gluten
0836767,09/28/2019,WA,78.0,78,,F,,"After injection, site bled. Cotton ball was used to apply pressure on site, then bandage was applied over site. Patient experienced injection site soreness afterwards, later on the date it developed to a bruise. 3 days post injection, soreness bothered so took a Tylenol at night to be able to sleep. Bruise has gotten darkened, purplish in color with edge yellowish, size of bruise ~1.5 inch in diameter. Full range of shoulder motion. No fever or other systemic symptoms other than the pain associated with bruise and neck sore/tightness. Suggested patient to apply cold compress, Tylenol as needed for pain and monitor symptoms and bruise. Recommended urgent care if symptoms worsen or new symptom(s) appear. Pharmacist will call patient's PCP to consult as well.",,,,,,,,,N,09/24/2019,09/24/2019,0,,PHM,,"amlodipine, benazepril, lovastatin",None,"hypertension, osteoporosis",,,2,09/28/2019,,,,None
0836768,09/28/2019,KY,72.0,72,,M,,"Patient received 3 immunizations at 7:15 pm on September, 27, 2019. He woke up at 1:15 am on September 28 ,2019 and went to the bathroom. When he returned to bed he had trouble breathing . It continued to get worse. He tried to sleep on his side and continued to get worse. He sat up in bed. At 1 :30 am he went downstairs and sat at his table and continued to get worse, shortness of breath , could not catch his breath and felt like he was being smothered. He called his wife and told he her that he  needed to go the the ER. He arrived at the ER AT 1:50 am and was immediately given an IV of Benadryl, solu-medrol and an albuterol breathing treatment.  His pulse ox was 86 and he was tachycardic. He brought 3 prescription to me at 9 am on September, 28. Prednisone 20 mg 1 bid #10, benadryl 25 mg 1 q 6 h #20, zyrtec 10mg  1 qd #5",,,,,,,,,Y,09/27/2019,09/28/2019,1,no test or  labs were performed,PHM,,"levothyroxine 225 mcg, tesosterone 1% gel",none,hypothyroidism,,,2,09/28/2019,,,Y,"levaquin, codeine"
0836769,09/28/2019,RI,74.0,74,,F,,patient says she could not get out of bed and feels a heavy weight on her chest,,,,,,,,,Y,09/27/2019,09/27/2019,0,,PHM,,not that im aware of,none,none that we're aware of,,,2,09/28/2019,,,,allergic to fentanyl
0836770,09/28/2019,TN,14.0,14,,M,,"Patient received flu shot. He has had flu shots in the past and has never fainted before. However, this time he had the flu shot and while his mom was checking out, he fainted in the aisle of store and hit his head on the shelf.",,,,,,,,,U,09/28/2019,09/28/2019,0,None,PHM,,Allegra,Seasonal Allergies,None,,,2,09/28/2019,,Y,,None
0836771,09/28/2019,NY,71.0,71,,F,,"Had chills upon awakening early Sunday AM after receiving the vaccine Saturday AM.  I took my temperature upon arising in AM at approx. 7AM --it was 100 orally.  I had overwhelming fatigue and malaise-- Went back to bed and slept for periods during the day.  Had no appetite --ate very little. Temperature came down as day proceeded..  The left arm was reddened and very sensitive to touch.  The week after the injection, the arm became less reddened and painful but this took many days",,,,,,,,,Y,08/24/2019,08/25/2019,1,None,PHM,,"Prilosec, Synthroid, Lipitor, Vitamin D, Vitamin E, MVI, Co Q 10, Biotin, Probiotic, Calcium,",None,"Tinnitus,  double vision due to 4th Cranial nerve problem, hypothyroidism, GI reflux,,  osteoarthritis, blood cholesterol elevation, osteoporosis",,,2,09/28/2019,,,,Tamiflu
0836772,09/28/2019,OH,66.0,66,,F,,Patient described a red and swollen area around the injection site roughly 4x6 inches. The affected area is also warm to the touch.,,,,,,,,,U,09/27/2019,09/27/2019,0,,PHM,,Unknown,None,None,,,2,09/28/2019,,,,PCN
0836773,09/28/2019,CA,6.0,6,,F,,"My son was taken to get a standard flu shot on September  26, 2019 around 5 pm. Later that night I noticed swelling and redness around the injection site around an inch in diameter. The next morning his injection site had a huge red, swollen welt about the size of a baseball or 3.2 inches in diameter. I added a cold compress to try and relieve his swollen arm but nothing happened. By day three, today, we took him back to office and they told us he had an allergic reaction to the injection and to apply a cold compress again and they prescribed him benadryl. Words cannot fathom what my son is going through right now. He is starting to blister where the injection site is. He is never to get another flu shot again.",,,,,,,,,N,09/26/2019,09/26/2019,0,,OTH,,None,None,None,,,2,09/28/2019,,,Y,None
0836774,09/28/2019,MO,82.0,82,,F,,"Patient received both pneumovax 23 and fluzone hd on 9/26 in left arm, one inch for each other. patient came in on 9/28 stating that her left are was swollen and hot. When looking at her arm, most of her upper bicep was red. She stated that it did not hurt. She stated that she was taking an NSAIDs to help with swelling and had applied cold compress. I instructed her to contact pcp asap and then to let us know the result of the conversation and to go seek medical treatment if get worse.",,,,,,,,,N,09/26/2019,09/27/2019,1,,PHM,,,,,,,2,09/28/2019,,Y,,
0836775,09/28/2019,,71.0,71,,M,,Patient reports temporary loss of muscle function (he could not get out of bed); when he gained strength back and got up he felt very weak and dizzy. He has a follow-up appointment with his primary care doctor in a couple weeks.,,,,,,,,,U,09/24/2019,09/24/2019,0,,PHM,,Lansoprazole 15 mg 1 capsule twice daily; Hydrochlorothiazide 25 mg 1 tablet daily; Irbesartan 300 mg 1/2 tablet twice daily,,,,,2,09/28/2019,,Y,,
0836776,09/28/2019,MI,68.0,68,,F,,"Patient reported the day after injection: muscle soreness at injection site, fatigue, nausea, upset stomach, low pulse rate and dizziness that subsided after 1 day. After 3 days, patient reported developing severe joint swelling in right knee, right ankle, and pain hip. Patient also developed shingles type rash on back, buttock, and down right leg. Patient went to urgent care on Day 8 post injection and PA diagnosed rash as shingles.",,,,,,,,,N,09/20/2019,09/21/2019,1,,PHM,,"Enbrel, Nabumetone",No acute illness,"Rheumatoid Arthritis, managed with Enbrel",,,2,09/28/2019,,Y,,None
0836778,09/28/2019,FL,75.0,75,,F,,Patient began experiencing pain within a few hours after vaccination.  Treated with tyenol. Arm was very swollen and red by morning. Pt visited physician and measured arm for swelling. Arm was not swollen enough for emergency room but was very swollen and painful. Physician treated with rx for Septra DS and otc Zyrtec and Benadryl. The patient began improving over the course of the next few days but is still not returned to normal.,,,,,,,,,N,09/23/2019,09/23/2019,0,n/a,PHM,,,,hypertension,,,2,09/28/2019,,Y,,no
0836780,09/28/2019,IL,55.0,55,,F,,"Pt stood up after receiving second vaccine (Boostrix) and stated she felt a little light headed.  Pt sat back down then lost consciousness after about 15 seconds.  Pharmacy placed ice pack on the back of her neck, called her name, checked breathing, and called 911.  After 15 seconds, pt briefly regained consciousness but was incoherent, pt lost consciousness again for about 10 seconds.  Then pt regained consciousness and was given some water.  The EMTs arrived within 10 minutes and evaluated the patient.  Pt refused to go to hospital and left the pharmacy at about 10:30 am under her own power with her husband.",,,,,,,,,Y,09/28/2019,09/28/2019,0,none,PHM,,Levothyroxine 50 mcg,none,hypothyroidism,,,2,09/28/2019,,,,NKA
0836781,09/28/2019,,4.0,4,,F,,patient's mom is saying the inject site is red and swollen and hot to the touch. she states there is a perfect red circle around where the needle was put in.,,,,,,,,,,09/27/2019,09/28/2019,1,,UNK,,,,,,,2,09/28/2019,,,,
0836782,09/28/2019,OH,62.0,62,,M,,Hematoma at injection site/ swelling. no pain minimal redness.,,,,,,,,,U,09/28/2019,09/28/2019,0,,PHM,,"aspirin, flu shot administered in other arm",,,,,2,09/28/2019,,,,none disclosed
0836783,09/28/2019,OR,4.0,4,,M,,"Pt received varicella injection on 9/25. Father handed pt on to pt's mother then got him back on 9/28 at which time father noted 3""x2""  size swelling on left thigh where Varivax was given. Father unsure when symptoms started as mother did not communicate any concerns. No fevers noted at time of call on 9/28. Father also notes that lympth node in left groin is inflamed. Appears to be tender to touch.",,,,,,,,,N,09/25/2019,09/25/2019,0,None,PVT,,unknown,No,Global developmental delay,,,2,09/28/2019,,,,NKA
0836784,09/28/2019,TN,77.0,77,,F,,extremely red sore swollen painful shoulder,,,,,,,,,Y,09/15/2019,09/15/2019,0,unknown,PHM,,sertraline 100mg montelulast 10mg benazepril eliquis meloxicam atrovastin,unknown,unknown,,,2,09/28/2019,,,,unknown
0836785,09/28/2019,,72.0,72,,F,,"extreme chills, fever 101.8F, Advil 24 hour duration",,,,,,,,,Y,09/26/2019,09/26/2019,0,,UNK,,,,,,,2,09/28/2019,,,,
0836786,09/28/2019,OR,68.0,68,,F,,"Itching in right arm, 101.6 degree fever, muscle aches, join paint, large red lump on right arm",,,,,,,,,Y,09/25/2019,09/25/2019,0,none,PHM,,"morphine Sulfate, duloxetine, tizanidine, duloxetine, hydrochlorothiazide, multivitamin, vitamin d, Zyrtec, Align probiotic",None,chronic pain due to failed back surgery,flu shot in 2004 had similar reaction,,2,09/28/2019,,,,Amoxapine and related augmentin
0836787,09/28/2019,SC,69.0,69,,F,,"Headache, fever (as high as 102.2), shivers, extreme muscle aches, 36  hours,  Pharmacy recommended Tylenol.  Injection site developed hand-sized welt (still there Saturday night (80 hours later).",,,,,,,,,Y,09/25/2019,09/26/2019,1,None,PHM,,"Singulair, Celexa, Tylenol",None,"Tendon, cervical spinal disc problems",,,2,09/28/2019,,,,"IV contrast (redialing 240), iodine, Avelox, sulfamethoxazole, trimethoprim, inderal,augmentin"
0836788,09/28/2019,AZ,30.0,29,,F,,"Patient received vaccine at workplace.    Symptoms started at night: area started getting knotted, turned red, turning like a bruise and stiffness on arm and neck.  Next morning, symptoms worsen; a 4 inch bruise started to spread from injection site--on back of arm and bottom of arm. Area was hot--like fever.    At work doctor thought it could be an infection.  Patient called PCP and also went to employee health.  They gave patient an steroid cream and use of ice packs.  The cream was helpful and inflammation decreased.   Today, there is a little bit of redness on vaccine injection; it doesn't hurt to touch anymore.   Stiffness in arm is almost gone. In terms of recovery, at 95%, symptoms almost resoved",,,,,,,,,Y,09/24/2019,09/24/2019,0,,PVT,,No,Not sick at the time but had a small cold that lasted 2 days within 30 days,No,,,2,09/27/2019,,Y,,Cephalexin
0836789,09/28/2019,CA,31.0,31,,F,,"PATIENT REPORTS ON DAY OF THE VACCINATION, SHE FELT NAUSEOUS, SORENESS, MUSCLE ACHES IN THE LEGS. PATIENT MENTIONED THAT SHE BLACKED OUT IN THE EVENING AFTER HER FLU SHOT AND WAS UNABLE TO SLEEP THAT NIGHT. THE NEXT DAY PATIENT STATES THAT SHE WAS STILL GETTING NAUSEOUS WHILE STANDING UP.",,,,,,,,,Y,09/27/2019,09/27/2019,0,,PHM,,NO INFORMATION AVAILABLE,NO INFORMATION AVAILABLE,,,,2,09/28/2019,,,,NO INFORMATION AVAILABLE
0836790,09/28/2019,TX,65.0,65,,F,,PT HAD DEVELOPED RASH UNTIL HER ELBOW ALL AROUND THE ARM AND WAS INF LAMMED FOR 3 TO 4 DAYS,,,,,,,,,Y,09/20/2019,09/21/2019,1,N/A,PHM,,"TAMOXIFEN,ATENOLOL, BENAZEPRIL/HCTZ",NO,N/A,,,2,09/28/2019,,,,"QUINOLONES, CEPHALOSPORINS, SULFA DRUGS"
0836791,09/28/2019,TX,59.0,59,,F,,"Horrible pain at the site of injection, spreading to entire arm, neck, shoulder and back.  High fever 103+ shivers, body aches.  Still sick.",,,,,,,,,N,09/27/2019,09/28/2019,1,,PHM,,"Liothyronine mcg, Lisinopril 20 mg, , levothyoxin 50 mcg",none,Low thyroid,,,2,09/28/2019,,,,no.
0836792,09/28/2019,PA,23.0,23,,M,,syncope,,,,,,,,,Y,09/28/2019,09/28/2019,0,,PHM,,not known,none,none,,,2,09/28/2019,,,,unknown
0836793,09/28/2019,MN,67.0,67,,M,,Patient states the day of he just had soreness in the arm. The next day however he had a lot of swelling and he said he slept for about 30 hours. He went in to see his doctor for a stress test and the swelling had started coming down and the doctor just told him to monitor it but that it should go continue to go away.,,,,,,,,,Y,09/25/2019,09/26/2019,1,none,PHM,,,bad head cold,,,,2,09/28/2019,,Y,,
0836794,09/28/2019,SC,68.0,68,,F,,"shortly after administration, patient became diaphoretic and dizzy.  patient, while sitting, lowered head but did not relieve.  She sat upright, became unresponsive to verbal direction.  911 was notified and then while patient's husband and I were moving patient to a prone position on the floor, patient fainted.   Patient regained consciousness within 15-20 seconds.  Patients vitals were checked afterwards and were within normal ranges.  Paramedics arrived, checked vitals and glucose - all within normal ranges.  Patient declined transportation to hospital but remained at pharmacy for another 15 minutes as she continued to feel better and regained strength.  Contacted patient about 6pm this evening and she felt fine at that time.",,,,,,,,,Y,09/28/2019,09/28/2019,0,,PHM,,unknown,none,none,,,2,09/28/2019,,,,none
0836795,09/28/2019,CA,76.0,76,,M,,"Approximately 8 hours after the flu shot, the patient developed a fine red rash on his chest and upper back, no itching, pain or discharge.  Pt had facial flushing and a ""racoon"" like red rash under eyes. Slight fever 99.1 F, slight swelling and itching at sight of injection.  All symptoms lasted approx 24 hours except the site reaction lasted about a week.  Pt's  primary care MD contacted 9/17/2019 who recommended tylenol 325 mg bid for 2 days...tol well.  Pt had this same vaccine for several years prior without any reaction.",,,,,,,,,Y,09/16/2019,09/16/2019,0,None,PHM,,none,none,asthma,,,2,09/28/2019,,,,none
0836796,09/28/2019,CA,4.0,4,,M,,Inability to walk upstairs the night of the shots.  He had to be carried.  Intense pain in his thighs where the injection took place.  Horrible rash all over back and abdomen. Enlarged lymph nodes. Went to pediatrician and dermatologist and was given amoxicillin.  Awful rash continued for 2 weeks and then cleared.,,,,,,,,,Y,07/11/2017,07/12/2017,1,7/21 seen by dermatologist and tested negative for chickenpox.,PVT,,none,none,none,,,2,09/28/2019,,Y,,none
0836797,09/28/2019,NY,83.0,83,,M,,"3 days later rash started from top of feet to waist on both legs.  There are pronounced rash is like if was shot with BB guns.  It tingles like crazy just like shingles. On 9/23 had pre-scheduled appointment with dermatologist for something else.   For the rash, the doctor prescribed (triamcinolone acetonide cream); hives improved but it  took away the itching and tingles.    Started using cream yesterday. At 75% recovery, rash has improved; has residual elevated red bumps like if bitten by several hundred mosquitoes.  Patient has follow-up appointment with dermatologist for a different condition.  Patient was part of shingle trial.",,,,,,,,,U,09/16/2019,09/19/2019,3,,PHM,,No,No. No,"Low grade leukemia,",,,2,09/26/2019,,Y,,No
0836798,09/28/2019,CA,53.0,53,,F,,"Patient received the first dose of Shingrix on 9/21/19. She started having sensation on the left side of upper back on 9/24/19. Patient stated that she had shingles break out on the front and the back of left side of upper torso years back. On 9/25/19, she felt pulsating sensation which intensified with hot and burning  feeling on the following day (9/26/19). She visited doctor's office and was diagnosed with shingles.",,,,,,,,,U,09/21/2019,09/24/2019,3,,PHM,,,,,,,2,09/28/2019,,Y,,
0836799,09/28/2019,,75.0,75,,M,,"Left facial paralysis the day after vaccine was administered. Droopy left eye, watery left eye, droopy left side of mouth.",,,,,,,,,U,09/25/2019,09/26/2019,1,,PHM,,,,,,,2,09/28/2019,,,,
0836800,09/28/2019,TX,75.0,75,,F,,"Arm was swollen and sore after vaccination.  Laid down to rest and fell sleep.  Next day felt terrible all day;  tried to sleep but couldn't.  Last night slept 13 hours straight.   Feels out of norms, has chills on and off.   Patient had problems sleeping because joints pain on ankles, left hip and back of calf, middle of back.  Took 1 Tylenol to help with symptoms.   On Tuesday couldn't even walk.   Started taking 2 Acetaminophen every 6 hours because in excruciating pain.    Today called the doctor and has appointment with orthopedic doctor tomorrow.   This year symptoms were worse than in past years.",,,,,,,,,U,09/19/2019,09/19/2019,0,,PVT,,"Topomax, Ensure, Magnesium, Vitamin D, B complex",Allergies and swollen glands,Hips pain flairs up in the fall after Flu vaccine; it bother her at night,Flu: hip pain,,2,09/26/2019,,Y,,"Pain medications, Sulfur, Iodine, proprofol"
0836801,09/28/2019,CA,4.0,4,,M,,"NOTE: DTaP #5 and IPV #4 was the first time this specific combination vaccine noted above was given to this patient.  Mom had wanted the 4 year vaccines for patient to be given with DTaP-IPV and MMR on 9/25/2019 AND the Varicella vaccine to be given 1 month later. However, when they came for the nurse visit with dad, he was given all three at one time by the MA who was not aware of mom's preferences, and there was no objection by dad to doing all three at one time.  ~1 hour afterwards, when mom saw patient, she felt he had a blank stare on his face and was not responding to mom.  She felt he did not look with it.    Last time he got the vaccine he had regression of his milestones and stopped making eye contact and stopped talking.  He just finally started getting better.  Mom is terrified that he is regressing again or WILL regress again.  Rash and redness of the anterolateral thigh developed on 9/26/2019. RASH DESCRIPTION: Red blotchy rash on left thigh - large Chickenpox like rash - looked like vessicles (fluid filled blisters) on a red base, some popped and started scabbing.  Initially on shins, arms and neck. On 9/27/2019, when patient was brought to clinic, more lesions had developed.  ASSOCIATED SYMPTOMS/ROS (all started on 9/26/2019): Some aggression - pushing more than normal 3 accidents while previously potty trained. Pushing more buttons repeatedly, has not done this for a long time before this last set of vaccines.. More dazed than normal, seems more fatigued than normal. Per patient, he is feeling better on 9/27 than he was on 9/26. He continues making eye contact, responding to questions and remains alert.  Mom concerned he has a possible underlying inflammatory process/problem.",,,,,,,,,U,09/25/2019,09/25/2019,0,,PVT,,None,Autsim Morbid Obesity,Autism Morbid Obesity,"9/30/2016 - 12 months/6 days, developed loss of milestones, loss of eye contact, less interactive, and autism like behaviors. Su",,2,09/28/2019,,Y,,None
0836802,09/28/2019,MI,46.0,46,,F,,"Large, raised, hard red welt x2 days so far.  3"" x 2"".   Extremely painful.  Very hot at welt.  Chills, body aches, full body pain, feverish,  sensitivity to cold, all over weakness.",,,,,,,,,N,09/26/2019,09/27/2019,1,None,PHM,,"Strattera, Cortef,  wellbutrin, protonix, norco.",None,"Adrenal Insufficiency,  lupus, common variable immune deficiency",,,2,09/28/2019,,,,None
0836803,09/28/2019,NM,72.0,72,,F,,pt reports itchy rashy some pain on arm following 2nd dose  getting better but would like incident reported,,,,,,,,,N,09/15/2019,09/15/2019,0,,PHM,,,,,,,2,09/28/2019,,,,
0836804,09/28/2019,CA,60.0,60,,F,,Chills in the morning followed by fever (ranging from 99.9-100.6). Muscle ache (full body). Headache. Stomach pain. Weakness.  So far it has been 24 hours and symptoms are continuing.,,,,,,,,,N,09/27/2019,09/28/2019,1,"None.   I am staying in bed.  Today is Saturday. If I am not better on Monday, I will consult my physician.",PHM,,Zonisamide 200 mg once per day for migraines.,None.,Migraines.,,,2,09/28/2019,,,,None
0836805,09/28/2019,CA,1.0,1,.0,M,,"He was wheezing, tired, sick, lethargic for weeks, fever, no energy, flushed, got pneumonia, upper respiratory infection, ear infection, was out on albuterol again, was hospitalized.",,,,,Y,5,,Y,N,08/19/2015,08/20/2015,1,They did every single test known to bed. Blood work which showed his WBC was extremely low. He wouldn?t even eat. This al happened between 8/19/25-10/31/16 they couldn?t give me a straight answer. They said it was just a ?virus? but is wasn?t. They told me he was leukemic  like.,PVT,,"He was put on Zantac, albuterol, amoxicillin, he has numerous reactions to all of his vaccines. I just didn?t connect it until he was hospitalized.",Besides having chronic pneumonia and upper respiratory infections from previous vaccines. He never had issues. Just each time he received a vaccines he got sicker and sicker.,"Chronic asthma, chronic cough, also had shown signs of ADHD",,,2,09/28/2019,,Y,Y,Dairy. All dairy and soy. All seasonal allergies as well. Hay fever etc.
0836806,09/28/2019,TX,58.0,58,,F,,redness initially which progressed to swelling from shoulder to elbow,,,,,,,,,U,09/26/2019,09/27/2019,1,,PHM,,,unknown,none listed on profile,,,2,09/28/2019,,Y,,unknown
0836807,09/28/2019,TX,65.0,65,,F,,"4 consecutive days of fever, extreme soreness in arm of injection site, bright red heated rash on arm of site, itchiness",,,,,,,,,N,09/25/2019,09/25/2019,0,,PHM,,,,Osteoporosis,,,2,09/28/2019,,,,
0836808,09/28/2019,NY,6.0,6,,M,,"he woke up on 9/11/19 with bad stomach pains and diarrhea  9/12/19 came home from school with 101 fever  middle of the night woke up burning up, crying, yelling, thrashing, screaming and trembling.  He was delirious and having hallucinations.   This continued 9/13/19  and 9/14/19",,,,,,,,,Y,09/04/2019,09/11/2019,7,Went to the pediatrician on 9/13.  He didn't have any fever in the day and dr. said it was a side effect,PVT,,,He received his first vaccination ever on 8/20/2019 - Hep. B,none,,,2,09/28/2019,,Y,,no
0836809,09/28/2019,TN,64.0,64,,F,,"Severe headache, muscle aches,fever, chills lasting for 15 hoursnone",,,,,,,,,Y,09/28/2019,09/28/2019,0,,PHM,,"Rovastatin, amlodipine",None,"High blood pressure, high cholesterol",Zostavax,,2,09/28/2019,,,,None
0836810,09/28/2019,NV,66.0,66,,M,,patient experienced itching in the whole body with breathing difficulty,,,,,,,,,Y,09/27/2019,09/28/2019,1,,PHM,,none,,,,,2,09/28/2019,,,,
0836812,09/28/2019,FL,66.0,66,,F,,"patient came back saturday after receiving a flu and pneumovax shot on thursday night. she complained of pain, redness, swelling and she calims she had a fever as well. Told her to try some benadryl tonight and if that doesnt help the redness and swelling then to go see the doctor tomorrow. Tylenol for fever if it is present.",,,,,,,,,U,09/26/2019,09/27/2019,1,,PHM,,unknown. patient has no medication on her profile,unknown but not mentioned when patient came,nothing on profile so unknown,,,2,09/28/2019,,,,no allergies on profile.
0836813,09/28/2019,WA,81.0,81,,F,,Severely sore arm progressing to neck and back over a period of four days.,,,,,,,,,U,09/26/2019,09/26/2019,0,None,PHM,,"Levothyroxine, rosuvastatin, furosemide, metropolol, oxcarbazepine, vitamin D, Benadryl",One,High blood pressure,,,2,09/28/2019,,,,"Tylenol, sulpha, codeine"
0837237,09/28/2019,OH,72.0,72,,M,,"PATIENT RETURNED TO STORE 4 DAYS LATER TO ASK ABOUT LARGE YELLOW/PURPLE BRUISE ON LEFT DELTOID. PATIENT STATED THAT IS STARTED TO HURT THE DAY AFTER INJECTION AND STARTED TO BRUISE. PATIENT STATED NO NUMBNESS OR TINGLING AND NO KNOW SWELLING TO AREA, JUST TENDERNESS.",,,,,,,,,U,09/24/2019,09/25/2019,1,NONE,PHM,,"ATENOLOL, AMLODIPINE, CRESTOR, GLIMEPIRIDE, TRADJENTA, VIT D3",,"BLOOD PRESSURE, HEART, DIABETES",,,2,09/28/2019,,,,NONE
0837238,09/28/2019,AZ,74.0,74,,F,09/28/2019,"PT DEVELOPED WHEEZING, SOB AND FELT HER THROAT CLOSING. SHE TOOK BENADRYL AND ALL SX RESOLVED BY NEXT MORNING",,,,,,,,,Y,09/27/2019,09/27/2019,0,,OTH,PUB,"LIPITOR, SYNTHROID, NORVASC, ACYCLOVIR, PEPCID",,,,,1,,,,,
0837427,09/28/2019,MO,79.0,79,,F,,"Redness started 2 days after shot given, by evening the redness had grown to an estimated 4 inch area with heat",,,,,,,,,U,09/26/2019,09/28/2019,2,,PHM,,,,,,,2,09/28/2019,,Y,,
0836814,09/29/2019,WA,28.0,28,,F,,"I, am writing this report in the voice of the patient, as dictated to me by her. She was 32 weeks pregnant when she had the Dtap vaccine. The paperwork she was given regarding the vaccine just indicated Dtap vaccine, with no additional information regarding manufacturer, etc. She got very sick. Her symptoms did not improve over time. She felt exhausted and toxic. She had chills and hot flashes. Her baby died at 3 1/2 weeks later.    Tuesday 8/27/2019:   I went to my normal, scheduled prenatal visit for my 32 week check-up. I was healthy, feeling good and strong. My OB Dr suggested I have the Dtap vaccine. He told me about the side effects. I told him I didn?t want it, that I don?t like taking any medicines or drugs and was worried about the side effects on my baby. I said that I did not have it for my two other pregnancies and everything went well, no problem. He told me it was necessary, not only to protect my baby but to protect the other babies in the hospital when I gave birth. He said all the other moms were getting it. So I said okay. They gave me the vaccine.   Wednesday 8/28/19:  The next day, Wednesday, I woke up feeling really sick. I felt like I had a fever, but I didn?t, though I was having hot flashes. My arm was very sore. I couldn?t raise it. It hurt too much to sleep on. I felt exhausted. I had a sore throat and runny nose. The injection site on my arm was very painful, and felt numb. Couldn?t sleep on it. painful inside. The sickness never got better. It didn?t go away. I just took things day by day, thinking I would feel better soon.   Thursday 9/12/19:  I went in for my next prenatal appointment, my 34 week check-up. I told the doctor about my symptoms since they gave me the vaccine injection. He said it was normal and maybe I had a cold or flu. My body still felt very weird, tired, sick, weak, hot flashes, chills. It never went away. We scheduled a routine ultra sound for Sept 18th. At 20 weeks pregnant, the routine ultrasound had shown a possible low lying placenta.   Wednesday 9/18/19:  I had the ultrasound. It showed no problem. The placenta was in the right position and everything was normal. Everything was good. I heard the baby?s heartbeat. It was strong and good. No problems. But I was still feeling sick.   Sunday 9/22/19:  The baby wasn?t moving. I felt something was wrong. I went to the emergency that was close to my house. They did an ultrasound and found that there was no heartbeat. They said the baby was dead. They told me to go home and rest. I was almost 36 weeks. They said to call my doctor and schedule an appointment with him at Hospital for the next day.   Monday 9/23/19: I checked into Hospital. I saw Dr. He induced labor in the afternoon.          Tuesday:  I gave birth near 5 pm, a baby girl. She weighed 5 lbs 4 oz. No cord wrapped around her neck. No bleeding. Everything seemed very normal. She looked perfect, no abnormalities and a good size for 36 weeks. They put her on my chest. She stayed with me until I left the next day afternoon   They asked if I wanted an autopsy. They said it would be helpful to understand what happened and why the baby died. I agreed. The baby is now at Hospital undergoing the autopsy.  Wednesday 9/25/19: I checked out of hospital and went home.    Follow up postpartum appointment:  Mon Sept 30   My due date was:  Oct 22, 2019",,,,,Y,3,,,N,08/27/2019,08/28/2019,1,Ultrasound 9/22/2019: determined the baby was dead,PVT,,none,none,none,,,2,09/29/2019,,Y,Y,none
0836815,09/29/2019,VA,18.0,18,,F,,fever seizure,,,,,,,,,Y,09/27/2019,09/28/2019,1,,PVT,,zofran Zoloft,,pots hashmotos,,,2,09/29/2019,,,,penicillin tree nuts tree fruit seeds shellfish mustered
0836816,09/29/2019,MI,47.0,47,,F,,Body chills Fever rose to 102 with use of ibuprofen (200 mg) Fever is down to 100 this morning,,,,,,,,,Y,09/28/2019,09/28/2019,0,None,PHM,,Symbicort Montelukast  Levocetirzine,"1week prior,  minor cold. No fever",Asthma  Allergies,,,2,09/29/2019,,,,No allergies to medicine Allergies to some food (secondary from allergies to pollen) - not allergic to egg
0836817,09/29/2019,,61.0,61,,F,,"Sore arm, headache, nausea, muscle soreness",,,,,,,,,N,09/27/2019,09/27/2019,0,,PHM,,Synthroid; Trintelix,,,,,2,09/29/2019,,,,Tree nuts
0836818,09/29/2019,VA,60.0,60,,F,,Right arm tingling and numbness from injection site down; right hand cooler than left hand,,,,,,,,,N,09/09/2019,09/10/2019,1,,PVT,,NONE,NONE,NONE,,,2,09/29/2019,,,,NONE
0836819,09/29/2019,GA,60.0,60,,F,,"Injection site very sore and hard within 2 hrs.  Took Tylenol.  Then headache around 4 hrs. Rest and took warm shower.  Total body aches and chills at 10 hours or so.  Took 2 Advil.   Then by 11 PM my skin from my shoulder blades down to mid thighs was very sensitive to touch like it was on fire.    At 22 hours now, full body soreness and stiff, continue to have headache , took 2 Advil.",,,,,,,,,N,09/28/2019,09/28/2019,0,,PHM,,Levothyroxine 75 mg.,None,None,"1st dose if Shingrix, but not as bad. Didn?t have any reaction on skin.  Had also disappeared by the next morning.",,2,09/29/2019,,,,"Crawfish, horses and fire ants"
0836820,09/29/2019,MD,71.0,71,,F,,"Difficulty breathing, onset of acute asthma symptoms with persistent coughing and mucous.  started at 8:45 PM",,,,,,,,,N,09/27/2019,09/27/2019,0,POX 96.  Peak flow 250 (normal 400),PHM,,"Gabapentin, Clonazepam, Zolpidem, Alprazolam,Acebutolol,",None,"Asthma, Chronic Viral Meningitis, RLS, SVT, GERD, Migraines, Stage 3 renal disease",,,2,09/29/2019,,Y,,"Latex,Sulfa,Levaquin,Tobramycin,NSAIDS"
0836821,09/29/2019,FL,72.0,72,,M,,"Patient came to the pharmacy 3 days after immunizations were given, the injection site was swollen and red and reached down to his mid forearm.  Pt stated that he felt sick went to the ER a few days prior to get treated.  He was given benadryl, fluids, and a course of bactrim.",,,,,,,,,Y,09/21/2019,09/22/2019,1,,PHM,,"omeprazole 40mg, tramdol 50mg, simvastatin 10mg,",,"elevated cholesterol,",,,2,09/29/2019,,,Y,
0836822,09/29/2019,CO,59.0,59,,F,,"Onset less than 12 hours after vaccination: SEVERE CHILLS; DRY COUGH; INABILITY TO WARM; STABBING AND SHOOTING PAIN IN RIGHT LEG, RIGHT HIP, RIGHT SHOULDER, EPISODES OF HEART RACING; CHEST PAIN; NAUSEA; EXTREME MUSCLE WEAKNESS; SEVERE BODY ACHES. RED FACE/FLUSHING OF FACE. Onset 24 hours after vaccination: NIGHT SWEATS.  EXTREME FATIGUE.  GREAT EFFORT TO WALK DOG AND TO SHOWER. Saw PA in doctor's office for other matter on same day but Shingrix vaccine administered at the Pharmacy, 2 hours after doctor visit.  Currently have scheduled visit with M.D. on Oct. 1st.",,,,,,,,,U,09/27/2019,09/28/2019,1,,PHM,,single dose of Lasix,none,none  Excellent health,,,2,09/29/2019,,,,none
0836823,09/29/2019,VA,37.0,37,,F,,"Flu-like symptoms: achy joints, sore muscles, severe headache, high fever (106 at the highest), swollen lymph nodes in underarm of arm where vaccine was given. I was very tired, felt horrible,and had trouble staying awake for any length of time during the day after I got the vaccine. This was my second Shingrix vaccine, and the side effects were worse with this one than the first one.",,,,,,,,,Y,09/27/2019,09/28/2019,1,NONE,PHM,,"Lyrica, Adderall, Norco",NONE,"Attention deficit disorder, nerve pain in neck from bulging discs","Herpes Zoster vaccine, Shingrix, first dose recieved 5/10/19, 37 years old. Side effects: flu-like symptoms, achy joints and sor",,2,09/29/2019,,,,NONE
0836824,09/29/2019,PA,80.0,80,,F,,"The patient received the shingles shot and about 2 hours later started experiencing arm pain where she was vaccinated. The arm pain continued to get worse and 2 days later the patient saw her PCP because she could barely move her arm. Her PCP referred her to an orthopedic doctor who diagnosed her with ""frozen shoulder"" and prescribed a short course of weekly physical therapy for the patient. The patient is expected to fully recover and says her arm is almost back to full range of motion and normal as it was before the vaccine.",,,,,,,,,U,09/07/2019,09/07/2019,0,Unknown as of present time,PHM,,"Atorvastatin 10 mg tab, metoprolol tartrate 25 mg tab, furosemide 20 mg tab, alendronate 70 mg tab, alprazolam 0.5 mg tab, potassium citrate 1080mg tab",none,none,,,2,09/29/2019,,Y,,none
0836825,09/29/2019,SC,63.0,63,,F,,Patient had swelling and redness in arm where injection was given.,,,,,,,,,U,09/25/2019,09/25/2019,0,,PHM,,,,,,,2,09/29/2019,,Y,,
0836826,09/29/2019,TX,56.0,56,,M,,"Patient broke out in a severe rash with itching on right arm, left elbow and private area about 5 hours after administration. Rash has resulting in oozing wounds with scratching as well.",,,,,,,,,N,09/28/2019,09/28/2019,0,,PHM,,,,,,,2,09/29/2019,,Y,,"PCN, Sulfa Drugs, Cedar"
0836827,09/29/2019,NY,72.0,72,,M,,"Patient stated that when he left the vaccination area, he felt a pain in his lower right back. He stated he has had muscular issues in that area before, but this felt like a nerve pain radiating up his back. He said within 5 minutes all pain was gone. He thought it may have been due to the vaccination.",,,,,,,,,Y,09/27/2019,09/27/2019,0,n/a,PHM,,,,,,,2,09/29/2019,,,,none
0836828,09/29/2019,TN,74.0,74,,F,,"Patient called complaining about fever that lasted more than 24 hours and pain all over. Also had a very large blister around the injection site. On 09-29-2019, talked to patient and she no longer has fever or aches and site blister getting better.",,,,,,,,,U,09/25/2019,09/01/2019,,Advised patient to apply cold compressions and hydrocortisone to site and take Tylenol for fever.,PHM,,,None,,,,2,09/29/2019,,Y,,NKA
0836829,09/29/2019,CO,75.0,75,,F,,"Pt woke in the middle of the night with lots of pain in the vaccination arm, and a near inability to move it due to the pain. The patient got mild relief from Tylenol. Pt was instructed to continue dosing Tylenol, as the pt was now able to move the arm, just having pain, and to be seen if pain continued or symptoms worsened.",,,,,,,,,U,09/28/2019,09/28/2019,0,,PHM,,"amlodipine, voltaren gel, irbesartan, rosuvastatin, spironolactone, hydrochlorothiazide",,diabetes,,,2,09/29/2019,,,,"hydrocodone, tramadol"
0836830,09/29/2019,,65.0,65,,F,,"about 4 hours after getting vaccine patient experienced 104 degree fever, chills, shaking, aches, blurry eyes and felt delirious, this lasted one day",,,,,,,,,,09/24/2019,09/29/2019,5,,PHM,,,,,,,2,09/29/2019,,,,
0836831,09/29/2019,CO,66.0,66,,M,,Pounding and rapid  heart Headache  General malaise,,,,,,,,,N,09/28/2019,09/28/2019,0,,PHM,,Satin  Saw Palmetto Niqwell,N/a,None,,,2,09/29/2019,,,,Penicillin Crab
0836832,09/29/2019,AZ,65.0,65,,M,,"Extreme Soreness and inability to use the arm for activities of daily living. Over the last week arm was swollen, very black and blue and it looks like an extreme bruise over 16 inches long and 4 to 5 inches wide on the inside of the upper right arm.",,,,,,,,,N,09/13/2019,09/19/2019,6,None,PVT,,"Amlodipine 10mg One a Day Vitamin E, C , Fish Oil, Calcium,  Multi Vitamin",None,High Blood Pressure,,,2,09/29/2019,,Y,,None
0836833,09/29/2019,IN,65.0,65,,F,,Pt developed swelling and redness at the site the day after the vaccination. She visited the pharmacy to show the reaction to the pharmacist on duty within the first week after having both vaccines. The pharmacist suggested she take IBU and ice the spot. She came back today and the redness is gone but there is still a sizeable hard knot that she says hurts when touched or bumped. Pharmacist who gave shots suggested she didn't get them in the same arm.,,,,,,,,,N,09/14/2019,09/15/2019,1,No medical test required yet.,PHM,,"Levothyroxine 100 mcg, ambien 10 mg, olmesartan hctz 20-12.5.",none,none,,,2,09/29/2019,,Y,,None
0836834,09/29/2019,TN,1.5,1,.5,F,,"at 2pm following vaccine, one of Patient's eyes rolled back into her head.  At 7pm that evening she started vomiting. She vomited 3 times that evening. the following day 9/25 she was lethargic, not eating much and threw up at 5pm. She threw up in her crib the night of 9/25 into 9/26. Not eating or drinking much and not peeing much. She is still very clingy and cuddly today 9/29 which is very out of character for her. She's high energy and an explorer typically. We went to Urgent Care on 9/26 thinking she would get IV fluids. since she had a pee diaper that morning, they did not see a need for IV fluids. They prescribed Zofran for nausea and I did not administer it because the throwing up seemed to be subsiding then.",,,,,,,,Y,U,09/24/2019,09/24/2019,0,She had bloodwork taken the same day 9/24 following the vaccine.,PVT,,1/2 plexus xfactor kids chewable multivitamin with probiotic,had a cold the weekend before the vaccine,kidney hydronephrosis mild hearing loss inner ear deformities,"April 30 2019 MMR vaccine at 13 months old, threw up 3x that day and May 1. Also vomitted after 1 month well visit vaccines. Req",,2,09/29/2019,,,Y,no
0836835,09/29/2019,PA,82.0,82,,F,,"arm numbness following vaccination day, arm was paralyzed as described by caregiver",,,,,,,,,U,09/27/2019,09/28/2019,1,n/a,PHM,,n/a,n/a,n/a,,,2,09/29/2019,,,,n/a
0836836,09/29/2019,TX,65.0,65,,F,,"Patient presented two hours later with new red, itchy rashes and hives. Reaction present on face, neck, chest, and arms. Patient was recommended to take 1 to 2 tablets every 4 to 6 hours until her rash resolves. She was to also get hydrocortisone cream. She refused both. She was told to go to urgent care to see the nurse practitioner or go immediately to the emergency room if it worsens. Her husband drove her. Also asked her if she'd like to stay for extra observation but she refused and said she'd talk to her doctor.",,,,,,,,,,09/29/2019,09/29/2019,0,,PHM,,,,HYPERTENSION,,,2,09/29/2019,,Y,Y,NO KNOWN ALLEGIES
0836837,09/29/2019,CO,78.0,78,,F,,"1/2"" bruise at injection site, swelling and redness area 5""x4"" down upper arm, soreness, heat.  Joint pain.  Tiredness, malaise.   Rx ibuprofen, rest, fluids.  It's only been 2 days.",,,,,,,,,N,09/27/2019,09/29/2019,2,None,PHM,,"Amlodipine, Lisinopril, L-Thyroxine, Trazodone, Pantoprazole, Cetirizine, Senior Multivitamin, Calcium, Fibercon",None,"Hypertension, controlled",,,2,09/29/2019,,Y,,"Codeine, Percocet"
0836838,09/29/2019,MI,67.0,67,,F,,"developed cellulitis at injection site of right arm, treatment is 10 day course of doxycycline 100mg twice daily, Upper right arm was red, hot to touch, swollen and painful. Antibiotic should treat.",,,,,,,,,U,09/25/2019,09/25/2019,0,n/a,PHM,,n/a,n/a,n/a,,,2,09/29/2019,,Y,,n/a
0836839,09/29/2019,MO,15.0,15,,F,,"Patient was very nervous before and during her flu shot. After giving the patient the shot, she seemed fine, so I had her move to a chair a few feet away so I could give her family member their shot. After administering the family member's shot, I saw the patient messing with her hair and looking upward oddly and slumping over a bit. Her eyes rolled back in her head, and she went rigid in the chair. Both the family member and I rushed over to her. She was breathing the whole time, but her skin and lips were very pale. I ran out of the room and called 911. We stood by her whilst waiting for the medics, and I made sure she was still breathing. The ambulance arrived and took her blood pressure. After checking her out, the medics pushed her out to her car in a wheelchair.",,,,,,,,,Y,09/29/2019,09/29/2019,0,None,PHM,,None,None,None,,,2,09/29/2019,,,,None
0836840,09/29/2019,SC,60.0,60,,F,,patient woke up sweating and vomited liquid but did not have upset stomach or nausea,,,,,,,,,Y,09/19/2019,09/20/2019,1,none,PHM,,,,,,,2,09/29/2019,,,,
0836841,09/29/2019,CO,70.0,70,,F,,"41/2 months after receiving the vaccine I began having chronic dizziness. After seeing Dr. I was told that a virus had ""killed""/attacked my acoustic nerve in my left ear. I did not have a cold, flu or other conditions at the time of the vaccine or at the onset of the dizziness. I have had the dizziness for 41/2 years everyday. I have been treated with medication, antihistamines, physical therapy and acu puncture.",,,,,,,,Y,N,11/01/2014,01/14/2015,74,,PHM,,,,"hyperlipidemia, hypertension, heart murmur",,,2,09/29/2019,,Y,,"Steroids, scallops, cats"
0836842,09/29/2019,OH,76.0,76,,F,,"Patient stated her arm was sore day of and day after shot but with out redness or rash. On Saturday pt said her arm was hot,red, itchy, painful, and raised. The reaction was not at the injection site but lower and spread down the arm away from the injection site.  The patient stated  she was feeling  fine otherwise. The patient also mentioned she was in the sun on Saturday and at a petting zoo/safari park.  I recommended the patient visit her Dr or go to a walk in clinic/hospital if she was really bothered by her arm or not feeling well. She will keep me  updated on how she is feeling and how her arm is doing and if she sees her Dr",,,,,,,,,N,09/26/2019,09/28/2019,2,none at this time,PHM,,"amlodipine,citaloprqm,pantoprazole,lisinpiril,buspirone,atorvastatin",,,,,2,09/29/2019,,,,"pcn,sulfa"
0836843,09/29/2019,WA,39.0,39,,F,,"10 hours after injection, severe chills began.  About 15 hours after, extreme fever. I received the injection at about 2 pm on a Tuesday, went to bed about midnight that night. I slept through all of Wednesday, and wasn't able to get up until Thursday morning at 9am.  I attempted to get up once Wednesday night, and was extremely dizzy and disoriented. I was able to get up a few times to use the bathroom. While I was sleeping I  felt like I was having sleep paralysis. I was having a massive fever (grade unknown), and I was unable to respond to my fiance when she came into the room. I wanted to ask for tylenol, or a doctor, but even though I could hear her, I wasn't able to  say anything.  This feeling lasted for about 10 hours, which was almost 24 hours after the injection. On 9/5/19, I went back to work. I still felt miserable, but was able to move about. I felt like I had the flu however. From 9/5-9/9/9 I experienced memory issues. I had a hard time recalling peoples names, including close family members. My speech and memory were not working well. My fiance was showing me a photo with something red and something yellow on it, and I couldn't recall the names for the colors. The memory issues were the worst until the 9th, and at this point, have improved, but are not completely back to normal.",,,,,,,,,U,09/03/2019,09/04/2019,1,Was not able to go to a DR,PUB,,none,none,none,,,2,09/29/2019,,,,"Ceclor, lactose intolerant"
0836844,09/29/2019,KY,71.0,71,,F,,"Patient called and spoke to RPH on 09-25-19 about a red, hard, hot-to-the-touch welt that appeared on her arm following her vaccine on 09-24-2019. She was told to take ibuprofen and apply a cold compress to the area. If the reaction did not resolve, she should contact her provider. RPH spoke with the patient on 09-29-19 and she stated that the ice and ibuprofen appeared to work and the reaction had alleviated. She did not contact her md about the reaction.",,,,,,,,,Y,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,09/29/2019,,,,
0836846,09/29/2019,TX,62.0,62,,M,,Patient took 2 advil OTC,,,,,,,,,Y,09/27/2019,09/28/2019,1,Patient reports no medical tests or lab results. Patient reports that they called Doctor to discuss symptoms on 9/28/19 and was told to go to ER if symptoms worsened and that the symptoms were most likely a side effect of vaccination.,PHM,,Mens Multivitamin,none,hemochromotosis,,,2,09/29/2019,,Y,,Codeine
0836847,09/29/2019,FL,66.0,66,,F,,"Fever, chills, numbness in fingers about 6 hours post vaccine",,,,,,,,,Y,09/28/2019,09/28/2019,0,Patient went to ER and was given ibuprofen and rest. Feels better today,PHM,,no medications here,none mentioned,none mentioned,,,2,09/29/2019,,,,morphine allergy
0836848,09/29/2019,FL,71.0,71,,F,,"""1 1/2 day of severe joint pain, felt like a huge hammer repeated[sic} hitting ankle and top of left foot - complete loss of bladder just once upon waking up""",,,,,,,,,Y,09/13/2019,09/13/2019,0,,PHM,,E-Z tear tablet,N/A - blood in urine per recent lab work,Raynaud disease,,,2,09/29/2019,,,,sulfa
0836849,09/29/2019,KY,66.0,66,,F,,"Patient came in the day following the vaccinations complaining of swelling, aches , uspet stomach, head ache, ear ache, sweeting thoughout the night. Called patient 9/29/19 and she is feeling much better",,,,,,,,,Y,09/27/2019,09/27/2019,0,none,PHM,,unknown,no,no,,,2,09/29/2019,,,,NSaids
0836850,09/29/2019,TN,13.0,13,,M,,"Patient awoke at 3am on 9/29/19 and was observed by his parents to have a fever of 102 F with a headache, body aches, and chills. He was taken to a local emergency room where he was tested negative for strep throat and observed to have some redness in his throat and ears. The parent also mentioned he had pharyngitis at the ER as well. The patient was sent home and had been receiving ibuprofen and tylenol to help control his fever and instructed to provide supportive measures such as fluid intake as well. ER was unsure of what the cause of the symptoms were but have suggested vaccine may be the cause due to proximity and timing of the events. No site reaction or skin reaction such as hives had been observed at the time of reporting to the pharmacy at 4:45pm on 9/29/19. Patient advised to followup with their pediatrician Dr. as soon as able for reevaluation.",,,,,,,,,U,09/28/2019,09/29/2019,1,Quick strep test was negative.,PHM,,"Cetirizine, ibuprofen, acetaminophen",None,Asthma,,,2,09/29/2019,,,Y,None
0836851,09/29/2019,AZ,68.0,68,,F,,Patient reports sharp arm/shoulder pain with movement for greater than 9 days after the injection.,,,,,,,,,U,09/20/2019,09/25/2019,5,,PHM,,metoprolol,hypertension - controlled,see 11,,,2,09/29/2019,,,,nka
0836852,09/29/2019,CA,51.0,51,,F,,"2 hours after flu vaccine injection, my arm was very painful, swollen and red. Blue and red pattern started to appear, then blisters appeared and kept on growing and filling up with liquid. It was extremely painful. Next day, the doctor burst the blisters to drain them. The skin ripped exposing flesh. Cortisone was prescribed with ibuprofen. Doctor said they would report to CDC but no one had followed with me.",,,,,,,,,N,09/23/2019,09/23/2019,0,none,PVT,,Had been taking Amoxicillin for 1 day for a knee infection.,,None,,,2,09/29/2019,,Y,,None
0836853,09/29/2019,FL,76.0,76,,F,,"I collapsed on July 19th and could not use my legs, I was admitted to the hospital and was diagnosed with Guillain-Barre Syndrome. It then went up to my chest , arms  and affected the use of my arms and my respiratory system. I was treated with Plasmaphoresis blood plasma therapy. I was in the hospital   until Aug31 and then to in- patient physical  and occupational therapy until August 8th. My treatment is ongoing for I still have weakness.",,,,,Y,21,,,N,07/10/2019,07/19/2019,9,,PHM,,"coumadin, Pindolol, Pravastatin, Dicyclomine, Alendronate, Vitamin B complex, Tylenol, CoQ-10 200mg, Caltrate 600 plus D3, Replens, Tums, Align Probiotic, Centrum silver for Women, Vitamin C, D3 25mg",,"AFib, irritable bowl, arthritus",,,2,09/29/2019,,,,"prevacid, pradaxa"
0836855,09/29/2019,TX,79.0,79,,F,,"VERY TIRED NEXT DAY--RASH IN AREA OF INJECTION ON SECOND DAY AFTER INJECTION WHICH ENLARGED TO FIVE INCHES ON THIRD DAY, FEET VERY ITCHY WITH WIDE SPREAD HIVES ON FEET AND LEGS , ALSO ON HANDS AND LOWER ARMS, DOCTOR VISIT FOUR DAYS AFTER INJECTION, DR. PRESCRIBED ANTIHISTAMINE AND STEROID, BY DAY SIX THE HIVES WERE FLAT RED SPOTS AND NOT ITCHY --DOCTOR AT CLINIC HAS ALSO FILED REPORT",,,,,,,,,Y,09/23/2019,09/24/2019,1,NONE,OTH,,"1200mg CALCIUM, MULTIVITAMINS,  PROLIA INJECTION TWICE YEARLY--LAST GIVEN JULY 5 2019",NONE,OSTEOPOROSIS,,,2,09/29/2019,,,,LATEX--NOT CONTAINED IN BAND-AID USED AT TIME OF INJECTION
0836856,09/29/2019,TX,63.0,63,,F,,None stated.,,,,,,,,,U,09/27/2019,09/27/2019,0,,PHM,,,,,,,2,09/29/2019,,,,None
0836857,09/29/2019,NJ,54.0,54,,F,,PT REPORTED REDDNESS SORE ARM FEVER OVER 101 CHILLS 1 DAY AFTER SHOT IN THE RIGHT ARM. PT WENT TO DR AND HE GAVE AN ANTIBIOTIC AND PREDNISONE.  PT SAID STARTED TO FEEL ALITTLE BETTER THE NEXT DAY. PT GOT ON A WED AND WAS FEELING BETTER BY SUNDAY. I WAN CONTACTED BY THE SCHOOL NURSE AND TRIED MULTIPLE TIMES TO GET BACK TO NURSE WITH DETAILS AND CALLED PT WITH NO ANSWER. FINALLY GOT IN TOUCH WITH PT 9-29 AND GOT ALL THE DETAILS. PT IS FINE AT THIS TIME,,,,,,,,,Y,09/04/2019,09/05/2019,1,NA,WRK,,NOT KNOWN,NOT KNOWN,NOT KNOWN,TETNUS,,2,09/29/2019,,Y,,NONE
0836858,09/29/2019,CA,3.0,3,,M,,"After getting a shot, my son was fussy then slept all day. He developed an earache and become feverish. In the middle of the night (10/11 pm) my husband and I were awakened by our son groaning and gnashing his teeth, moving his body in strange ways, grinding his teeth and growling as if he was possessed. He was sweating and feverish. I brought him into bed with me and he stopped making the scary sounds. I looked it up online and this type of growling, teeth gnashing is a symptom of encephalitis, which is one of the potential side effects of the DTap shot he'd received that morning.",,,,,,,,,Y,05/30/2019,05/30/2019,0,None. I called the doctors office and they did not return my call.,PVT,,None,None,None,,,2,09/29/2019,,,,None
0836859,09/29/2019,CT,76.0,76,,F,,"SEVERE FLU-LIKE SYMPTOMS.  PAINFUL ACHES, HEADACHE, SWEATING ALTERNATING WITH VIOLENT, SHAKING CHILLS, DIZZINESS...LASTING ABOUT 8 HOURS.",,,,,,,,,Y,09/28/2019,09/28/2019,0,NONE,PHM,,METFORMIN JANUVIA TRILIPIX PRESERVISION TIMOLOL,NONE,DIABETES TYPE 2 ARTHRITIS GLAUCOMA,"FALL, 2018...SAME REACTION, NOT AS SEVERE.",,2,09/29/2019,,,,PENICILLIN
0836860,09/29/2019,WY,62.0,62,,F,,"8-30-19 hives on palms, fingers, moving to scalp . I carry a prednisone burst RX due to previous allergic events, started the burst 60mg for 5 days, famotidine daily and Benadryl 25mg at night to help with itching. After burst completed, still have uticaria , another burst course following the same routine.  At completion of 2nd course, took OTC loratadine antihistamine for 2 days to manage symptoms at physician's suggestion.  9-15-19 experienced  angioedema in the mouth, hives on feet and scalp, went to ER. BP and pulse rate were WNL, ER physician placed on long prednisone taper  60mg daily for 5 days, 30mg for 3 days, 20 mg for 3 days, 10 mg for 3 days. After finishing the taper, 24 hours later angioedema occurred in mouth and throat took 25mg Benadryl, adm EPI PEN, famotidine. Went to Urgent Care clinic, adm 125mg Prednisone IM injection. RX prednisone 40 mg taper, hydroxyzine HCL 50 MCG and famotidine.",,,,,,,,,N,08/23/2019,08/31/2019,8,Tryptase blood test at ER WNL,PVT,,"levothyroxine 50MCG, menopause supplement (like Estroven); Vit D3 2000IU, Magnesium 250mg, Vit B Complex,  Women 50+ multi vitamin, fluticasone propionate 50mcg nasal spray",Seasonal hayfever,"hypothyroid, sporadic allergic reactions to unknown etiology approx. every 2-3 years lasting in duration 1-2 days",,,2,09/29/2019,,Y,Y,Phenergan sensitivity (drowsiness)
0836861,09/29/2019,FL,73.0,73,,F,,"site of injection is inflamed and itchy , and fluid comes out of it",,,,,,,,,U,09/25/2019,09/25/2019,0,,PHM,,,,,,,2,09/29/2019,,,,Allergic to soy products
0836862,09/29/2019,CO,51.0,51,,M,,"Soreness at injection site, full body aches and nausea one day after shot (9/28/2019).  Entire day.",,,,,,,,,Y,09/27/2019,09/28/2019,1,,PHM,,Flonase as needed,None,Seasonal allergies,,,2,09/29/2019,,,,Sulfa
0836863,09/29/2019,CA,57.0,57,,F,,"Very painful upper arm at injection site day 1, developing day 2  into hard swelling and redness with pain/itch similar to a bee sting. Day 1 Body ache, nausea, fever (102 deg) w/chills. Tylenol helped so I could go to work but symptoms came back after Tylenol wore off. Day 2 could not do planned activities due to tiredness and nausea, arm still extremely painful. Day 3 body aches improving, nausea gone but arm still very painful.  Redness subsiding but hard knot still there.",,,,,,,,,N,09/26/2019,09/26/2019,0,none,PVT,,Advair Singulaire Turmeric Multi-Vitamin Vitamin D Calcium Tylenol,no,"asthma, allergies",,,2,09/29/2019,,,,no
0836864,09/29/2019,NY,58.0,58,,F,,"redness and swelling on left arm, not near the injection site.  patient was told to seek medical attention if it spread. it did, went to see urgent care and was diagnosed with cellulitis and got antibiotics to resolve infection.",,,,,,,,,U,08/30/2019,09/03/2019,4,,PHM,,,,,,,2,09/29/2019,,,Y,no known drug allergies
0836865,09/29/2019,,67.0,67,,F,,Patient has been complaining for shoulder pain for 3 weeks and sometimes is unable to lift up,,,,,,,,,N,09/08/2019,09/08/2019,0,,UNK,,,,,,,2,09/29/2019,,Y,,
0836866,09/29/2019,FL,58.0,58,,F,,"Extreme weakness, body aches, fever/chills, Pain rating #8 back pain & headache. Unable to hold cell phone. Awoke, approx 0800, with symptoms. With great difficulty, walked from bedroom to couch, getting phone along the way to call husband.",,,,,,,,,Y,06/13/2019,06/14/2019,1,"Urgent Care.  Recorded fever. IV meds. Back pain better with knees bent in supine position. Migraine ""cocktail"" ineffective (no surprise to me as I have migraines).  MRI neg. No meningitis.  Once home, took Fiorinal, with decrease of headache.",PHM,,"Amitriptyline, Memantine 10mg , Aspirin 81 mg, Life Extension Two-Per-Day multivitamin, Citracal Calcium, CoQ10, Glucosamine/Chondroitin/MSM.   Excedrine.",None,Migraines,,,2,09/29/2019,,,Y,"Naprosyn, Aleve.  Other NSAIDS & Ibuprophen OK."
0836867,09/29/2019,IA,72.0,72,,U,,"Patient experienced redness and stiffness of the skin surrounding the injection site (radius 0.5-1 in). It also warm to touch. Patient was unsure if it was getting better or worse at the time she initially report the reaction (9/27/19). Asked patient to keep and eye on it to make sure it's not getting worse. If it becomes more painful or the redness surrounding the site expands in size, advised patient to seek care at walk in clinic or with provider. In addition advised patient she may take Tylenol and apply cold pack/ice to injection site to help with the pain. Did not have any symptoms of achiness, malaise, etc. Only pain at site.",,,,,,,,,U,09/24/2019,09/25/2019,1,n/a,PHM,,"furosemide 20mg, gabapentin 300mg, levothyroxine 75mcg, pantoprazole 40mg, potassium cl 20meq, topiramate 25mg, tizanidine 4mg",no illnesses,,,,2,09/29/2019,,,,no known allergies
0836868,09/29/2019,CA,54.0,54,,M,,Hives,,,,,,,,,U,09/18/2019,09/19/2019,1,,WRK,,None,None,None,,,2,09/29/2019,,,,None
0836869,09/29/2019,UT,59.0,59,,M,,"headache, chills, fever, vomitting, diarareah, joint aches ibuprofen, sleep, alka seltzer",,,,,,,,,Y,09/28/2019,09/29/2019,1,none,PHM,,omega 3,none,none,,,2,09/29/2019,,,,none
0836870,09/29/2019,CO,74.0,74,,F,,"PT CALLED REPORTING INTENSE HEAT IN LEFT ARM /INJECTION SITE. NO SWELLING, BRUISING, INFLAMMATION, ERYTHEMA.",,,,,,,,,U,09/27/2019,09/28/2019,1,,PHM,,"VENTOLIN, FLONASE, CLARATIN, INCRUSE",,ASTHMA/COPD,,,2,09/29/2019,,,,ASPIRIN
0836871,09/29/2019,VA,72.0,72,,M,,Pt woke up day after receiving the vaccine(received 9/27/2019) with swollen arm and redness. He had lower back pain that required ice. He felt weak and nauseated and just bad in general. As of 9/29/2019 he was feeling better and his arm was not so tender and this weakness had subsided.,,,,,,,,,Y,09/27/2019,09/28/2019,1,na,PHM,,SINGULAIR 10MG     FINASTERIDE 5MG      SIMVASTATIN 20MG   TAMSULOSIN 0.4MG,na,"high cholesterol, allergies, BPH",,,2,09/29/2019,,,,"Celebrex, Sulfa drugs, hydrocodone(can take ultram, though)"
0836872,09/29/2019,NC,57.0,57,,M,,"Headache, muscle and joint aches, malaise",,,,,,,,,Y,09/28/2019,09/28/2019,0,,PHM,,Claritin,none,none,,,2,09/29/2019,,,,NKDA
0836873,09/29/2019,FL,74.0,74,,F,,"A small, red, raised welt appeared 9/25 evening. Two days after the shot, she had no appetite and had a 101.3 deg F fever. She was icing the area and also took tylenol. Fever went away but she still had headache. Symptoms continued - itching, burning, swelling and redness so she went to the doctor on Sept 29 and was prescribed medication (antihistamines and NSAID) to help with symptom relief. The right upper arm (about an area of 5 inches in length)  was swollen, red and itchy, and painful.",,,,,,,,,,09/25/2019,09/25/2019,0,,PHM,,,,,,,2,09/29/2019,,,Y,
0836874,09/29/2019,FL,71.0,71,,F,,Starting late after noon of 9/27/19 patients arm was extremely sore.  9/28/19 arm was still extremely sore.  When patient woke up 9/29/19 she was ad a red hot swollen rash starting about 3-4 inches away from injection site (injection site clear) and ran all around elbow.  Elbow extremely puffy/swollen.,,,,,,,,,,09/27/2019,09/27/2019,0,,PHM,,,,,,,2,09/29/2019,,,,
0836875,09/29/2019,FL,16.0,16,,F,,"Vomiting and diarrhea, general ill feeling, fatique, dizziness, platelets abnormally low /weight loss (over 18 pounds since above referenced date)",,,,,,,,,N,08/20/2019,08/21/2019,1,CBC/ER visit/several labs unknown 8/31/2019 CBC/Thyroid/other labs unknown 9/16/2019 CBC/approx 6 other labs unknown 9/27/2019,PUB,,"Vyvanse, Guanfacine",None,None,,,2,09/29/2019,,Y,Y,None known
0836876,09/29/2019,KS,33.0,33,,F,,THE INCIDENT HAPPENED ON FRIDAY 09/27/19. PATIENT HAD A VERY SWOLLEN LEFT ARM 30 MINUTES AFTER THE INJECTION . SHE WENT TO EMERGENCY ROOM AND HER PROVIDER ADVISED HER TO APPLY ICE PACK ON THE AREA AND GAVE HER AN ANTIBIOTIC.  WHEN SHE CAME INTO THE PHARMACY ON SUNDAY 09/29/2019 TO REPORT. THE SWELLING HAD GONE DOWN SLIGHTLY. I ADVISED HER TO TAKE IBUPROFEN AND TYLENOL TO HELP WITH SWELLING AND PAIN.,,,,,,,,,N,09/27/2019,09/27/2019,0,NONE THAT SHE INDICATED,PHM,,ALBUTEROL INHALER GABAPENTIN 300MG,,ASTHMA/COPD,,,2,09/29/2019,,,Y,NSAID METHADONE
0836877,09/29/2019,CA,54.0,54,,F,,"Shivers, fever, fatigue, local soreness/slight swelling",,,,,,,,,U,09/28/2019,09/28/2019,0,None,PHM,,"Estrogen patch, progesterone capsules",None,None,,,2,09/29/2019,,,,Nka
0836878,09/29/2019,NY,59.0,59,,F,,"Patient came into the pharmacy on 9/29/19 stating both forearms are a red rash. developed on 9/24/19 and got flu shot at store on 9/17/19.  Patient has not changed any soaps, or denied sunburn.",,,,,,,,,,09/17/2019,09/24/2019,7,,PHM,,"Hydrochlorothiazide, Haloperidol, Flovent Inhaler, Quetiapine, Norco",,,,,2,09/29/2019,,,,
0836879,09/29/2019,OR,71.0,71,,F,,"Severe shoulder and chest pain, enough to have me believe I might be having a heart attack.  Fever, chills, and unremitting pain.   I've never experience anything like this as a result of any immunization. It was truly terrifying.",,,,,,,,,U,09/10/2019,09/10/2019,0,,PVT,,none,none,none,,,2,09/29/2019,,Y,,none
0836880,09/29/2019,NJ,65.0,65,,F,,"1. September 9 at 2:30 p.m., I had tingling in my left forearm, left palm and my left pinky became numb. This lasted 4 days.  2. My left arm became very sore starting at 4 p.m.; by 9 p.m. I could barely lift my left arm parallel to the ground and could barely undress myself. This lasted 5 days. 3.  I became weak, fatigued, dizzy, nauseous, and all of my joints started to ache. By 9:00 p.m on 9/9/19, my nose became very stuffy, my face hurt like a sinus infection, my thinking became foggy, my speech became difficult to sequence, and I had delayed motor skills. These symptoms lasted 13 days! 4. A dull headache started 9./9/19 and it became a migraine on 9/12/19. The severe migraine with extreme nausea lasted 9/11-9/18. I still get a severe headache occasionally and it is September 29. 5. I had severe chills and sweats 9/9/19-9/10/19. 6. I developed cellulitis in my left arm. It began 9/9/19 in the pm. and was diagnosed and treated with antibiotics by my doctor on 9.11/19. It was NOT at the injection site, rather is was in my bicep BELOW where the injection was given and went to the under side of my arm and into my left arm pit. My doctor, put me on Cefadroxil 500 MG capsules 2 capsules by mouth twice a day for 5 days to treat the cellulitis.  7. As of September 29, 2019, I am still very weak and fatigued, my joints still ache, I get a severe headache out of the blue that wakes me out of a sound sleep at times, and I'm still slightly nauseous.",,,,,,,,,N,09/09/2019,09/09/2019,0,1. 9/11/19 my doctor examined my arm and prescribed an antibiotic for cellulitis,PHM,,"Only supplements: vitamin C, magnesium, Citracal, vitamin D, zinc, biotin, lutein, fish oil","I had had a cold August 24, 2019 through September 4, 2019. At the time of the vaccine I'd felt perfectly fine, no cold symptoms, for a full 5 1/2 days.","1. Celiac disease 2. Post lyme syndrome--exhibited in ""hypersensitivity"" 3. Rapid transit","Arm gets sore at injection site from flu vaccines. I got a mild case of the shingles from the Zoster shingle vaccine, it lasted ",,2,09/29/2019,,Y,,"gluten (I have celiac disease), metoclopramide, baclofen, sulfa drugs, sulfites, sulfates, doxycycline, flagyl, copra, codeine, cortisone ointments, betamethasone, lanolin, wool, aloe, ducal temporary dental cement"
0836881,09/29/2019,CA,73.0,73,,F,,Patient had a big bruise at the site of injection. It was a little hot at the touch. And when touching it with pressure it was painful.,,,,,,,,,N,09/28/2019,09/28/2019,0,none at this time,PHM,,"Metoprol , amlodipine, MTX",none,none,,,2,09/29/2019,,,,Patient had none
0836882,09/29/2019,AZ,68.0,68,,F,,"redness, soreness, of deltoid muscle ; warm to touch",,,,,,,,,Y,09/20/2019,09/20/2019,0,,PHM,,"flovent,montelukast,proair hfa inhaler,alendronate,estradiol patch, fluzone high-dose (1 week prior)",,,,,2,09/29/2019,,,,aspirin
0836883,09/29/2019,NJ,61.0,61,,M,,pt states contracted shingles as a result of the vaccine. Pt states dx confirmed by Dr. Pt was prescribed Valtrex by MD,,,,,,,,,U,08/23/2019,09/24/2019,32,,PHM,,,,,,,2,09/29/2019,,Y,,
0836884,09/29/2019,OR,51.0,51,,M,,Patient said that around 8:00 pm on 9/28/19 he noticed some redness and a bump at injection site and this morning on 9/29/19 he said it changed to this fluid filled blister a little less than a dime in size at the injection site only. He said he has some tenderness at the site also.  The patient does not have a primary doctor so I instructed him to go to an urgent care or ER if the reaction gets worse or does not go away in a couple days. I also told him to keep the area clean and cover the blister with a gauze pad to help keep it from opening. I also instructed him to take benadryl tablets if  the reaction gets worse.    The patient will be contacted within a couple of days for followup.,,,,,,,,,N,09/28/2019,09/28/2019,0,none,PHM,,Valproic Acid 250 mg capsules,nothing per patient,seizure disorder,,,2,09/29/2019,,,,Penicillin
0836885,09/29/2019,CO,69.0,69,,F,,Patient had swelling on the arm from injection site to just above the elbow.  It is also hot and painful.  She stated she was able to move it (raise the arm) on Saturday which she wasn't able to do Friday evening. She spoke with her doctor on Sunday and he said to continue with benadryl and tylenol. She still has swelling and redness around elbow but it is not as hot or as painful as before.,,,,,,,,,N,09/27/2019,09/27/2019,0,,PHM,,,,,,,2,09/29/2019,,Y,,
0836886,09/29/2019,ID,57.0,57,,F,,"Swelling size of an egg, a red spot about 1 1/2 times the size of a silver dollar and a white spot in the center at the injection site similar to a hornet sting/bite.  It feels hot and on the 2nd and 3rd day became itchy and sore to the touch along with other muscle and joint pain.",,,,,,,,,N,09/26/2019,09/26/2019,0,none.,PHM,,Carbazapine,none,muscular-skeletal back issues and Bi-Polar,,,2,09/29/2019,,,,Some food allergy or something unknown due to rashes.  pork intolerance
0836887,09/29/2019,NY,30.0,30,,M,,"Patient's mom called on phone 9/29/19 at 10PM to say her son got flu shot yesterday and developed some concerning symptoms. We are not sure if it is from the flu shot or something else. Symptoms included: sore throat, swollen lips, hives on body. Symptoms have been gradually developing since yesterday.",,,,,,,,,N,09/28/2019,09/28/2019,0,None yet. Patient's mom is giving him benadryl and watching him to make sure symptoms don't get worse. Advised them to take him to the doctor as soon as they can for evaluation and advised that worsening of swollen lips/tongue/throat is serious reaction and should go to the ER.,PHM,,Lamotrigine 200mg (been on ~10 years per mother) Latuda 20mg,None,Not sure,,,2,09/29/2019,,,,None
0836888,09/29/2019,FL,68.0,68,,F,,"Onset of chills and fever of 100 within two hrs of shot,  24 hrs later fever rose to 101, 36 hrs later 99.5.  Muscle aches, general weakness and sick feeling, no swelling, red or tenderness noticed at injection sight. 48 hrs all symptoms completely gone.  High fever scary for someone in excellent health!",,,,,,,,,Y,09/27/2019,09/27/2019,0,,PHM,,,,,"Similar reaction to last year's flu vac, 10/2018, but no fever.",,2,09/29/2019,,,,Sulfa
0837037,09/29/2019,FL,67.0,67,,F,,"Patients arm is red, swollen and painful",,,,,,,,,U,09/28/2019,09/29/2019,1,,PHM,,,,,"patient states she had the same reaction to the influenza vaccine, but unsure which vaccine she received",,2,09/29/2019,,,,
0837111,09/29/2019,ID,,62,,F,,"The evening of vaccine, Tues night, Arm very sore-difficulty sleeping despite Ibuprofen 600mg - Shoulder very stiff Wed through now feels like ""frozen shoulder"" No redness not hot to touch. 9/27 Can't life arm (Right) and sore. Contacted Dr. and recommended heat and cold and take ibuprofen. Pt took Acetaminophen Last night. 9/29 called patient and stated doing much better and icing Right arm as instructed by DR.",,,,,,,,,,09/24/2019,09/24/2019,0,0,PHM,,,,,a couple year ago-same thing-stiff shoulder which resolved in ~ 2 weeks,,2,09/26/2019,,,,
0836889,09/30/2019,CA,30.0,30,,F,,"mild swelling, blotchy erythema, severe pain in the area of Pneumovax vaccination no reaction on the other arm where influenza vaccine was given",,,,,,,,,U,09/24/2019,09/25/2019,1,,PVT,,Levora received influenza vaccine at the same time but to the other arm - no symptoms there,none,asthma,,,2,09/30/2019,,Y,,none
0836890,09/30/2019,VA,62.0,62,,F,,"Pain and swelling at injection site, malaise, nausea, low grade fever",,,,,,,,,N,09/29/2019,09/29/2019,0,,UNK,,"Calcium, vitamin D, vitamin b-12, Valsartan",,Non toxic goiter,,,2,09/30/2019,,,,Seafood
0836891,09/30/2019,NC,55.0,55,,F,,"Patient experienced a rash and swelling in the throat and mouth shortly after receiving the vaccine. She took benadryl and used her ProAir inhaler which resolved the symptoms. Pt's husband is an EMT, so she did not feel it necessary to go to a medical facility for treatment.",,,,,,,,,Y,09/20/2019,09/20/2019,0,,PHM,,,none known,none known,,,2,09/30/2019,,,,none known
0836892,09/30/2019,MD,58.0,58,,F,,"Starting within 12 hours, moderate muscle soreness in center of upper left arm (not near injection site). Within 24 hours pain became severe and constant. Treated with ice and OTC NSAIDs with little relief. Xray taken 9/23 to rule out broken bone. Office visit 9/27 - received prescriptions for antibiotic and percoset and order for MRI. MRI is scheduled for 10/2 (today is 9/30).",,,,,,,,Y,N,09/18/2019,09/19/2019,1,ongoing,PVT,,,,,,,2,09/30/2019,,Y,Y,
0836893,09/30/2019,GA,41.0,41,,F,,"Cold like symptoms: Runny nose, head cold, Scratchy throat. Lethargy, muscle aches, congestion,",,,,,,,,,N,09/23/2019,09/27/2019,4,,PVT,,None,None,None,Same symptoms every year with flu vaccine.,,2,09/30/2019,,,,None
0836946,09/30/2019,IL,,57,,F,,"The patient had a blood work after the immunization were the titer showed  zero improvement with her immunity; This spontaneous report was received from a currently 57-year-old female consumer referring to herself. The patient's concurrent conditions included high blood pressure and a drug reaction or allergy to sulfa and azithromycin drug. There was no information about the patient's medical history. Concomitant medication included high blood pressure medicine.  In approximately August 2019 (reported as about a month ago), the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) for measles, mumps, rubella prevention (strength, dosage schedule, route of administration, lot number and expiration date were not reported). The patient was vaccinated because she would be traveling outside of the country and because her titer reveled that she had little immunity to the rubella virus. The patient had a blood work after the immunization were the titer showed  zero improvement with her immunity. The patient did not receive any treatment for the event. The patient soghlt edical attention by speaking with a physician. At the time of the report, the patient had not recovered from the event.  The causal relationship between the event and the vaccine was not reported.",,,,,,,,,N,08/01/2019,08/01/2019,0,,UNK,,,Blood pressure high; Drug hypersensitivity; Sulfonamide allergy,,,US0095075131909USA002958,2,09/27/2019,,,,
0836947,09/30/2019,CO,31.0,31,,F,,"The patient also complained of headache, sinus congestion and left ear pain/left ear infection; The patient also complained of headache, sinus congestion and left ear pain; Injection site erythema; Injection site swelling; The patient also complained of headache, sinus congestion and left ear pain; This spontaneous report was received from a registered nurse refers to a 31 year old (also reported as 33 year old) non-pregnant female patient. The patient's pertinent medical history included smoker and hashimoto thyroiditis. The patient's drug reactions/allergies was reported as none. Concomitant therapies included levothyroxine sodium(SYNTHROID).     On 27-AUG-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (lot # R034248 with expiry date of 07-AUG-2020) (strength and dose were not reported) intramuscularly in the left arm for smoking history(prophylaxis). On 27-AUG 2019, the patient experienced erythema and swelling at the injection site especially noted after working at her salon, which progressed over a 48 hour period. On the same day, the patient also experienced headache, sinus congestion and left ear pain. She was seen by her doctor on 29-AUG-2019 and diagnosed with injection-site erythema and a left ear infection. The patient was treated with meloxicam as needed for pain and amoxicillin 875 mg twice a day for 7 days for the ear infection and told to rest, ice the injection site and call if the erythema and swelling increased further at the injection site or within the next two weeks if not better. Laboratory diagnostics performed was reported as none. The outcome of ear infection, headache, injection site swelling, injection site erythema and sinus congestion was reported as recovered on an unknown date in 2019(recovery date also reported as no phone call from the patient as of 09-SEP-2019). The causality assessment was not provided by the reporter. No product quality complaint was filed.",,,,,,,,,Y,08/27/2019,08/27/2019,0,,UNK,,SYNTHROID,Hashimoto's thyroiditis; Smoker,,,US0095075131909USA003569,2,09/27/2019,,Y,,
0836948,09/30/2019,OH,1.0,,,U,,"No adverse event; patient was administered an expired dose of VAQTA; This spontaneous report was received from a nurse referring to a 12 month old patient. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided.     On 10-SEP-2019, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated( VAQTA) lot # R027431 (verified to be a valid lot number), expiration date reported and established as 08-SEP-2019, for prophylaxis. No adverse event was reported.",,,,,,,,,U,09/10/2019,09/10/2019,0,,UNK,,,,,,US0095075131909USA003973,2,09/29/2019,,,,
0836949,09/30/2019,CO,,30,,M,,"Sings of fever and injection site swelling; Sings of fever and injection site swelling; This spontaneous report was received from a pharmacy technician, a 30-year-old male patient reporting on himself. His medical relevant history was not reported.  The patient's concurrent conditions included diabetes and hyperlipidemia. His concomitant medications included rosuvastatin, lisinoplril and insulin lispro (HUMALOG). The patient had no drug reactions or allergies.   On 11-SEP-2019, the patient was vaccinated with a dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PENUMOVAX 23), intramuscularly, (strength, dose, frequency, lot number and expiration date were unknown by reporter) for prophylaxis.   On 12-SEP-2019 (also reported as ""the following date""), the patient experienced having signs of fever (pyrexia) and injection site swelling. The reporter also stated that self-blood glucose checks were performed to him, at home.   At the reporting time, the patient was recovering from the aforementioned events.   The reporter did not assess the causal relationship between Pneumococcal Vaccine, Polyvalent (23-valent) (PENUMOVAX 23) and the events occurrence.",,,,,,,,,N,09/11/2019,09/12/2019,1,,UNK,,rosuvastatin; lisinopril; HUMALOG,Diabetes; Hyperlipidaemia,,,US0095075131909USA005683,2,09/27/2019,,,,
0836950,09/30/2019,CA,,17,,U,,"No adverse effect; patient recieved improperly stored VARIVAX; This spontaneous report was received from a nurse practitioner referring to a male patient of unknown age. The patient's medical history, concurrent conditions, drug allergies/reactions and concomitant medications were not reported.   On 23-SEP-2019, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) lot #S012039, expiration date: 17-APR-2021(strength, dose, schedule and route of administration were unknown) for prophylaxis (product storage error). The varicella virus vaccine live (Oka/Merck) (VARIVAX) was reconstituted with properly stored sterile diluent (lot # S015238, expiry date 08-MAR-2022. No adverse effect reported.  The vaccine underwent temperature excursion below -9 degree Celsius to 8 degree Celsius (0.84 C) for a duration of 8 hours. There was no previous temperature excursion. There was an involvement of data logger. No product quality complaints (PQC) were involved.",,,,,,,,,U,09/23/2019,09/23/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA009520,2,09/30/2019,,,,
0836952,09/30/2019,NY,,,,U,,"No adverse effect; administered a dose ofVARIVAX, on 9/24/2019, that had been improperly stored; This spontaneous report was received from a vaccine coordinator, also reported as office manager regarding a patient of unknown age. The patient's concurrent conditions, pertinent medical history, drug reactions or alleries and concomitant medication were not reported. On 24-SEP-2019, the patient was inadvertently administered with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # R035222, expiry date: 04-DEC-2020 or lot # S008692, expiration date: 21-MAR-2021 or lot # S019463 has been verified to be a valid lot number, expiration date reported as 24-JAN-2021, but upon internal validation established as 24-JUN-2021 (exact dose, strength, route of administration and anatomical location were not reported) for prophylaxis (product storage error). All the lots of varicella virus vaccine live (oka/merck)(VARIVAX) were reconstituted with a well stored sterile diluent. The vaccine underwent temperature excursion of 27.1 degree Fahrenheit for a duration of 40 minutes. There was no previous temperature excursion. There was an involvement of a data logger. No product quality complaints were involved.",,,,,,,,,U,09/24/2019,09/24/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA013949,2,09/30/2019,,,,
0836953,09/30/2019,,,,,U,,"Became sick afterwards; Local paediatrician sent me at the first vial so i tested and turned out to be positive altogether 16 vial; This spontaneous report was received from a consumer via social media refers to a patient of unknown age. On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) for prophylaxis. On an unknown date, the patient received the ""faux"" placebo of HPV vaccine and became sick (malaise) afterwards. There was no saline placebo it was a faux placebo. The physician reported in social media regarding product quality complain ""Local paediatrician sent me at the first vial so reporter tested and turned out to be positive (altogether 16 vial) (product quality issue)"". The outcome of malaise and product quality issue was unknown. Reporter's causality was not provided.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA014049,2,09/27/2019,,,,
0836954,09/30/2019,NY,,,,U,,"No adverse effect reported; patient was inadvertently administered a dose of PROQUAD that had been improperly stored; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not provided.   On 24-SEP-2019, the patient was inadvertently vaccinated with  improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # R030805 (verified to be a valid lot number), expiration date reported and established as 22-APR-2020 and lot #S003326 (verified to be a valid lot number), expiration date reported and established as 02-AUG-2020, both for prophylaxis and reconstituted with a properly stored sterile diluent. Both lots were improperly stored at 27.1F during a time frame of 40 minutes. The call was because of a data logger. No adverse effect neither previous temperature excursions were reported.",,,,,,,,,U,09/24/2019,09/24/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA014566,2,09/29/2019,,,,
0836955,09/30/2019,MD,,,,U,,"No adverse effects reported; Nurse reports the administration of one dose of an improperly stored vaccine,; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications and historical drugs were not reported.  On 10-SEP-2019, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) per oral route with lot # R030924 and expiration date 10-JUL-2020 for prophylaxis.   The administered dose of vaccine experienced the temperature excursion of 0.24 degrees Celsius (multiple) for 5 hours and 30 min. There was a digital data logger involved, but there was no previous temperature excursion. No adverse effects were reported.",,,,,,,,,U,09/10/2019,09/10/2019,0,,UNK,,,,,,US0095075131909USA014595,2,09/30/2019,,,,
0836956,09/30/2019,FL,,,,M,,"fever; red spots that move around the whole shoulder; This spontaneous report as received from a consumer, an elderly male patient of currently 91 years old. The patient's pertinent medical history, history of drug reactions/allergies, concurrent conditions and concomitant medications were not reported.  On an unknown date approximately in 2014 (also reported as ""4-5 years ago""), the patient was vaccinated with zoster vaccine live (ZOSTAVAX) vial, 1 dose (strength, frequency, lot # and expiry date was not reported) via subcutaneous route (also reported as underneath the skin) for prophylaxis. On an unknown date approximately in 2018, the patient experienced fever (pyrexia) and he was hospitalized on 04-FEB-2018 for the same. On an unknown date, the patient also developed ""red spots that moved around the whole shoulder"" (generalised erythema) after receiving zoster vaccine live (ZOSTAVAX). The patient sought medical attention by talking with physician. It was reported that no treatment was provided for the adverse events. No lab diagnostics/ studies were performed and no product quality complaint was reported. The outcome of the events, pyrexia and generalised erythema was reported as not recovered. Causality assesement was not provided by the reporter.",,,,,Y,,,,N,,,,,UNK,,,,,,US0095075131909USA014604,2,09/30/2019,,,,
0836957,09/30/2019,,,,,U,,"rash on my left arm only, the arm I got my shot; hives; This case was reported by a consumer via call center representative and described the occurrence of hives in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st August 2019, the patient received the 1st dose of Shingrix. In August 2019, 2 days after receiving Shingrix, the patient experienced hives. On an unknown date, the patient experienced rash. On an unknown date, the outcome of the hives was recovered/resolved and the outcome of the rash was unknown.   It was unknown if the reporter considered the hives and rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The patient stated that had hives that cleared up but now at the time of reporting experiencing a rash on left arm.",,,,,,,,,Y,08/01/2019,08/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836958,09/30/2019,,,,,U,,"minor swelling at the site of vaccine injection; rash; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site swelling and injection site rash. On an unknown date, the outcome of the injection site swelling and injection site rash were not recovered/not resolved.   It was unknown if the reporter considered the injection site swelling and injection site rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient asked the duration required to completely recover from rash and swelling which occurred at injection site and if any treatment needed for that. The patient did not provided demographic details and preferred to remain anonymous.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836959,09/30/2019,MS,,3,,M,,"Foreign body reaction to something in the vaccine; Foreign body reaction to something in the vaccine; Developed a draining area; This case was reported by a physician via sales rep and described the occurrence of injection site discharge in a 4-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2018-2019 season) for prophylaxis.   In November 2018, the patient received Fluarix Quadrivalent 2018-2019 season. In January 2019, between 2 and 3 months after receiving Fluarix Quadrivalent 2018-2019 season, the patient experienced injection site discharge. On an unknown date, the patient experienced foreign body reaction and reaction to excipient. On an unknown date, the outcome of the injection site discharge, foreign body reaction and reaction to excipient were unknown.   It was unknown if the reporter considered the injection site discharge, foreign body reaction and reaction to excipient to be related to Fluarix Quadrivalent 2018-2019 season.  Additional case details were provided as follows: The age at vaccination was not reported but it could be 3 years or 4 years. In November 2018, the patient received Fluarix quadrivalent. Subsequently developed a draining area in general area of where vaccine was administered in January 2019.  Biopsy was done by a pediatric dermatologist which showed negative culture and the dermatologist thought the patient likely had a foreign body reaction to something in the vaccine.",,,,,,,,,U,11/01/2018,01/01/2019,61,"Test Date: 2019; Test Name: Biopsy; Result Unstructured Data: Test Result: Negative culture, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,Y,,
0836960,09/30/2019,IL,,,,U,,"Mild chills / Shivering; Hands, arms, head were shaking so hard; head were shaking so hard; This case was reported by a consumer and described the occurrence of chills in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th September 2019 14:30, the patient received the 2nd dose of Shingrix. In September 2019, 12 hrs 30 min after receiving Shingrix, the patient experienced chills, tremor and head tremor. On an unknown date, the outcome of the chills was unknown and the outcome of the tremor and head tremor were recovering/resolving.   It was unknown if the reporter considered the chills, tremor and head tremor to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  The patient received 2nd dose of Shingrix on day before reporting at 2:30pm.  The patient woke up at 3:00 am with mild chills. By 3:30am the chills were much worse. The patient's hands, arms, head were shaking so hard. It was alarming. By the 5:00 am the shivering/shaking had calmed (very slight shivering).  The patient read about the side effects and hoping that the shivering doesn't return.  The patient concerns were long term side effects. The reporter consented to follow up.",,,,,,,,,N,09/17/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836961,09/30/2019,TX,71.0,71,,F,,"rash on her back, neck, shoulders and under her arms and was itchy; whelps; Possible Shingles; This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax and Shingrix with an associated reaction of erythema (1st dose received on an unknown date and had whelps and swelling at the injection site, for tolerance refer case US2019170013).   On 14th September 2019, the patient received the 2nd dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced itchy rash, welts and shingles. The patient was treated with hydrocortisone and benadryl (nos) (Benadryl). Rechallenge with Shingrix was positive. On an unknown date, the outcome of the itchy rash, welts and shingles were recovering/resolving.   It was unknown if the reporter considered the itchy rash, welts and shingles to be related to Shingrix.  Additional details were provided as follows: The patient reported for herself. The patient received Zostavax a long time ago but she never had issues with the Zostavax. On the past Saturday (before the reporting date), the patient had her 2nd dose of Shingirx at the pharmacy.   She stated, she now had a rash on her back, neck, shoulders and under her arms. It was itchy and had whelps.  The patient reported the events to the pharmacy, where she got the vaccine and they advised to call GlaxoSmithKline and also to take Benadryl and use hydrocortisone cream.   The patient was wondered, these events could be Shingles, so she was referred to her physician for follow- up. The patient consented to follow up and also provided her physician's details.",,,,,,,,,N,09/14/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836962,09/30/2019,CT,,,,U,,"flu-like symptoms; Muscle ache; Lethargy; Chills; This case was reported by a consumer via call center representative and described the occurrence of flu-like symptoms in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th September 2019, the patient received the 2nd dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced flu-like symptoms, muscle pain, lethargy and chills. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the flu-like symptoms, muscle pain, lethargy and chills were unknown.   It was unknown if the reporter considered the flu-like symptoms, muscle pain, lethargy and chills to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. On the day before reporting date, the patient received his 2nd Shingrix shot. The patient experienced side effects including flu-like symptoms, muscle ache, lethargy and chills but no fever. The patient was asking for treatment for Shingrix side effects and told he would be going to receive Ibuprofen. He took Tylenol for his flu-like symptoms. The patient did not want to provide his street address or MD contact information. No further information provided.",,,,,,,,,U,09/18/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836963,09/30/2019,FL,,,,M,,"passed out; dizziness; feeling nauseos; fell; hitting his head; This case was reported by a other health professional and described the occurrence of passed out in a male patient who received HAV (Havrix) (batch number 299X2, expiry date unknown) for prophylaxis.   On an unknown date, the patient received Havrix. On an unknown date, less than 6 months after receiving Havrix, the patient experienced passed out (serious criteria GSK medically significant), dizziness, nausea, fall and head injury. On an unknown date, the outcome of the passed out, dizziness, nausea, fall and head injury were unknown.   It was unknown if the reporter considered the passed out, dizziness, nausea, fall and head injury to be related to Havrix.  Additional information was reported as follows: The age at vaccination was not reported. After vaccination, the patient experienced dizziness and feeling nauseous. The patient was stood up and passed out. The patient fell backwards hitting his head on floor. This accident occurred under circumstances for which super markets. The reporter requested that, GlaxoSmithKline (GSK) report this promptly to the insurer or arrange for proper investigation and disposition. Also requested that, GSK acknowledge receipt of this notice in writing within fifteen (15) days and advise the undersigned of the name and address of the insurer or other person to whom they might look for handling. This case has been linked with case US2019AMR172641, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/27/2019,,,,
0836964,09/30/2019,FL,,,,F,,"dizziness; feeling nauseos; This case was reported by a other health professional and described the occurrence of dizziness in a female patient who received HAV (Havrix) (batch number 299X2, expiry date unknown) for prophylaxis.   On an unknown date, the patient received Havrix. On an unknown date, less than 6 months after receiving Havrix, the patient experienced dizziness and nausea. On an unknown date, the outcome of the dizziness and nausea were unknown.   It was unknown if the reporter considered the dizziness and nausea to be related to Havrix.  Additional details were provided as follows: The age at vaccination was not reported. After vaccination with dose of Havrix, the patient experienced dizziness and nausea. This accident occurred under circumstances for which super markets. The reporter requested that, GlaxoSmithKline (GSK) report this promptly to the insurer or arrange for proper investigation and disposition. Also requested that, GSK acknowledge receipt of this notice in writing within fifteen (15) days and advise the undersigned of the name and address of the insurer or other person to whom they might look for handling. This case has been linked with case US2019AMR172635, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0836965,09/30/2019,NM,,,,F,,"skin crawling sensation; This case was reported by a consumer via call center representative and described the occurrence of crawling sensation of skin in a 64-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced crawling sensation of skin. On an unknown date, the outcome of the crawling sensation of skin was recovered/resolved.   It was unknown if the reporter considered the crawling sensation of skin to be related to Influenza vaccine Quadrivalent unspecified season.  Additional case details were reported as follows: The age at vaccination was not reported. Several years ago the patient had a reaction to a flu vaccine that caused a skin crawling sensation.  This lasted for almost one year before resolving.  At that time the patient thought it might be due to the thimerosal in the vaccine. The reporter did not consent to follow up. This case had been linked to the case US2019166421, reported for same patient.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0836966,09/30/2019,FL,65.0,65,,F,,"Painful Injection; Accidental Exposure; exposure via skin contact; extra diluent was used; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of swelling (received 1st dose on 8th July 2019).   On 11th September 2019, the patient received the 2nd dose of Shingrix. On 11th September 2019, immediately after receiving Shingrix, the patient experienced injection site pain, inadvertent exposure to vaccine, exposure via skin contact and inappropriate preparation of medication. On an unknown date, the outcome of the injection site pain, inadvertent exposure to vaccine, exposure via skin contact and inappropriate preparation of medication were unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient received 2nd Shingrix dose in her left arm and believed that vaccine was administered incorrectly and that she did not receive full dose of vaccine.  The patient reported that when the pharmacist attempted injection, the needle felt dull and not sharp causing her to jump due the extreme pain from reportedly dull needle. It was reported that clear, cold liquid ran down her arm causing her to suspect full dose was not administered, which led to inadvertent exposure to vaccine, exposure via skin contact. The pharmacist informed that the extra diluent was used while preparing vaccine and that the administered dose was sufficient, which led to inappropriate preparation of medication.  The patient did not experienced reaction to 2nd dose. The patient reported that if the vaccine received intramuscularly. The reporter was unsure of lot number/expiry date.  The reporter desired to know if she was protected from shingles and seeks guidance on either how she can get a refund from pharmacy or  how to receive a 3rd dose without paying for it again.",,,,,,,,,U,09/11/2019,09/11/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836967,09/30/2019,NY,78.0,78,,M,,"rash; yellow rash; This case was reported by a pharmacist via call center representative and described the occurrence of red rash in a 78-year-old male patient who received Herpes zoster (Shingrix) (batch number TB2PK, expiry date 5th October 2021) for prophylaxis.   On 13th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In September 2019, less than a week after receiving Shingrix, the patient experienced skin discoloration. On 17th September 2019, the patient experienced red rash. The patient was treated with avena sativa (Aveeno). On an unknown date, the outcome of the red rash and skin discoloration were not recovered/not resolved.   It was unknown if the reporter considered the red rash and skin discoloration to be related to Shingrix.  Additional details were provided as follows: The patient developed a red rash. He applied Aveeno cream and stated the rash was now yellow in colour. The reporter consented to follow up.",,,,,,,,,N,09/13/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836968,09/30/2019,MA,68.0,68,,F,,"increased discomfort on left arm; intermittent rashes; injection site rash; redness; Pain; looks like psoriasis; eczema; This case was reported by a nurse via call center representative and described the occurrence of arm discomfort in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number H7JY4, expiry date 1st July 2021) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain (received 1st dose on 14th May 2019, refer case US2019169164).   On 17th July 2019, the patient received the 2nd dose of Shingrix. In July 2019, 1 day after receiving Shingrix, the patient experienced psoriasis and eczema. On 18th July 2019, the patient experienced arm discomfort, rash recurrent, injection site rash, erythema and pain. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the arm discomfort, rash recurrent, injection site rash, erythema, pain, psoriasis and eczema were not recovered/not resolved.   It was unknown if the reporter considered the arm discomfort, rash recurrent, injection site rash, erythema, pain, psoriasis and eczema to be related to Shingrix.  Additional details were provided as follows: It was reported that with the second dose patient experienced redness and pain the day after vaccination.  The patient also experienced increased discomfort on her left arm, developed a rash on 18th July 2019. The patient experienced rash at the injection site after the second dose, and had been also experiencing random and intermittent rashes on her upper extremities.  She had one on her right arm that looks like psoriasis or eczema. These events were ongoing. The reporter consented to follow up.  No further details were provided.",,,,,,,,,N,07/17/2019,07/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/27/2019,,,,
0836969,09/30/2019,CA,,,,F,,"Fever Blisters; This case was reported by a pharmacist via call center representative and described the occurrence of fever blister in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th September 2019, the patient received Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced fever blister. The patient was treated with antivirals nos. On an unknown date, the outcome of the fever blister was unknown.   It was unknown if the reporter considered the fever blister to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient underwent a dental procedure after she developed fever blisters. The patient had been prescribed antiviral medications. The reporter did not want to provide any additional details.",,,,,,,,,U,09/16/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/27/2019,,,,
0836970,09/30/2019,IL,64.0,64,,F,,"fatigue; joint pain; muscle pain; Unable to sleep; Sore left arm/ injection ste pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 11th September 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. In September 2019, the patient experienced fatigue, joint pain, muscle pain and sleeplessness. The patient was treated with ibuprofen. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the fatigue, joint pain, muscle pain and sleeplessness were unknown.   It was unknown if the reporter considered the pain in arm, fatigue, joint pain, muscle pain and sleeplessness to be related to Shingrix.  Additional details were provided as follows: The patient same day after receiving vaccine experienced pain at the injection site with sore left arm which resolved in three days. The patient also experienced fatigue, muscle pain and joint pain. For the muscle pain and join pain, the patient was taking ibuprofen which was not helping her much and she was unable to sleep because of that. On the day of reporting the joint pain was localized to both her hips and both the knees. The patient consented to follow up.",,,,,,,,,Y,09/11/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0836971,09/30/2019,NC,21.0,,,F,,"Rash; This case was reported by a other health professional via call center representative and described the occurrence of rash in a 21-year-old female patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2019-2020 season) for prophylaxis.   On 14th September 2019, the patient received FluLaval Tetra 2019-2020 season. In September 2019, less than a week after receiving FluLaval Tetra 2019-2020 season, the patient experienced rash. On an unknown date, the outcome of the rash was recovered/resolved.   It was unknown if the reporter considered the rash to be related to FluLaval Tetra 2019-2020 season.  Additional details were provided as follows: The reporter stated that, the patient developed a rash after receiving vaccine. The reporter stated that, the patient had not taken any treatment. Rash has resolved. The healthcare provider did not provide the patient's initials and did not have the lot or expiry date.",,,,,,,,,Y,09/14/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0836972,09/30/2019,FL,64.0,64,,M,,"Rash; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th September 2019, the patient received Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was   Additional details were reported as follows: The pharmacist reports a patient was in emergency department with a rash on the day of reporting.  The reporter consented to follow up.  The vaccine was given at unknown location, details regarding product were unavailable at time of initial report.",,,,,,,,,U,09/16/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,Y,
0836973,09/30/2019,MA,,,,U,,"Fatigue; Flu-like symptoms; This case was reported by a pharmacist via call center representative and described the occurrence of fatigue in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fatigue and influenza-like symptoms. On an unknown date, the outcome of the fatigue and influenza-like symptoms were unknown.   It was unknown if the reporter considered the fatigue and influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The pharmacist reported that, the patient reported fatigue and flu like symptoms. The reporter did not provide number of patients and vaccine details. The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0836974,09/30/2019,SC,75.0,75,,F,,"Nauseous; Vomiting; Severe headache; Fever; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th September 2019, the patient received the 2nd dose of Shingrix. On 19th September 2019, less than a day after receiving Shingrix, the patient experienced nausea, vomiting, headache and fever. On an unknown date, the outcome of the nausea, vomiting and fever were resolved with sequelae and the outcome of the headache was recovering/resolving.   It was unknown if the reporter considered the nausea, vomiting, headache and fever to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's husband. At 11:00 AM, the patient received a dose of Shingrix. During the day the patient started to feel nauseous. By night time she was vomiting and had a severe headache and a fever.   At the time of report, the patient was in bed due to the headache. The reporter consented to follow up.",,,,,,,,,N,09/19/2019,09/19/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0836975,09/30/2019,GA,51.0,51,,F,,"Welts/shoulder to her elbow; product supply issue; This case was reported by a pharmacist via call center representative and described the occurrence of welts in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 23rd August 2018, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and Shingrix, the patient experienced welts and product supply issue. On an unknown date, the outcome of the welts and product supply issue were unknown.   It was unknown if the reporter considered the welts and product supply issue to be related to Shingrix and Shingrix.  Additional details were received as follows: After 1st vaccination, the patient experienced  welts from her shoulder to her elbow. Pharmacist states when it was time for the patient's second dose, the Shingrix was out of stock at the pharmacy. The reporter consented to follow up. Pharmacist states she did not have further information available at the time of this call, but she could get additional details from the patient. Pharmacist granted permission for follow up.",,,,,,,,,U,08/23/2018,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/29/2019,,,,
0836976,09/30/2019,NJ,,74,,F,,"shingles; rash; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number 2Y9R4, expiry date 28th June 2021) for prophylaxis.   In March 2019, the patient received the 1st dose of Shingrix. In August 2019, less than 5 months after receiving Shingrix, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles and rash were unknown.   It was unknown if the reporter considered the shingles and rash to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The patient received first dose of Shingrix in March 2019 and developed a rash on part of his body in August 2019. The rash was diagnosed as shingles. The reporter consented to follow up.",,,,,,,,,U,03/01/2019,08/01/2019,153,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0836977,09/30/2019,,,,,F,,"vertigo; threw up; dizzy; This case was reported by a consumer via call center representative and described the occurrence of vertigo in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th September 2019, the patient received the 1st dose of Shingrix. On 17th September 2019, less than a day after receiving Shingrix, the patient experienced vertigo, vomiting and dizziness. On an unknown date, the outcome of the vertigo, vomiting and dizziness were not recovered/not resolved.   It was unknown if the reporter considered the vertigo, vomiting and dizziness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The case was reported by patient's sister. The patient had the first dose of Shingrix and the same day vertigo, threw up and was dizzy.  Till the time of reporting the patient was experiencing the events. Reporter did not want to share any personal information.",,,,,,,,,N,09/17/2019,09/17/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0836978,09/30/2019,PA,,,,F,,"Injection site cellulitis; This case was reported by a pharmacist via call center representative and described the occurrence of injection site cellulitis in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced injection site cellulitis. On an unknown date, the outcome of the injection site cellulitis was unknown.   It was unknown if the reporter considered the injection site cellulitis to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The pharmacist reports that a patient developed cellulitis at the injection site the day after receiving the 1st dose of Shingrix.  The dose was given approximately one month ago. The patient was told by urgent care that she would need to repeat the 1st dose. The reporter consented to follow up. Pharmacist did not have many details at the time of the call.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0836979,09/30/2019,PA,78.0,,,F,,"vomiting; This case was reported by a consumer via call center representative and described the occurrence of vomiting in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a day after receiving Shingrix, the patient experienced vomiting. On an unknown date, the outcome of the vomiting was recovered/resolved.   It was unknown if the reporter considered the vomiting to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the Spring of 2019 in the left arm. The patient reported that, in the night after vaccination, the patient experienced vomiting for about 5 hours and then it resolved in the next morning. The patient did not consent to follow up.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0836980,09/30/2019,VA,61.0,61,,M,,"Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th March 2019, the patient received the 1st dose of Shingrix. In August 2019, between 5 and 6 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported that, in August 2019, the patient experienced shingles after vaccination with dose of Shingrix. The pharmacist stated that, the acute stage of shingles resolved. The reporter consented to follow up.",,,,,,,,,Y,03/20/2019,08/01/2019,134,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0836981,09/30/2019,TX,66.0,66,,F,,"little discomfort at the site of the injection; patient received 2 doses on Fluzone Highdose same day; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 66 years old female patient who experienced little discomfort at the site of the injection (vaccination site discomfort), while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Immunisation.  On 19-Sep-2019, the patient received a 0.5 ml dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (injection) lot AG8347 (Expiry date 06-May-2020), twice via intramuscular route in the left deltoid.  On an unknown date, the patient developed a non-serious little discomfort at the site of the injection (vaccination site discomfort), unknown latency following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  It was also a case of actual medication error case due extra dose administered.  Other relevant tests were not reported.  Final diagnosis was little discomfort at the site of the injection.  It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for little discomfort at the site of the injection.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/19/2019,,,,UNK,,PREVNAR 13,,,,USSA2019SA263294,2,09/26/2019,,,,
0836982,09/30/2019,MO,31.0,31,,F,,"31 years old female received Fluzone High Dose, no AE; 31 years old female received Fluzone High Dose, no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 31 years old female breast feeding patient who received 0.5 ml dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ238AB (Expiry date 14-Apr-2020) via unknown route in unknown administration site on 19-Sep-2019.  This case inked with case 2019SA268841 (baby case).  The patient's medical history and concomitant medications were not reported.  It was an actual medication error case due to inappropriate age at vaccine administration and overdose.   At a time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/19/2019,,,,UNK,,,,,,USSA2019SA263295,2,09/27/2019,,,,
0836983,09/30/2019,PA,59.0,,,F,,"patients came in to get Adacel and the nurse accidently gave TD, no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 59 years old female patient who received vaccine DIPHTHERIA AND TETANUS TOXOIDS lot number not reported via unknown route in unknown administration site instead of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL], on 19-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to wrong vaccine administered.  It was reported that one of the patients came in to get Adacel and the nurse accidently gave TD or is there a pertusis vaccine.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,09/19/2019,,,,UNK,,,,,,USSA2019SA263429,2,09/26/2019,,,,
0836984,09/30/2019,KY,0.33,,,U,,"red flat rash that was not a raised like a bee sting; rash over the back of the neck and over the right ear; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves a four months old patient who experienced red flat rash that was not a raised like a bee sting rash over the back of the neck and over the right ear (rash erythematous and rash), while he/she received vaccines DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL], HEPATITIS B VACCINE and PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) [PREVNAR].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received first set of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot number not reported via unknown route in the right thigh.  On an unknown date, the patient received first set of suspect HEPATITIS B VACCINE and PREVNAR not produced by Sanofi Pasteur lot number not reported via unknown route in the in left thigh.  On an unknown date, the patient developed a non-serious red flat rash that was not a raised like a bee sting (rash erythematous) and rash over the back of the neck and over the right ear (rash) 15 minutes following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE, HEPATITIS B VACCINE and PREVNAR.  Other relevant tests not reported.  Final diagnosis was rash and rash erythematous.  It was not reported if the patient received a corrective treatment.  The outcome was unknown for the events.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA263478,2,09/26/2019,,,,
0836985,09/30/2019,NJ,,,,F,,"nurse took a vial and the vial shattered in her hand having the vaccine to spill on the hand, no AE; nurse took a vial and the vial shattered in her hand having the vaccine to spill on the hand, no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 47 years old female patient who was exposed to the vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] lot U6543AB,exp. Date: 23-Feb-2021 on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is an actual medication error case due to accidental exposure to product and exposure via skin contact. It was reported that nurse took a vial from a carton and the vial shattered in her hand having the vaccine to spill on her hand.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA263512,2,09/26/2019,,,,
0836986,09/30/2019,,,,,U,,"didn't come come back in 8 weeks for the 2nd dose, no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves an unknown demographic patient did not come come back in 8 weeks for the second dose of vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] and had a first dose lot number not reported via unknown route in unknown administration site on an unspecified date of Nov-2018.  The patient's past medical history, medical treatment(s), vaccination(s) concomitant medications and family history were not provided.  It is an actual medication error case due to missed dose as the patient missed her second dose.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,11/01/2018,,,,UNK,,,,,,USSA2019SA263514,2,09/26/2019,,,,
0836987,09/30/2019,NY,12.0,12,,F,,"received Ipol from a MDV that was opened and deemed not safe to use / no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.   This case is linked to case 2019SA264028 (same reporter).  This case involves a 12 years old female who received 0.5 ml dose of IPV (VERO) lot PIE70 via intramuscular route in the right arm on 12-Sep-2019.  The patient's past vaccination included OPV (Polio vaccine live oral). Past medical history, medical treatment(s), and family history were not provided.  Concomitant medications included VARICELLA ZOSTER VACCINE (VARICELLA VACCINE), HPV VACCINE (HPV VACCINE) and HEPATITIS A VACCINE (HEPATITIS A).  It was a actual medication error case due to incorrect product storage. It was reported that 2 patient's that received Ipol from a MDV that was opened and deemed not safe to use. The physician mentioned that she thinks that she should be able to use her clinical judgment as to whether or not to reinjection her patient's and she did not believe that this situation warrented it.  At a time of reporting no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/12/2019,,,,UNK,,VARICELLA VACCINE; HPV VACCINE; HEPATITIS A,,,,USSA2019SA264011,2,09/26/2019,,,,
0836988,09/30/2019,TX,,0,.5,F,,"given the diluent portion only from Pentacel; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a non-hcp (Office Staff).  This case involves female patient who received DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] VACCINE lot UJ098AAA via unknown route in the right thigh on 19-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included ROTAVIRUS VACCINE (ROTAVIRUS VACCINE).  It was a case of actual medication error due to inappropriate reconstitution technique.   It was reported that patient was given only the diluent portion of Pentacel.  At a time of reporting no adverse event reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/19/2019,,,,UNK,,ROTAVIRUS VACCINE; PNEUMOCOCCAL VACCINE CONJ 13V (CRM197),,,,USSA2019SA264133,2,09/26/2019,,,,
0836989,09/30/2019,,,,,M,,"painful; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a non-health care professional.  This case involves a male patient of unknown age who experienced that vaccine was painful, while he received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient experienced that vaccine was painful (pain) (Unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  Details of lab data not reported.  Final diagnosis was painful.   It was not reported if the patient received any corrective treatment.  At the time of reporting, event outcome was unknown.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA264549,2,09/27/2019,,,,
0836990,09/30/2019,,,,,F,,"red, swollen, hot to the touch, all local reaction symtoms; red, swollen, hot to the touch, all local reaction symtoms; red, swollen, hot to the touch, all local reaction symtoms; red, swollen, hot to the touch, all local reaction symtoms; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a non-health care professional.  This case involves A female patient of unknown age who experienced red, swollen, hot to the touch, all local reaction symptoms (vaccination site inflammation, vaccination site warmth, vaccination site erythema, vaccination site swelling) while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication not reported.   On an unknown date, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (prefilled syringe) lot UT6647KA via unknown route in unknown administration site.  On an unknown date, the patient developed red, swollen, hot to the touch, all local reaction symptoms (vaccination site inflammation), (vaccination site warmth), (vaccination site erythema) and (vaccination site swelling) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Details of lab data not reported.  Final diagnosis was red, swollen and hot to the touch, all local reaction symptoms.   It was not reported if the patient received any corrective treatment.  At the time of reporting, event outcome was not reported.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA264561,2,09/26/2019,,,,
0836991,09/30/2019,,,,,M,,"wet his pants after getting the flu shot; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 8 years old male patient who wet his pants after getting the flu shot (dysuria), while he received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient wet his pants after getting the flu shot (dysuria) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Lab data was not reported.  Final diagnosis was dysuria.   It was not reported if the patient received a corrective treatment.  The patient outcome was not reported for dysuria.  Information on the batch number was requested.  List of document held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA264620,2,09/26/2019,,,,
0836992,09/30/2019,NC,,,,U,,"patient received only the DTAP-IPV and not the ActHIB portionof Pentacel, no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a patient who received only the DTAP-IPV and not the ACT-HIB portion of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot and expiry date was not reported, on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error due to inappropriate reconstitution technique.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number is requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA264635,2,09/26/2019,,,,
0836993,09/30/2019,IN,,1,.3,F,,"was accidentally given Pentacel with no AE; given an extra dose of ActHIB with no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 15 months old female patient who received vaccines HIB (PRP/T) VACCINE [ACT-HIB] and DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] and reported that was accidentally given Pentacel with no AE (inappropriate schedule of product administration) and given an extra dose of ActHib with no AE (extra dose administered).  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On 20-Sep-2019, the patient received 3rd dose of suspect 0.5 ml DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot UJ013AA and expiry date: 10-Oct-2020 via intramuscular route in the left thigh.  On an unknown date, the patient received a dose of suspect HIB (PRP/T) VACCINE lot UI957AA via unknown route in unknown administration site.  It was a case of actual medication error due to inappropriate schedule of vaccine administered and extra dose administered.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/20/2019,,,,UNK,,,,,,USSA2019SA264783,2,09/27/2019,,,,
0836994,09/30/2019,NY,,1,.3,F,,"Daptacel that expired on Sep 18 was administered to a patient, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 15 months old female patient who was inadvertently vaccinated with an expired dose of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (frequency once) lot C5254AA, expiry date: 18-Sep-2019 via intramuscular route in the left arm on 20-Sep-2019.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is an actual medication error case due to expired vaccine used.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/20/2019,,,,UNK,,ACTHIB,,,,USSA2019SA264967,2,09/27/2019,,,,
0836995,09/30/2019,MD,1.5,1,.5,F,,"Daptacel was given to a consumer that expired 2 days prior, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 18 months old female patient who was inadvertently vaccinated with an expired dose of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (frequency once) lot C5254AB, expiry date: 18-Sep-2019 via intramuscular route in the left deltoid on  20-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  concomitant vaccine included hep A (hepatitis A vaccine) and Flu shot (influenza vaccine)  It is an actual medication error case due to expired vaccine used. It was reported that by mistake gave an expired Daptacel.   At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/20/2019,,,,UNK,,HEPATITIS A; FLU VACCINE VII,,,,USSA2019SA264968,2,09/27/2019,,,,
0836996,09/30/2019,PA,30.0,,,M,,"30 year old male was given Fluzone High Dose, no AE; 30 year old male was given Fluzone High Dose, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 30 years old male patient who was vaccinated with a dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot number not reported via unknown route in unknown administration site on 19-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is an actual medication error case due to overdose and Inappropriate age at vaccine administration.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,09/19/2019,,,,UNK,,,,,,USSA2019SA264986,2,09/27/2019,,,,
0836997,09/30/2019,NY,,,,F,,"a female patient received Flublok that was out of range for more than 24 hours because they donot have data logger/No AE; Initial information and additional information received on 20-Sep-2019 regarding an unsolicited non-valid non-serious case received from a consumer (office staff).  This case is linked to cases 2019SA267191, 2019SA267208, 2019SA267209, 2019SA267210, 2019SA267211, 2019SA267212, 2019SA267213, 2019SA267214, 2019SA267215, 2019SA267216, 2019SA267217, 2019SA267218, 2019SA267219, 2019SA267220, 2019SA267221, 2019SA267222, 2019SA267223, 2019SA267224, 2019SA267225, 2019SA267226, 2019SA267227, 2019SA267228, 2019SA267229, 2019SA267230, 2019SA267231 and 2019SA267232.  This case involves a female patient (age unknown) who received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] that was out of range for more than 24 hours because they do not have data logger (lot number and expiry date not reported).  It was an actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA265193,2,09/27/2019,,,,
0836998,09/30/2019,KY,,56,,M,,"patient received an expired dose of Fluzone / no AE; 56 year patient receive Fluzone HD dose/ no AE; 56 year patient receive Fluzone HD dose / no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 56 years old male patient who received 0.5 ml dose of  INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ000AB (Expiry date Mar-2019) via intramuscular route in the left deltoid on 20-Sep-2019.  The patient's medical history and concomitant medications were not reported.  It was an actual medication error case due to Expired vaccine used, inappropriate age at vaccine administration and overdose.   At a time of reporting no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/20/2019,,,,UNK,,,,,,USSA2019SA265507,2,09/27/2019,,,,
0836999,09/30/2019,VA,,,,M,,"severe alpha-gal reaction; possible hives; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a male patient (age unknown) who experienced severe alpha-gal reaction (food allergy) and possible hives (urticaria), while he received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number and expiry date not reported via unknown route in unknown administration site.  On an unknown date, the patient experienced a non-serious severe alpha-gal reaction (food allergy) and possible hives (urticaria) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was severe alpha-gal reaction.   It was not reported if the patient received a corrective treatment.  The patient outcome was not reported for the events.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA265509,2,09/27/2019,,,,
0837000,09/30/2019,TX,23.0,23,,F,,"MA mistakingly gave a pregnant patient preservative free Flublok in stead of preservative free Fluzone Quad/no AE; MA mistakingly gave a pregnant patient preservative free Flublok in stead of preservative free Fluzone Quad/no AE; Initial pregnancy information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA266136, 2019SA266138 and 2019SA266137 (same reporter).  This case involves a 23 years old female patient who was mistakenly exposed to preservative free vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] instead of preservative free INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] while she was pregnant.  Patient's gestation period at onset and gestation period at exposure was not reported, the date of last menstrual period was not reported, the estimated due date is 16-DEC-2019.  The patient's past medical history, previous pregnancy/ies, medical treatment(s), vaccination(s) and family history were not provided.  Patient was not on any concomitant therapy.  On 20-Sep-2019, the patient received a 0.5 ml single dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number 16-DEC-2019 via unknown route in the right deltoid.  It was a case of actual medication error due to wrong vaccine administered (Wrong product administered).  It was reported that patient did not experience any adverse event at the time of reporting.  Additionally, at time of reporting, the outcome of the pregnancy was unknown because patient's delivery due date is on 16-DEC-2019.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,09/20/2019,,,,UNK,,,,,,USSA2019SA266135,2,09/26/2019,,,,
0837001,09/30/2019,TX,39.0,39,,F,,"MA mistakingly gave a pregnant patient preservative free Flublok instead of preservative free Fluzone Quad/no AE; MA mistakingly gave a pregnant patient preservative free Flublok instead of preservative free Fluzone Quad/no AE; Initial pregnancy information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA266135, 2019SA266138 and 2019SA266137 (same reporter).  This case involves a 39 years old female patient who was mistakenly exposed to preservative free vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] instead of preservative free INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] while she was pregnant.  Patient's gestation period at onset and gestation period at exposure was 3 weeks, the date of last menstrual period was 28-DEC-2018 and the estimated due date is 12-NOV-2019.  The patient's past medical history, previous pregnancy/ies, medical treatment(s), vaccination(s) and family history were not provided.  Patient was not on any concomitant therapy. . On 20-Sep-2019, the patient received a 0.5 ml single dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number 16-DEC-2019 via unknown route in the right deltoid.  It was a case of actual medication error due to wrong vaccine administered (Wrong product administered).  It was reported that patient did not experience any adverse event at the time of reporting.  Additionally, at time of reporting, the outcome of the pregnancy was unknown because patient's delivery due date is on 12-NOV-2019.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,09/20/2019,,,,UNK,,,,,,USSA2019SA266136,2,09/26/2019,,,,
0837002,09/30/2019,TX,25.0,25,,F,,"MA mistakingly gave a pregnant patient preservative free Flublok instead of preservative free Fluzone Quad/no AE; MA mistakingly gave a pregnant patient preservative free Flublok instead of preservative free Fluzone Quad/no AE; Initial pregnancy information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA266135, 2019SA266138 and 2019SA266136 (same reporter).  This case involves a 25 years old female patient who was mistakenly exposed to preservative free vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] instead of preservative free INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] while she was pregnant.  Patient's gestation period at onset and gestation period at exposure was 3 weeks, the date of last menstrual period was 13-FEB-2019 and the estimated due date is 07-DEC-2019.  The patient's past medical history, previous pregnancy/ies, medical treatment(s), vaccination(s) and family history were not provided.  Patient received DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, TETANUS VACCINE TOXOID (ADACEL) as concomitant therapy on 20-Sep-2019 in the left deltoid.   On 20-Sep-2019, the patient received a 0.5 ml single dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number 16-DEC-2019 via unknown route in the right deltoid.  It was a case of actual medication error due to wrong vaccine administered (Wrong product administered).  It was reported that patient did not experience any adverse event at the time of reporting.  Additionally, at time of reporting, the outcome of the pregnancy was unknown because patient's delivery due date is on 07-DEC-2019.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,09/20/2019,,,,UNK,,ADACEL,,,,USSA2019SA266137,2,09/26/2019,,,,
0837003,09/30/2019,TX,32.0,32,,F,,"MA mistakingly gave a pregnant patient preservative free Flublok instead of preservative free Fluzone Quad/no AE; MA mistakingly gave a pregnant patient preservative free Flublok instead of preservative free Fluzone Quad/no AE; Initial pregnancy information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA266135, 2019SA266137 and 2019SA266136 (same reporter).  This case involves a 32 years old female patient who was mistakenly exposed to preservative free vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] instead of preservative free INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] while she was pregnant.  Patient's gestation period at onset and gestation period at exposure was unknown, the date of last menstrual period was 06-JAN-2019 and the estimated due date is 13-OCT-2019.  The patient's past medical history, previous pregnancy/ies, medical treatment(s), vaccination(s) and family history were not provided.  No concomitant therapy was received.  On 20-Sep-2019, the patient received a 0.5 ml single dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number 16-DEC-2019 via unknown route in the left deltoid.  It was a case of actual medication error due to wrong vaccine administered (Wrong product administered).  It was reported that patient did not experience any adverse event at the time of reporting.  Additionally, at time of reporting, the outcome of the pregnancy was unknown because patient's delivery due date is on 13-OCT-2019.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,09/20/2019,,,,UNK,,,,,,USSA2019SA266138,2,09/26/2019,,,,
0837004,09/30/2019,,,,,U,,"flu-like symptoms; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a patient of unknown demographics who experienced flu-like symptoms (influenza like illness), while he/she received vaccine INFLUENZA VACCINE.  The patient's past medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route.  On an unknown date, The patient developed a non-serious flu-like symptoms (influenza like illness) Unknown latency following the administration of INFLUENZA VACCINE.  No lab test reported.  Final diagnosis was flu-like symptoms.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for flu-like symptoms.  Information on the batch number was requested.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA266489,2,09/27/2019,,,,
0837005,09/30/2019,UT,12.0,,,U,,"administered Flublok instead of Fluzone Quad/no AE; administered Flublok instead of Fluzone Quad/no AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case is linked to case 2019SA267237.  This case involves a 12 years old patient who vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] instead of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported via unknown route.  It was of actual medication error due to Inappropriate age at vaccine administration and wrong vaccine administered.  It was unknown where adverse event was experienced or not.  Information on the batch number was requested.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267184,2,09/27/2019,,,,
0837006,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial and follow-up information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267208; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267227; 2019SA267226; 2019SA267229; 2019SA267228; 2019SA267230; 2019SA267231; 2019SA267232, 2019SA265193.  This case involves a female patient of unknown age who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the right deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No other concomitant vaccine was given.  It was a case of actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267191,2,09/27/2019,,,,
0837007,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial and follow-up information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267227; 2019SA267226; 2019SA267229; 2019SA267228; 2019SA267230; 2019SA267231; 2019SA267232, 2019SA265193.  This case involves a female patient of unknown age who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left arm on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No other concomitant vaccine was given.  It was a case of actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267208,2,09/27/2019,,,,
0837008,09/30/2019,NY,,,,M,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193 (same reporter).  This case involves (an adult) male patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left Upper deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267212,2,09/26/2019,,,,
0837009,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff)  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.   This case involves (an elderly) female patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267213,2,09/26/2019,,,,
0837010,09/30/2019,NY,,,,M,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193;.  This case involves (an elderly) male patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267214,2,09/26/2019,,,,
0837011,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff)  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193;   This case involves (an elderly) female patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267215,2,09/26/2019,,,,
0837012,09/30/2019,NY,,,,M,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff)  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves (an elderly) male patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267216,2,09/26/2019,,,,
0837013,09/30/2019,NY,,,,M,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff)   This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193;.  This case involves (an elderly) male patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267217,2,09/26/2019,,,,
0837014,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff)   This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193;   This case involves (an adult) female patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the right deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267219,2,09/26/2019,,,,
0837015,09/30/2019,NY,,,,M,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff)  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves (an adult) male patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267220,2,09/26/2019,,,,
0837016,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves (an adult) female patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267221,2,09/26/2019,,,,
0837017,09/30/2019,NY,,,,M,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves (an elderly) male patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the right deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267222,2,09/26/2019,,,,
0837018,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial and additional information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves a female patient of unknown age who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this Flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267223,2,09/27/2019,,,,
0837019,09/30/2019,NY,,,,M,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves a male patient of unknown age who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the right upper deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267224,2,09/27/2019,,,,
0837020,09/30/2019,NY,,,,M,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves a male patient of unknown age who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directiveand Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267225,2,09/27/2019,,,,
0837021,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial and follow-up information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves a female patient of unknown age who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccination included Pneumococcal Conjugate Vaccine 13.  It was a case of actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,PNEUMOCOCCAL VACCINE CONJ 13V (CRM197),,,,USSA2019SA267226,2,09/27/2019,,,,
0837023,09/30/2019,NY,,,,M,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves an adult male patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-Jun-2020 via intramuscular route in the left deltoid on an unspecified date, which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No other vaccine was administered.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267227,2,09/26/2019,,,,
0837024,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial and follow-up information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267227; 2019SA267226; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves a female patient of unknown age who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No other concomitant vaccine was given.  It was a case of actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267228,2,09/27/2019,,,,
0837025,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case involves a female patient (elderly) who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No other vaccine was administered.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267229,2,09/27/2019,,,,
0837026,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial and follow-up information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267227; 2019SA267226; 2019SA267229; 2019SA267228; 2019SA267231; 2019SA267232; 2019SA265193.  This case involves a female patient of unknown age who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left arm on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No other concomitant vaccine was given.  It was a case of actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267230,2,09/27/2019,,,,
0837027,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial and follow-up information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267227; 2019SA267226; 2019SA267229; 2019SA267228; 2019SA267230; 2019SA267232; 2019SA265193 (same reporter).  This case involves a female patient of unknown age who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the right deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No other concomitant vaccine was given.  It was a case of actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267231,2,09/27/2019,,,,
0837028,09/30/2019,NY,,,,F,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial and follow-up information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267227; 2019SA267226; 2019SA267229; 2019SA267228; 2019SA267230; 2019SA267231; 2019SA265193 (same reporter).  This case involves a female patient of unknown age who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the right arm on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No other concomitant vaccine was given.  It was a case of actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267232,2,09/27/2019,,,,
0837029,09/30/2019,AZ,,,,F,,"I was giving the injection, it leaked onto my hand, and it was close to the barrel, no AE; I was giving the injection, it leaked onto my hand, and it was close to the barrel, no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a female patient who was giving the injection INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UJ236AA, expiry date: 04-Apr-2019) and half of the dose was leaked onto his hand on 19-Sep-2019  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of vaccine exposure via skin contact and syringe issue.  At the time of reporting the patient had no adverse event.  It was also reported that screwing the needle on tight for injecting the dose her gloved hand was suddenly wet from the vaccine leaking. She stated the leaking must have come from the barrel of the syringe on the side or perhaps the orange part of the needle because that is where her finger was resting. Rph mentioned the other doses in the carton were fine to administer. She asked if the dose should be repeated, she will call the patient back to the pharmacy.  Needle type: Safety, BD safety glide, 25g by 1 inch.  List of document held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA268222,2,09/26/2019,,,,
0837033,09/30/2019,VA,56.0,56,,F,,Red rash on both legs lasting less than 24 hours,,,,,,,,,Y,09/28/2019,09/29/2019,1,,PUB,,"Premarin, Vesicare, Vitamin D3, Allegra",none,"Environmental allergies, over active bladder, menopause",,,2,09/30/2019,,,,"Morphine, sulfa meds"
0837034,09/30/2019,MA,12.0,12,,F,,FAINTED IN THE OFFICE,,,,,,,,,Y,09/27/2019,09/27/2019,0,"CLOSE MONITORING,  RANDOM GLUCOSE TEST, FLUIDS.",PVT,,,CHILLS,,,,2,09/30/2019,,,,NKDA
0837035,09/30/2019,NY,70.0,70,,M,,a few drops dripped out,,,,,,,,,U,09/30/2019,09/30/2019,0,,PHM,,,,,,,2,09/30/2019,,,,
0837036,09/30/2019,MO,81.0,81,,F,,"Pt stated on 9/30/2019 that she had been experiencing vomiting for 3 days following her Shingrix vaccination. She also stated she was having pain below her right ribs. I suggested she go to the urgent care to seek care as soon as possible, and she said she would do that.",,,,,,,,,U,09/27/2019,09/27/2019,0,,PHM,,unknown,,,,,2,09/30/2019,,Y,,nkda
0837042,09/30/2019,IN,,,,U,,"No adverse events.; a patient was administered 1 dose of improperly stored VAQTA and 1 dose of improperly stored GARDASIL 9; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 09-SEP-2019, the patient was vaccinated with 1 dose of improperly stored hepatitis a vaccine, inactivated (VAQTA) ( lot # S017739 has been verified to be a valid lot number, expiry date 29-AUG-2020) (exact dose and route of administration were not reported) for prophylaxis.  On the same day, the patient also received 1 dose of improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # 1621934, expiry date 29-JAN-2022) (exact dose and route of administration were not provided) for prophylaxis.  The storage temperature was above 47 Fahrenheit degrees/ 9 Celsius degrees (28 Fahrenheit degrees) for 24 hours. A data logger was not involved. The event was first identified on 10-SEP-2019. No adverse events were reported. The outcome was unknown.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,US0095075131909USA004183,2,09/30/2019,,,,
0837043,09/30/2019,TX,,,,U,,"No adverse effects; improperly stored vaccine, VARN AX, was administered to one patient; Assistant confirmed route of administration was ""intramuscular""; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information regarding patient's pertinent medical history, drug reactions, allergies and concomitant therapies provided. On 12-SEP-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 milliliter, once, via intramuscular route (confirmed by medical assistant) (lot # S002877 has been verified to be a valid lot number, expiration date 29-JAN-2021) for prophylaxis (anatomical location was not reported). The vaccine was reconstituted with a properly stored sterile diluent (lot # S000130, expiration date 23-AUG-2021).  The vaccine underwent a temperature excursion of 8.1 degrees Fahrenheit for 20 minutes. Previous temperature excursions were reported of 8.1 degrees Fahrenheit for 17 minutes and 9.5 degrees Fahrenheit for 21 minutes.  Digital Data Logger was involved in recording of the excursion. No adverse effects were reported.",,,,,,,,,U,09/12/2019,09/12/2019,0,,UNK,,sterile diluent,Prophylaxis,,,US0095075131909USA005924,2,09/30/2019,,,,
0837044,09/30/2019,TX,,,,F,,"unable to go to work/Bad reaction; patient had received second Shingrix dose onemonth late at 7 months past the first dose; This case was reported by a pharmacist via call center representative and described the occurrence of inability to work in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date ).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced inability to work and drug dose administration interval too long. On an unknown date, the outcome of the inability to work and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the inability to work to be related to Shingrix.  Additional details were received as follows: The patient received second Shingrix dose one month late at 7 months past the first dose, which led to lengthening of vaccination schedule.  The patient told her she was unable to go to work for one week after getting the vaccination. HCP calling regarding a female patient On an unknown date the patient received dose one of Shingrix and 7 months later received dose two. The HCP reported the patient experienced a bad reaction after receiving dose two.  The reporter did not consented to follow up.  The pharmacist was reporting a patient that had experienced this in the past.  The patient did not know all the details.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837045,09/30/2019,CA,,,,U,,"feel lousy/ malaise; upset stomach; Headache; Malaise; This case was reported by a consumer via call center representative and described the occurrence of feeling abnormal in a 71-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, 1 day after receiving Shingrix, the patient experienced feeling abnormal, upset stomach, headache and malaise. On an unknown date, the outcome of the feeling abnormal, upset stomach, headache and malaise were unknown.   It was unknown if the reporter considered the feeling abnormal, upset stomach, headache and malaise to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced headache, upset stomach and malaise. The patient asked whether it is normal to feel lousy the next day after receiving shingrix.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837046,09/30/2019,RI,67.0,67,,M,,"Redness at the injection site; Injection site itched; Chills; This case was reported by a consumer via call center representative and described the occurrence of chills in a 67-year-old male patient who received Herpes zoster (Shingrix) (batch number 9LG54, expiry date 25th September 2021) for prophylaxis.   On 17th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 18th September 2019, 1 days after receiving Shingrix, the patient experienced chills. On 19th September 2019, the patient experienced injection site erythema and injection site itching. On 19th September 2019, the outcome of the chills was recovered/resolved. On an unknown date, the outcome of the injection site erythema and injection site itching were recovering/resolving.   It was unknown if the reporter considered the chills, injection site erythema and injection site itching to be related to Shingrix.  Additional details were provided as follows: The patient experienced chills, redness the size of a baseball at the injection site and it itched. The chills were gone when the patient woke up on Thursday, September 19, 2019. On 20th September 2019, the patient noted that both the redness and itching were less. The patient gave permission for his physician to be contacted.",,,,,,,,,N,09/17/2019,09/18/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837047,09/30/2019,NJ,67.0,67,,F,,"Abnormal reading / Neutrophils were slightly elevated; Neutrophils were slightly elevated; This case was reported by a consumer via call center representative and described the occurrence of complete blood count abnormal in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number BY2Y4, expiry date 13th November 2021) for prophylaxis.   On 2nd September 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 3rd September 2019, 1 days after receiving Shingrix, the patient experienced complete blood count abnormal and neutrophils increased. On an unknown date, the outcome of the complete blood count abnormal and neutrophils increased were unknown.   It was unknown if the reporter considered the complete blood count abnormal and neutrophils increased to be related to Shingrix.  Additional details were provided as follows: The patient stated that the following day after receiving vaccine had a complete blood count test and resulted an abnormal reading which is unusual because blood test normally is within normal limits. The patient stated that the neutrophils were slightly elevated. The patient stated that the expiry date was September 2020 from her paperwork because that was 1 year from administration date, but system show 13th November 2021. The patient consented to follow up.",,,,,,,,,U,09/02/2019,09/03/2019,1,"Test Date: 20190903; Test Name: Complete blood count; Result Unstructured Data: Test Result: abnormal, Test Result Unit: unknown; Test Date: 20190903; Test Name: Neutrophils; Result Unstructured Data: Test Result: 03-SEP-2019, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837048,09/30/2019,TX,35.0,35,,F,,"Small papular rash on upper chest, deltoid, back, and neck; This case was reported by a nurse via call center representative and described the occurrence of papular rash in a 35-year-old female patient who received HBV (Engerix B) (batch number 2224M, expiry date 1st March 2022) for prophylaxis.   On 16th September 2019, the patient received the 2nd dose of Engerix B. On 17th September 2019, 1 days after receiving Engerix B, the patient experienced papular rash. On an unknown date, the outcome of the papular rash was unknown.   It was unknown if the reporter considered the papular rash to be related to Engerix B.  Additional details were provided as follows: The reporter stated that, the patient developed small papular rash on upper chest, deltoid, back, and neck the next day after receiving vaccine. No itching, fever, or malaise. The reporter consented to follow up.",,,,,,,,,U,09/16/2019,09/17/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837049,09/30/2019,CA,,,,F,,"Soreness around the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced soreness around the injection site. The caller did not want to answer any adverse event questions.  The patient briefly mentioned that she had heard a lot of people who had experienced many reactions for 2 days after getting Shingrix vaccine. No further details were provided.",,,,,,,,,U,09/19/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837050,09/30/2019,NM,50.0,50,,M,,"Shingles rash; This case was reported by a pharmacist via call center representative and described the occurrence of rash zosteriform in a 50-year-old male patient who received Herpes zoster (Shingrix) (batch number BP57E, expiry date 7th December 2021) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Shingrix. In September 2019, couple of days after receiving Shingrix, the patient experienced rash zosteriform. On an unknown date, the outcome of the rash zosteriform was unknown.   It was unknown if the reporter considered the rash zosteriform to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient developed rash after receiving vaccine. The rash was on one side of his body including his arm and trunk and looks like a shingles rash.",,,,,,,,,U,09/09/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837051,09/30/2019,IL,4.0,4,,F,,"red warm swollen right thigh, tender",,,,,,,,,U,09/25/2019,09/28/2019,3,none,PVT,,cetririzine hcl 5mg 1/2 tab daily,none,none,,,2,09/30/2019,,Y,,nka
0837052,09/30/2019,GA,71.0,71,,F,,"Per patient report via email 9/29/19:  My arm was swollen, feverish red & very sensitive from my underarm to my elbow. I took some aspirin & slept most of Wednesday afternoon & Thursday  Yesterday the redness and swelling were gone",,,,,,,,,Y,09/25/2019,09/25/2019,0,,PVT,,lisinopril/HCTZ diclofenac topical gel alendronate lovastatin calcium citrate/vitamin D3,,hypertension hyperlipidemia Diabetes osteopenia,,,2,09/30/2019,,,,metformin penicillin
0837053,09/30/2019,NY,11.0,11,,M,,Patient vaccinated on 9/26/19. Had some soreness on that date at night. on 9/27/19 in the am had a little redness applied ice at school. Came to office for visit. Local redness swelling and blotchy. Dx Cellulitis at apt with provider. Antibiotic prescribed along with Benadryl.,,,,,,,,,U,09/26/2019,09/27/2019,1,None,PVT,,None,Ankle Sprain 9/11/19,None,,,2,09/30/2019,,Y,,None
0837054,09/30/2019,TN,90.0,90,,F,,"Sleepiness, confusion, shaking, left eye blood vessel rupture, Muscle weakness - head droops to left side and cannot get up or down without assistance, can barely walk with a walker, doesn't speak unless asked a question and delayed response, right arm jerking constantly, incontinence, itchy skin, easily distracted and forgets what she is doing",,,,,Y,2,,Y,N,09/22/2019,09/22/2019,0,"EKG, bloodwork, CT scan of head, urinalysis",PVT,,Entrestro Levothyroxine Carvedilol Warfarin Bumetanide Tamsulosin Centrum Silver Calcium Focus Select,,Congestive Heart Failure Atrial Fib Thryroid,,,2,09/30/2019,,,Y,Latex Amiodarone
0837055,09/30/2019,MS,55.0,55,,F,,"Fever, Redness and swelling in the left arm, approximately 36 hours after injection",,,,,,,,,Y,09/23/2019,09/25/2019,2,,PHM,,"Protonix 40mg, Zanaflex 4mg, Klonopin 1mg, Cymbalta 60mg and 30mg, Ventolin HFA",,,,,2,09/30/2019,,Y,Y,No Known
0837056,09/30/2019,MD,37.0,37,,F,,"On July 19, patient received pre-travel vaccinations, Hep A#1, IPV, JEV, Rabies #1, and Typhoid vaccines. The next morning she was ill and remained ill for 10 days with fever, occipital headache, vomiting, and dizziness. She had only a mild residual occipital HA when she received Rabies vaccine #2 July 26th.  Within about 36 hrs she was ill as before with headache, vertigo, palpitations, chest heaviness, and sweating. About 14 days post the earlier vaccinations and 3 days following Rabies #2, while seated, she passed out.  LOC lasted less than 5 minutes.  In the ER her HR was 248. She was Dx'd with SVT and treated with Adenosine. Since, the headache, chest pressure, and vertigo persisted. Cardiology cleared her and Rx with Diltiazem. Two days later with onset of chest pressure she suffered another acute LOC while seated lasting about 1 minute. Since then, she has had bouts of tachycardia, sweating, dizziness generally in the morning with arising.  She has had one bout of dyspnea, tachycardia, and chest pain which awoke her from sleep.  She no longer exercises as symptoms worsen. She awakes unrefreshed, feeling generally fatigued.  She feels anxious/tremulous most all the time and feels her concentration is impaired.  She was Dx'd with an adjustment disorder with anxiety for which she took hydroxyzine. She denies further vomiting, or history of dysuria, incontinence, constipation, diarrhea, postprandial syncope, flushing, neurogenic pain, or heat/cold intolerance.  Tentative Diagnosis: Dysautonomia.",,,,,,,,,N,07/19/2019,08/06/2019,18,"05 AUG 2019: HCT 36.3 (L), TSH 0.58 (nl), CMP (nl), Troponin T <6.0 (nl), D-Dimer 0.31 (nl) 27 SEP 2019: CRP 0.082 (nl), ESR 9 (nl), Troponin T <6.0 (nl)",MIL,,"Azelsatine spray, Fluticasone,  Diclofenac gel,  Capsaicin",None,,,,2,09/30/2019,,Y,Y,None
0837057,09/30/2019,MO,0.25,0,.3,M,,"Received Rotateq on 9/25/19 @ 1100, vomiting started @ 2330 9/26/19, vomited 2 episodes then, denies hematemesis, did not feed @ 0400 on 9/27/19, blood noted in diaper without stool @ 0400, called exchange and sent to ED, unable to reduce intussusception, surgery (reduction & appendectomy) @ 1230 9/27/19",,,,,Y,1,,,U,09/25/2019,09/26/2019,1,NO HOSPITAL REPORT AVAILABLE AT THIS TIME,PVT,,NONE,BRONCHIOLITIS 8/27/19,CONGENITAL CHORDEE  NEONATAL DACROCYSTITIS,,,2,09/30/2019,,,,"NKDA, NO FOOD ALLERGIES"
0837058,09/30/2019,IL,54.0,54,,F,,left arm pain and redness around injection site,,,,,,,,,,09/24/2019,09/25/2019,1,,PVT,,,,,,,2,09/30/2019,,,,Levofloxacin Meperidine
0837060,09/30/2019,OK,16.0,,,F,,"premature ovarian failure; This spontaneous report was received from a physician via a company representative and refers to a 16-year-old female patient. There was no information regarding patient's pertinent medical history, drug reactions, allergies and concomitant therapies provided. On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis. On an unknown date, the patient developed premature ovarian failure. No details were provided. The patient sought medical attention, however it was unknown, if she received any treatment. The outcome of the event was unknown. The causality assessment was not provided.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA007150,2,09/30/2019,,,,
0837061,09/30/2019,,,,,F,,"died after hpv vaccine; HPV 16,11,18 (first vial tested and turn out to be positive); PQC Present: Yes; This spontaneous report was received from a consumer via social media referring to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (dose, route, lot# and expiry date were not reported) for prophylaxis. On an unknown date, the patient died after administration of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL). It was reported that the first vial was sent to the reporter by the local paediatrician. The reporter tested the vial and was turned to be positive (Human papilloma virus test positive and product quality issue). Cause of death was unknown and it was unknown whether autopsy was performed. The outcome of papilloma viral infection and product quality issue was unknown. The reporter considered the event of death and human papilloma virus test positive as related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL). Causality assessment for product quality issue was not reported.  This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-0807USA02497:Same reporter US-009507513-1609USA002149:Same reporter; Reported Cause(s) of Death: unknown cause of death",Y,,,,,,,,N,,,,Test Name: human papilloma virus test; Test Result: Positive,UNK,,,,,,US0095075131909USA012460,2,09/30/2019,,,,
0837062,09/30/2019,IN,,,,F,,"dehydration/ patient was admitted to the hospital for IV hydration; symptom of feeling ill; injection site swelling at both sites; This spontaneous report has been received from a physician via a field employee referring to a female patient in her 70's years of age. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided.   On an unknown date the patient was vaccinated with flu vaccine (unspecified name and manufacturer) (lot #, expiration date, dose, frequency and route were unknown) in one arm and pneumococcal vaccine (manufacturer unknown) (lot #, expiration date, dose, frequency and route were unknown) in the other arm for prophylaxis.    On an unknown date (reported as after two days), the patient was seen in the office with symptoms feeling ill, injection site swelling at both sites and dehydration. The patient was admitted to the hospital (unspecified name and location) for intravenous (IV) hydration. The patient was discharged from the hospital on an unspecified date.  The outcome and causality of the events was unknown.",,,,,Y,,,,U,,,,,UNK,,,Prophylaxis,,,US0095075131909USA012472,2,09/30/2019,,Y,,
0837063,09/30/2019,MN,,,,F,,"vesicular rash; This case was reported by a physician via sales rep and described the occurrence of vesicular rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, 21 days after receiving Shingrix, the patient experienced vesicular rash. On an unknown date, the outcome of the vesicular rash was unknown.   It was unknown if the reporter considered the vesicular rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient developed vesicular rash which looked like herpes type rash but more scattered presentation. Developed 3 weeks post shingrix dose.  The reporter was unsure if related.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837064,09/30/2019,FL,80.0,,,M,,"swelling in his left shoulder, hand, wrist, and arm; pain arm/pain in arm; pain in shoulder; pain in wrist; This case was reported by a consumer via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than a week after receiving Shingrix, the patient experienced extensive swelling of vaccinated limb, pain in arm, shoulder pain and wrist pain. The patient was treated with analgesic, nos (Pain Pills (Nos)) and paracetamol (Tylenol). On an unknown date, the outcome of the extensive swelling of vaccinated limb, pain in arm, shoulder pain and wrist pain were unknown.   It was unknown if the reporter considered the extensive swelling of vaccinated limb, pain in arm, shoulder pain and wrist pain to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and developed severe pain and swelling in his left shoulder, hand, wrist, and arm. He states it was so severe he went to the emergency room, and called his MD. He states he took two pain pills and tylenol. He states the swelling was decreasing, but the pain and swelling are still there at this time. The reporter consented to follow up. The emergency room visit was required. The reporter did not have vaccine adverse event information for this case.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,09/30/2019,,,Y,
0837066,09/30/2019,IA,72.0,72,,F,,"Patient reports hives on bilateral arms, neck and some on torso.  Some localized erythema and swelling, but hives were more bothersome.  Alleviated by Benadryl.",,,,,,,,,Y,09/27/2019,09/28/2019,1,None,PHM,,"Hydrochlorothiazide, xarelto",N/A,History of pulmonary embolism,,,2,09/30/2019,,,,NKDA
0837068,09/30/2019,GA,61.0,61,,F,,"Participant complains of ""slight pain at injection site"" 1 week post vaccination ""which progressed to debilitating pain in the left arm.  Extreme tenderness at injection site and extreme pain upon movement of arm"" 10 days post vaccination.",,,,,,,,,Y,09/16/2019,09/28/2019,12,None - participant declined examination.  States symptoms controlled with Tylenol and Benadryl and better on 9/30/19.,WRK,,,,,,,2,09/30/2019,,,,
0837069,09/30/2019,MA,65.0,65,,F,,"Approximately 4 hours after receiving the vaccines, I had nasal congestion, swelling of eye lids, wheezing, chest tightness, fever (99.5), hoarseness, headache, nausea, dizziness, and passed out x2 when I stood up.  After about 24 hours after receiving the vaccines, I  was able to get up without being dizzy and gradually felt better over the next day.  I did not go to the emergency room.  I took diphenhydramine 25 mg and used my Albuterol inhaler.  I called my PCP office on 9/30/19 to report this adverse reaction and to obtain information necessary to report this adverse event.   I have never previously. had an adverse event to a vaccine.",,,,,,,,,Y,09/27/2019,09/27/2019,0,None,PVT,,none,none,"Mild asthma, osteoarthritis",,,2,09/30/2019,,,,"Ibuprofen - hives Sudafed - fever, joint swelling"
0837070,09/30/2019,NC,29.0,29,,M,,"YEL-AVD (Yellow Fever associated viscerotropic disease) Patient states he was in his normal state of health of 23 Aug 2019 when he received 3 vaccines as part of his immunization requirements to include AVA #1, Typhoid and YF-Vax. He tolerated the vaccines well without any immediate adverse reactions. Within a few hours, he developed bilateral shoulder soreness that lasted about 3 days before resolving. He then did fine until Monday, 2 Sep when he awoke with some subtle left sided chest discomfort. Patient describes the chest discomfort began as a tugging/pulling sensation in his left chest. The pain progressed the following day and began to have associated dyspnea which was worse when lying down or when taking a deep breath. His symptoms continued to worsen and he sought care in the ED on 6 Sep 19. There he was noted to have a (+) D-dimer and CTPA done which did not reveal a PE but did show a small -moderate sized left-sided pleural effusion. In addition, he was noted to have an elevated creatinine and liver associated enzymes. He was hemodynamically stable, oxygenationg at 98% on RA and afebrile in the ED. He also endorses some chills and night sweats that developed during this time. He notes having daily headaches, as well. He further describes his chest pain as a constant dull pain 4 out of 10 in intensity but with acute excaerbations of a sharp pain (9 out of 10) with deep inspiration or lying down. Upon presentation today, he states his symptoms are all resolved other than rare episodes of substernal chest discomfort that occur at rest and resolve within a couple minutes, which he notes as distinctly different than his original pain and dyspnea.He denies any associated nausea, vomiting or diarrhea associated with his symptoms, but did endorse some LH associated with his dyspnea. He denies any recent travel and has never been outside the country. No high risk sexual encounters, etc. He denies a history of atopy/allergies. He received all routine childhood vaccines without any adverse reactions. Patient denies any other known adverse events following immunizations. Patient states he tolerates ingestion of eggs and gelatin and denies any known adverse reactions to latex, neomycin, polymixin, streptomycin, thimerosal, yeast, or formaldehyde.  Patient with clinical history and laboratory findings most consistent with Yellow fever vaccine associated viscerotropic disease (YEL-AVD). This is a rare Adverse Event Following Immunizations (AEFI) that was first described in 2001. It is reported to occur in 0.3 per 100,000 vaccines and is exclusively seen in patients receiving the YF-Vax for the first time, typically occurring within 1-8 days following vaccination but has been reported as far out as 18 days (patient's symptoms began at 10 days out from vaccination). YEL-AVD mimics naturally acquired yellow fever disease with the vaccine virus proliferating and disseminating throughout the patient's tissues. YEL-AVD is defined as acute multiple organ system dysfunction that occurs following vaccinization; it can range from relatively mild multi-system disease to severe multiple organ system failure and death. Initial symptoms of YEL-AVD are nonspecific including fever, headache, malaise, arthralgias, myalgias, nausea, vomiting and diarrhea; as it progresses it can include thrombocytopenia, elevation of transaminases, bilirubin and creatinine; less frequent manifestations include rhabdomyolysis and DIC. YEL-AVD is fatal in more than 60% of reported cases. Unfortunately, patient has no baseline CMPs/BMPs to compare his elevated LAEs and creatinine to. However, his LAEs are already trending down. The patient had multi-system organ involvement to include pleural effusion with dyspnea, elevated liver associated enzymes and acute kidney injury, elevated fibrin degradation products, as well as headaches. I suspect that patient will meet Brighton Collaboration case definition for viscerotrophic disease (level 2 of diagnostic certainty) with elevated Fibrin Degradation Products (elevated D-dimer) as well as a creatinine >/= 1.5 times his baseline value. (baseline value pending but suspect as patient convalesces his creatinine will decrease to less than 1 which will then meet this criteria). Interestingly, several cases of YEL-AVD have involved a history of autoimmune disease or diseases with potential autoimmune etiology. The literature includes 3 patients with SLE, 2 with Addison's disease, 1 with Crohn's disease, 1 with PMR and hypothyroidism, 1 with UC and 1 with myasthenia gravis. This patient has known mild eosinophilia with recent striae and weight gain, as well as some white and blue color changes to his digits. As suggested by his pulmonologist it is prudent to rule out Addison's disease as well as CVD given the literature and patient's history. No history of immunodeficiency, but given YEL-AVD can be associated with immunodeficiency will rule out common immunodeficiency with screening flow cytometry and quantitative Immunoglobulin levels; of note, patient denies a history of thymectomy or myasthenia gravis. Patient should not receive YF-Vax in the future but would not have an indication for such anyways. Patient may receive AVA and Typhoid as needed in the future but would consider dosing them in isolation from other vaccines. Serum sent to CDC for PRNT testing which may also provide some additional diagnostic certainty (already in discussions with Dr.).Patient currently feels his is back to his pre-immunization baseline.",,,,,,,,,Y,08/23/2019,09/02/2019,10,+ D-Dimer (elevated FDP) elevated ALT at 79 (6-43) elevated Creatinine at 1.50 (0.2-1.2) leukocytosis at 13.1k (3.2-10.8) and elevated CD8+ T cells on immunophenotyping,MIL,,"None; denies OTC, herbals or body-building supplements",NONE,NONE,,,2,09/30/2019,,Y,Y,"NKDA; denies, food, stinging insect or environmental allergies"
0837071,09/30/2019,SC,59.0,59,,F,,"It started on 9/28/19, I felt a lump in my throat and I coughed up some phlegm. I thought it was just a cold or maybe I swallowed something, so I started drinking plenty of fluids and sucking on a peppermint. This didn't do the trick, to help me with the problem I was experiencing. I called my PA to ask a question of what to take over the counter that will help, but I have not heard back from his office as of yet.",,,,,,,,,N,09/26/2019,09/28/2019,2,I didn't have any tests or laboratory results taken as of yet.,PVT,,Multi-Vitamins,None,None,,,2,09/30/2019,,,,None
0837072,09/30/2019,NC,13.0,13,,M,,"headache, light sensitive",,,,,,,,,U,09/29/2019,09/30/2019,1,,PVT,,"Flovent, Flocalin, Citalopram, , Flonase, Vitamin D, Ferrous sulfate",,"ADHD,  migraines, asthma",,,2,09/30/2019,,,,"Almonds, hazelnuts, cockroach - very mild Dust mites sensitive"
0837073,09/30/2019,OH,66.0,66,,F,,Severe shaking and cold feeling all over. Uncontrollable movement in both hand especially in left hand. Tightening in throat area. Extreme coldness and could not get warm. Extreme shaking.  Extreme shaking part lasted 20 minutes. Throat tightening lessened after a few minutes.,,,,,,,,,Y,09/24/2019,09/24/2019,0,None,PHM,,"Regiment Aspirin, Multi Vitamin, Omega Plus, and Pro Biotic",None,None,,,2,09/30/2019,,,,Motrin
0837074,09/30/2019,IN,89.0,89,,F,,DIZZY AND LIGHTHEADED,,,,,,,,,U,09/30/2019,09/30/2019,0,AMBULANCE CALLED,PHM,,"eliquis,carvedilol, amiodarone, furosemide, allopurinol, omeprazole",unknown,afib,,,2,09/30/2019,,,Y,
0837075,09/30/2019,MD,72.0,72,,F,,"Out of balance, weakness, not super dizzy, odd severe headache. There adverse reactions started several hours after vaccination.",,,,,,,,,Y,09/27/2019,09/27/2019,0,None.,PHM,,"Progesterone 100mg, Estradiol TDS 0.1 mg patches, Synthroid 50 mcg.",Not known.,Not known.,,,2,09/30/2019,,,,NKA
0837076,09/30/2019,AZ,63.0,63,,F,,SWELLING ON THE ARM AND INFECTION,,,,,,,,,Y,09/24/2019,09/26/2019,2,,UNK,,,,,,,2,09/30/2019,,Y,,
0837077,09/30/2019,IL,56.0,56,,F,,"Began getting body aches, and nausea about 10 pm on same evening, then diarrhea  by early morning.  Lasted until late Sunday 2 days later.",,,,,,,,,Y,09/27/2019,09/27/2019,0,none,PVT,,Zoloft 100mg Xanax 50mg HS,none,Depression,,,2,09/30/2019,,,,none
0837078,09/30/2019,NY,53.0,53,,F,,"Sense of heaviness and soreness, within 10 minutes of injection given.   Tiredness and chills started about 3 hrs later, followed by lower back and upper back - across the shoulders pain.   Muscles were sore, specially in the injection arm and the upper legs and back. Five hours later, the chills were not going away and I had a 101.78  (F) fever.   I took a Tylenol and the fever went down to 100 (F) The body aches got  worse, no appetite,  fever between 99 and 102 until the morning of Sep. 23.  Spent most of Sunday in bed with body aches, fever and a headache - the headache did not start until late Saturday.",,,,,,,,,Y,09/21/2019,09/21/2019,0,"N/A, did not do to MD.",PHM,,crestor 5 mg ( every other day) bystolic 5 mg ( daily) b complex CoQ 10 multi -vitamin,none,high blood pressure,,,2,09/30/2019,,,,penicillin
0837079,09/30/2019,NY,73.0,73,,M,,patient complained of arm hurting,,,,,,,,,Y,09/21/2019,09/21/2019,0,none,PHM,,,,,,,2,09/30/2019,,Y,,
0837080,09/30/2019,NH,0.17,0,.2,M,,"Rotarix vaccine was inadvertently administered intramuscularly instead of orally on 9/26/19 by a per diem nurse working in this office.  The nurse filing this report received a call from mom today who wanted to inquire why the rotavirus vaccine was given IM because she researched and found that it is only given orally.  Reviewed chart and found that the nurse did document it as given in the Right thigh on the consent form.   Patient had some irritability and and one episode of vomiting but patient did receive other vaccinations that day as well.  Spoke to Glaxo Smith Kline regarding this and was advised that there are no studies on the safety of IM injection for Rotavirus but was advised to bring patient back in ASAP to administer an oral dose as the IM dose is invalid.  Patient was brought to the office on 9/30/19 and received an oral dose of Rotarix.  Injection sites were assessed at this time and no symptoms noted.  There was no swelling, redness, or bruising of any of the injection sites.",,,,,,,,,Y,09/26/2019,09/30/2019,4,None,PVT,,None,None,None,,,2,09/30/2019,,,,None
0837081,09/30/2019,FL,81.0,81,,F,,"Arm sensitive to touch, painful, swelling. no redness. Primary Care Physician contacted by patient and told to take Tylenol and Ice area",,,,,,,,,Y,09/25/2019,09/25/2019,0,none,PHM,,"latanaprost, brimonidine, pravastatin, duloxetine",none,cholesterol and glaucoma,,,2,09/30/2019,,,,none
0837082,09/30/2019,UT,29.0,29,,F,,Caregiver returned to employee health office the next r/t concerns for rash on bilateral thighs and lower back following the flu shot.  Pt had the same reaction following Tdap in 2/2019.  Injection site was WNL and employee state the rash was not raised today as it was the night the shot was given.  I recommend she receive all  future vaccines and flu shots from PCP for extra monitoring.,,,,,,,,,Y,09/26/2019,09/26/2019,0,,PVT,,,,,Tdap in 02/2019,,2,09/30/2019,,,,
0837083,09/30/2019,PA,68.0,68,,F,,PATIENT COMPLAINED OF NECK PAIN AND LIGHTHEADEDNESS. ADVISED PATIENT TO SIT DOWN AND CHECK BLOOD PRESSURE. PRESSURE WAS VERY HIGH AT 199/113. CALLED PATIENT'S MD OFFICE AND THEY ADVISED US TO CALL 911. PATIENT WAS TAKEN TO HOSPITAL BY AMBULENCE.,,,,,,,,,U,09/30/2019,09/30/2019,0,UNKNOWN AT THIS TIME,PHM,,AMLODIPINE 10MG BENAZEPRIL 20MG ELIQUIS 5MG SOTALOL 80MG METFORMIN ER 500MG GLIPIZIDE ER 2.5MG,NONE KNOWN,DIABETES HYPERTENSION,,,2,09/30/2019,,,Y,CODEINE QUINOLONES
0837084,09/30/2019,VA,71.0,71,,F,,"Shot made my arm feel very heavy and was sore for several days.  Within 24 hours, I experienced flu-like symptoms--Body aches, fever, headache, fatigue. The fever and body aches are mostly at night; I feel better though tired during the day. (Also, coughing at night but that may just be coincidental rather than causal. ) I took Tylenol as needed to reduce aches and fever which helps temporarily but after 2 nights, I'm still not completely well.  I also use Flovent inhaler and saline nasal spray for coughing as needed.",,,,,,,,,N,09/26/2019,09/26/2019,0,None,PHM,,None,none,Osteoporosis,"Shingrix--flu-like symptoms--body aches, chills/fever, fatigue. I previously reported this on VAERs. Vaccine administered on 7/2",,2,09/30/2019,,,,none known
0837085,09/30/2019,WA,73.0,73,,F,,"Pain level 8 down to fingers for hours, swelling, redness, fever, itching, unable to lift arm 2 days, third day swelling from elbow up and feeling like there is lump in my arm, some soreness, 4th day, today still swelling and upper arm turning yellow.  The injection site never was a problem,  but from shoulder to elbow was very painful and could not move some of the time.  I have had these shots before, the flu shot every year, always a little sore, but this side effect.  It was the week end, did not go to the doctor.  Advil and ice packs and being still.",,,,,,,,,Y,09/27/2019,09/27/2019,0,,PHM,,"Aspirin low dose, atorvastatin 20 mg,  centrum silver tab ,clonazepam tab 1/2 mg,, Glucosamine 1 tab, metoprolol 25 mg, potassium tab, magnesium tab",,,,,2,09/30/2019,,,,penicillin
0837087,09/30/2019,MI,68.0,68,,F,,"Approximately 8 hours after receiving the Shingrix vaccine, I got very cold and had a headache. I was feverish, aching and shivering uncontrollably. My skin was hot to the touch but I could not stop shaking with the cold. This lasted approximately 12 hours. I took an ibuprofen about 10 p.m Did not sleep most of the night. Symptoms subsided the next morning.",,,,,,,,,,09/23/2019,09/23/2019,0,,UNK,,"none; Multivitamin, Vitamin C, Iodine, Magnesium, Collagen",,none,,,2,09/26/2019,,,,none
0837088,09/30/2019,NM,,12,,M,,My son was given the shot the nurse set the needle down my son began having a sezier,,,,,Y,,,,,09/27/2019,09/27/2019,0,,UNK,,None,,,,,2,09/28/2019,,,,Penecilin
0837089,09/30/2019,MO,4.0,4,,M,,"Immediately after receiving injections, pt developed head to toe hives & a cough Tx: Benadryl, prednisone, albuterol, epi Jr.  outcome: Sent to ER",,,,,,,,,Y,08/30/2019,08/30/2019,0,Sent to ER,PVT,,Triamcinolone 0.1% cream Epinephrine,None,"Food: Egg, Peanut, nut allergies  atopic dermatitis",,,2,08/30/2019,,,Y,"Egg, peanut, nut, wheat"
0837090,09/30/2019,TN,12.0,,,M,,"After administration of the gardisil my 12 year old had an intense splitting headache, an intense stomach cramp, and passed out. The doctor had to monitor his blood pressure and make him lie down for a while. Even after we left the doctors office, he was having muscle spasms in his arm that lasted almost 3 hours after we left the doctors office.",,,,,,,,,,09/27/2019,09/27/2019,0,,UNK,,none,none,Na,,,2,09/27/2019,,,,penueceillin
0837099,09/30/2019,NY,,,,F,,"he examined her and noted ""swelling above the elbow, with redness"". The Pharmacist reported that the patient stated it ""feels like the swelling is travelling to the back of my arm"".; swelling in the arm and trouble lifting the arm; he examined her and noted ""swelling above the elbow, with redness"". The Pharmacist reported that the patient stated it ""feels like the swelling is travelling to the back of my arm"".; he examined her and noted ""swelling above the elbow, with redness"". The Pharmacist reported that the patient stated it ""feels like the swelling is travelling to the back of my arm"".; swelling in the arm and trouble lifting the arm; This spontaneous report was received from a pharmacist (R.Ph.) and refers to a non-pregnant female patient of unknown age.  No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.    On 17-SEP-2019, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # R016640 with expiration date of 28-JAN-2020, intramuscularly, for prophylaxis. It was reported that the patient called later in the day (17-SEP-2019) reporting swelling in the arm (peripheral swelling) and trouble lifting the arm (limb discomfort). The pharmacist reported that the patient returned to the Pharmacy, where he examined her and noted swelling above the elbow (joint swelling), with redness (erythema). The Pharmacist reported that the patient stated it ""feels like the swelling was travelling to the back of her arm"", pharmacist reported the swelling as ""transient limb swelling, not directly associated with the injection site"" (oedema). It was referred the patient did seek medical attention but not treatment was provided.   The outcome of oedema, peripheral swelling, erythema, joint swelling and limb discomfort was not provided.  The causality assessment between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.",,,,,,,,,U,09/17/2019,09/17/2019,0,,UNK,,,,,,US0095075131909USA007556,2,09/30/2019,,,,
0837100,09/30/2019,NE,0.17,0,.2,U,,"NO ADVERSE EFFECT; expired dose of rotatteq inadveretently administered; This spontaneous report was received from a Nurse refers to a 9 week old patient. No information was provided regarding the patient's pertinent medical history, concomitant medication and drug reactions/allergies. On 24-SEP-2019, the patient was administered properly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # R002805, expiry date: 23-SEP-2019) for prophylaxis. The vaccine was expired one day prior to administration (expired product administered). No adverse effect reported. The nurse confirmed that the product did not have any temperature excursion. No PQC involved. No additional information provided.",,,,,,,,,U,09/24/2019,09/24/2019,0,,UNK,,,,,,US0095075131909USA014679,2,09/30/2019,,,,
0837101,09/30/2019,CO,,,,U,,"NO ADVERSE EFFECT; expired dose administered; This spontaneous report was received from a medical assistant regarding a patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 25-SEP-2019, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, rHA (recombinant human albumin) (M-M-R II) lot # N025892, expiration date: 19-SEP-2019 (exact dose, strength, route of administration and anatomical location were not reported) for prophylaxis. The vaccine was reconstituted with a sterile diluent (lot number: N030846, expiration date: 26-APR-2020). No product quality complaints were involved.",,,,,,,,,U,09/25/2019,09/25/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA014690,2,09/30/2019,,,,
0837102,09/30/2019,,,,,U,,"Small spot of shingles on my lower back; Small spot; This case was reported by a consumer and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles and rash were unknown.   It was unknown if the reporter considered the shingles and rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per the vaccine indication. The patient had a small spot of shingles on her lower back broke out the day after receiving Shingrix.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837103,09/30/2019,,,,,U,,"mild shingles rash; This case was reported by a physician via sales rep and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: This case was reported by the physician (MD). The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The reporter stated that, the patient experienced mild shingles rash following first dose of shingrix. The reporter stated that did not recall specifics regarding the patient but wanted to share with GlaxoSmithKline(GSK). The physician did not agree to be followed up. This case has been linked with case US2019AMR172649, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837104,09/30/2019,,,,,U,,"mild shingles rash; This case was reported by a physician via sales rep and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: This case was reported by the physician (MD). The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The reporter stated that, the patient experienced mild shingles rash following first dose of shingrix. The reporter stated that did not recall specifics regarding the patient but wanted to share with GlaxoSmithKline(GSK). The physician did not agree to be followed up. This case has been linked with case US2019AMR172644, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837105,09/30/2019,,,,,M,,"Suspected vaccination failure; Came down with the flu; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a 71-year-old male patient who received Flu unspecified (Influenza vaccine) for an unknown indication.   On an unknown date, the patient received Influenza vaccine at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and influenza. On an unknown date, the outcome of the vaccination failure and influenza were unknown.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Influenza vaccine.  Additional details were provided as follows: The age at vaccination was not reported, however the patient could be 71 or 70 years old at time of vaccination. The reporter stated that they took childhood vaccinations and were ok with those. But knowing what they do now about what our Government had been doing, they could not pay us enough money to get those poisonous things. The patient had received flu shot back a few years ago and came down with the flu of which he did never had.  The reporter stated that she never had a vaccine since she was small and she never will. The reporter never had anything that they were supposed to prevent. This case was considered as suspected vaccination failure as details regarding full vaccination schedule and time to onset for the event was unknown at the time of reporting.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837106,09/30/2019,TX,61.0,61,,F,,"Joint pain/hip joint; leg pain; neck pain; Pain upon movement; This case was reported by a consumer via call center representative and described the occurrence of joint pain in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received the 1st dose of Shingrix (intramuscular). In August 2019, less than a day after receiving Shingrix, the patient experienced joint pain, leg pain, neck pain and pain upon movement. On an unknown date, the outcome of the joint pain, neck pain and pain upon movement were recovering/resolving and the outcome of the leg pain was not recovered/not resolved.   It was unknown if the reporter considered the joint pain, leg pain, neck pain and pain upon movement to be related to Shingrix.  Additional details were reported as follows: The patient received her first dose of Shingrix vaccine about 5 weeks ago. The night of vaccination she experienced joint soreness all over the body. The soreness in her neck got better within 4 days, but the soreness in both of her legs was still present and more dominantly on the left legs. The hip joint pain was not gotten better and it was painful upon moving. The reporter consented to follow up. No further details were provided.",,,,,,,,,N,08/01/2019,08/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837108,09/30/2019,AZ,76.0,76,,F,,"felt cold; achiness; This case was reported by a consumer via call center representative and described the occurrence of feeling cold in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd July 2019, the patient received the 1st dose of Shingrix (intramuscular). On 23rd July 2019, less than a day after receiving Shingrix, the patient experienced feeling cold and pain. On 23rd August 2019, the outcome of the feeling cold and pain were recovered/resolved.   It was unknown if the reporter considered the feeling cold and pain to be related to Shingrix.  Additional case details were reported as follows: This case was reported by the patient's husband. The patient received vaccine in left arm. The reporter consented to follow up. This case had been linked to the case US2019171931, reported by same reporter.",,,,,,,,,Y,07/23/2019,07/23/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837110,09/30/2019,IL,71.0,71,,F,08/29/2019,Reported to pharmacy on 8/29 to report a potential adverse Rnx to Shigrix. Hives on arm. Advised to see her physician ASAP Patient has been taking Benadryl.,,,,Y,,,,,U,08/20/2019,,,unknown - apparent Rxn due to hives,OTH,PVT,,,,,,1,,,,,
0837112,09/30/2019,TX,71.0,71,,F,,"Redness at injection site - between size of a quarter and half dollar; generalized fatigue, stomach cramps, nausea  chills and low grade fever.   These started within 1 - 2 hours after vaccination.   Lasted  1 1/2 days . Injection site painful with extreme soreness when moving arm especially overhead.   Pain is receding and is sore to touch and minial pain on moving. Redness is approximately size of a dime now.",,,,,,,,,Y,09/28/2019,09/28/2019,0,None,PHM,,"Armour Thyroid, Preservision,  Culturelle, Garlic,",none,none,,,2,09/30/2019,,,,"Thimerasol, Sulfa"
0837113,09/30/2019,LA,2.0,2,.0,F,,"Administered prior to recommended dose date, due to mix up with sibiling. No adverse reactions to vaccines.",,,,,,,,,N,09/26/2019,09/26/2019,0,,PVT,,Singulair 4 mg daily,None,None,,,2,09/30/2019,,,,None
0837114,09/30/2019,TX,67.0,67,,F,,patient had both shots done on Friday 9/27/2019 at pharmacy. Patient came in with a swollen and itchy arm.,,,,,,,,,N,09/27/2019,09/27/2019,0,N /A,PVT,,"Calcium 600 - D3, Colace, Lidex , Probiotic, Melatonin, Nolvadex , Effexor XR, and Sonata.",N/A,,,,2,09/30/2019,,Y,,N/A
0837115,09/30/2019,OK,0.5,0,.6,M,,"APPROX 5 MIN AFTER VACCINE PARENTS REPORTED TO PROVIDER LEG RED AND SWOLLEN.  UPON ASSESSMENT PT WITH APPROX 4 IN ROUND, RED, WARM AREA AT INJECTION SITE.  PROVIDER DISCUSSED CARE WITH FAMILY. FAMILY INSTRUCTED TO CALL THE CLINIC TOMORROW WITH UPDATE ON PATIENTS CONDITION.  TO SEEK CARE WITH ANY EMERGENT ISSUES.",,,,,,,,,U,09/30/2019,09/30/2019,0,N/A,PVT,,N/A,TEETHING,N/A,,,2,09/30/2019,,,,N/A
0837116,09/30/2019,FL,73.0,73,,F,,"Patient felt like she was going to faint. She felt flushed, and weak",,,,,,,,,Y,09/30/2019,09/30/2019,0,None,PHM,,eliquis,Not known,Not Known,,,2,09/30/2019,,,,No Known allergies
0837117,09/30/2019,TX,27.0,27,,F,,"Patient reported a 3 inch rash at the injection site, with swelling, redness and warmth",,,,,,,,,U,09/28/2019,09/29/2019,1,,PHM,,,,,,,2,09/30/2019,,,,
0837118,09/30/2019,AZ,61.0,61,,F,,"SIRVA  Shoulder pain, trouble lifting arm",,,,,,,,,U,09/17/2019,09/17/2019,0,,PVT,,None,,,,,2,09/30/2019,,Y,,Minocycline Sulfa
0837119,09/30/2019,OR,53.0,53,,F,,"Patient called to report severe pain in the arm following the administration of the vaccination.  ""It hurts really bad, I haven't been able to lift it to hold my cell phone or drive for the last two weeks.""",,,,,,,,,N,09/14/2019,09/14/2019,0,,PHM,,"complete history unknown, has been filling elsewhere.",none reported.,hypertension,,,2,09/30/2019,,Y,,"Bee Sting, cherry, honey, wild cherry, lamotrigine, sulfa antibiotics"
0837120,09/30/2019,NY,12.0,12,,M,,"Severe migraine like headache, light sensitivity, eye pain and strain, hallucinations, mild fever, tremors, confusion, fatique, muscle weakness, exhaustion, trouble speaking.  Began on 9/24 in the morning and progressed throughout the night.  The next 4 days continued with headache, eye pain, and exhaustion.  Symptoms still continue mildly.  I believe it is encephalitis.",,,,,,,,,U,09/17/2019,09/24/2019,7,,PVT,,"Cromolyn Dexmethylphenidate Allegra Ranitidine Vitamin C, D3",,Mast Cell Activation disorder,"6/1/2007 received polio, DTaP, Hep B, Hib, Pnemacocal.  Had 104+ fever, seizures, malaise.",,2,09/30/2019,,Y,,Gluten Cefzil
0837121,09/30/2019,CA,76.0,76,,F,,"I got the Flu shot for this year.I cannot answer the above questions as to exactly what it was. This morning after 1/2 walk came home and after bowel movement vomitted bile. Lower back ache.  An hour later another bowel movement followed by nausea and no vomitting. Still nauseous 1/2 later.  I do not drink, use drugs, have not eaten anything unusual, and am in good health until this am.",,,,,,,,,N,07/27/2019,09/30/2019,65,,PVT,,"multi vitamin for seniors, k2, D3, B complex, calcium/magnesium",no,no,,,2,09/30/2019,,,,multiple allergies
0837122,09/30/2019,OR,62.0,62,,F,,"Later that day I felt extreme fatigue, lack of appetite, thirst and pain and swelling at the injection site spreading to my whole arm and swelling my underarm area. Extremely painful arm due to swelling, especially underarm area. I had chills and felt sick. That night when I tried to sleep my heart rate was really high all night, but seemed to calm down the next day. Had to take pain relieving drugs for 3 days after in order to sleep. (Advil or Tylenol). Still have underarm swelling and pain and it is now 96 hours later.",,,,,,,,,N,09/26/2019,09/26/2019,0,,WRK,,Vitamin D Calcium B Vitamins,,hypertension,,,2,09/30/2019,,,,"Almonds, Water chestnuts, mold on cheese"
0837123,09/30/2019,IL,88.0,88,,F,,Patient stated she had a bruise approximately 3x4 inches in size around the injection site. She did not have any pain.,,,,,,,,,Y,09/19/2019,09/19/2019,0,,PHM,,Low dose aspirin lisinopril allopurinol januvia novolin-R Novolin-N omeprazole amlodipine alprazolam simvastatin levothyroxine gabapentin,,"diabetes, hypertension, anxiety",,,2,09/30/2019,,,,"penicillin, acetaminophen, codeine"
0837124,09/30/2019,OH,66.0,66,,F,,"flu like symptoms - fever, chills, headache, body aches and pains. increased redness and soreness at injection sight. Skin is hot to the touch, painful, and about 6"" X 4"". The redness started on 09/28/2019",,,,,,,,,N,09/27/2019,09/29/2019,2,,PHM,,Atorvastatin Oxybutinin Lisinopril low dose aspirin vitamin (Centrum),none,none,,,2,09/30/2019,,Y,,sulfa
0837125,09/30/2019,CA,10.0,10,,F,,Patient had rash around injection site within 15 minutes of administering vaccine. No breathing issues. Prescribed Benadryl.,,,,,,,,,Y,09/30/2019,09/30/2019,0,,PVT,,None,None,Mild intermittent asthma,,,2,09/30/2019,,Y,,None
0837132,09/30/2019,,,,,U,,"died from Hpv vaccine; HPV 16 11 18 (first vial tested and turned out to be positive); PQC present: Yes/sent me at the first vial so i tested and it turned out to be positive altogether 16 vials; This spontaneous report was received from a consumer via social media referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, anatomical location, lot# and expiry date not reported) for prophylaxis. On an unknown date, the patient died from quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL). It was reported that, the first vial was sent to the reporter by the local paediatrician. The reporter tested the vial and was turned to be positive with strains HPV 16, 11, 18 (Human papilloma virus test positive and product quality issue). Cause of death was unknown and it was unknown whether autopsy was performed. The outcome of papilloma viral infection and product quality issue was unknown. The reporter considered the event of death as related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL). Causality assessment for human papilloma virus test positive and product quality issue was not reported.  This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA012460:same reporter US-009507513-0807USA02497:same reporter; Reported Cause(s) of Death: unknown cause of death",Y,,,,,,,,N,,,,Test Name: Human papilloma Virus test; Test Result: Positive,UNK,,,,,,US0095075131909USA012618,2,09/30/2019,,,,
0837133,09/30/2019,AR,,,,U,,"No adverse event; A patient was given a fourth dose of Gardasil; This spontaneous report as received from a nurse refers to a patient of unknown age and gender.      The patient's pertinent medical history, drug reaction, allergies and concomitant medications were not reported.  On an unknown dates, the patient was vaccinated with the first, second and third doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), for prophylaxis (dose, route of administration, lot# and expiration date were not provided).         On 23-SEP-2019, the patient was given a fourth dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), lot# S008151 with expiration date of 20-NOV-2021, intramuscular injection, for prophylaxis (dose was not provided) (product use issue). No adverse effects reported.",,,,,,,,,U,,09/23/2019,,,UNK,,,,,,US0095075131909USA013592,2,09/30/2019,,,,
0837134,09/30/2019,CA,,,,U,,"No adverse effects were reported; one patient was inadvertently administered one dose of expired VARTVAX (lot N021318 exp 8/7/2019) on 24SEP2019; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No pertinent medical history, concurrent conditions, drug reactions or allergies were provided. Concomitant therapies included sterile diluent.  On 24-SEP-2019, the patient was inadvertently vaccinated with an expired dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # N021318 with an expiration date on 07-AUG-2019) for prophylaxis (dosage schedule, route and anatomical location were not reported). No adverse effects were reported.",,,,,,,,,U,09/24/2019,09/24/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA014664,2,09/30/2019,,,,
0837135,09/30/2019,ND,,,,U,,"No adverse effects reported; Nurse reports one dose of improperly stored pneumovax was administered to patient on 9/23/2019; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug allergies/reactions and concomitant medications were not reported. On 23-SEP-2019, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection; lot # R009163, expiration date: 06-JAN-2020 (strength, dose, schedule, anatomical location, and route of administration were not reported) for prophylaxis (product storage error). The vaccine underwent temperature excursion below 36-degree Fahrenheit: 34.9 Fahrenheit (reported as ""lowest temperature"") for a duration of 119 minutes. There was no previous temperature excursion. There was an involvement of data logger. No adverse effects reported. No product quality complaints (PQC) were involved.",,,,,,,,,U,09/23/2019,09/23/2019,0,,UNK,,,,,,US0095075131909USA014724,2,09/30/2019,,,,
0837136,09/30/2019,AL,,,,M,,"Altered dosing schedule; No adverse effect; This spontaneous report was received from a Registered nurse refers to a male patient of unknown age. No information was provided regarding the patient's pertinent medical history, concomitant medication and drug reactions/allergies. On an unknown date in 2016 (approximately 3 years ago), the patient was administered his first dose of hepatitis a vaccine, inactivated (VAQTA) 1 dosage form for prophylaxis. (strength, dose, frequency, route, lot number, expiry date unspecified). On 26-SEP-2019, the patient was in office to receive booster dose of hepatitis a vaccine, inactivated (VAQTA) (inappropriate schedule of product administration). No adverse effect reported. No PQC involved.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA014730,2,09/30/2019,,Y,,
0837137,09/30/2019,MO,,,,F,,"Pain; Hives; Extreme itching; Redness turned purple and to this day goes its goes completely around my arm; My arm was bright red, hot, swollen at injection site/its goes completely around my arm; My arm was bright red, hot, swollen at injection site; Arm  swollen at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th August 2019, the patient received the 1st dose of Shingrix. In August 2019, less than a day after receiving Shingrix, the patient experienced injection site erythema, injection site warmth and injection site swelling. In September 2019, the patient experienced pain, hives, pruritus and skin discoloration. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the injection site erythema, injection site warmth, injection site swelling, pain, hives, pruritus and skin discoloration were unknown.   It was unknown if the reporter considered the injection site erythema, injection site warmth, injection site swelling, pain, hives, pruritus and skin discoloration to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. On the night of vaccination, the patient's arm was bright red, hot, swollen at injection site.  Several days later, the patient got hives and extreme itching along with the pain.  The patient called the doctor who advised to take OTC (over the counter) benedryl.  The patient stated, the redness turned purple and to this day it spread completely around arm, still painful and occasionally itches.  The patient stated, she would not receive 2nd dose of shingles shot and wished to never get the 1st dose.",,,,,,,,,U,08/30/2019,08/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,Y,,
0837138,09/30/2019,PA,,,,F,,"side effects; This case was reported by a consumer via call center representative and described the occurrence of adverse event in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was not recovered/not resolved.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional information received were as follows: This case was reported by the patient's husband. The age at vaccination was not reported. The patient experienced all of the side effects of her second shingles shot. The reporter asked if could she take anything to lessen them.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837139,09/30/2019,OR,,,,F,,"Infection; Swelling; The site had a ""small rash""; This case was reported by a pharmacist via call center representative and described the occurrence of infection in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2019, the patient received the 1st dose of Shingrix. In September 2019, 1 day after receiving Shingrix, the patient experienced infection, swelling and injection site rash. The patient was treated with antibiotics nos, (Antibiotic (Details Unknown)). On an unknown date, the outcome of the infection, swelling and injection site rash were unknown.   It was unknown if the reporter considered the infection, swelling and injection site rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The reporter stated that the patient developed swelling. The patient sought treatment at urgent care and was diagnosed with an infection for which she was prescribed antibiotics. The patient also had small rash at the injection site. The reporter consented to follow up.",,,,,,,,,U,09/01/2019,09/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,Y,
0837140,09/30/2019,TX,91.0,91,,F,,"Injection site swelling; Fever blister; This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 91-year-old female patient who received Herpes zoster (Shingrix) (batch number BP57E, expiry date 7th December 2021) for prophylaxis.   On 17th September 2019, the patient received Shingrix (intramuscular). In September 2019, less than a week after receiving Shingrix, the patient experienced injection site swelling and fever blister. On an unknown date, the outcome of the injection site swelling and fever blister were unknown.   It was unknown if the reporter considered the injection site swelling and fever blister to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left deltoid. The patient experienced injection site swelling and a fever blister of the mouth following a dose of Shingrix. The healthcare professional did not provide exact start date or outcome of events. The reporter consented to follow up.",,,,,,,,,U,09/17/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837141,09/30/2019,MI,70.0,69,,F,,"elevated blood pressure, 160/100; This case was reported by a consumer and described the occurrence of increased blood pressure in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included hypertension. Concomitant products included medication unknown (Blood Pressure Medication).   On 19th September 2019, the patient received the 1st dose of Shingrix. On 20th September 2019, 1 days after receiving Shingrix, the patient experienced increased blood pressure. On an unknown date, the outcome of the increased blood pressure was not recovered/not resolved.   It was unknown if the reporter considered the increased blood pressure to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in right arm. The patient had an elevated blood pressure of 160/100.  The patient also undergoing a blood pressure medication adjustment at this time as well. The reporter does not have vaccine information for this adverse event. The reporter consented to follow up. In the XML document outcome of event was reported as recovering, but in Argus its mentioned as not recovered, so kept as reported in Argus.",,,,,,,,,N,09/19/2019,09/20/2019,1,"Test Date: 20190920; Test Name: Blood pressure; Result Unstructured Data: Test Result: 160/100, Test Result Unit: unknown",UNK,,BLOOD PRESSURE MEDICATION,Hypertension,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837142,09/30/2019,AZ,81.0,,,M,,"right arm hurts to lift up; unable to lift his right arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 81-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced pain in arm and mobility decreased. On an unknown date, the outcome of the pain in arm and mobility decreased were unknown.   It was unknown if the reporter considered the pain in arm and mobility decreased to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in unknown arm. The patient was unable to lift his right arm because it hurts.  The event was ongoing. The reporter consented to follow up.",,,,,,,,,U,09/19/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837143,09/30/2019,,,,,F,,"Upset Stomach; Chills; Headache; Muscle aches; This case was reported by a consumer via call center representative and described the occurrence of upset stomach in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th September 2019, the patient received the 2nd dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced upset stomach, chills, headache and muscle pain. On an unknown date, the outcome of the upset stomach, chills, headache and muscle pain were unknown.   It was unknown if the reporter considered the upset stomach, chills, headache and muscle pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported, however it could be 69 or 70 years. The age group was captured as adult as per Shingrix indication.  The day before reporting, the patient received the second dose of her Shingrix vaccine. The patient experienced upset stomach, chills, headache, and muscle aches. The patient did not want to provide her entire birth date, but she stated her birth year was 1949. The reporter did not consent to follow up.",,,,,,,,,U,09/19/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837144,09/30/2019,NC,82.0,82,,M,,"bleeding under the skin; it was green on the top part like a bruise and the darker part of blood is down by the elbow; leaking capillary; Bruising; lump that is movable in front of the deltoid.; This case was reported by a pharmacist via call center representative and described the occurrence of hemorrhage subcutaneous in a 82-year-old male patient who received Herpes zoster (Shingrix) (batch number BP57E, expiry date 7th December 2021) for prophylaxis.   Previously administered products included Shingrix. Concomitant products included warfarin sodium (Coumadin).   On 13th September 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 20th September 2019, 7 days after receiving Shingrix, the patient experienced hemorrhage subcutaneous (serious criteria GSK medically significant), injection site discoloration, capillary hemorrhage, contusion and skin mass. On an unknown date, the outcome of the hemorrhage subcutaneous and capillary hemorrhage were not recovered/not resolved and the outcome of the injection site discoloration, contusion and skin mass were unknown.   It was unknown if the reporter considered the hemorrhage subcutaneous, injection site discoloration, capillary hemorrhage, contusion and skin mass to be related to Shingrix.  Additional information was provided as follows: The case US2019172828 was found to be duplicate of case US2019172814 . Hence case US2019172828 would be deleted and all the information of this case will be added in case US2019172814 which is the case of record for this patient. The patient received Shingrix on left deltoid. The pharmacist reported that that she might have hit or nicked a capillary while administering Shingrix to a patient taking warfarin. It was leaked/bleed under the skin for some time and now it was down past the elbow. There was no blood at the injection site. It looks like it stopped. It was green on the top part like a bruise and the darker part of blood was down by the elbow. It started the following week after receiving Shingrix. He also reported a lump that is movable in front of the deltoid. The pharmacist was not sure if this was due to the Shingrix injection given its location. The reporter consented to follow up.",,,,,,,,,N,09/13/2019,09/20/2019,7,,PHM,,Coumadin,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837145,09/30/2019,NJ,48.0,48,,F,,"Patient stated at 12:30 am on 9/27/19 started having fever of 102 F, swelling in her neck, and hives all over her left arm. Today she came in to tell us about the reaction. No swelling evident anymore, and hives were slowly going away. She took nyquil and tylenol.",,,,,,,,,Y,09/26/2019,09/27/2019,1,,PHM,,none,no illnesses,she is a smoker which is why the pneumonia vaccine was recommended. She stated she has been given pneumovax before.,,,2,09/30/2019,,,,penicilline
0837146,09/30/2019,NC,67.0,67,,F,,patient complaining of red itchy rash area at injection site and more soreness than expected,,,,,,,,,U,09/28/2019,09/28/2019,0,,PHM,,"Sertraline, Omeprazole, Alendronate, Clonazepam",,,,,2,09/30/2019,,,,nkda
0837147,09/30/2019,IN,62.0,62,,F,,mild left flank erythema and itching suspect mild zoster,,,,,,,,,Y,07/25/2019,07/01/2019,,none,PVT,,Dexlansoprazole (DEXILANT) 60 MG CPDR   metFORMIN (GLUCOPHAGE) 500 MG tablet   BYSTOLIC 20 MG TABS   olmesartan (BENICAR) 40 MG tablet   amLODIPine (NORVASC) 5 MG tablet   Blood Glucose Monitoring Suppl (ONE TOUCH ULTRA 2) w/Device KIT   di,none,"Type 2 diabetes mellitus without complication, without long-term current use of insulin Hypertension, essential Mixed hyperlipidemia ASD (atrial septal defect) MVP (mitral valve prolapse) History of rheumatic fever Gastroesophageal reflux disease with esophagitis Fear of flying Panic attack Hemangioma of liver S/P hysterectomy Migraine without aura and without status migrainosus, not intractable Essential tremor",,,2,09/30/2019,,,,Bactrim [Sulfamethoxazole W-trimethoprim] Hives  Ciprofloxacin Palpitations Levofloxacin Palpitations   Codeine Nausea Only  Diphenhydramine Palpitations Simvastatin Myalgias
0837148,09/30/2019,FL,56.0,56,,F,,"Day of vaccination 9/26: Progressive chills throughout the day, subsequent diffuse muscle aches, mild headache, congestion, weakness, finger tingling, fever >102 for several hours with shaking chills. Alternated Advil and Tylenol from approximately 18:00 until 02:00. Fever ~100 at 02:00. Low grade fever over 100 the next day 9/27, treated with Advil and Tylenol. Muscle aches improved. Temp and symptoms resolved on 9/28 upon waking.",,,,,,,,,Y,09/26/2019,09/26/2019,0,"I am a physician and my daughter is a nurse. We treated at home conservatively, although my daughter wanted to bring me to the hospital to be assessed. I declined.",OTH,,,,,,,2,09/30/2019,,,,None
0837149,09/30/2019,MI,0.42,0,.5,M,,Pentacel was mixed with sterile diluent instead of the HIB component that it is supposed to be mixed with.,,,,,,,,,U,09/25/2019,09/25/2019,0,,PVT,,none,none,none,,,2,09/30/2019,,,,none
0837150,09/30/2019,SC,71.0,71,,F,,Patient came in stating that she had chills right after the vaccine. Her arm was red and swollen and warm to the touch.,,,,,,,,,U,09/24/2019,09/29/2019,5,,PHM,,"Levothyroxine, Atenolol, Lisinopril,",N/A,n/a,,,2,09/30/2019,,Y,,NKA
0837151,09/30/2019,IA,14.0,14,,F,,"Patient collapsed to the ground, hit her head and was unresponsive within 5 minutes of vaccine administration.  Her eyes rolled back, lips started turning blue, skin went pale and hand were cold.  Within a few minutes she came to but then passed back out.  Within 5 minutes of initial collapse she woke screaming in pain (head and stomach).  911 was called. Pharmacist monitored breathing and pulse.  Blood pressure was 112/60.  Paramedics wanted a blood glucose so pharmacist checked and it was 102.  Patients eyes rolled back into head again and it was decided to transport her to the hospital where they monitored her and performed an EKG.  Everything  was normal and patient was released around 2pm.  Parents report that she is fine now (9/30/19)",,,,,,,,,Y,09/28/2019,09/28/2019,0,Blood glucose 102,PHM,,None,None,None,,,2,09/30/2019,,,Y,None
0837152,09/30/2019,LA,22.0,22,,M,,"Severe chest pain onset during PT. Rated # 8 on scale 1-10. Radiation to rt arm. Center of chest described as a squeezing, hard to breath. No palpitations, diaphoresis or dizziness. Would have intermittent pain in past during PT but nothing like this.   Symptoms: CHEST PAIN, UNSPECIFIED(R079).",,,,,Y,1,,,N,07/15/2019,07/22/2019,7,"Elevated troponin I 0.145 EKG- NSR. No STEMI, mild atrial enlargement.  TTE-normal Chemical Stress test- normal",MIL,,denies,denies,Anemia,,,2,09/30/2019,,,Y,denies
0837153,09/30/2019,VA,45.0,45,,F,,"Patient states that on the 2nd day after receiving the vaccine she developed cellulitis around the injection site (warmth, redness, itching).  She was seen by an MD and prescribed antibiotics.  She states the symptoms are resolving.",,,,,,,,,,09/26/2019,09/28/2019,2,,WRK,,,,,,,2,09/30/2019,,Y,,
0837154,09/30/2019,,74.0,74,,F,,The patient was given an expired vaccine. The patient was contacted and advised to return in 2-4 weeks per recommendation of our Chief Medical Officer to get the current flu vaccine.,,,,,,,,,,09/24/2019,09/24/2019,0,,OTH,,,,,,,2,09/30/2019,,,,
0837155,09/30/2019,NY,63.0,63,,M,,I have a tremendous headache and I've lost the hearing in my left ear,,,,,,,,,N,09/26/2019,09/27/2019,1,Visit to an Urgent Care facility,PHM,,"Benicar, Simvastatin, Jardiance Atenelol",none,Type 2 diabetes,,,2,09/30/2019,,,,none
0837156,09/30/2019,,76.0,76,,F,,The patient was given an expired vaccine. The patient was contacted and advised to return in 2-4 weeks per recommendation of our Chief Medical Officer to get the current flu vaccine.,,,,,,,,,,09/24/2019,09/24/2019,0,,OTH,,,,,,,2,09/30/2019,,,,
0837157,09/30/2019,,76.0,76,,M,,The patient was given an expired vaccine. The patient was contacted and advised to return in 2-4 weeks per recommendation of our Chief Medical Officer to get the current flu vaccine.,,,,,,,,,,09/24/2019,09/24/2019,0,,OTH,,,,,,,2,09/30/2019,,,,
0837158,09/30/2019,WA,10.0,10,,F,,"Chicken pox rash.  Parent reports it started 2 days ago with about 20 lesions, now she has at least 200.",,,,,,,,,N,09/20/2019,09/28/2019,8,none,PVT,,none,no,no,,,2,09/30/2019,,,,none
0837159,09/30/2019,WA,39.0,36,,F,,"She developed low grade fevers, chills, myalgia and fatigue in the first week following vaccination. Her fevers tapered off and she developed knee, hip and shoulder pain and stiffness that transitioned into symmetric, polyarthritis of the wrists, ankles, MTPs, MCPs and PIPs. She started Motrin OTC that has helped with the swelling of her hands and feet but she remains with pain, stiffness and difficulty typing  Symptoms: PAIN IN UNSPECIFIED JOINT(M2550), EDEMA, UNSPECIFIED(R609), FEVER, UNSPECIFIED(R509), OTHER FATIGUE(R5383), MYALGIA(M791).",,,,,,,,,Y,06/27/2016,06/30/2016,3,"11 Jul: CRP 0.5, UA neg, ESR 13",MIL,,unk,unk,unk,,,2,09/30/2019,,Y,,unk
0837172,09/30/2019,KY,,,,M,,"was diagnosed with life-threatening meningitis, encephalopathy, diplopia, and suffered rhabdomyolysis and life-altering stroke, as well as permanent disabilities; was diagnosed with life-threatening meningitis, encephalopathy, diplopia, and suffered rhabdomyolysis and life-altering stroke, as well as permanent disabilities; was diagnosed with life-threatening meningitis, encephalopathy, diplopia, and suffered rhabdomyolysis and life-altering stroke, as well as permanent disabilities; was diagnosed with life-threatening meningitis, encephalopathy, diplopia, and suffered rhabdomyolysis and life-altering stroke, as well as permanent disabilities; was diagnosed with life-threatening meningitis, encephalopathy, diplopia, and suffered rhabdomyolysis and life-altering stroke, as well as permanent disabilities; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a male patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided.     On 29-SEP-2014, the pt was inoculated with a dose of zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, frequency, lot/batch # and expiration date were not reported).     Shortly after receiving zoster vaccine live (ZOSTAVAX), in early December 2014, the pt was diagnosed with life-threatening meningitis, encephalopathy, diplopia, and suffered rhabdomyolysis and life-altering stroke (cerebrovascular accident), as well as permanent disabilities and injuries resulting in prolonged hospitalization and acute care. After of several months of being hospitalized, the pt endured a progression of medical care including physical therapy which continued today.  As a direct and approximate result of zoster vaccine live (ZOSTAVAX), the pt suffered sustained, severe, serious, and permanent/incurable personal injuries and life-long disabilities not present prior to using zoster vaccine live (ZOSTAVAX), which were directly caused by zoster vaccine live (ZOSTAVAX). Pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition and has suffered economic losses due to his inability to work, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.   The reporter considered the events to be related to zoster Vaccine Live (ZOSTAVAX).  The reporter considered all the events to be disabling, and meningitis to be life-threatening. Upon internal review, meningitis, encephalopathy, rhabdomyolysis and  stroke were considered to be medically significant events.",,,Y,,,,Y,Y,N,09/29/2014,12/01/2014,63,,PHM,,,,,,US0095075131909USA009244,2,09/30/2019,,Y,,
0837173,09/30/2019,WA,11.0,,,F,,"Experienced arm swelling which progressed from the elbow all the way up the arm; Itching; This spontaneous report was received via a company representative from a nurse practitioner who is also the mother of the patient and refers to an 11 year old female patient.  The patient's concurrent conditions, medical history, drug allergies or reactions and concomitant therapies were not reported.  On 28-AUG-2019, the patient was vaccinated with a dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) as prophylaxis on an unspecified arm (dose, frequency, anatomical location, route of administration, lot number and expiration date were not reported).  On the same date, the patient experienced arm swelling, which progressed from the elbow all the way up the arm, and itching. The patient went to the emergency  room where she was treated with unspecified intravenous (IV) antibiotics and then was sent home. No further information was provided.  On an unspecified date, the patient recovered from the events.  The causal relationship between the events and therapy with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) was not reported.",,,,,,,,,Y,08/28/2019,08/28/2019,0,,UNK,,,,,,US0095075131909USA009354,2,09/30/2019,,,,
0837174,09/30/2019,CA,,,,U,,"An improperly stored dose of GARDASIL9 was administered to the patient on an unknown date; No adverse effects; This spontaneous report was received from a medical assistant referring to a patient of unknown age and unknown gender. Information about pertinent medical history, drug reactions/allergies and concomitant medication was not reported.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # N022952 with expiration date 14-JUN-2020, dose detail and route were not reported) for prophylaxis.  The vaccine experienced improperly stored and was stored below 36 Fahrenheit degrees (F) and was stored at 32.1 F for 8 hours. There was no previous temperature excursion. The call was because of a data logger involved. No adverse effects were reported.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009472,2,09/30/2019,,,,
0837175,09/30/2019,,,,,F,,"HPV ""vaccine injury""/patient is in wheelchair and has chronic pain; HPV ""vaccine injury"". patient is in wheelchair and has chronic pain; HPV 16,11,18 (first vial tested and turn out to be positive); PQC Present: Yes/Local pediatrician sent me at the first vial so I tested & it turned out to be positive altogether 16 vials""; This spontaneous report was received from a consumer via social media referring to a 16-year-old female patient. The patient's concurrent conditions, medical history, drug reaction/allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (strength, dose, route of administration, lot/batch # and expiry date were not reported) for prophylaxis. On an unknown date, the patient had ""vaccination injury"" (vaccination site injury). The patient was on a wheelchair and had chronic pain (pain). It was reported that, the first vial was sent to the reporter by the local paediatrician. The reporter tested the vial and was turned to be positive with strains HPV 16, 11, 18 (Human papilloma virus test positive and product quality issue). Outcome of the events vaccination site injury, pain, human papilloma virus test positive and product quality issue was unknown. The reporter considered the events vaccination site injury and pain was related to HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9). Causality assessment for human papilloma virus test positive and product quality issue was not reported.  The reporter considered the events vaccination site injury and pain to be disabling.",,,,,,,,Y,U,,,,Test Name: Human Papilloma virus test; Test Result: Positive,UNK,,,,,,US0095075131909USA012513,2,09/30/2019,,,,
0837176,09/30/2019,MD,,,,U,,"no adver event; the administration of one dose of an improperly stored vaccine; This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender.      The patient's pertinen medical history, drug reactions, allergies and concomitant medications were not provided.  On 16-SEP-2019, the patient was vaccinated with an improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # R030924 with expiry date of 10-JUL-2020, for prophylaxis (dose and route of administration were not provided). The vaccine was exposed to a temperature of 0.24 C during a time frame of 5 hours and 30 minutes. There was not previous temperature excursion and there was call because of a digital data logger. No adverse effects reported.",,,,,,,,,U,09/16/2019,09/16/2019,0,,UNK,,,,,,US0095075131909USA013600,2,09/30/2019,,,,
0837178,09/30/2019,MO,,23,,F,,"10 CHICKEN POX blisters; This spontaneous report was received from a Nurse practitioner refers to a 23 year old female patient. No information was provided regarding the patient's pertinent medical history, concomitant medication and drug reactions/allergies. On an unknown date in August 2019 (also reported as 19-AUG-2019), the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (lot # S010296, expiry date: 03-APR-2021) 1 dosage form, via subcutaneous route for prophylaxis. On 19-AUG-2019 (2 week later), the patient developed 10 chikenpox blister (varicella). No treatment received. The patient did not seek medical attention. No intervention to prevent seriousness criteria. No Cancer. No PQC involved. On an unknown date in 2019, the patient had recovered from the event and the blister have healed. Reporter's causality was not provided.",,,,,,,,,Y,08/01/2019,08/19/2019,18,,UNK,,,,,,US0095075131909USA014739,2,09/30/2019,,,,
0837179,09/30/2019,,,,,U,,"My face and particularly forehead broke out with red lesions; My face and particularly forehead broke out with red lesions; Acne outbreak; This case was reported by a nurse and described the occurrence of acne in a elderly patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced acne, skin lesion and erythema. On an unknown date, the outcome of the acne, skin lesion and erythema were unknown.   It was unknown if the reporter considered the acne, skin lesion and erythema to be related to Shingrix.  Additional details were reported as follows: The case was reported by nurse who was patient. The age at vaccination was not reported. The patient reported that the after taking first injection of Shingrix, the patient's face and particularly forehead broke out with red lesions all over the rest of face but the forehead was specially.  The patient asked if this was a very common side effect . The Alfie hydroxide face cream usually had cleared this up but now it looks like an acne outbreak.  The patient did not normally have acne the patient was really surprised that the patient's face reacted to the anti shingles shot.  The patient asked if GlaxoSmithKline could provide any more information on this events.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837180,09/30/2019,CA,,,,F,,"lupus; Shingles; inappropiate schedule of vaccine; This case was reported by a physician via sales rep and described the occurrence of systemic lupus erythematosus in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis, mepolizumab (Nucala) powder for solution for injection for drug use for unknown indication and prednisone for drug use for unknown indication.   On an unknown date, the patient received the 1st dose of Shingrix, the 2nd dose of Shingrix, Nucala 100 mg at an unknown frequency and prednisone at an unknown dose and frequency. On an unknown date, less than 2 years after receiving Shingrix, Nucala and prednisone and not applicable after receiving Shingrix, the patient experienced systemic lupus erythematosus (serious criteria GSK medically significant), shingles and incomplete course of vaccination. The action taken with Nucala was unknown. The action taken with prednisone was unknown. On an unknown date, the outcome of the systemic lupus erythematosus, shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the systemic lupus erythematosus and shingles to be related to Shingrix. The reporter considered the systemic lupus erythematosus and shingles to be unrelated to Nucala.  Additional information was reported as follows: The age at vaccination was not reported. The patient received 1st dose of Shingrx but never received booster, which led to incomplete course of vaccination. The patient was on Nucala 100mg per 4 weeks for approximately 8 months. The patient experienced Shingles. The reporter told that, the patient had other comorbidities like lupus and was on frequent courses of prednisone. The reporter did not think it was related to Nucala since was in presence of other factors, but did discontinue Nucala. It was unknown if the reporter considered the systemic lupus erythematosus and shingles to be related to prednisone.",,,,,,,,,U,,,,,UNK,,NUCALA; PREDNISONE,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837181,09/30/2019,VA,54.0,54,,F,,"Depression; This case was reported by a consumer via call center representative and described the occurrence of depression in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included escitalopram (Lexapro).   On 3rd September 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 4th September 2019, 1 days after receiving Shingrix, the patient experienced depression. On an unknown date, the outcome of the depression was unknown.   It was unknown if the reporter considered the depression to be related to Shingrix.  Additional information received were as follows: The patient stated that about 24 hours after receiving the second dose of Shingrix, she started experiencing depression, and it was still present at the reporting date. The patient had been on Lexapro before she received the Shingrix vaccine.  The repoter did not consent to follow-up. No further details were provided.  The reporter referred to healthcare professional.",,,,,,,,,U,09/03/2019,09/04/2019,1,,UNK,,LEXAPRO,,,,USGLAXOSMITHKLINEUS201916,2,09/30/2019,,,,
0837182,09/30/2019,MD,91.0,91,,F,,"The site of injection that was red; The site of injection that was warm; The site of injection that was moist; Scratching the site of injection; A worm like piece with black dot scraped off from skin / Dark brown scab at the middle of the circlet at redness; Injection site blisters; Itching; Broke out in red hives on both of her ankles, right arm and left shoulder; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 91-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th August 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 15th September 2019, 16 days after receiving Shingrix, the patient experienced injection site erythema, injection site warmth, injection site discharge, injection site abrasion, injection site scab, injection site blisters, pruritus and erythema urticarial. On an unknown date, the outcome of the injection site erythema, injection site warmth, injection site discharge, injection site abrasion, injection site scab, injection site blisters, pruritus and erythema urticarial were unknown.   It was unknown if the reporter considered the injection site erythema, injection site warmth, injection site discharge, injection site abrasion, injection site scab, injection site blisters, pruritus and erythema urticarial to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left arm. Last Sunday, before reporting the patient started itching and broke out in red hives on both of her ankles, right arm and left shoulder. The patient was scratching the site of injection and a worm like piece with black dot scraped off from skin.  She noticed one inch by one inch circle at the site of injection that was red, warm, and moist.  The redness had been now decreased and now there was a dark brown scab at the middle of the circlet at redness. No further details were provided. The reporter consented to follow up.",,,,,,,,,U,08/30/2019,09/15/2019,16,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837183,09/30/2019,AZ,81.0,81,,M,,"pain / right arm pain / pain is more localized to injection site; difficult to lift his arm up; Vaccine administered at inappropriate site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 81-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th September 2019, the patient received the 2nd dose of Shingrix. On 19th September 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, injected limb mobility decreased and vaccine administered at inappropriate site. On an unknown date, the outcome of the injection site pain, injected limb mobility decreased and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the injection site pain and injected limb mobility decreased to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in right arm. The patient was stated the injection was given above the deltoid muscle which led to vaccine administered at inappropriate site.  The patient stated a day before reporting he started to have right arm pain and the pain was more localized to the injection site but the patient was finding it difficult to lift his arm up. The reporter consented to follow up. This case had been linked to the case US2019171934, reported by same reporter.",,,,,,,,,U,09/19/2019,09/19/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,09/30/2019,,,,
0837184,09/30/2019,MD,,,,U,,"Pain, sore at the injection site after getting Trumenba; This is a spontaneous report from a contactable nurse via a Pfizer sales representative.  A patient of unspecified age and gender received meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration on an unspecified date at single dose for immunization.  The patient medical history and concomitant medications were not reported.  The patient experienced pain, sore at the injection site after getting meningococcal group b rlp2086. The outcome of the event was recovered on an unspecified date.   No follow-up attempts are possible; information on the batch number cannot be obtained.",,,,,,,,,Y,,,,,UNK,,,,,,USPFIZER INC2019420208,2,09/30/2019,,,,
0837185,09/30/2019,TX,92.0,92,,M,,"Patient described that they started feeling extremely cold with shivers, yet their skin felt like it was burning. Stated they did not have fever, hives or trouble breathing.  Felt this way 9/27/19 and 9/28/2019",,,,,,,,,Y,09/26/2019,09/27/2019,1,Patient did not seek medical attention from PCP,PHM,,"Fluzone HD, shingrix, pneumovax 23, simvastatin, pramipexole, lamasil, metoprolol, eliquis",No conditions listed on file,No conditions listed on file,,,2,09/30/2019,,,,NA
0837186,09/30/2019,MI,73.0,73,,F,,Pt described severe rash on right arm,,,,,,,,,Y,09/10/2019,09/11/2019,1,unknown,PHM,,,,,,,2,09/30/2019,,,,
0837187,09/30/2019,NY,67.0,67,,M,,"Anaphylaxis, Patient's throat closed due to swelling. Occurred 4 hours post dose, was administered epinephrine in Urgent care and transferred to hospital.",,,,,,,,,Y,09/28/2019,09/28/2019,0,"Cardiac Monitoring 09/28/2019-no abnormal results, CAT Scan 09/28/2019-no abnormal results",PHM,,"Citalopram, simvastatin, fluticasone nasal spray,",None,None,,,2,09/30/2019,,,Y,No known Drug Allergies
0837188,09/30/2019,TX,88.0,88,,F,,"Patient described that they started feeling extremely cold with shivers, yet their skin felt like it was burning. Stated they did not have fever, hives or trouble breathing.  Felt this way 9/27/19 and 9/28/2019",,,,,,,,,Y,09/26/2019,09/27/2019,1,PT did not seek medical attention,PHM,,"lisinopril, pantoprazole, metformin,",Not on file,not on file,,,2,09/30/2019,,,,Penicillins
0837189,09/30/2019,SD,20.0,20,,F,,"Patient reported that she has passed out from a vaccination in the past. After administering the vaccine, patient began to sweat and feel faint. I ran to get her a candy bar and some juice. During that time, the patient's husband and another pharmacist helped her to the floor. The patient took a few sips of Powerade and ate a candy bar. After about 15 minutes, the patient was able to get back up into the chair. She remained there for another 5 minutes before she left with her husband.",,,,,,,,,Y,09/30/2019,09/30/2019,0,,PHM,,,,,unknown,,2,09/30/2019,,,,
0837190,09/30/2019,MI,56.0,56,,F,,"1800 - left shoulder ache started 2200- Took Motrin 200mg preventative at bedtime 0430 (9/27/19)- extreme pain upon movement left shoulder, ache entire shoulder area, bone hurts to touch, no redness or swelling 0700- drive to work with left arm  held to body, feels like  knife stabbing into left shoulder joint. 0730: Seen in Employee health, ice applied to left shoulder, No redness or swelling present,;advised 800 mg  every 8 hours, for next day; sent home from work. 9/28/19- had extreme pain upon movement in left shoulder until 1400 - then eased up.  9/30/19 Able to work without pain- still has some bone tenderness",,,,,,,,,Y,09/26/2019,09/26/2019,0,none,WRK,,Biotin,none,none,,,2,09/30/2019,,,,Steroid nasal spray -allergy
0837191,09/30/2019,OH,68.0,68,,F,,"patient was doing ok until she received 2 vaccines, within minutes , she was flushed red and sweating down her back and felt pain in her chest .  She started to have pain go from her head down her spinal column and reported it on a level of 10/10.   she lied down where we could take care of her, she never lost consciousness and kept her talking, her pain level went down we she left to go to the hospital to a level of 5/5.",,,,,,,,,U,09/30/2019,09/30/2019,0,,PHM,,none known,none was feeling in good health,none,,,2,09/30/2019,,,Y,none
0837192,09/30/2019,PA,49.0,49,,F,,"injection site red  swollen and hot to touch  approx. 4 x 4 inches .  patient c/o it was ""itchy""  but no other complaints",,,,,,,,,Y,09/25/2019,09/26/2019,1,no,WRK,,celexa and omeprozol,no,no,,,2,09/30/2019,,,,"cats, birds and horses"
0837193,09/30/2019,TX,68.0,68,,F,,"Rash at injection site, pharmacist recommended taking 50mg Benadryl and wait a couple hours to see if it helps then go to urgent care if not. 2 days later, on 9/30/2019, pt reported in the morning that the rash went down to her elbow, and she had to go to urgent care and was diagnosed with arm infection.",,,,,,,,,U,09/26/2019,09/28/2019,2,unknown,PHM,,"Simvastatin 40mg, Symbicort 160-4.5mcg, Olmesartan 40mg, Buspirone 5mg, Ipratropium-albuterol 0.5-3mg/3ml nebulizer solution",Unknown,Unknown,,,2,09/30/2019,,,Y,Cipro
0837194,09/30/2019,WA,70.0,70,,M,,"Patient wanted to get 2 vaccines on the same arm on 8/19.  He was due for 2nd Shingrix vaccine and also was due for an annual flu shot.  The two injection sites were separated by about 1 inch apart.  The patient came to the pharmacy complaining of sore arm that has been lasting for longer than 2 weeks.  Per patient, he cannot lift his right arm freely due to severe pain.  Morning seems to be worse than the evening.  We are suspecting that getting 2 vaccines on the same arm probably burdened his immunity.  The patient has never had unusual reactions to any vaccines.  The patient has been taking Tylenol for pain with a minimal pain relief.  The patient would seek medical help soon, but her wife is sick, so he will wait until her wife gets better first.",,,,,,,,,N,08/21/2019,08/22/2019,1,N/A,PHM,,1. Gabapentin 100 mg: 2 capsules by mouth nightly 2. Hydrochlorothiazide 25 mg: 1 tablet by mouth once daily  3. Potassium Chloride 10 mEq ER: 1 tablet by mouth twice daily  4. Tamsulosin 0.4 mg: 1 capsule by mouth once daily in the evening,"Neuropathy, Lower back pain, Hx of prostate surgery, Hypertension, Enlarged prostate","Neuropathy, Lower back pain, Hx of prostate surgery, Hypertension, Enlarged prostate",,,2,09/30/2019,,Y,,No known drug allergies
0837195,09/30/2019,MN,65.0,65,,M,,Sharp pain in deltoid when he reaches up and around. Instructed to ice deltoid and apply aspercream with lidocaine 2-3 times daily as needed.,,,,,,,,,N,09/10/2019,09/10/2019,0,,PVT,,,,,,,2,09/30/2019,,Y,,
0837196,09/30/2019,IL,86.0,86,,M,,Lump that developed in the same arm below the injection sites within 24 hours of receiving. The injections were given more than an inch apart. Patient did not want the shots to be given in separate arms.,,,,,,,,,U,09/24/2019,09/25/2019,1,none,PHM,,,,,,,2,09/30/2019,,,,
0837197,09/30/2019,MI,72.0,72,,F,,"On the same day that I received the injections, in the afternoon, around 3 p.m., started to get very cold,  started shivering and my teeth were chattering.  I assumed it was from the air conditioning.  Later at dinner, around 5:30, in a different location, I two cups of hot tea to try and warm myself, with no luck.  After returning home I went to bed around 9 pm, still feeling extremely cold and shivering.  I slept poorly.  I felt very achy.  I awoke around 5 a.m. feeling very hot.  My husband took my temperature and it was 101.8 degrees.  He gave me two extra strength acetaminophen, which helped bring my fever down and relieved some of my aches.  However, all day that day (Sunday, Sept. 29, 2019) I was extremely tired and fatigued and the aches returned, but not the fever.  Today, Monday, Sept. 30, 2019, I have no fever or aches, but am extremely fatigued.",,,,,,,,,N,09/28/2019,09/28/2019,0,none,PHM,,"Atenolol, Lisinopril, Multaq, Xarelto, Cetirizine, Acetaminophin, Folate, multivitamin",none,"high blood pressure, arthritis",,,2,09/30/2019,,,,"morphine, erythromycin, Bactrim, cashew nuts, pistachios, chick peas"
0837198,09/30/2019,,12.0,12,,M,,Arm became itchy and had hives. Mom gave Benadryl. Hives did not return. Vaccines were given in the same arm so unsure of which vaccine the reaction was from.,,,,,,,,,,09/26/2019,09/26/2019,0,,PVT,,,,,,,2,09/30/2019,,,,
0837200,09/30/2019,CA,21.0,21,,M,,"Joints ache, exhaustion, dizziness, headache, sore-throat, upset-stomach, soreness at injection site and weakness.",,,,,,,,,N,09/29/2019,09/30/2019,1,,PHM,,None,None,None,,,2,09/30/2019,,,,Augmentin and Hydrocodone
0837201,09/30/2019,PA,4.0,4,,F,,hives to left side of face and right arm- both vaccines given in right arm,,,,,,,,,U,09/30/2019,09/30/2019,0,,PVT,,n/a,n/a,n/a,,,2,09/30/2019,,Y,,penicillin
0837202,09/30/2019,SC,26.0,26,,F,,Needle Stick after giving vaccination,,,,,,,,,Y,09/30/2019,09/30/2019,0,,PHM,,Sprintec,,,,,2,09/30/2019,,Y,,
0837203,09/30/2019,MD,74.0,74,,F,,"Patient suffered from lightheaded episode, dizziness, and little vomiting  few minutes after the injection.   After checking patient's blood pressure, providing hydration and being check by first res ponders , she was OK and drove back home.",,,,,,,,,Y,09/29/2019,09/29/2019,0,,PHM,,no,"anxious before vaccination, afraid of needles, ate little that day, possible low blood sugar or dehydrated.",,,,2,09/30/2019,,,,no
0837204,09/30/2019,TN,77.0,77,,M,,"Timeline September 8, 2019 Received Fluad TVS 2019-2020 SYR  (65 YR UP) Adjuvant Rt arm at Pharmacy September 12, 2019 Awakened with enlarged mass in left side of neck and itching in area; no fever September 13, 2019 Office Visit with APRN Walk-In Clinic      started on     clindamycin 300 mg capsule    Commonly known as: CLEOCIN     Take 1 capsule (300 mg total) by mouth 3 times a day for 7 days.    PrescribedSeptember 13, 2019    Approved by APRN    Quantity21 capsules      AND    triamcinolone 0.1 % cream    Commonly known as: KENALOG     Apply bid prn in a thin coat on affected area x 7-10. avoid chronic use.    PrescribedSeptember 13, 2019     September 8, 2019 Received Fluad TVS 2019-2020 SYR  (65 YR UP) Adjuvant Rt arm at Pharmacy September 12, 2019 Awakened with enlarged mass in left side of neck and itching in area; no fever September 13, 2019 Office Visit with APRN Walk-In Clinic    started on     clindamycin 300 mg capsule    Commonly known as: CLEOCIN     Take 1 capsule (300 mg total) by mouth 3 times a day for 7 days.    PrescribedSeptember 13, 2019    Approved by APRN    Quantity21 capsules      AND    triamcinolone 0.1 % cream    Commonly known as: KENALOG     Apply bid prn in a thin coat on affected area x 7-10. avoid chronic use.    PrescribedSeptember 13, 2019    Approved by  APRN    Quantity15 g     Quantity15 g got US neck-- US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) Specimen    US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) Impressions Performed At   There is subcutaneous edema seen in the area of concern below the   patient's left ear.    US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) Narrative Performed At ULTRASOUND OF THE POSTOPERATIVE NECK    TECHNIQUE: Grayscale and color Doppler evaluation of the   infra-auricular area of the left neck was performed.    INDICATION: Swelling. Possible bee sting.    COMPARISON: None    FINDINGS: There is some subcutaneous edema seen within the area of   the patient's swelling below his left ear.    There is no evidence of pathologic regional lymphadenopathy.   US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) Procedure Note Interface, Radiology Results In - 09/13/2019 10:28 AM  ULTRASOUND OF THE POSTOPERATIVE NECK  TECHNIQUE: Grayscale and color Doppler evaluation of the infra-auricular area of the left neck was performed.  INDICATION: Swelling. Possible bee sting.  COMPARISON: None  FINDINGS: There is some subcutaneous edema seen within the area of the patient's swelling below his left ear.  There is no evidence of pathologic regional lymphadenopathy.  IMPRESSION:  There is subcutaneous edema seen in the area of concern below the patient's left ear.  Electronically signed on 9/13/2019 10:26 AM   US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) Performing Organization Address City/State/Zipcode Phone Number      September 14, 2019 Developed measles-like rash with itching over trunk of body, visited walkin clinic    no change in treatment plan; no fever September 16, 2019 Saw PCP Dr.--no fever; CT scan of neck done  CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM) CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM) Specimen    CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM)  Impressions Performed At   Areas of fat stranding centered around two lymph nodes deep to the   left sternocleidomastoid mastoid and in the left submandibular region   as described in the findings. Findings likely reflect an inflammatory   or infectious etiology given adjacent enlargement of the musculature   and fat stranding. However, malignancy, possibly lymphoma or   metastatic disease, cannot be excluded and follow-up imaging is   recommended after treatment to ensure resolution.    I, have reviewed the images and verify the   above interpretation on 9/17/2019 10:52 AM.    Electronically signed on 09/17/2019 10:52  CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM) Narrative Performed At CT NECK WITH CONTRAST    HISTORY: R22.1; Localized swelling, mass and lump, neck  COMPARISON: PET scan 12/20/2018, ultrasound 9/13/2019  TECHNIQUE: Spiral CT of the neck was performed following the   intravenous administration of IV contrast. Coronal and sagittal   reformatted images were generated.  INTRAVENOUS CONTRAST ADMINISTRATION (mL Omnipaque 350): 100  DOSE REPORT (Total DLP mGy*cm): 879    FINDINGS:    There is a region of fat stranding that measures approximately 2.9 x   1.5 cm centered about a left IIB lymph node which measures   approximately 4 mm. In the left submandibular area there is another   approximately 4 mm level IB lymph node at the center of a 1.6 x 2.4   cm area of fat stranding.  There is adjacent overlying asymmetric   thickening of the left platysma.  A few additional mildly prominent   left cervical chain lymph nodes are also present, none of which are   pathologically enlarged.    There are no pathologically enlarged right cervical lymph nodes or   areas of surrounding fat stranding.    The nasopharynx and oropharynx are unremarkable.  There is a cystic   focus along the anterior right aspect of the epiglottis which   measures 7 x 4 mm in greatest axial dimension likely representing a   vallecular cyst as it encroaches into the right vallecula.  The   airway remains patent.    There is mild multifocal calcific atherosclerosis.    1.3 cm lipoma overlying the superior medial left trapezius.    Lung apices are clear. Status post left temporoparietal craniotomy   with an area of encephalomalacia the left temporal lobe. No air-fluid   levels in the paranasal sinuses or mastoid air cells. Moderate   degenerative changes of the cervical spine. Small hypodense nodules   in the thyroid.    CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM) Procedure Note Interface, Radiology Results In - 09/17/2019 10:54 AM  CT NECK WITH CONTRAST  HISTORY: R22.1; Localized swelling, mass and lump, neck COMPARISON: PET scan 12/20/2018, ultrasound 9/13/2019 TECHNIQUE: Spiral CT of the neck was performed following the intravenous administration of IV contrast. Coronal and sagittal reformatted images were generated. INTRAVENOUS CONTRAST ADMINISTRATION (mL Omnipaque 350): 100 DOSE REPORT (Total DLP mGy*cm): 879  FINDINGS:  There is a region of fat stranding that measures approximately 2.9 x 1.5 cm centered about a left IIB lymph node which measures approximately 4 mm. In the left submandibular area there is another approximately 4 mm level IB lymph node at the center of a 1.6 x 2.4 cm area of fat stranding. There is adjacent overlying asymmetric thickening of the left platysma. A few additional mildly prominent left cervical chain lymph nodes are also present, none of which are pathologically enlarged.  There are no pathologically enlarged right cervical lymph nodes or areas of surrounding fat stranding.  The nasopharynx and oropharynx are unremarkable. There is a cystic focus along the anterior right aspect of the epiglottis which measures 7 x 4 mm in greatest axial dimension likely representing a vallecular cyst as it encroaches into the right vallecula. The airway remains patent.  There is mild multifocal calcific atherosclerosis.  1.3 cm lipoma overlying the superior medial left trapezius.  Lung apices are clear. Status post left temporoparietal craniotomy with an area of encephalomalacia the left temporal lobe. No air-fluid levels in the paranasal sinuses or mastoid air cells. Moderate degenerative changes of the cervical spine. Small hypodense nodules in the thyroid.  IMPRESSION:  Areas of fat stranding centered around two lymph nodes deep to the left sternocleidomastoid mastoid and in the left submandibular region as described in the findings. Findings likely reflect an inflammatory or infectious etiology given adjacent enlargement of the musculature and fat stranding. However, malignancy, possibly lymphoma or metastatic disease, cannot be excluded and follow-up imaging is recommended after treatment to ensure resolution.  I, have reviewed the images and verify the above interpretation on 9/17/2019 10:52 AM.  Electronically signed on 9/17/2019 10:52 AM   CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM) Performing Organization Address City/State/Zipcode Phone Number and blood work done-- CREATININE - EXTERNAL MANUAL - Final result (09/16/2019 5:26 PM) CREATININE - EXTERNAL MANUAL - Final result (09/16/2019 5:26 PM) Component Value Ref Range Performed  Creatinine - Ext Man 1.2 0.5 - 1.5 mg/dL IMAGING    CREATININE - EXTERNAL MANUAL - Final result (09/16/2019 5:26 PM) Specimen Blood  CREATININE - EXTERNAL MANUAL - Final result (09/16/2019 5:26 PM) Performing Organization Address City/State/Zipcode Phone Number IMAGING         EGFR/EGFRAA - Final result (09/16/2019 4:56 PM) EGFR/EGFRAA - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed  eGFR >60Comment: Estimated glomerular filtration rate (eGFR) and eGRFAA are calculated using the IDMS MDRD equation which is recommended for use in normal healthy individuals 18-70 years of age and has not been validated in other populations. See eGFR in the Test Directory for additional information. ml/min/1.73 m2    eGFRAA >60Comment: Estimated glomerular filtration rate (eGFR) and GFRAA are calculated using the IDMS MDRD equation which is recommended for use in normal healthy individuals 18-70 years of age and has not been validated in other populations. See eGFR in the Test Directory for additional information. ml/min/1.73 m2 VUMC ESB    EGFR/EGFRAA - Final result (09/16/2019 4:56 PM) Specimen Blood  EGFR/EGFRAA - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number AUTO DIFF - Final result (09/16/2019 4:56 PM) AUTO DIFF - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed At  Neutrophils 65.0 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   %  LAB   Absolute Neutrophils 4.53 1.60 - 8.10 x10(3)/mcL LAB   Lymphs 13.3 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Lymphocytes 0.93 1.10 - 3.50 x10(3)/mcL LAB   Monocytes 11.9 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Monocytes 0.83 0.30 - 1.10 x10(3)/mcL VUMC CERNER LAB   Eosinophils 8.5 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Eosinophils 0.59 0.00 - 0.50 x10(3)/mcL LAB   Basophils 0.6 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Basophils 0.04 0.01 - 0.08 x10(3)/mcL LAB   Imm Gran Automated 0.7 % LAB   Absolute Imm Gran Automated 0.05Comment:  AUTO DIFF - Final result (09/16/2019 4:56 PM) Specimen Blood  AUTO DIFF - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number EHRLICHIA AB PANEL (EHRLICHIA CHAFFEENSIS IGG/IGM) - Final result (09/16/2019 4:56 PM) EHRLICHIA AB PANEL (EHRLICHIA CHAFFEENSIS IGG/IGM) - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed  Ehrlichia chaffeensis IgG Antibody <1:64 Comment: INTERPRETIVE INFORMATION: Ehrlichia Chaffeensis IgG Ab   Less than 1:64 ....... Negative: No significant level of                          Ehrlichia chaffeensis IgG antibody                          detected.   1:64-1:128 ........... Equivocal: Questionable presence                          of Ehrlichia chaffeensis IgG                          antibody detected. Repeat testing                          in 10-14 days may be helpful.   1:256 or greater ..... Positive: Presence of IgG antibody                          to Ehrlichia chaffeensis detected,                          suggestive of current or past                          infection. Seroconversion between acute and convalescent sera is considered strong evidence of recent infection. The best evidence for infection is a significant change (fourfold difference in titer) on two appropriately timed specimens, where both tests are done in the same laboratory at the same time. Test developed and characteristics determined Laboratories. See Compliance Statement B: <1:64 LAB   Ehrlichia chaffeensis IgM Antibody < 1:16 Comment: INTERPRETIVE INFORMATION: Ehrlichia Chaffeensis IgM Ab   Less than 1:16 ....... Negative - No significant level                          of Ehrlichia chaffeensis IgM                          antibody detected.   1:16 or greater ...... Positive - Presence of IgM                          antibody to Ehrlichia                          chaffeensis detected,                          suggestive of current or                          recent infection. While the presence of IgM antibodies suggest current or recent infection, low levels of IgM antibodies may occasionally persist for more than 12 months post-infection. A single IgM result should be interpreted with caution. Test developed and characteristics determined by lab Laboratories. See Compliance Statement B:   <1:16 LAB    EHRLICHIA AB PANEL (EHRLICHIA CHAFFEENSIS IGG/IGM) - Final result (09/16/2019 4:56 PM) Specimen Blood  EHRLICHIA AB PANEL (EHRLICHIA CHAFFEENSIS IGG/IGM) - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number RICKETTSIA RICKETTSII (ROCKY MOUNTAIN SPOTTED FEVER) ANTIBODY (ROCKY MOUNTAIN SPOTTED FEVER IGG/IGM) - Final result (09/16/2019 4:56 PM) RICKETTSIA RICKETTSII (ROCKY MOUNTAIN SPOTTED FEVER) ANTIBODY (ROCKY MOUNTAIN SPOTTED FEVER IGG/IGM) - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed  Rocky Mountain Spotted Fever Antibody IgG <1:64 Comment: INTERPRETIVE INFORMATION: Rickettsia rickettsii (Rocky Mtn.                           Spotted Fever) Ab, IgG          Less than 1:64 ....... Negative - No significant level of                          IgG antibody detected.   1:64 - 1:128 ......... Low Positive - Presence of IgG                          Antibody detected, suggestive of                          current or past infection.   1:256 or greater ..... Positive - Presence of IgG                          antibody detected, suggestive of                          current or past infection. Antibody reactivity to Rickettsia rickettsii antigen should be considered Spotted Fever group reactive. Other organisms within the group include R. akari, R. conorrii, R. australis and R. sibirica. Seroconversion, a fourfold or greater rise in antibody titer, between acute and convalescent sera is considered strong evidence of recent infection. Acute-phase specimens are collected during the first week of illness and convalescent-phase samples are generally obtained 2-4 weeks after resolution of illness. Ideally these samples should be tested simultaneously at the same facility. If the sample submitted was collected during the acute-phase of illness, submit a marked convalescent sample within 25 days for paired testing.  <1:64 LAB   Rocky Mountain Spotted Fever Antibody IgM <1:64 Comment: INTERPRETIVE INFORMATION: Rickettsia rickettsii (Rocky Mtn.                           Spotted Fever) Ab, IgM   Less than 1:64 ....... Negative - No significant level of                          IgM antibody detected.   1:64 or greater ...... Positive - Presence of IgM antibody                          detected, which may indicate a                          current or recent infection;                          however, low levels of IgM                          antibodies may occasionally persist                          for more than 12 months                          post-infection. Antibody reactivity to Rickettsia rickettsii antigen should be considered Spotted Fever group reactive. Other organisms within the group include R. akari, R. conorrii, R. australis and R. sibirica. Seroconversion, a fourfold or greater rise in antibody titer, between acute and convalescent sera is considered strong evidence of recent infection. Acute-phase specimens are collected during the first week of illness and convalescent-phase samples are generally obtained 2-4 weeks after resolution of illness. Ideally these samples should be tested simultaneously at the same facility. If the sample submitted was collected during the acute-phase of illness, submit a marked convalescent sample within 25 days for paired testing. The CDC does not use IgM results for routine diagnostic testing of Rocky Mountain Spotted Fever, as the response may not be specific for the agent (resulting in false positives) and the IgM response may be persistent from past infection. Performed by Laboratories,                             <1:64 LAB    RICKETTSIA RICKETTSII (ROCKY MOUNTAIN SPOTTED FEVER) ANTIBODY (ROCKY MOUNTAIN SPOTTED FEVER IGG/IGM) - Final result (09/16/2019 4:56 PM) Specimen Blood  RICKETTSIA RICKETTSII (ROCKY MOUNTAIN SPOTTED FEVER) ANTIBODY (ROCKY MOUNTAIN SPOTTED FEVER IGG/IGM) - Final result (09/16/2019 4:56 PM)  Performing Organization Address City/State/Zipcode Phone Number CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/16/2019 4:56 PM) CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed White Blood Cells 7.0 3.9 - 10.7 x10(3)/mcL LAB   Red Blood Cells 4.37 4.50 - 6.00 x10(6)/mcL LAB   Hemoglobin 14.7 14.0 - 18.1 gm/dL LAB   Hematocrit 43 41 - 49 % LAB   Mean Cell Volume 99 81 - 98 fL LAB   Mean Cell Hemoglobin 33.6 27.0 - 32.0 pg LAB   Mean Cell Hemoglobin Concentration 33.9 31.0 - 35.0 gm/dL LAB   RDW SD 47.8 37.4 - 52.4 fL LAB   RDW CV 13.2 11.1 - 14.3 % LAB   Platelet 220 135 - 371 x10(3)/mcL LAB   Mean Platelet Volume 9.8 9.3 - 12.8 fL LAB   Nucleated RBC 0 /100 WBC LAB   Nucleated RBC Abs 0.00 x10(3)/mcL LAB   Auto Neutrophil Absolute 4.53Comment: This test was performed at: Laboratory, 1.60 - 8.10 x10(3)/mcL LAB    CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/16/2019 4:56 PM) Specimen Blood  CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number PSA - Final result (09/16/2019 4:56 PM) PSA - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed  Prostate Specific Antigen 1.19 Comment: PSA is used to assist in diagnosis and monitoring of prostate cancer. When used as an initial screening test, there is no universally accepted normal range for PSA. The PSA value should be interpreted in light of factors such as age, race, family history of prostate cancer, digital rectal examination result, and result of prior prostate biopsy. For more information on calculating prostate cancer risk based on these factors, see the Prostate Cancer Prevention Trial risk calculator.    ng/mL LAB    PSA - Final result (09/16/2019 4:56 PM) Specimen Blood  PSA - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/16/2019 4:56 PM) COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed   Sodium Level 139 136 - 145 mmol/L LAB   Potassium Level 3.8Comment: Serum Potassium Reference Range = 3.5-5.1 mmol/L 3.3 - 4.8 mmol/L LAB   Chloride Level 107 98 - 107 mmol/L LAB   Carbon Dioxide 24 23 - 31 mmol/L LAB   Anion Gap 8   LAB   Glucose Level 113 70 - 99 mg/dL LAB   Blood Urea Nitrogen 17 8 - 26 mg/dL LAB   Creatinine Level 1.11 0.72 - 1.25 mg/dL LAB   Calcium Level Total 9.2 8.4 - 10.5 mg/dL LAB   Bilirubin Total 0.5Comment: Patients receiving indocyanine green for procedures will show falsely elevated total and direct bilirubin results until the drug is cleared. 0.2 - 1.2 mg/dL LAB   Albumin Level 4.0 3.2 - 4.6 gm/dL LAB   Protein Total 6.9Comment: Plasma samples are 0.3 - 0.5 g/dL higher than serum 6.0 - 8.3 gm/dL LAB   Alkaline Phosphatase 69 40 - 150 unit/L LAB   Aspartate Aminotransferase 19 5 - 40 unit/L LAB   Alanine Aminotransferase 27 0 - 55 unit/L  LAB    COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/16/2019 4:56 PM) Specimen Blood  COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number , no fever September 17, 2019 Photo documentation of rash taken by wife      September 18, 2019 Rash spread over entire front and back trunk, in to groin and upper legs, saw     Dr., dermatologist,  who repeated blood work  EGFR/EGFRAA - Final result (09/18/2019 10:26 AM) EGFR/EGFRAA - Final result (09/18/2019 10:26 AM) Component Value Ref Range Performed  eGFR >60Comment: Estimated glomerular filtration rate (eGFR) and eGFRAA are calculated using the IDMS MDRD equation which is recommended for use in normal healthy individuals 18-70 years of age and has not been validated in other populations. See eGFR in the Test Directory for additional information. ml/min/1.73 m2    eGFRAA >60Comment: Estimated glomerular filtration rate (eGFR) and eGRFAA are calculated using the IDMS MDRD equation which is recommended for use in normal healthy individuals 18-70 years of age and has not been validated in other populations. See eGFR in the Test Directory for additional information. ml/min/1.73 m2     EGFR/EGFRAA - Final result (09/18/2019 10:26 AM) Specimen Blood  EGFR/EGFRAA - Final result (09/18/2019 10:26 AM) Performing Organization Address City/State/Zipcode Phone Number   AUTO DIFF - Final result (09/18/2019 10:26 AM) AUTO DIFF - Final result (09/18/2019 10:26 AM) Component Value Ref Range Performed At  Neutrophils 65.8 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Neutrophils 4.14 1.60 - 8.10 x10(3)/mcL LAB   Lymphs 10.6 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Lymphocytes 0.67 1.10 - 3.50 x10(3)/mcL LAB   Monocytes 10.6 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Monocytes 0.67 0.30 - 1.10 x10(3)/mcL LAB   Eosinophils 11.6 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Eosinophils 0.73 0.00 - 0.50 x10(3)/mcL LAB   Basophils 0.8 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Basophils 0.05 0.01 - 0.08 x10(3)/mcL LAB   Imm Gran Automated 0.6 % LAB   Absolute Imm Gran Automated 0.04 0.00 - 0.03 x10(3)/mcL LAB    AUTO DIFF - Final result (09/18/2019 10:26 AM) Specimen Blood  AUTO DIFF - Final result (09/18/2019 10:26 AM) Performing Organization Address City/State/Zipcode Phone Number CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/18/2019 10:26 AM) CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/18/2019 10:26 AM) Component Value Ref Range Performed  White Blood Cells 6.3 3.9 - 10.7 x10(3)/mcL LAB   Red Blood Cells 4.70 4.50 - 6.00 x10(6)/mcL LAB   Hemoglobin 15.9 14.0 - 18.1 gm/dL LAB   Hematocrit 46 41 - 49 % LAB   Mean Cell Volume 98 81 - 98 fL LAB   Mean Cell Hemoglobin 33.8 27.0 - 32.0 pg LAB   Mean Cell Hemoglobin Concentration 34.4 31.0 - 35.0 gm/dL LAB   RDW SD 45.8 37.4 - 52.4 fL LAB   RDW CV 12.7 11.1 - 14.3 % LAB   Platelet 237 135 - 371 x10(3)/mcL LAB   Mean Platelet Volume 10.3 9.3 - 12.8 fL LAB   Nucleated RBC 0 /100 WBC LAB   Nucleated RBC Abs 0.00 x10(3)/mcL LAB   Auto Neutrophil Absolute 4.14 1.60 - 8.10 x10(3)/mcL LAB    CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/18/2019 10:26 AM) Specimen Blood  CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/18/2019 10:26 AM) Performing Organization Address City/State/Zipcode Phone Number COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/18/2019 10:26 AM) COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/18/2019 10:26 AM) Component Value Ref Range Performed Sodium Level 140 136 - 145 mmol/L LAB   Potassium Level 3.8Comment: Serum Potassium Reference Range = 3.5-5.1 mmol/L 3.3 - 4.8 mmol/L LAB   Chloride Level 106 98 - 107 mmol/L LAB   Carbon Dioxide 22 23 - 31 mmol/L LAB   Anion Gap 12  LAB   Glucose Level 93 70 - 99 mg/dL LAB   Blood Urea Nitrogen 18 8 - 26 mg/dL LAB   Creatinine Level 1.00 0.72 - 1.25 mg/dL LAB   Calcium Level Total 9.2 8.4 - 10.5 mg/dL LAB   Bilirubin Total 0.9Comment: Patients receiving indocyanine green for procedures will show falsely elevated total and direct bilirubin results until the drug is cleared. 0.2 - 1.2 mg/dL LAB   Albumin Level 4.0 3.2 - 4.6 gm/dL LAB   Protein Total 7.0Comment: Plasma samples are 0.3 - 0.5 g/dL higher than serum 6.0 - 8.3 gm/dL LAB   Alkaline Phosphatase 73 40 - 150 unit/L LAB   Aspartate Aminotransferase 23 5 - 40 unit/L LAB   Alanine Aminotransferase 27 0 - 55 unit/L LAB    COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/18/2019 10:26 AM) Specimen Blood  COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/18/2019 10:26 AM) Performing Organization Address City/State/Zipcode Phone Number and did skin biopsy, no fever  Knee replacement surgery scheduled for Sept. 26 canceled indefinitely  September 23, 2019 Biopsy of rash inconclusive (report not available to patient), completed      antibiotics, neck mass decreased, referred to hematology/oncology re: possible     lymphoma appointment scheduled for 10/2/ 2019 September 30, 2019 (day 22) Rash remains over entire trunk, neck, arms, legs--fades a little during      sleep but becomes reddened again after awakening    Rash Photo documented by wife",,,,,,,,,N,09/08/2019,09/12/2019,4,"Timeline September 8, 2019 Received Fluad TVS 2019-2020 SYR  (65 YR UP) Adjuvant Rt arm at Pharmacy September 12, 2019 Awakened with enlarged mass in left side of neck and itching in area; no fever September 13, 2019 Office Visit with APRN Walk-In Clinic      started on     clindamycin 300 mg capsule    Commonly known as: CLEOCIN     Take 1 capsule (300 mg total) by mouth 3 times a day for 7 days.    PrescribedSeptember 13, 2019    Approved by APRN    Quantity21 capsules      AND    triamcinolone 0.1 % cream    Commonly known as: KENALOG     Apply bid prn in a thin coat on affected area x 7-10. avoid chronic use.    PrescribedSeptember 13, 2019    Approved by APRN    Quantity15 g  got US neck-- US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) Specimen    US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) Impressions Performed At   There is subcutaneous edema seen in the area of concern below the   patient's left ear.    Electronically signed on 9/13/2019 10:26 AM    US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) Narrative Performed At ULTRASOUND OF THE POSTOPERATIVE NECK    TECHNIQUE: Grayscale and color Doppler evaluation of the   infra-auricular area of the left neck was performed.    INDICATION: Swelling. Possible bee sting.    COMPARISON: None    FINDINGS: There is some subcutaneous edema seen within the area of   the patient's swelling below his left ear.    There is no evidence of pathologic regional lymphadenopathy.     US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) Procedure Note Interface, Radiology Results In - 09/13/2019 10:28 AM  ULTRASOUND OF THE POSTOPERATIVE NECK  TECHNIQUE: Grayscale and color Doppler evaluation of the infra-auricular area of the left neck was performed.  INDICATION: Swelling. Possible bee sting.  COMPARISON: None  FINDINGS: There is some subcutaneous edema seen within the area of the patient's swelling below his left ear.  There is no evidence of pathologic regional lymphadenopathy.  IMPRESSION:  There is subcutaneous edema seen in the area of concern below the patient's left ear.  Electronically signed on 9/13/2019 10:26 AM   US NECK SOFT TISSUE - Final result (09/13/2019 10:20 AM) Performing Organization Address City/State/Zipcode Phone Number  September 14, 2019 Developed measles-like rash with itching over trunk of body, visited walkin clinic, no change in treatment plan; no fever September 16, 2019 Saw PCP Dr. --no fever; CT scan of neck done  CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM) CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM) Specimen    CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM) Impressions Performed At   Areas of fat stranding centered around two lymph nodes deep to the   left sternocleidomastoid mastoid and in the left submandibular region   as described in the findings. Findings likely reflect an inflammatory   or infectious etiology given adjacent enlargement of the musculature   and fat stranding. However, malignancy, possibly lymphoma or   metastatic disease, cannot be excluded and follow-up imaging is   recommended after treatment to ensure resolution.    I, have reviewed the images and verify the   above interpretation on 9/17/2019 10:52 AM.    Electronically signed on 9/17/2019 10:52 AM    CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM) Narrative Performed At CT NECK WITH CONTRAST    HISTORY: R22.1; Localized swelling, mass and lump, neck  COMPARISON: PET scan 12/20/2018, ultrasound 9/13/2019  TECHNIQUE: Spiral CT of the neck was performed following the   intravenous administration of IV contrast. Coronal and sagittal   reformatted images were generated.  INTRAVENOUS CONTRAST ADMINISTRATION (mL Omnipaque 350): 100  DOSE REPORT (Total DLP mGy*cm): 879    FINDINGS:    There is a region of fat stranding that measures approximately 2.9 x   1.5 cm centered about a left IIB lymph node which measures   approximately 4 mm. In the left submandibular area there is another   approximately 4 mm level IB lymph node at the center of a 1.6 x 2.4   cm area of fat stranding.  There is adjacent overlying asymmetric   thickening of the left platysma.  A few additional mildly prominent   left cervical chain lymph nodes are also present, none of which are   pathologically enlarged.    There are no pathologically enlarged right cervical lymph nodes or   areas of surrounding fat stranding.    The nasopharynx and oropharynx are unremarkable.  There is a cystic   focus along the anterior right aspect of the epiglottis which   measures 7 x 4 mm in greatest axial dimension likely representing a   vallecular cyst as it encroaches into the right vallecula.  The   airway remains patent.    There is mild multifocal calcific atherosclerosis.    1.3 cm lipoma overlying the superior medial left trapezius.    Lung apices are clear. Status post left temporoparietal craniotomy   with an area of encephalomalacia the left temporal lobe. No air-fluid   levels in the paranasal sinuses or mastoid air cells. Moderate   degenerative changes of the cervical spine. Small hypodense nodules   in the thyroid.  CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM) Procedure Note Interface, Radiology Results In - 09/17/2019 10:54 AM  CT NECK WITH CONTRAST  HISTORY: R22.1; Localized swelling, mass and lump, neck COMPARISON: PET scan 12/20/2018, ultrasound 9/13/2019 TECHNIQUE: Spiral CT of the neck was performed following the intravenous administration of IV contrast. Coronal and sagittal reformatted images were generated. INTRAVENOUS CONTRAST ADMINISTRATION (mL Omnipaque 350): 100 DOSE REPORT (Total DLP mGy*cm): 879  FINDINGS:  There is a region of fat stranding that measures approximately 2.9 x 1.5 cm centered about a left IIB lymph node which measures approximately 4 mm. In the left submandibular area there is another approximately 4 mm level IB lymph node at the center of a 1.6 x 2.4 cm area of fat stranding. There is adjacent overlying asymmetric thickening of the left platysma. A few additional mildly prominent left cervical chain lymph nodes are also present, none of which are pathologically enlarged.  There are no pathologically enlarged right cervical lymph nodes or areas of surrounding fat stranding.  The nasopharynx and oropharynx are unremarkable. There is a cystic focus along the anterior right aspect of the epiglottis which measures 7 x 4 mm in greatest axial dimension likely representing a vallecular cyst as it encroaches into the right vallecula. The airway remains patent.  There is mild multifocal calcific atherosclerosis.  1.3 cm lipoma overlying the superior medial left trapezius.  Lung apices are clear. Status post left temporoparietal craniotomy with an area of encephalomalacia the left temporal lobe. No air-fluid levels in the paranasal sinuses or mastoid air cells. Moderate degenerative changes of the cervical spine. Small hypodense nodules in the thyroid.  IMPRESSION:  Areas of fat stranding centered around two lymph nodes deep to the left sternocleidomastoid mastoid and in the left submandibular region as described in the findings. Findings likely reflect an inflammatory or infectious etiology given adjacent enlargement of the musculature and fat stranding. However, malignancy, possibly lymphoma or metastatic disease, cannot be excluded and follow-up imaging is recommended after treatment to ensure resolution.  I, have reviewed the images and verify the above interpretation on 9/17/2019 10:52 AM.  Electronically signed on 9/17/2019 10:52 AM   CT SOFT TISSUE NECK W CONTRAST - Final result (09/16/2019 5:29 PM) Performing Organization Address City/State/Zipcode Phone Number and blood work done-- CREATININE - EXTERNAL MANUAL - Final result (09/16/2019 5:26 PM) CREATININE - EXTERNAL MANUAL - Final result (09/16/2019 5:26 PM) Component Value Ref Range Performed Creatinine - Ext Man 1.2 0.5 - 1.5 mg/dL IMAGING    CREATININE - EXTERNAL MANUAL - Final result (09/16/2019 5:26 PM) Specimen Blood  CREATININE - EXTERNAL MANUAL - Final result (09/16/2019 5:26 PM) Performing Organization Address City/State/Zipcode Phone Number IMAGING         EGFR/EGFRAA - Final result (09/16/2019 4:56 PM) EGFR/EGFRAA - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed  eGFR >60Comment: Estimated glomerular filtration rate (eGFR) and eGRFAA are calculated using the IDMS MDRD equation which is recommended for use in normal healthy individuals 18-70 years of age and has not been validated in other populations. See eGFR in the Test Directory for additional information. ml/min/1.73 m2    eGFRAA >60Comment: Estimated glomerular filtration rate (eGFR) and eGRFAA are calculated using the IDMS MDRD equation which is recommended for use in normal healthy individuals 18-70 years of age and has not been validated in other populations. See eGFR in the Test Directory for additional information. ml/min/1.73 m2     EGFR/EGFRAA - Final result (09/16/2019 4:56 PM) Specimen Blood  EGFR/EGFRAA - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number AUTO DIFF - Final result (09/16/2019 4:56 PM) AUTO DIFF - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed  Neutrophils 65.0 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Neutrophils 4.53 1.60 - 8.10 x10(3)/mcL LAB   Lymphs 13.3 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Lymphocytes 0.93 1.10 - 3.50 x10(3)/mcL LAB   Monocytes 11.9 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Monocytes 0.83 0.30 - 1.10 x10(3)/mcL LAB   Eosinophils 8.5 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Eosinophils 0.59 0.00 - 0.50 x10(3)/mcL LAB   Basophils 0.6 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Basophils 0.04 0.01 - 0.08 x10(3)/mcL LAB   Imm Gran Automated 0.7 % LAB   Absolute Imm Gran Automated 0.05Comment: 0.00 - 0.03 x10(3)/mcL LAB    AUTO DIFF - Final result (09/16/2019 4:56 PM) Specimen Blood  AUTO DIFF - Final result (09/16/2019 4:56 PM ) Performing Organization Address City/State/Zipcode Phone Number EHRLICHIA AB PANEL (EHRLICHIA CHAFFEENSIS IGG/IGM) - Final result (09/16/2019 4:56 PM) EHRLICHIA AB PANEL (EHRLICHIA CHAFFEENSIS IGG/IGM) - Final result (09/16/2019 4:56 PM) Component Value Ref Range Ehrlichia chaffeensis IgG Antibody <1:64 Comment: INTERPRETIVE INFORMATION: Ehrlichia Chaffeensis IgG Ab   Less than 1:64 ....... Negative: No significant level of                          Ehrlichia chaffeensis IgG antibody                          detected.   1:64-1:128 ........... Equivocal: Questionable presence                          of Ehrlichia chaffeensis IgG                          antibody detected. Repeat testing                          in 10-14 days may be helpful.   1:256 or greater ..... Positive: Presence of IgG antibody                          to Ehrlichia chaffeensis detected,                          suggestive of current or past                          infection. Seroconversion between acute and convalescent sera is considered strong evidence of recent infection. The best evidence for infection is a significant change (fourfold difference in titer) on two appropriately timed specimens, where both tests are done in the same laboratory at the same time. Test developed and characteristics determined Laboratories. See Compliance Statement B  <1:64 LAB   Ehrlichia chaffeensis IgM Antibody < 1:16 Comment: INTERPRETIVE INFORMATION: Ehrlichia Chaffeensis IgM Ab   Less than 1:16 ....... Negative - No significant level                          of Ehrlichia chaffeensis IgM                          antibody detected.   1:16 or greater ...... Positive - Presence of IgM                          antibody to Ehrlichia                          chaffeensis detected,                          suggestive of current or                          recent infection. While the presence of IgM antibodies suggest current or recent infection, low levels of IgM antibodies may occasionally persist for more than 12 months post-infection. A single IgM result should be interpreted with caution. Test developed and characteristics determined  Laboratories. See Compliance Statement B:  Performed by Laboratories,                              <1:16 LAB   EHRLICHIA AB PANEL (EHRLICHIA CHAFFEENSIS IGG/IGM) - Final result (09/16/2019 4:56 PM) Specimen Blood  EHRLICHIA AB PANEL (EHRLICHIA CHAFFEENSIS IGG/IGM) - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number RICKETTSIA RICKETTSII (ROCKY MOUNTAIN SPOTTED FEVER) ANTIBODY (ROCKY MOUNTAIN SPOTTED FEVER IGG/IGM) - Final result (09/16/2019 4:56 PM) RICKETTSIA RICKETTSII (ROCKY MOUNTAIN SPOTTED FEVER) ANTIBODY (ROCKY MOUNTAIN SPOTTED FEVER IGG/IGM) - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed  Rocky Mountain Spotted Fever Antibody IgG <1:64 Comment: INTERPRETIVE INFORMATION: Rickettsia rickettsii (Rocky Mtn.                           Spotted Fever) Ab, IgG          Less than 1:64 ....... Negative - No significant level of                          IgG antibody detected.   1:64 - 1:128 ......... Low Positive - Presence of IgG                          Antibody detected, suggestive of                          current or past infection.   1:256 or greater ..... Positive - Presence of IgG                          antibody detected, suggestive of                          current or past infection. Antibody reactivity to Rickettsia rickettsii antigen should be considered Spotted Fever group reactive. Other organisms within the group include R. akari, R. conorrii, R. australis and R. sibirica. Seroconversion, a fourfold or greater rise in antibody titer, between acute and convalescent sera is considered strong evidence of recent infection. Acute-phase specimens are collected during the first week of illness and convalescent-phase samples are generally obtained 2-4 weeks after resolution of illness. Ideally these samples should be tested simultaneously at the same facility. If the sample submitted was collected during the acute-phase of illness, submit a marked convalescent sample within 25 days for paired testing.  <1:64 LAB   Rocky Mountain Spotted Fever Antibody IgM <1:64 Comment: INTERPRETIVE INFORMATION: Rickettsia rickettsii (Rocky Mtn.                           Spotted Fever) Ab, IgM   Less than 1:64 ....... Negative - No significant level of                          IgM antibody detected.   1:64 or greater ...... Positive - Presence of IgM antibody                          detected, which may indicate a                          current or recent infection;                          however, low levels of IgM                          antibodies may occasionally persist                          for more than 12 months                          post-infection. Antibody reactivity to Rickettsia rickettsii antigen should be considered Spotted Fever group reactive. Other organisms within the group include R. akari, R. conorrii, R. australis and R. sibirica. Seroconversion, a fourfold or greater rise in antibody titer, between acute and convalescent sera is considered strong evidence of recent infection. Acute-phase specimens are collected during the first week of illness and convalescent-phase samples are generally obtained 2-4 weeks after resolution of illness. Ideally these samples should be tested simultaneously at the same facility. If the sample submitted was collected during the acute-phase of illness, submit a marked convalescent sample within 25 days for paired testing. The CDC does not use IgM results for routine diagnostic testing of Rocky Mountain Spotted Fever, as the response may not be specific for the agent (resulting in false positives) and the IgM response may be persistent from past infection. Performed by Laboratories,                             <1:64 LAB   RICKETTSIA RICKETTSII (ROCKY MOUNTAIN SPOTTED FEVER) ANTIBODY (ROCKY MOUNTAIN SPOTTED FEVER IGG/IGM) - Final result (09/16/2019 4:56 PM) Specimen Blood  RICKETTSIA RICKETTSII (ROCKY MOUNTAIN SPOTTED FEVER) ANTIBODY (ROCKY MOUNTAIN SPOTTED FEVER IGG/IGM) - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/16/2019 4:56 PM) CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed  White Blood Cells 7.0 3.9 - 10.7 x10(3)/mcL LAB   Red Blood Cells 4.37 4.50 - 6.00 x10(6)/mcL LAB   Hemoglobin 14.7 14.0 - 18.1 gm/dL LAB   Hematocrit 43 41 - 49 % LAB   Mean Cell Volume 99 81 - 98 fL LAB   Mean Cell Hemoglobin 33.6 27.0 - 32.0 pg LAB   Mean Cell Hemoglobin Concentration 33.9 31.0 - 35.0 gm/dL LAB   RDW SD 47.8 37.4 - 52.4 fL LAB   RDW CV 13.2 11.1 - 14.3 % LAB   Platelet 220 135 - 371 x10(3)/mcL LAB   Mean Platelet Volume 9.8 9.3 - 12.8 fL LAB   Nucleated RBC 0 /100 WBC LAB   Nucleated RBC Abs 0.00 x10(3)/mcL LAB   Auto Neutrophil Absolute 4.53Comment: This test was performed.   1.60 - 8.10 x10(3)/mcL LAB    CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/16/2019 4:56 PM) Specimen Blood  CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number PSA - Final result (09/16/2019 4:56 PM) PSA - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed  Prostate Specific Antigen 1.19 Comment: PSA is used to assist in diagnosis and monitoring of prostate cancer. When used as an initial screening test, there is no universally accepted normal range for PSA. The PSA value should be interpreted in light of factors such as age, race, family history of prostate cancer, digital rectal examination result, and result of prior prostate biopsy. For more information on calculating prostate cancer risk based on these factors, see the Prostate Cancer Prevention Trial risk calculator.   ng/mL LAB    PSA - Final result (09/16/2019 4:56 PM) Specimen Blood  PSA - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/16/2019 4:56 PM) COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/16/2019 4:56 PM) Component Value Ref Range Performed  Sodium Level 139 136 - 145 mmol/L LAB   Potassium Level 3.8Comment: Serum Potassium Reference Range = 3.5-5.1 mmol/L 3.3 - 4.8 mmol/L LAB   Chloride Level 107 98 - 107 mmol/L LAB   Carbon Dioxide 24 23 - 31 mmol/L LAB   Anion Gap 8  LAB   Glucose Level 113 70 - 99 mg/dL LAB   Blood Urea Nitrogen 17 8 - 26 mg/dL LAB   Creatinine Level 1.11 0.72 - 1.25 mg/dL LAB   Calcium Level Total 9.2 8.4 - 10.5 mg/dL LAB   Bilirubin Total 0.5Comment: Patients receiving indocyanine green for procedures will show falsely elevated total and direct bilirubin results until the drug is cleared. 0.2 - 1.2 mg/dL LAB   Albumin Level 4.0 3.2 - 4.6 gm/dL LAB   Protein Total 6.9Comment: Plasma samples are 0.3 - 0.5 g/dL higher than serum 6.0 - 8.3 gm/dL LAB   Alkaline Phosphatase 69 40 - 150 unit/L LAB   Aspartate Aminotransferase 19 5 - 40 unit/L LAB   Alanine Aminotransferase 27 0 - 55 unit/L LAB    COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/16/2019 4:56 PM) Specimen Blood  COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/16/2019 4:56 PM) Performing Organization Address City/State/Zipcode Phone Number , no fever September 17, 2019 Photo documentation of rash taken by wife      September 18, 2019 Rash spread over entire front and back trunk, in to groin and upper legs, saw     Dr. dermatologist,  who repeated blood work EGFR/EGFRAA - Final result (09/18/2019 10:26 AM) EGFR/EGFRAA - Final result (09/18/2019 10:26 AM) Component Value Ref Range Performed eGFR >60Comment: Estimated glomerular filtration rate (eGFR) and eGRFAA are calculated using the IDMS MDRD equation which is recommended for use in normal healthy individuals 18-70 years of age and has not been validated in other populations. See eGFR in the Test Directory for additional information. ml/min/1.73 m2    eGFRAA >60Comment: Estimated glomerular filtration rate (eGFR) and eGRFAA are calculated using the IDMS MDRD equation which is recommended for use in normal healthy individuals 18-70 years of age and has not been validated in other populations. See eGFR in the  Test Directory for additional information. ml/min/1.73 m2     EGFR/EGFRAA - Final result (09/18/2019 10:26 AM) Specimen Blood  EGFR/EGFRAA - Final result (09/18/2019 10:26 AM) Performing Organization Address City/State/Zipcode Phone Number AUTO DIFF - Final result (09/18/2019 10:26 AM) AUTO DIFF - Final result (09/18/2019 10:26 AM) Component Value Ref Range Performed  Neutrophils 65.8 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Neutrophils 4.14 1.60 - 8.10 x10(3)/mcL LAB   Lymphs 10.6 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Lymphocytes 0.67 1.10 - 3.50 x10(3)/mcL LAB   Monocytes 10.6 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Monocytes 0.67 0.30 - 1.10 x10(3)/mcL LAB   Eosinophils 11.6 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Eosinophils 0.73 0.00 - 0.50 x10(3)/mcL LAB   Basophils 0.8 Comment: Per CAP, reference ranges should not be reported for percent cell counts when reporting reference ranges for absolute number counts to prevent misinterpretation of WBC differential data.   % LAB   Absolute Basophils 0.05 0.01 - 0.08 x10(3)/mcL LAB   Imm Gran Automated 0.6 % LAB   Absolute Imm Gran Automated 0.04 0.00 - 0.03 x10(3)/mcL LAB    AUTO DIFF - Final result (09/18/2019 10:26 AM) Specimen Blood  AUTO DIFF - Final result (09/18/2019 10:26 AM) Performing Organization Address City/State/Zipcode Phone Number CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/18/2019 10:26 AM) CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/18/2019 10:26 AM) Component Value Ref Range Performed  White Blood Cells 6.3 3.9 - 10.7 x10(3)/mcL LAB   Red Blood Cells 4.70 4.50 - 6.00 x10(6)/mcL LAB   Hemoglobin 15.9 14.0 - 18.1 gm/dL LAB   Hematocrit 46 41 - 49 % LAB   Mean Cell Volume 98 81 - 98 fL LAB   Mean Cell Hemoglobin 33.8 27.0 - 32.0 pg LAB   Mean Cell Hemoglobin Concentration 34.4 31.0 - 35.0 gm/dL LAB   RDW SD 45.8 37.4 - 52.4 fL LAB   RDW CV 12.7 11.1 - 14.3 % LAB   Platelet 237 135 - 371 x10(3)/mcL LAB   Mean Platelet Volume 10.3 9.3 - 12.8 fL LAB   Nucleated RBC 0 /100 WBC LAB   Nucleated RBC Abs 0.00 x10(3)/mcL LAB   Auto Neutrophil Absolute 4.14 1.60 - 8.10 x10(3)/mcL LAB    CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/18/2019 10:26 AM) Specimen Blood  CBC WITH DIFFERENTIAL (CBC W/ DIFFERENTIAL) - Final result (09/18/2019 10:26 AM) Performing Organization Address City/State/Zipcode Phone Number COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/18/2019 10:26 AM) COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/18/2019 10:26 AM) Component Value Ref Range Performed  Sodium Level 140 136 - 145 mmol/L LAB   Potassium Level 3.8Comment: Serum Potassium Reference Range = 3.5-5.1 mmol/L 3.3 - 4.8 mmol/L LAB   Chloride Level 106 98 - 107 mmol/L LAB   Carbon Dioxide 22 23 - 31 mmol/L LAB   Anion Gap 12  LAB   Glucose Level 93 70 - 99 mg/dL LAB   Blood Urea Nitrogen 18 8 - 26 mg/dL LAB   Creatinine Level 1.00 0.72 - 1.25 mg/dL LAB   Calcium Level Total 9.2 8.4 - 10.5 mg/dL LAB   Bilirubin Total 0.9Comment: Patients receiving indocyanine green for procedures will show falsely elevated total and direct bilirubin results until the drug is cleared. 0.2 - 1.2 mg/dL LAB   Albumin Level 4.0 3.2 - 4.6 gm/dL LAB   Protein Total 7.0Comment: Plasma samples are 0.3 - 0.5 g/dL higher than serum 6.0 - 8.3 gm/dL LAB   Alkaline Phosphatase 73 40 - 150 unit/L LAB   Aspartate Aminotransferase 23 5 - 40 unit/L LAB   Alanine Aminotransferase 27 0 - 55 unit/L LAB    COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/18/2019 10:26 AM) Specimen Blood  COMPREHENSIVE METABOLIC PANEL (CMP) - Final result (09/18/2019 10:26 AM) Performing Organization Address City/State/Zipcode Phone Number      and did skin biopsy, no fever    Knee replacement surgery scheduled for Sept. 26 canceled indefinitely September 23, 2019 Biopsy of rash inconclusive (report not available to patient), completed      antibiotics, neck mass decreased, referred to hematology/oncology re: possible     lymphoma appointment scheduled for 10/2/ 2019 September 30, 2019 (day 22) Rash remains over entire trunk, neck, arms, legs--fades a little during      sleep but becomes reddened again after awakening    Rash Photo documented by wife     Office Visit with MD Monday September 16, 2019Hospital Outpatient Visit   Monday September 16, 2019Office Visit with MD Saturday September 14, 2019Office Visit Walk-In Clinic   Friday September 13, 2019Hospital Outpatient Visit",PHM,,metoprolol succinate XL 50 mg 24 hr tablet; azelastine 137 mcg (0.1 %) nasal spray; losartan 50 mg tablet; amLODIPine 5 mg tablet; pantoprazole 40 mg EC tablet; apixaban 5 mg tablet; ezetimibe 10 mg tablet; flunisolide 25 mcg (0.025 %) spra,None,"1. High BP 2. High cholesterol 3. Intermitent episodes atrial fibrillation 4. Renal cell carcinoma , awaiting surgery; in December 2019 for removal of kidney cancer; osteoarthritis Rt knee, awaiting surgery 9/26/2019",,,2,09/30/2019,,Y,,"Penicillin and synthetic penicillins; environmental grasses and trees, grasses, weeds; bee venom;"
0837205,09/30/2019,,62.0,62,,F,,"Pt. stated that vaccination site was warm to the touch, red and itchy. Was wondering if it was an allergic reaction. Told pt. to follow up with MD.",,,,,,,,,U,09/22/2019,09/30/2019,8,,UNK,,,,,,,2,09/30/2019,,Y,,
0837206,09/30/2019,FL,69.0,69,,F,,"27 days since the shot, and it feels as though I have had a severe case of shingles without the blisters/rash.  Arm on fire traveling on the radial nerve.  Skin so sensitive, at times i could not have anything touch on my arm or left shoulder.  This was WAAAYYY beyond site soreness which I expected.  I am still having pain, electric shocks down my arm.",,,,,,,,,N,09/03/2019,09/06/2019,3,Exam by my PCP,PHM,,65 mg Nature thyroid   occasional 10 mg Ambien (zolpidem)   occasional pregnisolone pack   occasional 4 mg Zanaflex/Tizanidine   4 mg Tolterodine   Align probiotic   B-100 complex   500 mg Vitamin C   500 mg Citrucel fiber capsules   1000 m,None,Transverse Myelitis (onset was 17 plus years ago),"flu vaccine in 2002,possibly resulting in transverse myelitis",,2,09/30/2019,,Y,,"Erythromycin, Demerol both make me vomit"
0837207,09/30/2019,TX,66.0,66,,F,,"Severe migraine/sinus headache, left sinus tenderness & congestion, body aches",,,,,,,,,Y,09/25/2019,09/26/2019,1,09/26/2019 Urgent Care Clinic - anti-inflammatory injection,WRK,,"Depakote, Norco, Oxybutynin","09/05/2019-09/07/2019 & 09/12/2019 Sore throat, fever, chills, headache","Arthritis, migraines",,,2,09/30/2019,,,Y,Decongestants
0837208,09/30/2019,OH,59.0,59,,F,,"patient developed a red hot rash that took up the majority of her left upper arm. once that resolved, she developed white pustules in several areas over her body that intensely itched for several weeks. she went to see her doctor who prescribed her a topical to relieve the itching and told her not to receive the 2nd dose of series. symptoms resolved by time of discussion with pharmacist, though her skin is scarred where the pustules were.",,,,,,,,,Y,09/03/2019,09/03/2019,0,,PHM,,unknown,unknown,unknown,,,2,09/30/2019,,Y,,lidocaine
0837210,09/30/2019,OH,,,,F,,"Suffered damages as they paid for a product that was not effective for its stated purpose.; Suffered damages as they paid for a product that was not effective for its stated purpose.; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a female patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided.     On or about 23-OCT-2017, the pt received vaccination with a dose of zoster vaccine live (ZOSTAVAX) for the long-term prevention of herpes zoster (or shingles) (strength, route, frequency, lot/batch # and expiration date were not reported).  On an unknown date, the pt suffered damages as it was paid for a product that was not effective (vaccination failure) for its stated purpose; she suffered actual damages, including economic damages, physical pain and suffering and/or other damages (adverse event). The outcome of vaccination failure, adverse event and pain was nor provided.  The reporter considered vaccination failure, and an the unspecified adverse event to be related to Zoster Vaccine Live (ZOSTAVAX).",,,,,,,,,U,10/23/2017,,,,OTH,,,,,,US0095075131909USA009396,2,09/30/2019,,,,
0837211,09/30/2019,PA,,44,,F,,"shipment was delayed, breaking cold chain regulations, No AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 44 years old female patient who received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] and reported that shipment was delayed, breaking cold chain regulations (product storage error).  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On 23-Sep-2019, the patient received a dose of suspect 0.5 ml INFLUENZA QUADRIVAL A-B VACCINE lot UJ223AA and expiry date: 30-Jun-2020 via unknown route in the left deltoid.  It was a case of actual medication error due to incorrect product storage.  It was unknown if the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA265830,2,09/30/2019,,,,
0837212,09/30/2019,IA,62.0,,,M,,"62 years old patient received a high dose flu vaccine, no AE; 62 years old patient received a high dose flu vaccine, no AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 62 years old male patient who received a dose of vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot number and expiry date not reported) via unknown route in unknown administration site on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  At the time of the event, the patient had ongoing Chronic obstructive pulmonary disease.   It was a case of actual medication error due to inappropriate age at vaccine administration and overdose.   At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,COPD exacerbation,,,USSA2019SA266007,2,09/30/2019,,,,
0837213,09/30/2019,FL,,0,.4,U,,"patient received 2 does of DTAP and Polio/no AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse and additional information received on same date.  This case involves a 5 months old patient of unknown gender who received extra doses comprised with vaccines HEPATITIS B VACCINE (HEPATITIS B VACCINE), DIPHTHERIA VACCINE TOXOID, HEPATITIS B VACCINE RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (PEDIARIX) and DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (UI992AAA, left deltoid, 0.5 ml via intramuscular route) on 23-Sep-2019 for all vaccines. The patient received 2 does of DTAP and Polio.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  As concomitant therapy, patient received ROTAVIRUS VACCINE.   It was of actual medication error due to extra dose administered.  It was unknown whether adverse event was experienced or not. .  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,09/23/2019,,,,UNK,,ROTAVIRUS VACCINE,,,,USSA2019SA266131,2,09/27/2019,,,,
0837214,09/30/2019,GA,,,,U,,"large amount of swelling at injection site; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a patient who experienced large amount of swelling at injection site (vaccination site swelling), while he/she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route and unknown site.  On an unknown date, the patient had large amount of swelling at injection site (vaccination site swelling) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Lab data was not reported.  Final diagnosis was vaccination site swelling.   It was not reported if the patient received a corrective treatment.  The patient outcome was reported as unknown for vaccination site swelling.  Recommended ice to site, motrin, and benedryl.  Information on the batch number is requested.  List of document held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267125,2,09/27/2019,,,,
0837215,09/30/2019,OH,67.0,,,M,,"flu like symptoms; sick like a dog; sniffles; headache; feeling like having a fever; feeling like they were dying for a day; Initial and Additional information received on 23-Sep-2019 and 24-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacy other/non-hcp.  This case is linked to cases 2019SA267183 and 2019SA267182 (same reporter).  This case involves a 67 years old male patient who experienced flu like symptoms (influenza like illness), sick like a dog (malaise), sniffles (rhinorrhoea), headache (headache), fever (pyrexia) and feeling like they were dying for a day (unevaluable event), while he received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  The concomitant vaccination included prevnar.   On 06-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (Lot: UJ232AA and expiry date: 10-Apr-2020) via intramuscular route in the left deltoid.  On 07-SEP-2019, 1 days post vaccination, the patient had flu like symptoms (influenza like illness), sick like a dog (malaise), sniffles (rhinorrhoea), headache (headache), fever (pyrexia) and feeling like they were dying for a day (unevaluable event) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  Lab data was not reported.  Final diagnosis was influenza like illness, malaise, rhinorrhoea, headache, pyrexia and unevaluable event.   It was not reported if the patient received a corrective treatment and spent the whole day in bed.  The patient outcome was reported as unknown for all the events.  List of document held by sender:  none.",,,,,,,,,U,09/06/2019,09/07/2019,1,,UNK,,PREVNAR,,,,USSA2019SA267181,2,09/30/2019,,,,
0837217,09/30/2019,TX,56.0,56,,F,,"Received the shingles vaccination (50 Mcg/0.5 ml injection) at 12:00 pm on Tuesday, September 24, 2019. Felt lethargic for the remainder of the day and went to sleep at 10:00 pm. Awoke at 1:00 am Wednesday, September 25, 2019 with extreme shivering and feeling unwell. Took aspirin and went back to bed. Awoke at 5:00 am of the same day and felt extremely hot. Took temperature and it was 100.5 degrees F. Took Tylenol and a Benadryl and lied on the couch watching TV. At 6:30 am I experienced extremely loose bowel movements with abdominal cramping. Ate some breakfast at 7:30 am. Took more Tylenol and Benadryl at 9:00 am and went back to bed. Awoke at 1:00 pm feeling extremely tired--temperature was 98.8 degrees F. Rested the remaining part of the afternoon. At 5:00 pm temperature had returned to 100 degrees F. Took additional Tylenol. Went to bed at 7:30 pm with more Tylenol and Benadryl.",,,,,,,,,,09/24/2019,09/24/2019,0,,UNK,,"Armour Thyroid, Benazepril HCL, Amlodipine Besylate, Compounded Progesterone, Multi-vitamin, Vitamin D, Tumeric, Calcium, Magnesium, Vitamin C, Probiotic, Dim","4 glasses of wine per week, non-smoker","High blood pressure, hypo thyroidism",,,2,09/25/2019,,,,All weeds
0837223,09/30/2019,NJ,25.0,25,,F,,Patient felt like something was in her throat after the vaccine and she was not feeling right.,,,,,,,,,U,09/30/2019,09/30/2019,0,EMS was called and patient went to hospital for observation.,PHM,,,,,,,2,09/30/2019,,,Y,
0837224,09/30/2019,MD,65.0,65,,F,,"Patient had to go to the hospital and reports ""cellulitis"" caused by the shingles vaccination. Hospital informed her it could have been a contaminated vaccine.",,,,,,,,,U,09/26/2019,09/26/2019,0,,PHM,,,,,,,2,09/30/2019,,,Y,
0837225,09/30/2019,MT,67.0,67,,F,,"She notes that she developed a rash about an inch below injection site the day she received, it worked it's way down to elbow crook. Initially raised slightly almost like hives. On Monday 8/12/19 she was going to request and appointment however it had almost completely resolved",,,,,,,,,Y,08/09/2019,08/09/2019,0,none,PVT,,"ibuprofen, calcium, iron, vitamin d",none,"elevated LDL, osteoprosis",,,2,09/30/2019,,,,NKDA
0837226,09/30/2019,KS,53.0,53,,F,,"First of all, I just went in to get my shingles vaccine at the request of my doctor. The pharmacist asked if I've had my flu vaccine, which I hadn't so I said no. She recommended I get both vaccines at the same time. She said it's better for your immune system if you get them both at once. Within an hour, I had the ""common symptoms"" from the Shingrix literature...redness and swelling at the injection site, muscle pain, tiredness, headache, shivering, fever and upset stomach. On day three after the injection, I developed a shingles blister on the back of my neck. I called my doctor. She had me come in to verify it was shingles, which it was. Over the next 4 days I developed 8 more shingles blisters and a coldsore on my lip. My Dr. gave me a prescription for Valtrex but said not to take it unless I got significantly worse as it would make the vaccines less effective. At day 7, I started taking 1000 mg Lysine due to the coldsore. The other blisters dried up and scabbed over by day 9.  Today is day 17 and the blisters and coldsore are all gone except the one on the back of my neck. It still has a scab. I've since heard from several nurse friends that the pharmacist shouldn't have recommended I get bot the Shingrix and the Flu vaccines at the same time.",,,,,,,,,Y,09/14/2019,09/14/2019,0,,PHM,,"Adderall XR, Imipramine, HRT, Xyzal, Multi-Vitamin, B-Complex Supplement, Vitamin D 2000 i.u., Protandim, Aspirin 81 mg., Magnesium 1000 mg, Glucosamine Chondroitin, GLA-90, Fat Flush Supplement (Liver support) Allergy injections (3 per wee",None,Celiac Disease Seasonal Allergies,,,2,09/30/2019,,Y,,Augmentin Gluten (Intolerance)
0837227,09/30/2019,OH,2.0,2,.0,M,,"Complex febrile seizure with status epilepticus with in 6 -8 hours of vaccination, + fever prior to seizure",,,,,Y,2,,,Y,09/23/2019,09/23/2019,0,+ rhinoenterovirus on nasal swab 9/24/2019 CBC 9/23/2019 NORMAL BMP NORMAL  EEG - normal,PVT,,None,Viral URI,Recurrent AOM - PETs placed 4 months prior,,,2,09/30/2019,,,,Amoxicillin
0837228,09/30/2019,FL,61.0,61,,F,,"Friday - Pt reports no adverse events Saturday -Arm swelled up wrapping around inside of bicep from underarm (glands swollen) to elbow, glands in neck swollen as well; Headache ""like an ice pick in head"" went to sleep at 6pm Saturday, ""couldn't wake up, kept trying to open eyes but body wasn't listening to brain"" didn't wake up until 350P on Sunday Sunday - Arm redness/swelling approx 4 inch x 3 inch area Patient reports fever all weekend (highest temp 102*), generally around 99/100* being treated with otc ibuprofen Patient also reports intermittent vomiting all weekend, last vomiting Sunday but ""afraid to eat"" today on Monday so uncertain if symptoms resolved Patient reports headache improved on Monday, intermittent sharp pains behind ear, not constant.",,,,,,,,,N,09/27/2019,09/28/2019,1,,PHM,,,,,,,2,09/30/2019,,Y,,
0837229,09/30/2019,FL,77.0,77,,F,,"Patient reported arm was ""very, very sore"", red rash across entire width of arm from injection site to elbow, swollen, greatly improving as of today 9/30 Monday (3 days post-injection)",,,,,,,,,N,09/27/2019,09/27/2019,0,,PVT,,,,,,,2,09/30/2019,,,,
0837230,09/30/2019,UT,4.0,4,,M,,"On 09/27/19 my son was complaining of his leg hurting, limping and wouldn't really walk much.  Saturday morning (09/28/19) his entire right thigh was swollen from his knee cap to his hip.  He took a nap that afternoon and woke up around 3PM, when he woke up his face was swollen, his hands/feet were swollen, his thigh was still swollen and there were hives on his leg, abdomen and face.  He was complaining about his hands/feet hurting.  He wouldn't walk or put shoes on due to pain.  I gave him 5mls of children's Benadryl and took him to the urgent care clinic.  By the time we got there the redness/swelling of his face had gone down but the hives, swollen thigh and hand/foot pain was still present.  He was evaluated by a physician assistant I believe.  We were instructed to do Benadryl/ranitidine and giving  a dosing schedule.  We were also given the option to try zyrtec during the day rather than Benadryl.  He has been taking the allergy medications since and the hives are gone, he is acting better and walking normal again but his thigh is still swollen at this time.",,,,,,,,,Y,09/27/2019,09/28/2019,1,basic vital signs 09/28/19,WRK,,children's multivitamin,common cold couple weeks ago,none,,,2,09/30/2019,,,Y,amoxicillin and omnicef
0837231,09/30/2019,SC,63.0,63,,M,,"STEMI (likely unrelated), complex treatment course, died 9/7/19",Y,09/07/2019,,,Y,7,,,N,08/30/2019,08/30/2019,0,Extensive 8/30/19 through 9/7/19,PHM,,"diclofenac 1% gel, fluticasone nasal spray, rizatriptan ODT, famotidine, celecoxib, doxepin, zolpidem","migraines, meralgia paresthecia, basal cel carcinoma of face, psoriatic arthritis",PE (2008) treated with Warfarin for 1 year,,,2,09/30/2019,,,Y,NKDA
0837232,09/30/2019,OH,73.0,73,,F,,"9/30/19 Based on patient's weight (210 lb), a 22 G 1 & 1/2 inch needle was used to administer the vaccine. The patient jumped during administration & moved arm, but the full dose was given to the patient. Immediately after the vaccine, she said it hurt really bad and she felt tingling in her hand. She was asked to sit for observation. She left while giving a thumbs up to my technician. I called to follow up with her at 5:06 pm. She said the tingling subsided, but her arm is very sore down into her forearm, and she's having a hard time moving it. She said she has some range of motion, but she had a hard time putting her dog's leash on. I told her that a sore arm is typical with the vaccine. She was advised to use a cold compress and oral pain reliever if needed. She said she already took an oral pain reliever. She was advised that if any severe symptoms develop, she should seek emergency medical attention. If symptoms persist, she was advised to follow up w/ her doctor. She received her vaccination today, so I will follow up with patient in a few days to see how she is doing.",,,,,,,,,,09/30/2019,09/30/2019,0,,PHM,,,,,,,2,09/30/2019,,,,
0837233,09/30/2019,GA,68.0,68,,F,,Patient states that her RIGHT Arm has been hurting since the administration of the Shingrix vaccine. Pharmacy records indicate that shot was given in left arm.,,,,,,,,,N,01/01/2019,01/01/2019,0,,PHM,,Amlodipine 5mg Metformin 500mg Glipizide 5mg Simvastatin 20mg Lisinopril/HCTZ 20/12.5mg,,,,,2,09/30/2019,,,,"Penicillin, Sulfur Drugs"
0837234,09/30/2019,WA,54.0,54,,F,,red hot area of about 70mm circular from point of injection started in approx. 3-4 hrs after injection and was painful and hot and red all weekend and today (4 days after) remains somewhat red and continues to be slightly warm to touch but appears to be resolving.,,,,,,,,,Y,09/27/2019,09/27/2019,0,none,PVT,,"omeprazole, vit B12, biotin, allegra, allergy injections for grasses and trees weekly, every 8 weeks wasp and mixed vespid (last allergy shot 9/25/19)",none,"GERD, allergies",,,2,09/30/2019,,,,"bees, yellow jackets, wasps, bell peppers,"
0837239,09/30/2019,FL,70.0,70,,F,,"Swollen very painful, hot to touch site and entire muscle up into shoulder and neck, fever 99- 101 started 24 hrs after shot, weak legs, body aches, nausea, lack of appetite.  Felt just out of it, staggering  when fever high.   Sxs  began within hours of injection. Sxs  abated 48 hours after injection except for sore site. I took 500 mg of Tylenol several  doses  and ondansetron  2 doses/2 days",,,,,,,,,Y,09/27/2019,09/27/2019,0,none,PHM,,"amlodipine, baby aspirin, atorvastatin, bupropion XL, clopidogrel, colace, Vit B-12, allegra, gabapentin, Levemir flexpen,  losartan, metformin, metoprolol tartrate, ondansetron, ranididine, Tylenol","Diabetes M,  Hx of CVA, hyperlipidemia, hypertensioon, peripheral neuropathy,  GERD,",Diabetes M strokes allergies,,,2,09/30/2019,,,,"PCN, Ceclor, Levaquin, Demerol  artichokes mold, pollens, grasses etc"
0837240,09/30/2019,IL,88.0,88,,M,,"dizziness, nausea beginning at bedtime, and worsening through the night, chills and fever of 102 degrees next morning. Joint pain in the left shoulder was severe.",,,,,,,,,Y,09/18/2019,09/18/2019,0,none,PHM,,"Nexium, Janumet, Altace, Carvedilol, Furosemide, Potassium chloride ER, Vytorin, Clarinex, Lumigan, Tamsulosin, Low Dose aspirin, Vitamin B1",none,"GERD, diabetes, High Blood Pressure, Heart, high cholesterol, environmental allergies, glaucoma, prostate",,,2,09/30/2019,,,,"Penecillin, lactose intolerance"
0837241,09/30/2019,CA,1.25,1,.3,F,,"Prior to these vaccines, patient had not been sick once. Patient had unusual cries, she developed a fever and we gave her children's tylenol per doctors instruction. We tried to cool her down the best we could. She suddenly began to stiffen her hand and legs and her eyes rolled back, her lips turned blue and she had a seizure for about 4 minutes. We called 911 and paramedics took us to ER. She was given fever medication at hospital to relieve fever. They ran tests and found nothing wrong and said it was a febrile seizure. I didn't see Hib 4 dose on the list but it is the one administered that resulted in the seizure.",,,,,,,,,,06/28/2016,06/29/2016,1,,PVT,,None,None,None,"Facial Palsy, 10/5/15, Dtap, IPV/Hib, Hep B, Rotavirus, PCV 13, Influenza Vaccine Quad, Split PreservFree",,2,09/30/2019,,Y,Y,None
0837242,09/30/2019,NC,66.0,66,,F,,"pt called 9/26/2019 reported left arm was swollen size of baseball, raised and hot.",,,,,,,,,Y,09/24/2019,09/01/2019,,none,PVT,,"ASA, Carvedilol, Crestor, Ferrous Sulfate, Fish Oil, Gabapentin, Lisinopril, NTG, Oxycodone, Pantoprazole, Ventolin inhaler and Vitamin B12",none,"DDD, Hypertension, Hyperlipidemia, GERD, Depression with Anxiety, Iron Deficiency",,,2,09/30/2019,,,,NKA
0837243,09/30/2019,OH,74.0,74,,F,,"At the end of the next day after getting the vaccine, patient reported that she had blisters in her mouth and a rash over the trunk and arms of her body. Patient went to the ER and was given an injection of Kenalog. That did not fully treat all the symptoms, so she went to her family doctor and received prednisone 10mg (9/27/19), triamcinolone 0.1% cream (9/27/19), and azithromycin 250mg dose pack (9/19/19).",,,,,,,,,U,08/28/2019,08/29/2019,1,,PHM,,"Sotalol, prednisone, famotidine, cyclobenzaprine, trazodone, lorazepam, shingrix, havrix (gotten at same time as shingrix), carvedilol, amlodipine",,,,,2,09/30/2019,,Y,Y,opioids (morphine analogs)
0837244,09/30/2019,TX,38.0,38,,F,,"right deltoid at site of injection redness, swelling 5cm",,,,,,,,,Y,09/28/2019,09/29/2019,1,,PVT,,methocarbmonal  sertraline synthroid  trazadone,none,depression,,,2,09/30/2019,,Y,,Sulfa
0837245,09/30/2019,NC,65.0,65,,F,,localized rash painful,,,,,,,,,U,09/29/2019,09/29/2019,0,,PHM,,,,,,,2,09/30/2019,,,,
0837246,09/30/2019,CA,66.0,66,,F,,"Patient received both Fluad and Pneumovax 23 on 9/26/19 in the morning. Both were administered in the left arm (deltoid muscle) at least 1 inch apart. By Thursday evening, patient had massive headaches and soreness at injection site. The next morning,  patient had fever of 101 degrees Fahrenheit and has body aches as well as lack of appetite for 3 days. Patient's left arm is also hot and inflamed with an area of about 4.5 inches by 7.5 inches. Patient went to her primary care physician and was prescribed cephalexin in case of skin infection. Ibuprofen and Benadryl was also ordered as needed for pain and itching. Will follow up with patient in the next couple days to see if low grade fever subsides.",,,,,,,,,N,09/26/2019,09/26/2019,0,,PHM,,,,,,,2,09/30/2019,,Y,,no known drug allergies
0837247,09/30/2019,CO,78.0,78,,F,,"Patient was shopping in the store right after the vaccination and daughter said patient started shaking and that she helped patient to the floor, and shouted for help. Pharmacist responded , patient was unconscious. She regained consciousness within a minute and was disoriented. patient's blood pressure was taken and it was 192/93.  Emergency paramedics were called and they took over care and transported  patient to the ambulance.",,,,,,,,,U,09/30/2019,09/30/2019,0,,PHM,,,,,,,2,09/30/2019,,,Y,
0837248,09/30/2019,MI,50.0,50,,F,,"Pain in arm, and redness and swelling where the Shingrix injection was given a few hours of the injection. Flu-like symptoms, (fatigue, chills) within 12 hours lasting 24 hours. After 24 hours, a large area of redness and swelling (more than 4"" in diameter) with intense itching developed.",,,,,,,,,N,09/27/2019,09/27/2019,0,,PHM,,,,,,,2,09/30/2019,,,,sulfa drugs
0837250,09/30/2019,VA,61.0,61,,F,,"Shivering, redness on the site of vacine.",,,,,,,,,Y,09/21/2019,09/22/2019,1,,PHM,,"Premarin, Mucinex, Allegra, Fluticasone, Azelastine, Pantoprazole, Zantac, Align, Calcium, multivitamins.",,,,,2,09/30/2019,,,,
0837251,09/30/2019,AK,62.0,62,,F,,"Symptoms:  pounding headache, muscle aches (big time), increased heart rate, chills, lasted about 48 hours.  Swelling  and redness (about the size of a golf ball in circumference) at injection site.  I received NO verbal or written information from the medical office re possible side effects ( my friend who is a nurse told me that these side effects can occur with the vaccine).  I didn't pursue treatment (as I didn't want to move my head to get off the couch) and I didn't think I was going to die...  Anyway, I am reporting this because I told the medical office about 4 times about the reaction I had when they try to reschedule the second vaccine (I can't bring myself to go through that again in order to get the second vaccine).  Thank you.  BTW, I am not the only patient who had an adverse reaction and was not provided with info (verbal or written).",,,,,,,,,Y,11/01/2018,11/01/2018,0,None.,OTH,,None,None,None,,,2,09/30/2019,,,,"Sulfa, penicillin"
0837252,09/30/2019,CA,78.0,78,,F,,"pt called and said her arm is red and raised but have no pain in the arm that pt got the shingrix vaccine. rec. pt to ice the area and take ibuprofen and check with pt tomorrow. Checked with pt the day after pt states redness at site is going away, still raised and warm.  advised pt to call dr. Otherwise pt is feeling fine.",,,,,,,,,,09/24/2019,09/26/2019,2,,PHM,,,,,,,2,09/30/2019,,,,
0837253,09/30/2019,IL,58.0,58,,F,,"Red, raised rash (wheel), warm to touch and measuring 2x2 1/4 inches",,,,,,,,,N,09/29/2019,09/30/2019,1,,PHM,,"levothyroxine 50mcg, black cohash, fish oil, asa 81, calcium, vit. d, Mg. Prolia","hashimoto's, osteoporosis",see above,,,2,09/30/2019,,,,nkda
0837254,09/30/2019,HI,0.75,0,.8,F,,"Immediate hive, redness",,,,,,,,,Y,09/30/2019,09/30/2019,0,given 7.5 mg benedryl with near resolution of rash,PVT,,,none,,,,2,09/30/2019,,Y,,none
0837255,09/30/2019,FL,21.0,21,,M,,"Patient reported soreness in the arm continuing for over 3 weeks after receiving Afluria immunization.  He has noticed significant weakening in the right arm, and pain when lifted laterally.",,,,,,,,,N,09/03/2019,09/03/2019,0,Patient has not yet followed up with primary physician.,PHM,,Patient was currently taking prednisone at time of immunization.,None Reported,None Reported,,,2,09/30/2019,,,,None Reported
0837256,09/30/2019,WA,11.0,11,,M,,patient had no adverse events,,,,,,,,,Y,09/30/2019,09/30/2019,0,,PVT,,n/a,n/a,n/a,,,2,09/30/2019,,Y,,Azithromycin
0837257,09/30/2019,WA,74.0,74,,F,,"After 1 week, patient reported that she had shingles (confirmed by lab results) and was started on empiric antiviral and antibiotic therapy. She had previously received shingrix and fluad on the same visit.",,,,,,,,,U,09/13/2019,09/20/2019,7,,PHM,,,,,,,2,09/30/2019,,Y,,
0837258,09/30/2019,OR,58.0,58,,M,,Provider ordered proquad for patient after consult with pharmacy. Patient did not need varicella d/t age per CDC guidelines there for this is a medication error.,,,,,,,,,Y,09/26/2019,09/26/2019,0,N/A no harm from error,PVT,,none,none,"HTN, Thyroid disorder",,,2,09/30/2019,,,,none
0837259,09/30/2019,MT,18.0,18,,F,,Redness and Swelling at the site. 10 cm x 11 cm,,,,,,,,,Y,09/27/2019,09/28/2019,1,NONE,PVT,,"Taking Melatonin 1 mg tablet 1 tab(s) orally once a day (at bedtime), Notes: prn, Taking Effexor XR 75 mg capsule, extended release 1 cap(s) daily orally once a day",NONE,Anxiety,,,2,09/30/2019,,,,Penicillin: Hives
0837260,09/30/2019,KY,72.0,72,,F,,"patient experienced high fever, rash, warm to touch redness and swollen arm patient went to minor emergency and received antibiotics and steriods presented to pharmacy 4 days after showed signs of improvement but still had pain and some redness and swelling",,,,,,,,,U,09/26/2019,09/26/2019,0,n/a,PHM,,n/a,n/a,n/a,,,2,09/30/2019,,Y,,n/a
0837261,09/30/2019,CT,76.0,76,,F,,Patient received second dose of shingrix vaccine on 9/13/19.  Patient came to pharmacy on 9/30/19 to report that her arm was still sore.  Stated that there was some redness initially but that had gone away but some pain was still there.  Patient was instructed to contact their physician to discuss the reaction,,,,,,,,,U,09/13/2019,09/14/2019,1,,PHM,,,,,,,2,09/30/2019,,Y,,"sulfa, sulfonylureas, thiazide diuretics"
0837262,09/30/2019,MA,53.0,53,,F,,"9/26 typical local reaction. Quarter sized are, red, pain-full swollen and warm to touch. Body temp 102-102.5 9/27 area of redness increased. Body temp at 08:15 was 103.5. As day progressed area increased by approximately 300%. T-max was 104.  9/28 temp was 103, went to ER area was 10cm x 7-8 cm.  Dx?d as cellulitis. IV  clindamycin given then sent home on oral clindamycin course of treatment. 9/29 no change temp 101.5 9/30 afebrile. Area less red, swollen and painful.",,,,,,,,,Y,09/25/2019,09/27/2019,2,"cbc with diff.   WBC 11,600. Need to contact hosp.",PVT,,Kineret 100mg.  Via s.c. injection once a day Wellbutrin 450mg total once a day Celexa 40mg once a day Ibuprofen prn,Rheumatoid arthritis.  Steroidal spine injection 9 days previously.,Rheumatoid Arthritis. Degenerative changes of spine.,,,2,09/30/2019,,,Y,Adhesive tape causes blisters
0837263,09/30/2019,KY,16.0,16,,M,,"Dad describes as a mild itchy rash that began the same night after receiving vaccine. No other new exposures. He was seen in the office today (6 days later) and dad says that the rash has gotten worse. Dad says that the rash is worse with heat.  He took one dose of Benadryl on 9/26/19. He denies fever or any other symptoms. APRN describes the rash as ""erythema present to full body, sparing face, palms of hands, and soles of feet - c/w hives to neck and chest,""",,,,,,,,,N,09/24/2019,09/24/2019,0,None,PVT,,Flonase (has been on this for years),cough and congestion three weeks prior (not seen by a dr),No,,,2,09/30/2019,,Y,,No
0837264,09/30/2019,TN,18.0,18,,F,,"swelling, soreness, redness, itching",,,,,,,,,N,09/28/2019,09/29/2019,1,None,PHM,,None,None,None,,,2,09/30/2019,,Y,,None
0837265,09/30/2019,,62.0,62,,F,,"Significant site pain after nearly 2 weeks (12 days) pt had pain upon  raising arm. no redness, swelling or warm to the touch.",,,,,,,,,U,09/18/2019,09/18/2019,0,,UNK,,,,,,,2,09/30/2019,,,,
0837266,09/30/2019,IL,60.0,60,,F,,Hives on torso and back,,,,,,,,,N,09/29/2019,09/30/2019,1,,PHM,,methimazole and metoprolol,unkown,hyperthyroidism,,,2,09/30/2019,,,,penicillin
0837267,09/30/2019,CA,4.0,4,,F,,"We were driving and patient was in her car seat. She appeared to be falling asleep when suddenly her eyes opened up wide, they rolled up and she appeared frozen. She lost her skin color, was not blinking eye lids, her hands were shaking a bit. She then had clear bubbly liquid coming out of her mouth. She was unresponsive for about 3 minutes as she had the seizure. After that she made slight sounds as if she wanted to speak but could not. The paramedics arrived. We were on the freeway and they took us to the nearest ED. Patient had a fever out of nowhere and they gave her ibuprofen. They did urine test and she had no infections. She slept for an hour and cooled down and they determined she had a febrile seizure. Prior to the seizure patient was not sick nor had a fever.",,,,,,,,,,08/14/2019,09/28/2019,45,Urine test determined she had no infections. 9/28/2019,PVT,,pro biotics,none,none,"seizure on 6/29/2016 following vaccines given on 6/28/2016. D Tap, Hib 4 Dose, Pneumococcal Conjugate PCV 13. She also had a rea",,2,09/30/2019,,Y,,none
0837268,09/30/2019,CA,59.0,59,,F,,"Headache, chills, fever (unsure of temperature since thermometer did not work, but not super high), increased sensitivity to light and to dust and other trigger allergens, shaking/shivering,",,,,,,,,,,09/23/2019,09/23/2019,0,,UNK,,Simvastatin; Flonase,None,Weak kidneys; high cholesterol,,,2,09/30/2019,,,,"Hay fever (ragweed, other)"
0837269,09/30/2019,KY,66.0,66,,F,,"patient stated about 12 hours after immunization she woke up with a severe headache, itching, weak feeling and pain, thirsty, cold, fever and chills. She stated 12 hours later she was back to normal with only a weak feeling that she has all the time without regard to the immunization.",,,,,,,,,Y,09/27/2019,09/27/2019,0,,PHM,,,,,,,2,09/30/2019,,,,
0837270,09/30/2019,WA,4.0,4,,M,,"Local injection site reaction, first noticed by parent on morning of 9/30/19. Patient complained of pain. No fevers or other signs of infection or illness. Recommended treating with cool compresses and ibuprofen.",,,,,,,,,N,09/27/2019,09/30/2019,3,,PVT,,,,Recurrent ear infections,,,2,09/30/2019,,Y,,
0837271,09/30/2019,NY,69.0,69,,F,,6 Days post immunization pt saw spots appearing on trunk and legs- they then became red and painful where she went to her dr and he diagnosed her with shingles,,,,,,,,,Y,09/20/2019,09/29/2019,9,,PHM,,,,,,,2,09/30/2019,,Y,,
0837272,09/30/2019,FL,37.0,37,,F,,"Patient states swelling/inflammation, redness, soreness, and hotness down to wrist",,,,,,,,,N,09/28/2019,09/29/2019,1,none,PHM,,unknown,none reported,none reported,,,2,09/30/2019,,,,none
0837273,09/30/2019,PA,27.0,27,,F,,"Patient reported immediately feeling numbness/""pins and needles"" down her left arm after injection. Monitored for about 25 minutes and no other signs or symptoms of a serious reaction or injection site reaction occurred. When patient left the pharmacy she stated the ""tingly feeling"" was only in her fingertips.",,,,,,,,,U,09/30/2019,09/30/2019,0,none,PHM,,"escitalopram, zolpidem, baclofen, humira, methylphenidate, sulfasalazine, midodrine, nadolol, pantoprazole, advair, sucralafate, diclofenac, medroxyprogesterone",unkown,ankylosing spondylits,,,2,09/30/2019,,,,no known drug allergies
0837274,09/30/2019,NJ,60.0,60,,F,,"dizzy, weak and not breathing well",,,,,,,,,U,09/30/2019,09/30/2019,0,called 911 and the ambulance took the patient to check up,PHM,,n/a,N/A,"diabetic, hypertension and hypercholesteolaemia",,,2,09/30/2019,,,,none
0837275,09/30/2019,PA,26.0,26,,M,,"Patient felt light headed after second shot, laid head down on table in room.  Complained of feeling ""loss of sense of reality"".  Respirations normal, blood pressure 112/77, heart rate 83.  Cold, clammy skin.  Asked for water and asked me to call 911.  Patient was able to respond to questions, but did close eyes and seemed to lose full consciousness for a few seconds.  Patient was checked out by EMS and released.",,,,,,,,,Y,09/30/2019,09/30/2019,0,,PHM,,"high blood pressure medication unspecified, depression medication unspecified",,"hypertension, anxiety, depression",,,2,09/30/2019,,,,penicillin
0837276,09/30/2019,AZ,75.0,,,U,,"REDNESS, SWELLING, PAIN",,,,,,,,,U,09/29/2019,09/30/2019,1,,PHM,,,,,,,2,09/30/2019,,,,
0837277,09/30/2019,,72.0,72,,F,,"Pt states that 3 hours after leaving pharmacy, she started getting chills, fever of 100, severe headache, weakness, fatigue, chest tightness, trouble breathing, arm pain, and later on large red blotches on her arm, not at the injection site but farther down her arm. Pt went to the ER.  Pt followed up with a dermatologist, dermatologist diagnosed her as having severe adverse reactions to the vaccine, as well as an allergic reaction to the vaccine.",,,,,,,,,Y,09/27/2019,09/27/2019,0,,UNK,,,,,,,2,,,Y,Y,
0837278,09/30/2019,TX,58.0,58,,F,,SWOLLEN ARM AND ITCHING IN HER ARM,,,,,,,,,Y,09/28/2019,09/29/2019,1,,PHM,,,,,,,2,09/30/2019,,,,
0837279,09/30/2019,,65.0,65,,F,,"fever, body ache, headache, diarrhea",,,,,,,,,,09/29/2019,09/30/2019,1,,UNK,,,,,,,2,09/30/2019,,,,
0837280,09/30/2019,MO,67.0,67,,M,,"Vaccine given in AM, patient called in PM complaining of fatigue, fever, swollen eyes, and itchy throat. Patient has never had symptoms with previous flu shots. Patient advised to take Benadryl and attend ER if any anaphylaxis symptoms.",,,,,,,,,U,09/30/2019,09/30/2019,0,,PHM,,,,,,,2,09/30/2019,,,,
0837281,09/30/2019,FL,68.0,68,,F,,"Patient developed warm red induration adjacent to injection site, starting the days she received the injection. When the patient came in 2 days later on Saturday, it was warm to the touch and was still warm, red and swollen. The pharmacist referred patient to seek medical care. The patient was assessed at an urgent care and given an antibiotic.",,,,,,,,,N,09/26/2019,09/26/2019,0,,PHM,,NONE,UNKNOWN/NONE,UNKNOWN/NONE,,,2,09/30/2019,,,Y,NKDA
0837282,09/30/2019,NC,1.0,0,1,M,,High fever and head to toe rash. Racing pulse and occasional fast breathing. Joint pain and inconsolable crying with no appetite for 6 weeks...,,,Y,,,,,,U,12/01/2014,12/01/2014,0,"Unsure of all the tests, but my son was taken to his doctor more than once and to the emergency room more than once....   Not one person ever told me about vaccine reporting until now.... with a new doctor in a different state.",PVT,,None,None,CM/AVM Rasa 1,,,2,09/30/2019,,Y,Y,None
0837283,09/30/2019,TX,77.0,77,,F,,"Patient brought this to our attention today 9/30/2019.  But complained of itchiness on her left arm the next day after getting the arm.  She then said it got swollen and bumpy spots appeared on her shoulder area.  She then said she developed a rash between both her legs, shoulder, thight and that it would itch a lot.  She said it has gotten a little better but rash is still there.  I recommended that she see her MD, Dr. since this has been going on since 9/11/19 to get proper treatment.  She has a visit with her MD last week but forgot to mention it to her.",,,,,,,,,N,09/10/2019,09/11/2019,1,None,PHM,,none,"No know acute illness, other than chronic condition",Diabetes and Cholesterol,,,2,09/30/2019,,,,NKDA
0837284,09/30/2019,,27.0,27,,F,,"Panic attack: dizziness, disorientation, tingling and numbness in both arms and hands, muscle stiffness in both hands, near fainting, white lips. Episode lasted 5-10 minutes.",,,,,,,,,Y,09/30/2019,09/30/2019,0,,PHM,,Multivitamin,,,,,2,09/30/2019,,,,Keflex/Cephalexin
0837285,09/30/2019,AZ,50.0,50,,F,,"Arm pain, rash (2 inch), fatigue, joint pain (shoulder on that arm)",,,,,,,,,N,09/28/2019,09/28/2019,0,,PHM,,"Hydroxyzine HCL, Lamictal, Yaz, Bupropion, chlorpheniramine maleate",none,"IBS, depression/anxiety",,,2,09/30/2019,,,,Moncycline
0837286,09/30/2019,UT,73.0,73,,M,,"Pain started the evening of injection, Redness started 48 hours after injection with more pain, Symptoms resolved 5 days after injection",,,,,,,,,Y,09/24/2019,09/24/2019,0,None,PHM,,"Multivitamin, Mineral Oil",None,"High blood pressure, Hypercholesterolemia",,,2,09/30/2019,,,,None
0837287,09/30/2019,CA,73.0,73,,F,,"Swollen , redness at injection site. Cellulitis -looking skin.  No systemic symptoms reported .",,,,,,,,,Y,09/04/2019,09/04/2019,0,,PHM,,,,,,,2,09/30/2019,,,,
0837288,09/30/2019,CA,61.0,61,,M,,"Pt had fever, nausea/vomiting, body ache and pain. ""FEEL LIKE HAVING A PNEUMONIA""",,,,,,,,,Y,09/16/2019,09/16/2019,0,,PHM,,,,,,,2,09/30/2019,,,,
0837360,09/30/2019,,13.0,13,,F,,"Patient got the shot & got up from her chair & sat on another chair. I was giving vaccine to her sister, & when done we turned around she started to role up her eyes & head started falling then she threw up (vomited) Called 911 & hollered Per MD SYNCOPE",,,,,,,,,,09/28/2019,09/28/2019,0,,UNK,,,,,,,2,09/29/2019,,,Y,
0837361,09/30/2019,VA,,,,U,,"SHOT GIVEN ON /  /19 - 2 hrs. later - congestion in throat, + bronchial area, sneezing. Approx 10.30 AM on /  /19 left arm + jaw numbness - Rushed to ER. Neurologist reviews MRI. Admitted to hospital. Brain scan. No STROke - Flu shot reaction",,,,,Y,2,,,Y,,,,MRI    EKG    CT SCAN,PHM,,-0-,-0-,AFIB - quit after ablation 3/2019,Jan. 2019 - next day after shot -> AFIB,,2,,,,Y,-0-
0837362,09/30/2019,CO,72.0,72,,F,,"erythema, edema, heat, formation of blisters weeping clear fluid, covering entire upper arm of affected side",,,,,,,,,U,09/25/2019,09/26/2019,1,N/A,PVT,,"Clopidogrel, furosemide, metoprolol, pantoprazole, pravastatin, protein, ranitidine, spironolactone, warfarin",,"atrial fibrillation, CAD, CHF, cervical dystonia, gastric reflux, lymphedema, dyslipidemia, osteoporosis, OSA",,,2,09/30/2019,,Y,,"doxycycline, Cipro, codeine, fluoxetine, synvisc, toradol, tramadol"
0837363,09/30/2019,FL,67.0,67,,F,,Patient stated couldn't think straight. Felt weak and was hearing voices. She said it was keeping her up all night and she was blacking out.,,,,,,,,,,09/21/2019,09/21/2019,0,,UNK,,,,,,,2,09/23/2019,,,,
0837392,09/30/2019,WV,72.0,72,,M,,"high blood pressure, lightheadness, nauseated",,,,,,,,,U,09/30/2019,09/30/2019,0,,PHM,,None,None,BP.,,,2,09/30/2019,,,,None
0837393,09/30/2019,AZ,72.0,72,,M,,BUE achyness & weakness BUE. Very high ESR/CRP - pt being Txd with prednisone  - a polymyalgia like illness,,,,,,,,,N,09/04/2019,09/12/2019,8,Increased ESR = 67,PVT,,"Amlodipine, Benzapril, Thyroid, Sertaline","Diabetis, CAD, HTN","Increased Chol, HTN, IGT, Obesity",,,2,09/23/2019,,Y,,Sulfa
0837433,09/30/2019,KY,4.0,4,,F,,"9-26-19 Jaw swelling, left ear felt hot. Joint pain, knee swelled Lt. Rash all over her body.  9-30-19 Rash on lower extremities, worse on anterior right tigh, dark red in color.",,,,,,,,,N,09/26/2019,09/26/2019,0,"Urine analysis - trace protein CBC, CMP, CRP, GSR, RA, ANA, Triptase",PVT,,None,None,None,,,2,09/30/2019,,Y,Y,Amoxicillin
0837434,09/30/2019,KY,64.0,64,,M,09/26/2019,"Joint pain, stiff neck, feels poorly -",,,,,,,,,Y,09/18/2019,09/20/2019,2,,PVT,PVT,,0,HTN,,,1,,,,,
0837435,09/30/2019,CA,76.0,76,,F,,body aches           fatigue chills severe HA (L) arm pain,,,,,,,,,Y,09/21/2019,09/22/2019,1,n/a,PHM,,,n/a,n/a,,,2,09/30/2019,,,,Amox
0837454,09/30/2019,FL,83.0,83,,F,09/30/2019,"Patient came today 9/30/19 to report that on the day of the vaccine after she got home her arm swelled up and she noticed a rash on the inection site. The next day her arm swelled up completely from shoulder to elbow She did cold compresses and Ibuprofen, she was fine after",,,,,,,,,Y,09/27/2019,09/27/2019,0,None reported by patient,OTH,PUB,,None reported,None,,,1,,,,,
0837618,09/30/2019,IN,70.0,70,,M,,"Approximately 18 to 24 hours post-injection, patient experienced a fever of 102 degrees, a corneal guttata of the left eye, and pain and impaired movement in the left arm. The fever and eye symptoms resolved within 24 hours, and the symptoms in the arm resolved within 48 hours. All symptoms have completely resolved.",,,,,,,,,,08/03/2019,08/04/2019,1,None,PHM,,Allegra-D,None,Chronic Sinus Infection,,,2,08/09/2019,,Y,,None
0837619,09/30/2019,IN,61.0,61,,F,,"-Fever and chills; sore swollen arm -suggested taking ibuprofen and/or Tylenol -if symptoms don't resolve or get better by tomorrow, patient is going to call back",,,,,,,,,U,09/29/2019,09/30/2019,1,N/A,PHM,,N/A,N/A,N/A,,,2,09/30/2019,,,,none
0837289,10/01/2019,AZ,67.0,67,,F,,"Right after injection of all 3 vaccines patient started coughing, having trouble breathing with lips turning blue. Patient was given 0.3mg EpiPen. Symptoms resolved after one minute. 911 was also called. EMT arrived about 10 minutes after vaccination. Patient was examined but no further treatment was needed. Patient went home with daughter.",,,,,,,,,Y,09/30/2019,09/30/2019,0,Blood pressure was taken and EMT examined breathing and blood glucose and blood pressure as well.,PHM,,unknown,none,COPD,,,2,10/01/2019,,,,unknown
0837290,10/01/2019,AK,65.0,65,,F,,"Around 7:45 pm on Saturday, I began to feel unwell.  Around 8:30 pm, my heart rate was racing,  I had a terrible headache, I was shivering and unable to get warm, my hands and feet were like ice, my upper left arm (site of injection) was hot, swollen, and painful.  I felt feverish. My heart raced the entire night and did not return to a normal beat until early in the morning.    Today, on Tuesday, the injection site has an angry rash that extends down to my elbow.  It is hot and swollen and painful.  My history:  I got shingles while undergoing chemotherapy in 2014.  I received the shingles vaccine in 11/2015.  I also received the flu shot at the same time as the shingles vaccine on Saturday, 9/28/2019.",,,,,,,,,N,09/28/2019,09/28/2019,0,,PHM,,"Multi-vitamin, citracal, vitamin D, salmon oil, tumeric",none,none,,,2,10/01/2019,,,,none
0837291,10/01/2019,MS,44.0,44,,F,,PATIENT HAS RASH ON HER ARM THAT SHE STATES BEGAN NEAR THE INJECTION SITE AND THEN MOVED DOWN THE ARM AND TO THE OTHER ARM.  SHE STATES THAT SHE DID VISIT HER PRIMARY CARE PHYSICIAN ON 9/30/2019 FOR A STEROID CREAM AND ORAL STEROID BECAUSE SHE FELT THAT SHE MAY BE ALLERGIC.  SHE DID RECEIVE THE SAME BRAND OF SHOT LAST YEAR.,,,,,,,,,U,09/27/2019,09/29/2019,2,,PHM,,,,,,,2,10/01/2019,,Y,,
0837292,10/01/2019,CA,59.0,59,,F,,"soreness, redness that developed and persists , 4x4 inches",,,,,,,,,U,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,10/01/2019,,Y,,
0837294,10/01/2019,,48.0,48,,F,,"chills, muscle ache, and syncope requiring EMS",,,,,,,,,Y,09/30/2019,09/30/2019,0,none,PVT,,calcium chews,none,none,,,2,10/01/2019,,Y,,avelox
0837295,10/01/2019,OH,39.0,39,,F,,"Flat red rash developed next morning on neck, chest, both arms; Hive developing on right hand; No increased SOB; only itching on right hand at time of exam",,,,,,,,,N,09/30/2019,10/01/2019,1,instructed to have evaluation at clinic after leaving this office,PVT,,"Levothyroxine, Propanolol",none,POTS/thyroid disease,,,2,10/01/2019,,,,NKDA/NKA
0837307,10/01/2019,CA,4.0,4,,U,,"no adverse effects; patient received improperly stored PROQUAD; This spontaneous report was received from a medial assistant and refers to a 4 year old patient of unknown gender. Information about the patient's medical history, concurrent conditions, concomitant medications and drug reactions or allergies was not provided.      On 12-SEP-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # S002494 with an expiration date in 23-JUL-2020), for prophylaxis (strength, dose, route and frequency were not provided), that underwent a temperature excursion from 6 degrees Fahrenheit to 14 degrees Fahrenheit ,during a time frame of 50 minutes, and was reconstituted with properly stored    sterile diluent. No previous temperature excursion was reported, Digital data logger was involved. No adverse effects were reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA005231:",,,,,,,,,U,09/12/2019,09/12/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005139,2,09/30/2019,,,,
0837308,10/01/2019,TX,,,,U,,"No adverse effect; One dose of an improperly stored vaccine; Route of administration: Intramuscular; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. The patient's concomitant therapy included sterile diluent (possible lot# S000130 and possible expiration date 23-AUG-2021) which was reported to be stored in the correct storage temperature range. On 10-SEP-2019, the patient was vaccinated with one dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (strength and anatomical locations were unknown) of lot # S002877 with an expiration date of 29-JAN-2021, at a dose of 0.5 milliliter, once via intramuscular route (Incorrect route of product administration) for prophylaxis (Product storage error). The temperature excursion for varicella virus vaccine live (oka/merck) (VARIVAX) was at 8.1 Fahrenheit (F) for 20 minutes. The previous temperature excursion reported as 8.1 F for 17 minutes and (9.5 F) for 21 minutes. No adverse effects were reported. The data logger was involved. No Product quality complaint (PQC) was present.",,,,,,,,,U,09/10/2019,09/10/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005907,2,09/30/2019,,,,
0837309,10/01/2019,PA,,,,U,,"No adverese effects; A dose of PROQUAD was given to an unspecified ""53 year old patient""; This spontaneous report has been received from a medical assistant referring to a 53 year old patient of unknown gender. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not provided      On 03-SEP-2019, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD), subcutaneously (strength, frequency, dose, lot # and expiration date were not provided) for prophylaxis. No adverse effects were reported.",,,,,,,,,U,09/03/2019,09/03/2019,0,,UNK,,,,,,US0095075131909USA006284,2,09/30/2019,,,,
0837310,10/01/2019,IA,1.0,0,.2,M,,"The patient was inadvertently given a fourth dose of ROTATEQ; fever; vomiting; Diarrhea; This spontaneous report has been received from a nurse regarding to a 12-month-old male patient. The patient's concurrent conditions included asthma, ear infection and gastroesophageal reflux disease. The patient's medical history included gastroesophageal reflux disease. Concomitant therapies included albuterol, omeprazole and cefdinir. The patient had not drug reaction or allergies.   On 25-OCT-2018, the patient was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # N034400, expiration date 10-MAY-2019; on 22-JAN-2019, he received the second dose of the vaccine, lot # N030150, expiration date 29-AUG-2019, and on 07-MAR-2019, the patient received the third dose of the vaccine, lot # N030150, expiration date 29-AUG-2019; all doses were administered orally for prophylaxis.  On 22-AUG-2019, the patient was prescribed with antibiotic such as cefdinir as treatment for an ear infection. On 16-SEP-201,9 the patient at his 1 year well check exam, he was inadvertently given a fourth dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), lot # R030924, expiration date 10-JUL-2020, Orally for immunizations. On 17-SEP-2019, the patient's mother called to the office to report that he presented fever, vomiting and diarrhea but, it was stated that he had been ill prior to receiving the fourth dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ). However, respiratory film panel were done but not results were reported; additionally, treatment as comfort measures and monitor were provided. At the reporting time, the outcome for fever, diarrhea and vomiting was reported as not recovered.   The causality assessment between fever, diarrhea, vomiting and Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was unknown.",,,,,,,,,N,10/25/2018,09/01/2019,311,,UNK,,cefdinir; albuterol; omeprazole,Asthma; Ear infection; Gastrooesophageal reflux disease,Medical History/Concurrent Conditions: Gastroesophageal reflux disease,,US0095075131909USA007527,2,09/30/2019,,,,
0837311,10/01/2019,VA,,,,M,,"suffered a persistent, papulovesicular rash on Plaintiff's dermatomes and was diagnosed with herpes zoster.; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a male patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided.     In or around 25-sep-2017, the pt was inoculated with a dose of zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, frequency, lot/batch # and expiration date were not reported).     On an unknown date, reported as ""shortly after receiving zoster vaccine live (ZOSTAVAX)"", the pt suffered a persistent, papulovesicular rash on pt dermatomes and was diagnosed with herpes zoster.  As a direct and proximate result of zoster vaccine live (ZOSTAVAX), pt symptoms had resulted in physical limitations not present prior to using it. Pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition.  As a result of the manufacture, marketing, advertising, promotion, distribution, and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained serious, progressive, incurable and permanent personal injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.    The reporter considered the event to be related to zoster Vaccine Live (ZOSTAVAX).  Herpes zoster was considered as disabling event, due to the pt's permanent and incurable injuries.",,,,,,,,Y,N,09/25/2017,,,,UNK,,,,,,US0095075131909USA009257,2,09/30/2019,,Y,,
0837312,10/01/2019,CA,,,,U,,"improperly stored dose of GARDASIL 9; no adverse effects; This spontaneous report was received from a medical assistant concerning to an patient of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions or concomitant medications.  On an unknown date, the patient was vaccinated with an improperly stored dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot number N022952 with expiration date on 14-JUN-2020 (dosage schedule, route and anatomical location were not reported) for prophylaxis.  Administered doses of vaccine experienced temperature excursion below 36 degrees Fahrenheit (F) (32.1 F)  for 8 hours. There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009303,2,09/30/2019,,,,
0837313,10/01/2019,CA,,,,U,,"The patient was vaccinated with improperly stored LIQUID PEDVAXHIB vaccine; No adverse effects were reported.; This spontaneous report was received form a medical assistance, referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications.  On an unknown date, the patient was vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) for prophylaxis, lot# N024570 expiration date on 01-MAY-2020 (dose, dose number, route of administration and anatomical location were not provided). It was reported that the dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) that the patient received, was improperly stored.    It was reported that on an unspecified date, the vaccine was exposed to a temperature below of 36 Fahrenheit degrees and 32.1 Fahrenheit degrees for 8 hours. There was no previous temperature excursion. The call was placed because of a Digital Data logger report. No adverse effects were reported.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009312,2,09/30/2019,,,,
0837314,10/01/2019,CO,,,,U,,"A 13-year-old patient received properly stored PROQUAD; No adverse effects reported; This spontaneous report was received from a registered nurse, referring to a 13-year-old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications.  On an unknown date, the patient was vaccinated with properly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (product administered to patient of inappropriate age)for prophylaxis, lot number S002490  expiration date on 23-JUL-2020 (dose, dose number, route of administration and anatomical location were not provided) and properly stored sterile diluent (MERCK STERILE DILUENT) lot # R019504 (expiration date unknown by reporter). No adverse effects were reported.",,,,,,,,,U,,,,,UNK,,STERILE DILUENT,,,,US0095075131909USA009330,2,09/30/2019,,,,
0837315,10/01/2019,,5.0,,,F,,"The patient may have experienced a mild fever after the second vaccination; Route of administration: intramuscular (IM); This spontaneous report was received from the patient's mother concerning an approximately 5 year old female patient. The patient had no medical history, concomitant medications, drug reactions or allergies.  On an unspecified date in 2011, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot #, expiration date, anatomical location were not provided), administered intramuscularly (IM) (incorrect route of product administration) as prophylaxis (reported as states mandated). After the second vaccination, the patient might have experienced mild fever (pyrexia). In consequence, she sought for medical attention and the patient was treated with ibuprofen. It was reported that the patient received separately the first 3 doses of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II) and then she received the ""follow up titers because it was a state mandated"". No laboratory diagnostics or studies were performed. At the reporting time, the outcome of fever (mild) was unknown.   The causality between the event of fever (mild) and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II) was not reported.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009343,2,09/30/2019,,,,
0837316,10/01/2019,CA,,,,U,,"improperly stored dose os PEDVAX; no adverse effects; This spontaneous report was received from a medical assistant concerning to an patient of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions or concomitant medications.  On an unknown date, the patient was vaccinated with an improperly stored dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot number N024570 with expiration date on 01-MAY-2020 (dosage schedule, route and anatomical location were not reported) for prophylaxis.  Administered doses of vaccine experienced temperature excursion below 36 degrees Fahrenheit (F) (32.1 F)  for 8 hours. There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009368,2,09/30/2019,,,,
0837317,10/01/2019,PA,61.0,61,,M,,"death; shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a 61-year-old male patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 23-SEP-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, exact dose, dose# and route not specified) at a pharmacy. On an unknown date in 2017, reported as within one month after receiving zoster vaccine live (ZOSTAVAX), and as a result of his receipt of zoster vaccine live (ZOSTAVAX), the patient was caused to suffer shingles, including any and all of its sequelae. As a result of his receipt of zoster vaccine live (ZOSTAVAX), the patient had been caused to suffer severe personal injuries, pain, suffering and emotional distress, as well as to incur substantial economic damages. On an unknown date, the patient died. The cause of death and if autopsy was done was unknown. The outcome of the event of shingles was not reported. The reporter considered the event of shingles to be related to zoster vaccine live (ZOSTAVAX). The relatedness between the event of death and zoster vaccine live (ZOSTAVAX) was not reported.",Y,,,,,,,,N,09/23/2017,,,,PHM,,,,,,US0095075131909USA012757,2,10/01/2019,,,,
0837318,10/01/2019,OH,,,,M,,"Meniere's disease; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In or around September 2014, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, exact dose, dose# and route not specified) for routine health maintenance and for its intended purpose: prevention of shingles (herpes zoster). On an unknown date, reported as shortly after receiving zoster vaccine live (ZOSTAVAX), the patient suffered Meniere's disease. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine use, the patient's symptoms had resulted in physical limitation not presented prior to zoster vaccine live (ZOSTAVAX) vaccination. The patient also experienced mental and emotional distress due to resulting physical limitation and seriousness of the patient's condition. As a result of zoster vaccine live (ZOSTAVAX) vaccination, the patient sustained severe and permanent personal injuries; suffered serious progressive permanent and incurable injuries as well as significant conscious pan and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury; suffered and incurred damages, included medical expanses; the loss of accumulations and other. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).  The event of Meniere's disease was considered to be disabling. Upon internal review, the event of Meniere's disease was considered to be medically significant.",,,,,,,,Y,N,09/01/2014,,,,UNK,,,Routine health maintenance,,,US0095075131909USA012767,2,10/01/2019,,,,
0837319,10/01/2019,SC,,,,U,,"No adverse events.; Patient was administered an improperly stored VAQTA.; This spontaneous report was received from a Nurse Practitioner referring to an unspecified patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, historical drugs, drug reaction and allergies were not reported.  On 23-SEP-2019, the patient was vaccinated with an improperly stored dose Hepatitis A Vaccine, Inactivated(VAQTA) with lot # S007769, expiration date on 24-JUL-2020 (strength, route, dose, frequency, and anatomical location were unknown) for prophylaxis.  The administered dose of vaccine experienced above temperature of 47F/9C(11.3C) C degrees Celsius, for 9 hours and 55 minutes. There was no digital data logger invloved, and no previous temperature excursion. No adverse effects reported.",,,,,,,,,U,09/23/2019,09/23/2019,0,,UNK,,,,,,US0095075131909USA013656,2,09/30/2019,,,,
0837320,10/01/2019,SC,,,,U,,"No adverse effects reported; Reporter states patient was administered VAQTA post expiration; This spontaneous report was received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent conditions, drug reactions, allergies, concomitant therapies and pertinent medical history was not provided.   On 24-SEP-2019, the patient was vaccinated with post expiration (expire vaccine used) Hepatitis A Vaccine, Inactivated (VAQTA) 0.5 ml, one dose, lot number R027431, expiration date 08-SEP-2019  for prophylaxis. No adverse effects were reported.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA011985:",,,,,,,,,U,,09/24/2019,,,UNK,,,,,,US0095075131909USA014391,2,09/30/2019,,,,
0837321,10/01/2019,OK,13.0,12,,M,,"respiratory infection; rash; This spontaneous report was received from a registered nurse and refers to a 13 year old male patient. No information was given regarding the patient's concurrent conditions, concomitant medications or medical history.      On 20-FEB-2019, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # N025429, with expiration date on 21-JUL-2020 for Human Papilloma Virus (HPV) prevention (strength, dose and route were unknown). On 23-SEP-2019, the patient developed a respiratory tract infection and a rash. The patient sought medical attention and was treated with unspecified corticosteroids. The events were no cancer events and did not produce a significant disability or incapacity, hospitalization or was life threatening.     The outcome of the events and the causal relationship between vaccination with of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) and the events were not reported.        Upon internal review, the event respiratory tract infection was considered to be a medically significant event.",,,,,,,,,U,02/20/2019,09/23/2019,215,,UNK,,,,,,US0095075131909USA014471,2,09/30/2019,,Y,,
0837322,10/01/2019,FL,,,,U,,"No adverse effects; The patient received the first dose of GARDASIL 9 on 01-AUG-2018 and the second dose of GARDASIL 9 on 07-AUG-2019; This spontaneous report has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant mediations and drug reactions or allergies were not provided.  On 01-AUG-2018, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 0.5 ml (route, lot number: N028567 and expiration date: 17-MAY-2020) for prophylaxis. On 07-AUG-2019, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 0.5 ml (route, lot number: R008165 and expiration date: 12-NOV-2020) for prophylaxis. The second dose was a late dose (inappropriate schedule of vaccine administered). No adverse effects reported. No further information was provided.",,,,,,,,,U,08/01/2018,08/07/2019,371,,UNK,,,Prophylaxis,,,US0095075131909USA015126,2,09/30/2019,,,,
0837323,10/01/2019,IL,,,,F,,"The rash at site of injection was about 5 inches top to bottom; This case was reported by a nurse via sales rep and described the occurrence of injection site rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site rash. On an unknown date, the outcome of the injection site rash was unknown.   It was unknown if the reporter considered the injection site rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but was between 50 to 60 years. The patient experienced a very large rash in 2 areas on the arm where injection was given. The patient experienced injection site rash about 5 inches top to bottom and 2nd lower rash was about half dollar size. This case is 1 of the 2 linked cases, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837324,10/01/2019,IL,,,,F,,"The rash at injection site was about 5 inches top to bottom; This case was reported by a nurse via sales rep and described the occurrence of injection site rash in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site rash. On an unknown date, the outcome of the injection site rash was unknown.   It was unknown if the reporter considered the injection site rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but was between 50 to 60 years. The patient experienced a very large rash in 2 areas on the arm where injection was given. The patient experienced injection site rash about 5 inches top to bottom and 2nd lower rash was about half dollar size. This case is 1 of the 2 linked cases, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837325,10/01/2019,WI,,,,U,,"small rashes, itchy; This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of rash (received shingle shot 5 years ago from time of reporting and received several rashes slightly bigger).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced itchy rash. On an unknown date, the outcome of the itchy rash was unknown.   It was unknown if the reporter considered the itchy rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but as per indication of the vaccine age group was captured as adult. The patient developed 3 small rashes, itchy, but did not spread. The patient inquired of everything was normal or not and asked if the patient should get the second dose or not.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837326,10/01/2019,NY,57.0,57,,U,,"Pain at Injection Site; Low-grade fever; Nausea; Headache; Generalized Aches and Pain; Redness; pain down neck; flu-like symptoms; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 57-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (received 1st dose on 1st April 2019, refer case US2019127814).   On 12th July 2019, the patient received the 2nd dose of Shingrix .5 ml. In July 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, low grade fever, nausea, headache, generalized aching, erythema, neck pain and influenza-like symptoms. The patient was treated with paracetamol (Tylenol) and ibuprofen (Advil). Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain, low grade fever, nausea, headache, generalized aching, erythema, neck pain and influenza-like symptoms were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, low grade fever, nausea, headache, generalized aching, erythema, neck pain and influenza-like symptoms to be related to Shingrix.  Additional information received were as follows: The caller reported that she received 1st and 2nd dose of Shingrix doses over a period of 3 months. Within about 6 to 8 hours following vaccination the patient experienced pain at injection site, redness, low grade fever, nausea, headache, generalized aches and pain down neck (flu-like symptoms). The patient reported that the current symptoms were not bad as 1st dose. The reporter consented to follow up reports taking Tylenol and Advil intermittently . This was 1 of the 2 cases reported by same reporter.",,,,,,,,,N,07/12/2019,07/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,09/30/2019,,,,
0837327,10/01/2019,CA,63.0,63,,F,,"Extra Dose; Fever; did not want to move/Fatigue; This case was reported by a consumer via call center representative and described the occurrence of fever in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 24th January 2019) and Shingrix (2nd dose received in 24th May 2019).   In August 2019, the patient received the 3rd dose of Shingrix (intramuscular). In August 2019, not applicable after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the patient experienced fever and fatigue. On an unknown date, the outcome of the fever and fatigue were resolved with sequelae and the outcome of the extra dose administered was unknown.   The reporter considered the fever to be related to Shingrix. It was unknown if the reporter considered the fatigue to be related to Shingrix.  Additional details were reported as follows: The reporter was the daughter and patient was the mother.  The patient lives with the reporter. The reporter states that her mother did not speak English very well and that she received a third dose of Shingrix, which led to extra dose administered.  The reporter did not know the exact. The reporter did not have the lot number for any of the doses.  The reporter said all three doses were given at the same pharmacy.  The reporter states that all three were given intramuscularly.  The reporter also stated that after the 3rd shot of Shingrix her mother had a fever and was fatigued for 2 days.  She said she did not want to move.  The reporter consented to follow up.",,,,,,,,,N,08/01/2019,08/01/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201916,2,09/30/2019,,,,
0837328,10/01/2019,KY,,,,U,,"Feeling sick; This case was reported by a pharmacist via call center representative and described the occurrence of feeling unwell in an  unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patients received Shingrix at an unknown dose. On an unknown date, 1 day after receiving Shingrix, the patients experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not applicable for this report. A pharmacist reports that she had had a number of patient complain that they feel sick for at least a day after receiving the Shingrix vaccine.  The reporter consented to follow up.  The pharmacist estimated 50 plus patients. When asked to elaborate on feeling sick she stated it was all the symptoms listed in the prescribing information.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837329,10/01/2019,AZ,72.0,72,,F,,"Hearing Loss; This case was reported by a consumer via call center representative and described the occurrence of hearing loss in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number 477S3, expiry date 5th July 2021) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 22nd July 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 22nd July 2019, 2 hrs 30 min after receiving Shingrix and 61 days after receiving Shingrix, the patient experienced hearing loss (serious criteria GSK medically significant). On 22nd July 2019, the outcome of the hearing loss was recovered/resolved.   It was unknown if the reporter considered the hearing loss to be related to Shingrix.  Additional details were provided as follows: The patient received vaccine on left arm. The patient and her husband were watching TV and she noticed she had trouble hearing a show. Hearing loss reportedly lasted 2.5 hours. The patient had supporting documentation of hearing loss. The reporter consented to follow up.",,,,,,,,,Y,07/22/2019,07/22/2019,0,,PHM,,Shingrix,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837330,10/01/2019,CA,,,,F,,"arms start swelling was red, and right below the reaction site and very sore; arm was red right below the reaction site; arms start swelling right below the reaction site; arm was very sore right below the reaction site; Hard time sleep due to every time she rolled over it hurt; Initial information received on 16-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves female patient of an unknown age who experienced arms start swelling was red, and right below the reaction site and very sore (inflammation), (erythema), (swelling), (pain in extremity) and hard time sleep due to every time she rolled over it hurt (sleep disorder), while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date in morning at 11:30 AM, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ245AA via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious arms start swelling was red, and right below the reaction site and very sore (inflammation), (erythema), (swelling), (pain in extremity) and hard time sleep due to every time she rolled over it hurt (sleep disorder) on same day by that afternoon following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was hard time sleep due to every time she rolled over it hurt and arms start swelling was red, and right below the reaction site and very sore.  It was not reported if the patient received a corrective treatment.  The patient was Recovering from inflammation, erythema, swelling and outcome of the other events was unknown.  Documents held by sender: none.",,,,,,,,,N,,,,,UNK,,,,,,USSA2019SA260925,2,09/28/2019,,,,
0837331,10/01/2019,NY,1.17,,,F,,"received Ipol from a MDV that was opened and deemed not safe to use / no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.   This case is linked to case 2019SA264011 (same reporter).  This case involves a 14 years old female patient who received 0.5 ml dose of IPV (VERO) lot PIE70 via intramuscular route in the right arm on 11-Nov-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP), MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3) (MMRVAXPRO) and HEPATITIS B VACCINE (HEPATITIS-B).  It was a actual medication error case due to incorrect product storage.  It was reported that 2 patient's that received Ipol from a MDV that was opened and deemed not safe to use. The physician mentioned that she thinks that she should be able to use her clinical judgment as to whether or not to reinjection her patient's and she did not believe that this situation warrented it.  At a time of reporting no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,TDAP; MMR; HEPATITIS-B,,,,USSA2019SA264028,2,09/26/2019,,,,
0837332,10/01/2019,AZ,,,,M,,"I was giving the injection, it leaked onto my hand, no AE; pharmacist was giving a patient a Fluzone High Dose and almost half of the dose came off on my shot and shirt, no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  The case is linked with 2019SA268222 (same reporter).  This case involves a 65 years old male patient who received almost half of the dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UJ236AA, expiry date: 04-Apr-2019, via intramuscular route in the right arm) and half of the dose was came off on my shot and shirt on 19-Sep-2019  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of vaccine underdose and syringe issue.  At the time of reporting the patient had no adverse event.  It was also reported that screwing the needle on tight for injecting the dose her gloved hand was suddenly wet from the vaccine leaking. She stated the leaking must have come from the barrel of the syringe on the side or perhaps the orange part of the needle because that is where her finger was resting. Rph mentioned the other doses in the carton were fine to administer. She asked if the dose should be repeated, she will call the patient back to the pharmacy.  Needle type: Safety, BD safety glide, 25g by 1 inch.  List of document held by sender: none.",,,,,,,,,U,09/19/2019,,,,UNK,,,,,,USSA2019SA264983,2,09/26/2019,,,,
0837333,10/01/2019,NM,10.0,10,,U,,"a 10 year old received Flublok accidentally, no AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 10 years old patient who received a 0.5 ml dose of vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (lot: QFAA1914, expiry date: 30-Jun-2020) accidentally, via intramuscular route in the right arm on 21-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to the inappropriate age at vaccine administration.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/21/2019,,,,UNK,,,,,,USSA2019SA265459,2,09/30/2019,,,,
0837334,10/01/2019,NY,,,,M,,"patient had a reaction; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a male patient of an unknown age who had a reaction (adverse event), while he received vaccine DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious patient had a reaction (adverse event) (Unknown latency) following the administration of DIPHTHERIA and TETANUS AND ACELLULAR PERTUSSIS VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was patient had a reaction.  It was not reported if the patient received a corrective treatment.  The outcome of the event was reported as Unknown.  The caller has three children, ages 7, 9, and 11. One of the children received DTaP in the past and had a reaction. After that, the mom and physician decided to delay DTP immunization of the three children until the youngest is age 7. All three children received Sanofi Tdap about 4 weeks ago. It was the first dose for two of the children. It was the second dose of one of the children. Lot --C5609AA expiry 04-Apr-2021 and concomitant medication MMR.  Information on the batch number was requested.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA265488,2,09/30/2019,,,,
0837335,10/01/2019,KY,13.0,,,U,,"13 year old patient was accidentally administered Flublok, no AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 13 years old patient who received a 0.5 mL dose of vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot QFAA1914, expiry date: 30-Jun-2020,  via intramuscular route in the left deltoid on 21-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to Inappropriate age at vaccine administration.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/21/2019,,,,UNK,,,,,,USSA2019SA265622,2,09/30/2019,,,,
0837336,10/01/2019,TN,,74,,M,,"gave the Fluzone HD, all of the vaccine didn't enter the Left Deltoid/ No AE; Pharmacist stated after giving the consumer their Fluzone HD injection the vaccine began to drip down their arm/ No AE; The vaccine liquid came out between the hub of the needle and the syringe on injection, It was the needle and not the syringe/ No AE; Initial information received on 23-Sep-2019 and additional information received on 24-SEP-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 74 years old male patient who did not received full dose of vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ232AB via unknown route in the left deltoid on 23-Sep-2019, the vaccine liquid came out between the hub of the needle and the syringe on injection, it was the needle and not the syringe.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of vaccine underdose, Exposure via skin contact and Needle leak.  At the time of report no adverse event was reported.  The leakage occurred during the injection of the Fluzone HD. Caller stated she placed the needle with the syringe in the arm and pushed the plunger. The vaccine liquid came out between the hub of the needle and the syringe on injection. Caller stated, ""When she took the needle off of the syringe the needle looked wobbly and loosey goosey. Caller stated the needle didn't look right."" 'It was the needle and not the syringe.  Documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA265855,2,09/30/2019,,,,
0837337,10/01/2019,PA,67.0,67,,F,,"patient received dose of Fluzone HD on 20Sep2019 in which there was a needle malfunction and some of the dose leaked out, no AE; the leakage was not from the tip of the needle, but further up the syringe and some of the dose leaked out, no AE; Initial information received on 23-Sep-2019 and additional information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 67 years old female patient who received a 0.5 mL dose of vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UJ242AA, expiry date: 04-May-2020) via intramuscular route in the right deltoid on 20-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of vaccine underdose and syringe leak.   Pharmacist reported that patient received dose of Fluzone HD in which there was a needle malfunction and some of the dose leaked out. It was reported that the leakage was not from the tip of the needle, but further up the syringe. Leakage did occur during administration and it was believed the needle might not have been attached properly/screwed in tight.  At the time of reporting, no adverse event was reported.  List of documents held by sender: none.",,,,,,,,,U,09/20/2019,,,,UNK,,,,,,USSA2019SA266479,2,09/28/2019,,,,
0837338,10/01/2019,CO,,89,,F,,"body shaking; trouble breathing; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 90 years old female patient who experienced body shaking (tremor) and trouble breathing (dyspnea), while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 23-Sep-2019, the patient received a single dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ251AB via unknown route in the arm nos.  On an unknown date, The patient developed a non-serious body shaking (tremor) and trouble breathing (dyspnea) Unknown latency following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  No lab test reported.  Final diagnosis was trouble breathing and body shaking.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for body shaking and as Unknown for trouble breathing.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA266630,2,09/27/2019,,,Y,
0837339,10/01/2019,VA,,0,.4,M,,"patient only e liquid DTAP- IPV portion of Pentacel without mixing it with the powder Hib portion; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 4 months old male patient who recieved only e liquid dtap- ipv portion of pentacel without mixing it with the powder hib portion, while he received vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 20-Sep-2019, the patient received a 0.5 ml dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot number - U6138AB in left Vastus Lateralis.  Concomitant medications included ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) for Immunisation; PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PNEUMOCOCCAL VACCINE CONJ 13V (CRM197)) for Immunisation; and HEPATITIS B VACCINE (HEPATITIS B VACCINE) for Immunisation.  It was a case of actual medication error due to Inappropriate reconstitution technique.  No adverse event reported as none symptoms reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,09/20/2019,,,,UNK,,ROTAVIRUS VACCINE; PNEUMOCOCCAL VACCINE CONJ 13V (CRM197); HEPATITIS B VACCINE,,,,USSA2019SA266644,2,09/27/2019,,,,
0837340,10/01/2019,IL,,64,,M,,"64 year old patient was inadvertently given the Fluzone High Dose vaccine instead of an influenza vaccine/ no AE; 64 year old patient was inadvertently given the Fluzone High Dose vaccine instead of an influenza vaccine/ no AE; 64 year old patient was inadvertently given the Fluzone High Dose vaccine instead of an influenza vaccine/ no AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 64 years old male patient who vaccines INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ251AB, expiry- 01-05-2020 via unknown route in the left arm instead of INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to wrong vaccine administered, inappropriate age at vaccine administration and overdose.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  Documents held by sender: none.",,,,,,,,,U,09/22/2019,,,,UNK,,,,,,USSA2019SA266787,2,09/30/2019,,,,
0837341,10/01/2019,VA,,63,,F,,"Fluzone HD administered to 63 year old patient/no AE; Fluzone HD administered to 63 year old patient/no AE; Fluzone HD administered to 63 year old patient/no AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 63 years old female patient received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 21-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ251AB via intramuscular route in the left deltoid.  It was of actual medication error due to inappropriate age at vaccine administration, off label use and overdose.  It was unknown where adverse event was experienced or not.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,09/21/2019,,,,UNK,,,,,,USSA2019SA266859,2,09/27/2019,,,,
0837342,10/01/2019,GA,,,,U,,"large amount of swelling at the side, redness, and heat; large amount of swelling at the side, redness, and heat; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a patient (reported as 1) who experienced large amount of swelling at the side, redness, and heat (Inflammation  and vaccination site reaction), while he/she received vaccine INFLUENZA VACCINE  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date (09/17), the patient received a dose of suspect INFLUENZA VACCINE lot number not reported via unknown route and unknown site.  On an unknown date, the patient had experienced large amount of swelling at the side, redness, and heat (Inflammation and vaccination site reaction) (Unknown latency) following the administration of INFLUENZA VACCINE.  Lab data was not reported.  Final diagnosis was vaccination site inflammation, vaccination site swelling, vaccination site erythema and vaccination site warmth.   Office recommended ice to site of injection, motrin, and benedryl. Seen in office 9/19 (flu shot administered 9/17), oral steroids if not improved with OTC recommendations  The patient outcome was reported as unknown for experienced large amount of swelling at the side, redness, and heat (Inflammation  and vaccination site reaction).  Information on batch number was requested.  List of document held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA266992,2,09/27/2019,,,,
0837343,10/01/2019,GA,,,,U,,"large amount of swelling at injection site, redness, and heat.; large amount of swelling at injection site, redness, and heat.; large amount of swelling at injection site, redness, and heat.; large amount of swelling at injection site, redness, and heat.; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional in via Sales Representative.  This case involves a 10 years old patient who experienced large amount of swelling at injection site, redness, and heat (vaccination site inflammation), while he/she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.   On 17-Sep-2019, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported.  On an unknown date, The patient developed a non-serious large amount of swelling at injection site, redness, and heat. (vaccination site inflammation) (vaccination site swelling) (vaccination site erythema) (vaccination site warmth) Unknown latency following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  No lab test reported.  Final diagnosis was large amount of swelling at injection site, redness, and heat..   The patient was treated with ice the site, NAPROXEN (MOTRIN [NAPROXEN]) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]).  The patient outcome is reported as Unknown for the events.  Information on the batch number was requested.",,,,,,,,,U,09/17/2019,,,,UNK,,,,,,USSA2019SA267015,2,09/27/2019,,,,
0837344,10/01/2019,GA,,,,U,,"Large amount of swelling at the injection site; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 18  old patient who experienced large amount of swelling at the injection site (vaccination site swelling), while he/she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route.  On an unknown date, The patient developed a non-serious large amount of swelling at the injection site (vaccination site swelling) Unknown latency following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  No lab test reported.  Final diagnosis was large amount of swelling at the injection site.   The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]), ice to the site and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]).  The patient outcome is reported as Unknown for large amount of swelling at the injection site.  Information on the batch number was requested.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267072,2,09/27/2019,,,,
0837345,10/01/2019,GA,,,,U,,"swelling and itching at injection site; swelling and itching at injection site; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a patient (reported as 4) who experienced swelling and itching at injection site (vaccination site pruritus and vaccination site swelling), while he/she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route and unknown site.  On an unknown date, the patient had swelling and itching at injection site (vaccination site pruritus and vaccination site swelling) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Lab data was not reported.  Final diagnosis was vaccination site pruritus and vaccination site swelling.   It was not reported if the patient received a corrective treatment.  The patient outcome was reported as unknown for vaccination site pruritus and vaccination site swelling.  Information on the batch number is requested.  List of document held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267080,2,09/27/2019,,,,
0837346,10/01/2019,OH,,,,M,,"fever; flu like symptoms; sniffles; headache; sick like a dog; feeling like they were dying for a day; Initial and Additional information received on 23-Sep-2019 and 24-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacy other/non-hcp.  This case is linked to cases 2019SA267183 and 2019SA267181 (same reporter).  This case involves a 67 years old male patient who experienced flu like symptoms (influenza like illness), sick like a dog (malaise), sniffles (rhinorrhoea), headache (headache), fever (pyrexia) and feeling like they were dying for a day (unevaluable event), while he received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 06-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (Lot: UJ232AA and expiry date: 10-Apr-2020) via intramuscular route in the left deltoid.  On an unknown date, the patient had flu like symptoms (influenza like illness), sick like a dog (malaise), sniffles (rhinorrhoea), headache (headache), sick like a dog (malaise), fever (pyrexia) and feeling like they were dying for a day (unevaluable event) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  Lab data was not reported.  Final diagnosis was influenza like illness, rhinorrhoea, headache, malaise, pyrexia and unevaluable event.   It was not reported if the patient received a corrective treatment and Spent the whole day in bed.  The patient outcome was reported as unknown for all the events.  List of document held by sender:  none.",,,,,,,,,U,09/06/2019,,,,UNK,,,,,,USSA2019SA267182,2,09/30/2019,,,,
0837347,10/01/2019,OH,,,,M,,"feeling like they were dying for a day; fever; flu like symptoms; sniffles,; headache; sick like a dog; Initial and Additional information received on 23-Sep-2019 and 24-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacy other/non-hcp.  This case is linked to cases 2019SA267183 and 2019SA267182 (same reporter).  This case involves a 66 years old male patient who experienced flu like symptoms (influenza like illness), sick like a dog (malaise), sniffles (rhinorrhoea), headache (headache), sick like a dog (malaise), fever (pyrexia) and feeling like they were dying for a day (unevaluable event), while he received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 06-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (Lot: UJ232AA and expiry date: 10-Apr-2020) via intramuscular route in the left deltoid.  On an unknown date, the patient had flu like symptoms (influenza like illness), sick like a dog (malaise), sniffles (rhinorrhoea), headache (headache), sick like a dog (malaise), fever (pyrexia) and feeling like they were dying for a day (unevaluable event) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  Lab data was not reported.  Final diagnosis was influenza like illness, rhinorrhoea, headache, malaise, pyrexia and unevaluable event.   It was not reported if the patient received a corrective treatment and Spent the whole day in bed.  The patient outcome was reported as unknown for all the events.  List of document held by sender:  none.",,,,,,,,,U,09/11/2019,,,,UNK,,,,,,USSA2019SA267183,2,09/30/2019,,,,
0837348,10/01/2019,NY,,,,M,,"FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267212; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193;   This case involves (an adult) male patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267218,2,09/30/2019,,,,
0837349,10/01/2019,UT,10.0,,,U,,"10 years old patient was administered Flublok instead of Fluzone Quad/no AE; 10 years old patient was administered Flublok instead of Fluzone Quad/no AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.   This case is linked to case 2019SA267184 (same reporter).  This case involves a 10 years old patient of unknown gender who received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] instead of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT).  The patient's past medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported via unknown route.  It was of actual medication error due to inappropriate age at vaccine administration and wrong vaccine administered.  It was unknown where adverse event was experienced or not.  Information on the batch number was requested.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267237,2,09/30/2019,,,,
0837350,10/01/2019,PA,,,,F,,"possibly Parsonage Turner Syndrome; Severe pain in the shoulder, and arm; random neck pain or a flare; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 33 years old female patient who experienced possible parsonage turner syndrome (neuralgic amyotrophy), while she received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Rheumatoid arthritis and Sjogren's syndrome.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route.  On an unknown date, The patient developed a non-serious possible parsonage turner syndrome (neuralgic amyotrophy) severe pain in the shoulder, and arm (pain in extremity) and random neck pain or a flare (neck pain) one or two days following the administration of INFLUENZA VACCINE.  No lab test was reported.  Final diagnosis was possible parsonage turner syndrome.   Several physical therapy sessions, and unsuccessful steroid attempts to ease the pain corrective treatment was received.  The patient outcome is reported as Not Recovered / Not Resolved on an unknown date for the events.  Information on the batch number will be requested.",,,,,,,,,N,,,,,UNK,,,Rheumatoid arthritis; Sjoegren's syndrome,,,USSA2019SA267427,2,09/27/2019,,,,
0837351,10/01/2019,TX,40.0,40,,F,,Vaccine was not given at our facility. Unsure of Manufacturer and/or Lot numbers etc.,,,,,,,,,N,09/30/2019,09/30/2019,0,N/A,PHM,,None,None current. Unsure for the last month,unknown,,,2,10/01/2019,,Y,,None
0837352,10/01/2019,,1.0,1,.0,M,,Patient developed rash starting on torso and spreading to back and legs and became itchy.,,,,,,,,,,09/10/2019,09/17/2019,7,,PVT,,,,,,,2,10/01/2019,,Y,,
0837353,10/01/2019,NY,13.0,13,,M,,"Head to toe rash all over body, baseball sized red and swollen at injection site, migraines and blurry vision, trouble sleeping",,,,,,,,,N,09/17/2019,09/17/2019,0,,PVT,,none,none,none,,,2,10/01/2019,,Y,,no
0837354,10/01/2019,MI,44.0,44,,F,,"Staff member came to clinic and received her flu vaccine, left the clinic with no reports immediate reactions. went back to work place. A bit later a coworker came to clinic to inform us she had a reaction and was in the ED. Coworker stated she was pale, the red cheeks, and her tongue was starting to feel funny and they brought her to ED.",,,,,,,,,U,09/30/2019,09/30/2019,0,,WRK,,unknown,unknown,unknown,,,2,10/01/2019,,,Y,unknown
0837356,10/01/2019,NY,68.0,68,,F,,"Client states ,via phone call ,that 2 days after vaccine administration 9/28., she experienced blotchy redness on cheek area of her face. No itching or shortness of breath. As of 9/30 redness has faded.",,,,,,,,,Y,09/26/2019,09/28/2019,2,"none, did not seek medical attention",WRK,,osteoporosis medication and beta blockers,none,HTN and osteoporosis,,,2,10/01/2019,,,,none
0837358,10/01/2019,IA,51.0,51,,F,,"Sore and very painful and swollen and red at injection site. Headache, aches",,,,,,,,,N,09/29/2019,09/30/2019,1,,PHM,,,Allergies,,,,2,10/01/2019,,,,"Zertec, Penicillian, Nutmeg"
0837359,10/01/2019,MI,68.0,68,,M,,SEVERE FEVER,,,,,,,,,N,09/30/2019,09/30/2019,0,,PVT,,"WELLBUTRIN,COZAAR,MELOXICAM,VITC,MULTI VIT, VIT D,B COMPLEX,",BARRETTS ESPOGHAGUS,"DEPRESSION, HIGH BLOOD PRESSURE",,,2,10/01/2019,,,,NONE
0837364,10/01/2019,TX,28.0,28,,M,,LOCALIZED RASH ALONG THE MIDDLE OF THE BACK AND SHOULDERS.,,,,,,,,,N,09/26/2019,09/30/2019,4,,MIL,,N/A,N/A,N/A,,,2,10/01/2019,,,,N/A
0837365,10/01/2019,MI,29.0,29,,F,,"Patient woke up with a Red rash around her neck, itching.  Patient had redness at injection site also",,,,,,,,,Y,09/29/2019,09/29/2019,0,None,OTH,,Unknown,none,none,,,2,10/01/2019,,Y,,None reported
0837367,10/01/2019,MI,47.0,47,,F,,"Patient received her flu vaccine on 9/30/2019.   Woke this morning with a red bumpy rash , itching on her Lt upper Thigh.  Patient reports no changes in her health, denies any food allergies or changes in any home products.",,,,,,,,,U,09/30/2019,10/01/2019,1,None,OTH,,None reported,None,None  reported,,,2,10/01/2019,,Y,,None
0837368,10/01/2019,PA,67.0,67,,F,,"hives on neck and chest patient reports taking Benadryl and using hydrocortisone cream on the rash area with improvement denies SOB / trouble swallowing/ any other symtpoms refused appointment in office for this, she simply called in to alert us of her reaction. she told me over the phone she tested positive for allergic reaction to eggs in the past but never had a problem with the flu shot in the past.",,,,,,,,,,09/27/2019,09/27/2019,0,,PVT,,,,,,,2,10/01/2019,,,,"egg, onion, pollen"
0837377,10/01/2019,CO,1.0,,,F,,"No adverse effects reported.; patient was inadvertently administered one dose of expired VAQTA (lot R018935 exp 09/05/2019) on 09/06/2019; This spontaneous report was received from a nurse and refers to a 12-month-old female patient. No information regarding the patient's concurrent conditions, pertinent medical history and concomitant medications was reported. On 06-SEP-2019, the patient was inadvertently vaccinated with one dose of expired hepatitis a vaccine, inactivated (VAQTA) lot # R018935, expiration date: 05-SEP-2019 (strength, dose, frequency, route of administration were not reported) for prophylaxis. No adverse effects were reported.",,,,,,,,,U,09/06/2019,09/06/2019,0,,UNK,,,,,,US0095075131909USA003281,2,10/01/2019,,,,
0837378,10/01/2019,WA,,,,F,,"two unspecified patients, who were over the age of 64 years old and already had cervical cancer; two unspecified patients, who were over the age of 64 years old and already had cervical cancer; No adverse events; This spontaneous report was received from a pharmacist via a company representative and refers to a female patient over the age of 64 years old. The patient had already experienced cervical cancer.   On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route of administration, lot # and expiration date were not provided) for prophylaxis. No adverse events were reported.   This is one of two reports received from the same reporter (linked with MARRS # 1910USA000552).; Sender's Comments:  US-009507513-1910USA000552:",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Cervical cancer,,US0095075131909USA004120,2,10/01/2019,,,,
0837379,10/01/2019,CA,0.17,,,U,,"after first dose, patient experienced laryngospasms while in the office; This spontaneous report was received from a nurse practitioner via a company representative regarding a 2-month-old patient of unknown gender. The patient's concurrent conditions and medical history were not reported. Concomitant therapies were unknown by the reporter, however it was reported that there might have been other vaccinations (non oral) on an unspecified date (reported as ""that day"").  On an unspecified date (also reported as ""about 1.5 to 2 years ago""), the patient was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally for rotavirus (lot number, expiration date, dose and frequency were not reported).  While in the office for the 1 dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), after being administered with the first dose, the infant experienced laryngospasms. No treatment was given for this adverse event (AE). No laboratory diagnostics or studies were performed regarding the event. The patient sought medical attention. Limited information was provided by the reporter. The patient recovered from the event in 15 to 20 minutes.   The relatedness between the event of laryngospasms and the suspect vaccination was not provided.",,,,,,,,,Y,,,,,UNK,,,Gastroenteritis rotavirus; Prophylaxis,,,US0095075131909USA007961,2,10/01/2019,,,,
0837380,10/01/2019,OH,,,,F,,"Deltoid went necrotic after getting the dose at the site; This spontaneous report was received from a nurse prescriber regarding a 15 year old female patient. Patient's concurrent condition, medical history and concomitant medication were not reported. On an unknown date, the patient was vaccinated with 2nd dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) in the deltoid (dose, strength, lot/batch and expiry: unknown) for prophylaxis. It was reported that, on an unknown date, deltoid went necrotic after getting the dose at the site (injection site necrosis). Treatment was received for the event. Patient sought medical attention. There was no adverse effect with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). Cancer was not involved. The outcome of injection site necrosis was recovering. Causality of the event with respect to suspect therapy was unknown.  Upon internal review, the event injection site necrosis was determined to be medically significant.",,,,,,,,,N,,,,,UNK,,,,,,US0095075131909USA014736,2,10/01/2019,,Y,,
0837381,10/01/2019,WA,,,,F,,"two unspecified patients, who were over the age of 64 years old and already had cervical cancer; two unspecified patients, who were over the age of 64 years old and already had cervical cancer; No adverse events; This spontaneous report was received from a pharmacist via a company representative and refers to a female patient over the age of 64 years old. The patient had already experienced cervical cancer.   On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route of administration, lot # and expiration date were not provided) for prophylaxis. No adverse events were reported.   This is one of two reports received from the same reporter (linked with MARRS # 1909USA004120).; Sender's Comments:  US-009507513-1909USA004120:",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Cervical cancer,,US0095075131910USA000552,2,10/01/2019,,,,
0837382,10/01/2019,IL,,,,U,,"passed out; This case was reported by a nurse via sales rep and described the occurrence of passed out in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo .5 ml. On an unknown date, unknown after receiving Menveo, the patient experienced passed out (serious criteria GSK medically significant). On an unknown date, the outcome of the passed out was unknown.   It was unknown if the reporter considered the passed out to be related to Menveo.  Additional information was reported as follows: This case was reported by the registered nurse. The age at vaccination was not reported. After vaccination, the patient had passed out. The reporter wanted know if that was normal. This case is 1 of 4 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837383,10/01/2019,IL,,,,U,,"passed out; This case was reported by a nurse via sales rep and described the occurrence of passed out in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo .5 ml. On an unknown date, unknown after receiving Menveo, the patient experienced passed out (serious criteria GSK medically significant). On an unknown date, the outcome of the passed out was unknown.   It was unknown if the reporter considered the passed out to be related to Menveo.  Additional information was reported as follows: This case was reported by the registered nurse. The age at vaccination was not reported. After vaccination, the patient had passed out. The reporter wanted know if that was normal. This case is 1 of 4 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837384,10/01/2019,IL,,,,U,,"passed out; This case was reported by a nurse via sales rep and described the occurrence of passed out in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo .5 ml. On an unknown date, unknown after receiving Menveo, the patient experienced passed out (serious criteria GSK medically significant). On an unknown date, the outcome of the passed out was unknown.   It was unknown if the reporter considered the passed out to be related to Menveo.  Additional information was reported as follows: This case was reported by the registered nurse. The age at vaccination was not reported. After vaccination, the patient had passed out. The reporter wanted know if that was normal. This case is 1 of 4 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837385,10/01/2019,IL,,,,U,,"passed out; This case was reported by a nurse via sales rep and described the occurrence of passed out in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo .5 ml. On an unknown date, unknown after receiving Menveo, the patient experienced passed out (serious criteria GSK medically significant). On an unknown date, the outcome of the passed out was unknown.   It was unknown if the reporter considered the passed out to be related to Menveo.  Additional information was reported as follows: This case was reported by the registered nurse. The age at vaccination was not reported. After vaccination, the patient had passed out. The reporter wanted know if that was normal. This case is 1 of 4 cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837386,10/01/2019,,,,,F,,"I had some of the side effects; This case was reported by a consumer via interactive digital media and described the occurrence of adverse drug reaction in a female patient who received DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis.   On an unknown date, the patient received Tdap Vaccine at an unknown dose. On an unknown date, unknown after receiving Tdap Vaccine, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Tdap Vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported that the patient got the Tdap vaccine so she could be around her new grandson who is expected in February.  The patient had some of the side effects after receiving Tdap Vaccine but it was still worth it. The case has been linked with the case US2019AMR174475, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837387,10/01/2019,,,,,M,,"Had some of the side effects; This case was reported by a consumer via interactive digital media and described the occurrence of adverse drug reaction in a male patient who received DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis.   On an unknown date, the patient received Tdap Vaccine at an unknown dose. On an unknown date, unknown after receiving Tdap Vaccine, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Tdap Vaccine.  Additional details were provided as follows: The case was reported by patient's parent. The age at vaccination was not reported. It was reported that the patient got the shot and also had some of the side effects. The case has been linked with the case US2019AMR174465, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837388,10/01/2019,MN,,,,U,,"Fever; Chills; Myalgias; This case was reported by a physician via call center representative and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax (in November 2015, received Zostavax).   On 1st April 2019, the patient received the 1st dose of Shingrix. On 1st April 2019, less than a day after receiving Shingrix, the patient experienced fever, chills and myalgia. On an unknown date, the outcome of the fever, chills and myalgia were recovered/resolved.   It was unknown if the reporter considered the fever, chills and myalgia to be related to Shingrix.  Additional details were provided as follows: The age group of the patient was not reported, but selected as an adult as per vaccine indication. The medical assistant reported that, after vaccination with dose of Shingrix, the patient had very unpleasant side effects with fever, chills, myalgias for 36 hours. The reporter did not consent to follow up.",,,,,,,,,Y,04/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837389,10/01/2019,,86.0,86,,M,,"itching; itching spread all over her body/ take out her hearing aid to scratch the area; quick pin stick in her arm and then the itching starts; This case was reported by a consumer via call center representative and described the occurrence of genital itching in a 87-year-old male patient who received Herpes zoster (Shingrix) (batch number J4D5J, expiry date unknown) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 24th May 2018 (batch number B9739, expiry date unknown)). Concomitant products included cardiovascular system drugs (Heart Medication).   On 25th September 2018, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced genital itching, generalized pruritus and tingling skin. The patient was treated with dermatologicals nos (Lotion). On an unknown date, the outcome of the genital itching, generalized pruritus and tingling skin were not recovered/not resolved.   It was unknown if the reporter considered the genital itching, generalized pruritus and tingling skin to be related to Shingrix.  Additional details were provided as follows: The patient did not experience any reactions until 3 months before the reporting date and then her genital area started to itch.   Within 3 to 4 days later, the itching spread all over her body, she specifically mentioned her head, arms, back and ears.   She said it felt like a quick pin stick in her arm and then the itching started. The itching come and go but was not resolved. The patient's physician took her off all her medications including her heart medication but that did not help with the itching. Her dermatologist prescribed various lotions and none relieved the itch. There was no rash or pimples of any kind. The patient was suffering with the symptom in her ear when she was reporting these adverse events.  She had to take out her hearing aid to scratch the area while speaking to the call center representative. The patient consented to follow up and also provided her physician's details.",,,,,,,,,N,09/25/2018,,,,UNK,,HEART MEDICATION,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,Y,,
0837390,10/01/2019,TX,49.0,49,,F,,"Inappropriate age at vaccine administration; Shingles rash; Shingles rash; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 49-year-old female patient who received Herpes zoster (Shingrix) (batch number 3B2S7, expiry date 15th November 2021) for prophylaxis.   On 16th September 2019, the patient received the 1st dose of Shingrix (intramuscular). In September 2019, less than 2 weeks after receiving Shingrix, the patient experienced shingles and vesicular rash. On 16th September 2019, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the shingles, vesicular rash and inappropriate age at vaccine administration were unknown.   It was unknown if the reporter considered the shingles and vesicular rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left arm. The pharmacist reported that patient received first dose of Shingrix and had now been diagnosed with shingles rash.",,,,,,,,,U,09/16/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837394,10/01/2019,OH,11.0,11,,M,,"(R) arm swelling, erythema and pain 24-48 hrs after injection - area involved 4 x 6""",,,,,,,,,Y,09/26/2019,09/27/2019,1,0,PVT,,none,none,none,,,2,09/28/2019,,Y,,none
0837395,10/01/2019,IL,80.0,80,,F,,Her arm started to swell that night and she developed hives.  By the next morning the swelling was about half the size of a grapefruit and very red.  It was also itchy. Patient took Advil for two days.  Her arm is almost back to normal.  She states the redness is fading and her arm is almost flat. The hives have disappeared. Her arm is still a little itchy.  Provider encouraged pt to take Benadryl.,,,,,,,,,Y,09/09/2019,09/09/2019,0,,PVT,,"levothyroxine 100 mcg tablet, TAKE 1 TABLET BY MOUTH EVERY DAY, ?  mupirocin 2 % ointment, Apply to affected area twice daily for 10 days",,Hyperglycemia     ? Hyperlipidemia    ? Hypothyroidism ,,,2,10/01/2019,,Y,,Amoxicillin-pot clavulanate; Cefadroxil; Clarithromycin; and Azithromycin
0837396,10/01/2019,ME,45.0,45,,F,,Patient presented 1 hour post vaccination with Rash - puff lips...Treated 25mg diphenhydramine every 2 hours x 24 hour next developed angioedema and needed to present to ED.,,,,,,,,,U,09/30/2019,09/30/2019,0,no idea - went to ED 10/1/19,WRK,,none,Had flu like illness prior 2 years s/p flu vaccine for 3 days each...no IGG mediated prior response.,No idea,,,2,10/01/2019,,,Y,"Reglan, PVK, MS, Metronidazole, Maxalt, Iodinated Dx Agent and  Astromorph"
0837397,10/01/2019,FL,68.0,68,,F,,Left neck/shoulder stiffness and pain,,,,,,,,,N,09/20/2019,09/20/2019,0,,PHM,,N/A,None,None,,,2,10/01/2019,,,,NKDA
0837398,10/01/2019,NC,0.33,0,.4,F,,"The family states the injections were given without incidence. She had mild fever for 2 days. There was erythema at the injection sites, about the size of a nickel. MOP was concerned the left thigh site is too lateral. She continues to have hard lumps at both injection sites. She does not seem to have pain and they do not impari activity. She is otherwise baseline. She tolerated her 2 month vaccines without incidence. Physical exam showed  palpable bilateral firm, mobile, irregular, knotty, pea-sized, nontender, left slightly larger than right nodules at quadriceps injection sites with superficial skin discoloration but no signs of other local site inflammation. Family reported nodules still present on 14 AUG 2019. F/u was planned for SEPT. We telephoned on -1 OCT since they hadn't scheduled and report was sites improved and visit  was declined by family.",,,,,,,,,Y,07/31/2019,08/01/2019,1,no,MIL,,none,none,none,,,2,10/01/2019,,Y,,No  history of adverse reactions to drugs No history of adverse reactions to hymenoptera stings No history consistent with food intolerance No history consistent with latex intolerance .
0837399,10/01/2019,CO,58.0,58,,M,,"Flu-like symptoms, minus the fever.  Body aches, extreme fatigue, headache",,,,,,,,,Y,09/28/2019,09/29/2019,1,N/A,PHM,,"Buproprion, Lisinopril, Viibryd, Bystolic, Simvistatin, Rittalin, Advair, Montelukast",None,Asthma,,,2,10/01/2019,,,,"None currently.    When very young (approximately 7-8 years old) I had a very bad reaction to a Rubella vaccination given at school.  At the time, I was informed this was due to an egg allergy.  I didn't eat eggs for several years but resumed eating them, with no apparent ill effect, around the age of 11 and have been ever since."
0837400,10/01/2019,PA,66.0,66,,F,,"Chills then fever which were gone by morning.  I had blotchy red marks around the site, but no itching.  Redness was gone by Sunday night.",,,,,,,,,Y,09/26/2019,09/26/2019,0,None,PHM,,"Metoprolol Succ Er 25mg, multi vitamin, calcium plus D, glucosamine chondroitin, fish oil, Claritin non-drowsy, low dose aspirin, B-12",None,"Fibromyalgia, arthritis in shoulders, palpitations",,,2,10/01/2019,,,,None
0837401,10/01/2019,GA,12.0,12,,M,,Patient felt weak and light headed and had a syncope episode in the chair 5-10 minutes after injection was given,,,,,,,,,Y,10/01/2019,10/01/2019,0,n/a,PUB,,n/a,dehydration,n/a,,,2,10/01/2019,,,,n/a
0837402,10/01/2019,FL,66.0,66,,F,,"Patient came in 7 days post immunization to report  that she felt feverish, lethargic, and reported at first she was only had nausea to then stating she did vomit one time and by the end of taking her report had said she actually vomited 3 times.  All symptoms lasted for one day per patient.",,,,,,,,,Y,09/24/2019,09/01/2019,,N/A,PHM,,"Only meds listed on patients record: Bentyl 20mg, Valtrex 500mg, Elmiron 100mg, Zocor 20mg",n/a,n/a,,,2,10/01/2019,,,,NKDA
0837403,10/01/2019,TX,88.0,88,,F,,RED RAISED AREA 2 INCHES IN DIAMETER NO ITCHING SHE STATES FEELS WARM,,,,,,,,,U,09/26/2019,09/27/2019,1,NONE,PHM,,NONE KNOWN,NONE,HYPERTENSION COPD,,,2,10/01/2019,,,,NKA
0837404,10/01/2019,TX,10.0,10,,F,,"Five minutes after injection child was leaving and started coughing, felt like she couldn't breathe, face turned red, and eyes began to water.  Coughing subsided, but child reported that it felt like something was in throat.  Face was still red and eyes tearing.  Vital signs obtained BP 114/72. HR 86, SpO2 97%.  Lung sounds clear bilaterally and no wheezing heard on auscultation.  Reaction seemed to subside and child was no longer coughing or reporting feeling like something was in throat.  Redness in face resolved with tearing.  15 minutes post injection redness noted at injection site in oval shape extending approximately 3 inches.  20 minutes post injection MD to see patient.  Child showing no more signs of reaction.  All symptoms resolved.  No redness at injection site 25 min post injection.",,,,,,,,,Y,09/30/2019,09/30/2019,0,None,PVT,,cetirizine 10 mg tablet daily,none,none,,,2,10/01/2019,,,,none
0837405,10/01/2019,AR,53.0,53,,F,,"Muscle aches, headache, diarrhea, fever of 100.5, nausea",,,,,,,,,N,09/29/2019,09/30/2019,1,None yet,PHM,,"Emgality, tramadol, Ambien, levothyroxine, amytriptaline",None,"Asthma,  Bipolar, parkinsonism",,,2,10/01/2019,,,,Nadalol
0837406,10/01/2019,MO,28.0,28,,F,,"My arm that got the injection was hurting too bad to lift up to shoulder height. This started two hours after the injection. Then shortly after the arm pain, it felt like there was a weight on my chest, which caused difficulty breathing. At that same time, I started feeling dizzy and confused.  About 5 hours after injection, I was shivering and cold feeling, but my skin was hot to the touch.",,,,,,,,,Y,09/30/2019,09/30/2019,0,None,WRK,,Kyleena birth control IUD.,A couple of headaches.,Migraines.,,,2,10/01/2019,,,,Mustard
0837407,10/01/2019,CA,74.0,74,,F,,"fever 100.1, headache and dizziness-overall sick and yucky feeling",,,,,,,,,U,09/30/2019,09/30/2019,0,,PHM,,,,,,,2,10/01/2019,,,,none
0837408,10/01/2019,PA,4.0,4,,F,,Localized left arm erythema,,,,,,,,,U,09/26/2019,09/27/2019,1,n/a,PVT,,"Albuterol MDI as needed, Asmanex MDI 1 puff BID","9/14/2019 Coxsackie Virus, 9/23/2019 Viral URI",Asthma (mild intermittent),,,2,10/01/2019,,Y,,NKDA
0837409,10/01/2019,CO,53.0,53,,M,,"Rash over midsection, red not raised",,,,,,,,,N,09/27/2019,09/27/2019,0,none,OTH,,Omeprazole,None,None,,,2,10/01/2019,,,,Naproxen Sodium
0837410,10/01/2019,CA,16.0,16,,F,,"Swelling, redness and pain to site of injection",,,,,,,,,Y,09/24/2019,09/26/2019,2,,PVT,,,no,Exercise-induced asthma,,,2,10/01/2019,,Y,,NKDA
0837411,10/01/2019,OH,7.0,7,,M,,Extensive limp swelling to knee.,,,,,,,,,,09/26/2019,09/27/2019,1,,PVT,,Zyrtec 5ml daily,No,No,,,2,09/28/2019,,Y,,None
0837412,10/01/2019,MI,75.0,75,,F,,"very sore and swollen UPPER LT. ARM very PINK AND WARM UPPER FOR 8 days 2 FIFTY CENT SIZED bletches oN my chEST no itcHING, chesT site",,,,,,,,,Y,09/03/2019,09/04/2019,1,none,PHM,,"FLECAINIDE ASPiRiN ATORVASTATIN  Citalopram CiTRAZiNE ALPRAZALAM Calcium CHEWS PRESERVISION PRENATAL ViT  PROBIOTIC ViTAMiN D3 ViTAMiN B COMPLEX ViTAMiN B12 COQ10 STOOL SOFTENER  FLONASE SPRAY HAIR, SKiN and NAILS ZINC  ESGIC  HYOSCiAMiNE",None,ATRIAL FIBRILLATION,,,2,09/20/2019,,,,"PCN, SULFA, SHRIMP, ConTRAST Dye"
0837413,10/01/2019,SC,58.0,58,,F,,"I was weak during the dates listed, dizzy also very sore in the muscles. also was having faint like my blood sugar might have been low or sugar level low also drownsy. I will not take this Flu shot again  Did get a urinary track during week of symptoms of vaccine I do not know if From the Vaccine.",,,,,,,,,Y,08/28/2019,08/30/2019,2,,PHM,,"Oxcarbazephine, Pravastatin belsoma, latuda, hydroxzincetteL",NA,"chlosteral patient, mental health.",,,2,09/27/2019,,,,unknown
0837414,10/01/2019,IN,70.0,70,,F,,"patient reported redness & swelling, pain in injection site. Warm to touch patient advised to apply ice, take NSAID & diphenhydramine & to contact PCP if worsens.",,,,,,,,,U,09/25/2019,09/25/2019,0,N/A,PHM,,Vitamin D,N/A,N/A,,,2,09/27/2019,,,,NKDA
0837428,10/01/2019,DE,,,,U,,"no adverse events; A patient received a dose of PEDV AX on 02/01/2019, on 04/01/2019, on 06/01/2019, and on 09/09/2019; This spontaneous report as received from an administrator refers to a patient of unknown age and gender. No information on patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 01-FEB-2019, the patient was vaccinated with a first dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot#, expiration date, dose and route of administration were not provided) for prophylaxis. The patient was vaccinated with a second, third and fourth dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot#, expiration date, dose and route of administration were not provided) for prophylaxis, on 01-APR-2019, 01-JUN-2019 and 09-SEP-2019, respectively. No known adverse effects were reported.",,,,,,,,,U,02/01/2019,06/01/2019,120,,UNK,,,,,,US0095075131909USA007132,2,10/01/2019,,,,
0837429,10/01/2019,WA,,,,F,,"Shortly after receiving Defendants' Zostavax vaccine, Plaintiff suffered shingles.; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a female patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  In or around October 2016, the pt was inoculated with a dose of zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, frequency, lot/batch # and expiration date were not reported). Shortly after receiving zoster vaccine live (ZOSTAVAX), the pt suffered shingles (herpes zoster). As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms had resulted in physical limitations not present prior to using it. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution, and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence the pt suffered serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The reporter considered the event to be related to zoster Vaccine Live (ZOSTAVAX). The reporter considered the event to be disabling.",,,,,,,,Y,N,10/01/2016,,,,UNK,,,Routine health maintenance,,,US0095075131909USA010873,2,10/01/2019,,,,
0837430,10/01/2019,UT,,,,F,,"Shortly after receiving Defendants' Zostavax vaccine, Plaintiff suffered shingles.; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a female patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  In or around July 2016, the pt was inoculated with a dose of zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, frequency, lot/batch # and expiration date were not reported). Shortly after receiving zoster vaccine live (ZOSTAVAX), the pt suffered shingles (herpes zoster). As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms had resulted in physical limitations not present prior to using it. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution, and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence the pt suffered serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.  The reporter considered the event to be related to zoster Vaccine Live (ZOSTAVAX). The reporter considered the event to be disabling.",,,,,,,,Y,N,07/01/2016,,,,UNK,,,Routine health maintenance,,,US0095075131909USA010977,2,10/01/2019,,,,
0837431,10/01/2019,,,,,U,,"Tired; This case was reported by a consumer and described the occurrence of tiredness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th September 2019, the patient received Shingrix. On 25th September 2019, 1 days after receiving Shingrix, the patient experienced tiredness. On an unknown date, the outcome of the tiredness was unknown.   It was unknown if the reporter considered the tiredness to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. The patient reported that the patient received a Shingrix vaccination yesterday and feeling tired at the time of reporting. The asked if this was normal.",,,,,,,,,U,09/24/2019,09/25/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837432,10/01/2019,PA,,,,M,,"vaccination failure; Shingles; swelling in groin area; difficulty walking; itching; This case was reported by a other health professional via call center representative and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and 183 days after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, groin swelling, walking difficulty and pruritus. On an unknown date, the outcome of the vaccination failure, shingles, groin swelling, walking difficulty and pruritus were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pruritus to be related to Shingrix and Shingrix. It was unknown if the reporter considered the groin swelling and walking difficulty to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient developed a widespread case of shingles. The shingles was itchy and the patient developed swelling in the groin area had difficulty walking as a result. The reporter consented for follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837436,10/01/2019,MO,46.0,46,,M,,"patient experience fluid-filled blister at injection site in the evening after receiving immunization, immunization site was red and swollen; blister popped during the night.    Patient inquired about it and showed pharmacist the area on Tuesday.  Area was no longer red or raised, a scabbed area approximately 1/8' was visible",,,,,,,,,Y,09/27/2019,09/27/2019,0,,PHM,,"nystatin suspension, bupropion 150mg, potassium 20meq, prochloperazine 10mg, tasigna 200mg, metoprolol er 50mg, amlodipine 10mg, temazepam 30mg, Adderall xr 20mg, Percocet 10/325, atorvastatin 40mg, hctz 50mg, singular 10mg",oral thrush,"diabetes, hypertension, hypokalemia, hypercholesterolemia, chronic myelocytic leukemia",,,2,10/01/2019,,,,ACE inhibitors
0837437,10/01/2019,SC,77.0,77,,F,,"Patient stated that some of the vaccine dripped out on her arm, she was worried that she did not get the full shot.   She came back a few days later and I gave her another 0.2 ml of a flu shot.",,,,,,,,,Y,09/26/2019,09/26/2019,0,,PHM,,,,,,,2,10/01/2019,,,,
0837438,10/01/2019,MA,16.0,16,,F,,Pt. had a syncopal episode immediately following third vaccine. Pt. was assisted to lay down on exam table. Pt. regained consciousness within 3-4 seconds. Pt. was given juice and crackers and continued lying down for 10 minutes after episode. Pt. was assessed by physician. Pt. felt well enough to leave the office.,,,,,,,,,Y,10/01/2019,10/01/2019,0,None.,PVT,,multivitamin,No known illnesses.,"Sleep walking disorder, Raynaud's, and anxiety",,,2,10/01/2019,,,,NKDA
0837439,10/01/2019,FL,75.0,75,,F,,"About 8pm on the 27th of sept,,  as I was about to get up from a sitting position , I encountered such severe vertigo that I could not stand up. I waited a bout 15 minutes to see if it would subside but it only got worse and was accompanied by severe nausea. My husband then checked the paperwork I received after my flu shot at 12:pm that day and per instructions carries me to our auto and drove me to the ER. The instruction sheet stated this was a serious side affect.                                               I encountered such severe",,,,,,,,,N,09/27/2019,09/27/2019,0,"EKG, blood tests,  MRI, CAT scan",PHM,,"zocar , 2 cranberry softgels ,  1 baby aspirin 81 mg, 1 womens multivitamin",none,none,,,2,10/01/2019,,,,none
0837440,10/01/2019,NJ,78.0,78,,F,,Hives,,,,,,,,,Y,09/25/2019,09/27/2019,2,N/A,PVT,,"Bactrim, Colace, Diphenhydramine, Ditropan, Duloxetine, Estrace, Oxybutin, Premarin, Telmisartan, B12",Burning with urination,"DJD, GERD, HTN, Pulmonary HTN, Edema, Angina Pectoris, Anxiety Disorder, Overactive Bladder",,,2,10/01/2019,,Y,,Strawberries
0837441,10/01/2019,ID,72.0,72,,F,,"Beginning the night after the immunizations, she began to experience headache, neck soreness, swollen and red upper arms, severe nausea, muscle weakness/ataxia, and incontinence. These were severe from Friday night to Sunday night. Beginning Monday morning they began to decrease in severity.",,,,,,,,,N,09/26/2019,09/27/2019,1,N/A,PHM,,"B-vitamin complex, glutathione, liver MD, Prevagen, Lion's mane, Chaga mushroom, Collagen, Spirolina, Vitamin C, Garlic, Multivitamin, digestin cleanse, immupro, hydrocodone/acetaminophen, trazodone, Synthroid, albuterol, Montelukast, omep",Gallbladder surgery (about a week before),Lupus,,,2,10/01/2019,,,,"Sulfa antibiotics, morphine"
0837442,10/01/2019,MA,74.0,74,,F,,patient presented to office with redness at injection site,,,,,,,,,Y,09/25/2019,09/28/2019,3,none,PUB,,"Lasix 20 mg daily, potassium chloride 10 meq once daily, hydralazine 25 mg tid,cozaar 100 mg daily, acarbose 100 mg tid, norvasc 5 mg daily,claritan 10 mg daily, Glucotrol xl 10 mg, 2 daily, omeprazole 20 mg daily, zocor 20 mg dailiy",none,CKD stage 3 DM Hypertension hyperlipidemia schizoaffective disorder,,,2,10/01/2019,,Y,,navane penicillin Zyprexa lisinopril pork
0837443,10/01/2019,MN,48.0,48,,F,,Patient has been experiencing ongoing muscle pain since flu shot was administered. She called 10/1/19 approximately 1 month after getting flu shot noting she is still experiencing pain and soreness in her arm. She indicates she is a nurse and has had many flu shots before and hasn't experienced this previously. She notes she felt as though immunization administration technique was correct.,,,,,,,,,,09/04/2019,09/04/2019,0,,PHM,,,,,,,2,10/01/2019,,,,"latex, mercury, neomycin"
0837444,10/01/2019,WA,64.0,64,,F,,"High fevers of over 101.5; severe body ache/malaise; shortness of breath; elevated blood pressure; extreme fatigue; no appetite-- all these symptoms continued over the course of 2 weeks, followed by severe, sporadic internal pain in the left ear--- my physician believed this was post-herpetic trigeminal nerve pain. Lab tests performed at clinic indicated raised white blood count but no evidence of bacterial infection. Treatment discussed for me was a visit to the neurologist, an MRI and putting me on a course of anti-seizure med's, long term, to control the nerve pain. Fortunately, after two days of extreme pain, my symptoms went away.",,,,,,,,,Y,08/17/2019,08/20/2019,3,"A complete blood work-up was done for me at clinic on August 26, 2019. I can provide the exact results in a follow-up document as it's in my on-line patient portal data.",PHM,,None,None,None,,,2,10/01/2019,,Y,,Penicillin; Sulfa
0837445,10/01/2019,OH,72.0,72,,F,,"7X 8 cm area of redness approximately 2 inches below site of injection.  Area is also swollen and has some fluid collection at the lower portion of the redness.  Client reports itching in the am, but has decreased.  Voices discomfort to touch similar to what a bruise feels like. Discomfort level is 2/ 10 when touched.",,,,,,,,,N,09/30/2019,10/01/2019,1,none,PUB,,Potassium Chloride 40 meq- 3 X a day Losartan Potassium 25mg-daily Metoprolol ER 50mg- 3 x a day Spironolactone 50mg-  2 X a day Amiloride 10mg-2x a day Famotidine 40mg- daily Atorvastatin 10mg- daily Metformin ER 500mg- daily Magnesium 500,none to report at this time,Coronary Artery Disease- sarcoidosis of lungs- Gitelman's syndrome-,"Tetanus (Td)- redness and swelling  Flu- also redness and swelling years ago, but states has had no issues until this dose (has ",10012019SM,2,10/01/2019,,Y,,Nitroglycerin- causes unconsciousness Isordil- excessvice decline of BP Tetanus- redness/ swelling levofloxin- GI distress N/V/ diarrhea
0837446,10/01/2019,NY,59.0,59,,F,,"Pt came back from receiving flu shot, states feels funny. When asked states throat feels ""weird"", feels dizzy, and unsteady on feet. Pt also c/o withdrawal symptoms from narcotics. VSS, pulse and heart rate regular. Spoke to provider, gave 25 mg of PO benadryl. Pt remained stable and observed for 30 minutes and improved. Ambulated independently out of office. Provider aware",,,,,,,,,Y,10/01/2019,10/01/2019,0,,PVT,,"Gabapentin, oxycodone-acetaminophen",None,Chronic Low back pain,,,2,10/01/2019,,Y,,"epinephrine, codeine"
0837447,10/01/2019,MI,50.0,50,,F,,"STARTED 9/29/19 NIGHT AROUND MIDNIGHT, WITH HEADACHE & NAUSEA. THEN BODY ACHES & CHILLS, EVERYTHING HURT. WORST AT LATER PART OF DAY ON 9/30/19.  DR VISIT ON 10/1 @ 12:15PM, DR SAID REACTION TO VACCINE, DR SAID SHE'S SEEN THIS REACTION BEFORE. 10/1 STILL CHILLS COME & GO, & SWEAT, AND HEADACHE, NAUSEA & ACHES CONSTANT",,,,,,,,,N,09/29/2019,09/29/2019,0,"NONE, GOT PHYSICAL EXAM",PHM,,"TAKE MEIJER MULTIVITAMIN GUMMY, VIT D, VIT C & PROBIOTIC MEIJER BRAND GEQ FOR ALIGN DAILY MEDS- LEVOTHYROXINE, DETROL, SOMETIMES USES VENTOLIN",NONE,"ASTHMA, HYPOTHYROID, DAMAGED BLADDER",SHINGRIX BY GSK  ON 7/22/19 L5E43 & H2HM2 - ADVERSE REACTION 12 HOURS LATER NOTICED SEREVE HEADACHE & NAUSEA LASTED 24 HOURS,,2,10/01/2019,,Y,,"ALLERGIC TO BACTRIM- GETS RED & HOT, CECLOR- GETS RED & HOT, MACROBID -VIOLENT VOMITING, PAXIL -CLOSED  AIRWAY"
0837448,10/01/2019,CA,52.0,52,,F,,"Fever 103.1 a little later it went down to 101.3, left side numbness from head to foot, chest/back pain, headache, chills, fatigue, loss of appetite, soreness",,,,,,,,,Y,09/27/2019,09/27/2019,0,None,WRK,,None,None,None,"Numbness, 51, 9/2018, Fluzone",,2,10/01/2019,,,,Sulfa
0837449,10/01/2019,NV,80.0,80,,M,,"Patient has had numbness, tingling, and pain in his arm, shooting down to his hand since his shot.  He is going to see a neurologist soon but his doctor thinks we hit a nerve.",,,,,,,,,N,03/27/2019,03/27/2019,0,He will see a neurologist soon,PHM,,zonisamide,none known,none known,,,2,10/01/2019,,Y,,none known
0837450,10/01/2019,CA,70.0,70,,F,,"COMPLETE LEFT ARM NUMBNESS AS WELL AS SORENESS AT SITE.  TEMPERATURE, OVERALL MALAISE 24 HR",,,,,,,,,Y,09/27/2019,09/27/2019,0,NONE,WRK,,"holy basil, aspirin, tumeric",none noted,"high bp; cholesterol, hypo thyroid",,,2,10/01/2019,,,,lisinopril
0837451,10/01/2019,NY,68.0,68,,F,,"Swelling of left bicep, streaks of red down bicep from injection site to elbow, skin hot & painful to the touch. 48 hours after injection, severe nausea, weakness and muscle pain. Nausea subsided after another 24 hours; weakness and muscle pain persist.",,,,,,,,,Y,09/26/2019,09/27/2019,1,None,PVT,,"Gavison Advance, Vitamin B2, Magnesium",None,GERD,,,2,10/01/2019,,,,None
0837452,10/01/2019,FL,37.0,37,,M,,"A 37 year-old  M received HEP A IM at 8:55 a.m. Patient was monitored for 15-minutes without any complaints of weakness, dizziness, or allergic response.  10:39 a.m. Received call too Clinic from mission reporting that patient was feeling dizzy. Upon arrival, patient was found sitting in a chair awake, alert, and oriented complaining of feeling dizzy.  Patient denies blurry vision, chest pain or shortness of breath.  BP 150/88; HR 88  Bilateral breath sounds clear to auscultation; heart sounds with regular rate and rhythm, no murmurs.  Assessment: Dizziness   Plan: Monitor patient for s/s of respiratory or cardiac distress Call fire rescue 9-1-1 Remain with patient until rescue arrived  Note; Upon fire rescue arrival, patient requested transport to nearest hospital for further evaluation.",,,,,,,,,U,10/01/2019,10/01/2019,0,none done,PUB,,none known,Anxiety Obesity,Obesity,,not applicable,2,10/01/2019,,Y,Y,no known allergies to drugs or foods
0837453,10/01/2019,ME,68.0,68,,F,,Pt. reported redness and swelling at site and down to inside of arm starting on day 3 after inj. It worsened from day 3 to day 5 with warmth to touch and then started to resolve. She reports complete resolution at this time. No treatment was required.,,,,,,,,,Y,09/19/2019,09/22/2019,3,0,PVT,,see continuation page,None Known,HTN Hyperlipidemia  Prediabetes,,,2,10/01/2019,,,,NKA
0837465,10/01/2019,VA,,,,F,,"Shortly after receiving Defendants' Zostavax vaccine, Plaintiff suffered shingles and retinal damage.; Shortly after receiving Defendants' Zostavax vaccine, Plaintiff suffered shingles and retinal damage.; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a female patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided.     In or around May 2012, the pt was inoculated with a dose of zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, frequency, lot/batch # and expiration date were not reported). Shortly after receiving zoster vaccine live (ZOSTAVAX), the pt suffered shingles (herpes zoster) and retinal damage (retinal injury). As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms had resulted in physical limitations not present prior to using it. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution, and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.   The reporter considered the events to be related to zoster Vaccine Live (ZOSTAVAX).  The reporter considered the events to be disabling.  Upon internal review, retinal injury was determined to be a medically significant event.",,,,,,,,Y,N,05/01/2012,,,,UNK,,,,,,US0095075131909USA011003,2,10/01/2019,,,,
0837466,10/01/2019,CA,,,,U,,"an improperly stored dose of PEDVAX was administered to the patient; No adverse effects.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history or concomitant medications was provided.  On an unknown date, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot # N024570 and expiration date: 01-MAY-2020 (exact dose, frequency and route of administration were not reported) for prophylaxis. No adverse effects were reported.  The vaccine was stored in the temperature below 36 Fahrenheit (F) in 32.1 F for 8 hours. There was no previous temperature excursion. The improper storage was recorded because of digital ""data logger"".",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA012491,2,10/01/2019,,,,
0837467,10/01/2019,,,,,F,,"migraine; felt awful; Pain; severe flu / flu-like symptoms; This case was reported by a other health professional via sales rep and described the occurrence of pain in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain, influenza-like symptoms, migraine and feels awful. On an unknown date, the outcome of the pain, influenza-like symptoms and feels awful were recovered/resolved and the outcome of the migraine was unknown.   It was unknown if the reporter considered the pain, influenza-like symptoms, migraine and feels awful to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient reported pain and severe flu-like symptoms following receipt of Shingrix dose 1 that lasted about 1 day.  The patient stated a migraine was triggered and she felt awful for about a day, then was fine.  The patient did not experience this severe type of reaction with dose 2. The reporter consented to follow up.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837468,10/01/2019,CO,59.0,59,,M,,"myalgias; slight fever; difficult to sleep; sweating profusely; injection site pain; This case was reported by a other health professional via call center representative and described the occurrence of myalgia in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced injection site pain. On 19th September 2019, the patient experienced myalgia, fever, difficulty sleeping and excess sweating. The patient was treated with paracetamol (Acetaminophen). On 21st September 2019, the outcome of the myalgia was recovered/resolved. On an unknown date, the outcome of the fever, difficulty sleeping and excess sweating were unknown and the outcome of the injection site pain was not recovered/not resolved.   The reporter considered the myalgia, fever, difficulty sleeping, excess sweating and injection site pain to be related to Shingrix.  Additional details were provided as follows: This report concerns to patient himself. The patient did not receive any other vaccine at the same time. Approximately 8 hours after receiving a dose of Shingrix, the patient began experiencing myalgias and slight fever (101 degrees F). The patient took acetaminophen which helped, and during the evening, it was difficult to sleep for him and he was sweating profusely. The myalgias continued into 20th September 2019 during which the patient continued taking acetaminophen. The patient also experienced some injection site pain which was continuing at the time of reporting.  The myalgias fully resolved by A.M. of 21st September 2019 and the patient had ceased acetaminophen. The patient stated, the injection site pain was minor. There were no other local reactions. The suspect vaccines course was not discontinued. The report did not include any product complaint. The reporter agreed to be followed up.",,,,,,,,,N,09/19/2019,09/01/2019,,"Test Date: 20190919; Test Name: Body temperature; Result Unstructured Data: Test Result: 101, Test Result Unit: degree F",UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837469,10/01/2019,,,,,M,,"Fever; Weakness; fatigue; Muscle aches; This case was reported by a consumer via call center representative and described the occurrence of fever in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever, weakness, fatigue and muscle pain. On an unknown date, the outcome of the fever, weakness, fatigue and muscle pain were unknown.   It was unknown if the reporter considered the fever, weakness, fatigue and muscle pain to be related to Shingrix.  Additional case details were provided as follows: The patient reported for himself. The age at vaccination was not reported. The patient experienced fever, weakness, fatigue and muscle aches after receiving Shingrix vaccine. The patient would not provide any additional details.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837470,10/01/2019,,36.0,36,,M,,"Rash on hip and forearm; allergic reaction to the vaccine; Pain at injection site; Fatigue; Feeling sick; This case was reported by a nurse via call center representative and described the occurrence of allergic reaction in a 36-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 53BF4, expiry date 14th August 2021) for prophylaxis.   Co-suspect products included HBV (Engerix B) (batch number N754X, expiry date 11th November 2021) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Boostrix (intramuscular) and the 3rd dose of Engerix B (intramuscular). On 12th September 2019, 3 days after receiving Boostrix and Engerix B, the patient experienced allergic reaction, injection site pain, fatigue and feeling unwell. On 23rd September 2019, the patient experienced localized rash. On an unknown date, the outcome of the allergic reaction, injection site pain, fatigue, feeling unwell and localized rash were unknown.   It was unknown if the reporter considered the allergic reaction, injection site pain, fatigue, feeling unwell and localized rash to be related to Boostrix and Engerix B.  Additional details were provided as follows: The patient received both Boostrix and Engerix B in her left deltoid. On 12th September 2019, the patient reported to his employer that, he was experiencing fatigue, pain at injection site and feeling sick.  On 23rd September 2019, the patient again reported to his employer that, he had a rash on hip and forearm and he was wondering if he was having an allergic reaction to the vaccines.  The reporter consented to follow up. The reporter stated that, further details were not known to her and she could only relay what the patient's employer reported to her.",,,,,,,,,U,09/09/2019,09/12/2019,3,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837471,10/01/2019,TN,63.0,63,,F,,"Product Storage Error; Flu Like Symptoms; Muscle ache on entire body; This case was reported by a consumer via call center representative and described the occurrence of flu like symptoms in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th March 2019, the patient received the 1st dose of Shingrix (intramuscular). On 28th March 2019, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the patient experienced flu like symptoms and generalized muscle aches. On an unknown date, the outcome of the flu like symptoms and generalized muscle aches were recovered/resolved and the outcome of the incorrect storage of drug was unknown.   It was unknown if the reporter considered the flu like symptoms and generalized muscle aches to be related to Shingrix.  Additional case details were provided as follows: The patient was administered a frozen dose of Shingrix vaccine in her left arm, which led to incorrect storage of vaccine. She experienced flu like symptoms and muscle ache on entire body for about 3 days.  The patient had reported this event to her physician. The patient did not consent to follow-up. No further details were provided.",,,,,,,,,Y,03/28/2019,03/28/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837472,10/01/2019,KS,69.0,69,,F,,"redness at injection site; swelling at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 69-year-old female patient who received Herpes zoster (Shingrix) (batch number TB2PK, expiry date 5th October 2021) for prophylaxis.   On 17th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 18th September 2019, 1 days after receiving Shingrix, the patient experienced injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site erythema and injection site swelling were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema and injection site swelling to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left arm. The day after receiving the vaccine, the patient developed redness and swelling at the injection site. The reporter did not provide any additional information. The reporter consented to follow up.",,,,,,,,,N,09/17/2019,09/18/2019,1,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837473,10/01/2019,MA,,,,F,,"A-Fib exacerbation; This case was reported by a other health professional via call center representative and described the occurrence of atrial fibrillation aggravated in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included atrial fibrillation.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced atrial fibrillation aggravated (serious criteria GSK medically significant). On an unknown date, the outcome of the atrial fibrillation aggravated was recovered/resolved.   It was unknown if the reporter considered the atrial fibrillation aggravated to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, however the patient could be 72 or 71 years old at time of vaccination. The pharmacy intern stated that the patient with history of rate-controlled A-Fib. The patient received the first dose of Shingrix and then experienced an exacerbation of the A-Fib. The patient had to be rate-controlled for two weeks, and then the episode resolved. The reporter was consented to follow up. No further details available to pharmacy intern at the time of this call.",,,,,,,,,Y,,,,,UNK,,,Atrial fibrillation,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837474,10/01/2019,IA,17.0,17,,F,,"Hospitalized for possible encephalitis; Problems with thyroid; Prolonged confusion; Weakness; Unresponsive for several hours; Loss of urinary control; Syncopal episode; This case was reported by a physician via call center representative and described the occurrence of encephalitis in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number ABXA12BA, expiry date 28th February 2021) for prophylaxis.   Previously administered products included Bexsero (received 1st dose on 31st July 2019).   On 3rd September 2019, the patient received the 2nd dose of Bexsero. On 3rd September 2019, 6 hrs after receiving Bexsero, the patient experienced syncopal attack (serious criteria GSK medically significant). In September 2019, the patient experienced encephalitis (serious criteria hospitalization and GSK medically significant), thyroid disorder (serious criteria hospitalization), confusion (serious criteria hospitalization) and weakness (serious criteria hospitalization). On an unknown date, the patient experienced unresponsive to stimuli (serious criteria GSK medically significant) and urinary incontinence. The patient was treated with thyroid medication {nos} (Thyroid Medication). On an unknown date, the outcome of the encephalitis, thyroid disorder, confusion, weakness and urinary incontinence were unknown and the outcome of the syncopal attack and unresponsive to stimuli were recovered/resolved.   It was unknown if the reporter considered the encephalitis, thyroid disorder, confusion, weakness, syncopal attack, unresponsive to stimuli and urinary incontinence to be related to Bexsero.  Additional details were provided as follows: On 3rd September 2019, the physician reported that on day patient had second Bexsero vaccination, the patient was running in a cross country event and experienced a syncopal episode. The event occurred about 6 to 8 hours after patient had received vaccination. The patient was unresponsive for several hours with loss of urinary control. In September 2019, less than 3 weeks after receiving Bexsero the patient experienced possible encephalitis, problems with her thyroid, prolonged confusion and weakness. In September 2019, the patient was hospitalized for 2 weeks with possible encephalitis, problems with her thyroid, prolonged confusion and weakness. The patient's thyroid issue was confusing and did not respond to treatment with thyroid medication. A lumbar puncture and other lab tests were all negative. The patient did not receive a specific diagnosis for event. The reporter was consented to follow up.      Lab Comments: On unknown date, Other lab test were negative.",,,,,Y,14,,,Y,09/03/2019,09/01/2019,,"Test Date: 201909; Test Name: Lumbar puncture; Result Unstructured Data: Test Result: Negative, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837475,10/01/2019,NY,64.0,64,,F,,"flu like symptoms; FEVER; WEAKNESS; HEADACHE; NAUSEA; MUSCLE PAIN; This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number 3HX44, expiry date 15th November 2021) for prophylaxis.   On 23rd September 2019 04:00, the patient received the 2nd dose of Shingrix .5 ml. On 23rd September 2019, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms, fever, weakness, headache, nausea and muscle pain. On an unknown date, the outcome of the influenza-like symptoms, fever, weakness, headache, nausea and muscle pain were recovering/resolving.   It was unknown if the reporter considered the influenza-like symptoms, fever, weakness, headache, nausea and muscle pain to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix at 4:00 pm and few hours later she began to experience flu like symptoms including, fever, weakness, headache, nausea and muscle pain. The symptoms are resolving but not entirely resolved. There is discrepancy between the outcome reported in the structured field of system recovering while in source document it is reported as fatal.",,,,,,,,,N,09/23/2019,09/23/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837476,10/01/2019,WA,,,,F,,"cellulitis/ cellulitis from the injection site down to the antecubital fossa; looks like chickenpox; This case was reported by a physician via call center representative and described the occurrence of cellulitis of arm in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included rheumatoid arthritis. Concomitant products included methotrexate.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced cellulitis of arm (serious criteria GSK medically significant) and varicella-like rash. On an unknown date, the outcome of the cellulitis of arm and varicella-like rash were unknown.   It was unknown if the reporter considered the cellulitis of arm and varicella-like rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The physician reported that a patient with rheumatoid arthritis developed what looks like chickenpox and cellulitis (according to their primary care physician) from the injection site down to the antecubital fossa. The patient was also on methotrexate. The date of administration was also not available. The six month mark since the first dose will be in two days. Th e lot number was not available. The reporter was did not consent to follow-up.",,,,,,,,,U,,,,,UNK,,METHOTREXATE,Rheumatoid arthritis,,,USGLAXOSMITHKLINEUS201917,2,10/01/2019,,,,
0837477,10/01/2019,FL,,,,F,,"PCV13 in 2015 and had pneumonia in 2017; PCV13 in 2015 and had pneumonia in 2017; This is a spontaneous report from a Pfizer sponsored program. A 95-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date in 2015 at single dose for immunization. Medical history included had pleurasie in lungs when she was young and is susceptible for pneumonia; blood disorders. Concomitant medication included atorvastatin calcium (LIPITOR); BP medications and pills for blood disorders. The patient previously took PPSV23 in 2013. It was reported that the patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein)  in 2015 and had pneumonia in 2017. It was reported that the patient took another flu shot (not specified). It was also reported that the patient is still very active. Outcome of the events was unknown.; Sender's Comments: Based on the information currently available, a lack of efficacy with pneumococcal 13-valent conjugate vaccine in this patient cannot be completely excluded.  Further information like confirmative pathological/serotype results are needed for full medical assessment.",,,,,,,,,U,,,,,UNK,,LIPITOR,,Medical History/Concurrent Conditions: Blood disorder; Infection susceptibility increased; Pleurisy; Pneumonia,,USPFIZER INC2019420933,2,10/01/2019,,,,
0837478,10/01/2019,,,,,U,,"it seems like ever since I have been kind of short-winded and I have emphysema anyways but I am usually not this short-winded; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at a single dose for immunization. Medical history included ongoing emphysema and short-winded. The patient's concomitant medications were not reported. The patient had a shot of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) and ever since that the patient has been kind of short winded. The patient has emphysema but reported not usually that short-winded. The outcome of the event was unknown.   Information on the batch number has been requested.",,,,,,,,,U,,,,,UNK,,,Dyspnea; Emphysema,,,USPFIZERINC2019422424,2,10/01/2019,,,,
0837479,10/01/2019,PA,65.0,65,,F,,"PATIENT STATES  SHE HAS HAD PAIN ON HER LEFT SIDE. SHE STATES THE PAIN HAS MOVED UP AND DOWN HER ARM AND INTO HER SHOULDER. SHE HAS FELT WEAK AND EXHAUSTED SINCE 9/28/19. SHE DESCRIBES IT AS FEELING FLU-LIKE WITH ACHES AND FATIGUE.  SHE STATES SHE IS FEELING SLIGHTLY BETTER BUT HAS FATIGUE THAT WORSENS IN THE AFTERNOON. SHE ALSO HAD A COLD SORE DEVELOP FOR THE FIRST TIME IN HER LIFE. I SUGGESTED SHE SPEAK TO HER PHYSICIAN SINCE IT SOUNDS LIKE SHE IS HAVING NERVE PAIN AND HER IMMUNE SYSTEM IS HYPER-RESPONDING TO THE VACCINE.  SHE STATED SHE HAD A YEAR LONG REACTION TO A HEPATITIS B VACCINE, BUT DID NOT REPORT THAT TO US AT THE TIME OF HER SHINGRIX VACCINATION.",,,,,,,,,N,09/27/2019,09/27/2019,0,UNKNOWN,PHM,,"ARMOUR THYROID 90 MG, RANITIDINE 300MG",,,,,2,10/01/2019,,Y,,SULFA ANTIBIOTICS
0837480,10/01/2019,FL,72.0,72,,F,,"Dizziness, body pain and soreness, swelling and redness and heat in the area immunized, fatigue, one episode of night sweat",,,,,,,,,N,09/26/2019,09/27/2019,1,n/a,PHM,,"tylenol arthritis, hair and nail vitamins, magnesium","arthritis, thyroid disease, angina","arthritis, thyroid disease, angina",,,2,10/01/2019,,,,penicillin
0837481,10/01/2019,LA,62.0,62,,F,,Fever 101.3 Muscle aches 3? diameter redness and swelling about 2 inches below the injection site with several bumps contained in swelling area,,,,,,,,,Y,09/25/2019,09/26/2019,1,,PHM,,Pantoprazole Atorvastatin Allegra,,,,,2,10/01/2019,,Y,,Sulpha Tetracycline
0837482,10/01/2019,,33.0,33,,M,,"Pt fainted about 2 minutes after receiving the vaccine. He was safely lowered to the floor, administered an epipen, and he regained consciousness withing 2 minutes.",,,,,,,,,,09/23/2019,09/23/2019,0,,PHM,,,,,,,2,10/01/2019,,,,
0837483,10/01/2019,MI,15.0,15,,M,,"Patient came to the clinic today, with his father, to get a Td.  His father wanted him to get a Td because he poked himself with a tack. Patient was administered the Td vaccination in the left deltoid muscle, he reported he was feeling fine after vaccine and was talkative. Father and son then left clinic room. Approximately 10-15 minutes later the father came to desk and reported that his son just had a seizure.  RN was at the desk when father reported incident and went into the Immunization room and told RN, emergency supplies and oxygen canister were gathered by both RNs and returned to waiting room.  By that time father had brought son (patient) back into the waiting room from parking lot and patient was sitting in a chair.  RN asked how he was feeling and he stated ?fine? there was no visible signs of injury.  RN suggested he lay down in the clinic room and he verbalized okay and that he also could walk there on his own.  Patient was steady when he walked to the clinic and lay down on the exam table, RN elevated his legs.  A third RN was in the clinic room with oxygen canister and gave him 8L oxygen via mask.  Throughout patient was alert and talking to RNs.  BP was 102/62, pulse 60.  Father explained to RNs that they walked to the car and as son was getting into the car he had a ?seizure.?  911 was called and arrived within approximately 10 minutes, patient talked with EMS crewmember for approximately 10 minutes and then walked to gurney and got on.  Patient then was transported to the hospital for further evaluation.",,,,,,,,,Y,09/30/2019,09/30/2019,0,Unknown,OTH,,none,none,none,,,2,10/01/2019,,,Y,NKDA
0837484,10/01/2019,NY,52.0,52,,F,,Patient complained of Redness at the injection site and pain that went from her armpits down her sides.,,,,,,,,,Y,09/26/2019,09/30/2019,4,She went to her MD today 10/1 and they gave her a Medrol Dose pak for the inflammation,PHM,,"Levothyroxinne, Cymbalta, Estrogen, Nexium",no,Mental Health but nothing serious,,,2,10/01/2019,,Y,,No
0837485,10/01/2019,WI,41.0,41,,F,,"No history of adverse reaction to flu vaccine; receives a flu shot every year; received vaccine as required by workplace through occupational health dept, approximately 30 mins later began feeling as if ""throat was closing"" and thought maybe it was ""all in her head""; sought treatment from emergency department at approximately 1345",,,,,,,,,Y,09/30/2019,09/30/2019,0,n/a,WRK,,albuterol; ascorbic acid; citalopram; ferrous gluconate; multivitamin;,n/a,Asthma; IBS,,,2,10/01/2019,,,Y,"""tape"""
0837486,10/01/2019,,72.0,72,,F,,pt reports swelling rash in area of injection became painful and required visit to PCP office and treatment with antibiotic,,,,,,,,,Y,07/29/2019,07/30/2019,1,,UNK,,victoza gabapentin furosemide linzess labetalol nexium vitamin d vitamin c,,,,,2,10/01/2019,,Y,,Lisinopril Penicillins Potassium Chloride Praluent Repatha Statins sulfa antibiotics
0837487,10/01/2019,OH,73.0,73,,F,,"PATIENT EXPERIENCED A RED RASH AROUND ARMPIT AREA THAT SPANNED ABOUT 2 INCHES, THAT BEGAN 4 DAYS AFTER VACCINATION.  DOES NOT REPORT ITCHING OR PAIN, JUST REDNESS.",,,,,,,,,Y,09/21/2019,09/25/2019,4,NONE,PHM,,"CLOPIDOGREL, DULOXETINE, SERTRALINE",,,,,2,10/01/2019,,,,"LATEX, LOVASTATIN, RALOXIFENE, NSAIDS"
0837488,10/01/2019,PA,1.25,1,.3,F,,"Fussiness, Stumbling and Unsteadiness within an hour of receiving the vaccine",,,,,,,,,N,08/16/2019,08/16/2019,0,,PVT,,,,,,,2,10/01/2019,,Y,,
0837489,10/01/2019,TX,65.0,65,,F,,"Muscle aches (body), arm sore to the touch, armpit nodes painful, low grade fever, chills, slightly nauseous.,",,,,,,,,,N,09/30/2019,10/01/2019,1,n/a,PHM,,Valtrex (generic) 500 mg.; oxybutynin 10 mg,None,None,"soreness, aches but much less intense  (CURRENT SYMPTON ALSO FATIGUE, no way to go back to enter)",,2,10/01/2019,,,,"Sulfa drugs, topical iodine"
0837490,10/01/2019,PA,65.0,65,,M,,The patient stated he experienced severe shaking and chills that worsened over time starting at around 8-9pm the night of 9/24 after receiving the Fluzone High Dose Vaccine. It progressed and eventually he was experiencing chest tightness and went to the emergency room for medical treatment around 10pm. He was admitted for 1 day there and released after that.,,,,,Y,1,,,,09/24/2019,09/24/2019,0,,PHM,,,,,,,2,10/01/2019,,,,
0837491,10/01/2019,TN,65.0,65,,M,,Patient said intern gave him shot to high and his shoulder still aches.,,,,,,,,,N,09/12/2019,09/13/2019,1,,PHM,,"Atorvastatin, metoprolol er ,ezetimibe,isosorbide",none,,,,2,10/01/2019,,,,none
0837493,10/01/2019,OH,36.0,36,,F,,Patient went to primary care doctor and was diagnosed with a shoulder injury due to vaccine given too high. She was given a Medrol dose pack for inflammation and pain.,,,,,,,,,N,09/27/2019,09/27/2019,0,,PHM,,,,,,,2,10/01/2019,,Y,,
0837494,10/01/2019,NY,4.0,4,,F,,"Daughter woke up at 4am, morning after vaccination of MMR. Woke up with hot, earache and headache. Could not go back to sleep for 2 hours. Lethargic all day, flu like body symptoms, fever on and off and super sensitive.",,,,,,,,,N,09/30/2019,10/01/2019,1,,PVT,,no,fever and runny nose 2 weeks prior. Completely fine days before.,no,,,2,10/01/2019,,,,no
0837495,10/01/2019,CA,36.0,36,,F,,"Patient developed a painful, red, warm, hard, and sharply circumscribed patch below the injection site (not at the injection site) next day after the vaccination. She was seen by her dermatologist 3 days after (9/19/19) - it was felt it is cellulitis vs injection site rxn vs reactive skin eruption. She was treated empirically for cellulitis with  cephalexin 500 mg PO tid x 10 days. The red area started to get better within hours after the 1st dose of antibiotics, and resolved on 9/23/19.",,,,,,,,,Y,09/16/2019,09/17/2019,1,none,PVT,,"colchicine, methotrexate, leucovorin, omeprazole, prednisone",no acute illness,"psoriasis, psoriatic arthritis vs. rheumatoid arthritis",,,2,10/01/2019,,Y,,hydroxychloroquine
0837496,10/01/2019,NY,1.0,1,.1,M,,Complex Febrile Seizure on 9/30- 10/1 . Two in 6 hours.,,,,,Y,1,,,U,09/20/2019,09/30/2019,10,EEG - 10/1,PVT,,None,,None,,,2,10/01/2019,,,Y,None disclosed or known of
0837497,10/01/2019,IL,25.0,25,,F,,"Patient reported adverse reaction from immunization (9/29/19) to the pharmacy on 10/1/19. She detailed having hives, labored breathing (chest tightness), congestion, drainage on 9/30/19. She also reported having a migraine/headache immediate after the administration of the immunization. Patient has been nursing her symptoms and monitoring  her progress.",,,,,,,,,U,09/29/2019,09/30/2019,1,None,PHM,,none on file,none,none,,,2,10/01/2019,,,,none on file
0837498,10/01/2019,KS,70.0,70,,M,,"Began feeling bad within a couple of hours after immunizations.  Was given two, both in left arm.  One was for the seasonal influenza and the other was for the #2 Pneumonia immunization.  Began to feel feverish, achy, and left arm began to be sore and by following evening, Oct 1, the area below immunization site was very red and hot and swelled up.  Had felt sick and feverish all night  the first night after the shots and also the second night.  On second day after shot, the top part of arm underneath injection site is still very swelled up, red and hot.  Tried a cold compress the second morning on it and it seemed to reduce the redness and swelling to some extent.  We took photos of the arm if that would be helpful.  He is still waiting it out to see if it clears up and he gets to feeling better.  Have sought no medical intervention.",,,,,,,,,U,09/29/2019,09/29/2019,0,NONE,PHM,,"TOPIRAMATE 100 MG tab 2x daily, RIZATRIPTAN 10MG tab, 1 time at onset of migraine (but had NOT taken any on immunization day), SAW PALMETTO PROSTATE PLUS herbal sup, JOINT VITAMIN with CM Complex (composed of Cetyl Myristoleate 40%, Cetyl O",NONE,MIGRAINE HEADACHES OCCASIONALLY throughout lifetime,,,2,10/01/2019,,,,NONE
0837499,10/01/2019,TN,33.0,33,,M,,Experienced an episode of feeling very dizzy and light headed that started within 15 mins after having both shots and lasted for about an hour.,,,,,,,,,Y,07/12/2018,07/12/2018,0,,MIL,,None,None,None,,,2,10/01/2019,,,,None
0837500,10/01/2019,MO,36.0,36,,F,,"Palpitations, dizziness, shortness of breath ( wheezing), flushing, nausea Palpitations started when left arm raised, followed by flushing, shortness of breath and nausea.  Dizziness and flushing lasted over one hour",,,,,,,,,U,10/01/2019,10/01/2019,0,none,PVT,,Levothyroxine  Celexa,none,Hashiomotos,,,2,10/01/2019,,Y,,Sulfa and Sulfites
0837504,10/01/2019,NJ,,33,,M,,"Tingling sensation; Stinging in the left hand; Stinging in some parts of the leg; Patient developed slight headache; This spontaneous report was received from a consumer referring to a 33-year-old male patient. The patient's concurrent conditions included vomiting, Human Immunodeficiency Virus (HIV) infection and blood pressure measurement. The patient's medical history included papilloma viral infection. Concomitant therapies included antiviral (unspecified)(ANTIVIRAL (UNSPECIFIED)), escitalopram oxalate(LEXAPRO), diacerein(ART), ASSRI and beta blocker. On 26-SEP-2019, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) about 2 inches from the to of shoulder (strength, formulation, dose/frequency, lot# and expiry date were unknown) for prophylaxis. On 26-SEP-2019, after receiving the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) the patient experienced headache, tingling sensation (paraesthesia), stinging in the left hand (pain in extremity) and some parts of leg (pain in extremity). Patient had routine blood work. Patient did not seek any medical attention. The outcome of events paraesthesia, headache and pain in extremity was reported as not recovered. The causality of the events was not reported with respect to suspect therapy hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9).",,,,,,,,,N,09/26/2019,09/26/2019,0,,UNK,,antiviral (unspecified); LEXAPRO; ART (diacerein),Blood pressure; HIV disease; Vomiting,Medical History/Concurrent Conditions: Human papilloma virus infection,,US0095075131909USA014764,2,10/01/2019,,,,
0837505,10/01/2019,TX,,,,F,,"arm soreness; swelling at injection site; white dot at injection site; can't lift arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced pain in arm, injection site swelling, injection site hypopigmentation and injected limb mobility decreased. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm, injection site swelling, injection site hypopigmentation and injected limb mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, injection site swelling, injection site hypopigmentation and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient demographic details were not reported. 5 weeks ago from the date of reporting, the patient received 2nd dose of Shingrix. The patient experienced soreness in arm, on which the inajection has been received, since from the day of vaccination. At the time of reporting, the events were unresolved, and the patient stated that she can not lift her arm above shoulder. The patient did not consent to follow up. This case was 1 of 3 linked cases.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837507,10/01/2019,,80.0,80,,M,,"Stroke; This case was reported by a consumer via call center representative and described the occurrence of stroke in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingix (1st dose received on 20th April 2019).   On 20th July 2019, the patient received the 2nd dose of Shingrix. On 23rd August 2019, 34 days after receiving Shingrix, the patient experienced stroke (serious criteria GSK medically significant). On an unknown date, the outcome of the stroke was unknown.   It was unknown if the reporter considered the stroke to be related to Shingrix.  Additional information was reported as follows: The patient wanted to know, could a 3rd dose of Shingrix would safe on blood thinner.",,,,,,,,,U,07/20/2019,08/23/2019,34,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837508,10/01/2019,CA,,,,U,,"Shingles / mild outbreak; Small area about the size of a dime with one tiny blister the size of a straight pin head; This case was reported by a consumer via call center representative and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had chronic outbreaks for over 20 years).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced shingles and blister. On an unknown date, the outcome of the shingles and blister were unknown.   It was unknown if the reporter considered the shingles and blister to be related to Shingrix.  Additional information was reported as follows: The age at vaccination was not reported. Two months before the time of reporting, the patient received a dose of Shingrix. The patient was pretty confident this was a mild outbreak, there was just one small area about the size of a dime with one tiny blister the size of a straight pin head. The patient wanted to know, had broke out with Shingles between a Shingrix Vaccination. The patient was not comfortable to giving out the information online. The GSK pharmacist provided the information that, during clinical trials, evaluation of the efficacy of Shingrix started 1 month after the 2nd dose. Therefore, the efficacy of the vaccine was unknown if the second dose was not received. Also, the GSK clinical trials (ZOE50 and ZOE70) excluded patients who had a history of previous herpes zoster (shingles). The patient guessed that, the patient would contact the physician.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Shingles (had chronic outbreaks for over 20 years),,USGLAXOSMITHKLINEUS2019AM,2,10/01/2019,,,,
0837509,10/01/2019,TX,,,,F,,"arm soreness; Injection site swelling; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm and injection site swelling. On an unknown date, the outcome of the pain in arm and injection site swelling were recovered/resolved.   It was unknown if the reporter considered the pain in arm and injection site swelling to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient received dose of Shingrix in the left arm a while ago. After vaccination, the patient experienced soreness in arm, for only a few days. The patient did not consent to follow up. For tolerance to 2nd dose of Shingrix, refer case US2019AMR123504. This case has been linked with the case US2019122954, reported by the same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201912,2,10/01/2019,,,,
0837510,10/01/2019,MI,,,,U,,"Hepatitis; This case was reported in a literature article and described the occurrence of hepatitis in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   Concurrent medical conditions included non-small cell lung cancer.   On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, unknown after receiving Flu vaccine, the patient experienced hepatitis (serious criteria GSK medically significant). On an unknown date, the outcome of the hepatitis was unknown.   The reporter considered the hepatitis to be related to Flu vaccine.  This case was reported in a literature article and described the occurrence of hepatitis in a patient of unspecified age and gender who was vaccinated with unspecified influenza vaccine (manufacturer unknown) for prophylaxis.  The patient was a part of single-center retrospective analysis that was conducted for patients with advanced non-small cell lung cancer (NSCLC) who received prolonged cell death 1 (PD-1) or prolonged cell death ligand 1 (PD-L1) inhibitor monotherapy between March 2015 and December 2018 to interrogate if influenza vaccination in patients with NSCLC receiving immune checkpoint inhibitors (ICPI) therapy had an increased incidence of immune-related adverse events (irAEs) compared to non-vaccinated patients. Comparisons of adverse event incidence between flu vaccinated and control patients were tested using chi-square statistics. The patient had history of non-small cell lung carcinoma (NSCLC). No information on patient's family history was provided.   On an unspecified date, between March 2015 and December 2018, the patient received unspecified influenza vaccine (administration route and site unspecified, dosages unknown, batch number not provided). [In this study, influenza immunization records from both institutional and state-wide registries were obtained from 2014 -2019. 19 received quadrivalent influenza vaccine, 13 received trivalent influenza vaccine and 1 was undetermined]. The age at vaccination was not reported. The patient also received prolonged cell death 1 (PD-1) or prolonged cell death ligand 1 (PD-L1) inhibitor monotherapy (ICPI). [In this study, 33 were vaccinated during ICPI therapy].   On an unspecified date, an unknown period after vaccination, the patient had hepatitis. It was considered as irAE.  [In this study, 22 vaccinated patients had an irAE versus 53 patients who were not vaccinated during ICPI therapy. 8 vaccinated patients had an irAE leading to discontinuation of therapy].  Treatment was unknown.  The outcome of the event was not reported.  The authors commented and concluded ""Our study suggests that irAEs are not significantly increased with vaccination for influenza during ICPI therapy. However, there is a slight trend toward increased incidence of irAE warranting ICPI discontinuation for which further investigation is needed. Limitations of this study include a small sample size and inability to grade irAE retrospectively.""",,,,,,,,,U,,,,,UNK,,,Non-small cell lung cancer,,,USID BIOMEDICAL CORPORATI,2,10/01/2019,,,,
0837511,10/01/2019,TX,4.0,4,,F,,Dx with Varicella (Chicken Pox) 10/1/2019. Atarax 10mg/5ml TID prescribed for symptoms.  Pt also treated for ear infection today with Amoxicillin.,,,,,,,,,N,09/04/2019,09/29/2019,25,,PVT,,None,Umbilical hernia. Acute constipation.,Umbilical hernia,,,2,10/01/2019,,Y,,None
0837512,10/01/2019,FL,65.0,65,,F,,"Feeling feverish, achy, headache, nausea, injection site pain.",,,,,,,,,N,09/30/2019,10/01/2019,1,,PHM,,GABAPENTIN,,Dystonia,1st injection just mild injection site pain,,2,10/01/2019,,,,Penicillin
0837513,10/01/2019,CA,52.0,52,,F,,Multiple hives noted to the upper limbs with itching. Hives subsided and through the weekend and redness faded,,,,,,,,,Y,09/20/2019,09/21/2019,1,,PVT,,propolis Losartan Montelukast Sodium 10mg Pravastatin Sodium 20mg Vitamin D 2000 UNIT,no,Hyperglycemia Hypertension,,,2,10/01/2019,,,,no
0837514,10/01/2019,FL,41.0,41,,F,,"Patient's reports warmth all around neck, and pain in arm where she was vaccinated lasting from 9/19/2019 until present (10/1/2019). Patient's arm pain extends to neck and can not fully lift arm.",,,,,,,,,N,09/19/2019,09/19/2019,0,,PHM,,,,,,,2,10/01/2019,,Y,,
0837515,10/01/2019,CA,66.0,66,,F,,10 hours after injection I became shivery  and couldn't get warm.  My body started shaking uncontrollably from head to toe. It was very intense. Muscles spasms with cramps. I felt very dizzy and nauseous with headache and pains in arms and legs. I had feverish hot sweats and chills which continued all night with intermittent fitful sleep. Next day I felt better but very weak with aches and pains.,,,,,,,,,Y,09/30/2019,09/30/2019,0,,PHM,,,,Osteoporosis,,,2,10/01/2019,,,,Penicillin
0837516,10/01/2019,TX,54.0,54,,F,,"Swollen eye, rash on neck, fever and tingling in her nose",,,,,,,,,N,09/30/2019,10/01/2019,1,,PHM,,Simvastatin 10mg,none,none,,,2,10/01/2019,,Y,,none
0837517,10/01/2019,PA,54.0,54,,M,,"Nausea Muscle aches, especially legs Tired",,,,,,,,,N,09/30/2019,10/01/2019,1,,PHM,,ATENOLOL CANDESARTAN,NONE,HYPERTENSION,,,2,10/01/2019,,,,NONE
0837518,10/01/2019,NC,1.0,1,.1,M,,Fever  Cough  Rash/chicken pox,,,,,,,,,N,09/20/2019,09/27/2019,7,,PVT,,,Chicken pox,,,,2,10/01/2019,,Y,,
0837519,10/01/2019,FL,58.0,58,,M,,pt states he had severe pain in the left arm. he was evaluated by his doctor and they believe he had a reaction to the vaccine. his arm was very painful and unable to move.,,,,,,,,,,09/22/2019,09/22/2019,0,,PHM,,,,,,,2,10/01/2019,,Y,,
0837520,10/01/2019,CA,71.0,71,,F,,"within 2 hours of shot, my right arm hurt (possibly left- Not sure) and then immediately within an hour I started to feel like my head was shooting small bursts of pain. It felt similar to really bad flu. I asked nurse if I should have any questions and she said ""your arm will hurt"". I knew the arm pain was due to shot, I did not know where the other symptoms came from or why. From that day forward, my teeth became extremely sensitive to touch and eating food became a painful event. I did not call the doctor, because I had no idea this was related. On June 29th I went to urgent care as my tongue swelled up so bad I couldn't open my mouth except to swallow small amounts of food and water. The urgent care said to go to ER as this could be life threatening. ER said it was an infection of the salivary gland involving the lymph nodes. I was given a prescription for Keflex(?) and told to follow up with the doctor. I spent the next 10 days sick and in pain. I finally returned to work on July 8th. On August 10th I returned to Urgent Care and said I felt horrible. Everything from my neck up hurt and it kept moving around. The doctor said he had never seen this before and didn't know what to do. He gave me a prednisone shot and sent me home.   I finally made an appointment with my primary for August 30th. She referred me to an infectious disease specialist and to a neurologist. I am still waiting until November 27th to see the neurologist. I saw Dr on Tuesday, September 10th. I explained the symptoms again and what I had been through. He diagnosed me with Trigeminal Neuralgia Zoster. He also gave me a prescription for Valtrex. I took if for two weeks and my face swelled up under both lower right and left chins. He referred me to a pain management specialist and told me to stop taking the Valtrex.   I cannot seem to get into see anybody without waiting months and in the mean time I am in tremendous, actually horrific pain and I cannot take pain meds.  My body rejects them. I understand that Trigeminal Neuralgia has no cure. I got this because of the shingles shot, and absolutely no one listened to me when I mentioned when my personal hell started. But apparently, it is true... some people have extremely adverse reations to vaccines, and I am one of them. I feel as it I am on my own and basically with no help or resources. How dare they put out a product with no warning or testing.",,,,,,,,,,04/19/2019,04/19/2019,0,,PVT,,,,,,,2,10/01/2019,,,,"no tolerance for pain meds, codeine, and most drugs"
0837521,10/01/2019,FL,61.0,61,,F,,Patient reported vaccine was given too high in deltoid muscle. Patient reports not being able to lift arm. Patient reports numbness and tingling.,,,,,,,,,U,10/01/2019,10/01/2019,0,N/A,WRK,,"Vagifem (weekly), and Ocu-vite OTC",No acute illness,"No chronic disorder, previous history of frozen shoulder",,,2,10/01/2019,,Y,,"contrast dye, penicillin, and gluten"
0837522,10/01/2019,IA,58.0,58,,F,,Pt developed shingles starting about 9/13/19 in C2 distribution left side of neck.  This was 8 days after her first shingrix vaccine.,,,,,,,,,U,09/05/2019,09/13/2019,8,,PVT,,,,,,,2,10/01/2019,,Y,,
0837523,10/01/2019,GA,69.0,69,,F,,broke out in rash near the injection site. rash spread out near upper arm. still present today after a week. pt states it is getting better. has not complained of anything further.,,,,,,,,,N,09/24/2019,09/25/2019,1,,PHM,,blood pressure and cholesterol medication,none,n/a,,,2,10/01/2019,,,,nka
0837524,10/01/2019,CA,78.0,78,,F,,"The day after the vaccine, on Saturday,, 09/28, I felt like I had swollen glands in my neck, and that feeling persists to this day 10/01/19.",,,,,,,,,N,09/27/2019,09/28/2019,1,,PHM,,"Venlafaxine, Hydrochlorothiazide, Losartan,  Calcium w/D, Red Yeast Rice w/CoQ10, Lecithen, Multi-Vitamin w/Iron, Folic Acid, Biotin, Tumeric, Pro Bifido, Prilosec",N/A,Breast Cancer in  remission; Arthritis;,,,2,10/01/2019,,,,Lipitor
0837525,10/01/2019,MA,59.0,59,,F,,"Patient developed a localized rash, with shingles like vesicles/blisters. Blisters began to spread to other areas of the body.  Low grade fever the night of the vaccinations.",,,,,,,,,U,09/25/2019,09/30/2019,5,,PHM,,Unknown,Unknown,Unknown,,,2,10/01/2019,,Y,,unknown
0837526,10/01/2019,FL,33.0,33,,F,,"Woke up at 2:30 am unable to breathe well, hoarse voice, racing heart, sweating, coughing, etc. Immediately took 5 mg of prednizone and two benadryl. Had an old albuterol inhaler from bronchitis a few years ago and used that.  Symptoms continue 23 hours later, but prednizone, benadryl, and albuterol are helping. Still short of breath and difficult to breathe. Joint aches. Bad headache.   Father is a physician and consulted with him. Also consulted with a pharmacist at pharmacy and my mother-in-law, a nurse practitioner and former ER nurse on what to do.",,,,,,,,,N,09/30/2019,10/01/2019,1,,PHM,,Adderall XR 20 mg daily; Trazodone 25 mg at night; Tumeric and Ginger gummy vitamin daily for joint pain; Emergen-C drink.,Common cold a week before.,"migraine headaches; positive ANA recently and some on-and-off joint pain throughout last year. However, rheumatologist ruled out any rheumatological diseases.",,,2,10/01/2019,,Y,,"No known allergies to medications, foods, or products."
0837527,10/01/2019,CA,28.0,28,,F,,"Patient had itching and some redness on the nape, lower lip, upper mid chest, bilateral shoulder and shoulder blades. She said her throat is also itchy.",,,,,,,,,Y,10/01/2019,10/01/2019,0,,OTH,,"No OTC, Codeine and Tylenol",Mass on her right ovary,Mass on her right ovary,,,2,10/01/2019,,Y,,NKA
0837528,10/01/2019,MS,48.0,48,,F,,"patient woke up with redness around injection site and swelling that progressed to underarm as well, sore arm and neck and two days after complaints of bad headache but swelling going down",,,,,,,,,N,09/29/2019,09/30/2019,1,,PHM,,,,,,,2,10/01/2019,,,,NONE REPORTED
0837529,10/01/2019,KS,65.0,65,,F,,Painful itchy chicken pox type rash at injection site. Spread down to elbow & around outer arm. Was bright red & hot to the touch. Still fading on day 5. Took benadryl & used hydrocortisone cream & Ibuprofen. Also had achy body flu like symptoms for 2 days. The rash was/is very bothersome! Only had flu symptoms & sore arm with 1st injection.,,,,,,,,,N,09/24/2019,09/25/2019,1,,PHM,,Synthroid  Vivelle Dot estrogen transdermal patch Spironolactone  Doxycycline  Restasis eye drops,None,None,,,2,10/01/2019,,,,Sulfa
0837530,10/01/2019,MI,67.0,67,,F,,"red swollen left arm that migrated down arm, treated with antibiotic on 9/30/19",,,,,,,,,U,09/27/2019,09/28/2019,1,none,PHM,,unknown,not known,none known,,,2,10/01/2019,,Y,,nka
0837531,10/01/2019,AL,51.0,51,,F,,"Patient presented today, reports onset of increased somnolence and delirium two days after receiving the injection. On day three after the injection, she reports has firm and tender swelling  with small ecchymosis at the site of the injection - left deltoid. Reports somnolence has decreased and delirium  resolved later on the day of onset.  The left deltoid swelling has slowly and progressively worsened, pain minimally increased.  Warm compresses to site, antihistamine, prednisone. Patient taking antibiotics (amoxicillin) for otitis media, changed to Ceclor because she reported medication makes her feel uncomfortable",,,,,,,,,N,09/26/2019,09/28/2019,2,"CBC c diff, CMP, PT/INR.  X-ray left deltoid",OTH,,"Metoprolol, Irbesartan, Protonix, Potassium Chloride; infrequently Naprosyn as needed","Otitis Media, Sinusitis, Dental abscess","Hypertension, hypokalemia, GERD, metabolic syndrome, Cyst of kidney",,,2,10/01/2019,,Y,,atenolol
0837532,10/01/2019,,81.0,81,,F,,"patient's inside of mouth felt hot day after vaccine and within a couple days has felt like sores inside. patient unsure if from vaccine or from shrimp and sauce she ate that night of vaccine, but occasionally eats shrimp. she is trying Benadryl to see if that helps - informed patient to call 911 if swelling of throat, mouth, tongue and/or shortness of breath occur. (patient not currently having these symptoms)",,,,,,,,,,09/26/2019,09/27/2019,1,,UNK,,,,,,,2,10/01/2019,,,,
0837533,10/01/2019,PA,40.0,40,,F,,"PATIENT HAD SORE ARM FOR 2 DAYS, THEN WORSENING NEURAL/MUSCLE PAIN FROM SHOULDER DOWN HAND, COULD POSSIBLY BE BRACHIAL NEURITIS. PATIENT WILL BE SEEING HER PRIMARY CARE PHYSICIAN, WAITING TO HEAR BACK FROM THEM.",,,,,,,,,,09/19/2019,09/19/2019,0,,UNK,,,,,,,2,10/01/2019,,Y,,
0837534,10/01/2019,FL,43.0,43,,F,,"patient's site of injection at her arm started to swollen and become red . hot to touch  . so she went to her doctor on Monday , dr told her that this is cellulitis as a result from the flu shot , so he gave her antibiotic",,,,,,,,,U,09/28/2019,09/29/2019,1,,PHM,,,,,,,2,10/01/2019,,Y,,
0837535,10/01/2019,FL,55.0,55,,F,,SWEATING NAUSEA,,,,,,,,,Y,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/01/2019,,,,
0837536,10/01/2019,OH,17.0,17,,M,,Pateint had  the vaccine and  then had a sports event and  then went home and had a headache and nausea. Had something to eat and  then went to his girlfriend's house  to drop her off. He was returning from there and thinks he had blacked out for few seconds and woke up after his car hit a concrete steps on side of road. The air bag deflated.. EMS was  on the scene and took him to Er and had him checked. he was admitted for observation for 1 day,,,,,Y,1,,,Y,09/27/2019,09/28/2019,1,"He was in ED on 9/28 /2019 and admitted for observation.He had  blood work- toxicology screen, cbcd, cmp, chest x-ray and head CT done. EKG and cardiac ECHO was done. All results were okay.",PVT,,allegra,none,allergic rhinitis mild intermittent asthma,,,2,10/01/2019,,,Y,azithromycin peanut and tree nut allergy  shell fish amoxicillin
0837537,10/01/2019,AZ,41.0,41,,F,,sustained shoulder pain and partial immobility/range of motion likely due to bursitis,,,,,,,,,N,09/17/2019,09/18/2019,1,ultrasound,PVT,,,,cervical dysplasia,,,2,10/01/2019,,Y,,
0837538,10/01/2019,FL,25.0,25,,F,,SWEATS AND NAUSEA,,,,,,,,,Y,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/01/2019,,,,
0837540,10/01/2019,CA,55.0,55,,F,,"Her current symptoms include, fever, chills, body aches, and fatigue. She also notes a developing sore sore like lesion on her outer upper lip. I let the patient know that other than the lip lesion, the other symptoms were common after the Shingrix vaccine and that they usually subside after 48 hours. She will call back if her symptoms worsen. She confirmed approval for sending adverse reaction report to the CDC.",,,,,,,,,U,09/30/2019,09/30/2019,0,N/a,PVT,,multivitamin probiotic,none,none,,,2,10/01/2019,,,,codeine
0837541,10/01/2019,TN,77.0,77,,F,,Patient received the Fluzone High Dose vaccine today at a clinic hosted by Pharmacy. The patient later called her local pharmacist and complained of pain under arm when she lifted it and the patient believed she received the vaccination too high on her arm.,,,,,,,,,U,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/01/2019,,,,lisinopril
0837542,10/01/2019,GA,38.0,38,,F,,was informed that patient had passed out  like 30 to 45 minutes after shot was adminstered,,,,,,,,,U,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/01/2019,,,Y,
0837543,10/01/2019,GA,70.0,70,,F,,patient states she is experiencing an itching and tingling sensation in her left arm . patient took oral Benadryl and topical hydrocortisone cream if no relief patient was advised to go to the ER or contact her doctor,,,,,,,,,N,09/22/2019,09/22/2019,0,,PHM,,none given,none,none listed,,,2,10/01/2019,,,,morphine
0837544,10/01/2019,SC,74.0,74,,F,,"All over body aches, fever, nausea, pain and swelling at injection site",,,,,,,,,U,09/30/2019,10/01/2019,1,,PHM,,,,,,,2,10/01/2019,,,,"tetracyclines, penicillin, codeine"
0837545,10/01/2019,SC,75.0,75,,F,,"The patient reported that shortness of breath/throat swelling began about 3 hours after receiving the high-dose flu vaccine. She began coughing and eyes became swollen and itchy. Throughout the evening her eyes began to ooze and felt like they were closing. She also reported a severe headache.  She took a Benadryl immediately.  Throughout the rest of the evening/next day she took aleve, zyrtec, and Tylenol (aleve did not relieve pain from headache).   The following day her eyes were still swollen/red/itchy.  By Monday, 9/30/19,  she felt better.",,,,,,,,,Y,09/27/2019,09/27/2019,0,,PHM,,"Activella, Temazepam, Eliquis, and Gabapentin",None,Atrial fibrillation,,,2,10/01/2019,,Y,,Kiwi
0837546,10/01/2019,PA,70.0,70,,F,,"Patient described severe muscle aches, joint pain, and fatigue for approximately one week following vaccination. She reported no injection site reaction.",,,,,,,,,Y,07/08/2019,07/08/2019,0,,PHM,,,,,,,2,10/01/2019,,,,
0837547,10/01/2019,NH,76.0,76,,F,,"The pt came in the following morning c/o redness, warmth and swelling about 5 inches below where she got the flu shot.  I suggested she be seen by mad and was do with cellulitis and given cephalexin.   To be followed up in 2 days",,,,,,,,,,09/30/2019,09/30/2019,0,,PHM,,,,,,,2,10/01/2019,,,,
0837548,10/01/2019,WV,66.0,66,,M,,Patient reported feeling nauseated and under the weather 48 hours after receiving the vaccination and then developing an infection on both lower legs requiring an oral antibiotic and topical antibiotic ointment.  Patient also reported being unable to stomach solid foods since receiving the vaccination.,,,,,,,,,U,09/21/2019,09/23/2019,2,Patient reported PCP cultured infection and is awaiting results,PHM,,"Calcitriol, Hydralazine, Lisinopril, Rosuvastatin, Clopidogrel, Toujeo",none,"Diabetes, HTN",,,2,10/01/2019,,Y,,NK
0837549,10/01/2019,PA,68.0,68,,F,,"Pt reports waking up at 3am with severe, disseminated flushing (over full body), having chills alternating with hot flashes, muscle aches and weakness. Patient also reports having the feeling that ""the top of her head was going to blow off"".  At the time patient reported incident to the pharmacy (around 10:30am on 10/1/19, severity of reaction had diminished substantially, and flushing was limited to injection site only)",,,,,,,,,N,09/30/2019,10/01/2019,1,N/A,PHM,,Escitalopram 20mg daily Ventolin 90 mcg HFA inhaler - 1 puff every 4 hours as needed,None reported,,,,2,10/01/2019,,,,"Iodine, Latex, Morphine, Streptomycin"
0837550,10/01/2019,FL,3.0,3,,F,,"Marked local reaction, with induration, erythema; Warmth to the entire lateral thigh with swelling of the thigh 2x the other side (I am a physician and also her mother; and have never seen such a dramatic reaction before). It almost looks vasculitic.",,,,,,,,,,09/30/2019,09/30/2019,0,,PVT,,None,None,None,,,2,10/01/2019,,,,None
0837551,10/01/2019,MD,64.0,64,,F,,"09/21/2019 - Fever, Headache, Chills, Injection Site Pain (no redness or swelling) symptoms increased in terms of headache and pain between 21 to 26 September 09/26/2019 - Continued low-grade fever, headache, chills,  injection site pain with redness, hot to touch and swelling extending to a 5-inch x 7-inch oval pattern from injection site down toward the elbow (Margins marked at home, a photo was taken) 09/27/2019 - went to Urgent care prescribe 50 mg prednisone per day x 5 days, sulfamethoxazole TMP DS tablets  10 days bid; Naproxen Sodium 550 mg bid as needed for pain.   (Margins - increased from previous day marked) 10/1/2019 - Rash remains slightly visible [Note: margins increased through 09/28/2019 with swelling and redness extended down to elbow crease]; last day of prednisone and several more days of antibiotic remain. Photos were taken through 30 September 2019",,,,,,,,,N,09/21/2019,09/21/2019,0,,PVT,,"Flonase, Xyzal",N/A,Post-viral/Cough variant asthma,,,2,10/01/2019,,,Y,"Dust, pollen (tree, weeds, grasses), feathers, animal dander (dog, cat)"
0837552,10/01/2019,OH,66.0,66,,F,,Patient started to experience severe pain in the arm where the injection was received. She experienced muscle tics and could not lift her arm up and away from her body. She experienced insomnia due to the severity of the pain. She also experienced swelling in the shoulder area.,,,,,,,,,Y,09/23/2019,09/23/2019,0,NA,PVT,,No other medications,None,"In the arm where the vaccine was administered, patient has been previously diagnosed with a rotator cuff tear.",,,2,10/01/2019,,,,None
0837553,10/01/2019,IL,17.0,17,,M,,"Patient came into the pharmacy with his father to get the meningitis vaccine as requested by his high school and the HPV vaccine as requested by his mother who is a nurse.  Menactra was administered in his left arm and he switched chairs to give the RPh easier access to give the other vaccination. The Gardasil 9 was given in the right arm.  When patient stood up after the vaccinations he said he felt dizzy so he sat back down.  A pharmacy technician was called to help lay the patient on the floor .  The RPH talked with the patient as the technician held his feet up off the ground.  His pulse and blood pressures were taken results as follows, 5:27 101/51 & 43,  5:28 108/47 & 44, & 5:31 97/52 & 52. after about 10 minutes the patient said he felt better and sat upright in the chair.  His father went to get him a snack and a drink.  When the father returned the patient felt better still they walked around/stayed in the store before going home.  An hour later the patient's mother came to the pharmacy to get an administration record to give to the school as proof of getting the Menactra and to tell us that the patient was feeling fine.  She also wanted to get the return dates for the remaining Gardisil 9 shots.",,,,,,,,,Y,09/30/2019,09/30/2019,0,blood pressure & pulse as above,PHM,,unknown,unknown,unknown,,,2,10/01/2019,,,,none
0837554,10/01/2019,FL,66.0,66,,F,,"-rash over entire body, mostly on trunk and inner thighs (solid), less on extremities -light itching -lasted for 4 days",,,,,,,,,Y,09/19/2019,09/20/2019,1,none,PHM,,"Cranberry, citalopram, pravastatin, alendronate, calcium + vit D",none,none,,,2,10/01/2019,,,,"sulfa, kiwi, penicillin(?)"
0837555,10/01/2019,CA,0.33,0,.4,M,,"Per parents, high fever peaking at 104.3 degrees F in the morning after the vaccines, inconsolable crying. Treated with infant acetaminophen. Fever reduced to 102 F per parents. When in clinic the afternoon after vaccines, fever 99.9 by temporal artery scan, child inconsolable in clinic.",,,,,,,,,N,09/30/2019,10/01/2019,1,None,PVT,,None,None,None,,,2,10/01/2019,,Y,,"NKDA, no other known allergies"
0837556,10/01/2019,CA,44.0,44,,F,,patients arm became swollen and red at injection site.  Patient went to the doctors office and the doctor stated it was an infection and prescribed keflex,,,,,,,,,U,09/27/2019,09/28/2019,1,patient went to her primary care md office,PHM,,"simvastatin, metformin",,"diabetic, hypercholesteremia",,,2,10/01/2019,,Y,,none
0837557,10/01/2019,PA,11.0,11,,M,,"Local reaction at the sites where he received Flu and Menveo vaccinations 3 x 4 inches wide total area of redness.  Flu was administered left upper deltoid, Menveo administered left lower deltoid.",,,,,,,,,N,09/30/2019,10/01/2019,1,none,PVT,,"Pepcid, fexofenadine, multi-vitamins, levalbuterol, flovent","asthma flare, vomiting within the past one month.","mild persistent asthma, GERD",,,2,10/01/2019,,Y,,none known
0837558,10/01/2019,FL,59.0,59,,F,,"pt said she had fever and rash on the body, she has been improving day by day. her fever is gone now",,,,,,,,,Y,09/28/2019,09/30/2019,2,,PHM,,,,,,,2,10/01/2019,,,,
0837560,10/01/2019,,56.0,56,,F,,"PT HAD FEVER, CHILLS AFTER RECEIVING THESE VACCINATIONS. PT CALLED US AND TOLD US ABOUT IT.",,,,,,,,,,09/27/2019,09/28/2019,1,,UNK,,,,,,,2,10/01/2019,,Y,,
0837561,10/01/2019,MO,78.0,78,,F,,"Arm (from injection site to elbow) became red and swollen by the end of the day.  Two days later when patient presented, the swelling had went down but the arm was still slightly red and warm.",,,,,,,,,U,09/28/2019,09/28/2019,0,,PHM,,,none reported,,,,2,10/01/2019,,,,none reported
0837562,10/01/2019,ID,76.0,76,,F,,"Pt left arm, from injection sit to elbow, large area of bruising and pooled blood. Looks like  a giant blood blister/ hematoma",,,,,,,,,U,09/30/2019,09/30/2019,0,Pt going to quick care now.,PHM,,"mycophenalate , losartan, zortress. Xanax, raloxifene",,,,,2,10/01/2019,,Y,,codeine
0837563,10/01/2019,IN,66.0,66,,F,,Patient experienced redness and swelling of right arm one day after vaccine given. Patient also complained of being unable to sleep and feeling restless the night after she received the vaccine.,,,,,,,,,N,09/30/2019,10/01/2019,1,,PHM,,,,,,,2,10/01/2019,,,,
0837564,10/01/2019,OR,53.0,53,,M,,"Contracted shingles in right ear, causing Ramsay Hunt Syndrome. Sustained approx 50% hearing loss in the right ear, constant ringing in the right ear, right side facial paralysis (mouth drupe, right eye stays open) severe vertigo.  Given medicine to kill the virus, prednisone steroids to heal damaged ear, two steroid shots to the eardrum.",,,,,,,,Y,N,07/02/2019,08/01/2019,30,08/18/2019 emergency visit confirmed diagnosis.,PVT,,Losartan 100 MG daily,bruised shin,High blood pressure,,,2,10/01/2019,,Y,Y,none
0837565,10/01/2019,TX,67.0,67,,F,,Redness and pain on left arm.,,,,,,,,,U,09/28/2019,09/28/2019,0,,PHM,,,,,,,2,10/01/2019,,,,
0837566,10/01/2019,MO,59.0,59,,F,,"Most were normal reaction reactions per documentation - pain, redness at the injection site  Additional:  Severe deep shoulder pain (right). Unable to raise right arm. This started during sleep the night of receiving the shot and continued for 3 days, subsiding on day 4. Upper body rash, Chest, arms, and back. Started day 3 and continued through Day 4. The rash appeared to only be in the area where exposed to sunlight. Rash appeared as raised irregular shaped red blotches with severe itching, No fluid.  On day 5, at the time of this report. Symptoms have subsided slightly and appears to getting better but no completely gone. able to raise arm level with shoulder but painful any further. Raise appears to be lessening with Benadryl and topical creams.",,,,,,,,,N,09/26/2019,09/27/2019,1,None done. Consulted with Pharmacist and elected to wait it out. Pharmacist suggested that we report since the symptoms were not common.,PHM,,Opdivo -  Aspirin 80mg Bupropion Folic Acid Doxycycline Meloxicam Plaquenl Metroprol Omeprazole Flaxseed Oil Estroven Clarintin Probiotic Biotin,Cancer - Non-small-cell lung carcinoma (NSCLC) -  adenocarcinoma RA - Rheumatoid arthritis,Cancer - Non-small-cell lung carcinoma (NSCLC) -  adenocarcinoma RA - Rheumatoid arthritis,,,2,10/01/2019,,Y,,Azithromycin Flagyl (Metronidazole) Neomycin
0837567,10/01/2019,VA,69.0,69,,F,,"Her fibromyalgia flared up for about 10 days starting 3 days after the vaccination. She developed cold sores/fever blister and had the chills; Her fibromyalgia was especially bad in her feet, hands, and elbows where her most troubled areas are.",,,,,,,,,Y,09/16/2019,09/19/2019,3,none-,PHM,,"buproprion, duloxetine, alprazolam, butalbital/asa/caffeine,",no illness,"fibromyalgia, cold sores",,,2,10/01/2019,,,,no allergies
0837568,10/01/2019,PA,66.0,66,,F,,pt presented to pharmacy the day after flu shot with red swollen spot on arm,,,,,,,,,U,09/30/2019,10/01/2019,1,"not sure if patient will go to dr, may try to ice it - told her to follow up with dr if does not improve or if gets any worse",PHM,,lisinopril/hctz diltiazem,none known,htn,,,2,10/01/2019,,Y,,"penicillin, cephalosporin"
0837569,10/01/2019,CO,68.0,68,,F,,"pt returned to the pharmacy after having immunizations on sunday, she showed her arm it was red and swollen at the lower end above the elbow below the injection site nearer the lateral arm and toward the elbow. She states the pharmacist administered bothinjections at the same site in the same inject safe barrier. I told her I would report to VAERS as she has not had a reaction to a vaccination previously, i suggested benadryl if she fears allergic reaction. i checked her hx pt got prevnar 13 on 10/7/2018 pneumaovax delivered 9/30. 1 week early . pt rash went down after benadryl administration 10/1/2019",,,,,,,,,Y,09/29/2019,09/29/2019,0,n/a,PHM,,"warfarin, simvastatin gabapentin, metformin, losartan /hctz,",none to mention,"blood pressure , pre-diabetes,",,,2,10/01/2019,,,,nkda or foods
0837570,10/01/2019,CA,76.0,76,,M,,"I woke shaking violently I was extremely cold with chills coming and going, my heart was racing and I felt as if I were in a dream. I could not quite grasp reality. I do not take any drugs. (Of any kind) I was was sweating a great deal and it required me to change clothes and to get out of the bed. My wife gave me a Tylenol because my shoulder was very sore and painful.  My wife said there was an order ?musky? she could smell  which I suppose was from my sweating. I don?t have a musky odor ever.  You can call me if you wish to discuss this further. I have only had a shot once or twice before.   It is called Inactivated Influenza Vaccine Recombinant on the paper I was given",,,,,,,,,U,09/30/2019,10/01/2019,1,,PVT,,None,None,None,,,2,10/01/2019,,,,None
0837571,10/01/2019,TX,54.0,54,,M,,arm swollen and painful,,,,,,,,,N,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/01/2019,,,,
0837572,10/01/2019,,54.0,54,,F,,Patient reported a bump at the injection site. She called to ask if this was normal. We advised her to use a cold pack and take ibuprofen and if the symptoms got worse to follow up with her doctor.,,,,,,,,,,10/01/2019,10/01/2019,0,,UNK,,,,,,,2,10/01/2019,,,,
0837573,10/01/2019,OH,90.0,90,,F,,"itching and burning at site of administration, itching and swelling of same arm, some swelling of hand, patient believes some swelling of shoulder.",,,,,,,,,U,09/23/2019,09/23/2019,0,,PHM,,"liothyronine, levothyroxine, hydrocortisone rectal suppository, Xarelto, eplerenone",none known,thyroid,,,2,10/01/2019,,,,codeine
0837574,10/01/2019,CA,66.0,66,,M,,"Patient came to pharmacy on 9-24-19 around 630pm to show me reaction on his arm. Patient states reaction began evening of 9-23-19 with his left arm starting to swell, turn red, was hot to touch. It started from site of injection on his left arm and traveled down the left arm to just above the elbow area. The reaction has stopped traveling but was still red, swollen, hot to touch and painful.",,,,,,,,,U,09/23/2019,09/23/2019,0,,PHM,,unknown,upper respiratory infection,unknown,,,2,10/01/2019,,,Y,no
0837575,10/01/2019,CA,79.0,79,,M,,Seizure on 9/30/19,,,,,,,,,Y,09/26/2019,09/30/2019,4,CT head- no acute intracranial abnormality,PVT,,"Patient on as needed medications only: hydrocodone-acetaminophen 5-325 mg 1 tablet every 6 hours as needed, Sennosides 8.6 mg 1-2 tablets up to 2x/day as needed, ibuprofen 200 mg as needed",none,"allergic rhinitis, beta thalassemia trait, chronic cough, hearing loss, colon polyps",,,2,10/01/2019,,,Y,No known drug allergies
0837576,10/01/2019,KS,62.0,62,,F,,"Patient also received an injection of just the adjuvant/diluent for Shingrix in the left arm. Once error was caught, patient received the vaccine in full with adjuvant mixed with antigen in the right arm. Followed up with patient after about 24 hours, and patient stated she had a low grade fever of about 100 degrees Fahrenheit. She had no injection site reactions at any of the 4 injections. This was the only symptom reported.",,,,,,,,,U,09/30/2019,10/01/2019,1,,WRK,,Unknown,Patient stated she had a cold at the time of vaccination.,Unknown,,,2,10/01/2019,,,,NKA
0837617,10/01/2019,IL,66.0,66,,F,,"APPROXIMATELY 10:15 PM BOTH LEGS GOT MAJOR CHARLIE HORSES LASTING 20 MiN. NEXT MORNING WOKE UP WITH HEADACHE - 102 DEGREE FEVER, OFF & ON. CHiLLS, FAST HEART BEAT - Dizzy & HARD SWALLOWiNG. VISION PROBLEMS AS WELL. * AFTER TAKING MEDS - FELL ASLEEP (TOOK MEDS FOR 2 DAYS - LT ARM STILL SORE 9-26-19 & WEAK)",,,,,,,,,Y,09/13/2019,09/13/2019,0,,PVT,,CLONAZEPAM - LEXAPRO - FISH OIL - FLUTICASONE - ACETAMINOPHEN,HURT WRIST - PTSD,TUBE IN NOSTRILS FOR SINUS - BRAIN ANUERISM - SOME SEIZURES - PTSD,,,2,09/26/2019,,Y,,DEMEROL - SULFA
0837661,10/01/2019,IL,0.25,0,.2,M,,RE: Pentacel No adverse reaction noted. Realized that the diluent portion of the Pentacel was not mixed with the powder portion after administrating vaccine. Called manufacturer and spoke to pharmacist who advised to give Hib vaccine as a separate vaccination which was done.,,,,,,,,,,08/26/2019,,,N/A,PVT,,N/A,N/A,congenital circumcision,,,2,09/26/2019,,,,NKDA
0837665,10/01/2019,GA,66.0,66,,F,,"REDNESS, SWELLING, PAIN, FEVER",,,,,,,,,Y,09/20/2019,09/20/2019,0,,PHM,,ALSO RECEIVED FLU VACCINE,NONE KNOWN,,,,2,10/01/2019,,,,NKA
0837694,10/01/2019,PA,3.0,3,,F,,"Later the same day as vaccines given, patient developed warm erythematous blotchy rash of (L) upper arm, just distal to injection site. Parents treated with po Benadryl, Cetirizine. Had significantly improved by time of office evaluation 9/30/19.",,,,,,,,,Y,09/27/2019,09/27/2019,0,None,PVT,,Fluticasone nasal spray prn,sinusitis,"Recurrent otitis, sinusitis",,,2,10/01/2019,,Y,,NKA
0837699,10/01/2019,PA,0.5,0,.5,M,,"Pt had crying @ 7:30 PM for just over 3 hr., has been well since",,,,,,,,,Y,09/26/2019,09/26/2019,0,0,PVT,,0,0,0,vomiting after 4mo shots Pentacel/Rotateq + Prevnar 13,,2,10/01/2019,,,,0
0837700,10/01/2019,NY,79.0,79,,F,,"Pain in arm - arm red & swollen Chills, shivering for 10 hours Headache Very tired & weak 4 days later developed a fever blister & peeling skin in the mouth",,,,,,,,,Y,09/12/2019,09/13/2019,1,,PHM,,,None,ARTHRITIS,,,2,09/24/2019,,,,Codeine Immodium AD - Tide
0837701,10/01/2019,OH,72.0,72,,F,,"A few hours after patient received vaccine, she felt like a ""ball was in her throat"" & her lips started to swell/tingle. She phoned her provider who instructed her to go to urgent care. They didn't give her any meds so she went to ER & was given antihistamine & prednisone",,,,,,,,,U,10/01/2019,10/01/2019,0,,PHM,,Atorvastatin 10mg Lumigan eye drops,,,,,2,10/10/2019,,,Y,NKDA
0837702,10/01/2019,NY,71.0,71,,M,10/01/2019,"Rash on torso, arms, neck, and face one behind right knee",,,,,,,,,U,09/27/2019,09/29/2019,2,Patient was referred to doctors office has appointment at 1PM on 10/1/19,OTH,PVT,,none,codeine,,,1,,,,,
0837703,10/01/2019,GA,11.0,11,,M,09/13/2019,Circular erythema + tenderness to (R) upper arm (widest appx 5 cm). 2 areas of circular erythema + tenderness to (L) upper arm (top: widest appx: 1 cm; bottom: widest 4 cm). Appeared morning after vaccine.,,,,,,,,,Y,09/11/2019,09/12/2019,1,N/A,PVT,PUB,O,O,O,,,1,,,,,
0837989,10/01/2019,WA,17.0,17,,M,,Severe headache lasted for 48 hrs.,,,,,,,,,Y,09/16/2019,09/16/2019,0,None,PVT,,,,,,,2,09/18/2019,,Y,,
0837990,10/01/2019,OH,67.0,67,,M,,RED AROUND SHOT - HOT TRAVELED DOWN AROUND ARM,,,,,,,,,,09/10/2019,09/10/2019,0,,OTH,,,,,,,2,09/28/2019,,Y,Y,
0837991,10/01/2019,PA,83.0,83,,F,,"Patient called today and said she had several episodes of ""dizziness"" since getting the flushot on 9-19-19.",,,,,,,,,N,09/19/2019,09/26/2019,7,,PHM,,zoloft 25mg,unknown,unknown,,,2,10/01/2019,,,,"codeine, penicillin"
0838198,10/01/2019,OR,58.0,58,,F,10/07/2019,"Rash, swelling of lips, itching at site",,,,Y,,,,,Y,09/30/2019,09/30/2019,0,,OTH,PUB,SINGULAIR,None,N/A,,,1,,,,,
0838233,10/01/2019,PA,82.0,82,,F,10/01/2019,"12 hours after vaccine - anxious, fever, chills, body aches. 15 days later claims to still not feel right",,,,,,,,,Y,09/13/2019,09/13/2019,0,,OTH,PVT,,,,,,1,,,,,
0837578,10/02/2019,AK,87.0,87,,F,,"fever, shakiness, red eyes that are sensitive to light,  partial facial numbness above eye and nose, pt has high tolerance to pain and had severe pain in left arm, some slight tightness in chest  pt used proair and tightness stopped, fever recordings 99.4,100.7,101.4,101.8 @ 8pm ,101.5 @830pm pt took 2 extra strength Tylenols at 7pm. also added cold wash rag at 8pm.101.0",,,,,,,,,U,10/01/2019,10/01/2019,0,none,PHM,,"Carafate, prenavite, low dose aspirin, herbal life protein drink, macular support vitamin aereds, calcium magnesium zinc, systane drops, Januvia, proair, breo, pataday,","balance issues, fall on 090519","gerd, hiatal hernia, macular degeneration,  coronary arterial calcification, neuropathy, diabetes 2, pace maker,",,,2,10/02/2019,,,,"amoxil-hives, codeine-vomiting, milk insensitivity,  garlic insensitivity"
0837579,10/02/2019,CA,3.0,3,,F,,"I have pictures, today is her eight day and her entire leg is swollen, in pain, has trouble walking",,,,,,,,,N,09/23/2019,09/24/2019,1,None,PVT,,None,None,None,,,2,10/02/2019,,Y,,This I can not answer because my provider will not do an allergy test unless she has a reason too. This is why I asked them to do an allergy test before her vaccinations.
0837580,10/02/2019,HI,70.0,70,,M,,On 9/28/19 patient couldn't sleep because the area of the injection site (right deltoid) felt hot. On 9/29/19 and 9/30/19 the injection site continued to feel hot. Patient went to see his doctor on 9/30/19. On 10/1/19 patient returned to his doctor due to pain and swelling in arm from injection site extending down past the elbow to about the mid forearm.,,,,,,,,,N,09/28/2019,09/28/2019,0,None,PHM,,"Imipramine 50mg, Tamsulosin 0.4mg, Nortriptyline 10mg, Losartan 50mg",None,"Prostate, Hypertension, Depression",,,2,10/02/2019,,Y,,Local anesthetics
0837581,10/02/2019,,4.0,4,,M,,About 2 hours after vaccination Mother noticed fever of 102F and administered 7.5ml of Motrin and Pt rested on the couch. after another hour and a half  the fever had not improved and Mom  gave 7.5ml of Tylenol. After the Tylenol mother noticed that the Pt was staring off into space and would not acknowledge his mothers presence. Mother also noted the Pt was shaking as though he was cold and decided to bring him upstairs to bed. Pt was also refusing water and mom tucked him in and watched him and believes that the fever reduced while the pt slept for 2-3 hours. Pt woke up and was  not happy until he was fed ice cream and his reheated dinner. At around 1030 pm pt went back to bed. Pt woke up at around 2AM and was given more 7.5ml Motrin due to another 102F fever and went back to bed. Pt woke up around 6 am and was given Tylenol preemptively and ate breakfast and seems to have recovered.,,,,,,,,,Y,10/01/2019,10/01/2019,0,,MIL,,Over the counter Multi Vitamin taken daily,Common cold/nasal congestion + discharge,None,,,2,10/02/2019,,,,Amoxicillin and Cephalosporin
0837582,10/02/2019,SC,66.0,66,,M,,"15-30 minutes of serious threat of fainting, perspiration then shivering.  Had to get to the floor several times.  Got through the worst of it after, maybe 30 minutes, but felt unsteady & weak for approx. 4+ hours.    Also, experienced extreme sensitivity to cold water/ice on upper left side of teeth.  No treatment, yet.  I think I've recovered, but only time will tell.",,,,,,,,,Y,09/29/2019,09/30/2019,1,none,PHM,,"celecoxib, rosuvastatin, esomeprazole magnesium, lorazepam, aspirin, folic acid, vitamin B12 and latanoprost (eye drop).",,glaucoma (right eye),,,2,10/01/2019,,,,sulfa drugs
0837583,10/02/2019,MD,37.0,37,,F,,Tingling and numbness in lips.,,,,,,,,,Y,10/01/2019,10/01/2019,0,None,PUB,,"Lisinopril, omeprazole, wellbutrin, ajoy, skyla IVD, atorvastatin, monteukast, flintstones multivit., calcium, probiotic,  vitamin, potassium.",None,"High blood pressure, migrain headaches",,,2,10/02/2019,,,,ceftin
0837584,10/02/2019,MI,24.0,24,,F,,"Patient received Flu shot in Left Upper arm, immediately had sudden onset Back pain, nausea, lightheadedness, Red Rash on  chest up into her face.",,,,,,,,,U,10/01/2019,10/01/2019,0,None,OTH,,None,Resolving cold symptoms,None reported,,,2,10/02/2019,,Y,,"Sheep, Cats, Horses"
0837585,10/02/2019,FL,61.0,61,,F,,"9/26/19: PAIN AT INJECTION SITE, SWELLING, SORENESS, HEADACHE.  LIMITED MOVEMENT OF LEFT SHOULDER JOINT. SEVERE PAIN WHEN RAISING ARM OR REACHING BEHIND. UNABLE TO SLEEP DUE TO PAIN. TREATED WITH NAPROXEN 220 mg. 9/27/19: CONTINUED LIMITED MOVEMENT OF LEFT SHOULDER JOINT. SEVERE PAIN WHEN RAISING ARM OR REACHING BEHIND. CONTINUED HEADACHE. RESTED ALL DAY AND DID NOT USE SHOULDER JOINT. NAPROXEN 220 mg. X 2 9/28/19 to PRESENT:  LIMITED MOVEMENT OF LEFT SHOULDER JOINT. CONTINUING PAIN WHEN RAISING ARM OR REACHING BEHIND. WEAKNESS IN LEFT ARM WHEN SHOULDER JOINT HAS ROLE IN TASK. TAKING NAPROXEN AND RESTRICTING MOVEMENT OF LEFT SHOULDER AS MUCH AS POSSIBLE",,,,,,,,,N,09/26/2019,09/26/2019,0,NONE AT THIS TIME,PHM,,NONE,NONE,NONE,"ABNORMAL PAIN AT INJECTION SITE LASTING 6 DAYS FOLLOWING 2010 INFLUENZA VACCINE (DATE, TYPE, BRAND UNKNOWN)",,2,10/02/2019,,,,NONE
0837586,10/02/2019,FL,35.0,35,,F,,"The following day after receiving flulaval injection, patient started to get a red welt around the injection site. It was also very warm to touch. Over the next few days, the area of redness spread and then started to turn purple like a bruise. The area, which patient states took up most of her upper arm, was also still very warm to touch. Skin discoloration is fading but you can still see some residual today 3 weeks later.",,,,,,,,,Y,09/11/2019,09/12/2019,1,n/a,PVT,,1. phentermine 37.5mg tablet; 0.5 tab daily 2. drospirenone 3mg-ethinyl estradiol 0.03mg; 1 tab daily,none known,obesity dyslipidemia,,,2,10/02/2019,,,,none known
0837587,10/02/2019,MA,19.0,19,,F,,Developed a few hives (urticaria) 8 hours after vaccination and more generalized urticaria involving trunk the next morning,,,,,,,,,Y,09/24/2019,09/24/2019,0,None known.  Seen at Urgent Care,OTH,,Singulair Multivitamin,Denies,Denies,,,2,10/02/2019,,,Y,Seasonal allergies only.
0837602,10/02/2019,NY,,,,U,,"patient as administered 1 dose of improperly stored MMR II; no adverse effects reported; This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 10-JUL-2019, the patient was vaccinated with the first dose of an improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # R015165 exp date 29-MAY-2020) (route not reported) which was reconstituted with properly stored sterile diluent. A data logger issue was reported. The temperature of excursion was 50 F for 4 hours. There was no previous temperature excursion. No adverse effects were reported.",,,,,,,,,U,07/10/2019,,,,UNK,,STERILE DILUENT,,,,US0095075131909USA003893,2,10/01/2019,,,,
0837604,10/02/2019,MD,,,,U,,"No adverse effects reported; the administration of one dose of an improperly stored vaccine, VAQTA, to one patient; This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. Information on pertinent medical history and drug reactions/allergies was not reported.   On 12-SEP-2019, the patient was vaccinated with an improperly stored Hepatitis A Vaccine, Inactivated (VAQTA) (dose, dose number, route of administration and location of administration were not reported) (lot # S005723, expiration date 10-JUL-2020), administered for prophylaxis.   The vaccine was exposed to a temperature of 0.24 degree Celsius multiple times for a time frame of 5 hours and 30 minutes as recorded by a digital data logger. There were no previous temperature excursions. No adverse effects were reported.",,,,,,,,,U,09/12/2019,09/12/2019,0,,UNK,,,,,,US0095075131909USA011657,2,10/01/2019,,,,
0837605,10/02/2019,MD,,,,U,,"No adverse effects reported; One dose of an improperly stored vaccine, VAQTA, to one patient; This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 09-SEP-2019, the patient was vaccinated with an improperly stored doses of hepatitis a vaccine, inactivated (VAQTA) injection, for prophylaxis, lot number S005723 with expiration date in 10-JUL-2020 (strength and anatomical location  were not reported).  The hepatitis a vaccine, inactivated (VAQTA) was stored at a temperature of 0.24 Celsius (C) (reported as multiple) for the time frame of 5 hours and 30 minutes. There was no previous temperature excursion and the call was because of a data logger.   No adverse effects reported.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,US0095075131909USA013175,2,10/01/2019,,,,
0837606,10/02/2019,NY,4.0,4,,U,,"No adverse effects; A patient was administered improperly stored PROQUAD; Information has been received from a medical assistant regarding a 4-year-old patient of unknown gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 05-SEP-2019, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) injection, for prophylaxis, lot number S009759 with expiration date in 27-SEP-2020 which was reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT) (dose, strength and anatomical location were not reported).  The measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was stored at a temperature range of 15 degrees Fahrenheit (F) to 46 F (17.6 F) for the time frame of 56 hours and 40 minutes. A previous temperature excursion was reported of 6 F to 14 F (6.2 F) for 10 minutes. The call was not because of a data logger.  No adverse effects reported.",,,,,,,,,U,09/05/2019,09/05/2019,0,,UNK,,STERILE DILUENT,,,,US0095075131910USA001639,2,10/01/2019,,,,
0837607,10/02/2019,NY,,,,F,,"Pain from the injection; This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The pharmacy student stated that her mom experienced pain from the injection when she received Shingrix.  The reporter consented to follow up. Additional details not provided at the time of this call, but pharmacy student granted permission to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/02/2019,,,,
0837608,10/02/2019,CA,19.0,19,,M,,"Shoulder pain; radiating pain; This case was reported by a nurse via call center representative and described the occurrence of shoulder pain in a 19-year-old male patient who received Men B NVS (Bexsero) (batch number ABXA12AZ, expiry date 28th February 2021) for prophylaxis.   Previously administered products included Bexsero with an associated reaction of musculoskeletal pain (1st dose received on 3rd August 2018, refer linked case US2019148696).   On 9th August 2019, the patient received the 2nd dose of Bexsero. In August 2019, less than a week after receiving Bexsero, the patient experienced shoulder pain and radiating pain. In August 2019, the outcome of the shoulder pain and radiating pain were recovered/resolved.   It was unknown if the reporter considered the shoulder pain and radiating pain to be related to Bexsero.  Additional information received were as follows: The registered nurse called to report a Bexsero adverse event. The patient received vaccine in left deltoid. The patient had the same reaction as he had to the 1st dose, significant shoulder pain that radiated to the back. The reporter reported that the pain lasted a while as she spoke to the patient's mother, 4 days after the 2nd dose. The reporter consented to follow up. This case had been linked to the case US2019148696, reported for same patient by same reporter.",,,,,,,,,Y,08/09/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/02/2019,,,,
0837609,10/02/2019,,,,,U,,"Bad side effects; This case was reported by a consumer and described the occurrence of adverse event in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was not recovered/not resolved.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient was having bad side affects after receiving Shingrix.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/02/2019,,,,
0837610,10/02/2019,IL,,,,U,,"Injection Site Redness; Discomfort at injection site; This case was reported by a nurse via sales rep and described the occurrence of injection site erythema in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received the 1st dose of FluLaval Quadrivalent .5 ml. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced injection site erythema and injection site discomfort. On an unknown date, the outcome of the injection site erythema and injection site discomfort were unknown.   It was unknown if the reporter considered the injection site erythema and injection site discomfort to be related to FluLaval Quadrivalent.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced redness and discomfort at injection site. The reporter consented to follow up. This is 1 of the 5 linked cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/02/2019,,,,
0837611,10/02/2019,IL,,,,U,,"Injection Site Redness; Discomfort at injection site; This case was reported by a nurse via sales rep and described the occurrence of injection site erythema in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received the 1st dose of FluLaval Quadrivalent .5 ml. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced injection site erythema and injection site discomfort. On an unknown date, the outcome of the injection site erythema and injection site discomfort were unknown.   It was unknown if the reporter considered the injection site erythema and injection site discomfort to be related to FluLaval Quadrivalent.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced redness and discomfort at injection site. The reporter consented to follow up. This is 1 of the 5 linked cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/02/2019,,,,
0837612,10/02/2019,IL,,,,U,,"Discomfort at injection site; Injection Site Redness; This case was reported by a nurse via sales rep and described the occurrence of injection site erythema in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received the 1st dose of FluLaval Quadrivalent .5 ml. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced injection site erythema and injection site discomfort. On an unknown date, the outcome of the injection site erythema and injection site discomfort were unknown.   It was unknown if the reporter considered the injection site erythema and injection site discomfort to be related to FluLaval Quadrivalent.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced redness and discomfort at injection site. The reporter consented to follow up. This is 1 of the 5 linked cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/02/2019,,,,
0837613,10/02/2019,IL,,,,U,,"Injection Site Redness; Discomfort at injection site; This case was reported by a nurse via sales rep and described the occurrence of injection site erythema in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received the 1st dose of FluLaval Quadrivalent .5 ml. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced injection site erythema and injection site discomfort. On an unknown date, the outcome of the injection site erythema and injection site discomfort were unknown.   It was unknown if the reporter considered the injection site erythema and injection site discomfort to be related to FluLaval Quadrivalent.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced redness and discomfort at injection site. The reporter consented to follow up. This is 1 of the 5 linked cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/02/2019,,,,
0837614,10/02/2019,IL,,,,U,,"Injection Site Redness; Discomfort at injection site; This case was reported by a nurse via sales rep and described the occurrence of injection site erythema in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received the 1st dose of FluLaval Quadrivalent .5 ml. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced injection site erythema and injection site discomfort. On an unknown date, the outcome of the injection site erythema and injection site discomfort were unknown.   It was unknown if the reporter considered the injection site erythema and injection site discomfort to be related to FluLaval Quadrivalent.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced redness and discomfort at injection site. The reporter consented to follow up. This is 1 of the 5 linked cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/02/2019,,,,
0837615,10/02/2019,,80.0,80,,M,,"Hurt arm; Tiredness for a couple of days; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced tiredness and pain in arm. On an unknown date, the outcome of the tiredness was recovered/resolved and the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the tiredness and pain in arm to be related to Shingrix.  Additional case details were reported as follows: The patient reported after 1st dose of Shingrix in August 2019, experienced tiredness for a couple of days and arm hurt. The reporter did not consented to follow up.",,,,,,,,,Y,08/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/02/2019,,,,
0837616,10/02/2019,NM,58.0,58,,M,,"Suspected shingles after SHingrix; This case was reported by a other health professional via call center representative and described the occurrence of suspected shingles in a 58-year-old male patient who received Herpes zoster (Shingrix) (batch number 2AH5M, expiry date unknown) for prophylaxis.   On 20th September 2019, the patient received the 1st dose of Shingrix. In September 2019, 7 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional information received were as follows: The patient experienced a suspected case of shingles. The reporter did not consent to follow-up. The caller refused to give any further details.",,,,,,,,,U,09/20/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/02/2019,,,,
0837620,10/02/2019,FL,2.0,2,.0,F,,"swollen, hard and red at injection site",,,,,,,,,N,09/30/2019,09/30/2019,0,none,PVT,,none,cough and congestion on the 24th,none,,,2,10/02/2019,,Y,,none
0837621,10/02/2019,NJ,62.0,62,,F,,"This was my 2nd dose of Shingrix Vial Kit . 1st shot no problems, this one when I woke up day after shot had: chills, a fever of 100.6, achy, feeling tired, headache really horrible. Left work early went home & slept for 2.5 hours, on a bright & sunny day! Was feeling better by Wednesday morning. (shot received late afternoon on Monday)",,,,,,,,,Y,09/30/2019,10/01/2019,1,,PHM,,"vitamins only...multi vitamin, Vit K, Lecithin, Vit E, calcium, Vit A",0,0,,,2,10/02/2019,,,,0
0837622,10/02/2019,MO,49.0,49,,F,,"vomiting, fever, tightness in chest, body ache, heavy breathing, numbing in face",,,,,,,,,Y,10/01/2019,10/01/2019,0,none.  took 3 Benadryl over course of day 10/1/2019,WRK,,"Lisinopril/hztc 20/12.5, Glipizide ER 5mg, Dulexetine DR 60 mg, Furosemide 20mg, Potassium Chloride 20 meq, Alprazolam .25mg, zyrtec 10mg(over counter)",no,"high blood pressure, pre-diabetic, depression, anxiety",,,2,10/02/2019,,,,"penicillin, steroids, lithium, metformin, avocados, strawberries, bananas"
0837623,10/02/2019,CA,67.0,67,,M,,"Received the first shot for Shingrix. I got quite sick in the evening, with flu-like symptoms, vomited 4 times, diarrhea,  shivers, sweats.",,,,,,,,,Y,10/01/2019,10/01/2019,0,None,PHM,,None,None,None,,,2,10/02/2019,,,,None
0837624,10/02/2019,LA,35.0,35,,F,,"rapid heartbeat, weakness, tired/fatigue, sinus symptoms such as facial pressure around the eyes, sneezing, cough (at bedtime) and diarrhea.",,,,,,,,,N,10/01/2019,10/01/2019,0,,PVT,,none,none,type 2 DM; HTN,,,2,10/02/2019,,,,none
0837625,10/02/2019,,,,,M,,"Soreness at injection site; This case was reported by a physician via sales rep and described the occurrence of injection site pain in a 61-year-old male patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, unknown after receiving Flu vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Flu vaccine.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced soreness at the injection site following previous flu shots. The caller did not provide any additional details. The reporter denied permission to follow up. This was 1 of the 3 cases reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/02/2019,,,,
0837626,10/02/2019,OR,64.0,64,,F,,"Patient experienced pain, swelling, redness in left arm at injection site. Approximately 14 hours post injection, also experienced nausea. These symptoms lasted 48 hours, except for nausea.",,,,,,,,,Y,09/30/2019,09/30/2019,0,None,PVT,,"Levothyroxine, naproxen",,Hypothyroidism,,,2,10/02/2019,,,,Doxycycline
0837627,10/02/2019,GA,62.0,62,,M,,"Received the vaccine shot in the morning, about 12 hours later started experiencing typical flu symptoms - achy,  shivering, pain in joints, headache.   Went to bed shivering.  Woke up not shivering, but still achy all over.   Like I have a hang over.    No nausea associated.",,,,,,,,,N,10/01/2019,10/01/2019,0,,PHM,,Losarten;  Bystolic ; Juice Plus; Vit C; Vit D; pro-biotics,none,High Blood Pressure,,,2,10/02/2019,,,,n/a
0837628,10/02/2019,SC,72.0,72,,M,,"NAUSEA, PAIN AND SWELLING AT INJECTION SITE, HEADACHE",,,,,,,,,U,09/30/2019,10/01/2019,1,,PHM,,,,,,,2,10/02/2019,,,,"STATINS, LYRICA"
0837629,10/02/2019,KS,12.0,12,,F,,"Patient developed vomiting shortly after receiving injection on 9/27/19, 2 days post vaccine developed muscle aches which continued to worsen. 4 days after vaccine, muscle pains continued along with red blotchy areas to back and face.",,,,,,,,,,09/27/2019,09/27/2019,0,,PVT,,None,,,,,2,10/02/2019,,Y,,Penicillin
0837631,10/02/2019,KY,52.0,52,,F,,"Fever, chills, violent shivering,  headache",,,,,,,,,Y,10/01/2019,10/01/2019,0,,PVT,,Vitamin D Vitamin B12 Turmeric supplement  Flonase,None,None,,,2,10/02/2019,,,,Penicillin
0837634,10/02/2019,CA,,,,M,,"Shortly after receiving Defendants' Zostavax vaccine, Plaintiff suffered chronic inflammatory demyelinating polyneuropathy.; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a male patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided. In or around 2015, the pt was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, frequency, lot/batch # and expiration date were not reported).  On an unknown date, reported as ""shortly after receiving zoster vaccine live (ZOSTAVAX)"", the pt suffered chronic inflammatory demyelinating polyneuropathy.  As a direct and proximate result of zoster vaccine live (ZOSTAVAX), pt symptoms had resulted in physical limitations not present prior to using it. Pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution, and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The reporter considered the event to be related to zoster Vaccine Live (ZOSTAVAX). Chronic inflammatory demyelinating polyneuropathy as disabling event, due to the pt's permanent and incurable injuries. Upon internal review, chronic inflammatory demyelinating polyneuropathy was determined to be a medically significant event.",,,,,,,,Y,N,,,,,UNK,,,,,,US0095075131909USA011489,2,10/02/2019,,,,
0837635,10/02/2019,GA,,,,F,,"Scar; Large blister; Red Injection Site; Warm Injection Site; Itchy; This case was reported by a consumer via call center representative and described the occurrence of blister in a female patient who received Flu Seasonal QIV Dresden (Influenza vaccine 2017-2018 season) for prophylaxis.   In October 2017, the patient received Influenza vaccine 2017-2018 season. In October 2017, less than a day after receiving Influenza vaccine 2017-2018 season, the patient experienced blister, injection site erythema and injection site itching. On an unknown date, the patient experienced injection site warmth and scar. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the blister, injection site erythema, injection site warmth and injection site itching were recovered/resolved and the outcome of the scar was not recovered/not resolved.   It was unknown if the reporter considered the blister, injection site erythema, injection site warmth, injection site itching and scar to be related to Influenza vaccine 2017-2018 season.  Additional details were received as follows: The age at vaccination was not reported.  The patient received flu vaccine in October of 2017. She states that within 1-2 hours she developed a large blister that led to a scar after it resolved in 2.5 weeks. she states she also developed itching (resolved in 48-72 hours after taking benadryl)and a red, warm injection site, both of which resolved within one week. The reporter consented to follow up. Consumer does not know or declined to provide any further information at this time, consents to HCP follow up. Received the injectioN. She does not know the name or manufacturer of the flu vaccine.",,,,,,,,,N,10/01/2017,10/01/2017,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,10/02/2019,,,,
0837636,10/02/2019,NC,21.0,,,F,,"rash/rash on shoulder, back and chest; This case was reported by a other health professional via call center representative and described the occurrence of rash in a 21-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) for prophylaxis.   On an unknown date, the patient received Fluarix Quadrivalent 2019-2020 season at an unknown dose. On an unknown date, couple of hours after receiving Fluarix Quadrivalent 2019-2020 season, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Fluarix Quadrivalent 2019-2020 season.  Additional details were received as follows: The patient experienced rash on shoulder, back and chest a few hours after receiving the vaccine. The reporter did not consented to follow up.  The reporter notesdshe was unable to locate the lot and expiration date since RN did not enter it on the paperwork",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/02/2019,,,,
0837637,10/02/2019,,,,,M,,"Fetal exposure during pregnancy; Preterm birth; This is an observational study case, initially received from other health professional on 18-Sep-2019, concerning a male, neonate subject, whose mother was 25-year-old, pregnant female subject of body weight 106 lbs, height 62 inches and body mass index 19.4, enrolled in, a prospective observational safety study on pregnancy outcomes in women immunized with seasonal cell culture influenza trivalent (TIVc) or quadrivalent (QIVc) vaccine during pregnancy.  The mother's medical history included urinary tract infection. Concomitant medications included Vitafol One (ascorbic acid, betacarotene, colecalciferol, cupric oxide, cyanocobalamin, folic acid, magnesium oxide, nicotinamide, omega-3 fatty acids, polysaccharide-iron complex, potassium iodide, pyridoxine hydrochloride, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide) for healthy pregnancy and Macrobid (clarithromycin) for urinary tract infection.   The subject's mother had no previous pregnancies. The mother did not use tobacco, alcohol or illicit drugs during pregnancy. Also, the subject's mother had no maternal or paternal history with major congenital malformations. The mother's last menstrual period (LMP) date was 18-Aug-2018, and the expected delivery date was 25-May-2019. The type of pregnancy was singleton.   On 06-Oct-2018, the subject's mother was administered Flucelvax QIVc [influenza vaccine, subunit influenza virus vaccine polyvalent, batch number: 252232, dose: 0.5 ml, route of administration, expiration date and anatomical location: not reported] (explicitly coded as Foetal exposure during pregnancy') for influenza immunisation.  On, at gestational age of 36.9 week, the mother delivered live birth, male neonate [explicitly coded as Premature baby'] through vaginal method. The neonate's birth weight was 2765 grams, head circumference was 31 cm and body length was 50 cm. The appearance, pulse, grimace, activity, and respiration (APGAR) scores were 9 (one minute), 9 (five minutes) and 9 (ten minutes). There was no pregnancy complication noted and no major congenital malformation identified at birth.   At the time of initial reporting, the outcome of the event Birth premature' was not reported.  This case is linked to 201902925 (corresponding mother case).  Company comment: Reportedly, a male neonate subject was delivered as premature baby after foetal exposure during pregnancy, after maternal receipt of Flu Vaccine Cell Subunit QIV NVD at gestation age of 7 weeks. Chronology is plausible. The mother's concomitant treatment with clarithromycin confounds causality. However, causal role of the suspect vaccine cannot be totally excluded and is assessed as related. Foetal exposure during pregnancy is assessed as unrelated per company's conventions.; Reporter's Comments: Reportedly, a male neonate subject was delivered as premature baby after foetal exposure during pregnancy, after maternal receipt of Flu Vaccine Cell Subunit QIV NVD at gestation age of 7 weeks. Chronology is plausible. The mother's concomitant treatment with clarithromycin confounds causality. However, causal role of the suspect vaccine cannot be totally excluded and is assessed as related. Foetal exposure during pregnancy is assessed as unrelated per company's conventions.",,,,,,,,,U,10/06/2018,05/03/2019,209,,UNK,,VITAFOL ONE; MACROBID [CLARITHROMYCIN],,Comments: None.,,USSEQIRUS201904703,2,10/02/2019,,,,
0837638,10/02/2019,,,,,M,,"Foetal exposure during pregnancy; Preterm birth; This is a serious observational study case, initially received from other health professional on 18-Sep-2019, concerning a male subject which mother was enrolled in, a prospective observational safety study on pregnancy outcomes in women immunized with seasonal cell culture influenza trivalent (TIVc) or quadrivalent (QIVc) vaccine during pregnancy.  The subject's mother had seven previous pregnancies, five previous full-term live birth, one previous preterm live birth and one previous spontaneous abortion. The subject's mother had no maternal or paternal history with major congenital malformations (MCMs). The subject's mother had no history of offspring with MCM. The subject's mother did not use tobacco, alcohol or illicit drugs during pregnancy.  The subject's mother's last menstrual period (LMP) was on 25-Jun-2018. Estimated delivery date (EDD) and corrected EDD was reported as 01-Apr-2019. The type of pregnancy was singleton. The pregnancy status of the was collected, and no MCMs were noted.   The subject's mother historical condition included bacterial vaginitis (from 07-Aug-2018 to 17-Aug-2018) and historical drug included Metrogel (metronidazole) for bacterial vaginitis. Concomitant medications included prenatal vitamins (minerals not specified (nos), vitamins nos) for pregnancy.   On 01-Aug-2018, the subject's mother underwent spinal muscular atrophy screen and cystic fibrosis mutation analysis and no MCMs were noted.   On 07-Aug-2018, 13-Aug-2018 and 27-Aug-2018, the subject's mother underwent ultrasound and no MCMs were noted.  On 15-Oct-2018, at approximately 16 weeks of gestation, the mother was administered Flucelvax QIV [influenza vaccine, subunit influenza virus vaccine polyvalent, cell cultured derived, batch number: 252664, dose: 0.5 ml, route of administration, anatomical location and expiry date: not reported] (explicitly coded as Foetal exposure during pregnancy') for influenza immunisation. On the same day, the mother underwent ultrasound and Quad Screen and no MCMs were noted.  On 12-Dec-2018, the subject's mother developed anaemia and was treated with ferrous sulfate one tablet, twice daily, orally.  On 22-Dec-2018, the subject's mother recovered from the event of anaemia.  On 14-Feb-2019, the subject's mother developed yeast and was treated with Metrogel 0.75 % gel, twice daily, vaginally.  On 09-Jan-2019, 31-Jan-2019 and 21-Feb-2019, the subject's mother underwent ultrasound and no MCMs were noted.  On 24-Feb-2019, the subject's mother recovered from the event of yeast.  On, at 36.7 gestational weeks, mother vaginally delivered a live normal male neonate. The neonate's birth weight was 2977 grams, body length was 52.1 cm and head circumference was 33 cm. The reported appearance, pulse, grimace, activity, and respiration (APGAR) scores at one minute was 9, five minutes was 9 and at 10 minutes no data was provided. There was no MCM identified at birth.  This case is linked to case number 201904704 (corresponding mother case).  Company Comment: Reportedly, the male neonate subject was delivered as premature baby after foetal exposure during pregnancy, at gestation age of 16 weeks, with the suspect product Flucelvax QIV. Chronology is plausible.  Mother's medical history of bacterial vaginitis and anaemia may have contributed to development of the event. Causality was confounded by therapy with multiple concomitant medications.  Foetal exposure during pregnancy is assessed as not related. For the event premature baby, causal role of the suspect product cannot be totally excluded and is assessed as related.; Reporter's Comments: Reportedly, the male neonate subject was delivered as premature baby after foetal exposure during pregnancy, at gestation age of 16 weeks, with the suspect product Flucelvax QIV. Chronology is plausible.  Mother's medical history of bacterial vaginitis and anaemia may have contributed to development of the event. Causality was confounded by therapy with multiple concomitant medications.  Foetal exposure during pregnancy is assessed as not related. For the event premature baby, causal role of the suspect product cannot be totally excluded and is assessed as related.",,,,,,,,,U,10/15/2018,03/09/2019,145,,PVT,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; METROGEL; FERROUS SULFATE,,Comments: None.,,USSEQIRUS201904705,2,10/01/2019,,,,
0837639,10/02/2019,FL,61.0,61,,F,,Patient described and intense burning and itching  that radiated down the whole arm. Symptoms began approximately 24 hours after injection and occurred mainly in the evening. Symptoms where treated by patient's physician with Gabapentin and resolved in about 12 days.,,,,,,,,,Y,07/19/2019,07/20/2019,1,none known,PHM,,Bupropion XL 150mg daily,none known,patient has chronic pain related to spine issues,,,2,10/02/2019,,Y,,Codein
0837640,10/02/2019,MI,71.0,71,,F,,"Patient felt minor pain the day of the vaccination. The next day, the patient noticed fever and chills and more severe pain. The patient noted muscle pain as well as neck pain. The patient also noted difficulty breathing on the day after administration, causing her to use her inhalers more frequently. The patient went in to see her primary care physician and was examined. Four days after vaccine administration, the patient still reports general malaise, but no specific side effects like described above.",,,,,,,,,N,09/27/2019,09/28/2019,1,N/A,PHM,,Allegra Aspirin Buspirone Citalopram Combivent Fluticasone nasal spray Levothyroxine Lisinopril Pravastatin Prilosec OTC Proair Qvar Tylenol Extra Strength Vitamin D3,Shingles,Anxiety Asthma COPD Depression High blood pressure High cholesterol Pain Thyroid disorder,,,2,10/02/2019,,Y,,Cephalosporins Penicillins Sulfa Zyrtec
0837642,10/02/2019,WI,52.0,52,,F,,"Possibly cellulitis, was given cephalexin by urgent care provider.   On Sept 27th, pt stated symptoms improving",,,,,,,,,Y,09/19/2019,,,None,PVT,,,,,,,2,10/02/2019,,Y,,Sulfa Drugs
0837643,10/02/2019,FL,72.0,72,,F,,Patient described a bursitis like feeling beginning the morning following vaccination. Shoulder and upper arm of the left side were stiff and achy. Symptoms were intense for a few days but became progressively milder over time. Patient stated that her partner is a physician and expressed the opinion that the vaccine administration site may have been too high on the shoulder and caused irritation to the tendon or bursa.,,,,,,,,,Y,09/23/2019,09/24/2019,1,None known,PHM,,"Famotidine 40mg twice daily, Oxybutinin XL 5mg daily and Zolpidem 5mg nightly at bedtime if needed",none known,not known,,,2,10/02/2019,,,,none known
0837644,10/02/2019,AR,68.0,68,,F,,"Patient husband called concerning his wife and her symptoms post immunization.  Last night she developed fever, chills, diarrhea, upset stomach, etc.  All side effects mentioned by husband are listed as potential side effects of shingrix.  Patient received shingrix and flu shot at visit.  Advised OTC pain reliever for fever and to follow up with physician if symptoms do not diminish.",,,,,,,,,U,10/01/2019,10/01/2019,0,,PHM,,,No,No,,,2,10/02/2019,,,,"Iodine, codeine"
0837645,10/02/2019,MO,59.0,59,,M,,"When patient woke up day after vaccine administartion, one side of his face/cheek was swollen. Patient is concerned it may have something to do with the flu shot.",,,,,,,,,U,09/30/2019,10/01/2019,1,,PHM,,"Amox-clav 500-125 mg tablets, lisinopril 10 mg, incruse ellipta 62.5 mcg inh, rosuvastatin 10mg, metoprolol tartrate 50 mg tab",,,,,2,10/02/2019,,Y,,none
0837646,10/02/2019,PA,9.0,9,,M,,"Monday 9/30/19 at 8pm arm was red and swollen, applied cool compresses. Tuesday 10/1/19 at 4pm when the child returned from school arm had increased redness, pain, and swelling.  Applied cool compresses, circled the area to check for increasing redness and swelling, and gave benadryl.  Wednesday 10/3/19 the redness had spread outside the line, brought  to walk-in clinic  and was diagnosed with a reaction to the flu vaccine",,,,,,,,,N,09/30/2019,09/30/2019,0,none,PVT,,none,none,none,,,2,10/02/2019,,Y,,none
0837647,10/02/2019,NE,44.0,44,,M,,After about 1 hour noted mild numbness of face. Started on right. Transitioned to entire face. Lasted about 20 hours leaving a mild stiffness in the cheek/facial area. Right arm injection site is sore.,,,,,,,,,U,10/01/2019,10/01/2019,0,,WRK,,Airborne Vitamin,Cold,None,,,2,10/02/2019,,,,None
0837648,10/02/2019,IN,17.0,17,,M,,"PT WAS ANXIOUS AT TIME OF ENTERING FACILITY, COMPLAINS OF FEAR OF NEEDLES.  WAS CLAMMY INITIALLY AFTER INJECTION.  HAD PT LIE DOWN WITH FEET UP AND  GAVE HIM A  SUCKER. COOL WET COMPRESS TO FOREHEAD. AFTER QUESTIONING PT STATES NO BREAKFAST JUST A SMALL COOKIE. PT FEELING BETTER REPEATEDLY STATES I'M OK. OFFERED WATER, PT DECLINED.  AFTER APPROX 10 MINUTES ALLOWED PT TO LEAVE WITH PARENT STATING ALSO, SHE FELT OK LEAVING WITH HIM.  AFTER GETTING OUTSIDE ANOTHER PERSON CAME INTO CLINIC STATING PT WAS OUTSIDE HAVING A ""SEIZURE"". ANOTHER STAFF MEMBER CALLING 911. FOUND PT ON GROUND WITH JERKING MOVEMENTS TO EXTREMITIES, EYES ROLLED BACK, BITING LIP. AFTER COUPLE MINUTES ( APPROX) PT CAME AROUND IN VIOLENT MANNER. PT STATES HE COULD NOT OPEN HIS EYES, DID NOT HEAR WHAT WAS GOING ON AROUND HIM. STATES HE ""COULD FEEL HIS HEART"" AND ALL  HIS MEMORIES WERE FLASHING. NO APPARENT INJURIES NOTED, NO LOSS OF B&B AMBULANCE ARRIVED AND TRANSFERRED PT TO LOCAL HOSPITAL. PT REFUSED IV IN AMBULANCE. UPON ARRIVAL AT HOSPITAL PT REFUSED TO HAVE GLUCOSE FINGER STICK. LABS DONE AND WNL GLUCOSE NOTED TO BE 98. CT OF HEAD PERFORMED AND WAS NEGATIVE FOR ACUTE ABNORMALITIES. EKG DONE IN SINUS BRADYCARDIA.",,,,,,,,,Y,09/30/2019,09/30/2019,0,SEE ABOVE,PUB,,UNKNOWN,NONE,NONE,,,2,10/02/2019,,,Y,NKA
0837649,10/02/2019,TX,60.0,60,,F,,"Per pt., started to experience extreme itchiness and tachycardia around 8 PM. No other changes to diet or routine besides Influenza vaccine and TB test administered a couple of hours earlier. Pt. had to take a Benadryl around 8:15 PM d/t uncomfortable feeling of itchiness. Pt. called employee health nurse to report reaction on 10/2 @ 9:50 AM. Informed pt. that employee health nurse would be making a VAERS report in which she verbalized understanding. Pt. states that she does have seasonal allergies, and does take Zyrtec for tx. Pt. continues to report some itchiness this morning, but somewhat better than last night. No c/o of SOB, throat closure, etc. Informed pt. to consult PCP in regards to reaction to Influenza vaccine, and to go to ER if she starts experiencing s/s of anaphylaxis reaction in which she verbalized understanding. At this time, pt. states that she feels like she does not need to see her PCP unless s/s worsen, and will inform PCP about Influenza vaccine on scheduled appt. on 10/13.",,,,,,,,,,10/01/2019,10/01/2019,0,,WRK,,,,,,,2,10/02/2019,,,,
0837650,10/02/2019,FL,82.0,82,,M,,pt states that he woke up the next morning with bruising between ring and pinkie finger on palm of right hand. Hand did have bruising about 1 inch in diameter on the palm between 4th and 5th fingers,,,,,,,,,U,09/26/2019,09/27/2019,1,none,PHM,,do not know,none,unkown,,,2,10/02/2019,,,,nka
0837651,10/02/2019,MA,64.0,64,,M,,"I want to report that I had a serious adverse event produced by the Shingrix vaccine. I have never had an allergic response to a vaccine. After the injection on Monday August 26th, I felt little discompfort at the site of injection but dry cough appeared after 3-days. The symptoms continued with rhinitis, sinusitis, headacke, blocked ear drums, chills, cold sweat that made me go to the Emergency room.  X rays were clean but CRP level  was 105 mg/L. Monocytes were 10.5% with 1.08*10^9. All other cell types and levels were within normal range. They treated me with paracetamol IV and polaramine im. I stayed for over 3hrs and they let me go with bilastine 20 mg qd. When returned home visited the Drs. office and was treated with amoxicillin and Flonase .  I also visited an ENT due to the ear blockade.  She told me it will take sometime to clear up (ears were ok but my hearing was decreased).Today, October 2nd, I am still with ear drum blockade but no headache or pain. FYI I had chicken pox when I was a child and was vaccinated with Zostavax approximately 3 years ago.",,,,,,,,,N,08/26/2019,09/01/2019,6,Medical tests doe in ER Chest X-rays--normal Blood test all normal except monocytes  that were 10.5% with 1.08*10^9 L CRP level  was 105 mg/L.,PUB,,"Loasartan, Synthroid,lipitor",None,N/A,,,2,10/02/2019,,Y,Y,None
0837652,10/02/2019,PA,68.0,68,,F,,"The day after the injection - 10/2/19, i developed severe fatigue and body aches from head to toe.  Approximately 24 hours after vaccination, I developed (2) areas approximately 3 inches by 2 inches, that were firm red and warm, 3 inches below the injection in the left arm and a similar area on the right shoulder. I took Benadryl 10/2/19.  By the next morning 10/3/19, the aches have subsided and the area on the opposite shoulder has started to subside but the area beneath the injection site is still firm, warm and red.  I took Loratidine this morning.  No other treatment sought.  My Doctor was notified.",,,,,,,,,U,09/30/2019,10/01/2019,1,None,PHM,,"Lyrica, Synthroid, Hydrochlorothiazide, Atorvastatin, Low-dose Aspirin, Vit B-12, COQ-10, Estring, Vitamin D-3, Plexus Supplements - Slim, Pro Bio 5, Bio Cleanse, Accelerator, Block, Balance, Ease.",None,"Fibromyalgia, Asthma, Hypertension, Gerd, Hypothyroidism","02/12/2018, Shingrix, GlaxoSmithKline, Lot # P2275.  Developed a 3x2 inch hot, red and firm area below the injection site which ",,2,10/02/2019,,,,"Penicillin, Tree Nuts, Tape"
0837653,10/02/2019,KY,71.0,71,,M,,"Patient called the office the day after immunizations stating his right arm was very painful and he was unable to lift his arm up because of the pain. He denies any redness, rash, or swelling.",,,,,,,,,U,09/30/2019,10/01/2019,1,N/A,PVT,,"Zyrtec, Trazodone, Vitamin B Complex",None,"Secondary hypertension, Primary osteoarthritis involving multiple joints, Alcohol use disorder, Mixed conductive and sensorineural hearing loss of both ears, Tobacco use disorder",,,2,10/02/2019,,,,"Levofloxacin, Ace Inhibitors, NSAIDS"
0837654,10/02/2019,MA,15.0,15,,M,,I don't know which flu vaccine it was.,,,,,,,,,Y,09/27/2019,09/28/2019,1,,PVT,,N/A,None,Asthma,,,2,10/02/2019,,,,Shellfish
0837655,10/02/2019,MA,33.0,33,,F,,Patient got a shot in right arm.  She said the immunizer was standing over her while she was sitting. Her arm hurt after shot. She thought after two weeks of pain that the pain should have gone away by now. She emailed her MD. Dr told her to put on warm compresses on the site and take motrin.  Any heat/signs of infection/fever/swelling/redness to get evaluated. She came in today still in pain. She is going to make an appointment with her MD.,,,,,,,,,N,09/04/2019,09/04/2019,0,,PVT,,Nikki birth control and sertraline 50mg,no illnesses,acid reflux,,,2,10/02/2019,,Y,,no known allergies
0837656,10/02/2019,CO,11.0,11,,M,,"After administering the last injection, the patient lost consciousness and fell onto the floor from the chair he was sitting on, hitting his head on the floor. The patient was turned over onto his mother's lap, started regaining consciousness and and ammonia inhalant was used. The patient's mental status and pupil dilation were assessed, alert and oriented and pupils were small, round and reactive. Patient remained laying on floor for approximately 15 minutes, emergency response services activated. Patient denied visual changes, tingling of upper and lower extremities. After paramedics arrived they continued to assess patient and it was determined it was safe for his mother to take him home and continue to evaluate. Signs and symptoms of concussion and additional warning signs were reviewed with mother. She was instructed her to follow up in Emergency Room or dial 911 for any warning signs.",,,,,,,,,Y,10/01/2019,10/01/2019,0,none,PUB,,none reported,none reported,none reported,,,2,10/02/2019,,,,none reported
0837657,10/02/2019,MN,69.0,69,,F,,"Evening after immunization patient experience pain starting at injection site, going up arm, along shoulder and neck to base of skull.  Pain was very severe.  She used ibuprofen , I suggested she also  use ice, and contact her provider as well.   she was going to call her provider immediately after our conversation.",,,,,,,,,N,09/30/2019,09/30/2019,0,,PHM,,,,,,,2,10/02/2019,,,,
0837658,10/02/2019,CA,71.0,71,,F,,Patient received second series of Shingrix and complains of pain and not being able to lift arm up.,,,,,,,,,U,10/01/2019,10/02/2019,1,,PHM,,,,,,,2,10/02/2019,,Y,,
0837659,10/02/2019,,27.0,27,,M,,"Generalized Vaccinia, lesions on abdomen, back, bilateral arms, face, neck and head appeared 10 days after vaccination, also swollen left axilla lymph nodes, no pruritus. No history of skin conditions. Had chills and feeling sick a couple days after vaccination but has resolved. No treatment, usually self limiting. Placed on 72 hr quarters and provided infection control precautions. Patient to follow up if signs of infection.",,,,,,,,,,09/20/2019,09/30/2019,10,,MIL,,None,None,None,,,2,10/02/2019,,Y,,None
0837660,10/02/2019,CA,65.0,65,,F,,"The name of the vaccine was Trivalent High-Dose 2:00 (ish) - flu shot Ate a light lunch (1/2 sandwich) around 3:00 Had 1/2 beer and some almonds around 5:15 5:45 - stabbing pain in upper abdomen, nausea (no vomiting) 6:15 (ish) - pain seemingly moving from injection site to right side of body, exhausted, had to lie down. Chills, low fever (99.5). Couldn't move to get more blankets. Heart starts racing (could have been a panic attack), took 1/4 mg of xanax . Mild  delirium. For the next 8 hours, imagined the pain as a video game board that I was 'clearing' - the pain in the area would lessen each time I 'cleared' it.  2:30 AM - finally able to fall asleep, fever at 100.5 5:00 AM - fever breaks, able to get up for water 6:00 - 11:00 AM  - sleep, listless and fatigued the rest of the day",,,,,,,,,Y,09/26/2019,09/26/2019,0,,PVT,,"Xanax (generic) .25 mg as needed Tylenol, 500 mg as needed Diclofenac Sodium Topical Gel, 1 % as needed Tums antacid, as needed",None,Cervical spinal stenosis Panic disorder Anxiety disorder 3.6 mm widening of ascending aorta,"About 15 years ago, I got a flu shot and had mild flu-like symptoms for two weeks",,2,10/02/2019,,,,"Morphine Codeine Bad reaction, drops blood pressure"
0837662,10/02/2019,WI,41.0,41,,F,,"Staff member spoke with Infection Prevention on 10/2/2019 at 1105 am to report that she developed a rash on her chest and that she had an itching sensation on her face starting around 5 pm on 10/1/2019 after receiving the flu vaccine.  No respiratory concerns reported, no medications taken for rash per report.  Advised to contact her health care provider to document the event and to seek medical care if condition worsens.",,,,,,,,,,10/01/2019,10/01/2019,0,,WRK,,"ymbalta, Gabapentin, Vitamin D, Vitamin B Complex, Omeprazole, singular, advair, nasonex",Chronic sinus issues,"chronic sinus issues, asthma, colon removed",,,2,10/02/2019,,,,"Sulfa, Flagyl"
0837663,10/02/2019,TN,1.25,1,.3,M,,redness to site 3 days later after vaccine,,,,,,,,,N,09/19/2019,09/29/2019,10,,PVT,,None,Hand foot mouth,None,,,2,10/02/2019,,Y,,None
0837664,10/02/2019,TN,53.0,53,,F,,"Muscle aches started first on 9/30 pm then on 10/1 pm fever started, 10/1 6 pm chills (had to use 3 blankets and gloves to get relief).  Fever 100.3.  Fever at 100.0 at 1 a.m. 10/2 and fever broke before 5 a.m.  Started taking 2 acetaminophen tablets every 4 hours 10/1 - 10/2.  Today is 10/2 and just feel tired and nauseous. Had flu shot at same time but different arm.  Was unsure which flu vaccine to list above so just chose 1st one.",,,,,,,,,N,09/30/2019,09/30/2019,0,none,WRK,,"Humalog, Tresiba, ASA, Atenolol, Vit D, Women's multivitamin, Ranitidine",None,Type 1 diabetes HTN,,,2,10/02/2019,,,,sulfa
0837667,10/02/2019,PA,52.0,52,,M,,"a patient showed negative titers on 06/28/2019 for measles, mumps, and rubella after receiving a dose ofMMR II on 03/18/2014, and then a second dose of MMR II on 06/27/2016; a patient showed negative titers on 06/28/2019 for measles, mumps, and rubella after receiving a dose of MMR II on 03/18/2014, and then a second dose of MMR II on 06/27/2016; a patient showed negative titers on 06/28/2019 for measles, mumps, and rubella after receiving a dose of MMR II on 03/18/2014, and then a second dose of MMR II on 06/27/2016; Route of Administration: ""IM injection""; This spontaneous report was received from a nurse and refers to a 52-year-old male patient. No information regarding the patient's concomitant medications was provided. He had no pertinent medical history or drug reactions and allergies.  On 18-MAR-2014, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin (rHA) (M-M-R II) intramuscularly, lot # J006136 and expiration date: 24-APR-2015 (dose and frequency were not reported) for prophylaxis. On 27-JUN-2016, the patient was vaccinated with the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin (rHA) (M-M-R II) intramuscularly, lot # L001336 and expiration date: 13-JAN-2017 (dose and frequency were not reported) for prophylaxis. On 28-JUN-2019, the patient showed negative titers for measles, mumps, and rubella in antibody IgG tests. The patient sought medical attention and had unspecified ""regular check-up"", but did not receive any treatment for the events. The outcome of the events was reported as recovered on an unknown date in 2019. The causality assessment was not provided.",,,,,,,,,Y,03/18/2014,03/18/2014,0,Test Date: 20190628; Test Name: measles antibody IgG blood test; Test Result: Negative  ; Test Date: 20190628; Test Name: mumps antibody IgG; Test Result: Negative  ; Test Date: 20190628; Test Name: rubella antibody IgG; Test Result: Negative,UNK,,,,,,US0095075131909USA014296,2,10/02/2019,,,,
0837668,10/02/2019,TX,,,,F,,"left sided burning sensation, blisters, and persistent sharp pain which was diagnosed as shingles; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a female patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided.   In or around 08-SEP-2017, the pt was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, frequency, lot/batch # and expiration date were not reported).   In October 2017 (reported as ""one month after receiving zoster vaccine live (ZOSTAVAX))"", the pt suffered a left sided burning sensation, blisters, and persistent sharp pain which was diagnosed as shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), pt symptoms had resulted in physical limitations not present prior to using it. Pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution, and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.  The reporter considered the event to be related to zoster Vaccine Live (ZOSTAVAX). Shingles was considered to be a disabling event, due to the pt's permanent and incurable injuries.",,,,,,,,Y,N,09/08/2017,10/01/2017,23,,UNK,,,,,,US0095075131910USA001651,2,10/02/2019,,,,
0837669,10/02/2019,FL,71.0,71,,F,,"Headache, chills with fever 101F X 24hrs, whole body aches, fatigue",,,,,,,,,Y,09/30/2019,09/30/2019,0,N/A,PHM,,"naproxene EC, Centrum Womens 55+, Calcium w D, Vit C, Vit E, ASA 81mg",None,None,,,2,10/02/2019,,,,"PCN, IVP Dye, Oxycodone, milk, chocolate, cola, seasonal allergies"
0837670,10/02/2019,FL,76.0,76,,F,,Hives and lymph nodes swelling,,,,,,,,,Y,09/05/2018,09/07/2018,2,,PHM,,UNKNOWN,N/A,UNKNOWN,,,2,10/02/2019,,Y,,PEN/CEPH
0837671,10/02/2019,IN,29.0,29,,F,,"At 10:45 pm on Oct. 1, 2019 I had severe chills and generalized skin sensitivity accompanied by 101 degree F temperature. At 4:45 am Oct. 2, 2019 I woke up with 102.47 degree F with a severe headache, extreme weakness, and generalized body aches.",,,,,,,,,N,10/01/2019,10/01/2019,0,,PHM,,Generic Zyrtec and generic Flonase. Prenatal vitamins.,None,None,,,2,10/02/2019,,,,Allergic reaction to Amoxicillin as a child-rash
0837672,10/02/2019,GA,60.0,60,,F,,"Nausea, diaphoretic, lethargy,  sweating  Treatment. Ginger ale, fluids, rest.",,,,,,,,,U,10/02/2019,10/02/2019,0,Temp check,WRK,,Losartan,None,High Blood Pressure,"Nausea, sweating, vomiting lethargy",,2,10/02/2019,,,,None
0837673,10/02/2019,MN,45.0,45,,F,,"Redness, pain, swelling left shoulder with limited range of motion.  Fever, chills, fatigue.  All symptoms commencing within 12 hours of immunizations. Also note this patient was given pneumococcal vaccine (PPSV23 Given 0.5 mL 04/24/2015 IM LD Merck & Co. Inc S004548 ) in the same arm on the same date.  Uncertain which vaccine is the culprit. Will commence cefadroxil for cellulitis",,,,,,,,,N,09/30/2019,09/30/2019,0,None,PVT,,"methotrexate, prednisone, folic acid, omeprazole, sonata",,sarcoidosis,,,2,10/02/2019,,Y,,none
0837674,10/02/2019,MS,65.0,65,,F,,"Started as a small rash on the arm opposite from injection site on 9/30/19, then progressed to widespread hives on stomach and back and some on arms and legs,  Also developed swollen lips on 10/2/19. No treatment received on 9/30/19 except Benadryl. On 10/2/19 received cortisone injection and oral dose pack and continuing Benadryl.",,,,,,,,,N,09/27/2019,09/30/2019,3,Physical exam only,PHM,,"atorvastatin 10 mg, esomeprazole 20 mg, raloxifene 60 mg, meloxicam 7.5 mg, calcium + vitamin d",no,no,,,2,10/02/2019,,Y,,no known allergies
0837675,10/02/2019,,55.0,55,,F,,Patient states she went to her hair dresser and the hair dresser noted visicles on forehead and in hair line.  Patient states she had itching on abdomen and on head.  She continues to have itching but it is decreasing.  She has done nothing to treat this up until this point.  States she will treat with Benadryl once she is at home.,,,,,,,,,,09/29/2019,09/30/2019,1,,UNK,,,,,,,2,10/02/2019,,,,
0837676,10/02/2019,VA,75.0,75,,F,,swollen arm to elbow and hot to the touch. more inflammation and swelling located below injection site.,,,,,,,,,,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/02/2019,,Y,,
0837677,10/02/2019,DE,39.0,39,,M,,Patient received vaccine and 48 hours later developed right sided dystonic reaction with significant muscle contractions which have now been going on and worsening.,,,,,,,,,N,09/05/2019,09/07/2019,2,None,MIL,,None,None,Cervicalgia,,,2,10/02/2019,,Y,Y,None
0837678,10/02/2019,TX,27.0,27,,F,10/02/2019,redness and swelling near injection site,,,,,,,,,U,10/01/2019,10/02/2019,1,,PUB,UNK,"Levothyroxine, Claritin",None,hyperthyroid (2006),,,1,,,,,
0837679,10/02/2019,IL,,1,.9,M,10/02/2019,"Patient at a birthday party, started to feel warm, as family began to leave, arms began shaking. Patient's muscles were clenched & he was shaking, but not not overly tense, jaw clenching & blood vessels in face were bulging. EMS arrived, seizure stopped. Temp 103.3. Patient eyes began to roll back & put in ambulance. Given Tylenol while in ED. Patient had a brief 10-15 second episode where he was unfocused & muscles clenching. Patient admitted & EEG done.",,,,Y,Y,1,,,Y,09/24/2019,09/29/2019,5,Flu panel - negative  EEG - normal  C-Reactive - 0.29,PVT,PVT,N/A,none,N/A,shakiness~Influenza (Seasonal) (no brand name)~~0.00~Patient,,1,,,,,
0837682,10/02/2019,TX,,,,F,,"a Nurse cut her on finger on the broken finger flange of a syringe while preparing to administer 1 dose of PNEUMOVAX 23; a Nurse cut her on finger on the broken finger flange of a syringe while preparing to administer 1 dose of PNEUMOVAX 23; a Nurse cut her on finger on the broken finger flange of a syringe while preparing to administer 1 dose of PNEUMOVAX 23; This spontaneous report was received from a business support coordinator and refers to a female nurse of unknown age. No information regarding her pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On 09-SEP-2019, the nurse was preparing a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), 0.5 ml (lot # S002582, expiration date 10-AUG-2020) to administer it to the patient. While preparing the dose, she cut her finger on the broken finger flange of a syringe. It was ""tiny cut"". She had it bandaged. It was reported that the syringe broke before it came in contact with the patient. It was reported that on 16-SEP-2019, the hospital pharmacy received 2 other syringes that were broken at the finger flange (lot # S012244, expiration date 09-FEB-2021). One had a broken piece with a sharp edge and the other two syringe finger flange were broken into several pieces (product quality complaint only). The outcome of product quality issue was unknown. The outcome of product package associated injury was reported as recovered on an unknown date in 2019. The causality assessment was not provided.",,,,,,,,,Y,,09/09/2019,,,UNK,,,,,,US0095075131909USA007273,2,10/02/2019,,,,
0837683,10/02/2019,TN,,,,U,,"No adverse effects reported; a patient was given an expired dose of VARIVAX; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was not provided.  On 30-SEP-2019, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) (expired product administered) 1 injection, subcutaneously, lot  # N024566 with expiration date 07-SEP-2019, for prophylaxis. No adverse effects reported.",,,,,,,,,U,09/30/2019,09/30/2019,0,,UNK,,,,,,US0095075131910USA001538,2,10/02/2019,,,,
0837684,10/02/2019,VA,15.0,15,,F,,Pt. fainted after receiving flu vaccine. Pt. also urinated when she fainted. Mother said she is prone to fainting but never this bad. Pt. was about to fall off of chair but her mother and I caught her and reposition back in the chair. pt. didn't respond to smelling salt and 911 was called. pt. came to as the paramedics arrived. she was very agitated and upset. The paramedics took her vitals and tried to calm her down and then put her on a stretcher. They took her to hospital ER.,,,,,,,,,Y,09/29/2019,09/29/2019,0,N/A,PHM,,N/A,N/A,N/A,,,2,10/01/2019,,,Y,N/A
0837685,10/02/2019,NY,88.0,88,,M,,"Patient received the Shingrix vaccine outside of our office.  88 yo male here with pain behind his left ear that has been present for the past 8-10 days. Described as a throbbing pain with radiation down the neck. Pain with turning the pain to the right. When he turns his head quickly he hears a ringing ""ting"" sound in left ear. No headache or dizziness. No trouble with swallowing. No globus. No fever or chills.  No new medications and no recent travel. No tobacco abuse.  Had some pains behind his left ear. Went away with tylenol. Slowly improving. Now feels an occasional pulsation, from behind the ear to an area over the clavicle. This has gone on for about 2 weeks.  Had shingles shot 16th sept., just before sx's began. Likely an attenuated course due to previous administration of the old shingles vaccine.  He did receive his first dose of the shingrex a week before the current sx's began, but I am not aware of any reports of shingrex causing shingles.  His sx's already fading, and the 3 lesions are healing with no new ones appearing, so no treatment indicated at this time.",,,,,,,,,N,09/16/2019,09/18/2019,2,"CBC And Differential  Status:  Final result Visible to patient:  No (Not Released) Next appt:  12/02/2019 at 08:50 AM Dx:  Pain of left mastoid   Ref Range & Units 6d ago 2mo ago WBC 4.0 - 10.8 10 3/uL 10.4  10.1High  R RBC 4.20 - 5.90 10 6/uL 4.76  4.7 R HGB 13.0 - 17.5 g/dL 14.9  14.5 R HCT 40.0 - 52.0 % 44.4  45 R MCV 81.0 - 99.0 FL 93.3  96High  R MCH 26.0 - 34.0 PG 31.3  31 R MCHC 32.0 - 36.0 g/dL 33.6  33 R PLATELET COUNT 140 - 400 10 3/uL 314  284 R NEUTROPHILS 40.0 - 75.0 % 47.3   LYMPHOCYTES 17.0 - 44.0 % 40.5   MONOCYTES 4.0 - 12.0 % 10.4   EOSINOPHILS 0.0 - 7.0 % 1.3   BASOPHILS 0.0 - 1.8 % 0.5   NEUTROPHIL # 1.5 - 7.7 10 3/uL 4.9  5.4 R, CM LYMPHOCYTE # 0.9 - 3.8 10 3/uL 4.2High    MONOCYTE # 0.2 - 1.0 10 3/uL 1.1High    EOSINOPHIL # 0.0 - 0.5 10 3/uL 0.1   BASOPHIL # 0.0 - 0.2 10 3/uL 0.1   RDW 11.5 - 15.0 % 11.9  13.3 R DIFFERENTIAL  AUTOMATED",PVT,,? CYANOCOBALAMIN/FOLIC ACID (VITAMIN B12-FOLIC ACID) 500-400 mcg Oral Tab Take  by mouth.   ? fluorouracil 5 % Top cream    ? hydrocortisone 0.2 % Top cream    ? pravastatin 40 MG Oral tablet Take 1 tablet by mouth daily. 90 tablet 3 ? psyl,None,"Patient Active Problem List Diagnosis ? Actinic keratosis ? Chronic midline low back pain without sciatica ? Benign hypertension ? Reduced libido ? Pure hypercholesterolemia ? Benign neoplasm of large intestine ? Impaired fasting glucose ? Malignant melanoma (HCC) ? Lymphoma (HCC) ? Routine general medical examination at a health care facility ? Benign non-nodular prostatic hyperplasia with lower urinary tract symptoms ? Tremor ? Degenerative arthritis of thumb, right ? Melanoma of scalp (HCC) ? Early dry stage nonexudative age-related macular degeneration of both eyes ? Primary osteoarthritis of both knees ? Herpes zoster without complication ? Vaccine reaction, sequela",,,2,10/02/2019,,Y,,No known allergies.
0837686,10/02/2019,OH,51.0,51,,F,,"Flu like symptoms, weakness",,,,,,,,,N,10/01/2019,10/02/2019,1,,PHM,,Spironolactone and vitamins,None,None,,,2,10/02/2019,,,,None
0837687,10/02/2019,TX,51.0,51,,F,,Patient stated that she started a high fever on Saturday night (9/28) that continued through Tuesday(10/2). She also stated injection site pain that was hot to the touch. She stated to have a red area that was approximately 7 inches by 4inches. She stated that her kidneys were hurting. She went to her doctor today(10/2) and they started her on antibiotics.,,,,,,,,,N,09/28/2019,09/28/2019,0,She went for doctor appointment today (10/2) and they started her on antibiotics.,PHM,,none provided,none,chronic sinusitis,,,2,10/02/2019,,Y,,Erythromycin
0837688,10/02/2019,CA,23.0,23,,M,,"Client reports that after the last Typhoid (Vivotif) tablet and after an extraordinarily long exhausting day at work he felt exhausted the next day evolving into a migraine headache and feeling like his eyes felt swollen, abdominal cramping with abdominal pain with nausea. 2 hours later he reports chills with a low grade fever which broke overnight. He denies diarrhea or vomiting but admits to dysphagia lasting the weekend d/t on going nausea. He reports Monday he continued to feel achy but admits the episode has now resolved without seeking medical attention.",,,,,,,,,Y,09/19/2019,09/29/2019,10,Client denies seeking medical attention,OTH,,Denies all prescriptions,Reports infrequent skin irritations but denies active illness at the time of the vaccinations,Denies all chronic illnesses,,,2,10/02/2019,,,,Denies all allergies
0837689,10/02/2019,IL,70.0,70,,F,,Given the first shingrix vaccine. at store.    Three days later started getting tingling (nerve ending) in the back of head.,,,,,,,,,N,09/23/2019,09/23/2019,0,,PHM,,"Simbacort      potassium   HCTZ  Calcium  Vit C, fish oil   , singulair,  asa,  zinc Amlodipine Synthroid      flu shot two weeks before Preservision",,"asthma, thyroid   mac  degeneration",,,2,10/02/2019,,Y,,Rouvsastatin   (quit due to muscle problems) two weeks prior
0837690,10/02/2019,NY,34.0,34,,M,,"Multiple Hives, Bilateral from chest to waist Treatment OTC Benadryl. Prednisone .  If systems worsen go to ER.",,,,,,,,,U,10/01/2019,10/01/2019,0,non,MIL,,OTC Tylenal,Felt with flu like symtoms,non,Had similar symptoms to last years flu shot.,,2,10/02/2019,,Y,,non
0837691,10/02/2019,VA,49.0,49,,F,,"SX started 15 minutes after flu shot, SOB, wheezing and stridor. Sensation of throat closing, swelling, and SOB with associated wheezing and stridor",,,,,Y,1,,,U,09/19/2019,09/19/2019,0,"admitted to hospital, ICU",PVT,,,,,,,2,10/02/2019,,,,"allergic to mushrooms (lead to intubation 10 years prior) , coconut oil"
0837692,10/02/2019,MI,83.0,83,,M,,"Patient has very large red patch of skin extending from inner upper arm near armpit, traveling down to elbow. The red area of skin is very slight raised, seems almost flaky, and is mildly itchy. The redness is a bright pink, solid area, with well defined margins. The redness started on Tuesday, 1 day after vaccination, and was across the vaccination area. The redness has since moved down and under the arm.",,,,,,,,,U,09/30/2019,10/01/2019,1,,PHM,,Xarelto,,,,,2,10/02/2019,,Y,,None known
0837693,10/02/2019,TN,64.0,64,,F,,started with a red rash on and around injection site about 12 hours after injection.  Over the next two days she developed clear fluid filled pustules over her trunk and arms.  Patient reports that they resemble chicken pox.,,,,,,,,,U,09/26/2019,09/27/2019,1,,PHM,,,,,,,2,10/02/2019,,Y,,
0837695,10/02/2019,FL,76.0,76,,F,,"Patient experienced pain, fatigue, and asthenia",,,,,,,,,U,09/27/2019,09/30/2019,3,,PHM,,,,,,,2,10/02/2019,,,,
0837696,10/02/2019,NJ,63.0,63,,F,,"Left arm stiffness and soreness which was reported on 9/5/19. No fever, swelling or redness. Symptoms resolved as of 10/1/19.",,,,,,,,,Y,08/28/2019,09/05/2019,8,,PVT,,Alprazolam Celecoxib,,,,,2,10/02/2019,,Y,,Levaquin Levofloxacin
0837697,10/02/2019,NC,11.0,11,,M,,"Large hive grew over injection sight left deltoid had to be picked up at school and taken to Doctors Treated with strong antihistamine Mother has family history of vaccine reaction but in compliance with the law pediatrition agreed to separate and to space patient's shots and monitored him because patient recently had a DTP reaction school was informed by mother to watch for adverse reaction day after shot red mark at injection sight was size of 50 cent piece Nurse outlined called mom I would like confirmation you received this paper work on adverse reactions that my son had for (Tdap) (Menigalcocal) ""some kind of documentation"" for future",,,,,,,,,,01/07/2019,01/07/2019,0,,UNK,,"Cytrazine, citrazyne, epipen",Family history of 11 beta hydroxy defficiency/ Aunts & Mother,"Autism, ocular albinism, supermamorie (extra nipple)",,,2,01/16/2019,,,,"Fish, chocolate, dairy, spores, pollen, dust"
0837698,10/02/2019,TX,61.0,,,F,,"I had my 2nd Shingrix 50mcg Injection on 9/26/19. On 9/27 I was extremely tired and weak. Slept through most of the day, unable to even eat. On 9/28 I was still exhausted and now covered in a rash from my neck down to my waist and down both arms. I took Benadryl for this. Only able to eat a waffle, still no appetite. On 9/29 still covered with rash and now had diarrhea. Today, 9/30 diarrhea is mild. Still tired I went to my doctor today just to have her check me out.",,,,,,,,,,09/26/2019,09/27/2019,1,,UNK,,"Restasis, Calcium, fish oil, Biotin, vitamin D, multi vitamin",None,Fibromyalgia,,,2,09/30/2019,,,,Bactrim
0837704,10/02/2019,WV,80.0,80,,M,09/24/2019,"Gave flu shot, waited 5 minutes, gave pneumonia shot, 5-10 minutes after second shot, patient became flushed and complained of lower back and upper leg pain. Called 911, arrive in 10 minutes. Patient taken to E.R. but was non-symptomatic as he entered ambulance",,,,Y,,,,,Y,09/24/2019,09/24/2019,0,"E.R. visit, vitals & visual exam",OTH,PVT,ELIQUIS VIAGRA BYSTOLIC NORVASC,NO,"Kidney disease, hypertension",,,1,,,,,
0837706,10/02/2019,,,,,F,,"Chest cold; Vicious cough; Couldn't sleep nights; Ribs so sore couldn't hardly stand to move; Flu; Ribs so sore; This is a spontaneous report contactable consumer reporting for herself from a Pfizer Sponsored Program Prevnar Adult.   A female patient of an unspecified age (age 65, units unknown) received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration at single dose on an unspecified date 2 or 3 yrs befor this report for immunisation.   Medical history included influenza when a few times in the past she had the flu shot and every time got the worse case of flu. The patient's concomitant medications were not reported.   On an unspecified date after vaccination the patient experienced chest cold with, vicious cough, couldn't sleep nights, ribs so sore couldn't hardly stand to move, flu, ribs so sore. The outcome of all events was unknown. Course of events: She was never sick over winter, except when a few times in the past she had the flu shot and every time she got the worse case of flu. After PREVNAR 13 shot that winter she had awful chest cold with vicious cough that took several months to get rid of. She couldn't sleep nights from coughing, ribs were so sore and couldn't hardly stand to move. Then next winter she had a minor case again and this past winter nothing, no colds, flu, finally got all that shot out of her system with massive amount of immune building supplements.  Information on the lot/batch number has been requested.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Flu (when a few times in the past I had the flu shot & everytime got the worse case of flu),,USPFIZER INC2019421743,2,10/02/2019,,,,
0837707,10/02/2019,VA,17.0,17,,F,,"Swollen lymph nodes in neck, sore throat, Elevated WBC",,,,,,,,,N,09/30/2019,10/01/2019,1,WBC 11.4 without left shift  strep negative,PVT,,Sprintec (28) 0.25mg - 35mcg tablet,None,None,,,2,10/02/2019,,Y,,NKA
0837708,10/02/2019,IN,72.0,72,,F,,Patient reported an extra sore arm with redness and stiffness at the injection site.,,,,,,,,,U,10/01/2019,10/02/2019,1,N/A,PHM,,"Unknown, patient has not filled any prescription besides a flu shot with pharmacy in past 2 years.",None listed by patient on vaccination form,None listed by patient on vaccination form,,,2,10/02/2019,,,,Sulfa allergy
0837709,10/02/2019,CT,72.0,72,,F,,She experienced lightheadedness/dizziness 24 hours after the injection,,,,,,,,,U,09/30/2019,10/01/2019,1,,PHM,,synthroid,no other illness,None reported,,,2,10/02/2019,,Y,,no known allergies
0837710,10/02/2019,NY,60.0,60,,F,,"Patient called on 10/2/19 to let us know that since her vaccination, her blood pressure has been uncontrolled. Patient stated that the event began the night of the immunization.  She has been to her physician as well as looked into on her own and is aware that this possible adverse response is not common or listed as possible reaction. Her Physician does not know why this could be a result of the immunization.  Patient started to contact the VAERS  phone line but hung up d/t the questions.  We as healthcare providers are providing the information provided to us by the customer  to VAERS as we feel it is our obligation to the customer and to the healthcare system. Ptx di state she received an influenza and pneumonia immunization in past 4 weeks but which of each is unknown to us.",,,,,,,,,U,09/16/2019,09/17/2019,1,unknown,PHM,,n/a      not current customer  does not live locally,"asthma per screening checklist ,  hypertension per conversation with patient",Asthma per screening,,,2,10/02/2019,,Y,,nka
0837711,10/02/2019,PA,1.0,0,1,M,,Patient has had a lump at the injection site since the injection. It has not gotten smaller in the past 18 months. It is very itchy and has caused disturbance of sleep. It is so itchy that the first summer after patient could not wear shorts. The skin is now showing signs of the constant irritation from the scratching and grabbing at the lump.  Often it has a small scab.,,,,,,,,,N,03/10/2018,03/10/2018,0,I do not have exact dates on hand of the initial dr visit when the shot was administered.  It was approximately at patient's 1 year check up. An ultrasound was done after 1 year and 18 months when there was no improvement.,OTH,,None,,,,,2,10/02/2019,,Y,,"Minor allergy to strawberries, minor topical allergy to late in bandaids"
0837712,10/02/2019,MI,72.0,72,,F,,"Patient experienced more severe soreness in her arm starting several hours after administration. Within hours, she developed one large hive running from her upper arm to her elbow, and the area was swollen and sore.",,,,,,,,,U,10/01/2019,10/01/2019,0,,PHM,,"Atorvastatin, Losartan",None,"Hypertension, dyslipidemia",,,2,10/02/2019,,,,No known allergies
0837713,10/02/2019,WA,70.0,70,,F,,"injection site pain, headache, tired muscle and joint aches, shivers, slightly sick to stomach.",,,,,,,,,U,10/01/2019,10/02/2019,1,none so far.,PVT,,"Multiple B; and Vit. D, aspirin",No,Have had silent acid reflux - no heartburn -  no medications; Osteoarthritis (knees) - no medicines,,,2,10/02/2019,,,,No
0837714,10/02/2019,KS,38.0,38,,F,,"very sore arm that day, then chills, 101 fever, severe headache, muscle stiffness and soreness over whole body. Feeling of having the Flu for 3 full days following shot.",,,,,,,,,Y,09/28/2019,09/29/2019,1,,PVT,,"venlifaxine xr 300mg daily, armour thyroid 60mcg daily",none,"arthritis, hashimotos, depression, anxiety disorder",,,2,10/02/2019,,,,none
0837715,10/02/2019,FL,46.0,46,,F,,"immediate itching , rash and redness at site, redness and itching radiated to lower arm, shoulder, chest and face.  With hives forming 45 minutes later hives to upper lip.    Treated with Ice, Triamcinolone Acetonide Inj and diphenhydrAMINE Injection  denies throat swelling, or any type of respiratory distress",,,,,,,,,U,10/02/2019,10/02/2019,0,none,OTH,,"Atorvastatin, Estradiol, Progesterone, and  Micronized Cap",none,substance abuse methamphetamines and hyperlipidemia,,,2,10/02/2019,,,,no known allergies
0837716,10/02/2019,AZ,70.0,70,,F,,"Patient became violently ill. Symptoms included nausea, vomiting, diarrhea, and malaise. Patient went to urgent care and was treated and released. Patient was ill for 3 days",,,,,,,,,Y,09/27/2019,09/27/2019,0,,PHM,,,,,,,2,10/02/2019,,,Y,
0837717,10/02/2019,SC,69.0,69,,F,,"patient arm red, hot to touch, and body aches elbow to shoulder",,,,,,,,,U,10/01/2019,10/02/2019,1,nka-dr office called inform us of her arm being red,PHM,,"atorvastatin 20mg,  levothyroxine 88, omeprazole 20mg  propranolol 40mg  metformin 500mg duloxetine 60mg",n/a,"thyroid condtion, diabetes,  muscle spasms",,,2,10/02/2019,,Y,,pcn allergy
0837718,10/02/2019,CA,69.0,69,,F,,"I did not inquire whether I was being given a Senior's dosage.  I left it up to them  From 5.5 hours later, I had severe chills with shaking, didn't take my temperature--too busy shivering and trying to concentrate my body heat in bed. Not conscious of muscle aches, very uncomfortable.    Severe Chills lasted    mostly 3-4 hours. Headache still now, 24 hours after shot.  (Occasional mild vertigo as before)",,,,,,,,,,10/01/2019,10/01/2019,0,"*** Medical office does not bother to inform patients whether 3 or 4-valent vaccine.  I asked.  Quadrivalent.  Medical office does not report to patient whther Senior Dose--unless asked.   Directly on the Medical office location, they sometimes HAVE NOT HAD SENIOR DOSE. Am not reporting to doctor; have not fully recovered yet. I've been aware that reactions can occur.  Last year, I felt a bit ill for a few hours, and two or 3 years ago, I was nauseous and achy for a full few hours.",PHM,,"Zoloft, Wellbutrin, Levothyroxin (thyroid),  Calcium w/D3,  Vit. B complex, biotin, gingko, iron,","Within the last 10 days,  occurrence of vertigo (from ear filament)--mild",Had 60 % of thyroid removed after 3+ years of a big blob growing in it (not trying to recall correct term).  benign,reactions only as described above,,2,10/02/2019,,,,allergic to one type penicillin -reaction after 10 days
0837719,10/02/2019,WI,20.0,20,,M,,"5 hours after getting vaccination, developed chills, fever, light headed with some nausea.  High fever continued, reported 103-104, for 36 hours, then went to an Urgent Care clinic.  Fever, low grade, and headache persisted for 72 hours.",,,,,,,,,Y,09/27/2019,09/27/2019,0,None,SCH,,None,None,None,,,2,10/02/2019,,Y,Y,"Bees, wasps, Motrin, nuts"
0837720,10/02/2019,NY,5.0,5,,F,,"High fever, lethargy, vomiting, excessive yawning (every 10 seconds), severe neck pain and headache. Lasted from June 24th through June 30th.  I brought her to the doctor 2 or 3 times during this reaction.  After the severe reaction subsided, she continued to experience BPPV (vertigo) 3 times in 2 weeks, which has never happened that close together.",,,,,,,,,Y,06/19/2019,06/24/2019,5,,PVT,,None,None,BPPV - occurs once every couple of months (around 5 times/year),,,2,10/02/2019,,Y,,None
0837721,10/02/2019,NY,78.0,78,,F,,"Patient reports blood clots in nose, nasal congestion, swollen joins in knees and fingers, and pain in right ankle tendon from previous sprain. Patient visited Dr to follow up",,,,,,,,,U,09/18/2019,09/20/2019,2,Awaiting lab results done on 9/30/2019 by Dr,PHM,,Atorvastatin 10 mg,,Hyperlipidemia,,,2,10/02/2019,,Y,,NKA
0837722,10/02/2019,CA,38.0,38,,F,,"Patient came in complaining of numbness in left arm and left side of face at 10:55 am. The pharmacist gave 1 dose of Banophen 25 mg tablet at 11 am. Patient came back down at 11:30 am complaining of tingling and the feeling spreading to right side of face along with itchy throat making her want to cough. Pharmacist advised patient to be seen by paramedics, but refused and instead called her primary care physician across the street and was advised by the office to come in for consultation.",,,,,,,,,U,10/02/2019,10/02/2019,0,,OTH,,,None,None,,,2,10/02/2019,,Y,,none
0837723,10/02/2019,CT,68.0,68,,F,,"Left arm pain around the site of injection - first few days.  Headache, low grade but constant - 3+ weeks (Possible) low grade fever - in the first week. Body aches - first week. Nerve pain, tenderness to the touch - torso, left side - front, side, and back L - lasted 3+ weeks. Sometimes severe, with stabbing pain. Extreme tiredness, napping. Sometimes insomnia - this lasted about 4 weeks. Stomach pain - 3+ weeks",,,,,,,,,Y,08/12/2019,08/13/2019,1,"Various blood work done on 8/19, 8/22 and 8/27, trying to determine what might be wrong. One of the tests was for Lyme Disease, which was negative.",PHM,,"Nortriptylene, Atenolol, Gabapentin, Spironolactone, Metoprolol, Restasis drops. B Complex, D3, Magnesium.","Pain radiating in my left leg from lumbar issues. Other than that, none.",High blood pressure / cholesterol - both under control with medications. Spinal stenosis.,,,2,10/02/2019,,Y,,"Allergies: molds/spores, various animals.  No known food allergies. Have had reactions to several medications in the past 30-40 years (muscle relaxant, antibiotic). Reaction (possibly) to Oxycodone after surgery in 2017 - shortness of breath."
0837724,10/02/2019,,48.0,48,,F,,"Fluzone High Dose was inadvertently administered to patient under the age of 65.  Previous provider had administered High Dose and 1 extra (unused) vial remained at administration site instead of being returned to storage.  Assistant set up area, and provider assumed correct vaccine was provided.  Provider did not check vaccine name prior to administration and did not realize mistake until documenting vaccine administration.   Patient has been informed.",,,,,,,,,U,10/02/2019,10/02/2019,0,,WRK,,,Pain with urination,"Urinary tract operation 3 months ago, hospitalized for kidney infection 2 weeks ago for IV antibiotics, presented with dysuria (negative UA).",,,2,10/02/2019,,,,Meperidine
0837725,10/02/2019,GA,36.0,36,,F,,vomiting and upset stomach on and off since yesterday. i instructed her to stay hydrated with alternating pedialyte or gatorade with water and if she begins to feel weak to contact her doctor to see how she needs to carry forward. there is a stomach bug going around in our area so she understood it could be related to that,,,,,,,,,U,10/01/2019,10/01/2019,0,n/a,PHM,,"atorvastatin, novolog, hydrocodone/apap, augmentin, diflucan, ibuprofen, klor-con, penlac, clonidine, furosemide, metolazone, iron, coreg, tizanidine,  hydralazine, voltaren topical,",something warranting augmentin,"heart failure, diabetes",,,2,10/02/2019,,,,NKDA
0837726,10/02/2019,CT,69.0,69,,F,,PATIENT DEVELOPED SEVERE PAIN ON RIGHT ARM AND COULD BARELY LIFT THE ARM. THERE WAS A LITTLE BIT OF REDNESS AROUND THE INJECTION SITE AREA. THESE SYMPTOMS STARTED THE DAY OF VACCINATION AND STARTED TO IMPROVE OVER SEVERAL DAYS. PATIENT FULLY RECOVERED BY 10/1/2019,,,,,,,,,Y,09/28/2019,09/28/2019,0,,PHM,,,,,,,2,10/02/2019,,,,
0837727,10/02/2019,VA,45.0,45,,F,,"Patient is a 45 y.o. female w/out significant PMHx on file who p/w moderate persistent LUE pain that begins at her shoulder and radiates to the center of her palm that began acutely about 5minutes after receiving a flu shot. She mentions that at first the pain was so severe that she was incoherent. The pain is intensified when the site of the flu shot is touched.   She also thought that he throat felt a little bit tight, but did not have any difficulty breathing. Denies any fever or CP. Denies rash, numbness, or tingling.  ",,,,,,,,,U,10/02/2019,10/02/2019,0,,PVT,,,,,,,2,10/02/2019,,Y,Y,
0837728,10/02/2019,NJ,55.0,55,,M,,"patient stated that 24 hours after the vaccine started to experience fatigue, fever, runny nose, headache, cough.  pt hasn't taken a body temp but thinks we feels warm.",,,,,,,,,N,09/30/2019,10/01/2019,1,none known,PHM,,,,diabetes,,,2,10/02/2019,,,,
0837729,10/02/2019,CA,68.0,68,,M,,Pain in arm and hips that effected ability to walk. Also complained of numbness in the fingers.,,,,,,,,,N,10/01/2019,10/02/2019,1,,PHM,,,,,,,2,10/02/2019,,,,
0837730,10/02/2019,KS,57.0,57,,F,,"2 HR. AFTER ADMINISTRATION PT. LT. ARM BECAME RED, RAISED AREA HOT TO TOUCH FELT LIKE FLU SYMPTOMS. LEFT WORK TO GO HOME AND REST. REPORTS ICE PAK PLACED ON LT. UPPER ARM. LATE EVENING REPORTED 100.9 TEMP, RECOMMENDED PT.TAKE TYLENOL AS SHE IS ALLERGIC TO IBUPROFEN.  NEXT MORNING PT PHONED TO REPORT AREA IS LARGER AND SHE FEELS PAIN IN THE PELVIC REGION AND KNEES,STILL FEELING EXHAUSTED, REPORTS HEADACHE AND STATED SHE DOES NOT USUALLY GET HEADACHES.  ENCOURAGED PT TO USE ICE PAK AND BENADRYL PT. DECLINED TO USE BENADRLY AS IT MAKES HER TIRED AND SHE WAS ALREADY TIRED. PT THEN REVEALED SHE WAS GIVEN A B12 SHOT ON THE SAME DAY AS THE OTHER 2 INJECTIONS.   B12 WAS GIVEN IN SAME ARM AS SHINGRIX  (RT DELTOID) . Td WAS GIVEN IN LT. DELTOID AS LISTED.",,,,,,,,,Y,09/03/2019,09/03/2019,0,"NO MEDICAL VISIT PER PATIENT REQUEST, PT PHONED TO PROVIDE UPDATES DAILY OF HER S/S.",OTH,,"Lisinopril20mg, clonidine0.2mg,pantoprazole40mgDR, Metformin 1000mg, Alogliptin 25mg tab., Atenolol 25 mg, ASA 81 mg tab., Simvastatin 10 mg, Ergocalciferol 1.25 mg.",none,none,,,2,10/02/2019,,,,"Amlodipine, Augmentin XR, HCTZ, Ibuprofen, Levofloxacin, Nitrofurantoin, Sulfamethoxazole"
0837731,10/02/2019,AK,53.0,53,,M,,"Right arm pain, swelling and redness.   Also with fever, shortness of breath.      Went to ER, diagnosed with pneumonia and treated with outpatient antibiotics.  Arm and respiratory symptoms resolved over next 2-3 days.",,,,,,,,,Y,09/23/2019,09/23/2019,0,Chest X Ray - No acute abnormality Negative influenza/ strep testing.,PVT,,Remote ATORVASTATIN CA 20MG TAB         TAKE ONE TABLET BY MOUTH AT BEDTIME FOR CHOLESTEROL            Last Filled: 06/25/19 (Active)            Rx Expiration Date: 01/17/20                 Days Supply: 90  OUTPT ATORVASTATIN CALCIUM 40MG T,None,"10 Problems ST PROBLEM                                           LAST MOD     A  Obesity (SCT 414916001) (ICD-10-CM E66.9)         08/22/2019    A  Sleep apnea (SCT 73430006) (ICD-10-CM G47.30)     08/22/2019   A  Diabetes mellitus type 2 (SCT 44054006)           08/22/2019      (ICD-10-CM E11.9)   A  Low back pain (SCT 279039007) (ICD-10-CM M54.5)   08/22/2019          Hx of L1-L2 osteomyelitis, on chronic        opioid therapy  A  Neck pain (SCT 81680005) (ICD-10-CM M54.2)        08/22/2019    A  Tobacco use (SCT 110483000) (ICD-10-CM Z72.0)     08/22/2019          Chews tobacco  A  Chronic pain (SCT 82423001) (ICD-10-CM G89.4)     08/22/2019    A  H/O: surgery (SCT 161615003) (ICD-10-CM R69.)     08/22/2019          Tonsillectomy, adenoidecomy, nasal        fracture repair, testicular torsion  A  Benign prostatic hypertrophy with outflow         08/22/2019      obstruction (SCT 236646007) (ICD-10-CM    N40.1/N13.8)   A  Erectile dysfunction (SCT 397803000) (ICD-10-CM   08/22/2019      N52.9)",Remote history of a reaction to a flu shot >10y,,2,10/02/2019,,Y,Y,Adhesives
0837734,10/02/2019,FL,,,,U,,"no adverse effect; administered 2 doses of M-M-R II; This spontaneous report was received from office manager refers to a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medication and drug reactions/allergies. On 27-SEP-2019, the patient may have inadvertently administered 2 doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (inappropriate schedule of product administration) for prophylaxis (Therapy type: rHA, Lot # S004118, Expiry date: 11-FEB-2021, strength, dose, frequency, route unspecified). No adverse effect reported. No PQC involved. No further information provided.",,,,,,,,,U,09/27/2019,09/27/2019,0,,UNK,,,,,,US0095075131910USA000006,2,10/02/2019,,,,
0837735,10/02/2019,AZ,48.0,,,F,,"diagnosed with sudden sensoineural hearing loss in her right ear; vertigo goes and comes, mostly feels in the morning; she had a sore throat, and then lost her hearing; achy and tired and slept for 2 hours; muscle pain, achy and tired and slept for 2 hours; Initial information received on 25-Sep-2019 regarding an unsolicited valid serious case received from a consumer/non-hcp.  This case involves a 48 years old female patient who experienced diagnosed with sudden sensoineural hearing loss in her right ear, vertigo goes and comes, mostly feels in the morning, she had a sore throat, and then lost her hearing, achy and tired and slept for 2 hours and muscle pain, achy and tired and slept for 2 hours, while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s) and family history were not provided. The patient's past vaccination(s) included flu vaccine. The patient's had no concomitant medications.  On 21-Sep-2019, the patient received a dose  dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via intramuscular route in the left arm.  The patient developed a serious diagnosed with sudden sensoineural hearing loss in her right ear (deafness) <<Unknown latency>> following the administration of INFLUENZA QUADRIVAL A-B VACCINE. This event was assessed as medically significant. The patient developed a non-serious vertigo goes and comes, mostly feels in the morning (vertigo) <<Unknown latency>> following the administration of INFLUENZA QUADRIVAL A-B VACCINE. The patient developed a non-serious she had a sore throat, and then lost her hearing (oropharyngeal pain) <<Unknown latency>> following the administration of INFLUENZA QUADRIVAL A-B VACCINE. The patient developed a non-serious achy and tired and slept for 2 hours (fatigue) <<Unknown latency>> following the administration of INFLUENZA QUADRIVAL A-B VACCINE. The patient developed a non-serious muscle pain, achy and tired and slept for 2 hours (myalgia) <<Unknown latency>> following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  (Other relevant tests included No lab data.) Final diagnosis was muscle pain, achy and tired and slept for 2 hours, achy and tired and slept for 2 hours, she had a sore throat, and then lost her hearing, vertigo goes and comes, mostly feels in the morning and diagnosed with sudden sensoineural hearing loss in her right ear.    The patient was treated with PREDNISONE (PREDNISONE).  The patient outcome is reported as Unknown for vertigo goes and comes, mostly feels in the morning, as Recovered / Resolved on an unknown date for achy and tired and slept for 2 hours, as Unknown for she had a sore throat, and then lost her hearing, as Not Recovered / Not Resolved on an unknown date for diagnosed with sudden sensoineural hearing loss in her right ear and as Recovered / Resolved on an unknown date for muscle pain, achy and tired and slept for 2 hours.; Sender's Comments: This case concerns a 42 year old female patient who presented with vertigo which goes and comes, had sore throat, diagnosed with sudden sensoineural hearing loss in her right ear and muscle pain, achy, tired and slept for two hours after vaccination with FLUZONE QUADRIVALENT. The time to onset is unknown. Patient's medical history, condition at time of vaccination and lab tests ruling out alternate etiologies were not provided. Based upon the reported information, the role of the vaccine cannot be assessed.",,,,,,,,,N,09/21/2019,,,,UNK,,,,,,USSA2019SA268315,2,10/02/2019,,,Y,
0837736,10/02/2019,VA,59.0,59,,F,,"Starting from about  9:30 or 10:30 pm on Tues night,  I had about 5 bouts of liquid stools and cramping over an hr or so.   I went to bed and woke up and threw up at about 1:00pm.   I was awake until at least 4 feeling very thirsty, a bit dizzy, light headed and in general sick.  I was extremely thirsty and got up on the hour and drank 8 to 10 oz of water until about 4 am or so.    I slept then for a while and woke up again around 7 am or so, by then my stomach and cramps were ok but then I had a little ringing in the left hear and had a low grade head ache.    I called the Dr. around the time the office opened and spoke with the nurse and ate a breakfast cookie.    We decided that I was much better than during the night but that I should get gatorade or coconut milk to replace electrolytes.  Over the next couple of hours I drank 2 cans of coconut milk ,stayed in bed feeling like I had the flu and slept pretty much all day until I got up and had rice when my husband had dinner.    The next day, I felt like I had a mild flu and was up and out of bed all day.  I took my temperature with a mercury oral themometer just once and it read 101.2 at about 7 am.   Usually I would be 98 or a little below.   The following day I felt a bit better yet.     It is now a week out on Wed.   Except for my stomach and intestines getting back to normal, I feel fine.  Except, I went out to dinner last night, had a substantial meal and had one liquid stool and one throwing up episode.  Because , I feel like I should be fine, I saw my Dr. today who ran some blood work to make sure that nothing else is brewing along with this ""reaction.""  Temperature at the Dr. office was 98. The first shot, I had mild flu like symptoms for a couple of days but this was far worse.    My arm did hurt and had a little bump at the site but was not red over any of the three days.",,,,,,,,,U,09/24/2019,09/24/2019,0,pending,PHM,,"Nature-throid,  norethindrone ace tab estrogen patch pregnenolone",none known,I take replacement hormones and a thyroid supplement,,,2,10/02/2019,,,,seasonal and possible digestive allergy to molds and dusts and possibly cockroaches or pets.  No recent testing but historically I have had some allergies.  None rated as  severe.
0837737,10/02/2019,AR,16.0,16,,M,,Patient received in error. Requested to receive meningitis,,,,,,,,,U,09/30/2019,09/30/2019,0,NA,PHM,,unknown,NA,NA,,,2,10/02/2019,,Y,,NKA
0837738,10/02/2019,CA,92.0,92,,F,,"Pain, muscle fatigue, flu like symptoms.  Shingrix shot was given in her left arm and she is left handed.  The pain was so intense she lost use of her left arm for a week.  Within 2 hours a sore arm.  Within 6 hours my brother took mom  to a local urgent care at 8:30pm, said take a pain pill.   My brother put her to bed.  She did not answer her phone in morning. I found her on the floor as she was not able to get up to go to the bathroom and ended up on the floor.  No use of left arm and entire body had muscle fatigue.  Used walker to move her to my house for rehab.  After a week she could walk again without walker but still had Flu like symptoms. Almost 2 weeks now and she is still a little off balance in feeling.",,,,,,,,,N,09/20/2019,09/20/2019,0,"8:30pm same day as shot:  Urgent care.  Diagnosis, take a pain pill.",PHM,,carvedilol 6.25 mg; ELIQUIS 2.5 mg; valsartan-hydrochlorothiazide 320-25 mg;,No,Hypertension; COPD,,,2,10/02/2019,,,,No
0837739,10/02/2019,CA,62.0,62,,M,,"Patient describes numbness and tingling in upper arm of injection site starting 9/28/19 and began to subside the morning of 10/2/19.  Soreness had not been present until the morning of 10/2/19.  During the early afternoon, patient describes the numbness and tingling ""returned with a vengeance"" and proceeded to call me as I instructed if the numbness and tingling returned.",,,,,,,,,N,09/27/2019,09/28/2019,1,none,PHM,,zolpidem 10mg,none,insomnia,,,2,10/02/2019,,,,"penicillins, macrolides"
0837740,10/02/2019,MS,56.0,56,,F,,"Patient called pharmacy to report of pain ""where the bra line is"" and ""throughout the back area"". She also listed the pain as ""around her rib area and around the back"". Patient said pain has been continuing for 3 days since receiving the vaccine.",,,,,,,,,,09/01/2019,09/12/2019,11,,PHM,,,,,,,2,10/02/2019,,,,
0837741,10/02/2019,,77.0,77,,F,,"NEXT DAY ARM STARTED TO HURT AND SWELL, ALSO WAS HOT TO TOUCH. WENT TO PHARMACY AND THEY SAID TO SEE THE DOCTOR, WENT TO DOCTOR THEY SAID IT WAS A REACTION TO THE INJECTION SITE, AND TO TAKE BENADRYL AND DO COLD PACKS. WENT TO PHARMACY AND DOCTOR ON OCT 3RD.",,,,,,,,,U,10/01/2019,10/02/2019,1,NO TEST DONE,PHM,,"MELOXICAM,TRAMADOL,OMEPRAZOLE,SERTRALINE,VYTORIN,SYMBICORT",NO,NO,,,2,10/02/2019,,Y,,NKA
0837742,10/02/2019,VT,0.17,0,.2,M,,"Patient received the dtap/ipv portion of Pentacel vaccine without reconstitution with the hib portion of the vaccine. The patient was then revaccinated with dtap/ipv/hib (pentacle) that was reconstituted properly. These were given the same day but in separate sites. The parents were notified same day of error and the only reaction noted by  parents and reported to provider was that the patient slept more than usual, patient did not have any adverse effects from vaccination. No fever, no adverse site reaction. Patient was monitored by parents and reported above to provider more then 24 hours after vaccination.",,,,,,,,,Y,09/27/2019,09/27/2019,0,none,PVT,,Vitamin D3 400 iu/ml liquid,none,none,,,2,10/02/2019,,,,"no known drug allergies, no known food or environmental allergies"
0837743,10/02/2019,OH,68.0,68,,F,,"According to caregiver, site of injection red and hot feeling.  Started day after injection and continues to today.  Recommended she call her doctor.",,,,,,,,,U,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,10/02/2019,,,,Penicillin
0837744,10/02/2019,CA,45.0,45,,M,,"Patient was experiencing urine problems and leakage leading up to the vaccine on 9/24/19. No fever was present at time of vaccination.  on 9/23/19 patient had a urine culture but did not get results of culture back until 9/26.  On 9/25/19 patient had a 10 second seizure and his brain was ""disorganized"".  Mother thought that this may have been because it was the result of having an undiagnosed UTI (which was confirmed on 9/26) and being dehydrated from hot temperatures/travel on the days leading up to the vaccine.  Patient also was experiencing delirium symptoms on 9/26/19.",,,,,,,,,U,09/24/2019,09/25/2019,1,Patient had a urine culture on 9/23 but did not get results back from culture until 9.26/19 confirming UTI,PHM,,Dilantin Flonase nexium propranolol ranitidine xarelto Lexapro chlorhexidine  allegra calcium carbonate,"undiagnosed UTI, patient may have been dehydrated",epilepsy depression blood clot gerd,,,2,10/02/2019,,Y,,nka
0837745,10/02/2019,WA,76.0,76,,M,,"patient's wife reports when patient got home, he had fever, chills that his teeth were clattering, nausea, and high bloog glucose.  they called 911 and paramedics came and checked his blood pressure.",,,,,,,,,Y,09/30/2019,09/30/2019,0,,PHM,,"allopurinol 300 mg, amlodipine 5 mg, atorvastatin 20 mg, cilostazol 100 mg, colchicine 0.6mg. gabapentin 300 mg, hctz 25 mg, Januvia 25 mg, lantus 26 units daily, metoprolol er 100 mg, omeprazole 20 mg, tramadol 50 mg.",,"diabetes, blood pressure, kidney disorders",,,2,10/02/2019,,Y,,lasix
0837746,10/02/2019,PA,54.0,54,,F,,pt presented at pharmacy today with redness swelling and tenderness at the injection site and around injection site area,,,,,,,,,N,09/28/2019,10/02/2019,4,,PHM,,,,,,,2,10/02/2019,,,,"NSAIDS, tramadol, ace inhibitors, bupropion"
0837747,10/02/2019,CA,15.0,15,,M,,"Adverse reaction: lightheadedness and sweating. Place pt in supine position, Monitored VS continuously. BP stabilized prior to discharged @ 1PM BP 106/74 HR 68",,,,,,,,,Y,10/02/2019,10/02/2019,0,,SCH,,None,None,None,,,2,10/02/2019,,,,NKDA/NKFA
0837748,10/02/2019,CA,71.0,71,,F,,"Per MD office, patient got vaccination in Left arm. She experienced ""strange"" sensation across her chest/body, aching pain in Right arm, and also had some swelling in the throat.  They called pharmacy on 10/2 to inform pharmacy of reaction.",,,,,,,,,U,09/30/2019,09/30/2019,0,unknown,PHM,,unknown,unknown,unknown,,,2,10/02/2019,,Y,,penicillin
0837749,10/02/2019,AL,29.0,29,,F,,"on 10/2, patient work up with redness and hard knot at injection site. pt complains of numbness in entire arm, including  fingers. I advised her to contact md immediately",,,,,,,,,N,09/30/2019,10/02/2019,2,,PHM,,,,,,,2,10/02/2019,,Y,,
0837750,10/02/2019,NJ,63.0,63,,F,,"Patient called at 10am on 10/2/2019 stating that this morning when she woke up she had a rash on her lower legs. Rash did not cause any pain or irritation. Just small red bumps. Confirmed no changes in any detergent, soaps or fragrances. Stated only change was Shingrix and flu shot given on 9/30/2019. She knows a rash can occur but was surprised on lower legs. Patient knows if gets worse to see provider.",,,,,,,,,U,09/30/2019,10/02/2019,2,,PHM,,,,,,,2,10/02/2019,,,,
0837751,10/02/2019,TX,71.0,71,,F,,"Caused blood pressure to be very high (BP 198/95), REALLY BAD NAUSEA AND VOMITING, FELT SICK, PAIN AND REDNESS AT INJECTION SITE, PATIENT STATE SHE WENT TO THE ER, PER PT THEY ONLY MONITORED HER AND DID NOT GET ANY TREATMENT; FOLLOWED UP WITH PCP AND WAS GIVEN CLONIDINE 0.1MG FOR BP >160 AND ONDANSETRON 8MG FOR NAUSEA AS NEEDED",,,,,,,,,Y,06/10/2019,06/10/2019,0,"CAT-SCAN, BLOOD/LAB WORK, EKG, CHECKED BP",PHM,,"PLAVIX 75MG (CLOPIDOGREL), ZETIA 10MG, ALPRAZOLAM 1MG, BENICAR 40MG (OLMESARTAN), DILTIAZEM ER 240MG, PREVACID CHEWABLE TABLETS 30MG; VITAMIN-D3 125MCG",NONE,"HIGH BLOOD PRESSURE, HIGH CHOLESTEROL, STROKE (APRIL 2019), FIBROMYALGIA, GERD",,,2,10/02/2019,,Y,Y,"PENICILLIN, SULFA DRUGS, CODEINE, CLARITHROMYCIN (BIAXIN), STATIN (CHOLESTEROL) MEDICATIONS"
0837752,10/02/2019,AZ,37.0,37,,F,,Rash with welts over 80% of body with concentration to neck and torso.,,,,,,,,,U,10/01/2019,10/01/2019,0,,OTH,,none,none,Iron Deficiency  anemia,,,2,10/02/2019,,,,none
0837753,10/02/2019,OR,28.0,28,,F,,"Red pigment to L hand below wrist. pt denied any itching, swelling, discomfort.",,,,,,,,,,09/16/2019,09/16/2019,0,,PVT,,,,,,,2,10/02/2019,,Y,,
0837754,10/02/2019,TX,51.0,51,,F,,"Within 30 minutes of injection, she started having all over body itching and flushing of her cheeks.  Dexamethasone IM, Benadryl IM.  Prescribed a Medrol Dose Pack to start the following day and ranitidine to start this evening.",,,,,,,,,U,10/02/2019,10/02/2019,0,,OTH,,"Orencia, Claritin, Xanax, Hydrocodone and acetaminophen, Olumiant, mycophenolate mofetil,","RA, allergic rhinitis, anxiety, thyroid disease","RA, allergic rhinitis, anxiety, thyroid disease",,,2,10/02/2019,,Y,,"Cipro, codeine, duloxetine, naproxen, topiramate"
0837755,10/02/2019,MA,72.0,71,,M,,"cellulltius    swollen red arm, low grade temperature",,,,,,,,,Y,01/24/2019,01/24/2019,0,,PVT,,Flu shot and second pneumonia vaccine,none,Asthma,,,2,10/02/2019,,Y,,none
0837756,10/02/2019,OH,62.0,62,,M,,pt came in for 2nd dose and reported pain/soreness of his nose for almost 1 month after 1st dose. Pt reports history of nasal cancer. Contacted Dr. (PCP) for a recommendation on how to proceed after this reaction and whether to give 2nd dose. Spoke with nurse and Dr. himself - PCP has ok'd second dose of Shingrix as he does not believe it is due to the vaccine. He advised patient to call office immediately if any reaction occurs after 2nd dose.,,,,,,,,,,07/09/2019,07/10/2019,1,,PHM,,,,,,,2,10/02/2019,,,,
0837757,10/02/2019,NY,66.0,66,,F,,"Duplicate prevnar 13....Doctor's office called 10/2/19 informing us they gave pt prevnar 13 back on 1/6/16 (before pt was 65 years old). When pt was in pharmacy in August, she was getting something else and we screened for prevnar due to age and she said yes (had no memory of it) and we administered it in August 2019..insurance company paid for it as well.",,,,,,,,,Y,08/13/2019,10/02/2019,50,,PHM,,,,,,,2,10/02/2019,,,,
0837758,10/02/2019,TX,68.0,68,,F,,"Sore arm at injection site; aching body; shivering all day 10/2/19.    Took Excedrin, helped a little.",,,,,,,,,N,10/01/2019,10/02/2019,1,,PHM,,"Provastatin 80mg, CQ-10, Meloxicam, Melatonin 5mg.  Received 2nd Dose of Shingrix 10/1/2019.  First dose only sore arm; second dose sore arm aching all over, shivering.",sinus infection 3 weeks ago,"High Cholesterol, High blood pressure, Thyroid disease [-[removed]",,,2,10/02/2019,,,,"Sulfa drugs, Erythromycin, Morphine, Some statins"
0837759,10/02/2019,NC,81.0,81,,F,,PATIENT PRESENTED WITH RAISED AND RED AREA AROUND MOST OF THE TOP OF UPPER LEFT ARM.  DID NOT REPORT ANY OTHER SYMPTOMS.  CALLED PATIENT'S PRIMARY CARE OFFICE AND THEY WERE ABLE TO GET HER IN TO BE SEEN.  PT RETURNED WITH RX AND DID NOT REPORT ANY RAISED WBC COUNTS PER MD TESTING AND PRESENTED WITH STEROID RX AND CLARITIN TO BE TAKEN AT REQUEST OF MD,,,,,,,,,U,10/01/2019,10/02/2019,1,,PHM,,,,,,,2,10/02/2019,,Y,,
0837760,10/02/2019,FL,63.0,63,,M,,"Fever, shaking awakened patient presented to clinic still not feeling well. Responded well to naproxen otc",,,,,,,,,U,10/01/2019,10/02/2019,1,none,UNK,,,,,,,2,10/02/2019,,Y,,
0837761,10/02/2019,,77.0,77,,F,,"patient developed diarrhea after receiving two shots in office, diarrhea persisted x3 weeks causing low potassium resulting in shock for defibrillator.",,,,,Y,,,,,09/16/2019,09/17/2019,1,,PVT,,,,,,,2,10/02/2019,,Y,Y,
0837762,10/02/2019,CA,74.0,74,,F,,"Pt reports abdominal pain, nausea, diarrhea, loss of appetite. St's she feels like she has the flu.",,,,,,,,,N,10/01/2019,10/01/2019,0,None at this time,PVT,,unknown,,"hypertension, hyperparathyroidism, history of breast cancer",,,2,10/02/2019,,,,Penicillins
0837763,10/02/2019,AZ,61.0,61,,F,,"I was given the shot 9/27/19 mid-morning and by early afternoon my arm hurt, I was getting achy feeling, like I was coming down with something.  I took two regular Aspirins and felt so much better after a short time.  I went home and slept.       I woke up the next day and felt achy again, like I did before I took Aspirins.  I got to work and I ached all over, my hand, my knees, my back, everywhere.. just like I would feel had I been coming down with something.  So I took two more regular Aspirins and they helped so much!  I was able to go about my day to day routine, as normal once the Aspirins kicked in!  I took a couple of regular Aspirins on Saturday and Sunday too.   By Monday I felt normal again and didn't  need any Aspirins,  I did not take my temp and I wish I had... sorry",,,,,,,,,Y,09/27/2019,09/27/2019,0,None,WRK,,None,None,Eczema,,,2,10/02/2019,,,,None
0837764,10/02/2019,ND,65.0,65,,M,,"Patient came in 10-02-19 to get second vaccine but stated that immediately after getting first dose his arm turned BLACK. He states it did not itch, swell, become hardened, or ache. He states it was severely discolored like this for nearly 6 weeks.   I cannot find literature if this is allergic reaction, hesitant to give second dose if this is allergy.",,,,,,,,,Y,07/14/2019,07/14/2019,0,None,PHM,,Qvar Redihaler,none,asthma,,,2,10/02/2019,,,,none
0837765,10/02/2019,CA,0.17,0,.2,F,,PT TAKEN TO EMERGENCY ROOM  07/12/19 FOR DIARRHEA X5 DAYS. GASTROENTERITIS PCR PANEL COLLECTED TO IDENTIFY SOURCE AND PT WAS POSITIVE FOR ROTAVIRUS A.,,,,,,,,,Y,06/27/2019,07/07/2019,10,GASTROENTERITIS PCR PANEL,PVT,,NONE,FEVER  DAY AFTER VACCINES,NONE,,,2,10/02/2019,,Y,Y,NONE KNOWN
0837766,10/02/2019,NJ,51.0,51,,F,,Arm pain immediately after vaccine given. Pain radiates down arm weakness in arm PT with only partial relief,,,,,,,,,N,03/13/2019,03/13/2019,0,None,PVT,,"aspirin, advair, allegra, singulair",none known,"asthma, factor 5 leiden",,,2,10/02/2019,,Y,,"latex, sulfa drugs"
0837767,10/02/2019,MA,2.0,2,.1,M,,patient presented to the emergency department with a generalized tonic clonic seizure (in the setting of fever to 103.5,,,,,,,,,Y,10/01/2019,10/02/2019,1,none,PVT,,Motrin 5 mL last administered at 4:45 pm,none,none,,,2,10/02/2019,,,Y,none
0837768,10/02/2019,OK,67.0,67,,F,,"Patient presented to the pharmacy on 10/2/19 saying she will not be getting any other injections here. When asked what she meant, she pulled up her sleeve to expose her left arm.  It was red, hot, and swollen at and below injection site. She said she began to have fever and chills on 10/1/19 around 8AM and today could not hardly move her left arm so she sought medical care. She  was given an oral antibiotic and topical steroid ointment as Urgent Care staff told her they were afraid it may get infected.",,,,,,,,,N,09/30/2019,10/01/2019,1,Urgent Care visit 10/2/19,PHM,,"Lisinopril/HCTZ, Naproxen, Breo, Invokamet, Lovastatin",None,"Diabetes, High Blood Pressure",,,2,10/02/2019,,Y,,None
0837769,10/02/2019,OR,5.0,5,,M,,"Left arm has a pink area approximately 3""x5"", warm to touch, mild swelling, tender with palpation.",,,,,,,,,N,09/30/2019,09/30/2019,0,,PVT,,Multivitamin,Healthy,None,,,2,10/02/2019,,Y,,NKA
0837770,10/02/2019,,71.0,71,,F,,"10/2/19 - Pt called to report that she had welts on her left arm that were warm to the touch and reddish pink.  She also had pain in her underarm area.  It began on 10/1 and she went to the Dr today (before reporting it to pharmacy).  Her Dr told her to ice the area TID and take OTC Ibuprofen prn.  Dr also told her to let her know if the condition worsened.  At the end of the pt?s explanation, I told her to let us know the same.",,,,,,,,,,09/30/2019,10/01/2019,1,,UNK,,,,,,,2,10/02/2019,,Y,,
0837771,10/02/2019,NC,68.0,68,,F,,severe swelling and tissue loosening - discomfort from shoulder to wrist - skin reaction,,,,,,,,,U,09/29/2019,09/29/2019,0,,PHM,,,none,,,,2,10/02/2019,,Y,,no known
0837772,10/02/2019,,61.0,61,,M,,Patient received Shingrix without any active drug. Diluent shot into powder vial and did not check whether or not drug dissolved. The powder did not dissolve in the diluent.,,,,,,,,,,10/02/2019,10/01/2019,,,UNK,,,,,,,2,10/02/2019,,,,
0837773,10/02/2019,WA,29.0,29,,F,,High dose Influenza was given instead of regular dose. No adverse reaction,,,,,,,,,Y,10/02/2019,10/02/2019,0,,PVT,,,,,,,2,10/02/2019,,,,
0837774,10/02/2019,TX,65.0,65,,M,,"Patient received Pneumovax 23 last year in September. He came in this year to get his next pneumonia shot and was given another Pneumonia 23 instead of Prevnar 13. Patient stated today (10-2-19) that his arm started to swell Sunday evening, got worse Monday, then started to get better on Tuesday. I advised him to call his doctor. I also called his doctor and spoke with employee. She gave the information to the doctor and said they will follow up with the patient. Patient already had an appointment scheduled for Friday, 10-4-19 prior to this event.",,,,,,,,,U,09/29/2019,09/29/2019,0,,PHM,,"Gabapentin 600mg, Lactulose 10gm/15ml, Furosemide 20mg, Xifaxan 550mg, Tizanidine 4mg, Testosterone 1.62%, Mirtazapine 15mg, Fluocinonide cream, Doxycycline Monohydrate 100mg, Oxycodone 5mg.",,,,,2,10/02/2019,,,,Penicillin
0837775,10/02/2019,PA,80.0,80,,M,,Patient claims the arm in which the vaccine was given has had pain and numbness since he received the vaccine.  We called his doctor and advised the patient to do the same.,,,,,,,,,U,09/12/2019,09/13/2019,1,unknown,PHM,,unknown,unknown,unknown,,,2,10/02/2019,,,,unknown
0837776,10/02/2019,WV,58.0,58,,F,,"Gave patient flucelvax  (right upper deltoid) and pneumovax 23 (right lower deltoid) at flu clinic . Patient was concerned with fusion in left arm so we decided to administer both in her right deltoid. By that evening (about 4 - 5 hours later) patient started feeling light headed and having warmth and redness at the injection site. Patient went to the emergency room later that evening because arm became worse and she developed a fever. She was given IV antibiotics in the ER and told to return the following day for another dose of IV antibiotics. Her fever broke after the second dose, but the arm still had some redness/swelling. She was diagnosed with cellulitis. Patient is doing better now. Will follow up again with her tomorrow (1 week after notification).",,,,,,,,,Y,09/25/2019,09/25/2019,0,N/A,SEN,,Unaware,None,"Anemia, chronic smoker - lung disease.",,,2,10/02/2019,,,Y,None
0837777,10/02/2019,,61.0,61,,F,,No adverse reaction but diluent without the powder drug was injected. Vaccine dissolving in vial was not observed.  Diluent was injected and drawn out from powder vial.,,,,,,,,,,10/02/2019,10/02/2019,0,,UNK,,,,,,,2,10/02/2019,,,,
0837778,10/02/2019,CA,55.0,55,,F,,"Fever of 101.8, chills, nausea, headache. Lasted about 36 hours",,,,,,,,,Y,09/25/2019,09/26/2019,1,,PHM,,None,None,None,,,2,10/02/2019,,,,NOne
0837779,10/02/2019,AL,88.0,88,,F,,"redness, swollen, and bruising underneath injection site. patient was advised to decrease swelling via an ice pack and to call Dr as a steroid may need to be prescribed &/or administered if no relief after 1-2 days.  patient still has some redness as of 10/2/19 but the swelling has reduced. pt has yet to contact her Dr.",,,,,,,,,N,09/25/2019,09/25/2019,0,,PHM,,"Ambien, Norvasc, Xanax",,"insomnia, hypertension, anxiety",,,2,10/02/2019,,,,Metronidazole and others in same class
0837780,10/02/2019,NC,69.0,69,,F,,"patient got ill, vomit and sickness - no local reaction -severe sickness she describes went to urgent care vitals were not good she stated and went to hospital- stable today doing better - on prednisone",,,,,,,,,Y,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/02/2019,,Y,Y,none
0837781,10/02/2019,IN,67.0,67,,M,,"Fever, acky sore muscles, ringing in ears, exhaustion,",,,,,,,,,N,09/30/2019,09/30/2019,0,,PHM,,Lisinopril 10mg  atrovastatin 40 mg 81mg aspirin fish oil 1200 mg calcium 1200 mg  apple cider vinegar 600 mg,None,None,,,2,10/02/2019,,,,None
0837782,10/02/2019,MI,53.0,53,,F,,"One day following the vaccine, patient begun experiencing bruising all over the body. the sizes range from about 2mm to 12 mm. Patient states that the spots are itchy from the inside and feel very uncomfortable. The largest bruised area was underneath the breasts, but those ones have reduced in size as of the 2nd of October. There some bruised spots on the trunk and one on the fore head and the nose and well as a little one close to the corner of the left eye. Patient had not taken any medication to try and mitigate the situation-Suggested an antihistamine until she's able to see  her physician.  Patient has an appointment to see her primary doctor on the 3rd of October.",,,,,,,,,,09/27/2019,09/28/2019,1,N/A,PHM,,"amlodipine 10 mg tabs once daily, vitamin b12 injection 1000 mcg once a month",Influenza on September 25th,"High blood pressure, Mild asthma",,,2,10/02/2019,,Y,,sulfa
0837783,10/02/2019,GA,5.0,5,,M,,He developed erythema multiforme or Henoch Schonein purpura,,,,,,,,,U,09/24/2019,09/30/2019,6,,PVT,,None,None,None,,,2,10/02/2019,,Y,Y,None
0837784,10/02/2019,KS,58.0,58,,F,,"Patient, - came into the pharmacy on 10/2/19 at 1:25 pm and reported that her right arm is very red and swollen from her immunizations. The patient reported that the arm ""feels warm to the touch."" The patient stated that the arm does not itch. The patient also reports that she is not experiencing any breathing problems, and no other systemic reactions reported. The patient showed me her arm, and I observed the arm to be very bright red and swollen from the top of the arm up near the shoulder down to the elbow. It was a fairly large area affected on the outside of the right arm. Due to the severity of the reaction, I advised the patient to seek medical care. Recommended the patient see a physician to rule out reactions suchas cellulitis/infection versus an allergic reaction. The reaction is severe enough that it should not be treated OTC. The patient was going into her doctor office about this today per my recommendation to follow up with physician about this. I looked up the patient's recent immunization history in our computer: on 9/30/2019, this pharmacy gave the patient 3 immunizations ... Fluzone Quad and Pneumovax 23 were administered in the right arm, and Shingrix was administered in the left arm. The patient did not experience any reactions in the left arm where the Shingrix was administered. This IMZ reaction in the right arm would be from either the Fluzone Quad and/or the Pneumovax 23.  CALLED THE PT. TO CHECK UP ON HER 10/2/19 8:55 PM - PT. SAID SHE WENT TO HER DR. AND THEY GAVE HER AN ORAL ANTIBIOTIC BECAUSE DR. THOUGHT IT MIGHT BE INFECTED DUE TO ""RED STREAKS"" - HER DR. TOLD HER THAT IF SHE DOES NOT GET BETTER, TO GO TO THE ER.",,,,,,,,,U,09/30/2019,10/02/2019,2,NONE,PHM,,"TRULICITY, GABAPENTIN, PLENVU SOLUTION, INVOKANA, ZETIA, PIOGLITAZONE, PRAVASTATIN, LEVEMIR FLEXTOUCH, ESTRACE VAGINAL CREAM, METFORMIN,",NONE,"DIABETES, HIGH CHOLESTEROL,",,,2,10/02/2019,,Y,,NO KNOWN ALLERGIES
0837785,10/02/2019,GA,65.0,65,,F,,Hives that got progressively worse for up to 7 hours,,,,,,,,,N,10/02/2019,10/02/2019,0,None - I took another Loratidine,PHM,,Wellbutrin XL 150 Loratidine 10 mg Metropolol  Vit D3 Pravastatin 40 mg Sertraline 100 mg,None,"High cholesterol, high blood pressure, depression",,,2,10/02/2019,,,,Demurol
0837786,10/02/2019,VA,19.0,19,,F,,"About 2-5 minutes after giving the vaccine the patient started to convulse in the waiting area while I was administering flu vaccine to her friend.  This lasted for about 10 seconds and she was conscious and not convulsing when I ran to her to ensure her safety and 911 was called. I returned to administer the vaccine to her friend where she began convulsing again and fell to the floor, in which I instructed her to lay on the floor until help arrived.  About 5 minutes later the paramedics arrived and took her and her friend to the hospital.",,,,,,,,,U,10/02/2019,10/02/2019,0,"Unknown, do not have access",PHM,,"Unknown, no history of medications at pharmacy, and PT was taken to the hospital before I could obtain medical history","Unknown, see above","Unknown, see above. According to the patient this is a recurring event after receiving vaccines","pt told me that this has happened before, she answered no on the question regarding pmh of seizures",,2,10/02/2019,,,Y,"Unknown, see above"
0837787,10/02/2019,WA,30.0,30,,F,,6 months pregnant. Due date of 12/12/19  Left shoulder is locking up as a reaction.,,,,,,,,,N,09/27/2019,09/28/2019,1,,PVT,,"Prenatal vitamin, iron, baby aspirin",,,,,2,10/02/2019,,Y,,
0837789,10/02/2019,TX,67.0,67,,F,,"MYALGIA, CHILLS, HEADACHES, MIGRAINE HEADACHE, SEVERE NAUSEA, VOMITING, (NO FEVER) FOR 10 DAYS  VISION DIFFICULTY WITH MIGRAINE HEADACHE",,,,,,,,,N,09/21/2019,09/23/2019,2,NONE,PHM,,"Janumet, Pravastatin, ramipril, spironolactone, fish oil, baby aspirin",none,mild diabetes type 2,,,2,10/02/2019,,Y,,none
0837790,10/02/2019,ID,75.0,75,,M,,"Patient states at the time of call that he was experiencing a little bit of chest tightness. It was hard to say the severity of his condition, because he was also speaking normally and ordering other medications on the phone.  I advised that he should go to the emergency room if he has reasonable doubt.",,,,,,,,,U,10/02/2019,10/02/2019,0,,PHM,,"Tamsulosin, lovastatin, levothyroxine",None,Review drug list.,,,2,10/02/2019,,,,None
0837791,10/02/2019,AZ,66.0,66,,F,,"Red, swollen, hot, injection site is low on the arm (beneath deltoid above elbow)",,,,,,,,,U,09/30/2019,09/30/2019,0,,PHM,,"Ibuprofen, tylenol",none,none,,,2,10/02/2019,,,,no known allergies
0837792,10/02/2019,AK,61.0,61,,F,,"Patient stated that she received the vaccination the evening of 9/19/19, and on the morning of 9/20/19 she experienced pain on the top of her head, right side of her face, and the right side of her neck. She stated that she does not know of any other reason why she experienced this pain. She did not present to a doctor or seek care for her symptoms. She stated that the pain lasted for a few days.",,,,,,,,,Y,09/19/2019,09/20/2019,1,None,PHM,,Unknown,None,None,,,2,10/02/2019,,,,No known allergies
0837793,10/02/2019,AZ,77.0,77,,F,,Lethargic and sleepy day after and not as much on 2nd day. Had extreme leg cramping on day after.  Center back and down both legs.  Tears because i had no control of pain. 3rd day site sore and warm bruising still there but not painful.,,,,,,,,,Y,09/12/2019,09/13/2019,1,None. Sleepy?   Reactions ?,PHM,,"Crestor,  Hydrochlorithiazide, Levothyroxine, Losartin Potasium, Meloxicam, Metoprolol succ er, potassium cler, c, calcium, milk thistle, luetin, magnesium, super B complex, Krill, Omeprozole, biotin, enbrell, aspirin",,RH,,,2,10/02/2019,,,,"Doxycycline,, sulfa, pennicilien, isorbide dinitrate hci soln endolac and other arthritis RX"
0837810,10/02/2019,CT,89.0,89,,F,,"Very red rash, lower then injection site. Told patient to take some Benadryl and use ICE topically & come back tomorrow.",,,,,,,,,U,10/01/2019,10/02/2019,1,,PHM,,"Risedronate, Cipro, Prednisone, Amlod./Benaz Folic Acid, Simvastatin, MTX",,,,,2,10/02/2019,,,,NKDA
0837922,10/02/2019,AK,21.0,21,,F,,"Patient woke up with red bumpy hives on both arms. No itching, no swelling and no shortness of breath or difficulty swallowing.",,,,,,,,,,09/25/2019,09/26/2019,1,,PVT,,Dulera Inhaler,Cough/cold/congestion,No,,,2,09/26/2019,,Y,,Pollen/Band Aids
0837985,10/02/2019,TX,1.0,1,.0,F,,Red 2 inX2in ring on right lower thigh,,,,,,,,,Y,09/30/2019,10/02/2019,2,,PVT,,None,None,None,,,2,10/02/2019,,Y,,None
0837986,10/02/2019,AZ,36.0,36,,F,,I was have fevers/body aches/hot flashes/neck/left shoulder pain/itchy/numbness/tingling. Has red spot on site area with swelling & heat.,,,,,,,,,U,09/30/2019,09/30/2019,0,None,OTH,,None,No,No,"Same reaction as now. 36 yrs old. 06/12/2018. Sub Q Vaccine, Varicella #1.",,2,10/02/2019,,Y,,None
0837988,10/02/2019,PA,5.0,5,,F,,"7 PM - started with hives on her legs, torso, and face. Subsided after an hour. Went to sleep. Woke up at 6AM, red rash present on legs, torso, & chest. Had coughing throughout night needed nebulizer. Pt did not need hospitalization; she did develop a headache and mood changes resulting in frequent doctors visits. Patient also now is going through testing for auto-immune encephalitis.",,,,,,,,,U,03/20/2018,03/20/2018,0,,PVT,,"Singulair 4mg daily, Pulmicort 0.5mg/2ml BID",n/a,reactive airway disease,,,2,03/21/2018,,Y,,None
0838199,10/02/2019,AL,61.0,61,,M,10/02/2019,Felt faint about 1 hours after injection. Headache and fatigue.,,,,,,,,,Y,09/27/2019,09/27/2019,0,NA,PVT,OTH,Lisnopril,N/A,Hypertension,,,1,,,,,
0838200,10/02/2019,ID,66.0,66,,F,10/02/2019,Pt given Pneumovax in (L) arm 10/01/19. Within hours severe pain and very significant swelling. 5 hours later felt nauseated. Went to ER and was given Prednisone and diphenhydramine. Sent with the same Rx's to take for 4 days.,,,,Y,,,,,U,10/01/2019,10/01/2019,0,,OTH,PUB,"Simvastatin, lisinopril, levothyroxine, pantoprazole, gabapentin, Estrace",none,n/a,,,1,,,,,
0838201,10/02/2019,OH,,26,,F,,Pt noticed hives from top of left shoulder down to top of hand just red dots all over / no fever no SOB.,,,,,,,,,Y,09/30/2019,10/02/2019,2,,UNK,,None,None,None,,,2,10/02/2019,,Y,,NA
0838202,10/02/2019,IL,55.0,55,,F,,"Headache, muscle aches diarrhea felt very ""sick"" (3 day duration) Was going to go to ER but did not",,,,,,,,,Y,09/25/2019,,,None,PHM,,Unknown,unknown,unknown,,,2,10/01/2019,,,,NKA
0838203,10/02/2019,WA,6.0,6,,M,,"Swollen, erythymatous, sore & hot to the touch near & surrounding injection site. (4"" x 6"" area!)",,,,,,,,,N,09/24/2019,09/24/2019,0,N/A - Phone consult,PVT,,Multivitamin,None,None,,,2,09/27/2019,,,,None
0838204,10/02/2019,UT,16.0,16,,F,,Patient seen on 9/30/19 with right foot drop. Cannot roll her right foot when walking - weakness barrier. Received Bexsero vaccine in Right thigh on 09/11/19 and Menactra IM in left thigh on 9/11/19.,,,,,,,,,N,09/11/2019,09/14/2019,3,None - Appt. with Neurologist 10/9/19.,PVT,,None,None,None,,,2,10/02/2019,,Y,,None
0838210,10/02/2019,FL,,69,,F,10/02/2019,"Local irritation at / nearby injection site very red, hot, harden and swole area. Patient reports no systemic effects, was seen by her doctor w/ medications to reduce inflammation will monitor.",,,,,,,,,U,09/30/2019,10/01/2019,1,,OTH,PVT,,,,Red/swollen~Zoster (Shingrix)~1~69.00~Patient,,1,,,,,
0853285,10/02/2019,ME,,,,U,,"temperature excursion of Tenivac at an unknown extreme temperature, for a cumulative time of 10 minutes due to being prepared and then finding out the patient did not need the dose because of handling error/No AE; Initial information received on 02-Oct-2019 regarding an unsolicited valid non-serious case received from an other health care professional.  This case involves a patient of unknown demographics.  This case involves a temperature excursion of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] at an unknown extreme temperature, for a cumulative time of 10 minutes due to being prepared and then finding out the patient did not need the dose excursion was due to handling error (lot number: U6187AA and expiry date: 06-Feb-2021).  It was a potential medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA275258,2,10/09/2019,,,,
0837794,10/03/2019,CA,65.0,65,,M,,"patient states they felt pain and burning during vaccine, had fever for several days after, and that he still has pain in his arm and cannot move his arm.",,,,,,,,Y,U,09/10/2019,09/10/2019,0,"patient was referred to see his physician, but is out of the country currently and was advised to see his dr when he comes back.",PHM,,"tamsulosin, trospium cl, losartan atorvastatin, others unknown",unknown,"hypertension, high cholesterol, prostate issues",,,2,10/03/2019,,,,none noted
0837795,10/03/2019,WA,60.0,60,,F,,"patient had redness, swelling, and pain develop over a large area where the immunization was given. The area was about 3-4 inches across when I saw it. She had seen a physician, who diagnosised it  as possible cellulitis, per the patient. She was given antibiotics, cephalexin, to treat this.",,,,,,,,,U,09/30/2019,10/01/2019,1,none,PHM,,unknown,none,"neuropathy, depression",,,2,10/03/2019,,,Y,no allergies
0837796,10/03/2019,OH,92.0,92,,F,,"About 9:00 pm there was onset of nausea. Patient went to bed and at 9:30 pm began vomiting. This continued throughout the night, episodic about 12 times. The facility nurse came in and reported fever of 102 degrees at 10:30 pm and again at 12:00 am. Gave patient sips of water which she could not hold down. Put on ""sea bands"" at 1:00 am to help relieve nausea which helped enough to give patient Tylenol to help reduce fever. Vomiting subsided at about 2:00 am. At 10:00 am patient had some diarrhea and when she drank a sip of juice she vomitted twice. There was lingering nausea throughout the day but patient improved throughout the weekend.",,,,,,,,,Y,09/27/2019,09/27/2019,0,n/a,SEN,,"coumadin, Hydralazine, Losartan Potassium, Metoprolol Tartrate, Simvastatin, Spironolactone, Torsemide, Warfarin",n/a,"congestive heart failure, high blood pressure, high cholesterol",,,2,10/03/2019,,,,n/a
0837797,10/03/2019,IA,54.0,54,,F,,"Fever (~100) lasting more than 24 hours, severe body aches starting 8-9 hours after shots and lasting about 16 hours.",,,,,,,,,N,10/01/2019,10/01/2019,0,none,PHM,,"allegra-d, singulair, mucinex",none,dustmite allergy,,,2,10/03/2019,,,,none
0837798,10/03/2019,NJ,66.0,66,,F,,Swollen eyes Eye pain,,,,,,,,,U,09/28/2019,09/29/2019,1,,PVT,,Flonase Prolia Hydroxycoroquinr,Dermatomyositis,Dermatomyositis,,,2,10/03/2019,,Y,,None
0837799,10/03/2019,IL,47.0,47,,F,,The following morning after the flu injection I had severe pain to the bottom of my feet causing major difficulty in walking. The pain became progressively worse that day and had to stop walking several times that day. The pain was better by the evening and progressively improved by 9pm.  Still have tolerable mild pain but able to function.,,,,,,,,,Y,09/26/2019,09/27/2019,1,None,PHM,,None,None,None,,,2,10/03/2019,,,,None
0837800,10/03/2019,MD,65.0,65,,F,,"Flu like symptoms. Woke up in middle of the night feeling feverish, achy and shivering. No elevated temperature. Worked only a half day the following day due to similar, less severe symptoms and fatigue.",,,,,,,,,U,10/01/2019,10/02/2019,1,,PHM,,"Sodium sulfacetamide, plant-based calcium, tumeric, daily multivitamin, low-dose aspirin (81mg)",Cold,,,,2,10/03/2019,,,,Penicillin
0837811,10/03/2019,IL,4.0,4,,U,,"no adverse effect; patient received improperly stored PROQUAD; This spontaneous report was received from a nurse and refers to a 4-year-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies, drug reactions, allergies or medical history provided.     On 13-AUG-2019, the patient was vaccinated with one of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live albumin status rHA (PROQUAD) vaccines: lot # R023499, expiration date 13-FEB-2020 or lot # R026722, expiration date 17-MAR-2020 (strength, dose, frequency, route of administration and anatomical location were not reported). The vaccines were reconstituted with properly stored sterile diluent. The nurse stated that the vaccine experienced two temperature excursions on 12-AUG-2019 and on 13-AUG-2019. Neither were reported to the nurse until 06-SEP-2019. Administered dose of vaccine experienced the temperature excursion between minus 14 to minus 10 degrees Celsius, multiple minus 11.91 degrees Celsius for 8 hours. Data logger was involved. There was no previous temperature excursion. No adverse effects were reported.",,,,,,,,,U,08/13/2019,08/13/2019,0,,UNK,,STERILE DILUENT,,,,US0095075131909USA003228,2,10/03/2019,,,,
0837812,10/03/2019,WV,,,,U,,"No adverse effects reported; patient received a ""booster dose"" ofMMR II (R031680 exp 11/1/2020) on 5/15/2019 and then the patient received another dose of MMR II (S014430 exp 5/9/2021) on 9/13/2019; This spontaneous report as received from a medical assistant refers to a 44 year old patient of unknown gender. No information on patient's pertinent medical history, concomitant medication and drug reactions or allergies was provided.      On 15-MAY-2019, the patient was vaccinated with ""booster dose"" of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (recombinant human albumin (rHA) lot # R031680  has been verified to be a valid lot number, expiration date 01-NOV-2020, dose was not reported) ) subcutaneously, for prophylaxis. On 13-SEP-2019, the patient was vaccinated with another dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (recombinant human albumin(rHA) lot # S014430 has been verified to be a valid lot number, expiration date 09-MAY-2021, dose was not reported) ) subcutaneously, for prophylaxis. No adverse event was reported.",,,,,,,,,U,05/15/2019,09/13/2019,121,,UNK,,,,,,US0095075131909USA005948,2,10/03/2019,,,,
0837813,10/03/2019,CA,13.0,13,,U,,"No adverse effects reported; the Patient received improperly stored VARN AX; This spontaneous report was received from a medical assessment and refers to a 13-year-old patient. No information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On 13-AUG-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) lot # R023513, expiration date 16-AUG-2020 (strength, route of administration and dose were not reported) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (lot # S000130, expiration date 23-AUG-2021). No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion of -14 Celsius degrees (C) to -10 C (also reported as -13.2 C) for 46 minutes. The digital data logger was involved in recording the temperature excursion details. There were no previous excursions reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA007312: US-009507513-1909USA006939: US-009507513-1909USA007512: US-009507513-1909USA007118:",,,,,,,,,U,08/13/2019,08/13/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA007177,2,10/03/2019,,,,
0837814,10/03/2019,,,,,U,,"patient receied the second dose of GARDASIL 9, 30 days later.; no adverse effects reported; This spontaneous report was received from a consumer via company representative and refers to a 26-year-old patient of unknown gender. Patient's concurrent conditions, concomitant therapies, previous drug reactions, allergies, historical drugs or medical history were not reported.  On an unknown date, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). The second dose was administered 30 days later, on an unspecified date (strength, dose, frequency, route of administration, anatomical location, indication, lot #, and expiration date were not reported for both doses) (Drug dose administration interval too short). No adverse effects reported.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA007542,2,10/02/2019,,,,
0837815,10/03/2019,AR,,,,F,,"No adverse effects were reported; Administered a fourth dose of GARDASIL 9; This spontaneous report was received from a nurse, via company representative, referring to a 15-year-old female patient. The patient's pertinent medical history, concurrent conditions, previous drug allergies/reactions and concomitant medications were not reported.  On unspecified dates, the patient received the first, second and third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, anatomical location, route of administration, lot number and expiration date were not provided), as prophylaxis. On 23-SEP-2019, the patient was vaccinated with a fourth dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9)(extra dose administered)(concentration, dose, anatomical location, route of administration were not provided; lot number S008151 has been verified to be a valid lot number, and expiration date was reported and internally confirmed as 20-NOV-2021) as prophylaxis. No adverse effects were reported.",,,,,,,,,U,,09/23/2019,,,UNK,,,,,,US0095075131909USA014363,2,10/02/2019,,,,
0837816,10/03/2019,MO,,,,U,,"NO ADVERSE EFFECT; Nurse reports a patient received a dose of PROQUAD, when the patient should have received their second dose of MMR II; Patient receiveied their first dose of MMR II on 08/28/2019 and received the dose of PROQUAD on 09/25/2019.; Nurse reports a patient received a dose of PROQUAD, when the patient should have received their second dose of MMR II; This spontaneous report was received from a nurse referring to a 7 years patient of unknown gender. The patient's current condition, pertinent medical history, concomitant medications, drug reaction/ allergies were not reported. On 28-AUG-2019, patient received their first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (dose, strength, lot number, expiry date, frequency, route of administration were not reported) for prophylaxis. On 25-SEP-2019, the patient was administered with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) of lot number R030804, expiry date 22-APR-2020, therapy type rHA(dose, strength, frequency were not reported) via subcutaneous route for prophylaxis, when the patient should have received their second dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (dose, strength, lot number, expiry date, frequency, route of administration were not reported) for prophylaxis(interchange of vaccine products) (wrong product administered)(inappropriate schedule of product administration)(adverse event onset date was also reported as 26-SEP-2019). No adverse effects were reported. There was no product quality complaint (PQC) present. The outcome of the events was unknown.",,,,,,,,,U,08/28/2019,09/25/2019,28,,UNK,,,,,,US0095075131909USA014568,2,10/03/2019,,,,
0837817,10/03/2019,WA,,33,,F,,"A patient received a dose of VARIVAX, then on 09/25/2019, the patient had a positive urine pregnancy test; This spontaneous prospective pregnancy report was received from a physician concerning to a female patient of unknown age. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported.     On 17-SEP-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX), subcutaneously, for prophylaxis (strength, dose, frequency, lot # and expiration date were not provided), then on 25-SEP-2019, a urine pregnancy test was performed and showed that the patient was pregnant (exposure during pregnancy). The gestation was 4 weeks and 3 days as of 30-SEP-2019. The last menstrual period was estimated as 30-AUG-2019 and the estimated date of conception was estimated to 05-JUN-2020.The pregnancy outcome was outcome pending.",,,,,,,,,U,09/17/2019,,,Test Date: 20190925; Test Name: Urine pregnancy test; Test Result: Positive,UNK,,,,,,US0095075131910USA000954,2,10/02/2019,,,,
0837818,10/03/2019,NY,,4,,U,,"No adverse effects.; A patient was administered improperly stored PROQUAD.; This spontaneous report was received from a Medical Assistant referring to a 4 year old patient. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On 30-AUG-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA)(PROQUAD) with lot # S009759 and expiration date 27-SEP-2020 (strength, route, dose, frequency, and anatomical location were unknown) for prophylaxis. The sterile diluent(MERCK STERILE DILUENT) that was used to reconstitute the measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA)(PROQUAD)  was properly stored.   The administered dose of the vaccines experienced the temperature excursion of 15F to 46F (17.6 F) degrees Fahrenheit  for 56 hours and 40 minutes and a previous excursion of 6 F to 14F (6.2 F) degrees Fahrenheit  for 10 minutes  There was no digital data logger invloved,and no adverse effects reported.",,,,,,,,,U,08/30/2019,08/30/2019,0,,UNK,,MERCK STERILE DILUENT,,,,US0095075131910USA001263,2,10/02/2019,,,,
0837819,10/03/2019,,,,,F,,"experienced soreness in the arm; This spontaneous report was received from a consumer referring to herself, a female patient of unknown age. The patient did not have any pertinent medical history, concurrent conditions, drug reactions or allergies. No information was provided regarding the patient's concomitant medications.  On an unknown date in 2013, the patient was vaccinated with an unspecified zoster vaccine live (manufacturer unknown) in the left arm as prevention of shingles (dose, dose number, route of administration, lot number and expiration date were not reported).  On an unknown date in 2013, the patient experienced soreness in the arm (pain in extremity). The patient did not seek for medical attention and did not received any treatment; but she recovered from the event.  At the time of the report, the causality assessment between pain in extremity and zoster vaccine live (manufacturer unknown) was not reported.",,,,,,,,,Y,,,,,UNK,,,,,,US0095075131910USA001340,2,10/02/2019,,,,
0837820,10/03/2019,CA,,,,F,,"A pient experienced a lot of swelling in her arm  after receiving her first dose of GARDASIL 9; This spontaneous report was received from a physician via company representative referring to a 14 year old female patient. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.     On an unknown date, during a routine checkup, the patient experienced  a lot of swelling in her arm (peripheral swelling ) after receiving her first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (strength, route, dose, frequency, anatomical location, indication, lot # and expiration date were unknown) for prophylaxis.    At the time of the report, the outcome of peripheral swelling was unknown. The reporter did not mention the causality assessment between the event and  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) vaccination.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131910USA001671,2,10/02/2019,,,,
0837821,10/03/2019,NJ,,,,M,,"no adverse effect; 2 doses administered over the age of 65 years and more than 5 years apart; This spontaneous report as received from a pharmacist refers to a 86 year old male patient. The patient's medical history, concurrent conditions and concomitant medications were not reported.       On an unknown date in 2013 and 2019, the patient was subsequently vaccinated with first and second dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (dose, anatomical location, Lot # and expiry date was not reported) for prophylaxis (inappropriate schedule of product administration). On an unknown date in 2015, the patient was vaccinated with pneumococcal 13v conj vaccine (crm197)(PREVNAR 13) (dose, anatomical location, Lot # and expiry date was not reported). There was no adverse event reported.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131910USA002589,2,10/03/2019,,,,
0837822,10/03/2019,,,,,U,,"No adverse effect reported; expired dose of VAQTA was administered; This spontaneous report was received from a medical assistant refers to a patient of unknown age. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 30-SEP-2019 the patient was vaccinated with  expired dose of hepatitis a vaccine, inactivated(VAQTA) (lot # R027431, expiry date: 08-SEP-2019, route and anatomical location were not reported) for prophylaxis (expired product administered). No adverse effect reported. No additional information provided.",,,,,,,,,U,09/30/2019,09/30/2019,0,,UNK,,,,,,US0095075131910USA002606,2,10/03/2019,,,,
0837823,10/03/2019,,16.0,,,M,,"Several pin sizes to quart size non inflammed and non-colored palpulas; Information has been downloaded from regulatory authority (US-CHIRONMA-PHHY2014US001265).  This spontaneous report was received from a health professional refers to a 16 years old male patient. The patient's medical history, concurrent conditions and concomitant medications were not reported.   On 24-AUG-2019, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (batch/lot number# H021608, expiry date not reported but upon internal validation established as 13-AUG-2015) one dosage form via intramuscular route for immunization and varicella virus vaccine live (oka/merck) (VARIVAX) (batch/lot number# J003219, expiry date not reported but upon internal validation established as 15-MAR-2015) one dosage form via subcuteneous route for immunization.  On the same day, the patient received other co suspects included meningococcal acyw conj vaccine (crm197) (MENVEO) injection(batch/lot number# M12130, expiry date not reported) one dosage form(1 DF) via intramuscular route for immunisation and diphtheria toxoid, pertussis acellular 5-component vaccine, tetanus toxoid( ADACEL) (batch/lot number#U4567AA, expiry date not reported) one dosage form via intramuscular route for immunization.  On 31-AUG-2013, the patient experienced several pin sizes to quart size non inflammed and non-colored palpulas (palpable purpura). The outcome of palpable purpura was reported as recovered. The relatedness between the event and meningococcal acyw conj vaccine (crm197) (MENVEO) was suspected. The relatedness between the event and other suspect therapies was not provided.  The Agency considered the event palpable purpura as medically siginificant.; Sender's Comments:  509674:",,,,,,,,,Y,08/24/2013,08/31/2013,7,,UNK,,,Immunisation; Immunization,,,US0095075131909USA014057,2,10/03/2019,,,,
0837824,10/03/2019,AL,,,,F,,"Guillain-Barre Syndrome; This case was reported by a consumer via call center representative and described the occurrence of guillain barre syndrome in a female patient who received Flu Seasonal TIV Dresden (Flu trivalent vaccine) for prophylaxis.   On an unknown date, the patient received Flu trivalent vaccine at an unknown dose. On an unknown date, less than a year after receiving Flu trivalent vaccine, the patient experienced guillain barre syndrome (serious criteria death and GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was fatal. The reported cause of death was guillain barre syndrome.   It was unknown if the reporter considered the guillain barre syndrome to be related to Flu trivalent vaccine  Additional details were received as follows: The age at vaccination was not reported. The patient had a flu injection in 1978, and experienced Guillain-Barre Syndrome, and died on 23rd August 2018. The reporter consented to follow up. This case was linked with case US2019170062, reported by same reporter.; Reported Cause(s) of Death: Guillain Barre syndrome",Y,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837825,10/03/2019,GA,,,,F,,"Swelling; This case was reported by a physician via call center representative and described the occurrence of swelling arm in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced swelling arm. On an unknown date, the outcome of the swelling arm was unknown.   It was unknown if the reporter considered the swelling arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that the patient received the Shingrix vaccine and experienced swelling of her whole upper arm. Unable to obtain additional details. This is 1 of 3 cases reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837826,10/03/2019,CA,72.0,72,,F,,"pain; chileed; cant walk; worsened condition; fever; nausea; headache; This case was reported by a consumer via call center representative and described the occurrence of headache in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of headache (1st dose received in June 2019, experienced right knee and ankle sore, refer linked case US2019172858).   On 19th September 2019, the patient received the 2nd dose of Shingrix. On 19th September 2019, less than a day after receiving Shingrix, the patient experienced headache, fever and nausea. On 20th September 2019, the patient experienced knee pain, chills, walking difficulty and condition aggravated. On 21st September 2019, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the headache, knee pain, nausea, chills, walking difficulty and condition aggravated were unknown.   It was unknown if the reporter considered the headache, knee pain, fever, nausea, chills, walking difficulty and condition aggravated to be related to Shingrix.  Additional information received were as follows: On Thursday, the patient received Shingrix in her left arm. On the same night, the patient experienced headache with a fever and nausea. 1 day after receiving Shingrix, the patient was chilled and knees started to hurt. The patients left knee was sore and her left ankle. The knee pain was still unresolved after 10 days but the others side effects had resolved. The patient reported that the second injection had a lot more side effects than the first vaccination. The patient had a fever for two days. The patient reported that she was in pain and she cannot walk. The patient had previous flares of knee pain but the pain had worsened after the vaccination. The patient use to run two miler per day and at the reporting date, she cannot walk across her house. The reporter consented to follow up. The reporter reported that they follow-up directly with the patient.",,,,,,,,,Y,09/19/2019,09/19/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837827,10/03/2019,,,,,U,,"Muscle pain; This case was reported by a consumer and described the occurrence of muscle pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th August 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced muscle pain. On an unknown date, the outcome of the muscle pain was unknown.   It was unknown if the reporter considered the muscle pain to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient experienced muscle pain which still persisted at the reporting date. The patient asked that how long would the muscle pain continue.",,,,,,,,,U,08/14/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837828,10/03/2019,,,,,U,,"Fever; This case was reported by a consumer and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient was just wondering how high the fever could get as a side effect of taking the Shingrix. The patient thanked and asked how high the fever could get low grade or 102.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837829,10/03/2019,CA,65.0,65,,F,,"fever; chills; rash on her breast; This case was reported by a consumer via call center representative and described the occurrence of fever in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included breast cancer (breast cancer in one breast treated with radiation). Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received in early June 2019, refer linked case US2019172899).   On 12th August 2019, the patient received the 2nd dose of Shingrix. On 12th August 2019, less than a day after receiving Shingrix, the patient experienced fever and chills. In August 2019, the patient experienced generalized rash. The patient was treated with cortisone (non-proprietary) (Cortisone Cream). On an unknown date, the outcome of the fever, chills and generalized rash were unknown.   It was unknown if the reporter considered the fever, chills and generalized rash to be related to Shingrix.  Additional information received were as follows: The patient's medical condition included hyperimmune system. The patient experienced fever and chills which started later the day of vaccination. The patient missed work the following day but these symptoms resolved and she was able to go to work on 14th August 2019. Within 2 weeks of the 2nd dose, the patient experienced a small triangle size rash on one of her breast. The patient kept an eye on it and it continued to get bigger.  The patient was given cortisone cream which helped but at the reporting date it had come back and spread to her other breasts and parts of her body. The reporter consented to follow up. Emergency room visit required.",,,,,,,,,U,08/12/2019,08/01/2019,,,UNK,,,,Medical History/Concurrent Conditions: Breast cancer (breast cancer in one breast treated with radiation),,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837830,10/03/2019,,,,,U,,"Fever; This case was reported by a consumer and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per vaccine indication. The patient experienced fever with Shingrix. The patient prefered not to give information.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837831,10/03/2019,TX,73.0,73,,U,,"vomiting; like having the flu; severe rash; swelling; fever; chills; aching in my stomach; gut wrenching; been sick; This case was reported by a consumer via call center representative and described the occurrence of sickness in a 73-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2018-2019 season) for prophylaxis.   The patient's past medical history included measles (had red measles). Previously administered products included Shingrix with an associated reaction of malaise (1st dose received on unknown date and had sickness).   On 19th September 2019, the patient received the 2nd dose of Shingrix and Influenza vaccine Quadrivalent 2018-2019 season. On 22nd September 2019, 3 days after receiving Shingrix and Influenza vaccine Quadrivalent 2018-2019 season, the patient experienced stomach pain and gut wrenching. On an unknown date, the patient experienced sickness, vomiting, influenza like illness, rash, swelling, fever and chills. On an unknown date, the outcome of the sickness and vomiting were recovered/resolved and the outcome of the influenza like illness, rash, swelling, fever, chills, stomach pain and gut wrenching were unknown.  Additional details were provided as follows: The patient received dose of Shingrix in the right arm and flu vaccine in the left arm. After vaccination, the patient had sickness for 2days after each dose. The patient laso had vomitting but not diarrhea and crunching on ice and having like flu. After vaccination, the patient had severe rash, swelling, fever and chills and contacted with doctor's because of more concern for heart. After vaccination, the patient had gut wrenching, aching in stomach before bed time. Less than a week, after vaccination with dose of shingrix and Flu vaccine, the patient had sickness, vomiting, influenza like illness, rash, swelling, fever, chills and adverse drug reaction.  It was unknown if the reporter considered the sickness, vomiting, influenza like illness, rash, swelling, fever, chills, stomach pain and gut wrenching to be related to Shingrix and Influenza vaccine Quadrivalent 2018-2019 season.",,,,,,,,,Y,09/19/2019,09/22/2019,3,,UNK,,,,Medical History/Concurrent Conditions: Measles (had red measles),,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837832,10/03/2019,CO,,,,F,,"Felt ill; This case was reported by a pharmacist via sales rep and described the occurrence of feeling unwell in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of malaise (received 1st dose on unknown date, refer case US2019AMR174219).   On 20th September 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced feeling unwell. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the feeling unwell was recovered/resolved.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and felt ill. The reporter would amend report with additional details once received.  The report incomplete as the reporter did not have adequate time to discuss.",,,,,,,,,Y,09/20/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837833,10/03/2019,CO,,,,F,,"Felt ill; This case was reported by a pharmacist via sales rep and described the occurrence of feeling unwell in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix .5 ml. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was recovered/resolved.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and felt ill. The reporter would amend report with additional details once received.  The report incomplete as the reporter did not have adequate time to discuss. For tolerances of 2nd dose, refer case US2019AMR174202, reported by same reporter.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837835,10/03/2019,MA,,,,U,,"The injection itself was extremely painful; Burning feeling, while it was being administered; This case was reported by a nurse and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced injection site pain and burning sensation. On an unknown date, the outcome of the injection site pain and burning sensation were unknown.   It was unknown if the reporter considered the injection site pain and burning sensation to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient reported that the injection itself was extremely painful, in addition to a burning feeling, while it was being administered. The nurse giving the injection stated that this vaccine is always extremely painful to patients. The patient wanted to know that neither  Z-track method or changing the needle after reconstituting the vaccine was mentioned in the Shingrix video or insert also will lyophilized antigen Ig used to reconstitute Shingrix interfere with an IgE blood level test which was drawn the same day?",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837836,10/03/2019,,,,,U,,"Area is red; This case was reported by a consumer and described the occurrence of injection site erythema in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was unknown.   It was unknown if the reporter considered the injection site erythema to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group adult was selected as per vaccine indication. The patient got shingles 2nd shot and the area was red.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837837,10/03/2019,,,,,U,,"Flu like symptoms; This case was reported by a consumer and described the occurrence of influenza-like symptoms in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. The patient experienced flu like symptoms after the 2nd dose of Shingrix. The patient asked how long did flu like symptoms last?",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837838,10/03/2019,,75.0,75,,U,,"Headache; My vision is off; This case was reported by a consumer and described the occurrence of headache in a 75-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd September 2019, the patient received Shingrix. On 24th September 2019, 1 days after receiving Shingrix, the patient experienced headache and visual impairment. On an unknown date, the outcome of the headache and visual impairment were unknown.   It was unknown if the reporter considered the headache and visual impairment to be related to Shingrix.  Additional details were provided as follows: The patient reported that the after receiving Shingrix shot yesterday, the patient woke up with a monster of a head ache. The patient's vision was off.",,,,,,,,,U,09/23/2019,09/24/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837839,10/03/2019,TX,,,,F,,"Allergic reaction; Racing heart rate; Feeling dizzy; Trouble swallowing; This case was reported by a consumer and described the occurrence of allergic reaction in a female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) (batch number 3N4F7, expiry date 30th June 2020) for prophylaxis.   On 23rd September 2019, the patient received Fluarix Quadrivalent 2019-2020 season. On 23rd September 2019, less than an hour after receiving Fluarix Quadrivalent 2019-2020 season, the patient experienced allergic reaction, heart racing, dizziness and swallowing difficult. On an unknown date, the outcome of the allergic reaction, heart racing, dizziness and swallowing difficult were unknown.   It was unknown if the reporter considered the allergic reaction, heart racing, dizziness and swallowing difficult to be related to Fluarix Quadrivalent 2019-2020 season.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the Fluarix QIV vaccine yesterday and experienced an allergic reaction, within 10 minutes started having a racing heart rate, feeling dizzy, and trouble swallowing. The patient contacted with pharmacy but she was looking to report the reaction to the manufacturer as well. The patient would like a list of ingredients of this specific vaccine so she could know what to avoid in future vaccines.",,,,,,,,,U,09/23/2019,09/23/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837840,10/03/2019,,,,,M,,"Fever; Weakness; Fatigue; This case was reported by a consumer via call center representative and described the occurrence of fever in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever, weakness and fatigue. On an unknown date, the outcome of the fever, weakness and fatigue were unknown.   It was unknown if the reporter considered the fever, weakness and fatigue to be related to Shingrix.  Additional case details were provided as follows: The patient reported for himself. The age at vaccination was not reported. The patient experienced fever, weakness and fatigue after receiving Shingrix. The patient declined to provide his contact information.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837841,10/03/2019,CA,71.0,71,,F,,"right knee and ankle were sore; headache; This case was reported by a consumer via call center representative and described the occurrence of headache in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included sjogren's syndrome.   In June 2019, the patient received the 1st dose of Shingrix (intramuscular). In June 2019, less than a day after receiving Shingrix, the patient experienced headache. On an unknown date, the patient experienced pain. On an unknown date, the outcome of the headache was recovered/resolved and the outcome of the pain was unknown.   It was unknown if the reporter considered the headache and pain to be related to Shingrix.  Additional details were provided as follows: The patient had the first dose of Shingrix in June 2019 on left arm and had a headache that night but it was gone the next morning. Her right knee and ankle were also sore. The patient consented to follow up. This case has been linked with case US2019AMR173285, reported by the same reporter.",,,,,,,,,Y,06/01/2019,06/01/2019,0,,UNK,,,Sjogren's syndrome,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837842,10/03/2019,CA,65.0,65,,F,,"sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included breast cancer (breast cancer in one breast treated with radiation). Concurrent medical conditions included immune system disorder (hyperimmune system).   In June 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in early June in the left arm and the only effect she experienced was a sore arm that resolved within several days. The reporter consented to follow up. Emergency room visit required. For tolerances of 2nd dose, refer case US2019AMR173490, reported by same reporter for the same patient.",,,,,,,,,Y,06/01/2019,,,,UNK,,,Immune system disorder (hyperimmune system),Medical History/Concurrent Conditions: Breast cancer (breast cancer in one breast treated with radiation),,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,Y,
0837843,10/03/2019,GA,,,,F,,"redness; rash; Injection site swelling; lip tingling; This case was reported by a other health professional via call center representative and described the occurrence of injection site swelling in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2019, the patient received the 1st dose of Shingrix. In September 2019, 2 days after receiving Shingrix, the patient experienced injection site swelling, tingling lips and rash. On an unknown date, the patient experienced erythema. On an unknown date, the outcome of the injection site swelling, tingling lips, erythema and rash were unknown.   It was unknown if the reporter considered the injection site swelling, tingling lips, erythema and rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number was not reported. The patient received Shingrix last week, and two days later she developed the following symptoms lip tingling; injection site swelling, redness, and rash.  The reporter consented to follow up. The reporter declined to provide date of birth.  The vaccine was administered elsewhere.; Sender's Comments: Medical assistant reported that a patient received her first dose of Shingrix last week, and two days later she developed the following symptoms: lip tingling; injection site swelling, redness, and rash. Consented to follow up.Call Notes:Reporter declined to provide DOB. Vaccine was administered elsewhere, so the lot # was not available.",,,,,,,,,U,09/01/2019,09/01/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837844,10/03/2019,NJ,68.0,68,,F,,"Sore Arm; Itching; Redness; Hot area; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th July 2019, the patient received the 1st dose of Shingrix (intramuscular) 50 g. On 31st July 2019, 1 days after receiving Shingrix, the patient experienced pain in arm, pruritus, erythema and skin warm. The patient was treated with non-drug therapy (Warm Compress) and benadryl (nos) (Benadryl). On an unknown date, the outcome of the pain in arm, pruritus, erythema and skin warm were recovered/resolved.   It was unknown if the reporter considered the pain in arm, pruritus, erythema and skin warm to be related to Shingrix.  Additional details were provide as follows: The patient received dose of Shingrix in the left arm. After vaccination with dose of Shingrix, experienced sore arm, which lasted for 5 to 7 days. The patient also experienced redness, itching and hot area starting from the site of injection site to above the elbow for about 5 to 7 days. No further details were provided. The patient did not consent to follow up.",,,,,,,,,Y,07/30/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837845,10/03/2019,SC,55.0,,,F,,"heartburn; This case was reported by a consumer via call center representative and described the occurrence of heartburn in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 2 days after receiving Shingrix, the patient experienced heartburn. On an unknown date, the outcome of the heartburn was recovering/resolving.   It was unknown if the reporter considered the heartburn to be related to Shingrix.  Additional details were provided as follows: The patient stated that approximately 2 days after receiving the vaccine, she developed heartburn. The patient did not consent to follow up. The patient did not provide any additional information.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837846,10/03/2019,PA,56.0,56,,F,,"Itching; Redness; This case was reported by a pharmacist via call center representative and described the occurrence of injection site itching in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number 9H524, expiry date 22nd October 2021) for prophylaxis.   On 10th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 10th September 2019, less than a day after receiving Shingrix, the patient experienced injection site itching and injection site erythema. On an unknown date, the outcome of the injection site itching and injection site erythema were recovering/resolving.   It was unknown if the reporter considered the injection site itching and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient developed an itchy red area around the infection site the evening the product was administrated. The reporter stated that after about 11 days, the patient came in and the itching and redness were improving and have been improving everyday. The reporter consented to follow up.",,,,,,,,,N,09/10/2019,09/10/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,Y,,
0837847,10/03/2019,MA,,,,F,,"fever; muscle aches; body aches; This case was reported by a physician via call center representative and described the occurrence of fever in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number 52R7X, expiry date 10th October 2021) for prophylaxis.   On 22nd July 2019, the patient received the 1st dose of Shingrix (intramuscular). On 22nd July 2019, less than a day after receiving Shingrix, the patient experienced fever. On an unknown date, the patient experienced muscle pain and general body pain. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the fever, muscle pain and general body pain were recovered/resolved.   It was unknown if the reporter considered the fever, muscle pain and general body pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be between 55 or 56 years. The reporter stated that the patient developed fever, muscle aches and body aches following her first dose of Shingrix. The reporter stated that, the patient within 24 hours of vaccination called the MD stating she had a fever. The fever went up to 101 F. The patient took with good effects. The reporter stated that the fever was followed by muscle aches throughout the week. The Tylenol helped with that too. The patient also experienced body aches. Onset  and resolution time of muscle aches and body aches was unknown. The physician believed that the symptoms resolved within 24-48 hours because the patient would have called otherwise. The reporter consented to follow up. The reporter did not wish to provide patient's dob or initials.",,,,,,,,,Y,07/22/2019,,,"Test Date: 20190722; Test Name: Body temperature; Result Unstructured Data: Test Result: 101, Test Result Unit: degree F",UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,Y,,
0837848,10/03/2019,,77.0,76,,M,,"Headache; Heart rate rose to 88 Beats per minute; This case was reported by a consumer via call center representative and described the occurrence of headache in a 77-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th September 2019, the patient received the 1st dose of Shingrix. On 24th September 2019, less than a day after receiving Shingrix, the patient experienced headache and heart rate increased. On an unknown date, the outcome of the headache and heart rate increased were not recovered/not resolved.   It was unknown if the reporter considered the headache and heart rate increased to be related to Shingrix.  Additional details were provided as follows: A patient reported that he received the 1st dose of Shingrix yesterday and developed a headache not resolved by the next day.  He also stated that his heart rate rose to 88 Beats per minute. The reporter consented to follow up.",,,,,,,,,N,09/24/2019,09/24/2019,0,"Test Date: 20190924; Test Name: Heart rate increased; Result Unstructured Data: Test Result: 88, Test Result Unit: beats/min",UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837849,10/03/2019,TN,24.0,24,,F,,"Vaccine Administered at Inappropriate Site; erythema at injection site; warmth at injection site; induration at injection site; This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 24-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) (batch number 2LL97, expiry date 30th June 2020) for prophylaxis.   On 24th September 2019, the patient received Fluarix Quadrivalent 2019-2020 season (intramuscular). In September 2019, less than a week after receiving Fluarix Quadrivalent 2019-2020 season, the patient experienced injection site erythema, injection site warmth and injection site induration. On 24th September 2019, the patient experienced vaccine administered at inappropriate site. On an unknown date, the outcome of the injection site erythema, injection site warmth and injection site induration were not recovered/not resolved and the outcome of the vaccine administered at inappropriate site was unknown.   It was unknown if the reporter considered the injection site erythema, injection site warmth and injection site induration to be related to Fluarix Quadrivalent 2019-2020 season.  Additional details were reported as follows: Caller was a nurse practitioner in a hospital.  One of the hospital employees received a dose of Fluarix and caller states that the vaccine was not injected into the deltoid muscle.  The vaccine was injected in the left arm below the deltoid, and more in the tricep area, which led to vaccine administered at inappropriate site. The patient had developed erythema and induration at the injection site and the injection site was warm to the touch.  The erythematous area was approximately 9 cm by 7 cm in size. Emergency room visit required. Caller did not provide any additional details.",,,,,,,,,N,09/24/2019,09/01/2019,,,PVT,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,Y,
0837850,10/03/2019,CA,65.0,65,,F,,"Inappropriate schedule of vaccine; Circumstance or information capable of leading to medication error; mildly fluish; very sore arm; achy; tired; headache; ""out of it""; This case was reported by a other health professional via call center representative and described the occurrence of influenza in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 12th August 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On 13th August 2019, 1 days after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced influenza, pain in arm, pain, tiredness, headache and spaced out. On an unknown date, the patient experienced drug dose administration interval too short and circumstance or information capable of leading to medication error. On an unknown date, the outcome of the influenza, pain in arm, pain, tiredness, headache and spaced out were recovered/resolved and the outcome of the drug dose administration interval too short and circumstance or information capable of leading to medication error were unknown.   It was unknown if the reporter considered the influenza, pain in arm, pain, tiredness, headache and spaced out to be related to Shingrix.  Additional details were reported as follows: Health care provider was also the patient.  Asking about receiving the second dose of Shingrix before 2 months.  Also reported feeling mildly fluish, very sore arm, headache, tired, ""out of it"" the next day. AE reported for the possibility of early dose administered, which led to shortening of the vaccination schedule and or information capable of leading to medication error.  The patient or HCP did not state that they would be receiving the second dose early, this was a near miss.   No lot number or expiry date of vaccine available since nothing had been administered. The reporter did not give consent to follow up.",,,,,,,,,N,08/12/2019,08/13/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837851,10/03/2019,KY,0.33,,,U,,"Rash; Hives/broke out in an urticarial hive/raised welts; Inappropriate schedule of vaccine; This case was reported by a physician via call center representative and described the occurrence of rash in a 4-month-old patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PREVNAR) for prophylaxis and PENTACEL for prophylaxis.   On an unknown date, the patient received the 2nd dose of Engerix B, PREVNAR at an unknown dose and PENTACEL at an unknown dose. On an unknown date, less than a year after receiving Engerix B, the patient experienced rash, hives and drug dose administration interval too long. On an unknown date, the outcome of the rash and hives were recovered/resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the rash and hives to be related to Engerix B.  Additional details were received as follows: MD reported that a 4 month old received the second dose of Hep B 4 months after the first dose was received as a newborn.  Second dose of Hep B was administered at the MD's office. This led to lengthening of vaccination schedule. The physician stated that he is not certain of the vaccine used for the first dose, unsure of the vaccine used for the second dose, but he was pretty sure that the second dose was Engerix-B.  After the infant received the Hep B vaccination, they broke out in an urticarial hive rash around the back of its neck and behind its ear, raised welts.  The rash lasted a couple of days, infant is doing fine now.  Infant also received Pentacel and Prevnar. Physician was not at the office, unable to provide vaccine name or lot/exp, no patient information available. The reporter consented to follow up.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837852,10/03/2019,VA,,0,.5,F,,"5 months old female patient who received DTaP-IPV diluent separately and did not receive ACT-HIB powder portion of pentacel, no AE; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA257163 and 2019SA261801 (same reporter).   This case involves a 5 months old female patient who received DTaP-IPV diluent separately and did not receive ACT-HIB powder portion of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [Pentacel] (lot: UJ060AA, expiry vdate: 04-Oct-2020, the outer carton is lot: UJ060AAA, expiry date: 04-Oct-2020) via unknown route in the left thigh, on 27-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccinations included ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) and PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13).  It was a case of actual medication error due to inappropriate reconstitution technique.  At a time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/27/2019,,,,UNK,,PREVNAR 13; ROTAVIRUS VACCINE,,,,USSA2019SA261800,2,09/26/2019,,,,
0837853,10/03/2019,VA,0.33,0,.4,F,,"patient who received only the DTaP-IPV diluent portion of the Pentacel vaccine and not of ActHIB powder, no AE; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA257163 and 2019SA261800 (same reporter).   This case involves a 4 months old female patient who received DTaP-IPV diluent separately and did not receive ACT-HIB powder portion of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [Pentacel] (lot: UJ060AA, expiry vdate: 04-Oct-2020, the outer carton is lot: UJ060AAA, expiry date: 04-Oct-2020) via unknown route in the left thigh, on 28-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccinations included ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) and PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13).  It was a case of actual medication error due to inappropriate reconstitution technique.  At a time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/28/2019,,,,UNK,,PREVNAR 13; ROTAVIRUS VACCINE,,,,USSA2019SA261801,2,09/26/2019,,,,
0837854,10/03/2019,CA,,,,F,,"flu like symptoms; chills; dizziness; fever; night sweats; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a other non health care professional (Pharmacy-Other).  This case involves a female patient who experienced night sweats (night sweats), flu like symptoms (influenza like illness), chills (chills), dizziness (dizziness), fever (pyrexia), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), and family history were not provided. It was reported that she has never had a reaction over the last 20 plus years of getting the flu shot.   On an unknown date, the patient received 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UT6647MA, exp date: 30 June 2020 via unknown route in unknown administration site.  On an unknown date, the patient had night sweats (night sweats), flu like symptoms (influenza like illness), chills (chills), dizziness (dizziness), fever (pyrexia) in the evening same day following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Lab data was not reported.  Final diagnosis was fever, dizziness, chills, flu like symptoms and night sweats.   It was not reported if the patient received a corrective treatment.  The patient was recovered from all the events on an unspecified date.  List of document held by sender: none.",,,,,,,,,Y,,,,,UNK,,,,,,USSA2019SA262369,2,09/30/2019,,,,
0837855,10/03/2019,UT,,,,U,,"was given the invalid ActHIB also asked how many hours is the vaccine viable for use after mixed and drawn up in syringe/ no AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a non-hcp (Office Staff).  This case involves a 4 months old patient who was administered HIB (PRP/T) VACCINE [ACT-HIB] lot UJ176AA (Expiry date unknown) via intramuscular route in the right vastus lateralis, on 12-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13), ROTAVIRUS VACCINE (ROTAVIRUS VACCINE),ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) and DIPHTHERIA VACCINE TOXOID, HEPATITIS B VACCINE RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (PEDIARIX) .   It was an actual medication error case due extra dose administered.   It was reported that child that was given the invalid ActHIB was 4 months old and this was a Well Child Check Up in live follow up reported that She also asked how many hours is the vaccine viable for use after mixed and drawn up in syringe and stored properly in refrigerator?  It was unknown whether the patient had any adverse reactions.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/12/2019,,,,UNK,,PREVNAR 13; ROTAVIRUS VACCINE; ROTATEQ; PEDIARIX,,,,USSA2019SA262821,2,09/27/2019,,,,
0837856,10/03/2019,PA,,,,U,,"unable to draw up 0.5 mL of Fluzone (multi-dose vial) while administering it to a nine years old patient they cannot administer the whole product into the skin because they feel pressure when they press down/No AE; unable to draw up 0.5 mL of Fluzone (multi-dose vial) while administering it to a nine years old patient they cannot administer the whole product into the skin because they feel pressure when they press down/No AE; Initial information received on 18-Sep-2019 and additional information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a nine years old patient (gender unknown).  In this case it was reported that they were unable to draw up 0.5 ml of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] (multi-dose vial) while administering it to the patient, they cannot administer the whole product into the skin because they feel pressure when they press down lot number: UJ237AB, expiry date: 30-Jun-2020 via unknown route in unknown administration site on an unknown date.  It was a case of vaccine underdose and liquid product flow abnormal.  It was unknown whether patient experienced any adverse event following vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA263366,2,09/30/2019,,,,
0837857,10/03/2019,GA,20.0,20,,F,,"a female patient received a 0.5 ml dose of Fluzone Quadrivalent which was already expired on 30Jun2019/No AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case is linked to cases 2019SA263392, 2019SA263393 and 2019SA263394 (same reporter).  This case involves a 20 years old female patient who received a 0.5 ml dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] Prefilled syringes which was already expired on 30-Jun-2019 lot UJ041AB via unknown route in the left deltoid on 17-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to expired vaccine used.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/17/2019,,,,UNK,,,,,,USSA2019SA263367,2,09/27/2019,,,,
0837858,10/03/2019,GA,36.0,36,,F,,"a female patient received a 0.5 ml dose of Fluzone Quadrivalent which was already expired on 30Jun2019/No AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case is linked to cases 2019SA263367, 2019SA263393 and 2019SA263394 (same reporter).  This case involves a 36 years old female patient who received a 0.5 ml dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] Prefilled syringes which was already expired on 30-Jun-2019 lot UJ041AB via unknown route in the right deltoid on 17-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to expired vaccine used.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/17/2019,,,,UNK,,,,,,USSA2019SA263392,2,09/27/2019,,,,
0837859,10/03/2019,GA,20.0,20,,F,,"a female patient received a 0.5 ml dose of Fluzone Quadrivalent which was already expired on 30Jun2019/No AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case is linked to cases 2019SA263392, 2019SA263367 and 2019SA263394 (same reporter).  This case involves a 20 years old female patient who received a 0.5 ml dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] Prefilled syringes which was already expired on 30-Jun-2019 lot UJ041AB via unknown route in the right deltoid on 17-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to expired vaccine used.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/17/2019,,,,UNK,,,,,,USSA2019SA263393,2,09/27/2019,,,,
0837860,10/03/2019,GA,,,,F,,"patient received a 0.5 ml dose of Fluzone Quadrivalent which was already expired on 30Jun2019/No AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case is linked to cases 2019SA263392, 2019SA263393 and 2019SA263367.  This case involves a female patient (age unknown) received a 0.5 ml dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] Prefilled syringes which was already expired on 30-Jun-2019 lot UJ041AB via unknown route in the left deltoid on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to expired vaccine used.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA263394,2,09/27/2019,,,,
0837861,10/03/2019,UT,,,,U,,"reconstituted the dry lyophilized component of the Hib vaccine with a sterile diluent and not the diluent provided in the packaging, no AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves an unknown demographic patient who was vaccinated with a dose of DIPHTHERIA/TETANUS/2 AC PERTUSSIS/IPV (VERO)/HIB (PRP/T) VACCINE [PENTAXIM] reconstituted with a sterile diluent instead of diluent provided, lot number not reported via unknown route in an unknown administration site on an unknown date.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is an actual medication error case due to inappropriate reconstitution technique. It was reported that the they reconstituted the dry lyophilized component of the Hib vaccine vial in the Pentacel packaging with a sterile diluent and not the diluent provided in the packaging.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA263412,2,09/25/2019,,,,
0837862,10/03/2019,,,,,U,,"Rash broke out in flat rashes in the back of his neck and right ear; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves an infant patient who experienced rash broke out in flat rashes in the back of his neck and right ear (rash), while he/she received vaccines HEPATITIS B VACCINE, PREVNAR 13 and DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot number not reported via unknown route in the right thigh, a dose of suspect PREVNAR 13 not produced by Sanofi Pasteur lot number not reported via unknown route in the right thigh and a dose of suspect HEPATITIS B VACCINE not produced by Sanofi Pasteur lot number not reported via unknown route in the right thigh.  On an unknown date, the patient developed a non-serious rash broke out in flat rashes in the back of his neck and right ear (rash) 15 min following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE, PREVNAR 13 and HEPATITIS B VACCINE.  Other relevant tests were not reported.  Final diagnosis was rash broke out in flat rashes in the back of his neck and right ear.  It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for the event.  Information on the batch number was requested  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA265244,2,10/01/2019,,,,
0837863,10/03/2019,CA,,21,,F,,"student requesting Adacel inadvertently received Tenivac, patient received 1st dose of Tenivac on 07/08/2019 and 2nd on 09/20/2019/ No AE; student requesting Adacel inadvertently received Tenivac/ No AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 21 years old female patient who inadvertently received 0.5 mL dose vaccines DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] on 08-Jul-2019 and 20-Sep-2019 (lot U6101AA, expiry date-23-10-2020 via intramuscular route in the left deltoid) instead of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  no other vaccines received.   It was a case of actual medication error due to wrong vaccine administered and inappropriate schedule of vaccine administered.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,07/08/2019,,,,UNK,,,,,,USSA2019SA265494,2,10/01/2019,,,,
0837864,10/03/2019,CA,,0,.2,F,,"a patient was administered the liquid only portion of the Pentacel vaccine which was the Dtap and polio and it was never reconstituted with Hib powder/No AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to case 2019SA262075.  This case involves a 8 weeks old female (also reported as two months) patient who was administered the liquid only portion of the DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] vaccine which was the dtap and polio and it was never reconstituted with hib powder lot number and expiry date not reported via intramuscular route in the left thigh on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HEPATITIS B VACCINE (HEPATITIS B VACCINE), PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVENAR 13) and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE).  It was an actual medication error due to inappropriate reconstitution technique.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,HEPATITIS B VACCINE; PREVENAR 13; ROTAVIRUS VACCINE,,,,USSA2019SA266039,2,09/30/2019,,,,
0837865,10/03/2019,FL,,,,U,,"Vaccine tdap was given to a 9  year old patient; Tdap or pediatric DTaP is inadvertently administered to a child, no adverse event; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 9 years 6 months old patient who received fourth 0.5 mL vaccine DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE produced by unknown manufacturer lot U62772AA, expiry date-26-04-2021 via intramuscular route in the right deltoid on 23-Sep-2019, instead of DIPHTHERIA AND TETANUS TOXOIDS.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to inappropriate age at vaccine administration and wrong vaccine administered.   The reported queried that What should be give between the ages of 7-10 for Tetanus and Diphtheria. Reportedly Tdap or pediatric DTaP is inadvertently administered to a child aged 7-9 years instead of Td.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Query for batch number reconfirmation was sent.  Documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA266701,2,10/01/2019,,,,
0837866,10/03/2019,CT,6.0,,,U,,"Tenivac was given to a 6 year old in error, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 6 years old patient who was vaccinated with a dose of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] lot number not reported via unknown route in an unknown administration site on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is an actual medication error case due to Inappropriate age at vaccine administration. It was reported that the Tenivac was given to a 6 year old in error.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA266779,2,10/01/2019,,,,
0837867,10/03/2019,DE,5.0,,,M,,"expired Daptacel was given to the patient, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 5 years old male patient who was inadvertently vaccinated with an expired fourth dose of 0.5 mL DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] lot C5254AA, expiry date: 18-Sep-2019 via intramuscular route in the right thigh on 23-Sep-2019.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included POLIO VACCINE INACT 3V (VERO) (IPOL [POLIO VACCINE INACT 3V (VERO)]) for Immunisation; and MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3), VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (PROQUAD) for Immunisation.  It is an actual medication error case due to expired vaccine used.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,IPOL [POLIO VACCINE INACT 3V (VERO)]; PROQUAD,,,,USSA2019SA266912,2,10/01/2019,,,,
0837868,10/03/2019,IL,11.0,11,,F,,"11 years old received Flublok instead of prescribed Fluzone Quadrivalent/ NO AE; 11 years old received Flublok instead of prescribed Fluzone Quadrivalent/ NO AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (Office Staff).  This case is linked with 2019SA267180, 2019SA267186, 2019SA267188 (same reporter)  This case involves a 11 years 6 months old female patient who was vaccinated with dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] instead of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 12 Sep 2019, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE , Frequency = once, lot QFAA1903, exp date: 19 May 2020 intramuscularly in left arm instead of prescribed dose of INFLUENZA QUADRIVAL A-B VACCINE lot number not reported.  It was a case of actual medication error due to inappropriate age at vaccine administration and wrong vaccine administered.  At the time of the report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error  List of documents held by the sender: none",,,,,,,,,U,09/12/2019,,,,UNK,,,,,,USSA2019SA267187,2,10/02/2019,,,,
0837869,10/03/2019,CA,,,,U,,"4 patients were inadvertently given the expired vaccine, NO AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.   This case involves four patients of an unknown demographics who received an expired vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267202,2,10/02/2019,,,,
0837870,10/03/2019,,89.0,89,,F,,"vaccines that are administered but have been deemed not suitable for use, the vaccines were on the truck on thursday but did not arrive to them until around 11 am / No AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case is linked to cases 2019SA267341, 2019SA267342, 2019SA267344, 2019SA267345 and 2019SA267346 (same reporter).  This case involves a 89 years old female patient who received 0.5mL dose of vaccines INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] (lot UJ223AA, expiry-30-06-2020) via intramuscular route in the right deltoid.  It was a case an actual medication error due to incorrect product storage.  Caller is saying the vaccines were on the truck on Thursday but didn't arrive to them until around 11 AM but they did not hear until late in the day not to use them stating they received a message around 4:20 PM. Caller states as soon as they arrived she started giving injections and feels they should have been told earlier in the day that the vaccines shouldn't have been given.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA267336,2,10/02/2019,,,,
0837871,10/03/2019,,,73,,M,,"vaccines that are administered but have been deemed not suitable for use, the vaccines were on the truck on thursday but didn't arrive to them until around 11 am/No AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case is linked to cases 2019SA267336, 2019SA267342, 2019SA267344, 2019SA267345 and 2019SA267346 (same reporter).  This case involves a 73 years old male patient who received 0.5mL dose of vaccines INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] (lot UJ223AA, expiry-30-06-2020) via intramuscular route in the left deltoid.  It was a case an actual medication error due to incorrect product storage.  Caller is saying the vaccines were on the truck on Thursday but didn't arrive to them until around 11 AM but they did not hear until late in the day not to use them stating they received a message around 4:20 PM. Caller states as soon as they arrived she started giving injections and feels they should have been told earlier in the day that the vaccines shouldn't have been given.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA267341,2,10/01/2019,,,,
0837872,10/03/2019,,59.0,59,,M,,"vaccines that are administered but have been deemed not suitable for use, the vaccines were on the truck on thursday but didn't arrive to them until around 11 am/No AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case is linked to cases 2019SA267341, 2019SA267336, 2019SA267344, 2019SA267345 and 2019SA267346 (same reporter).  This case involves a 59 years old male patient who received 0.5mL dose of vaccines INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] (lot UJ223AA, expiry-30-06-2020) via intramuscular route in the right deltoid on 23-Sep-2019.  It was a case an actual medication error due to incorrect product storage.  Caller is saying the vaccines were on the truck on Thursday but didn't arrive to them until around 11 AM but they did not hear until late in the day not to use them stating they received a message around 4:20 PM. Caller states as soon as they arrived she started giving injections and feels they should have been told earlier in the day that the vaccines shouldn't have been given.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA267342,2,10/01/2019,,,,
0837873,10/03/2019,,,68,,F,,"vaccines that are administered but have been deemed not suitable for use. the vaccines were on the truck on Thursday but didn't arrive to them until around 11 AM / No AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case is linked to cases 2019SA267341, 2019SA267342, 2019SA267336, 2019SA267345 and 2019SA267346 same reporter.  This case involves female patient who received 0.5mL dose of vaccines INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] (lot UJ223AA, expiry-30-06-2020) via intramuscular route in the left deltoid.  It was a case of actual medication error due to incorrect product storage. Caller is saying the vaccines were on the truck on Thursday but didn't arrive to them until around 11 AM but they did not hear until late in the day not to use them stating they received a message around 4:20 PM. Caller states as soon as they arrived she started giving injections and feels they should have been told earlier in the day that the vaccines shouldn't have been given.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA267344,2,10/01/2019,,,,
0837874,10/03/2019,,,60,,M,,"vaccines that are administered but have been deemed not suitable for use. the vaccines were on the truck on Thursday but didn't arrive to them until around 11 AM / No AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.   This case is linked to cases 2019SA267341, 2019SA267342, 2019SA267344, 2019SA267336 and 2019SA267346 same reporter.  This case involves 60 years male patient who received 0.5mL dose of vaccines INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] (lot UJ223AA, expiry-30-06-2020) via intramuscular route in the left deltoid but have been deemed not suitable for use.  It was a case of actual medication error due to incorrect product storage. Caller is saying the vaccines were on the truck on Thursday but didn't arrive to them until around 11 AM but they did not hear until late in the day not to use them stating they received a message around 4:20 PM. Caller states as soon as they arrived she started giving injections and feels they should have been told earlier in the day that the vaccines shouldn't have been given.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA267345,2,10/01/2019,,,,
0837875,10/03/2019,,42.0,42,,M,,"vaccines that are administered but have been deemed not suitable for use. the vaccines were on the truck on Thursday but didn't arrive to them until around 11 AM / No AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to cases 2019SA267341, 2019SA267342, 2019SA267344, 2019SA267345 and 2019SA267336 same reporter.  This case involves 42 years male patient who received 0.5mL dose of vaccines INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] (lot UJ223AA, expiry-30-06-2020) via intramuscular route in the right deltoid but have been deemed not suitable for use.  Patient past medial history, vaccination, treatment and family history not reported.  No other vaccine was given.  It was a case of actual medication error due to Product storage error.  Caller is saying the vaccines were on the truck on Thursday but didn't arrive to them until around 11 AM but they did not hear until late in the day not to use them stating they received a message around 4:20 PM. Caller states as soon as they arrived she started giving injections and feels they should have been told earlier in the day that the vaccines shouldn't have been given.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA267346,2,10/01/2019,,,,
0837876,10/03/2019,UT,11.0,,,F,,"patient received 2 flu vaccines Flublok and Fluzone Quadrivalent, It was intended that the patient receive Gardasil with an influenza vaccine/ No AE; Patient received 2 flu vaccines Flublok and Fluzone Quadrivalent, It was intended that the patient receive Gardasil with an influenza vaccine. They were picked back up, a Flublok syringe was picked up in place of the Gardasil syringe/ No AE; 11 year old patient received 2 flu vaccines Flublok and Fluzone Quadrivalent, It was intended that the patient receive Gardasil with an influenza vaccine/ No AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (Office Staff).  This case involves a 11 years old female patient who received vaccines INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot QFAA1903, expiry May-2020 via unknown route in the right arm and INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] lot UJ223AA via unknown route in the left arm On 23-Sep-2019. The patient received FLUBLOK QIV instead of HPV VACCINE VLP RL1 4V (YEAST) [GARDASIL].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No other vaccines received. Notes: The patient does not have an egg allergy   It was a case of actual medication error due to Extra dose administered, Inappropriate age at vaccine administration and wrong vaccine administered. It was intended for the patient to receive influenza vaccine and Gardasil. Two medical assistants were working with the same physician. The Medical Assistant laid the shots down after they were prepared, and then when they were picked back up, a Flublok prefilled syringe was picked up in place of the Gardasil prefilled syringe. The caller stated that the patient ""weighs a lot"" and she was hoping that the weight of the patient might mitigate any adverse effect of receiving a double dose of influenza vaccine  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,Comments: The patient does not have an egg allergy,,USSA2019SA267361,2,10/01/2019,,,,
0837877,10/03/2019,KY,,,,U,,"11 year old child received Adacel, 8 months later, received second immunization/ NO AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional. Additional information was received on 24-Sep-2019   This case involves a 11 year old received DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL], 8 months later, received second immunization but not received previous DTAP.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose 1  dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot number not reported via intramuscular route. 1 other doses were administered on unknown dates for suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  It was a case of actual medication error due to extra dose administered.  It was not reported if any adverse event occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA267364,2,10/01/2019,,,,
0837878,10/03/2019,TX,,,,F,,"left side swelling neuropathy; high Blood pressure; low Heart rate; severe headache; 38 weeks pregnant female received Flublok QIV; Initial information received on 24-Sep-2019 regarding an unsolicited valid serious case received from a nurse.  This case involves female patient of an unknown age who experienced left side swelling neuropathy (neuropathy peripheral), high Blood pressure (hypertension), low Heart rate (heart rate decreased) and severe headache (headache) and was 38 weeks pregnant, while she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].   Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known.   The date of last menstrual period was not reported.  The estimated due date was not reported.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported via intramuscular route in unknown administration site.  On an unknown date, the patient developed a serious left side swelling neuropathy (neuropathy peripheral), high Blood pressure (hypertension), low Heart rate (heart rate decreased) and severe headache (headache) (Unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. The patient was hospitalized for this event.  It was also the case of Vaccine exposure during pregnancy.  (Other relevant tests included no lab data.)  Final diagnosis was severe headache, low Heart rate, high Blood pressure and left side swelling neuropathy.  It was not reported if the patient received a corrective treatment.  The outcome of the event was reported as Unknown for all the events.  Pregnancy outcome was unknown at the time of report.  Information on the batch number was requested  Documents held by sender: none.; Sender's Comments: Patient experienced peripheral neuropathy, high blood pressure, decreased heart rate, severe headache after vaccination. Time to onset is unknown. However, further information including patient's medical history, concomitant medications, previous vaccination and tolerance, laboratory investigations excluding other etiology would be needed to fully assess this case. Based on available information the role of vaccine cannot be assessed.",,,,,Y,,,,U,,,,,UNK,,,,,,USSA2019SA267369,2,10/02/2019,,,,
0837879,10/03/2019,,34.0,,,F,,"consumer was given Fluzone Quadrivalent 0.5 mL that was expiredwho was 35-weeks pregnant, no AE; consumer was given Fluzone Quadrivalent 0.5 mL that was expired, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from non-healthcare professional.  This case involves a 34 years old female patient who received 0.5 ml dose of expired vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (lot U63O2AA, Exp. Date 30-Jun-2019) via intramuscular route in the left deltoid, on 24-Sep-2019 and was 35 weeks pregnant.   Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The gestation period at onset was reported as 35 weeks. The date of last menstrual period was not reported. The estimated due date is 27-Oct-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing gestational diabetes.  It was a case of actual medication error due to expired vaccine used.  It was also a case of vaccine exposure during pregnanacy.  It was reported that a consumer was given Fluzone Quadrivalent 0.5 mL that was expired. The caller reported that the consumer received the dose on the morning of 24-Sep-2019, the vaccine expiration was on 30-Jun-2019. The consumer is 35-weeks pregnant.  At the time of reporting, no adverse reactions were reported.  Additionally, at time of reporting, the outcome of the pregnancy was unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/24/2019,,,,UNK,,,Gestational diabetes,,,USSA2019SA267492,2,10/01/2019,,,,
0837880,10/03/2019,KY,26.0,26,,F,,"26 years old pregnant patient recieved Fluzone Quadrivalent, no AE; while needle in the patients arm, pushed the plunger, and liquid leaked where the needle meets the syringe, no AE; vaccine leaked while injecting, patient received partial dose, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a Nurse.  This case involves a 26 years old female patient who was pregnant and received partial dose of vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (lot UJ212AB, Exp. Date 30-Jun-2020) via intramuscular route in the left deltoid, on 24-Sep-2019 .  Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The patient was exposed to INFLUENZA QUADRIVAL A-B VACCINE at 8 weeks of pregnancy, during first pregnancy trimester for INFLUENZA QUADRIVAL A-B VACCINE. The date of last menstrual period was reported as 29-Jul-2019. The estimated due date is 13-May-2020. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to vaccine underdose.  It was a case of vaccine exposure during pregnancy, syringe leak.  It was reported that vaccine leaked while injecting the patient with pre-filled 0.5 mL syringe. When asked how nurse connected the needle to syringe, she stated she twisted needle. She stated it appeared normal until pushing the plunger while needle in patients arm. Patient received partial dose, caller stated liquid leaking from multiple areas around syringe where needle meets syringe.  At the time of reporting, no adverse reactions were reported.  Additionally, at time of reporting, the outcome of the pregnancy was unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/24/2019,,,,UNK,,,,,,USSA2019SA267497,2,10/01/2019,,,,
0837881,10/03/2019,MO,,,,U,,"administered Fluzone High-Dose to a breastfeeding mother, no AE; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case is linked to case 2019SA263295 (mother case).  This case involves infant patient who was exposed to 0.5 ml dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot number: UJ238AB Expiry date 14-Apr-2020) at the time of lactation, via transmammary route, on 19-Sep-2019.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to vaccine exposure via breast milk.   At a time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/19/2019,,,,PHM,,,,,,USSA2019SA268841,2,09/30/2019,,,,
0837882,10/03/2019,CA,,,,F,,"permanent swelling on her arm which permanently deformed on her arm related to the Adacel vaccine.; permanent swelling on her arm which permanently deformed on her arm related to the Adacel vaccine.; Initial information received on 25-Sep-2019 regarding an unsolicited valid serious case received from a consumer/non-hcp.  This case involves a female patient (unknown age) who experienced swelling on her arm which permanently deformed on her arm (peripheral swelling) (Arm deformity), while she received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date (5 years ago), the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient had swelling on her arm which permanently deformed on her arm (peripheral swelling) (Arm deformity) (Unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. These events was considered as medically significant.  Lab data was not reported.  Final diagnosis was peripheral swelling and Arm deformity.   It was not reported if the patient received a corrective treatment.  The patient was not recovered from the swelling on arm and Arm deformity.  Information on batch number is requested.  List of document held by sender: none.; Sender's Comments: This case concerns a female patient who had limb deformity and peripheral swelling, following the vaccination with ADACEL. The time to onset was unknown. The patient's past medical history, concomitant medications, conditions at the time of vaccination and lab data ruling out other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.",,,,,,,,,N,,,,,UNK,,,,,,USSA2019SA269027,2,10/02/2019,,,,
0837883,10/03/2019,PA,48.0,48,,M,,"48 years old patient was accidentally administered Fluzone High Dose on 24Sep2019, no AE; 48 years old patient was accidentally administered Fluzone High Dose on 24Sep2019, no AE; Initial information received on 25-Sep-2019 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 48 years old male patient who was accidentally administered with a 0.5 mL dose of vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UJ221AB, expiry date: 01-Apr-2020) via intramuscular route in the left deltoid on 24-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to inappropriate age at vaccine administration and overdose.  At the time of report, No adverse event was reported.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/24/2019,,,,UNK,,,,,,USSA2019SA269687,2,10/02/2019,,,,
0837884,10/03/2019,MN,54.0,54,,M,,"gave Imovax in the gluteal area, NO AE; Initial information received on 25-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves an 54 year old male patient who was vaccinated with dose of RABIES (HDC) VACCINE [IMOVAX RABIES] in the gluteal area.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 24-Sep-2019, the patient received a 1 ml first dose of suspect RABIES (HDC) VACCINE lot N1L13, exp date: Nov 14, 2019 via unknown route in the gluteal area due to bat exposure.  It was a case of actual medication error due to Vaccine administered at inappropriate site.  At the time of the report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error  List of documents held by the sender: none",,,,,,,,,U,09/24/2019,,,,UNK,,,,,,USSA2019SA269734,2,10/02/2019,,,,
0837885,10/03/2019,MA,64.0,64,,F,,"pt reported symptoms of swelling, redness, soreness, and nausea that began the day prior to receiving the vaccine.",,,,,,,,,N,09/01/2019,10/01/2019,30,,PHM,,N/A,,,,,2,10/03/2019,,,,N/A
0837886,10/03/2019,MA,30.0,30,,F,,Arm pain since given the shot on 9/18,,,,,,,,,N,09/18/2019,09/19/2019,1,,OTH,,,,,,,2,10/03/2019,,Y,,
0837887,10/03/2019,FL,84.0,84,,F,,"Patient reports she became extremely cold the evening of her vaccine and has remained cold constantly since then. In addition, patient states she has developed a very dry mouth and extreme thirst. Patient states there has been no fever or other symptoms during this period. Patient reports no new medications or changes in routine outside of the flu vaccine. Patient was referred to her doctor for evaluation. Patient was convinced these symptoms were from the vaccine and requested we report as an adverse event on her behalf.",,,,,,,,,N,10/01/2019,10/01/2019,0,,PHM,,none reported by patient,none reported by patient,patient states she has an auto-immune disease,,,2,10/03/2019,,,,Sulfonamide antibiotics
0837888,10/03/2019,MA,66.0,66,,F,,"Within a half hour the patient could feel a tightness in her bronchial passageway. She does not feel like it was life threatening. In about half an hour after onset of symptoms, the patient began to cough. In the evening she began wheezing with little bits of mucous. Patient sought treatment from pharmacist via phone and primary care physician after hours via phone (nurse practitioner provided phone support). Nurse advised that the patient visit urgent care. Patient declined. Patient took ibuprofen.",,,,,,,,,Y,10/02/2019,10/02/2019,0,None,PHM,,"Levothyroxine 75 mcg, Hydrochlorothiaziade 12.5 mg",None,None,,,2,10/03/2019,,,,Dermatological allergy to latex
0837889,10/03/2019,PA,39.0,39,,M,,"Patient called about 5-6 hours after vaccination stating he was not feeling well. He had fever, nausea and vomiting. Went to ER, but they measured his blood pressure and it was normal, they just sent him home. Followed-up with the patient the next morning, he stated his symptoms are much better now and are resolving.",,,,,,,,,Y,10/02/2019,10/02/2019,0,,PHM,,none,none,none,,,2,10/03/2019,,,Y,none
0837890,10/03/2019,TX,19.0,19,,F,,"Patient had nausea, vomiting several hours after getting vaccine. The morning after receiving the vaccine she awoke with ""hives"" that resolved. She then presented to the emergency room with only symptoms of vomiting/diarrhea",,,,,,,,,Y,10/02/2019,10/02/2019,0,No laboratory tests ordered.,MIL,,Deneis,None,None,,,2,10/03/2019,,,Y,Denies
0837891,10/03/2019,NC,51.0,51,,F,,Low grade fever ~100 degrees;  erythema extending in a 2 inch radius from injection site.; chills,,,,,,,,,Y,09/30/2019,09/30/2019,0,n/a,OTH,,,,,,,2,10/03/2019,,,,
0837892,10/03/2019,PA,58.0,58,,F,,"Periorbital edema and ecchymosis- patient woke up the day after the vaccine with this. Presented to office 2 days after the vaccine. treatment- cool compresses, antihistamine.",,,,,,,,,Y,10/01/2019,10/02/2019,1,none,PVT,,Lisinopril 40mg daily Actos 15mg BID Amitriptyline 100mg HS Prozac 20mg  three tabs daily Neurontin 800mg QID,none,"DM, HTN, Peripheral neuropathy, depression, morbid obesity",,,2,10/03/2019,,Y,,"Steroid, Sulfa"
0837893,10/03/2019,MO,34.0,34,,F,,"Site of injection became swollen, red, hot to touch a few hours after injection.  Redness and heat spread to several inches and remained >24 hours.  Saw occupational health nurse and MD who provided zyrtec and pepcid to reduce histamine reaction.  48 later area is still red, swollen, and warm to touch but improving.",,,,,,,,,,09/30/2019,09/30/2019,0,,WRK,,"ortho tri-cyclen lo, centrum MVI",NA,NA,,,2,10/03/2019,,Y,,NA
0837894,10/03/2019,ME,81.0,81,,F,,"fever, chills, joint pain, headache",,,,,,,,,N,10/02/2019,10/03/2019,1,,PHM,,"morphine sulf, furosemide, vaccine adjuvant",n/a,,,,2,10/03/2019,,,,nka
0837895,10/03/2019,PA,68.0,68,,M,,"Headache, intestinal ache, aching in neck, shoulders, back, elbows wrists, hands, hips, knees, feet",,,,,,,,,U,10/02/2019,10/02/2019,0,None,PHM,,"Celebrex, acetomenophen, omeprazole, syvella, verapamil, liposomal vitamin C, super lysine, opti prostate, flomax, singulair, atorvastin, vitamin D, docusate sodium plus sennosides",None,Fibromyalgia,,,2,10/03/2019,,,,"Neurontin, keppra"
0837896,10/03/2019,NC,28.0,28,,F,,"weak, sweaty, pale (? vasovagal) immediately after Flu vaccine. Itching at injection site L arm began within 5 minutes and spread to chest. Throat felt tight and lips tingled within 30 minutes.",,,,,,,,,Y,09/30/2019,09/30/2019,0,None,PVT,,"Zoloft, Bupronion, Xanax, Loestrin, Omeprazole",None,"HTN, hypoglycemia",,,2,10/03/2019,,,,Latex
0837899,10/03/2019,CA,,,,U,,"No adverse effect reported; patient received improperly stored PROQUAD; This spontaneous report was received from a medical assistant referring to a patient of unknown age. The patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not provided.   On 05-SEP-2019, the patient was vaccinated with an improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S002494 (verified to be a valid lot number), expiration date reported and established as 23-JUL-2020, for prophylaxis. The measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was reconstituted with a properly stored sterile diluent.  The vaccine was improperly stored at a temperature between 6F to 14F (10.2F, multiple) during a time frame of 50 minutes. The call was because of a data logger and no adverse effect neither previous temperature excursions were reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA005231:",,,,,,,,,U,09/05/2019,09/05/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA005129,2,10/03/2019,,,,
0837900,10/03/2019,NV,,,,U,,"No adverse event; a patient was administered an expired MMR Il vaccine; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 11-SEP-2019, the patient was vaccinated with an expired dose of with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # N027779 has been verified to be a valid lot number, expiration date 08-AUG-2019, recombinant Human albumin (exact dose, dose number, route and site of administration were not reported) for prophylaxis. No adverse event was reported. The outcome of the events was unknown.",,,,,,,,,U,09/11/2019,09/11/2019,0,,UNK,,,,,,US0095075131909USA005405,2,10/03/2019,,,,
0837901,10/03/2019,PA,0.58,0,.7,M,,"no adverse effect; a 7 month old infant received a first dose of Rotateq on 12-SEP-2019; This spontaneous report was received from a medical assistant and refers to a 7-month-old male patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 12-SEP-2019, the infant was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 1 dose, orally, lot # R035374 and expiration date 15-SEP-2020 (exact dose was not reported) for prophylaxis, outside of prescribing information. No adverse effect was reported.",,,,,,,,,U,09/12/2019,09/12/2019,0,,UNK,,,,,,US0095075131909USA005927,2,10/03/2019,,,,
0837902,10/03/2019,CO,,,,U,,"No adverse effects reported; expired MMR II (N024703 9/8/2019) was administered to a patient on 9/30/2019; This spontaneous report was received from a medical assistant and refers to an identifiable patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On 30-SEP-2019, the patient was vaccinated with expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHa) (M-M-R II), lot # N024703, expiration date 08-SEP-2019 (strength, dose, route of administration were not reported) for prophylaxis. It was reconstituted with not expired sterile diluent (lot # S025290, expiration date 20-MAR-2022). There was no temperature excursion for the vaccine and for the diluent. No adverse effect were reported.",,,,,,,,,U,09/30/2019,09/30/2019,0,,UNK,,sterile diluent,,,,US0095075131910USA002007,2,10/03/2019,,,,
0837903,10/03/2019,MO,61.0,61,,F,,"shingles; Information has been received from a lawyer concerning a case in litigation and refers to a 61 year old female patient. No information regarding the pt's medical history, concurrent conditions and concomitant medications was reported. On 09-OCT-2014, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) injection (dose, route of administration, vaccination site, lot # and expiry date were not specified) for prophylaxis, at a pharmacy. As a result of her receipt of zoster vaccine live (ZOSTAVAX), on 17-FEB-2015, the pt was caused to suffer shingles, including any and all of its sequelae. As a result of her receipt of zoster vaccine live (ZOSTAVAX), the pt has been caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages. As a foreseeable, direct, and proximate consequence of Company's actions, omissions, and misrepresentations, the pt suffered shingles and other related health complications. In addition, the pt required and would continue to require healthcare and services. The pt had incurred and would continue to incur medical and related expenses. The pt also had suffered and would continue to suffer diminished capacity for the enjoyment of life, a diminished quality of life, increased risk of premature death, aggravation of preexisting conditions, activation of latent conditions, and other losses and damages. The pt's direct medical losses and costs include physician care, monitoring, and treatment. The pt had incurred and would continue to incur mental and physical pain and suffering. The outcome of the event was not recovered. The causality was related.  The event of shingles was considered to be disabling.",,,,,,,,Y,N,10/09/2014,02/17/2015,131,,PHM,,,,,,US0095075131910USA002134,2,10/03/2019,,,,
0837904,10/03/2019,,,,,F,,"reverse blood flow; babies were in the same sack; Maternal exposure; Low birth weight; premature birth; Live birth; This retrospective pregnancy case was reported by a nurse via call center representative and described the occurrence of cardiovascular insufficiency in a female patient exposed to Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2018-2019 season) (batch number D4E29, expiry date 30th June 2019) in utero. The mother received the product for prophylaxis.   On 26th October 2018, the 23-year-old mother received Fluarix Quadrivalent 2018-2019 season .5 ml. The mother's last menstrual period was on 18th July 2018 and estimated date of delivery was 25th April 2019. The patient was exposed to Fluarix Quadrivalent 2018-2019 season at week 14 of gestation and during the second trimester of pregnancy. At 31 weeks and 1 day, the patient was born via cesarean delivery. The patient was diagnosed with birth weight low, premature birth and live birth. On an unknown date, the patient experienced cardiovascular insufficiency (serious criteria GSK medically significant), monoamniotic twin pregnancy and maternal exposure during pregnancy. On an unknown date, the outcome of the cardiovascular insufficiency, birth weight low, premature birth, live birth, monoamniotic twin pregnancy and maternal exposure during pregnancy were unknown.   It was unknown if the reporter considered the cardiovascular insufficiency and birth weight low to be related to Fluarix Quadrivalent 2018-2019 season. The reporter considered the premature birth to be unrelated to Fluarix Quadrivalent 2018-2019 season.     See case US2018199479 for details regarding the mother case.  Additional details were provided as follows: The patient's mother did not had any known medical history. One hundred and eighteen days after receiving the vaccine to the patient's mother, premature delivery led to premature birth. The Nurse reported that the twin babies were in same sack and one twin did not get adequate blood flow also there was reverse blood flow to one twin. The reporter considered that the event premature birth was not due to the flu shot. It was unknown, if the reporter considered the event cardiovascular insufficiency was related to Flu Seasonal QIV Dresden. The VARS details were updated. This is 1 of 3 cases linked for parent-child cases.",,,,,,,,,U,10/26/2018,02/21/2019,118,,PUB,,,,,,USGLAXOSMITHKLINEUS2018AM,2,10/03/2019,,,,
0837905,10/03/2019,MD,,,,M,,"pain at site/ muscle soreness; This case was reported by a consumer via call center representative and described the occurrence of injection site muscle pain in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis.   In September 2019, the patient received the 1st dose of Shingrix and Influenza vaccine Quadrivalent 2019-2020 season. In September 2019, less than a week after receiving Shingrix and Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced injection site muscle pain. On an unknown date, the outcome of the injection site muscle pain was unknown.   It was unknown if the reporter considered the injection site muscle pain to be related to Shingrix and Influenza vaccine Quadrivalent 2019-2020 season.  Additional details were provided as follows: This case was reported by the patient's sister. The age at vaccination was not reported. The patient received a dose of Shingrix and the flu vaccine last week from the date of reporting on the same day in the separate arm. The reporter stated that, the patient experienced pain and muscle soreness in the Shingrix arm. This was the only information she had on the vaccine. This case has been linked with cases US2019172789 and US2019173375 reported by the same reporter.",,,,,,,,,U,09/01/2019,09/01/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837906,10/03/2019,NY,,,,F,,"flu-like symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and developed flu-like symptoms. The reporter did not consent to follow up. This report 3 of 3 reported by the consumer. The consumer did not have any further information, did not consent to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837907,10/03/2019,NY,,,,U,,"Injection site pain; inappropriate schedule of vaccine; This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced injection site pain and incomplete course of vaccination. On an unknown date, the outcome of the injection site pain and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per vaccine indication. The pharmacy student stated some patients at the pharmacy have missed the 2-6 month window for the second dose. The pharmacy student also mentioned that patients often report pain from the injection after getting Shingrix. Till the time of reporting patients did not received the 2nd dose, which led to incomplete course of vaccination. The pharmacy student consented to follow up. Additional details not provided at the time of this call, but pharmacy student granted permission to follow up. This case has been linked with US2019174653, reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837909,10/03/2019,GA,,,,M,,"unable to get adequate blood flow; cord was not attached as it should; babies were in the same sack; Maternal exposure during pregnancy; Birth weight low; premature birth; Live birth; This case was reported by a nurse via call center representative and described the occurrence of cardiovascular insufficiency in a male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2018-2019 season) (batch number D4E29, expiry date 30th June 2019) for prophylaxis.   On 26th October 2018, the patient received Fluarix Quadrivalent 2018-2019 season (transplacental) .5 ml. 118 days after receiving Fluarix Quadrivalent 2018-2019 season, the patient experienced birth weight low, premature birth and live birth. On an unknown date, the patient experienced cardiovascular insufficiency (serious criteria GSK medically significant), umbilical cord abnormality, monoamniotic twin pregnancy and maternal exposure during pregnancy. On an unknown date, the outcome of the cardiovascular insufficiency, umbilical cord abnormality, birth weight low, premature birth, live birth, monoamniotic twin pregnancy and maternal exposure during pregnancy were unknown.   It was unknown if the reporter considered the cardiovascular insufficiency, umbilical cord abnormality and birth weight low to be related to Fluarix Quadrivalent 2018-2019 season. The reporter considered the premature birth to be unrelated to Fluarix Quadrivalent 2018-2019 season.     See case US2018199479 for details regarding the baby case.   Additional details were provided as follows: The patient's mother did not had any known medical history. One hundred and eighteen days after receiving the vaccine to the patient's mother, premature delivery led to premature birth. The Nurse reported that the twin babies were in same sack and one twin did not get adequate blood flow also there was reverse blood flow to one twin. The reporter considered that the event premature birth was not due to the flu shot. It was unknown, if the reporter considered the event cardiovascular insufficiency was related to Flu Seasonal QIV Dresden. The VARS details were updated. This is 1 of 3 cases linked for parent-child cases.",,,,,,,,,U,10/26/2018,02/21/2019,118,,PUB,,,,,,USGLAXOSMITHKLINEUS2018AM,2,10/03/2019,,,,
0837910,10/03/2019,FL,,,,F,,"Boostrix reaction; This case was reported by a pharmacist via call center representative and described the occurrence of adverse reaction in a 75-year-old female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On an unknown date, the patient received Boostrix at an unknown dose. On an unknown date, unknown after receiving Boostrix, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Boostrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient had a reaction to the Boostrix vaccine years ago. They suspect it was to the Equine blood used during manufacturing. The reporter was did not consent to follow-up. The reporter had no additional information on the previous vaccination",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837911,10/03/2019,WI,,,,F,,"Pain at the injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number was not reported. The patient received Shingrix and had little bit of pain at the injection site that lasted for maybe a day or 2 days. The reporter did not consent to follow up. The pharmacist was retired, no information was available for vaccine used",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837912,10/03/2019,OH,,,,F,,"Headache; Tiredness; This case was reported by a nurse via call center representative and described the occurrence of headache in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced headache and tiredness. On an unknown date, the outcome of the headache and tiredness were unknown.   It was unknown if the reporter considered the headache and tiredness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had headache and tiredness. The reporter did not consent to follow up. The caller was the patient and health care professional refused to give any additional details about themselves or the vaccine.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837913,10/03/2019,OH,52.0,52,,F,,"Fever; Chills; Nausea; Feeling Sick to her stomach; This case was reported by a consumer via call center representative and described the occurrence of fever in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd September 2019 12:00, the patient received the 1st dose of Shingrix. On 24th September 2019, 1 days after receiving Shingrix, the patient experienced fever, chills, nausea and upset stomach. On an unknown date, the outcome of the fever, chills, nausea and upset stomach were unknown.   It was unknown if the reporter considered the fever, chills, nausea and upset stomach to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix at 12:00 pm and had fever, chills, and nausea.  She had to end the call because she was feeling sick to her stomach. The reporter unable to obtain additional details because the reporter felt sick to her stomach and ended the call.",,,,,,,,,U,09/23/2019,09/24/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837914,10/03/2019,,69.0,68,,M,,"Itchy rash on his hands and lower legs; This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included hand operation. Previously administered products included Xiaflex injections.   On 29th May 2019, the patient received the 1st dose of Shingrix. On an unknown date, 30 days after receiving Shingrix, the patient experienced itchy rash. On an unknown date, the outcome of the itchy rash was not recovered/not resolved.   It was unknown if the reporter considered the itchy rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and approximately 1 month after receiving the vaccine, the patient developed an itchy rash on his hands and lower legs. The rash comes and goes. The reporter did not consent to follow up. The emergency room visit required. The caller did not want to provide his address.  The caller did not provide any additional information.",,,,,,,,,N,05/29/2019,,,,UNK,,,,Medical History/Concurrent Conditions: Hand operation,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837917,10/03/2019,NV,,,,M,,"Bells Palsy; This case was reported by a other health professional via call center representative and described the occurrence of bell's palsy in a child male patient who received HAV (Havrix) (batch number 3TG52, expiry date 26th June 2020) for prophylaxis.   On an unknown date, the patient received the 1st dose of Havrix. On an unknown date, 3 days after receiving Havrix, the patient experienced bell's palsy (serious criteria GSK medically significant). On an unknown date, the outcome of the bell's palsy was unknown.   It was unknown if the reporter considered the bell's palsy to be related to Havrix.  Additional details were provided as follows: The age at vaccination was not reported. The medical assistant reported that the patient's mother, reported that the child developed Bells Palsy 3 to 5 days after receiving first dose of Havrix.  The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837918,10/03/2019,IL,59.0,59,,M,,"Shingles/ Shingles flare up; facial/ scalp lesions; rash; This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis.   Concurrent medical conditions included scalp pain and facial pain.   On 11th September 2019, the patient received Shingrix and Influenza vaccine Quadrivalent 2019-2020 season. On 12th September 2019, 1 days after receiving Shingrix and Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced shingles, skin lesion and facial rash. The patient was treated with antivirals nos, antivirals nos, antivirals nos, antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the shingles and facial rash were not recovered/not resolved and the outcome of the skin lesion was unknown.   It was unknown if the reporter considered the shingles, skin lesion and facial rash to be related to Shingrix and Influenza vaccine Quadrivalent 2019-2020 season.  Additional case details were provided as follows: The patient complained of soreness in the face and scalp area prior to vaccination. A day after the vaccination with Shingrix and Quadravalant vaccine, the patient developed facial or scalp lesion and rash with a confirmed diagnosis of Shingles. Antiviral therapy was given to the patient but the he reported that, rash was again developed on the same area on his face. The patient consented to follow up.",,,,,,,,,N,09/11/2019,09/12/2019,1,,UNK,,,Facial pain; Scalp pain,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837919,10/03/2019,AR,23.0,23,,M,,"Hepatitis A; This case was reported by a pharmacist via call center representative and described the occurrence of hepatitis a in a 23-year-old male patient who received HAB (Twinrix adult) (batch number 3597P, expiry date 12th March 2022) for prophylaxis.   Concomitant products included HAB (Twinrix adult).   On 30th August 2019, the patient received the 2nd dose of Twinrix adult (intramuscular). On 26th September 2019, less than a month after receiving Twinrix adult, the patient experienced hepatitis a. On an unknown date, the outcome of the hepatitis a was unknown.   It was unknown if the reporter considered the hepatitis a to be related to Twinrix adult.  Additional details were provided as follows; The pharmacist reported that a patient got Twinrix vaccine 1st dose and Twinrix vaccine 2nd dose on left arm. On 26th September 2019, the patient had some blood works done at the doctor's office and the doctor's office informed the pharmacist. In 2019, the patient tested positive for hepatitis A. The reporter was consented to follow up.",,,,,,,,,U,08/30/2019,09/26/2019,27,"Test Date: 20190926; Test Name: Hepatitis A virus test; Result Unstructured Data: Test Result: Positive, Test Result Unit: unknown",PHM,,Twinrix adult,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837920,10/03/2019,CA,77.0,77,,F,,"left shoulder pain; swelling at injection site; pain and tenderness in muscles; felt shaky; felt sweaty; lost appetite; felt dizzy; slept a lot; This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than 3 weeks after receiving Shingrix, the patient experienced shoulder pain, injection site swelling, muscle pain, shaky feelings, sweating, appetite lost, dizziness and sleep excessive. On an unknown date, the outcome of the shoulder pain was not recovered/not resolved and the outcome of the injection site swelling, muscle pain, shaky feelings, sweating, appetite lost, dizziness and sleep excessive were recovered/resolved.   It was unknown if the reporter considered the shoulder pain, injection site swelling, muscle pain, shaky feelings, sweating, appetite lost, dizziness and sleep excessive to be related to Shingrix.  Additional details were provided as follows: The patient experienced left shoulder pain, swelling at injection site, pain and tenderness in muscles of arm, upper back and neck, was shaky, felt sweaty, lost appetite, dizzy and slept a lot the following two days. The patient stated that the issues have all resolved except that her shoulder has still some sore at the time of reporting. The patient did not consent to follow up. This case was link with case US2019175456, reported by the same reporter.",,,,,,,,,N,09/08/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837921,10/03/2019,FL,,,,F,,"pneumonia; had pneumonia after having Prevnar 13; Inappropriate dose of vaccine administered; This is a spontaneous report from a Pfizer-sponsored program, by a contactable consumer reported for herself.  This 93-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration at single dose for pneumonia shot. She received her first Prevnar 13 in 2013 and a second Prevnar 13 in 2015. Medical history included that she had scarred lungs as a teen and when she gets a cold it goes to her chest. Concomitant medications were not reported. On an unspecified date in Nov2017, the patient had pneumonia after having Prevnar 13 with outcome of unknown.  The information on the lot number has been requested.",,,,,,,,,U,,11/01/2017,,,UNK,,,,Medical History/Concurrent Conditions: Lung scarring (scarred lungs as a teen),,USPFIZERINC2019423477,2,10/03/2019,,,,
0837923,10/03/2019,PA,28.0,28,,F,,"Patient reported hives on lower right arm followed by ""throat tightening"" and difficulty breathing approximately 2 hours post Flublok administration. She received IV Benadryl from paramedics and observed in Emergency Room and discharged the same day.",,,,,,,,,,10/02/2019,10/02/2019,0,,OTH,,,,,,,2,10/03/2019,,,Y,
0837924,10/03/2019,FL,0.75,0,.8,F,,"Around 11am, child started with ""heavy breathing.""  Child's pediatrician was contacted.  Advised to bring child to ER - enroute child's respiratory distressed increased.  Generalized body rash and temp 100.6 R upon arrival at ER.  Family reports child given ""injection"" in ER - unsure of medication given.",,,,,,,,,Y,10/02/2019,10/02/2019,0,none,PUB,,none,none,none,,,2,10/03/2019,,,Y,cow's milk
0837925,10/03/2019,AL,66.0,66,,F,,"Injection site swelling, itching and pain; chills, fever and headache.  It's been more than 72 hours and I still have low grade fever and injection site swelling and pain.",,,,,,,,,N,09/30/2019,10/02/2019,2,Tested for flu and was negative.,PHM,,"Cellcept, levothyroixine, prednisone, Ejovi, monolucast, varapamil; Omega 3, calcium, daily vitamin","SLE, infection in toe (on antibiotics for 3 days).","SLE (lupus nephritis, neuro-psychiatric lupus)",,,2,10/03/2019,,Y,,
0837926,10/03/2019,TX,45.0,45,,F,,Macular rash following influenza vaccine,,,,,,,,,,10/02/2019,10/02/2019,0,,WRK,,"Aspirin, Zantac, Hydrochlorothiazine, Atorvastatin, Norenthindron",,"Hypertension, GERD, high cholesterol, hormone therapy",,,2,10/03/2019,,Y,,Sulfa
0837927,10/03/2019,TN,74.0,74,,F,,"swelling, redness, whelp at injection site along with throat swelling",,,,,,,,,Y,09/23/2019,09/23/2019,0,went to ER that night for eval and given decadron,PVT,,"Eliquis, amiodarone, carvedilol, trazadone, furosemide, potassium, aspirin, atorvastatin, losartan, multivitamin","CHF, hyperlipidemia, PHTN, reactive airway disease, atrial fibrillation","CHF, hyperlipidemia, PHTN, reactive airway disease, atrial fibrillation",,,2,10/03/2019,,Y,Y,"morphine, lisinopril"
0837928,10/03/2019,FL,42.0,42,,F,,"my feet began to cramp a week after receiving the vaccine. I felt a sensation of tingling and cramping, accompanied by an unbearable burning. I was diagnosed with transverse myelitis caused by the vaccine. The treatment is with steroids, gabapentin, tramadol, pantoprasol, duloxetine. I could not walk. using a wheelchair with therapies and on the way with the help of a walker. I'm going for 5 months in this condition",,,Y,,Y,19,,Y,N,05/24/2019,05/31/2019,7,MRI  06/22/2019 lumbar punsion    06/24/2019,WRK,,Levotiroxine,N/A,Hypothyroidism,,,2,10/03/2019,,Y,Y,N/A
0837929,10/03/2019,AZ,65.0,65,,F,,"I received the High Dose Vaccine at 4PM, at 8PM my arm started hurting, then I develop a continuous congested cough , over the next hour I slowly developed very itchy eyes, bilateral red conjunctiva, tingling and numbness of my lips and it felt like my throat was closing up. I as going to leave to go to the ER when the symptoms started to gradually dissipate but not completely go away, my lips were a little tingly . By midnight I had a headache and this morning I still have some residual tingling of my lips, I feel like I have the flu, frontal headache, achy all over, and nasal congestion.",,,,,,,,,N,10/02/2019,10/02/2019,0,None,OTH,,"Fish oil, Flaxseed oil, Calcium with D, Vit D 2000 iu, Vit E, Tumeric, Vit B6, Vit B12",None,None,,,2,10/03/2019,,,,"Sulfa, Minocycline, Erythromycin, Ancef, Penicillin"
0837930,10/03/2019,VT,8.0,8,,M,,There has not been any adverse reaction noted at this time. VAERS is being filed because child received DTaP instead of Tdap. He is 8 years old and just starting the tetanus containing vaccine series. Measures have been implemented to avoid this error in the future. Vaccine dose will count as first dose of tetanus containing vaccine.,,,,,,,,,U,10/03/2019,10/03/2019,0,,PUB,,unknown,none,none,,,2,10/03/2019,,,,Oak tree pollin
0837931,10/03/2019,AL,12.0,12,,M,,"After administering vaccines patient had a syncopal episode that lasted 3-5 seconds. Applied cold compress, had patient sip water slowly, made patient to continue to lay on exam table.  Monitored patient for 15 minutes and obtained vitals: b/p:120/74 left arm ,patient was alert, oriented x3.  Patient was seen  ambulating down hallway accompanied by mother with no signs of distress noted.",,,,,,,,,Y,10/03/2019,10/03/2019,0,N/A,PUB,,unknown,None,None,,,2,10/03/2019,,,,NKDA
0837932,10/03/2019,NC,1.0,0,.9,F,,Patient developed a rash 1 year and 10 months that would not go away. Patient was tested and came back positive for Shingles.,,,,,,,,,Y,11/01/2017,09/23/2019,691,VZV Testing,PVT,,none,Yes- Hand Foot and Mouth Disease.,None,,,2,10/03/2019,,Y,,NKDA
0837933,10/03/2019,CO,0.5,0,.5,M,,"fever x 5 days, rash 3 days",,,,,,,,,Y,08/08/2019,08/15/2019,7,none,PVT,,none,none,none,,,2,10/03/2019,,Y,Y,none
0837934,10/03/2019,MI,67.0,67,,F,,Injection site very sore but no redness or swelling.   Redness and swelling below injection site with warmth to touch.  Arm is very sore.,,,,,,,,,U,10/02/2019,10/01/2019,,,PVT,,None,None,"HTN, GERD IBS Dysphagia DM 2 Arthritis",,,2,10/03/2019,,,,Bactrim Codeine Eggs Omeprazole Tetracyclines
0837935,10/03/2019,TX,87.0,87,,F,,"Patient called day after reporting around 12pm she has over a 104 degree temperature and experiencing flu-like symptoms: fever, body chills, achiness and a feeling of being unwell. I asked her to contact her prescriber and to visit urgent care due to her temperature being elevated at 104. Followed up with patient around 4pm and fever went down to 99. She contacted prescriber who recommended monitoring and take OTC pain meds.",,,,,,,,,U,10/01/2019,10/01/2019,0,,PHM,,tylenol and advil,none,"Hypertension, sensitive system",,,2,10/02/2019,,Y,,"codeine, penicillin, sulfa, pain medications"
0837936,10/03/2019,MI,18.0,18,,F,,Flu Vaccine was given from Private Stock and not VFC stock. Pt tolerated injection well with no known reaction.,,,,,,,,,U,10/02/2019,10/02/2019,0,,PVT,,,,,,,2,10/03/2019,,,,
0837937,10/03/2019,TX,59.0,59,,M,,"This vaccine is administered in two injections. The first was on 02/06/19 and the second on 04/09/19. A few days after the first injection, I had back and leg pain. After the second shot I could barely get out of bed. My hands, arms and shoulders were so sore I was unable to dress my self for several weeks. I contacted Dr. and he said the Shingrex was not a factor.  A few weeks later I went to a Rheumatoligst and was diagnosed with rheumatoid arthritis. I am currently taking methotrexate that has somewhat helped, but my shoulders remain very sore. I am unable to any lifting.",,,,,,,,,N,04/09/2019,04/10/2019,1,Multiple blood tests confirmed that I had rheumatoid arthritis.,PVT,,"Micardis 20 Mg, Singular 10 Mg, Dymista, Metoprolol Tartrate  50 Mg x 2 a day, Eliquis 5 Mg 2 x day, Nexium OTC",,"High Blood pressure, A-Fib, Factor 5 Liden",,,2,10/03/2019,,Y,,N/A
0837938,10/03/2019,,65.0,65,,M,,"The morning after receiving the vaccine, patient felt light headed and measured blood pressure to be in 80s/40s. Happened the morning after both doses with no further problems.",,,,,,,,,Y,08/15/2019,08/16/2019,1,,UNK,,"Albuterol HFA, amlodipine, Advair HFA,  Irbesartan-hydrochorothyazide, pravastatin, triamcinolone",,,,,2,10/03/2019,,,,Lisinopril
0837939,10/03/2019,ND,18.0,18,,M,,"client notice large redden area around site of injection, No swelling , some tenderness at site. Otherwise client feels physically fine. RN recommended marking all area of redness with marker to watch for spreading. RN recommended ice occasionally and ibuprofen.",,,,,,,,,N,09/30/2019,10/03/2019,3,,PUB,,Fluoxetine and Allegra Dr,no,diagnosed with a immune deficiency disorder at the age of 5 years old due to reoccurring pneumonia. But as he has gotten older he rarely gets sick. physicians told parents he could eventually out grow it.,,,2,10/03/2019,,,,"Outdoor dust, molds, and pollen"
0837940,10/03/2019,SC,76.0,76,,F,,"Patient's husband states that a few hours after receiving the flu vaccine, the patient was swimming and became very cold. She then tried to warm up in the hot tub.  After that, her arms began uncontrollably flailing around. She was taken to the emergency room.",,,,,,,,,U,10/01/2019,10/01/2019,0,unknown,PHM,,"Alendronate 70mg, Carbidopa/Levodopa 25/100mg tab",,Parkinson's Disease,Flu vaccine High Dose in Fall 2016,,2,10/03/2019,,,Y,no known allergies
0837941,10/03/2019,NC,54.0,54,,F,,"Hives, itching from about 10 minutes after receiving the vaccine through now",,,,,,,,,N,10/02/2019,10/02/2019,0,none,WRK,,,None,asthma,,,2,10/03/2019,,,,NOne
0837942,10/03/2019,,65.0,65,,F,,"chills, fever, rigors, redness at site of reaction.  Fever for 48 hrs.  Redness longer lasting for days after injection",,,,,,,,,,09/25/2019,09/26/2019,1,,PVT,,,,,,,2,10/03/2019,,Y,,
0837943,10/03/2019,MA,68.0,68,,F,,severe chills almost to convulsing and then weakness unable to walk without assistance,,,,,,,,,Y,10/02/2019,10/02/2019,0,,PVT,,potassium 99mg  vitamin c 1000mg,,hbp   high cholesterol,,,2,10/03/2019,,,,vitamin d  lipitor 20 mg
0837944,10/03/2019,RI,72.0,72,,F,,"Large, inch-high by about 3-inch wide swelling and very painful at injection site; joint pain, fever, and fatigue to the extent that normal activity was impossible and going to bed was required. Felt much better after bed rest and limited activity for about 24 hours. Arm/injection site stayed very sore for about 5 days.",,,,,,,,,Y,09/10/2019,09/11/2019,1,none,PHM,,none,none,none,,,2,10/03/2019,,,,cashews
0837945,10/03/2019,CO,4.0,4,,F,,"Pt was given multiple vaccines as part of her WCC; she began to have reaction sxs this morning 9/25/19 , which started as what FOC describes as a ""bug bite,"" but then progressed to include a large area of spreadig redness, significant swelling, and itching. Pt does not c/o pain, and has not had fevers or discharge from the area, though she has seemed a bit tired. No n/v, anorexia, malaise, paresthesia, or weakness of the leg. # Vaccines adverse reaction  (T50.Z95A): Consistent with a localized (though moderately/severe) reaction; not concerning for infection or anaphylaxis. Start with topical steroids; recommended close f/u friday which MOC will call to schedule. May consider oral steroids if not improving dt the degree of swelling. Will report to VAERS, close monitoring discussed. Plan printed and provided to patient: PRESCRIBE: triamcinolone 0.1% topical cream, Apply to affected area 2 times a day, # 100, RF: 0. (Transmitted by PA-C) The injection given in the left thigh was Kinrix, which includes DTap and Polio- these are both vaccines that she's had 3 ad 4 times prior respectively, so I am suspecting this is a localized reaction to carrier substances present in the specific Kinrix formulation of the vaccine, rather than a reaction to the specific polio or dtap components. She is finished with both of these series, and won't require another Dtap- (though she will eventually need a Tdap). Recommend a topical steroid cream as prescribed, with close monitoring for worsening problems, such as swelling of lips, tongue, or face, trouble breathing, coughing, or wheezing- which would warrant urgent follow up or ER visit. Otherwise we will report this reaction to the manufacturer and agency.",,,,,,,,,Y,09/23/2019,09/25/2019,2,N/A,PVT,,"triamcinolone 0.1% topical cream, Apply to affected area 2 times a day",None,None,,,2,10/03/2019,,Y,,NKA
0837946,10/03/2019,MO,58.0,58,,F,,Patient reported the day after receiving the vaccination that she woke up during the night with nausea and aching.  These symptoms persisted upon awakening.  She took acetaminophen and that helped to resolve the symptoms.,,,,,,,,,Y,10/01/2019,10/01/2019,0,NA,PHM,,Unknown,,Unknown,,,2,10/03/2019,,,,Unknown
0837947,10/03/2019,GA,73.0,73,,M,,itching  almost every day but not every minute for last 3 months,,,,,,,,,N,07/01/2019,07/02/2019,1,,PHM,,none,none,health very good,,,2,10/03/2019,,,,"malarone,  malaria preventative"
0837948,10/03/2019,IA,65.0,65,,F,,"The evening of oct. 1 started feeling ill with symptoms of headache. vomited in the middle of the night and had some diarrhea. extremely nausea all the next day, body aches, weak couldn't lift arms up. starting to fill better but still not 100 percent",,,,,,,,,U,10/01/2019,10/03/2019,2,no medical test done,PHM,,"atenolol, amlodipine, prednisone,calicum, multivitamin, magiusum oxide,yumfem,","no other illnesses,","high blood pressure, osteoprosis, inflamation",,,2,10/03/2019,,,,"sulfa,augmentin , ciprofloxin"
0837950,10/03/2019,CA,,,,U,,"an improperly stored dose of PEDVAX was administered to lhe patient on an unknown date; No adverse effects; This spontaneous report was received from a medical assistant and concerns to a patient of unknown age and gender. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.         On an unknown date, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) lot # N024570 and expiration date 01-MAY-2020, for prophylaxis (dosage schedule, route, and anatomical location were not reported).  The administered dose of the vaccine experienced a temperature excursion below 36F: 32.1 Fahrenheit (F) for 8 hours, as recorded by a data logger. No previous temperature excursion. There was no adverse effect reported.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA009268,2,10/03/2019,,,,
0837951,10/03/2019,OR,,,,F,,"persistent zoster-like rash from her shoulder to her elbow on the outside of her arm, neck and back which were associated with blisters and severe burning sensations; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a female patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided.   In or around 18-SEP-2017, the pt was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, frequency, lot/batch # and expiration date were not reported).    On an unknown date, reported as ""shortly after receiving zoster vaccine live (ZOSTAVAX)"", the pt suffered a reaction to the vaccine, causing persistent zoster-like rash from her shoulder to her elbow on the outside of her arm, neck and back which were associated with blisters and severe burning sensations. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), pt symptoms had resulted in physical limitations not present prior to using it. Pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution, and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The reporter considered the event to be related to zoster Vaccine Live (ZOSTAVAX). The event was considered as disabling events, due to the pt's permanent and incurable injuries.",,,,,,,,Y,N,09/18/2017,,,,UNK,,,,,,US0095075131910USA001606,2,10/03/2019,,,,
0837952,10/03/2019,TX,3.0,3,,U,,"No adverse event; patient was administered improperly stored VAQTA; This spontaneous report was received from a medical assistant concerning to a patient of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions or concomitant medications.  On 27-SEP-2019, the patient was vaccinated with an improperly stored dose of Hepatitis A Vaccine, Inactivated (VAQTA) lot number S007770 with expiration date on 24-JUL-2020 (dosage schedule, route and anatomical location were not reported) for prophylaxis.  Administered doses of vaccine experienced temperature excursion below 36 degrees Fahrenheit (F) / 2 degrees Celsius (C) for 10 minutes. There was no previous temperature excursion. Digital data logger was not involved. No adverse effects were reported.",,,,,,,,,U,09/27/2019,09/27/2019,0,,UNK,,,,,,US0095075131910USA002532,2,10/03/2019,,,,
0837953,10/03/2019,NY,,4,,U,,"No adverse effects; Administered improperly stored PROQUAD; This spontaneous report was received from a Medical Assistant referring to a 4-year-old patient. The patient's concurrent conditions, medical history and drug allergies/ reactions were not reported. On 07-SEP-2019, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (strength, formulation, dose/frequency and route were unknown) (lot # S009759, expiry date: 27-SE-2020, therapy type: recombinant human albumin (rHa)) for prophylaxis. The diluent used to reconstitute the measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) was properly stored. On 07-SEP-2019, the patient was administered improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (product storage error). No adverse effects reported. The outcome of product storage error and no adverse event was unknown.",,,,,,,,,U,09/07/2019,09/07/2019,0,,UNK,,sterile diluent,,,,US0095075131910USA002979,2,10/03/2019,,,,
0837954,10/03/2019,CA,,,,U,,"Rash / rash on the face and body; This case was reported by a nurse via sales rep and described the occurrence of rash in a patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, less than a day after receiving Bexsero, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Bexsero.  Additional case details were reported as follows: The age at vaccination was not reported. The vaccine lot number and expiry date was unknown. The nurse reported to a field representative that a patient reported a rash within days of Bexsero administration.  The patient developed a rash after having Bexsero, not itchy, on the face and body. No other information was available. The reporter consented to follow up. This is 1 of the 5 linked cases reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201916,2,10/03/2019,,,,
0837955,10/03/2019,NY,64.0,64,,F,,"trouble hearing/ hearing impaired; inflammed inner ear; head felt inflamed; flu-like symptoms; fever; shakes; shivers; headache; Increased heart rate; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included prednisone for inner ear inflammation.   The patient had a Family History of brain neoplasm (father died 6 months ago). Previously administered products included Shingrix with an associated reaction of injection site warmth (for tolerance, refer case US2019175376).   On 1st September 2019, the patient received the 2nd dose of Shingrix .5 ml. On an unknown date, the patient started prednisone at an unknown dose and frequency. On 1st September 2019, 7 hrs after receiving Shingrix, the patient experienced influenza-like symptoms (serious criteria clinically significant/intervention required), fever (serious criteria clinically significant/intervention required), tremor (serious criteria clinically significant/intervention required), shivers (serious criteria clinically significant/intervention required) and headache (serious criteria clinically significant/intervention required). On 5th September 2019, the patient experienced hearing loss (serious criteria GSK medically significant and clinically significant/intervention required), inner ear inflammation (serious criteria clinically significant/intervention required) and feeling abnormal (serious criteria clinically significant/intervention required). In September 2019, the patient experienced heart rate increased (serious criteria clinically significant/intervention required). The patient was treated with vitamins nos (Multivitamin). On 5th September 2019, the outcome of the influenza-like symptoms, fever, tremor, shivers and headache were recovered/resolved. On an unknown date, the outcome of the hearing loss and inner ear inflammation were not recovered/not resolved and the outcome of the feeling abnormal and heart rate increased were unknown.   It was unknown if the reporter considered the influenza-like symptoms, fever, tremor, shivers, headache, hearing loss, inner ear inflammation, feeling abnormal and heart rate increased to be related to Shingrix.  Additional details were provided as follows: The case US2019175386 was found to be duplicate of case US2019175381. Hence case US2019175386 would be deleted and all the information of this case will be added in case US2019175381 which is the case of record for this patient. The patient received vaccine on left arm. The patient received Shingrix and within 7-8 hours experienced flu-like symptoms. The patient also had fever, shakes, shivers, and headache that started on same day. On 5th Sepptember 2019, the patient had trouble hearing and her head felt inflamed. The patient went to the physician and received a prescription for prednisone and a head MRI. In September 2019, the patient had head MRI (Nuclear magnetic resonance imaging brain) and result was within normal limits and her physician only ordered it because her father died of a brain tumor 6 months ago. The patient only took the prednisone for 2 days and physician discontinued the medication because she had an increased heart rate. The patient had 30-40 percent hearing loss that persisted due to an inflamed inner ear. It was unknown if the reporter considered the influenza-like symptoms, fever, tremor, shivers, headache, hearing loss, inner ear inflammation, feeling abnormal and heart rate increased to be related to Prednisone. The reporter did not consent to follow up.",,,,,,,,,N,09/01/2019,09/01/2019,0,"Test Date: 201909; Test Name: Head MRI; Result Unstructured Data: Test Result: within normal limits, Test Result Unit: unknown",UNK,,Prednisone,,Medical History/Concurrent Conditions: Brain neoplasm (father died 6 months ago),,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837956,10/03/2019,NY,,,,F,,"Suspected Vaccination Failure; Got both shingrix vaccines and still broke out with shingles a month later; This case was reported by a physician and described the occurrence of suspected vaccination failure in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient who got both shingrix vaccines and still broke out with shingles a month later. This case was considered as suspected vaccination failure since the details regarding laboratory confirmation of shingles were unknown at the time of reporting.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837957,10/03/2019,MD,54.0,54,,F,,"hives / hives at the site and from head to toe; chills; dark urine; tired; felt bad; itching; rash; rash was a red pin prick appearance; couldn't move arm; tongue swelling; dizziness; tongue heavy; This case was reported by a consumer via call center representative and described the occurrence of feeling bad in a 54-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in May 2019.) and MMR vaccine (received an MMR in June between her two doses of Shingrix.).   On 17th September 2019, the patient received Influenza vaccine Quadrivalent 2019-2020 season. On 18th September 2019, the patient received Shingrix. In September 2019, not applicable after receiving Influenza vaccine Quadrivalent 2019-2020 season and immediately after receiving Shingrix, the patient experienced feeling bad, urine discoloration, tiredness, pruritus, rash, red rash, mobility decreased, swollen tongue, dizziness and tongue abnormal feeling of. On 19th September 2019, the patient experienced chills and hives. The patient was treated with methylprednisolone and benadryl (nos) (Benadryl). On an unknown date, the outcome of the feeling bad, chills, urine discoloration, tiredness, hives, pruritus, rash, red rash, mobility decreased, swollen tongue and dizziness were unknown and the outcome of the tongue abnormal feeling of was recovered/resolved.   It was unknown if the reporter considered the chills, urine discoloration, tiredness, hives, pruritus, rash, red rash, mobility decreased, swollen tongue, dizziness and tongue abnormal feeling of to be related to Influenza vaccine Quadrivalent 2019-2020 season and Shingrix. It was unknown if the reporter considered the feeling bad to be related to Shingrix.  Additional case details were reported as follows: The patient had an unknown manufacturers flu vaccine in her left arm and on Wednesday the day before reporting she had her second dose of Shingrix in her right arm.  The patient stated she immediately felt bad after receiving the Shingrix vaccine.  On Thursday, before day of reporting, after 2 days of vaccination the patient covered in hives at the site and from head to toe.  She could not move her arm. She noted the rash was a red pin prick appearance on Friday, before day of reporting.  On Sunday, before day of reporting, the patient went to urgent care and was given methylprednisone prescription. She stated on the way leaving urgent care to get the prescription her tongue felt like it was swelling, she was dizzy and itching. Once she took a dose of the methylprednisone she noted the tongue issue resolved.  Thursday and Friday, before day of reporting she had chills, mono feeling which was how she described the tired feeling, and dark urine.  She was drinking water to resolve the dark urine, which was better. She stated the itching was better but notices it in her arm pits. Her tongue was no longer heave, the pin prick rash was the same and still all over her body, head to toe.  The patient was still tired but contributed that to taking round the clock Benadryl as prescribed from Urgent care. She was on a total of 5 days of methylprednisone. The reporter did note that, the patient received an MMR in June between her two doses of Shingrix. She denied a rash after the MMR. The emergency room visit was required. The reporter consented to follow up. This case has been linked with cases US2019172796 and US2019173375 reported by the same reporter.",,,,,,,,,Y,09/18/2019,09/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,Y,
0837958,10/03/2019,IN,56.0,56,,F,,"chills; shaking; fever; dizziness; fast heart rate; headache; almost passed out; This case was reported by a consumer via call center representative and described the occurrence of chills in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th April 2019, the patient received the 1st dose of Shingrix (intramuscular). In April 2019, less than a day after receiving Shingrix, the patient experienced chills, tremor, fever, dizziness, heart rate increased, headache and presyncope. On an unknown date, the outcome of the chills, tremor, fever, dizziness, heart rate increased, headache and presyncope were recovered/resolved.   It was unknown if the reporter considered the chills, tremor, fever, dizziness, heart rate increased, headache and presyncope to be related to Shingrix.  Additional case details were reported as follows: When the patient went to bed on 12th April 2019, evening she noticed that her heart rate was elevated.  At 2:30 AM on 13th April 2019, 1 day after vaccination she was woken from sleep by shaking because she was so cold. The patient had chills, fever of 101 degree Fahrenheit, dizziness such that she almost passed out, her heart rate was 115 and had headache.  The patient visited the clinic where she got the vaccine and was told the symptoms would resolve.  The symptoms resolved after 24 hours. Emergency room visit required. The reporter did not consent to follow up.",,,,,,,,,Y,04/12/2019,,,"Test Date: 20190413; Test Name: Body temperature; Result Unstructured Data: Test Result: 101, Test Result Unit: degree F; Test Date: 20190413; Test Name: Heart rate; Result Unstructured Data: Test Result: 115, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,Y,
0837959,10/03/2019,VA,57.0,57,,F,,"rash; swelling upper left arm; hardness upper left arm; headache; chills; body aches; felt hot; flu like symptoms; This case was reported by a consumer via call center representative and described the occurrence of headache in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had 6 years ago). Previously administered products included Zostavax (received a few years ago).   On 13th September 2019, the patient received the 1st dose of Shingrix. On 14th September 2019, 1 days after receiving Shingrix, the patient experienced chills, general body pain, feeling hot and influenza-like symptoms. On 15th September 2019, the patient experienced headache. On an unknown date, the patient experienced rash, injection site swelling and injection site induration. On an unknown date, the outcome of the headache was not recovered/not resolved and the outcome of the chills, general body pain, feeling hot, influenza-like symptoms, rash, injection site swelling and injection site induration were recovered/resolved.   It was unknown if the reporter considered the headache, chills, general body pain, feeling hot, influenza-like symptoms, rash, injection site swelling and injection site induration to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. The patient stated that, after vaccination with dose of Shingrix, had rash near injection site. The patient reported that upper left arm was swollen and hard. After vaccination with Shingrix, the patient had headache that came and gone. The patient did not received medication like Tylenol or Advil that seems to help with headache. No any additional information was provided. The patient consented to follow up.",,,,,,,,,N,09/13/2019,09/14/2019,1,,PVT,,,,Medical History/Concurrent Conditions: Shingles (had 6 years ago),,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837960,10/03/2019,IA,73.0,73,,M,,"Yesterday between 16:00 - 17:00 started having pain and swelling, left bicep to shoulder. Redness noted at top of shoulder, no redness at injection site. Bicep area quite swollen. Denies fevers.",,,,,,,,,U,10/02/2019,10/02/2019,0,N/A,PVT,,"Aspirin 81mg, Colace 100 mg , Flonase Allergy Relief 50 mcg/actuation nasal spray, gabapentin 300 mg, naproxen 500 mg, omeprazole 20 mg,  Qvar RediHaler 80 mcg/actuation HFA, Tylenol Extra Strength 500 mg",1.  COPD 2.  Back pain. 3.  Constipation. 4.  Allergic rhinitis. 5.  GERD. 6.  Leg pain. 7.  Need for pneumococcal immunization. 8.  Fatigue,"COPD, Depression",,,2,10/03/2019,,Y,,No known allergies
0837961,10/03/2019,GA,41.0,41,,M,,presented with left shoulder pain- diagnosed with bursitis- given NSAIDS and exercises to do at home.,,,,,,,,,U,09/19/2019,09/20/2019,1,,WRK,,actos amlodipine atorvastatin jardiance lisinopril glypizide,,diabetes hypertension elevated cholesterol obesity GERD,,,2,10/03/2019,,Y,,hydromorphone
0837962,10/03/2019,CA,68.0,68,,F,,"Swelling and aching at injection site.  Onset of Fever, chills, aches, vomiting  on Saturday night.  Vomiting ended on Sunday.  Fever broke on Monday morning.  General fatigue lasting through Monday night.",,,,,,,,,Y,09/28/2019,09/28/2019,0,none,PHM,,"Vitamin B, Low dose aspirin",none,asthma,"When I  was 7 or 8 years old, similar reaction",,2,10/03/2019,,,,sulfur
0837963,10/03/2019,IN,9.0,9,,F,,"Patient presented to office 10/3 complaining of itchiness with redness on bilateral legs, neck, and chest that started 10/2/19 at night. Mom states she had flu shot on Tuesday (Oct. 1) and a child she sits for has impetigo.  Physician notes include: A blanching macular rash throughout the body in small areas- a few appear more urticarial. Suspect reaction to the flu vaccine.",,,,,,,,,U,10/01/2019,10/02/2019,1,,PVT,,"pediatric multivitamin, chewable",none reported,none reported,,,2,10/03/2019,,Y,,none known
0837964,10/03/2019,OH,70.0,70,,F,,"pt stated had nausea, vomiting , high fever, chills, weak in legs on 10/2 -- she stated she feels better today other than be a little weak and is contacting her doctor just to let him know of reaction and if she needs to do anything else",,,,,,,,,Y,10/02/2019,10/02/2019,0,n/a,PHM,,prilosec 20mg,no other illnesses at time of vaccination or on month prior,diabetes  high blood pressure,,,2,10/03/2019,,Y,,penicillin and sulfonamides
0837965,10/03/2019,KY,40.0,40,,F,,"Started having pain in my right arm immediatley after the shots, Went to the doctor a few weeks later once the pain did not go away. He ordered xrays , then on next appt. he sent me to an orthopedic specialist.  that doctor ordered MRI of the arm, it shows a contusion, but he disagrees that a contusion can be there that length of time. He tehn ordered a bone scan wich was normal. I am now being referred to a shoulder specialist, My orthopedic doctor had diagnosed me with either busitis or tendonitis , he is not sure , he also wanted to do exploratory surgery which I denied at this time. I was given cortizone shot to try to relieve the pain with no avail, in 9/2019.",,,,,,,,Y,N,10/05/2018,10/05/2018,0,XRAY 11/2018? MRI 3/2019? Bone scan 7/2019,PHM,,,no,"Already have limited mobility in my left arm from an old injury, now my left arm hurts worse than that one due to these shots",,,2,10/03/2019,,Y,,"Codeine, Vacamiacin, latex,penicillian"
0837966,10/03/2019,MI,53.0,53,,F,,"Patient developed pain, redness, swelling, warmth around the injection site (left deltoid), patient came to urgent care for evaluation on 10/03/19- was prescribed keflex for cellulitis",,,,,,,,,N,09/30/2019,09/30/2019,0,Initiated antibiotic- keflex 500mg qid for 10 days,PVT,,"Zocor, Victoza, Glucophage, Lisinopril, Dilantin, Zyrtec",n/a,"Seizure disorder, HTN, migraines, allergic rhinitis, DM",,,2,10/03/2019,,Y,,"Codeine, Macrobid, Sulfa, Prednisone"
0837967,10/03/2019,FL,21.0,21,,F,,I have had a sharp pain in my left arm that stems from the injection site with any movement of my left arm. This has been going on for exactly one month now. Since the vaccine,,,,,,,,,N,09/03/2019,09/03/2019,0,,PHM,,None,None,None,,,2,10/03/2019,,,,Shell fish
0837968,10/03/2019,AK,56.0,56,,F,,"Profound swelling, pain, headache, lethargy, shortness of breath. Unable to move arm without pain. Debilitating pain",,,,,,,,,N,10/02/2019,10/02/2019,0,,PVT,,"Estradiol, Progesterone, Multi Vitamin",cold/sinus pressure,,,,2,10/03/2019,,,,Lea Quinn Biaxin Reclast
0837969,10/03/2019,,65.0,65,,F,,"Get aches, pain, but resolved within 24 hours",,,,,,,,,Y,09/18/2019,09/18/2019,0,N/A,UNK,,,,,,,2,10/03/2019,,,,
0837970,10/03/2019,OR,52.0,52,,F,,Redness around injection sites of both arms. Slide warm to the site. Flu like symptoms. No streaking of redness for local sites.,,,,,,,,,N,10/01/2019,10/02/2019,1,N/a,PVT,,Ibuprofen 800 mg,unavailable information,N/A,,,2,10/03/2019,,Y,,NKDA
0837971,10/03/2019,OK,44.0,44,,F,,"70mm x 35mm reddened area that is wam, tender and  hard to touch.",,,,,,,,,N,10/01/2019,10/01/2019,0,none to date,PVT,,Meloxicam 15mg 1 daily fluoxetine HCL 20mg  Lisinopril 10mg daily omeprazole 20mg by mouth every am LoEstrin daily 0.05-30/0.075/40/0.125-30 metformin 500mg daily with food Aspirin 81mg daily,None,Hyperglycemia High blood pressure,small red spot size of nickel  from  past flu vaccine,,2,10/03/2019,,,,Stated just a little red spot with past influenza vaccine that was not preservative free.  No other known allergies
0837972,10/03/2019,MI,59.0,59,,F,,"Chills, body aches, tiredness, congestion, flu-like symptoms, lack of hunger, mild headache",,,,,,,,,N,10/02/2019,10/03/2019,1,,PVT,,50 mcg Levothyroxine,None,None,,,2,10/03/2019,,,,Penicillin
0837973,10/03/2019,NJ,30.0,30,,M,,ADEM/with paralysis,,,,,Y,15,,Y,N,09/11/2019,09/29/2019,18,Admiitted 09/30/MRI/CT/LP..Getting IV steroids and plasmapheresis is starting 10/03.,PVT,,Metformin-BID,DM,Newly diagnosed diabetic,,,2,10/03/2019,,,,NKA
0837974,10/03/2019,FL,56.0,56,,F,,"On June 24,2019. Husband and I was gave the shingles shot, My husband went first, and then I went. Three weeks later I develop a rash on my left breast . I called my primary doctor, he treated me for a yest infection. Four week later the symptoms was not gone. So my primary doctor refer me to a dermatology, the dermatology took a swap culture, and a biopsy from my left breast. In a week the reult came back I have psoriasis, which I have on my belly line, my hair, and feet, genital area. two week later the swap culture came back I hae e-coli and staph infection. it only effect me and not my husband,",,,,,,,,,N,06/24/2019,07/01/2019,7,"Psoriasis, e-coli, and staph infection",PHM,,none,"High blood pressure,Diabetes.","diagnose with psoriasis, E-coli, and staph infection",,,2,10/03/2019,,Y,Y,Darvices
0837975,10/03/2019,CA,26.0,26,,M,,"6cm  oval mild swelling  and redness , injected  .1cc flu vaccine intradermally instead of PPD for tuberculin skin screening",,,,,,,,,Y,10/01/2019,10/01/2019,0,none,SCH,,none,none,none,,,2,10/03/2019,,,,none
0837976,10/03/2019,CO,56.0,56,,F,,Gave a subcutaneous injection in the muscle.  Patient complained of soreness,,,,,,,,,Y,10/02/2019,10/02/2019,0,,PHM,,,None,Diabetes,,,2,10/03/2019,,,,None
0837977,10/03/2019,TX,70.0,70,,F,,Patient initially asked for flu vaccine at drop off and requested regular dose.  Insurance rejected the claim but the High Dose vaccine was covered due to he age.  Patient agreed to try the high dose was fine but swelling and rash occurred late that evening.  She started to experience stiffness in her neck which alarmed her to see Urgent Care.  Patient came by next day to pick up prednisone and informed me at counseling that ER gave her a dose of prednisone and she feels much better. She has a bit of swelling but rash has subsided.,,,,,,,,,Y,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/03/2019,,,,
0837978,10/03/2019,OR,69.0,69,,F,,"FACIAL PARALYSIS, FACIAL DROOP",,,,,,,,,U,10/02/2019,10/03/2019,1,,PVT,,,,,,,2,10/03/2019,,,Y,
0837979,10/03/2019,UT,22.0,22,,F,,"Initial symptoms were sensativity to light, headaches, extreme fatigue;  Initial symptoms were followed by cognative issues, joint pain including costochondritis (swollen, painful, inflammed sternum, shoulder, elbow, ribs); moody and inability to do physical activity due to joint pain and fatigue;  Irritability and light-headedness; mouth sores; developed sensativity to dairy; hair loss; miscarriage; anxiety; flushing; allergies; and a myriad of other random complaints.  Over a number of years I visited an eye doctor, general physicians, two chiropractors, urgent care, a naturopath, an allergy Md, an endocrinologist, a rheumatologist, etc.   I've had numerous diagnostic tests while dealing with these issues.",,,,,,,,Y,N,08/07/2012,08/07/2012,0,,PVT,,Trinessa,Cannot recall any.,None at the time of vaccination.,,,2,09/30/2019,,Y,Y,Possibly Sulpha
0837980,10/03/2019,NC,16.0,16,,F,,"Pediarix was given in lieu of the Flu vaccine that was ordered.   They are very similar in appearance,",,,,,,,,,Y,10/03/2019,10/03/2019,0,,PVT,,,,,,,2,10/03/2019,,,,
0837981,10/03/2019,NY,57.0,57,,F,,"patient received first dose. Woke up with fever, rash and headache.",,,,,,,,,U,10/01/2019,10/02/2019,1,,PHM,,"Valcyclovir,Lovastatin",,,,,2,10/03/2019,,,,Tetracycline
0837982,10/03/2019,CA,2.0,2,.2,M,,My son is 2 years old an can talk full sentences clear as day. Very smart. He is out of the blue stuttering BAD for the first time an can barley talk an say a sentence. It?s very very bad. I?m  very concerned and want to know what to do.  He has never had a problem with speech before. He was fine before the shots,,,,,,,,,N,09/30/2019,10/01/2019,1,,PVT,,,,,,,2,10/03/2019,,,,
0837983,10/03/2019,MA,66.0,66,,F,,"Fever, chills, aches and pains, general malaise, headache Starting day after second dose of Shingrix",,,,,,,,,Y,09/24/2019,09/25/2019,1,,PHM,,,,,,,2,10/03/2019,,,,
0837984,10/03/2019,MA,15.0,15,,M,,Expired vaccine given - No adverse reaction.,,,,,,,,,,09/27/2019,,,N/A,OTH,,N/A,N/A,N/A,,,2,10/03/2019,,Y,,N/A
0837987,10/03/2019,PA,89.0,89,,F,,"Patient told me on 10/2/19, that she went to the hospital the evening of the vaccination because she had fever & chills. She stated they sent her home. She stated she felt her fever & chills were related to the vaccination, but they couldn't be sure. I told her I thought we needed to report this to VAERS, but she did not want to, stating they couldn't be sure so she didn't want to report it. I left a message for her family Dr & called VAERS for guidance.",,,,,,,,,Y,09/26/2019,09/26/2019,0,Unknown - only info patient provided is above,PHM,,Unknown,none reported on consent,none reported on consent,,,2,10/03/2019,,,Y,none reported on consent
0837992,10/03/2019,FL,,,,U,,"no adverse affects; first dose was given on 8/5/2019, and second was given on 9/18/2019; This spontaneous report was received from a nurse prescriber via company representative and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported.  On 05-AUG-2019, the patient received the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (exact dose, route of administration, anatomical location, lot# and expiration date were not reported) for prophylaxis. On 18-SEP-2019, the patient received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (exact dose, route of administration, anatomical location, lot# and expiration date were not reported) for prophylaxis. The nurse prescriber reported that the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was given sooner than it should be. No adverse effects reported.",,,,,,,,,U,08/05/2019,09/18/2019,44,,UNK,,,,,,US0095075131909USA014248,2,10/03/2019,,,,
0837993,10/03/2019,CA,,,,F,,"sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional case details were provided as follows: The patient's sister reported the case. The age of vaccination was not reported. The patient experienced sore arm after receiving Shingrix. No further details were available. The reporter did not consent to follow up. This case has been linked to US2019175459, reported by the same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837994,10/03/2019,WI,,,,U,,"A lot of pain; Cannot move arm very well; This case was reported by a consumer via call center representative and described the occurrence of pain in a elderly patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced pain and mobility decreased. On an unknown date, the outcome of the pain and mobility decreased were unknown.   It was unknown if the reporter considered the pain and mobility decreased to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, however the patient could be elderly. After receiving 1st dose of Shingrix, the patient did not experienced any event but after 2nd shot experienced lot of pain and could not move arm. The reporter consented for follow up.",,,,,,,,,U,,,,,UNK,,Shingrix,,,,USGLAXOSMITHKLINEUS2019AM,2,10/03/2019,,,,
0837995,10/03/2019,NJ,,,,F,,"Pain at Injection; Lousy/ feeling terrible; Flu-like Symptoms; Chills; Feeling tired; Hurting; not feel good/ felt like crap; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th September 2019, the patient received the 1st dose of Shingrix. On 19th September 2019, immediately after receiving Shingrix, the patient experienced injection site pain, feeling bad, influenza-like symptoms, chills, tiredness, pain and feeling unwell. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the injection site pain, feeling bad, influenza-like symptoms, chills, tiredness, pain and feeling unwell were unknown.   It was unknown if the reporter considered the injection site pain, feeling bad, influenza-like symptoms, chills, tiredness, pain and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The patient stated that it hurt when needle was injected into her arm. The patient approximately 4 hours after vaccination felt lousy. The patent approximately 6 hours after vaccination was  in bed with flu like symptoms. The flu like symptoms described as chills, feeling tired, hurting, and not feel good. The patient took 2 extra strength Tylenol before going to bed early at 7:30 PM which helped a little. The patient took Tylenol the next morning after waking up because she felt like crap. The patient did not consent to follow up.",,,,,,,,,U,09/19/2019,09/19/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837996,10/03/2019,AZ,77.0,77,,F,,"muscle aches; nerve pain; sore arm/ left arm very tender; could not sleep; feeling stiff and sore all over; fatigue; sore all over; nausea; joint pain; flu; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included fluconazole (Fluzone (Fluconazole)) for product used for unknown indication.   The patient's past medical history included head and neck cancer and stroke. Concurrent medical conditions included blindness, automobile accident (- soft tissue injuries, broken sernum, Nov 2018, still recovering from injuries), thyroid disorder, vestibular disorder (caused by head and neck cancer treatment), gastroesophageal reflux disease, soft tissue injury (still recovering from injuries) and fractured sternum (still recovering from injuries). Concomitant products included omeprazole, paracetamol (Tylenol), thyroid hormones (Thyroid Hormone) and medication unknown (Blood Pressure Medication).   On 18th September 2019 16:30, the patient received the 1st dose of Shingrix. On 18th September 2019, the patient started Fluzone (Fluconazole) at an unknown dose and frequency. In September 2019, 9 hrs 30 min after receiving Shingrix, the patient experienced muscle pain, nerve pain, pain in arm, insomnia, stiffness, fatigue, general body pain, nausea, joint pain and influenza. On an unknown date, the outcome of the muscle pain, nerve pain, pain in arm, nausea, joint pain and influenza were recovered/resolved and the outcome of the insomnia, stiffness, fatigue and general body pain were unknown.   It was unknown if the reporter considered the muscle pain, nerve pain, pain in arm, insomnia, stiffness, fatigue, general body pain, nausea, joint pain and influenza to be related to Shingrix.  Additional details were provided as follows: On 18th September 2019, The reporter stated that the patient got the first dose of Shingrix, as well as Fluzone, , around 4:30 PM. Prior to getting the vaccines the patient had physical therapy for previous car crash injuries and also did some shopping. The patient went to bed around 8:30 PM exhausted from a busy day. On 19th September 2019, at 2 am around, the patient woke up with severe muscle pains, her left arm very tender, and the sheet moving against her body causing nerve pain. The patient felt like she did right after her car accident. The patient got up feeling stiff and sore all over and took some Tylenol.  The patient could not sleep the rest of the night. That morning she had two previously scheduled appointments with her physician and ophthalmologist. The patient got home from her appointments around 2 PM and was so fatigued she fell asleep as soon as she got home. The patient woke up about 4 PM and drank a lot of water. The patient spent the rest of the day treating herself like she had the flu. The symptoms resolved after about 24 hours. During this period she had these symptoms she had a little bit of nausea, which was solved by eating food. The patient thinks she was hungry and also had flashes of joint pain like her knees were getting electric shots. The patient noted that she was often stiff and sore after physical therapy, so she was not sure how much of the symptoms were due to the vaccine versus her previous activities. She does not think any of it was caused by Fluzone. She has never had problems with flu vaccines in the past.",,,,,,,,,Y,09/18/2019,09/01/2019,,,UNK,,Omeprazole; Tylenol; THYROID HORMONE; BLOOD PRESSURE MEDICATION; Fluconazole,"Automobile accident (- soft tissue injuries, broken sernum, Nov 2018, still recovering from injuries); Blindness; Fractured sternum (still recovering from injuries); Gastroesophageal reflux disease; Soft tissue injury (still recovering from injuries); Thyroid disorder; Vestibular disorder (caused by head and neck cancer treatment)",Medical History/Concurrent Conditions: Head and neck cancer; Stroke,,USGLAXOSMITHKLINEUS201917,2,10/03/2019,,,,
0837997,10/03/2019,DE,,,,U,,"Can not administer the whole product into the skin, completely depress the plunger; it stops with either 0.2ml or 0.3ml remaining, no AE; Can not administer the whole product into the skin, completely depress the plunger; feel pressure when they press down, no AE; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 17 years old patient who was vaccinated with a dose of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] lot number lot UJ237AB via unknown route in an unknown administration site on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is an actual medication error case due to vaccine underdose. It was reported that when they drew up the 0.5ml dose and the assistant practice manager attempted to inject into a staff member and the plunger stopped with 0.2 ml remaining in the syringe. It is also a case of syringe issue as it was reported that the nurse is not able to completely depress the plunger; it stops with either 0.2ml or 0.3ml remaining. Can not administer the whole product into the skin,  feel pressure when they press down.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA268261,2,09/30/2019,,,,
0837998,10/03/2019,ME,84.0,84,,F,,"expired dose of Fluzone HD administered to the patient, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA268361, 2019SA268355, 2019SA268356, 2019SA268357, 2019SA268358, 2019SA268359, 2019SA268360 and 2019SA268362 (same reporter).  This case involves a 84 years old female patient who received 0.5 ml dose of expired vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UI994AA, Exp. Date 09-Apr-2019) via intramuscular route in the left deltoid, on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA268346,2,10/01/2019,,,,
0837999,10/03/2019,ME,90.0,90,,F,,"expired dose of Fluzone HD administered to the patient, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA268361, 2019SA268346, 2019SA268356, 2019SA268357, 2019SA268358, 2019SA268359, 2019SA268360 and 2019SA268362 (same reporter).  This case involves a 90 years old female patient who received 0.5 ml dose of expired vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UI994AA, Exp. Date 09-Apr-2019) via intramuscular route in the right deltoid, on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA268355,2,10/01/2019,,,,
0838000,10/03/2019,ME,87.0,87,,F,,"expired dose of Fluzone HD administered to the patient, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA268361, 2019SA268355, 2019SA268346, 2019SA268357, 2019SA268358, 2019SA268359, 2019SA268360 and 2019SA268362 (same reporter).  This case involves a 87 years old female patient who received 0.5 ml dose of expired vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UI994AA, Exp. Date 09-Apr-2019) via intramuscular route in the right deltoid, on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA268356,2,10/01/2019,,,,
0838001,10/03/2019,ME,86.0,86,,F,,"expired dose of Fluzone HD administered to the patient, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA268361, 2019SA268355, 2019SA268356, 2019SA268346, 2019SA268358, 2019SA268359, 2019SA268360 and 2019SA268362 (same reporter).  This case involves a 86 years old female patient who received 0.5 ml dose of expired vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UI994AA, Exp. Date 09-Apr-2019) via intramuscular route in the left deltoid, on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA268357,2,10/01/2019,,,,
0838002,10/03/2019,ME,65.0,65,,F,,"expired dose of Fluzone HD administered to the patient, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA268361, 2019SA268355, 2019SA268356, 2019SA268357, 2019SA268346, 2019SA268359, 2019SA268360 and 2019SA268362 (same reporter).  This case involves a 65 years old female patient who received 0.5 ml dose of expired vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UI994AA, Exp. Date 09-Apr-2019) via intramuscular route in the left deltoid, on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA268358,2,10/02/2019,,,,
0838003,10/03/2019,ME,87.0,87,,M,,"expired dose Fluzone HD administered, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA268346, 2019SA268355, 2019SA268356, 2019SA268357 and 2019SA268358 (same reporter).  This case involves a 87 years old male patient who received 0.5 ml dose of expired vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UI994AA, Exp. Date 09-Apr-2019) via intramuscular route in the right deltoid, on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA268359,2,10/02/2019,,,,
0838004,10/03/2019,ME,84.0,84,,F,,"expired dose of Fluzone HD administered to the patient, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA268361, 2019SA268362, 2019SA268346, 2019SA268355, 2019SA268356, 2019SA268357, 2019SA268358 and 2019SA268359 (same reporter).  This case involves a 84 years old female patient who received 0.5 ml dose of expired vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UI994AA, Exp. Date 09-Apr-2019) via intramuscular route in the left deltoid, on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA268360,2,10/02/2019,,,,
0838005,10/03/2019,ME,81.0,81,,F,,"expired dose of Fluzone HD administered to the patient, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA268346, 2019SA268355, 2019SA268356, 2019SA268357, 2019SA268358, 2019SA268359, 2019SA268360 and 2019SA268362 (same reporter).  This case involves a 81 years old female patient who received 0.5 ml dose of expired vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UI994AA, Exp. Date 09-Apr-2019) via intramuscular route in the right deltoid on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA268361,2,10/02/2019,,,,
0838006,10/03/2019,ME,74.0,73,,M,,"expired dose Fluzone HD administered, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA268361, 2019SA268346, 2019SA268355, 2019SA268356, 2019SA268357, 2019SA268358, 2019SA268359 and 2019SA268360 (same reporter).  This case involves a 74 years old male patient who received 0.5 ml dose of expired vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UI994AA, Exp. Date 09-Apr-2019) via intramuscular route in the left deltoid, on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/13/2019,,,,UNK,,,,,,USSA2019SA268362,2,10/02/2019,,,,
0838007,10/03/2019,CA,,2,.1,F,,"expired dose of Daptacel was given to patient on 24SEP2019/no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 2 years old female patient who received expired 0.5 mL dose of vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] lot C5254AA, expiry date-18-09-2019 Frequency = once via unknown route in the right thigh on 24-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3), VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (PROQUAD) for Immunisation; INFLUENZA VACCINE INACT SPLIT VIRION 4V (FLUZONE QUADRIVALENT) for Immunisation; and POLIO VACCINE INACT 3V (VERO) (IPOL POLIO VACCINE) for Immunisation.  It was a case of actual medication error due to Expired vaccine used.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/24/2019,,,,UNK,,PROQUAD; FLUZONE QUADRIVALENT; IPOL POLIO VACCINE,,,,USSA2019SA268415,2,10/02/2019,,,,
0838008,10/03/2019,CO,,0,.0,F,,"patient received expired dose of vaccine Pentacel/ No AE; Initial information received on 25-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 4 months old female patient who received expired dose of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] lot C55428A/ C55428AA, expiry date- 08-Sep-2019 via unknown route in the left vastus lateralis On 25-May-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) for Immunisation; and PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Immunisation.  It was a case of actual medication error due to Expired vaccine used.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,05/25/2019,,,,UNK,,ROTATEQ; PREVNAR 13,,,,USSA2019SA268581,2,10/02/2019,,,,
0838009,10/03/2019,WI,,74,,F,,"patient was given Fluzone Quadrivalent this morning instead of Fluzone HD/NO AE; Initial information received on 25-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 74 years old female patient who received vaccinesand INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] instead of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE]   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 25-Sep-2019, the patient received a  dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UT6645MA via intramuscular route in the right deltoid instead of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number not reported.  It was a case of actual medication error due to wrong vaccine administered.  It was unknown if any adverse event occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,09/25/2019,,,,UNK,,,,,,USSA2019SA268671,2,10/02/2019,,,,
0838011,10/03/2019,CT,10.0,10,,M,,"patient was administered Daptacel that expired on Sep 18, 2019, no AE; 10 years old patient received Daptacel, no AE; Initial information received on 25-Sep-2019 regarding an unsolicited valid non-serious case received from a health care professional (X-Ray Technician).  This case involves 10 year old male patient who was vaccinated with expired 0.5 ml dose of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included POLIO VACCINE (POLIO) for Immunisation; and HEPATITIS A VACCINE (HEPATITIS A) for Immunisation.  On 25-Sep-2019, the patient received a 0.5 ml dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE Lot C5254AA, expiration date: Sep 18, 2019 via unknown route in the left upper arm.  It was a case of actual medication error due to expired vaccine used and inappropriate age at vaccine administration.  At the time of the report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error  List of documents held by the sender: none",,,,,,,,,U,09/25/2019,,,,UNK,,POLIO; HEPATITIS A,,,,USSA2019SA269536,2,10/02/2019,,,,
0838012,10/03/2019,AL,16.0,,,F,,"Flublok Quadrivalent was administered to a 16 year old, NO AE; Initial information received on 25-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (Office Staff).  This case is linked to case 2019SA269553 (same reporter).  This case involves a 16 years old female patient who was vaccinated with Flublok quadrivalent (INFLUENZA QUADRIVALENT RECOMBINANT VACCINE) [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 23-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot QFAA1913, Exp 6/29/2020 via intramuscular route in the right deltoid.  It was a case of actual medication error due to Inappropriate age at vaccine administration.  At the time of the report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error  List of documents held by the sender: none",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA269551,2,10/02/2019,,,,
0838013,10/03/2019,AL,,,,F,,"Flublok Quadrivalent was administered to a 14 year old, no adverse event; Initial information received on 25-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to case 2019SA269551 (same reporter).  This case involves a 14 years old female patient who received a 0.5 ml dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] QFAA1913, exp date (06-Jun-2020)  via intramuscular route in the right deltoid on 23-Sep-2019.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  no other vaccine was given.    It was a case of actual medication error due to inappropriate age at vaccine administration.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA269553,2,10/03/2019,,,,
0838014,10/03/2019,CT,,1,.5,F,,"expiration date of 18SEP2019 on the label was given today/no AE; Initial information received on 25-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 18 months old female patient who received expired dose of vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 25-Sep-2019, the patient received a 0.5 ml dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot C5254AA via intramuscular route in the left thigh.  It was of actual medication error due to expired vaccine used.  It was unknown whether adverse event was experienced.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.",,,,,,,,,U,09/25/2019,,,,UNK,,,,,,USSA2019SA269589,2,10/02/2019,,,,
0838015,10/03/2019,TN,1.5,1,.5,M,,"patient was administered expired daptacel vaccine, no AE; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 18 months old male patient who received an expired vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (dose number: 4) (lot C5254AB, exp.date: 18-Sep-2019) via intramuscular route in right Vastus Lateralis on 20-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/20/2019,,,,UNK,,HEPATITIS A VACCINE; FLULAVAL,,,,USSA2019SA270586,2,10/03/2019,,,,
0838016,10/03/2019,IL,15.0,15,,M,,"Fluzone Quadrivalent was administered to a patient which was was unstable, plus it took a long time before delivery, no AE; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from other health professional.  This case is linked with 2019SA274480 (same reporter).  This case involves a 15 years old male patient who received 0.5 mL dose of vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (lot UT6654KA, expiry date: 13-Jun-2020) via intramuscular route in the left deltoid on 06-Sep-2019, which was incorrectly stored.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual mediation error due to incorrect product storage. It was reported that vaccine was unstable, plus it took a long time before delivery. Shipment come and it took 3-4 days to be delivered. Vaccine was out of range and unstable.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/06/2019,,,,UNK,,,,,,USSA2019SA270664,2,10/03/2019,,,,
0838017,10/03/2019,TX,,,,M,,"pain on his neck and back; pain on his neck and back; unsteady headaches; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 68 years old male patient who experienced pain on his neck and back (bac pain and neck pain), and unsteady headaches (headache), while he received vaccine RABIES (HDC) VACCINE [IMOVAX RABIES].  The patient's past vaccination(s): The patient stated that he had received the series of Imovax vaccines in the past and everything was fine.  The patient's past medical history, medical treatment(s) and family history were not provided.  No other vaccine was given.   On 24-Aug-2019, the patient received a first dose of 1 ml suspect RABIES (HDC) VACCINE lot CP1C85, exp date: 25-Sep-2020, via intramuscular route in the left arm. for an unknown indication.  On an unknown date, the patient developed a non-serious pain on his neck and back (neck pain and back pain) and unsteady headaches (headache) (Unknown latency) following the administration of RABIES (HDC) VACCINE.  case details: Physician stated that the Imovax vaccine was administered and being experiencing headache from  time to time since. He was supposed to receive two doses but didn't do to the side effects of the fisrt dose. He went to see his doctor on the September 3th who confirmed the symptoms were due to the vaccine. As of today September 26th , he is still experiencing unsteady headaches. . His doctor suggested that he see a neurologic and he is going to see one today.  (Other relevant tests included no lab data.)  Final diagnosis was unsteady headaches, pain on his neck and back and pain on his neck and back.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Not Recovered / Not Resolved on an unknown date for unsteady headaches, as Unknown for pain on his neck and back and as Unknown for pain on his neck and back.  Causality: Physician confirmed the symptoms were due to the vaccine.",,,,,,,,,N,08/24/2019,,,,UNK,,,,,,USSA2019SA270829,2,10/03/2019,,Y,,
0838018,10/03/2019,IL,21.0,21,,F,,"Fluzone Quadrivalent was administered to a patient which was was unstable, plus it took a long time before delivery, no AE; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from other health professional.  This case is linked with 2019SA270664 (same reporter).  This case involves a 21 years old female patient who received 0.5 mL dose of vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (lot UT6654KA, expiry date: 13-Jun-2020) via intramuscular route in the left deltoid on 17-Sep-2019, which was incorrectly stored.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual mediation error due to incorrect product storage. It was reported that vaccine was unstable, plus it took a long time before delivery. Shipment come and it took 3-4 days to be delivered. Vaccine was out of range and unstable.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/17/2019,,,,UNK,,,,,,USSA2019SA274480,2,10/03/2019,,,,
0838019,10/03/2019,WA,16.0,16,,F,,"Shortly after 6 vaccine injections were given today, her cousin states that she got up from the table and felt nauseated and vomited and passed out completely, landing on the floor and hitting the back of her head against the bottom of the IPAD stand, and then regained consciousness almost immediately and felt weak. At that point cousin stepped out of the room and asked for help. Dr and Dr along with the clinical nurse supervisor and MA's went into the room immediately and patient was getting up with assistance from cousin. Rapid response was called and immediately after Urgent care nurse and urgent care provider also arrived. Incident was noted to have occurred at 10:10 am. Blood sugar was 90. She was noted to be alert and oriented with strong pulses and regular rhythm and even respirations. Initial BP 100/62, pulse 72, temps 94.9 F, respiratory rate 16, O2 sat 100% pain 0 out of 10. She was given some food and a repeat BP was 102/70 pulse 80, respirations 16, 02 sat 100% pain 0 out of 10. Orthostatic BP were taken 15 minutes later, prior to discharge and were at the same at 100/70 and 100/59. She then left with cousin, was back to her usual self.",,,,,,,,,Y,09/16/2019,09/16/2019,0,Random blood glucose - normal,PVT,,None,None,None,,,2,10/03/2019,,Y,,None
0838020,10/03/2019,NC,78.0,78,,F,,"About 24 h after shot, pt notice a low-grade fever (99 degrees) and then a 3in diameter red patch (slightly beneath injection site on the left arm). She reported otherwise feeling fine.",,,,,,,,,U,09/30/2019,10/01/2019,1,,PHM,,,,,,,2,10/03/2019,,,,
0838021,10/03/2019,IA,38.0,38,,M,,patient received influenza and pneumonia vaccines. both vaccines given in left deltoid. very reddened and swollen. temperature 101.5,,,,,,,,,N,09/30/2019,09/30/2019,0,,PVT,,none,,,,,2,10/03/2019,,,Y,"shellfish, peanuts"
0838022,10/03/2019,NY,52.0,52,,F,,"Employee complaining of redness, swelling, heat, and pain at injection site later that day. The following day had a ""slight fever"" and swelling was worse. Went to Urgent Care and was told she had cellulitis and was put on antibiotics.",,,,,,,,,Y,09/25/2019,09/25/2019,0,,WRK,,unknown,unknown,unknown,,,2,10/03/2019,,,Y,Amoxicillin
0838023,10/03/2019,MA,86.0,86,,F,,Patient called pharmacy Tuesday late afternoon 10/01/2019 and asked if she could use advil after a flu shot. The pharmacist said yes. Patient visited pharmacy today 10/03/2019 stating her arm hurt all day 10/02/2019 and a little this morning. She wanted to report the experience. I told her that I would make a report for her.,,,,,,,,,U,10/01/2019,10/01/2019,0,,PHM,,"After administration patient used Advil at 5pm, and used it 10/02/2019 and one dose 10/03/2019 at 7:30am",none noted,none noted,,,2,10/03/2019,,,,nka
0838024,10/03/2019,CA,75.0,75,,F,,"dizziness, tiredness, feelings of faintness",,,,,,,,,U,10/02/2019,10/02/2019,0,,PVT,,none,,low blood pressure anemia,,,2,10/03/2019,,,,none
0838025,10/03/2019,NC,8.0,8,,M,,"2 inch circumference raised, red hive-like area that appeared within 24 hrs at site of injection.  Remained for over 48 hrs with no other complications.  Had annual flu vaccines throughout life with no previous reactions.  Sister vaccinated at same time had a milder, but similar reaction at same time as well.",,,,,,,,,Y,10/01/2019,10/02/2019,1,,PVT,,None,None,None,,,2,10/03/2019,,Y,,None
0838026,10/03/2019,FL,80.0,80,,M,,"Patient reported that the arm was ""infected"". Within 24 hours of the vaccine, a ""boil"" appeared and was leaking fluid and pus for 2 weeks. Upon examination, there are no signs of infection. The area of the injection site is slightly pink  as expected with a healing lesion. There is no swelling, pain, or significant redness.  No increased temperature/fever. The patient and his caregiver stated that the appearance today is greatly improved.",,,,,,,,,Y,09/18/2019,09/19/2019,1,None,PHM,,"DOXAZOSIN, ENALAPRIL, ATORVASTATIN, OMEPRAZOLE, CARVEDILOL, SERTRALINE, FLUZONE HD",NONE,"CARDIOVASCULAR DISEASE, HYPERTENSION",,,2,10/03/2019,,,,NONE
0838028,10/03/2019,ME,11.0,11,,F,,Student presented to school nurse office with headache followed nausea and vomiting. No fever was present.,,,,,,,,,Y,10/01/2019,10/01/2019,0,None,SCH,,none reported,none reported,none reported,,,2,10/03/2019,,Y,,none reported
0838030,10/03/2019,MA,38.0,38,,F,,"shock, cellulitis",,,,,Y,3,,,Y,09/24/2019,09/24/2019,0,,PVT,,none,none,asthma,,,2,10/03/2019,,Y,Y,azithromycin
0838031,10/03/2019,OH,66.0,66,,F,,"After 2 hours my arm was so sore I could not movelm by itself. I had a fever, chills, nausea, nasal congestion, boydyaches. I slept for 12 hours straight. Did not eat for 24 hours. The next day I still slept all day and finally the symtoms subsided on Sunday evening.  I felt terrible and almost had my daughter take me to the emergency room. If I had been a caregiver I would not have been able to take care of anyone",,,,,,,,,Y,09/28/2019,09/28/2019,0,none,PHM,,"Losartan, Cardiazem, calcium, glucosamine, vitamin D, singulair",none,hypertension allergic rhinitis,,,2,10/03/2019,,,,sulfa
0838032,10/03/2019,TX,54.0,54,,F,,"Joint pain all over my body. No energy. Bad headaches. Shooting pains across shoulder blades and up the back of my neck. My neck is also stiff. Middle and lower back pain. Middle back stiffness. Dizzy spells. GI discomfort. On day 2, I could hear my heart beating in my ears. Injection site very sore and has heat in it. It is also swollen. I am not able to lay on that side in bed at all. Lifting that arm also causes pain at the injection site.",,,,,,,,,N,10/01/2019,10/02/2019,1,,PHM,,"RX- hydroxychloroquine, escitalopram, naltrexone, lisinopril-hctz, gabapentin, Supplements - Krill oil, Vitamin D3, Vitamin B12, CoQ10, VItamin C",None,Rheumatoid arthritis,,,2,10/03/2019,,,,
0838033,10/03/2019,NE,78.0,78,,M,,"Patient presented to pharmacy at 9am on 10/03/2019 to report arm tenderness, redness, swelling, warmness below and interior of right upper arm. Pharmacist on duty on 10/03/2019 informed patient to be seen by physician. Pharmacist on duty called physicians office to inform of patients side effects. Nurse stated she would put it in the chart.",,,,,,,,,U,10/01/2019,10/03/2019,2,,PHM,,,,,,,2,10/03/2019,,Y,,
0838034,10/03/2019,,52.0,52,,M,,"Seizure: saliva (foaming), bleeding from mouth, unresponsive",,,,,Y,,,,Y,09/27/2019,10/02/2019,5,,PVT,,"levothyroxine, B complex",,hypothyroidism,,,2,10/03/2019,,,Y,levaquin
0838035,10/03/2019,TN,42.0,42,,F,,"Patient requested tp receive her annual employee flu vaccination on 10/01/2019. The injection was given IM into the R deltoid muscle after was wiped clean with an alcohol prep pad. Within 5 minutes of the injection, the employee began to complain of excessive itching at the injection site. Approximately 10 minutes later, a visible light red ring appeared around the injection site  about 2"" in diameter. After about another 30 minutes, the employee complained of a ""hard knot"" under the injection site and the ring had become a full darker red circle on her arm that was warm to the touch from inflammation. On 10/03/2019, it was observed that the ""knot"" and circle are still present. There are no complaints of fever or other symptoms by the employee at this time.",,,,,,,,,N,10/01/2019,10/01/2019,0,NONE,PUB,,NONE,PATIENT HAD A COLD 2 WEEKS PRIOR,NONE,,,2,10/03/2019,,,,"NAPROXEN, CODEINE"
0838036,10/03/2019,FL,25.0,25,,F,,Ice applied 8/5/19 Advised to call Agency 910/3/19,,,,,,,,,N,08/02/2019,08/02/2019,0,n/a,PVT,,Ibuprofen,none,Intracoastal Chondritis,,,2,10/03/2019,,,,none
0838037,10/03/2019,IN,16.0,16,,F,,Hep B was supposed to be given. Hep was given instead. Patient reported no symptoms of illness.,,,,,,,,,,10/03/2019,10/03/2019,0,,PUB,,none,none,none,,,2,10/03/2019,,,,none
0838038,10/03/2019,OR,71.0,71,,F,,"Headache. Acute Joint & Muscular pain. 99.8 temp. Feeling Shakey. Pain in Left Arm shoulder, especially. pain in  cheekbones, strangely. Lying down caused acute pain every time I moved. First time any reaction to flu shot.",,,,,,,,,U,10/02/2019,10/02/2019,0,none,OTH,,Losartan. Simvastatin.,None,None,,,2,10/03/2019,,Y,,None
0838039,10/03/2019,OH,15.0,15,,F,,"ON 9/4/19 PT RECEIVED HEP A #1. ON 9/17/19 PT WAS BROUGHT TO OFFICE FOR AN ITCHY RED RAISED RASH ON BOTH LEGS NOTED FOR ONE WEEK. MOM ALSO STATED AT THAT TIME THAT ON THE EVENING OF THE DAY SHE RECEIVED THE HEP A VACCINE, PT'S UPPER  AND LOWER LIPS SWELLED W/ REDNESS AND ITCHING AND LATER PEELED.  NO WHEEZING/COUGHING/TONGUE SWELLING/HIVES NOTED. SYMPTOMS RESOLVED ON THEIR OWN OVER THE NEXT TWO WEEKS. THE SWELLING WAS AT FIRST CONTINUAL FOR ONE WEEK, THEN OFF AND ON FOR THE SECOND WEEK.  MOM STATED THIS HAPPENED AFTER BOTH FIRST AND SECOND DOSES OF HPV ALSO, ON 9/12/17 AND 8/28/18.  PT WAS SEEN AFTER 9/12/17 DOSE IN THE OFFICE ON 10/10/17 FOR WHAT WAS DETERMINED TO BE A STERILE ABSCESS AT SITE OF INJECTION. MOM SHOWED A PHOTO OF LIP SWELLING TO DR. AT THAT VISIT, BUT SHE WROTE THAT THE SWELLING WAS DIFFICULT TO APPRECIATE IN PHOTO.",,,,,,,,,Y,09/04/2019,09/04/2019,0,NONE,PVT,,NONE,RIGHT ELBOW ITCHY RASH,FLEXURAL ECZEMA,"AS WRITTEN IN DESCRIPTION OF EVENTS EARLIER IN THIS FORM, PT HAD SAME REACTION BOTH TIMES SHE RECEIVED HER HPV VACCINES. THOSE D",,2,10/03/2019,,Y,,CEFDINIR
0838040,10/03/2019,NY,50.0,50,,F,,"After the first shot I began feeling weak and achy all over, from my head to my feet. I was hobbling the pain was so bad. The palms of my hands hurt, my legs, my arms. It was very scary and I was in near tears. The next morning I called doc services and the doctor said to be seen by a doctor to check my white blood cells. (My physical shows all my numbers are normal every year). I went to urgent care about 11 am and he said because I didn?t have a fever there wasn?t need for concern. He prescribed methylprogesterone. Since that said to start in the morning, I simply took ibuprofen. By the next morning I was feeling better and did not take the medication.  For the second shot, I pre-medicated using the prescription I didn?t use the first time. The pain was nominal about four hours post shot and I almost finished that. The last two days however, I have had constant noticeable heart palpitations. Although I was told years ago I had a heart murmur it has not affected me, so this was puzzling then I read the pkg insert saying if this happens just after the shot to contact the doctor. Since this shot was given on Sunday 9/29/19 at 2:00pm I didn?t think this was just after. If it persists I?ll contact my doctor.",,,,,,,,,Y,05/30/2019,05/30/2019,0,,PHM,,Paxil 10mg qd Prazosin 1mg qd valerian root 500mg qd,,Herpes ll,,,2,10/03/2019,,Y,,Penicillin-rash
0838041,10/03/2019,AZ,78.0,78,,F,,Pt reports extreme pain and inflammation.  Ice does not resolve pain.  She feels like he injected in her bone.,,,,,,,,,N,10/01/2019,10/01/2019,0,Pt went to hospital on 10/03 and was prescribed prednisone 50mg qd x5 days and benadryl 50mg tid x5 days,PHM,,,,,,,2,10/03/2019,,,Y,
0838042,10/03/2019,GA,11.0,10,,F,,"PATIENT PRESENTED URTICARIA RASH APROX 5 MINUTES AFTER SHOTS. LUNGS CLEAR AT EXAMINATION. GIVEN BENADRYL 25MG PO. BESIDES, RASH. PATIENT IN GOOD CONDITIONS.  GIVEN PRESCRIPTION FOR PREDNISONE PO.  WILL REFER TO ALLERGIST BEFORE NEXT DOSE OF SHOTS",,,,,,,,,Y,09/18/2019,09/18/2019,0,None,PVT,,Methylphenidate 5MG Methylphenidate 27MG  Clonidine 0.1MG,None,ADHD  Dyslexia,,,2,10/03/2019,,,,None
0838043,10/03/2019,MI,53.0,53,,F,,"Redness, swelling, pain at injection site. Patient has not taken anything. She did not report to her primary care provider. I will contact them.",,,,,,,,,N,09/30/2019,10/02/2019,2,,PHM,,,,,,,2,10/03/2019,,,,n/a
0838044,10/03/2019,MO,65.0,65,,M,,"Patient said he experienced vomitting, diarrhea, sweating, weakness, bloating, he had shortness of breath and difficulty breathing.",,,,,,,,,Y,09/25/2019,09/25/2019,0,unkown,PHM,,Losartan 100mg Terazosin 5mg Pravastatin 40mg Hydrochlorothiazide 25mg,Unknown,Uknown,,,2,10/03/2019,,,Y,No
0838045,10/03/2019,NM,76.0,76,,F,,"Oct. 1 experienced pain, reddness and swelling Oct. 2  pain in left side of neck Oct. 2. Using my left to pick up a solid item, I felt water drops on my left hand",,,,,,,,,N,10/01/2019,10/02/2019,1,,PHM,,"Simvastatin, effexor",,arthritis,,,2,10/03/2019,,,,codeinenone
0838047,10/03/2019,NC,,63,,F,,"The patient developed a big knot, bruising, redness and swelling at the injection site; The patient developed a big knot, bruising, redness and swelling at the injection site; The patient developed a big knot, bruising, redness and swelling at the injection site; The patient developed a big knot, bruising, redness and swelling at the injection site; This spontaneous report was received from a pharmacist concerning a 63-year-old female patient. No information was provided regarding the patient's pertinent medical history, concomitant medications or drug reactions/allergies.  On 02-SEP-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) on the left arm, via intramuscular, lot number R033342, and expiration date on 03-AUG-2020 (strength and dosage schedule were not reported) to prevent pneumonia (prophylaxis).  On 03-SEP-2019, she developed a big knot (injection site nodule), bruising (injection site bruising), redness (injection site erythema) and swelling (injection site swelling) at the injection site in the left arm.  The patient did not seek medical attention. Therefore, she did not receive treatment for the events or had any laboratory diagnostics/studies performed. The outcome of the events injection site nodule, injection site bruising, injection site erythema and injection site swelling was not recovered.  The causal relationship between all the aforementioned events and therapy with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not provided.      Upon internal review, the events injection site nodule, injection site bruising, injection site erythema and injection site swelling were determined to be events of significant disability or incapacity.",,,,,,,,Y,N,09/02/2019,09/03/2019,1,,UNK,,,,,,US0095075131909USA015013,2,10/03/2019,,,,
0838056,10/03/2019,CT,79.0,79,,F,,"Patient states that the got the shivers, nausea and aches after receiving vaccination.  Informed patient that these are known possible side effects to vaccination. Call doctor if they persist",,,,,,,,,U,10/02/2019,10/02/2019,0,,PHM,,,,,,,2,10/03/2019,,Y,,penicillin/ macrodantin
0838057,10/03/2019,TX,27.0,27,,F,,"pressure like pain to right arm, feels like she cannot stretch arm, right forearm and right fingers are tingling, right pinky finger numb-ish, dizziness, nausea",,,,,,,,,N,10/02/2019,10/02/2019,0,TB skin test administered to left forearm on 10/2/2019,OTH,,Ibuprofen as needed,"Reports had a  ""cold"" in mid September.",None,,,2,10/03/2019,,,,No Known Allergies
0838058,10/03/2019,MN,66.0,66,,F,,Patient reported pain traveling up from injection site on arm up through shoulder and neck and a white bump that developed under the vaccination site and traveled down the arm. The patient also reported hives developing on the arm and leg below. She reported symptom resolution by day of report on 10/3/2019 and hive resolution 2 days after treating with Benadryl at home.,,,,,,,,,Y,09/27/2019,09/27/2019,0,none reported,PHM,,Levothyroxine,no illness reported at time of vaccination,thyroid condition,,,2,10/03/2019,,,,Soy
0838059,10/03/2019,NV,67.0,67,,F,,patient stated that she was shivering with high fever (around 103F) and had body aches at around 8pm of the same night she got her flu shot. She went to the hospital for the condition.,,,,,Y,,,,Y,09/24/2019,09/24/2019,0,none provided,PHM,,none,none,none mentioned,,,2,10/03/2019,,,Y,ndka
0838060,10/03/2019,WI,4.0,4,,F,,Broke out in hives on 10/2/2019 and call the health Department on 10/3/2019.  Public Health Nurse went out to day care to check on 10/3/2019 and there was no more rash/hives and the injection site was clear.,,,,,,,,,Y,10/02/2019,10/02/2019,0,None,PUB,,None,None,None,,,2,10/03/2019,,,,None
0838061,10/03/2019,IL,62.0,62,,F,,"Patient stated the day after receiving the vaccine she felt chills, dizzy, sweating, slight diarrhea and fainted.",,,,,,,,,U,10/02/2019,10/03/2019,1,,PHM,,,,,,,2,10/03/2019,,,,
0838062,10/03/2019,MO,86.0,86,,F,,Patient's daughter called on 10/3/19@3:30PM reporting that her mother is having the red rash on the right hand and inside of right wrist. Patient was asking if that is the reaction to one of the vaccine that the patient was received on 10/2/19 (shingrix given on LA and fluzone HD on RA). Daughter was advised to contact PCP.   10/3/19 @ 3:37PM - (pharmacy intern) contacted Dr. and left a message.  10/3/19 @349PM - pharmacist talked to the caregiver about the rash on the right knuckle no rash at the injection site.,,,,,,,,,U,10/02/2019,10/03/2019,1,,PHM,,No,no,vascular dementia,,,2,10/03/2019,,,,No
0838063,10/03/2019,CA,88.0,88,,F,,"Before the vaccine was administered,vaccine administrator noticed that there was a bruise (about 1/2 thumb in size) near the elbow area; patient specified that she bumped her arm.  Next day, patient's bruise, not on vaccine site, grew to about 2 fingers wide, it was hot/warm to touch; bruise had brown area.  On Saturday, patient went back to pharmacy; per patient, bruise was getting better but was still there.  Patient did not do any treatment at home or call the doctor. Patient asked vaccine provider to report event.",,,,,,,,,U,09/25/2019,09/27/2019,2,,PHM,,"Amitriptyline 50mg, Levothyroxine 0.25mg,",No,Thyroid,,,2,10/03/2019,,,,No
0838064,10/03/2019,,61.0,61,,F,,"Red rash, hot to the touch, tenderness upper arm area.",,,,,,,,,Y,10/02/2019,10/02/2019,0,,WRK,,,,,Similar reaction to previous flu shot,,2,10/03/2019,,,,
0838065,10/03/2019,AL,54.0,54,,F,,By 1240-1 pm my shoulder started hurting and feeling very painful. By 230 I took pain meds and tried to get relief at 431 on I called 911 because the pain had spread and become so severe and my arm was locked to my side and I was having issues breathing. I was transported to the Er,,,,,,,,,N,10/01/2019,10/01/2019,0,Head CT and labs,PVT,,Plaquenil  Xarelto Protonix Montelukast Levothyroxine  Cytomel Lamotrigine Clonazepam Well utrin,Only long standing as below,Lupus Hyperadrenergic POTS Dysautonomia  Hashimotos  CVID Antiphospholipid antibody syndrome Raynauds,,,2,10/03/2019,,,,Latex
0838066,10/03/2019,CO,78.0,78,,F,,"Swollen left arm below injection site around the bicep/elbow area in the anterior section of arm for 1.5 days, +erythema, +pain. No fevers. Taking ibuprofen for pain.",,,,,,,,,N,10/01/2019,10/02/2019,1,n/a,PUB,,Ibuprofen- PRN pain  Pepsid Amlodipine triamterene NAC  Biotin Aquavit Albuterol Budesinide Brovana Yutiupelri,N/a,COPD HTN GERD,,,2,10/03/2019,,,,Amoxicillin- hives Codeine
0838067,10/03/2019,IN,42.0,42,,F,,The patient came to pharmacy and complained her arm has been swollen for several days and warm to touch,,,,,,,,,U,09/29/2019,09/29/2019,0,None,PHM,,"The patient uses Emgality,120mt/ml, Vyvanse 30mg",Not known,Not Known,,,2,10/03/2019,,,,NSAIDS
0838068,10/03/2019,CA,2.0,2,.6,F,,"Pt's mother called the clinic stating that her daughter received 3 vaccines yesterday and that the pt is having redness, tenderness, and welling on her Rt leg. Upon chart review, I  saw that only one vaccine was documented as administered on her Rt thigh and that was the Hep B vaccine. Mom reports that the pt's left leg ""is fine and that's where 2 vaccines were administered."" Mom denies any other s/s outside of localized redness and swelling at vaccine site. Mom added that pt is c/o tenderness and soreness of her rt leg when she is walking. I asked if pt had experienced something similar to this event when pt received her previous Hep B vaccines. Mom stated that pt did have similar findings with the previous administrations of the Hep B which pt had recovered from.",,,,,,,,,U,10/02/2019,10/02/2019,0,Just the phone call in the pt's chart.,PVT,,No Active Medications,"Pt presented to clinic on 09/09/2019 for c/o fever. Diagnosed with ""Viral infection.""",No known chronic or long standing illnesses at this time.,"Mom states that pt had localized redness, swelling, and pain with Hep B vaccine",,2,10/03/2019,,,,NKA
0838069,10/03/2019,TN,56.0,56,,F,,"Arm started hurting a little that night.  Arm got worse and couldn't sleep well.  Next day, had flu-like symptoms, was tired, and arm was very sore.   Patient couldn't do much all day. Patient took Tylenol which helped to cut level of pain. On Sunday felt a little better; still tired but was able to move around. Today,  arm still very tender, swollen, hot area 2 inches below injection site.  Called doctor this morning; and was told to keep eye on it to see if worsens.   Recovery at 95%, it is mainly the sore arm that is not back to normal.",,,,,,,,,U,09/27/2019,09/27/2019,0,,PHM,,"Multi-Vitamin, D3, Fish Oil, Magnesium","No, UTI several weeks before vaccine",Diverticulosis,"Shingrix: arm sore, day after flu-like symptoms, aching, fever, no energy--for the rest of the day. Lasted 1 day.",,2,10/01/2019,,Y,,Darvon
0838070,10/03/2019,MO,68.0,68,,F,,"Pt had fever/chills, vomiting, uncontrolled urination, and temporarily unable to stand/walk. Pt is still using walker day after, but is able to move about.",,,,,,,,,Y,10/02/2019,10/02/2019,0,None. Pt felt she couldn't afford ER visit so was checked out by ambulance staff and stayed home.,PHM,,"atorvastatin, metformin",,"Diabetes, asthma",,,2,10/03/2019,,,,"cephalosporins, morphine"
0838071,10/03/2019,OH,62.0,62,,F,,"Nausea, upper g.i. cramping, headache, followed by aching whole body muscle pain, chills, headache, left arm pain to elbow",,,,,,,,,Y,10/01/2019,10/01/2019,0,None,UNK,,"Mobic, calcium citrate (cholesterol), multivitamin, vitamin E, potassium, Co-q 10",None,"Osteoarthritis, obesity",,,2,10/03/2019,,,,None known
0838073,10/03/2019,MI,86.0,86,,F,,"patient had soreness in neck and couldn't lift arm above head, pt went to er and was told to take Tylenol and ice, re=-checked with patioen on 10-3 and she is doing some better, also some pain in armpit area but no redness or pain at site of injection",,,,,,,,,Y,09/30/2019,10/01/2019,1,,PHM,,received a flu shot in opposite arm at same time,,,,,2,10/03/2019,,,Y,
0838074,10/03/2019,NV,16.0,16,,F,,"Mother came in complaining that daughter has had left shoulder pain since injection on 8/29/2019. Patient is scheduled to see our provider next Wed. 10/09/2019 at 0830. Mother provided with Biofreeze, hot packs and warm packs until patient can be seen.",,,,,,,,,N,08/29/2019,08/29/2019,0,,PUB,,none,none,none,,,2,10/03/2019,,Y,,none
0838075,10/03/2019,TN,12.0,12,,M,,Pt was given an expired vaccine.,,,,,,,,,Y,09/05/2019,09/05/2019,0,None,PVT,,None,None,None,,,2,10/03/2019,,,,None
0838076,10/03/2019,CA,0.17,0,.2,F,,"Large amount of blood in stool with mucous 2 days after Rotarix  given. Normal stools until one week later when patient again had blood in stool, less amount",,,,,,,,,U,09/24/2019,09/26/2019,2,OB positive stool.,PVT,,Zantac,"Mild GERD, ex premie twin 35 weeks gestation",None,,,2,10/03/2019,,Y,,None
0838077,10/03/2019,OR,57.0,57,,F,,"Right arm redness, swelling, hot to the touch. No fever noted on exam.",,,,,,,,,N,10/02/2019,10/03/2019,1,N/A,PVT,,N/A,Vertigo,"Hypothyroid, Hyperlipidemia",,,2,10/03/2019,,Y,,NKA
0838078,10/03/2019,GA,53.0,53,,F,,The patient had a swollen lymph node on her clavicle on the left side.,,,,,,,,,N,09/30/2019,10/01/2019,1,pt saw doctor and they said it was related to the shot,PHM,,,,,,,2,10/03/2019,,Y,,
0838079,10/03/2019,CA,4.0,4,,M,,Tolerated  the injection in office ok but later at night mom noted redness at Quadracel vaccine site on rt shoulder/upper arm area.  Subsequently had spotty rash next day on rt chest.   No itch or discomfort.  No fever.  Was able to use arm ok and acting usual self.   Rash lasted 1-2 days.   Photo sent on day 2 showed faint pink rash  in chest/axilla area  (could not distinguish much else).,,,,,,,,,Y,06/10/2019,06/10/2019,0,None,PVT,,None,None,None,,,2,10/03/2019,,,,Environmental allergies  (ie pollen).     Lactose-intolerant but not believed to be milk allergic.
0838080,10/03/2019,CA,39.0,39,,F,,"The morning after getting this flu shot I suddenly came down with fever, chills, muscle aches, fatigue, muscle weakness, and sore throat.  It feels exactly like I have the full-blown flu.  I went to work in the early morning and had to leave at 11 because I couldn't keep my head up anymore.",,,,,,,,Y,N,10/02/2019,10/03/2019,1,,PHM,,None,None,None,,,2,10/03/2019,,,,None
0838081,10/03/2019,NM,56.0,56,,F,,Right axillary lymphadenopathy,,,,,,,,,U,09/30/2019,10/03/2019,3,None,PVT,,Patient started on Humira 40 units twice a month by Rheumatologist.  Pneumovax 23 was given on 10/01/2019 by PCP Dr. on left arm.,None History of Lupus erythematosus,Lupus erythematosus,,,2,10/03/2019,,Y,,"steroids, Albuterol, Darvocet, Hydroxychloroquine"
0838082,10/03/2019,,61.0,61,,F,,"Splitting headache, extreme fatigue/flu like symptoms.",,,,,,,,,Y,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/03/2019,,,,
0838083,10/03/2019,PA,65.0,65,,F,,Day after administration the patient felt pain at injection site.  There was a large bulge described as the size of an orange.  It was red and painful.  The next day the bulge still existed but became itchy and less painful but appeared to be same size.  Advised to seek medical care.,,,,,,,,,U,09/30/2019,10/01/2019,1,,PHM,,,,,,,2,10/03/2019,,,,
0838084,10/03/2019,CO,67.0,67,,F,,"Fever up to 102.2 for 36 hours, severe chills, nausea, stomach ache, headache, muscle soreness throughout, injection site became quite red, swollen",,,,,,,,,N,09/30/2019,10/01/2019,1,,PHM,,"Pantoprozole, Levothyroxine, Losartan, Triamterene/HCTZ, Amlopidine, Clopidogrel, Centrum Women's Multivitamin 50+, Vitamin E, Glucosamine Condroitin, Fish Oil, Biotin, Atorvastatin, Symbicort, Montelukast Sodium, Lyrica, Probiotic, Xopene","UTI, Asthma Exacerbation","Asthma, Stroke, OA, High BP (under control), High cholesterol (under control), Hypothyroid (under control)",,,2,10/03/2019,,,,"Demerol, Novocain, Imitrex, Marcaine, Meloxicam, NSAID's, Mupirocin Ointment, Gadolinium, Bandage Adhesive"
0838085,10/03/2019,AR,77.0,77,,F,,"Tremors started to get worse by 9:30pm.  Around 11:30pm pain started on lower part of abdomen and back.  Tried to get up but could not; she had no strength on legs in bathroom. Patient had to wait for husband to arrive and by then she wet the bed.   Patient noticed that arm was fine at vaccination site however at about 4 inches from elbow got a red huge rash that was hot.  Patient went back to bed.    A second time at night, patient tried to get out of bed and could not--she wet bed again.  She went back to sleep. Husband slept in room next door to be closer in case patient needed help again.   Patient has never gone to the bathroom so much in one night especially since she takes Myrbetriq; she just couldn't hold it long enough to get to the toilet.  Next morning, patient felt so weak that needed help to get out of bed and could not walk without the walker. Patient took normal medicinesno medications out of norm. Patient did take some Tylenol but did not help. Since Saturday morning, tremors continue and they are getting worse. Because of tremors patient could not even eat cereal by herself this morning.",,,,,,,,,U,09/27/2019,09/27/2019,0,,PHM,,"Topiramate 50mg, Primidone, Plavix, Atorvastatin, Omnipred eye drops,   Nabumetone, Farxiga, Gabapentin","No, No",Diabetes,,,2,09/30/2019,,,,"Penicillin, Tetracycline"
0838086,10/03/2019,MD,20.0,20,,M,,"Onset of erythema within 4 hours of injection at injection site.  Onset of Fatigue, Headache with muscle aches approx. 12 hours after injection.",,,,,,,,,N,10/01/2019,10/01/2019,0,None,MIL,,None,None,None,,,2,10/03/2019,,Y,,None
0838087,10/03/2019,CA,3.0,3,,F,,"The next morning child was crying and holding her stomach complaining of stomach pain. From September  24, 2019 every morning she wakes up and says "" tummy hurts""  holding her stomach with both hands, crying from pain. I took patient to Dr. today October 3, 2019",,,,,,,,,U,09/23/2019,09/24/2019,1,none,PVT,,none,none,none,,,2,10/03/2019,,Y,,Not know allergies at this time
0838089,10/03/2019,NC,34.0,34,,F,,Bloody nose,,,,,,,,,Y,10/03/2019,10/03/2019,0,N/A,WRK,,Mydayis,N/A,ADHD,,,2,10/03/2019,,,,"Chipotle, dilaudid, Effexor, lexapro, and augmentin"
0838090,10/03/2019,OK,4.0,4,,F,,Right side Bell?s palsy,,,,,,,,,N,10/02/2019,10/03/2019,1,,PVT,,None,None,None,,,2,10/03/2019,,Y,,Augmentin. Rash 6/3/2016
0838091,10/03/2019,TX,55.0,55,,F,,"Fever, shivering, and muscle aches. Fatigue. Soreness in left arm. Symptoms persisting to present, 25 hours after injection.",,,,,,,,,N,10/02/2019,10/03/2019,1,none,PHM,,Allegra and MucinexD for allergies. Received flu shot and DATP in the other arm on the same occasion.,allergies,allergies,,,2,10/03/2019,,,,"Molds, pollen, poison ivy"
0838092,10/03/2019,OR,85.0,85,,F,,pt having extreme pain in arm and it's causing nausea and also mentioned dizziness- she called me at about 4 hours post vaccination,,,,,,,,,U,10/03/2019,10/03/2019,0,none yet,PHM,,sertraline amlodipine,mentioned rotator cuff tear,unknown,,,2,10/03/2019,,,,penicillins
0838093,10/03/2019,KY,41.0,41,,F,,"Received flu shot at work. About 2 am, I was awoken with tingling and pain in both my thumbs and index fingers. By 6 am, it had spread to all 10 fingers. Difficulty with fine motor, using an utensil etc.  By 6pm, I had red splotches on both hands and throbbing pain with use and at rest.  Consulted with employee health and agreed to wait and see.",,,,,,,,,N,10/02/2019,10/03/2019,1,None as of yet,PVT,,"Birth control, Allegra, Nasonex",None,Migraines,,,2,10/03/2019,,,,Penicillin and Cephalosporins
0838094,10/03/2019,PA,65.0,65,,F,,"A half hour after receiving vaccine, pt got head cold symptoms, nausea, and vomiting.  Lasted a few hours for vomiting.  The next day felt better but had a ""hung over"" feeling.",,,,,,,,,Y,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/03/2019,,,,
0838095,10/03/2019,MS,69.0,69,,M,,"about 12 hours after the vaccination, I developed fever to 102, shivers, weakness, and chills, and muscle aches.  after Tylenol, it took about another 12 hours for all symptoms to clear.  The vaccine was administered at pharmacy after I had visited my oncologist with a good report.",,,,,,,,,Y,10/02/2019,10/03/2019,1,none,PHM,,"81 mg ASA, Flecainide 50 mg, HCTZ 12.5 mg, atorvastatin 20 mg",none,"hypertension, elevated cholesterol, premature supraventricular contractions, GIST stomach cancer",,,2,10/03/2019,,,,"IV contrast causes sneezing, clindamycin caused a rash after finishing the med, Zofran caused my tongue to swell"
0838096,10/03/2019,IL,82.0,82,,F,,"Developed headache soon after receiving second Shingrix dose.  Headache persisted for 2 days, and pt then developed an itchy urticarial rash over neck, chest, and abdomen",,,,,,,,,Y,09/26/2019,09/26/2019,0,None,PHM,,"Atorvastatin, Levothyroxine, Omeprazole, Metoprolol, Calcium Carbonate, Vitamin D",None,"GERD, paroxysmal atrial fibrillation, Hyperlipidemia, Hypertension, hearing loss, hydronephrosis, osteoporosis, lumbar spinal stenossi, migraine",,,2,10/03/2019,,,,Sulfa causes a rash Iodinated contrast causes swelling
0838097,10/03/2019,VA,16.0,16,,F,,Morning after daughter had pain and large lump around site of shot in her upper arm .  Lump was about 4 inches wide vertically and 2 inches wide. Painful and alittle red.  She  iced it and took advil.  Same results 2 days after but more red.    I left message for nurse. They are closed now. Will call them back tomorrow.,,,,,,,,,N,10/02/2019,10/03/2019,1,,PVT,,None,None,None,,,2,10/03/2019,,,,None
0838098,10/03/2019,AR,21.0,21,,F,,"Patient received both flu and pneumonia shots in the left arm. She states that later that day it was swollen and very painful with muscle strain. She states that her upper arm is painful to the touch and that her lower forearm has a tingling sensation that radiates to her fingers. She has been using oral and topical NSAIDS but that doesn't help. She states that the feeling she has was similar to when she had a blood clot, so she went to the doctor for an ultrasound and results were negative. The doctor thinks it might be cellulitis, so they prescribed her some antibiotics to help with her reaction but the patient doesn't feel like it's working.",,,,,,,,,N,10/01/2019,10/01/2019,0,ultrasound 10/3/19- negative,PHM,,N/A,N/A,N/A,,,2,10/03/2019,,Y,,NKAA
0838099,10/03/2019,FL,82.0,82,,M,,"the patient came in the pharmacy with a severe inflamed arm. it looked red, inflamed and it had pus coming out of it. I advise the patient to immediately go to a minute clinic or urgent care to have this checked by doctor. Patient said he was going to the doctor and would let me know the outcome.",,,,,,,,,U,09/18/2019,10/03/2019,15,none,PHM,,none that were disclosed to me.,none,high blood pressure,,,2,10/03/2019,,,,"no allergy information in the system,"
0838100,10/03/2019,NY,59.0,59,,F,,"Start as inflammation at injection site with pain, unable to raise arm, developed into infection which had to go to hospital for, now in treatment with doxycycline.",,,,,,,,,N,09/30/2019,10/01/2019,1,,PHM,,,,,,,2,10/03/2019,,Y,,
0838101,10/03/2019,CA,6.0,6,,F,,Urticaria for 10 days.,,,,,,,,,Y,09/20/2019,09/20/2019,0,NA,PVT,,Multivitamin Chewable,None,Thalassemia minor,,,2,10/03/2019,,Y,,None
0838102,10/03/2019,PA,72.0,72,,M,,"Red rash, that was warm to the touch. Pain also.",,,,,,,,,U,10/01/2019,10/03/2019,2,n/a,PHM,,Not sure of medications,nsaid allergy,Not sure.,,,2,10/03/2019,,Y,,not sure
0838103,10/03/2019,TX,72.0,72,,F,,Patient experience a sore arm following the vaccination that has not improved since the vaccination. Patient sought medical treatment and received a steroid shot. Patient stated that MD examining arm stated that the deltoid muscle in the arm was collapsed and would take time to recover. Patient is continuing to seek medical care and will follow up with the pharmacy if there are any new developments in health status. Patient experienced no issues with the 1st dose of the shingrix vaccine,,,,,,,,,,08/20/2019,08/21/2019,1,,PHM,,,,,,,2,10/03/2019,,Y,,
0838104,10/03/2019,MI,87.0,87,,M,,"patient presented to emergency room with sore right arm and pain radiating up to neck, breathing fast, and color out of face. EKG performed and it came back normal. Patient also had difficulty lifting arm above head. There was no problem at the site of the injection. He was told to ice, use Tylenol. The patient called by the pharmacist after 72 hours and is improving now",,,,,,,,,Y,09/30/2019,10/01/2019,1,,PHM,,patient received a flu vaccine in opposite arm at the same time as this vaccine without any problem,,,,,2,10/03/2019,,,Y,
0838105,10/03/2019,IL,59.0,59,,F,,"Severe chills, then sweating, headache, body aches, severe fatigue lasting 24 hours for both doses.",,,,,,,,,,10/02/2019,10/02/2019,0,,PVT,,"Calcium, Vitamin D, magnesium",none,,"First Shingrix dose, 3 months prior",,2,10/03/2019,,,,none
0838106,10/03/2019,FL,43.0,43,,F,,"Palpitaions in right upper chest, then pain in injection sited that extende down arm, also in opposite arm. Followed by then joint pain in shoulders, that then spread to all my joints, with intense pain in neck. Headache and then after about 4 hours after start of reaching stomach pain and nausea.",,,,,,,,,Y,10/02/2019,10/03/2019,1,n/a,PHM,,"no medications, or otc. I only take green vibrance nutritional supplents and vit c on occasion.",none,none,"simialar but less severe reaction to flu shot, no other vaccine reations. Fully vaccinated otherwise.",,2,10/03/2019,,,,none known highly sensetive to any prescribed medicaitons
0838107,10/03/2019,,8.0,8,,M,,"red, hot, hard area around injection site approx. 4 inchs by 4 inches. Child complained about pain and itching day 2 post injection. Went to ER day 2 started motrin, benadryl with intermittent ice.  Day three the redness grew larger continued motrin, benadryl, and intermittent ice.",,,,,,,,,N,09/30/2019,10/02/2019,2,,MIL,,none,none,none,,,2,10/03/2019,,,Y,sesame
0838108,10/03/2019,NY,65.0,65,,M,,"Patient returned to pharmacy approx 2 weeks later saying he has been experiencing shoulder pain ,possibly nerve related since shot ws given",,,,,,,,,N,09/19/2019,10/02/2019,13,n/a,PHM,,metformin 500mg,no,Diabetes,,,2,10/03/2019,,,,NO
0838109,10/03/2019,,25.0,25,,M,,"Patient came to clinic stating arm was very itchy and red. Arm was indeed red, warm, and hard to the touch. Patient stated itchyness began the day after receiving the vaccine, and today (two days later) it was extremely itchy. Patient was told to monitor the site, take Tylenol/Motrin for the discomfort and to use Hydrocortisone cream on arm to help with itchyness. Pharmacy provided all medications to patient.",,,,,,,,,,10/02/2019,10/03/2019,1,,MIL,,,,,,,2,10/03/2019,,,,
0838110,10/03/2019,NE,68.0,68,,F,,"Sore arm for 5 days, warm to touch, 3x3 in rash",,,,,,,,,N,09/27/2019,09/28/2019,1,,PHM,,,,,,,2,10/03/2019,,,,
0838111,10/03/2019,WA,77.0,77,,F,,HOT TO TOUCH RED SWELLING ABOUT 3 BY 5 INCHES,,,,,,,,,N,09/30/2019,10/01/2019,1,NONE,PHM,,"GABAPENTIN 300 MG, LEXAPRO 10 MG, ROPINIROLE 4 MG",NONE,"HYPERTENSION, RESTLESS LEG SYNDROME",,,2,10/03/2019,,,Y,NONE
0838112,10/03/2019,MI,72.0,72,,M,,"2 hours after receiving these vaccinations the patient had started to feel disoriented.  By 9:30pm that night he felt aches in his muscles and experienced a flushed feeling.  The next morning, 10/2, he had pain in his joints and a droopy eye.  He was able to see the doctor on 10/2, but by the time he was in the office the symptoms had resolved.  I spoke with the patient on 10/3 midday and he said that his symptoms were all improving over today.",,,,,,,,,Y,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/03/2019,,Y,,
0838113,10/03/2019,NY,72.0,72,,M,,"Patient has had a fever of 102.8 since this afternoon, has been treating with ibuprofen. Counseled to continue pain medication and see a physician if it continues or gets any worse.",,,,,,,,,N,10/02/2019,10/03/2019,1,,PHM,,"tramadol, metoprolol, lisinopril, simvastatin, flomax, anoro",no,"high blood pressure, copd, high cholesterol",,,2,10/03/2019,,,,no
0838114,10/03/2019,CA,57.0,57,,M,,"painful injection site, red, hard to touch and warm. pt can't lift his arm",,,,,,,,,,10/01/2019,10/02/2019,1,,PVT,,no,,infection of colon,,,2,10/03/2019,,,,"he said just some antibiotics - augmentin, cipro no food allergies, not allergic to eggs"
0838115,10/03/2019,TN,71.0,71,,F,,Patient developed uveitis in the right eye.  Patient was treated by opthalmologist starting 8/8/19 with prednisolone eye drops from 8/8/19 until current time and cyclogyl drops from 8/8/19 until 8/13/19.  Patient reported achy dull eye pain with redness (similar to conjunctivitis) for the first two to three days after vaccine administered.  Patient self treated with ibuprofen 200 mg with no improvement in symptoms for two days. She then went to primary care on 08/07/2019 and was prescribed polymyxin b - trimethoprim eyedrops which she used for one day before going to opthalmologist.,,,,,,,,,Y,07/30/2019,08/02/2019,3,I have attached labs from Dr.'s office.,PHM,,"diltiazem, metoprolol, hydrochlorothiazide, vitamin c, vitamin d3, caltrate, levothyroxine, atorvastatin",none,"hypertension, hypothyroidism, hypercholsterolemia",patient states had flu vaccine that developed into flu like symptoms.  couldn't remember the year.,,2,10/03/2019,,Y,,sulfa
0838116,10/03/2019,TN,45.0,45,,F,,"patient started experiencing swelling, pain and redness the day after vaccine. got worse and more painful and patient decided to visit doctor. he diagnosed her with cellulitis",,,,,,,,,N,10/02/2019,10/02/2019,0,,PHM,,,,,,,2,10/03/2019,,Y,,
0838117,10/03/2019,FL,78.0,78,,F,,PAtient got chills seats and experienced shaking,,,,,,,,,Y,09/20/2019,09/20/2019,0,,PHM,,,,,,,2,10/03/2019,,,,
0838118,10/03/2019,CA,42.0,42,,F,,"Have received the flu vaccine every year without incident and was 100% well when I received it. Received my vaccine at 12pm. By 2 pm had hot hard painful lump so I took 1 gram of oral tylenol. By 4pm had 101 fever and lump had increased to 4 inches in diameter and was raised 1 inch from surrounding tissue applied an ice pack for half hour. By 8 pm that night lump had increased to six inches in diameter and remained one inch raised and it was incredibly painful home from work at that time and ice pack applied, temperature remained >101 degrees. Fell asleep, woke up at 2300 with 102.7 temp and rigors. Lump in arm remained 6 inches in diameter and incredibly painful. Took another gram of tylenol and reapplied ice. Continued to have a fever >101 until the morning of October 3 despite taking antipyretics around the clock. In the morning of Oct 3 noted that the lump with still 6 inches in diameter but not nearly as raised or hard and less painful than previously. Notified my employee health RN as I had received the vaccine at work which is mandatory by my employer. i did end up missing one day of work on October 2nd as I still had a fever 101-102 degrees.",,,,,,,,,Y,10/01/2019,10/01/2019,0,none.  I am an RN for 21 years and self treated/monitored the site.,PVT,,"1 aleve , 1 zyrtec, and 1 10mg torsemide taken at 0600 the morning of vaccination.",none,chronic leukopenia and thrombocytopenia,"tetanus vaccine 2011- 48 hour fever >103, confusion, and loss of urinary control and excruciating headache Seen by MD and told t",,2,10/03/2019,,,,penicillin and E-mycin
0838119,10/03/2019,CA,62.0,62,,F,,"Pt became with dizziness; denies near syncope, BP well controlled, no fever, SOB, HA, palpitations, chills. Pt called clinic at 4:55pm 10/2/19 spoke to RN who ordered the vaccine and assessed pt this morning. Pt also received the flu shot with no hx of reactions to flu shot. Pt given ER precautions.  On 10/3/19 pt states eye pain in both eye and redness. No discharge, no headache, just dizziness, blurry vision and eye pain bilaterally. Pt given ER precautions for worsening pain and appt made for eye exam tomorrow in clinic 10/4/19",,,,,,,,,N,10/02/2019,10/02/2019,0,"RN phone triage 10/2/19 and 10/3/19. Consults with Dr. and Dr. 10/3/19 for adverse effects. Eye exam scheduled today for tomorrow AM 10/4/19. Pt went to her rheumatologist today 10/3/19 states no fever, chills, HA, just still dizzy with blurry vision, able to ambulate fine, BP normal 118/78.  Rheumatologist deemed pt to be ok/stable. Pt will have eye exam tomorrow with Optometrist.",PVT,,"Chlorthalidone 25 mg 1 PO qd; Amlodipine Besylate 10mg 1qd; calcium 600 + Vit D 600-400mg-unit 1/2 tab PO with meals, folic acid 1mg qd; lipitor 20mg qd; metformin hCL 500mg I PO qd; Methotrexate 2.5mg 1 PO qd",,"HTN, DM, Seronegative Rheumatoid arthritis",,,2,10/03/2019,,Y,,NKA
0838120,10/03/2019,OR,58.0,58,,M,,The day following the vaccination he developed yellow blotches on both medial lower legs which to him looked like hives.  The next day he developed generalized pruritus and clusters of water blisters in streaks on arms and legs and beneath his nose. The following day it dawned on him that these tiny blisters were identical to what he had seen in the past on his genitalia during outbreaks of herpes.  So he began the same regimen of treatment which had been effective for his herpes outbreaks.  Within eight hours of the first dose of 2 grams of valacyclovir the pruritus had resolved.  Twelve hours later he took the second dose and soon thereafter the water blisters began crusting over.  Just to be sure he repeated the course the following day.  The rash and all of his symptoms quickly resolved and he has remained asymptomatic since.  He first reported this to me today when he was in my office for an unrelated matter.,,,,,,,,,Y,09/05/2019,09/06/2019,1,None,PVT,,Vitamin D 1000 IU daily Vitamin B 12 1000 mcg IM weekly,None,Occaisional genital herpes,,,2,10/03/2019,,,,Penicillin
0838121,10/03/2019,AZ,61.0,61,,F,,"I woke up at 3 am shivering uncontrollably, with chills and a low grade fever.  After taking Tylenol, I fell back asleep an hour later. I got up at 7 am, but was extremely weak, lightheaded, and lethargic. I went back to bed by 8 am and slept until 1 pm. I awoke with a fever and chills again.  It is now 7 pm, and I no longer have chills, but I am still very weak and lightheaded. I also have no appetite.",,,,,,,,,Y,10/02/2019,10/03/2019,1,,PHM,,Escitalopram 20 mg,None,None,,,2,10/03/2019,,,,Penicillin
0838122,10/03/2019,TX,74.0,74,,F,,Pt states she received the immunizations on 9/30/19.  The next day she woke up and her right arm (the arm with influenza and PPSV 23) was red and painful.  She also states she has ran a low grade fever since she received the immunizations.  She states that there was a short time her fever went up to 102 but went back down.  Pt states she has used ice packs and ibuprofen.,,,,,,,,,N,09/30/2019,10/01/2019,1,n/a,PHM,,"methocarbamol, acetaminophen/codeine",n/a,pain copd,,,2,10/03/2019,,,,cephalosporins
0838123,10/03/2019,OH,83.0,83,,F,,"said she had ""the shakes"", loss of appetite, drowsiness, loss of balance for 1-2 days after the shot",,,,,,,,,Y,09/30/2019,09/30/2019,0,,PHM,,unknown,,"Acid reflux, high cholesterol",,,2,10/03/2019,,,,NKA
0838124,10/03/2019,WI,39.0,39,,F,,"Within an hour of the shot in my non-dominant arm, I started to feel unusually sore. By 8 p.m. in the evening, I started to get the chills and by 9 p.m., my entire body was aching painfully. By 10 p.m., I was trembling from the chills, could barely move from the aches, and started to get dizzy. I went to bed immediately. The next day, I still felt somewhat achy, but it felt like the pain from the shot was more localized in my left shoulder and the left side of my jaw. The chills were mostly gone. I took two doses of advil (two capsules each time) during the day.  By the evening of day 2 (~36 hours after the shot), I still felt very tired and the aches were starting to come back in my left shoulder and lower back. The exhaustion continues.",,,,,,,,,N,10/02/2019,10/02/2019,0,,SCH,,Birth control (Blisovi),None,None,,,2,10/03/2019,,,,Penicillin
0838125,10/03/2019,CA,90.0,90,,F,,"Patient experience bruising mainly in the left triceps area with spotty bruising in the left bicep area. The bruises are not near the deltoids area but below it. Per patient, the bruising has spread. Recently the bruising extends down to her elbow",,,,,,,,,N,09/26/2019,09/27/2019,1,,PHM,,N/A at our pharmacy. Usually goes to different pharmacy. Is on chronic COPD medications,n/a,COPD,,,2,10/03/2019,,Y,,n/a
0838126,10/03/2019,NC,68.0,68,,F,,Patient was fine upon leaving  pharmacy on 10/01/19. Called on 10/03/19 and reported via telephone swelling at injection site and extreme shoulder pain.,,,,,,,,,U,10/01/2019,10/03/2019,2,,PHM,,,,,,,2,10/03/2019,,,,"penicillins, sulfa abx"
0838127,10/03/2019,,72.0,72,,F,,"per pt she felt back pain, headaches, flu like symptoms during the first 24 hours after taking both. she stated that its her second dose of shingrex and she did not feel bad. But when taken with fluzone she felt like she could not get out of bed the next day.",,,,,,,,,,09/30/2019,09/30/2019,0,,UNK,,,,,,,2,10/03/2019,,,,
0838128,10/03/2019,MO,74.0,74,,F,,"The patient received both immunizations and started to leave the store. A few minutes later she had walked back to the pharmacy. After checking on her, she was having an extremely difficult time breathing, could barely speak a couple of words. She tried to give herself a puff of albuterol and after a couple of minutes she was still having trouble breathing and had no improvement. 911 was called for assistance. I administered one dose of epinephrine into her right thigh. A few moments after the injection she was able to breathe without any difficulty. She did complain of hip pain post epihephrine but remained stable until EMS arrived.",,,,,,,,,U,10/01/2019,10/01/2019,0,unknown,PHM,,unknown. she fills her prescriptions at a different pharmacy. She did state she took very few medications. She did have an albuterol inhaler.,none,unknown. she mentioned she had very mild recently diagnosed copd,,,2,10/03/2019,,,Y,nkda
0838129,10/03/2019,VA,56.0,56,,M,,"Per patient's oral history, he experienced some typical muscle soreness characteristic of previous vaccinations on days 1-2 postvaccination. Vaccines were given 1 inch apart in the same deltoid. After initial day or 2, patient experienced some redness and swelling (more itchy than painful per his report) starting a few inches below the injection site and spreading downward and medially toward his bicep/inner elbow. He said thinking it may have been an insect bite he did apply OTC hydrocortisone to the initially reddened area (starting approx. 3-4 inches below the injection site). This area has cleared up but there is still some minor redness/puffiness on the patient's bicep proximal to the inner elbow. Patient also complains of some tingling in right fingertips, and depending on arm position occasionally escalates to ""pins and needles"" sensation. Upon assessment of initial injection site IM injections appear placed appropriately about 3 inches down from acromion process. Redness appeared distal to injection site according to patient's report. Visible erythema seems to have almost cleared up, but due to paresthesia side effect advised patient that if this symptom is unremitting after the weekend (4 days' time) to seek further care and follow up.",,,,,,,,,U,09/29/2019,09/30/2019,1,,PHM,,n/a,n/a,,,,2,10/03/2019,,,,nkda
0838130,10/03/2019,CO,23.0,23,,F,,"Fever, light headed, dizzy, stiff Limbs, cold chills.",,,,,,,,,U,04/09/2019,04/09/2019,0,,PVT,,,,,,,2,10/03/2019,,,,Keflex
0838131,10/03/2019,CO,0.08,0,.0,F,,"Jaundice, liver filling with toxins",,,,,,,,,U,04/05/2019,04/06/2019,1,,PVT,,,,,,,2,10/03/2019,,,,
0838132,10/03/2019,OR,51.0,51,,F,,Pt stated that her arm was itchy and upon looking it was red and swollen. When pt presented to the pharmacy the majority of her bicept was red and swollen. She purchased some Benadryl to take and was going to keep an eye on any worsening symptoms or spreading of the inflamed area.,,,,,,,,,U,10/01/2019,10/03/2019,2,,PHM,,"Ventolin, duoneb, suboxone 8/2 films,",none,none,,,2,10/03/2019,,,,peanuts
0838133,10/03/2019,SC,66.0,66,,F,,Immediate pain in left arm spread to elbow and across breast bone. Flu like symptoms nausea joint pain headache fever of 103 went to ER and followed up with my physician,,,,,,,,,Y,09/30/2019,09/30/2019,0,"White blood cells were up 16,000",PVT,,None,None,Depression  Diabetes,,,2,10/03/2019,,Y,Y,None
0838190,10/03/2019,NY,,3,,M,09/19/2019,Area of large local inflammatory redness encompassing entire left upper arm at site of flu vaccine one day prior,,,,,,,,,Y,09/18/2019,09/19/2019,1,0,PVT,PVT,ProAir HFA prn Albuterol nebs prn,Cough/cold sx,"Eczema, Mild intermittent asthma",,,1,,,,,
0838195,10/03/2019,CA,18.0,18,,M,,Seen 9/27/19 for (L) distal arm weakness. Noted to have decreased pulses & cool (L) hand. Doppler showed thrombus (L) brachial/ulnar/radial artery thrombus. Now known family history known of emboli/thrombi.,,,,,Y,2,,,N,09/23/2019,09/24/2019,1,See above #18,PVT,,Vyvanse 50mg,None,"H/o myasthenia gravis,>resolved H/o absence seizures",,,2,10/03/2019,,Y,Y,Peanuts
0838219,10/03/2019,MA,5.0,5,,M,,(L) upper arm red and swollen AM after vaccine administration. Apply cold compresses Will put a Note in chart to monitor for reactions for future vaccines.,,,,,,,,,Y,09/24/2019,09/25/2019,1,N/A,PVT,,None,None,None,,,2,10/03/2019,,Y,,NKDA
0838246,10/03/2019,VA,73.0,73,,M,08/30/2019,Rash: small red unraised rash itched,,,,,,,,,Y,08/16/2019,08/18/2019,2,Shingles shot #2 (Shingrix),OTH,OTH,,None,"Sulfa, amoxicillin",,,1,,,,,
0838265,10/03/2019,WI,49.0,49,,F,,"patient called stating limited range of motion, pain, tingling. Visited primary provider. Concern of muscle, nerve, bone pain continuing. Patient reports having a feeling of pressure/resistance on injection. Concern is that discomfort is continuing one month later.",,,,,,,,,U,09/05/2019,09/06/2019,1,,UNK,,,,,,,2,10/03/2019,,Y,,
0838266,10/03/2019,FL,76.0,76,,F,,"Red, swollen Arm",,,,,,,,,U,09/27/2019,,,,PHM,,N/A,,Too many to list,,,2,10/01/2019,,Y,,Augmentin
0838267,10/03/2019,OH,45.0,45,,F,10/03/2019,"Patient was given vaccination and almost immediately had redness + itching at the injection site. She put ice on it and was given 25mg IM diphenhydramine 45 min later she developed an itchy/burning throat, shortness of breath and nausea. She was given another 25mg IM diphenhydramine but did not improve so she was sent to the emergency room with an epi pen just in case",,,,Y,,,,,,10/03/2019,10/03/2019,0,,PVT,PVT,"Viibryd, meclizine chlorthalidone, Femring, Vyvanse, nicotine patch",,"Sulfa, Topiramate",,,1,,,,,
0838268,10/03/2019,AL,22.0,22,,F,,"Patient contacted us complaining of swelling and pain which began immediately after injection. I explained that if this is continuing, contact her physician to prevent a possible allergic reaction. She wanted me to fill this adverse event form out.",,,,,,,,,N,10/01/2019,10/01/2019,0,N/A,PHM,,N/A,n/a,n/a,,,2,10/03/2019,,,,nka
0838269,10/03/2019,UT,3.0,3,,M,,Hives- around shot site. Ibu & Benadryl given in clinic spoke with Mom @ 3:10pm. Sx have resolved.,,,,,,,,,Y,10/03/2019,10/03/2019,0,,PVT,UNK,,N/A,,,,1,,,,,
0838314,10/03/2019,CA,69.0,69,,F,,"Patient complained of pain in multiple joint areas including wrist, hips, back & neck plus generalized ""lethargy"" - all for 5 days.",,,,,,,,,Y,09/22/2019,09/22/2019,0,N/A,UNK,,"Levothyroxine, Lyrica, Atorvastatin, Metoprolol, Zolpidem, Omeprazole",,"Fibromyalgia, HTN, high cholesterol, hypothyroidism",,,2,10/03/2019,,,,"Aspirin, Sulfa, Dexilant"
0838325,10/03/2019,CA,83.0,82,,F,,"Rash on (R) arm that came up the day after she got shingrix #1 vaccination in that arm. Rash started distal to (R) axilla + was painful + itchy. Used Cortisone + it didn't help. Rash spread to ears, neck, chest, back, legs, feet bilaterally",,,,,,,,,Y,09/03/2019,09/04/2019,1,,PHM,,,,,,,2,,,Y,,
0838326,10/03/2019,NY,12.0,12,,M,,Eye swelling for 2 days. Resolved. Sx began 1 day after vaccine No tx.,,,,,,,,,Y,09/24/2019,09/24/2019,0,,PVT,,None,Cold,None,,,2,10/02/2019,,,,Codeine Phosphate
0838327,10/03/2019,TX,1.58,1,.7,M,,Redness 10 cm,,,,,,,,,,10/01/2019,10/01/2019,0,N/A,PVT,,N/A,None,None,,,2,10/03/2019,,,,NKDA
0838332,10/03/2019,WV,,,,F,10/03/2019,Flu Symptoms a day after Shot Patient states The immunisation Gave her Pneumonia.,,,,,,,,,Y,09/04/2019,09/05/2019,1,NA,OTH,OTH,,NA,NA,NA~ ()~~0.00~Patient,,1,,,,,
0838333,10/03/2019,NY,85.0,85,,F,,pt developed large swollen area at injection site. Was seen by Dr. and was given Cephalexin 500 1 PO TID x 7days due to MD believing it was a bacterial infection caused by vaccine,,,,,,,,,U,09/30/2019,10/03/2019,3,,PHM,,,,,,,2,10/03/2019,,Y,,"topical Petin, Altace, Codeine, Coreg, doxycycline, lipitor, iodine, Lipitor, metronidazole, morphine, niacin prn"
0838334,10/03/2019,MO,,66,,U,,Pain in ARM after injection,,,,,,,,,N,10/01/2019,10/01/2019,0,none,PHM,,,none,High blood pressure,,,2,10/03/2019,,Y,,Metoclopramide
0838335,10/03/2019,IN,50.0,50,,F,,Patient's whole upper arm and shoulder began hurting immediately after vaccination and has continued to hurt. She has had trouble lifting or reaching with the arm. Patient stated she works at Hospital and questioned a nurse practitioner who felt the injection was given too high but should resolve within 6 weeks.,,,,,,,,,N,09/20/2019,09/20/2019,0,,PHM,,,,,,,2,10/03/2019,,,,
0838336,10/03/2019,NV,57.0,57,,M,10/03/2019,Swelling IN Bicep of Injection ARM. Redness in large area of upper ARM. Started Next Day IN morning.,,,,,,,,,U,10/02/2019,10/03/2019,1,,OTH,UNK,,NONE,None,,,1,,,,,
0838134,10/04/2019,CA,25.0,25,,F,,"Staff complained of itching  mild redness to neck, arm and back  after Flu vaccine was given- referred to urgent care was given bemadryl and breathing treatment",,,,,,,,,Y,09/24/2019,09/24/2019,0,,OTH,,unknown,unknown,unknown,,,2,10/04/2019,,,Y,unknown
0838135,10/04/2019,AL,55.0,55,,F,,"Red sore eyes and  some pain in arm  on October 2, 2019 at 5 pm.  No treatment. Pain in left arm and elbow on October 2, 2019 at 10 pm. Ibuprofen and Tylenol. Excruciating pain in left arm, elbow, shoulder, and spine and headache on October 3, 2019 at 8:30 pm.  Headache pain relief (acetaminophen 250 mg / aspirin 250 mg / caffeine 65) and  massage. Headache pain was relieved, left arm and shoulder pain relieved,  but still spine pain.  Right shoulder beginning to hurt as well.  Diclofenac Sodium Topical Gel 1%.  Less pain except for spine.",,,,,,,,,N,10/02/2019,10/02/2019,0,,WRK,,Synthroid and Black Cohosh,None,Hashimotos,"influenza vaccine date, type, and brand unknown - swelling in elbow",,2,10/04/2019,,,,Percocet
0838136,10/04/2019,PA,66.0,66,,F,,"nausea, stomach pain, vomiting, fever, body aches, headache. Vomiting in night. Other symptoms all night and following day",,,,,,,,,Y,10/02/2019,10/03/2019,1,none,PHM,,"simethicone, fish oil,  melatonin, gabapentin, .25 mg clonazepam",GI pain,"undiferentiated connective tissue disease, BOOP/COP, Hashimotos thyroiditis, weight loss",,,2,10/04/2019,,,,"doxepin, biaxin, Bactrim, Rifaximin"
0838137,10/04/2019,,25.0,25,,F,,"On 4 OCT 2019, PT discovered that she has been in positive on urine pregnancy test after she received the smallpox on 24 SEP 2019.",,,,,,,,,,09/24/2019,09/24/2019,0,Urine Test by patient,MIL,,Flonase (Nasal Spray),N/A,N/A,,,2,10/04/2019,,Y,,Allergy medication (Unknown)
0838138,10/04/2019,,28.0,28,,F,,Large local reaction started about 6 hours after the vaccines were administered.  Urticaria developed two days later.  Patient was seen in the Emergency Department for this reaction.,,,,,,,,,U,10/02/2019,10/02/2019,0,"CBC with leukocytosis (WBC > 16,000).  Other labs were unremarkable.",MIL,,None,None,Steatohepatitis,,,2,10/04/2019,,,Y,None
0838139,10/04/2019,OH,21.0,21,,M,,"First sign that appeared was soreness in the arm. This started approximately 2 hours after vaccination. By hour 4 after vaccination, the arm was so stiff that it was hard to move. At hour 6, the injection site was inspected for the first time. There was a bright red welt with an approximate 1 inch diameter; the welt was giving off a large amount of heat. The following morning, the welt had grown to approximately 2.5 inches in diameter. The arm was still extremely sore and difficult to move without pain. The soreness and pain went down as time went on. Today, five days after the vaccine, the welt is finally gone, but there is still residual muscle soreness.",,,,,,,,,Y,09/29/2019,09/29/2019,0,,PHM,,"Omeprazole 20mg Tablet, Loratidine 10mg Tablet, Vitamin D3 2000U Capsule",Vitamin D Deficiency Diagnosis,Vitamin D Deficiency,,,2,10/04/2019,,,,Amoxicillin - Hives
0838140,10/04/2019,TN,65.0,65,,F,,"Swelling at site of injection. Redness, Skin is hard. Skin is hot. Fever, nausea and pain at site of injection. These symptoms occurred within 24 hours and today is day three after the injections. Symptoms remain. I did contact the doctor on the day after injections to let him know about the reactions. He said next year they will give them in separate sites as these were given in the same site. And perhaps on different days.",,,,,,,,,N,10/01/2019,10/01/2019,0,,PVT,,"Estrodial,  Medroxyprogersterone, Centrum multiple vitamin, calcium, magnesium.",GI upset. Vomiting/ diarrhea. Two weeks prior to vaccinations.,,,,2,10/04/2019,,,,Biaxin
0838142,10/04/2019,NY,67.0,67,,F,,"Started with body aches, fever, lethargy, exhaustion developed cough lasted for 5 days.  Cough still lingers now on day 6.  Haven?t felt this bad in a very long time.  Felt it important to report this.  2nd dose.  No real reaction after first except a little soreness. Crazy. Why this reaction?",,,,,,,,,Y,09/27/2019,09/28/2019,1,None,PHM,,10 mg atovastorin,None,High cholesterol,,,2,10/04/2019,,Y,,No
0838143,10/04/2019,NC,32.0,32,,M,,"Patient presented to clinic with cellulitis at vaccination site. The site at which the patient was immunized is lower than the recommended distance from the acromion process. Approximate 10cm lesion at time of appointment. Patient denied shortness of breath or difficulty breathing, no generalized rashes present, negative for axial lymphadenopathy. Lesion was erythemic and hot to touch, tender to palpation. Physician Assistant prescribed Keflex for treatment. Patient advised to follow up with the clinic if his symptoms do not improve.",,,,,,,,,,10/02/2019,10/03/2019,1,N/A,MIL,,None,None,Pseudofolliculitis barbae,,,2,10/03/2019,,Y,,"Trees, pollen"
0838144,10/04/2019,KY,60.0,60,,M,,"Muscle soreness, chills, fever, stiffness,  insomnia. Took Tylenol. Symptoms abated after 24 hours.",,,,,,,,,Y,10/01/2019,10/01/2019,0,none,SCH,,none,none,none,,,2,10/04/2019,,,,none
0838145,10/04/2019,NJ,60.0,60,,F,,Patient reports to muscle discomfort and limited movement 3 weeks after vaccine,,,,,,,,,U,09/06/2019,10/03/2019,27,,PHM,,,,,,,2,10/04/2019,,Y,,
0838160,10/04/2019,MO,62.0,,,F,,"a horrible local reaction with swelling and redness on the arm; a horrible local reaction with swelling and redness on the arm; it had gotten worse everyday for at least 3 days; This spontaneous report has been received from a pharmacist via a company representative referring to a 62 years old female patient. No information on patient's pertinent medical history, concomitant medications, drug reaction or allergies was provided.  On an unknown date, the patient was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot #, expiration date, dose and route of administration were not provided) for prophylaxis.   On an unspecified date, she experienced a horrible local reaction with swelling and redness on the arm and it had gotten worse (disease progression) every day for at least 3 days. The outcome of all the events was not recovered. It was unknown if treatment was given or lab diagnostics/studies were performed for the events.  The causality between varicella virus vaccine live (Oka/Merck) (VARIVAX) and all the events was not provided.",,,,,,,,,N,,,,,UNK,,,,,,US0095075131909USA002478,2,10/03/2019,,,,
0838161,10/04/2019,CO,,,,F,,"medical assistant administering the dose was cut on her hand from the broken edge.; Syringe number one broke at the finger flanges during administration/the dose was cut on her hand from the broken edge; product quality complaint; Syringe number one broke at the finger flanges during administration; THE NEEDLE APPEARED CROOKED; This spontaneous report was received from a pharmacist referring to a female patient of unknown age, who was not pregnant. No concurrent, conditions, medical history or concomitant therapies were provided.  On 18-SEP-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, route were not provided) for prophylaxis. Lot No. S012245 has been verified to be a valid lot number for [pneumococcal vaccine, polyvalent (23-valent)], expiration date reported as 09-FEB-2021, and upon internal validation established as the same.  On this same date, during the vaccine administration two vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringes out of a carton of ten broke.   The first syringe broke at the finger flanges while using it, but there was no initial crack on the syringe. The finger flanges broke up after the administration of the shot (product quality issue). The medical assistant was administering the dose and was cut on her hand from the broken edge (skin laceration; accidental exposure to product). The patient who received the vaccine reported no adverse effects. There was no difficulty trying to attach the syringe needle to the syringe, but the needle appeared crooked (needle issue). The medical assistant saw the physician and the physician cleaned up the cut and bandaged it. The outcome of skin laceration was reported as resolved on 20-SEP-2019.  The second syringe broke at the luer lock while the medical assistant was sliding the safety tip off of the needle. It was stated that it broke after administration while attempting to put the safety mechanism on after administration. No patient was involved.   The outcome of product quality issue, accidental exposure to product, needle issue and syringe issue was unknown.     The reporter did not provide a causal relationship between the events and the Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23).",,,,,,,,,Y,,09/18/2019,,,UNK,,,,,,US0095075131909USA008762,2,10/03/2019,,,,
0838162,10/04/2019,MD,,,,U,,"No adverse effect reported; one dose of an improperly stored vaccine ROTATEQ to one patient; This spontaneous report was received from a nurse and concerns to a patient of unknown age and gender. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.         On 12-SEP-2019, the patient was vaccinated with an improperly stored dose of  rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  lot # R030924 and expiration date 10-JUL-2020, for prophylaxis. The administered dose of the vaccine experienced a temperature excursion of 0.24 degrees Celsius (multiple) for 5 hours and 30 minutes, as recorded by a data logger. There was no  previous temperature excursion. No adverse effect reported.",,,,,,,,,U,09/12/2019,09/12/2019,0,,UNK,,,,,,US0095075131909USA010959,2,10/03/2019,,,,
0838163,10/04/2019,NY,,,,U,,"No adverse effect reported; the patient was inadvertently administered a dose of PROQUAD; This spontaneous report was received from the vaccine coordinator and refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions and historical drugs was not provided.  On 24-SEP-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(rha)(PROQUAD) (strength, dose, route and anatomical location were not provided) for prophylaxis. The following lot numbers were reported: lot # R030805 with expiration date on 22-APR-2020 and lot # S003326 with expiration date on 02-AUG-2020.  The vaccine was exposed to a temperature of 27.1 degrees fahrenheit during 40 minutes. There was not previous temperature excursion. It was reported that digital data logger was involved. No adverse effects were reported. The vaccine was reconstituted with properly sterile diluent.",,,,,,,,,U,09/24/2019,09/24/2019,0,,UNK,,sterile diluent,,,,US0095075131909USA013557,2,10/03/2019,,,,
0838164,10/04/2019,MI,,,,F,,"pneumonia; This spontaneous report was received from a pharmacist regarding a 74 year old female patient. Information on medical history, concurrent condition, concomitant medications and drug reactions/ allergies were unknown.  Approximately on an unspecified date in 2014 when she was over 65 years of age, (Also reported as about five years ago), the patient was vaccinated with first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, frequency, therapy duration, route, anatomical location, lot # and expiry date were unknown) for prophylaxis.   Approximately on an unspecified date in 2018 (Also reported as last year), the patient experienced pneumonia. On an unspecified date, the patient was hospitalized due to event for an unspecified period of time. The patient received unspecified treatment for the event.  The outcome of the event pneumonia was reported as recovered. The causality assessment was not provided. There was no product quality complaint associated with this reported.    Upon internal review, the event pneumonia was determined to be medically significant.",,,,,Y,,,,Y,,,,,UNK,,,,,,US0095075131910USA000028,2,10/04/2019,,,,
0838165,10/04/2019,NY,,4,,U,,"No adverse effects; A patient was administered improperly stored PROQUAD; This spontaneous report was received from a pharmacist referring to a 4-year-old patient of unknown gender. The patient medical history, concurrent conditions and concomitant medications were not reported.  On 09-SEP-2019, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) for prophylaxis (strength, dose, frequency and route of administration were not provided) (lot # S009759 has been verified to be a valid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live, expiration date reported and establish as 27-SEP-2020). A sterile diluent properly stored was used to reconstitute the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD).   The temperature of storage and time frame of the excursion were 15F (Fahrenheit) to 46F (17.6F) and 56 hours and 40 minutes respectively, a previous temperature excursion was at 6F to 14F (6.2F) for 10 minutes. A datta logger was not used. No adverse effect was reported",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,sterile diluent,,,,US0095075131910USA001198,2,10/03/2019,,,,
0838166,10/04/2019,NY,4.0,4,,U,,"No adverse effects; a patient was adminitered improperly stored PROQUAD; This spontaneous report was received from a medical assistant referring to a 4-year-old patient of an unknown gender. Information about the patient's pertinent medical history, concurrent conditions and previous drug reactions or allergies were not provided. The concomitant medications included sterile diluent.  On 04-SEP-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (PROQUAD) for prophylaxis, lot number S009759 and expiration date 27-SEP-2020 (strength, route of administration and anatomical location were not provided) (product storage error).  The vaccine was exposed to a temperature excursion of 17.6-Farenheit degree (F) (range from 15 F to 46 F) for 56 hours and 40 minutes. There was a previous temperature excursion of 6.2 F (range from 6 F to 14 F) for 10 minutes. There was no digital data logger involved.  It was reported that the sterile diluent that was used to reconstitute the vaccine was properly stored.   There were no adverse effects reported.",,,,,,,,,U,09/04/2019,09/04/2019,0,,UNK,,sterile diluent,,,,US0095075131910USA001779,2,10/03/2019,,,,
0838167,10/04/2019,,,,,M,,"a bad rash; constricted throat; This spontaneous report was received from the patient's mother and refers to a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not provided.  On an unknown date, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) for prophylaxis (strength, dosage, frequency, route, lot# and expiration date were not provided).        On an unknown date, the patient experienced a bad rash and constricted throat (throat tightness).     The outcome of rash and throat tightness was unknown.        The reporter did not provide causality assessment between the events and measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD).",,,,,,,,,U,,,,,UNK,,,,,,US0095075131910USA002437,2,10/03/2019,,,,
0838168,10/04/2019,NY,,,,U,,"no adverse effects noted; the patient received an expired dose of PROQUAD; This spontaneous report was received from a nurse practitioner refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported.  On 02-OCT-2019, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # R008205 (expiration date: 16-SEP-2019), subcutaneously in the left deltoid for prophylaxis. No adverse effects noted.",,,,,,,,,U,10/02/2019,10/02/2019,0,,UNK,,STERILE DILUENT,,,,US0095075131910USA003306,2,10/03/2019,,,,
0838169,10/04/2019,CA,72.0,72,,F,,"Signs of cellulitis at the injection site; This spontaneous report has received from an officer manager through a company representative, regarding to a 72-year-old female patient. The patient's concurrent conditions, medical history and concomitant medications were not provided.   On 24-SEP-2019, the patient was vaccinated with a dose pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # S013490, has been verified to be a valid lot number for pneumococcal vaccine, polyvalent (23-valent), expiration date not reported, but upon internal validation established as 06-MAR-2021 (strength, dose, route of administration and anatomical location of vaccine were not provided) for vaccination.   On 26-SEP-2019, the patient returned to the facility with signs of cellulitis at the injection site (Injection site cellulitis); however, she sought for medical atention and an unspecified physician placed the patient on antibiotic (unspecified treatment). At the reporting time, the outcome of injection site cellulitis was unknown.  The causality assessment between the injection site cellulitis and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was unknown.",,,,,,,,,U,09/24/2019,09/26/2019,2,,UNK,,,,,,US0095075131910USA003334,2,10/03/2019,,,,
0838170,10/04/2019,ME,,,,M,,"Erythematous wheal extending down to elbow; This case was reported by a physician via sales rep and described the occurrence of erythema urticarial in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced erythema urticarial. On an unknown date, the outcome of the erythema urticarial was unknown.   It was unknown if the reporter considered the erythema urticarial to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient experienced erythematous wheal extending down to elbow.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838176,10/04/2019,GA,,,,U,,"Anaphylaxis; a missed contraindication for Tdap; Anaphylaxis; This case was reported in a literature article and described the occurrence of anaphylaxis in a patient who received Hepatitis A vaccine for prophylaxis.  Co-suspect products included DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis, Flu unspecified (Flu vaccine) for prophylaxis, Men ACWY-CRM NVS (Meningococcal ACWY Vaccine (potential Menveo)) for prophylaxis, DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis, ADENOVIRUS VACCINE for prophylaxis and POLIOMYELITIS VACCINE (IPV VACCINE) for prophylaxis.   On an unknown date, the patient received Hepatitis A vaccine at an unknown dose, Tdap Vaccine at an unknown dose, Flu vaccine at an unknown dose, Meningococcal ACWY Vaccine (potential Menveo) at an unknown dose, Tdap Vaccine at an unknown dose, ADENOVIRUS VACCINE at an unknown dose and IPV VACCINE at an unknown dose. On an unknown date, unknown after receiving Hepatitis A vaccine and Tdap Vaccine and not applicable after receiving Flu vaccine, Meningococcal ACWY Vaccine (potential Menveo) and Tdap Vaccine, the patient experienced anaphylaxis (serious criteria GSK medically significant), anaphylaxis (serious criteria hospitalization and GSK medically significant) and contraindicated drug administered. On an unknown date, the outcome of the anaphylaxis, anaphylaxis and contraindicated drug administered were unknown.   It was unknown if the reporter considered the anaphylaxis to be related to Hepatitis A vaccine and Tdap Vaccine. The reporter considered the anaphylaxis to be possibly related to Flu vaccine, Meningococcal ACWY Vaccine (potential Menveo) and Tdap Vaccine.  Additional details were reported as follows: This case was reported in a literature article and described the occurrence of anaphylaxis in a patient of unspecified age and gender who was vaccinated with unspecified inactivated poliovirus (IPV), unspecified inactivated influenza (IIV), unspecified meningococcal conjugate (MCV4) and unspecified tetanus, diphtheria & acellular pertussis vaccine (Tdap) vaccines and unspecified adenovirus (manufacturer unknown for all vaccines) for prophylaxis.  The patient was the part of the observational study that aimed to investigate adverse event (AE) reports following the adenovirus vaccine submitted to the Vaccine Adverse Event Reporting System (VAERS). They searched the VAERS database for reports among persons who received adenovirus vaccine during 1st October 2011 through 31st July 2018 including participants in a military observational study. [In this study, they identified those reports filled from 24th October 2011 to 5th October 2012, an FDA-mandated, post marketing military observational study was conducted using the database. This study compared 100,000 recruits exposed to the adenovirus vaccine with a historical unexposed cohort and identified statistical signals for psoriasis, anaphylaxis and other hypersensitivity reactions as emergent AEs possibly related to vaccination. During the study period, VAERS received a total of 100 reports following adenovirus vaccine; among all reports, the earliest vaccination date with the adenovirus vaccine the study identified was November 9, 2011]. The patient was from the military observational study. The patient had a past history of anaphylaxis following Tdap and hepatitis A vaccines (i.e., a missed contraindication for Tdap). No information on patient's family history or concomitant condition was provided. On unspecified date, the patient had received unspecified inactivated poliovirus (IPV), unspecified inactivated influenza (IIV), unspecified meningococcal conjugate (MCV4) and unspecified tetanus, diphtheria & acellular pertussis vaccine (Tdap) vaccines and unspecified adenovirus (administration route and site unspecified, dosage unknown; batch number not provided for all). The age of vaccination was not provided.  On an unspecified date between 1st October 2011 through 31st July 2018, unknown period after vaccination, the patient presented to the hospital with the episode of anaphylaxis. [In this study, The main diagnosis for each report was categorized into a MedDRA System Organ Class (SOC) grouping. Reports suggestive of anaphylaxis or GBS were further classified using the Brighton Collaboration criteria or a physician's diagnosis. Reports are classified as serious based on the Code of Regulations if one of the following is reported: death, life-threatening illness, hospitalization or prolongation of hospitalization, permanent disability, or congenital anomaly]. This case has been considered as serious due to the hospitalization. Treatment was unknown. [In this study, each of the patients was treated with epinephrine, antihistamine and corticosteroid therapy]. The outcome of event was not reported.  The author commented, ""We identified eight reports of anaphylaxis following adenovirus vaccine classified as serious and on review of medical records all were identified as participants in the military observational study. In two patients the anaphylaxis was considered as possibly related to vaccines. In addition, 95 percent of the adenovirus vaccine reports documented co-administration of other vaccines and 50 percent reported co-administration of penicillin G (or other antibiotic if allergic to penicillin) according to standard protocol in this military population. The investigators of the earlier military observational study also commented that concurrent vaccine exposures in the recruit population was an important limiting factor for attributing the statistical signaling outcomes including psoriasis, anaphylaxis and other hypersensitivity reactions as possibly related to the vaccine"". The author concluded ""The reporting rate for serious AEs was higher than with other vaccines administered in the comparison military recruit population (39 percent vs 18 percent however, we identified no unexpected or concerning pattern of adenovirus vaccine AEs. Co-administration of vaccines and IM Pen G was commonly reported in this military population. These exposures may have contributed to the GBS and anaphylaxis outcomes observed with the adenovirus vaccine. Future adenovirus vaccine safety studies in a population without these co-administrations would be helpful in clarifying the vaccine's safety profile"". This is 1 of the 19 valid cases reported in this literature article.",,,,,Y,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019GS,2,10/03/2019,,,,
0838177,10/04/2019,GA,,,,U,,"Anaphylaxis; This case was reported in a literature article and described the occurrence of anaphylaxis in a patient who received DTPa (Reduced antigen) (dTpa vaccine) for prophylaxis.   Co-suspect products included Men ACWY-CRM NVS (Meningococcal ACWY Vaccine (potential Menveo)) for prophylaxis, LIVE ATTENUATED INFLUENZA VACCINE for prophylaxis and ADENOVIRUS VACCINE for prophylaxis.   On an unknown date, the patient received dTpa vaccine at an unknown dose, Meningococcal ACWY Vaccine (potential Menveo) at an unknown dose, LIVE ATTENUATED INFLUENZA VACCINE at an unknown dose and ADENOVIRUS VACCINE at an unknown dose. On an unknown date, 1 day after receiving dTpa vaccine and Meningococcal ACWY Vaccine (potential Menveo) and an unknown time after receiving LIVE ATTENUATED INFLUENZA VACCINE, the patient experienced anaphylaxis (serious criteria GSK medically significant and other: as per reporter). On an unknown date, the outcome of the anaphylaxis was unknown.   The reporter considered the anaphylaxis to be possibly related to dTpa vaccine and Meningococcal ACWY Vaccine (potential Menveo).  Additional details were reported as follows: This case was reported in a literature article and described the occurrence of anaphylaxis in a patient of unspecified age and gender who was vaccinated with unspecified live attenuated influenza (LAIV); unspecified meningococcal conjugate vaccine (MCV4) and unspecified tetanus, diphtheria & acellular pertussis vaccine (Tdap) vaccines and unspecified adenovirus vaccine (manufacturer unknown for all vaccines) for prophylaxis.  The patient was the part of the observational study that aimed to investigate adverse event (AE) reports following the adenovirus vaccine submitted to the Vaccine Adverse Event Reporting System (VAERS). They searched the VAERS database reports among persons who received adenovirus vaccine during 1st October 2011 through 31st July 2018 including participants in a military observational study. [In this study, they identified those reports filled from 24th October 2011 to 5th October 2012, a post marketing military observational study was conducted using the Medical Surveillance System database. This study compared 100,000 recruits exposed to the adenovirus vaccine with a historical unexposed cohort and identified statistical signals for psoriasis, anaphylaxis and other hypersensitivity reactions as emergent AEs possibly related to vaccination. During the study period, VAERS received a total of 100 reports following adenovirus vaccine; among all reports, the earliest vaccination date with the adenovirus vaccine the study identified was November 9, 2011]. The patient was from the military observational study. No information on patient's medical or family history or concurrent or concomitant condition were provided. On unspecified date, the patient had received unspecified live attenuated influenza (LAIV); unspecified meningococcal conjugate vaccine (MCV4) and unspecified tetanus, diphtheria & acellular pertussis vaccine (Tdap) vaccines and unspecified adenovirus vaccine (administration route and site unspecified, dosage unknown; batch number not provided for all). The age of vaccination was not provided.  On an unspecified date between 1st October 2011 through 31st July 2018, 1 day following concurrent receipt of the vaccines, the patient onset of symptoms occurred and has been diagnosed with the anaphylaxis. [In this study, the main diagnosis for each report was categorized into a MedDRA System Organ Class (SOC) grouping. Reports suggestive of anaphylaxis or GBS were further classified using the Brighton Collaboration criteria or a physician's diagnosis]. This case has been considered as serious as per the author. [In this study, Reports are classified as serious based on the Code of Regulations if one of the following is reported: death, life-threatening illness, hospitalization or prolongation of hospitalization, permanent disability, or congenital anomaly]. Treatment was unknown. [In this study, each of the patients was treated with epinephrine, antihistamine and corticosteroid therapy]. The outcome of event was not reported.  The author commented, ""We identified eight reports of anaphylaxis following adenovirus vaccine classified as serious and on review of medical records all were identified as participants in the military observational study. In two patients the anaphylaxis was considered as possibly related to vaccines. In addition, 95 percent of the adenovirus vaccine reports documented co-administration of other vaccines and 50 percent reported co-administration of penicillin G (or other antibiotic if allergic to penicillin) according to standard protocol in this military population. The investigators of the earlier military observational study also commented that concurrent vaccine exposures in the recruit population was an important limiting factor for attributing the statistical signaling outcomes including psoriasis, anaphylaxis and other hypersensitivity reactions as possibly related to the vaccine"". The author concluded ""The reporting rate for serious AEs was higher than with other vaccines administered in the comparison military recruit population (39 percent vs 18 percent however, we identified no unexpected or concerning pattern of adenovirus vaccine AEs. Co-administration of vaccines and IM Pen G was commonly reported in this military population. These exposures may have contributed to the GBS and anaphylaxis outcomes observed with the adenovirus vaccine. Future adenovirus vaccine safety studies in a population without these co-administrations would be helpful in clarifying the vaccine's safety profile"". This is 1 of the 19 valid cases reported in this literature article.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019GS,2,10/03/2019,,,,
0838178,10/04/2019,IA,70.0,70,,M,,"Small rash appeared at the injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site rash in a 70-year-old male patient who received Herpes zoster (Shingrix) (batch number 54H72, expiry date 1st October 2021) for prophylaxis.   On 16th July 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, immediately after receiving Shingrix, the patient experienced injection site rash. On an unknown date, the outcome of the injection site rash was recovered/resolved.   The reporter considered the injection site rash to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. The pharmacist confirmed with the patient, that it was not just red but was rash at the injection site. The reporter did not know how soon after vaccination with dose of Shingrix, the patient experienced injection site rash. The healthe care professional stated that, the injection site rash resolved in 4 days. The pharmacist was transfered to medical information on whether the patient should receive the 2nd dose.",,,,,,,,,Y,07/16/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838179,10/04/2019,FL,62.0,62,,F,,"unsure if shingles rash; Rash along their torso; Rash along their torso; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th September 2019, the patient received Shingrix (intramuscular). In September 2019, less than a week after receiving Shingrix, the patient experienced shingles, rash and injection site rash. On an unknown date, the outcome of the shingles, rash and injection site rash were unknown.   It was unknown if the reporter considered the shingles, rash and injection site rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist stated that the patient received Shingrix and developed a rash at the injection site and along their torso (unsure if shingles rash). No details were regarding lot or expiration date, onset and duration of rash, administrator of vaccine, location of administration available at this time. The reporter consented to follow up.",,,,,,,,,U,09/24/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838180,10/04/2019,,61.0,,,F,,"late dose; Malaise; Body aches; This case was reported by a physician via sales rep and described the occurrence of malaise in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In November 2018, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, the patient received the 2nd dose of Shingrix. In November 2018, immediately after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced malaise and general body pain. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the malaise and general body pain were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the malaise and general body pain to be related to Shingrix.  Additional case details were provided as follows: Soon after receiving a dose of Shingrix, the patient began to experience significant malaise and body aches and due to which she had to stay in bed for 48 hours. From the reported information, it seems that, till the time of reporting, the patient did not receive her 2nd dose, which led to an incomplete course of vaccination. All symptoms were resolved after 48 hours. The sales representative indicated that, the reporter provided this information to her during a Congress she was attending and was unable to provide any additional details. This is 1 of the 4 cases reported by the same reporter. There was a discrepancy in the reported outcomes of the events body aches and malaise. In XML, outcome was mentioned as recovered/resolved with sequel and in Argus, it was reported as recovered/resolved. However outcome of these events is captured as per Argus.",,,,,,,,,Y,11/01/2018,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838181,10/04/2019,FL,53.0,53,,M,,"Malaise/not feeling great; Shivers; This case was reported by a consumer via call center representative and described the occurrence of shivers in a 53-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 24th September 2019, less than a day after receiving Shingrix, the patient experienced shivers. On 25th September 2019, the patient experienced malaise. On an unknown date, the outcome of the shivers was recovered/resolved and the outcome of the malaise was not recovered/not resolved.   It was unknown if the reporter considered the shivers and malaise to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported that after receiving 1st Shingrix dose in his left arm at his physician's office and experienced shivers that lasted all night long. The following day the patient was not feeling great (malaise). The patient reported that he was starting to come out of it, however it was still slightly lingering around. The reporter consented to follow up.",,,,,,,,,N,09/24/2019,09/24/2019,0,,PVT,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838182,10/04/2019,NY,74.0,74,,M,,"pain; swelling; This case was reported by a other health professional via call center representative and described the occurrence of pain in arm in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2019, the patient received Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced pain in arm and injection site swelling. On an unknown date, the outcome of the pain in arm and injection site swelling were recovered/resolved.   It was unknown if the reporter considered the pain in arm and injection site swelling to be related to Shingrix.  Additional details were provided as follows: The medical assistant reported that the physician at her office received the first dose of Shingrix about 1 month ago. Afterwards he had pain like someone punched him in the arm and swelling at the injection site. The reporter would not provide her full name.",,,,,,,,,Y,09/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838183,10/04/2019,VA,,,,U,,"Neurological events; This case was reported by a other health professional via sales rep and described the occurrence of neurological symptom in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) (batch number 72RS4, expiry date 30th June 2020) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced neurological symptom (serious criteria hospitalization). On an unknown date, the outcome of the neurological symptom was recovering/resolving.   It was unknown if the reporter considered the neurological symptom to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. The healthcare provider administered 10,000 vials of FluLaval vaccines to all employees. Three patients developed Neurological events, 1 of those 3 patients was currently in the intensive care unit (ICU). The healthcare professional (HCP) reached out to the local health department. This matter went up to leadership at the HCP. The reporter consented to follow up. This case is 1 of 3 cases reported.",,,,,Y,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838184,10/04/2019,FL,,,,M,,"Guillian Barre Syndrome; This case was reported by a physician via sales rep and described the occurrence of guillain barre syndrome in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included chemotherapy, nos (Chemotherapy).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, several days after receiving Shingrix, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was unknown.   The reporter considered the guillain barre syndrome to be unrelated to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced Guillian Barre Syndrome a few days after receiving the Shingrix vaccine.  The physician did not believed that the vaccine was the related to the event and planed to gave the second dose. The reporter consented for follow up.",,,,,,,,,U,,,,,UNK,,CHEMOTHERAPY,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838185,10/04/2019,NC,67.0,67,,F,,"tenderness at injection site/localized reaction to the injection site; warmth at injection site/localized reaction to the injection site; redness at injection site/localized reaction to the injection site; malaise; inappropriate reconstitution technique; Inappropriate dose of vaccine administered; sleepness; This case was reported by a consumer via call center representative and described the occurrence of injection site tenderness in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th September 2019, the patient received Shingrix. On 24th September 2019, less than a day after receiving Shingrix, the patient experienced injection site tenderness, injection site warmth, injection site erythema, malaise, sleepiness, inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the injection site tenderness, injection site warmth, injection site erythema, malaise, sleepiness, inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   It was unknown if the reporter considered the injection site tenderness, injection site warmth, injection site erythema, malaise and sleepiness to be related to Shingrix.  Additional details were reported as follows: The vaccine was given by a medical assistant at her physician's office.  she received a call from the medical assistant and was told that she was given the adjuvent before reconstituting with antigen component (powder), which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.  Caller reported that she experienced a localized reaction to the injection site, redness, tenderness and hot to the touch, she also felt malaise and came home that evening from work and slept for 10 hours. The medical assistant informed her that she would have to retake her Shingrix injection in three weeks. Caller inquired if she should retake her Shingrix vaccine. caller was referred to her physician regarding if she should retake her Shingrix injection in three weeks, provided GSK contact number for her physician to call Medical Information department for additional information. The reporter consented to follow up.",,,,,,,,,U,09/24/2019,09/24/2019,0,,PVT,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,Y,,
0838186,10/04/2019,NH,0.17,0,.2,M,,"Inappropriate Route of Vaccination; Patient experienced fussiness; Vomit after the injection; This case was reported by a other health professional via call center representative and described the occurrence of irritability in a 2-month-old male patient who received Rota (Rotarix) (batch number KZ97P, expiry date 22nd September 2020) for prophylaxis.   On 26th September 2019, the patient received Rotarix (intramuscular). In September 2019, less than a week after receiving Rotarix, the patient experienced irritability and vomiting. On 26th September 2019, the patient experienced inappropriate route of vaccination. On an unknown date, the outcome of the irritability, vomiting and inappropriate route of vaccination were unknown.   It was unknown if the reporter considered the irritability and vomiting to be related to Rotarix.  Additional details were received as follows: The vaccine was given in the right thigh on September 26, 2019. A male patient was given Rotarix via the intramuscular route, which led to inappropriate route of vaccination. The patient experienced fussiness and did vomit after the injection. The reporter consented to follow up.",,,,,,,,,U,09/26/2019,09/01/2019,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838189,10/04/2019,,,,,M,,"ECHOCARDIOGRAM ABNORMAL; Coronary artery dilatation; Kawasaki's disease; Information has been downloaded from regulatory authority (US-PFIZER INC-2012090348).   This spontaneous report was received from an other health professional concerning a 12 month old male patient. His concurrent conditions included respiratory tract infection and candida nappy rash. No concomitant therapy was reported.      On 25-FEB-2011, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) (bath/lot# 1510Z, 1 dosage form, intramuscular), measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (batch/lot# 0811Z, 1 dosage form, subcutaneous), varicella virus vaccine live (Oka/Merck) (VARIVAX) (batch/lot# 1044Z, 1 dosage form, subcutaneous), pneumococcal 13v conj vaccine (CRM197) (PREVNAR 13) (batch/lot# E84462, 1 dosage form, intramuscular) and Hib conj vaccine (tet toxoid), diphtheria toxoid, pertussis acellular 5-component vaccine, poliovirus vaccine inactivated (MRC-5), tetanus toxoid (PENTACEL) (batch/lot# C3747AB, 1 dosage form, intramuscular) for immunisation.    On 05-MAR-2011, the patient experienced Kawasaki's disease. On 18-MAR-2011, the patient experienced coronary artery dilatation. On an unknown date, the patient experienced echocardiogram abnormal. All the events caused hospitalization. The outcome of all the events was reported as resolved.  Action taken with suspect drugs was not applicable.   The causality between the events and suspect drugs was not reported.",,,,,Y,,,,Y,02/25/2011,03/05/2011,8,,UNK,,,Immunisation; Immunization,Medical History/Concurrent Conditions: Candidal diaper rash; Respiratory tract infection,,US0095075131909USA013829,2,10/04/2019,,,,
0838191,10/04/2019,MI,70.0,70,,F,,"3 inch raised, red, warm, itchy area located approximately 2 inches below injection site.  Symptoms showed up one day post vaccine, although itchiness resolved same day.",,,,,,,,,N,10/02/2019,10/03/2019,1,none,WRK,,unknown,unknown,unknown,,,2,10/04/2019,,,,NKA
0838192,10/04/2019,DC,1.67,1,.7,F,,"Diarrhea, vomiting, cough 2 days after flu shot and fever 3 days after flu shot",,,,,,,,,Y,09/27/2019,09/29/2019,2,,PVT,,none,none,none,,,2,10/04/2019,,,,none
0838193,10/04/2019,TX,37.0,37,,M,,"within hrs of vaccination with AVA began to notice arm swelling, redness and discomfort. Sought care the following day, given steroids with resolution of sx within a couple of days. Swelling did not extend past deltoid. Did have LLR with previous AVA admin between 2003-05.  Symptoms: EDEMA, UNSPECIFIED(R609), OTHER ERYTHEMATOUS CONDITIONS(L53).",,,,,,,,,Y,09/18/2019,09/18/2019,0,AVA Lot Number: FAV 623A,MIL,,unk,unk,unk,,,2,10/03/2019,,Y,,unk
0838194,10/04/2019,PA,66.0,66,,F,,"Woke up at 12:30 a.m. with severe chills and aches - put on socks and heavy sweatshirt and went back to bed.  When I woke at 7 a.m. I had body aches - difficult to walk,  was off-balance,  exhaustion, nauseousness, vomited immediately after taking my morning vitamins and had a headache.   I am a very active and healthy and strong person - these side effects landed me in bed all day.  Today, October 4, I'm feeling much better with a slight headache and body aches and nauseousness and feeling a bit tired.   I'm hoping I am on the mend.  I called my PCP who told me to take Tylenol and call if my condition worsened.",,,,,,,,,N,10/02/2019,10/03/2019,1,None,PHM,,"Zyrtec, Vitamin C, Calcium, One A Day Vitamin, Lipitor",None,High cholesterol - take medication,,,2,10/04/2019,,,,None
0838196,10/04/2019,IN,,,,U,,"No adverse events; a patient was administered 1 dose of improperly stored VAQTA; This spontaneous report was received from a nurse and refers to a patient of an unknown age and gender. There was no information about the patient's concurrent condition, concomitant medication and medically history provided.  On 09-SEP-2019, the patient was vaccinated with the first dose of improperly stored hepatitis a vaccine, inactivated (VAQTA) lot number: S017739, expiration date: 29-AUG-2020 for prophylaxis (formulation, dose and route of administration were not reported).   The administrated dose of vaccine was exposed to the highest temperature above 47 degrees Fahrenheit / 9 degrees Celsius for 24 hours. There was no previous temperature excursion. The data logger was not involved. No adverse events were reported.",,,,,,,,,U,09/09/2019,09/09/2019,0,,UNK,,,,,,US0095075131909USA004174,2,10/04/2019,,,,
0838197,10/04/2019,CO,63.0,63,,F,,"pain started in her shoulder where she got the shot; muscle pain; muscle atrophy/ it is hard like muscle atrophy; Intense muscle spasm; then spread to her other shoulder and her entire back and the muscle in the back of her thigh; then spread to her other shoulder and her entire back and the muscle in the back of her thigh; then spread to her other shoulder and her entire back and the muscle in the back of her thigh; muscle on the back of her thigh sticks out; pain throughout her body; cannot stand up straight and has to crawl out of bed due to the pain; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Previous severe reaction to Crestor medication with an associated reaction of myalgia (had experienced similar but severe reaction).   On 26th August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 29th August 2019, 3 days after receiving Shingrix, the patient experienced injection site pain, muscle pain, muscle atrophy, muscle spasm, shoulder pain, back pain, pain on lower thigh, muscle stiffness, general body pain and difficulty in standing. The patient was treated with trolamine salicylate (Aspercreme), paracetamol (Tylenol) and ibuprofen (Advil). On an unknown date, the outcome of the injection site pain, muscle pain, muscle atrophy, muscle spasm, shoulder pain, back pain, pain on lower thigh, muscle stiffness, general body pain and difficulty in standing were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, muscle pain, muscle atrophy, muscle spasm, shoulder pain, back pain, pain on lower thigh, muscle stiffness, general body pain and difficulty in standing to be related to Shingrix.  Additional case details were provided as follows: The patient had Shingrix in her left arm. The patient experienced intense muscle spasms and pain throughout her body.  She reported that, 3 days after vaccination, the pain started in her shoulder where she got the shot. It then spread to her other shoulder and her entire back and the muscle in the back of her thigh. She claimed that, the muscle was worst on her left side of her thigh and it was so bad that she could not sit on the toilet. She further stated, the muscle on the back of her thigh stuck out and it was hard like it was muscle atrophy. She could not stand up straight and she had to crawl out of bed due to the pain.  She had to put Aspercream on her entire body. She had been treating the condition with two Tylenol and three Advair just so that she could get out of bed. The patient also mentioned that, she would not be getting another shot and she understood why people took their lives after this experience. The patient could not seek treatment due to a high insurance deductible and no automobile to take her to a physician. The patient consented to follow up and provided her physician's details. The call center representative added that, they contacted the local police department requesting a wellness check after the call disconnected because the patient stated that ""it just did not matter anymore"" at the end of their phone conversation.",,,,,,,,,N,08/26/2019,08/29/2019,3,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838205,10/04/2019,NE,38.0,38,,F,,"Injections site red, hot to touch. Itchy and pain down arm and into neck. Did ice, Benadryl and this helped. 10/04/2019 area at site reddened the size of a golf ball.",,,,,,,,,Y,10/01/2019,10/03/2019,2,,OTH,,Unknown,None,None,,,2,10/04/2019,,,,NONE
0838206,10/04/2019,NC,12.0,12,,M,,"6 hours after vaccines he developed vesicular rash initially on bilat lower extremities w evolution to involve bilat upper extremities. vesicles superimposed on erythem papules -similar appearance to poison ivy or perhaps even varicella like. But no systemic symptoms, otherwise well",,,,,,,,,N,09/20/2019,09/20/2019,0,none,PVT,,none,none,none,,,2,10/04/2019,,Y,,no known drug/food allergies
0838207,10/04/2019,,55.0,55,,F,,"3 hours after the injection, the area of the injection was very sore (I was told that this may occur); soreness (it felt like I had been punched by a professional boxer but without the bruising or swelling) lasted for 2 days (until 10/2).  I noticed a rash on the shoulder where the vaccine was injected on 10/3 (morning).  It doesn't itch and the rash is contained to the shoulder. As of 10/4, there is a slight soreness.  But, I have to press down on my should to feel any soreness.",,,,,,,,,,09/30/2019,09/30/2019,0,None,PHM,,Estradiol 10 MCG Vaginal Tablet,none,none,,,2,10/04/2019,,,,Lamisil the pill (breakout in hives)
0838208,10/04/2019,MI,54.0,54,,F,,"08-02-2019 Office visit: History of Present Illness: Rash:  The patient presents for rash.  This episode began gradually and has lasted caries.  The symptom(s) are described as moderate, unchanged and occurs daily.  The patient describes the affected area(s) as burning, itchy and red.  Associated symptoms include erythema (skin) and pruritus.  States had Tdap injection on 7/22 [given in R deltoid] and states ever since has had a rash on her arm.  Says it is hot, painful, and will not go away.  States she also felt somewhat sick for 2 days after.  Review of Systems: Integumentary:  Positive for erythema, pruritis  Assessment and Plan:  Rash.  Please take the steroids and antibiotic.  If you do not improve let us know.  (Prednisone 20 mg.  Take 2 tabs by mouth once daily for 4 days, take 1 tab daily for 3 days;  cephalexin 500 mg.  Take 1 capsule by oral route 3 times every day.  Dispense 21 capsules.)  10-03-2019 Outgoing call at 4:08 PM:  I called to follow-up on the rash on arm from a Tdap administration on 7-22.  To see that is has fully resolved and about how long it took to do that.  This is my third day/attempt to contact patient and each time a recording says mailbox is full. 10-04-2019 at 9:08 AM:  I called and mailbox is full.  All communications since the OV re: arm/rash have nothing to do about arm/rash.  I will fill out VEARS report.",,,,,,,,,Y,07/22/2019,07/23/2019,1,None,OTH,,"Prednisone 20 mg (see assessment and plan); cephalexin 500 mg; Wellbutrin SR 150 mg, 1 tab BID; Claritin 10 mg, 1 tab PO QD; levothyroxine 125 mcg, 1 tab PO QD; nystatin 100,000 u/gm topical crm, AAA 2X?s a day; ProAir HFA 90 mcg/action, in",Was in for a med recheck appointment,"Hypertension, hypercholesterolemia, hypothyroidism, depression, morbid obesity, tobacco dependence.",,,2,10/04/2019,,Y,,"APAP, hydrocodone, codeine, bitartrate"
0838209,10/04/2019,OK,65.0,65,,F,,"Patient preferred to receive both injections in same arm.  Administering Pharmacist failed to separate injection sites by minimum one inch (best practice recommendation).  Within 24 hours upper left arm was painful, red, hot, and very swollen.  Patient treated with acetaminophen, diphenhydramine, and ice.  Now, third day, swelling still present, heat still present, and still sore, though symptoms are slowly resolving.",,,,,,,,,N,10/01/2019,10/03/2019,2,none,PHM,,"atorvastatin , metoprolol er, alendronate, calcium, Vitamin d",none,none,,,2,10/04/2019,,,,nka
0838211,10/04/2019,MI,2.0,2,.0,F,,A Kinrix vaccine was given to someone under the age of 4.,,,,,,,,,Y,09/12/2019,09/12/2019,0,,PVT,,,,,,,2,10/04/2019,,,,
0838212,10/04/2019,PA,59.0,59,,F,,"Muscle and shoulder really aches with use or sleeping on her left side.  Patient stated she felt slight soreness the day of shot but the soreness has not gone away after 2 weeks. Described as a deep muscle soreness.  No swelling, bruising or heat to touch was reported. Patient stated that there was some slight pain with administration similar to immunizations that she had in the past, nothing out of the ordinary.   Spoke with patient on october 1st and recommended making an appt. with doctor to get checked out. Recommended Ibuprofen for pain until doctor could be seen.  Spoke to patient again on 10/4/19 and she is still having the soreness.  She has made an appt. with her PCP.",,,,,,,,,N,09/18/2019,09/01/2019,,none at this time,WRK,,"triamterene/hctz, enalapril, nifedipine,pantoprazole","none reported, patient did have colonoscopy 2 weeks prior.",none reported,,,2,10/04/2019,,Y,,none reported
0838213,10/04/2019,MI,1.25,1,.3,F,,A Kinrix vaccine was given to someone under the age of 4.,,,,,,,,,Y,09/05/2019,09/05/2019,0,,PVT,,,,,,,2,10/04/2019,,,,
0838214,10/04/2019,MI,0.42,0,.5,M,,A Kinrix vaccine was given to someone under the age of 4.,,,,,,,,,Y,09/19/2019,09/19/2019,0,,PVT,,,,,,,2,10/04/2019,,,,
0838215,10/04/2019,AZ,5.0,5,,F,,Arm is extremely swollen like a baseball on her shoulder. It's very red and hot to the touch. She is complaining her entire arm itches and burn. Looks like the start of hives directly on the site.  She has a fever and complaining of all her muscles hurting.,,,,,,,,,U,10/02/2019,10/03/2019,1,,PVT,,None,None. Perfectly healthy.,None.,,,2,10/04/2019,,,,Allergic to laundry soaps
0838216,10/04/2019,MI,0.42,0,.5,F,,A Kinrix vaccine was given to someone under the age of 4.,,,,,,,,,,09/19/2019,09/19/2019,0,,PVT,,,,,,,2,10/04/2019,,,,
0838217,10/04/2019,MD,32.0,32,,M,,"High fever, rigors, headache, myalgia, confusion that came on suddenly at around 5pm, lasted until 4am the next day and then quickly resolved.  There were no symptoms or any prodrome prior to this, as I was completely in my usual state of health.",,,,,,,,,Y,10/03/2019,10/03/2019,0,,UNK,,"Flonase, Zyrtec","Absolutely none, healthy.",None,,,2,10/04/2019,,,,Allergic to peanuts and tree nuts
0838220,10/04/2019,CA,,,,U,,"an improperly stored dose of PEDVAX was administered to the patient on an unknown date; No adverse effects; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug allergies/reactions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot # N024570, expiration date: 01-MAY-2020 (strength, dose, schedule and route of administration were unknown) for prophylaxis (product storage error). The vaccine underwent temperature excursion below 36-degree Fahrenheit: 32.1 Fahrenheit for a duration of 8 hours. There was no previous temperature excursion. There was an involvement of data logger. No product quality complaints (PQC) were involved.",,,,,,,,,U,,,,,UNK,,,,,,US0095075131909USA012563,2,10/04/2019,,,,
0838221,10/04/2019,OH,,,,U,,"No adverse effects; the patient was inadvertently administered an expired dose of ROTATEQ; This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 29-JUL-2019, the patient was inadvertently vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally, lot # R030924, expiration date reported as 11-JUN-2019, but upon lot# validation, expiration date was established as 10-JUL-2020 (dose was not provided) for prophylaxis. No adverse effects were reported.",,,,,,,,,U,07/29/2019,07/29/2019,0,,UNK,,,,,,US0095075131910USA001875,2,10/04/2019,,,,
0838222,10/04/2019,,,,,F,,"Malaise; Body aches; Fever; This case was reported by a physician via sales rep and described the occurrence of malaise in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced malaise, general body pain and fever. On an unknown date, the outcome of the malaise, general body pain and fever were recovered/resolved.   It was unknown if the reporter considered the malaise, general body pain and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the first dose of the Shingrix vaccine and experienced malaise, body aches, and a fever of 101 degrees.  All symptoms resolved within two day. The reporter was unable to provide any additional details.  This is 1 of 4 cases reported by same reporter.      Lab Comments: the patient's body temperature was 101 degree F on an unknown date",,,,,,,,,Y,09/01/2019,,,"Test Name: Body temperature; Result Unstructured Data: Test Result: 101, Test Result Unit: degree F",UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838223,10/04/2019,,,,,M,,"Pain in arm over 1 month; This case was reported by a physician via sales rep and described the occurrence of pain in arm in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patinet received Shingrix and experienced pain in arm over 1 month. The reporter was agree to follow up from the GlaxoSmithKline.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838224,10/04/2019,CA,,,,F,,"pain in lymph node under the arm; This case was reported by a consumer via call center representative and described the occurrence of lymph node pain in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced lymph node pain. On an unknown date, the outcome of the lymph node pain was unknown.   It was unknown if the reporter considered the lymph node pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient had pain in the lymph node under the arm, after first shot of Shingrix. The reporter consented to follow up. For tolerance to the 2nd dose of Shingrix, refer case US2019171918.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838225,10/04/2019,IA,,,,F,,"Malaise; This case was reported by a physician via call center representative and described the occurrence of malaise in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced malaise. On an unknown date, the outcome of the malaise was recovered/resolved.   It was unknown if the reporter considered the malaise to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The physician reported that, the patient received dose of Bexsero and experienced malaise for 4 days. The reporter consented to follow up.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838226,10/04/2019,KS,,,,F,,"Rash on the lower part of both arms / located from the elbow down; Redness; Itchy rash; Crusting over; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced rash, red rash, itchy rash and crust. On an unknown date, the outcome of the rash, red rash, itchy rash and crust were not recovered/not resolved.   The reporter considered the rash, red rash, itchy rash and crust to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received dose of Shingrix, in the unknown arm. Soon after vaccination with dose of Shingrix, the patient experienced rash on the lower part of both arms, rash was located from the elbow down and was itchy, red and crusting over. Till the time of reporting, the patient still had rash and scheduled to get the 2nd dose. The pharmacist had limited information as she was not at the pharmacy at the time of the call.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838227,10/04/2019,WI,66.0,66,,F,,"Arm pain; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th June 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional information received were as follows: The pharmacist on the line with a patient reporting substantial arm pain following the first dose.  The patient was on the fence about getting the second dose.  The reporter consented to follow up. No other details to provide at the time of report about site of injection, lot number and expiry date.",,,,,,,,,U,06/25/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838228,10/04/2019,NY,60.0,,,F,,"fatigue; Low grade fever; Incomplete course of vaccination; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced fatigue, fever and incomplete course of vaccination. On an unknown date, the outcome of the fatigue and fever were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the fatigue and fever to be related to Shingrix and Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. Over 7 months ago from the date of reporting, the patient received dose of Shingrix and experienced fatigue and low grade fever for a couple of days and did not received 2nd dose yet, which led to incomplete course of vaccination. The reporter consented to follow up.",,,,,,,,,Y,,,,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838229,10/04/2019,GA,60.0,,,F,,"Swelling; Redness; Pain; This case was reported by a physician via call center representative and described the occurrence of injection site swelling in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site swelling, injection site erythema and injection site pain. On an unknown date, the outcome of the injection site swelling, injection site erythema and injection site pain were recovered/resolved.   It was unknown if the reporter considered the injection site swelling, injection site erythema and injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient had severe swelling, redness, and pain at the injection site after receiving the Shingrix. The symptoms resolved after 10 days.  The swelling was the diameter of a tennis ball. The field representative indicated that she was at a conference and was provided information from two separate contacts for three adverse events reports. This was report 2 of 3, reported by same reporter. The reporter unable to obtain additional details.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838230,10/04/2019,AZ,,,,M,,"Bullous Pemphigoid generalized all over the body; Can't walk; very debilitating; This case was reported by a physician via sales rep and described the occurrence of bullous pemphigoid in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pemphigoid (1st dose received on an unknown date, for tolerance refer case US2019AMR176390).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced bullous pemphigoid (serious criteria GSK medically significant), unable to walk and debility. The patient was treated with dapsone and steroids nos (Steroids). Rechallenge with Shingrix was positive. On an unknown date, the outcome of the bullous pemphigoid, unable to walk and debility were not recovered/not resolved.   It was unknown if the reporter considered the bullous pemphigoid, unable to walk and debility to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient again developed bullous pemphigoid condition after receiving the 2nd dose of Shingrix.  The reporter stated that, the condition had been very debilitating for the patient and he could not walk and had to miss work as a result. The patient was treated with high doses of steroids and was now taking Dapsone. Emergency visit was required. The reporter consented to follow up and provided address for further contact. The reporter did not provide any additional information.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,Y,
0838231,10/04/2019,,,,,M,,"Foetal exposure during pregnancy; Preterm birth; Low birth weight; This is an observational study case, initially received from other health professional on 27-Sep-2019, concerning a male, neonate subject, whose mother was 25-year-old, pregnant female subject of body weight 193 lbs, height 66 inches and body mass index 31.1, enrolled in a prospective observational safety study.  The mother's historical medical condition included bacterial vaginosis. The mother's current medical conditions included bacterial vaginosis, nausea, vomiting, Herpes simplex, hypertension, trichomoniasis, anemia, elevated alpha-fetoprotein and uterine dehiscence. The mother's historical medications included Metrogel (metronidazole). The mother's concomitant medications included: Metrogel (metronidazole) for bacterial vaginosis, Flagyl (metronidazole) for trichomoniasis, Procardia (nifedipine) for hypertension, Venofer (saccharated iron oxide) for anaemia and Prenatal vitamins (minerals NOS, vitamins NOS) for pregnancy.   The subject's mother had six previous pregnancies. Five pregnancies ended with full term live birth and one ended with pre-term live birth. The mother did not use tobacco, alcohol or illicit drugs during pregnancy. Also, the subject's mother had no maternal or paternal history with major congenital malformations. The mother's last menstrual period (LMP) date was 29-Jun-2018. Estimated delivery date and corrected estimated delivery date were 05-Apr-2019. The type of pregnancy was singleton.   On 03-Oct-2018, the subject's mother was administered Flu Vaccine Cell Subunit QIV NVD (Flucelvax QIVc) [influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5 ml, batch number: 252664, route of administration, expiration date and anatomical location: not reported] [explicitly coded as Foetal exposure during pregnancy'] for influenza immunisation.  At gestational age of 32.9 week, the mother delivered live birth, male neonate [explicitly coded as Birth premature'] through Caesarean method. The neonate's birth weight was 2140 grams [explicitly coded as Low birth weight baby'], head circumference and body length were not provided. The appearance, pulse, grimace, activity, and respiration (APGAR) scores were 8 (one minute) and 9 (five minutes). There were pregnancy complications noted which included hypertension, uterine dehiscence and preterm labor. There was no major congenital malformation identified at birth.   At the time of initial reporting, the outcomes of the events were not reported.  This case is linked to 201904853 (corresponding mother case).  Company Comment: Reportedly, the male neonate subject was delivered as premature and low birth weight baby after foetal exposure during pregnancy with the suspect product Flucelvax QIVc. Chronology is plausible. Mother's medical history of herpes simplex, hypertension, trichomoniasis and anaemia may have contributed to development of the events. Causality was confounded by use of multiple concomitant drugs. Foetal exposure during pregnancy is assessed as not related per company conventions. For all other events, causal role of the suspect product cannot be totally excluded and is assessed as related.; Reporter's Comments: Reportedly, the male neonate subject was delivered as premature and low birth weight baby after foetal exposure during pregnancy with the suspect product Flucelvax QIVc. Chronology is plausible. Mother's medical history of herpes simplex, hypertension, trichomoniasis and anaemia may have contributed to development of the events. Causality was confounded by use of multiple concomitant drugs. Foetal exposure during pregnancy is assessed as not related per company conventions. For all other events, causal role of the suspect product cannot be totally excluded and is assessed as related.",,,,,,,,,U,10/03/2018,02/14/2019,134,,PVT,,FLAGYL [METRONIDAZOLE]; METROGEL VAGINAL; PROCARDIA [NIFEDIPINE]; PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; VENOFER,,Comments: None.,,USSEQIRUS201904856,2,10/03/2019,,,,
0838232,10/04/2019,,34.0,,,F,,"Pregnancy induced hypertension; Vaccine exposure during pregnancy; This is an observational study case, initially received from other health professional on 27-Sep-2019, concerning a 34-year-old, pregnant, female subject of body weight: 135 lbs, height: 65 inches and body mass index (BMI): 22.5, enrolled in a prospective observational safety study on pregnancy outcomes.  The subject's obstetrical history included two previous spontaneous abortions. The subject did not have history of offspring with major congenital malformation (MCM) and did not have maternal and paternal history with MCM. The subject did not consume tobacco, alcohol or illicit drugs. The subject's current condition included headaches and anemia. Concomitant medications included Prenatal vitamins (minerals NOS, vitamins NOS), butalbital/acetaminophen and ferrous sulphate.  The subject's last menstrual period (LMP) date was 12-May-2018, the estimated delivery date (EDD) and corrected estimated delivery date (CEDD) were 16-Feb-2019. The type of pregnancy was singleton.  On an unspecified date, at 7 weeks of gestational period, the pregnancy status was collected and small subchorionic hematoma (SCH) was noted.  On 25-Jun-2018, 02-Jul-2018 and 16-Jul-2018, the subject underwent ultrasound and no MCM was noted.  On 13-Aug-2018, the subject performed Q natal and no MCM was noted.  On 06-Sep-2018, the subject performed MSAFP/serum markers and no MCM was noted.  On 03-Oct-2018, approximately at gestational age of 20 weeks, the subject was administered Flu Vaccine Egg Split QIV NVD (Flucelvax QIVc) [influenza vaccine, subunit influenza virus vaccine polyvalent; batch number: 252664, dose: 0.5 ml, route of administration, anatomical location and expiration: not reported] (explicitly coded as 'Vaccine exposure during pregnancy') for influenza immunisation.  On 05-Dec-2018, 10-Jan-2019 and 14-Jan-2019, the subject underwent ultrasound and no MCM was noted.  On 14-Jan-2019, approximately three months after vaccination, the subject developed pregnancy induced hypertension.   On 25-Jan-2019, the subject underwent ultrasound and no MCM was noted.  At gestational age of 37.4 weeks, the subject vaginally delivered male neonate. The neonate's birth weight was 2778 g, head circumference was 31.8 cm and length was 49.5 cm. The appearance, pulse, grimace, activity and respiration (APGAR) scores were 8 (one minute) and 9 (five minutes) and no data was reported for APGAR score at ten minutes. No major congenital malformation was identified at birth.  On the same day, the subject recovered from the event of 'pregnancy induced hypertension'.  Company comment: The patient developed gestational hypertension, approximately three months after vaccination with Flu Vaccine Cell Subunit QIV NVD. Vaccine was administered at 20 weeks of gestation, which was coded as vaccine exposure during pregnancy. Chronology is plausible. More information regarding medical history is needed. However, causal role of the suspect vaccine cannot be totally excluded and it is assessed as related. Vaccine exposure during pregnancy is assessed as unrelated per company's conventions.; Reporter's Comments: The patient developed gestational hypertension, approximately three months after vaccination with Flu Vaccine Cell Subunit QIV NVD. Vaccine was administered at 20 weeks of gestation, which was coded as vaccine exposure during pregnancy. Chronology is plausible. More information regarding medical history is needed. However, causal role of the suspect vaccine cannot be totally excluded and it is assessed as related. Vaccine exposure during pregnancy is assessed as unrelated per company's conventions.",,,,,,,,,Y,10/03/2018,10/03/2018,0,Test Date: 20180906; Test Name: MSAFP/serum markers; Result Unstructured Data: No major congenital malformation; Test Date: 20180813; Test Name: Q natal; Result Unstructured Data: No major congenital malformation; Test Date: 20180625; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation; Test Date: 20180702; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation; Test Date: 20180716; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation; Test Date: 20181205; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation; Test Date: 20190110; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation; Test Date: 20190114; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation; Test Date: 20190125; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation,UNK,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; BUTALBITAL AND ACETAMINOPHEN; FERROUS SULFATE,Headache (Start date: 0 weeks prior to conception),Medical History/Concurrent Conditions: Anemia; Multigravida; Spontaneous abortion; Subchorionic hematoma (Noted at gestational age of 7 weeks),,USSEQIRUS201904860,2,10/03/2019,,,,
0838234,10/04/2019,FL,59.0,59,,F,,"Eyes dilated, vision fuzzy around edges of object, perception off.  Feel very lethargic,",,,,,,,,,N,10/03/2019,10/03/2019,0,,WRK,,Nothing,None,Arthritis,"Similar to current reaction, 56 years old , unknown date,  influenza vaccine",,2,10/04/2019,,,,None
0838235,10/04/2019,PA,13.0,13,,M,,"PATIENT WAITED APPORIATE AMOUNT OF TIME BEFORE LEAVING THE OFFICE. WENT HOME AS ALL OKAY, PATIENT WENT TO BED AND AROUND 9:00 PM PATIENT STARTED WITH ABDONIMAL PAIN, NAUSEA, VOMITTING AND DIARRHEA",,,,,,,,,Y,09/26/2018,09/26/2018,0,,PVT,,"LEVOTHYROXINE 50 MG, VITAMIN D 50,000 UNITS, FLONASE, ZRYTEC 10MG","HASHIMOTO'S THRYODITIS, VITAMIN D DEFICENCY","HASHIMOTO'S THRYODITIS, VITAMIN D DEFICENCY",,,2,10/04/2019,,Y,Y,"PENICILLINS, AZITHROMYCIN"
0838236,10/04/2019,IL,66.0,66,,M,,After taking the shingles vaccine I suffered a 50% hearing loss in my right ear. My ENT prescribed # shots of steroids in my ear as well as oral medicine [steroids] I also have been involved with HBOT therapy at my own expense,,,,,,,,,N,08/28/2019,08/30/2019,2,An MRI was done at Hospital on September 10th,PHM,,Atorvastatin20mg; Diltiazem180mg; Fenofibric135mg; Flecainide100mg; Irbesartan300-12.5mg; Xarelto20Mg,Ear infection early July,A-Fib for last two years,,,2,10/04/2019,,Y,,None
0838237,10/04/2019,PA,66.0,66,,M,,"The gentleman reported that his arm felt ""locked up"" the evening after receiving the shot for which he went to the doctor.",,,,,,,,,U,09/25/2019,09/25/2019,0,"Not reported, tried to call the patient to obtain more information as this was discovered while I was not at work but the patient did not answer.",PHM,,"oxycodone 15mg, cyclobenzaprine 10mg, trazodone 50mg, pantoprazole 40mg, bisoprolol-hctz 5-6.25mg,",none reported,none reported,,,2,10/04/2019,,Y,,no known allergies
0838238,10/04/2019,IL,56.0,56,,U,,"Arm soreness began immediately after injection.  Started chilling in middle of night.  By morning, still chilling, very weak and nauseous. Headache started very early morning and wouldn't go away, despite Tylenol  (8am), Ibuprofen (noon) or aspirin (3pm).  Temp in early morning was 100.   Chills lessened during day, but every time I tried to sit up, headache and nausea worsened.  Threw up fluids in early morning and at noon.  By 5pm, was able to get a little fluid and plain bread to stay down.  Headaches and fatigue on Sunday and , although lessened, that continues today (Monday).  For whatever it's worth, I reacted to first vaccine 3 months ago, with chills, aches and fatigue, but not all the rest.  Also, got bette",,,,,,,,,,09/20/2019,09/21/2019,1,,UNK,,none,,,,,2,09/23/2019,,,,"penicillin, sulfa"
0838239,10/04/2019,VA,3.0,3,,M,,pt experienced eye itching and swelling about 20min after vaccination and within an hour had hives to body - was taken to the ER and received steroids and Benadryl .,,,,,,,,,Y,09/28/2019,09/28/2019,0,Pt has had flu shots in the past but this was a new brand GSK- had Sanofi Pastuer in the past with no reaction,OTH,,,NONE,,,,2,10/04/2019,,,Y,NONE
0838240,10/04/2019,SD,69.0,69,,F,,"pt reports  ""vaccine reaction.""  Veteran received influenza vaccine in left deltoid in clinic on 10/2/19. States left arm is ""hard as a rock, swollen, itchy. Happened within 15 minutes of shot. Red 5"" from top to  bottom. Have chills & fever"" - received Shingrex vaccination same date, right deltoid. Reports ""about the size of an egg, firm,  doesn't itch""",,,,,,,,,U,10/02/2019,10/02/2019,0,n/a,PVT,,Apixaban; Carvedilol; Clonidine; Flecainide; HCTZ; Losartan; Paroxetine; Allopurinol; Hydralazine; Morphine Sulfate; Omeprazole; Oxycodone/APAP; Tizanidine,Gout,Fibromyalgia; Atrial Fibrillation,,,2,10/04/2019,,,,Penicillin; Sulfa; Codeine;; Indapamide; Lisinopril; Metoprolol; Pravastatin; Pregabalin; Fentanyl
0838241,10/04/2019,FL,77.0,77,,F,,"pt experienced bruising. She stated 2 days after the vaccine her arm starting getting red, swollen and itchy. pt states arm is warm to touch and has a red circle right below where vaccinations were administered. Pt was going to contact doctor immediatley after visiting the pharmacy .",,,,,,,,,N,09/25/2019,09/27/2019,2,,PHM,,"levothyroxine 50 mcg 1 tablet daily ranitidine 150 fish oil vitamin c 500 mg vitamin d 1000 biotin 10,000",had a cold 2 weeks before but was fine at time of vaccination,no,,,2,10/04/2019,,,,none
0838242,10/04/2019,NE,37.0,37,,F,,"Reddened, painful, itchy area at injection site the size of a hockey puck.",,,,,,,,,Y,10/02/2019,10/03/2019,1,,OTH,,,,,,,2,10/04/2019,,,,NONE
0838243,10/04/2019,MA,4.0,4,,F,,"9/24/19-redness, swelling and itching at site of flu vaccine 9/26/19-The size of the red skin has increased by 1.5 fingers approx. It?s bigger in the bottom part. The top it is still intact. Same place mark. Patient says it hurts and that it?s uncomfortable.  She is scratching/ touching it.  9/26/19-blotchy pink 3 inch irregular rash at site of immunization  deltoid region.  Slight  induration right at site of shot-rest is soft and there is no tenderness and moving arm freely.",,,,,,,,,U,09/23/2019,09/24/2019,1,None,PVT,,none,none noted,none,,,2,10/04/2019,,Y,,nkda
0838244,10/04/2019,LA,28.0,28,,F,,"On 10/01/2019 the evening of getting flu shot started having body aches by that night had a fever and chills along with body aches. Wednesday, October 2, 2019 symptoms got worse, Thursday, October 3, 2019 developed a rash all over my body, the rash is very itchy",,,,,,,,,N,10/01/2019,10/01/2019,0,None,PVT,,None,None,None,,,2,10/04/2019,,Y,,Morphine
0838245,10/04/2019,,50.0,50,,F,,"Fever of 100 degrees, aches, soreness at injection site",,,,,,,,,N,10/03/2019,10/03/2019,0,,PVT,,"L glutamine, probiotics, zinc",,Autoimmune food intolerances,,,2,10/04/2019,,,,
0838252,10/04/2019,AR,,,,M,,"redness and swelling at the injection site; redness and swelling at the injection site; This spontaneous report as received from a physician via a company representative refers to a 72-year-old male patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 11-SEP-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), one dose subcutaneously for prophylaxis (frequency, lot # and expiration date were not provided). On 12-SEP-2019 (reported as within 24 hours after injection), the patient developed redness and swelling at the injection site. The patient sought medical attention, however there was no treatment given for the events. The outcome of the events was reported as recovered on the same date.  The causality assessment between the events and the suspect vaccine was not reported.",,,,,,,,,Y,09/11/2019,09/12/2019,1,,UNK,,,,,,US0095075131909USA005394,2,10/04/2019,,Y,,
0838253,10/04/2019,KY,,,,U,,"No adverse event; expired dose of M-M-R II was administered; This spontaneous report as received from a Nurse refers to a patient of unknown age and gender.  No information was provided regarding the patient's medical history, concurrent conditions and previous drug reactions. Concomitant therapies included sterile diluent.  On 23-SEP-2019, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (strength, dosage information, route of administration and anatomical locations were unknown) (lot # N025895, Expiry date: 19-SEP-2019) for prophylaxis.     The diluent that was used to reconstitute the vaccine had not expired. No adverse event. No additional information.",,,,,,,,,U,09/23/2019,09/23/2019,0,,UNK,,sterile diluent,,,,US0095075131910USA002739,2,10/04/2019,,,,
0838254,10/04/2019,,56.0,,,M,,"Body aches; Significant Malaise; Stay in bed for 48 hours; This case was reported by a physician via sales rep and described the occurrence of general body pain in a 56-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2018, the patient received the 1st dose of Shingrix. In November 2018, immediately after receiving Shingrix, the patient experienced general body pain, malaise and bedridden. On an unknown date, the outcome of the general body pain, malaise and bedridden were recovered/resolved.   It was unknown if the reporter considered the general body pain, malaise and bedridden to be related to Shingrix.  Additional details were provided as follows: The patient was the reporter's husband. Soon after receiving dose of Shingrix, the patient experienced significant malaise and body aches causing him to have to stay in bed for 48 hours. The reporter stated that, all symptoms were resolved after 48 hours. The sales representative indicated that, the reporter provided this information to her during a Congress she was attending and was unable to provide any additional details. For tolerance to the 2nd dose of Shingrix, refer case US2019AMR175952. This was 1 of the 4 cases, reported by the same reporter.",,,,,,,,,Y,11/01/2018,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838255,10/04/2019,,63.0,,,M,,"Malaise; Body aches; Fever of 101 degrees; This case was reported by a physician via sales rep and described the occurrence of malaise in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a month after receiving Shingrix, the patient experienced malaise, general body pain and fever. On an unknown date, the outcome of the malaise, general body pain and fever were recovered/resolved.   It was unknown if the reporter considered the malaise, general body pain and fever to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and experienced malaise, body aches, and a fever of 101 degrees.  All symptoms resolved within two days. The field representative indicated that the reporter provided this information to her during a Congress she was attending.  The field representative was unable to provide any additional details.  This was report 1 of 4 cases, reported by same reporter.",,,,,,,,,Y,09/01/2019,,,"Test Date: 201909; Test Name: Body temperature; Result Unstructured Data: Test Result: 101, Test Result Unit: degree F",UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838256,10/04/2019,AZ,,,,M,,"Bullous Pemphigoid generalized all over the body; This case was reported by a physician via sales rep and described the occurrence of bullous pemphigoid in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced bullous pemphigoid (serious criteria GSK medically significant). The patient was treated with steroids nos (Steroids). On an unknown date, the outcome of the bullous pemphigoid was recovered/resolved.   It was unknown if the reporter considered the bullous pemphigoid to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The condition was generalized all over the body and eventually resolved. The patient was treated with high doses of steroids. Emergency visit was required. The reporter consented to follow up and provided address for further contact. The reporter did not provide any additional information. For tolerance of 2nd dose of Shingrix, refer case US2019176207.",,,,,,,,,Y,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,Y,
0838257,10/04/2019,FL,,,,F,,"Low titers; This case was reported by a pharmacist via call center representative and described the occurrence of therapeutic response decreased in a 19-year-old female patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis and HBV (Engerix B) for prophylaxis.   On an unknown date, the patient received Engerix B at an unknown dose, the 2nd dose of Engerix B and the 3rd dose of Engerix B. On an unknown date, unknown after receiving Engerix B, Engerix B and Engerix B, the patient experienced therapeutic response decreased. On an unknown date, the outcome of the therapeutic response decreased was unknown.   It was unknown if the reporter considered the therapeutic response decreased to be related to Engerix B, Engerix B and Engerix B.  Additional details were provided as follows: The age at vaccination was not reported, however the patient was infant at the time of vaccination series. The pharmacist reported, initial series of Engerix B was administered to the patient at an unknown location in 2000. At the age of 19, the patient was tested and was told that the titers were too low, which led to therapeutic response decreased. The vaccine lot number was not available since the series had not been restarted. The reporter did not consent to follow up.      Lab Comments: Lab test performed on unknown date",,,,,,,,,U,,,,"Test Name: Hepatitis B antibody; Result Unstructured Data: Test Result: low titers, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838258,10/04/2019,NY,,,,F,,"Rash on buttocks / Rash as tingling and pnching feeling; Tingling feeling; Pinching feeling; This case was reported by a physician via call center representative and described the occurrence of rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th September 2019, the patient received the 2nd dose of Shingrix. On 15th September 2019, 3 days after receiving Shingrix, the patient experienced rash, tingling sensation and pain. On an unknown date, the outcome of the rash, tingling sensation and pain were unknown.   It was unknown if the reporter considered the rash, tingling sensation and pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The physician reported that the patient received second Shingrix vaccine and three days later, developed a rash on buttocks.  The patient describes the rash as tingling and pinching feeling.  The physician had not made a formal diagnosis of patient's event. The physician had no details regarding product or event at time of reporting. The reporter consented to follow up.",,,,,,,,,U,09/12/2019,09/15/2019,3,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838259,10/04/2019,FL,,,,M,,"Hives; This case was reported by a consumer via call center representative and described the occurrence of hives in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th June 2019, the patient received the 1st dose of Shingrix. On 13th June 2019, 1 days after receiving Shingrix, the patient experienced hives. On an unknown date, the outcome of the hives was not recovered/not resolved.   It was unknown if the reporter considered the hives to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After vaccination with dose of Shingrix, experienced hives that still had not clear up. The patient wanted to know how many people have called in to report side effects. The patient stated that, did not want clinical trial information from the PI. No addiational information was provided concerning this event. This case has been linked with case US2019AMR175765, reported by same reporter. The patient did not consent to follow up. The event outcome was reported as recovering which is discrepant so considered as not recovered as per narrative.",,,,,,,,,N,06/12/2019,06/13/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838260,10/04/2019,NY,,,,F,,"Fever; This case was reported by a physician via sales rep and described the occurrence of fever in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. The patient received Shingrix vaccine and experienced fever. The field representative indicated that she was at a conference and was provided information from two separate contacts for three adverse events reports. The reporter unable to obtain additional details. This was 1 of 3 cases reported by same reporter.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838261,10/04/2019,AZ,74.0,74,,M,,"Herpes Zoster Ophthalmicus; mild vesicular cutaneous eruption along the skin of the eye lids; This case was reported by a physician via call center representative and described the occurrence of ophthalmic herpes zoster in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In April 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant) and vesicular eruption. On an unknown date, the outcome of the ophthalmic herpes zoster and vesicular eruption were recovered/resolved.   It was unknown if the reporter considered the ophthalmic herpes zoster and vesicular eruption to be related to Shingrix.  Additional details were provided as follows: The patient reported for himself. The patient received 1st dose of Shingrix on 25th or 26th April 2019.   The patient had a mild vesicular cutaneous eruption along the skin of the eyelids and mild form of HZ (herpes zoster) ophthalmicus, after receiving the first dose of Shingrix. The events lasted for about 2 to 3 weeks.   The patient was not sure if he would receive the 2nd dose of Shingrix. The patient did not know the address of facility where the vaccine was administered and no vaccine specifics were available. The patient did not consent to follow up.",,,,,,,,,Y,04/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838262,10/04/2019,MI,55.0,,,M,,"Received vaccine exposed to temperature excursion; Received vaccine exposed to temperature excursion; Difficulty lifting arm; May have been a patient who received the vaccine beyond the end of the workday; This is a spontaneous report from a Pfizer-sponsored program, IBCC (Inbound Call Center for HCPs), received from a contactable nurse. A 55-year-old male patient received pneumococcal 13- valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), intramuscular in the left deltoid on 16Jul2019 08:30 at 0.5 ml, single for immunization. Medical history included ongoing hypertension, substance abuse, arthralgia, hyperlipidemia and tobacco use. Concomitant medication included atorvastatin calcium (LIPITOR) for hyperlipidaemia, losartan potassium (COZAAR) for hypertension and ranitidine hydrochloride (ZANTAC); all ongoing. Concomitant vaccines includes hepatitis a vaccine (HEPATITIS A; lot number: N39BM, expiry date: 31Jan2022) intramuscular in the right deltoid, diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP; lot number: X5R7Y, expiry date: 14Nov2020) intramuscular in the left deltoid and hepatitis b vaccine (lot number: L9539, expiry date: 07Dec2021) intramuscular in the right deltoid; all administered on 16Jul2019 for immunization. On 16Jul2019, the patient received the vaccine exposed to temperature excursion on unspecified date. The vaccine was labeled with 'do not use' however was still given to the patient. Information on the batch number has been requested.  Follow-up (23Aug2019): This follow-up is being submitted to notify that the batch number is not available despite the followup attempts made. Follow-up attempts have been completed and no further information is expected.  Follow-up (05Sep2019): This is a follow-up report combining information from duplicate reports 2019306934 and 2019310592. The current and all subsequent information will be reported under manufacturer report number 2019310592. This is a spontaneous report from a contactable other health professional. A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. The caller reported that once the sterile seal had been broken, the vaccine should be used or discarded at the end of the workday. Caller stated there might have been a patient who received the vaccine beyond the end of the workday.  Follow-up (23Aug2019): This follow-up is being submitted to notify that the batch number is not available despite the followup attempts made. Follow-up attempts have been completed and no further information is expected.  Follow-up (05Sep2019): New information reported from a contactable Nurse included: Incorrect info given to reporter. There was not a temp excursionit was given the day after it was 'drawn up'. (as reported). Suspect pneumococcal 13- valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13) Batch/Lot # X62324 was administered by a Physician. Concomitant vaccines: 1st dose of hepatitis a vaccine (HAVRIX Hep A, Glaxo Smith Kline), diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (BOOSTRIX Tdap, Glaxo Smith Kline, Lot # 2Y74B, Expiry Date 11Oct2020) IM at left deltoid, 1st dose of hepatitis b vaccine (ENERGIX Hep B, Glaxo Smith Kline). Vaccine single dose syringe has needle applied to syringe during clinic the day i.e. 15Jul2019 before and should have been wasted, however a staff member used it anyway on 16Jul2019. The patient experienced difficulty lifting arm on 16Jul2019 3:00pm, not requiring hospital admission.",,,,,,,,,U,07/16/2019,07/16/2017,,,PVT,,LIPITOR; COZAAR; ZANTAC; ZANTAC; ZANTAC; HAVRIX; BOOSTRIX; ENGERIX B,Arthralgia; Hyperlipemia; Hypertension; Substance abuse; Tobacco user,Comments: None,,USPFIZER INC2019310592,2,10/03/2019,,,,
0838263,10/04/2019,,,,,F,,"Uterine dehiscence; Premature delivery; Hypertension; Trichomonas; Bacterial vaginosis; Nausea; Vomiting; Elevated AFP; Vaccine exposure during pregnancy; This is an observational study case, initially received from other health professional on 27-Sep-2019, concerning a 25-year-old, female pregnant subject of body weight: 193 lbs, height: 66 inches and body mass index (BMI): 31.1 (Ethnicity: not reported) enrolled in, a prospective observational safety study.  The subject's past medical history included bacterial vaginosis and the subject's historical drug included Metrogel (metronidazole) for bacterial vaginosis. The subject's current condition included Herpes simplex virus II and anemia. The subject's concomitant medications included: Prenatal vitamins (mineral nos, vitamins nos) for pregnancy and Venofer (saccharated iron oxide) for anemia.  The subject's obstetrical history included six previous pregnancies with five full-term live births and one preterm live births. The subject had no history of offspring with major congenital malformation (MCM) and no relevant maternal and paternal medical history. The subject did not use tobacco, alcohol or illicit drugs during pregnancy.  The subject's last menstrual period (LMP) date was 29-Jun-2018. The subject's estimated delivery date (EDD) and corrected estimated date of delivery (CEDD) were 05-Apr-2019. The type of pregnancy was singleton.  On 22-Aug-2018, the subject underwent cystic fibrosis mutation analysis and spinal muscular atrophy test and no MCMs were noted.  On 05-Sep-2018 and 20-Sep-2018, the subject underwent ultrasound and no MCMs were noted.  On 03-Oct-2018, at gestational age at 13 weeks, the subject was administered Flucelvax QIVc [influenza vaccine, subunit influenza virus vaccine polyvalent, batch number: 252664, dose: 0,5 ml, anatomical location, route of administration and expiration date: not reported] (explicitly coded as Vaccine exposure during pregnancy') for influenza immunisation. On the same day, the subject underwent ultrasound and no MCM was noted.  On 22-Oct-2018, 19 days after vaccination, the subject underwent maternal serum alpha fetoprotein (MSAFP)/Serum markers test and the result was 3.33 (no units were provided) and it was reported as elevated alpha 1 foetoprotein (AFP). On the same date, the subject underwent ultrasound and Qnatal test and no MCM was noted.  On 15-Nov-2018, 1 month and 12 days after vaccination, the subject experienced nausea and vomiting.   On 18-Dec-2018, 2 months and 15 days after vaccination, the subject developed bacterial vaginosis.  From 18-Dec-2018 to 28-Dec-2018, the subject was treated with Metrogel gel for bacterial vaginosis, dose reported as 0.75 %, two times a daily (BID), vaginally.   On 28-Dec-2018, the subject recovered from the event of bacterial vaginosis.  On 15-Jan-2019, the subject underwent Non-stress test and no MCM was noted.  On 28-Jan-2019, 3 months and 25 days after vaccination, the subject developed hypertension and trichomonas.  From 28-Jan-2019 to 08-Feb-2019, the subject was treated with Procardia capsule (prasugrel hydrochloride) for hypertension, at one dose, every six hours (Q6h), orally and with Flagyl (metronidazole) for trichomonas, at dose of 375 mg, BID, orally.  On 05-Feb-2019, the subject underwent ultrasound and no MCM was noted.  On 07-Feb-2019, the subject underwent Non-stress test and no MCM was noted.  On 08-Feb-2019, the subject underwent ultrasound and Non-stress test and no MCMs were noted. On the same date, the subject recovered from the event of trichomonas.  On 11-Feb-2019, the subject underwent Non-stress test and no MCM was noted.  On 14-Feb-2019, at gestational age of 32.9 weeks, the mother delivered live birth, male neonate by caesarean method of delivery. The neonate's birth weight was 2140 g, his head circumference and length: were not reported. The appearance, pulse, grimace, activity, and respiration (APGAR) scores were 8 (one minute) and 9 (five minutes). At the time of delivery, pregnancy complication uterine dehiscence was noted, but details were not specified. There was no MCMs identified at birth. On the same date, the subject recovered from the event nausea and vomiting.  At the time of initial reporting, the outcome of the events uterine dehiscence, premature delivery and alpha 1 fetoprotein increased was not reported, while the event of hypertension was not resolved.  This case is linked to 201904856, the corresponding child case.  Company Comment: The subject experienced uterine dehiscence, premature delivery, alpha 1 fetoprotein increased, hypertension, trichomoniasis, bacterial vaginosis, nausea and vomiting after vaccination with the suspect product Flucelvax QIVc. Reportedly, vaccination occurred during pregnancy.   Chronology is plausible. Medical history of bacterial vaginosis, Herpes simplex virus II, anaemia and pregnant state may have contributed to development of the events. Considering all the above mentioned, causal relationship between the suspect product and exposure during pregnancy is assessed as not related per company conventions. For all other events, causal role of the suspect product cannot be totally excluded and is assessed as related.; Reporter's Comments: The subject experienced uterine dehiscence, premature delivery, alpha 1 fetoprotein increased, hypertension, trichomoniasis, bacterial vaginosis, nausea and vomiting after vaccination with the suspect product Flucelvax QIVc. Reportedly, vaccination occurred during pregnancy.   Chronology is plausible. Medical history of bacterial vaginosis, Herpes simplex virus II, anaemia and pregnant state may have contributed to development of the events. Considering all the above mentioned, causal relationship between the suspect product and exposure during pregnancy is assessed as not related per company conventions. For all other events, causal role of the suspect product cannot be totally excluded and is assessed as related.",,,,,,,,,N,10/03/2018,10/03/2018,0,Test Date: 20190115; Test Name: Non-Stress test; Result Unstructured Data: No major congenital malformation.; Test Date: 20190207; Test Name: Non-Stress test; Result Unstructured Data: No major congenital malformation.; Test Date: 20190208; Test Name: Non-Stress test; Result Unstructured Data: No major congenital malformation.; Test Date: 20190211; Test Name: Non-Stress test; Result Unstructured Data: No major congenital malformation.; Test Date: 20180822; Test Name: Cystic Fibrosis Mutation Analysis; Result Unstructured Data: No major congenital malformation.; Test Date: 20181022; Test Name: Qnatal; Result Unstructured Data: No major congenital malformation.; Test Date: 20180822; Test Name: Spinal Muscular Atrophy; Result Unstructured Data: No major congenital malformation.; Test Date: 20180905; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.; Test Date: 20180920; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.; Test Date: 20181003; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.; Test Date: 20181022; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.; Test Date: 20190205; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.; Test Date: 20190208; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformation.,UNK,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; VENOFER,Anemia; Herpes simplex,Medical History/Concurrent Conditions: Bacterial vaginosis; Live birth; Multigravida; Premature delivery,,USSEQIRUS201904853,2,10/03/2019,,,,
0838264,10/04/2019,,24.0,,,F,,"Eclampsia at 34 weeks; Vaccine exposure during pregnancy; This is an observational study case, initially received on 27-Sep-2019, concerning a 24-year-old, pregnant, female subject [Ethnicity: Not reported] of body weight 158 lbs, height 64 inches and body mass index (BMI) 27.1, enrolled, a prospective observational safety study.  The subject's obstetrical history noted that the subject had two previous pregnancies including one previous full-term live birth and one preterm live birth pregnancy. The subject had no history of offspring with major congenital malformation (MCM). Also, the subject had no maternal or paternal history with MCM. The subject did not use tobacco, alcohol or illicit drugs during pregnancy. The subject's current conditions included anxiety, depression and hypertension. Concomitant medications included prenatal vitamins (minerals NOS, vitamins NOS) for pregnancy and Zoloft (sertraline hydrochloride) for anxiety.  The subject's last menstrual period (LMP) date was 10-Nov-2018, the estimated date of delivery (EDD) and corrected estimated date of delivery was 17-Aug-2019. The type of pregnancy was singleton.   On 12-Mar-2019, the subject underwent spinal muscular atrophy, cystic fibrosis mutation analysis and hemoglobin electrophoresis and no MCM was noted.  On 19-Mar-2019, the subject underwent ultrasound and quad screen, and no MCM was noted.  On 15-May-2019, at approximately 26 weeks of gestation, the subject was administered Flu Vaccine Cell Subunit QIV NVD [influenza vaccine, subunit influenza virus vaccine polyvalent, batch number: 252664, dose: 0.5 mL, route of administration, anatomical location and expiration date: not reported] (explicitly coded as 'Vaccine exposure during pregnancy') for influenza immunisation.   On an unreported date, at 34 weeks of gestation, the subject experienced eclampsia, reported as pregnancy complication.  On 13-Aug-2019, at gestational age of 39.4 weeks, the subject delivered a live birth, male neonate via caesarean section. The neonate's birth weight was 3250 grams, head circumference was 35.6 cm and length was 50.8 cm. The appearance, pulse, grimace, activity, and respiration (APGAR) scores were 8 (one minute) and 9 (five minutes). There was no APGAR score data for 10 minutes reported. No MCM was identified at birth.   At the time of initial reporting, the outcome for the event of 'eclampsia' was not reported.  Company Comment: The subject experienced eclampsia after vaccination with the suspect product Flu Vaccine Cell Subunit QIV NVD. Chronology is plausible. Reportedly, vaccination occurred during pregnancy. Chronology is plausible. Medical history of hypertension and pregnant state may have contributed to development of the event. Causality was confounded by use of concomitant medication, Zoloft (sertraline hydrochloride). Causal relationship between the suspect product and exposure during pregnancy is assessed as not related. For the event eclampsia, causal role of the suspect product cannot be totally excluded and is assessed as related.; Reporter's Comments: The subject experienced eclampsia after vaccination with the suspect product Flu Vaccine Cell Subunit QIV NVD. Chronology is plausible. Reportedly, vaccination occurred during pregnancy. Chronology is plausible. Medical history of hypertension and pregnant state may have contributed to development of the event. Causality was confounded by use of concomitant medication, Zoloft (sertraline hydrochloride). Causal relationship between the suspect product and exposure during pregnancy is assessed as not related. For the event eclampsia, causal role of the suspect product cannot be totally excluded and is assessed as related.",,,,,,,,,U,05/15/2019,05/15/2019,0,Test Date: 20190312; Test Name: Cystic Fibrosis Mutation Analysis; Result Unstructured Data: No major congenital malformations noted.; Test Date: 20190312; Test Name: Hemoglobin electrophoresis; Result Unstructured Data: No major congenital malformations noted.; Test Date: 20190319; Test Name: Quad Screen; Result Unstructured Data: No major congenital malformations noted.; Test Date: 20190312; Test Name: Spinal Muscular Atrophy; Result Unstructured Data: No major congenital malformations noted.; Test Date: 20190319; Test Name: Ultrasound; Result Unstructured Data: No major congenital malformations noted.,PVT,,PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; ZOLOFT,Anxiety (Start date: prior to conception); Depression (Start date: prior to conception); Hypertension (Start date: prior to conception),Medical History/Concurrent Conditions: Live birth; Multigravida; Preterm labour,,USSEQIRUS201904862,2,10/04/2019,,,,
0838270,10/04/2019,FL,65.0,65,,F,,"Pain in right arm and shoulder with an hour of injection, worsened to where I couldn't raise my arm without much difficulty. Took Ibuprophen and it helped for a few hours. Got somewhat better overtime, thought I was going to recover in time. Still have pain at this time....though not nearly as bad as it was. Was hoping it would be resolve itself over time.",,,,,,,,Y,N,08/29/2019,08/29/2019,0,"None so far, was hoping it would resolve itself over time.",PHM,,"Losartan, Unithroid, Atorvastatin, Fish oil, Vitamin B-12, calcium. magnesium, vitamin D, melatonin",none,"Hypothyroidism, high cholesterol, high blood pressure (all under-control)",,,2,10/04/2019,,,,Codeine
0838271,10/04/2019,NY,79.0,79,,F,,"Rash all over upper-left arm. In subsequent days, customer reports pain in left hand. Recommended customer go to MD office to have arm and hand evaluated.",,,,,,,,,N,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/04/2019,,Y,,
0838272,10/04/2019,MI,62.0,62,,M,,"Very soon after the RZV shot, started to feel shoulder stiffness, rapid heart beat, feeling hot in my face.  As the day continued, started to feel a little dizzy and tired.  By evening I was not well at all.  Fever hot, feeling nausea, bad headache, Insomnia, some shivering.  Could not fall asleep.  Very weak when try to get up.  Unable to go to work this work.  No energy.  No strength.  Still feel some headache.  My ears are ringing.  Pulse is still a little fast.  Cannot sleep.",,,,,,,,,,10/03/2019,10/03/2019,0,,PUB,,none,none,none,"When I had the first RZV vaccination a couple of months ago, I had a mild reaction.  Nothing to complain about.   Did not disrup",,2,10/04/2019,,,,none
0838273,10/04/2019,CA,34.0,34,,M,,"States that on Monday, he had his 2019-2020 Influenza Vaccine (flu shot) from Employee Health. States that on Thursday, he started to feel itchiness at his arms and noted to have welchesThen on Friday, the welshes and itchiness scattered to the neck and torso. On Saturday around 0100 early dawn, he woke up with welches and itchiness at his arms, neck, abdomen, underarms and legs. States that he went to the Emergency Room because he thought he has scabies. He was treated for urticarial with Solumedrol. States that he is on his last pill. States that the moment he started the steroids, most of the welches and itchiness disappeared. States that the only bad experience he had with the steroids is that he does not like the weird feeling he has when he takes the medication. States he will finish the medication as prescribed",,,,,,,,,Y,09/16/2019,09/19/2019,3,none,WRK,,none,none,"PMH: palpitations, fatty liver, hyperlipidemia","02/26/2016: MMR II [Lot # L033589] (Merck & Co, Inc.) & Varivax [Lot #L037560] (Merck & Co, Inc.). 30-year-old male Operating Ro",,2,10/04/2019,,,Y,Verapamil
0838274,10/04/2019,CO,16.0,16,,F,,"Right arm injection sites became red, hot and swollen and entire arm swelled",,,,,,,,,Y,07/25/2019,07/26/2019,1,None.  Reaction was not reported to us until 9/27/19 when patient returned for more immunizations,PVT,,"Albuterol, Flonase, Singulair.  Zatador was ordered on the date of immunizations in question","chiropractor care for back and neck pain from cheerleading, allergic rhinitis",allergic rhinitis,,,2,10/04/2019,,,,"PCN, Vancomycin"
0838275,10/04/2019,FL,52.0,52,,F,,arm is still in pain,,,,,,,,Y,N,09/17/2019,09/24/2019,7,,PHM,,,,,,,2,10/04/2019,,,,
0838277,10/04/2019,NY,4.0,4,,U,,"No adverse effects; a patient was administered improperly stored PROQUAD; This spontaneous report was received from a medical assistant and refers to a 4-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 04-SEP-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S009759 has been verified to be a valid lot number, expiration date 27-SEP-2020, recombinant Human albumin (exact dose, dose number, route and site of administration were not reported) for prophylaxis. The sterile diluent that was used to reconstitute the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) vaccine was properly stored. No adverse effect was reported.  Administered dose of vaccine were exposed to the temperature excursion of 15 degrees Fahrenheit to 46 degrees Fahrenheit (17.6 degrees Fahrenheit) for 56 hours and 40 minutes. Data logger was not involved. There was previous temperature excursions of 6 degrees Fahrenheit to 14 degrees Fahrenheit (6.2 degrees Fahrenheit) for 10 minutes. There was no adverse effects reported.",,,,,,,,,U,09/04/2019,09/04/2019,0,,UNK,,sterile diluent,Prophylaxis,,,US0095075131910USA001991,2,10/04/2019,,,,
0838278,10/04/2019,IL,,,,F,,"joint pain; muscle pain; headache severe; This case was reported by a nurse via sales rep and described the occurrence of joint pain in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced joint pain, muscle pain and headache. On an unknown date, the outcome of the joint pain, muscle pain and headache were unknown.   It was unknown if the reporter considered the joint pain, muscle pain and headache to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient experienced joint and muscle pain that felt like there was a golf ball in her arm. The patient also experienced severe headache.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838279,10/04/2019,WA,82.0,82,,M,,"Cold sore; Didn't feel normal; Felt achy; Felt flu like symptoms; Was tired; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 82-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th July 2019, the patient received the 1st dose of Shingrix (intramuscular). On 16th July 2019, the dose was an unknown dose. On 17th July 2019, 1 days after receiving Shingrix, the patient experienced influenza-like symptoms and tiredness. On 18th July 2019, the patient experienced pain. On 19th July 2019, the patient experienced feeling abnormal. On an unknown date, the patient experienced cold sores. On an unknown date, the outcome of the influenza-like symptoms, pain, feeling abnormal and cold sores were recovered/resolved and the outcome of the tiredness was unknown.   It was unknown if the reporter considered the influenza-like symptoms, tiredness, pain, feeling abnormal and cold sores to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and felt flu like symptoms and was tired. He rested the whole day. The second day he stayed in bed and felt achy and then the following day, he didn't feel normal and didn't do a lot. He also reported a cold sore several days after receiving the first shot of Shingrix.  All his symptoms were resolved. For tolerances of 2nd dose, refer case US2019AMR174145, reported by same reporter.",,,,,,,,,Y,07/16/2019,07/17/2019,1,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838280,10/04/2019,NC,,,,M,,"weakness; Loss of appetite; Thought ""was going to die""; Laid in bed and couldn't get out of bed; Flu reaction; This case was reported by a other health professional via call center representative and described the occurrence of weakness in a male patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, unknown after receiving Flu vaccine, the patient experienced weakness, appetite lost, impending doom, bedridden and flu like symptoms. On an unknown date, the outcome of the weakness, appetite lost, impending doom, bedridden and flu like symptoms were unknown.   It was unknown if the reporter considered the weakness, appetite lost, impending doom, bedridden and flu like symptoms to be related to Flu vaccine.  Additional details were provided as follows: The age at vaccination was not provided. The health care professional stated that, unsure what Flu vaccine received last year. The patient received dose of Flu vaccine last year and experienced flu reaction of weakness, loss of appetite and thought was going to die and laid in bed and not getting out of bed. The reported asked, for any information or recommendation on getting flu vaccine. The reporter consented to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838281,10/04/2019,TX,,,,M,,"brain fog; dizziness/light headed; bad flu like feelings; weakness; This case was reported by a consumer via call center representative and described the occurrence of influenza like illness in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 23rd September 2019, 1 days after receiving Shingrix, the patient experienced influenza like illness and weakness. On 24th September 2019, the patient experienced foggy feeling in head and dizziness. On an unknown date, the outcome of the influenza like illness, weakness and dizziness were resolved with sequelae and the outcome of the foggy feeling in head was recovering/resolving.   It was unknown if the reporter considered the influenza like illness, weakness, foggy feeling in head and dizziness to be related to Shingrix.  Additional details were received as follows: The age vaccination was not reported but could be between 58 or 59 years. The patient had bad flu symptoms, weakness, brain fog, dizziness and light headed. The patient stated that all events resolved except the brain fog. The patient did not consent to follow up.",,,,,,,,,N,09/22/2019,09/23/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838282,10/04/2019,,,,,U,,"There is redness and it's still warm to the touch; There is redness and it's still warm to the touch; Swelling; This is a spontaneous report from a non-contactable consumer. A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date (reported as this past Monday) at a single dose for immunization. The patient's medical history and concomitant medications were not reported. It was reported that there was redness and it's still warm to the touch; and a little swelling on an unspecified date. The patients stated that he/she gets allergy shots so this was not unusual for him/her and getting little reactions like that. The patient was not concerned because there weren't any other side effects to speak of and was wondering how long he/she should watch it like that. The patient clarified that it was red but not like 'in slender' (not clarified). According to the patient, he/she had redness before with injections so just wondered what would be the normal course of time. Outcome of the events was unknown.  No follow-up attempts are possible. Information regarding the batch number cannot be obtained.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2019429438,2,10/04/2019,,,,
0838283,10/04/2019,TN,15.0,15,,F,,"Mom called stated pt complained of spine pain, headache, nausea, & trouble walking. Mom took child to ER on 10/2/19. Called mom this morning stated the ER informed them pt was having muscle pain due to flu vaccine.",,,,,,,,,U,09/30/2019,10/02/2019,2,10/2/19 Hospital,OTH,,None,unknown-mom states no,unknown-mom states no,,,2,10/05/2019,,,Y,PCN & sulfa
0838284,10/04/2019,MI,42.0,42,,F,,"2 inch area of erythema, warmth, itchiness to area around injection site of the flu vaccine.",,,,,,,,,Y,09/27/2019,09/28/2019,1,none,WRK,,"levothyroxine, zyrtec, nasacort nasal spray",none,hypothyroid,,,2,10/04/2019,,,,none
0838285,10/04/2019,OH,72.0,72,,F,,SWALLOWING INJECTION SITE   area spredding down arm  tissue became very hot    fluid  in the upper arm    had much pain when moving arm  took two tylenol  went to bed.    in the morning area of soreness much lower  almost to the elbow.  heat tenderness and redness on upper arm.   pain not as sever      during the day i was able to move shoulder and arm more   next mornimg now friday pain and swelling had gone to mid forearm arm was still very hot  to the touch     returned to the pharmacy and showed arm to the pharmacist she told me to continue with the tylenol and call my primary care doctor,,,,,,,,,N,10/02/2019,10/02/2019,0,non at this time,PHM,,omeprazole  ursodiol atorvastatin  furosemide carvedilol oxybutynin levothyroxine biotin  B12,aniama,PBC    shortness of breath     Aortic valve stenosis,,,2,10/04/2019,,,,no
0838286,10/04/2019,CA,58.0,58,,F,,"Several hours after the injection, I experienced fatigue.  Within a short time after that, I had a fever, chills, and moderate nausea (to the point of not being able to eat).  During the night, I got a bad headache.  The fever, chills, and fatigue continued throughout the night as well and prevented a good night?s sleep.",,,,,,,,,N,10/03/2019,10/03/2019,0,None.,PVT,,Calcium (daily); Zofran (as needed).,None.,Digestive disorder (gastroparesis).,"I received the first Shingrix vaccine on 07/23/2019 and experienced similar side effects (headache, fever, chills, fatigue).  I ",,2,10/04/2019,,,,None.
0838287,10/04/2019,MA,33.0,33,,F,,Patient started experiencing palpitations and dizziness 2 minutes after receiving flu vaccine.,,,,,,,,,Y,10/02/2019,10/02/2019,0,none,PVT,,unknown,unknown,unknown,,,2,10/04/2019,,Y,,"Past reactions to flu vaccine including dizziness, swelling, and palpittaions"
0838288,10/04/2019,WY,5.0,5,,M,,Unknown vaccine information. The patient was vaccinated through a local vaccination clinic - 10/3/2019. He came into the walk-in clinic today 10/4/2019 with a large localized reaction. Erythema with slight edema to the upper left arm 12cm x 10cm. No systemic symptoms.,,,,,,,,,N,10/03/2019,10/04/2019,1,N/A,PVT,,none,none,none,,,2,10/04/2019,,,,none
0838289,10/04/2019,AR,70.0,70,,F,,"After initial shot healed patient is left with a tiny bump on the skin of her arm in that spot. It looks like it wants to scab over, but it will not scab and remains a little bump at that injection site a year later.",,,,,,,,,,08/03/2018,09/17/2018,45,,UNK,,,,,,,2,10/04/2019,,,,
0838290,10/04/2019,,35.0,35,,F,,got shot at noon. by 10pm right eye was swollen itchy and foggy. had a severe headache and congestion,,,,,,,,,,10/03/2019,10/03/2019,0,,PHM,,,,,,,2,10/04/2019,,Y,,
0838291,10/04/2019,MA,64.0,64,,F,,"I just wanted to report my reaction to the shingles vaccine, which was stronger than I had thought possible from the nurse's advice at the time. In fact I had much greater side effects than I've ever had to a shot, with acute symptoms over five days and milder symptoms persisting today, eight days later. The list: significant swelling (swollen bright-red area radiating 2+ inches from injection site) and pain in the injected arm first three days, sleeplessness and malaise over five days with mild headache on fifth day, gradually reduced swelling and return of sleep on days 5-8. Now the area is gradually less red but still tender and itchy.",,,,,,,,,N,09/26/2019,09/26/2019,0,,PVT,,,,,,,2,10/04/2019,,Y,,
0838292,10/04/2019,MA,62.0,62,,M,,"Patient received pneumonia vaccine on 9/30/19 at 18:53 in left deltoid.  On 10/1/19 at 15:30 pt complained of swelling, tenderness, warmth and pain in the left arm which he stated the previous night. Ice applied. MD notified. Keflex 500mg po QID started. Vitals signs 99.4-72-18 129/74.  Swelling, redness, and pain increased that evening  and due to his hx of DVT was sent to the local hospital ED for evaluation at 21:00.  Pt later returned with no new orders. Continued on Keflex.  Seen by MD in rounds 10/02/19 at about 9:00-10:00.  Afebrile. Tenderness, erythema and warmth noted. Area about 10cm in diameter.  Elevate arm and continue with ice packs and Keflex.  On 10/03/19 pt was seen by the nurse practitioner in rounds. Vital signs stable. Afebrile. Erythema and edema improving.  Pt routinely discharged.",,,,,,,,,U,09/30/2019,10/01/2019,1,,OTH,,"Nicotine patch, multi vit, Xarelto, Trazodone, Flomax, Buspar, Mag Oxide, Tolnaftate, Zoloft, Tigan, Benedryl, Clonidine, Librium,  Thiamine, Albuterol neb Tx, Ativan, Zoloft","COPD, Substance abuse, Hepatitis C, BPH, Arthritis, Hx, DVT, anxiety, depression",See above,,,2,10/04/2019,,,Y,NKA
0838293,10/04/2019,CA,17.0,17,,M,,"Patient developed ""a not feeling well"", followed by nausea, 102 fever, and vomiting. Still present at the time of writing this, 2 1/2 days later.",,,,,,,,,N,09/30/2019,10/02/2019,2,,PVT,,n/a,n/a,Sleep trouble. Low iron.,,,2,10/04/2019,,,,n/a
0838294,10/04/2019,TX,70.0,70,,F,,"Patient called 2 days after receiving vaccine on 10/2/19 stating area has become red and is growing larger - referred patient to seek medical attention, patient will see NP at dr's office today at 12pm",,,,,,,,,U,10/02/2019,10/03/2019,1,unknown at this time,PHM,,"diltiazem, premarin, atorvastatin",none,"Hypertension, cholesterol",,,2,10/04/2019,,Y,,"Losartan, Ceftin"
0838295,10/04/2019,PA,78.0,78,,F,,Patient complained of swollen injection site. Pain upon lifting arm. Recommended Benadryl and NSAID to patient. Informed if reaction worsens to seek medical attention from a Doctor.,,,,,,,,,U,10/03/2019,10/04/2019,1,,PHM,,,,,,,2,10/04/2019,,,,none
0838296,10/04/2019,MA,0.5,0,.5,F,,"Fever for the last 2 days.  Had recent OM and amox, finished 5 days ago.  Had had congestion resolved during the amox course, but started again 4 days ago.  Seen for CPE 2 d ago, got vaccines, including flu.  Was ""a mess"" after coming back from school 2 days ago and has been fussier and not eating as well since.  Wet diapers ok but a bit less than usual.  bowel movements ok.  No vomiting.  Not wanting to lie down.  Not sleeping as well.  Overnight had a 2-3 minute stint of crying and having starts and blinking intermittently with interruption of crying and then resumption of crying.  15-20 sec between starts, repeated several times.  As the issue faded, had a few episodes of just arm shakes and then went back to sleep.  No further episodes, though was fussy the rest of the night intermittently. ?febrile seizure.  Will see neurology at Hospital  ",,,,,,,,,U,10/02/2019,10/02/2019,0,None to date.,PVT,,Cholecalciferol 400mg/ml.  Takes 1ml QD.,Finished amoxicillin 5 days prior for an ear infection.,None,,,2,10/04/2019,,Y,,NKA
0838297,10/04/2019,CA,75.0,75,,F,,red circle and itchy about size of orange,,,,,,,,,N,09/25/2019,09/30/2019,5,,PHM,,pt has been taking tylenol once noticed the redness. Told pt to add benadryl,no,no,,,2,10/04/2019,,,,none
0838298,10/04/2019,ID,4.0,4,,F,,"Pt has a golf ball size, red, raised, area on the outer Right thigh and injection site.  Parent denies fever, or rash since vaccine administration.",,,,,,,,,N,09/27/2019,09/27/2019,0,NONE,PVT,,None,NONE,NONE,,,2,10/04/2019,,Y,,NKDA
0838300,10/04/2019,VA,,,,M,,"Fever; Small painful sore on the mid shaft of penis; Penile ulcer; This case was reported by a physician via sales rep and described the occurrence of fever in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In July 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced fever, penile pain and penile ulcer. On an unknown date, the outcome of the fever was unknown and the outcome of the penile pain and penile ulcer were recovered/resolved.   It was unknown if the reporter considered the fever, penile pain and penile ulcer to be related to Shingrix.  Additional information received were as follows: The patient returned on the reporting date after receiving Shingrix vaccine 2 months ago. The patient experienced fever that night then recuperated. Three days later after receivng Shingrix, the patient experienced a small painful sore on the mid shaft of his penis. The patient was widowed and dating. The patient never had penile sores in past.  The patient did not seek medical care at the time.  It took 3 weeks for the painful sore to resolve. At the reporting date, the patient asked if this could be related to the Shingrix vaccine and should he receive a second dose. The reporter had advised that he seek medical care for viral cultures should a second sore develop and no intercourse if a sore develops.",,,,,,,,,Y,07/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838301,10/04/2019,WA,26.0,26,,F,,"drug exposure during pregnancy; This prospective pregnancy case was reported by a pharmacist via call center representative and described the occurrence of vaccine exposure during pregnancy in a 26-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) (batch number 3N4F7, expiry date 30th June 2020) for prophylaxis.   On 24th September 2019, the patient received Fluarix Quadrivalent 2019-2020 season. The patient's last menstrual period was on an unknown date and estimated date of delivery was 20th November 2019. The patient received Fluarix Quadrivalent 2019-2020 season during the third trimester of pregnancy. On 24th September 2019, unknown after receiving Fluarix Quadrivalent 2019-2020 season, the patient experienced vaccine exposure during pregnancy. On an unknown date, the outcome of the vaccine exposure during pregnancy was unknown. The pregnancy was ongoing.  Additional details were provided as follows: The reporter stated that, the patient with estimated date of delivery on or around 20th November 2019 received the vaccine, which led to vaccine exposure during pregnancy. No other events reported.",,,,,,,,,U,09/24/2019,09/24/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838302,10/04/2019,NY,,,,U,,"Why does Prevnar 13 burn at a higher rate than other vaccines?/Prevnar 13 burns when it is administered at a higher incidence rate compared with other childhood vaccines.; This is a spontaneous report from two contactable physicians received via a Pfizer sales representative. A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13, lot number and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The reporter inquired as to why did pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) burn at a higher rate than other vaccines. It was reported that pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) burnt when it was administered at a higher incidence rate compared with other childhood vaccines. The event took place after use of product. The outcome of the event was unknown.  Information on the lot/batch number has been requested.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2019428055,2,10/04/2019,,,,
0838303,10/04/2019,FL,72.0,72,,F,09/28/2019,"Immediately, upon standing after Injections, I felt faint + nauseous; sat down + immediately felt searing, burning pain across neck, down to Lower Lumber for about 10 min. After 20 min. Felt well enough to go home. However, at 7 PM, I felt like a truck hit me! Extremely dizzy, nauseous, pain all over body, including my chest + High Blood Pressure 150/105 90 BPM - I proceeded to have uncontrollable shakes + Felt Freezing cold. Lasted 5 hrs. My husband, called my PCP to see what to do + kept in touch with him. My husband gave me 1 Advil + later 1 x strength Tylenol + slowly my Blood Pressure returned to 114/60 87 BPM at 11:50 PM. Extremely Terrifying Experience!",,,,,,,,,Y,09/15/2019,09/15/2019,0,N/A - none,OTH,PVT,(Currently taking)  Prolia shot 6-7-19 Troprol XL Crestor Lorazepam Claritin,None,Diagnosed with (moderate) Heart Valve Regurgitations & Myocardial Bridge,,,1,,,,,
0838304,10/04/2019,OH,82.0,82,,F,,Hard lump on arm. Very sore next 2 or 3 days sores on head and on hairline - Eye lid swolen on left side - Itching over upper body.,,,,,,,,,Y,09/04/2019,09/05/2019,1,Doctor checked red scaley areas,PHM,,Metformin Lisinopril Rosuvastatin Glipizide Metoprolol Megan Red CoQ10 Baby Aspirin Vit D3 PreserVision,,Diabetis,,,2,09/25/2019,,Y,,Biaxin - Vicodin - Penicillin
0838305,10/04/2019,NM,72.0,72,,F,,"Within 24 hours of injection patient reported severe redness, pain and swelling from shoulder to elbow . Patient stated that she could barely move her arm. After 3 days, all symptoms resolved.",,,,,,,,,Y,09/16/2019,09/17/2019,1,none,PHM,,unknown,none known,none known,,,2,10/04/2019,,,,no known allergy
0838306,10/04/2019,OH,71.0,71,,F,,"PATIENT COMPLAINED OF A VERY SORE ARM, 100 DEGREE FEVER, FATIGUE, MUSCLE ACHES IN ARMS AND LEGS, FLU-LIKE SYMPTOMS THAT LASTED APPROXIMATELY 12 HOURS",,,,,,,,,,09/25/2019,09/26/2019,1,,PHM,,,,,,,2,10/04/2019,,,,
0838307,10/04/2019,MN,60.0,60,,M,,Trunk covered in hives 1 day after Shingrix injection,,,,,,,,,U,10/02/2019,10/03/2019,1,None,PVT,,Fish Oil Heal and Soothe,none,none,,,2,10/04/2019,,Y,,none
0838308,10/04/2019,FL,65.0,65,,M,,"Patients wife states the evening of his vaccine he experienced  a fever, chills, nausea and body aches...she reported this the next day...follow up call to check on  patient-wife stated he was feeling much better-fever free and not further complaints",,,,,,,,,Y,10/02/2019,10/02/2019,0,,PHM,,,,,,,2,10/04/2019,,,,
0838309,10/04/2019,MI,1.5,1,.5,M,,"Was mistakenly give the wrong vaccine at well child visit. Was caught right away, parents notified, and no reaction to date.",,,,,,,,,U,10/03/2019,10/03/2019,0,,PVT,,None,No,No,,,2,10/04/2019,,Y,,Amoxicillin
0838310,10/04/2019,TX,65.0,65,,F,,"Cellulitis to right arm at injection site spreading to forearm.  Hot to touch, bruised, erythema.  Denies any fever, nausea, vomiting, diarrhea, itching",,,,,,,,,Y,10/01/2019,10/02/2019,1,none,PVT,,"Aspirin, Centrum Silver, Metformin, Nexium, pravastatin, Vitamin D",none,"GERD, diabetes, hyperlipidemia",,,2,10/04/2019,,Y,,penicillin
0838311,10/04/2019,DC,54.0,54,,F,,"Developed tender red bump on 9/28/19 on right upper abdomen. Then felt pain on her right flank and saw a similar red bump posteriorly. Pain radiated around torso like ""nerve is burning"".",,,,,,,,,U,09/26/2019,09/28/2019,2,"9/30/19 Swabbed lesions for Varicella Zoster culture (results pending). Explained to patient that  yield/sensitivity of cultures can be low due to sampling variability. Her vesicles were small; her rash clinically looked like herpes zoster, and were in dermatomal distribution matching her neuralgic pain. Clinical diagnosis was herpes zoster and patient was treated with appropriate medication.",PVT,,"Escitalopram, Dextroamphetamine",none known,Insomnia,,,2,10/04/2019,,Y,,Sulfa causes rash Wellbutrin causes anxiety Augmentin causes itching
0838312,10/04/2019,,25.0,25,,F,,Redness rash on right upper arm at the site of injection. Warm to touch. Apply cold compress and to follow up if condition continues.,,,,,,,,,U,09/30/2019,10/01/2019,1,,UNK,,,,,,,2,10/04/2019,,Y,,
0838313,10/04/2019,MI,49.0,49,,F,,"Severe headache lasting 4 days, general malaise",,,,,,,,,Y,09/03/2019,09/04/2019,1,,OTH,,Hydroxicine,NA,NA,,,2,10/04/2019,,,,NA
0838315,10/04/2019,AZ,66.0,66,,F,,"Headache, low grade fever",,,,,,,,,N,10/03/2019,10/04/2019,1,None,PHM,,"Amlodipine, Benicar, Adderall, Levothyroxine, Trazodone.  Kelp, Red Yeast Rice, Co-Q10, Celadrin, Multivitamin. (may be others)","Cold (approx 1 month prior), sprained ankle",Degenerative disc disease,,,2,10/04/2019,,,,Latex
0838316,10/04/2019,AL,61.0,61,,M,,patient stated that his muscle swelled the night of injection.  still red 3 days later when he called pharmacy to report. has been using ice on it .,,,,,,,,,N,10/01/2019,10/01/2019,0,,PHM,,,,,,,2,10/04/2019,,,,
0838317,10/04/2019,PA,4.0,4,,M,,"Within one hour an anaphylactic reaction, acute emesis, red rash, pruitis-extreme hives-red-rash diffuse, stable vital signs, negative oral swelling, negative respiratory distress, negative wheezing, negative diarrhea",,,,,,,,,Y,10/04/2019,10/04/2019,0,examed and almost 80 minutes later-Benadryl and oral Prednisone given,PVT,,"Loratadine, Singulair, Memetasone Furoate 0.1%",No,Asthma,,,2,10/04/2019,,Y,,NO
0838318,10/04/2019,NY,57.0,57,,F,,"Felt hoarseness within 2 hours and the hoarseness got progressively worse, eyes got very red, was difficult to take full breaths, head hurt, arm very sore. Called Pharmacy at 8:30 PM, was advised to take 2 benadryl and could take both ibuprofen and acitomenaphen.  Took 2 Benadryl and 2 ibuprofen. Still felt hoarseness in morning and eyes still red and did not feel well. Took 1 more Benadryl and 2 ibuprofen. Slept most of the day and by evening felt 80% better. The next morning 10/4/2019, felt all better.",,,,,,,,,Y,10/02/2019,10/02/2019,0,,PHM,,Vitafusion Women's gummy vitamins (2 gummies); Natrol Biotin 5000mcg (1 pill); Kirkland Ibuprofen 200mg (2 pills).,None,None,,,2,10/04/2019,,,,Erythromycin
0838319,10/04/2019,,65.0,65,,F,,"Flu symptoms, injection site reactions, fever and malaise",,,,,,,,,N,10/01/2019,10/02/2019,1,,PHM,,,,,Shingrix,,2,10/04/2019,,,,
0838320,10/04/2019,SC,66.0,66,,M,,"Lost shoulder mobility, chills, throbbing.  Mobility is improving slightly today",,,,,,,,,N,10/03/2019,10/03/2019,0,,PHM,,Lisinopril and Pravastatin,None,None,,,2,10/04/2019,,,,No Known Allergies
0838321,10/04/2019,ID,68.0,68,,F,,visual disturbances,,,,,,,,,U,10/04/2019,10/04/2019,0,,PHM,,,,,,,2,10/04/2019,,,,none
0838322,10/04/2019,MO,81.0,81,,F,,"large red, swollen rash covering the majority of left deltoid muscle, told patient to take benadryl and let us know if it gets better or worse",,,,,,,,,U,10/02/2019,10/04/2019,2,,PHM,,"Candesartan, Atorvastatin",no,"high blood pressure, high cholesterol",,,2,10/04/2019,,,,no
0838323,10/04/2019,CT,64.0,64,,M,,9/25 Patient presents to ED complaining of left sided throbbing headache 9/28 Patient presents to ED with facial droop 10/4 Patients primary care doctor diagnosis Bell's Palsy,,,,,Y,1,,,U,09/15/2019,09/25/2019,10,9/25 CT Angiogram Head - unremarkable 9/29 MRI brain - negative,PHM,,Aspirin Atorvastatin Flonase Afrin nasal spray Pantoprazole,,Elevated blood pressure reading without diagnosis of hypertension Mixed hyperlipidemia Seasonal allergic rhinitis due to pollen cerebral aneurysm in 1996,,,2,10/04/2019,,Y,Y,No known drug allergies
0838324,10/04/2019,,7.0,7,,M,,"Mom reported Patient's injection site became swollen and red. She also noted that it was ""hot to the touch"". Patient did not show any signs of trouble breathing or itch or any other adverse reaction. I advised mom to place an ice pack on the site and to take Patient to the ER if he shows signs of troubled breathing. Mom said she will watch him. I called mom on 10/3 to see how Patient was doing but mom did not pick up the phone. I asked the mom to call back.",,,,,,,,,U,09/29/2019,09/29/2019,0,,PHM,,n/a,n/a,,,,2,10/04/2019,,,,n/a
0838328,10/04/2019,PA,6.0,6,,F,,"Had slight localized reaction (redness, no itching) at injection site.",,,,,,,,,,10/01/2019,10/01/2019,0,,PVT,,None,None,None,,,2,10/01/2019,,Y,,NKDA
0838329,10/04/2019,OH,54.0,54,,M,,"Pt reports he had an extreme headache, severe chills, pain at injection site & nausea.",,,,,,,,,Y,08/30/2019,08/30/2019,0,None.,PVT,,"Metoprolol, Seroquel, Vit D3, Klonapin flonase",none.,"Benign HTN, Bipolar.",,,2,10/04/2019,,,,NKDA
0838330,10/04/2019,AZ,65.0,65,,F,,Patient reported hives/rash about 30 minutes after administration of the immunization. We referred patient to urgent care where an injectable steroid was administered which resolved the reaction. No further action was necessary per patient.,,,,,,,,,Y,10/01/2019,10/01/2019,0,Urgent care visit on 10/1,PHM,,"Tessalon, Singulair, theophylline, omeprazole, azithromycin",None specifically indicated,Unknown.,,,2,10/04/2019,,Y,Y,No known allergies
0838331,10/04/2019,SC,11.0,11,,U,,"Syncope, hit head (5-10 min. after injections) Dizzy x 30 min after syncope",,,,,,,,,Y,10/03/2019,10/03/2019,0,0,PVT,,NONE,,,,,2,10/03/2019,,Y,,Egg
0838341,10/04/2019,CA,,,,F,,"the pregnant patient was administered one dose of GARDASIL 9; No adverse effects; This spontaneous report was received from a physician referring to a female patient of unknown age. Information about medical history, concurrent conditions and concomitant therapies was not provided.    On 11-SEP-2019, this pregnant patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (lot # and expiration date were not reported) via intramuscular route for prophylaxis (maternal exposure during pregnancy). Information about the last menstrual period (LMP) and estimated date of delivery (EDD) was not known. The pregnancy outcome was outcome pending. No adverse effects were reported.",,,,,,,,,U,09/11/2019,,,,UNK,,,,,,US0095075131909USA009521,2,10/04/2019,,,,
0838342,10/04/2019,NY,4.0,4,,U,,"no adverse effects; a patient was administered improperly stored PROQUAD; This spontaneous report was received from a medical assistant and refers to a 4-year-old patient. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On 06-SEP-2019, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S009759, expiration date 27-SEP-2020 (exact dose, injection site and route of administration were not reported) for prophylaxis. The sterile diluent used to reconstitute the vaccine was properly stored. Administered dose of vaccine experienced the temperature excursion of 15 to 46 degrees Fahrenheit (17.6 degrees) for 56 hours and 40 minutes. Administered dose of vaccine experienced previous temperature excursion of 6 to 14 degrees Fahrenheit (6.2 degrees) for 10 minutes. The digital data logger was not involved in recording the temperature excursion details. There was no adverse effects reported.",,,,,,,,,U,09/06/2019,09/06/2019,0,,UNK,,sterile diluent,,,,US0095075131910USA001936,2,10/04/2019,,,,
0838343,10/04/2019,MS,60.0,60,,F,,"intermittent headaches; diarrhea; dizzy; This spontaneous report was received from a registered nurse and refers to a 60-year-old female patient. The patient's pertinent medical histories included Cushing's. The patient was allergic to levofloxacin (LEVAQUIN) and codeine. The patient had no concomitant therapies.  On 27-SEP-2019, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # S020157 has been verified to be a valid lot number, expiration date not reported, but upon internal validation established as 30-JUN-2021 (exact dose, dose number, route and site of administration were not reported) for immunization.  On 27-SEP-2019, reported as in 30 seconds after vaccine administration, the patient became dizzy. On 28-SEP-2019, reported as on the next day, the patient developed diarrhea and intermittent headaches. On an unknown date in 2019, the patient had basic lab work, electrocardiogram (EKG) and chest x-ray, the results were not provided. The patient sought medical attention, the patient had emergency room visit and office visit. The treatment was not given. On 29-SEP-2019, the patient recovered from diarrhea, it was reported that diarrhea lasted for one day. The dizziness and headaches had decreased at the reporting time. The causality assessment was not provided.",,,,,,,,,N,09/27/2019,09/27/2019,0,,UNK,,,Cushing's disease; Drug hypersensitivity; Immunisation,,,US0095075131910USA001966,2,10/04/2019,,Y,Y,
0838344,10/04/2019,NC,,,,U,,"Severe muscle aches; Severe bone aches; Very strong reaction; This case was reported by a consumer and described the occurrence of muscle pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included surgery (previous failed surgery).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced muscle pain, bone pain and back pain. The patient was treated with prednisone (Prednisone Dose Pack). On an unknown date, the outcome of the muscle pain, bone pain and back pain were recovered/resolved.   It was unknown if the reporter considered the muscle pain, bone pain and back pain to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. On 22nd September 2019, the patient just completed a 12 day Prednisone dose pack  and it just so happened that the patient's pharmacy called and said they had second dose of the vaccine available for the patient until 28th September 2019. The patient asked would it be better to put this off as the recent prednisone may make it so the patient did had an effective response to the vaccine. The patient asked that if so then how long should the patient wait. The prednisone was because of terrible back pain and the Magnetic resonance imaging showed so much that it was time the patient had to have surgery to do a fusion from a previous failed surgery.  The patient asked in regards to this would it be best to hold off until after surgery. The patient experienced very strong reaction the first time with 10 days of severe muscle and bone aches.",,,,,,,,,Y,,,,"Test Date: 2019; Test Name: Nuclear magnetic resonance imaging; Result Unstructured Data: Test Result: terrible back pain, Test Result Unit: unknown",UNK,,,,Medical History/Concurrent Conditions: Surgery (previous failed surgery),,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838345,10/04/2019,,,,,M,,"Sky High Fevers; Was actually allergic to the tetanus in this combo vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a male patient who received DTPa (DTPa vaccine) for prophylaxis.   Concurrent medical conditions included tetanus immunization.   On an unknown date, the patient received DTPa vaccine. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced fever and allergy. On an unknown date, the outcome of the fever and allergy were unknown.   It was unknown if the reporter considered the fever and allergy to be related to DTPa vaccine.  Additional information received were as follows: This case was reported by the patient's parent. The age at vaccination was not reported. The reporter reported that their son also ran sky high fevers with DPT. Years later the reporter found out that he was actually allergic to the tetanus in this combo vaccine.",,,,,,,,,U,,,,,UNK,,,Tetanus immunization,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838346,10/04/2019,FL,,,,F,,"Hives; This case was reported by a consumer via call center representative and described the occurrence of hives in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th June 2019, the patient received the 1st dose of Shingrix. On 13th June 2019, 1 days after receiving Shingrix, the patient experienced hives. On an unknown date, the outcome of the hives was not recovered/not resolved.   It was unknown if the reporter considered the hives to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced hives after the shot and that they still have not cleared up.  The reporter wanted to know how many people have called in to report side effects. The reporter advised them that he may have his physician call GlaxoSmithKline MI department.  The reporter stated he wanted to speak to a manager. No additional information was provided concerning this event. The reporter did not consent to follow-up. No physician information was provided. This case has been linked with US2019175400 having same reporter.",,,,,,,,,N,06/12/2019,06/13/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838347,10/04/2019,,,,,M,,"Inappropriate Schedule of Vaccine; Body aches; Significant Malaise; This case was reported by a physician via sales rep and described the occurrence of general body pain in a 56-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of malaise (1st dose received on November 2018, refer case US2019175365).   On 12th September 2019, the patient received the 2nd dose of Shingrix. On 12th September 2019, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. In September 2019, the patient experienced general body pain and malaise. On an unknown date, the outcome of the general body pain and malaise were recovered/resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the general body pain and malaise to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received dose of Shingrix approximately two weeks ago from the date of reporting, which led to lengthening of vaccination schedule. After vaccination with dose of Shingrix, the patient experienced symptoms but were milder. The symptoms were resolved within 2 days. The sales representative indicated that, the reporter provided this information to her during a Congress she was attending and was unable to provide any additional details. This case is one of 5 cases, reported by the same reporter.",,,,,,,,,Y,09/12/2019,09/12/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838348,10/04/2019,,,,,U,,"Fatigue; This case was reported by a consumer and described the occurrence of fatigue in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fatigue. On an unknown date, the outcome of the fatigue was not recovered/not resolved.   It was unknown if the reporter considered the fatigue to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. The patient asked how long the fatigue typically last after receiving the second dose of Shingrix.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838349,10/04/2019,SC,,,,U,,"Slight pain at the injection site; Headache; Mild fever; Extreme tenderness of arm starting about 2"" below the injection site and extending about 4"" toward the elbow; Rash; This case was reported by a consumer and described the occurrence of injection site pain in a 77-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included methotrexate and infliximab (Remicade).   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site pain, headache, fever, tenderness and rash. On an unknown date, the outcome of the injection site pain, headache, fever, tenderness and rash were unknown.   It was unknown if the reporter considered the injection site pain, headache, fever, tenderness and rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, however the patient could be 77 or 76 years old at time of vaccination. The patient had a few symptoms or reaction some of which are listed as possible reactions and a couple of which do not see noted. The patient stated that the ones that are apparently common are very slight pain at the injection site, headache and mild fever 100.8. The unexpected reactions include extreme tenderness of my arm starting about 2 inch below the injection site and extending about 4 inch toward the elbow with a rash appearing in this. The tendered was sufficient than the patient cannot lay on that side. The patient just wanted to check this out as do not know anyone else who has experienced these symptoms and have not seen them listed anywhere.      Lab Comments: On unknown date, body temperature was 100.8",,,,,,,,,U,,,,"Test Name: Body temperature; Result Unstructured Data: Test Result: 100.8, Test Result Unit: degree F",UNK,,METHOTREXATE; REMICADE,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838350,10/04/2019,,,,,U,,"Side Effects; This case was reported by a consumer via sales rep and described the occurrence of adverse drug reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The patient experienced side effects after receiving vaccine. The patient asked for how many days the side effects occur.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838351,10/04/2019,VA,51.0,51,,U,,"Muscle aches; Shivering; Pain at the injection site; Tired; Diarrhea; Headaches; muscle fatigue; aching; This case was reported by a consumer and described the occurrence of muscle pain in a 51-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th September 2019, the patient received the 1st dose of Shingrix. On 26th September 2019, 2 days after receiving Shingrix, the patient experienced muscle pain, shivering, injection site pain, tiredness, diarrhea, headache, muscle fatigue and pain. The patient was treated with ibuprofen (Motrin) and paracetamol (Tylenol). On an unknown date, the outcome of the muscle pain, shivering, injection site pain, tiredness, diarrhea, headache, muscle fatigue and pain were unknown.   It was unknown if the reporter considered the muscle pain, shivering, injection site pain, tiredness, diarrhea, headache, muscle fatigue and pain to be related to Shingrix.  Additional details were provided as follows: The patient received 1st shingrix vaccine 2 days ago, and pretty much had all of the side effects. The patient had severe muscle aches, shivering and pain at the injection site, headache muscle ache so severe. The patient was putting ice pack everywhere. On 26th September 2019, the patient feel tired and had diarrhea all day. Th patient bother getting the second vaccine 2 months. The patient stated that am young, very healthy, exercise regularly and take no medications for any underlying issues. The patient had no choice but to be in bed. The muscle fatigue and aching was pretty intense and patient took Motrin and Tylenol around the clock so would had any benefits at all in just having this vaccine or must had both.",,,,,,,,,U,09/24/2019,09/26/2019,2,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838352,10/04/2019,AL,,,,F,,"Rash that looks like chicken pox / Vesicular rash; This case was reported by a physician via sales rep and described the occurrence of varicella-like rash in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th September 2019, the patient received the 1st dose of Shingrix. On 26th September 2019, 1 days after receiving Shingrix, the patient experienced varicella-like rash. Shingrix was discontinued. On an unknown date, the outcome of the varicella-like rash was unknown.   It was unknown if the reporter considered the varicella-like rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, however the patient could be 61 or 60 years old at time of vaccination. The physician reported the patient developed vesicular rash one day after first dose of Shingrix. The dermatologist at practice biopsied site and believes it could be chicken pox. The adverse event was reported on 26th September 2019 at 12:17pm. Upon speaking with physician morning, physician stated that they would not be administering the second dose of the Shingrix series. The reporter was agree to follow up from GlaxoSmithKline.",,,,,,,,,U,09/25/2019,09/26/2019,1,,UNK,,,,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838353,10/04/2019,,,,,F,,"Suspected vaccination failure; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included handicap.   On an unknown date, the patient received Shingles vaccine at an unknown dose. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional information was reported as follows: This case was reported by the reporter's friend wife. The age at vaccination was not reported. After vaccination, the patient instantly got shingles. The reporter told that, the shingles was cured very quickly with hydrogen peroxide. The reporter's husband had shingles for maybe a week. With hydrogen peroxide compresses and hydrogen peroxide bath, it was gone in a week. The results were seen within the first treatment and did not need a shingles shot which was full of dangerous poisons. Getting the shingles shot did not guarantee that the patient won't get shingles infected causes shingles in many cases.  She could very well get shingles again also, it was no guarantee getting a vaccine did not guarantee to anything. Well the reporter took that back and pretty well guaranteed of having bad results from the poisons and various viruses and bacteria that have now had put into the bloodstream. The patient could not put something in their body that was never meant to be there and expect to secure anything because it won't because it could not. The patient body would fight to get rid of it.  This vaccination agenda was insanity on steroids. This case was considered as suspected vaccination failure as details regarding vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting.",,,,,,,,,U,,,,,UNK,,,Handicap,,,USGLAXOSMITHKLINEUS2019AM,2,10/04/2019,,,,
0838354,10/04/2019,TX,,,,M,,"Suspected vaccination failure; Influenza virus infection; retropharyngeal abscess; Peritonsillar abscess; Streptococcus pyogenes/bacterial head and neck infections; with polymicrobial infection with Prevotella; This case was reported in a literature article and described the occurrence of suspected vaccination failure in a 13-year-old male patient who received Flu unspecified (Flu vaccine) for prophylaxis.  Co-suspect products included PNEUMOCOCCAL VACCINE (PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE) for prophylaxis.   Previously administered products included influenza vaccine (in 2006, 2007, 2009, 2012, 2014 and 2015.) and PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE (1st 3 doses received on unknown date).   On an unknown date, the patient received Flu vaccine at an unknown dose and the 4th dose of PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE. On an unknown date, less than a year after receiving Flu vaccine, the patient experienced vaccination failure (serious criteria hospitalization and GSK medically significant), influenza (serious criteria hospitalization), retropharyngeal abscess (serious criteria hospitalization and GSK medically significant), peritonsillar abscess (serious criteria hospitalization and GSK medically significant), streptococcal infection (serious criteria hospitalization and GSK medically significant) and bacterial infection (serious criteria hospitalization). The subject was treated with benzylpenicillin (Penicillin). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the influenza, retropharyngeal abscess, peritonsillar abscess, streptococcal infection and bacterial infection were recovering/resolving.   The reporter considered the vaccination failure, influenza, retropharyngeal abscess, peritonsillar abscess, streptococcal infection and bacterial infection to be related to Flu vaccine.  Additional details were reported as follows: This case was reported in a literature article and described the suspected vaccination failure in a 13.9-year-old male patient, who was vaccinated with unspecified 2017-2018 seasonal influenza vaccine (manufacturer unknown) for prophylaxis. This case corresponds to case-5 from table 1 reported in this literature article. The patient was a part of retrospective review that was performed for pediatric patients hospitalized with bacterial head or neck infections following influenza infection between October 2017 and March 2018.The patient had received influenza vaccine previously in 2006, 2007, 2009, 2012, 2014 and 2015. No information on patient's medical history, family history or concurrent condition or concomitant medication was provided. On an unspecified date in 2017, the patient received unspecified 2017-2018 seasonal influenza vaccine (administration route and site unspecified, dosage unknown; batch number not provided). The patient had also received 4 doses of unspecified 7-valent pneumococcal conjugate vaccine (PCV7). The age of vaccinations was not provided.  On an unspecified date, an unknown period after the seasonal influenza vaccination, the patient developed influenza virus infection that was subsequently diagnosed with positive rapid influenza diagnostic test. The type of influenza virus was unknown. On an unspecified date between October 2017 and March 2018, at the age of 13.9 years, 6 days after the influenza diagnosis, the patient was hospitalised for retropharyngeal abscess (RPA) and peritonsillar abscess (bacterial head or neck infections which were associated with influenza infection).  The incision and drainage was performed. The causative pathogen for head or neck infection was found to be Streptococcus pyogenes. The patient was also found positive with polymicrobial infection with Prevotella. The duration of hospitalization was between 5 and 35 days. The treatment was started with penicillin (definitive treatment). The duration of treatment was 3 weeks. The patient had completed penicillin treatment successfully and had favorable outcome. This case has been considered as suspected vaccination failure being the time to onset was unknown. This case has been considered as serious due to suspected vaccination failure/hospitalisation. The author did not comment on the relationship between the event of influenza virus infection, and unspecified seasonal influenza vaccine. However the authors stated, ""Seasonal influenza infection is associated with secondary bacterial complications involving the upper and lower respiratory tract. However, the association of influenza infection with secondary severe or complicated head and neck infections is not appreciated."" The authors concluded, ""It was suggested that complicated bacterial head and neck infections may represent an under recognized co-infection or secondary complication of infection with influenza virus, further stressing the importance of prevention and treatment of influenza infection."" This article corresponding to this case is not available for regulatory submission due to copyright restriction. This is 1 of the 2 valid cases reported in this literature article.      Lab Comments: On an unspecified date between October 2017 and March 2018,  lab test were performed.",,,,,Y,,,,N,,,,"Test Name: Bacterial test; Result Unstructured Data: Test Result: positive polymicrobial infection with Prevotella, Test Result Unit: unknown; Test Name: Rapid influenza diagnostic test; Result Unstructured Data: Test Result: positive (type unknown), Test Result Unit: unknown; Test Name: Streptococcus pyogenes test positive; Result Unstructured Data: Test Result: positive, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS2019GS,2,10/04/2019,,,,
0838355,10/04/2019,TX,,,,M,,"Influenza virus infection; Sinusitis; Orbital cellulitis; pott's puffy tumor; pott's puffy tumor; Peptostreptococcus/Streptococcus mitis/ Streptococcus anginosus; polymicrobial infection with Prevotella; This case was reported in a literature article and described the occurrence of influenza in a 12-year-old male patient who received Flu unspecified (Flu vaccine) for prophylaxis. Co-suspect products included PNEUMOCOCCAL VACCINE (PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE) for prophylaxis.   Previously administered products included PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE (1st 3 doses received on unknown date).   On an unknown date, the patient received Flu vaccine at an unknown dose and the 4th dose of PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE. On an unknown date, unknown after receiving Flu vaccine, the patient experienced influenza (serious criteria hospitalization), sinusitis (serious criteria hospitalization), orbital cellulitis (serious criteria hospitalization and GSK medically significant), subperiosteal abscess (serious criteria hospitalization and GSK medically significant), osteomyelitis (serious criteria hospitalization and GSK medically significant), streptococcal infection (serious criteria hospitalization) and bacterial infection (serious criteria hospitalization). The subject was treated with ceftriaxone and metronidazole. On an unknown date, the outcome of the influenza, sinusitis, orbital cellulitis, subperiosteal abscess, osteomyelitis, streptococcal infection and bacterial infection were recovering/resolving.   The reporter considered the influenza, sinusitis, orbital cellulitis, subperiosteal abscess, osteomyelitis, streptococcal infection and bacterial infection to be related to Flu vaccine.  Additional details were reported as follows: This case was reported in a literature article and described the occurrence of influenza virus infection (type unknown) in a 12-year-old male patient, who was vaccinated with unspecified influenza vaccine (manufacturer unknown) for prophylaxis. This case corresponds to case-3 from table 1 reported in this literature article. The patient was a part of retrospective review that was performed for pediatric patients hospitalized with bacterial head or neck infections following influenza infection between October 2017 and March 2018. No information on patient's medical history, family history or concurrent condition or concomitant medication was provided. On an unspecified date, the patient received unspecified influenza vaccine (administration route and site unspecified, dosage unknown; batch number not provided). It was reported that, the patient had not received in the current 2017-2018 seasonal influenza vaccine. The patient had also received 4 doses of unspecified 7-valent pneumococcal conjugate vaccine (PCV7). The age of vaccinations was not provided.  On an unspecified date, an unknown period after the seasonal influenza vaccination, the patient developed influenza virus infection that was subsequently diagnosed with positive rapid influenza diagnostic test. The type of influenza virus was unknown. On an unspecified date between October 2017 and March 2018, at the age of 12 years, 4 days after the influenza diagnosis, the patient was hospitalized for sinusitis, pott's puffy tumor and orbital cellulitis (bacterial head or neck infections which were associated with influenza infection). The endoscopic sinus surgery (ESS) was performed. The causative pathogen for head or neck infection was found to be Streptococcus anginosus group. The patient was also found positive with polymicrobial infection with Peptostreptococcus, Prevotella and S.mitis. The duration of hospitalization was between 5 and 35 days. The treatment was started with ceftriaxone and metronidazole (definitive treatment). The duration of treatment was 5 weeks. The patient had completed ceftriaxone and metronidazole treatment successfully and had favorable outcome.  This case has been considered as serious due to hospitalization. The author did not comment on the relationship between the event of influenza virus infection, and unspecified seasonal influenza vaccine. However the authors stated, ""Seasonal influenza infection is associated with secondary bacterial complications involving the upper and lower respiratory tract. However, the association of influenza infection with secondary severe or complicated head and neck infections is not appreciated."" The authors concluded, ""It was suggested that complicated bacterial head and neck infections may represent an under recognized co-infection or secondary complication of infection with influenza virus, further stressing the importance of prevention and treatment of influenza infection."" This article corresponding to this case is not available for regulatory submission due to copyright restriction. This is 1 of the 2 valid cases reported in this literature article.      Lab Comments: On an unspecified date between October 2017 and March 2018, lab test were done. The causative pathogen for head or neck infection was found to be Streptococcus anginosus group. The patient was also found positive with polymicrobial infection with Peptostreptococcus, Prevotella and S.mitis",,,,,Y,,,,N,,,,"Test Name: Bacterial test; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown; Test Name: Rapid influenza diagnostic test; Result Unstructured Data: Test Result: positive (type unknown), Test Result Unit: unknown; Test Name: Streptococcus test; Result Unstructured Data: Test Result: see text, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS2019GS,2,10/04/2019,,,,
0838356,10/04/2019,NJ,75.0,75,,F,,"Generalized Bodily Muscle Pain; Injection Site Redness; Pain at the injection site; Feeling Tired; Feeling Weak; Felt sick; acute dermatitis; Persistent rash developed on her back and shoulder that is red and bumpy; Shivers; Terrible Headache / headache was on and off stemming from her neck into her head; Stomach Pain; Persistent rash developed on her back and shoulder that is red and bumpy; This case was reported by a consumer via call center representative and described the occurrence of shivers in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th August 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In August 2019, less than a day after receiving Shingrix, the patient experienced shivers, headache, stomach pain, erythropapular rash, dermatitis and red rash. On 16th August 2019, the patient experienced muscle pain, injection site erythema, injection site pain, tiredness, feelings of weakness and feeling unwell. The patient was treated with ibuprofen and prednisone. On an unknown date, the outcome of the shivers, headache, stomach pain, muscle pain, injection site erythema, tiredness and feelings of weakness were recovered/resolved and the outcome of the injection site pain was unknown and the outcome of the erythropapular rash, dermatitis and red rash were not recovered/not resolved and the outcome of the feeling unwell was recovering/resolving.   It was unknown if the reporter considered the shivers, headache, stomach pain, muscle pain, injection site erythema, injection site pain, tiredness, feelings of weakness, erythropapular rash, feeling unwell, dermatitis and red rash to be related to Shingrix.  Additional details were provided as follows: The patient receiving 2nd dose Shignrix in her left arm in the late afternoon and the next morning waking up with shivers followed by quick onset of a terrible headache and then stomach pains.  The patient also experienced generalized bodily muscle pain, redness and pain at the injection site, and feeling weak and tired.  The patient still felt sick but not as sick as the previous day and the patient had taken ibuprofen.  The patient reported that headache was on and off stemming from her neck into her head for a couple of weeks and taking ibuprofen for relief. Approximately 1 to 2 weeks after vaccination, the patient  reported a persistent rash developed on her back and shoulder that was red and bumpy and appears similar to acute dermatitis.  The patient was taking a 15-day course of prednisone, but reported that she still having rash as it had not completely subsided or cleared. The reporter consented to follow up. There was discrepancy in the onset date of the event tired and weak it was reported as 15th August 2019 and time to onset was given as 1 day, hence onset date was taken as 16th August 2019.",,,,,,,,,N,08/15/2019,08/01/2019,,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838357,10/04/2019,MA,84.0,,,F,,"Rash on trunk; This case was reported by a nurse via call center representative and described the occurrence of rash in a 84-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included bedridden and dementia.   In March 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced rash. The patient was treated with valaciclovir hydrochloride (Valtrex). On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional case details were reported as follows: The immunocompromised female patient with history of dementia received the first dose of Shingrix about 6 months ago, and afterwards she experienced a rash on her trunk.  The reporter described the rash as ""white and pink bumps, could not say whether there was a head, and she had no other symptoms or pain, and it did not spread.""  The nurse practitioner treated the rash with Valtrex, but stated it could have just been a heat rash. The reporter stated she could not provide further information. The reporter did not consented to follow up.",,,,,,,,,U,03/01/2019,,,,UNK,,,Bedridden; Dementia,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838358,10/04/2019,PA,54.0,54,,M,,"decreased blood glucose levels; This case was reported by a consumer via call center representative and described the occurrence of blood glucose decreased in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included insulin nos (Insulin).   On 13th September 2019, the patient received the 1st dose of Shingrix (intramuscular). In September 2019, less than 2 weeks after receiving Shingrix, the patient experienced blood glucose decreased. On an unknown date, the outcome of the blood glucose decreased was not recovered/not resolved.   It was unknown if the reporter considered the blood glucose decreased to be related to Shingrix.  Additional information received were as follows: This case was reported by the patient's wife. The patient received Shingrix on left arm. Since receiving the vaccine, the patient's blood glucose levels had been lower than normal. The caller stated that the patient had not needed his normal doses of insulin since receiving the vaccine.  The reporter consented to follow up.",,,,,,,,,N,09/13/2019,09/01/2019,,"Test Date: 201909; Test Name: Blood glucose; Result Unstructured Data: Test Result: lower than normal, Test Result Unit: unknown",UNK,,INSULIN,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838359,10/04/2019,MN,77.0,77,,F,,"Reaction was itchy; Hives; This case was reported by a consumer via call center representative and described the occurrence of hives in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Fluzone (On 4th September 2019, received Fluzone 0.5 ml high dose 2019-2020, manufactured by Sanofi).   On 22nd September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 22nd September 2019, couple of hours after receiving Shingrix, the patient experienced hives. On an unknown date, the patient experienced pruritus. On an unknown date, the outcome of the hives and pruritus were recovering/resolving.   It was unknown if the reporter considered the hives and pruritus to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Singrix in the left arm. Approximately couple hours after vaccination, the patient had 1 small hive appeared around the area of injection and then spread about 5 inches on arm and continued to spread around arm from the front to the side of arm. The patient woke up the following morning and discovered noticeably more hives and then reports several little hives combined to form one large hive. It was localized reaction to upper arm. The patient reported that, the hives was itchy. The reporter stated that, reaction was slowly going away and that it was not as itchy. The patient stated that, simillar reaction occurred with Fluzone High Dose 2019-202 0.5 mL manufactured by Sanofi that was administered on 4th September 2019. The reporter wanted to compare and contrast ingredients in Shingrix and flu vaccine. The reporter did not consent to follow up.",,,,,,,,,N,09/22/2019,09/22/2019,0,,PHM,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838360,10/04/2019,OH,,,,F,,"Water blister at site of injection; This case was reported by a pharmacist via call center representative and described the occurrence of injection site blisters in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number 3FJ59, expiry date 27th November 2021) for prophylaxis.   On 22nd September 2019, the patient received the 1st dose of Shingrix. On 22nd September 2019, couple of hours after receiving Shingrix, the patient experienced injection site blisters. On an unknown date, the outcome of the injection site blisters was not recovered/not resolved.   It was unknown if the reporter considered the injection site blisters to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be between 70 or 71 years. The reporter stated that, the patient developed a water blister at site of injection a couple hours after vaccination. The event was ongoing.",,,,,,,,,N,09/22/2019,09/22/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838361,10/04/2019,NY,64.0,64,,F,,"Hot injection site; Red injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site warmth in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced injection site warmth and injection site erythema. On an unknown date, the outcome of the injection site warmth and injection site erythema were recovered/resolved.   It was unknown if the reporter considered the injection site warmth and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The patient developed a hot, red injection site that lasted for 2 weeks. The patient did not consent to follow up. This case is 1 of the 3 linked cases, reported by the same reporter.",,,,,,,,,Y,05/01/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838362,10/04/2019,IA,48.0,,,M,,"Sore arm; Inappropriate Age at Vaccine Administration; This case was reported by a nurse via call center representative and described the occurrence of pain in arm in a 48-year-old male patient who received Herpes zoster (Shingrix) (batch number LS42K, expiry date 4th December 2021) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced pain in arm and inappropriate age at vaccine administration. On an unknown date, the outcome of the pain in arm and inappropriate age at vaccine administration were unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were received as follows: The reporter stated that, the patient who was 48 years old was given Shingrix, which led to inappropriate age at vaccine administration. The patient experienced sore arm after vaccination. No other details provided. The reporter did not consent to follow up.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838363,10/04/2019,NC,60.0,60,,F,,"get redness five inches beyond the injection site with swelling; felt discomfort at the injection site; flu like symptoms; red; tingling; uncomfortable; area hurt / she felt pain during the injection; This case was reported by a consumer via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number HY4GT, expiry date 21st September 2021) for prophylaxis.   On 23rd September 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 23rd September 2019, less than a day after receiving Shingrix, the patient experienced extensive swelling of vaccinated limb, injection site discomfort, influenza-like symptoms, erythema of extremities, tingling, discomfort and injection site pain. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the extensive swelling of vaccinated limb was unknown and the outcome of the injection site discomfort, influenza-like symptoms, erythema of extremities, tingling, discomfort and injection site pain were not recovered/not resolved.   It was unknown if the reporter considered the extensive swelling of vaccinated limb, injection site discomfort, influenza-like symptoms, erythema of extremities, tingling, discomfort and injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. After vaccination with dose of Shingrix, the patient experienced discomfort at the injection site and flu like symptoms, and on Monday afternoon, the arm was swelling, red and felt tingling and described it as an uncomfortable reaction. The patient stated that, did not experienced pain during injection with 1st dose, but felt pain with 2nd dose of Shingrix and it was uncomfortable. As the area hurt, the patient took Tylenol as an treatment medication. On 25th September 2019, the patient got redness five inches beyond the injection site with swelling and discomfort again. The reporter consented to follow up.",,,,,,,,,N,09/23/2019,09/23/2019,0,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838364,10/04/2019,NJ,62.0,62,,F,,"Fever; sore arm; hot site of injection; flu like symptoms; This case was reported by a consumer via call center representative and described the occurrence of fever in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th September 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 20th September 2019, 1 days after receiving Shingrix, the patient experienced fever, pain in arm, injection site warmth and influenza-like symptoms. The patient was treated with ibuprofen (Advil). On 23rd September 2019, the outcome of the pain in arm, injection site warmth and influenza-like symptoms were recovered/resolved. On an unknown date, the outcome of the fever was not recovered/not resolved.   The reporter considered the fever, pain in arm, injection site warmth and influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the right deltoid. The patient had fever of 103.9 degree F. The patient had Advil as a treatment medication for fever, but it keeps popping up again. The patient stated that, all symptoms were resolved except fever. On the day of reporting, the patient had routine check up, but forgot to have temperature taken. All other test were normal. The patient consented to follow up.      Lab Comments: Unspecified laboratory test were normal.",,,,,,,,,N,09/19/2019,09/20/2019,1,"Test Date: 20190920; Test Name: Body temperature; Result Unstructured Data: Test Result: 103.9, Test Result Unit: degree F; Test Date: 20190926; Test Name: Laboratory test; Result Unstructured Data: Test Result: Normal, Test Result Unit: unknown",UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838365,10/04/2019,FL,62.0,62,,M,,"Injection site inflamed; right arm was red; spots four inches wide by two inches high on his arm at the injection site; tiredness; achiness; feel crappy; headache; fever; stuffy nose; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 62-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a week after receiving Shingrix, the patient experienced injection site erythema, injection site inflammation, injection site rash, tiredness, pain, feeling bad, headache, fever and nasal stuffiness. On an unknown date, the outcome of the injection site erythema, injection site inflammation, injection site rash, tiredness, pain, feeling bad, headache, fever and nasal stuffiness were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site inflammation, injection site rash, tiredness, pain, feeling bad, headache, fever and nasal stuffiness to be related to Shingrix.  Additional details were provided as follows: The patient received the injection on his right arm just below the deltoid muscle. The patient received Shingrix and within 36 hours he started to feel crappy and his right arm was red and inflamed and he has spots four inches wide by two inches high on his arm at the injection site. He was tired, achy, has a headache, fever, and a stuffy nose. He claims that he has all the side effects listed on our website for Shingrix. He reported that he started to get a little better and all his symptoms are back. He claims that he received the injection on his right arm just below the deltoid muscle. The reporter consented to follow up.",,,,,,,,,N,09/20/2019,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838366,10/04/2019,PA,,,,M,,"pain at injection site; swelling at injection site; fatigue; This case was reported by a non-health professional via call center representative and described the occurrence of injection site pain in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site pain, injection site swelling and fatigue. On an unknown date, the outcome of the injection site pain and injection site swelling were unknown and the outcome of the fatigue was resolved with sequelae.   It was unknown if the reporter considered the injection site pain, injection site swelling and fatigue to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient after receiving the vaccine, developed severe pain and swelling at the injection site. The patient also developed fatigue that lasted for a few days. The reporter did not have healthcare professional name or contact information at the time of the reporting. The reporter stated that he will get the information and more details and call back to Agency.",,,,,,,,,N,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838367,10/04/2019,,,,,U,,"Vaccination Failure; Herpes zoster with vesicles and lesions which were painful and itchy; Lesions; Painful lesion; Itchy; Vesicles; This case was reported by a physician via sales rep and described the occurrence of vaccination failure in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), herpes zoster, skin lesion, pain, pruritus and vesicles. The patient was treated with capsaicin (Capsaicin Cream). On an unknown date, the outcome of the vaccination failure, herpes zoster, skin lesion, pain, pruritus and vesicles were unknown.   It was unknown if the reporter considered the vaccination failure, herpes zoster, skin lesion, pain, pruritus and vesicles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The age group was not reported but was selected as adult as per vaccine indication. The patient received the two doses of the Shingrix vaccine about two years ago and about two weeks ago, the patient developed herpes zoster with vesicles and lesions which were painful and itchy. The patient was not prescribed any antiviral therapy. The patient only applied topical Capsaicin Cream.",,,,,,,,,U,,,,,UNK,,,,,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,,,
0838368,10/04/2019,OK,62.0,62,,F,,"toothache / tooth throbbing; lessions on chest and back; blisters in throat; sore throat; Sore arm; This case was reported by a consumer via call center representative and described the occurrence of throat blister in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included root canal procedure.   On 28th May 2019, the patient received the 2nd dose of Shingrix. On 28th May 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. On 29th May 2019, the patient experienced throat blister (serious criteria GSK medically significant) and sore throat. On 7th July 2019, the patient experienced skin lesion. On an unknown date, the patient experienced toothache. The patient was treated with Antibiotic (Details Unknown) and antivirals nos, antivirals nos, antivirals nos, antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the throat blister, sore throat and toothache were not recovered/not resolved and the outcome of the pain in arm was recovered/resolved and the outcome of the skin lesion was unknown.   It was unknown if the reporter considered the throat blister, pain in arm, sore throat, toothache and skin lesion to be related to Shingrix.  Additional information was reported as follows: The patient experienced a sore arm after the injection. The day after the injection, the patient started having a sore throat. By the end of the week, her throat was still sore, so the patient looked at it and saw blisters in her throat. Around 16th June 2019, after 3 weeks the blisters and sore throat were resolved. The patient did not seen her physician, she thought did place a call towards the end and an antiviral was prescribed which she never took because the symptoms resolved. On 7th July 2019, the sore throat and blisters were returned, along with lesions on her chest and back and lasted another 2 to 3 weeks. This time the patient had visited her physician and she was prescribed an antibiotic and antiviral. A culture of the throat was also taken, which was negative for strep. The symptoms were resolved about 4 days after starting the medications. Less than two months after vaccination, during this 2nd outbreak the patient also started having a toothache in a tooth that previously had a root canal. The patient had a regular dental visit scheduled on 19th July 2019, which happened to occur shortly after the resolution of the second outbreak of blisters. The patient's physician referred her to another provider, who advised that she would need to get an implant.  On 24th September 2019, the patient started having another outbreak of blisters in her throat that was still ongoing. The patient also noted that, her tooth was not aching and throbbing as much as it was, but she can still feel it when using her water pick. The reporter consented to follow up.",,,,,,,,,N,05/28/2019,05/28/2019,0,"Test Date: 2019; Test Name: Culture throat; Result Unstructured Data: Test Result: negative for strep, Test Result Unit: unknown",PHM,,,,Medical History/Concurrent Conditions: Root canal procedure,,USGLAXOSMITHKLINEUS201917,2,10/04/2019,,Y,,
0838369,10/04/2019,SC,75.0,75,,M,,"fever, especially first day, over 102 Chills Muscle and joint pain high heart rate.  it was steady between 90 and 100 (normal in the 60's) insomnia Felt terrible",,,,,,,,,Y,09/23/2019,09/23/2019,0,"None. This is all the info I have on the injection from my record> INTRAMUSCULAR ADMINISTRATION OF 0.5 ML OF ANTIBIOTIC FREE, CELL CULTURE DERIVED, QUADRIVALENT SUBUNIT INFLUENZA VACCINE (90756)",PVT,,"Telmisartan, one-a-day vitamin, vitamin E, Ranitidine, lexapro, pravastatin, 81 mg aspirin, Pradaxa,, Vascepa",None,None,,,2,10/04/2019,,,,penicillin
0838370,10/04/2019,MO,55.0,55,,M,,"Headache, fever, chills, body aches",,,,,,,,,N,10/03/2019,10/03/2019,0,NA,PVT,,Doxycycline 50MG,NA,NA,,,2,10/04/2019,,,,NA
0838371,10/04/2019,AR,42.0,42,,F,,Warm and red to touch,,,,,,,,,Y,10/02/2019,10/03/2019,1,,WRK,,Lisonopril 10mg QD Cymbalta 120mg QD Yaz oral contraceptive Multivitamin (OTC),Sinus infection 9/9/19,"High blood pressure, depression",,,2,10/04/2019,,,,None noted
0838372,10/04/2019,PA,54.0,54,,F,,"15 hours post Shingrix vaccine.  Developed fever 101-103 F..., chills, body aches, resting heart rate 108-113, headache, legs felt heavy when attempting to walk. Symptoms mimic the flu that lasted for 12 hours.",,,,,,,,,Y,07/02/2019,07/03/2019,1,None,PVT,,Spironolactone 75mg q d.  For acne.,None,None,,,2,10/04/2019,,,,Seasonal Allergies.  No drug or food allergies.
0838373,10/04/2019,UT,69.0,69,,F,,"Red and extremely sore at injection site beginning night of administration. Over next two days, redness moved to inside of upper arm, became itchy but pain subsided. Advised patient to monitor for 2 to 3 more days and seek medical attention in the meantime if it gets worse instead of better.",,,,,,,,,U,09/29/2019,09/29/2019,0,n/a,PHM,,n/a,n/a,n/a,,,2,10/04/2019,,,,n/a
0838374,10/04/2019,PA,72.0,72,,F,,"Patient reported redness, welts, warmth and itching at the site of the Prevnar  injection",,,,,,,,,U,09/28/2019,10/04/2019,6,,PHM,,,,,,,2,10/04/2019,,,,reported an allergy to an NSAID
0838375,10/04/2019,IN,27.0,27,,F,,Body rash,,,,,,,,,U,09/20/2019,09/20/2019,0,n/a,PHM,,,,,,,2,10/04/2019,,,,
0838376,10/04/2019,GA,83.0,83,,F,,"Patient's left arm is inflamed, rash, red and swollen.",,,,,,,,,N,10/03/2019,10/04/2019,1,N/A,PHM,,N/A,No illnesses at the time of vaccination according to flu vaccine form.,No health conditions per flu vaccine form.,,,2,10/04/2019,,,,"NKDA, no allergies to food, or other products."
0838377,10/04/2019,FL,17.0,17,,F,,"17yr old female complained about pain, redness , some swelling and warmness to right arm, she received MCV4 vaccine on Tuesday.",,,,,,,,,Y,10/01/2019,10/02/2019,1,,PVT,,None,none,none,,,2,10/04/2019,,Y,,none
0838378,10/04/2019,NJ,72.0,72,,F,,Patient received both vaccinations in left arm at 2pm. Patient reported getting red spots at first then throughout the day gradually got puffy and red. She put an ice pack and took advil. She had very similar reaction to the prevnar 13 which was never reported. She had chills and feverish but never took a temperature.,,,,,,,,,N,10/02/2019,10/02/2019,0,,PHM,,,,,"Prevnar 13. She said she had very similar reaction with swollen, rash, and red, but never reported",,2,10/04/2019,,,,
0838379,10/04/2019,FL,44.0,44,,F,,Patient states that her arm started to become stiff and hot at the injection site and complained of inability to pick up anything without severe pain. Patient presented to the pharmacy with symptoms 2 days after receiving the injection.,,,,,,,,,N,10/02/2019,10/03/2019,1,,PHM,,,,,,,2,10/04/2019,,,,Geodon
0838380,10/04/2019,IN,56.0,56,,M,,Patients wife stated that they had pain in upper chest area however it was on the left side of chest not the right side and vaccine was given in right deltoid,,,,,,,,,N,09/30/2019,10/02/2019,2,,PHM,,,none,none,,,2,10/04/2019,,,,none+
0838381,10/04/2019,TX,77.0,77,,F,,"Feeling of tightness in chest as if there were an air bubble,  then tightening of throat with some difficulty of swallowing,  then several hours of  nausea, fever and body aches  over a period of 6 hours.   Took an antihistamine for the chest and throat reaction   and then in a couple of hours took ibuprophen for the fever and aches. After about 6 hours I began to feel  better but still weakness through the next day.",,,,,,,,,Y,10/02/2019,10/02/2019,0,none,PVT,,"levothyroxin, atenolol, gabapentin,  vitamins, calcium, magnesium",none,"controlled high blood pressure, controlled hypothroidism",flu like symptoms  from other flu shots,,2,10/04/2019,,,,none
0838382,10/04/2019,IN,58.0,58,,F,,Patient described pain on left side of upper side of chest however flu shot was given in right arm,,,,,,,,,Y,09/30/2019,10/02/2019,2,,PHM,,?,no,no,,,2,10/04/2019,,,,ibuprofen CT Contrast
0838383,10/04/2019,WI,25.0,25,,F,,Patient had received the flu vaccine and had gone to waiting room to wait 15 before leaving. Patient had not been sitting one minute when she reported to her friend she was dizzy and had a syncopal event. She fell to the left hitting her head on the wall. Patient was unconscious for approximately one minute. Vitals were stable. Patient remained pale and lightheaded for approximately 20 + minutes until EMS took her in for further evaluation.,,,,,,,,,U,10/04/2019,10/04/2019,0,,SCH,,unknown,unknown,unknow,,,2,10/04/2019,,,Y,unknown
0838384,10/04/2019,CT,82.0,82,,F,,"patients  doctor called saying patient had an allergic reaction to the shot, since the pneumovax 23 was given in error (patient was supposed to get prevnar 13, as they had pneumovax23 back in 2011.) Md said the allergic reaction was due to getting the same shot twice , and the reaction involved a sore arm, with redness at the injection site",,,,,,,,,U,10/02/2019,10/04/2019,2,,PHM,,,,,,,2,10/04/2019,,Y,,
0838385,10/04/2019,MO,37.0,37,,M,,Pt described his left upper arm and leg being numb the day after flu vaccination and it was resolved the following day.   He did not report the symptoms (until today 10/4/19) or require/request treatment.,,,,,,,,,Y,09/20/2019,09/21/2019,1,,PHM,,,,SMOKER,,,2,10/04/2019,,,,NKDA
0838386,10/04/2019,CO,0.17,0,.2,F,,"Gave patient extra dose of HIB, patient has to catch up on hep b vaccine.",,,,,,,,,Y,10/03/2019,10/03/2019,0,NONE,PVT,,NONE,NONE,NONE,,,2,10/04/2019,,,,NONE
0838387,10/04/2019,TX,10.0,10,,M,,Patient was vaccinated in exam room and after 5 minutes patient was instructed to walk to the lab for additional testing.  The lab assistant  heard a knock on the wall and looked out into the hallway when she witnessed patient falling to floor.  She grabbed patient in time before he hit the floor.  The patient was quickly examined by physician who reports he had a tonic clonic seizure for 5-10 seconds.  The patient awoke after seizure and vital done (wnl) and juice was given.  The patient was brought back to room and assessed.  He was sent to ER for evaluation given neurologic sx after head injury.,,,,,,,,,Y,10/02/2019,10/02/2019,0,None,PUB,,none,none,,,,2,10/04/2019,,Y,,NKA
0838388,10/04/2019,MD,63.0,63,,M,,"Pt reported he started having redness and swelling at the injection site within 2 hours.  Redness, swelling & pain progressed through the evening.  He reported to the office the following day with redness and pain extending through (L)Deltoid around the injection site.  Pt was seen here at the office by Dr. and advised pt to use hot/cold compress and Tylenol as needed to help with symptoms.  Pt was also advised to go to ER if he experiences any numbness, tingling or weakness in (L)UE.",,,,,,,,,N,10/02/2019,10/02/2019,0,NA,PVT,,"ASA 81mg, Sertraline 100mg, Gabapentin 300mg, Baclofen 10mg, Ranitidine 150mg, Pravastatin 40mg, Metoprolol Succ 25mg, Amlodipine 5mg, Lorazepam 1mg, Plavix 75mg, Nicotine 21mg Patch",None,"Hypertension, Hyperlipidemia, CAD, Anxiety, Insomnia, Nicotine Dependence",,,2,10/04/2019,,Y,,Demerol
0838389,10/04/2019,NE,6.0,6,,M,,Mom stated this AM pt woke up site was about a dollar size in redness and itched. Mom then gave Benadryl and redness and itching went away.,,,,,,,,,Y,10/02/2019,10/04/2019,2,none,PVT,,cetirizine 10mg,none reported,none,,,2,10/04/2019,,,,NKA
0838390,10/04/2019,MA,14.0,14,,M,,"developed hives 24 hours later, itchy, treated with benadryl seen in Dr's office 48 hours later, still with hives, treat with benadryl, referred to allergist",,,,,,,,,N,10/02/2019,10/03/2019,1,none,PVT,,trileptal,none,epilepsy,,,2,10/04/2019,,Y,,none
0838391,10/04/2019,NY,69.0,69,,F,,"I started with a severe headache and neck pain around 10PM the night of my getting the vaccine.  I woke up in a soaked bed from sweat and had chills around 7AM.  I had muscle aches, was feverish and my throat was bothering me.  I took some cough medicine to help my throat, which is soothed it for awhile.  All that day I slept a lot and when awoke felt very warm inside but chills outside of my body.  The following night while I was asleep, I woke again in a soaked bed and felt warm inside with chills outside.  This subsided as the day went on.  I do not know for sure this was from the vaccine but thought I should complete this form.  I want you to know that I lost my husband 6 months ago and have been having a hard time coping with being alone.  I have been getting flu vaccines for decades and have never had a reaction.",,,,,,,,,Y,10/01/2019,10/01/2019,0,None,PHM,,"Atorvastatin, Ranitidine, Trazodone, Amabelz Lo, Calcium, CoQ1 Centrum Silver, Fish Oil",None,Fibromyalgia,,,2,10/04/2019,,,,None
0838392,10/04/2019,MS,67.0,67,,F,,"Within 5 minutes of receiving  vaccine, she experienced itching all over and flushing, but no rash. She was given Benadryl 25mg po with minimal relief. She was kept in the clinic for observation. Within 30 minutes, she reporting shaking and dizziness on standing. Blood pressure was checked and was 195/98 (136 systolic on arrival to clinic). She continued to be significantly hypertensive and was sent to the Emergency Department for further treatment. She was eventually hospitalized.",,,,,Y,,,,U,10/04/2019,10/04/2019,0,,PVT,,"amlodipine, baclofen, Vitamin D, Catapres patch, colchicine, Eliquis, Flonase, hydrocodone, insulin, losartan, magnesium, antivert, metoprolol, protonix",de Quervain's tenosynovitis,"Hypertension, breast cancer, diabetes type 2, GERD, OSA< Atrial fibrillation",,,2,10/04/2019,,,,"iodine, IV contrast, diltiazem, Levaquin, doxycycline"
0838393,10/04/2019,CA,51.0,51,,F,,"A few hours after receiving vaccine, she noted a firm red ""bump"" around the injection site.  Bump was slightly tender to palpation.  Felt itchy by the center.  A few days later indurated area is wider but not as firm or red.  Arm also felt ""heavy.""  Still had full mobility and strength to arm and shoulder.",,,,,,,,,N,10/01/2019,10/01/2019,0,none,WRK,,,,,,,2,10/04/2019,,Y,,"co-trimoxazole, Naproxen, Sulfa antibiotics"
0838394,10/04/2019,OH,74.0,74,,F,,"10/2/2019; 4pm; diarrhea ( no food since 12 noon) 10/3/2019;4 am; abdominal cramps, diarrhea ( no food since 7 pm, 10/2, light meal)                           8 am- 12 midnight; low grade fever, photophobia, malaise, headache, body aches, and continuing abdominal cramps( no food intake, water and coca cola only) 10/4/2019 ; 10 am, diarrhea 30 min following intake of chicken broth with boiled egg; today the other symptoms are gone, but the diarrhea persisted with food intake.  Missed two days of work as RN due to diarrhea and other symptoms.",,,,,,,,,N,10/01/2019,10/02/2019,1,none,PHM,,levothyroxine 75 mcg daily,none,cardiac pace maker inserted 2017,,,2,10/04/2019,,,,"Iodine, fluoride, Augmentin"
0838395,10/04/2019,,63.0,63,,M,,Rash surrounding injection site (approximately 3 inches in diameter),,,,,,,,,,10/01/2019,10/02/2019,1,,UNK,,,,,,,2,10/04/2019,,Y,,
0838396,10/04/2019,IA,9.0,9,,F,,"Parent states child's right arm became red, swollen, and painful at the injection site after one hour of receiving the injection. Parent states she has adminstered benadryl and ibuprofen to the child Parent states she applied an ice pack to child's right arm. Since the time of injection, parent states the redness and swelling have increased over the child's arm and skin is warm to touch.",,,,,,,,,N,10/03/2019,10/03/2019,0,,PUB,,Multi-vitamin,No,No,,,2,10/04/2019,,Y,,NKDA
0838397,10/04/2019,PA,6.0,6,,F,,"Child inadvertently received 2 doses of flu mist within minutes of each other. The order for administration of flumist was sent electronically to both the medical assistant and the RN (me) working in the sick clinic. After I received the order for the flumist, I entered the patient's room and advised mother that the child was receiving flumist. I verified child's name and date of birth and reviewed the screening questions with the mother of the child. All answers were negative for contraindications, mother signed the screening form. Flumist was administered to the child and the mother then requested a school note. Upon returning to the room with the school note, Dr was in the room. At that time it was discovered that the child had received the flumist minutes before, administered by the medical assistant. Mother did not inform me that the child had already received the flumist. The mother had completed the screening questionaire prior to the first dose of flumist also. Child received 2 doses of flumist within minutes of each other. Mother was counseled to return to office or seek medical attention for any adverse effects. No medical treatment was provided. Dr spoke with mother on 10/04/19. Mother stated child was in her usual state of health.",,,,,,,,,,10/03/2019,10/03/2019,0,none,PVT,,none,Upper respiratory Infection,none,,,2,10/04/2019,,,,none
0838398,10/04/2019,,51.0,51,,F,,"Within minutes of receiving vaccine pain began in my left shoulder.  The pain continued to increase until it was SEVERE.  I treated it with Ibuprofen which offered some relief.  However, 3 weeks s/p the shot, though improved somewhat, the pain continues and some ranges of motion are almost impossible.",,,,,,,,,N,09/12/2019,09/12/2019,0,none yet,PHM,,magnesium; vitamin D,none,none,,,2,10/04/2019,,,,No known allergies with the exception of alcohol and acesulfame potassium when ingested simultaneously.
0838404,10/04/2019,KY,,,,U,,"no adverse effects reported; A patient 14 months old was administered GRDASIL 9; This spontaneous report was received from a medical assistant, concerning a 14-months-old patient of unknown gender. The patient's medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported.   On 23-SEP-2019, the 14-months-old patient was vaccinated with a dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (product administered to patient of inappropriate age) 0.5 milliliter (ml), for prophylaxis, lot number 1614897, with an expiration date on 20-SEP-2021 (frequency, route of administration and anatomical location were not reported). No adverse effects were reported.",,,,,,,,,U,09/23/2019,09/23/2019,0,,UNK,,,,,,US0095075131909USA009331,2,10/04/2019,,,,
0838406,10/04/2019,,,,,U,,"unspecified patient or multiple unspecified patients may have received improperly stored doses of vaccine on unspecified date or multiple unspecified dates; No adverse effects reported; This spontaneous report was received from a health care professional referring to an unspecified patient or multiple unspecified patients of unknown age and gender. Information regarding the patients' pertinent medical history, concomitant medications, or drug reactions and allergies was not provided.  On an unknown date, the patient or multiple patients may have been vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, route of administration, lot # and expiration date were not reported), for prophylaxis. Sterile diluent was properly stored (lot "" and expiration date not reported). The dose of the vaccine was exposed to a temperature excursion of 19 Centigrade (C), total time and highest temperature above 47 Fahrenheit (F)/9C, during a timeframe of 2 hours 30 minutes, which was detected by a data logger. There were no previous temperature excursions. No adverse effects reported.",,,,,,,,,U,,,,,UNK,,MERCK STERILE DILUENT,,,,US0095075131910USA003448,2,10/04/2019,,,,
0838407,10/04/2019,GA,,,,U,,"swelling and hard lump at the injection site, redness, and heat; swelling and hard lump at the injection site; at the injection site redness; at the injection site heat; hard lump at the injection site; hard lump at the injection site; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a patient (reported as 4) who experienced swelling and hard lump at the injection site, redness, and heat (vaccination site inflammation, vaccination site mass, vaccination site induration, vaccination site swelling, vaccination site erythema and vaccination site warmth), while he/she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 18-SEP-2019, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route and unknown site.  On an unknown date, the patient had swelling and hard lump at the injection site, redness, and heat (vaccination site inflammation, vaccination site mass, vaccination site induration, vaccination site swelling, vaccination site erythema and vaccination site warmth) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Lab data was not reported.  Final diagnosis was vaccination site inflammation, vaccination site mass, vaccination site induration, vaccination site swelling, vaccination site erythema and vaccination site warmth.   Patient was recommended with ice the injection site, take Motrin and Benadryl  The patient outcome was reported as unknown for vaccination site inflammation, vaccination site mass, vaccination site induration, vaccination site swelling, vaccination site erythema and vaccination site warmth.  Information on the batch number is requested.  List of document held by sender: none.",,,,,,,,,U,09/18/2019,,,,UNK,,,,,,USSA2019SA267124,2,10/04/2019,,,,
0838408,10/04/2019,,16.0,16,,F,,"nurse reports that an MA gave16 year old Flublok instead of prescribed Fluzone Quadrivalent. No adverse event; nurse reports that an MA gave16 year old Flublok instead of prescribed Fluzone Quadrivalent. No adverse event; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a Nurse via Office Staff.  This case is linked with 2019SA267180, 2019SA267187, 2019SA267188 (same reporter)  This case involves a 16 years old female patient who was vaccinated with dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] instead of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 11 Sep 2019, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE , Frequency: once, lot QFAA1903 , exp date: 19 May 2020 intramuscularly in left arm instead of prescribed dose of INFLUENZA QUADRIVAL A-B VACCINE lot number not reported.  It was a case of actual medication error due to Inappropriate age at vaccine administration and wrong vaccine administered.  At the time of the report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error  List of documents held by the sender: none",,,,,,,,,U,09/11/2019,,,,UNK,,,,,,USSA2019SA267186,2,10/04/2019,,,,
0838409,10/04/2019,AZ,,,,U,,"hard nodule in the arm then the next day this turned into a knot; swelling and redness then diffused over the arm; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves two patients (demographics unknown) who experienced hard nodule in the arm then the next day this turned into a knot (nodule), swelling and redness then diffused over the arm (inflammation), when they received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE prefilled syringe lot number and expiry date not reported via unknown route in unknown administration site.  On an unknown date, the patient experienced a non-serious hard nodule in the arm then the next day this turned into a knot (nodule), swelling and redness then diffused over the arm (inflammation) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was swelling and redness then diffused over the arm and hard nodule in the arm then the next day this turned into a knot.   It was not reported if the patient received a corrective treatment.  The patient outcome was not reported for the events.   Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA269782,2,10/04/2019,,,,
0838410,10/04/2019,TX,32.0,,,F,,"thrombocytopenia; red dots on her body, like freckles, throughout the body, was diagnosed with thrombocytopenia; Initial information received on 26-Sep-2019 regarding an unsolicited valid serious case received from a pharmacist in the.   This case involves a 32 years old female patient who experienced thrombocytopenia (thrombocytopenia) and red dots on her body, like freckles, throughout the body (Ephelides), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history included Bacterial infection (patient had been fighting a bacterial or viral bug for the last month, and she thought it was could have been pneumonia) and Malaise (had been sick for a month on and off).  The patient's past vaccination(s) included flu vaccines. The patient's past medical treatment(s) and family history were not provided.  On 24-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UJ209AB, Exp. Date 30-Jun-2020 via intramuscular route in the left arm.  On 25-Sep-2019, the patient developed a serious thrombocytopenia (thrombocytopenia) and red dots on her body, like freckles, throughout the body (Ephelides) one day following the administration of INFLUENZA QUADRIVAL A-B VACCINE. This events were assessed as medically significant. The patient was hospitalized for these events.  Other relevant tests not reported. It was reported hematologists were conducting more tests  Final diagnosis was thrombocytopenia.  An unknown corrective treatment was received. Patient received a blood transfusion  The outcome was unknown for thrombocytopenia and Ephelides.  List of documents held by sender: none.; Sender's Comments: This case involves a 32 years old female patient who developed thrombocytopenia one day after vaccination with FLUZONE QUADRIVALENT. Time to onset was compatible. The patient's past medical history included Bacterial infection (patient had been fighting a bacterial or viral bug for the last month, and she thought it was could have been pneumonia) and Malaise (had been sick for a month on and off) and weaken immune system due to infection is common cause of thrombocytopenia. Therefore, additional information including patient's medical condition at the time of vaccination, lab test excluding other etiologies are needed for further assessment of the case. Based on the available information, the role of vaccine cannot be assessed.",,,,,Y,,,,U,09/24/2019,09/25/2019,1,,UNK,,,,"Medical History/Concurrent Conditions: Bacterial infection (had been fighting a bacterial or viral bug for the last month, and she thought it was could have been pneumonia); Sickness (had been sick for a month on and off)",,USSA2019SA269830,2,10/04/2019,,,Y,
0838411,10/04/2019,OH,,,,U,,"13 year old patient was administered a dose of Adacel and Menactra vaccine which had a temperature excursion due to the malfunction with data logger at 52 F for about 31 hours and 31.2 F for 30 minutes/No AE; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from an other health professional.  This case is linked to case 2019SA273650 (same reporter).  This case involves a 13 years old patient who was administered a dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot number: U6521AA and expiry date: 26-Jan-2021) DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (lot number: U6128AA and expiry date: 20-Nov-2020) vaccine which had a temperature excursion due to the malfunction with data logger at 52 f for about 31 hours and 31.2 f for 30 minutes.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA269833,2,10/04/2019,,,,
0838412,10/04/2019,NY,,,,F,,"pain as like it is broken, can barely lift it; cannot sleep well from the discomfort; sweats and has clammy skin; Bad injection site pain in the left arm; patient received a dosde of Adacel at Gestation age: 30 weeks; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a 32 years old female patient who experienced pain as like it is broken, can barely lift it (injected limb mobility decreased), cannot sleep well from the discomfort (poor quality sleep), sweats and has clammy skin (cold sweat) and bad injection site pain in the left arm (vaccination site pain), while she received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] at Gestation age: 30 weeks on an unknown date.   Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The events occurred at 30 Weeks of pregnancy.  The date of last menstrual period was not reported. The estimated due date was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Epilepsy and was taking KEPPRA. The patient previous pregnancy/ies details not reported.   No concomitants reported.  On an unknown date (over 9 days ago), the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot U6272AA, expiry date: 26-Apr-2021, via unknown route in the left arm.  On an unknown date, the patient developed a non-serious pain as like it is broken, can barely lift it (injected limb mobility decreased), cannot sleep well from the discomfort (poor quality sleep), sweats and has clammy skin (cold sweat) and bad injection site pain in the left arm (vaccination site pain), unknown latency following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  It was also a case of vaccine exposure during pregnancy.  Other relevant tests were not reported.  Final diagnosis was injected limb mobility decreased, poor quality sleep, cold sweat and vaccination site pain.  It was not reported if the patient received a corrective treatment.  The patient had not recovered from the events.  Additionally, at time of reporting, the outcome of the pregnancy was unknown.  List of documents held by sender: none.",,,,,,,,,N,,,,,UNK,,,Epilepsy,,,USSA2019SA270583,2,10/04/2019,,,,
0838413,10/04/2019,CA,2.0,,,M,,"child received Fluzone Quadrivalent doses two weeks apart, no AE; Initial and additional information received on 26-Sep-2019 and 30-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 2 years old male patient who received twice 0.5 ml INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED (lot number: UJ237AB, expiry date: 30-Jun-2020), two weeks apart, on 11 Sep 2019 and 25 Sep 2019 in left thigh.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error due to inappropriate schedule of vaccine administration.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/11/2019,,,,UNK,,,,,,USSA2019SA270665,2,10/04/2019,,,,
0838414,10/04/2019,DC,,,,U,,"Flublok Quadrivalent was given to a patient under 18 years of age, no AE; Initial information received on 26-Sep-2019 and Additional information was received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional via sales representative.  This case involves patient (less than 18 year of age) who was vaccinated with vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a Dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported via unknown route in unknown administration site.  It was a case of actual medication error due to Inappropriate age at vaccine administration.  At the time of the report, no adverse event was reported.  Information on the batch number was requested.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error  List of documents held by the sender: none",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA270721,2,10/04/2019,,,Y,
0838415,10/04/2019,VA,,0,.3,F,,"a patient they believe received the diluent only and did not receive the Hib portion of Pentacel, no adverse event; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 4 months old female patient who received the diluent only and did not receive the hib portion of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 20-Aug-2019, the patient received a second dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot U6187AA/U6137AA Exp date: 06-Feb-2021, via unknown route in the right thigh.  It was a case of actual medication error case due to Inappropriate reconstitution technique.   lot details: Lot #--The administering LPN documented the lot given as U6187AA with expiry 06Feb2021. The practice knows that the lone lyophilized Hib portion of Pentacel found in the refrigerator was UJ060AA from carton UJ060AAA, expiry 04Oct2020. PQC provided the corresponding diluent as lot U6137AA. The nurse documented everything the same with the exception of the ""8"" which she stated perhaps was supposed to be a ""3"". She says this LPN is known to have such errors in documentation. This is the closest lot that the practice can find to the one provided by PQC as corresponding to the lone Hib and carton that was found.)  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,08/20/2019,,,,UNK,,,,,,USSA2019SA270909,2,10/04/2019,,,,
0838416,10/04/2019,WV,,,,F,,"bruise at injection site; consumer having a complete dose of Fluzone High-Dose due to after the injection having just a little bit of fluid to come back out; consumer having a complete dose of Fluzone High-Dose due to after the injection having just a little bit of fluid to come back out; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 70 years old female patient who experienced bruise at injection site (vaccination site bruising), consumer having a complete dose of fluzone high-dose due to after the injection having just a little bit of fluid to come back out (underdose and exposure via skin contact) while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] and while treated with ACETYLSALICYLIC ACID [ASPRIN].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ238AB via intramuscular route in the left arm.  On an unknown date, The patient developed a non-serious bruise at injection site (vaccination site bruising) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  It was a case of actual medication error due to underdose and exposure via skin contact.   Final diagnosis was consumer having a complete dose of fluzone high-dose due to after the injection having just a little bit of fluid to come back out and bruise at injection site.  On an unknown date, the patient started taking ASPRIN (ACETYLSALICYLIC ACID) dosage unknown (with an unknown batch number). as corrective treatment  The patient outcome is reported as Unknown for bruise at injection site.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA271023,2,10/03/2019,,,,
0838417,10/04/2019,MD,,,,F,,"reaction 5 mins after shot. large welt came up and it was red; reaction 5 mins after shot. large welt came up and it was red; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case was linked to 2019SA271041 (same reporter).  This case involves a 30 years old female patient who experienced large welt came up (urticarial) and it was red (erythema), while she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No concomitant medication received.  On 24-Sep-2019, the patient received a single dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported in the left deltoid.  On an unknown date, The patient developed a non-serious large welt came up and it was red (urticaria) (erythema) 5 minutes following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  No lab test reported. . Final diagnosis was reaction large welt came up and it was red.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for the events.  Information on the batch number was requested.",,,,,,,,,U,09/24/2019,,,,UNK,,,,,,USSA2019SA271040,2,10/03/2019,,,,
0838418,10/04/2019,MD,,,,F,,"reaction 5 mins after shot. large welt came up and it was red; reaction 5 mins after shot. large welt came up and it was red; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case was linked to 2019SA271040 (same reporter).  This case involves a 70 years old female patient who experienced large welt came up (urticarial) and it was red (erythema), while she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No concomitant medication received.  On 24-Sep-2019, the patient received a single dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported in the left deltoid.  On an unknown date, The patient developed a non-serious large welt came up and it was red (urticaria) (erythema) 5 minutes following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  No lab test reported. . Final diagnosis was reaction large welt came up and it was red.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for the events.  Information on the batch number was requested.",,,,,,,,,U,09/24/2019,,,,UNK,,,,,,USSA2019SA271041,2,10/03/2019,,,,
0838419,10/04/2019,TX,,,,M,,"unable to lift the left arm up (only about halfway); mild, constant pain in left arm/stung really bad; fever up 102F; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 48 years old male patient who experienced fever up 102f (pyrexia), mild, constant pain (pain in extremity) in left arm/stung really bad and unable to lift the left arm up (only about halfway) (movement disorder), while he received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.   On 24-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported via intramuscular route in the left deltoid.  On 24-Sep-2019, The patient developed a non-serious fever up 102f (pyrexia) few hours following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  On an unknown date, The patient developed a non-serious mild, constant pain in left arm/stung really bad (pain in extremity) and unable to lift the left arm up (only about halfway) (movement disorder) Unknown latency following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  Body temperature - On 24-Sep-2019: 38.8 Cel [38.8]  Final diagnosis was fever up 102f, unable to lift the left arm up (only about halfway) and mild, constant pain in left arm/stung really bad.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Recovered / Resolved on an unknown date for fever up 102f, as Unknown for mild, constant pain in left arm/stung really bad and as Unknown for unable to lift the left arm up (only about halfway).  Information on the batch number was requested.",,,,,,,,,Y,09/24/2019,09/24/2019,0,Test Date: 20190924; Test Name: body temperature; Test Result:  38.8 {DF}; Result Unstructured Data: 38.8,UNK,,,,,,USSA2019SA271043,2,10/03/2019,,,,
0838420,10/04/2019,,,,,F,,"fever; chills; sick; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a Consumer/Non-HCP.  This case involves female patient who experienced fever (pyrexia), chills (chills) and sick (malaise), while she received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Breast cancer.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious fever (pyrexia), chills and sick (malaise) (Unknown latency) following the administration of INFLUENZA VACCINE.  (Other relevant tests included no lab data.) Final diagnosis was sick, chills and fever.  It was not reported if the patient received a corrective treatment.  The event outcome is reported as Unknown for fever, chills and sick.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,Breast cancer,,,USSA2019SA271070,2,10/04/2019,,,,
0838421,10/04/2019,,,,,U,,"gave Fluzone High-Dose to patient Under 65 year age / no AE; gave Fluzone High-Dose to patient Under 65 year age / no AE; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a non-hcp (office staff).  This case involves unknown demographic (patient under 65 year age) patient who received  INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot number and Expiry date unknown) via unknown route in unknown administration site.  The patient's medical history and concomitant medications were not reported.  It was an actual medication error case due to inappropriate age at vaccine administration and overdose.   At a time of reporting no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,,,,USSA2019SA271080,2,10/04/2019,,,,
0838422,10/04/2019,AR,,,,F,,"sick; chills; fever; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a health care professional.  This case involves female patient unknown age who was sick (malaise), had chills (chills) and fever (pyrexia), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  At the time of the event, the patient had ongoing Breast cancer.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious events sick (malaise), chills (chills) and fever (pyrexia), next day (1 day) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Other relevant tests were not reported.  Final diagnosis was fever, chills and sick.  It was not reported if the patient received a corrective treatment.  The outcome of the events was not reported.  Reporter felt these events were as a result of the vaccine.  Information on the batch number was requested.  List of documents held by sender: none.",,,,,,,,,U,,,,,UNK,,,Breast cancer female,,,USSA2019SA271625,2,10/04/2019,,,,
0838423,10/04/2019,KS,,,,M,,"administered the Fluzone High Dose last night and it leaked around the hub of the syringe, no adverse event; administered the Fluzone High Dose last night and it leaked around the hub of the syringe, the patient did get some dose but not all, no adverse event; Initial and follow-up information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 74 years old male patient who was administered the INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE], prefilled syringe last night and it leaked around the hub of the syringe, (lot number: UJ213A, exp date: 26-Mar-2020 in arm NOS via unknown route on 26-Sep-2019.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccination included PNEUMOCOCCAL VACCINE POLYSACCH 23V (PNEUMOVAX) for Immunisation.  It was a case of actual medication error due to vaccine underdose (underdose).  This was also a case of device issue (syringe leak).  Case details: Nurse states she administered the Fluzone High Dose last night to a male patient and the vaccine leaked around the hub of the syringe. The patient only got about  to a  of the dose. The patient was not of good health.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/26/2019,,,,UNK,,PNEUMOVAX,,,,USSA2019SA271961,2,10/04/2019,,,,
0838424,10/04/2019,MN,,64,,M,,"accidentally administered the Fluzone high dose to a 64 year patient rather than 65 year old, no adverse event; accidentally administered the Fluzone high dose to a 64 year patient rather than 65 year old, no adverse event; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 64 years old male patient who was accidentally administered the INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE], lot UJ253AB via intramuscular route in unknown administration site, on 19-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Reporter was not sure according to the chart if the patient had any other vaccines during the same visit.   This was a case of actual medication error due to product administered to patient of inappropriate age and overdose.  Caller said that the accidentally administered the Fluzone high dose to a 64 year patient rather than 65 year old. Caller said that he will be 65 years old next month.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.",,,,,,,,,U,09/19/2019,,,,UNK,,,,,,USSA2019SA271978,2,10/04/2019,,,,
0838425,10/04/2019,WI,14.0,,,F,,"all the medication went down the patients arm, didn't feel anything go in her arm, no AE; Typhim syringe that started leaking, fault of the syringe, no AE; all the medication went down the patients arm, didn't feel anything go in her arm so readministered the injection, no AE; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 14 years old female patient who had exposure via skin contact, Inappropriate dose of vaccine administered and syringe issue while she received vaccine TYPHOID VI POLYSACCHARIDE VACCINE [TYPHIM VI].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 27-Sep-2019, the patient received a Dose of suspect TYPHOID VI POLYSACCHARIDE VACCINE lot R2A26, exp date: May 10, 2021 via intramuscular route in the left deltoid.  On 27-Sep-2019, while administering the vaccine as HCP pressed on the plunger, all the medication went down the patients arm, patient didn't feel anything go in her arm so she readministered the injection (exposure via skin contact). While placing the needle on the syringe she heard a ""cracking sound"" but nothing leaked out at that time. HCP states that was fault of the syringe. It was stated that the carton did not have any damage upon arrival but the cartons from shipping are opened by their purchasing department and she didn't notice any leaking before the injection nor any damage to the carton the actual syringe was in.  It was case of actual medication error due to Inappropriate dose of vaccine administered.  At the time of the report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error  List of documents held by the sender: none",,,,,,,,,U,09/27/2019,,,,UNK,,,,,,USSA2019SA272036,2,10/04/2019,,,,
0838427,10/04/2019,MI,67.0,,,M,,"Fluzone High- Dose to be administered to a 67 year old man, MA administered Flublok Quadrivalent instead, no AE; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 67 years old male patient who received 0.5 ml dose of vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (lot QFAA1905, Exp. Date 21-May-2021 via unknown route in unknown administration site) instead of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE], on 27-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to wrong vaccine administered.  It was reported that MD order was for Fluzone High- Dose to be administered to a 67 year old man. The MA administered Flublok Quadrivalent instead.  No adverse effects reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/27/2019,,,,UNK,,,,,,USSA2019SA272249,2,10/04/2019,,,,
0838428,10/04/2019,CO,,,,F,,"a 9 year old female patient received a dose of Quadracel/No AE; a 9 year old female patient received a dose of Quadracel instead of Adacelwhich was prescribed/No AE; a 9 year old female patient was prescribed a dose of Adacel/No AE; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from an other health care professional.  This case is linked to case 2019SA272368.  This case involves a nine years old female patient received a 0.5 ml booster dose of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] lot C5635AA, expiry date: 18-Jun-2021 via intramuscular route in the left deltoid on 23-Sep-2019 instead of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] which was prescribed to her.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 23-Sep-2019, the patient received a dose Booster dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE lot C5635AA via intramuscular route in the left deltoid.  It was an actual medication error due to inappropriate age at vaccine administration, wrong vaccine administered and product prescribing error.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,09/23/2019,,,,UNK,,,,,,USSA2019SA272344,2,10/04/2019,,,,
0838429,10/04/2019,CO,11.0,11,,F,,"11 year old consumer to receive Pentacel and not the Adacel that was prescribed, no AE; 11 year old consumer to receive Pentacel and not the Adacel that was prescribed, no AE; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to case 2019SA272344 (same reporter).  This case involves a 11 years old female patient who received 0.5 ml dose (booster dose) of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot UJ019AAA, expiry date: 09-Oct-2020) via intramuscular route in left deltoid instead of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] that was prescribed on 23-Aug-2019.  It was a case of actual medication error due to wrong vaccine administered and inappropriate age at vaccine administration.  It was reported that 11 year female patient old consumer to receive Pentacel and not the Adacel that was prescribed.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.",,,,,,,,,U,08/23/2019,,,,UNK,,,,,,USSA2019SA272368,2,10/04/2019,,,,
0838430,10/04/2019,IN,32.0,32,,F,,"My lips have swollen about 6 different times (1 time per side upper left, upper right side, lower right side,lower left side) all at different. Also my finger, toe, and side have all swollen at different times. I have also had rashes on my legs, hands, arms, stomach.",,,,,,,,,N,08/28/2019,08/28/2019,0,No tests or labs have been done.,PVT,,None,None,None,,,2,10/04/2019,,Y,,Fabric softner
0838431,10/04/2019,IA,7.0,7,,M,,Parent states child's left arm became reddened and swollen one hour after injection was given. Parent states redness and swelling have spread across the child's arm and is now warm to touch and hard. Parent states she gave the child benadryl and ibuprofen to the child. Parent states she applied an ice pack to the left arm.,,,,,,,,,N,10/03/2019,10/03/2019,0,,PUB,,Multi-vitamin Claritin,,,,,2,10/04/2019,,Y,,Zithromax Bactrim
0838432,10/04/2019,VA,61.0,61,,F,,"Spotting  started 4 days after vaccine and lasted for 2 days.  Localized pain on areas of the head/forehead, left elbow, left armpit, groin crease area on both sides started 3 days after the vaccine Inflammed cyst formed under right armpit 4 days after the vaccine and one week later the swelling has decreased, but it is still there.",,,,,,,,,N,09/27/2019,09/30/2019,3,N/A until next MD office visit,PHM,,METOPROLOL ER 50MG 1QD LEVOTHYROXINE 100MCG 1QD,N/A  VIVOTIF ON 2/11/19,"HYPOTHYROIDISM, HYPERTENSION",,,2,10/04/2019,,,,NONE THAT PATIENT IS AWARE
0838433,10/04/2019,,66.0,66,,F,,"Redness-- > Monday doubled in size, fever, no heat,  hardness, chills on Monday and Tuesday; Tuesday doubled again, MD Tuesday afternoon started Keflex h/x of MRSA",,,,,,,,,N,09/29/2019,09/30/2019,1,n/a,UNK,,"losartan, pantorazole, metformin, gasx nasacort",gallbladder removed 3 weeks prior,"HBP, pre-DM, acid-reflux",,,2,10/04/2019,,Y,,"PCN, thiazide, sulfa, loratidine/fexofenadine"
0838434,10/04/2019,CO,6.0,6,,M,,"swelling, spreading redness extending from injection site with treatment of Benadryl x 2 - dx of cellulitis, tx with higher dose of Benadryl and steroid Rx",,,,,,,,,U,10/03/2019,10/03/2019,0,,PVT,,Current Outpatient Medications on File Prior to Visit Medication Sig Dispense Refill ? albuterol (VENTOLIN/PROVENTIL) (2.5 MG/3ML) 0.083% Nebu Soln 2.5 mg (3 mL) inhaled using nebulizer every 4 hours as needed 1 BOX 3 ? albuterol HFA (PROAI,unknown,"history of MED12 gene mutation, global developmental delay, EoE, feeding difficulties and G-tube dependence, CLD, asthma, and RML bronchomalacia with recurrent respiratory infections",,,2,10/04/2019,,Y,,"eggs, milk, soybean, wheat"
0838435,10/04/2019,AR,54.0,54,,F,,"Patient is an employee who is a nurse who works in ED. Reported to me today that she had severe pain all over her body, deep ""crushing"" bone pain and limited range of motion in arms. No treatment. Resolved in 24 hours.",,,,,,,,,Y,09/25/2019,09/25/2019,0,none,OTH,,not known,no,none,,,2,10/04/2019,,,,Sulfa
0838436,10/04/2019,MN,80.0,80,,F,,"Patient reports she was not feeling well the next day (10/02/2019) and was experiencing ""irregular heart beat"".  Went to ER on 10/03/2019. Reported symptoms 10/04/2019. Patient states she feels ""fine"" today.",,,,,,,,,Y,10/01/2019,10/02/2019,1,Patient was seen in the ER,OTH,,81mg Asprin Q morning Mulitvitamin  Calcium 600 Co-Q10  Omega 3 Fatty Acid  Evening meds:  Escitalopram 10mg by mouth Biotin 2500mcg with Supper  VitD3 2000IU  Lutein 20mg Melatonin 5mg Claritin Ready 24 Hour Tab Lumigan 0.01% in left eye A,Patient did not report any illness.,myo-cognitive impairment Past history of Pulmonary Embolism  Irregular heart beats (5 years ago) was given Metoprolol but experienced side effects and this med was discontinued.,,,2,10/04/2019,,,Y,Sulfa- bad reaction patient does not really consider this an allergy
0838437,10/04/2019,OH,76.0,76,,M,,Patient presented 12 days after injection with a large bruise at the injection site.   Patient stated the site was swollen initially then turn bruised and has been healing since.,,,,,,,,,,09/22/2019,09/01/2019,,,PHM,,"omeprazole 20mg, allopurinol 300mg, glipizide 10mg, metformin 1000mg, pravastatin 40mg, tamsulosin 0.4mg, lisinopril 20mg",unknown,"hypertension, diabetes, hypercholesterolemia, gout",,,2,10/04/2019,,,,no known allergies
0838438,10/04/2019,FL,4.0,4,,M,,"Two days ago DTAP+ IPV IM given in left thigh, MMR+ Varicella subcutaneously given in right thigh. Findings today consistent with localized, inflammation delayed reaction to vaccines. Sites marked. Cool compresses and motrin encouraged. Sites' symptoms should not worsen. Monitor for increasing redness, pain, drainage, and swelling- if these occur he needs to be reevaluated, office open weekends and evenings.  Should not be scratching as it can make worse.",,,,,,,,,U,10/02/2019,10/03/2019,1,,PVT,,NONE,NONE,NONE,,,2,10/04/2019,,Y,,NONE
0838439,10/04/2019,WA,10.0,10,,F,,"Within 1-2 minutes of receiving vaccine pt developed facial flushing  and reported she didn't fell well. Also reports feeling pressure in her chest. Pt was laid down and within 3-5 minutes her symptoms had resolved. By the time I examined her (about 5 minutes after she developed the reaction), she had a normal exam and felt fine. I believe we gave her something to drink.",,,,,,,,,Y,09/16/2019,09/16/2019,0,none,PVT,,methylphenidate 2.5-5 mg as needed for attention (not taken on this day) Albuterol in haler (not taken on this day),mild cough off and on for a few weeks,Exercise induced asthma,,,2,10/04/2019,,Y,,none known
0838440,10/04/2019,IN,62.0,62,,M,,"patient friend called, said there was an adverse effect to flu shot that the pt received, they called their insurance nurse, nurse told them to call pharmacy to report adverse event, said that pt arm was swollen from shoulder to middle arm, was told to put ice and take acetaminophen",,,,,,,,,N,10/02/2019,10/03/2019,1,,PHM,,"meloxicam,benztropine, amlodipine, risperidone",,,,,2,10/04/2019,,,,nka
0838441,10/04/2019,CO,76.0,76,,M,,Headache which progressed to a more severe headache.  Severe chills.,,,,,,,,,Y,10/02/2019,10/02/2019,0,,PHM,,,,,Reported that got a headache after the 2018-2019 Fluzone HD but not years previous to that.,,2,10/04/2019,,,,
0838442,10/04/2019,WI,68.0,68,,F,,"Patient experienced pain at injection site, overall joint/body aches,  fatigue, and severe chills that started the evening after vaccination.  Will apply ice to arm, rest and take otc pain medication of choice (tylenol/ibuprofen) if needed to help with pain and discomfort.  Will follow up with pharmacy or physician if symptoms worsen or do not resolve in 2 days.",,,,,,,,,U,10/03/2019,10/03/2019,0,,PHM,,,,,,,2,10/04/2019,,,,
0838443,10/04/2019,AZ,74.0,74,,F,,"Patient called pharmacist 2 days after receiving the Fluad and Shingrix vaccines to report that she developed a red, raised, and slightly warm red patch on her upper arm approximately 24 hours after being vaccinated.  This was the same arm in which she received the vaccines.  The spot was not painful and did not particularly bother her aside from the intermittent itching. Patient said she was not experiencing any signs on anaphylaxis and would continue to monitor. She believes it had improved since the day before.",,,,,,,,,U,10/02/2019,10/03/2019,1,,PHM,,"ELIQUIS, METFORMIN, SOTALOL, ALSO RECEIVED FLUAD AT THE SAME TIME",,"DIABETES, A FIB",,,2,10/04/2019,,,,
0838444,10/04/2019,TX,70.0,70,,M,,Severe skin rash that the patient described as petechiae that stretched from his knees to his torso and back. Had a severe itch. Had to go to the doctor and got a prescription for triamcinolone.,,,,,,,,,N,09/20/2019,09/21/2019,1,,PHM,,"clonidine, carvedilol, gabapentin, Norco, dicyclomine, simvastatin, amlodipine",unknown,"hypertension, hyperlipidemia, IBS, anxiety, peptic ulcer",,,2,10/04/2019,,Y,,none up to this point
0838445,10/04/2019,TX,5.0,5,,F,,"Diabetes Mellitus Type 1, became very dehydrated, blood sugars were in the 900's, taken to the hospital and was given insulin and fluids and continue to take insulin daily, for the rest of my life to survive.",,,Y,,Y,5,,Y,N,05/02/1995,11/02/2001,2376,Hospitalization,PVT,,None,None,,,,2,10/04/2019,,Y,Y,None
0838446,10/04/2019,AZ,65.0,64,,F,,"patient arm swollen, red and hot. two hours later she returns with some signs of bleeding under the skin on the same arm.  First advised the patient to take some Benadryl, the when she returns I advise to check with urgent care",,,,,,,,,U,10/03/2019,10/04/2019,1,,PHM,,N/A,none,none,,,2,10/04/2019,,,,none
0838447,10/04/2019,TX,66.0,66,,F,,"No side effects from Flu Shot.  Side effects of Shringrix  Shot #1: - Next day - soreness, redness, slight pain - Next day - very sore, redness traveling down arm (from top of arm) to elbow - Pain - had to take Tylenol. - Arm was extremely HOT and BLOOD  RED for 4 days  - Used cold packs on arm. - After 4 days, redness started going away - October 1 - noticed a ""peeling"" (dry, flakey skin) at top of arm near injection site. - Skin issue still there.  I put lotion on to give it moisture.",,,,,,,,,Y,09/09/2019,09/10/2019,1,,PHM,,Flu Shot in other arm. No meds.,None,"Diabetes Type 2, Heart issues (AFIB all the time).",,,2,10/04/2019,,,,None
0838448,10/04/2019,AZ,78.0,78,,M,,"Patient called pharmacist approximately 24 hours after receiving the Fluad and Pneumovax23 vaccines. He reported that the left arm, the arm in which the Pneumovax23 was administered, was causing him a great deal of pain the night before. He said it was difficult to sleep that night. During the conversation with the pharmacist he reported that his pain had since significantly improved and that he was not experiencing any other complications such as redness, swelling, allergic reaction, or loss of arm function/mobility. He did not feel like he needed to follow up with his primary doctor as his arm pain was much improved.",,,,,,,,,U,10/03/2019,10/03/2019,0,,PHM,,"MONTELUKAST, AZITHROMYCIN 250 MG (1 TAB TWICE WEEKLY)",,,,,2,10/04/2019,,,,
0838449,10/04/2019,TX,32.0,32,,F,,"pain 3/10 right deltoid affected site 98.6, 84, 20, 97 % on room air, 117/79, 5 ft., 134.2 lbs. Right deltoid area  with erythematous  patch  appears oval size shape approximately  1.5-inch x 3/4 inch in diameter, afebrile, no ulceration",,,,,,,,,N,10/03/2019,10/04/2019,1,none done,OTH,,"Tylenol 500 prn, Atenolol 25 mg 1 daily",no illness at present time,tachycardia,,,2,10/04/2019,,Y,,NKA
0838450,10/04/2019,PA,24.0,24,,F,,"Pt reports an itchy, warm, painful, red spot at the sign of the injection that began the evening of receiving Afluria. Pt came in to pharmacy 3 days and 4 days afterwards to be seen by two different pharmacists. Both pharmacists, including myself, determined the reaction to be allergic in nature and advised pt to take Benadryl at night. On second visit to pharmacy, pt reported reaction to be the same or a little bit better and not getting any worse.",,,,,,,,,Y,09/30/2019,09/30/2019,0,,PHM,,"nortriptyline 30mg daily, propranolol 200mg daily, naproxen 1000mg daily, aimovig 140mg/ml monthly, topiramate 150mg daily, kariva daily, hyoscyamine er 0.75mg daily, course of prednisone 40mg daily x 7days finished on 9/25/19",None,,,,2,10/04/2019,,,,No known allergies
0838451,10/04/2019,CO,69.0,69,,F,,"patient reports pain radiation across upper body and up neck, temperature of 101.0, and shivers.   She took a Percocet  that night for the pain and symptoms resolved within a day.",,,,,,,,,Y,09/12/2019,09/13/2019,1,,PHM,,,,,,,2,10/04/2019,,,,
0838452,10/04/2019,MI,,64,,F,,"Patient woke up at 2am, symptoms included: muscle aches, headache, upset stomach, profuse vomiting, chills, body aches and dizziness.  Has not taken any medicine or called the vaccine administrator.    Symptoms similar as the last time received vaccines. Currently, dizziness is gone but headache still is there.",,,,,,,,,U,10/03/2019,,,,PHM,,"Venlafaxine, Vitamin for hair/skin/nails :Biotin","No, No",COPD,"Flu: muscle aches, headache, upset stomach, profuse vomiting, chills; gradually got better after 24 hours",,2,10/04/2019,,,,None
0838453,10/04/2019,OR,3.0,3,,M,,Patient had a secondary cellulitis around the injection site and into his right arm and neck.,,,,,,,,,Y,10/01/2019,10/01/2019,0,none,PVT,,none,none,none,,,2,10/04/2019,,Y,,mosquito
0838454,10/04/2019,WA,43.0,43,,F,,"Arm was sore for three days. Patient denies any swelling or redness. On the third day in the morning patient noted redness and swelling at the injection site. Denies fever, but states injection site was hot to touch. Patient called clinic and was advised to go to the walk in clinic. Patient was seen at the walk in clinic on 9/26/19. Antibiotics and Motrin were prescribed. Dx of cellulitis was made. patient states she completed antibiotic therapy. Patient states it took 3-4 days following start of  antibiotics for the swelling and redness to go down. Currently patient feels a lump under the skin at the injection site. Patient states it felt like her arm was asleep starting on the third day after injection. Patient states are still feels weak.",,,,,,,,,Y,09/20/2019,09/23/2019,3,denies,PVT,,Trazodone 50 mg QD Flovent HFA 110 mcg ProAir Albuterol Zyrtec,9/23 vaginal Infection Bacterial vaginosis. Was taking Metronidazole 500mg x days. Did not complete course of antibiotics,Asthma,,,2,10/04/2019,,Y,,denies
0838455,10/04/2019,CA,68.0,68,,M,,"3.5 hours after getting the shot, I had massive chills and accompanying shaking -- hand and arm movements of 6-12 inches. I had difficulty walking, being very clumsy, bumping into things, and having to use fixed objects (doorways...) to help guide myself. Was weak -- took multiple tries to get up from a recliner. There was also stiffness in the muscles. The injection site was only slightly tender. Temperature for 8pm-12M varied slightly around 103.6 degrees. When I went to bed at 3am it was down to 102.2 degrees. At 7am it was 101.8; at 1pm 99.6. At 24 hours after the shot, still stillness. I have had annual flu shots for as long as I can remember, and never had anything more than a mild reaction.  Reporting this because the rapid onset of symptoms and the severity could put people in danger if they are out-and-about.",,,,,,,,,Y,10/03/2019,10/03/2019,0,none,PVT,,"AM: Escitalopram (for Lexapro), Bupropion (for Wellbutrin) PM (just before bed): Trazodone, Tamsulosin (for Flomax)",none,Obstructive Sleep Disorder,,,2,10/04/2019,,,,Penicillin (from childhood)
0838456,10/04/2019,NY,51.0,51,,M,,"sharp pain immediately after vaccine, pain has persisted for now the two weeks post and continues. sharp pain, sore muscular pain, hurst to lift arm, tender",,,,,,,,,N,09/13/2019,09/13/2019,0,n/a,PHM,,"acarbose, enalapril, farxiga, metformin",none known,"diabetes, high blood pressure",,,2,10/04/2019,,,,penicillin
0838457,10/04/2019,CA,66.0,66,,M,,"Pt had prevnar 13 on 10/2/18.  Pneumovax 23 was last vaccine to give.  Patient stated the next morning he felt like his arm was swollen, warm to touch below injection site.  The pharmacist yesterday instructed him to ice and use an anti-inflammatory.  Patient came in today around 3:16pm stating his arm was still swollen and red, but the redness had moved down his arm.  The swelling was above and below elbow.  Contacted the patient's pcp Dr. and left a message.  Instructed the patient to go to the urgent care next door, but he said he would ice it and take Naproxen.  We had him mark his arm, and I instructed him if the redness expands or is still warm to touch seek medical treatment.",,,,,,,,,N,10/02/2019,10/03/2019,1,,PHM,,Atorvastatin 40mg - 1 tab qd,,,,,2,10/04/2019,,,,
0838458,10/04/2019,MT,67.0,67,,F,,Patient noticed rash at injection site of shingrix morning of 10/4/19. Told patient she could take benadryl to help speed up the healing process or it would resolve on its on. Rash was about one inch by one inch.,,,,,,,,,N,10/02/2019,10/04/2019,2,,PHM,,,,,,,2,10/04/2019,,,,
0838459,10/04/2019,,67.0,67,,M,,"Shivers, fatigue, stuffy head, pain in injection site",,,,,,,,,N,10/03/2019,10/04/2019,1,,UNK,,None,None,None,,,2,10/04/2019,,,,None
0838460,10/04/2019,,81.0,81,,F,,"patient came in on 10/4/19-reported red swollen area of arm around half circumference of arm.  are was about size of her hand. injection site had black and blue small area.  patient said was warm to touch, and occasionally it was itchy.  she came in because her dermatologist examined her.  she said she didn't think it got worse symptoms since injection. she will monitor , use cold compresses, and see doctor possibly / if gets worse.",,,,,,,,,,09/30/2019,09/30/2019,0,,PHM,,,,,,,2,10/04/2019,,,,
0838461,10/04/2019,SC,69.0,69,,F,,"Total and complete lethargy.  And it hasn't gotten much better since. I couldn't function for the first 2 weeks after.  About the 2nd or third day, I woke up with stopped-up ears and dizziness, that didn't go away so I went to Urgent care. That doctor said my ears look clear but said I had Vertigo and gave me a prescription for Prednisone and one for Meclizine. I finished the Prednisone but only feel about 11% better.  I already had an appointment with my Family doctor on 10/03/2019, for a medication and he's sending me to an ENTon Oct 22, 2019.   I don't know what's going on but  I'm miserable. I'm also not sure if was the vaccines. But it all started AFTER I had them.",,,,,,,,,N,09/09/2019,09/11/2019,2,Stated above,PHM,,Fluoxetine 20 mg./ Omeprazole 40 mg/ Flonase 50 mcg/ Zyrtec 10 mg,None,Back pain/ fibromyalgia/ Arthritis,,,2,10/04/2019,,,,codeine
0838462,10/04/2019,TX,57.0,57,,F,,12 hours after the vaccination the patient developed a fever she measured at 102 F. The fever lasted over 24 hours with little respite after taking OTC ibuprofen and acetaminophen. While she had the fever she also had a severe migraine headache. After the headache and the migraine abated the patient developed a rash on her neck that is burning.,,,,,,,,,U,10/02/2019,10/03/2019,1,,PHM,,Fluoxetine 20mg,No illnesses,None,,,2,10/04/2019,,,,KNDA
0838463,10/04/2019,AZ,45.0,45,,F,,"3 days of severe pain and global weakness of entire right upper extremity; loss of dexterity of right hand; progressive, unremitting pain; symptoms continuing",,,,,,,,,,09/25/2019,10/01/2019,6,,UNK,,,,,,,2,10/04/2019,,Y,Y,
0838464,10/04/2019,NC,69.0,69,,F,,"red, swollen, painful knot at injection site with fever",,,,,,,,,N,10/03/2019,10/03/2019,0,,PHM,,"tylenol, ibuprofen, ice application","sore body, fell on her porch earlier the day of vaccination",smoker,shingrix,,2,10/04/2019,,,,codeine
0838465,10/04/2019,WY,7.0,7,,M,,Patient reports that he began to feel ill immediately following his vaccination. He had a temperature recorded by his mother at 5pm and his temperature was 102.9. He was brought into the walk-in clinic for possible adverse reaction. A rapid strep test was positive in the clinic and the patient was treated for strep. It is possible that the vaccination coincided with bacterial infection. I feel his reaction was due to illness from strep bacteria and not caused from vaccine.  Mother comforted that the VAERS was filed.,,,,,,,,,U,10/04/2019,10/04/2019,0,Rapid strep - result positive.   and UA- Color: light yellow.  Clarity: clear.  Glucose: negative.  Bilirubin: negative.  Ketones: negative.  Specific Gravity: 1.010.  Blood: negative.  pH: 7.0.  Protein: trace.  Urobilinogen: normal.  Nitrite: negative.  Leukocytes: negative.,PVT,,none,none,a possible intestinal issue that has not been diagnosed,,,2,10/04/2019,,,,Parents removed lactose from diet
0838466,10/04/2019,TN,27.0,27,,M,,"His fiancee call the pharmacy about 2 hours after he got his flu shot. He was feeling dizzy, had numbness in his face, and his blood pressure was elevated. He did not have any breathing problems. He had been working outside in the hot sun. The RPh told him to come inside and sit down and cool off for a while to see if he improved. He showed up at the pharmacy about 3 hours later, and he still felt poorly but blood pressure had improved. RPh advised him to take Benadryl. He said is could not.  She then suggested Claritin or Zyrtec and to see medical attention if his symptoms did not improve. I called him today. He said all of his symptoms have went away and he is feeling better except for a bad headache today.",,,,,,,,,Y,10/03/2019,10/03/2019,0,none,PHM,,Unknown,Unknown,Unknown,,,2,10/04/2019,,,,none
0838467,10/04/2019,MI,64.0,64,,F,,"blistering pain, flu like symptoms, headache, huge reddish rash around shot area (left arm) blurred vision, burning sensations for over a week duration",,,,,,,,,N,09/27/2019,09/28/2019,1,,PVT,,atenolol lisinopril advil,,"high blood pressure, tinnitus overweight",,,2,10/04/2019,,Y,,not identified
0838468,10/04/2019,,66.0,66,,F,,Patient reported swelling in left arm for 1 day following the vaccination. She was advised to see the doctor to make sure it was not an infection. The doctor treated her with benadryl and told her it was likely a reaction to her shots. She followed up with us after her doctor's appointment and she said the swelling has significantly decreased.,,,,,,,,,Y,10/02/2019,10/02/2019,0,,UNK,,,,,,,2,10/04/2019,,Y,,
0838469,10/04/2019,MN,53.0,53,,F,,"Developed hives over my entire body (legs, stomach, chest, back, butt, arms).  The hives were very itchy.  The rash lasted for one week.  I took allergy pills and used anti itch cream and calamine lotion to help with the itching.",,,,,,,,,Y,09/13/2019,09/13/2019,0,,PHM,,None,None,None,,,2,10/04/2019,,,,None
0838470,10/04/2019,CA,73.0,73,,F,,Student pharmacist mistakenly gave a third Shingrix vaccination. No treatments given or outcomes reported.,,,,,,,,,Y,10/04/2019,10/04/2019,0,,PHM,,,,,,,2,10/04/2019,,,,
0838471,10/04/2019,DE,62.0,62,,M,,"Flu like symptoms. Body ache, fever, headache. Over counter Tylenol and Nyquill",,,,,,,,,N,10/03/2019,10/04/2019,1,,PHM,,"Aspirin, Bupropion, Synthroid,  Fenofibrate",No,No,,,2,10/04/2019,,,,No
0838472,10/04/2019,OR,40.0,40,,F,,"On 10/4/19, the patient reported that she experienced severe stiffness/soreness in the back and neck as well as soreness in the left arm that started the next day after vaccination. Patient was referred to her provider in case of adverse effect. Although body aches occur in 1 out of 3 patients, patient reported that her body ache resulted in her not being able to move her neck and back for a few days.  She reports icing it to little effect, but she explained that she may be ""feeling a little bit better"" as of 10/4/19.",,,,,,,,,N,09/28/2019,09/29/2019,1,Unknown.,PHM,,Meloxicam,N/A,N/A,,,2,10/04/2019,,,,NKDA
0838473,10/04/2019,OR,69.0,69,,F,,"Beginning Wednesday 9/18, while driving, felt a little whoozy then ""head was in bubble bath or attacking itself"" then whole body got tingly.  Tingling has persisted until current day, weakness and dizziness.  lack of appetite.  Did not experience typical side effects listed in the information statement",,,,,,,,,N,09/16/2019,09/18/2019,2,none to date,PHM,,"Levothyroxine 125mcg, Loratadine 10mg, MVI",none,none,,,2,10/04/2019,,,,none
0838474,10/04/2019,OH,71.0,71,,M,,"Patient called on 10/4/19 and said that he still has a ""dull ache"" in his left arm after getting Prevnar 13. He said the pain continues from the ""upper arm"" and ""stops at the elbow"". He said it started the day of vaccine and has continued. He said if he lays on his arm for a while, he sometimes gets a sharp pain. He denies any problems with range of motion, but he states APAP did not help. Patient says he has not discussed his sx with his doctor, and he was advised to follow up with his PCP.",,,,,,,,,N,08/23/2019,08/23/2019,0,,PHM,,,,,,,2,10/04/2019,,,,
0838475,10/04/2019,CT,67.0,67,,F,,"Next evening after the vaccine (9/24/19), on the ventral aspect of the left arm from injection site to elbow was red, hot, painful to movement, swollen. Symptoms lasted until 9/27/19. Patient took Benadryl from 9/25-9/27 and did not seek medical care. Condition was self-resolved.",,,,,,,,,Y,09/24/2019,09/25/2019,1,none,PHM,,"red yeast rice extract, calcium, vitamin d 1000 units, vitamin c 500mg, omega-3-fatty acids",none,none,,,2,10/04/2019,,,,none
0838476,10/04/2019,AR,64.0,64,,M,,"pain at injection site, malaise.",,,,,,,,,U,10/02/2019,10/04/2019,2,,PHM,,"invokana, Humalog mix, losartan, metformin, atorvastatin, omeprazole, carvedilol",,"DM, HTN",,,2,10/04/2019,,,,nkda
0838478,10/04/2019,CA,55.0,55,,F,,patient feels pain at injection site. her arm is warm and looks like there is redness in the arm area that has spread over the upper arm. patient has taken acetaminophen for the pain,,,,,,,,,,10/02/2019,10/02/2019,0,,PHM,,,,,,,2,10/04/2019,,,,
0838479,10/04/2019,,70.0,70,,F,,"Redness, swelling and Rash on the back of pt",,,,,,,,,,09/06/2019,09/06/2019,0,,UNK,,,,,,,2,10/04/2019,,,,
0838480,10/04/2019,NV,62.0,62,,F,,"next evening she was feverish, nausea and severe cough with brochial spasm. she went to MD office next day",,,,,,,,,Y,09/19/2019,09/20/2019,1,,PHM,,,,,,,2,10/04/2019,,Y,,
0838666,10/04/2019,WI,60.0,60,,F,,First day there was pain in her right arm at the injection site. Second day she had pain around most of her upper arm and the injection site. Third day she had a non-itchy rash around the injection site and around her upper arm.,,,,,,,,,Y,06/21/2019,06/22/2019,1,,PVT,,"atorvastatin, glipizide, levothyroxine, lisinopril, Janumet, citalopram, Lantus insulin",None,"Diabetes, hypothyroidism, Dyslipidemia",,,2,06/25/2019,,,,Cheap metals & Nickel
0838667,10/04/2019,NY,11.0,11,,M,,"On 9/22/19 pt. ambulatory came to ER w/ c/o headache frontal, neck pain & pain in low back when bending over or attempt to touch his chin to his chest (hx of viral meningitis w/similar symptoms on 2015 but no immunization) 2 days ago had Menatra Tdap & HPV9 Date seen in ER 9/22/19 Vital Signs T - 37.2 Oral Pulse 90 RR18 Wt - 50.3 kg. BP 107/67 Pulse Ox 97% Review of system - photophobia  No vomiting P.E alert awake, NHD Skin - eczema wrist, knees, elbow Neck & meningismus unable to filex past midline No other neurological signs Laboratory - CBC, CMP Lumbar Tap see result -  Transferred to other Hospital - Admitted 9/22/19 Discharged 9/24/19 at 16:00 Discharge Diagnosis Aseptic Mengitis Hospital Course in Medical Center Though there was a low suspicion for bacterial meningitis, patient was empirically treated w/ 2nd dose of Ceftriaxone (9/23/19) On day of discharge 9/24/19 - Afebrile, no headache walking, no abnormal neurological findings on discharge 9/27/19 - 9/30/19 10/1/2019} Had been calling mother to make a f/ up appointment",,,,,Y,3,,,,09/20/2019,09/22/2019,2,9/22/19} 1 dose ceftriaxone 50 mg/kilo 1 dose acyclovir (10mg) kilo TRANSFERRED,PVT,,Eucrisa,None on day of vaccine 9/3/19 cellulitis-wrist,Eczema,,,2,09/20/2019,,Y,Y,"Augmentin, Red dye"
0838678,10/04/2019,SD,11.0,11,,M,10/04/2019,"Red, hot, swollen arm & entire right arm gave solumedrol injection",,,,,,,,,U,10/02/2019,10/03/2019,1,CBC,PVT,PVT,,0,,,,1,,,,,
0838679,10/04/2019,FL,53.0,52,,M,,Patient says that 1-2 days after first shot he had a fever of 103 degrees F for another 1-2 days. Resolved after Tylenol OTC.,,,,,,,,,Y,06/25/2019,06/26/2019,1,None,PHM,,unknown,,unknown,upon questions patient indicated this happened once b/f after tetanus hot.,,2,10/04/2019,,,,None
0838707,10/04/2019,IL,0.5,0,.5,F,,No reaction occurred after dose was given,,,,,,,,,,09/03/2019,,,N/A,PVT,,N/A,N/A,N/A,,,2,10/04/2019,,,,N/A
0838730,10/04/2019,IL,11.0,11,,M,10/04/2019,"Pts left deltoid has reddened area at injection site the size of a softball. Area is swollen - pt had Menveo vaccination in Lt Deltoid on 10-1-19 - woke up 10-3-19 with swelling / redness, Benadryl 25 mg every 4-6 hrs for 24 hours apply ice pack to area.",,,,,,,,,,10/01/2019,10/03/2019,2,,PVT,OTH,,NONE,NKA,,,1,,,,,
0838731,10/04/2019,AK,75.0,75,,F,,"10/2: Severe left upper arm pain radiating into left shoulder, unable to raise left arm occurring approximately 4 hours after administration 10/3: Clinic visit: persistent (L) upper arm pain without erythema, edema or induration @ injection site (Left deltoid muscle) unable to raise arm d/t pain: Hydrocodone/acetaminophen 7.5 mg/325 mg prescribed for pain control 10/4/19: Telephone follow-up: Mild improvement in left upper arm pain - still requiring narcotic pain medication for pain control. Patient report 0 edema, erythema or induration at injection site",,,,,,,,,N,10/02/2019,10/02/2019,0,None,PVT,,"ASA, candesartin, Atorvastatin, Plavix, metoclopramide, Ranitidine",viral Bronchitis,"HTN Hypercholesterolemia, T2 DM, CVA, GERD",,,2,10/04/2019,,Y,,cephalexin
0838732,10/04/2019,TX,62.0,62,,F,10/03/1957,"throat started closing up, lots of Phlegm + asthma like coughing/wheezing. Just like what happens when I encounter eggplant. Took Benadryl + it subsized except heart racing + itching",,,,,,,,,Y,10/03/2019,10/03/2019,0,,PUB,UNK,,NONE,Eggplant + thimerosal,,,1,,,,,
0838733,10/04/2019,MA,11.0,11,,F,,"Approximately 5 min after vaccines given, patient laughing hysterically then crying. Several cycles of this laughing/crying for no reason. Pt monitored x 1hr. vss alert + oriented x 3. Mom in with patient and states ""not usual for her"" Episodes resolved after appox 1 hour Pt d/c'd to  home with mother",,,,,,,,,Y,09/26/2019,09/26/2019,0,None,PVT,,None,None known,Innocent cardiac murmur,,,2,10/02/2019,,Y,,NKA
0838734,10/04/2019,AZ,77.0,77,,F,,"Swelling, redness, Hot, tedernes on upper right arm redness moved down arm by FRI 10/4",,,,,,,,,U,10/01/2019,10/01/2019,0,NONE,PHM,,"ARMOUR THYROID, ANTONAL",NONE,NONE,,,2,10/04/2019,,Y,,NONE
0838744,10/04/2019,OH,70.0,70,,F,,"Patient called approximately 45-50 minutes after receiving the vaccine. She stated that she had swelling of her upper and lower lips. She had not eaten or drank anything different. She stated her breathing was fine. She confirmed she had access to liquid Benadryl, instructed her to drink 10-30 ml of Benadryl. She is to call 911 if she feels throat swelling or difficulty breathing. Contacted patient 50 minutes later and she stated the swelling had not progressed and she still had no issues breathing. Informed her if swelling still not receding after 4 hours, may repeat Benadryl. Called patient 4 hours later and she stated that the swelling had gone down and she was back to normal.",,,,,,,,,Y,10/04/2019,10/04/2019,0,none,PHM,,,unknown,none,,,2,10/04/2019,,,,"macrolides, penicillin, quinolones, sulfa"
0838753,10/04/2019,MA,66.0,66,,F,,"The patient arm was painful, red, swollen and she had pain with movement after the injection. She went to her PCP 2 days later and he gave her an anitibiotic. I spoke with the office and was told they believed she had cellulitis from the vaccination.",,,,,,,,,N,10/01/2019,10/01/2019,0,unknown,PHM,,"zolpidem5mg, combivent respimat, albuterol hfa mdi, quetiapine 200mg, quetiapine 300mg, Spiriva 18mcg handihaler, docusate 100mg, clonazepam 0.5 mg, lisinopril 40mg, multivitamin,",unknown,,,,2,10/04/2019,,Y,,penicillin
0838481,10/05/2019,CA,74.0,74,,F,,"swelling,redness, hives",,,,,,,,,U,10/01/2019,10/02/2019,1,,SEN,,n/a,n/a,n/a,,,2,10/05/2019,,,Y,n/a
0838482,10/05/2019,NY,4.0,4,,F,,Nausea Vomiting Fever,,,,,,,,,Y,10/03/2019,10/03/2019,0,,PVT,,None,None,None,,,2,10/05/2019,,,,Nka
0838483,10/05/2019,IL,30.0,30,,M,,"Overall the vaccine administration went well, however, when I woke up the next day my right arm had a significant amount of pain and loss in range of movement. It feels very stiff in my shoulder, more tender when touched, and less painful when not moved at all. When becoming a certified APhA to vaccinate we were warned about this being an ADE, but I never thought it might happen to  myself. I have a photo of where the injections were given and they were given much too high.",,,,,,,,,N,10/03/2019,10/04/2019,1,None yet but I will be contacting the health clinic this morning to notify them of this and what we need to do about it.,PUB,,Genvoya and lisinopril 5 mg daily,none,HIV - Undetectable,,,2,10/05/2019,,,,ibuprofen
0838484,10/05/2019,MO,51.0,51,,F,,"PATIENT CAME IN LAST EVENING AND SHOWED ME A LARGE RED ROUND AREA, HOT TO THE TOUCH.  SHE SAID IT HAS BEEN GROWING IN SIZE.",,,,,,,,,U,10/02/2019,10/03/2019,1,,PHM,,,NO,NO,,,2,10/05/2019,,,,NONE
0838485,10/05/2019,GA,68.0,68,,U,,"Given Shringrix Vial Kit (Mfg: GlXOAMITHLINW).  Receive shot at 10/02/2019, second shot of series @ 16:16PM.  On 10/03/2019 @ 3:00am I got up to use restroom.  Black out in bathroom, came thru. Pulled myself up to go back to bed, blacked out again. Came back through and climbed into bed, it  was 5am. Woke up at 6:00am with a real bad headache.  Got up at 8am.  My head was really hurting, took an Alive.  Had 2 big knots on both sides of my head, cut on my arm and bruises from where I fell.  Laid back down.  Had cold chills and flu systems and a fever the rest of the day (10/03/2019).  Cold sweats that night..",,,,,,,,,,10/02/2019,10/03/2019,1,,UNK,,,none,none,,,2,10/05/2019,,,,
0838486,10/05/2019,NC,3.0,3,,F,,"Tuesday 10/1 Fever began in the evening sometime reaching up to 102 with decreased appetite.  Lower next morning but returned again that evening again up to 102.  Thursday  10/3 no fever but polka-dot rash all over body persisting until now, 10 AM Saturday 10/5.  White spots present in mouth inside of cheeks with blueish centers.",,,,,,,,,N,09/23/2019,10/01/2019,8,None. Went to Urgentcare  10/3 and they said they have no idea what it could be.,PVT,,Children's multivitamin,None,None,,,2,10/05/2019,,Y,,None
0838488,10/05/2019,NY,17.0,17,,F,,"Patient had nausea, diarrhea, stomach upset, fever and painful leg cramps",,,,,,,,,Y,08/27/2019,08/27/2019,0,none... Went to a natural doctor for detox,PVT,,,"Headaches, low Vitamin B-12",,,,2,10/05/2019,,,,Pennicilin
0838489,10/05/2019,NY,17.0,17,,F,,"High fever, severe muscle aches, severe headaches located in the back of her head, migraines, vision problems with grid-like vision, nausea and diarrhea with lose of 6 pounds and dizziness",,,,,,,,,U,09/18/2019,09/18/2019,0,none  other than chiropractic adjustments and detox treatments,PVT,,,"Headaches, low b-12",,same reaction as mentioned above,,2,10/05/2019,,Y,,Penicillin
0838490,10/05/2019,GA,66.0,66,,F,,"Flu like systoms, hard red hot knot at injection site. Nausea for days",,,,,,,,,N,10/02/2019,10/02/2019,0,,PHM,,"Glimerpride, metformin, atavorastatin, januvia, metropol",None,Diabetes,,,2,10/05/2019,,,,Penicillin
0838491,10/05/2019,GA,71.0,71,,F,,Patient states she began having excruciating pain beginning over one week after receiving vaccine.,,,,,,,,,N,09/23/2019,09/23/2019,0,,PHM,,unknown,,,,,2,10/05/2019,,,,penicillin
0838492,10/05/2019,,25.0,25,,F,,PATIENT REPORTED HAVING SEIZURES THE DAY AFTER THE VACCINE,,,,,,,,,U,09/25/2019,09/25/2019,0,,UNK,,,,,,,2,10/05/2019,,Y,Y,
0838493,10/05/2019,TX,53.0,53,,M,,fever and muscle pain,,,,,,,,,N,10/04/2019,10/05/2019,1,,PHM,,"yes, liptor",no,no,,,2,10/05/2019,,,,no
0838495,10/05/2019,KY,45.0,45,,M,,"Donor called into the plasma center and reported gnawing, throbbing pain deep in right arm 2 weeks after Tdap immunization. Donor reports that a resting position alleviates pain minimally and movement/use increases pain. Donor states there is no bruising present  and initial muscle soreness from injection subsided about 3-4 days after the injection. Donor states he has used Advil and Pennsaid topical ointment (Diclofenac) for treatment of pain with little to no improvement. Donor states he is going to see his primary care doctor to follow up as soon as possible.",,,,,,,,,N,09/20/2019,09/23/2019,3,,OTH,,,,,,,2,10/05/2019,,Y,,
0838496,10/05/2019,TX,61.0,61,,F,,"Patient reports fever over 102 - non-responsive to ibuprofen/tylenol.  All over body aches, severe joint pain.",,,,,,,,,N,10/04/2019,10/04/2019,0,,PHM,,,,auto-immune disease,,,2,10/05/2019,,Y,,none
0838498,10/05/2019,GA,70.0,70,,F,,THE PATIENT CALLED THE PHARMACY STATING THAT SINCE LAST NIGHT SHE HAS HAD SEVERE ACHES/PAINS ALL OVER HER BODY AND CHILLS FROM A FEVER. SHE WAS CONSULTED TO TAKE SOME NAPROXEN TO HELP WITH THE ACHES AND CONTINUE HER NORCO AS PRESCRIBED TO HELP AS WELL WITH THE FEVER AND PAIN. SHE WILL WAIT UNTIL MONDAY TO CONTACT HER DOCTOR IF HER CONDITION DOESN'T IMPROVE.,,,,,,,,,U,10/04/2019,10/05/2019,1,,PHM,,"NORCO, OXYCONTIN",,"FIBROMYALGIA, MIGRAINE, SPINE DISORDERS",,,2,10/05/2019,,,,
0838499,10/05/2019,FL,55.0,55,,F,,"I know other people who had recent flu vaccine at pharmacy and they are reporting the same adverse reaction.  I don't think it was the flu or a cold.  But it has lingered and I feel poisoned is the best way to describe it.  The symptoms are high fever, exhaustion, pain, weakness and sinus congestion.  For me it didn't result in coughing like flu normally does.  It didn't produce any mucus either as flu normally does.  Maybe you should have the vaccinetested given all of the problems recently with tainted medications being imported.",,,,,,,,,U,09/24/2019,09/24/2019,0,,PHM,,not applicable,none,none,,,2,10/05/2019,,Y,,not applicable
0838500,10/05/2019,OR,72.0,72,,F,,PATIENT EXPERIENCED AN ITCHY WELT AT THE INJECTION SITE. THIS GRADUALLY SPREAD ACROSS HER SHOULDER AND NECK AND FACE. SHE SHOUGHT TREATMENT AT HER LOCAL CLINIC AFTER TOPICAL BENADRYL WAS NOT RELIEVING HER SYMPTOMS,,,,,,,,,Y,09/30/2019,09/30/2019,0,,PHM,,"QUETIAPINE, CITALOPRAM, AMPHETAMINE SALTS, ALENDRONATE, MONTELUKAST, HYDROCHOLORTHIAZIDE",RECEIVED GUAIFENSIN WITH CODEINE SYRIP ON 09/26/19,"OSTEOPOROSIS, DEPRESSION, ADHD, HYPERTENSION",,,2,10/05/2019,,Y,,NO KNOWN ALLERGIES
0838501,10/05/2019,FL,77.0,77,,F,,"Chills first night Tiredness for a couple weeks Rash 2  1/2 weeks after injection -  large area around rectum  inflamed and spots extremly painful Treated with gentle wipes, A&D ointment   Healing began Oct 4    after 9 days",,,,,,,,,Y,09/11/2019,09/11/2019,0,,PHM,,Shingrix 50 mcg inj,none,Breast Cancer Feb 2013 in remission,,,2,10/05/2019,,,,none
0838502,10/05/2019,WV,2.0,2,.3,M,,Large red circle just below injection site. Outside edge of circle was bright red. The site was swollen and warm to the touch. Pediatrician advised cold compress and Benadryl. Side effect continues to be there 3 days later.,,,,,,,,,N,10/02/2019,10/03/2019,1,None,PVT,,None,None,None,,,2,10/05/2019,,,,No known allergies
0838503,10/05/2019,IL,61.0,61,,F,,"At approximately 6:45pm on the day of the vaccination, I noticed two  1? hives on my right thigh.  They were  red, raised, hot and itchy. I was awakened at approximately 10:45pm  by uncontrollable shivers and convulsions, which lasted around 45 minutes.  There was no fever. The next day (10/04/2019), I was fatigued, with a headache and light sensitivity.  Another hive appeared on my right buttocks. I took ibuprofen on the day of the vaccination to alleviate soreness at the injection spot.",,,,,,,,,N,10/03/2019,10/03/2019,0,,PVT,,pravastatin aspirin,none,none,"Shingrix, first dose on  07/08/2019, 61 years old, fever and headache",,2,10/05/2019,,,,penicillin antibiotics
0838504,10/05/2019,FL,51.0,51,,M,,"Patient received Flucelvax Quad 2019/20 injection on 9/28/2019  and reports that he had pain on the next day radiating from injection site  up to neck and shoulder blade and down to fingers ""nerve"" like pain in fingers. Pain reported as 9 out of 10 scale per patient.  On 10/5/2019 patient came into pharmacy to report adverse reaction has pain currently 7 out of 10 scale per patient. Patient wanted to see a doctor and was advised that pharmacy would follow up with him on Monday 10/7/19",,,,,,,,,N,09/28/2019,09/29/2019,1,,PHM,,,,,,,2,10/05/2019,,Y,,
0838505,10/05/2019,PA,80.0,80,,F,,"Patient called and reported an 8 out of 10 pain scale that night and she was sick in her stomach, no sense of tingling at all but when asked where the vaccine was administered she measured three fingers from her the top of her shoulder and stated the immunization was given much higher than that. This event is likely due to the administration of the vaccine however it is not possible to tell for sure. The patients physicians office was notified and the patient was instructed to contact her doctor as well for follow up to ensure no permanent lasting injury was sustained. She stated the day of reporting that the pain was at 4-5 and had subsided tremendously.",,,,,,,,,U,09/15/2019,09/15/2019,0,None to report at this time.,PHM,,"Pradaxa 150mg, simvastatin 20mg, potassium er 10meq, losartan 100mg, diltiazem er(cd) 360mg) sotalol 120mg, combivent 20-100mcg respimat, furosemide 20mg to the best of my knowledge",no other acute illness at time of immunization based on questionaire,"hyperlipidemia, hypertension, edema, cardiac condition likely afib, COPD possibly based on drug therapy",,,2,10/05/2019,,,,none known
0838506,10/05/2019,NY,74.0,74,,M,,Patient came in two days after vaccine to report erythema and tenderness spreading down arm from injection site/,,,,,,,,,U,10/03/2019,10/03/2019,0,Went to urgent care 10/5,PHM,,N/A,,,,,2,10/05/2019,,Y,,beta-blockers
0838507,10/05/2019,IL,67.0,67,,F,,"Big red rash beneath the injection site. Started experiencing symptoms late Monday and progressed into late Tuesday, October 1st, 2019.",,,,,,,,,U,09/30/2019,09/30/2019,0,,PHM,,"FluBlok (administered same day, opposite arm), Atorvastatin 1 tablet daily",N/A,N/A,,,2,10/05/2019,,,,diphtheria toxoid-containing vaccines
0838508,10/05/2019,MN,38.0,38,,F,,"Swollen arm, red and very sore to touch and with movement on the right arm injection site. I had fever that afternoon, night and next day of 100-102 degree F. Went to ER on 10/04/19 and diagnosed with sepsis. Went to ICU, then critical care, now on 10/05/2019 I went to general care. Edema found with MRI on right arm.",,,Y,,Y,2,,,N,10/02/2019,10/02/2019,0,"MRI, chest X-ray, Epi  (2 doses), steroids, multiple antibiotics, lots of fluids, inhaler, albuterol, high prolactocin, high white blood count, edema on right arm, picc line, very low blood pressure 80/50. All of this on 10/04/2019-10/05/2019",PHM,,Lamictal Seroquel Vitamin D Multi vitamin Probiotic Prebiotic,Tonsillitis a few weeks before,Bipolar,,,2,10/05/2019,,,Y,None
0838509,10/05/2019,NY,69.0,69,,F,,"Starting about 15 hrs after receiving Shingrix awakened with shaking chills. Soon after started hyperventilating and heart racing. I thought it might be from injection (retired nurse), so I did relaxation breathing and within 20 minutes or so my breathing started to relax as well as sense of heart racing. Chills continued for about 1 hr 30 min. Eventually fell asleep then awakened with headache and nausea. The headache and nausea contnued until this morning -about 18 hours after start of event.",,,,,,,,,Y,10/03/2019,10/04/2019,1,None,PHM,,"Synthroid, Prilosec, Crestor, Baby ASA, Probiotic",None,Elevated cholesterol Mitral Valve Prolapse Hypothyroid Hiatal hernia Barretts esophagus,,,2,10/05/2019,,,,NKA
0838510,10/05/2019,FL,66.0,66,,F,,"Patient states she was not able to sleep night of vaccination, felt like knife sticking in her arm. She states she had a low grade fever, headache, no energy and nauseous. Patient states she had pain on her right side from her neck to her waist.",,,,,,,,,U,10/03/2019,10/03/2019,0,none,PHM,,Tekmisartan 40mg,,Hypertension,,,2,10/05/2019,,,,nkda
0838511,10/05/2019,MN,66.0,66,,F,,Severe vomiting and diarrhea started at 1:45pm (about 3 hours after the fluzone vaccine) Also severe aches and pain in joints and  chills with teeth chattering intermixed with sweats ( high fever 102 degrees.) This lasted until 7pm. Then it subsided with just extreme fatigue for the next 24 hours.,,,,,,,,,Y,10/03/2019,10/03/2019,0,"None, ** note that I have been getting the regular flu shot most of my life and I have never had an adverse reaction until getting this newer high dose flu vaccine for seniors this year",PHM,,Atorvastatin early am,None,"Lung cancer, no treatment since Feb 2018",,,2,10/05/2019,,,,Penicillen
0838512,10/05/2019,CA,34.0,34,,F,,"RASH DEVELOPED OVERNIGHT. FIRST ON ARM, THEN CHEST AND BOTH LEGS.  ADVISED PT TO APPLY HYDROCORTISONE TO AFFECTED AREAS 2 TO 3 TIMES PER DAY  AND TAKE LORATADINE FOR PRURITIS.  PT BREASTFEEDING, SO PT  DID NOT WANT TO TAKE DIPHENHYDRAMINE.",,,,,,,,,U,10/03/2019,10/04/2019,1,NONE,PHM,,NONE,NONE,NONE,,,2,10/05/2019,,,,"EGGPLANT, ASPIRIN"
0838513,10/05/2019,NY,9.0,9,,F,,fainting;hit head on floor,,,,,,,,,,10/05/2019,10/05/2019,0,,UNK,,,,,,,2,10/05/2019,,,Y,
0838514,10/05/2019,SD,54.0,54,,M,,"Since 8 hours post shot patient experiencing: shakes, chills, fatigue, nausea, temperature of 101  Muscle pain, body aches, diapharetic.",,,,,,,,,N,10/04/2019,10/04/2019,0,None,PHM,,"Tenex, lyrica, methocarbimal, lamictal, vrylar, morphine sulfate, hydromorphone,  omeprazole, levothyroxine, movantik, temazepam,  trazadone, mirtazapine",None,Stage 4 Non Hodgkin's lymphoma. In remission for 22 months.,,,2,10/05/2019,,,,"Lasix, latuda, gabapentin"
0838515,10/05/2019,WV,68.0,68,,F,,The patient states that the arm she got her pneumonia shot in is extremely red and swollen. She states that the swelling is spreading and moving around and under her arm.,,,,,,,,,U,10/03/2019,10/04/2019,1,unknown,PHM,,unknown.. patient does not fill all meds at our pharmacy,Unknown,Unknown,,,2,10/05/2019,,,,Penicillin
0838516,10/05/2019,IL,69.0,69,,F,,"redness, warmth and inflammation in the upper arm",,,,,,,,,Y,09/30/2019,10/01/2019,1,urgent care prescribed prednisone and keflex,PHM,,"famotidine, omeprazole, ursodiol, potassium, valtrex, liothyronine, lexapro, lethothyroxine",unknown,unknown,,,2,10/05/2019,,,Y,benzonatate and sulfa drugs
0838517,10/05/2019,GA,44.0,44,,F,,Pain...especially at night and limited mobility of arm.  Patient says the pain is inside the arm,,,,,,,,,N,09/17/2019,09/17/2019,0,,PHM,,,,,,,2,10/05/2019,,,,
0838518,10/05/2019,CO,73.0,73,,F,,"Soreness, redness and swelling of right arm,  from shoulder to the elbow. On 10/5 the area was slightly red and there was some swelling near the elbow. Pt said it did not hurt, she was just concerned that there was a cellulitis. Did not appear infected, not warm to the touch and she said the swelling had gone down significantly. She stated that she wanted the pneumovax in left arm and flu in right. I have documented that we gave pneumo in right arm and flu in left so I am not very confident that the flu is the vaccine that caused the problem. I believe it was pneumovax, but patient is insisting that it was the flu shot",,,,,,,,,Y,10/02/2019,10/02/2019,0,none,PHM,,,,,,,2,10/05/2019,,,,
0838519,10/05/2019,NM,83.0,83,,M,,"Patient reports trouble breathing, dizziness and lower back pain. Patient bp checked, O2 checked and visually monitored. After aprox 10 mins Patient has was asymptomatic",,,,,,,,,Y,10/05/2019,10/05/2019,0,"BP 161/98- Patient reports elevated BP last 2 weeks, Pulse o2 within normal limits. al 10/05/2019",PHM,,none,,Lung issues chronic,,,2,10/05/2019,,,,none
0838520,10/05/2019,CA,74.0,74,,M,,"Chills, weakness, dizziness, aches in legs and arms, light headed",,,,,,,,,Y,10/03/2019,10/03/2019,0,,PHM,,none,none,none,,,2,10/05/2019,,,,none
0838521,10/05/2019,IL,86.0,86,,F,,"Patient reports that the day after Shingrix injection (injection 10/3/19, adverse event started 10/4/19) her ""left leg was useless"" and that if she ""didn't have a walker at home {she} would not have been able to move around."" The following day, 10/5/19, patient reported adverse event to pharmacy and states that at this time she is experiencing no more adverse event, and leg feels normal",,,,,,,,,Y,10/03/2019,10/04/2019,1,Flu shot received 10/1/2019 (from another source),PHM,,None known,None reported - also received flu shot 10/1/2019 (from another source/provider),None reported,,,2,10/05/2019,,,,None known
0838522,10/05/2019,FL,51.0,51,,M,,"Pain and soreness around shoulder muscle in the arm that received the Shingrix vaccine; progressively worsening full-fledged flu-like symptoms: fever of 102; chills; severe nausea; upset stomach; general malaise; entire body muscle aches; severe headache; pain around eye sockets, ears, and neck; inability to function normally.  Treatment: stayed in bed for 14 hours, took regular dosages of aspirin every 4 - 6 hours, drank water frequently.  It is currently 23 hours following the time of vaccine injection, and fever has gone down to 100; full-fledge flu-like symptoms remain.  I am convinced these side effects are the result of the Shingrix, as I have gotten a seasonal flu shot annually for over 10 years, always with little or no side effects.",,,,,,,,,N,10/04/2019,10/04/2019,0,None.,PHM,,Influenza (flu) shot taken at same time.,None.,None.,,,2,10/05/2019,,,,None.
0838523,10/05/2019,,71.0,71,,F,,"Patient reported redness, swelling, and heat at site of injection and below the site of injection (total area affected was about 6-10 inches surrounding injection site) for 3 days.",,,,,,,,,,10/05/2019,10/05/2019,0,,PHM,,,,,,,2,10/05/2019,,,,"anaprox, Bactrim, bentyl, cefadroxil, cipro, clemastine, Compazine, Demerol, donnatal, doxycycline, erythromycin, hydroxyzine, penicillin, Phenergan, reglan, sulfasalazine, terfenadine, vistaril, zithromax"
0838524,10/05/2019,WV,72.0,72,,F,,"patient said she suffered a low grade fever, sore arm, and flu like symptoms for 48 hours after receiving the vaccine.",,,,,,,,,Y,10/02/2019,10/03/2019,1,,PHM,,,,,,,2,10/05/2019,,,,
0838525,10/05/2019,IN,59.0,59,,F,,"First dose was July 2, 2019.   Had slight reaction....swollen red arm, some achiness, but able to work (though not to usual standard).   Anticipated perhaps same issue for second dose so I took one Ibuprofen within hour of receiving vaccination.     12 hours post vaccination: began low grade fever @100 degrees, severe body aches, headache, racing heart, nausea and extreme fatigue.  Took another ibuprofen. 21 hours post vaccination: above symptoms, plus balance issues, weakness and beginning vomiting.   Took another ibuprofen.  Cancelled all work and events for day.  Went back to bed and slept.   28 hours post vacc, was able to eat a little soup without vomiting.  Went back to bed and slept until 35 hours post vacc.  Got up and ate a very small plate.  Went back to bed with another ibuprofen at 36 hours post vacc.  Still slight fever.   45 hours post vacc. woke up without fever, but still achey.  Strong enough to eat more and do light work.   I usually do not have reaction to vaccinations, so was very surprised to encounter such a severe reaction.",,,,,,,,,Y,10/03/2019,10/03/2019,0,None,PVT,,none,none,"none, slight osteo-arthritis",,,2,10/05/2019,,,,none
0838526,10/05/2019,NY,72.0,72,,M,,Extreme arm pain- cannot move arm- could not sleep due to pain- cannot get himself dressed- took motrin to help the pain but over 24 hours later and still in a lot of pain,,,,,,,,,U,10/04/2019,10/04/2019,0,N/a,PHM,,None,None,None,,,2,10/05/2019,,Y,,None